SAMPLE_ID	SAMPLE_NAME	PUBCHEM_SID	PRIMARY_MOA	ASSAY_NAME	LIBRARY	CAS	ALIAS	AC50	LOG_AC50	AUC	CURVE_CLASS2	DATA_POINTS	DRUG_NAME	EFFICACY	MAX_RESPONSE	P_HILL	R2	GENE_ID	GENE_SYMBOL	SMILES	SUPPLIER	SUPPLIER_ID	DATA0	DATA1	DATA2	DATA3	DATA4	DATA5	DATA6	DATA7	DATA8	DATA9	DATA10	DATA11	DATA12	DATA13	DATA14	CONC0	CONC1	CONC2	CONC3	CONC4	CONC5	CONC6	CONC7	CONC8	CONC9	CONC10	CONC11	CONC12	CONC13	CONC14
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 			0.3722739479	4	4		0	0.73898126			846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	-0.35310734	-0.90466249	-1.10691145	0.73898126												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00018193-11	Fluvoxamine	170464809	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54739-18-3	;FLUVOXAMINE MALEATE;Fluvoxamine; Fluvoxamina;Fluvoxamine maleate; Fluvoxamine, (Z)-Isomer	12.5892541179	-4.9	30.1732068122	4	4		29.439524832	24.33359726	0.1484452355	0.9861876943	3350	HTR1A	FC(F)(F)c1ccc(cc1)C(\CCCCOC)=N\OCCN	Tocris	1033	2.42467043	-0.27835769	-0.78293736	24.33359726												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091070-02	Diisopropylamine	170466002	Pyruvate dehydrogenase kinase isoform 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	108-18-9				-3.0518126414	4	4		0	-1.16125627					CC(C)NC(C)C	Labotest	LTBB000412	-0.35310734	-1.80932498	0.1349892	-1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263541-01	Reboxetine mesylate	170465620		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	98769-84-7				-8.6722200436	4	5		0	0.390625					CS(=O)(=O)O.CCOc3ccccc3O[C@H](c1ccccc1)[C@H]2CNCCO2	Prestwick Chemical, Inc.	Prestw-1328	-2.34549516	-1.87094311	-2.42415847	-2.30624832	0.390625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160421-03	Tetrabenazine	170464675	Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-46-8	 ; Nitoman;Tetrabenazine; Tetrabenazine; Tetrabenazina; Xenazine			6.8679361054	4	5		0	-0.14907169			6571	SLC18A2	CC(C)CC2CN3CCc1cc(OC)c(OC)cc1C3CC2=O	Chemical Block	A2708/0115225	4.27308448	-0.40590406	0.49418993	-1.44121365	-0.14907169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018295-05	Isoxsuprine hydrochloride	170465968		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	579-56-6				1.3024086566	4	5		0	0.82667028					Cl.Oc1ccc(cc1)C(O)C(C)NC(C)COc2ccccc2	Prestwick Chemical, Inc.	Prestw-68	-0.88408644	6.53136531	-1.56270869	-1.64348925	0.82667028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179602-03	Testosterone propionate	170464835	Androgen Receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	57-85-2				1.2197289647	4	5		0	3.82254464				AR	CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801834	-0.18615041	-1.26002291	-0.37401302	-0.21453473	3.82254464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164543-02	Lomerizine dihydrochloride	170466010	Ca channel blocker - benzhydryl class	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	101477-54-7	 ; Terranas; Lomerizine HCl; LOMERIZINE DiHCl;Lomerizine; Lomerizine	12.5892541179	-4.9	44.9009992	3	5		48.609168108	44.61495536	0.1152614934	0.9368926675			Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC	Sequoia	SRP01568l	9.14619012	-3.29642357	-1.75924643	-2.6816841	44.61495536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164584-03	Cetraxate hydrochloride	170465783	Prostaglandin Synthesis and Regulation Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	27724-96-5				-6.4932262905	4	5		0	0.44642857					Cl.NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2	Sequoia	SRP02040c	-1.62571358	-1.89639812	-0.95581105	-2.60123357	0.44642857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018172-09	Indapamide	170465366	Carbonic Anhydrase Type VII Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	26807-65-8	; Veroxil;Indapamide; Indapamida; Lozol;INDAPAMIDE; Natrix; Indapamide Anhydride			-5.5151827639	4	5		0	-2.04634774			766	CA7	NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C	Microsource	01500349	-0.88408644	-0.18450184	-0.92159744	-2.25031606	-2.04634774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015074-14	Acetazolamide	170464692	Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59-66-5				-8.7130618787	4	5		0	-2.23607535					O=S(N)(=O)c1nnc(NC(C)=O)s1	Specs	AN-153/I110543	-2.21021611	-1.46371464	-2.41752371	-0.32869785	-2.23607535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022819-04	Ipratropium bromide		Muscarinic Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	66985-17-9	; Berodual; Atrovent; Bronchodual;Ipratropium bromide; fenoterol-ipratropium IK6; Duovent; Bromuro de ipratropio; Ipratroprium bromide; Iprafen			-6.1711708781	4	5		0	0.39300718					CC(C)[N+]1(C)[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	SIGMA	I1637	-2.06286837	0.33210332	-2.81821824	-1.28950695	0.39300718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015277-17	Cinoxacin	170465414	Topoisomerase IV Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	28657-80-9				-1.3037670603	4	5		0	2.0192438					O=C(O)C2=NN(CC)c1cc3OCOc3cc1C2=O	Microsource	01500190	-1.59626719	0.89790898	-0.78803259	0.1011378	2.0192438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091320-05	Decanoic acid	225144209	Peroxisome proliferator-activated receptor gamma Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	334-48-5				-10.2210542395	4	5		0	-4.296875			5468	PPARG	CCCCCCCCCC(O)=O	SIGMA	D1653	-2.76743609	-2.17640321	-1.23285774	0.72405471	-4.296875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017020-06	NCGC00017020-06			SARS-CoV-2_CPE_SRI	2019_NPC-2.2					0.7784149752	4	5		0	-2.51116071					CCCC1=NC=C(C[N+]2=C(C)C=CC=C2)C(N)=N1	Vitas	STL018669	3.98361876	-4.79826906	-1.73154176	-0.24135157	-2.51116071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015661-12	Molsidomine	170465872		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	25717-80-0				-6.1729507327	4	5		0	-1.47879464					O=C(OCC)[N-]c1c[n+](no1)N2CCOCC2	Microsource	01500673	-2.49441549	2.02367316	-0.42942236	-2.2257978	-1.47879464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249925-01	Tilmacoxib	170466033	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	180200-68-4				-10.9497527671	4	5		0	-1.12481366					Cc2nc(C1CCCCC1)c(o2)c3ccc(c(F)c3)S(N)(=O)=O	GVK	FFS-11-286-NCI-214	-2.84872299	-1.16851169	-2.52437558	-3.21112516	-1.12481366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016697-04	Trimetazidine dihydrochloride	170465797	"Trifunctional enzyme subunit beta, mitochondrial Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	13171-25-0				-3.6399413887	4	5		0	-1.04350183			3032	HADHB	Cl.Cl.COc2ccc(CN1CCNCC1)c(OC)c2OC	Vitas	STK315643	-3.33988212	4.31734317	-1.69627354	2.14917826	-1.04350183											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344528-01	TRYPAN BLUE	225144379		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72-57-1				-7.0866302407	4	5		0	-0.16741071					CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(C=C(C=C4N)[S]([O-])(=O)=O)C=C3[S]([O-])(=O)=O)C)N=NC5=C(O)C6=C(C=C(C=C6N)[S]([O-])(=O)=O)C=C5[S]([O-])(=O)=O	SIGMA	302643	-2.74261603	0.70001273	-2.20252112	-1.179941	-0.16741071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023230-10	Noscapine	170465539	Tubulin polymerization inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	128-62-1		0.0707945784	-7.15	16.1507968329	4	5		-10.7996781919	-1.11607143	0.2507596466	0.8467896505		TUBB	COc3c5OCOc5cc4CCN(C)[C@@H]([C@H]2OC(=O)c1c(OC)c(ccc12)OC)c34	Vitas	STK054401	8.69942914	1.20911289	2.34104447	-2.33306516	-1.11607143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160615-03	Sucrose octaacetate	170465525		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	126-14-7				-8.2495005125	4	5		0	-1.92522321					CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O	SIGMA	252603	-3.0900968	0.36909762	-3.22759385	1.31402521	-1.92522321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090957-05	Octanoic acid		Solute carrier family 22 member 8 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	124-07-2				-3.5613152979	4	5		0	-1.89732143					CCCCCCCC(O)=O	SIGMA	C2875	0.48399106	-3.3727886	0.87269705	-1.85036203	-1.89732143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167473-02	Capreomycin IB	174006669		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33490-33-4				11.9757772921	4	5		0	2.66973845					NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2	Bosche	C2304	-1.32612967	0.18450184	6.15733939	0.9608091	2.66973845											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00159451-06	Tinoridine	170465864	lipid oxidation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	24237-54-5				-0.8375841052	4	5		0	-0.25748746					O=C(OCC)c1c2CCN(Cc2sc1N)Cc3ccccc3	Vitas	STK036143	-0.19646365	-0.7503075	1.08187525	-0.73324905	-0.25748746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015095-15	Amitriptyline hydrochloride	170464758	Sodium-dependent serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	549-18-8				-3.6228429266	4	5		0	5.21750915			6532	SLC6A4	Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12	Microsource	01500117	-2.01375246	-0.799508	-3.40590357	-1.2136536	5.21750915											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017323-08	Tetracycline hydrochloride	170464838	30S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64-75-5	 Achromycin;; Tetraciclina; Tetracycline Hcl; Bristacycline; Tetrabid; Hostacyclin; Contramibial; Sustamycin;Tetracycline hydrochloride; Tetracycline hydrate; Ulcrux powder;Tetracycline;TETRACYCLINE HYDROCHLORIDE; Achromycin V; 4 Epitetracyclin; 4-Epitetracycline; Topicycline			4.0095042366	4	5		0	3.83520802				PADI1	Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O	Microsource	01500566	0.04911591	2.0295203	-1.53599573	1.011378	3.83520802											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183020-01	Minopafant	144206826	Platelet activating factor receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	128420-61-1	Menopafant; Minopafant; 			-6.6381754279	4	5	E-5880;E 5880;1-ethyl-2-(N-(2-methoxy)benzoyl-N-(2-methoxy-3-(4-octadecylcarbamoyloxy)piperidinocarbonyloxypropyloxy)carbonyl)aminomethylpyridinium chloride;MENOPAFANT;CIPLUS_707454;Minopafant;Menopafant;minopafantum;	0	-3.53706464					[Cl-].COc1ccccc1C(=O)N(Cc2cccc[n+]2CC)C(=O)OC[C@@H](COC(=O)N3CCC(CC3)OC(=O)NCCCCCCCCCCCCCCCCCC)OC	Pharmaron	PH-NIH-150353	-1.69449902	3.2103321	-0.78803259	-3.64096081	-3.53706464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183010-01	Pelubiprofen	144206823	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	69956-77-0	PELUBIPROFEN; 			-0.7150552312	4	5	2-OCMPP;BENZENEACETIC ACID, .ALPHA.-METHYL-4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)-;2-(4-((2-oxocyclohexylidene)methyl)phenyl)propionic acid;PELUBIPROFEN;CIPLUS_706216;Pelubiprofen;pelubiprofene;LS-176792;2-(4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)PHENYL)PROPANOIC ACID;(+/-)-P-(((E)-2-OXOCYCLOHEXYLIDENE)METHYL)HYDRATROPIC ACID;CS-670;pelubiprofenum;CS 670;	0	2.18186746			5743	PTGS2	O=C(O)C(C)c1ccc(cc1)\C=C2/CCCCC2=O	Pharmaron	PH-NIH-149772	-1.62082515	0.18450184	-0.68118071	1.44121365	2.18186746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159391-03	Sulfobromophthalein	170465816	Solute carrier organic anion transporter family member 1B1 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	71-67-0				-7.6659783469	4	5		0	1.13128492					[Na+].[Na+].[O-]S(=O)(=O)c1cc(ccc1O)C3(OC(=O)c2c(Br)c(Br)c(Br)c(Br)c23)c4ccc(O)c(c4)S([O-])(=O)=O	Labotest	LT03378988	-3.69525547	-1.05839871	-2.33239712	1.0184781	1.13128492											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160620-02	L-Methionine	225144244	S-adenosylmethionine synthetase (MAT 1 and MAT 2) Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63-68-3				0.9762093902	4	5		0	-0.54469274					CSCC[C@H](N)C(O)=O	SIGMA	64320	-0.38017032	-1.88021417	4.67700574	0.26189437	-0.54469274											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016959-06	Ciprofloxacin	170464757	DNA Topoisomerase IV Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	93107-08-5	 ;CIPROFLOXACIN; Bay0986; Ciprofloxacin hydrochloride; Bay 0986; Cipro IV;Ciprofloxacin; Ciprobay; Cipro; Ciprofloxacino; Ciprofloxacin Lactate; Ciprofloxacin Hcl; Ciprinol; Ciloxan;Ciprofloxacin hydrochloride; Bay-09867; Ciprofloxacin Base			-3.6806625243	4	5		0	-2.33240223			7155	TOP2B	Cl.O=C(O)C2=CN(c1cc(c(F)cc1C2=O)N3CCNCC3)C4CC4	Vitas	STK021082	0.10644769	-2.95106462	1.5264379	-1.62956496	-2.33240223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166088-02	Decitabine	170465126	DNA Methyltransferase (DNMT) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2353-33-5	 ;5-Aza-2 -deoxycytidine; Dacogen; 5-Aza-2??-deoxycytidine;Decitabine; Decitabine			-6.6973806942	4	5		0	-3.95251397			1786	DNMT1	NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Tocris	2624	-0.16727494	-0.93388121	-1.79509098	-2.18245308	-3.95251397											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344532-01	Mucic acid	170464883		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	526-99-8				5.3585865992	4	5		0	-2.66759777					O[C@@H]([C@H](O)[C@H](O)[C@@H](O)C(=O)O)C(=O)O	SIGMA	M89617	1.84002433	3.37442411	-0.03663451	2.29885057	-2.66759777											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015479-19	Genistein	170466848	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein			-1.016200434	4	5		0	-2.80525817			7153	TOP2A	Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O	Vitas	STK801619	1.03143418	0.4305043	-1.24215307	-0.37926675	-2.80525817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016490-12	Flufenamic acid	170465857	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	530-78-9		0.0446683592	-7.35	11.2862763189	4	5		9.299607068	10.01490717	0.629037616	0.3629185373			FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O	Vitas	STK985630	-2.33300589	10.04920049	0.92159744	0.6573957	10.01490717											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094818-09	Hexestrol	170466031	17-betahydroxysteroid dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	84-16-2	; ; Hexoestrolum; Hexestrol, (R*,S*)-Isomer;Hexestrol; Dihydrodiethylstilbestrol;meso-Hexestrol;HEXESTROL; HEXESTROL			-0.0922382341	4	5		0	-0.34916201			1645	AKR1C1	Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2	Microsource	01500632	-1.50547445	0.85917071	0.52509464	2.85173869	-0.34916201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167522-02	Hexoprenaline sulfate	170465755	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	32266-10-7				13.157176853	4	5		0	0.04189944					Oc1ccc(cc1O)C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2.O=S(=O)(O)O	Sequoia	SRP01560h	4.39476886	0.90897771	4.57931371	1.62956496	0.04189944											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249901-01	Thiocyanoacetic acid sodium salt	170465517		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63906-52-5				2.2175908522	4	5		0	4.12011173					[Na+].[O-]C(=O)CSC#N	GVK	FFS-11-286-NCI-92	-1.4446472	-1.40704769	2.55220418	1.45496872	4.12011173											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183829-01	Minodronic acid	144206806	Geranylgeranyl pyrophosphate synthetase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	180064-38-4				6.2569299299	4	5	Minodronic Acid;MINODRONIC ACID;acidum minodronicum;CIPLUS_707422;acide minodronique;YM 529;Minodronic Acid Hydrate;	0	1.96927374					O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O	Pharmaron	PH-NIH-115451	-3.05656934	0.28639024	2.91854927	-0.46558999	1.96927374											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00181028-02	D-Pantethine	225144316	HMG-CoA reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	16816-67-4				-5.498513659	4	5		0	-2.3603352					CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	SIGMA	P2125	-1.29257908	-1.0833022	-2.43008914	1.60046559	-2.3603352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091345-04	Hexanedioic acid	170465352		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	124-04-9				-2.7464516795	4	5		0	0.98929394					OC(=O)CCCCC(=O)O	Specs	AE-562/J262759	-2.35756385	0.87330873	-0.41405102	0.8091024	0.98929394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159450-04	Parethoxycaine	170465538		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-23-5		15.8489319246	-4.8	1.3974588658	4	5		-8.2122905039	-4.34357542	0.5251213099	0.55608271			CCOc1ccc(cc1)C(=O)OCCN(CC)CC	Specs	AO-365/40892107	-1.23175182	1.30743369	2.55220418	6.05266987	-4.34357542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159478-04	Benzoxiquine	170465534		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	86-75-9				-9.2571277742	4	5		0	-2.66759777					O=C(Oc1cccc2cccnc12)c3ccccc3	Specs	AE-848/01460057	-3.7256691	0.28639024	-1.25778483	0.46558999	-2.66759777											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016610-07	Tolnaftate	170465508	Fungal Squalene Monooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2398-96-1	; ; Separin;TOLNAFTATE; Tolnafrate;Tolnaftate; Tolnaftate; Tolnaftato; Tinactin			-3.9612031137	4	5		0	-2.5					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3ccccc3c2	Prestwick Chemical, Inc.	Prestw-70	-3.26946472	-0.88407421	2.86970326	3.69562054	-2.5											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091400-02	Allylthiourea	170465680		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	109-57-9				11.0626315104	4	5		0	3.0762976					NC(=S)NCC=C	Labotest	LT00025093	1.96463654	1.04551046	5.59636704	0.68268015	3.0762976											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182990-01	Tandospirone	144206869	Serotonin 1a (5-HT1a) receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	87760-53-0	Tandospirone citrate; Sediel; 			-1.4384163466	4	5	LS-178008;TANDOSPIRONE;Sediel;CIPLUS_196843;CIPLUS_667992;TANDOSPIRONE CITRATE;tandospirone;Tandospirone;tandospironum;SM-3997;sm 3997;(3A-A,4B,7B,7A-A)-HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-BUTYL)-4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE DIHYDROGEN CITRATE;SM 3997;Tandospirone citrate;LS-90979;4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione;	0	-0.87988827					O=C4N(CCCCN1CCN(CC1)c2ncccn2)C(=O)[C@@H]5[C@H]3CC[C@H](C3)[C@H]45	Pharmaron	PH-NIH-172250	-0.74513382	-0.90897771	-0.50067163	2.2697512	-0.87988827											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016602-04	Benperidol	170466409	Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2062-84-2				-12.3932428311	4	5		0	-4.59497207					Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=O	Prestwick Chemical, Inc.	Prestw-484	-3.54318735	-1.68098618	-0.13432654	-1.60046559	-4.59497207											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014711-14	Oxaprozin	170464987	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	21256-18-8				-7.6835612947	4	5		0	-0.83705357					OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3	Microsource	01505267	-1.70017374	-3.24551355	1.01122039	-3.35210512	-0.83705357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	7.9432823472	-5.1	60.2329266644	2.2	5		82.3080132762	64.20200893	0.0055761525	0.9972011169			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-2.89153636	1.13274787	3.11677518	20.9439528	64.20200893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159513-03	Cefprozil	225144231	Cephalosporin antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	92665-29-7	 ;Cefprozil hydrate; Cefprozilo; Cefprozil monohydrate;CEFPROZIL; cis-Cefprozil			0.2237210291	4	5		0	-0.08370536					C/C=C/C1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O	Selleck	S2544 	-2.29585505	8.03105511	-1.73154176	-0.75087155	-0.08370536											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016605-08	Nifenazone	170466050		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2139-47-1				-6.657434135	4	5		0	-2.06473214					O=C3C(NC(=O)c1cccnc1)=C(C)N(C)N3c2ccccc2	Microsource	01503230	-2.24621494	0.70001273	-2.67350048	0.61678734	-2.06473214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	12.5892541179	-4.9	47.5710673774	3	5		76.4876401783	65.68435754	0.0003081229	0.9998459472	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-0.77554745	-0.75955672	0.08548052	0.55288811	65.68435754											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021193-03	AMCINONIDE			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51022-69-6				-1.252772701	4	5		0	-1.57821229					CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]4[C@@H]5CCC/6=C/C(=O)/C=C\[C@]6(C)[C@@]5(F)[C@@H](O)C[C@]24C	FLUKA	A2428	-0.01520681	2.42809115	-1.64855294	-0.84388186	-1.57821229											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182997-01	Melinamide	144206837	Acyl coenzyme A:cholesterol acyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	14417-88-0	Melinamide; Artes; Melinamida; 			-2.0223186187	4	4	MELINAMIDE;LS-173854;N-(2-methylbenzyl)linoleamide;(z,z)-n-(1-phenylethyl)-9,12-octadecadienamide;melinamide;melinamidum;CIPLUS_214142;Artes;Melinamidum;LS-88004;Melinamida;N-(2-methylbenzyl)linoleamide, (S-(Z,Z))-isomer;Melinamide;	0	-0.94012865					CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)c1ccccc1	Pharmaron	PH-NIH-152054	-0.67665539	-0.86334484	0.82723513	-0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021575-05	Fluorometholone	170464629	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	426-13-1				0.7534143517	4	4		0	1.26682502					CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-718	-0.35310734	-0.90466249	0.62095032	1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016611-10	Bufexamac	170465813	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2438-72-4	; ; 7   Bufexamac; Anderm; Droxarol; Bufexamaco;BUFEXAMAC; Bufexamac;Bufexamac			-1.363329284	4	4		0	-1.16125627				PTGS1	ONC(=O)Cc1ccc(OCCCC)cc1	Microsource	01502003	-0.02354049	-0.83507307	0.51295896	-1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015964-17	Spiperone	170465856	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	749-02-0		12.5892541179	-4.9	89.6513818338	3	4		107.0104070262	83.24096068	0.0418946062	0.9989159734			Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3	Enzo	AC807	-1.34180791	1.8789144	-0.45896328	83.24096068												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018143-05	Enrofloxacin	170465572	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	93106-60-6				1.1151837457	4	4		0	-0.95588235					CCN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4	Vitas	STK711109	0.93245968	-0.25740026	-0.53161724	-0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015563-13	Imipramine	170464777	Serum paraoxonase/arylesterase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-49-7		8.9125093813	-5.05	101.1109299887	3	4		114.5890840457	94.94869771	0.004252457	0.9999888467	5444	PON1	CN(C)CCCN2c3ccccc3CCc1ccccc12	Enzo	AC813	-1.01694915	-1.00376412	-0.43070687	94.94869771												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182552-02	Atazanavir	170465290	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	198904-31-3	 ;ATAZANAVIR SULFATE; Atazanavir;Atazanavir sulfate; Reyataz			9.7849215065	4	4		0	3.44646146					CC(C)(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc2ccc(cc2)c3ccccn3	Sequoia	229975-97-7	2.08232446	1.35508156	1.14010641	3.44646146												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016367-08	Succinylsulfathiazole	170465721		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	116-43-8				-2.0226400159	4	4		0	1.02604578					O=S(=O)(Nc1nccs1)c2ccc(NC(=O)CCC(=O)O)cc2	Vitas	STK079059	-1.0653753	-0.80301129	-0.58272105	1.02604578												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178395-04	Piperidolate hydrochloride	170465927		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	129-77-1				-0.8545861628	4	4		0	0.18416206					Cl.CCN3CCCC(OC(=O)C(c1ccccc1)c2ccccc2)C3	Prestwick Chemical, Inc.	Prestw-1055	0.43583535	-0.50188206	-1.44413479	0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179295-03	Meptazinol hydrochloride	170466363	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59263-76-2				-1.6236822823	4	4		0	-0.04948046					Cl.CN1CCCCC(CC)(C1)c2cccc(O)c2	Prestwick Chemical, Inc.	Prestw-1004	-0.04833253	-1.25801677	-0.57270124	-0.04948046												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094819-07	Hexetidine	170465729		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	141-94-6		3.5481338923	-5.45	98.1189741954	3	4		90.4443316752	89.31222167	0.0068336597	0.9999711974			CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1	Microsource	01500633	-0.24166264	-0.76467686	1.08176901	89.31222167												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00390559-05	Azilsartan Medoxomil		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	863031-21-4				-1.1981943217	4	4		0	-0.14326648			185	AGTR1	CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)O[N-]5)C(=O)OC\C6=C(/C)OC(=O)O6	APExBIO	B2218	-0.56206089	1.79780528	-1.30541202	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168778-06	Solifenacin (hydrochloride)		Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	180468-39-7				0.1614280605	4	4		0	4.20248329					O=C(O[C@H]1CN2CCC1CC2)N3CCC4=C(C=CC=C4)[C@@H]3C5=CC=CC=C5	MedChem Express	HY-I0230	-1.07728337	-0.49031053	0.1631765	4.20248329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263831-02	NYSTATIN		Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	114-90-9				-1.4049859741	4	4		0	0.33428844					C[C@@H]1OC(=O)CC(O)CC(O)CC(O)CCC(O)C(O)C[C@]2(O)CC(O)C(C(CC(OC3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H]1C)O2)C(O)=O	Microsource	01500446	-1.31147541	-0.35022181	2.77400054	0.33428844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091010-03	Domiphen bromide	170465494	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	538-71-6				-3.1008414258	4	4		0	-2.81862745					[Br-].CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	Labotest	LT00847867	-0.73084677	2.05920206	-0.81141578	-2.81862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 			-7.5988592564	4	5		0	-2.24860335			846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	2.47871046	-1.70588968	-1.01355477	-0.55288811	-2.24860335											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00022019-03	Clobetasone butyrate	170465575	corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	25122-57-0				3.0319140501	4	5		0	2.84598214					ClCC(=O)[C@@]3(OC(=O)CCC)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)C(=O)C[C@@]23C	SIGMA	C5548	-0.63291139	5.30736922	0.40171769	-2.73531778	2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018277-06	Mebeverine hydrochloride	170466168		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2753-45-9				-6.6553959641	4	5		0	4.24107143					Cl.COc1cc(ccc1OC)C(=O)OCCCCN(CC)C(C)Cc2ccc(OC)cc2	Microsource	01501117	-2.44477538	-4.13643884	-2.11940712	-1.31402521	4.24107143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181912-01	Iomazenil	144206800	GABAergic synapse Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	127985-21-1				-1.3093493824	4	5	IOMAZENIL (123I);iomazenilum (123I);iomazenil (123 I);Ro 16-0154;Iomazenil(123I);Ro-16-0154;IOMAZENIL (123 I);CIPLUS_208012;Iomazenil (123I);Benzodine;ethyl 7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;iomazenil;Iomazenil ((sup 123)I);(123I)iomazenil;	0	0.9765625					O=C(OCC)c3ncn2c3CN(C)C(=O)c1c(I)cccc12	Pharmaron	PH-NIH-10	-0.28543063	-3.60188367	-1.45449508	2.89621883	0.9765625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179034-07	Pentamidine isethionate	170464786	PRL Phosphatase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	140-64-7	 cis-Pt(II) pentamidine; Pentamidin; Pt-pentamidine complex; platinum(II) pentamidine;4,4 -(Pentane-1,5-diylbis(oxy))dibenzimidamide; Pentam 300; Pt-pent; cis-Pt pentamidine iodide;Pentamidine isethionate;			-5.5024637358	4	5		0	-3.33798883				PTP4A1	OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N	Prestwick Chemical, Inc.	Prestw-553	-1.62712895	-1.80550367	2.57662718	-0.75658373	-3.33798883											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015822-15	Pyrilamine	170464656	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	91-84-9				-2.3874086047	4	5		0	-3.42178771					COc1ccc(cc1)CN(CCN(C)C)c2ccccn2	Enzo	AC277	-0.28892944	2.25376665	0.03663451	-1.28037247	-3.42178771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022248-04	Hydrocortisone 21-hemisuccinate sodium salt	170465053		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	125-04-2				-6.53412697	4	5		0	-0.12569832					[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Sequoia	125-04-2	-4.18187348	0.70974972	0.18317255	0.98937873	-0.12569832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013095-10	Geraniol	170465692	Trichomonas vaginalis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	106-24-1				-3.6689312609	4	5		0	-1.3671875					C\C(C)=C\CCC(\C)=C\CO	Microsource	01501132	0.33507074	-2.1509482	-2.23022579	-0.29498525	-1.3671875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00180889-03	Flunixin meglumine	170466598	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	42461-84-7		1.77827941	-5.75	18.5091924385	4	5		10.540656604	8.28683036	0.2970799756	0.8084165288	791253	PTGS2	CNC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.FC(F)(F)c2cccc(Nc1ncccc1C(=O)O)c2C	Microsource	01505113	3.31347729	-0.85274278	-2.95054717	12.6307321	8.28683036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094810-04	Warfarin sodium	170464790	Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2610-86-8	 ; Coumafene;WARFARIN; (S)-(-)-Warfarin;Warfarin; Warfarin; WARFARIN;Potassium warfarin; (R)-(+)-Warfarin; Warfarina; Warfarin Sodium Clathrate; actosin P; Coumadin; Athrombin-K;(?)-Warfarin			5.8617625455	4	5		0	4.87430168			79001	VKORC1	[K+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3	Labotest	LT00771738	2.84367397	-4.07172208	1.18451581	-1.48406809	4.87430168											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167525-02	Tazarotene	170464671	Retinoid RAR Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	118292-40-3	 ; Tazarotene;Tazarotene; Zorac; Tazorac;Tazarotene (Avage)	6.3095734448	-5.2	24.7365604806	4	5		19.5	19.14804469	0.0181502997	0.9908387751	5915	RARB	O=C(OCC)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2	Sequoia	SRP01178t	1.41423358	2.60241564	0.96470876	7.59493671	19.14804469											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00510749-15	Loracarbef		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	121961-22-6				-1.3957492996	4	4		0	0.51470588					N[C@@H](C(=O)N[C@H]1[C@H]2CCC(=C(N2C1=O)/C(O)=O)/Cl)C3=CC=CC=C3	USP	1370203	-1.03326613	1.64736165	-0.41969782	0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013095-10	Geraniol	170465692	Trichomonas vaginalis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	106-24-1				-0.4860905255	4	4		0	-0.86819258					C\C(C)=C\CCC(\C)=C\CO	Microsource	01501132	-0.1937046	-0.30112923	0.98809222	-0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00168759-05	PTC-124	170466862	CFTR-G542X nonsense allele Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	775304-57-9	Ataluren;PTC124			-0.5913299053	4	4		0	-0.79168728			1080	CFTR	O=C(O)c1cccc(c1)c2nc(on2)c3ccccc3F	Selleck	S6003	0.38666022	-1.01134682	0.25453388	-0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253613-01	Anileridine	170465266		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	144-14-9				1.9139571812	4	4		0	3.19961796					O=C(OCC)C2(CCN(CCc1ccc(N)cc1)CC2)c3ccccc3	GVK	FFS-11-286-NCI-043	-0.18735363	0.81718422	-0.81588251	3.19961796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346566-09	Roflumilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	162401-32-3				-1.8512650808	4	4		0	-0.38204394				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	SIGMA	SML1099	-0.28103044	-0.72379173	-0.48952951	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016957-05	Aceclofenac	170465979	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	89796-99-6				8.7128327534	4	4		0	1.20098039					Clc2cccc(Cl)c2Nc1ccccc1CC(=O)OCC(=O)O	Vitas	STK594349	1.83971774	3.08880309	1.37101287	1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274074-01	2-(Dodecyloxy)ethanol	170466587		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	4536-30-5				-2.9286080149	4	4		0	-0.90686274					OCCOCCCCCCCCCCCC	SIGMA	03819	-0.02520161	-1.02960103	-2.09848909	-0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016347-07	Benzthiazide	170465246	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	91-33-8				-0.6528367448	4	4		0	0.49986846					NS(=O)(=O)c3cc1c(N=C(NS1(=O)=O)CSCc2ccccc2)cc3Cl	Microsource	01500141	-0.8716707	0.10037641	0.32936407	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159469-04	Methoxyphenamine	170465530	Adrenergic receptor beta Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	93-30-1				2.7544614603	4	4		0	-0.9896091					COc1ccccc1CC(C)NC	ASDI	500012445	1.54664089	0.91267884	0.31816736	-0.9896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016634-04	Acetopromazine maleate	170465731		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3598-37-6		1.5848931925	-5.8	18.2687315754	4	4		18.8912185479	18.20880752	0.0507009648	0.9984169373			O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Prestwick Chemical, Inc.	Prestw-576	-0.33832769	-1.15934879	-0.25453388	18.20880752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093560-05	Finasteride	170464818	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	98319-26-7	; ; Propecia; Proscar; Finasterida;Finasteride; Finasteride			-1.2460893111	4	4		0	-1.4349332			374	AR	CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C	Prestwick Chemical, Inc.	Prestw-717	-0.04833253	0.024667	0.38180083	-1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016973-06	Letrozole	225144183	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	112809-51-5	 Letrozole; F??mara;Letrozole; ;Femara; Femara;CGS-20267;FEM-345?			-0.6063406468	4	4		0	0.94012865			1588	CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Prestwick	Prestw-1025	-0.62832286	-0.96201283	0.19090041	0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015216-17	Chlorpropamide	170464898	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	94-20-2				0.4868284397	4	4		0	0.14844137					O=S(=O)(NC(=O)NCCC)c1ccc(Cl)cc1	Microsource	01500185	-0.48332528	0.12333498	1.08176901	0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016505-06	PROPOXYCAINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	550-83-4				-2.4282283878	4	4		0	0.19102197					CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC	Microsource	01505572	-0.56206089	-0.53700677	-1.08784335	0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160471-02	Crocin?		Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	42553-65-1				6.4518760311	4	4		0	3.43839542					CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)\C=C\C=C(/C)C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O	DC Chemicals	DCZ-122	0.6557377	2.12467896	1.03345118	3.43839542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346587-16	Bergenin monohydrate			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	477-90-7				-1.5719936301	4	4		0	1.10294118					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	-0.78125	1.13256113	-1.70677112	1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388506-02	Pinaverium bromide			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	53251-94-8				3.4665035464	4	4		0	-1.59313725					COC1=C(OC)C=C(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)C(=C1)Br	Prestwick	Prestw-1601	1.94052419	0.72072072	-1.14717403	-1.59313725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185747-02	Niceritrol	170465789	Hydroxycarboxylic acid receptor 2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	5868-05-3				1.2119992233	4	4		0	1.83823529					O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c2cccnc2)COC(=O)c3cccnc3)c4cccnc4	Kemprotec	5868-05-3	-0.37802419	0.61776062	0.53161724	1.83823529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160504-01	Testosterone 17-phenylpropionate	144206667		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1255-49-8	testosterone 17-phenylpropionate; Retandrol; Mixogen; 			-0.0227981123	4	4	TESTOSTERONE PHENYL PROPIONATE;CIPLUS_3882657;testosterone phenylpropionate;Retandrol;Testosterone Phenylpropionate;CIPLUS_157987;Testosterone 17-phenylpropionate;testosterone 17-phenylpropionate;estandron prolongatum;4-Androsten-17beta-ol-3-one 17-phenylpropionate;Testosterone phenylpropionate;Mixogen;Testosterone hydrocinnamate;	0	0.36764706					O=C5CC[C@@]4(C)C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	InterBioScreen	STOCK1N-42343	-0.88205645	2.26512227	0.53161724	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159354-06	BORNYL ACETATE			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	76-49-3				2.5950172888	4	4		0	2.27941176					CC(=O)OC1CC2CCC1(C)C2(C)C	Microsource	01502510	0.9828629	-0.72072072	-1.59485171	2.27941176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015383-07	NCGC00015383-07			DPI_SARS-CoV-2_General	2019_NPC-5_CPE					4.3678443646	4	4		0	3.30882353					OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O	BIOMOL	S-110	-1.78931452	1.44144144	7.80637941	3.30882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181773-05	Parecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	198470-84-7				-0.7356438913	4	4		0	1.78921569					CCC(=O)N[S+]([O-])(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3	MedChem Express	HY-17474	-0.27721774	-1.02960103	-0.9233352	1.78921569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091066-01	3-Methylbutyl nitrite	144204625	vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	110-46-3	Isoamyl nitrite			-3.7704690139	4	4	Vaporole;CIPLUS_151172;Isopentyl nitrite-15N;Amyl nitrite;Nitrite, Amy;Amyl Nitrite;Amyl nitrite II;AMYL NITRITE;Isoamyl nitrite;LS-505;Isoamyl nitrite-15N;Isopentyl alcohol, nitrite;Amyl nitrite I;CIPLUS_167285;Isopentyl nitrite;isoamyl nitrite;Aspiral;isopentyl nitrite;AB07944735-01;	0	-1.15196078					CC(C)CCON=O	NIEHS	AB07944735	-0.78125	-0.72072072	-0.58757694	-1.15196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181012-01	Cefuzonam hydrochloride	144206215	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	NOCAS_46800	Cefuzonam; Cefozopran; 			-0.3083175208	4	4	LS-177675;Cefuzonam Sodium;Cefuzonam sodium;5-((7-((2-amino-4-(thiazoyl)-2-(methoxy-imino))acetyl)amino-4-carboxyceph-3-em-3-yl)methyl)-1,2,3-thiadiazole;CIPLUS_772243;CEFUZONAM;CIPLUS_735294;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-5-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(1,2,3-thiadiazol-5-ylmethyl)-, (6R-(6alpha,7beta(Z)))-;Cefozopran;CEFUZONAM SODIUM;cefuzonamum;CL-118523;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6R-(6alpha,7beta(Z)))-;CL 118523;cefuzonam;Cefuzonam;CIPLUS_213477;cefuzoname;	0	0.0245098					Cl.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(CS[C@@H]23)CSc4cnns4)C(=O)O	Bosche	C3450	-0.42842742	0.56628057	0.53161724	0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182851-02	Meprednisone	170465165	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1247-42-3	 ;Betapar;Meprednisone; Meprednisone; Meprednisona; Meprendisone; Betapar; Bitanisone			-2.5565136485	4	4		0	0.56372549				NRC31	OCC(=O)[C@@]3(O)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Bosche	B1751	-1.48689516	-0.92664093	2.09848909	0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091439-07	Cimetidine	170464651	Multidrug and toxin extrusion protein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51481-61-9				-1.2003714734	4	4		0	0.49986846					N#C\N=C(/NC)NCCSCc1ncnc1C	Microsource	01500684	-0.72639225	0.45169385	-0.68406385	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183858-01	Blonanserin	144206818	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	132810-10-7		5.0118723363	-5.3	19.4584910327	4	4	AD-5423;BLONANSERIN;blonanserin;AD 5423;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[B]PYRIDINE;blonanserinum;Blonanserin;blonanserine;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;CIPLUS_702318;	21.2784503599	15.91686398	0.0255142839	0.9996001351			CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3	Pharmaron	PH-NIH-148160	-1.0653753	-0.75282309	-0.58272105	15.91686398												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			0.7546428046	4	4		0	1.65745856			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	0.2905569	-0.05018821	-1.49480618	1.65745856												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253576-01	Amelometasone	170465753		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123013-22-9				2.212166	4	4		0	0.9896091					COCC(=O)[C@]3(OC(=O)CC)[C@@]4(C)C[C@H](O)C2(F)[C@@H](CCC1=CC(=O)C=C[C@@]12C)[C@@H]4C[C@@H]3C	GVK	FFS-11-286-NCI-162	-0.33832769	0.12333498	1.59083678	0.9896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016352-07	Benzocaine	170465463	Sodium channel protein type 10 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	94-09-7				6.6650102009	4	4		0	6.03661554			6336	SCN10A	Nc1ccc(cc1)C(=O)OCC	Vitas	STK043620	1.15998067	-1.01134682	-1.3363029	6.03661554												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015680-18	Melatonin	170465589	NOS2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	73-31-4	; ;Melatonin;MELATONIN; Melatonin			-1.3235659259	4	4		0	-0.14844137				MTNR1B	CC(=O)NCCc2cnc1ccc(cc12)OC	Specs	AN-153/I149495	0.04833253	0.024667	-1.20903595	-0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024027-09	Methysergide	170464684	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	361-37-5				6.4751884577	4	4		0	1.78129639					CC[C@@H](CO)NC(=O)[C@@H]3C=C2c4cccc1c4c(cn1C)C[C@H]2N(C)C3	Enzo	AC577	1.44997583	0.61667489	1.3363029	1.78129639												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00532494-01	PHENINDAMINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-0.248141246	4	4		0	-0.14326648					CN1CC\C2=C(/C1)C(C3=CC=CC=C3)C4=CC=CC=C24	SIGMA	A001025678	0.51522248	-1.05066542	-1.03345118	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507845-01	Netarsudil	384569326	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1253952-02-1				5.3919908377	4	4		0	-0.95510984				ROCK1	CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C	Selleck	S8226	2.529274	0.72379173	0.27196084	-0.95510984												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166241-02	2,6-DIIODO-4-NITROPHENOL	225144276		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	305-85-1		12.5892541179	-4.9	38.4771197775	3	4		55.5703942456	48.18529131	0.0382991364	0.9990946214			OC1=C(I)C=C(C=C1I)[N+]([O-])=O	SIGMA	145416	1.03044496	-0.67709549	0.43513734	48.18529131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183277-01	Micronomicin sulfate	144206497		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	66803-19-8				1.2439817824	4	4	D-Streptamine, O-2-amino-6-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-;micronomicine;Santemycin;micronomicin;XK-62-2;KW-1062;Micronomicin Sulfate;gentamicin C2b;D-Streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy;LS-146966;CIPLUS_684924;Micronomicine;MICRONOMICIN;Micronomicina;MICRONOMICIN SULFATE;Micronomicin sulfate;6'-N-methylgentamicin C;Micronomicin;DE 020;Micronomicinum;sagamicin;DE-020;micronomicinum;KW 1062;CIPLUS_749329;Sagamicin;	0	3.19961796					O=S(=O)(O)O.N[C@@H]3CC[C@@H](CNC)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	ACC	Micronomycin sulfate	-0.37470726	-0.49031053	0.21756867	3.19961796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			2.1438641814	4	4	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	0.95510984					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	0.14051522	1.09736166	0.43513734	0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165972-02	1-Phenyl-1-propanol		Glycolysis / Gluconeogenesis Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	93-54-9				-4.4929101906	4	4		0	0.07352941					CCC(O)C1=CC=CC=C1	SIGMA	111309	-1.38608871	-0.46332046	-0.97929491	0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160485-01	Diamthazole	144205400		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	95-27-2	Diamthazole; Asterol; 			0.9287174205	4	4	DIAMTHAZOLE HYDROCHLORIDE;diamthazole dihydrochloride;CIPLUS_151863;Benzothiazole, 6-(2-diethylaminoethoxy)-2-dimethylamino-, dihydrochloride;amikazol;DIMAZOLE DIHYDROCHLORIDE;DIAMTHAZOLE;Dimazole Dihydrochloride;diamthazole;dimazole;dimazol;Dimazole dihydrochloride;Dimazol;6-(2-diethylaminoethylaminoethoxy)-2- dimethylaminobenzothiazole;Dimazole;Asterol;Diamthazole;CIPLUS_207319;LS-40729;dimazolum;DIMAZOLE-DIHYDROCHLORIDE;CIPLUS_166123;dimazole hydrochloride;Dimazolum;DIMAZOLE;	0	-1.34803922					CCN(CC)CCOc1ccc2nc(sc2c1)N(C)C	InterBioScreen	STOCK1S-45555	0.42842742	-0.87516088	1.31505316	-1.34803922												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00018215-06	Acebutolol hydrochloride	170465309	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	34381-68-5				-0.4908509111	4	5		0	-1.62271805					Cl.CC(C)NCC(O)COc1ccc(cc1C(C)=O)NC(=O)CCC	Microsource	01500665	-0.26862027	-1.4664981	1.77646188	1.43575018	-1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016889-06	Tenoxicam	170465677	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59804-37-4	 Tilcotil; Tenoxicam; ;TENOXICAM;Tenoxicam; Mobiflex			-4.3605314458	4	5		0	-1.94726166				PTGS2	OC=2c1sccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Microsource	01503142	-0.31746032	-1.3653603	-1.13496176	-0.81359177	-1.94726166											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093366-05	(4-Aminophenyl)arsonic acid	170465635	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	98-50-0				-2.291964639	4	5		0	-1.86612576					O=[As](O)(O)c1ccc(N)cc1	Labotest	LTBB003365	0.31746032	-2.02275601	-0.24673082	0.14357502	-1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024016-03	Hydrocortisone valerate	170464775		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57524-89-7				0.9368881103	4	5		0	3.65111562					OCC(=O)[C@@]4(OC(=O)CCCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5395	0.17094017	-1.1630847	-1.18430792	-0.67001675	3.65111562											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262928-01	Clevidipine	170466066	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	167221-71-8	Butyroxymethyl methyl 4-(2 ,3 -dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;Clevidipinum;Clevidipine			4.3966753077	4	5		0	2.67748479					CC=1NC(C)=C(C(C=1C(=O)OCOC(=O)CCC)c2cccc(Cl)c2Cl)C(=O)OC	GVK	FFS-12-73-NCI-1401	2.22222222	-0.7585335	-1.18430792	-0.52644173	2.67748479											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159326-03	Lincomycin hydrochloride	170465252	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	859-18-7	 ; Lincocin; Lincomycin HCL; Lincomycin hydrochloride; Lincomicina;Lincomycin hydrochloride; Lincolcina			0.7357480371	4	5		0	0.64908722					Cl.O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]1SC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@@H](C)O	Prestwick	Prestw-302	-0.02442002	-0.8596713	1.28300025	0	0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178086-03	Aminolevulinic acid hydrochloride	170464700	DNA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5451-09-2				0.1959508218	4	5		0	0.24340771					Cl.NCC(=O)CCC(=O)O	Microsource	01504184	0.12210012	-1.011378	-0.34542314	1.05288346	0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015358-18	Disopyramide	174006632	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3737-09-5	 Rythmodan P; ;Disopyramide; Searle 703; Disopyramide, (S)-Isomer; Norpace; Disopyramide; Disopyramide, (R)-Isomer; Disopiramida			9.7833058408	4	5		0	6.2474645					CC(C)N(CCC(c1ccccn1)(c2ccccc2)C(N)=O)C(C)C	Microsource	01500261	0.9035409	0	1.23365408	3.68509213	6.2474645											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090680-06	Carbaryl	170465695	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	63-25-2				5.0602882545	4	5		0	1.78498986					CNC(=O)Oc2cccc1ccccc12	Bosche	C1592	1.58730159	0.4551201	-0.19738465	0.86145011	1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022882-03	Diazoxide	170465328	"Sulfonylurea receptor 1, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	364-98-7				-2.0976953731	4	5		0	0.40567951					Clc1ccc2N=C(C)NS(=O)(=O)c2c1	Enzo	KC115	-0.85470085	-1.8204804	1.03626943	-0.38286671	0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091454-07	Phenol	170465486		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	108-95-2				-2.7363614	4	5		0	-0.64908722					Oc1ccccc1	Specs	AE-562/J262148	0.02442002	-1.6182048	-1.33234641	-0.33500838	-0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094689-06	Guaifenesin	170464855		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	93-14-1				-2.3594040599	4	5		0	-0.89249493					OCC(O)COc1ccccc1OC	Vitas	STK365152	0.02442002	-1.2642225	-0.83888478	-0.38286671	-0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348378-01	FOSFOMYCIN		UDP-N-acetylglucosamine 1-carboxyvinyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	26016-99-9				10.5976789515	4	5		0	2.27180527					C[C@@H]1O[C@@H]1[P]([O-])([O-])=O	SIGMA	P5396	2.71062271	1.8710493	2.56600049	1.29217516	2.27180527											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00018291-03	Procaterol	170465820	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72332-33-3				-4.286371897	4	4		0	-1.65745856				ADRB2	CC(C)N[C@@H](CC)[C@H](O)c2ccc(O)c1NC(=O)C=Cc12	Bosche	P2505	-0.24213075	-1.25470514	-1.08943501	-1.65745856												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093588-04	cAMP	170466839	cAMP-dependent protein kinase type II-alpha regulatory subunit Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60-92-4				0.800008542	4	4		0	1.02604578			5576	PRKAR2A	Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2O	SIGMA	A9501	0.8716707	-0.30112923	-1.79883456	1.02604578												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00162150-04	Cilnidipine	170465867	Voltage-gated N-type calcium channel alpha-1B subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	132203-70-4		14.1253754462	-4.85	20.2468184085	4	4		27.8135593199	20.33675349	0.0303288633	0.9994339016			CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3	Prestwick	Prestw-1376	-0.6779661	-0.35131744	-0.53204966	20.33675349												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015997-10	Taurine	170465726	Antioxidant	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	107-35-7	L-Taurine;Taurine;l-Taurine; Taurine;TAURINE			-0.5141034257	4	4		0	-0.49480455				CAT	NCCS(=O)(=O)O	Microsource	01505463	-0.48332528	1.80069068	-0.31816736	-0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160484-02	Etafenone	170466000	vascular smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	90-54-0		5.0118723363	-5.3	13.6799975915	4	4		15.659980672	14.79465611	0.0513913927	0.99837644			CCN(CCOc2ccccc2C(=O)CCc1ccccc1)CC	Vitas	STK321191	-0.96665056	-0.22200296	-0.57270124	14.79465611												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015578-12	Ketoprofen	170465449	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	22071-15-4	 Alrheumat; Orudis; Alrheumum; ; Ketoprofen;Ketoprofen; Ketoprofeno; (S)-(+)-Ketoprofen; (S)-Ketoprofen; Profenid;KETOPROFEN			1.1813675709	4	4		0	-0.84116774				PTGS1	CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2	Microsource	01501215	-0.43499275	1.1100148	2.03627108	-0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160543-01	Pregnandiol	144205439	G-protein coupled bile acid receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	80-92-2	Pregnandiol; Diol; Pregnantriol; 			-5.549085086	4	4	ALLOPREGNANDIOL;CIPLUS_3727430;CIPLUS_149642;CIPLUS_679210;5BETA-PREGNANE-3ALPHA,20ALPHA-DIOL;CIPLUS_742702;CIPLUS_678965;allopregnane-3,20-diol;PREGNANDIOL;CIPLUS_696772;(3 alpha,5 alpha,20S)-pregnane-3,20-diol;Pregnantriol;Diol;Pregnanediol;Pregnandiol;PREGNANEDIOL;CIPLUS_742124;	0	0.66857689					CC(O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@@H]2C[C@@H](O)CC[C@]12C	SigmaAldrich	R195952	-1.54566745	-1.23745039	-0.81588251	0.66857689												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00188865-03	Pazopanib	170465625	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	444731-52-6	Pazopanib; Pazopanib;GSK-786034/Votrient/Armala			10.3258479775	4	4		0	8.54823305			10715	FLT1	NS(=O)(=O)c1cc(ccc1C)Nc2nccc(n2)N(C)c3ccc4c(C)n(C)nc4c3	Sequoia	SRP010772p	0.42154567	3.05860378	1.03345118	8.54823305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167470-05	Mezlocillin Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	42057-22-7				0.6430028209	4	4		0	1.14613181					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(C3=O)[S+](C)([O-])=O)C4=CC=CC=C4)C(=O)N2[C@H]1C(O)=O	APExBIO	B4959	-0.70257611	-0.02334812	2.28447104	1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182060-03	l-Oxyfedrine hydrochloride	170465929	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	16777-42-7				-0.1575344623	4	5		0	1.21703854					Cl.COc1cc(ccc1)C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2	APAC	555781	0.12210012	-1.7193426	-1.18430792	1.05288346	1.21703854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095748-04	3-(Octadecyloxy)-1,2-propanediol	170465730		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	544-62-7				0.216892612	4	5		0	-0.73022312					OC(CO)COCCCCCCCCCCCCCCCCCC	Microsource	01503983	0.51282051	0.0505689	0.49346163	-0.81359177	-0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160395-04	Dibenzepin hydrochloride	170466001	Monoamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	315-80-0				-2.275180054	4	5		0	-0.97363083					Cl.CN(C)CCN3c1ccccc1N(C)c2ccccc2C3=O	Enzo	NS107	-0.70818071	0.2528445	-0.44411547	-0.14357502	-0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016896-06	Amrinone	170465367	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	60719-84-8				-0.2396068271	4	5		0	2.59634888					NC1=CC(=CNC1=O)c2ccncc2	Microsource	01503084	-0.26862027	-0.505689	-1.13496176	-0.76573343	2.59634888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274067-01	Eltrombopag olamine	174006931	Thrombopoietin Receptor (TpoR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	496775-61-2	Eltrombopag	11.220184543	-4.95	32.6259641362	3	5		54.3625488183	43.56997972	0.0008883069	0.9995558424	4352	MPL	O=C(O)c1cccc(c1)c4cccc(N\N=C2\C(=O)N(N=C2C)c3ccc(C)c(C)c3)c4O	Selleck	S2229	-0.17094017	-0.8596713	-1.18430792	2.58435032	43.56997972											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159504-04	Thymol iodide	170465466		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	552-22-7				0.5474194773	4	5		0	-0.64908722					IOc1cc(C)c(cc1C(C)C)c2cc(C(C)C)c(OI)cc2C	SIGMA	T2763	1.53846154	-1.6687737	-0.88823094	-0.04785834	-0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274065-01	Desonide	174007408	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	638-94-8	Desonide			-1.9511411829	4	5		0	0.16227181				NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1701	0.46398046	-1.6687737	-1.28300025	-1.24431682	0.16227181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164155-02	Benzylparaben	170465711	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	94-18-8				0.0115523551	4	5		0	-0.24340771					Oc1ccc(cc1)C(=O)OCc2ccccc2	SIGMA	380709	0.56166056	-0.9608091	-0.44411547	0.19143336	-0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093889-12	Physostigmine	170465757		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57-47-6				-4.9352016201	4	5		0	-0.97363083					CNC(=O)Oc1cc2c(cc1)N(C)[C@H]3N(C)CC[C@@]23C	Enzo	AC241	-1.0989011	-1.7699115	-1.38169257	0.04785834	-0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016809-07	Moricizine hydrochloride	174006664	class 1c antiarrhythmic, Na(v)1.5 channel blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	29560-58-5	 Moracizina;Moricizine hydrochloride; Ethmozine; Moracizine;Moracizine; ; Ethmozin; Hydrochloride, Moricizin; Etmozin			4.2159449739	4	5		0	4.13793103					Cl.O=C(OCC)Nc1cc2N(c3ccccc3Sc2cc1)C(=O)CCN4CCOCC4	Prestwick	Prestw-1051	-0.12210012	-1.1630847	2.61534666	0.47858339	4.13793103											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249923-01	Cholesolvin	170466018	Triglyceride Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	14929-11-4				-1.0854985886	4	5		0	0.40567951					Clc2ccc(OC(C)(C)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1)cc2	GVK	FFS-11-286-NCI-201	-0.9035409	-1.4664981	-1.23365408	3.11079206	0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015067-14	Aspirin	170465039	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-78-2	 Komineks mixture; Alka Seltzer; Ascriptin; Micristin; 2-Acetoxybenzoic acid; Veganine; Vincents Powder; Solupsan; Istopirin; Norgesic forte; Alka-Seltzer; Carbasalato calcico; Aloxiprimum;Aspirin; Endosprin; Bayer Aspirin; Bayer EC Aspirin; Lysine acetylsalicylate; Equagesic; Dolomo; Kominek's mixture; Solprin; Sedalgin; Colfarit; DP-neuralgen; Bex Powder; Cu-aspirinate; Aspirin DL-lysine; Cogla; Magnyl; Aspisol; Apyron; Midol; Easprin; ; Acetard; Synalgos; Ecotrin; Triaminicin; Zorprin;Acetylsalicylic acid; 2-(Acetyloxy)benzoic Acid; Oxycodone w/Aspirin; Acylpyrin; Dispril;ASPIRIN; Acid, Acetylsalicyli; Polopiryna; Aspirin DL-Lysine; Fiorinal; Doleron; Astra 2167; Carisoprodol/Aspirin; Acetylsalicylic acid; Aspirin Tri-Buffered; O-Acetylsalicylic acid; Acetysal; Magnecyl; Polopirin			0.8783980093	4	5		0	0.56795132				HMGCR	O=C(C)Oc1ccccc1C(=O)O	Microsource	01500130	-0.31746032	-1.2642225	2.51665433	0.2392917	0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091512-04	(2E)-3-Phenylprop-2-enal	144204695	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14371-10-9	CINNAMALDEHYDE; trans-3-Phenyl-2-propenal; 			8.7514067609	4	4	CIPLUS_757838;CINNAMALDEHYDE;cinnamaldehyde;trans-3-Phenyl-2-propenal;2-propenal, 3-phenyl- (9ci);trans-cinnamaldehyde;CIPLUS_150798;Cinnamic aldehyde;LS-378;cinnamic aldehyde, (E)-isomer;AB08006278-01;cinnamic aldehyde;trans-Cinnamaldehyde;Cinnamaldehyde (trans), neat;CIPLUS_169354;beta-phenylacrolein;AB08007164-01;Cinnamaldehyde;LS-850;	0	2.01156069			5468	PPARG	O=C\C=C\c1ccccc1	Labotest	LT00939010	1.79948586	2.21584984	1.57936299	2.01156069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390678-03	Sevelamer Hydrochloride (Technical Grade)			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	152751-57-0				-2.5801912473	4	4		0	-1.22543353					CCC(CN)CC(C)CNCC(O)CNCC(CC)CC(CC)CN	Toronto Research	S256000	-0.97686375	-0.33889468	1.52671756	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167528-02	Alosetron hydrochloride	170465416	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	122852-69-1				-1.2596261991	4	4		0	1.59537572					Cl.Cc4ncnc4CN1CCc3c(C1=O)c2ccccc2n3C	Sequoia	SRP04894a	-0.5655527	-0.5995829	-0.84232693	1.59537572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183872-01	Brotizolam	144207150		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	57801-81-7				3.2590672291	4	4	We 941;CIPLUS_183076;2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;brotizolamum;Lendormin;Europharma brand of brotizolam;Sintonal;Boehringer Ingelheim brand of brotizolam;Lindormin;Brotizolam;brotizolam;LS-152570;Lendorm;WE-941;2-BROMO-4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;Brotizolamum;BROTIZOLAM;Promeco brand of brotizolam;WHO NO. 4549;WE 941;	0	-0.48554913					Clc4ccccc4C2=NCc1nnc(C)n1c3sc(Br)cc23	Toronto Research	B689280	-0.35989717	5.91762252	0.57909976	-0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164583-02	Amdinocillin	170465354		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	32887-01-7				-3.7112144696	4	4		0	-1.18389897					OC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C	Sequoia	SRP01690m	-0.6779661	-0.70263488	-0.63339245	-1.18389897												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160622-04	D-delta-Tocopherol	144206758		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	119-13-1				-2.6696451373	4	4		0	-0.49986846					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1	NCGCChem	XJB03-045	-0.8716707	0	-0.48137826	-0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016407-08	Sulfamethizole	170465369	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	144-82-1	; Sulfapral; ;Sulfamethizole; Sulfamethizole; Rufol; Sulfametizol; FNA, Sulfamethizo; Sulphamethizole; Thiosulfil; Sulfamethizol FNA;SULFAMETHIZOLE			10.3619477343	4	4		0	1.76269403					Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2	Labotest	LT00772293	2.66343826	1.30489335	2.45756271	1.76269403												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017323-08	Tetracycline hydrochloride	170464838	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	64-75-5	 Achromycin;; Tetraciclina; Tetracycline Hcl; Bristacycline; Tetrabid; Hostacyclin; Contramibial; Sustamycin;Tetracycline hydrochloride; Tetracycline hydrate; Ulcrux powder;Tetracycline;TETRACYCLINE HYDROCHLORIDE; Achromycin V; 4 Epitetracyclin; 4-Epitetracycline; Topicycline			1.5010622099	4	4		0	0.49480455				PADI1	Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O	Microsource	01500566	-0.38666022	1.06068081	0.8908686	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00162116-04	Cephapirin sodium	170465306	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	24356-60-3				-1.2179445665	4	4		0	-0.59376546					[Na+].[O-]C(=O)C=2N3C(=O)[C@@H](NC(=O)CSc1ccncc1)[C@H]3SCC=2COC(C)=O	Microsource	01500167	-0.24166264	-0.07400099	-0.06363347	-0.59376546												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018171-06	Clidinium bromide	170464768		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3485-62-9				4.5229168157	4	4		0	-0.09896091					[Br-].OC(c1ccccc1)(c2ccccc2)C(=O)OC4C[N+]3(C)CCC4CC3	Microsource	01500192	0.53165781	-0.32067094	3.69074133	-0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016069-13	Brimonidine	170464941	Alpha-2C adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59803-98-4				11.5780428051	4	4		0	0.74220683			152	ADRA2C	Brc2c3nccnc3ccc2NC1=NCCN1	Enzo	AC155	4.01159981	3.13270844	1.08176901	0.74220683												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00187912-17	Ibrutinib (PCI-32765)		BTK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	936563-96-1				-7.8575222392	4	4		0	-1.38490926			695	BTK	NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCN(C5)C(=O)C=C	APExBIO	A3001	-1.8735363	-1.28414663	-1.63176503	-1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178874-03	DL-Carnitine HCl		Mitochondrial carnitine/acylcarnitine carrier protein Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	461-05-2				-2.5000021462	4	4		0	-0.67052023			788	SLC25A20	C[N+](C)(C)CC(O)CC(O)=O	Selleck	S2293	-0.61696658	0.02606882	-0.6317452	-0.67052023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522012-01	CEFTOBIPROLE MEDOCARIL SODIUM			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	252188-71-9				0.1895210841	4	4		0	1.36416185					C\C1=C(COC(=O)N2CC[C@H](C2)N3CC\C(=C/C4=C(/N5[C@H](SC4)[C@H](NC(=O)\C(N=O)=C/6NS/C(=N6)N)C5=O)C(O)=O)C3=O)\OC(=O)O1	CheMall	HE073132	-0.46272494	-0.28675704	0.7896815	1.36416185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185751-06	Cefuroxime Axetil			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	64544-07-6				1.3779250429	4	4		0	0.80924855					[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N\OC)\C3=CC=CO3)C(=O)OC(C)OC(C)=O	Enzo	AC3055	0.30848329	-0.54744526	0.52645433	0.80924855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168748-02	Rotigotine	170465204	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	99755-59-6				-0.8338574624	4	4		0	1.2716763					Oc2cccc1C[C@H](CCc12)N(CCC)CCc3cccs3	Tocris	3896	-0.46272494	-0.65172054	-0.21058173	1.2716763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344529-02	Cefamandole (nafate)		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	42540-40-9				1.3841274811	4	4		0	0.11560694					C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](OC=O)C4=CC=CC=C4)C3=O)C([O-])=O	MedChem Express	HY-B1166	0.15424165	-0.33889468	1.63200842	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018167-05	Cladribine		Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	4291-63-8				2.4037154315	4	4		0	-1.50289017				ADA	NC1=NC(=NC2=C1N=C[N]2C3CC(O)C(CO)O3)Cl	APExBIO	A2187	1.49100257	0.65172054	-1.05290866	-1.50289017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476141-01	11?-Prostaglandin E1		Prostanoid EP1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	24570-01-2				-3.865660268	4	4		0	-0.6006006				PTGER2	CCCCCC(O)\C=C\[C@H]1[C@@H](O)CC(=O)C1CCCCCCC(O)=O	Cayman	13450	-1.0019084	-1.17554859	-0.05236973	-0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183365-02	ORNITHINE HYDROCHLORIDE		G-protein coupled receptor family C group 6 member A Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	70-26-8				0.2288899508	4	4		0	-1.6016016			222545	GPRC6A	NCCCC(N)C(O)=O	Microsource	01504524	0.23854962	1.17554859	0.78554595	-1.6016016												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167512-04	Everolimus		mTOR inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	159351-69-6				-9.3123912395	4	4		0	-2.15215215				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10374	-1.95610687	-2.53396029	-1.25687353	-2.15215215												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181159-03	Trabectedin	384568393	DNA-Damaging Drug	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	114899-77-3				15.9259229381	4	4		0	4.45445445				H2AFX	COC1=CC2=C(CCN[C@]23CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=C6C(=C(OC)C(=C7)C)O)[C@H](O)N5[C@@H](COC3=O)C8=C4C(=C(C)C9=C8OCO9)OC(C)=O)C=C1O	MedChem Express	HY-50936	4.86641221	-0.0261233	0.68080649	4.45445445												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00188443-01	Dapiprazole hydrochloride	144206586	Adrenergic Receptor Alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	72822-13-0				-0.7015851735	4	4	DAPIPRAZOLEHYDROCHLORIDE	0	-0.1001001					Cl.Cc4ccccc4N3CCN(CCc1nnc2CCCCn12)CC3	APAC	878039	-0.09541985	-0.75757576	0.20947892	-0.1001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344528-01	TRYPAN BLUE	225144379		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72-57-1				-0.5424997075	4	4		0	0.28939753					CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(C=C(C=C4N)[S]([O-])(=O)=O)C=C3[S]([O-])(=O)=O)C)N=NC5=C(O)C6=C(C=C(C=C6N)[S]([O-])(=O)=O)C=C5[S]([O-])(=O)=O	SIGMA	302643	-0.6779661	0.15056462	0.27869268	0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253592-01	Menadiol	170465455	regulation of blood coagulation Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	481-85-6				8.7215398234	4	4		0	1.63285502					Oc1cc(C)c(O)c2ccccc12	GVK	FFS-11-286-NCI-27	2.27162881	1.40601875	1.65447025	1.63285502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015110-09	Aminoglutethimide	170465259	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	125-84-8	 (S)-(-)-Aminoglutethimide; (+-)-p-Aminoglutethimide;(?)-p-Aminoglutethimide; Glutethimide, para-amino; (?)-p-Aminoglutethimide;AMINOGLUTETHIMIDE; (R)-(+)-Aminoglutethimide;Glutethimide, para-amino;p-Aminoglutethimide; Orimeten; p-Aminoglutethimide; ;Aminoglutethimide (Cytadren); Cytadren;Aminoglutethimide; Aminoglutetimida			-3.0665122733	4	4		0	-0.64324592			1588	CYP19A1	CCC1(CCC(=O)NC1=O)c2ccc(N)cc2	Vitas	STK802074	-0.28999517	-0.22200296	-1.59083678	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090693-11	D-Nicotine	170464932	Neuronal acetylcholine receptor; alpha4/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	25162-00-9				3.9854288746	4	4		0	0.64324592					CN2CCC[C@@H]2c1cnccc1	Microsource	02300259	1.11164814	0.024667	1.14540248	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166055-04	SODIUM NITROPRUSSIDE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	13755-38-9				-1.6133941739	4	4		0	-1.67144222					[O]=[N][Fe--]([C]#[N])([C]#[N])([C]#[N])([C]#[N])[C]#[N]	Microsource	01300037	0.32786885	-0.95727294	-0.76149035	-1.67144222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262907-01	Bilastine	170466329		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	202189-78-4	Bilastine;Bilastinum			0.8842008731	4	4		0	-0.62427746					O=C(O)C(C)(C)c4ccc(CCN1CCC(CC1)c3nc2ccccc2n3CCOCC)cc4	GVK	FFS-12-73-NCI-1870	0.20565553	0.33889468	0.84232693	-0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378889-01	PF-04971729		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1210344-57-2				1.4646163029	4	4		0	-0.02312139					CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)C=C1	MedChem Express	HY-15461	0.61696658	0.2346194	-0.36851803	-0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386242-02	Cilengitide		Integrin alpha-V/beta-5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	188968-51-6				-5.8212342844	4	4		0	-2.24277457					CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O	MedChem Express	HY-16141	-1.02827763	-1.17309698	-1.00026323	-2.24277457												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166146-02	Quinestrol	170465054	Estrogen receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	152-43-2				3.650768668	4	4		0	-2.15028902					C#C[C@]5(O)CC[C@@H]2[C@]5(C)CC[C@@H]3c4ccc(OC1CCCC1)cc4CC[C@@H]23	SIGMA	E7887	1.59383033	1.17309698	0.52645433	-2.15028902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263872-02	SPIRAMYCIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	8025-81-8				-0.0441080594	4	4		0	1.2012012					CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C	Microsource	01503423	-0.90648855	-0.13061651	2.09478921	1.2012012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095136-09	Olmesartan medoxomil			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	144689-63-4				-5.1088730292	4	4		0	-0.65065065					CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(=O)OCC/5=C(C)/OC(=O)O5)C(C)(C)O	APExBIO	A4082	-1.71755725	-0.80982236	0.47132757	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168786-02	Deserpidine	144206653	Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	131-01-1	Deserpidine	12.5892541179	-4.9	51.9434793451	3	4	deserpidinum;CIPLUS_151707;LS-178544;CIPLUS_743119;deserpidine;reserpidine;ORETICYL FORTE;Deserpidine;METHYCLOTHIAZIDE;LS-7299;3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester);Deserpidina;Deserpidinum;LS-178610;DESERPIDINE;	75.2486985513	65.26526527	0.018519341	0.9997884491			COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	GVK-NIH-19	1.0019084	-0.07836991	0.94265515	65.26526527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179310-03	Cefalonium	170466431	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5575-21-3				-0.8805728773	4	4		0	-0.65065065					NC(=O)c4cc[n+](CC=2CS[C@@H]3[C@H](NC(=O)Cc1cccs1)C(=O)N3C=2C([O-])=O)cc4	SIGMA	32904	-0.04770992	-1.2800418	0.89028542	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163742-05	d-LIMONENE		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	138-86-7				-2.0108463367	4	4		0	-1.3013013					CC(=C)C1CC\C(=C/C1)C	Microsource	00307080	-0.23854962	-0.86206897	-0.20947892	-1.3013013												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00167469-02	NCGC00167469-02			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-1.412343484	4	4		0	-1.1011011					[H][C@@]2(CC1=CC(OC)=C(OC)C(OC)=C1)C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]4(C)CCC5=CC(OC)=C(OC)C=C5[C@@]4([H])CC6=CC(OC)=C(OC)C(OC)=C6	ACC	API-03789	-0.23854962	-0.91431557	0.94265515	-1.1011011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263539-01	Ziprasidone	170465342	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	146939-27-7	Ziprasidone hydrochloride;Ziprasidone  Hydrochloride			7.2115858727	4	4		0	0.85085085			3356	HTR2A	O=C4Cc5cc(CCN1CCN(CC1)c3nsc2ccccc23)c(Cl)cc5N4	Prestwick Chemical, Inc.	Prestw-1188	1.19274809	1.54127482	3.50877193	0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182070-03	Ioxilan	170465160		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	107793-72-6				3.4354220249	4	4		0	0.4004004					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCCO	Kemprotec	107793-72-6	1.90839695	-0.96656217	-1.51872218	0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160513-01	Testosterone decanoate	144205416	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5721-91-5	TESTOSTERONE UNDECANOATE; 			1.5703592475	4	4	CIPLUS_669074;Testosterone decanoate;ORG-538;testosterone decanoate;CIPLUS_732550;TESTOSTERONE UNDECANOATE;	0	-0.45045045					CCCCCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	STOCK1N-56645	0.95419847	-0.70532915	-0.05236973	-0.45045045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015708-15	Maprotiline hydrochloride	170464778	Noradrenaline Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	10262-69-8	 ; Ciba 34276 Ba;MAPROTILINE HYDROCHLORIDE; Maprotilene Hydrochloride; Maprotiline hydrochloride;Maprotiline hydrochloride; Maprotilline HCl; Ludiomil; Maprotilina;Maprotiline	12.5892541179	-4.9	103.6688062662	3	4		120.4360874139	96.96489839	0.0114776427	0.9999187409		SLC6A2	CNCCCC24CCC(c1ccccc12)c3ccccc34	Vitas	STK711156	-0.49435028	-0.55671538	-1.32289417	96.96489839												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167472-03	Amlexanox	170465365	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	68302-57-8	 3   Amlexanox; ; Solfa;Amlexanox; Aphthasol; Amlenanox			2.3259372133	4	4		0	4.85616258				IL3	CC(C)c1cc2C(=O)c3cc(c(N)nc3Oc2cc1)C(=O)O	Bosche	A2169	-1.15348399	-0.13917884	-0.72894168	4.85616258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015831-06	Pheniramine maleate	170464902	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	132-20-7				-1.1058418812	4	4		0	-0.26392188					[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2	Microsource	01500478	-0.4472693	0.6263048	-0.4049676	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094854-07	Allantoin	170465460	Allantoinase Substrate	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	97-59-6				9.7728983387	4	4		0	4.79960416			854845	DAL1	O=C1NC(=O)NC1NC(=O)N	Specs	AE-562/J258555	2.07829869	1.60335471	-0.4454343	4.79960416												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022662-05	Dexamethasone acetate	170466872	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1177-87-3				-0.0308224538	4	4		0	0.64324592					CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-130	-0.53165781	-0.024667	0.25453388	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164600-10	ARTESUNATE		Antimalarial Agents	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	182824-33-5		14.1253754462	-4.85	15.5606863294	4	4		13.5	11.84336199	0.1883664424	0.9777584918		PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Microsource	01504829	1.264637	2.9652113	2.0125102	11.84336199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386298-01	Rifapentine		DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	61379-65-5				-3.9921274701	4	4		0	0.04775549				PRKDC	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(CC5)C6CCCC6	Selleck	S1760	-1.03044496	-0.58370301	-1.41419636	0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178554-03	AZLOCILLIN SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	37091-66-0				-1.7371666696	4	4		0	-0.43930636					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C4=CC=CC=C4)C(=O)N2C1C([O-])=O	Microsource	01503101	-0.97686375	-0.02606882	1.57936299	-0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246969-06	Latanoprost		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	130209-82-4				4.9211701238	4	4		0	0.30057803					CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2	SIGMA	L1167	2.72493573	-0.44316997	-0.36851803	0.30057803												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00166308-02	Difloxacin hydrochloride	170465623	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	91296-86-5				2.1152150322	4	4		0	0.06936416					Cl.CN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4	Vitas	STK618168	0.15424165	0.70385819	1.68465386	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163338-03	D-Phenylalanine			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	673-06-3				2.90420154	4	4		0	1.8265896					N[C@H](CC1=CC=CC=C1)C(O)=O	Selleck	S4153	-0.15424165	0.9645464	0.94761779	1.8265896												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015741-13	4,4 -(2,3-Dimethyltetramethylene)dipyrocatechol		5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	500-38-9				-0.9822385584	4	4		0	-0.02312139				ALOX5	CC(CC1=CC(=C(O)C=C1)O)C(C)CC2=CC(=C(O)C=C2)O	Prestwick	Prestw-NAT-0055	-0.61696658	-0.49530761	1.36878126	-0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179585-04	Rescinnamin	363676949	Serotonergic synapse Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					6.9892927037	4	4		0	2.55255255					CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\C6=CC(=C(OC)C(=C6)OC)OC	Analyticon	NP-011016	1.95610687	-0.28735632	0	2.55255255												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00180998-01	Amylmetacresol	144206204		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1300-94-3	Amylmetacresol; 			-0.8441780734	4	4	amylmetacresolum;amylmetacresol;AMYLMETACRESOL;CIPLUS_158004;6-N-AMYL-M-CRESOL;Amylmetacresol;	0	0.15015015					Oc1cc(C)ccc1CCCCC	SigmaAldrich	MFCD00127710	0.33396947	-1.64576802	-0.94265515	0.15015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373041-03	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	259793-96-9				2.5758307999	4	4		0	0.5005005					NC(=O)C1=NC(=CN=C1O)F	Bio Vision	2778	-0.33396947	1.17554859	3.19455355	0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167557-01	DL-Methionine methylsulfonium chloride	144206105	ERK1 and ERK2 cascade Activator	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	3493-12-7	Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-; Vitamin U; S-Methylmethionine; Vitamin U Chloride; S Methylmethionin; 			-0.6677308192	4	4	Methylsulfonium Chloride, Methionin;Vitamin U Chloride;CIPLUS_203938;LS-148013;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-;Vitamin U;S Methylmethionin;S-Methylmethionine;CIPLUS_723454;methionylmethylsulfonium chloride;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, L-;DL-Met-S-methylsulfonium chloride;CIPLUS_3886671;Methylmethionine sulfonium chloride;CIPLUS_8144825;DL-methionine-S-methylsulfonium chloride;CIPLUS_742496;Methylmethionine Sulfonium Chloride;Chloride, Methionine Methylsulfoniu;DL-Methionine Methylsulfonium Chloride;(3-Amino-3-carboxypropyl)dimethyl sulfonium chloride;CIPLUS_157505;CIPLUS_777498;Methyl-methionine sulphonium chloride;MMSC;Chloride, Methylmethioninesulfoniu;DL-Methionine methylsulfonium chloride;CIPLUS_775683;METHYLMETHIONINE SULFONIUM CHLORIDE;	0	-0.16301816					[Cl-].C[S+](C)CCC(N)C(=O)O	SigmaAldrich	64382	-0.59585492	1.19453925	0.20135917	-0.16301816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179401-03	Ethotoin	225144304	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	86-35-1				6.6210659988	4	4		0	2.44527247					CCN1C(=O)NC(C1=O)C2=CC=CC=C2	Prestwick	Prestw-696	0.64766839	1.97464651	2.51698968	2.44527247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319021-01	NCGC00319021-01	225144375	DNA synthesis involved in DNA replication Activator	DPI_SARS-CoV-2_General	2019_NPC-9_CPE					-3.7465165181	4	4		0	-1.0013973					COCC1=C(F)C(=C(COC(=O)C2C(\C=C\C)C2(C)C)C(=C1F)F)F	GVK	FFS-11-286-NCI-255	-1.11398964	-0.21940517	0	-1.0013973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274080-01	Estriol	170465807	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	50-27-1				-0.9234665973	4	4		0	-0.20959478				ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12)c4cc3	SIGMA	E3625	-0.44041451	0.51194539	0	-0.20959478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163953-03	Allethrin	144214035	Testis-specific androgen-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	584-79-2				-2.0065812737	4	4	Allethrin	0	0.11644155					O=C2CC(OC(=O)C1C(/C=C(\C)C)C1(C)C)C(C)=C2CC=C	LightBiologicals	MOP-20453	-0.18134715	-1.09702584	-1.10747546	0.11644155												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00179611-05	DIHYDROSTREPTOMYCIN [5mM]		Large-conductance mechanosensitive channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	128-46-1				2.0584276349	4	4		0	1.32743363			947787	mscL	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Microsource	01500249	0.33678756	-0.5607021	0.85577649	1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090787-08	Benzophenone	170465649		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	119-61-9				3.5701841475	4	4		0	0.89733439					O=C(c1ccccc1)c2ccccc2	Specs	AE-562/J256170	1.67137476	-0.20876827	-0.35097192	0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00261972-01	NCGC00261972-01	225144356		DPI_SARS-CoV-2_General	2019_NPC-7_CPE		Cymelarsan;Rm-110;Melarsominum;Merial brand of melarsomine			-2.2115070403	4	4		0	-0.14326648					NCCS[As](SCCN)C1=CC=C(NC2=NC(=NC(=N2)N)N)C=C1	GVK	FFS-11-286-NCI-125	-0.37470726	-1.42423535	-0.21756867	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091687-01	Benzene sulfonic acid	17389167		DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-2.4209417714	4	4	CIPLUS_668287;CIPLUS_746452;CIPLUS_158198;Benzene sulfonic acid;Sodium benzenesulfonate;SODIUM BENZENESULFONATE;CIPLUS_188702;AB08082695-01;CIPLUS_750422;Benzenesulfonic acid monohydrate;CIPLUS_3730420;Benzenesulfonic Acid Sodium Salt;CIPLUS_750425;CIPLUS_740728;CIPLUS_153872;CIPLUS_213852;4-Formyl-1-methylpyridinium benzenesulfonate;CIPLUS_213853;CIPLUS_750569;Benzenesulfonic acid;Benzene Sulfonic Acid;p-Toluenesulfonic acid, polymer-bound;benzenesulfonic acid;CIPLUS_664858;ALUMINUM PHENOLSULFONATE;SODIUM DECYLBENZENESULFONATE;CIPLUS_198271;CIPLUS_3741824;CIPLUS_753058;CIPLUS_203733;CIPLUS_752981;CIPLUS_198836;CIPLUS_763507;CIPLUS_210324;CIPLUS_750514;CIPLUS_750536;CIPLUS_198267;CIPLUS_198368;Benzenesulfonic acid sodium salt;CIPLUS_3729342;CIPLUS_198511;CIPLUS_150435;CIPLUS_204905;CIPLUS_198364;CIPLUS_670392;CIPLUS_3825062;CIPLUS_3745729;	0	0.14326648					O[S+]([O-])(=O)C1=CC=CC=C1	NIEHS	AB08082695	-1.17096019	0.44361429	0.21756867	0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346704-03	Cabazitaxel		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	183133-96-2				-2.6416262579	4	4		0	2.47398844				TUBB	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)/C(=C(/[C@@H](OC)C(=O)[C@]13C)C5(C)C)C	APExBIO	B2157	-1.33676093	-1.22523462	-0.3158726	2.47398844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179520-04	Metrizamide			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	31112-62-6				0.8227442104	4	4		0	-0.34682081					CN(C(C)=O)C1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-463	-0.46272494	-0.07820647	3.31666228	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167444-04	Cefpiramide (sodium)		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	74849-93-7				1.007086387	4	4		0	2.1021021					C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](NC(=O)C4=C(O)C=C(C)N=C4)C5=CC=C(O)C=C5)C3=O)C(O)=O	MedChem Express	HY-B0798	-0.28625954	-1.3322884	1.57109191	2.1021021												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253604-01	Rescimetol	170465875	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	73573-42-9		12.5892541179	-4.9	62.3161870729	3	4		95.9391538807	82.58258258	0.0188458977	0.9997808933			Oc1ccc(cc1OC)/C=C/C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	FFS-11-286-NCI-194	0.38167939	-0.96656217	0.41895784	82.58258258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389655-01	Angiotensin II			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	68521-88-0				2.3960071743	4	4		0	3.65365365					CCC(C)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(O)=O)C(C)C)C(=O)NC(CC2=CN=C[NH]2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(O)=O	APExBIO	A1042	0.04770992	-0.54858934	-0.10473946	3.65365365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179370-05	Methotrimeprazine maleat salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	7104-38-3		12.5892541179	-4.9	67.0799993649	3	4		102.1767652598	88.42571029	0.0124717539	0.9999040565			COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1	Prestwick	Prestw-797	-0.23316062	0.75572891	1.51019381	88.42571029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370833-02	NS-304		platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	475086-01-2				7.5265245458	4	4		0	5.33302282					CC(C)N(CCCCOCC(=O)N[S+](C)([O-])=O)C1=NC(=C(N=C1)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-14870	1.01036269	0.31691858	1.05713567	5.33302282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390811-01	Oxytocin		Oxytocin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	50-56-6				-6.0328230562	4	4		0	-0.11644155					CC[C@H](C)C1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	MedChem Express	HY-17571	-1.89119171	-1.19453925	-0.40271835	-0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096081-04	beta-Carotene	225144219	Vitamin/Supplement	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	7235-40-7	; ;BETA-CAROTENE; Solatene; Provitamin A; beta,beta-Carotene; Ro 8-8427; Ro-8-8427;beta-CAROTENE; Betacaroteno; beta-Carotene			-4.2059585893	4	4		0	-1.79466878				CAT	CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Microsource	01500143	-0.58851224	0.48712596	1.16090713	-1.79466878												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00161643-05	Fluorescein sodium	170464991		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	518-47-8				-0.2468625471	4	4		0	1.00290314					[Na+].[Na+].[O-]c4cc5Oc1cc([O-])ccc1C3(OC(=O)c2ccccc23)c5cc4	Microsource	01505396	0.07062147	-1.18302018	-0.62095032	1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016089-06	Nonivamide	170466476	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2444-46-4				-4.5089495619	4	4		0	-1.37239377					Oc1ccc(cc1OC)CNC(=O)CCCCCCCC	Specs	AN-153/I105041	-0.82391714	0.27835769	-1.59287257	-1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015467-20	Glybenclamide	170464964	Sulfonylurea receptor 2 Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	10238-21-8				0.038782641	4	4		0	1.37239377					O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3	Enzo	KC120	-0.21186441	-1.2526096	-0.18898488	1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00162068-06	Opipramol dihydrochloride	170465942	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	909-39-7				5.2426040592	4	4		0	1.7418844					Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Prestwick Chemical, Inc.	Prestw-1456	-0.40018832	1.2526096	3.05075594	1.7418844												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249896-01	Cinnamedrine	170465535		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	90-86-8				10.2507382321	4	4		0	8.60385326					OC(C(C)N(C)C/C=C/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-72	-0.11770245	0.13917884	0.89092873	8.60385326												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160662-02	Ambrisentan	170465143	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	177036-94-1				7.7756344574	4	4		0	2.69200317				EDNRA	O=C(O)[C@@H](Oc1nc(C)cc(C)n1)C(OC)(c2ccccc2)c3ccccc3	Prestwick	Prestw-1497	0.87099812	0.41753653	2.78077754	2.69200317												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164578-02	Etoricoxib	170465621	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	202409-33-4				-0.3224591691	4	4		0	1.58353127			5743	PTGS2	CS(=O)(=O)c1ccc(cc1)c3cc(Cl)cnc3c2cnc(C)cc2	Sequoia	SRP02700e	-0.16478343	-1.73973556	-0.51295896	1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165740-05	Benazepril	170465003	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	86541-74-4	; Briem; Benazepril Free base; BENAZEPRIL HCl; Lotensin HCT 20/12.5mg;Benzapril; Labopal; Benazepril Hcl; Cibacen; Lotensin; Benzapril;Benazepril hydrochloride; Cibac???ne	10	-5	95.8083021502	3	4		109.3841845462	89.65858486	0.0087619819	0.9999526477	1636	ACE	Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@H]3CCc2ccccc2N(CC(=O)O)C3=O	Microsource	01505200	-1.01498308	-0.27133695	-0.4454343	89.65858486												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164534-02	4-Phenolsulfonic acid	170465916		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	98-67-9				6.1898949776	4	4		0	2.96882731					Oc1ccc(cc1)S(O)(=O)=O	Labotest	LT03353562	1.59497342	1.1100148	-0.76360165	2.96882731												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166072-02	D-Galactitol	170465564	osmotic diuretic agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	608-66-2				-2.3189461262	4	4		0	-0.28653295				AVPR2	O[C@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO	SIGMA	D0256	-1.264637	0.30352557	1.30541202	-0.28653295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178877-03	Methicillin sodium hydrate	170465152	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	7246-14-2				-3.5569009025	4	4		0	-0.95510984					[Na+].O.O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)c1c(OC)cccc1OC)[C@H]3SC2(C)C	Microsource	01500395	-0.70257611	-0.63039925	-0.87027468	-0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166140-02	Pyrithioxin dihydrochloride	170465839	acetylcholine biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	10049-83-9				-2.5658727444	4	4		0	1.09837631					Cl.Cl.Oc1c(CO)c(cnc1C)CSSCc2cnc(C)c(O)c2CO	Vitas	STK801801	-1.31147541	0.16343684	-0.21756867	1.09837631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091399-01	Benzothiazole	17389158		DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-4.9610828342	4	4	CIPLUS_150270;Benzothiazole;benzothiazole;AB07993090-01;	0	-0.47755492					S1C=NC2=CC=CC=C12	NIEHS	AB07993090	-1.31147541	-0.49031053	-1.30541202	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181765-03	Pranlukast hydrate	384568399	Leukotriene CysLT1/2 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	103177-37-3				-4.6879377859	4	4		0	-2.05348615				CYSLTR1	O=C(NC1=CC=C2C(=O)\C=C(/OC2=C1)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	Selleck	S1829	-0.6557377	-1.19075414	-0.92466685	-2.05348615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178255-02	QUININE ETHYL CARBONATE		Ferriprotoporphyrin IX Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	83-75-0		10	-5	4.7285231143	4	4		12.5175643999	10.79274117	0.1046250876	0.9932564406			CCOC(=O)O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)C3=C4C=C(OC)C=CC4=NC=C3	Microsource	00310050	-1.264637	-0.21013308	0.05439217	10.79274117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164563-04	Entecavir (monohydrate)		DNA Polymerase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	209216-23-9				1.1347697426	4	4		0	1.14613181				SLC22A3	NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	0.18735363	0.58370301	-0.87027468	1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183030-02	Terodiline hydrochloride		HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	7082-21-5		11.220184543	-4.95	14.4765671923	4	4		27.4289049679	21.53772684	0.0320799186	0.9993664121			CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C	SIGMA	T4577	-0.56206089	-1.19075414	0.92466685	21.53772684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181788-01	Cefetamet pivoxil HCl	144206472		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	111696-23-2	Cefetamet pivoxil hydrochloride; Ro 15-8075; Ro-15-8075; Cefyl; 			0.3685955229	4	4	cefetamet pivaloyloxymethyl ester;7-(2 (2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-desacetoxyceph-3-em-4-carboxylic acid pivaloyloxymethyl ester;Cefyl;CIPLUS_685427;CEFETAMET PIVOXIL HYDROCHLORIDE;cefetamet pivoxil;CIPLUS_691806;Cefetamet pivoxil hydrochloride;Cefetamet Pivoxil Hydrochloride;Ro 15-8075;Ro-15-8075;CIPLUS_741318;cefetamet pivoxyl;	0	1.41040462					Cl.CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)C(=N\OC)\c1csc(N)n1)C=3C(=O)OCOC(=O)C(C)(C)C	ACC	CEFETAMET PIVOXIL HCl	-0.10282776	-0.02606882	-0.57909976	1.41040462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183870-01	Ethoheptazine hydrochloride	144206778	Opioid receptors; mu/kappa/delta Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	5982-61-6				1.5870090534	4	4	Equagesic;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester;Ethoheptazinum;heptacyclazin;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester, citrate;MEPROBAMATE;ERBULOZOLE ETHOHEPTAZINE;CIPLUS_213306;4-carbethoxy-1-methyl-4-phenylazacycloheptane;ethoheptazine citrate (1:1);ethylheptazine;CIPLUS_149424;LS-22816;ETHOHEPTAZINE CITRATE;ASPIRIN;ethoheptazine;LS-178547;LS-22817;1-methyl-1-carbethoxy-4-phenyl hexamethylenimine citrate;ethoheptazine HCl;ETHOHEPTAZINE;CIPLUS_165746;Etoheptazina;CIPLUS_675824;Ethoheptazine;ethoheptazinum;Ethoheptazine citrate;Ethoheptazine Citrate;	0	-0.34682081					Cl.CN1CCCC(CC1)(C(=O)OCC)c2ccccc2	NCI	NSC_400484	1.1311054	-0.9645464	-0.52645433	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-02	Ibandronate sodium hydrate	225144338	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	138926-19-9	Ibandronate sodium			-2.4165184139	4	4		0	-0.99421965				FDPS	CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	Prestwick	Prestw-1285	-0.10282776	-0.49530761	-0.6317452	-0.99421965												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00507775-01	Midecamycin Acetate		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	55881-07-7				-3.2130801929	4	4		0	0.55055055					CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@](C)(OC(C)=O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	AvaChem	2845	-0.8110687	-1.38453501	-0.83791568	0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532515-01	ROBENACOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					5.7023890936	4	4		0	1.5015015					CCC1=CC=C(NC2=C(F)C(=CC(=C2F)F)F)C(=C1)CC(O)=O	J&W Pharm	99R0028	-0.04770992	1.07105538	5.65593087	1.5015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346529-03	Safinamide		Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	133865-89-1				-5.1423398429	4	4		0	-0.4004004					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	-1.28816794	-1.2800418	-0.94265515	-0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181041-01	5-Chloro-2-methyl-3(2H)-isothiazolone	144206242	aerobic respiration Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	26172-55-4				-2.3073788831	4	4	MBC-215;5-chloro-N-methylisothiazolone;5-Chloro-2-methyl-4-isothiazolin-3-one solution;5-chloro-2-methyl-4-isothiazolin-3-one hydrochloride;5-Chloro-2-methyl-3(2H)-isothiazolone;5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE;5243-K-Cg;CIPLUS_182875;Kathon 886 biocide;MBC 215;5-Chloro-2-methyl-isothiazol-3-one;Kathon CG;5-chloro-2-methylisothiazolin-3-one;CIPLUS_182376;CIPLUS_180763;methylchloro-isothiazolinone;CIPLUS_175198;METHYLCHLOROISOTHIAZOLINONE;LS-86318;LS-174152;CIPLUS_694515;5-chloro-2-methyl-4-isothiazolin-3-one;Kathon 886;Kathon WT;Kathon biocide;kathon cg 5243;	0	-2.002002					ClC1=CC(=O)N(C)S1	SigmaAldrich	344	0.04770992	-0.33960293	-0.99502488	-2.002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508704-02	HALOPERIDOL DECANOATE		Dopamine D4 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE			12.5892541179	-4.9	14.9532360449	4	4		16.5	14.81481481	0.0882852749	0.9951933735			CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Key Organics	KS-1419	1.24045802	0.70532915	0.31421838	14.81481481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185775-01	Salidroside	144207114	beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	10338-51-9				-0.2113335181	4	4		0	0.75075075				APP	Oc2ccc(CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)cc2	Sinova	SL-02667	-0.23854962	-0.86206897	0.62843676	0.75075075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174046-02	Imidocarb dipropionate	170466330	Adenosine deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	55750-06-6				2.9460747628	4	4		0	1.14112715					CCC(=O)O.CCC(=O)O.O=C(Nc1cc(ccc1)C2=NCCN2)Nc3cccc(c3)C4=NCCN4	Vitas	STK379516	-0.38860104	1.38956607	2.3659703	1.14112715												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015155-11	Bepridil	170465240	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	64706-54-3	 ; Bepridil, (-)-Isomer; Bepridil;Bepridil; Vascor;Bepridil hydrochloride; Bepridil, (+)-Isomer	12.5892541179	-4.9	104.3581049027	3	4		120.1563162583	96.70097651	0.0087259762	0.999953035		KCNT1	CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3	BIOMOL	AC104	-0.25894539	-0.34794711	-0.94492441	96.70097651												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159478-04	Benzoxiquine	170465534		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	86-75-9				-3.1336428407	4	4		0	-0.52784376					O=C(Oc1cccc2cccnc12)c3ccccc3	Specs	AE-848/01460057	-0.54143126	-1.04384134	-0.78293736	-0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025158-02	(S)-(+)-Dimethindene maleate	170465880	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1217457-81-2		2.5118864315	-5.6	11.9344522567	4	4		10.5	10.53933696	0.0115763723	0.9999183259			C[C@@H](C=1c2ccccc2CC=1CCN(C)C)c3ccccn3.O=C(O)/C=C\C(=O)O	Tocris	1425	0.04833253	0.024667	0.25453388	10.53933696												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183004-01	Alilusem potassium	144206835	renal sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	114417-20-8	M-17055; Alilusem Potassium; 			2.7112679886	4	4	Alilusem Potassium;M-17055;7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid;LS-77484;M17055;CIPLUS_774461;M 17055;	0	0.74220683					[K+].Cc1ccccc1C(=O)N3CC/C(=N\OS([O-])(=O)=O)c2ccc(Cl)cc23	Pharmaron	PH-NIH-151932	1.40164331	-0.81401085	-0.12726694	0.74220683												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015237-07	Carbachol	170464972	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-83-2				0.9244530969	4	4		0	0					[Cl-].C[N+](C)(C)CCOC(=O)N	Enzo	AC911	-0.48332528	0.12333498	1.65447025	0												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179246-05	VIOMYCIN SULFATE		70s Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	37883-00-4				-0.4071287415	4	4		0	0.85959885					NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)[C@H]2C[C@H](O)N=C(N)N2	Microsource	01503848	-0.18735363	-0.81718422	0	0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344546-01	Fenipentol	225144389		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	583-03-9				1.2577621562	4	4		0	-0.47755492					CCCCC(O)C1=CC=CC=C1	Prestwick	Prestw-1501	1.03044496	-0.9105767	-0.54392168	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178826-03	Glucosamine hydrochloride	170466505	Solute carrier organic anion transporter family member 1B3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	66-84-2				-3.0709256128	4	4		0	0.09551098					Cl.O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1N	Microsource	01500316	-0.84309133	-0.81718422	-0.59831384	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167552-01	Piperocaine hydrochloride	144206100	Nicotinic acetylcholine receptor  Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	533-28-8	piperocaine; Piperocainio; Neothesin; 			-3.6451984236	4	4	Piperocaine;2-methylpiperidinepropanol benzoate;piperocaine hydrochloride;Neothesin;Piperocainio;CIPLUS_667885;piperocaine;Piperocainum;LS-172947;Methycaine hydrochoride;LS-116051;piperocaine, (+-)-isomer;(+/-)-2-methyl-1-piperidinepropanol benzoate (ester);PIPEROCAINE;piperocainum;CIPLUS_699088;piperocaine monohydrochloride, (+-)-isomer;CIPLUS_154086;CIPLUS_660991;PIPEROCAINE HYDROCHLORIDE;1-Piperidinepropanol, 2-methyl-, benzoate (ester), hydrochloride;METHYCAINE HYDROCHORIDE;metycaine hydrochloride;	0	1.48042025					Cl.CC2CCCCN2CCCOC(=O)c1ccccc1	SigmaAldrich	S403253	-1.54566745	-0.77048798	-0.38074517	1.48042025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094619-06	Chloramphenicol sodium succinate	170465429	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	982-57-0				-1.9565422941	4	4		0	1.47796252					[Na+].O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl	SIGMA	C3787	-0.9180791	-1.67014614	-0.674946	1.47796252												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091326-06	Acetanilide	170465493		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	103-84-4				-1.7106398004	4	4		0	-0.26392188					O=C(C)Nc1ccccc1	Vitas	STK046402	-0.6826742	1.60055672	-1.21490281	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015430-06	Fenoterol hydrobromide	170465657		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1944-12-3				1.6977035132	4	4		0	2.74478754					Br.Oc1cc(cc(O)c1)C(O)CNC(C)Cc2ccc(O)cc2	Microsource	01501007	-0.72975518	2.36604036	-1.53887689	2.74478754												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344584-01	Verapamil	170464904	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	52-53-9				8.5318752117	4	4		0	8.76220639				DRD2	COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C	SIGMA	V106	-0.9180791	2.71398747	-1.21490281	8.76220639												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179580-04	Biotin	170464763		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58-85-5				10.4159002542	4	4		0	1.68910003					O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1	Vitas	STK801941	2.33050847	4.24495477	1.21490281	1.68910003												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00345792-04	AN-2728		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	906673-24-3				-2.8641955996	4	4		0	1.59313725				PDE4A	OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N	MedChem Express	HY-10978	-1.18447581	-0.1029601	-1.37101287	1.59313725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095054-05	Resorcinol monoacetate	170465513		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	102-29-4				-0.5302408093	4	4		0	-0.22058824					O=C(C)Oc1cccc(O)c1	Microsource	01503500	-0.37802419	1.38996139	-0.53161724	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016403-06	Mafenide hydrochloride	170465055	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	138-37-4				-4.688277745	4	4		0	0.4453241					Cl.O=S(N)(=O)c1ccc(CN)cc1	Vitas	STK083032	-1.40164331	-1.1100148	-1.71810372	0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015520-11	Hydroxyurea	170465025	Ribonucleoside-Diphosphate Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	127-07-1	 Hydroxyurea;HYDROXYUREA;Hydroxyurea			-2.9680000766	4	4		0	-0.74220683			6240	RRM1	NC(=O)NO	Microsource	01500344	-0.77332044	1.35668476	-1.59083678	-0.74220683												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021274-04	ESTRADIOL BENZOATE			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-50-0				-2.2632501464	4	4		0	-0.02630887					C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)C5=CC=CC=C5)[C@@H]1CC[C@@H]2O	SIGMA	E8515	-0.53268765	-0.30112923	-0.98809222	-0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160527-03	Mosapride citrate	170466008	5-HT4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	112885-42-4	; Gasmotin; ;Mosapride citrate; Mosapride citrate;AS-4370			2.6472769273	4	4		0	1.97316496			3360	HTR4	O=C(O)C(O)(CC(=O)O)CC(=O)O.Clc1cc(c(OCC)cc1N)C(=O)NCC3CN(Cc2ccc(F)cc2)CCO3	Vitas	STK711184	0.33898305	-0.70263488	0.32936407	1.97316496												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015693-09	Mitoxantrone	170465183	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	70476-82-3	 ;Mitoxantrone; Mitoxantrone Hcl; Mitoxantrone; Mitozantrone;MITOXANTRONE HYDROCHLORIDE; Mitoxantrone dihydrochloride;Mitoxantrone dihydrochloride; Mitoxantrona;Mitoxantrone di?HCl;MITOXANTHRONE HYDROCHLORIDE			-4.2584399565	4	4		0	1.92054722			7153	TOP2A	Cl.Cl.OCCNCCNc3ccc(NCCNCCO)c2C(=O)c1c(O)ccc(O)c1C(=O)c23	Microsource	01503278	-1.7433414	-1.706399	-1.84950595	1.92054722												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166153-02	Climbazole	170465557		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	38083-17-9				-2.0392074732	4	4		0	-0.28939753					CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2	Bosche	C1228	-0.5811138	-0.35131744	-0.38003547	-0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167491-04	Lenalidomide	170465201	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	191732-72-6	; IMiD3 cpd; Lenalidomide;Lenalidomide;ENMD-0997; Revimid;CC-5013; Lenalidomide(Revlimid);Revlimid; Revlimid			-1.1293952639	4	4		0	1.76269403			7124	TNF	O=C1NC(=O)CCC1N3Cc2c(cccc2N)C3=O	Selleck	S1029	-0.5811138	-1.05395232	-1.19077781	1.76269403												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015848-09	Tranylcypromine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-2_CPE					2.4856966224	4	4		0	0.49986846					N[C@@H]1C[C@H]1C2=CC=CC=C2	Tocris	3852	0.33898305	-1.05395232	1.95084875	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182989-01	Glyclopyramide	144206854		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	631-27-6	Glyclopyramide; Deamelin-S; Gliclopiramida; 			1.5977786058	4	4	glyclopyramidum;1-(p-chlorobenzenesulfonyl)-3-pyrrolidin-1- ylurea;Glyclopyramide;CIPLUS_214070;GLYCLOPYRAMIDE;Deamelin-S;glyclopyramide;Gliclopiramida;Glyclopyramidum;	0	0.69272637					O=C(NS(=O)(=O)c1ccc(Cl)cc1)NN2CCCC2	Pharmaron	PH-NIH-169404	0.48332528	-0.37000493	0.19090041	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181103-02	Propiverine hydrochloride	170466036	Muscarinic acetylcholine receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	54556-98-8		12.5892541179	-4.9	74.8399860283	3	4		67.2471548775	57.59524988	0.0530305496	0.9982620187			Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3	Sequoia	54556-98-8	4.39826003	2.34336458	1.78173719	57.59524988												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181782-03	Sertindole	170465613	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	106516-24-9		1.5848931925	-5.8	23.711046083	4	4		19.7927400439	-2.72206304	1	0.9984179658			Fc1ccc(cc1)n5cc(C3CCN(CCN2CCNC2=O)CC3)c4cc(Cl)ccc45	Prestwick	Prestw-1341	-1.07728337	0.49031053	18.05819962	-2.72206304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021666-04	Nalmefene	170465281	Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	55096-26-9				6.9564392437	4	4		0	1.25					C=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick Chemical, Inc.	Prestw-1490	1.63810484	1.5958816	1.03525462	1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091151-04	Phenoxyacetic acid	170465537	cell proliferation Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	122-59-8				0.0656630435	4	4		0	0.07352941					O=C(O)COc1ccccc1	Vitas	STK300005	-0.88205645	0.41184041	2.8259653	0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249886-01	Prednisolone tebutate	170465430		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	7681-14-3				-1.6060059066	4	4		0	1.86792949					CC(C)(C)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-19	-1.3559322	-0.30112923	-0.88674943	1.86792949												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159384-04	6-Chlorothymol	170465546	Estrogen receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	89-68-9				-0.6897198592	4	4		0	0.71033938					Oc1cc(C)c(Cl)cc1C(C)C	Labotest	LTBB003695	0	-1.45545797	-0.43070687	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263949-02	Piperacillin sodium salt	170465380	Penicillin-binding protein 2B Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59703-84-3				0.0041502313	4	4		0	1.49960537			933948	penA	[Na+].O=C([O-])[C@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)[C@H]4SC3(C)C	Microsource	01500489	-0.1937046	-0.35131744	-0.98809222	1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166218-02	4,4'-Dinitrodiphenylurea	170465744		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	587-90-6				0.6150606318	4	4		0	-0.94012865					O=C(Nc1ccc(cc1)[N+]([O-])=O)Nc2ccc(cc2)[N+]([O-])=O	Specs	AN-153/I108774	0.09666506	-0.76467686	1.90900414	-0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249938-01	Glymidine sodium	170465939		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3459-20-9				9.1033379413	4	4		0	2.37506185					[Na+].O=S(=O)([N-]c1ncccn1)c2cc(OCCOC)ccc2	GVK	FFS-11-286-NCI-256	2.12663122	1.55402072	1.39993637	2.37506185												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015080-08	Methylatropine nitrate	170465893	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	52-88-0				1.7676210056	4	4		0	1.03908956					C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3.[O-][N+]([O-])=O	Vitas	STK108600	-0.28999517	-0.81401085	1.65447025	1.03908956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160383-02	Lenperone Hydrochloride		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	24677-86-9				0.0180995499	4	4		0	2.05348615					FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)C(=O)C3=CC=C(F)C=C3	Glixx	GLXC-06484	-0.42154567	-0.30352557	-0.32635301	2.05348615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538146-01	NCGC00538146-01		Adrenergic receptor beta Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.6365406937	4	4		0	-1.67144222					CN1\C=C(\OCC(O)CNC(C)(C)C)C2=C(C=CC=C2)C1=O	Pharmaron	PH-NIH-2017-009-L1-4-0	-1.12412178	-0.07004436	0.76149035	-1.67144222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532506-01	SODIUM LAURYL SULFOACETATE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.6965045101	4	4		0	0.09551098					CCCCCCCCCCCCOC(=O)C[S]([O-])(=O)=O	SIGMA	MFCD00214054	-1.45199063	-0.30352557	0.21756867	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388284-07	Darunavir (Ethanolate)		Hiv Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	635728-49-3				-4.2327536734	4	4		0	-1.05062082					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)[S+]([O-])(=O)C4=CC=C(N)C=C4	MedChem Express	HY-17041	-1.12412178	-1.09736166	0.27196084	-1.05062082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184999-01	Sultopride hydrochloride	144207174	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	23694-17-9				-3.2721972118	4	4	Sanofi Synthelabo brand of sultopride hydrochloride;CIPLUS_3883483;DAN 2163;N-(ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide;Sultopride;Sultopride Hydrochloride;sultopridum;SULTOPRIDE;sultopride;LIN 1418;CIPLUS_181627;sultopride hydrochloride;SULTOPRIDE HYDROCHLORIDE;Sultopride hydrochloride;Barnetil;Sultroprida;LS-20057;amisulpride;CIPLUS_182211;Solian;Sultopridum;	0	0.66857689					Cl.CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(=O)(=O)CC	Toronto Research	S790510	-1.8735363	1.937894	-0.48952951	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161344-07	Eicosapentaenoic Acid		lipoprotein oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	10417-94-4				-5.6836243075	4	4		0	-1.29901961					CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/CCCC(O)=O	MedChem Express	HY-B0660	-1.63810484	0.66924067	-1.42697258	-1.29901961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346517-07	Daptomycin		Lipopeptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	103060-53-3				-7.2362000124	4	4		0	-2.03431373					CCCCCCCCCC(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@@H](C)CC(O)=O	Enzo	A201	-1.53729839	-0.36036036	-1.98656967	-2.03431373												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00185990-04	Ketorolac	170464659	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	74103-07-4	Ketorolac tromethamine;KETOROLAC TROMETHAMINE			-1.105008416	4	4		0	-0.22058824				PTGS1	OCC(N)(CO)CO.O=C(O)[C@@H]1CCn2c(ccc12)C(=O)c3ccccc3	Vitas	STL018674	-0.07560484	-0.25740026	-0.81141578	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263960-01	OXANTEL PAMOATE		antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					7.612858561	4	4		0	3.1127451					CN1CCC/N=C1/C=C/C2=CC=CC(=C2)O.OC(=O)C3=CC4=CC=CC=C4C(=C3O)CC5=C(O)C(=CC6=CC=CC=C56)C(O)=O	Microsource	MS-01505982	1.38608871	1.18404118	1.31505316	3.1127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-32	NCGC00013226-32			DPI_SARS-CoV-2_General	2019_NPC-5_CPE			2.8183829313	-5.55	37.0885317014	4	4		31.735521236	-2.86764706	1	0.9988297213			CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	Labotest	LT00452002	-0.07560484	-1.02960103	26.27308338	-2.86764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165736-04	Acadesine	170465608	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2627-69-2	AICAR/AR-100/SCH-900395; AICA ribonucleoside; Acadesine (AICAR); Acadesine;Acadesine; Acadesina; AICA riboside; Z-riboside; 			-1.084746975	4	4		0	-0.0245098			5562	PRKAA1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2N	Tocris	2840	-0.78125	-0.15444015	1.48293229	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182036-01	Peplomycin sulfate	144206501		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	70384-29-1	Peplomycin sulfate; Peplomycin Sulfate (1:1); Peplomycina; Sulfate, Peplomyci; Pepleo; 			-5.8778662944	4	4	nk 631;Peplomycin;Sulfate, Peplomyci;Pepleo;Peplomycine;bleomycin pep;Peplomycina;NK63;Peplomycin Sulfate;CIPLUS_188638;LS-177021;PEPLOMYCIN SULFATE;Peplomycinum;LS-44906;Bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-;NK-631;peplomycinum;LS-102345;CIPLUS_699356;Peplomycin Sulfate (1:1);Peplomycin sulfate;NK 63;PEPLOMYCIN;peplomycine;	0	-2.13235294					O=C(N)C(N)CNC(CC(=O)N)c1nc(N)c(C)c(n1)C(=O)NC(C(O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]2O)c4cncn4)C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCN[C@@H](C)c7ccccc7)C(C)O.O=S(=O)(O)O	ACC	PEPLOMYCIN SULFATE	-1.08366935	-0.46332046	-1.70677112	-2.13235294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021761-05	Flumethasone	170465750	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2135-17-3				-5.6702829588	4	4		0	0.07352941					OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-734	-1.48689516	-0.77220077	-1.98656967	0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-14	Trametinib		Mek 1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1204531-25-8				-10.7389538592	4	4		0	-2.08333333				MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	ActiveBioChem	A-1258	-2.49495968	-1.6988417	-2.32232792	-2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181335-02	Fosfestrol tetrasodium	225144324	estrogen-related receptor gamma Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	4719-75-9				1.6331862079	4	4		0	0.41666667			2104	ESRRG	CC\C(=C(\CC)C1=CC=C(O[P](O)(O)=O)C=C1)C2=CC=C(O[P](O)(O)=O)C=C2	Bosche	F12397	-0.52923387	2.26512227	-1.14717403	0.41666667												1.6E-9	8E-9	4E-8	2E-7											
NCGC00181110-02	Cambendazole	124893647	glucose transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-5.7264621468	4	4		0	-0.75980392					CC(C)OC(=O)NC1=CC2=C([NH]C(=N2)C3=CSC=N3)C=C1	SigmaAldrich	32593	-1.63810484	-0.36036036	-1.03525462	-0.75980392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167798-05	Oxaliplatin		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	61825-94-3				-7.3346251069	4	4		0	-1.74019608				H2AFX	O=C1O[Pt]2(NC3CCCCC3N2)OC1=O	Cayman	13106	-1.73891129	-1.13256113	-1.14717403	-1.74019608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022408-04	Flumethasone pivalate			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2002-29-1				-1.5085271017	4	4		0	-0.28939753					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	SIGMA	F0891	0.5811138	-1.00376412	-1.49480618	-0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024246-15	Daunorubicin	170465048	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	20830-81-3	 WP900 hydrochloride; Cerubidine;Daunorubicin hydrochloride; ;; Daunoblastine;DAUNORUBICIN; Daunorubicin; Daunomycin HCL; Dauno-Rubidomycine; Daunomycin, hydrochloride; Daunomycin hydrochloride; Daunoblastin; Dauno Rubidomycin;Daunomycin hydrochloride; (-)-Daunorubicin			-2.4170562952	4	4		0	1.7100763				TOP2A	CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4	Microsource	01500223	-0.82324455	-0.80301129	-2.10286293	1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095129-06	Valdecoxib	170465163	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	181695-72-7				2.4597599586	4	4		0	-0.74220683				COX2	NS(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	SIGMA	PZ0179	0.53165781	0.12333498	2.09990455	-0.74220683												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	103766-25-2	Gimeracil			4.5453622435	4	4		0	2.62246413			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	-0.24166264	1.40601875	1.08176901	2.62246413												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015277-17	Cinoxacin	170465414	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	28657-80-9				1.1567839929	4	4		0	-0.59376546					O=C(O)C2=NN(CC)c1cc3OCOc3cc1C2=O	Microsource	01500190	0.91831803	-0.51800691	0.4454343	-0.59376546												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253607-01	Watanidipine	170465844	calcium ion transmembrane transport Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	116308-55-5				2.2831439032	4	4		0	0.69272637					[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCc3ccc(cc3)N4CCN(CC4)C(c5ccccc5)c6ccccc6	GVK	FFS-11-286-NCI-247	-0.57999033	-0.86334484	3.05440662	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167563-01	Mofezolac	144206111	Cyclooxygenase-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	78967-07-4	Mofezolac; Mofezolaco; 			1.7951623785	4	4	mofezolac;n-22;(3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid;mofezolacum;(3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid;Mofezolac;CIPLUS_213447;Mofezolaco;LS-86501;N-22;3,4-BIS(P-METHOXYPHENYL)-5-ISOXAZOLEACETIC ACID;3,4-DMPIAA;N 22;MOFEZOLAC;Mofezolacum;	0	-0.38204394					O=C(O)Cc2onc(c1ccc(OC)cc1)c2c3ccc(OC)cc3	SigmaAldrich	R678899	-0.42154567	1.47093159	3.04596138	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482976-01	Vorapaxar Sulfate		Proteinase-activated receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	705260-08-8		8.9125093813	-5.05	53.5101506848	2.2	4		75.1932802894	63.41929322	0.0169092915	0.999823649	2149	F2R	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3C([C@@H](C)OC3=O)[C@H]2\C=C\C4=NC=C(C=C4)C5=CC(=CC=C5)F	DC Chemicals	DC8229	-0.18735363	-0.58370301	10.00815883	63.41929322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166307-05	ERGOCALCIFEROL		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	50-14-6				1.7268740507	4	4		0	1.8872549					CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	E5750	-0.63004032	0.82368082	1.93060996	1.8872549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016497-09	Ethionamide	170465169	Cell Wall Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	536-33-4	 ; Ethionamide; Trecator S; Trecator;Ethionamide; Etionamida;ETHIONAMIDE; 9   Ethionamide; Trecator-SC			-4.7239597006	4	4		0	-0.85784314					CCc1cc(ccn1)C(N)=S	Microsource	01500292	-1.33568548	-0.20592021	-0.75545607	-0.85784314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507774-01	Cefbuperazone 		Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	76610-84-9				-7.1001671263	4	4		0	-1.39705882					CCN1CCN(C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@]2(OC)[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C(=O)C1=O	AvaChem	2487A	-1.94052419	-0.87516088	-0.69949636	-1.39705882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095156-06	Carbadox	170466261		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	6804-07-5				-3.456317991	4	4		0	-0.6127451					O=C(OC)N\N=C\c2c[n+]([O-])c1ccccc1[n+]2[O-]	Microsource	01505294	-0.93245968	-0.46332046	-0.41969782	-0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167969-02	Rubitecan	124893436		DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-11.3105336767	4	4		0	-0.56372549					CC[C@@]1(O)C(=O)OC/C2=C1/C=C/3N(CC4=CC5=C(C=CC=C5[N+]([O-])=O)N=C34)C2=O	SIGMA	R3655	-2.89818548	-2.11068211	-1.87465025	-0.56372549												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00181300-01	Riboflavin tetrabutyrate	144206329	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	752-56-7	CIPLUS_668986; Hibon; vitamin B2 tetrabutyrate; 			8.0897234066	4	4	Hibon;Riboflavin butyrate;Riboflavin Butyrate;riboflavin tetrabutyrate, riboflavin-2-14C-labeled;vitamin B2 tetrabutyrate;RIBOFLAVIN BUTYRATE;riboflavin tetrabutyrate;CIPLUS_668986;	0	4.04411765					CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12	ACC	riboflavin butyrate	0.9828629	2.00772201	1.65081142	4.04411765												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160444-02	Clofenamide	170466058	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	671-95-4				-3.9067599343	4	4		0	0.0245098					O=S(N)(=O)c1cc(ccc1Cl)S(N)(=O)=O	Enamine	Z401602360	-1.18447581	-0.30888031	-0.97929491	0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025125-18	Colchicine	170465011	Tubulin polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	64-86-8	; ; Colchicine;COLCHICINE; Colchicine derivatives; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer;Colchicine			5.2868572807	4	4		0	3.7605146			203068	TUBB	CC(=O)N[C@H]2CCc3cc(OC)c(OC)c(OC)c3C1=CC=C(OC)C(=O)C=C12	Prestwick Chemical, Inc.	Prestw-363	0.91831803	-1.06068081	0.19090041	3.7605146												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091865-02	Benzyl alcohol	124891475		DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.4859133946	4	4		0	-1.1938873					OCC1=CC=CC=C1	SigmaAldrich	108006	-0.74941452	-0.86388046	-0.10878433	-1.1938873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346551-03	Pomalidomide		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	19171-19-8				-1.1329270455	4	4		0	-1.71919771				TNF	NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1	APExBIO	A4212	0.14051522	-0.35022181	0.05439217	-1.71919771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018166-02	Estradiol valerate			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	979-32-8				-0.0693715084	4	4		0	1.14613181					CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)O)[C@H]3CC[C@]12C	APExBIO	B1506	-1.31147541	0.58370301	2.88278488	1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181294-01	Thiamine disulfide	144206326	HIV Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	67-16-3	thiaminedisulfide monoorotate; Thiamine Disulfide(TDS); Allynate F; Thiamine Phosphate; 			-0.1289394221	4	4	CIPLUS_3852341;thiaminedisulfide monoorotate;Thiamine Disulfide(TDS);Allynate F;CIPLUS_3887567;thiamine disulfide;Thiamine Disulfide Phosphate;Thiamine disulfide;THIAMINE DISULFIDE;thiooratin;N,N'-(dithiobis(2-(2-hydroxyethyl)-1-methylvinylene))bis(N-((4-amino-2-methyl-5-pyrimidinyl)-methyl)formamide);thiamine disulphide;Thiamine Phosphate;CIPLUS_789114;Thiamine Disulfide;CIPLUS_206877;CIPLUS_781198;	0	1.28939828					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCO)SSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N	ACC	thiamine disulfide	-0.09367681	-0.67709549	-0.54392168	1.28939828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522027-01	Predocol			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	630-67-1				1.9162281242	4	4		0	3.67717287					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C5=CC(=CC=C5)[S]([O-])(=O)=O	Toronto Research	P703795	-0.56206089	0.21013308	0.65270601	3.67717287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167451-04	Halobetasol Propionate			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	66852-54-8				-3.0637770871	4	4		0	-1.25					CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	APExBIO	B1767	-0.68044355	-0.30888031	-0.25181869	-1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015242-13	Chlorothiazide	170465303	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	58-94-6	; ; Clorotiazida;CHLOROTHIAZIDE; Chlorothiazide;Chlorothiazide; Fluitoran; SK-Chlorothiazide			12.434262509	4	4		0	0.66176471				SLC12A3	NS(=O)(=O)c2cc1c(N=CNS1(=O)=O)cc2Cl	Microsource	01500180	3.20060484	3.34620335	2.04252938	0.66176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182546-02	Gefarnate	170465908	positive regulation of mucus secretion Interacts	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	51-77-4				-4.6237905507	4	4		0	-1.29901961					C\C(C)=C\CCC(\C)=C\COC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C	Sequoia	51-77-4	-1.18447581	0.36036036	-1.25909345	-1.29901961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182034-01	Teprenone	144206513	Heat shock 70 kDa protein 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	6809-52-5	Teprenone; Selbex; Teprenona; 			-2.0070899491	4	4	CIPLUS_165824;tetraprenylacetone;geranyl-geranyl-acetone;Teprenone;teprenonum;Selbex;LS-174701;teprenon;TEPRENONE;LS-174702;Teprenona;geranylgeranylacetone, (Z,E,E)-isomer;6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one;CIPLUS_3885398;LS-96803;tetraprenyl acetone;geranylgeranylacetone;Teprenonum;geranylgeranylacetone, (E,E,E)-isomer;teprenone;	0	0.80882353					C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(C)=CCCC(C)=O	ACC	TEPRENONE	-1.63810484	4.06692407	-1.81869054	0.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1370468-36-2				-2.1765044996	4	4		0	-1.20098039					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	-0.73084677	1.5958816	-0.75545607	-1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263572-01	Deferasirox	170464723	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	201530-41-8		12.5892541179	-4.9	28.4739778463	3	5		43.6293071408	37.72819473	0.0043355755	0.9978270571		CAT	O=C(O)c1ccc(cc1)n3nc(nc3c2ccccc2O)c4ccccc4O	Sequoia	201530-41-8	-0.12210012	-0.7585335	1.33234641	0.14357502	37.72819473											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160423-02	Bamethan	225144236		DPI_SARS-CoV-2_General	2019_NPC-1_CPE					2.275247523	4	5		0	3.0831643					CCCCNCC(O)C1=CC=C(O)C=C1	SIGMA	R416398	-0.85470085	2.02275601	0.39476931	-0.19143336	3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016239-04	Methantheline bromide	170465350	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	53-46-3				7.8879327895	4	5		0	3.65111562			3274	HRH2	[Br-].CC[N+](C)(CC)CCOC(=O)C1c3ccccc3Oc2ccccc12	Prestwick	Prestw-1066	0.61050061	1.8710493	0.44411547	3.44580043	3.65111562											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025341-06	Isradipine	170465070	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	75695-93-1	;Isradipine; Isradipine; DynaCirc; Lomir; Isradipine, (S)-Isomer; Dynacirc; Isaradipine; Isradipine, (R)-Isomer; Isradipine, (+-)-Isomer			2.569473169	4	5		0	5.03042596					O=C(OC)C3=C(C)NC(C)=C(C(=O)OC(C)C)C3c1cccc2nonc12	Tocris	2004	0.46398046	-1.6182048	-0.78953861	-0.52644173	5.03042596											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013724-07	(-)-Scopolamine methyl bromide			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	155-41-9				-0.2064156461	4	5		0	1.29817444					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@@H](C[C@@]2([H])[N+]3(C)C)OC(=O)[C@H](CO)C4=CC=CC=C4	SIGMA	S8502	-0.75702076	0.4551201	-1.13496176	1.00502513	1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160515-02	Acarbose	170464784	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56180-94-0	; Lasa Brand of Acarbose; Glucobay; Glumida; Bayer Brand of Acarbose; Precose;ACARBOSE; Prandase;Acarbose; Glucor; Acarbosa			-3.5128840671	4	5		0	-0.97363083			2548	GAA	OCC4=C[C@H](N[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]1C)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](O)[C@@H]4O	Vitas	STK801930	-0.51282051	-0.9102402	-1.28300025	-0.43072505	-0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166262-03	Ensulizole	170465490		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	27503-81-7				-2.3085225393	4	5		0	-0.81135903					O=S(=O)(O)c1cc2nc(nc2cc1)c3ccccc3	Vitas	STK034479	0.31746032	-2.02275601	-0.34542314	-0.90930845	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181770-02	Garenoxacin mesylate hydrate	170465937	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	223652-90-2				5.6151618752	4	5		0	5.59837728					O.CS(=O)(=O)O.C[C@H]1NCc2cc(ccc12)c3ccc4c(c3OC(F)F)N(C=C(C4=O)C(=O)O)C5CC5	APAC	816272	-0.36630037	-0.8091024	0.49346163	0.76573343	5.59837728											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00164619-02	Anastrozole	170464923	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	120511-73-1	Anastrozole; Anastrozole; ; Arimidex; Zeneca ZD 1033; 4   Anastrazole			1.065160411	4	5		0	0.16227181			1588	CYP19A1	N#CC(C)(C)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2	Sequoia	SRP05647a	0.65934066	-1.1125158	-0.14803849	0.86145011	0.16227181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348371-01	Chloramphenicol palmitate		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	530-43-8				-1.8377022341	4	5		0	-0.48681542					CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	FLUKA	46109	0.21978022	-1.3653603	-1.13496176	-0.19143336	-0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015854-10	Propantheline bromide	170464881	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-34-0				-2.8749928775	4	5		0	-0.73022312					[Br-].CC(C)[N+](C)(CCOC(=O)C1c3ccccc3Oc2ccccc12)C(C)C	Microsource	01500511	-0.9035409	-1.3147914	-0.09869233	0.47858339	-0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025212-08	Cantharidin	170465704	PP-1 Inhibitors;PP-2A Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56-25-7				3.7751546822	4	5		0	1.86612576				PPP1CA	O=C2OC(=O)[C@]3(C)C1CCC(O1)[C@]23C	Enzo	PR105	1.83150183	-2.07332491	-0.09869233	0.71787509	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095795-06	5,7-Dichloro-8-hydroxy-2-methylquinoline	170465701	Botulinum neurotoxin type A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72-80-0				5.0124654047	4	4		0	1.97316496					Oc1c(Cl)cc(Cl)c2ccc(C)nc12	Microsource	00212151	2.08232446	-0.65244667	-0.53204966	1.97316496												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093347-05	Mestranol	170465357	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72-33-3	; Sequens;Mestranol; Infecundin; Aconcen;Ethynylestradiol 3-methyl ether; Norinyl 1-50; Angravid; Estirona; Orthonovin; Bisecurin I; Ovosiston; Ovaras; Ortho Novum; Sequence-Ovosiston; Bisecurin; Sesquelan; ; Ovulen; Ortho-Novum; Norinyl; Femigen; C-quens; Gestranol; Mestranol; Enovid-E	12.5892541179	-4.9	9.4217810478	4	4		13.8681276919	10.7077085	0.1024908113	0.9935307262	2099	ESR1	COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick Chemical, Inc.	Prestw-846	-0.53268765	-0.20075282	-1.14010641	10.7077085												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253579-01	Bolandiol dipropionate	170465909	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1986-53-4				6.3368578229	4	4		0	1.3943699					CCC(=O)O[C@H]2CCC3C4CCC1(C)C(CC[C@@H]1OC(=O)CC)C4CCC3=C2	GVK	FFS-11-286-NCI-219	1.2590799	2.35884567	0.78540664	1.3943699												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016777-08	Probucol	170464772	Serine Protease Hepsin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	23288-49-5	 Bisbid; Aventis Brand of Probucol; Panavir; Lorelco; Biphenabid;PROBUCOL; Probucol; Superlipid;Probucol; Lurselle; Hoechst Brand of Probucol; 			7.3351539053	4	4		0	2.81504867				ABCA1	CC(C)(C)c2cc(SC(C)(C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)cc(c2O)C(C)(C)C	Microsource	01501109	0.62953995	1.55583438	1.90017735	2.81504867												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018296-07	Meclizine hydrochloride	170464899	Constitutive Androstane Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1104-22-9	; Meclozine dihydrochloride;Meclozine dihydrochloride; Meclizine Hcl;Meclizine dihydrochloride;MECLIZINE HYDROCHLORIDE;Meclizine hydrochloride; Meclozina			-4.0720004753	4	4		0	0.18416206			9970	NR1I3	Cl.Cl.Cc1cccc(c1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4	Microsource	01500376	-1.40435835	-0.60225847	-1.19077781	0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016879-06	Torsemide	170465279	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	56211-40-6	 ;Torsemide (Demadex); Torasemida;TORSEMIDE; Luprac; Demadex;Torsemide; Torsemide			-0.3301999873	4	4		0	0.81557485					O=S(=O)(NC(=O)NC(C)C)c2cnccc2Nc1cc(C)ccc1	Prestwick	Prestw-1030	-0.43583535	0.05018821	-0.43070687	0.81557485												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159481-03	Sofalcone	170466017	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	64506-49-6		12.5892541179	-4.9	54.2628140929	3	4		60.4152667985	49.01341752	0.0159972544	0.9998421949			C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C	Bionet	KS-1141	0.3874092	-0.35131744	0.0253357	49.01341752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159486-06	Hippuric acid	170464791	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	495-69-2				1.6937899552	4	4		0	1.23701138					O=C(NCC(=O)O)c1ccccc1	Vitas	STK011394	-0.04833253	0.41933892	0.12726694	1.23701138												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016916-11	Norfloxacin	170464769	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	70458-96-7	; ; Norfloxacin-d5;NORFLOXACIN; Norfloxacino; Noroxin; Norfloxacin;Norfloxacin; Norfloxacin Glutamate			-0.3740121622	4	4		0	0.39584364			7155	TOP2B	O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3	Vitas	STK177250	-0.09666506	-0.51800691	-0.25453388	0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249925-01	Tilmacoxib	170466033	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	180200-68-4				-0.3880587566	4	4		0	-1.58337457					Cc2nc(C1CCCCC1)c(o2)c3ccc(c(F)c3)S(N)(=O)=O	GVK	FFS-11-286-NCI-214	1.69163847	-0.17266897	-1.59083678	-1.58337457												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167442-03	Tamsulosin hydrochloride	170464826	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	106463-17-6				4.0318073881	4	5		0	2.43407708				ADRA1A	Cl.O=S(N)(=O)c1cc(ccc1OC)C[C@@H](C)NCCOc2ccccc2OCC	Sequoia	106463-17-6	0.51282051	0.8596713	1.18430792	-0.2392917	2.43407708											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016557-06	Ethaverine hydrochloride	170466346	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	985-13-7				-1.9373807585	4	5		0	0.0811359					Cl.CCOc1ccc(cc1OCC)Cc3nccc2cc(OCC)c(cc23)OCC	Microsource	01501000	-0.17094017	-1.0619469	-0.09869233	-1.24431682	0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091563-12	Thiram	170465664		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	137-26-8				4.3566473673	4	5		0	6.32860041					CN(C)C(=S)SSC(=S)N(C)C	Microsource	01503322	0.12210012	-1.1125158	0.49346163	-0.2392917	6.32860041											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016098-11	Xylazine	170466147	Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	7361-61-7				-0.8788321125	4	5		0	-0.24340771					Cc2cccc(C)c2NC1=NCCCS1	Enzo	AC809	0.70818071	-1.011378	-1.52973106	-0.33500838	-0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179333-03	Phensuximide	170465315		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	86-34-0				6.0657078021	4	5		0	1.62271805					O=C1C(CC(=O)N1C)c2ccccc2	Specs	AE-562/J258174	1.63614164	1.2136536	0	1.38789184	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181124-02	Sparteine	170465740	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	90-39-1				-2.1956246093	4	5		0	-0.48681542					C3CCCN4C[C@@H]2C[C@@H](CN1CCCC[C@H]12)[C@@H]34	Vitas	STK801664	0.26862027	-1.6182048	-1.33234641	-0.38286671	-0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162218-05	Molindone hydrochloride	170465047	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	15622-65-8				0.9372140676	4	5		0	0.24340771					Cl.O=C1C(CCc2nc(C)c(CC)c12)CN3CCOCC3	Prestwick	Prestw-1035	1.83150183	-1.3653603	-0.69084629	-1.72290022	0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181040-02	dl-Coniine	170465693	Nicotinic acetylcholine receptor alpha1/beta1/gamma/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3238-60-6				1.809332968	4	5		0	1.70385396					CCCC1CCCCN1	Specs	AE-562/J259451	0.61050061	-0.6573957	-0.14803849	-0.04785834	1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016599-04	Flucytosine	170465407	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	2022-85-7	 Flucytosine;Flucytosine;Flucytosine (Ancobon)			-0.4502255908	4	5		0	3.0020284				TYMS	FC1=CNC(=O)N=C1N	Vitas	STK292386	-0.65934066	-0.7079646	-0.29607698	-1.1007418	3.0020284											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164591-04	Artemether	225144260	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	71963-77-4	duplicate RN; ; Artemetero; Arthemeter; Artemether;artemether;Artemether			5.2433489194	4	5		0	-0.40567951				PfATP6	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	SIGMA	A9361	4.17582418	-0.8596713	-1.18430792	-1.1007418	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389554-01	DORAMECTIN		chloride transmembrane transport Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	117704-25-3		12.5892541179	-4.9	30.3373965853	3	4		44.2913294815	37.80346821	0.0236001747	0.9996566109			CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2[C@H](C)O[C@@H](C[C@@H]2OC)O[C@H]\3[C@@H](C)\C=C\C=C\4CO[C@@H]5C(O)\C(=C/[C@@H](C(=O)O[C@H]6C[C@@H](C/C=C3C)O[C@@]\7(C6)O[C@@H]([C@@H](C)\C=C7)C8CCCCC8)[C@]45O)C	Microsource	01505902	0.20565553	1.01668405	1.21084496	37.80346821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159461-07	Amprenavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	161814-49-9				-3.2720831532	4	4		0	-0.62427746					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	SIGMA	SML0685	-1.23393316	0.5995829	-0.10529087	-0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164598-03	CEFPODOXIME PROXETIL			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	87239-81-4				-2.0528485976	4	4		0	0.76300578					COCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)/C3=CSC(=N3)N)C2=O)C(=O)OC(C)OC(=O)OC(C)C	Microsource	01505637	-0.97686375	-0.02606882	-0.1579363	0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168290-05	Avermectin B1a			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	65195-55-3		8.9125093813	-5.05	12.1704453971	4	4		16.561696656	15.74566474	0.0168555745	0.9998256702			CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C/C=C(C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6CO[C@@H]7[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]67O)C)O2)\C=C/[C@@H]1C	MedChem Express	HY-15308	-0.05141388	0.07820647	0.68439063	15.74566474												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532501-01	ARIPIPRAZOLE LAUROXIL		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					7.4731939916	4	4		0	0.43930636					CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C4=C(Cl)C(=CC=C4)Cl)C=C12	Astatech	42552	1.90231362	2.21584984	2.31639905	0.43930636												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00482960-01	Xanthophyll			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	127-40-2				-3.1650882248	4	4		0	-1.36416185					CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(\C)CC(O)CC1(C)C)\C=C\C=C(C)\C=C\C2\C(=C/C(O)CC2(C)C)C	DC Chemicals	DCY-149	-0.97686375	0.07820647	0.42116346	-1.36416185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183000-01	Lanperisone hydrochloride	144206892	Sodium channel alpha subunit Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	116287-13-9	Lanperisone; 			0.571459773	4	4	Lanperisone hydrochloride;lanperisone;LANPERISONE HYDROCHLORIDE;Lanperisone Hydrochloride;CIPLUS_775823;CIPLUS_3846316;LANPERISONE;Lanperisone;lanperisonum;	0	1.65745856					C[C@H](CN1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F	Pharmaron	PH-NIH-98442	-0.0968523	-0.65244667	-0.58272105	1.65745856												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091544-18	Estradiol		Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-28-2				2.158056848	4	4		0	3.1833728			2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-441	-0.0968523	-0.8531995	-0.53204966	3.1833728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022019-03	Clobetasone butyrate	170465575	corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	25122-57-0				-0.0223522873	4	4		0	1.92054722					ClCC(=O)[C@@]3(OC(=O)CCC)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)C(=O)C[C@@]23C	SIGMA	C5548	-0.92009685	0.95357591	-1.03876362	1.92054722												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016951-05	Clebopride maleate	170465853	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	84370-95-6				-0.0502990826	4	4		0	1.92054722					O=C(O)/C=C\C(=O)O.Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3	Prestwick	Prestw-380	-0.43583535	-0.9033877	-0.68406385	1.92054722												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094779-05	Salicyl alcohol	170465547		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	90-01-7				-1.8584824089	4	4		0	0.49986846					OCc1ccccc1O	Microsource	01500531	-1.01694915	-0.25094103	-0.32936407	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263575-01	Ezetimibe	170465013	NPC1L1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	163222-33-1				6.5442600811	4	4		0	3.3151905				NPC1L1	Fc1ccc(cc1)[C@@H](O)CC[C@H]3C(=O)N(c2ccc(F)cc2)[C@@H]3c4ccc(O)cc4	Sequoia	163222-33-1	0.91831803	-0.5673409	1.52720331	3.3151905												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262929-01	BIBR-1048	170466107	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	211915-06-9	Bibr 1048;BIBR-1048 (Dabigatran);3-((2-((4-Amino((e)-hexyloxycarbonylimino)methyl)-phenylamino)methyl-1-1h-benzoimidazole-5-carbonyl)pyridin-2-yl-amino)propionic acid ethyl ester;Dabigatranum etexilatum;Dabigatran etexilate; Dabigatran etexilate			5.0054422195	4	4		0	5.09648689				F2	O=C(OCCCCCC)\N=C(\N)c1ccc(cc1)NCc3nc2cc(ccc2n3C)C(=O)N(CCC(=O)OCC)c4ccccn4	GVK	FFS-12-73-NCI-1548	-0.19333011	-0.41933892	0.06363347	5.09648689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179578-03	Mometasone furoate	170464666	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	83919-23-7	; 2-Furoate;Mometasone furoate; Nasonex; Mometasone Fuorate; Elocon; Sch 32088	7.0794578438	-5.15	23.095597114	4	4		23.7539874319	22.3156853	0.0285546756	0.9994980116		CYP3A4	ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23	Prestwick Chemical, Inc.	Prestw-572	-0.62832286	-0.024667	-0.19090041	22.3156853												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091861-07	Dacarbazine	170464655	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	4342-03-4	; ; Dacarbazino;Dacarbazine; Dacarbazine; DTIC-Dome; DACARBAZINE; Dacarbizine;DACARBAZINE; 6   Dacarbazine			-1.3620642956	4	4		0	-0.19792182				H2AFX	CN(C)/N=N/c1ncnc1C(N)=O	Microsource	01500218	0.38666022	-0.46867292	-1.46356984	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025346-08	Mirtazapine		5-HT2A/3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	85650-52-8 				-5.1219381934	4	4		0	0.5730659				HTR2A	CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3	APExBIO	B2113	-1.59250585	-0.81718422	-1.30541202	0.5730659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184708-02	NCGC00184708-02	124896555	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	26538-44-3				7.7076915662	4	4	Zearalanol`	0	1.33715377					CC1CCCC(O)CCCCCC2=CC(=CC(=C2C(=O)O1)O)O	SIGMA	NTP_SID_1403	1.96721311	1.37753911	0.76149035	1.33715377												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178854-03	Minocycline hydrochloride	170465049	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	13614-98-7				1.9220913198	4	4		0	1.48042025				PARP1	Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O	Microsource	01500414	0.14051522	0.49031053	0.1631765	1.48042025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015675-11	Milrinone	170465221	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	78415-72-2	 ; Milrinone Lact; Milrinone;Milrinone			0.9559230702	4	5		0	3.48884381			5139	PDE3A	N#CC1=CC(=C(C)NC1=O)c2ccncc2	Prestwick	Prestw-1065	-0.21978022	-0.7585335	-0.5428078	-0.47858339	3.48884381											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015121-17	Phenoxybenzamine hydrochloride	170465147	Adrenergenic Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59-96-1	; ;Phenoxybenzamine; Fenoxibenzamina;PHENOXYBENZAMINE; Phenoxybenzamine HCl;Phenoxybenzamine HCl;Phenoxybenzamine hydrochloride;PHENOXYBENZAMINE HYDROCHLORIDE; Phenoxybenzamine hydrochloride			0.7254247909	4	5		0	3.89452333				ADORA1	CC(COc1ccccc1)N(Cc2ccccc2)CCCl	Microsource	02300176	-0.07326007	-1.4159292	-1.08561559	-0.43072505	3.89452333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179649-06	Prednisolone	170464732	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	50-24-8	; Prednisolona; Predonine; Delta-cortef;Prednisolone; Prednisolone Pivalate; P21EC cpd; 1-Dehydrohydrocortisone; 1-Dehydrocortisol;Benzo(a)pyrene; Di-Adreson-F;Prednisolone (Hydroretrocortine); Di Adreson; Socketol; Vasocidin; 21-NO-prednisolone; Predate; Prednisolone hexanoate; DiAdreson; Pal-PLS			-3.3172973608	4	4		0	-0.62427746				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-274	-1.07969152	0.2346194	-0.36851803	-0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025323-08	Ubenimex		Leukotriene A4 Hydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	[58970-76-6]				-2.5146916391	4	4		0	-1.22543353				LTA4H	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	Tocris	1956	-0.10282776	-1.01668405	-0.89497236	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181111-02	Tamibarotene	170465883	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	94497-51-5	 ; Am80; Am 80;AM 80; Tamibarotene;tamibarotene; Amnoid			9.8687661689	4	4		0	8.06936416			5915	RARB	O=C(O)c1ccc(cc1)C(=O)Nc2ccc3c(c2)C(C)(C)CCC3(C)C	Tocris	3507	0.35989717	1.01668405	3.15872598	8.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181148-01	Metharbital	144206305	GABA-A receptor; anion channel Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	50-11-3	Metharbital; Metarbital; 			-1.2749956717	4	4	metharbitone;Metharbital;metharbital;endiemal;metharbitalum;CIPLUS_148525;Metarbital;2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-;LS-24178;Metharbitalum;METHARBITAL;Barbituric acid, 5,5-diethyl-1-methyl-;methobarbitone;5,5-DIETHYL-1-METHYLBARBITURIC ACID;2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5,5-DIETHYL-1-METHYL-;CIPLUS_178471;	0	0.06936416					O=C1NC(=O)N(C)C(=O)C1(CC)CC	NCI	NSC-27156	-0.41131105	0.07820647	-0.4738089	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167462-03	Acamprosate Calcium	225144287		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	77337-73-6				4.0896298274	4	4		0	0.76300578					CC(=O)NCCC[S]([O-])(=O)=O	Bosche	A0044	0.92544987	0.44316997	1.21084496	0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183877-01	Unoprostone isopropyl ester	144207178	Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	120373-24-2				-2.7717337294	4	4	Ciba Vision brand of isopropyl unoprostone;Unoprostone;isopropyl 20-ethyl-9alpha,11alpha-dihydroxy-15-keto-cis-delta-5-prostanoate;ISOPROPYL UNOPROSTONE;UNOPROSTONE ISOPROPYL;unoprostone isopropyl;UF-021;Isopropyl unoprostone;Unoprostone isopropyl;Novartis brand of isopropyl unoprostone;CIPLUS_3762607;Eescula;LS-176760;ISOPROPYL Z-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)HEPT-5-ENOATE, D-;isopropyl unoprostone;UF 021;Rescula;CIPLUS_729221;	0	-1.4014014					O[C@@H]1C[C@H](O)[C@H](C/C=C\CCCC(=O)OC(C)C)[C@H]1CCC(=O)CCCCCCC	Toronto Research	U800050	-0.52480916	-0.13061651	-0.41895784	-1.4014014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167519-02	Ramatroban	170465980	prostaglandin D2 CRTH2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	116649-85-5	BAY u-3405; ; Ramatroban;Ramatroban; Baynas; BAY u3405;BAY-u3405; BAY u 3405; BAY u 3406			5.2902192128	4	4		0	3.3033033			11251	PTGDR2	Fc1ccc(cc1)S(=O)(=O)N[C@H]3Cc4c2ccccc2n(CCC(=O)O)c4CC3	Sequoia	SRP0101165r	0.8110687	0.18286311	0.89028542	3.3033033												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159443-05	BETAMETHASONE 17,21-DIPROPIONATE		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5593-20-4				-3.7904894403	4	4		0	2.3023023				NR3C1	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Microsource	01503210	-1.76526718	-1.90700104	0.47132757	2.3023023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521082-01	Mebezonium Iodide			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	7681-78-9				-4.6265004759	4	4		0	-0.85085085					C[N+](C)(C)C1CCC(CC1)CC2CCC(CC2)[N+](C)(C)C	Toronto Research	M202535	-1.09732824	-0.75757576	-0.94265515	-0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186028-02	Levetiracetam	170464988	N-Type Calcium Channel (Ca(v) 2.2) Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	33996-58-6	Levetiracetam			-1.7730880733	4	4		0	-2.2022022				CACNA1B	O=C1CCCN1C(CC)C(N)=O	Prestwick	Prestw-1427	-0.42938931	0.39184953	0.99502488	-2.2022022												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242511-03	Seocalcitol		Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	134404-52-7				6.3977725771	4	4		0	1.15115115				VDR	CCC(O)(CC)/C=C/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCCC12C)=C\C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32341	1.57442748	1.3322884	0.83791568	1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096122-05	Thioinosine	170465903	Serine/threonine-protein kinase N1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	574-25-4				3.1500102339	4	4		0	1.60484083			29355	Pkn1	Sc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	SIGMA	852686	1.11380145	-0.8531995	-0.07600709	1.60484083												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015838-06	Propionylpromazine hydrochloride	170466841	Trypanothione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	7681-67-6		12.5892541179	-4.9	96.9172135056	3	4		112.7996609618	90.58142594	0.0241755575	0.9996393611			Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	SIGMA	P7780	0.14527845	-0.95357591	-1.95084875	90.58142594												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016323-09	Sulfachloropyridazine	170466574	Salmonella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	80-32-0				-0.0710007529	4	4		0	-0.97342805					O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2	Microsource	01501142	0.24213075	1.50564617	-0.48137826	-0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016925-11	Omeprazole	170465443	ABCC3 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	73590-58-6	 ; Omeprazole ER; Zegerid; Prilosec;AGI-010/DM-3458;Omepral; ESOMEPRAZOLE Mg; Losec sodium; Esomeprazole;Omeprazole; Omeprazole; Omeprazol; Nexium; Losec			0.8800346411	4	4		0	-0.60510392			8714	ABCC3	Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC	Microsource	01505693	-0.1937046	0.10037641	1.74816316	-0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183010-01	Pelubiprofen	144206823	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	69956-77-0	PELUBIPROFEN; 			-0.1652248506	4	4	2-OCMPP;BENZENEACETIC ACID, .ALPHA.-METHYL-4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)-;2-(4-((2-oxocyclohexylidene)methyl)phenyl)propionic acid;PELUBIPROFEN;CIPLUS_706216;Pelubiprofen;pelubiprofene;LS-176792;2-(4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)PHENYL)PROPANOIC ACID;(+/-)-P-(((E)-2-OXOCYCLOHEXYLIDENE)METHYL)HYDRATROPIC ACID;CS-670;pelubiprofenum;CS 670;	0	-0.59376546			5743	PTGS2	O=C(O)C(C)c1ccc(cc1)\C=C2/CCCCC2=O	Pharmaron	PH-NIH-149772	-0.96665056	-0.27133695	2.35443843	-0.59376546												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274059-01	Nelarabine	170464759	Antimetabolite	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	121032-29-9				-2.7446452125	4	4		0	0.24740228				HPRT1	Nc3nc2c(ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O)c(OC)n3	Selleck	S1213	-0.53165781	-0.51800691	-1.59083678	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183597-01	Betamethasone butyrate propionate	144206581		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	5534-02-1				2.0770617744	4	4	Betamethasone butyrate propionate;BETAMETHASONE BUTYRATE PROPIONATE;Antebate;Betamethasone Butyrate Propionate;CIPLUS_213705;	0	3.82043935					CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	877861	-0.37470726	-0.72379173	0.97905902	3.82043935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159506-06	Cyclandelate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	456-59-7				-1.9654871717	4	4		0	0.90735435					CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2	APExBIO	B1718	-1.40515222	-0.44361429	1.79494153	0.90735435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182027-01	Amogastrin	144206458	Cholecystokinin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	16870-37-4	Amogastrin; Amogastrina; 			-2.3537023951	4	4	AMOGASTRIN;amogastrin;CIPLUS_214157;Amogastrina;tert-amyloxycarbonyltetragastrin;Amogastrinum;Amogastrin;Amogastrine;amogastrine;amogastrinum;	0	-0.66857689					NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)OC(C)(C)CC)Cc3cnc2ccccc23	ACC	AMOGASTRIN	-0.74941452	-0.02334812	0.10878433	-0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510003-01	Vaborbactam			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1360457-46-0				8.945760293	4	4		0	2.10404624					OB1O[C@@H](CC[C@@H]1NC(=O)CC2=CC=CS2)CC(O)=O	MedChem Express	HY-19930	1.74807198	2.37226277	1.78994472	2.10404624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181762-01	Nequinate	144206498	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	13997-19-8	Nequinate; Nequinato; Statyl; 			1.5635556807	4	4	nequinatum;Nequinato;CIPLUS_169121;LS-173071;methyl 7-(benzyloxy)-6-butyl-1,4-dihydro-4-oxo-3-quinolinecarboxylate;benzoquate;methylbenzoquate;Statyl;Nequinatum;nequinate;NEQUINATE;Nequinate;	0	2.42774566					O=C(OC)C3=CNc2cc(OCc1ccccc1)c(CCCC)cc2C3=O	ACC	NEQUINATE	0.05141388	-0.5995829	0.05264543	2.42774566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181771-02	Ibutilide fumarate		K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	[122647-32-9]				-2.771981994	4	4		0	-0.7007007					CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	Tocris	3908	-0.57251908	-0.44409613	-0.68080649	-0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262543-01	Midecamycin		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	35457-80-8				1.2317810542	4	4		0	-0.35035035					CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](OC2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	Prestwick Chemical, Inc.	Prestw-153	0.62022901	-0.80982236	0.68080649	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160511-01	Desoxycorticosterone Pivalate	29216193		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		DESOXYCORTICOSTERONE PIVALATE; Percorten; 			-3.0071429653	4	4	CIPLUS_156479;percoten pivalate;DESOXYCORTICOSTERONE PIVALATE;Percorten;Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-;dtma;11-DEOXYCORTICOSTERONE PIVALATE;LS-118664;deoxycortone pivalate;desoxycoticosterone trimethylacetate;desoxycorticosterone pivalate;Desoxycorticosterone pivalate;PREGN-4-ENE-3,20-DIONE, 21-(2,2-DIMETHYL-1-OXOPROPOXY)-;	0	-0.2002002					[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C	InterBioScreen	STOCK1N-55228	-0.8110687	-0.39184953	-0.73317622	-0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166147-02	Dihydrotachysterol	144205894	Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	67-96-9	Dihydrotachysterol; Dihydrotachysterin; Dihidrotaquisterol; Calcamine; Tachysterol, dihydro-; Tachystin; Hytakerol; 			0.7763209951	4	4	parterol;LS-148512;Tachystin;CIPLUS_149136;Dihydrotachysterin;AT 10;Calcamine;dihydrotachysterol;dihydrotachysterolum;Hytakerol;NCGC00166147-01;Tachysterol, dihydro-;DIHYDROTACHYSTEROL;Dihydrotachysterol;AT-10;Dihydrotachysterolum;Dihidrotaquisterol;9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-;VITAMIN D1;9,10-Secoergosta-5,7,22-trien-3beta-ol;NCGC_SIGMA_D9257;	0	0					C[C@H]3CC[C@H](O)C/C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C	SIGMA	D9257	-0.04770992	-0.80982236	2.09478921	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249908-01	Mefenorex	170465601		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	17243-57-1				1.099690303	4	4		0	0.45045045					CC(NCCCCl)Cc1ccccc1	GVK	FFS-11-286-NCI-140	-0.09541985	-0.0261233	1.46635245	0.45045045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378606-02	Ipragliflozin		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	761423-87-4				4.8155309847	4	4		0	-0.11644155					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=CC=C(F)C(=C2)CC3=CC4=C(S3)C=CC=C4	MedChem Express	HY-14894	1.01036269	2.31594344	1.00679587	-0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249897-01	Nitromersol	170465514		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	133-58-4				-5.1596475774	4	4		0	-2.53365004					Cc1ccc(c2[Hg]Oc12)[N+]([O-])=O	GVK	FFS-11-286-NCI-74	-1.43596987	2.22686152	-1.21490281	-2.53365004												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016760-08	Carbimazole	170465583		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	22232-54-8				8.4497043863	4	4		0	1.95302191					S=C1N(C=CN1C)C(=O)OCC	Microsource	01505323	3.27212806	0.13917884	0.1349892	1.95302191												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00378796-01	Tacalcitol		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	57333-96-7				7.5213135818	4	4		0	1.25125125					CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32337	2.67175573	-0.86206897	0.5236973	1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386364-01	Lomitapide		Microsomal triglyceride transfer protein large subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	182431-12-5		3.1622776602	-5.5	19.7256370089	4	4		19.22100314	-2.65265265	1	0.9988578885	4547	MTTP	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C5=C(C=CC=C5)C6=C1C=CC=C6	Selleck	S7635	-0.23854962	-0.60083595	14.3493061	-2.65265265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167301-02	Triptorelin		Gonadotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	57773-63-4				-1.3522801307	4	4		0	-0.3003003					CC(C)C[C@H](NC(=O)[C@@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=C[NH]C5=C4C=CC=C5)NC(=O)[C@H](CC6=CN=C[NH]6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N8CCC[C@H]8C(=O)NCC(N)=O	Enzo	DL310	-0.85877863	-0.13061651	1.41398272	-0.3003003												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00095191-12	Oseltamivir Phosphate		Neuraminidase (sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	204255-11-8				-0.6243459392	4	4		0	-1.25125125				NEU1	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	Enzo	DL194	0.57251908	-1.17554859	-0.47132757	-1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181008-02	Olsalazine sodium	225144315	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	6054-98-4				1.8662829523	4	4		0	1.3013013					OC1=CC=C(C=C1C([O-])=O)/N=N/C2=CC=C(O)C(=C2)C([O-])=O	Bosche	O2307	0.42938931	0.91431557	-1.2045038	1.3013013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263445-02	Brucine-N-oxide		Vascular endothelial growth factor receptor 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	357-57-3				0.3219841338	4	4		0	0.6006006					COC1=CC2=C(C=C1OC)[C@@]34CCN5CC/6=C/CO[C@H]7CC(=O)N2[C@H]3[C@H]7[C@H]6C[C@@H]45	Enzo	NP038	-0.14312977	-0.39184953	0.73317622	0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181756-01	gamma-Oryzanol	144206489	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	11042-64-1	ORYZANOL; Hi-Z; 			8.9432657751	4	4	gamma-oryzanol;cycloartenol ferulic acid ester;ferulic acid cycloartenol ester;CIPLUS_3885867;LS-7631;triacontane 3-(4-hydroxy-3-methoxyphenyl)-2-propenate;ORYZANOL;R-ORIZANOL;oryzanol;CYCLOARTENOL FERULATE;Gamma Oryzanol;Hi-Z;CIPLUS_666235;GAMMA ORYZANOL;FRACYE;9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-OL 4-HYDROXY-3-METHOXYCINAMATE;gamma Oryzanol;Gamma oryzanol;	0	2.58500233					Oc1ccc(cc1OC)/C=C/C(=O)O[C@H]4CC[C@]63C[C@@]56CC[C@]2(C)[C@H](CC[C@@]2(C)[C@@H]5CC[C@H]3C4(C)C)[C@H](C)CC\C=C(/C)C	ACC	GAMMA ORYZANOL	1.26943005	2.12091663	3.27208658	2.58500233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386216-07	Indacaterol (maleate)			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	753498-25-8				0.73349261	4	4		0	-1.60689334					CCC1=CC2=C(CC(C2)NC[C@H](O)C3=CC=C(O)C4=C3\C=C/C(=O)N4)C=C1CC	MedChem Express	HY-14299A	1.06217617	-0.6094588	-0.50339794	-1.60689334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248146-03	4-Methylbenzenesulfonic acid			DPI_SARS-CoV-2_General	2019_NPC-9_CPE					0.8618200272	4	4		0	3.28365161					CC1=CC=C(C=C1)[S+](O)([O-])=O	Specs	AE-562/J260927	-0.44041451	-0.31691858	-0.35237856	3.28365161												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178220-05	Dipyrone	170465672	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	68-89-3				1.409226263	4	4		0	1.46716348			5742	PTGS1	[Na+].[O-]S(=O)(=O)CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Vitas	STK177347	0.12953368	0.02437835	-0.05033979	1.46716348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090974-06	Diethyl phthalate	225144200	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	84-66-2				0.6171786229	4	4		0	4.16996569			367	AR	CCOC(=O)C1=CC=CC=C1C(=O)OCC	SIGMA	524972	-1.34180791	-0.27835769	-1.21490281	4.16996569												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159336-03	Sulbactam	170465248	beta-Lactamase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	68373-14-8	; Sultamicillin (base); B??tamaze; Sodium Sulbactam; Penicillanic Acid Sulfone; Sodium, Sulbacta; Combactam; Sulfone, Penicillanic Aci;Sulbactam sodium;Sulbactam			-0.7172704222	4	4		0	-0.79176564				bla	O=S2(=O)C(C)(C)[C@@H](N1C(=O)C[C@H]12)C(=O)O	Vitas	STK801889	-0.58851224	0.76548365	0.674946	-0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015819-15	Propafenone hydrochloride	170464755	Potassium Channel Subfamily K Member 3 (TASK-1; KCNK3) Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54063-53-5	Propafenona; ;Propafenone; Propafenone Hcl; Propafenone;Propafenone hydrochloride; Rythmol;Propafenone?HCl; Propafenone, (S)-Isomer; Rhythmol; Propafenone, (R)-Isomer	12.5892541179	-4.9	82.7132237211	3	4		97.2111064467	75.53444181	0.0209004634	0.9997305076		KCNK3	CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1	SigmaAldrich	P-4670	0.35310734	0.27835769	-0.94492441	75.53444181												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00184993-03	Amfenac Sodium	225144335	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE					-0.4653417744	4	4		0	-0.2111375					NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=CC=C2	APAC	872965	0.82391714	-1.67014614	-0.56695464	-0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164581-02	Estramustine	170466403	Estrogen receptor beta Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2998-57-4		10	-5	13.5070483463	4	4		11.5	11.50699393	0.0669862661	0.9972510198	4130		ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	Sequoia	SRP01725e	0.16478343	0.6263048	0.1349892	11.50699393												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249904-01	Butamisole	170466389	Nicotinic acetylcholine receptor alpha subunit Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54400-59-8				-3.8756680795	4	4		0	-0.05278438					CC(C)C(=O)Nc1cccc(c1)C2N=C3SCCN3C2	GVK	FFS-11-286-NCI-117	-1.38888889	-0.27835769	-0.99892009	-0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178317-03	Foscarnet trisodium	170465060	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63585-09-1				5.5154627142	4	4		0	1.63631565					[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O	Microsource	01502019	1.29472693	3.06193459	-0.78293736	1.63631565												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160596-03	Aluminum monostearate	225144243		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	7047-84-9				-6.7430570027	4	5		0	-1.39508929					CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O	SIGMA	06270	-1.45197319	-2.63459336	-1.45449508	-0.29498525	-1.39508929											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00182704-02	Luliconazole	144206804	Lanosterol 14-alpha demethylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	187164-19-8	Luliconazole; Lulicon; 			-5.7709403551	4	5	Lulicon;Luliconazole;LULICONAZOLE;CIPLUS_787907;	0	0.60983873			3641571	ERG11	N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3	Pharmaron	PH-NIH-102266	-3.04518664	-1.02091021	2.41752371	-2.22503161	0.60983873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166105-04	BENZYL NICOTINATE	225144269		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-44-0		7.9432823472	-5.1	24.2507161865	4	5		18.22158408	17.06193251	0.2901921701	0.8138152219			O=C(OCC1=CC=CC=C1)C2=CN=CC=C2	SIGMA	72351	6.16404715	-1.29151292	-2.6846534	4.07079646	17.06193251											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253585-01	Cyclomethycaine	170465528		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	139-62-8		11.220184543	-4.95	74.2835696921	2.1	5		120.5328526393	95.34040179	0.002090739	0.9989531368			CC3CCCCN3CCCOC(=O)c2ccc(OC1CCCCC1)cc2	GVK	FFS-11-286-NCI-76	-2.41995532	-0.98001782	1.50990442	10.21721641	95.34040179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM			-7.188928848	4	5		0	-2.00892857			217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-2.02283445	-5.05281914	0.54024103	1.74309466	-2.00892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022579-05	Carbenicillin disodium	170465106	Bacterial penicillin-binding protein Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	4800-94-6				3.7257567383	4	5		0	6.640625					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(c1ccccc1)C([O-])=O)[C@H]3SC2(C)C	Microsource	01500160	0.33507074	-1.36184294	-2.42415847	1.12630732	6.640625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091439-07	Cimetidine	170464651	Multidrug and toxin extrusion protein 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51481-61-9				-9.1466952233	4	5		0	-1.86941964					N#C\N=C(/NC)NCCSCc1ncnc1C	Microsource	01500684	-3.04045669	-2.55822833	1.92547444	-2.38669885	-1.86941964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023654-13	Captopril	170464644	Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	62571-86-2				6.1059459266	4	5		0	0.55803571					OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)CS	Vitas	STK802012	2.39513527	-1.82003309	4.08643856	-0.48270314	0.55803571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017354-07	Spectinomycin dihydrochloride	170465149	Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	21736-83-4	; Trobicin sulfate; Spectinomycin Sulfate; Espectinomicina;SPECTINOMYCIN HYDROCHLORIDE; Spectam; Stanilo;Spectinomycin dihydrochloride; Spectinomycin Sulphate			-1.9622088531	4	5		0	2.58842662					Cl.Cl.C[C@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@H](NC)[C@H](O)[C@H](NC)[C@H]3O[C@@]2(O)C(=O)C1	Microsource	01500538	-1.59626719	0.06150062	0.04006945	-1.44121365	2.58842662											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			-11.7414338495	4	5		0	-3.15290179			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	-3.61131794	0.59819269	-1.81465577	-2.62805042	-3.15290179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093588-04	cAMP	170466839	cAMP-dependent protein kinase type II-alpha regulatory subunit Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60-92-4				-9.0170860177	4	5		0	-2.06473214			5576	PRKAR2A	Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2O	SIGMA	A9501	0.93075205	-3.65279369	-1.92547444	-3.29847144	-2.06473214											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00018296-07	Meclizine hydrochloride	170464899	Constitutive Androstane Receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1104-22-9	; Meclozine dihydrochloride;Meclozine dihydrochloride; Meclizine Hcl;Meclizine dihydrochloride;MECLIZINE HYDROCHLORIDE;Meclizine hydrochloride; Meclozina			-8.4498606807	4	5		0	-2.00892857			9970	NR1I3	Cl.Cl.Cc1cccc(c1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4	Microsource	01500376	-3.48721767	1.38729795	0.09696634	-2.17216412	-2.00892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093802-06	Dehydroepiandrosterone	170465614	Steroid hormone	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53-43-0	 DHEA phosphatide; ; Prasterona; DHEA sulfotransferase; Androstenolone; Dehydroepiandrosterone;Dehydroepiandrosterone; DHEA receptor;Dehydroepiandrosterone (DHEA); 5a-Androstanedione; Prasterone, 3 alpha Isome; trans-Dehydroandrosterone;trans-Dehydroandrosterone; DHEA sulphotransferase; 5-Androsten-3-ol-17-one;; 7   Androstanedione;DHEA; 5 Androsten 3 ol 17 on			-3.4617937222	4	5		0	0.9765625				HSD11B1	O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Labotest	LT03329654	-2.69297592	-1.48911798	-0.95581105	3.59345669	0.9765625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015099-11	Alprenolol	170465812	Beta-adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	13655-52-2				-6.2695503359	4	5		0	-0.1953125					CC(C)NCC(O)COc1ccccc1CC=C	Enzo	AC812	1.15413254	-4.95099911	-2.3133398	-4.55886297	-0.1953125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181154-03	Nitarsone	170465716		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	98-72-6				-1.7704351583	4	5		0	3.97072774					O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O	Vitas	STK368450	-1.94007859	0.57810578	-0.41405102	-1.79519595	3.97072774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091888-09	3,3,5-Trimethylcyclohexyl salicylate	170465478		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	118-56-9				-1.7417083957	4	5		0	-1.14397321					O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O	Microsource	01505020	-1.07967238	-2.78732341	2.47956781	1.90399571	-1.14397321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016407-08	Sulfamethizole	170465369	Antibacterial	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	144-82-1	; Sulfapral; ;Sulfamethizole; Sulfamethizole; Rufol; Sulfametizol; FNA, Sulfamethizo; Sulphamethizole; Thiosulfil; Sulfamethizol FNA;SULFAMETHIZOLE			6.8072740714	4	5		0	-2.12053571					Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2	Labotest	LT00772293	2.99081658	-2.50731831	6.52444937	0.05363368	-2.12053571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015656-12	Mianserin	170465596	5-HT2A Antagonists?	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	24219-97-4	; ; Org GB 94;Mianserin; Mianserin Hcl;Mianserin hydrochloride; Mianserin hydrochloride; Mianserina;MIANSERIN HYDROCHLORIDE; Mianserine hydrochloride; Mianserine Hcl;Mianserin..HCl;Mianserine hydrochloride; Lerivon; Bolvidon; Tetramide; Hydrochloride, Mianseri; Tolvon			-1.0899072146	4	5		0	0.47431901			3356	HTR2A	CN1CC2N(CC1)c4ccccc4Cc3ccccc23	Enzo	AC554	1.6453831	-1.88191882	-3.05863497	-1.49178255	0.47431901											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167507-04	Lapatinib	170465125	EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	231277-92-2	;Lapatinib; Lapatinib;GW-572016F?; Lapatinib base;LAPATINIB DITOSYLATE; Tykerb;Tykerb	10	-5	26.10708775	3	5		45.5209146084	38.88060713	0.0130814657	0.9933994577	1956	EGFR	Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5	Sequoia	231277-92-2	0.44204322	-3.01353014	-3.21891278	0.83438685	38.88060713											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163128-08	Pioglitazone hydrochloride	170465116	PPARgamma Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	112529-15-4	Pioglitazona; Pioglitazone HCl;AA-10090;Pioglitazone HCl;PIOGLITAZONE HYDROCHLORIDE; ;Zactos;Actos;U-72107A;Glustin			8.025375878	4	5		0	4.70253422			5468	PPARG	Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3	Microsource	01504401	-0.49115914	0.13530135	-0.04006945	7.66118837	4.70253422											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159383-04	Propyl benzoate	170465563		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2315-68-6				-1.1724785983	4	5		0	0.01355197					O=C(OCCC)c1ccccc1	Labotest	LTBB003527	-0.83497053	2.76752768	-1.53599573	-0.7079646	0.01355197											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164520-02	L-Threonine	170465476		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72-19-5				-9.512631818	4	5		0	-1.03236607					O=C(O)[C@@H](N)[C@@H](C)O	Labotest	LTBB004859	-2.74261603	-0.75092274	-2.45186314	-2.76213462	-1.03236607											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00167538-02	Clorprenaline hydrochloride	170466032	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	6933-90-0				-5.5240121949	4	5		0	-3.57142857					Cl.OC(CNC(C)C)c1ccccc1Cl	Sequoia	SRP036805c	0.75701167	-3.93279878	-0.87269705	-1.28720837	-3.57142857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164552-06	Bromfenac Na			SARS-CoV-2_CPE_SRI	2019_NPC-3.2					0.2953067575	4	5		0	2.72394633					NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	Sequoia	SRP034005b	-0.54027505	0.70110701	-1.42914385	-0.32869785	2.72394633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263922-02	Darifenacin hydrobromide	170465079	Muscarinic acetylcholine receptor M3 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	133099-07-7				-2.9850911892	4	5		0	-0.3387993			1131	CHRM3	Br.NC(=O)C(c1ccccc1)(c2ccccc2)[C@@H]3CCN(C3)CCc4cc5CCOc5cc4	Microsource	01505714	-1.37524558	0.45510455	-1.77641245	1.0619469	-0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253600-01	Iothalamate sodium	170465058		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1225-20-3				-2.5370208635	4	5		0	-0.75334821					[Na+].O=C(C)Nc1c(I)c(c(I)c(c1I)C([O-])=O)C(=O)NC	GVK	FFS-11-286-NCI-047	-1.10449243	0.19091256	-0.54024103	0.4558863	-0.75334821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179382-03	Hexylcaine hydrochloride	170465088	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	532-76-3				-5.0652565979	4	5		0	-0.60055866					Cl.CC(CNC1CCCCC1)OC(=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-788	-1.3229927	-1.33233719	0.15874954	-1.92055871	-0.60055866											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016819-05	Gliquidone	170465581	Cytochrome P450 3A4 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33342-05-1				-7.2705306654	4	5		0	0.54469274					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3cc(ccc3C(C)(C)C4=O)OC	Prestwick Chemical, Inc.	Prestw-991	-3.81690998	-1.0833022	-1.86836	2.09515495	0.54469274											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095049-04	Exalamide	170465990		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53370-90-4				-7.6233586218	4	5		0	-3.44972067					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-2.23540146	-2.00473166	1.79509098	-1.07667685	-3.44972067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094748-07	Oxyphenbutazone	170465310		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	129-20-4				-5.1658299999	4	5		0	0.85377422					Oc1ccc(cc1)N3C(=O)C(CCCC)C(=O)N3c2ccccc2	Microsource	01500455	-2.60314342	-1.66051661	2.3373848	-2.07332491	0.85377422											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263544-01	Dexrazoxane hydrochloride	170464709	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	24584-09-6	Dexrazoxane hydrochloride;Dexrazoxane Hydrochloride	3.9810717055	-5.4	18.4553504239	4	5		13.171586712	12.96923702	0.1477473622	0.9173693407	7153	TOP2A	O=C2CN(C[C@H](C)N1CC(=O)NC(=O)C1)CC(=O)N2	Tocris	3857	2.57858546	-2.22632226	0.81474556	7.10493047	12.96923702											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016278-10	Mefenamic acid	170464813	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	61-68-7				3.3452406847	4	5		0	-0.25748746					O=C(O)c2ccccc2Nc1cccc(C)c1C	Vitas	STK666691	1.89096267	2.74292743	-1.53599573	-1.1630847	-0.25748746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164589-02	Phenprobamate	170465902		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	673-31-4				3.8330350833	4	5		0	3.26602521					NC(=O)OCCCc1ccccc1	Sequoia	SRP014251p	0.46660118	1.75891759	-0.60104181	-0.4045512	3.26602521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017258-08	Methergine	170465383	Serotonin 2b (5-HT2b) receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	113-42-8				-6.6132840315	4	5		0	-0.51675978					CC[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34	Enzo	AC576	-3.4823601	1.40704769	-0.23201856	-0.84388186	-0.51675978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160624-04	Ethopabate	170466827	folic acid biosynthetic process Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59-06-3				-9.4047008146	4	5		0	-0.98929394					CCOc1cc(ccc1C(=O)OC)NC(C)=O	SIGMA	00275	-3.26620825	2.25092251	-2.87164418	-3.10998736	-0.98929394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249902-01	Epsiprantel	170465737	calcium ion homeostasis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	98123-83-2				13.3686125833	4	5		0	3.75389619					O=C2CN(CC1c3ccccc3CCCN12)C(=O)C4CCCCC4	GVK	FFS-11-286-NCI-105	3.0697446	3.82533825	-0.12020836	3.26169406	3.75389619											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015769-32	Ouabain octahydrate			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	11018-89-6				2.7736579529	4	5		0	1.17902155					C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Enzo	CM109	-0.61394892	1.34071341	1.88326432	1.1125158	1.17902155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015701-06	Metyrosine	170465112	Tyrosine 3-hydroxylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	672-87-7				-3.3081019069	4	5		0	0.23038352					Oc1ccc(C[C@](C)(N)C(=O)O)cc1	Vitas	STK272180	-0.51571709	-2.17712177	-1.61613463	-0.88495575	0.23038352											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00091455-09	Celecoxib	170464693	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	169590-42-5	; 5   Celecoxib (Celebrex);Celecoxib; Celecoxib; Celebrex;CELECOXIB	11.220184543	-4.95	35.6965278719	3	5		59.0929045863	51.80918824	0.0054380902	0.9972710594	5743	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(C)cc2)C(F)(F)F	Microsource	01503678	-1.52259332	1.21771218	-1.96340323	0.4551201	51.80918824											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179244-03	Dorzolamide hydrochloride	170465119	Carbonic Anhydrase Type II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	130693-82-2	; Trusopt; 1   Dorzolamide;Dorzolamide HCL;Dorzolamide hydrochloride			-2.057245382	4	5		0	1.68994413			760	CA2	Cl.NS(=O)(=O)c1cc2[C@H](C[C@H](C)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-1116	-1.04927007	-1.1829162	2.03932104	-2.82263931	1.68994413											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095056-04	Retinyl palmitate	225144218		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	79-81-2				0.2674693769	4	5		0	-0.85195531					CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)\CCCC1(C)C	SIGMA	R1512	-0.01520681	0.43581123	2.52778117	-1.62956496	-0.85195531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162149-07	Demeclocycline hydrochloride	170465205	Bacterial 70S ribosome Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64-73-3				-3.3003529681	4	5		0	5.84089985					Cl.NC(=O)C=2C(=O)[C@@]3(O)C(O)=C4C(=O)c1c(c(Cl)ccc1O)[C@@H](O)[C@H]4C[C@H]3[C@@H](C=2O)N(C)C	Microsource	01500226	-2.8978389	-0.57810578	-2.97849606	0.27812895	5.84089985											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183004-01	Alilusem potassium	144206835	renal sodium ion transport Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	114417-20-8	M-17055; Alilusem Potassium; 			0.7955873076	4	5	Alilusem Potassium;M-17055;7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid;LS-77484;M17055;CIPLUS_774461;M 17055;	0	4.45859873					[K+].Cc1ccccc1C(=O)N3CC/C(=N\OS([O-])(=O)=O)c2ccc(Cl)cc23	Pharmaron	PH-NIH-151932	-2.21021611	0.57810578	-1.40243088	3.05941846	4.45859873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091219-08	DEET	170466080		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	134-62-3				-1.5978730556	4	5		0	0.0948638					Cc1cccc(c1)C(=O)N(CC)CC	Microsource	01601020	0.51571709	-1.9803198	-0.81474556	-0.9608091	0.0948638											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183025-01	Biliscopin	144206809		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51022-74-3	Iotroxic acid; Acido iotroxico; 			4.435370863	4	5	Acido iotroxico;3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino)bis(2,4,6-tri iodobenzoic acid));iotroxic acid, calcium salt;iotroxic acid;BENZOIC ACID, 3,3'-(OXYBIS(2,1-ETHANEDIYLOXY(1-OXO-2,1-ETHANEDIYL)IMINO))BIS(2,4,6, TRIIODO-;SH 213 AB;acidum iotroxicum;3,3'-(3,6,9-TRIOXAUNDECANEDIOYLDIAMINO)BIS(2,4,6-TRIIODOBENZOIC ACID);IOTROXIC ACID;Iotroxic acid;3,3'-(OXYBIS(ETHYLENEOXYMETHYLENECARBONYLIMINO))BIS(2,4,6-TRIIODOBENZOIC ACID);Iotroxic Acid;iotroxinate;iotroxic acid, magnesium salt;CIPLUS_180821;Acide iotroxique;Acidum iotroxicum;acide iotroxique;	0	-0.69115056					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Pharmaron	PH-NIH-120888-3	1.89096267	-0.28290283	3.99358889	-1.64348925	-0.69115056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094969-05	Anisindione	170465379	Vitamin K-dependent gamma-carboxylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	117-37-3				5.6423814916	4	5		0	6.35587478					COc1ccc(cc1)C3C(=O)c2ccccc2C3=O	Microsource	01502198	1.2524558	0.30750308	0.1736343	-2.52844501	6.35587478											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023193-06	Triamcinolone acetonide	170464660	Glucocorticoid steroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	76-25-5	; ; Cinonide; Kenalog; Pevisone; Kenacort A; Acetonide, Triamcinolon; A, Kenacor; Azmacort; Tricort 4;Triamcinolone acetonide; Kenalog 40; 40, Kenalo; Tricort4;TRIAMCINOLONE ACETONIDE; Triamcinolone acetonide; Monacort; Tricort-40			-7.0978775925	4	5		0	-0.01396648				NRC31	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	76-25-5	-3.8473236	-0.83426721	-0.23201856	1.1348756	-0.01396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164561-02	Zanamivir	170464662	Neuraminidase (Sialidase) Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	139110-80-8	 ; Zanamivir Anhydride;Zanamivir; Zanamivir; Relenza;Zanamivir (Relenza);Zanamavir			-0.1998911929	4	5		0	-3.22625698				NEU2	O[C@@H]([C@@H]1OC(=C[C@H](NC(=N)N)[C@H]1NC(C)=O)C(=O)O)[C@H](O)CO	Sequoia	SRP00400z	0.38017032	0.31129374	-0.89143974	2.73534119	-3.22625698											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023509-13	Lovastatin	170464913	HMG-CoA Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	75330-75-5	; ; Lovastatin (Mevinolin); Monacolin K; Mevacor;LOVASTATIN; Mevinolin (lovastatin); 6-Methylcompactin; 6 Methylcompacti; Lovastatin;Lovastatin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin	5.0118723363	-5.3	12.0199902731	4	5		19.6204379519	13.56145251	0.048472678	0.9750026353	3156	HMGCR	C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801953	-2.60036496	0.90897771	1.67297594	7.01294922	13.56145251											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015360-08	Pentetic acid	170465150	Radioactive metals Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	67-43-6				11.2480115606	4	4		0	7.47154874					O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	Vitas	STK373226	0.14499758	1.20868278	-0.25453388	7.47154874												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00091071-08	p,p'-DDT	170465529		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	50-29-3				8.5477435486	4	4		0	5.98713508					Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl	Specs	AE-562/J256064	-0.09666506	-1.1100148	2.79987273	5.98713508												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164547-06	Zafirlukast	174007053	Leukotriene CysLT1 (LTD4) Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	107753-78-6	 ; Zafirlukast;Zafirlukast			1.7616108312	4	5		0	0.12569832			10800	CYSLTR1	Cc1ccccc1S(=O)(=O)NC(=O)c5ccc(Cc3cn(C)c2ccc(cc23)NC(=O)OC4CCCC4)c(OC)c5	Sequoia	SRP00200z	-1.53588808	0.11206575	-0.25644157	6.60555798	0.12569832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016395-06	Diphenylpyraline hydrochloride	170464816	Histamine H1 receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	132-18-3		6.3095734448	-5.2	8.1354464055	4	5		20.642335764	18.19832402	0.0408829599	0.9789788587			Cl.CN3CCC(OC(c1ccccc1)c2ccccc2)CC3	Microsource	01500258	-3.45194647	0.11206575	-1.77066797	2.99723556	18.19832402											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164588-02	Malotilate	170465879	Liver Protein Metabolism	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59937-28-9	 Kantec; Malotilate; Malotilato;Malotilate; 			0.0804317174	4	5		0	-1.52234637				MMP1	CC(C)OC(=O)C(/C(=O)OC(C)C)=C1/SC=CS1	Sequoia	SRP01140m	0.80596107	0.90897771	-1.01355477	-0.29099374	-1.52234637											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015562-25	Indomethacin	170464705	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53-86-1	 Indocin;; Cu salt; Indocid; Al salt; Indocin I.V.; ; Li salt; Cu(2+) salt; Metindol; Mg salt; Indomethacin; Ca salt; Osmosin; Cu-IMCC; Zn salt; Combiflex;Indomethacin; Indomet 140; Amuno; NH4 salt;INDOMETHACIN; Indometacina			4.2694875025	4	5		0	4.90223464				PTGS2	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC	Microsource	01500350	-1.26216545	0.90897771	4.23739162	-0.93117998	4.90223464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016016-18	Triamterene	170464706	Heart phosphodiesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	396-01-0		11.220184543	-4.95	21.1312999126	3	5		42.326974679	35.37709497	0.0042394189	0.997875537			Nc2nc(N)nc1nc(N)c(nc12)c3ccccc3	Vitas	STK300348	-2.38746959	-0.88407421	-0.3785566	0	35.37709497											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017291-17	Riboflavin			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	 83-88-5				3.806790846	4	5		0	-2.83519553					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Selleck	S2540 	4.51642336	-0.65994272	-0.98913176	1.30947185	-2.83519553											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00164071-03	Isopropyl tetradecanoic acid	170465683		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	110-27-0				-3.9918828563	4	5		0	-1.74581006					CC(C)OC(=O)CCCCCCCCCCCCC	SIGMA	172472	-0.44099757	-1.78060017	-1.18451581	0.29099374	-1.74581006											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022304-21	ACETYLCYSTEINE			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	616-91-1				-11.4848552024	4	5		0	-2.86312849					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-3.23905109	-2.40318765	-1.06240078	-1.30947185	-2.86312849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249928-01	Eicosapentaenoic acid ethyl ester	170466007		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	73310-10-8				-2.7679560406	4	5		0	0.83705357					O=C(/C=C\C=C/C=C\C=C/C=C\CCCCCCCCC)OCC	GVK	FFS-11-286-NCI-230	-0.45917101	-1.33638793	-0.23548968	-2.06489676	0.83705357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185774-02	Erdosteine	170465586	Mucolytic Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	84611-23-4	Erdosteine			-9.4812433677	4	5		0	-0.08370536				CAT	O=C1SCCC1NC(=O)CSCC(=O)O	Bosche	E2165	-3.26383718	-0.9291078	-2.00858845	-1.87717887	-0.08370536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166312-02	Closantel	170466628		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57808-65-8		11.220184543	-4.95	39.6590408207	3	5		84.1216001336	63.05865922	0.0017528029	0.999122709			Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2	Vitas	STK378904	-4.18187348	-2.15415266	-1.892783	4.45220428	63.05865922											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018107-05	2-Thiosalicylic acid	170465571	prostaglandin biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	147-93-3				3.0824515743	4	5		0	-3.36592179					OC(=O)c1ccccc1S	SIGMA	T33200	3.11739659	-2.82654713	2.18585908	0.37829187	-3.36592179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016362-05	Benzonatate	170465391	Slowly adapting pulmonary stretch receptor Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104-31-4				-7.9581296681	4	5		0	-1.18715084					O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1	Prestwick	Prestw-12	-2.96532847	-1.83040717	1.64855294	-2.06605558	-1.18715084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016260-13	Ethacrynic acid	170465426	Sodium/potassium-transporting ATPase subunit alpha-1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	58-54-8				-7.6092471245	4	5		0	0.53013393			476	ATP1A1	Clc1c(ccc(OCC(=O)O)c1Cl)C(=O)C(=C)CC	Specs	AN-153/J108037	-1.45197319	-1.92185312	-2.72890982	-2.94985251	0.53013393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016640-06	Todralazine hydrochloride	170465782	histone acetylation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3778-76-5				-9.4641841227	4	5		0	-2.5390625					Cl.O=C(OCC)NNc2nncc1ccccc12	Microsource	01501174	-2.64333582	-2.71095838	-2.11940712	1.01903996	-2.5390625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine			1.4522980264	4	4		0	1.08857001			84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	0.62832286	-0.71534287	-0.82723513	1.08857001												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00181129-14	Dasatinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	302962-49-8				-5.9613171532	4	4		0	-0.04775549				ABL1	CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Adooq	A10290	-1.54566745	-1.47093159	-1.35980419	-0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485891-01	Norgestimate metabolite Norelgestromin	363681397	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	53016-31-2				-4.7200982383	4	4		0	-1.71919771					CC[C@]12CC[C@H]3[C@@H](CC\C4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-G0018	-0.98360656	-0.07004436	-1.25101985	-1.71919771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015823-17	Piroxicam	170464817	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	36322-90-4	; ;Piroxicam; Piroxicam cyclodextrin;PIROXICAM; Piroxicam;piroxicam; Feldene			0.6452225029	4	4		0	1.16125627			5742	PTGS1	OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Vitas	STK177288	0.07062147	-2.01809325	0.62095032	1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015508-16	Hydrochlorothiazide	170465005	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58-93-5	; Moduretic; Dyazide;HYDROCHLOROTHIAZIDE; ; Tenesor; Capozide; Slimin; Hydrochlorothiazide; Esidrix; HydroDIURIL; Tolerzide; Oretic; Sectrazide; Triampur compositum; Spiridazide; Esidrex; Triampur (combination); Hypothiazide; Dihydrochlorothiazide; Hydrochlorothiazid;Hydrochlorothiazide; Dichlothiazide; Maxzide; Triampur; Hidroclorotiazida; Moducren			-1.9370608116	4	4		0	-0.68619689				SLC12A3	NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl	Specs	AN-153/I107325	-0.58851224	0.06958942	-0.1349892	-0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249909-01	Fenbutrazate	170465618	Monoamine transporters; Norepinephrine & dopamine Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	4378-36-3				-2.9465169604	4	4		0	-2.26972816					CCC(c1ccccc1)C(=O)OCCN2CCOC(C2C)c3ccccc3	GVK	FFS-11-286-NCI-142	-0.82391714	-0.20876827	1.16090713	-2.26972816												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167498-02	Thiamphenicol glycinate			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2393-92-2				-6.639439492	4	4		0	0.26960784					C[S+]([O-])(=O)C1=CC=C(C=C1)[C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl	Enzo	DL143	-1.89012097	-1.28700129	-1.59485171	0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016003-10	Trihexyphenidyl hydrochloride	170464756	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52-49-3		11.220184543	-4.95	59.6011178284	3	4		68.5409749375	56.80084188	0.0101488613	0.999936485			Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500592	-0.92009685	-0.40150565	-0.68406385	56.80084188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263565-01	Gestodene	170466131	Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60282-87-3	Gestodene			-0.6712578143	4	4		0	0.0789266			5241	PGR	O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2C=C[C@@]1(O)C#C)=C4	Bosche	G2883	0.1937046	-1.10414053	-0.32936407	0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094437-05	d-Tryptophan	170465485	Tryptophan metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	153-94-6				-4.8061535255	4	4		0	0.34201526					O=C(O)[C@H](N)Cc2cnc1ccccc12	SIGMA	93660	-1.7433414	-1.30489335	-0.98809222	0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263559-01	Carbocysteine	170465800	regulation of mucus secretion Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2387-59-9				-1.5385674044	4	4		0	0.71033938					OC(=O)C(N)CSCC(O)=O	Bosche	S0868	-1.11380145	-0.70263488	0.22802128	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094908-06	Mephenesin	170466586	Glutamate NMDA receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59-47-2				-3.6854159724	4	4		0	-0.44725072					OCC(O)COc1ccccc1C	Microsource	01501140	-0.8716707	-1.00376412	-0.83607803	-0.44725072												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091517-06	L-Ascorbic acid	170464728		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	50-81-7				-2.354253654	4	4		0	-0.29688273					OC=1C(=O)O[C@H]([C@@H](O)CO)C=1O	Microsource	01502230	-1.01498308	0.17266897	-0.25453388	-0.29688273												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015273-19	Chlorpromazine	170465371	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	50-53-3		11.220184543	-4.95	69.5306654015	3	4		68.753399053	60.16823355	0.045069756	0.9987453834			CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12	Vitas	STK182870	1.25664572	2.1953626	-0.31816736	60.16823355												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274084-01	DL-Isoleucine	170465505		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	443-79-8				2.0920517053	4	4		0	1.08857001					CC(CC)C(N)C(=O)O	SIGMA	I2752	-0.67665539	2.98470646	0.06363347	1.08857001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178483-14	Limonin			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1180-71-8				-8.1344803226	4	5		0	-1.11607143					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	-3.16455696	-2.4564083	0.62335504	-0.21453473	-1.11607143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164526-02	Camylofin	170465936	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	54-30-8		8.9125093813	-5.05	6.4907440782	4	5		18.7000763679	15.90401786	0.0634594721	0.9668109271			CC(C)CCOC(=O)C(NCCN(CC)CC)c1ccccc1	Labotest	LT03328450	-1.55125341	-3.50006364	0.51253636	-0.61678734	15.90401786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095169-05	Miltefosine	170465622		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58066-85-6				-10.0002836288	4	5		0	-4.62290503					C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCC	Microsource	01505329	-2.23540146	-1.65608268	2.21028209	-3.98661429	-4.62290503											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160387-04	Clothiapine	170465938	GABA-A receptor; benzodiazepine site Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2058-52-8				-1.7056171237	4	5		0	3.61731844					CN1CCN(CC1)C3=Nc4ccccc4Sc2ccc(Cl)cc23	Enzo	D108	-3.42153285	0.36110073	-0.50067163	2.90993744	3.61731844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016009-19	Tolazamide	170465136	ATP-sensitive inward rectifier potassium channel 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1156-19-0				-4.3483800654	4	5		0	-0.51675978					Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2	Enzo	KC135	-1.0796837	-0.63503922	-0.45182562	-1.71686309	-0.51675978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164528-04	GLYCERYL LAURATE	225144258	Toxic shock syndrome toxin-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	142-18-7				-3.5683404408	4	4		0	-1.03908956			3552	tst	CCCCCCCCCCCC(=O)OCC(O)CO	SIGMA	M1765	-0.72498792	-1.45535274	-0.06363347	-1.03908956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262537-04	Thiethylperazine dimalate 		Dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	52239-63-1		2.8183829313	-5.55	14.4107427648	4	4		12.252159696	-2.38777459	1	0.9982190037			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	Prestwick	Prestw-1068	0.09367681	-0.21013308	9.89937449	-2.38777459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159390-14	PERMETHRIN		Voltage-sensitive sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	52341-33-0, 52645-53-1				5.8817811993	4	4		0	0.66857689					CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC2=CC=CC(=C2)OC3=CC=CC=C3	Microsource	01504932	1.49882904	1.19075414	1.03345118	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015163-09	Benserazide	170465804	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	14919-77-8	; ; Benserazida; Benserazide Hcl; Ro 8-0576-12; Ro 8-0576-7;Benserazide hydrochloride; Benserazide hydrochloride; Ro 8-0576;BENSERAZIDE HYDROCHLORIDE; Benseraszide; Ro 4460; Ro 4 460			-3.1090576713	4	4		0	-1.00490196			1644	DDC	Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O	Microsource	01500137	-0.68044355	0.87516088	-1.76273083	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013841-09	Cyclobenzaprine hydrochloride	170464953	5-HT2A Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	6202-23-9	 Lisseril; ; Flexeril; Ciclobenzaprina;CYCLOBENZAPRINE HYDROCHLORIDE; Cyclobenzaprine hydrochloride;Cyclobenzaprine hydrochloride	12.5892541179	-4.9	92.4496589655	3	4		108.1660893984	86.84556696	0.0088380172	0.9999518227	3356	HTR2A	Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12	Microsource	01503207	-0.4842615	-1.10414053	-1.08943501	86.84556696												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164569-02	Capecitabine	170464779	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	154361-50-9	Capecitabine;Capecitabine (Xeloda); Xeloda; Capecitabine; 			0.5127604927	4	4		0	1.3943699				TYMS	O=C(OCCCCC)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Sequoia	SRP01237c	0.0968523	0.15056462	-1.2414492	1.3943699												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095161-05	Rebamipide	170465891	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	90098-04-7	 ; Rebamipida;REBAMIPIDE; REBAMIPIDE; Rebamipide; Mucosta			0.7322947489	4	4		0	-0.29688273				CAT	Clc1ccc(cc1)C(=O)NC(CC3=CC(=O)Nc2ccccc23)C(=O)O	Microsource	01505310	1.11164814	-0.86334484	-0.38180083	-0.29688273												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178318-04	Sodium 2-mercaptoethanesulfonate	170464862	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	19767-45-4				3.4040375007	4	4		0	0.19792182				CAT	[Na+].[O-]S(=O)(=O)CCS	Microsource	01502014	0.53165781	-0.76467686	2.60897232	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164462-01	Pyriproxyfen	26757881	juvenile hormone metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	95737-68-1				-3.2952228526	4	4	pyriproxyfen;pyriproxyfen, (S)-isomer;2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine;CIPLUS_668570;Pyriproxifen;pyriproxyfen, (R)-isomer;NCGC00164462-01;S 31183;juvinal;2-[1-Methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine;NCGC00163945-01;CIPLUS_760107;Pyriproxyfen;S-31183;	0	0.6127451					CC(COC1=CC=C(OC2=CC=CC=C2)C=C1)OC3=NC=CC=C3	EPA	EPA-CAS-95737-68-1	-1.58770161	0.51480051	-0.08393956	0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182054-03	Aranidipine	170465977	Voltage-gated calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	86780-90-7				-5.7334630311	4	4		0	-1.83823529					CC=1NC(C)=C(C(C=1C(=O)OCC(C)=O)c2ccccc2[N+]([O-])=O)C(=O)OC	APAC	826079	-1.68850806	0.46332046	-0.53161724	-1.83823529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016288-06	Bemegride		GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	64-65-3				-4.2248670758	4	4		0	-0.80882353					CCC1(C)CC(=O)NC(=O)C1	APExBIO	B1672	-1.28528226	0.30888031	-0.58757694	-0.80882353												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00094719-08	Methenamine	170465468		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	100-97-0				1.6065924196	4	4		0	0.36764706					C1N3CN2CN(CN1C2)C3	Microsource	01500394	0.32762097	-0.1029601	0.81141578	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164631-05	Sunitinib malate	170465289	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	341031-54-7	 Sunitinib malate;Sunitinib malate; Sunitinib base; ;Sutent			-5.9759199449	4	4		0	-2.62246413			2321	FLT1	O=C(O)C(O)CC(=O)O.CCN(CC)CCNC(=O)C1C(C)=C(N=C1C)/C=C2/c3cc(F)ccc3NC2=O	Sequoia	SRP01785s	-0.28999517	-0.41933892	-2.16353802	-2.62246413												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091297-05	Anilinium nitrate	170465650		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	542-15-4				-0.1861275554	4	4		0	0.49480455					O[N+]([O-])=O.[NH3+]c1ccccc1	Vitas	STK301792	0.72498792	-0.96201283	-1.3363029	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024683-23	Parthenolide			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	20554-84-1		3.5481338923	-5.45	26.3944941867	4	4		26.4859835639	25.6308758	0.0197482044	0.9997598284			C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	SIGMA	P0667	-0.82165297	-0.5673409	0.19090041	25.6308758												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00390646-02	Isavuconazole			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	241479-67-4		1.2589254118	-5.9	18.0450021561	4	4		12.1124121719	1.24164279	1	0.999911783			C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](O)(C[N]3C=NC=N3)C4=CC(=CC=C4F)F	MedChem Express	HY-14273	-0.09367681	1.28414663	12.02066902	1.24164279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378841-01	Levomefolate calcium			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	151533-22-1				-1.9497314365	4	4		0	-0.19102197					CN\1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC\3=C1C(=O)NC(=N3)\N	MedChem Express	HY-17383	-0.04683841	-0.63039925	-1.57737286	-0.19102197												1.6E-8	8E-8	4E-7	0.000002											
NCGC00181156-01	Oxabolone cipioncate	144206313	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1254-35-9	Oxabolone cipionate; Cipionato de oxabolona; 			-0.6364580096	4	4	LS-172626;oxaboloni cipionas;OXABOLONE CIPIONATE;cipionate d'oxabolone;Oxabolone cipionate;4,17beta-dihydroxy-estr-4-en-3-one 17-cyclopentylpropionate;CIPLUS_211114;Cipionato de oxabolona;Oxabolone Cipionate;oxabolone cypionate;Oxaboloni cipionas;Cipionate d'oxabolone;	0	0.41666667					OC=5C(=O)CC[C@H]4C=5CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCC1CCCC1)CC[C@@H]23	NCI	NSC-522767	-0.63004032	1.02960103	-0.08393956	0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248225-03	9(Z)-Hexadecenoic acid		Gap junction Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	373-49-9				0.354381807	4	4		0	2.08333333					CCCCCC\C=C/CCCCCCCC(O)=O	Enzo	BL103	-0.42842742	-0.46332046	0.3077784	2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017134-08	Meclocycline sulfosalicylate			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	73816-42-9				6.4803304066	4	4		0	1.25					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@@H]\3C(=C)C4=C(Cl)C=CC(=C4C(=O)C3=C(\O)[C@@]2(O)C(=O)\C(=C1O)C(N)=O)O.OC(=O)C5=C(O)C=CC(=C5)[S+](O)([O-])=O	SIGMA	M1388	1.38608871	0.77220077	2.09848909	1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015469-09	Guanfacine hydrochloride	170465381	Alpha-2a adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	29520-14-7				6.566840822	4	4		0	-0.51470588					Cl.Clc1cccc(Cl)c1CC(=O)NC(=N)N	Enzo	AR102	2.39415323	0.05148005	1.14717403	-0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181083-01	Piperilate hydrochloride	144206255		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	4544-15-4	PIPERILATE; Glymor; Pipetanato; 			4.3630128213	4	4	Glymor;CIPLUS_163480;DPX-8;Benzilic acid, 2-piperidinoethyl ester, hydrochloride;2-(1-piperidino)ethyl benzilate;Pipethanate Hydrochloride;Benzilic acid, 2-piperidinoethyl ester;2-PIPERIDIN-1-YLETHYL HYDROXY(DIPHENYL)ACETATE;pipethanate;CIPLUS_163479;.ALPHA.-HYDROXY-.ALPHA.-PHENYL-, 2-(1-PIPERIDINYL)ETHYL ESTER;Pipethanatum;Pipethanate hydrochloride;pipethanate hydrochloride;LS-32519;LS-32518;Pipetanato;PIPETHANATE HYDROCHLORIDE;Piperilate;pipethanatum;N-piperidinoethyl benzilate;beta-Piperidylethyl benzilate;PIPETHANATE;PIPERILATE;piperilate;alpha-hydroxy-alpha-phenylbenzeneacetic acid, 2-(1-piperidinyl)ethyl ester;	0	-1.10294118					Cl.OC(c1ccccc1)(c2ccccc2)C(=O)OCCN3CCCCC3	NCI	NSC-30793	0.78125	3.14028314	1.42697258	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263893-02	Lactitol	170465917	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	585-86-4				-2.6127280953	4	4		0	0.0789266					OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	Microsource	01505436	-0.6779661	-0.20075282	-1.2414492	0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018271-07	Homochlorcyclizine	170465786		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	848-53-3		5.0118723363	-5.3	99.9719979686	3	4		97.2051275539	92.89660616	0.0049347252	0.9999849807			Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3	Enzo	AC927	-1.0653753	-0.65244667	0.48137826	92.89660616												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016853-06	Nabumetone	170464970	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	42924-53-8				-0.7660455124	4	4		0	0.97342805					CC(=O)CCc1ccc2cc(ccc2c1)OC	Microsource	01503650	-0.24213075	-0.80301129	-0.78540664	0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091641-12	MERCAPTOPURINE			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	6112-76-1, 50-44-2 [anhydrous]				6.1892243096	4	4		0	2.72142504					S=C1NC=NC2=C1NC=N2	Microsource	01500387	0.43499275	1.99802664	0.95450207	2.72142504												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167468-02	Benorylate	170466237	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5003-48-5				1.3733836008	4	4		0	2.27610094					O=C(C)Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1	Bosche	B1551	-0.28999517	-0.07400099	-0.50906777	2.27610094												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090548-04	Deferiprone		Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	30652-11-0				-1.9216655426	4	4		0	0.09551098					CN/1\C=C/C(=O)/C(=C1C)O	Selleck	S4067	-0.18735363	-0.95727294	-1.08784335	0.09551098												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178803-03	HOMATROPINE METHYLBROMIDE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	80-49-9, 87-00-3 [homatropine]				-4.7055380789	4	4		0	-0.38204394					C[N+]1(C)C2CC[C@H]1CC(C2)OC(=O)C(O)C3=CC=CC=C3	Microsource	01500333	-1.264637	-1.05066542	-0.65270601	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091534-02	o-Cresol	26753043		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	95-48-7	2-Methylphenol-d8; o-Cresol-d8; 			2.8034926496	4	4	2-methylphenol;CIPLUS_732542;CIPLUS_723417;methylphenol, polymer with formaldehyde;phenoaldehyde resinifying agent;CIPLUS_3741557;CIPLUS_3751665;CIPLUS_3881950;2-cresol, sodium salt;2-METHYLPHENOL;CIPLUS_749387;2-cresol, potassium salt;phenoaldehyde;CRESOL;CIPLUS_150287;CIPLUS_749458;O-CRESOL;ortho-cresol;Methylphenol tricresol;o-Cresol-d8;CIPLUS_3882512;o-cresol;NCGC00091534-02;Cresol mixture of isomers;CIPLUS_743211;CIPLUS_749586;AB08007336-01;2-cresol;CIPLUS_3752378;CIPLUS_671502;2-cresol, ammonium salt;CIPLUS_745732;tricresolformalin;2-Methylphenol-d8;CIPLUS_653786;CIPLUS_163487;2-Methylphenol;CIPLUS_3750176;CIPLUS_714209;CIPLUS_682977;o-Cresol;	0	0.62082139					CC1=C(O)C=CC=C1	SigmaAldrich	MFCD00002226	0.6088993	0.58370301	0.54392168	0.62082139												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165825-02	Milnacipran hydrochloride	225144261	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	101152-94-7				-2.6446505523	4	4		0	-1.05062082					CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	SIGMA	M1318	-0.6557377	-0.21013308	-0.05439217	-1.05062082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167502-01	NCGC00167502-01	50112755		DPI_SARS-CoV-2_General	2019_NPC-5_CPE		CIPLUS_205233; Santeson; 			-4.8161068037	4	4	Santeson;CIPLUS_684703;Dexamethasone Metasulfobenzoate Sodium;Dexamethasone metasulfobenzoate sodium;CIPLUS_205233;DEXAMETHASONE METASULFOBENZOATE SODIUM;	0	-0.6127451					CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)C5=CC=CC(=C5)S([O-])(=O)=O	Pharmeks	PHAR046594	-1.33568548	-0.82368082	-0.53161724	-0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167464-02	Hydrocortisone Sodium Phosphate	225144288		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	6000-74-4				1.6059606913	4	4		0	-0.26960784					C[C@]\12CCC(=O)\C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO[P]([O-])([O-])=O)[C@@]4(C)C[C@H](O)[C@H]23	Bosche	H6475	1.38608871	-0.61776062	-1.14717403	-0.26960784												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00024501-04	D-Glutamic acid	225144193	Metabotropic glutamate receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	6893-26-1				4.554222518	4	5		0	4.62474645					N[C@H](CCC(O)=O)C(O)=O	SIGMA	49460	-0.26862027	-1.4664981	0.49346163	1.14860014	4.62474645											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00183046-03	Mequitazine	170465794	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	29216-28-2		2.8183829313	-5.55	17.5988396053	4	5		17.4211695039	-3.24543611	0.1065313294	0.9929766636			c3ccc4Sc5ccccc5N(CC2CN1CCC2CC1)c4c3	Vitas	STK324459	-1.001221	0.1011378	-1.18430792	13.97463508	-3.24543611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165993-02	Picolinic acid	170466822		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	98-98-6				0.6187457662	4	5		0	0.81135903					O=C(O)c1ccccn1	Bosche	P0843	0.95238095	-1.6182048	-0.98692327	0.09571668	0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015466-11	Gabapentin	170464715	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	60142-96-3	 Go 3450;; Gabapentin hydrochloride;Gabapentin hydrochloride; ; Neurontin;Gabapentin; Gabapentino; Gabapentin; gabapentin ISTD			-1.3126766146	4	5		0	2.02839757				CACNA2D1	NCC1(CC(=O)O)CCCCC1	Vitas	STK598009	-0.61050061	0	-1.13496176	-1.29217516	2.02839757											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263529-01	Lacidipine	170465580	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	103890-78-4				-2.4648914145	4	5		0	-3.40770791					CC=1NC(C)=C(C(C=1C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C)C(=O)OCC	Sequoia	SRP00900l	0.75702076	-1.7193426	-0.9375771	0.76573343	-3.40770791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016375-09	Sulfadimethoxine	170465690	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	122-11-2	; ; Sulfadimetoxina; Sulfadimethoxine Sodium; Rofenaid; Sulfadimethoxine;Sulfadimethoxine;SULFADIMETHOXINE; Deposul; Abcid; Agribon; Sulphadimethoxine; Sulfadimethoxine Base			-3.4437866685	4	5		0	-0.81135903					COc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Vitas	STK018258	-0.12210012	-1.6687737	-1.87515421	-0.19143336	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021147-11	Doxylamine succinate	170465171	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	562-10-7				-0.7168042477	4	5		0	0.64908722					O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2	Vitas	STL018676	0.51282051	-1.4159292	-1.23365408	-0.43072505	0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015713-13	Nitrendipine	170465897	Intermediate conductance calcium-activated potassium channel protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	39562-70-4				0.9008793527	4	4		0	1.49960537					CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(c2)[N+]([O-])=O)C(=O)OC	SigmaAldrich	N144	-0.3874092	-0.15056462	0.07600709	1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018117-17	Theophyllamine	170466874	Adenosine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	58-55-9	; Theocolin; 1,3-Dimethylxanthine; Choledyl-SA; Quadrinal; Theophylline solution; Novurite; Mercurofilina; Guaithylline; Choledyl; oxtripylline-SA;Theophylline; Guaifilina; Mercumatilina sodica; Aminofilina; Elixophyllin;Aminophylline ethylenediamine;THEOPHYLLINE; Teofilinato de colina; Mercumatiline sodique;Aminophylline; Brondecon; Theobret; Aminophylline, dihydrate; Brondaxin; Butaphyllamine; Tedral; Theodur G; Theophylline-[8-3H]; Mercumatilinum natricum; Euspirax; Novurit; Somophyllin;Theophylline monohydrate			6.0664826839	4	4		0	1.81531176			134	ADORA1	O=C2c1ncnc1N(C)C(=O)N2C	Labotest	LT00000171	1.5496368	1.7565872	-0.0253357	1.81531176												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016794-13	Gemfibrozil	170464998	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil			-2.8246741944	4	4		0	-0.13154433			5465	PPARA	O=C(O)C(C)(C)CCCOc1cc(C)ccc1C	Vitas	STK618740	-1.50121065	-0.95357591	0.73473524	-0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249894-01	Fosphenytoin	170465016	Sodium channel protein type VIII alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	93390-81-9				-2.6400267894	4	4		0	-0.34201526					OP(=O)(O)OCN1C(=O)C(NC1=O)(c2ccccc2)c3ccccc3	GVK	FFS-11-286-NCI-63	-0.968523	-0.10037641	-0.38003547	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016806-13	Mebendazole	170464914	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	31431-39-7	; ; Vermox;Mebendazole; Mebendazol; Mebendazole;MEBENDAZOLE			0.2837528373	4	4		0	3.28860826			203068	TUBB	O=C(OC)Nc1nc2cc(ccc2n1)C(=O)c3ccccc3	Microsource	01501110	-0.33898305	-0.8531995	-2.00152014	3.28860826												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183029-02	Troxipide	170465889	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	30751-05-4				-1.8868077567	4	4		0	-0.34201526					O=C(NC1CCCNC1)c2cc(OC)c(OC)c(OC)c2	Sequoia	30751-05-4	-0.6779661	2.25846926	-1.74816316	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00014017-03	L-Proline	225144170		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	147-85-3				-1.5624245295	4	4		0	1.7100763					OC(=O)[C@@H]1CCCN1	SIGMA	81710	-1.2590799	-0.55207026	-0.68406385	1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163157-05	Mesoridazine	170465272	D(2) dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	5588-33-0		12.5892541179	-4.9	87.8172381817	3	4		106.2332919843	82.05735333	0.0158976594	0.9998440979	1813	DRD2	CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2	Prestwick Chemical, Inc.	Prestw-529	-0.2905569	-0.35131744	-1.34279199	82.05735333												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181042-02	Menthyl salicylate	225144318		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	89-46-3				3.0580537566	4	4		0	0.13154433					CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2O	SIGMA	84320	0.92009685	0.8531995	0.58272105	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178526-03	APRAMYCIN SULFATE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	65710-07-8				-1.7546144204	4	4		0	0.19102197					CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]4O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O	Microsource	01505249	-0.74941452	0.02334812	0	0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390238-01	Isepamicin		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	58152-03-7				-2.4176691529	4	4		0	-0.04775549					CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@@H]2[C@@H](O)[C@H](OC3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN	Adooq	A11662	-1.31147541	0.02334812	0.81588251	-0.04775549												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179599-03	Cefoperazone sodium	170465235	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	62893-20-3				0.557590345	4	5		0	0.89249493					[Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]5C(=O)N4C(=C(CSc3nnnn3C)CS[C@@H]45)C([O-])=O	Prestwick Chemical, Inc.	Prestw-327	0.17094017	-1.6182048	0.09869233	0.90930845	0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016408-09	Sulfapyridine	170464707	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	144-83-2	; ; Sulphapyridine; Sulfapiridina;Sulfapyridine; Sulfapyridine;SULFAPYRIDINE; Sulphapyridin			-3.4265033409	4	5		0	-1.86612576					O=S(=O)(Nc1ccccn1)c2ccc(N)cc2	Vitas	STK292439	-0.17094017	-1.517067	-0.88823094	-0.04785834	-1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159365-04	m-Cresyl acetate	170466849		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	122-46-3				-2.8801270175	4	5		0	-0.56795132					O=C(C)Oc1cc(C)ccc1	Labotest	LTBB001299	-0.36630037	-1.2642225	-1.08561559	-0.19143336	-0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167982-04	Pirarubicin			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	72496-41-4				-2.6384263748	4	5		0	-1.86612576					[H][C@]1(N)C[C@]([H])(O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O[C@@]6([H])CCCCO6	SIGMA	P8624	0.41514042	-0.4551201	-1.08561559	-1.3400335	-1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095165-07	Carmofur	170465833	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	61422-45-5	 Mifurol;CARMOFUR; CARMOFUR; Carmofur; 			-1.0633171413	4	5		0	-0.40567951				TYMS	O=C1NC(=O)C(F)=CN1C(=O)NCCCCCC	Microsource	01505317	0.61050061	-0.7079646	-1.23365408	-0.76573343	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016876-12	Albendazole	170464897	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	54965-21-8				-5.3640211264	4	5		0	-0.81135903					O=C(OC)Nc1nc2cc(ccc2n1)SCCC	Vitas	STK387550	-0.61050061	-1.8204804	-2.12188502	-1.24431682	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160546-02	Haloxon	170466328	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	321-55-1				4.8284604274	4	5		0	1.86612576					O=P(OCCCl)(OCCCl)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	SIGMA	290963	1.88034188	-0.9608091	-0.83888478	1.72290022	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159424-04	Tetramethylthiuram monosulfide	170465567		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	97-74-5				0.4934977752	4	5		0	0.73022312					CN(C)C(=S)SC(=S)N(C)C	Labotest	LT02090816	-0.26862027	-1.2136536	-0.49346163	2.34505863	0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00247665-04	Anagrelide hydrochloride	170465269	Phosphodiesterase III (PDE3) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	58579-51-4				1.516937603	4	5		0	0.73022312					Cl.Oc1cn2Cc3c(Nc2n1)ccc(Cl)c3Cl	Microsource	01505590	0.41514042	-0.505689	1.18430792	-0.52644173	0.73022312											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015279-08	Meclofenoxate hydrochloride	170465815		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3685-84-5				0.1205690918	4	5		0	0.40567951					Cl.Clc1ccc(OCC(=O)OCCN(C)C)cc1	Microsource	01503226	0.21978022	-0.3539823	-0.39476931	-0.09571668	0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167744-02	Methylperone	170466288		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3575-80-2				2.4238040801	4	5		0	4.86815416					Fc1ccc(cc1)C(=O)CCCN2CCC(C)CC2	Tocris	2495	-0.21978022	-0.7585335	-0.44411547	0.04785834	4.86815416											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024257-08	Phenylephrine hydrochloride	170465356	alpha1-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	61-76-7	; Naldecon; Neosynephrine; Metaoxedrin;Phenylephrine hydrochloride; Glauko-Biciron; ; Neo Synephrin; Neooxedrine chloride;PHENYLEPHRINE HYDROCHLORIDE; Neo-synephrine; dimotapp L.A.; Metasympatol; Fenilefrina; (-)-m-Oxedrine; Tannate, Phenylephrin; Neo-Synephrine; Phenylephrine Hcl; Mezaton; Dimetapp; Ru-Tuss; Phenylephrine hydrochloride			-1.8121265595	4	5		0	-2.10953347			148	ADRA1A	Cl.O[C@@H](CNC)c1cc(O)ccc1	Microsource	01500483	0.61050061	-0.1517067	-1.13496176	-0.67001675	-2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253595-01	Clocapramine	170465785	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	47739-98-0				-0.0123709485	4	5		0	-3.0831643					Clc4ccc5CCc1ccccc1N(CCCN2CCC(CC2)(C(N)=O)N3CCCCC3)c5c4	GVK	FFS-11-286-NCI-179	-0.80586081	-0.8596713	-1.33234641	7.60947595	-3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00177980-03	Oxiconazole nitrate	170465226	Steroid biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	64211-46-7				0.3697667712	4	4		0	-1.54913295					[O-][N+](=O)O.Clc3ccc(C(=N\OCc1ccc(Cl)cc1Cl)\Cn2ccnc2)c(Cl)c3	Microsource	01505330	0.82262211	0.39103233	-1.21084496	-1.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015264-13	Clomipramine hydrochloride	170464702	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	303-49-1	 7   Clomipramine; ; Chlomipramine;; Hydiphen;CLOMIPRAMINE HYDROCHLORIDE; Anafranil;Clomipramine; Anafranil hydrochloride; Chloripramine;Clomipramine?HCl; Clomipramina; 8   Clomipramine Hcl;Clomipramine hydrochloride; Clomipramine hydrochloride	10	-5	71.8767291462	3	4		81.2308286143	67.74533018	0.0174214664	0.9998127876	6532	SLC6A4	CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12	Microsource	02300061	-0.2905569	-1.30489335	-0.93742083	67.74533018												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095166-04	Clopidol	170465668		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2971-90-6				-2.570995364	4	4		0	-0.34201526					Oc1c(Cl)c(C)nc(C)c1Cl	Vitas	STK802181	-0.3874092	-0.80301129	-0.88674943	-0.34201526												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00249884-01	Sulfisoxazole acetal	170465159	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	80-74-0				11.6072288974	4	4		0	4.97237569					Cc1c(onc1C)N(C(C)=O)S(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-17	1.21065375	2.20828105	2.25487712	4.97237569												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024499-06	D-Aspartic acid	225144192	Isoaspartyl peptidase/L-asparaginase Interacts	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	56-84-8				-6.0562968912	4	4		0	-1.86792949			80150	ASRGL1	N[C@@H](CC(O)=O)C(O)=O	Enzo	AC367	-1.30750605	0.55207026	-1.34279199	-1.86792949												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00091469-04	Saquinavir	225144210	protease inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	149845-06-7	Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ; Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ;saquinavir			0.808502556	4	4		0	2.49934228					CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4	Prestwick	Prestw-1114	-1.21065375	-0.35131744	0.53204966	2.49934228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167539-03	Indole	170465733	Tryptophan synthase beta chain Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	120-72-9				-5.5463512838	4	4		0	-1.07866351			945768	trpB	c1cccc2nccc12	Specs	AE-562/J262413	-1.6464891	-1.45545797	-0.27869268	-1.07866351												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015817-14	Promethazine	170465107		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	60-87-7		12.5892541179	-4.9	100.9652601722	3	4		107.2107867374	87.97624938	0.0133550377	0.9998899837			CN(C)C(C)CN1c3ccccc3Sc2ccccc12	Enzo	AC765	1.49830836	1.45535274	0.63633471	87.97624938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00250382-07	Sonidegib		Smo Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1218778-77-8				-1.8091362374	4	4		0	-0.66857689				SMO	C[C@H]1CN(C[C@@H](C)O1)C2=NC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C2	Aobious	AOB87343	-0.32786885	0.30352557	-0.97905902	-0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509864-02	ORNIPRESSIN			DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.3986490275	4	4		0	-0.06936416					NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-P0083_cm1	-0.71979434	0.80813347	-0.10529087	-0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179364-03	Ioversol	170464725		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	87771-40-2				-1.5604525429	4	4		0	1.0867052					OCC(O)CNC(=O)c1c(I)c(N(CCO)C(=O)CO)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-878	-1.07969152	0.28675704	0.26322716	1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017337-17	(E)-Capsaicin		Nf-kappab Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	[404-86-4]				-4.0316563078	4	4		0	-1.17919075				NFKB1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1	Tocris	0462	-0.92544987	-0.5995829	-0.52645433	-1.17919075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165719-15	ALENDRONATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					3.1863745677	4	4		0	-0.2002002					NCCCC(O)(P(O)(O)=O)P(O)([O-])=O	Microsource	01505166	0.23854962	0.13061651	3.77062058	-0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162383-04	Vancomycin hydrochloride		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1404-93-9				0.9508750886	4	4		0	-0.3003003					CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=CC4=CC(=C3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)C(=C2)Cl	Selleck	S2575	0.71564885	-0.86206897	0.36658811	-0.3003003												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00183831-01	Aceglatone	144206883		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	642-83-1				7.8335838137	4	4	Aceglatone;aceglatone monosodium salt;CIPLUS_211093;2,5-di-o-acetyl-d-glucaro-1,4:6,3-dilactone;aceglatonum;Aceglatona;ACEGLATONE;LS-71328;glucaron;aceglatone;2,5-di-O-acetyl glucaro-(1,4)-(6-3)-dilactone;Glucaron;Aceglatonum;Glucaric acid, 1,4:6,3-dilactone, diacetate, D-;diacetyl glucaro-(1,4)-(6-3)-dilactone;	0	1.6016016					O=C1O[C@H]2[C@@H](OC(C)=O)C(=O)O[C@H]2[C@@H]1OC(C)=O	Pharmaron	PH-NIH-183676	0.71564885	2.74294671	4.13720869	1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016371-08	Diclofenamide		Carbonic Anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	120-97-8				-3.531036315	4	4		0	-0.9009009				CA1	N[S+]([O-])(=O)C1=CC(=C(Cl)C(=C1)[S+](N)([O-])=O)Cl	APExBIO	A8408	-0.8110687	-0.28735632	-0.83791568	-0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178510-09	Roxithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	80214-83-1				2.9515525536	4	4		0	-0.85085085					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	Prestwick	Prestw-854	1.66984733	-0.33960293	-0.62843676	-0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015769-32	Ouabain octahydrate			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	11018-89-6				9.5923073377	4	4		0	2.3255814					C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Enzo	CM109	1.93330111	1.60335471	2.22717149	2.3255814												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181088-01	Melitracen hydrochloride	144206258		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	10563-70-9	Melitracen hydrochloride; Melitraceno; Trausabun; Deanxit; Metrisil; 	11.220184543	-4.95	86.042815787	3	4	Melitracen Hydrochloride;LS-20367;n,n,10,10-tetramethyl-delta(sup 9(10h)),gamma-anthracenepropylamine hydrochloride;melitracenum;Melitracene;Melitracen hydrochloride;Metrisil;Trausabun;9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene (Italian);melitracene hydrochloride;N,N-dimethyl-3-(9,10-dihydro-10,10-dimethylanthracen-9-yliden)propylamine;CIPLUS_670601;melitracene;CIPLUS_168125;Melitracen;LS-20365;Melitracenum;MELITRACEN;MELITRACEN HYDROCHLORIDE;Melitraceno;	123.075644694	103.91595033	0.0059896394	0.9999778722			Cl.CN(C)CC\C=C2/c1ccccc1C(C)(C)c3ccccc23	NCI	NSC-78229	0.93676815	1.37753911	7.17976611	103.91595033												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189076-01	Dibromopropamidine dihydrochloride	144207153		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	50357-61-4				-2.6031476995	4	4	Dibromopropamidine dihydrochloride	0	-1.2716763					Cl.Cl.Brc2cc(ccc2OCCCOc1ccc(cc1Br)C(=N)N)C(=N)N	Toronto Research	D425800	-0.30848329	0.02606882	-1.26349039	-1.2716763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095123-10	Candesartan cilexetil (Atacand)			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	145040-37-5				6.3128815073	4	4		0	9.54913295					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(=O)OC(C)OC(=O)OC6CCCCC6	Adooq	A10176	-0.35989717	-0.39103233	0.52645433	9.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182606-01	Physalien	144206657		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	144-67-2	Helenien; Palmitato de xantofila; 			3.8697369888	4	4	xanthophyll dipalmitate;Xantofyl palmitate;Helenien;Palmitate de xantofyle;heleniene;CIPLUS_214390;palmitate de xantofyle;xantofyle palmitate;Xantofyli palmitas;helenien;Palmitato de xantofila;xantofyli palmitas;XANTOFYL PALMITATE;HELENIEN;	0	-0.48554913					O=C(O[C@@H]2CC(C)=C(/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C)C(C)(C)C2)CCCCCCCCCCCCCCC	INDOFINE	020309S	0.97686375	1.43378519	1.05290866	-0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017043-03	Denatonium benzoate		Taste receptor type 2 member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	3734-33-6				5.2562300952	4	4		0	-0.25433526			50836	TAS2R8	CC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC2=CC=CC=C2	Prestwick	Prestw-961	1.85089974	-0.33889468	1.36878126	-0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510142-01	Methylprednisolone aceponate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	86401-95-8				-1.757916872	4	4		0	0.8008008					CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Glixx	GLXC-08106	-0.85877863	-0.75757576	0.5236973	0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183332-01	Dihydroergocriptine	144206629	D(1A) dopamine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	25447-66-9		14.1253754462	-4.85	5.6146009473	4	4	CIPLUS_752814;Vasobral;LS-174243;CIPLUS_746395;Dihydroergocryptine Mesylate;CIPLUS_691892;CIPLUS_737198;CIPLUS_3861508;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl;Dihydroergocryptine;DIHYDROERGOCRYPTINE MESYLATE;	12.508248236	9.50950951	0.1627104679	0.9835089121	1812	DRD1	CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C	Chemical Block	A4425/0188924	0.09541985	-1.22779519	-1.25687353	9.50950951												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346502-04	Dienogest		Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	65928-58-7				5.81968449	4	4		0	0.85085085				PGR	C[C@]12CCC\3=C\4CCC(=O)\C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	MedChem Express	HY-B0084	1.76526718	0.75757576	0.20947892	0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188863-02	Dronedarone hydrochloride	170465064	alpha,beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	141626-36-0	Dronedarone; Dronedarone	2.8183829313	-5.55	19.8704368208	4	4		20.725705328	-3.05305305	1	0.9972411805	148	ADRA1A	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c3cc(ccc3oc2CCCC)NS(C)(=O)=O	SIGMA	D9696	-0.90648855	-1.85475444	16.23461639	-3.05305305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390545-01	Valrubicin		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	56124-62-0				-4.8727635433	4	4		0	-1.7017017				TOP2A	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O	MedChem Express	HY-13772	-0.42938931	-1.85475444	-1.7282011	-1.7017017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166415-03	Palonosetron hydrochloride	170465300	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	135729-62-3				-1.9759338871	4	4		0	2.3023023					Cl.O=C1N(C[C@H]3CCCc2cccc1c23)[C@@H]5CN4CCC5CC4	Bosche	P5846	-1.24045802	-1.01880878	0.26184865	2.3023023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166291-03	Lycopene		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-3.4647488162	4	4		0	1.5015015					CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	SigmaAldrich	75051	-1.28816794	-1.17554859	-0.68080649	1.5015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167534-02	Pazufloxacin	170465985	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	127045-41-4				-1.8108973231	4	4		0	-0.15015015					NC1(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)[C@@H](C)COc34	Sequoia	SRP010775p	-0.57251908	-0.75757576	0.41895784	-0.15015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181092-01	Ipodate sodium	144206261		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1221-56-3	IPODATE SODIUM; Ipodate; Biloptin; Oragrafin sodium; SoluBilopti; Calcium Ipodate; Calcium Iopodate; Iodopato sodico; Bilimin; Sodium, Ipodat; Solu Bilopti; Iopodate, Sodiu; Ipodate, Sodiu; Ipodate, Calciu; Solu-Biloptin; Iopodate, Calciu; 			2.6846744161	4	4	CIPLUS_157668;Ipodate sodium;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, SODIUM SALT;Benzenepropanoic acid, 3-(((dimethylamino)methylene)amino)-2,4,6-triiodo-;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, CALCIUM SALT;natrii iopodas;SODIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodate Sodium;NSC-106962;CIPLUS_157904;Natrii iopodas;IPODATE CALCIUM;Ipodate;Iopodate, Sodiu;Bilimin;iopodate de sodium;SoluBilopti;Sodium, Ipodat;Ipodate, Sodiu;Sodium iopodate;Ipodate, Calciu;Calcium Ipodate;Iopodate de sodium;Biloptin;Ipodate Calcium;Oragrafin sodium;Solu-Biloptin;CALCIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodic acid;CIPLUS_164488;Iodopato sodico;Sodium Iopodate;Solu Bilopti;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-;SODIUM IOPODATE;Iopodate, Calciu;IPODATE SODIUM;IPODIC ACID;3-(3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOPHENYL)PROPANOIC ACID;Calcium Iopodate;	0	2.75275275					[Na+].[O-]C(=O)CCc1c(I)c(/N=C/N(C)C)c(I)cc1I	NCI	NSC-106962	0.09541985	0.49634274	0.05236973	2.75275275												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017343-11	RETINOL		Retinol dehydrogenase 12 Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	68-26-8				-2.7565646329	4	4		0	-0.6006006			145226	RDH12	CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(\C)CCCC1(C)C	Microsource	01501203	-0.8110687	-0.86206897	0.5236973	-0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162222-04	Cibenzoline succinate		Voltage-sensitive sodium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	100678-32-8				-1.7871894597	4	4		0	-1.6016016					C1C/N=C(N1)/C2CC2(C3=CC=CC=C3)C4=CC=CC=C4	SIGMA	C1618	0.04770992	-1.12330199	0.10473946	-1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094857-05	9-Aminoacridine, monohydrochloride, monohydrate	170465046		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	52417-22-8				-0.0512226689	4	4		0	-1.68910003					Cl.O.Nc1c3ccccc3nc2ccccc12	Vitas	STK387428	0.40018832	2.36604036	-0.56695464	-1.68910003												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015718-12	Naftopidil	170466026	alpha1-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	57149-07-2	;Naftopidil;Naftopidil dihydrochloride; Flivas; KT-611 dihydrochloride; Naftopidil	12.5892541179	-4.9	74.7819412693	3	4		86.0878859819	65.82211665	0.0096228542	0.9999428936	148	ADRA1A	OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34	Tocris	0597	0.9180791	0.48712596	0.51295896	65.82211665												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016306-08	D-Cycloserine	170465249	NMDA Glycine-Site Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	68-41-7	D-cycloserine;CYCLOSERINE; Cycloserine;CYCLOSERINE (D);D-Cycloserine;(S)-(-)-Cycloserine; (S)-(-)-Cycloserine			-1.565918192	4	4		0	1.37239377			2903	GRIN2A	N[C@@H]1CONC1=O	Microsource	01500215	-0.35310734	-1.39178845	-1.37688985	1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249916-01	Dimorpholamine	170465773	skeletal muscle contraction Activator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	119-48-2				0.5866205434	4	4		0	0.68619689					O=C(N(CCCC)CCN(CCCC)C(=O)N1CCOCC1)N2CCOCC2	GVK	FFS-11-286-NCI-176	-0.11770245	-0.20876827	0.18898488	0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015529-15	Ibuprofen lysine	170464979	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	15687-27-1	; Ibuprofen, Aluminum Salt; Ibuprofen, (R)-Isomer;Ibuprofen Lysine (NeoProfen); Doctrin; Dexibuprofeno; (S)-(+)-Ibuprofen; Ibuprofen, Calcium Salt; Ibuprofen, (+-)-Isomer; Naproxen;IBUPROFEN; S-(+)-Ibuprofen; ; (?)-Ibuprofen; S(+)-Ibuprofen; Ibuprofen, Potassium Salt; ibuprofen-Lys; S-(+)-ibuprofen;(?)-Ibuprofen; Saren; Advil; Ibuprofen sodium salt; Ibuprofene; Arflamin;Ibuprofen; Ibufen; Ibuprofen, Magnesium Salt; Ibuprofeno			0.5815636622	4	4		0	-0.47505938			5742	PTGS1	CC(C(=O)O)c1ccc(CC(C)C)cc1	Vitas	STK177358	0.82391714	-0.48712596	-0.08099352	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022858-08	Sodium cromoglycate	170464887	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	15826-37-6	;CROMOLYN SODIUM; Nasalcrom; Cromolyn sodium salt; Cromoglycate; Cromoglycic Acid; Cromolyn disodium salt; Cromoglycate, Disodiu; Aarane; Intal;Cromolyn disodium salt; Cromoglycate, Sodiu; Sodium Cromoglicate; Opticrom; Gastrocrom; Cromoglycic acid; Sodium cromoglicate; 6   Cromolyn Sodium; Acido cromoglicico; Lomudal; Vicrom; Disodium chromoglycate; Nalcrom; Bicromat Spray			-0.6584169693	4	4		0	2.8698664				KCNMA1	[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4	Microsource	01500210	-1.06331561	-0.71534287	-1.27266942	2.8698664												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182079-09	TRANDOLAPRIL			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	87679-37-6				1.384428035	4	4		0	0.66857689					[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O	Microsource	01505264	-0.37470726	0.35022181	2.28447104	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182705-02	Azatadine	170464865	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	3964-81-6				-4.5902940559	4	4		0	-0.71633238					CN1CC\C(CC1)=C2\c4ncccc4CCc3ccccc23	APAC	555789	-1.07728337	-0.39691805	-1.46858852	-0.71633238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182998-01	Bisoxatin acetate	144206872		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14008-48-1	Bisoxatin acetate; 			1.3096563927	4	4	LS-41817;2H-1,4-Benzoxazin-3-(4H)-one, 2,2-bis(p-hydroxyphenyl)-, diacetate;BISOXATIN ACETATE;bisoxatin diacetate;Bisoxatin Acetate;bisoxatin acetate;CIPLUS_169129;laxonalin;Bisoxatin acetate;	0	-0.99421965					CC(=O)Oc1ccc(cc1)C2(Oc3ccccc3NC2=O)c4ccc(OC(C)=O)cc4	Pharmaron	PH-NIH-183223	0.92544987	-0.33889468	-0.10529087	-0.99421965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185772-01	Vindesine sulfate salt	124896659	Tubulin polymerization inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	59917-39-4	Vindesine sulfate salt			0.9388129505	4	4		0	-0.20809249			203068	TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@H]4C[C@@](O)(CC)C[N@@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](O)[C@]6(O)C(N)=O)[C@H]78	Toronto Research	V414550	-0.41131105	1.17309698	1.89523559	-0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160621-05	DEXTROSE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	50-99-7				-0.8824552065	4	4		0	-0.34682081					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	01300015	-0.77120823	-0.44316997	2.36904449	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345883-07	DESVENLAFAXINE SUCCINATE		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	93413-62-8				0.1969012562	4	4		0	0.25433526					CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2	Microsource	01504280	-0.20565553	0.2346194	0.52645433	0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346438-03	Retaspimycin (Hydrochloride)		Heat shock protein HSP90 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	857402-63-2		1.4125375446	-5.85	10.551585178	4	4		7.623393312	4.64739884	0.5335143301	0.7723947844		HSP90AB1	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=CC(=C2O)NC(=O)C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C\[C@H](C)[C@H]1O)/C)/C)O	MedChem Express	HY-10210	-0.10282776	0.07820647	10.42379574	4.64739884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532509-01	ISAVUCONAZONIUM SULFATE		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					1.0314816614	4	4		0	0.53179191					CNCC(=O)OCC1=C(N=CC=C1)N(C)C(=O)OC(C)[N+]2=C[N](C[C@@](O)([C@@H](C)C3=NC(=CS3)C4=CC=C(C=C4)C#N)C5=CC(=CC=C5F)F)N=C2	Astatech	40206	-0.46272494	0.86027112	1.73729929	0.53179191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015998-06	THIOTHIXENE		dopamine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5591-45-7, 3313-26-6 [//Z//]		12.5892541179	-4.9	72.3774682583	3	4		101.11960043	92.49249249	0.0181815533	0.9997960652			CN(C)[S+]([O-])(=O)C1=CC2=C(SC3=C(C=CC=C3)\C2=C/CCN4CCN(C)CC4)C=C1	Microsource	01500576	1.04961832	0.86206897	-0.05236973	92.49249249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480787-02	Cangrelor (AR-C69931)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	163706-36-3				1.1880760707	4	4		0	0.7007007					CSCCNC1=NC(=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P](O)(=O)C(Cl)(Cl)[P](O)(O)=O)[C@@H](O)[C@H]3O)SCCC(F)(F)F	DC Chemicals	DC7005	-0.04770992	0.49634274	0.62843676	0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183271-01	Bucillamine	144206469		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	65002-17-7				-0.3116142463	4	4	Bucilant;CIPLUS_186785;BUCILLAMINE;CIPLUS_3866301;bucillamine disulfide;Bucillamine;SA981 cpd;bucillaminum;2-mercapto-2-methylpropanoyl-L-cysteine;SA-96;N-(2-mercapto-2-methylpropionyl)-L-cysteine;L-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-;LS-59032;bucillamine;N-(2-MERCAPTO-2-METHYLPROPIONYL)-CYSTEINE;SA 96;tiobutarit;SA-981;SA 981;	0	2.05205205					O=C(N[C@@H](CS)C(=O)O)C(C)(C)S	ACC	Bucillamine	-0.14312977	-1.59352142	-0.5236973	2.05205205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522019-01	Polaprezinc			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	107667-60-7				1.4314360074	4	4		0	2.44527247					O=C1CCN[Zn++]2[O-]C(=O)[C@H](CC3=CN=C[NH]3)[N-]12	Toronto Research	P688000	-0.28497409	-0.31691858	-1.5605336	2.44527247												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00509984-01	Omapatrilat		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	167305-00-2				9.735971009	4	4		0	4.72752678			1636		OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3=CC=CC=C3)C(=O)N12	MedChem Express	HY-18208	0.90673575	3.14480741	2.41631009	4.72752678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-12	Ruxolitinib		Jak1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	941678-49-5				-5.8702892725	4	4		0	-1.7466232				JAK1	N#CC[C@H](C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-50856	-1.11398964	-0.95075573	-1.51019381	-1.7466232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246113-02	NCGC00246113-02			DPI_SARS-CoV-2_General	2019_NPC-9_CPE					0.7774114888	4	4		0	1.09455054					C(CC1=CC=CC=C1)NCC2=CC=CC=C2	Specs	AN-465/J120002	-0.07772021	0.02437835	0.20135917	1.09455054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162149-07	Demeclocycline hydrochloride	170465205	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	64-73-3				0.1646608737	4	4		0	1.28649184					Cl.NC(=O)C=2C(=O)[C@@]3(O)C(O)=C4C(=O)c1c(c(Cl)ccc1O)[C@@H](O)[C@H]4C[C@H]3[C@@H](C=2O)N(C)C	Microsource	01500226	-0.82165297	-0.27133695	0.4454343	1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016764-04	Benfotiamine	170465987		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	22457-89-2				-4.9027282869	4	5		0	-1.953125					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCOP(=O)(O)O)SC(=O)c1ccccc1	SIGMA	B9636	-2.69297592	5.18009418	-2.81202383	-1.20675784	-1.953125											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	57-41-0				-10.408938303	4	5		0	-3.01339286					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	-3.71059816	-0.26727759	-0.45712703	-1.09949048	-3.01339286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095099-05	Sildenafil citrate	170465285	Phosphodiesterase V (PDE5) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	171599-83-0	 ; Sildenafil(Viagra); SILDENAFIL;SILDENAFIL; Caverta; Viagra;SILDENAFIL CITRATE			-1.0781200598	4	5		0	-5.12569832			8654	PDE5A	CN1CCN(CC1)S(=O)(=O)c4cc(C3=Nc2c(CCC)nn(C)c2C(=O)N3)c(OCC)cc4.O=C(O)C(O)(CC(=O)O)CC(=O)O	Microsource	01504099	3.20863747	-0.31129374	-1.81951398	-2.44434745	-5.12569832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016345-08	4-Methylumbelliferone	170465819	MAO-A Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90-33-5	 Hymecromon; Cholestil; ; Mendiaxon; Himecromona; beta-Methylumbelliferone;4-Methylumbelliferone (4-MU); Cantabiline; 4-Methylumbelliferone;4-Methylumbelliferone;Hymecromone			-8.1311876945	4	5		0	-3.44972067				MAOA	Oc1ccc2c(c1)OC(=O)C=C2C	Vitas	STK364326	-3.81690998	-0.51052173	-1.37989987	4.07391241	-3.44972067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016551-04	Meprylcaine hydrochloride	170466009	"Sodium channel alpha subunits; brain (Types I, II, III) Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	956-03-6				-3.414496974	4	5		0	0.32122905					Cl.CC(C)(COC(=O)c1ccccc1)NCCC	Prestwick Chemical, Inc.	Prestw-1064	-3.26946472	-2.37828415	5.82488704	0	0.32122905											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016913-14	Astemizole	170465888	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	68844-77-9		1.77827941	-5.75	7.2541638128	4	5		10.952462776	-6.41741071	0.3988147351	0.888150433			Fc1ccc(cc1)Cn4c5ccccc5nc4NC3CCN(CCc2ccc(OC)cc2)CC3	Enzo	NH101	0.01241003	-4.54371898	-2.14711179	8.23277018	-6.41741071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159373-04	Thymol	170465504	Aldose reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	89-83-8				5.441499781	4	5		0	0.46089385			231	AKR1B1	CC(C)c1ccc(C)cc1O	Labotest	LTBB001943	0.56265207	0.73465322	0.52509464	4.5395024	0.46089385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166245-04	Proflavin hemisulfate	170466523	RNA Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1811-28-5				5.9570808326	4	5		0	6.94134078					O=S(=O)(O)O.Nc1cc2nc3cc(N)ccc3cc2cc1.Nc1cc2nc3cc(N)ccc3cc2cc1	Vitas	STK380650	-0.80596107	2.00473166	3.35816339	-2.12425433	6.94134078											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00065934-05	Oxcarbazepine	170464811	Sodium channel inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	28721-07-5	; Oxcarbazepina; Oxcarbazepine;Oxcarbazepine;OXCARBAZEPINE; Timox; Trileptal; Oxacarbazepine			-13.9836806094	4	5		0	-2.55586592					NC(=O)N3c1ccccc1C(=O)Cc2ccccc23	Vitas	STK594696	-4.39476886	-2.15415266	-2.38124313	-1.07667685	-2.55586592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016345-08	4-Methylumbelliferone	170465819	MAO-A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	90-33-5	 Hymecromon; Cholestil; ; Mendiaxon; Himecromona; beta-Methylumbelliferone;4-Methylumbelliferone (4-MU); Cantabiline; 4-Methylumbelliferone;4-Methylumbelliferone;Hymecromone			0.0019636349	4	4		0	0.05278438				MAOA	Oc1ccc2c(c1)OC(=O)C=C2C	Vitas	STK364326	0.63559322	-0.83507307	-0.62095032	0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00185770-01	Sucrose octasulfate, sodium salt	144207173		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	74135-10-7				-3.0705766883	4	4		0	0.73898126					[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)O[C@H]1[C@H](O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]1OS([O-])=O)O[C@]2(COS([O-])=O)O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]2OS([O-])=O	Toronto Research	S699020	-1.24764595	-1.39178845	-0.56695464	0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344583-01	Vinblastine sulfate	170464976	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	18556-44-0				-2.4841968378	4	4		0	0.42227501				TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@@H]4C[C@@](O)(CC)C[N@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]6(O)C(=O)OC)[C@H]78	SIGMA	V1377	-0.6826742	-1.8789144	-0.35097192	0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015959-09	Sanguinarine	170466353	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2447-54-3				-4.0006160683	4	4		0	-2.90314067			100009298	PPP1CA	C[n+]2cc1c6OCOc6ccc1c3ccc4cc5OCOc5cc4c23	Tocris	2302	-0.16478343	1.46137787	-0.674946	-2.90314067												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00178831-03	Acriflavine hydrochloride	170465670	Hypoxia-inducible factor 1 alpha Interacts	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	69235-50-3				-1.4316855867	4	4		0	-1.79466878					[Cl-].C[n+]1c3cc(N)ccc3cc2ccc(N)cc12.Nc1cc2nc3cc(N)ccc3cc2cc1	Microsource	01500618	0.58851224	-0.34794711	-0.29697624	-1.79466878												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022043-06	Deoxycorticosterone acetate	170465334	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	56-47-3				2.2058022567	4	4		0	2.85035629					CC(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	SIGMA	D7000	-0.4472693	1.04384134	-0.78293736	2.85035629												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095143-07	Rosuvastatin calcium (Crestor)			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	147098-20-2				-2.5291019328	4	4		0	0.46568627					CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Adooq	A10810	-0.9828629	-0.61776062	-0.53161724	0.46568627												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164128-02	Hexadecanoic acid, 1-methylethyl ester	170465544	N-acylsphingosine-amidohydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	142-91-6				0.4723926112	4	4		0	0.22058824					CC(C)OC(=O)CCCCCCCCCCCCCCC	SIGMA	291781	-0.17641129	0.72072072	0.36373811	0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159397-03	Iodoantipyrine	170465556		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	129-81-7				-5.4979110015	4	4		0	-0.71078431					O=C2C(I)=C(C)N(C)N2c1ccccc1	Labotest	LT00454726	-1.89012097	0.05148005	-0.25181869	-0.71078431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166113-04	Diphenylcyclopropenone	170465593	immune system process Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	886-38-4				1.6434152116	4	4		0	0.71033938					O=C2C(=C2c1ccccc1)c3ccccc3	Vitas	STK289679	-0.6779661	-0.80301129	2.5589055	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182704-02	Luliconazole	144206804	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	187164-19-8	Luliconazole; Lulicon; 			-0.0680723783	4	4	Lulicon;Luliconazole;LULICONAZOLE;CIPLUS_787907;	0	-0.09896091			3641571	ERG11	N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3	Pharmaron	PH-NIH-102266	0	-0.41933892	0.31816736	-0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024584-17	BROMOCRIPTINE			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	22260-51-1				2.7778971982	4	4		0	3.80999505					[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N3C(=O)[C@](NC(=O)[C@H]4CN(C)[C@]5([H])CC6=C(Br)NC7=CC=CC(=C67)C5=C4)(O[C@@]23O)C(C)C	SIGMA	B2134	-0.53165781	0.07400099	-0.4454343	3.80999505												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263574-01	Diflucortolone valerate	170465700	Annexin A1 Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59198-70-8				-3.2344901855	4	4		0	0.49480455			301	ANXA1	CCCCC(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Sequoia	59198-70-8	-0.82165297	-0.07400099	-2.09990455	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167499-02	Roxatidine acetate hydrochloride	170465941		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	93793-83-0				-3.5697422859	4	4		0	-1.08857001					Cl.CC(=O)OCC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Prestwick Chemical, Inc.	Prestw-428	-1.01498308	-0.41933892	-0.19090041	-1.08857001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249899-01	Cinoxate	170465555		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104-28-9				-2.1723344648	4	4		0	0.14844137					COc1ccc(C=CC(=O)OCCOCC)cc1	GVK	FFS-11-286-NCI-86	-0.67665539	0.17266897	-1.14540248	0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389309-01	Lubiprostone		ClC-2 Channel Activators	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	136790-76-6				-6.6263179795	4	4		0	0.09551098				CLCN2	CCCCC(F)(F)C1(O)CCC2C(CC(=O)C2CCCCCCC(O)=O)O1	APExBIO	B2108	-2.20140515	-0.72379173	-0.81588251	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379014-01	Cariprazine		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	839712-12-8				-3.2478898644	4	4		0	-1.14613181					CN(C)C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)C3=CC=CC(=C3Cl)Cl	MedChem Express	HY-14763	-1.31147541	0.86388046	0.43513734	-1.14613181												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00013683-06	Chlorprothixene	170465069	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	113-59-7		8.9125093813	-5.05	47.3077742322	3	4		50.3197062278	46.06682452	0.0498273886	0.9984663084	3269		CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12	Microsource	01503203	-1.5496368	0.60225847	-0.73473524	46.06682452												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015893-06	Ropinirole	170465139	Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	91374-21-9				-3.1496806615	4	4		0	-0.49480455					CCCN(CCC)CCc1cccc2NC(=O)Cc12	Microsource	01505178	-0.38666022	-0.22200296	-1.65447025	-0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00485958-01	Eluxadoline	363681443		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	864821-90-9				0.9261250214	4	4		0	1.38490926					COC1=CC=C(CN([C@@H](C)C2=NC=C([NH]2)C3=CC=CC=C3)C(=O)[C@@H](N)CC4=C(C)C=C(C=C4C)C(N)=O)C=C1C(O)=O	MedChem Express	HY-12247	-0.23419204	0.21013308	0.48952951	1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379045-01	Alfacalcidol-D6		Increase blood calcium level via a variety of mechanisms	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					3.3776243337	4	4		0	3.67717287					C(C(C([2H])([2H])[2H])CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C)([2H])([2H])[2H]	MedChem Express	HY-15332	-0.6088993	0.67709549	2.44764754	3.67717287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182971-01	Hexafluorenium dibromide	144206765	Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	317-52-2	HEXAFLUORENIUM BROMIDE; Bromuro de hexafluronio; Bromure d'hexafluronium; Mylaxen; 			-0.1784010883	4	4	Bromuro de hexafluronio;Hexafluorenium bromide;hexafluronium bromide;hexafluorenium dibromide salt;N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYLHEXANE-1,6-DIAMINIUM DIBROMIDE;hexafluorenium bromide;HEXAMETHYLENEBIS(FLUOREN-9-YLDIMETHYLAMMONIUM) DIBROMIDE;CIPLUS_163766;IN-117;Mylaxen;Bromure d'hexafluronium;Hexafluronium bromide;Hexafluronii bromidum;hexafluorenium;Mallinckrodt Brand of Hexafluronium Bromide;1,6-HEXANEDIAMINIUM, N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYL-, DIBROMIDE;CIPLUS_152643;hexamethylenebis(fluoren-9-yldimethylammonium) dibromide;HEXAFLUORENIUM BROMIDE;hexafluronii bromidum;HEXAFLURONIUM BROMIDE;LS-18141;bromure d'hexauronium;	0	0.19102197			590	BCHE	[Br-].[Br-].C[N+](C)(CCCCCC[N+](C)(C)C3c1ccccc1c2ccccc23)C6c4ccccc4c5ccccc56	NCI	NSC_19477	-0.09367681	-0.44361429	0.32635301	0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024595-08	Carbetapentane	170465562	Sigma-1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	77-23-6		14.1253754462	-4.85	15.2845309788	2.4	4		30.10800224	24.82843137	0.0265279368	0.9995665298			CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2	Enzo	NO103	-0.83165323	-0.72072072	-0.9233352	24.82843137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094652-06	DIGITOXIN			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	71-63-6				15.2634326237	4	4		0	2.27941176					C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C	Sequoia	71-63-6	3.85584677	1.64736165	3.66536094	2.27941176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016533-24	NCGC00016533-24			DPI_SARS-CoV-2_General	2019_NPC-5_CPE					2.4973665417	4	4		0	2.32843137					CC1=CC(N[S+]([O-])(=O)C2=CC=C(N)C=C2)=NO1	Labotest	LT00452029	0.07560484	1.33848134	-0.53161724	2.32843137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016507-05	Thonzonium bromide	170465335	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	553-08-2				-0.1607418757	4	4		0	-2.96568627					[Br-].COc1ccc(cc1)CN(CC[N+](C)(C)CCCCCCCCCCCCCCCC)c2ncccn2	Prestwick Chemical, Inc.	Prestw-925	1.23487903	-0.92664093	-0.64353665	-2.96568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166298-02	Melengestrol acetate	170465702		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2919-66-6				3.5977464862	4	4		0	4.02525651					CC(=O)[C@@]3(OC(C)=O)C(=C)C[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1435	-0.5811138	-0.50188206	0.58272105	4.02525651												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022653-09	Cefazolin	170465254	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	25953-19-9				6.8758715739	4	4		0	1.49960537					O=C(O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nnc(C)s2	Microsource	01500164	1.30750605	2.76035132	0.83607803	1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015482-07	Gallamine triethiodide	170465398	Muscarinic M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	65-29-2	 Triethiodide, Gallamin; ;Gallamine triethiodide; Gallamine triethiodide; Gallamine Triethyl Iodide; Triethyl Iodide, Gallamin;GALLAMINE TRIETHIODIDE; Triethioduro de galamina; Iodide, Gallamoniu; Triethochloride, Gallamin; Iodide, Gallamine Triethy; Gallamine Triethochloride; Flaxedil			8.0150675279	4	4		0	3.21622959				ACHE	[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	Enzo	C112	-0.09666506	0.5673409	4.07254216	3.21622959												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159522-05	Cephalexin	170464982	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	15686-71-2				6.0137368948	4	4		0	1.03908956					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O	SIGMA	33989	1.739971	2.73803651	-0.25453388	1.03908956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015802-18	Pimozide	170464864	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2062-78-4				-5.7637333617	4	4		0	-2.77090549					Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5	NCGCChem	NCGC00015802-17pur	-0.43499275	0.024667	-1.84537066	-2.77090549												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167449-02	Desogestrel	225144285	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	54024-22-5		11.220184543	-4.95	31.4410420348	3	4		54.8713285822	45.22445081	0.033518836	0.9993067734			CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/CCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	SIGMA	32809	-1.45199063	0.02334812	1.90372586	45.22445081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538141-01	NCGC00538141-01		Microsomal triglyceride transfer protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.1888206886	4	4		0	-1.14613181					CN(CC1=CC=CC=C1)C(=O)[C@H](NC(=O)C2=CC3=C(C=CC(=C3)NC(=O)C4=CC=CC=C4C5=CC=C(C=C5)C(F)(F)F)[N]2C)C6=CC=CC=C6	Pharmaron	PH-NIH-2017-009-L1-1-0	-0.37470726	-1.09736166	-0.87027468	-1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-02	Dabrafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1195765-45-7				5.8972949826	4	4		0	8.93027698				BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	Selleck	S2807	0	-0.67709549	-0.43513734	8.93027698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163329-03	Clopidogrel bisulfate	170465231	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	135046-48-9	; Clopidogrel hydrochloride;Plavix; Isocover;CLOPIDOGREL SULFATE; Iscover; 4   Clopidogrel;Clopidogrel hydrogen sulfate			1.451219879	4	4		0	-0.31862745			64805	P2RY12	O=S(=O)(O)O.Clc1ccccc1[C@H](N2CCc3sccc3C2)C(=O)OC	Vitas	STK580572	0.42842742	-0.46332046	1.31505316	-0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00074022-02	Pyricarbate	144204540	Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1882-26-4	Angioxine; Anginin; Movecil; Lisator; Sospitan; Duaxol; Prodectin; Pyricarbato; Duvaline; Gasparol; Parmidine; Colesterinex; 			-1.5437300471	4	4	CIPLUS_159179;Pyricarbate;Parmidine;Pyricarbato;Duaxol;2,6-Pyridinedimethanol, bis(methylcarbamate) (ester);Angioxine;Colesterinex;Gasparol;Movecil;Pyridinolcarbamate;Prodectin;LS-50369;Pyridinol carbamate;ravenil;Pyricarbatum;Duvaline;2,6-Pyridinedimethanol-bis-(N-methylcarbamate);Pyridinol Carbamate;PYRIDINOL CARBAMATE;pyricarbatum;Anginin;Sospitan;PYRICARBATE;Lisator;P-23;pyricarbate;PYRIDINOLCARBAMATE;	0	1.00490196					CNC(=O)OCc1cccc(COC(=O)NC)n1	InterBioScreen	STOCK4S-68399	-0.42842742	-0.51480051	-1.20313374	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160606-01	Sulbentine	144205485		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	350-12-9	Dibenzthion; Sulbentina; Afungin; 	28.1838293126	-4.55	15.354129921	4	4	Sulbentinum;Sulbentine;D 47;Afungin;Sulbentina;dibenzthione;DIBENZTHION;CIPLUS_209804;carbothialdine;2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dibenzyl-;SULBENTINE;sulbentinum;CIPLUS_3866698;LS-150185;sulbentine;Dibenzthion;3,5-dibenzylperhydro-1,3,5-thiadiazine-2-thione;	11.488416984	10.22058824	0.4969071578	0.8104391189			S=C3SCN(Cc1ccccc1)CN3Cc2ccccc2	SigmaAldrich	S545791	4.05745968	-0.82368082	-0.3077784	10.22058824												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00344540-01	17-BETA-ESTRADIOL 3,17-DIPROPIONATE	225144386		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	113-38-2				-5.8542871283	4	4		0	-0.80882353					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)OC(=O)CC)[C@H]3CC[C@]12C	SIGMA	E9125	-1.68850806	0.30888031	-1.65081142	-0.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390090-01	Alclometasone dipropionate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	66734-13-2				-1.6573189597	4	4		0	2.27941176					CCC(=O)OCC(=O)[C@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H](Cl)CC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	Prestwick	Prestw-771	-1.08366935	-0.20592021	-0.64353665	2.27941176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183848-01	Troxacitabine	124894563	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	145918-75-8	Troxacitabine			-3.5856179672	4	4	2R(-)-cis-HMD-cytosine;Troxacitabine;LS-173247;LS-173246;LS-173400;TROXACITABINE;BCH-4556;BCH 4556, trans-(+-)-isomer;LS-173262;2'-DEOXY-3'-OXACYTIDINE,1'S,4'S,L-;BCH 4556, cis-(+-)-isomer;BCH 4556, (2S-trans)-isomer;BCH 4556, 2R(-)-cis-isomer;LS-173106;troxacitabine;CIPLUS_728716;troxacitabinum;CIPLUS_703293;	0	0.17156863				POLB	OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O	Pharmaron	PH-NIH-148677	-1.18447581	-0.56628057	-0.41969782	0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182984-01	Tolindate	144206849		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	27877-51-6	Tolindate; 			-1.0670188966	4	4	tolindate;LS-174201;Tolindate;tolindatum;CIPLUS_175837;TOLINDATE;	0	0.46568627					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3CCCc3c2	Pharmaron	PH-NIH-154731	-0.93245968	1.8018018	-0.41969782	0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160355-01	NCGC00160355-01	29216036		DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Xylose; Xylan; D-Lyxopyranose; D-Arabinose-1-13C; D-Xylose-1-13C; L-(+)-Arabinose; DL-Xylose; D-(+)-Xylose; D-(-)-Arabinose; D-(-)-Lyxose; D Xylos; DL-Arabinose; 			-6.6830031209	4	4	NCGC_FLUKA_95740;CIPLUS_718758;Xylose;NCGC00165998-01;D Xylos;D-Arabinose-1-13C;CIPLUS_756836;L-(+)-Arabinose;CIPLUS_148884;D-Xylose-1-13C;D-(-)-Arabinose;DL-Xylose;CIPLUS_694406;XYLOSE, D-;CIPLUS_3887049;XYLOSE;CIPLUS_149908;D-Lyxopyranose;D-(-)-Lyxose;L-(-)-Xylose, mixture of anomers;DL-Arabinose;D-(+)-Xylose;ARABINOSE, L-;Xylan;D-Xylose;D-XYLOSE;CIPLUS_711441;	0	-1.49509804					[H][C@]1(O)CO[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Alfa Aesar	A11921	-1.94052419	0.41184041	-0.81141578	-1.49509804												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00182076-03	Polythiazide	170465068	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	346-18-9				-0.0637396589	4	4		0	-0.41666667					NS(=O)(=O)c2cc1c(NC(CSCC(F)(F)F)N(C)S1(=O)=O)cc2Cl	Kemprotec	346-18-9	-0.02520161	2.26512227	-1.81869054	-0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167546-03	S-(5 -Adenosyl)-L-methionine p-toluenesulfonate salt	225144292	S-adenosylmethionine synthase isoform type-2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	17176-17-9				0.764714199	4	4		0	3.1833728					C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N	SIGMA	A2408	-1.0653753	-0.20075282	-0.58272105	3.1833728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016418-15	Methoxsalen	170465041	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	298-81-7	 ;METHOXSALEN; Methoxsalen, 8-;Methoxy-8-psoralen; Ammoidin;Methoxsalen;8-Methoxypsoralen; Methoxy-8-psoralen			-4.377248451	4	4		0	-1.49960537			1544	CYP1A2	COc1c3occc3cc2C=CC(=O)Oc12	Microsource	01500400	-0.1937046	-1.30489335	-1.39346339	-1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253575-01	Arimoclomol	170465602	Heat shock 70 kDa protein 1 Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	289893-25-0				8.5153761197	4	4		0	2.77090549					O[C@H](CN1CCCCC1)CO\N=C(/Cl)c2ccc[n+]([O-])c2	GVK	FFS-11-286-NCI-145	1.15998067	1.70202269	2.03627108	2.77090549												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015389-14	Propofol	170464994	TRPV1 (Vanilloid VR1 Receptor) Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL			6.8450278396	4	4		0	1.53389411			7442	TRPV1	CC(C)c1cccc(C(C)C)c1O	SigmaAldrich	Lopac-D126608	1.06331561	3.13270844	0.95450207	1.53389411												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00481544-01	Cetrorelix		Gonadotropin-releasing hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					4.5018822149	4	4		0	1.67144222					CC(C)C[C@H](\N=C(/O)[C@@H](CCCNC(O)=N)\N=C(/O)[C@H](CC1=CC=C(O)C=C1)\N=C(/O)[C@H](CO)\N=C(/O)[C@@H](CC2=CN=CC=C2)\N=C(/O)[C@@H](CC3=CC=C(Cl)C=C3)\N=C(/O)[C@@H](CC4=CC5=CC=CC=C5C=C4)\N=C(\C)O)/C(O)=N/[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6\C(O)=N\[C@H](C)C(O)=N	APExBIO	B4975	0.37470726	-0.86388046	3.58988306	1.67144222												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00496843-01	Ripasudil		ROCK1/ROCK2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	887375-67-9				-3.8471949139	4	4		0	-1.57593123				ROCK1	C[C@H]1CNCCCN1[S+]([O-])(=O)C2=CC=CC3=CN=CC(=C23)F	Selleck	S7995	-0.46838407	-1.23745039	-0.87027468	-1.57593123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164590-02	Drospirenone	170464870	Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	67392-87-4	 ; Drospirenone and estrogen;Drospirenone; Drospirenone; Yasmin; Drospirenona;DROSPIRENONE			0.1548101508	4	4		0	1.83823529			5241	PGR	O=C1CC[C@]6(O1)[C@H]2C[C@H]2[C@H]5[C@@H]7[C@H]3C[C@H]3C4=CC(=O)CC[C@]4(C)[C@H]7CC[C@@]56C	Sequoia	SRP04800d	-0.32762097	-0.46332046	-0.08393956	1.83823529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164560-05	ABACAVIR SULFATE			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	188062-50-2				-1.436275232	4	4		0	-0.56372549					NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	SIGMA	SML0089	-0.9828629	0.82368082	1.31505316	-0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166206-04	1,2-Benzenedicarboxaldehyde	170466016		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	643-79-8				1.2017611223	4	5		0	-0.64908722					O=Cc1ccccc1C=O	Vitas	STK802214	0.85470085	0.7079646	0.39476931	-0.95716679	-0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182055-03	Bazedoxifene	170466793	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	198481-33-3	TSE-424/WAY-140424;Bazedoxifene; Bazedoxifene	3.1622776602	-5.5	23.6243464854	4	5		22.42477876	-3.48884381	0.0357124131	0.9992160969	2099	ESR1	CC(=O)O.Oc1ccc(cc1)c5c(C)c2cc(O)ccc2n5Cc3ccc(cc3)OCCN4CCCCCC4	APAC	872287	-0.02442002	-0.3539823	-0.34542314	16.70256042	-3.48884381											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164622-02	Voriconazole	170464890	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	137234-62-9	 ; Vfend; Voriconazole;Voriconazole			2.3393109199	4	5		0	-1.62271805			1595	CYP51A1	O[C@](Cn1cncn1)([C@@H](C)c2ncncc2F)c3ccc(F)cc3F	Sequoia	SRP01070v	1.48962149	1.5676359	-0.24673082	-0.19143336	-1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024427-05	Naltrexone hydrochloride	170465207	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	16590-41-3	;Naltrexone hydrochloride; ReVia;Naltrexone hydrochloride dihydrate; Naltrexona			2.0831629132	4	5		0	3.0831643			4988	OPRM1	O=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick	Prestw-116	0.17094017	0.5562579	-1.13496176	-0.19143336	3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00273564-01	Bropirimine	170465913	Toll-like receptor 7 Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56741-95-8				-3.1720301976	4	5		0	0.48681542					BrC1=C(NC(N)=NC1=O)c2ccccc2	Tocris	4316	-0.51282051	-1.4159292	-1.08561559	-1.19645848	0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015999-19	Tolbutamide	170465238	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	64-77-7				-2.9762458709	4	5		0	-2.27180527					Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC	Enzo	AC117	-0.36630037	-0.505689	-2.12188502	1.77075855	-2.27180527											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016256-17	Pyrimethamine	170464930	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	58-14-0	Pirimetamina; ; Daraprim; Tindurine; Fansimef; Chloridin;Pyrimethamine; Suldox; Maloprim; Pyrimethamine; A.E.S. mixture; Folaprim; Malocide	11.220184543	-4.95	31.4146496992	3	5		35	30.10141988	0.0039832506	0.9980056896	1719	DHFR	CCc1nc(N)nc(N)c1c2ccc(Cl)cc2	Microsource	01500520	1.24542125	2.73072061	2.26992351	4.45082556	30.10141988											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166397-04	Lofepramine hydrochloride	170465926	norepinephrine uptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	26786-32-3				8.5783380674	4	5		0	3.24543611					Cl.Clc1ccc(cc1)C(=O)CN(C)CCCN3c4ccccc4CCc2ccccc23	Sequoia	23047-25-8	2.12454212	1.2136536	1.23365408	0.71787509	3.24543611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015323-11	Decamethonium bromide	170465349	Muscle-type nicotinic acetylcholine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	541-22-0				8.4578357539	4	5		0	7.78904665					[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	Enzo	AC737	1.58730159	-1.011378	1.4803849	-0.90930845	7.78904665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023722-08	Floxuridine	170465247	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-91-9	; ; Floxiridina; 5-Fluorodeoxyuridine; Floxuridine; 5-Fluro-2??-Deoxyuridine; 5-FUdR;Floxuridine; 5 Fluorodeoxyuridin	7.0794578438	-5.15	5.0479597387	4	5		13.927307212	10.95334686	0.0121636613	0.9939136154		TYMS	FC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Vitas	STK801909	-1.001221	-2.02275601	-1.67776955	1.86647523	10.95334686											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091011-08	Chloramphenicol	225144201	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56-75-7	 Cloramfenicol;; Chlornitromycin;Chloramphenicol (Chloromycetin); Ophthochlor; ; Detreomycin; Corti-fluoral; Syntomycin;Chloramphenicol; Cloromisan; Chloramphenicol; Pantofenicol; Chloromycetin; Chlorocid			-2.4018399169	4	5		0	1.46044625					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Prestwick	Prestw-31	-0.85470085	-0.9102402	-1.62842339	-0.19143336	1.46044625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091612-09	Triacetin	170465543		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	102-76-1				-1.6550143624	4	4		0	0.0789266					O=C(C)OC(COC(C)=O)COC(=O)C	Microsource	01500585	-0.72639225	-0.60225847	0.0253357	0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015955-16	Salbutamol sulfate	170465034	beta2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	18559-94-9	 Ventolin;Albuterol; Albuterol (Salbutamol); ;Salbutamol hemisulphate; Proventil; Albuterol hemisulfate;Albuterol hemisulfate; Sultanol; R-albuterol hydrochloride; Xopenex; Salbutamol hemisulfate;ALBUTEROL (+/-);Salbutamol; Salbutamol; Salbutamol hemisulphate;Salbutamol sulfate; Asmaven sulfate; Levalbuterol			-3.2996266614	4	4		0	-0.81557485			154	ADRB2	OCc1cc(ccc1O)C(O)CNC(C)(C)C	Enzo	AC176	-0.8716707	0.05018821	-0.78540664	-0.81557485												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015095-15	Amitriptyline hydrochloride	170464758	Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	549-18-8		12.5892541179	-4.9	101.3357334612	3	4		116.8801732227	94.26026719	0.0196741897	0.9997611929	6532	SLC6A4	Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12	Microsource	01500117	-0.67665539	0.5673409	-1.14540248	94.26026719												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015605-09	Lamotrigine	170465024	Sodium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	84057-84-1	; Labileno; Lamiktal; Faes Brand of Lamotrigine; Lamictal; Lamotrigine;Lamotrigine; Crisomet			1.2167032396	4	5		0	-0.97363083					Clc1cccc(c1Cl)c2nnc(N)nc2N	Prestwick Chemical, Inc.	Prestw-1492	1.1965812	-1.1125158	0.04934616	0.67001675	-0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025297-04	Gabexate mesilate	170465830	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56974-61-9	; ;Gabexate mesylate; Gabexate mesylate;Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester;Gabexate mesilate; Gabexate Methanesulfonate; Arodate; Gabexato			4.1402244165	4	5		0	3.56997972			4790	NFKB1	O=C(Oc1ccc(cc1)C(=O)OCC)CCCCCNC(=N)N.CS(=O)(=O)O	Prestwick	Prestw-1008	0.41514042	-0.1517067	0.24673082	0.90930845	3.56997972											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093936-08	D-Glutamine	170465304	Protein-glutamine gamma-glutamyltransferase Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5959-95-5				5.2230758181	4	5		0	5.92292089			1503		O=C(N)CC[C@@H](N)C(=O)O	Microsource	01300018	0.26862027	0	-0.14803849	0.57430007	5.92292089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016522-10	Bisacodyl	170464843		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	603-50-9				-3.3400276383	4	5		0	0.24340771					CC(=O)Oc1ccc(cc1)C(c2ccc(OC(C)=O)cc2)c3ccccn3	Labotest	LT00134695	-0.51282051	-0.9608091	-1.23365408	-1.48360852	0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094985-05	Zoalene	170465727		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	148-01-6				-0.7395748639	4	5		0	-1.62271805					Cc1c(cc(cc1[N+](=O)[O-])[N+]([O-])=O)C(N)=O	Vitas	STK395739	0.31746032	0.9608091	-0.83888478	-0.28715004	-1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166210-02	PAROMOMYCIN SULFATE		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1263-89-4				12.2280570783	4	5		0	5.27383367					NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)[C@H](N)[C@@H](O)[C@@H]1O	SIGMA	P9297	-0.61050061	-1.2642225	-1.28300025	-0.38286671	5.27383367											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00094918-07	Saccharin	170465766	Taste receptor type 1 member 3 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	81-07-2				-0.7044269842	4	5		0	-2.19066937			83756	TAS1R3	O=C2NS(=O)(=O)c1ccccc12	Vitas	STK803263	0.46398046	-0.6068268	-0.24673082	0.95716679	-2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160623-04	Octinoxate	170464894		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5466-77-3				0.6093039444	4	5		0	-1.05476673					COc1ccc(C=CC(=O)OCC(CC)CCCC)cc1	SIGMA	437174	1.63614164	-1.1125158	-1.08561559	-0.14357502	-1.05476673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091146-08	Phenothiazine	170466563	Trichostrongylus colubriformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	92-84-2				0.5328542693	4	5		0	0.0811359					c1ccc2Sc3ccccc3Nc2c1	SIGMA	P14831	-0.36630037	1.4664981	-0.34542314	0.52644173	0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016715-04	Trapidil	170465770	C-C motif chemokine 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	15421-84-8				8.1004871807	4	5		0	0.40567951			100009130	CCL2	CCN(CC)c1cc(C)nc2ncnn12	Prestwick Chemical, Inc.	Prestw-1012	2.12454212	0.5562579	2.66469282	2.29720029	0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167513-04	Vandetanib	170465617	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	443913-73-3	 ;AZD-6474;Caprelsa;ZD-6474;Zactima;Vandetanib; Vandetanib;CH-331			3.8969860908	4	5		0	1.70385396			1956	EGFR	CN4CCC(COc2cc3ncnc(Nc1ccc(Br)cc1F)c3cc2OC)CC4	Sequoia	443913-73-3	0.85470085	-1.2136536	2.22057735	0.47858339	1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168784-03	Gemcitabine	170465129	Ribonucleotide reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	122111-03-9	 Gemcitabine; ; Gemcitabina;Gemzar;Gemcitabine;Inno-D07001			1.1449430508	4	5		0	1.94726166			6241	RRM2	Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	Prestwick	Prestw-1266	1.92918193	-1.9216182	-1.72711572	-1.91433357	1.94726166											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015829-12	Promazine hydrochloride	170464766	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	53-60-1		10	-5	83.2327493149	3	5		118.9085838915	109.77687627	0.0000353887	0.999982307			Cl.CN(C)CCCN1c3ccccc3Sc2ccccc12	Microsource	01500509	-0.31746032	-0.7079646	-0.39476931	3.63723379	109.77687627											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164597-02	Ropivacaine hydrochloride	170465120	Voltage-gated potassium channel subunit Kv1.5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	98717-15-8				1.795016785	4	5		0	4.38133874					Cl.CCCN2CCCC[C@H]2C(=O)Nc1c(C)cccc1C	Sequoia	SRP01307r	0.56166056	-1.3147914	-1.43103874	-0.86145011	4.38133874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016747-07	Dilazep	170465831	Equilibrative nucleoside transporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	35898-87-4		10	-5	17.2424394486	4	5		29.4563843199	24.90872211	0.0019386242	0.9990311667			COc1cc(cc(OC)c1OC)C(=O)OCCCN3CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC3	Enzo	AC640	-0.36630037	-1.2136536	-0.69084629	0.90930845	24.90872211											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160682-02	Isocaine	170466550		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	94-14-4				-2.6518403764	4	5		0	-1.13590264					Nc1ccc(cc1)C(=O)OCC(C)C	Vitas	STK267625	-0.26862027	-1.3147914	-0.83888478	0.28715004	-1.13590264											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182978-01	Tiaramide hydrochloride	144206772		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	35941-71-0				3.2394100273	4	4		0	2.05780347					Cl.OCCN1CCN(CC1)C(=O)CN2c3cc(Cl)ccc3SC2=O	NCI	NSC_289337	0.10282776	2.1637122	-0.10529087	2.05780347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522039-01	Pyrethrin 1		Trypanosoma brucei rhodesiense Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	121-21-1				-0.0571520766	4	4		0	-0.62427746					CC(C)=C[C@H]1[C@H](C(=O)O[C@H]\2CC(=O)\C(=C2C)C\C=C/C=C)C1(C)C	Toronto Research	P991245	-0.20565553	0.54744526	0.7896815	-0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	394730-60-0				2.0629268714	4	4		0	3.02890173					CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	-0.35989717	-0.07820647	1.10555409	3.02890173												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178778-07	DIETHYLCARBAMAZINE CITRATE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1642-54-2				1.9846983807	4	4		0	1.50289017					CCN(CC)C(=O)N1CCN(C)CC1	Microsource	01500242	0.10282776	1.22523462	-0.36851803	1.50289017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185774-02	Erdosteine	170465586	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	84611-23-4	Erdosteine			5.6519324529	4	4		0	1.23651671				CAT	O=C1SCCC1NC(=O)CSCC(=O)O	Bosche	E2165	-0.0968523	-0.55207026	4.63643273	1.23651671												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274272-01	Iobenzamic acid	170465948		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3115-05-7				4.4764304149	4	4		0	4.44619837					Ic1cc(I)c(N)c(I)c1C(=O)N(CCC(=O)O)c2ccccc2	GVK	FFS-11-286-NCI-258	-0.0968523	-0.05018821	-0.17734989	4.44619837												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091195-08	Hexachlorophene	170464690	Glucose-6-phosphate dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	70-30-4		0.8912509381	-6.05	64.4656627377	2.2	4		41.6199751149	41.54169955	0.020415226	0.9997430403			Clc2c(Cc1c(O)c(Cl)cc(Cl)c1Cl)c(O)c(Cl)cc2Cl	Vitas	STK377478	-0.1937046	0.15056462	18.26703826	41.54169955												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021318-08	Budesonide		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51333-22-3				-2.1629068704	4	4		0	0.14844137				NR3C1	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	SIGMA	B7777	-0.62832286	-0.41933892	-0.82723513	0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167489-03	Sarpogrelate hydrochloride	174006666	5HT(2A) and 5HT(2B) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	135159-51-2	 ; Sarpogrelate;Sarpogrelate; Anplag; Sarpogrelate HCl	12.5892541179	-4.9	58.7788758574	3	4		69.2793202346	53.68629391	0.0369672735	0.9991564656			Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C	Tocris	3739	0.33832769	0.5673409	-1.08176901	53.68629391												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178480-03	(+)-Tubocurarine chloride hydrochloride	170464882	Small conductance calcium-activated potassium channel protein 2 Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	57-94-3				1.7378910447	4	4		0	-1.38545275			1135		[Cl-].Cl.Oc7ccc1cc7Oc5cc6[C@H](Cc4ccc(Oc2c3[C@@H](C1)[N+](C)(C)CCc3cc(OC)c2O)cc4)N(C)CCc6cc5OC	Microsource	01500602	-0.53165781	-0.41933892	4.32707604	-1.38545275												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094812-05	Acetarsol	170466503		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	97-44-9				-2.7812736563	4	4		0	0					Oc1ccc(cc1NC(C)=O)[As](O)(O)=O	Microsource	01500616	-0.43499275	-1.01134682	-1.20903595	0												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00371104-01	Cevimeline hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[107220-28-0]				3.3089667337	4	4		0	0.5730659					C[C@H]1O[C@]2(CS1)CN3CCC2CC3	Tocris	3689	0.88992974	-0.16343684	1.03345118	0.5730659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181775-02	Toluidine blue	170466390		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	92-31-9		14.1253754462	-4.85	10.004584925	4	4		15.3916236121	13.27602674	0.0560133397	0.9980740005			[Cl-].CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1	Labotest	LT00451843	0.14051522	-0.07004436	-0.32635301	13.27602674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021191-09	Cortisone acetate	170464685	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-04-4	Cortisone acetate; ;; Cortisone 21-acetate;Cortisone 21-acetate; 6   Cortisone Acetate; Cortone acetate			-2.1393159348	4	5		0	-2.19066937				NRC31	CC(=O)OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C	Selleck	S2559	0.95238095	-0.8091024	-1.43103874	-1.00502513	-2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185754-01	Terlipressin	144206925	Vasopressin V1a Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14636-12-5				0.2809441682	4	4		0	-0.53179191				AVPR1A	NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N3	Sequoia	TERLIPRESSIN	-0.10282776	-0.39103233	1.73729929	-0.53179191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164005-06	PENICILLIN V POTASSIUM			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	132-98-9, 87-08-1 [penicillin, V]				-2.0219685355	4	4		0	-0.76300578					CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C([O-])=O	Microsource	01500467	-1.07969152	0.13034411	1.73729929	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179626-05	NCGC00179626-05		Mineralocorticoid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					2.851563197	4	4		0	3.39884393					C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC([O-])=O	Prestwick	CAS-102731	0	0.2346194	0.21058173	3.39884393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166138-04	Ethynodiol diacetate	170464933	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	297-76-7				1.3594873011	4	4		0	0.25433526			5241	PGR	CC(=O)O[C@@]4(C#C)CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=C[C@H](CC[C@@H]12)OC(C)=O	Prestwick Chemical, Inc.	Prestw-908	-0.30848329	1.69447341	1.10555409	0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-02	Valaciclovir	170465373	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	124832-27-5	Valaciclovir HCl; Valaciclovir Hcl;;Valacyclovir hydrochloride; valacyclovir, (DL)-isomer; valacyclovir, (D)-isomer; Valtrex;VALACYCLOVIR HYDROCHLORIDE			-0.4495417646	4	4		0	0.34682081					Cl.CC(C)[C@H](N)C(=O)OCCOCn2cnc1c2N=C(N)NC1=O	Vitas	STK802272	-0.51413882	0.44316997	0.42116346	0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142483-09	CYTIDINE		Dna Polymerase Inhibitors; Nucleoside	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	65-46-3				3.2261943752	4	4		0	1.0867052				POLB	NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503431	0.82262211	-0.07820647	0.52645433	1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168463-06	Bretylium tosylate		norepinephrine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	61-75-6				-1.7372433876	4	4		0	1.87283237					CC[N+](C)(C)CC1=C(Br)C=CC=C1	Prestwick	Prestw-942	-1.33676093	-0.07820647	0.4738089	1.87283237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091643-10	2-Mercaptobenzothiazole		Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-3.9102852591	4	4		0	-0.3003003				Tpo	SC1=NC2=C(S1)C=CC=C2	Specs	AE-562/J262422	-1.19274809	-0.33960293	-0.57606703	-0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00270540-02	Miglitol	170465326	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	72432-03-2	Miglitol;Miglitol (Glyset)			-1.7877881807	4	4		0	-0.85085085			2548	GAA	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Prestwick	Prestw-1169	0.14312977	-1.07105538	-1.09976434	-0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178501-04	CEFTIBUTEN		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	97519-39-6				2.1558489506	4	4		0	-1.1011011			944799	ftsI	NC1=NC(=CS1)\C(=C\CC(O)=O)C(=O)N[C@H]2[C@H]3SC\C=C(/N3C2=O)C(O)=O	Microsource	01505207	1.14503817	0.0261233	0.05236973	-1.1011011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188943-03	Orotic acid	170465761	metabolite	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	65-86-1	Orotic acid;Orotic acid (6-Carboxyuracil)			-2.4975531174	4	4		0	-0.0789266				DHODH	OC(=O)c1cc(O)nc(O)n1	Vitas	STK301771	-0.62953995	-0.75282309	-0.68406385	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182988-01	Acreozast	144206850		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123548-56-1	Acreozast; Acreozst; Adeozast; 			7.253997343	4	4	LS-172573;Acetamide, N,N'-(2-chloro-5-cyano-1,3-phenylene)bis(2-(acetyloxy))-;Acreozst;CIPLUS_706509;TYB-2285;TYB 2285;Acreozast;acreozast;Adeozast;ACREOZAST;acreozastum;3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile;	0	2.72142504					Clc1c(cc(cc1NC(=O)COC(C)=O)C#N)NC(=O)COC(C)=O	Pharmaron	PH-NIH-154940	1.30497825	-0.12333498	1.84537066	2.72142504												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166134-02	Estradiol cypionate	170464789	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	313-06-4				1.2676497619	4	4		0	3.05635148					Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4	SIGMA	E8004	-0.42154567	-0.02334812	0.10878433	3.05635148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379076-01	Maxacalcitol-D6		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					1.0194382683	4	4		0	-0.81184336					C[C@H](OCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-15329	-0.04683841	2.1713752	0.32635301	-0.81184336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344134-02	Limaprost			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	74397-12-9				4.3559716754	4	4		0	1.78034682					CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O	MedChem Express	HY-B0683	0.71979434	1.27737226	0.42116346	1.78034682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167506-04	Pimecrolimus		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	137071-32-0				8.4216090476	4	4		0	7.00578035					CC[C@@H]1/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)/C(C)=C/[C@@H]4CC[C@H](Cl)[C@@H](C4)OC	Selleck	S5004	0.25706941	4.19708029	-0.57909976	7.00578035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246968-04	Olmesartan		Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	144689-24-7				7.9304559446	4	4		0	1.75175175				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	Microsource	01505206	2.67175573	0.07836991	-0.36658811	1.75175175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378937-01	Setiptiline		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	57262-94-9				1.0893941191	4	4		0	1.35135135					CN1CC\C2=C(/C1)C3=C(CC4=CC=CC=C24)C=CC=C3	MedChem Express	HY-32329	0.66793893	-1.59352142	-0.73317622	1.35135135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159435-03	Amiloxate	29215377		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Amiloxate; Neo Heliopan; 			-0.1176083263	4	4	3-MPMBEPA;3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester;CIPLUS_669269;3-(4-Methoxy-phenyl)-acrylic acid pentyl ester;3-(4-methoxyphenyl)-3-methylbutylester, propenoic acid;AMILOXATE;ISOAMY 4-METHOXYCINNAMATE;Amiloxate;Neo Heliopan;amiloxatum;	0	-1.1011011					COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1	Chembridge	CB_5258581	0.57251908	-1.48902821	-0.31421838	-1.1011011												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263173-09	Rucaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	283173-50-2				8.5985969141	4	4		0	2.7027027				PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	APExBIO	A8893	1.33587786	-0.54858934	5.07986384	2.7027027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181136-01	Pyrrolnitrin	144206296	respiratory electron transport chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1018-71-9	Pyrrolnitrin; Pyrrolnitrin Microbial; Pirrolnitrina; 			-5.7113416963	4	4	3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole;Pirrolnitrina;pyrrolnitrine;LS-136879;Pyrrolnitrine;Pyrrolnitrinum;Pyrrolnitrin Microbial;PYRROLNITRIN;CIPLUS_157237;Pyrrolnitrin;pyrrolnitrinum;1H-Pyrrole, 3-chloro-4-(3-chloro-2-nitrophenyl)-;	0	-1.6016016					Clc2cncc2c1cccc(Cl)c1[N+]([O-])=O	NCI	NSC-107654	-1.14503817	-1.22779519	-1.04739461	-1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181794-01	Dimethyl(2-phenoxyethyl)-2-thenylammonium iodide	144207154	acetylcholine metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	109732-56-1	Thenium closylate; Thenatol; Closilato de tenio; Canopar; 			-3.3073826034	4	4	Closilato de tenio;thenium closylate;thenii closilas;Closilate de thenium;THENIUM CLOSYLATE;CIPLUS_163117;closilate de thenium;Thenii closilas;Canopar;CIPLUS_3795079;Thenatol;THENIUM CLOSILATE;CIPLUS_3750771;Thenium closylate;Thenium closilate;	0	1.4014014					[I-].C[N+](C)(Cc1cccs1)CCOc2ccccc2	Toronto Research	D476690	-1.66984733	-0.49634274	0.36658811	1.4014014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018213-06	Cyclopentolate hydrochloride	170464720	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	5870-29-1				4.1509925983	4	4		0	-0.52784376					Cl.OC1(CCCC1)C(C(=O)OCCN(C)C)c2ccccc2	Microsource	01500212	1.67137476	0.34794711	1.32289417	-0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167564-03	8-Bromotheophylline	170465479		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	10381-75-6				-1.3469182431	4	4		0	-0.63341251					O=C2c1nc(Br)nc1N(C)C(=O)N2C	Vitas	STK803299	-0.72975518	1.04384134	-0.02699784	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091219-08	DEET	170466080		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	134-62-3				2.4432635509	4	4		0	1.53389411					Cc1cccc(c1)C(=O)N(CC)CC	Microsource	01601020	-0.43499275	0.71534287	1.01813554	1.53389411												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013565-03	D-Leucine	170465492	Mammalian target of Rapamycin (mTORC1) Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	328-38-1				0.9125334632	4	4		0	2.07817912					CC(C)C[C@@H](N)C(=O)O	Bosche	L0932	-0.04833253	0.024667	-1.84537066	2.07817912												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00166104-04	alpha-Lipoic acid amide	170465868	apoptotic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	940-69-2				0.2603970059	4	4		0	2.52350322					NC(=O)CCCCC1CCSS1	Microsource	01505740	-0.43499275	-0.71534287	-1.14540248	2.52350322												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013495-15	Benztropine mesylate		Dopamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	132-17-2		11.220184543	-4.95	41.0196466793	3	4		68.6658972136	59.64660936	0.0094464251	0.9999449715			CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4	APExBIO	B1554	-1.17096019	-1.1440579	0.32635301	59.64660936												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262569-03	Thiostrepton		Toll-like receptor 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1393-48-2				9.4015461418	4	4		0	1.17919075			2305		CCC(C)[C@@H]1N[C@@H]2\C=C/C3=C(N=C(C=C3[C@H](C)O)C(=O)O[C@H](C)[C@@H]4NC(=O)C5=CSC(=N5)[C@@H](NC(=O)[C@H]\6CSC(=N6)\C(NC(=O)[C@@H](NC(=O)C7=CSC(=N7)[C@]8(CCC(=N/[C@H]8C9=CSC4=N9)\C%10=NC(=CS%10)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C/C)[C@@](C)(O)[C@@H](C)O)[C@H]2O	Prestwick	Prestw-522	3.18766067	0.91240876	-0.36851803	1.17919075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166299-03	BISMUTH SUBSALICYLATE	225144280		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14882-18-9				-5.098981445	4	4		0	-1.22543353					O[Bi]1OC(=O)C2=CC=CC=C2O1	Microsource	01505412	-1.64524422	-0.9645464	-0.21058173	-1.22543353												1.6E-9	8E-9	4E-8	2E-7											
NCGC00165846-04	Nefazodone hydrochloride	170465078	Serotonin transporter Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	82752-99-6				3.8472277506	4	4		0	2.75144509					Cl.Clc1cccc(c1)N4CCN(CCCN3N=C(CC)N(CCOc2ccccc2)C3=O)CC4	Prestwick	Prestw-1152	0.46272494	-0.28675704	1.15819953	2.75144509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181760-01	Lobenzarit sodium	144206494	response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	64808-48-6	lobenzarit; Carfenil; CCA lobenzarit; 			4.1681865387	4	4	U-69951F;2-((2-carboxyphenyl)amino)-4-chlorobenzoic acid;LOBENZARIT;CIPLUS_685410;Benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt;LS-36386;LOBENZARIT SODIUM;lobenzarit, disodium salt;Carfenil;4-chloro-2,2'-iminodibenzoic acid;CCA lobenzarit;CIPLUS_186740;lobenzarit disodium;lobenzarit;Lobenzarit Disodium;DISODIUM 4-CHLORO-2,2'-IMINODIBENZOATE;disodium 4-chloro-2,2'-iminodibenzoate;Lobenzaritum;N-(2-carboxyphenyl)-4-chloroanthranilic acid;Lobenzarit sodium;Lobenzarit;Lobenzarit disodium;lobenzaritum;lobenzart;LS-176311;	0	-0.67052023			2936		[Na+].[Na+].O=C([O-])c2ccc(Cl)cc2Nc1ccccc1C([O-])=O	ACC	LOBENZARIT DISODIUM	2.05655527	0.07820647	0.26322716	-0.67052023												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179619-06	Erythromycin propionate	170465433	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	134-36-1				-0.7971917454	4	4		0	-0.48554913					CCC(=O)O[C@@H]3[C@H](C[C@@H](C)O[C@H]3O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500280	0.05141388	-0.70385819	-0.10529087	-0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181343-03	Ivabradine hydrochloride		HCN [I(f)] Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	148849-67-6				2.182168872	4	4		0	-1.22543353				HCN	COC1=C(OC)C=C2CC(=O)N(CCCN(C)C[C@H]3CC4=CC(=C(OC)C=C34)OC)CCC2=C1	MedChem Express	HY-B0162A	1.23393316	-0.33889468	0.26322716	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346565-04	Elvitegravir		HIV Integrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	697761-98-1				-1.420278371	4	4		0	-0.43930636					COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	MedChem Express	HY-14740	-0.46272494	0.33889468	-0.21058173	-0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179685-03	Isoflupredone acetate	170465628		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	338-98-7				0.0045944581	4	4		0	-0.71676301					CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-6	0.46272494	-0.39103233	-0.52645433	-0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183868-02	Fentiazac	170466003		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	18046-21-4				-0.4984306567	4	4		0	1.15115115					O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3	Prestwick	Prestw-1254	-0.23854962	-0.44409613	-0.62843676	1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482546-01	Ganirelix			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	123246-29-7				-4.4049449697	4	4		0	-0.05005005					CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CO)NC(=O)[C@H](CC2=CN=CC=C2)NC(=O)[C@H](CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N6CCCC6C(=O)N[C@H](C)C(N)=O	DC Chemicals	DC8877	-1.0019084	-1.75026123	-0.83791568	-0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015033-03	p-Aminoclonidine hydrochloride	90341674	Alpha-2A adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-2.4469750233	4	4		0	-1.05105105			150	ADRA2A	NC1=CC(=C(N=C2NCCN2)C(=C1)Cl)Cl	SigmaAldrich	Lopac-A-0779	-0.85877863	-0.49634274	1.25687353	-1.05105105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389219-01	Oxeladin Citrate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	52432-72-1		7.9432823472	-5.1	13.8559888825	4	4		23.163009408	21.82182182	0.0657266109	0.9973326144			CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1	APExBIO	A8493	-0.38167939	-1.80250784	-0.31421838	21.82182182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181319-01	Plicamycin	144206340	DNA Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	18378-89-7	Plicamycin; Mithracin; Mithramycine; Mitramycin; Plicamicina; Mithramycinum; Mitramicina; Acid, Aureoli; 			-1.3105565796	4	4	Mithramycine;Plicamycinum;CIPLUS_741126;plicamycinum;Mithramycinum;Acid, Aureoli;Mithracin;mithramycin A;PA-144;Mithramycin A;NCGC00162423-01;NSC-24559;Mithramycin A Streptomyces plicatus;MITHRAMYCIN A;mithramycin;Plicamycin;MITHRAMYCIN;WHO NO. 2029;Mitramycin;Plicamicina;CIPLUS_171437;Aureolic acid;Plicamycine;PLICAMYCIN;Mitramicina;Mithramycin;plicamycin;AUREOLIC ACID;plicamycine;A-2371;LS-91528;	0	0					C[C@@H](O)[C@H](O)C(=O)[C@@H](OC)C6Cc7cc8cc(O[C@H]2C[C@@H](O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1)[C@@H](O)[C@@H](C)O2)c(C)c(O)c8c(O)c7C(=O)[C@H]6O[C@H]5C[C@@H](O[C@H]4C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O5	SIGMA	M6891	0.52480916	-1.90700104	-1.88531029	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483924-02	Brigatinib	384569265	IGF-1R Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1197953-54-0				-1.686984737	4	4		0	-1.79319981				IGFR1	COC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-12857	0.33678756	-0.31691858	-1.40951422	-1.79319981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386237-08	Brintellix		5-HT1D Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	508233-74-7				-2.6579842919	4	4		0	-2.67815557				HTR1D	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C	MedChem Express	HY-15414	-0.69948187	-0.95075573	2.56732947	-2.67815557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014648-04	Spiclomazine hydrochloride		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE			12.5892541179	-4.9	26.8714979081	3	4		38.9353695191	34.21052632	0.046673116	0.9986554472			ClC1=CC2=C(SC3=C(C=CC=C3)N2CCCN4CCC5(CC4)NC(=O)CS5)C=C1	NCI	NSC-290956	-0.07772021	1.34080936	0.8054367	34.21052632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00080392-05	Phosmet	170466810	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	732-11-6				-0.5412889536	4	4		0	-1.5307469					COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O	Vitas	STK097158	1.01224105	0.27835769	-0.89092873	-1.5307469												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160654-06	Ethylparaben	170465715		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	120-47-8				-3.6842848493	4	4		0	-0.31670625					Oc1ccc(cc1)C(=O)OCC	Vitas	STK070911	-0.82391714	-0.76548365	-1.21490281	-0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164568-04	Montelukast sodium	170465230	Cysteinyl leukotriene receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	151767-02-1				-3.3116595395	4	4		0	-0.36949063					[Na+].CC(C)(O)c5ccccc5CC[C@@H](SCC1(CC([O-])=O)CC1)c2cccc(c2)/C=C/c3ccc4ccc(Cl)cc4n3	Sequoia	SRP06641m	-1.29472693	0.20876827	-0.62095032	-0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166088-02	Decitabine	170465126	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2353-33-5	 ;5-Aza-2 -deoxycytidine; Dacogen; 5-Aza-2??-deoxycytidine;Decitabine; Decitabine			-4.643970807	4	4		0	-1.5307469			1786	DNMT1	NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Tocris	2624	-0.40018832	-1.60055672	-1.05291577	-1.5307469												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00189077-01	Methsuximide	144207162	Voltage-gated T-type calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	77-41-8				2.8471850757	4	4	Methsuximide	0	3.0614938					CC1(CC(=O)N(C)C1=O)c2ccccc2	Toronto Research	M271900	-0.4472693	-0.55671538	0.674946	3.0614938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015705-07	Memantine hydrochloride	170464999	NMDA Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	19982-08-2	 Namenda; ;Memantine;MEMANTINE HYDROCHLORIDE; Axura;Memantine hydrochloride; Ebixa; Memantine hydrochloride; Memantine HCL; Memantina;Memantine Hydrochloride; Memantin			-4.2960827036	4	4		0	-1.84745315			2903	GRIN2A	CC13CC2(C)CC(N)(C1)CC(C2)C3	Vitas	STK520682	-0.58851224	-0.83507307	-0.56695464	-1.84745315												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015400-05	Enoximone	170466419	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	77671-31-9				2.9010647134	4	4		0	1.58353127					O=C(C=1NC(=O)NC=1C)c2ccc(SC)cc2	Tocris	1693	1.10640301	-1.39178845	0.08099352	1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095606-02	(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone	170465578	TNF-alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	14073-97-3				0.8086368256	4	4		0	-1.47796252					CC(C)[C@@H]1CC[C@@H](C)CC1=O	SIGMA	63680	0.21186441	1.73973556	0.78293736	-1.47796252												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182040-01	Bevantolol hydrochloride	144206530	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	42864-78-8	Bevantolol hydrochloride; Calvan; Vantol; 			7.9179824876	4	4	bevantolol;1-((3,4-DIMETHOXYPHENETHYL)AMINO)-3-M-TOLYLOXY-2-PROPANOL HYDROCHLORIDE;1-((2-(3,4-dimethoxyphenyl)ethyl)amino)- 3-(3-methylphenoxy)-2-propanol;Bevantolol;CI 775;bevantololum;Bevantololum;Calvan;CIPLUS_180342;Bevantolol Hydrochloride;2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-, hcl (10ci);Bevantolol hydrochloride;bevantolol hydrochloride;CI-775;LS-122160;BEVANTOLOL;BEVANTOLOL HYDROCHLORIDE;Vantol;LS-122167;CIPLUS_668470;	0	-1.14613181					Cl.COc1cc(ccc1OC)CCNCC(O)COc2cc(C)ccc2	APAC	555783	2.85714286	1.19075414	0.92466685	-1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016527-06	Clopamine			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	636-54-4				1.9685136801	4	4		0	-0.09551098					C[C@H]1CCC[C@@H](C)N1NC(=O)C2=CC(=C(Cl)C=C2)[S+](N)([O-])=O	Enzo	CM112	-0.6088993	4.27270605	0.87027468	-0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344538-01	1,3-Propanedisulfonic acid disodium salt	225144385		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	36589-58-9				3.9926416291	4	4		0	-0.38204394					[O-][S](=O)(=O)CCC[S]([O-])(=O)=O	SIGMA	P8579	1.82669789	-0.77048798	0.21756867	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181037-03	Isoflurane		Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	26675-46-7				-0.3532884504	4	4		0	1.54913295					FC(F)OC(Cl)C(F)(F)F	SigmaAldrich	CPX6609	-1.1311054	0.39103233	1.57936299	1.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378911-02	(S)-Tedizolid		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1431699-67-0				4.3391981209	4	4		0	-0.9017341					C[N]1N=NC(=N1)C2=CC=C(C=N2)C3=CC=C(C=C3F)N4C[C@@H](CO)OC4=O	MedChem Express	HY-14855A	0.87403599	-0.44316997	4.42221637	-0.9017341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181116-02	Carbomycin A	124893648	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.3605149352	4	4		0	-0.30057803					CO[C@H]1[C@@H](CC(=O)O[C@H](C)C[C@@H]2OC2\C=C/C(=O)[C@H](C)C[C@H](CC=O)[C@@H]1OC3OC(C)C(OC4CC(C)(O)C(OC(=O)CC(C)C)C(C)O4)C(C3O)N(C)C)OC(C)=O	NCI	NSC-51001	-0.5655527	0.65172054	-0.21058173	-0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091351-01	m-Dinitrobenzene	17388932		DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-1.2546833871	4	4	NCGC00091351-02;1,3-Dinitrobenzene-15N2;1,3-Dinitrobenzene-d4;3-dinitrobenzene;m-dinitrobenzene;1,3-dinitrobenzene;m-Dinitrobenzene;1,3-Dinitrobenzene;CIPLUS_150522;meta-dinitrobenzene;1,3-Dinitrobenzene-13C6;AB07990178-01;CIPLUS_763212;	0	-0.3003003					[O-][N+](=O)C1=CC=CC(=C1)[N+]([O-])=O	NIEHS	AB07990178	0.04770992	-0.60083595	-1.04739461	-0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249930-01	Tolycaine	170465945		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3686-58-6				-2.4346003965	4	4		0	-0.25025025					O=C(Nc1c(C)cccc1C(=O)OC)CN(CC)CC	GVK	FFS-11-286-NCI-233	-0.28625954	-1.54127482	-0.62843676	-0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379065-05	Riociguat		Soluble Guanylate Cyclase (sGC) Activator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	625115-55-1				13.4894355149	4	4		0	1.95195195				GUCY1A2	COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24	MedChem Express	HY-14779	5.10496183	-0.65308255	-0.78554595	1.95195195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181165-01	Sodium decanehydroxamate	144206782		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	35440-53-0	n-decanohydroxamic acid; 			-2.8797286027	4	4	n-decanohydroxamic acid;Decanohydroxamic acid;CIPLUS_720094;DECANOHYDROXAMIC ACID;	0	-0.16301816					[Na+].[O-]NC(=O)CCCCCCCCC	NCI	NSC-111679	-0.75129534	-0.99951243	-0.20135917	-0.16301816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-04	Ixazomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1072833-77-2				-2.6057423909	4	4		0	1.5137401				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Selleck	S2180	-1.16580311	-1.38956607	0.30203876	1.5137401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379044-01	Paricalcitol-D6 (ABT-358)		Vitamin D Receptor (VDR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE					7.2348039943	4	4		0	-0.53563111				VDR	C[C@H](\C=C\[C@H](C)C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/[CH]=[C]3C[C@@H](O)[CH2][C@H](O)C3	MedChem Express	HY-76585	2.40932642	0.5607021	1.5605336	-0.53563111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166280-02	Bismuth(III) gallate basic hydrate	225144278		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	99-26-3				1.3046768084	4	4		0	-0.20959478					O[Bi]1OC2=CC(=CC(=C2O1)O)C(O)=O	SIGMA	15102	-1.06217617	3.63237445	-0.10067959	-0.20959478												1.6E-9	8E-9	4E-8	2E-7											
NCGC00344326-02	9(E),12(E)-Octadecadienoic acid		Streptococcus mutans Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	n/a				4.9169445131	4	4		0	5.10013973					CCCCC/C=C/C/C=C/CCCCCCCC(O)=O	Enzo	BL118	0.38860104	0.46318869	-0.30203876	5.10013973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094646-04	Dibenzothiophene	170465511	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	132-65-0				-1.6873918558	4	4		0	-0.84455001					c1cccc2sc3ccccc3c12	Vitas	STK367232	-1.05932203	1.60055672	0.08099352	-0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163700-12	Vincristine sulfate	404904683		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	[2068-78-2]				7.2716230882	4	4		0	7.49538137					CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Tocris	1257	0.96516008	-1.53096729	-1.59287257	7.49538137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090903-11	Sulfasalazine	170464716	NFKB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine			-0.5237758805	4	4		0	0.95011876			4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	Microsource	01500552	-0.63559322	-1.80932498	0.83693305	0.95011876												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159460-04	Indinavir sulfate	170465228	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	157810-81-6	 ;Indinavir sulfate salt hydrate; Crixivan; Indivanir Sulfate; Indinavir, Sulfate (1:1);Indinavir;Indinavir Sulfate; Indinavir sulfate; Sulfate, Indinavi			-0.1148059022	4	4		0	-0.73898126					O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O	Bosche	I2146	-0.30602637	-1.39178845	2.13282937	-0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00162143-03	Clodronate	225144247	ADP/ATP translocase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	22560-50-5				-8.3479580188	4	5		0	-2.5390625			293	SLC25A6	O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O	Prestwick	Prestw-1381	-1.89873418	-3.65279369	-1.14974373	1.52855994	-2.5390625											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00021202-03	Famotidine	170464877	Histamine H2 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	76824-35-6				5.4370349829	4	5		0	-1.17902155				HRH2	N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1	Enzo	AC925	0.7367387	2.54612546	3.77988513	0.7585335	-1.17902155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159425-09	ZINC UNDECYLENATE		Fatty Acid Biosynthesis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	557-08-4				-6.4048093512	4	5		0	-1.45089286					OC(=O)CCCCCCCCC=C	Microsource	01505467	-1.72499379	-0.98001782	0.40171769	-2.57441673	-1.45089286											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00017331-08	(-)-Epicatechin	170465932	superoxide anion generation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	490-46-0				-3.8574442127	4	5		0	0.390625					Oc1ccc(cc1O)[C@H]2Oc3cc(O)cc(O)c3C[C@H]2O	Microsource	00210205	-1.65053363	-3.16914853	3.86480122	-2.25261464	0.390625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018269-05	Trimebutine maleate	170465734		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	34140-59-5				-0.9221150242	4	5		0	-1.31138393					COc1c(cc(cc1OC)C(=O)OCC(CC)(c2ccccc2)N(C)C)OC.O=C(O)/C=C\C(=O)O	Microsource	01505011	0.35989079	0.39455263	1.06662973	-2.33306516	-1.31138393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015245-10	Bethanechol chloride	170464912	Muscarinic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	590-63-6	; ;Carbamyl-b-Methylcholine Cl; Urecholine; Bethanechol chloride;BETHANECHOL CHLORIDE;Bethanechol chloride			-4.4027697195	4	5		0	-2.23214286				CHRM2	[Cl-].C[N+](C)(C)CC(C)OC(=O)N	Enzo	AC912	-1.70017374	-1.43820797	1.23285774	0.80450523	-2.23214286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	11.220184543	-4.95	32.35539401	3	5		55.3358848678	50.69754464	0.010784186	0.9945663705			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	-0.9555721	-4.34007891	0.40171769	-1.44810941	50.69754464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015955-16	Salbutamol sulfate	170465034	beta2-Adrenoceptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	18559-94-9	 Ventolin;Albuterol; Albuterol (Salbutamol); ;Salbutamol hemisulphate; Proventil; Albuterol hemisulfate;Albuterol hemisulfate; Sultanol; R-albuterol hydrochloride; Xopenex; Salbutamol hemisulfate;ALBUTEROL (+/-);Salbutamol; Salbutamol; Salbutamol hemisulphate;Salbutamol sulfate; Asmaven sulfate; Levalbuterol			-4.2673878338	4	5		0	-3.79464286			154	ADRB2	OCc1cc(ccc1O)C(O)CNC(C)(C)C	Enzo	AC176	1.74981385	-4.46735395	-2.00858845	-0.21453473	-3.79464286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181042-02	Menthyl salicylate	225144318		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	89-46-3				-9.3287157699	4	5		0	-2.87388393					CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2O	SIGMA	84320	-2.49441549	-3.0673285	-2.00858845	1.42129257	-2.87388393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348372-01	LINDANE		GABA-A receptor Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-89-9				-5.6447351264	4	5		0	0.98929394					[Cl][C@H]1[C@H]([Cl])[C@H]([Cl])[C@@H]([Cl])[C@H]([Cl])[C@@H]1[Cl]	SigmaAldrich	233390	-1.9891945	-0.33210332	-1.34900494	-2.17446271	0.98929394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023217-08	Meclofenamate sodium	170464886	Cyclooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6385-02-0				-5.4239362921	4	5		0	-0.58273479					[Na+].O.Clc2ccc(C)c(Cl)c2Nc1ccccc1C([O-])=O	Microsource	01500377	-1.91552063	-0.50430504	-1.32229197	-0.22756005	-0.58273479											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160622-04	D-delta-Tocopherol	144206758		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	119-13-1				-2.7869652565	4	5		0	-1.171875					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1	NCGCChem	XJB03-045	-0.4095309	0.59819269	-1.03892506	-1.20675784	-1.171875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167539-03	Indole	170465733	Tryptophan synthase beta chain Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	120-72-9				-8.2453175729	4	5		0	-2.09263393			945768	trpB	c1cccc2nccc12	Specs	AE-562/J262413	-1.00521221	-2.60913835	-3.50464053	-0.77768839	-2.09263393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159377-04	4-tert-Butylphenol	170465689	UDP-glucuronosyltransferase 1-6 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	98-54-4				-11.2079260326	4	5		0	-3.15290179					CC(C)(C)c1ccc(O)cc1	Labotest	LTBB002519	-3.53685778	-0.67455772	-0.51253636	-2.0917136	-3.15290179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015389-14	Propofol	170464994	TRPV1 (Vanilloid VR1 Receptor) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL			1.7350938628	4	5		0	1.88372408			7442	TRPV1	CC(C)c1cccc(C(C)C)c1O	SigmaAldrich	Lopac-D126608	0.07367387	-0.87330873	0.38733805	0.7585335	1.88372408											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253608-01	Chlorexolone	170466039		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2127-01-7				-0.0233126676	4	5		0	1.3958531					NS(=O)(=O)c1cc2C(=O)N(Cc2cc1Cl)C3CCCCC3	GVK	FFS-11-286-NCI-259	-0.02455796	-0.89790898	-0.36062508	-0.2022756	1.3958531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094437-05	d-Tryptophan	170465485	Tryptophan metabolism Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	153-94-6				-2.414113619	4	5		0	0.44642857					O=C(O)[C@H](N)Cc2cnc1ccccc12	SIGMA	93660	0.93075205	-3.7037037	-0.90040172	-1.79672835	0.44642857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263906-02	Rolitetracycline	170465919		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	751-97-3				-4.0261078679	4	5		0	-0.23038352					O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O	Microsource	01505684	-2.33300589	0.03690037	-0.09349539	0.73324905	-0.23038352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262961-01	Cromoglicate lisetil	170465975	mast cell activation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	110816-79-0	O			-7.101520548	4	5		0	2.12053571					O=C(OCC)C=4Oc3cccc(OCC(OC(=O)[C@@H](N)CCCCN)COc1cccc2OC(=CC(=O)c12)C(=O)OCC)c3C(=O)C=4	GVK	FFS-11-286-NCI-234	-2.32067511	-3.90734377	-2.17481646	-0.18771789	2.12053571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018250-06	Sulconazole nitrate	170465344	Lanosterol 14-alpha demethylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	61318-91-0		10	-5	-0.8326800815	4	5		11.996350364	9.09217877	0.0985629349	0.9473162424			[O-][N+](=O)O.Clc3ccc(C(SCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501148	-3.33029197	-0.33619724	-1.01355477	-0.72748436	9.09217877											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163778-09	Imazalil sulfate	170466809	O75469|||Q9UJ26 REC20 - 20% relative effective concentration; the concentration of the test compound showing 20% of the agonistic activity of 1 _ 10_5 M rifampicin via hPXR	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58594-72-2				3.6654565507	4	5		0	-2.10055563					O=S(=O)(O)O.Clc2ccc(C(OCC=C)Cn1ccnc1)c(Cl)c2	Prestwick Chemical, Inc.	Prestw-963	2.87328094	0.33210332	1.45585682	-1.9216182	-2.10055563											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091861-07	Dacarbazine	170464655	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4342-03-4	; ; Dacarbazino;Dacarbazine; Dacarbazine; DTIC-Dome; DACARBAZINE; Dacarbizine;DACARBAZINE; 6   Dacarbazine			-4.7950029502	4	5		0	0.39300718				H2AFX	CN(C)/N=N/c1ncnc1C(N)=O	Microsource	01500218	-1.27701375	-1.34071341	-1.13530119	-1.4159292	0.39300718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015254-20	Clozapine	170464853	Dopamine D4 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5786-21-0	;Clozapine; ; clozapine N-glucuronide;CLOZAPINE; Leponex; Clozaril; Clozapine; Clozapina; Clo-Glu	12.5892541179	-4.9	22.4992078949	3	5		38.7546994639	35.05895108	0.0473627945	0.9754665492	1815	DRD4	CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23	Enzo	D107	-2.21021611	3.23493235	0.41405102	-3.08470291	35.05895108											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016878-04	Piretanide	170465869	Cystic fibrosis transmembrane conductance regulator Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	55837-27-9				-10.1140674864	4	5		0	-1.88547486					O=C(O)c2cc(c(Oc1ccccc1)c(c2)N3CCCC3)S(N)(=O)=O	Prestwick Chemical, Inc.	Prestw-1047	-3.11739659	-0.75955672	-1.5020149	-1.92055871	-1.88547486											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00080392-05	Phosmet	170466810	Acetylcholinesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	732-11-6				3.3007000484	4	5		0	-4.2877095					COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O	Vitas	STK097158	3.14781022	0.33619724	1.40432287	-0.78568311	-4.2877095											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015339-07	Dequalinium dichloride	225144172	Protein kinase C beta Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	522-51-0				-1.5761286529	4	5		0	-0.48882682					CC1=CC(=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)N	Prestwick	Prestw-388	-1.0796837	-1.65608268	3.18720234	-0.98937873	-0.48882682											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00179663-03	(-)-(5S,8R)-Lisuride	170465966	Dopamine D5 receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	159701-44-7				-4.2338598274	4	5		0	0.7122905					CCN(CC)C(=O)N[C@@H]2C=C1c3cccc4ncc(C[C@@H]1N(C)C2)c34	Tocris	4052	-1.71836983	-2.10434566	-0.32971059	0.17459625	0.7122905											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253646-01	Agomelatine	174006904	5-HT2C Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	138112-76-2	Agomelatine			-3.6983678055	4	5		0	-0.06775986			3358	HTR2C	CC(=O)NCCc1cccc2ccc(OC)cc12	GVK	FFS-12-73-NCI-2563	-1.89096267	-0.7503075	0.57432884	-0.02528445	-0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016397-04	Benzydamine hydrochloride	170465576	prostaglandin production involved in inflammatory response Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	132-69-4		7.0794578438	-5.15	9.1990311685	4	5		17.5324165	15.65252744	0.0014384123	0.9992833723			Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23	Vitas	STK711092	-1.27701375	-1.0701107	-1.24215307	2.12389381	15.65252744											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015045-09	Methacholine chloride	170464971	Muscarinic acetylcholine receptor M2 Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	62-51-1				-0.1432861167	4	5		0	-1.10335196					[Cl-].C[N+](C)(C)CC(C)OC(=O)C	Microsource	01500391	-0.80596107	1.68098618	1.25778483	0.17459625	-1.10335196											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183024-01	Proglumetacin	144206876	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57132-53-3	Proglumetacin; Miridacin; Proglumetacina; 	8.9125093813	-5.05	58.6161896269	3	5	LS-82118;proglumetacine;Proglumetacinum;proxil;Proglumetacina;Proglumetacin Maleate;Proglumetacin;Proglumetacine;CIPLUS_182770;proglumetacin;Proglumetacin maleate;METACINE-P;LS-175816;Miridacin;PROGLUMETACIN MALEATE;PROTACINE;3'-(4-(2-(1-p-chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate;PROGLUMETACIN;proglumetacinum;CIPLUS_685564;3-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)PROPYL DL-4-BENZAMIDO-N,N-DIPROPYLGLUTARAMATE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETATE;	91.395644486	86.25830058	0.0015916838	0.9992033374			CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5	Pharmaron	PH-NIH-183347	-2.79960707	-0.03690037	-2.63122746	1.7193426	86.25830058											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015360-08	Pentetic acid	170465150	Radioactive metals Chelating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	67-43-6		7.0794578438	-5.15	6.694664776	4	5		11.56321112	8.76812576	0.0547884436	0.9718000949			O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	Vitas	STK373226	-0.24557957	-1.24231242	-0.06678242	-1.7193426	8.76812576											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00091071-08	p,p'-DDT	170465529		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-29-3		5.6234132519	-5.25	10.1637393665	4	5		14.522973156	12.2103266	0.1406189456	0.9218092819			Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl	Specs	AE-562/J256064	1.22789784	-1.75891759	-3.35247763	3.33754741	12.2103266											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253606-01	Mexazolam	170465840		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	31868-18-5				-5.7819672309	4	5		0	-0.96219					Clc1ccccc1C34OCC(C)N4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-217	-2.50491159	-1.9803198	3.88673701	-2.50316056	-0.96219											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160611-03	1-Ethyl-2-pyrrolidinone	170465488		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2687-91-4				-0.8157118112	4	5		0	1.2150838					O=C1CCCN1CC	SIGMA	146358	-1.59671533	1.85531067	0.67163268	-0.75658373	1.2150838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015400-05	Enoximone	170466419	Phosphodiesterase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77671-31-9				-9.6156387293	4	5		0	-3.98044693					O=C(C=1NC(=O)NC=1C)c2ccc(SC)cc2	Tocris	1693	-3.23905109	-1.95492467	0.52509464	0.52378874	-3.98044693											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015730-11	Neostigmine bromide	170465765	Acetylcholinesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	114-80-7				-3.8416473397	4	5		0	-1.94134078					[Br-].O=C(Oc1cccc(c1)[N+](C)(C)C)N(C)C	Enzo	AC743	-2.41788321	2.05453866	0.32971059	0.61108686	-1.94134078											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160540-03	Ethiazide	170465925		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1824-58-4				-4.9103577333	4	5		0	-1.96503591					NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CC)cc2Cl	Menai	H2748	-1.69449902	-0.89790898	-2.79150528	3.26169406	-1.96503591											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090787-08	Benzophenone	170465649		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	119-61-9				1.0889186793	4	5		0	-1.10335196					O=C(c1ccccc1)c2ccccc2	Specs	AE-562/J256170	-0.07603406	1.90511767	2.57662718	-1.54226684	-1.10335196											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096014-03	Salsalate	170465545	prostaglandin biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	552-94-3				-1.4862679636	4	5		0	-2.08100559					O=C(Oc1ccccc1C(=O)O)c2ccccc2O	Specs	AN-153/I262078	-1.35340633	0.46071473	2.96739529	0.26189437	-2.08100559											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249894-01	Fosphenytoin	170465016	Sodium channel protein type VIII alpha subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	93390-81-9				-1.353279888	4	5		0	0.22321429					OP(=O)(O)OCN1C(=O)C(NC1=O)(c2ccccc2)c3ccccc3	GVK	FFS-11-286-NCI-63	-0.98039216	-3.95825379	0.84499238	3.53982301	0.22321429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178241-04	Dichloro(ethylenediamine)platinum(II)	170466890	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	14096-51-6				3.1183936314	4	5		0	1.64620536					[Cl-][Pt]1([Cl-])NCCN1	Microsource	01502107	-0.18615041	-3.44915362	2.72890982	3.91525878	1.64620536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168785-03	Diclazuril		antiprotozoal agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	101831-37-2	 ; Diclazuril;Diclazuril;DICLAZURIL	6.3095734448	-5.2	7.4471842311	4	5		14.4862542959	11.57924107	0.0817722067	0.9567412541			ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	FLUKA	34057	0.08687019	-3.32187858	-1.37138108	2.73531778	11.57924107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021274-04	ESTRADIOL BENZOATE			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-50-0		2.8183829313	-5.55	9.8016478276	4	5		15.14170938	-1.25558036	0.1625438378	0.9834645989			C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)C5=CC=CC=C5)[C@@H]1CC[C@@H]2O	SIGMA	E8515	-2.271035	-0.75092274	-2.61809115	11.31670689	-1.25558036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263560-01	6-Aminopenicillanic acid	225144362		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	551-16-6				-3.2896538373	4	5		0	-0.64174107					CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O	Bosche	A0928	-1.57607347	-2.66004836	0.73417371	0.75087155	-0.64174107											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00181091-01	Bunamidine hydrochloride	144206260		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1055-55-6	Bunamidine hydrochloride; Bunamidina; Scolaban; 	3.1622776602	-5.5	93.8851315477	3	4	bunamidinum;bunamidine monohydrochloride;N,N-DIBUTYL-4-(HEXYLOXY)-1-NAPHTHAMIDINE MONOHYDROCHLORIDE;bunamidine;LS-174664;Scolaban;CIPLUS_738221;CIPLUS_157296;Bunamidinum;N,N-dibutyl-4-(hexyloxy)-1-naphthamidine monohydrochloride;LS-95153;NSC-106571;1-Naphthamidine, N,N-dibutyl-4-hexyloxy-, monohydrochloride;CIPLUS_3885993;1-naphthalenecarboximidamide, n,n-dibutyl-4-(hexyloxy)-, hydrochloride;BUNAMIDINE HYDROCHLORIDE;Bunamidine hydrochloride;Bunamidina;BUNAMIDINE;Bunamidine;	90.0236722607	-3.05305305	1	0.99977772			Cl.CCCCN(CCCC)C(=N)c1ccc(OCCCCCC)c2ccccc12	NCI	NSC-106571	-0.85877863	-1.90700104	67.34747316	-3.05305305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017074-02	Hydergine	144206902	Adrenergic receptor alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	8067-24-1				-3.2923030116	4	4		0	2.35235235					CS(=O)(=O)O.CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@H](C(=O)N5CCC[C@H]56)C(C)C)C7=O)C(C)C	Prestwick Chemical, Inc.	CAS-8067-24-1	-1.24045802	-1.38453501	-1.30924326	2.35235235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094594-13	Bacitracin			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1405-87-4				2.6651095012	4	4		0	2.2022022					CCC(C)C(N)\C1=N\C(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=C[NH]3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC	Enzo	AC3027	-0.14312977	-0.86206897	1.83294056	2.2022022												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00386239-01	Mirabegron		Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	223673-61-8				0.9563895599	4	4		0	1.35135135					NC1=NC(=CS1)CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2	Selleck	S4009	0.28625954	-1.43678161	0.31421838	1.35135135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178499-08	Cefdinir		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	91832-40-5				16.8472365052	4	4		0	2.16581276					NC1=NC(=CS1)\C(=N\O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	Adooq	A10187	3.39378238	4.65626524	4.7319406	2.16581276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167532-02	Balofloxacin	170465911	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	127294-70-6	 ;Balofloxacin; Balofloxacin; Balofloxacin Hydrate			-2.108501927	4	4		0	1.37401025					CNC1CCCN(C1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Sequoia	SRP00850b	-1.11398964	-0.36567528	-0.05033979	1.37401025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090762-11	Rifabutin		Cytochrome P450 3a4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	72559-06-9				2.9509271785	4	4		0	5.70563577				PRKDC	[H][C@]1(C)\C=C\C=C(C)\C(=O)NC2=C3NC4(CCN(CC(C)C)CC4)N=C3C5=C(C2=O)C(O)=C(C)C6=C5C(=O)[C@](C)(O6)O\C=C\[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@]([H])(C)[C@@]1([H])O	MedChem Express	HY-17025	-0.49222798	0.17064846	-0.25169897	5.70563577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167523-03	Ormetoprim	170465718	Folate biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6981-18-6				-4.1431125767	4	4		0	-1.90023753					Nc2nc(N)ncc2Cc1cc(OC)c(OC)cc1C	Sequoia	SRP01245o	-0.82391714	-0.55671538	-0.1349892	-1.90023753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091367-05	Danthron	170465532	DNA topoisomerase II alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	117-10-2				-1.8945431355	4	4		0	-0.58062813					Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23	Labotest	LT00455159	0.07062147	-0.97425191	-0.674946	-0.58062813												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate			-1.0897475399	4	4		0	0.36949063			7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	-1.01224105	-1.11343076	1.10691145	0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182031-05	Etizolam		GABA-A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	40054-69-1				-2.408398197	4	4		0	0.42979943					CCC1=CC\2=C(S1)[N]3C(=NN=C3C\N=C2C4=CC=CC=C4Cl)C	MedChem Express	HY-B0677	-0.98360656	-0.58370301	0.27196084	0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183845-01	Pibutidine	144206830	Histamine H2 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	103922-33-4				-2.0017475804	4	4	LS-55930;Pibutidine hydrochloride;IT-066;pibutidine hydrochloride;pibutidinum;PIBUTIDINE;PIBUTIDINE HYDROCHLORIDE;3-amino-4-(4-(4-(1-piperidinomethyl)-2-pyridyloxy)-2-butenylamino)-3-cyclobutene-1,2-dione;3-Cyclobutene-1,2-dione, 3-amino-4-((4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)amino)-, monohydrochloride, (Z)-;IT 066;Pibutidine Hydrochloride;CIPLUS_3889336;pibutidine;CIPLUS_696295;	0	0.90735435					NC=3C(=O)C(=O)C=3NC\C=C/COc2cc(CN1CCCCC1)ccn2	Pharmaron	PH-NIH-151621	-0.84309133	-0.25682933	-1.25101985	0.90735435												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00345882-03	Silodosin		alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	160970-54-7				-2.9733878947	4	4		0	-1.00286533				ADRA1A	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC3=CC=CC=C3OCC(F)(F)F	Prestwick	Prestw-1749	-0.56206089	-0.9105767	-0.21756867	-1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181080-01	Phenacaine hydrochloride	144206789	"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	620-99-5	phenacaine hydrochloride; Fenacaina; 			6.9303697	4	4	Phenacainum;phenacaine hydrochloride;Phenacaine (N,N'-bis-(4-ethoxy-phenyl)-acetamidine);phenacainum;CIPLUS_150668;PHENACAINE;Phenacaine hydrochloride;Acetamidine, N,N'-bis(p-ethoxyphenyl)-, hydrochloride;phenacaine;LS-10332;CIPLUS_155428;PHENACAINE HYDROCHLORIDE;Phenacaine;LS-176183;Phenacaine Hydrochloride;CIPLUS_743918;Fenacaina;	0	6.1734104			5136	PDE1A	Cl.CCOc1ccc(cc1)NC(\C)=N\c2ccc(OCC)cc2	NCI	NSC-9293	-0.10282776	2.26798749	1.42142669	6.1734104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179351-03	Quinethazone	170465167	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	73-49-4				-0.1799924491	4	4		0	-0.30057803					NS(=O)(=O)c1cc2C(=O)NC(Nc2cc1Cl)CC	Prestwick	Prestw-1050	-0.20565553	0.07820647	0.73703606	-0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167437-02	Ramosetron hydrochloride	170465928	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	132907-72-3				9.7969616561	4	4		0	3.95375723					Cl.O=C(c2cn(C)c1ccccc12)[C@H]3Cc4ncnc4CC3	Bosche	R2999	1.95372751	0.80813347	1.84259016	3.95375723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185763-03	6?-Methylprednisolone 21-hemisuccinate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2921-57-5				-3.4905163318	4	4		0	-1.45145145					C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]\4(C)/C=C\C(=O)\C=C14	Cayman	11800	-0.62022901	-1.07105538	-0.10473946	-1.45145145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165957-07	Amlodipine	225144262		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	88150-42-9		12.5892541179	-4.9	63.094995846	3	4		102.3418226992	87.53753754	0.0119666727	0.9999116709			CCOC(=O)C/1=C(COCCN)/N\C(=C(C1C2=C(Cl)C=CC=C2)\C(=O)OC)C	Prestwick	Prestw-1219	-0.47709924	-1.22779519	-0.36658811	87.53753754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-11	Carfilzomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	868540-17-4				-4.6081613736	4	4		0	-1.42058687				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Selleck	S2853_CM1	-1.68393782	0.12189176	0.95645608	-1.42058687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183600-04	PARAMETHADIONE		Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	115-67-3				1.6388821626	4	4		0	1.65346996					CCC1(C)OC(=O)N(C)C1=O	Microsource	01505456	-0.12953368	0.99951243	0.05033979	1.65346996												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164561-02	Zanamivir	170464662	Neuraminidase (Sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	139110-80-8	 ; Zanamivir Anhydride;Zanamivir; Zanamivir; Relenza;Zanamivir (Relenza);Zanamavir			3.7923240033	4	4		0	1.47796252				NEU2	O[C@@H]([C@@H]1OC(=C[C@H](NC(=N)N)[C@H]1NC(C)=O)C(=O)O)[C@H](O)CO	Sequoia	SRP00400z	0.4472693	1.8789144	0.02699784	1.47796252												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	51773-92-3				-0.6956651949	4	4		0	-1.84745315				GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	1.67137476	-1.11343076	-0.94492441	-1.84745315												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263910-02	Aminopentamide sulfate	170466283	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	20701-77-3				-0.5971733071	4	4		0	0.15835313					O=S(=O)(O)O.NC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2	Microsource	01505650	0.21186441	-1.94850383	0.18898488	0.15835313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091125-07	Gallic acid	170465633	intrinsic apoptotic signaling pathway in response to oxidative stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	149-91-7				0.554627082	4	4		0	-1.05568752					Oc1cc(cc(O)c1O)C(=O)O	Vitas	STK298718	0.16478343	2.29645094	-0.18898488	-1.05568752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015989-17	Thalidomide	170465323	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	50-35-1	(?)-Thalidomide; ; (+)-Thalidomide; Sedoval; Thalidomide;Thalidomide; Thalomid;thalidomide;THALIDOMIDE; Talidomida; (-)-Thalidomide; (+/-)-Thalidomide; (R)-(+)-Thalidomide; (S)-(-)-Thalidomide; (?)-Thalidomide			3.4290059558	4	4		0	1.21404064			7124	TNF	O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O	Microsource	01503607	-0.16478343	2.99234516	0.29697624	1.21404064												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164593-02	Enalapril acid	170464938		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	76420-72-9				3.368259998	4	4		0	0.10556875					OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@H](CCc1ccccc1)C(=O)O	Sequoia	76420-72-9	0.63559322	4.38413361	-0.94492441	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094981-07	Benzyl benzoate	170465382		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	120-51-4				-0.0628338774	4	4		0	2.37529691					O=C(OCc1ccccc1)c2ccccc2	Microsource	01503002	-1.15348399	0.41753653	-0.78293736	2.37529691												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016311-19	Phentolamine mesilate	170464866	alpha-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	50-60-2	 Regitine;Phentolamine mesylate;Phentolamine;PHENTOLAMINE; ; Regitin;Phentolamine hydrochloride; Regitin mesylate; Vasomax;PHENTOLAMINE HYDROCHLORIDE; Phentolamine hydrochloride; Fentolamina;			-1.3082285281	4	4		0	0.84455001			148	ADRA1A	Cc1ccc(cc1)N(CC2=NCCN2)c3cc(O)ccc3	Vitas	STK802099	-1.34180791	-0.48712596	0.56695464	0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015399-16	Etodolac	170464915	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	41340-25-4	; ; Etodolac;Etodolac; Etodolaco; 6-OH etodolac glucuronide;ETODOLAC; Etodolac, (+-)-Isomer; Lodine; Etodolac, Monosodium Salt			-0.3340393063	4	4		0	1.37239377			5743	PTGS2	O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC	Microsource	01501005	-0.82391714	0	-0.29697624	1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022408-04	Flumethasone pivalate			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2002-29-1				-8.6163428319	4	5		0	-0.36272321					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	SIGMA	F0891	-2.74261603	-2.91459845	-2.23022579	0.48270314	-0.36272321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253670-01	Meropenem	170466350	Carbapenem Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	96036-03-2		15.8489319246	-4.8	5.1832180109	4	5		9.169530356	6.61272321	0.4332517188	0.677531996			O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@H](NC1)C(=O)N(C)C)[C@H](C)[C@@H]23)C(=O)O	GVK	FFS-12-73-NCI-194	0.65773145	-3.47460863	2.36874913	-0.29498525	6.61272321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024246-15	Daunorubicin	170465048	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	20830-81-3	 WP900 hydrochloride; Cerubidine;Daunorubicin hydrochloride; ;; Daunoblastine;DAUNORUBICIN; Daunorubicin; Daunomycin HCL; Dauno-Rubidomycine; Daunomycin, hydrochloride; Daunomycin hydrochloride; Daunoblastin; Dauno Rubidomycin;Daunomycin hydrochloride; (-)-Daunorubicin	11.220184543	-4.95	-12.4089462532	4	5		9.765941196	4.38058036	0.0927914245	0.9508753643		TOP2A	CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4	Microsource	01500223	-3.13973691	-5.63828433	-4.41889458	-4.04934299	4.38058036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015833-15	Pyrazinamide	170464703	Fatty Acid Synthase (FAS) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	98-96-4	Pyrazinecarboxamide;PYRAZINAMIDE; Pyrazinamide;Pyrazinamide; Pyrazinecarboxamide			-3.083092535	4	5		0	-0.78125			2194	FAS	NC(=O)c1cnccn1	Vitas	STK801661	-0.73219161	3.75461372	-2.83972849	-2.54759989	-0.78125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	108852-90-0				-10.8277975209	4	5		0	0.02790179				TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	-4.48001986	-0.9291078	0.54024103	-3.24483776	0.02790179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253587-01	Sitaxentan	170465720	Endothelin ETA Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	184036-34-8	Sitaxentan			-0.8477372867	4	5		0	-1.45006098				EDNRA	O=C(Cc1cc2OCOc2cc1C)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl	GVK	FFS-11-286-NCI-102	-0.34381139	0.70110701	1.9901162	-1.44121365	-1.45006098											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091449-10	Eugenol	170465464	reactive oxygen species biosynthetic process Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	97-53-0				-8.2951899567	4	5		0	-3.34821429					Oc1ccc(cc1OC)CC=C	Microsource	01500296	1.17895259	-4.95099911	-2.14711179	-4.3175114	-3.34821429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095112-05	Avobenzone	170464749	UVA ray absorber	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	70356-09-1	; ; Avobenzona; AVOBENZONE;AVOBENZONE; Shade uvaguard; Photoplex;Avobenzone; 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione			-2.237110149	4	5		0	4.53991056				CAT	COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C	Microsource	01504190	-1.32612967	-0.87330873	-2.07025511	-1.59292035	4.53991056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016504-09	Droperidol	170464722	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	548-73-2				4.9720820504	4	5		0	-1.171875					Fc1ccc(cc1)C(=O)CCCN2CC=C(CC2)N3c4ccccc4NC3=O	Microsource	01501002	1.17895259	-0.80183276	1.45449508	4.58567981	-1.171875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094614-06	4-Chloro-3,5-dimethylphenol	170465503		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	88-04-0				-6.0347327043	4	5		0	1.33928571					Oc1cc(C)c(Cl)c(C)c1	Microsource	01500182	-1.79945396	-1.87094311	-0.87269705	-2.54759989	1.33928571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021148-08	Metoprolol tartrate	170464652		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	56392-17-7				-7.5774511852	4	5		0	1.06026786					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC	Microsource	01500411	-2.14693472	-1.51457299	-2.61809115	-2.14534728	1.06026786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015202-08	Ciprofibrate	170466356	PPARalpha Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52214-84-3				-5.7117022981	4	5		0	-1.86941964				PPARA	ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1	Vitas	STK624758	-0.78183172	-3.52551865	0.12467101	-0.69723787	-1.86941964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00073457-04	Metomidate hydrochloride	170466159	Cytochrome P450 2A5 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	35944-74-2				-7.3209897686	4	5		0	-1.47879464					Cl.CC(c1ccccc1)n2cncc2C(=O)OC	Vitas	STK331722	-2.41995532	1.48911798	-2.67350048	-1.28720837	-1.47879464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091469-04	Saquinavir	225144210	protease inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	149845-06-7	Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ; Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ;saquinavir			-1.6582044024	4	5		0	1.86941964					CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4	Prestwick	Prestw-1114	-2.0476545	1.10729286	-2.67350048	2.62805042	1.86941964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017112-10	Ciclopirox	170464708	Antifungal Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	41621-49-2	; Dafnegin-CSC;Ciclopirox ethanolamine; Ciclopirox ethanolamine; Penlac;Ciclopirox; Batrafen; Loprox;ciclopirox; ciclopirox	5.0118723363	-5.3	36.124097042	2.2	5		48.086228346	39.6484375	0.0075239109	0.9962194924		CAT	CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO	Microsource	01500189	-2.24621494	-4.08552883	1.95317911	17.37731295	39.6484375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	83-79-4	;ROTENONE;Rotenone			-1.0372169743	4	5		0	0.96219			51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	2.30844794	-0.65190652	-4.42099639	-3.56510746	0.96219											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249883-01	Hydrocortamate	170465314	Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	76-47-1				0.4138759757	4	5		0	1.96503591					CCN(CC)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-02	-0.81041257	-1.85731857	-1.26886603	3.76738306	1.96503591											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179546-05	Bambuterol hydrochloride	170466370	Butyrylcholinesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	81732-46-9				-2.1805029833	4	5		0	-1.72991071					Cl.O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C	Microsource	01505173	1.55125341	-3.60188367	0.81728771	-2.60123357	-1.72991071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181911-01	Bucolome	144206890	Cytochrome P450 2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	841-73-6	Bucolome; Bucolom; Paramidine; Paramidin; Bucolomo; 			4.1648645092	4	5	Paramidine;2,4,6(1H,3H,5H)-Pyrimidnetrione, 5-butyl-1-cyclohexyl-;Barbituric acid, 5-butyl-1-cyclohexyl-;bucolome;CIPLUS_156649;LS-23912;Bucolomo;Paramidin;Bucolomum;Bucolome;bucolomum;1-cyclohexyl-5-butylbarbituric acid;Bucolom;BUCOLOME;CIPLUS_165895;	0	3.68303571					O=C2C(CCCC)C(=O)NC(=O)N2C1CCCCC1	Pharmaron	PH-NIH-95	1.00521221	1.79457808	-0.45712703	-1.98444623	3.68303571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015818-14	Praziquantel	170464906	antiparasitic agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	55268-74-1	; ; Praziquantel, (R)-Isomer; Praziquantel, (+-)-Isomer;PRAZIQUANTEL;Praziquantel; Praziquantel, (S)-Isomer; Biltricide; Praziquantel			7.5380507862	4	5		0	-1.89732143					O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4	Vitas	STK030186	-1.47679325	4.620084	4.30807591	7.80370072	-1.89732143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344542-01	Transfluthrin	225144388	Cytochrome P450 3A2 Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	118712-89-3				-11.7977382821	4	5		0	-4.15736607					CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=C(F)C(=CC(=C2F)F)F	SIGMA	46114	-2.49441549	-2.91459845	-1.37138108	-1.52855994	-4.15736607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016032-11	alpha-Lipoic acid	170465713		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1077-28-7				0.5780050361	4	5		0	-1.92522321					O=C(O)CCCCC1CCSS1	Vitas	STK801969	0.98039216	0.39455263	-0.51253636	0.40225261	-1.92522321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018194-08	Bendroflumethiazide	170465156	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	73-48-3				0.6165140947	4	5		0	1.34164521					FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)Cc3ccccc3	Microsource	01503104	-1.59626719	5.96555966	-0.84145853	-1.44121365	1.34164521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159518-05	Rabeprazole	170464736	H+/K+-ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole			3.3021608199	4	5		0	0.06775986				ATP4A	[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Microsource	01505943	-2.13654224	6.50676507	-0.30719915	4.12136536	0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263575-01	Ezetimibe	170465013	NPC1L1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	163222-33-1				13.3915305589	4	5		0	7.25030492				NPC1L1	Fc1ccc(cc1)[C@@H](O)CC[C@H]3C(=O)N(c2ccc(F)cc2)[C@@H]3c4ccc(O)cc4	Sequoia	163222-33-1	2.97151277	1.63591636	2.87164418	-0.98609355	7.25030492											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018171-06	Clidinium bromide	170464768		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3485-62-9				6.046697071	4	5		0	1.77530831					[Br-].OC(c1ccccc1)(c2ccccc2)C(=O)OC4C[N+]3(C)CCC4CC3	Microsource	01500192	2.18565815	-1.80811808	0.33391211	2.42730721	1.77530831											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016069-13	Brimonidine	170464941	Alpha-2C adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59803-98-4				-2.8691571046	4	5		0	-2.26317929			152	ADRA2C	Brc2c3nccnc3ccc2NC1=NCCN1	Enzo	AC155	-1.9891945	0.35670357	2.60451449	0.63211125	-2.26317929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 			-1.2657164907	4	5		0	1.47716493				KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	0.04911591	-2.07872079	-1.66956057	0.22756005	1.47716493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162068-06	Opipramol dihydrochloride	170465942	Serotonin 2 (5-HT2) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	909-39-7				-3.6898089393	4	5		0	-3.17039106					Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Prestwick Chemical, Inc.	Prestw-1456	-1.41423358	-0.38600423	0.94028575	1.30947185	-3.17039106											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090691-03	2',3'-Dideoxyinosine	174006954	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	69655-05-6	 Videx; Didanosina;Didanosine; ; didanosine (ddI);2',3'-Dideoxyinosine; didanosine??(ddI); 0   Didanosine; ddIno; 2',3' Dideoxyinosin; NunclonD multidishes; 2',3'-Dideoxyinosine (ddI); Inosine, 2',3'-dideoxy-	0.8912509381	-6.05	0.6000391174	4	5		-7.929835652	6.54560239	0.6484285848	0.6028836649	7015	TERT	O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1	Prestwick	Prestw-153	0.24557957	7.24477245	0.60104181	-3.69152971	6.54560239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00273481-01	Metixene hydrochloride	170465287	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1553-34-0		11.220184543	-4.95	75.4733445653	2.1	5		109.7477888023	84.4273743	0.002535696	0.9987299779			Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23	Prestwick Chemical, Inc.	Prestw-491	-0.25851581	0.41090773	3.62681646	14.34599156	84.4273743											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090749-12	Diethylstilbestrol	170464803	Estrogen Receptor (ER) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6898-97-1	; ;DIETHYLSTILBESTROL;Diethylstilbestrol; Diethylstilbesterol; pseudo-DES; (Z,E)-Diethylstilbestrol; 5   Diethylstilbestrol; Dietilestilbestrol; (E)-Diethylstilbestrol; Stilbestrol; Diethylstilbestrol [DES]	12.5892541179	-4.9	23.1125480325	3	5		45.0479781679	39.28716628	0.0025434192	0.9987268084	2099	ESR1	Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2	Microsource	01500244	-1.44891945	-0.84870849	-2.65794043	-1.59292035	39.28716628											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095125-05	Losartan	170465135	Angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	114798-26-4				11.7452495198	4	5		0	7.46713647					OCc4c(Cl)nc(CCCC)n4Cc1ccc(cc1)c2ccccc2c3nnnn3	Microsource	01504268	2.38212181	0.89790898	2.73807934	-1.13780025	7.46713647											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine			7.2356844866	4	5		0	4.70253422			84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	-3.70825147	-0.65190652	0.97502337	2.80657396	4.70253422											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00249910-01	Ibafloxacine	170466478	Bacterial DNA gyrase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	91618-36-9				-6.730039503	4	5		0	-2.86312849					O=C(O)C3=CN1c2c(cc(F)c(C)c2CCC1C)C3=O	GVK	FFS-11-286-NCI-148	-1.38381995	-1.68098618	0.79374771	-2.00785683	-2.86312849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091533-10	Ethinylestradiol	170464983	Estrogen Receptor (ER) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-63-6	;ETHINYL ESTRADIOL; Minulet; Ovulen 50; Conova 30; Oviol; Ovoresta M; Ovostat; Serial C; Varnoline;Ethinyl Estradiol; ; Trikvilar; Desogen (contraceptive); Practil 21; Yermonil (CIBA); Ministat; Oraconal; Mircette; Modicon; Valdys;17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol; Cilest; Novacyclin 22;Ethinylestradiol; Ethinyl estradiol;Ethinyl estradiol; Ortho-Cept; Fisioquens; Femovan; Diane-35; Etinilestradiol; Ethynyl estradiol; Femodene; Gynatrol; Diane; Lestrin; Tri-Ervonum; Bisecurin II; Ovulen-50; Ovidol;17alpha-Ethynylestradiol; Estinyl; Oracon; Demulen; Triregol			-1.0665666481	4	5		0	1.94134078			2099	ESR1	Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick	Prestw-1405	-1.29257908	1.90511767	-1.23336183	-0.84388186	1.94134078											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182989-01	Glyclopyramide	144206854		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	631-27-6	Glyclopyramide; Deamelin-S; Gliclopiramida; 			-1.7814254652	4	5	glyclopyramidum;1-(p-chlorobenzenesulfonyl)-3-pyrrolidin-1- ylurea;Glyclopyramide;CIPLUS_214070;GLYCLOPYRAMIDE;Deamelin-S;glyclopyramide;Gliclopiramida;Glyclopyramidum;	0	-0.74535845					O=C(NS(=O)(=O)c1ccc(Cl)cc1)NN2CCCC2	Pharmaron	PH-NIH-169404	-1.12966601	-0.03690037	1.05516228	0.22756005	-0.74535845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015860-06	Prilocaine hydrochloride	170464697	reactive oxygen species biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1786-81-8				-1.4885465016	4	5		0	-3.58938547					Cl.O=C(Nc1ccccc1C)C(C)NCCC	Microsource	01503270	-1.38381995	-2.20395966	4.99450482	2.58984432	-3.58938547											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090749-12	Diethylstilbestrol	170464803	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	6898-97-1	; ;DIETHYLSTILBESTROL;Diethylstilbestrol; Diethylstilbesterol; pseudo-DES; (Z,E)-Diethylstilbestrol; 5   Diethylstilbestrol; Dietilestilbestrol; (E)-Diethylstilbestrol; Stilbestrol; Diethylstilbestrol [DES]	4.4668359215	-5.35	39.5244192045	3	4		38.3206455469	36.12073231	0.02814615	0.9995115125	2099	ESR1	Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2	Microsource	01500244	-0.67665539	0.32067094	0.8908686	36.12073231												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167832-06	Carvedilol tartrate	170465440	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	NOCAS_45916	; carvedilol, 14C-labeled; 8   Carvedilol;Carvedilol; Coreg; carvedilol, (S)-isomer; Carvedilol; carvedilol, (R)-isomer	12.5892541179	-4.9	102.5261481991	3	4		118.0960122387	95.2498763	0.0280251423	0.9995152776	153	ADRB1	O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23	Microsource	01504257	-0.09666506	0.41933892	-1.97263761	95.2498763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183025-01	Biliscopin	144206809		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51022-74-3	Iotroxic acid; Acido iotroxico; 			-2.1343629716	4	4	Acido iotroxico;3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino)bis(2,4,6-tri iodobenzoic acid));iotroxic acid, calcium salt;iotroxic acid;BENZOIC ACID, 3,3'-(OXYBIS(2,1-ETHANEDIYLOXY(1-OXO-2,1-ETHANEDIYL)IMINO))BIS(2,4,6, TRIIODO-;SH 213 AB;acidum iotroxicum;3,3'-(3,6,9-TRIOXAUNDECANEDIOYLDIAMINO)BIS(2,4,6-TRIIODOBENZOIC ACID);IOTROXIC ACID;Iotroxic acid;3,3'-(OXYBIS(ETHYLENEOXYMETHYLENECARBONYLIMINO))BIS(2,4,6-TRIIODOBENZOIC ACID);Iotroxic Acid;iotroxinate;iotroxic acid, magnesium salt;CIPLUS_180821;Acide iotroxique;Acidum iotroxicum;acide iotroxique;	0	-1.4349332					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Pharmaron	PH-NIH-120888-3	0.28999517	-0.61667489	-0.63633471	-1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018107-05	2-Thiosalicylic acid	170465571	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	147-93-3				0.2365444659	4	4		0	-0.73898126					OC(=O)c1ccccc1S	SIGMA	T33200	-0.07062147	0.83507307	0.56695464	-0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159373-04	Thymol	170465504	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	89-83-8				1.0677509649	4	4		0	-0.10556875			231	AKR1B1	CC(C)c1ccc(C)cc1O	Labotest	LTBB001943	0.58851224	-0.55671538	0.45896328	-0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015257-14	Clofibrate	170465329	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	637-07-0	 ; Aluminium clofibrate; Miscleron; Athromidin; Atromid-S; Atromid S; Miskleron; Clofibrate;Clofibrate; Clofibrato; Atromid;CLOFIBRATE			6.2869809005	4	4		0	2.00580628			5465	PPARA	Clc1ccc(OC(C)(C)C(=O)OCC)cc1	Microsource	01503429	0.49435028	2.22686152	1.53887689	2.00580628												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165976-02	Squalane	170465658		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	111-01-3				-4.7359750172	4	4		0	-1.05392157					CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C	SIGMA	234311	-1.33568548	0.15444015	-0.9233352	-1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178830-05	Isosorbide dinitrate	170464980		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	87-33-2				-1.7744143158	4	4		0	-0.22058824					[O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+]([O-])=O)CO[C@H]12	Microsource	01500358	-1.18447581	0.20592021	1.81869054	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016686-13	Pimaricin		Anti-fungal	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7681-93-8				6.4090624411	4	4		0	5.90686274					C[C@@H]1O[C@@H](O[C@H]2C[C@@H]3O[C@@](O)(C[C@@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]4O[C@@H]4C=CC(=O)O[C@@H](C)CC=CC=CC=CC=C2)[C@H](O)[C@H](N)[C@@H]1O	Enzo	NP232	-0.63004032	-0.51480051	-0.86737549	5.90686274												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00018181-12	Nalidixic acid	170465215	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	389-08-2	; Negram-Citrat;NALIDIXIC ACID; Sodium, Nalidixat; Nevigramon; Acid, Nalidixi; Acido nalidixico; Nalidixic acid sodium; Mictral;Nalidixic acid; NegGram; Prestwick-03C08			1.6143245973	4	4		0	0.76295712					O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O	Vitas	STK735579	0	-1.05395232	1.44413479	0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090874-06	Piperonyl butoxide	170464741		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51-03-6				-3.3732526799	4	4		0	-2.02578269					CCCc1cc2OCOc2cc1COCCOCCOCCCC	SIGMA	45626	0	-1.30489335	-0.22802128	-2.02578269												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249885-01	Estradiol acetate	170465258		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4245-41-4		14.1253754462	-4.85	6.705291822	4	5		11.981509156	10.0698324	0.389138207	0.7230114019			CC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	GVK	FFS-11-286-NCI-18	-0.77554745	-2.90125763	4.62815973	-0.84388186	10.0698324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166020-03	Ethyl 3-aminobenzoate methanesulfonic acid salt	170465717	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	886-86-2				-7.6558409894	4	5		0	-1.91340782					Nc1cc(ccc1)C(=O)OCC.CS(=O)(=O)O	Vitas	STK344228	-4.66849148	0.93388121	-1.67297594	4.21940928	-1.91340782											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159336-03	Sulbactam	170465248	beta-Lactamase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68373-14-8	; Sultamicillin (base); B??tamaze; Sodium Sulbactam; Penicillanic Acid Sulfone; Sodium, Sulbacta; Combactam; Sulfone, Penicillanic Aci;Sulbactam sodium;Sulbactam			-5.9056702248	4	5		0	-3.0027933				bla	O=S2(=O)C(C)(C)[C@@H](N1C(=O)C[C@H]12)C(=O)O	Vitas	STK801889	-2.84367397	-1.1829162	1.45316888	2.03695621	-3.0027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163700-12	Vincristine sulfate	404904683		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	[2068-78-2]				-0.8698390958	4	5		0	3.05865922					CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Tocris	1257	-1.4446472	1.93002117	-3.45585542	0.84388186	3.05865922											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016590-06	Azaperone	170465697		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1649-18-9				8.6217107134	4	5		0	3.15290179					Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3	Vitas	STK802185	3.9091586	-0.90365279	-0.29089902	-0.21453473	3.15290179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181010-02	Mabuterol hydrochloride	170465921	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54240-36-7				4.6600231699	4	5		0	-2.55586592					Cl.Nc1c(cc(cc1Cl)C(O)CNC(C)(C)C)C(F)(F)F	Bosche	M5723	1.6879562	6.28813348	-0.23201856	-1.1348756	-2.55586592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181337-03	2,4-Dichlorobenzyl alcohol	170465574		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1777-82-8				0.6746383759	4	5		0	-0.1953125					OCc1ccc(Cl)cc1Cl	Bosche	D0540	0.83147183	-1.33638793	0.70646904	-0.40225261	-0.1953125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015693-09	Mitoxantrone	170465183	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	70476-82-3	 ;Mitoxantrone; Mitoxantrone Hcl; Mitoxantrone; Mitozantrone;MITOXANTRONE HYDROCHLORIDE; Mitoxantrone dihydrochloride;Mitoxantrone dihydrochloride; Mitoxantrona;Mitoxantrone di?HCl;MITOXANTHRONE HYDROCHLORIDE	7.9432823472	-5.1	-11.6150484937	4	5		13.151775484	7.58928571	0.0676564249	0.9646316874	7153	TOP2A	Cl.Cl.OCCNCCNc3ccc(NCCNCCO)c2C(=O)c1c(O)ccc(O)c1C(=O)c23	Microsource	01503278	-3.43757756	-6.37647957	-4.91757861	-4.3175114	7.58928571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159459-04	Mycophenolate mofetil	170464859	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	5.0118723363	-5.3	19.0944784402	4	5		23.97926784	21.01955307	0.0009979531	0.9995019999	727833	IMPDH1	Oc3c1C(=O)OCc1c(C)c(OC)c3C\C=C(/C)CCC(=O)OCCN2CCOCC2	Sequoia	115007-34-6	-0.89720195	-1.2327232	-0.15874954	8.61341481	21.01955307											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164555-03	Entacapone	170464850	NCI-H1299 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	130929-57-6				-5.6758988535	4	5		0	2.3603352					Oc1cc(\C=C(/C#N)C(=O)N(CC)CC)cc([N+]([O-])=O)c1O	Sequoia	SRP10885e	-2.99574209	-2.72693313	0.67163268	-0.64018624	2.3603352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167453-02	Clinofibrate	174007296	treatment of lipoprotein diseases	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	30299-08-2	 ; Lipoclin;Clinofibrate; Clinofibrate; Clinofibrato			-7.7421375031	4	5		0	1.42299107				HMGCR	O=C(O)C(C)(CC)Oc1ccc(cc1)C2(CCCCC2)c3ccc(OC(C)(CC)C(=O)O)cc3	Selleck	S2664	-2.64333582	-4.82372407	-2.3964538	1.6358273	1.42299107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163736-04	Imidacloprid	170465741		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	138261-41-3				3.9954985463	4	5		0	-2.52793296					[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1	Vitas	STK786692	2.29622871	-0.98368821	3.45585542	-0.14549687	-2.52793296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016611-10	Bufexamac	170465813	non-steroidal antiinflammatory	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2438-72-4	; ; 7   Bufexamac; Anderm; Droxarol; Bufexamaco;BUFEXAMAC; Bufexamac;Bufexamac			-3.6047908219	4	5		0	-4.70670391				PTGS1	ONC(=O)Cc1ccc(OCCCC)cc1	Microsource	01502003	0.56265207	0.58523223	-0.42740261	-1.77506184	-4.70670391											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015856-10	Prochlorperazine dimaleate	170464761	Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	84-02-6	; ;Prochloperazine dimaleate; Proclorperazina; Prochlorperazine dimaleate; Compazine syrup;Prochlorperazine; Compro; Compazine;Prochlorperazine dimaleate; Maleate, Prochlorperazin	12.5892541179	-4.9	46.9233997769	3	5		77.1053296903	66.82960894	0.0091891062	0.9953748306	1813	DRD2	O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Prestwick Chemical, Inc.	Prestw-399	-2.87408759	1.33233719	2.28355111	-0.32009312	66.82960894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016283-04	Diphemanil methylsulfate	170464876	antimitotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	62-97-5	 Vagophemanil; ; Diphemanil; Prantal;Diphemanil methylsulfate; Diphemanil methylsulfate			10.9309395044	4	4		0	3.0255196					[O-]S(=O)(=O)OC.C[N+]1(C)CC\C(CC1)=C(\c2ccccc2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-79	1.59806295	2.65997491	2.66024829	3.0255196												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018097-06	Paroxypropione	170465896	Succinate semialdehyde dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	70-70-2				3.5083555281	4	4		0	2.42454231					O=C(CC)c1ccc(O)cc1	Labotest	LT00855519	0.53165781	0.5673409	-0.50906777	2.42454231												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015439-11	Flumazenil	170464960	GABA(A) BZ Site Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	78755-81-4	 Lanexat; Anexate; Romazicon; ; Ro- 15-1788; Flumazenil;Flumazenil; Roche Brand of Flumazenil;FUMAZENIL; Ro 15178;FlUMAZENIL; Ro 15-1788; Ro 15 178			1.0919561375	4	4		0	0.39584364			2554	GABRA1	O=C(OCC)c3ncn2c3CN(C)C(=O)c1cc(F)ccc12	Microsource	01505701	-0.96665056	1.40601875	1.39993637	0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018204-13	Vinpocetine	170465859	Na channel blocker, also PDE1, IKK inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	42971-09-5	;Vinpocetine; Cavinton			-0.2753475417	4	4		0	1.63285502					O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC	Prestwick Chemical, Inc.	Prestw-268	-0.38666022	0.07400099	-1.3363029	1.63285502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344378-02	Norgestrel		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	6533-00-2				-1.3534378071	4	4		0	1.52817574				CYP19A1	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CCC34)[C@@H]1CC[C@@]2(O)C#C	Cayman	10006319	-0.84309133	-0.49031053	0	1.52817574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262588-02	Merbromin	225144359		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	129-16-8				-2.1973368755	4	4		0	-0.76408787					O.O.O.[Na+].[Na+].O[Hg]C1=C([O-])C(=CC2=C1OC3=CC(=C(Br)C=C3C24OC(=O)C5=CC=CC=C45)[O-])Br	Prestwick	Prestw-787	-1.63934426	1.70441279	1.95811803	-0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179499-05	Dipivefrin hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	64019-93-8				0.1453870461	4	4		0	3.10410697					CNCC(O)C1=CC(=C(OC(=O)C(C)(C)C)C=C1)OC(=O)C(C)(C)C	Prestwick	Prestw-632	-0.46838407	-0.9105767	-0.48952951	3.10410697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183873-03	GranisetronHCl			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	107007-99-8				-3.0484426078	4	4		0	-1.57593123					CN1N=C(C(=O)NC2C[C@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4	Enzo	DL166	-0.46838407	-0.9105767	-0.05439217	-1.57593123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183839-01	Rapacuronium bromide	144206855	Muscarinic acetylcholine receptor M5 Negative Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	156137-99-4				-5.700762621	4	4	rapacuronium bromide;rapacuronium;RAPACURONIUM BROMIDE;Rapacuronium Bromide;RAPACURONIUM;Org-9487;rapacuronii bromidum;ORG-9487;Raplon;LS-173498;bromure de rapacuronium;CIPLUS_755198;Org 9487;1-(3A-(ACETYLOXY)-17B-(1-OXYPROPOXY)-2B-(1-PIPERIDINYL)-5A-ANDROSTAN-16B-YL)-1-(2-PROPENYL)PIPERIDINIUM BROMIDE;1-ALLYL-1-(3.ALPHA.,17.BETA.-DIHYDROXY-2.BETA.-PIPERIDINO-5.ALPHA.-ANDROSTAN-16.BETA.-YL)PIPERIDINIUM BROMIDE, 3-ACETATE 17-PROPIONATE;Organon brand of rapacuronium bromide;	0	-0.31862745					[Br-].C=CC[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(=O)CC	Pharmaron	PH-NIH-169871	-1.89012097	-0.15444015	-0.75545607	-0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183854-01	Oxendolone	144206842		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	33765-68-3				3.9025896442	4	4	16 ethyl-17-hydroxy-4-estren-3-one;oxendolone;16-beta-Ethyl-19-nortestosterone;NE-19595;Oxendolonum;oxendolonum;(16 beta,17 beta)-16-ethyl-17-hydroxyestr-4-en-3-one;16 beta-ethyl-19-nortestosterone;CIPLUS_178076;Oxendolona;16 beta-ethyl-17 beta-hydroxyestr-4-en-3-one;TSAA291;LS-64849;Oxendolone;OXENDOLONE;EHOO;Prostetin;TSAA-291;TSAA 291;PROSTETIN;16B-ETHYL-17B-HYDROXYESTR-4-EN-3-ONE;	0	3.30882353					CC[C@H]2C[C@H]3[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@]3(C)[C@H]2O	Pharmaron	PH-NIH-152939	0.22681452	1.13256113	0.08393956	3.30882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015889-11	Raloxifene hydrochloride	170465341	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	82640-04-8	 ; Keoxifene;Evista; Raloxifene Lilly Bran; Evista;RALOXIFENE HYDROCHLORIDE; Lilly Brand of Raloxifene; Raloxifene hydrochloride;Raloxifene hydrochloride	2.2387211386	-5.65	60.4829295534	3	4		48.878006699	4.63235294	1	0.9990722288	2099	ESR1	Cl.Oc1ccc(cc1)c3sc2cc(O)ccc2c3C(=O)c5ccc(OCCN4CCCCC4)cc5	Microsource	01505622	-1.48689516	0.77220077	44.06827084	4.63235294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025000-14	Ketoconazole		Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	13463-41-7	; ; Ketoconazol; Nizoral;Ketoconazole; Ketoconazole; Ketocanazole			0.5851670099	4	4		0	0.31862745			1588	CYP19A1	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@@](C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	SIGMA	K1003	-0.12600806	1.54440154	-0.58757694	0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162247-06	Levallorphan	170465778	Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	152-02-3				-2.2492721952	4	4		0	-1.25			4988	OPRM1	Oc3ccc4C[C@H]1N(CC[C@@]2(CCCC[C@@H]12)c4c3)CC=C	SIGMA	L121	-0.37802419	-0.36036036	-0.13989927	-1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263961-02	Ceftriaxone disodium trihydrate	170465387	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	104376-79-6				2.5888965177	4	4		0	5.18284662			9376	SLC22A8	[Na+].[Na+].O.O.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC2=NC(=O)C([O-])=NN2C)CS[C@@H]34)C([O-])=O	Microsource	01503111	-1.6464891	-0.25094103	0.12667849	5.18284662												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024504-09	Kainic acid	170465818	Glutamate receptor ionotropic kainate 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	487-79-6				4.0668326803	4	4		0	1.08857001					CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O	Enzo	EA123	-0.14499758	-0.46867292	3.3089405	1.08857001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166144-03	2,3-Dihydroxypropyl octanoate	170465212		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	502-54-5				-4.4237941374	4	4		0	0.52531041					OCC(O)COC(=O)CCCCCCC	SIGMA	M2265	-1.59250585	-0.25682933	-0.81588251	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165767-04	Cyclofenil	170465970	Estrogen receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2624-43-3				0.3535014237	4	4		0	3.65196078			2100	ESR2	CC(=O)Oc1ccc(cc1)C(/c2ccc(OC(C)=O)cc2)=C3/CCCCC3	Tocris	3999	-1.73891129	0.46332046	2.49020705	3.65196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164524-02	D-Glucuronolactone	50111689		DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			-3.8307880598	4	4	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	-0.26960784					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	-1.28528226	-0.92664093	0.86737549	-0.26960784												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164559-03	Duloxetine hydrochloride	170465319	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	136434-34-9	 ; Duloxetine hydrochloride;Duloxetine hydrochloride; Cymbalta;DULOXETINE HYDROCHLORIDE;Duloxetine HCl; DULOXETINE HCl; 0   Duloxetine Hcl	8.9125093813	-5.05	57.5843144397	3	4		79.0561435375	75.66176471	0.0170430223	0.9998208262	6532	SLC6A4	Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3	Sequoia	SRP05005d	-0.07560484	-1.18404118	2.93788472	75.66176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159511-04	Butenafine	170465093	Trichophyton mentagrophytes Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	101828-21-1				3.1670310934	4	4		0	7.57352941					CN(Cc1ccc(cc1)C(C)(C)C)Cc3cccc2ccccc23	Bionet	KS-1035	-0.63004032	-0.56628057	-0.69949636	7.57352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181029-01	1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine	144206232	Apolipoprotein A-I Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	18656-38-7	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 			-0.5314106566	4	4	L-beta,gamma-Dimyristoyl-alpha-lecithin;L-LECITHIN, BETA,GAMMA-DIMYRISTOYL;DL-beta,gamma-Dimyristoyl-alpha-lecithin;9   Dimyristoyl-L-3-Lecithin;3-sn-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Dimyristoyl-sn-glycero-3-phosphocholine;1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine;Dimyristoylphosphatidylcholine;1,2-Dimyristoyl-rac-glycero-3-phosphocholine;DMPC;CIPLUS_670039;DL-alpha-Dimyristoyl-phosphatidylcholine;CIPLUS_168945;rac-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine;DIMYRISTOYL LECITHIN;DIMYRISTOYL PHOSPHATIDYLCHOLINE;1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE;CIPLUS_664335;3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, inner salt, 4-oxide;	0	0.56372549					C[N+](C)(C)CCOP([O-])(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC	SigmaAldrich	P7930	-0.27721774	-0.15444015	-0.19585898	0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022848-17	Hydrocortisone	170464635	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	50-23-7	 Hydrodexan; Proctosedyl ointment; Hydrocortisone Valerate; Hydrocortisone Buteprate; Acticort; Hydrocortisone Probutate; 11 Epicortiso;Calmurid-HC; ; Hidrocortisona; Reichstein's substance M; Hydrocortisone Caproate; Cortril; Hydrocortisone solution; Daktacort; Hydrocortisone Tebutate; 17-Hydroxycorticosterone; Hydrocortisone base; Hydrocortisone; Epicortisol; Kendall's compound F; Alphaderm; Hydrocortisone Base; Proctosedyl suppository; Canesten HC; oxycort A;Hydrocortisone; 11-Epicortisol; Cortifair			-2.2095632905	4	4		0	0.95588235			5743	PTGS2	OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Prestwick Chemical, Inc.	Prestw-447	-0.83165323	0.61776062	-1.76273083	0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016023-18	Theobromine	170465487	Phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	83-67-0	; ;Theobromine; Limptar; Theobromine;THEOBROMINE; 3,7-Dimethylxanthine			2.692962606	4	4		0	-0.22058824			5141	PDE4A	Cn1cnc2c1C(=O)NC(=O)N2C	Microsource	01500649	0.02520161	1.33848134	2.65808618	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092386-13	Sertraline hydrochloride	170465121	Selective Seratonin Reuptake Inhibitor (SSRI)	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	79559-97-0				-4.5962461753	4	4		0	-1.7100763				SLC6A4	Cl.Clc1ccc(cc1Cl)[C@@H]3CC[C@H](NC)c2ccccc23	Microsource	01505262	-0.53268765	-1.7565872	-0.48137826	-1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00247735-02	Varenicline tartrate	174007164	Nicotinic alpha3beta4 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	230615-23-3	Varenicline dihydrochloride;Varenicline tartrate			-1.6339331049	4	4		0	-0.02630887			1136	CHRNA3	Cl.c1c4c(cc2nccnc12)C3CC4CNC3	Selleck	S1440	-0.8716707	-0.40150565	0.27869268	-0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164612-02	Propyphenazone	170465821	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	479-92-5				-3.8190886806	4	4		0	-0.60510392					CC(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Specs	AE-562/J258456	-0.6779661	-0.8531995	-1.2414492	-0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015243-10	Clemizole hydrochloride	170465924	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1163-36-6				5.3357633253	4	4		0	4.91975796				HRH1	Cl.Clc1ccc(cc1)Cn3c4ccccc4nc3CN2CCCC2	Microsource	01505990	-0.82324455	-0.75282309	1.90017735	4.91975796												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022579-05	Carbenicillin disodium	170465106	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	4800-94-6				0.921702002	4	4		0	-0.44725072					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(c1ccccc1)C([O-])=O)[C@H]3SC2(C)C	Microsource	01500160	0.6779661	-0.65244667	0.58272105	-0.44725072												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023217-08	Meclofenamate sodium	170464886	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	6385-02-0				2.1035176286	4	4		0	-1.28649184					[Na+].O.Clc2ccc(C)c(Cl)c2Nc1ccccc1C([O-])=O	Microsource	01500377	0.04833253	-1.20868278	4.07254216	-1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00509863-01	Naloxegol (oxalate)		Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1354744-91-4				-0.0227112475	4	4		0	-0.52531041			4988	OPRM1	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC=C	MedChem Express	HY-A0118A	-0.6088993	1.937894	0.81588251	-0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378936-02	Letermovir		Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	917389-32-3				-3.4742585342	4	4		0	0.66857689			3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-1.31147541	-0.35022181	-0.54392168	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261969-01	Alatrofloxacin mesylate	170465095		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	146961-77-5	Alatrofloxacin mesylate;Cp-116,517;Cp 116517;Cp			-0.0894148952	4	4		0	0.0245098					CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@]2(C)[C@@H]1CN(C[C@@H]12)c3nc4c(cc3F)C(=O)C(=CN4c5ccc(F)cc5F)C(=O)O	GVK	FFS-11-286-NCI-04	-1.58770161	-0.25740026	5.9037493	0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016572-12	Sulfamonomethoxine	170465768		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1220-83-3				6.642580605	4	4		0	0.95588235					O=S(=O)(Nc1cc(OC)ncn1)c2ccc(N)cc2	Microsource	01501147	1.43649194	3.03732304	0.19585898	0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181044-04	Selenomethionine		dietary supplement	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	3211-76-5				-2.3105430246	4	4		0	-0.6127451				CAT	C[Se]CC[C@H](N)C(O)=O	Enzo	RD122	-0.32762097	-0.46332046	-0.86737549	-0.6127451												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015830-08	Phenelzine	170465229	MAO Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	156-51-4	 ;PHENELZINE SULFATE;Phenelzine sulfate; Phenelzine sulfate; 2-Phenelzine; Nardil;Phenylethylhydrazine sulfate; Phenylethylhydrazine sulfate; Fenelzina; Felazine			-2.1348441471	4	4		0	-0.80882353			4128	MAOA	O=S(=O)(O)O.NNCCc1ccccc1	Microsource	01500476	-0.68044355	0.77220077	-0.47565753	-0.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261973-01	Butoctamide semisuccinate	170466034		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	32838-28-1	Butoctamide hydrogen succinate, monosodium salt;Butoctamide			-5.4099312898	4	4		0	-0.51470588					CC(CC(=O)NCC(CC)CCCC)OC(=O)CCC(=O)O	GVK	FFS-11-286-NCI-226	-1.78931452	-1.18404118	0.53161724	-0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159370-04	Docosanol	124892111	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	661-19-8	; ; Tadenan;DOCOSANOL; Docosanol (Abreva); Abreva; Doconsanol; 1-Docosanol			-2.5974432059	4	4		0	-0.55248619					CCCCCCCCCCCCCCCCCCCCCCO	Labotest	LTBB001507	0.7748184	-0.40150565	-0.83607803	-0.55248619												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00015898-15	Rolipram	170465962	Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	61413-54-5	; ;Rolipram; Rolipram; (R)-(+)-Rolipram; (S)-(-)-Rolipram			3.8730308256	4	4		0	1.68233548			5141	PDE4A	COc2ccc(cc2OC1CCCC1)C3CC(=O)NC3	Prestwick Chemical, Inc.	Prestw-924	0.24166264	-0.22200296	1.65447025	1.68233548												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159331-07	CHOLECALCIFEROL		Vitamin D receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	67-97-0				0.376933612	4	4		0	0.49480455					CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	C9756	-0.43499275	-0.41933892	0.8908686	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	83-79-4	;ROTENONE;Rotenone	11.220184543	-4.95	12.6257812436	4	4		14.1872224999	12.51855517	0.1883431597	0.9776263206	51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	0.72498792	-1.40601875	-1.39993637	12.51855517												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181915-01	Mepranoprofen arbamel	144206887		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	118635-52-2	Y-23023; 			0.9285401542	4	4	N,N-DCDBPA;CIPLUS_747910;N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-1-benzopyrano(2,3-b)pyridine-7-acetate;LS-172989;Tilnoprofen Arbamel;TILMICOSIN PHOSPHATE;Mepranoprofen Arbamel;Mepranoprofen arbamel;CIPLUS_741518;TILNOPROFEN ARBAMEL;Y-23023;CIPLUS_3889595;Tilnoprofen arbamel;Tilmicosin Phosphate;Tilmicosin phosphate;tilnoprofenum arbamelum;THYMOSTIMULIN TILNOPROFEN ARBAMEL;Y 23023;MEPRANOPROFEN ARBAMEL;	0	0.34636319					CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1	Pharmaron	PH-NIH-7	-0.09666506	0.46867292	0.38180083	0.34636319												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018249-05	Ethoxzolamide	170465083	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	452-35-7				1.449129321	4	4		0	-0.09896091					NS(=O)(=O)c1nc2ccc(cc2s1)OCC	Labotest	LT00453128	0.57999033	-0.07400099	0.50906777	-0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095187-08	RAMELTEON			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	196597-26-9				4.3069816394	4	4		0	0.85959885					CCC(=O)NCC[C@@H]1CCC2=C1C3=C(OCC3)C=C2	Microsource	01505817	1.92037471	-0.95727294	-0.81588251	0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346456-05	Macitentan		Endothelin ETA/ETB Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	441798-33-0				3.7247875745	4	4		0	0.07352941				EDNRA	CCCN[S+]([O-])(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3	Glixx	GLXC-90056	0.78125	1.08108108	1.31505316	0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249936-01	Iocarmic acid	170465965		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	10397-75-8				0.5471893737	4	5		0	4.78701826					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)O)C(=O)NC)CCCCC(=O)Nc2c(I)c(C(=O)NC)c(I)c(C(=O)O)c2I	GVK	FFS-11-286-NCI-245	-0.95238095	-0.6068268	-1.77646188	0.57430007	4.78701826											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016354-11	Butylparaben	170465688		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	94-26-8				3.322114627	4	5		0	-1.70385396					Oc1ccc(cc1)C(=O)OCCCC	Microsource	01505995	3.2967033	-1.1630847	-0.14803849	-0.86145011	-1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094572-12	Amitraz	170465703		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	33089-61-1				2.5517821842	4	5		0	0.97363083					Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2	Microsource	01505299	1.58730159	-0.2022756	-0.39476931	-1.00502513	0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262939-01	Cycotiamine	170465848		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	6092-18-8	Cycotiamine;Cicotiamina;Cycotiaminum;Cycothiamine			2.3388043864	4	5		0	1.54158215					O=C1OCC\C(S1)=C(/C)N(C=O)Cc2cnc(C)nc2N	GVK	FFS-11-286-NCI-198	1.05006105	0	-1.18430792	0.09571668	1.54158215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015429-14	Felbamate	170465178	GABA(A) Receptor Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	25451-15-4	 Taloxa;; Felbamyl; ; Essex brand of felbamate;FELBAMATE; Felbatol;Felbamate; Felbamate			1.6801504802	4	5		0	-0.0811359			2554	GABRA1	NC(=O)OCC(COC(N)=O)c1ccccc1	SIGMA	F0778	0.41514042	1.1630847	-0.44411547	0.67001675	-0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179582-03	Bacampicillin hydrochloride	170465170		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	37661-08-8				0.0068307161	4	5		0	2.75862069					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]3C(=O)N2[C@@H](C(=O)OC(C)OC(=O)OCC)C(C)(C)S[C@@H]23	Prestwick Chemical, Inc.	Prestw-416	-0.51282051	-1.3147914	-0.83888478	0.57430007	2.75862069											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167434-02	Pemirolast potassium	170465431		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	100299-08-9				-2.311211169	4	5		0	-1.62271805					[K+].CC3=CC=CN1C3=NC=C(C1=O)c2[n-]nnn2	Bosche	P2486	0.21978022	-0.2528445	-0.24673082	-0.86145011	-1.62271805											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00163798-06	Triethylene glycol			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	112-27-6				-0.5820212976	4	5		0	3.0020284					OCCOCCOCCO	SIGMA	T59455	-0.70818071	-0.8596713	-0.39476931	-0.90930845	3.0020284											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159476-09	Tribromsalan	170465542		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	87-10-5		8.9125093813	-5.05	25.5620513945	2.4	5		30.1068268001	27.42393509	0.0134759363	0.9932051388			Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2	SIGMA	R416568	1.88034188	-0.505689	-0.44411547	3.20650873	27.42393509											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015649-08	Moxonidine hydrochloride hydrate	170466534	Imidazoline I1 Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	75438-57-2	 Zint; ; Moxon; MOXONIDINE HCl; Cynt;Moxonidine; Moxonidine; Lilly brand of moxonidine; Physiotens; Normatens;Moxonidine hydrochloride; Moxonidine hydrochloride			0.0607491661	4	5		0	1.37931034			11188	NISCH	COc2nc(C)nc(Cl)c2NC1=NCCN1	Prestwick	Prestw-1016	0.46398046	-1.2642225	-0.49346163	-0.86145011	1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015716-09	Nylidrin	170465637	Glutamate NMDA receptor; Grin1/Grin2c Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	447-41-6				8.5147408352	4	5		0	3.24543611					OC(c1ccc(O)cc1)C(C)NC(C)CCc2ccccc2	Specs	AO-080/40212238	2.36874237	0.4551201	0.29607698	1.67504188	3.24543611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015122-11	Bupropion hydrochloride	170464747	Dopamine Transporter (DAT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	31677-93-7	; ;Bupropion hydrochloride; 3   Bupropion Hcl; Bupropion hydrochloride; Bupropine HCl; Amfebutamonum;BUPROPION; Amfebutamona; Bupropion hydrocloride;Bupropion?HCl; Wellbutrin			-1.4728248719	4	4		0	0.13154433			6531	SLC6A3	Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C	Microsource	01504174	-0.62953995	-0.30112923	-0.22802128	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	10	-5	35.1437158028	3	4		33.5776539119	32.01789003	0.033312513	0.9993157225			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	0.43583535	-0.40150565	-0.48137826	32.01789003												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095304-05	Furazolidone	170464641	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	67-45-8				0.0188612155	4	4		0	0.39463299					[O-][N+](=O)c2oc(/C=N/N1CCOC1=O)cc2	Vitas	STK388219	-0.7748184	-0.70263488	1.44413479	0.39463299												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015089-17	Amiloride hydrochloride	170465124	Epithelial Sodium Channels (ENaC) Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2609-46-3	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren			-1.266681782	4	4		0	-0.39584364			6339	SCNN1D	Clc1nc(C(=O)NC(=N)N)c(N)nc1N	Enzo	CA200	-0.62832286	-0.76467686	0.82723513	-0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165912-03	Tofisopam			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	22345-47-7				0.130432304	4	4		0	-0.33428844					CCC1\C(=N/N=C(C2=CC(=C(OC)C=C2)OC)\C3=C1C=C(OC)C(=C3)OC)C	SIGMA	T8200	0.37470726	-0.77048798	-0.05439217	-0.33428844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509862-02	Fluralaner			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	864731-61-3		11.220184543	-4.95	20.2174802391	3	4		39.0737704919	30.65902579	0.0265617845	0.9995651501			CC1=C(C=CC(=C1)\C2=N\OC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F	MedChem Express	HY-16973	-1.31147541	-0.53700677	1.46858852	30.65902579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00027930-07	Moclobemide	170465663	Monoamine oxidase A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	71320-77-9				-1.3605732331	4	5		0	-0.89249493					Clc1ccc(cc1)C(=O)NCCN2CCOCC2	Vitas	STK222240	0.65934066	-0.4551201	-1.23365408	-1.05288346	-0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015209-11	Cyclophosphamide	170464624	Bcl-2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	6055-19-2	Cytophosphane;Endoxan;Neosar; Neosar; ; Sendoxan;Clafen;Revimmune; Cyclophosphane; Ciclophosphamide; Endoxon; Ciclofosfamida; (+-)-Cyclophosphamide; Cyclophosphamide; Cytoxan; Cytophosphan; Procytox;Cyclophosphamide;Cyclophosphamide monohydrate; Endoxan; (-)-Cyclophosphamide; Cytoxan Tablet; Cytoxan Injection;Procytox;Cytoxan			-1.0802928265	4	5		0	2.02839757			596	BCL2	O.O=P1(NCCCO1)N(CCCl)CCCl	Vitas	STK177249	-0.56166056	-1.5676359	0.44411547	-1.1007418	2.02839757											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016850-15	Bezafibrate	170465743	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	41859-67-0				0.3170529896	4	5		0	5.11156187					O=C(NCCc1ccc(OC(C)(C)C(=O)O)cc1)c2ccc(Cl)cc2	Microsource	01502046	-0.95238095	-1.1125158	-1.08561559	-0.28715004	5.11156187											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253577-01	Lenampicillin hydrochloride	170465777		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	80734-02-7				5.4476822753	4	5		0	2.10953347					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3[C@@H](C(=O)OCC=2OC(=O)OC=2C)C(C)(C)S[C@@H]34	GVK	FFS-11-286-NCI-173	1.83150183	-0.6573957	-1.72711572	3.06293372	2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164548-02	Danofloxacin	170466637	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	112398-08-0				2.8559359008	4	5		0	1.29817444					CN5C[C@@H]4C[C@H]5CN4c1cc2N(C=C(C(=O)O)C(=O)c2cc1F)C3CC3	Sequoia	SRP00900d	0.80586081	-0.9102402	0.44411547	0.81359177	1.29817444											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00164127-07	4-(1,1,3,3-Tetramethylbutyl)phenol	170465157		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	140-66-9		11.220184543	-4.95	26.0290611048	3	5		43.419940352	38.37728195	0.0007989722	0.9996006005			Oc1ccc(cc1)C(C)(C)CC(C)(C)C	SIGMA	290823	-0.51282051	-1.3147914	-0.74019245	-0.38286671	38.37728195											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016643-09	Trioxsalen	170465339	phototherapy treatment of skin disorders	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3902-71-4	 ; Trisoralen; ICN Brand of Trioxsalen; Trioxisalenum; Trioxisaleno; 4,5',8-Trimethylpsoralen;Trioxsalen; Trioxsalen;TRIOXSALEN			12.9349466968	4	5		0	2.83975659					Cc1oc2c(C)c3OC(=O)C=C(C)c3cc2c1	Microsource	01500596	2.75946276	1.1125158	3.15815445	3.87652548	2.83975659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188690-02	Prasugrel	174006898	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	389574-19-0	Prasugrel(Effient);Prasugrel hydrochloride			4.5093629627	4	5		0	5.92292089			64805	P2RY12	Cl.Fc1ccccc1C(N2CCc3sc(cc3C2)OC(C)=O)C(=O)C4CC4	Selleck	S1258	0.65934066	-0.2528445	-1.28300025	-0.09571668	5.92292089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179273-03	Rimexolone	170464695	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	49697-38-3				-0.2017547702	4	4		0	-0.16184971					O=C(OC)[C@@]4(C)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-1020	0.10282776	-0.91240876	0.42116346	-0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538320-01	NCGC00538320-01		Prostamide/prostaglandin F synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					0.8217781191	4	4		0	0.11560694			127281	FAM213B	OC(=O)C1CCC2=C1C=C(Cl)C(=C2)C3CCCCC3	Pharmaron	PH-NIH-2017-009-L1-7-0	0.66838046	-0.54744526	-0.84232693	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506875-01	Vilanterol (GW642444; GW 642444X)		"adrenoceptor beta 2, surface Agonist"	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	503068-34-6				-0.841417066	4	4		0	0.20809249			154	ADRB2	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl	TargetMol	T2645	-0.15424165	-0.5995829	-0.26322716	0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344537-01	L-Glutathione oxidized disodium salt	225144384	Glutathione reductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103239-24-3				2.5292326859	4	4		0	0.76300578					N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C([O-])=O)C(=O)NCC(O)=O)C(=O)NCC([O-])=O)C(O)=O	SIGMA	G4626	0.92544987	0.39103233	-0.73703606	0.76300578												1.6E-8	8E-8	4E-7	0.000002											
NCGC00016590-06	Azaperone	170465697		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1649-18-9				0.2894722512	4	4		0	0.86819258					Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3	Vitas	STK802185	0.5811138	-0.55207026	-1.2921206	0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178815-03	Tolmetin sodium dihydrate	170465216	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	64490-92-2				-0.5015720537	4	4		0	0.65772165					[Na+].O.O.O=C([O-])Cc2ccc(C(=O)c1ccc(C)cc1)n2C	Microsource	01500582	-0.2905569	0.35131744	-0.88674943	0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090997-11	Dichlorvos	170466226	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	62-73-7				0.0619569573	4	4		0	1.49960537					COP(=O)(OC)O\C=C(\Cl)Cl	Microsource	00330018	-0.8716707	-1.05395232	0.73473524	1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021623-05	Nadolol	170464945	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	42200-33-9				-2.0680802506	4	4		0	0.19792182					CC(C)(C)NCC(O)COc2cccc1C[C@@H](O)[C@@H](O)Cc12	Microsource	01503260	0.04833253	-1.01134682	-1.59083678	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249914-01	Bencyclane	170465760		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2179-37-5		12.5892541179	-4.9	68.2071588318	3	4		83.9100808879	64.4235527	0.025657211	0.9995938398			CN(C)CCCOC1(CCCCCC1)Cc2ccccc2	GVK	FFS-11-286-NCI-166	-0.43499275	-0.07400099	-1.52720331	64.4235527												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344521-01	1-(cis-3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride	225144377		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	51229-78-8				1.4666743689	4	4		0	2.67430755					Cl\C=C/C[N]12CN3CN(CN(C3)C1)C2	SIGMA	C3892	-0.42154567	1.05066542	-0.27196084	2.67430755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506872-01	Acotiamide hydrochlorid		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	773092-05-0				-2.8167267522	4	4		0	-0.52531041					COC1=C(OC)C=C(C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)C(=C1)O	TargetMol	T2319	-0.70257611	0.02334812	-0.92466685	-0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181140-02	Carboquone	124893654	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.1740667116	4	4		0	-1.00286533					CO[C@@H](COC(N)=O)\C1=C(/N2CC2)C(=O)\C(=C(\N3CC3)C1=O)C	NCI	NSC-134679	-0.51522248	-0.77048798	-0.81588251	-1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016438-04	Procarbazine hydrochloride	170465402	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	366-70-1	; ; PROCARBAZINE HCl; Procarbazine Hcl; Procarbazina; Procarbazine HCl;Procarbazine hydrochloride (Matulane); Matulane;Procarbazine hydrochloride; Procarbazine hydrochloride			0.0653456622	4	5		0	1.62271805				H2AFX	Cl.CC(C)NC(=O)c1ccc(CNNC)cc1	Prestwick	Prestw-1112	-0.21978022	-0.8091024	-1.92450037	1.67504188	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00242480-03	Ivacaftor		CFTR Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	873054-44-5				-0.0133938404	4	4		0	-2.52023121				CFTR	CC(C)(C)C1=CC(=C(NC(=O)C/2=C/NC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C	APExBIO	A5047	-0.41131105	0.70385819	3.47459858	-2.52023121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166290-03	Polyoxyethylene (9) lauryl ether	170466791		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3055-99-0				-4.0861839731	4	4		0	-2.05205205					CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	SIGMA	P9641	-0.62022901	-0.86206897	-0.5236973	-2.05205205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249911-01	Normethadone	170465674	Mu-type opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	467-85-6				-0.7220235748	4	4		0	2.3023023			25601	Oprm1	CCC(=O)C(CCN(C)C)(c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-156	-0.47709924	-1.07105538	-0.68080649	2.3023023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167503-02	Aclarubicin	174007366	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	57576-44-0	; Aclacin;Aclarubicin; Aclaplastin; Aclacinon; Aclarubicino;Aclacinomycin A			-0.046556735	4	4		0	-0.25025025			7153	TOP2A	CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(O)C6=C(C=C5[C@H]1C(=O)OC)C(=O)C7=CC=CC(=C7C6=O)O	Carbosynth	OA08264	0.19083969	-0.54858934	0.05236973	-0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484057-01	Methenolone (acetate)	363681150		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	434-05-9				-2.556385775	4	4		0	-1.001001					CC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C=C(C)/[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-A0094B	-0.28625954	-1.59352142	0.05236973	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160391-09	Auranofin		Thioredoxin Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					3.3831212395	4	4		0	-2.9029029				TXNRD1	CC[P](CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	SIGMA	A6733	0.62022901	1.59352142	4.08483896	-2.9029029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162179-08	cis-Flupentixol	170465964		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53772-82-0				-4.0040894277	4	4		0	-2.81504867					FC(F)(F)c2cc3C(=C\CCN1CCN(CCO)CC1)/c4ccccc4Sc3cc2	Tocris	4057	0.92009685	-1.05395232	-1.79883456	-2.81504867												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181795-02	Lumiracoxib	170465597	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	220991-20-8				2.1404612268	4	4		0	4.02525651					Clc2cccc(F)c2Nc1ccc(C)cc1CC(=O)O	Sequoia	220991-20-8	-0.72639225	-0.30112923	-0.68406385	4.02525651												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253646-01	Agomelatine	174006904	5-HT2C Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	138112-76-2	Agomelatine			0.0987748557	4	4		0	0.24740228			3358	HTR2C	CC(=O)NCCc1cccc2ccc(OC)cc12	GVK	FFS-12-73-NCI-2563	-0.77332044	0.46867292	0.8908686	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016397-04	Benzydamine hydrochloride	170465576	prostaglandin production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	132-69-4		12.5892541179	-4.9	70.8396810498	3	4		84.8030848746	65.95744681	0.0283426044	0.9995043052			Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23	Vitas	STK711092	-0.57999033	0.71534287	-0.8908686	65.95744681												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179630-03	Homatropine hydrobromide	170465642	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	51-56-9				3.3267025899	4	4		0	-0.28653295					Br.CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2	Labotest	LT00112435	-0.23419204	5.15993463	0.76149035	-0.28653295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389572-01	FIROCOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	189954-96-9				-2.4247998697	4	4		0	1.13294798					CC\1(C)OC(=O)\C(=C1C2=CC=C(C=C2)[S+](C)([O-])=O)OCC3CC3	Microsource	01504526	-0.77120823	-0.5995829	-1.26349039	1.13294798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168746-02	Methyldigoxin	99455400		DPI_SARS-CoV-2_General	2019_NPC-8_CPE					16.6894587571	4	4		0	1.36416185					CO[C@H]1[C@@H](O)CC(O[C@@H]1C)OC2[C@@H](O)CC(O[C@@H]2C)OC3[C@@H](O)C[C@@H](O[C@@H]3C)OC4CC[C@@]5(C)C(CCC6C5CC(O)[C@]7(C)[C@@H](CCC67O)C/8=C/C(=O)OC8)C4	Chemdiv	N001-0009	4.62724936	2.5286757	1.57936299	1.36416185												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00166097-02	Cinnamyl alcohol	225144268	prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	104-54-1				5.3591544484	4	4		0	1.59537572					OC\C=C\C1=CC=CC=C1	SIGMA	108197	0.71979434	1.17309698	2.15846275	1.59537572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183654-01	Etidocaine	144206521	Sodium channel protein type II alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	36637-18-0				2.3144060043	4	4	LS-45490;etidocaine;2',6'-Butyroxylidide, 2-(N-ethylpropylamino)-, hydrochloride, (+-)-;W-19053;etidocainum;DURANEST;CIPLUS_178862;CIPLUS_178863;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-)-, MONOHYDROCHLORIDE;CIPLUS_183648;ETIDOCAINE HYDROCHLORIDE;Etidocaina;Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-;Etidocaine;LS-178540;w-19053;2-(Ethylpropylamino)-2',6'-butyroxylidide;LS-48494;W1905;Duranest;W 1905;ETIDOCAINE;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-);(+-)-n-(2,6-dimethylphenyl)-2-(ethylpropylamino)butanamide;Etidocainum;	0	1.13294798					O=C(Nc1c(C)cccc1C)C(CC)N(CC)CCC	ACC		0.30848329	0.13034411	0.84232693	1.13294798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522021-01	Dexamethasone 21-Palmitate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14899-36-6				2.0993019569	4	4		0	-0.67052023					CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Toronto Research	D298830	0.92544987	0.28675704	0.05264543	-0.67052023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178840-05	Cloxacillin sodium	170465404	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	642-78-4	; Viccillin S (combination);CLOXACILLIN SODIUM; Tegopen; Dicloxacillin Sodium; Sodium syntarpen; Cloxacilina; Sodium, Cloxacilli; Syntarpen;Cloxacillin sodium salt; Orbenin D.C.; 4   Cloxacillin Sodium;Cloxacillin sodium; Sodium cloxacillin; Cloxapen; Cloxacillin, Sodiu; Oxacillin; Ampiclox; Cloxacillin sodium salt			2.3503129918	4	4		0	1.7017017					[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1ccccc1Cl)[C@H]4SC3(C)C	Microsource	01500201	0.71564885	-0.80982236	-0.26184865	1.7017017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164613-08	Epalrestat		Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	82159-09-9				1.6429267712	4	4		0	0.9009009				AKR1B1	CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O	MedChem Express	HY-66009	0.28625954	-0.39184953	0.73317622	0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386267-03	(R)-Lansoprazole		H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	138530-94-6				2.4101802362	4	4		0	0.5005005				ATP4A	CC1=C(C[S@@+]([O-])C2=NC3=C([NH]2)C=CC=C3)N=CC=C1OCC(F)(F)F	MedChem Express	HY-13662B	-0.71564885	-1.07105538	6.59858602	0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264110-02	AN-2690			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	174671-46-6				-3.0533756219	4	4		0	-1.6016016					OB1OCC2=CC(=CC=C12)F	MedChem Express	HY-10980	-0.76335878	-0.91431557	1.04739461	-1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015267-11	Citalopram hydrobromide		5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	[59729-32-7]				3.0361920882	4	4		0	1.25125125				HTR1A	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3	Tocris	1427	1.28816794	-0.70532915	-0.99502488	1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183366-07	NORETHINDRONE ACETATE		Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	51-98-9				-2.3183222677	4	4		0	3.7037037					CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C	Microsource	01500438	-1.38358779	-1.38453501	-0.83791568	3.7037037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-07	Verteporfin			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	129497-78-5				5.7750929792	4	4		0	-1.75175175					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(C=C)=C(N4)C=C5N=C(C=C1N2)\C(CCC(O)=O)=C5\C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Prestwick	Prestw-1105	2.6240458	0.44409613	0.10473946	-1.75175175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018250-06	Sulconazole nitrate	170465344	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	61318-91-0				2.6427293707	4	4		0	4.96173133					[O-][N+](=O)O.Clc3ccc(C(SCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501148	-0.6826742	-0.69589422	-0.99892009	4.96173133												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024567-03	Ambenonium chloride	170465386	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	115-79-7				6.5031145237	4	4		0	1.79466878					[Cl-].[Cl-].Clc2ccccc2C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](Cc1ccccc1Cl)(CC)CC	Tocris	0388	0.63559322	2.08768267	1.80885529	1.79466878												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00042523-03	N-Oxydiethylenebenzothiazole-2-sulfenamide	170465568		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	102-77-2				0.2087178942	4	4		0	1.16125627					c1cccc2sc(nc12)SN3CCOCC3	Labotest	LT00078541	-0.07062147	0	-0.89092873	1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094874-05	Esculin hydrate	225144214	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	66778-17-4				3.6112407065	4	4		0	0.95011876					OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)\C=C/C3=C2)[C@H](O)[C@@H](O)[C@@H]1O	SIGMA	E8250	1.01224105	0.13917884	0.56695464	0.95011876												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262942-01	Etifelmine hydrochloride	170465899		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1146-95-8	Etifelmine;Etifelmine	11.220184543	-4.95	29.6304768195	2.4	4		30.310734468	27.02560042	0.0354450387	0.9992256443			Cl.CCC(\CN)=C(/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-209	-0.25894539	0.6263048	0.02699784	27.02560042												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179392-03	Beclomethasone	170464981		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	4419-39-0				-0.0241664375	4	4		0	2.11137503					OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-855	-0.82391714	0.41753653	-1.05291577	2.11137503												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181776-02	Dicyclopentamethylenethiuram disulfide	170465709		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	94-37-1				4.7007146613	4	4		0	3.32541568					S=C(SSC(=S)N1CCCCC1)N2CCCCC2	Labotest	LT00159442	-0.30602637	-0.55671538	1.91684665	3.32541568												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024596-08	Carbidopa	225144194	decarboxylase inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	28860-95-9				-2.2684868391	4	4		0	-0.89064819				DDC	C[C@@](CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	Prestwick	Prestw-1177	-0.24166264	0.32067094	-1.01813554	-0.89064819												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016642-04	Piperacetazine	170465363		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3819-00-9		12.5892541179	-4.9	105.0322975208	3	4		118.9024985566	95.99208313	0.0265059513	0.9995664339			CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-1048	0.91831803	-0.61667489	-1.46356984	95.99208313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094762-08	Piperazine			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	110-85-0				-1.6243795297	4	4		0	0.14326648					C1CNCCN1	Microsource	01500490	-0.28103044	-0.72379173	-0.54392168	0.14326648												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00160673-01	Propicillin	144205529		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	551-27-9	Propicillin; Levopropylcillin; Propicilina; 			-4.5871395778	4	4	Propicillinum;CIPLUS_782900;Propicillin;levopropicillinum;levopropicilline;LS-175596;CIPLUS_750386;Propicilina;CIPLUS_206990;PROPICILLIN POTASSIUM;Propicillin potassium;LS-175076;CIPLUS_669806;Levopropylcillin Potassium;propicilline;Propicilline;brocillin;propicillin;propicillinum;Propicillin Potassium;alpha-phenoxy propylpenicillin;LS-174659;Levopropylcillin potassium;Levopropylcillin;PROPICILLIN;	0	-1.1938873					OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)C(CC)Oc1ccccc1)[C@H]3SC2(C)C	Vitas	STK177353	-1.54566745	-0.30352557	0.81588251	-1.1938873												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00094956-04	Cephaloridine	124891818	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-2.2594140544	4	4		0	-0.47755492			939990		[O-]C(=O)C/1=C(CSC2C(NC(=O)CC3=CC=CS3)C(=O)N12)\C[N+]4=CC=CC=C4	Waterstone	40972	-1.264637	1.51762783	0.38074517	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167562-01	Buquinolate	144206110		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	5486-03-3	Buquinolate; Buquinolato; Bonaid; 			-0.4517380486	4	4	buquinolatum;BUQUINOLATE;Buquinolatum;CIPLUS_164381;buquinolate;Buquinolato;ethyl 4-hydroxy-6,7-diisobutoxy-3-quinolinecarboxylate;Buquinolate;Bonaid;	0	1.00286533					CC(C)COc1cc2ncc(c(O)c2cc1OCC(C)C)C(=O)OCC	SigmaAldrich	R239542	-0.28103044	-0.25682933	-0.43513734	1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179665-04	Danazol	170464884	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	17230-88-5		12.5892541179	-4.9	30.7345048813	3	4		41.1379158191	37.75722543	0.03362679	0.999302504			C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-105	0.97686375	-0.13034411	0.1579363	37.75722543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160614-01	Glucuronamide	144205490		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	61914-43-0	Glucuronamide; D-Glucuronic acid amide; Guronamin; 			0.9874429962	4	4	Glucuronamide;CIPLUS_791650;GLUCURONAMIDE;glucuronamide;D-Glucuronic acid amide;glucuronamidum;Guronamin;	0	-0.16184971					O[C@H]1[C@H](O)[C@H](O[C@@H](O)[C@@H]1O)C(N)=O	SigmaAldrich	MFCD00006619	0.41131105	0.02606882	-0.3158726	-0.16184971												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00167422-01	Enflurane	144205979	Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	13838-16-9	Enflurane; Ethrane; Enflurano; Pisa Brand of Enflurane; Enlirane; Zeneca Brand of Enflurane; Etran; Abbott Brand of Enflurane; Alyrane; Enfran; 			-0.0503164854	4	4	enfluranum;LS-7376;Enfran;ENFLURANE;Alyrane;Etran;Zeneca Brand of Enflurane;Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-;Enflurano;Baxter Anaesthesia Brand of Enflurane;CIPLUS_169039;HS_566;Pisa Brand of Enflurane;Enlirane;Enflurane;Ethrane;AstraZeneca Brand of Enflurane;nsc-115944;Enfluranum;Abbott Brand of Enflurane;enflurane;	0	0.99421965					FC(Cl)C(F)(F)OC(F)F	Alfa Aesar	L16725	-0.71979434	0.5995829	0.89497236	0.99421965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373228-02	Fluorometholone Acetate	363678077		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	3801-06-7				-0.3813966481	4	4		0	-0.62427746					C[C@H]\1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)\C=C/C(=O)/C=C14	Selleck	S4228	0.25706941	0.13034411	-0.94761779	-0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384190-03	(S)-Crizotinib		HGFR (MET; c-Met) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1374356-45-2				-2.8014681738	4	4		0	-2.65895954				MET	C[C@H](OC1=CC(=CN=C1N)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F	Axon Medchem	2296	-1.02827763	1.43378519	1.15819953	-2.65895954												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181085-01	Miripirium chloride	144206257		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2748-88-1	CIPLUS_160809; Cloruro de miripirio; 			-3.5532913509	4	4	Miripirii chloridum;Miripirium chloride;1-TETRADECYL-4-PICOLINIUM CHLORIDE;MIRIPIRIUM CHLORIDE;Cloruro de miripirio;Chlorure de miripirium;CIPLUS_160809;MYRISTYL-GAMMA-PICOLINIUM CHLORIDE;miripirii chloridum;chlorure de miripirium;myristyl-gamma-picolinium chloride;1-myristylpicolinium;	0	-2.9029029					[Cl-].Cc1cc[n+](CCCCCCCCCCCCCC)cc1	NCI	NSC-36338	-0.19083969	-0.33960293	-0.94265515	-2.9029029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164076-03	SODIUM GLUCONATE			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	527-07-1				0.4631142146	4	4		0	-0.35035035					OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O	Microsource	01300035	0.47709924	-0.49634274	-0.20947892	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016251-13	Probenecid	170464839	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	57-66-9				0.9786742257	4	4		0	0.04948046					O=S(=O)(N(CCC)CCC)c1ccc(cc1)C(=O)O	Microsource	01500502	1.01498308	-0.32067094	-0.69996818	0.04948046												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018113-07	Sodium 4-phenylbutyrate	170465108	Glutamine Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1716-12-7				5.2223572976	4	4		0	0.19792182					[Na+].[O-]C(=O)CCCc1ccccc1	Microsource	00306001	0.91831803	0.71534287	2.67260579	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00185757-01	Diethylmethyl(2-3-methyl-2-phenylvaleryloxy)-ethyl)ammonium bromide	144207102	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	90-22-2				-0.5284758722	4	4		0	-0.42979943					[Br-].CC[N+](C)(CC)CCOC(=O)C(C(C)CC)c1ccccc1	SigmaAldrich	S422649	-0.42154567	0.21013308	1.03345118	-0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179526-05	Demecarium bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	56-94-0				-3.8769732371	4	4		0	-0.85959885					CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC2=CC(=CC=C2)[N+](C)(C)C	Prestwick	Prestw-616	-0.84309133	-0.67709549	-0.87027468	-0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249920-01	Nandrolone cyclohexylpropionate	170465905	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	912-57-2				-3.9299910707	4	4		0	-1.00286533					O=C5CC[C@H]4C(CC[C@@H]3[C@@H]4CC[C@@]2(C)[C@H]3CC[C@@H]2OC(=O)CCC1CCCCC1)=C5	GVK	FFS-11-286-NCI-188	-1.264637	0.07004436	0	-1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178864-03	Ethambutol dihydrochloride	174006619		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1070-11-7				-2.452928521	4	4		0	-0.19102197					Cl.Cl.CC[C@@H](CO)NCCN[C@H](CO)CC	Microsource	01500288	-1.03044496	0.67709549	-0.21756867	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168783-01	Diisopropyl fluorophosphate	144206196	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	55-91-4	Isoflurophate; Floropryl; Fluorostigmine; Dyflos; 			-4.5809756241	4	4	Diisopropylphosphofluoridate;DIFP;PHOSPHOROFLUORIDIC ACID, BIS(1-METHYLETHYL) ESTER;Bis(1-methylethyl) Phosphorofluoridate;Isoflurophate;CIPLUS_148756;DIISOPROPYLFLUOROPHOSPHATE;Phosphorofluoridic acid, bis(1-methylethyl) ester;Dyflos;Di isopropylphosphorofluoridat;diisopropyl phosphofluoridate;Fluorostigmine;Phosphoric acid diisopropyl ester fluoride;LS-108313;Floropryl;Di-isopropylphosphorofluoridate;6   Diisopropyl Fluorophosphate;ISOFLUROPHATE;Diisopropylfluorophosphate;Merck Brand of Isoflurophate;Diisopropyl phosphorofluoridate;	0	0.11560694					FP(=O)(OC(C)C)OC(C)C	Toronto Research	D455300	-1.49100257	-0.70385819	-0.52645433	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271513-02	Lofexidine	170466275	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	31036-80-3				-0.8559739239	4	4		0	-0.20809249					Clc2cccc(Cl)c2OC(C)C1=NCCN1	Prestwick	Prestw-1430	-0.15424165	-0.91240876	0.4738089	-0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183655-01	Tazanolast	144206520	histamine secretion by mast cell Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	82989-25-1				-3.2746385661	4	4	CIPLUS_710388;tazanolast;tazanolastum;butyl 3'-(1h-tetrazol-5-yl)oxanilate;Tazanolastum;TAZANOLAST;LS-12662;butyl-3'-(1H-tetrazol-5-yl)oxanilate;Acetic acid, oxo((3-(1H-tetrazol-5-yl)phenyl)amino)-, butyl ester;Tazanolast;Tazanol;	0	-0.9017341					O=C(OCCCC)C(=O)Nc1cccc(c1)c2nnnn2	ACC		-0.5655527	-0.39103233	-1.26349039	-0.9017341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181045-01	Pyridoxamine phosphate	144206246		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	529-96-4	Pyridoxamine phosphate; pyridoxamine-P; Pyridoxamine-5'-phosphate; 			-0.6900350918	4	4	4-Aminomethyl-5-hydroxy-6-methyl-3-pyridylmethyl phosphate;CIPLUS_3727741;Pyridoxamine Phosphate;CIPLUS_154034;pyridoxamine phosphate hydrochloride;PYRIDOXAMINE PHOSPHATE;pyridoxamine phosphate;Pyridoxamine Phosphate Anhydride;Pyridoxamine-5'-phosphate;Pyridoxamine phosphate;CIPLUS_3861203;pyridoxamine-P;	0	-0.43930636					Oc1c(CN)c(cnc1C)COP(=O)(O)O	SigmaAldrich	82890	-0.5655527	0.44316997	1.10555409	-0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378896-03	Teneligliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	760937-92-6				3.7413531977	4	4		0	0.16184971					CC1=N[N](C2=CC=CC=C2)C(=C1)N3CCN(CC3)[C@@H]4CN[C@@H](C4)C(=O)N5CCSC5	MedChem Express	HY-14806	1.33676093	-0.65172054	0.94761779	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179360-05	Tridihexethyl chloride		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	4310-35-4				-0.5120323384	4	4		0	1.0867052					CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C2=CC=CC=C2	Prestwick	Prestw-1042	-0.92544987	1.43378519	0.05264543	1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183852-01	Diponium bromide	144206825	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2001-81-2				-1.1558452242	4	4	Diponium Bromide;diponium iodide;SA-267;triethyl(2-hydroxyethyl)ammonium bromide dicyclopentyl acetate;Diponii bromidum;diponium bromide;DIPONIUM BROMIDE;Dipenine bromide;TRIETHYL(2-HYDROXYETHYL)AMMONIUM BROMIDE DICYCLOPENTYLACETATE;CIPLUS_771421;Ammonium, (2-hydroxyethyl)triethyl-, bromide, dicyclopentylacetate;Unospaston;DIPENINE BROMIDE;Bromuro de diponio;LS-18253;HL 267;2-((dicyclopentylacetyl)oxy)-N,N,N-triethylethanaminium;diponii bromidum;diponium;Dipenine Bromide;Bromure de diponium;Diponium bromide;bromure de diponium;CIPLUS_769588;spaslar;Ethanaminium, 2-((dicyclopentylacetyl)oxy)-N,N,N-triethyl-, bromide, mixt. with (T-4)-bis(((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonato)magnesium;CIPLUS_214084;	0	-0.02312139					[Br-].CC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C2CCCC2	Pharmaron	PH-NIH-150206	-0.30848329	0.18248175	-0.68439063	-0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263875-02	SELAMECTIN			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	165108-07-6				3.4104867644	4	4		0	-0.25433526					CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C(=N/O)\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	Microsource	01503720	0.5655527	-0.54744526	3.63253488	-0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378736-01	Cinepazide Maleate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	26328-04-1				0.8986032808	4	4		0	-0.06936416					COC1=C(OC)C(=CC(=C1)\C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3)OC	MedChem Express	HY-66010	0.5655527	-0.44316997	-0.26322716	-0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167448-02	Trepibutone	170465772	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	41826-92-0				-0.3350529499	4	4		0	0.7007007					CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(=O)O	Bosche	T5812	-0.42938931	0.13061651	0.20947892	0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093644-07	Amsacrine	404904675	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	54301-15-4				-5.5069431699	4	4		0	0.4004004				TOP2A	COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(=C1)N[S+](C)([O-])=O	Glixx	GLXC-03289	-1.33587786	-1.64576802	-1.78057083	0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181153-01	Treosulfan	144206310	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	299-75-2	treosulfan; Dimesyl-meso-erythritol; Treosulfano; L-dihydroxybusulfan; 			4.3756781387	4	4	treosulfan, (R*,R*)-isomer;Treosulfano;LS-173863;CIPLUS_677281;treosulfan, ((R*,R*)-(+-))-isomer;CIPLUS_152492;(S-(R*,R*))- 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate;LS-1145;(2R,3R)-4,5-Bis(mesyloxy)butane-2,3-diol;L-threitol-1,4-bismethanesulfonate;TREOSULFAN;CIPLUS_673029;Dimesyl-meso-erythritol;L-dihydroxybusulfan;treosulfan;Treosulfanum;LS-64629;NSC 39069;CIPLUS_168615;LS-174277;LS-173777;treosulfan, (R*,S*)-isomer;treosulfanum;treosulfan, (R-(R*,R*))-isomer;Treosulfan;	0	-1.001001					CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O	NCI	NSC-39068	2.09923664	-0.70532915	0.36658811	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015238-13	Chlorzoxazone	170464957	Intermediate conductance calcium-activated potassium channel protein 4 Activator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	95-25-0				7.0973031715	4	4		0	2.26972816					Clc1cc2NC(=O)Oc2cc1	Vitas	STK071582	1.53013183	1.60055672	0.62095032	2.26972816												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274075-01	1-Octacosanol		PI3K-Akt signaling pathway Activator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	557-61-9				-2.8133874229	4	4		0	-0.68619689					CCCCCCCCCCCCCCCCCCCCCCCCCCCCO	SIGMA	O3379	-0.49435028	-1.18302018	0.29697624	-0.68619689												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00166236-02	Oteracil potassium		Orotate Phosphoribosyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2207-75-2				1.1856990011	4	4		0	0.10556875				UMPS	OC1=NC(=NC(O)=N1)C([O-])=O	Bosche	O3085	0.77683616	0.55671538	0.18898488	0.10556875												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00015821-10	Piracetam	170465901	"Glutamate receptor ionotropic, AMPA 3 Positive Allosteric Modulator"	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	7491-74-9				0.0882548704	4	4		0	0.68619689					O=C1CCCN1CC(=O)N	Specs	AE-641/30117005	-0.02354049	-1.2526096	0.24298056	0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249910-01	Ibafloxacine	170466478	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	91618-36-9				-0.3398029487	4	4		0	1.95302191					O=C(O)C3=CN1c2c(cc(F)c(C)c2CCC1C)C3=O	GVK	FFS-11-286-NCI-148	-0.9180791	0.6263048	-1.16090713	1.95302191												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160611-03	1-Ethyl-2-pyrrolidinone	170465488		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2687-91-4				-2.9954171536	4	4		0	-0.05278438					O=C1CCCN1CC	SIGMA	146358	-1.38888889	-1.04384134	0.35097192	-0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091325-09	Dichlorophen	170465475	"Indoleamine 2,3-dioxygenase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	97-23-4		12.5892541179	-4.9	16.4517264172	4	4		20.3326439719	16.67491341	0.0995226042	0.9938671317			Oc2ccc(Cl)cc2Cc1cc(Cl)ccc1O	Microsource	01500626	0.04833253	-0.46867292	-1.52720331	16.67491341												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344523-01	L-(-)-Sorbose	170465548		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	87-79-6				-1.0387373874	4	4		0	0					O[C@H](C(=O)CO)[C@H](O)[C@@H](O)CO	SIGMA	140929	-0.74941452	0.49031053	0.76149035	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178145-03	Thonzylamine hydrochloride	170465519		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	63-56-9				1.1739318362	4	4		0	0					Cl.COc1ccc(cc1)CN(CCN(C)C)c2ncccn2	Microsource	01503135	-0.04683841	0.81718422	1.03345118	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181783-03	Iguratimod		NF-kappaB (NFKB) Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	123663-49-0				-1.6682848409	4	4		0	0.39306358			24835	NFKB1	C[S+]([O-])(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)\C(=C/O2)NC=O	MedChem Express	HY-17009	-0.71979434	-0.70385819	0.52645433	0.39306358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181101-01	Isothipendyl hydrochloride	144206270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1225-60-1	Isothipendyl hydrochloride; Andantol; Isotipendilo; Adanton hydrochloride; 			1.2229095541	4	4	ISOTHIPENDYL HYDROCHLORIDE;isothipendylum;isothipendyl;Isotipendilo;LS-133223;N,N,alpha-trimethyl-10H-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine;LS-133221;Isothipendyl;CIPLUS_157919;CIPLUS_213648;Andantol;10H-Pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, N,N,alpha-trimethyl-;Isothipendylum;Isothipendyl hydrochloride;Adanton hydrochloride;ISOTHIPENDYL;CIPLUS_694884;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-dimethylamino-2-methylethyl)-, hydrochloride;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-(dimethylamino)propyl)-;Isothipendyl Hydrochloride;	0	3.16763006					Cl.CN(C)C(C)CN1c3ccccc3Sc2cccnc12	NCI	NSC-169186	-0.51413882	-0.39103233	0.6317452	3.16763006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186629-04	ATP (disodium salt)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	987-65-5				-3.7468258392	4	4		0	-1.15115115					NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P]([O-])(=O)O[P](O)([O-])=O)[C@@H](O)[C@H]3O	MedChem Express	HY-B0345A	-0.42938931	-0.80982236	0.31421838	-1.15115115												1.6E-9	8E-9	4E-8	2E-7											
NCGC00090731-08	2-Phenoxyethanol	170465671	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	122-99-6				0.1350898379	4	4		0	-1.45145145					OCCOc1ccccc1	Bosche	P2904	0.19083969	-0.18286311	0.5236973	-1.45145145												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00253572-01	Embutramide	170465662		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	15687-14-6				7.8289881895	4	4		0	-0.05005005					COc1cc(ccc1)C(CC)(CC)CNC(=O)CCCO	GVK	FFS-11-286-NCI-121	1.66984733	2.01149425	3.14218382	-0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532499-01	ROMIFIDINE		Alpha-2B adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-2.9054485986	4	4		0	0.05005005				ADRA2B	FC1=CC=CC(=C1N\C2=N\CCN2)Br	Enamine	EN300-177066	-0.71564885	-0.65308255	-0.94265515	0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015004-13	Amoxapine	170465376	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	14028-44-5	 Amoxapina; ; Asendin; Amoxapine; 2   Amoxapine;Amoxapine;AMOXAPINE;	8.9125093813	-5.05	76.0297620239	3	4		69.739904985	65.82211665	0.0385939946	0.9990803722	3356	HTR2A	Clc1ccc2Oc4ccccc4N=C(c2c1)N3CCNCC3	Enzo	AC814	0.25894539	2.64439805	1.43088553	65.82211665												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017325-06	Kojic acid	170466814	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	501-30-4				6.8390994297	4	4		0	5.75349696					O=C1C=C(CO)OC=C1O	Labotest	LT00068503	-0.82391714	3.54906054	-0.4049676	5.75349696												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179308-04	Fluticasone propionate	170464975	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	80474-14-2	 Flovent;;Fluticasone propionate (Flonase, Veramyst); Cutivate;Fluticasone propionate			0.9884917313	4	4		0	-1.79466878				NR3C1	O=C(SCF)[C@@]4(OC(=O)CC)[C@H](C)C[C@H]3C2C[C@H](F)C1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Prestwick Chemical, Inc.	Prestw-997	1.90677966	-0.6263048	-0.1349892	-1.79466878												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00241108-04	Axitinib	170466656	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	319460-85-0	AG-013736;Inlyta;Axitinib; Axitinib;AG-13736			-4.7961335789	4	4		0	-1.62368672			2321	FLT1	CNC(=O)c4ccccc4Sc1ccc3c(c1)nnc3/C=C/c2ccccn2	Sequoia	319460-85-0	-0.98360656	-0.77048798	-0.76149035	-1.62368672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159366-02	m-Cresol	29215286		DPI_SARS-CoV-2_General	2019_NPC-7_CPE		3-Methylphenol-d8; m-Cresol-d8; 			2.393620829	4	4	3-Methylphenol-d8;3-cresol, sodium salt;CIPLUS_723418;CIPLUS_151039;CIPLUS_3741557;3-cresol;NCGC00159366-04;NCGC00159366-05;CIPLUS_3755532;m-Cresol;NCGC00159366-03;meta-cresol;Methylphenol tricresol;CRESOL, M-;CIPLUS_719811;3-Methylphenol;NCGC_FLUKA_61020;Cresol mixture of isomers;CIPLUS_161251;LS-460;Metacresol;3-cresol, calcium salt(1:2);m-Cresol-d8;m-Cresylic acid;CIPLUS_746155;3-methylphenol;	0	0.52531041					CC1=CC(O)=CC=C1	Labotest	LTBB001401	1.03044496	-0.30352557	-0.59831384	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025155-07	Omacetaxine mepesuccinate		Alkaloid	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	26833-87-4		3.1622776602	-5.5	65.4473392135	4	4		-27.0677542207	-0.06936416	0.6533816447	0.5869941801		RPL3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]\1[C@H]2C3=CC4=C(OCO4)C=C3CCN5CCC[C@]25\C=C1OC	MedChem Express	HY-14944	12.59640103	41.37122002	6.31745196	-0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095899-09	Rizatriptan Benzoate		5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	145202-66-0				-0.0849137044	4	4		0	1.59537572				HTR1B	CN(C)CCC1=C[NH]C2=CC=C(C[N]3C=NC=N3)C=C12	APExBIO	A8516	-0.46272494	0.54744526	-0.68439063	1.59537572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167542-01	Tiamulin	144206092	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	55297-95-5	Tiamulin; Tiamulina; 	10	-5	11.1980442042	4	4	TIAMULIN FUMARATE;THIAMUTILIN FUMARATE;tiamulin hydrochloride;(3AS,4R,5S,6S,8R,9S,9AR,10R)-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-6-VINYLDECAHYDRO-3A,9-PROPANOCYCLOPENTA(8)ANNULEN-8-YL ((2-(DIETHYLAMINO)ETHYL)THIO)ACETATE (2E)-BUT-2-ENEDIOATE (SALT);Tiamulina;sandoz 81723hfu;Tiamuline;Tiamulinum;ACETIC ACID, ((2-(DIETHYLAMINO)ETHYL)THIO)-, (3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER, (2E)-2-BUTENEDIOATE (1:1) (SALT);tiamulinum;Tiamulin Hydrogen Fumarate;tiamuline;(1S,2R,3S,4S,6R,7S,14R)-6-[(2-Diethylaminoethylthio)acetoxy]-3-hydroxy-2,4,7,14-tetramethyl-4-vinyltricyclo[5,4,3,01.8]tetradecan-9-one;LS-174933;Thiamutilin fumarate;2-(diethylaminoethyl)thioacetoxymutilin;14-DEOXY-14-((2-DIETHYLAMINOETHYL)THIOACETOXY)MUTILIN HYDROGEN FUMARATE;CIPLUS_182128;Tiamulin;TIAMULIN HYDROGEN FUMARATE;Tiamulin Fumarate;TIAMULIN;LS-11694;LS-11693;(3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYL-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXODECAHYDRO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL((2-(DIETHYL-AMINO)ETHYL)SULPHANYL)ACETATE HYDROGEN (E)-BUT-2-ENEDIOATE;CIPLUS_207320;Tiamulin fumarate;	18.8020565519	16.99421965	0.0369771441	0.9991594396			CCN(CC)CCSCC(=O)O[C@@H]3C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]21CCC(=O)[C@H]1[C@@]3(C)C(C)CC2	SigmaAldrich	34044	-0.66838046	-0.07820647	0.36851803	16.99421965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178802-06	Deferoxamine mesylate	170464752	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	138-14-7				10.9738298418	4	4		0	4				APP	ON(CCCCCNC(=O)CCC(=O)N(O)CCCCCN)C(=O)CCC(=O)NCCCCCN(O)C(C)=O.CS(=O)(=O)O	Microsource	01500224	2.31362468	0.44316997	2.52698078	4												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179259-06	Meropenem			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	96036-03-2				-2.62491318	4	4		0	-1.45145145					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C([N@@]2C1=O)C(O)=O	Prestwick	Prestw-1106	-0.52480916	-0.86206897	0.57606703	-1.45145145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181016-04	Bexarotene	170465308	Retinoid RXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	153559-49-0	 ; LG69 compound; Bexarotene;Bexarotene;Targretin; Elan brand of bexarotene; Bexarotene (Targretin); 3-methyl-TTNEB	8.9125093813	-5.05	32.6261372264	2.4	4		32.5	29.82982983	0.0409797693	0.9989645475	6256	RXRA	O=C(O)c1ccc(cc1)C(=C)c2cc3c(cc2C)C(C)(C)CCC3(C)C	CiVentiChem	CV-1209	2.14694656	1.22779519	5.7083006	29.82982983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016361-20	Acetaminophen		Cyclooxygenase-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	103-90-2				-2.5697298198	4	4		0	-1.001001				PTGS1	CC(=O)NC1=CC=C(O)C=C1	Adooq	A10030	-0.19083969	-1.12330199	-0.78554595	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00037856-01	Medronic acid	144204525		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1984-15-2				-2.0302897462	4	4	Medronate disodium;Acido medronico;Acide medronique;PHOSPHONIC ACID, METHYLENEBIS-;Methylene Diphosphonic Acid;CIPLUS_159401;acidum medronicum;METHYLENE DIPHOSPHONIC ACID;METHYLENEDIPHOSPHONIC ACID;Methylenediphosphonic acid trisodium salt tetrahydrate;CIPLUS_738322;MEDRONIC ACID;Medronic acid;MEDRONATE DISODIUM;Acidum medronicum;MEDRONATE SODIUM;Methylenediphosphonic acid;methylene diphosphonate;METHYLENE DIPHOSPHONIC ACID, SODIUM SALT;acide medronique;CIPLUS_175020;	0	-0.1001001					O=P(O)(O)CP(=O)(O)O	DPISMR	3714055	-0.71564885	-0.07836991	-0.10473946	-0.1001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522022-01	Befunolol		Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	39552-01-7				-1.7591972174	4	4		0	-0.6006006					CC(C)NCC(O)COC1=C2OC(=CC2=CC=C1)C(C)=O	Toronto Research	B131100	-0.19083969	-0.39184953	-0.78554595	-0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370823-03	Pitolisant (hydrochloride)		Histamine H3 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	903576-44-3		14.1253754462	-4.85	30.5982577008	3	4		38	32.68268268	0.0803860221	0.9959982696			ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1	MedChem Express	HY-12199B	1.19274809	3.10867294	1.36161299	32.68268268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180461-02	Hydroquinidine HCl		Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1476-98-8		12.5892541179	-4.9	66.8916604918	3	4		97.1899860299	84.79273405	0.0118957385	0.9999127168			CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	Prestwick	Prestw-NAT-0284	0.59585492	1.29205266	1.5605336	84.79273405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167524-02	Amorolfine hydrochloride	170466078	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	78613-35-1	 ;Amorolfine Hydrochloride;Amorolfine; Amorolfine; Amorolfine [USAN:BAN:INN];Amorolfine hcL; Loceryl; Pekiron			-1.0219273658	4	4		0	2.72473218					C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2	Sequoia	SRP0563571a	-1.11398964	-0.6582155	0.35237856	2.72473218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095118-17	Rofecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	162011-90-7				1.0932133037	4	4		0	-0.06986493				PTGS2	C[S+]([O-])(=O)C1=CC=C(C=C1)C/2=C(/C(=O)OC2)C3=CC=CC=C3	SIGMA	SML0613	0.95854922	-0.75572891	-1.10747546	-0.06986493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263825-02	HETACILLIN POTASSIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	5321-32-4, 3511-16-8 [hetacillin]				-3.1807588012	4	4		0	0.48905449					CC1(C)N[C@@H](C(=O)N1[C@@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C4=CC=CC=C4	Microsource	01500327	-0.90673575	-0.80448562	-0.95645608	0.48905449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167520-06	Cilomilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	153259-65-5				2.4381357166	4	4		0	1.23428039				PDE4A	COC1=CC=C(C=C1OC2CCCC2)C3(CCC(CC3)C(O)=O)C#N	APExBIO	A4329	0.59585492	-0.51194539	0.50339794	1.23428039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181352-01	Aspoxicillin	144206363		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	63358-49-6	Aspoxicillin; Aspoxicillin Anhydride; Doyle; 			2.8934204123	4	4	TA 058;TA-058;Doyle;Glycinamide, N-methyl-D-asparaginyl-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-D-2-(4-hydroxyphenyl)-, (2S-(2-alpha,5-alpha,6-beta))-;LS-72203;n(sup 4)-methyl-d-asparagininylamoxicillin;N(4)-methyl-D-asparaginylamoxicillin;CIPLUS_214228;aspoxicillinum;ASPOXICILLIN;Aspoxicillin;aspoxicilline;aspoxicillin;Aspoxicillin Anhydride;	0	1.5137401					OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)NC)c1ccc(O)cc1)[C@H]3SC2(C)C	APAC	550484	-0.12953368	1.58459288	1.40951422	1.5137401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186632-01	Strychnine	124897819	Glycine receptor subunit alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1421-86-9				1.465474382	4	4	STRYCHNINE HCl	0	2.16581276					O=C1C[C@@H]2OC\C=C/3C[N@]4CC[C@@]56[C@@H]4C[C@@H]3[C@@H]2[C@@H]5N1C7=C6C=CC=C7	BIOMOL	AC745	-0.59585492	0.95075573	1.00679587	2.16581276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249921-01	Omoconazole	170465847		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	74512-12-2		4.4668359215	-5.35	29.0487753203	4	4		29.8361169119	27.5006598	0.0347334218	0.9992563569			C\C(=C(\OCCOc1ccc(Cl)cc1)c2ccc(Cl)cc2Cl)n3ccnc3	GVK	FFS-11-286-NCI-199	-0.25894539	-1.11343076	0.1349892	27.5006598												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179248-03	Articaine hydrochloride	170464825	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	23964-57-0				1.9308037117	4	4		0	0.15835313					Cl.O=C(Nc1c(scc1C)C(=O)OC)C(C)NCCC	Prestwick Chemical, Inc.	Prestw-1032	-0.49435028	0.6263048	2.13282937	0.15835313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016322-13	Dapsone	170464895	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	80-08-0				-1.2324330709	4	4		0	1.5307469					Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2	Vitas	STK387118	-0.77683616	-1.73973556	-0.24298056	1.5307469												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263570-01	Sivelestat sodium hydrate	170465996	Neutrophil Elastase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	201677-61-4				9.9395994942	4	4		0	3.2726313				ELANE	O.O.O.O.[Na+].CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC([O-])=O	Bosche	S3046	1.24764595	2.57480863	2.13282937	3.2726313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274269-01	NCGC00274269-01	225144370		DPI_SARS-CoV-2_General	2019_NPC-4_CPE			1.995262315	-5.7	13.1824099356	4	4		11.920668064	10.34573766	0.1567858165	0.9846911378			CCCCCCCCCCCCNCCNCCNCC(O)=O	GVK	FFS-11-286-NCI-158	0.02354049	-1.60055672	-0.18898488	10.34573766												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			9.8356560258	4	4		0	2.16415941				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	2.14218456	-0.55671538	3.6987041	2.16415941												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179521-03	Cefixime		Bacterial penicillin-binding protein Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	125110-14-7				-0.8144041232	4	5		0	-0.83705357					NC1=NC(=CS1)\C(=N\OCC(O)=O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	FLUKA	18588	1.25341276	-2.53277332	-0.95581105	-0.10726736	-0.83705357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015970-11	Sulindac	170464648	ABCC1 Expression Enhancer	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac			5.0864601964	4	5		0	2.87388393				ABCC1	CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C	Microsource	01500556	2.07247456	-3.60188367	-0.40171769	2.70850094	2.87388393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249906-01	Nicoboxil	170465989	positive regulation of vasodilation Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	13912-80-6		14.1253754462	-4.85	7.1608132363	4	5		12.9063582239	10.10044643	0.2132195793	0.8738228984			O=C(OCCOCCCC)c1cccnc1	GVK	FFS-11-286-NCI-130	1.05485232	1.10729286	-3.25529852	-1.20675784	10.10044643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167356-07	Raltegravir			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	871038-72-1				-2.6119571484	4	5		0	4.21316964					CN1C(=O)C([O-])=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3	Selleck	S2005	-2.61851576	-2.12549319	2.09170245	-1.26039153	4.21316964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181914-01	Alloclamide	144206889		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5486-77-1	Alloclamide; Aloclamida; Hexacol; 			-11.2991608303	4	5	ALLOCLAMIDE HYDROCHLORIDE;Hexacol;Alloclamide;Alloclamidum;alloclamidum;alloclamide hydrochloride;alloclamide;ALLOCLAMIDE;2-allyloxy-4-chloro-N-(2-diethylaminoethyl)benzamide;264 CE;Aloclamida;LS-25294;CIPLUS_774246;CIPLUS_214111;Alloclamide hydrochloride;Benzamide, 2-(allyloxy)-4-chloro-N-(2-(diethylamino)ethyl)-;	0	-0.93508605					O=C(NCCN(CC)CC)c1ccc(Cl)cc1OCC=C	Pharmaron	PH-NIH-93	-3.0697446	-2.71832718	-1.72298651	-2.57901391	-0.93508605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015673-13	Minoxidil	170464704	K(ATP) Channel Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	38304-91-5	Minoxidil; Loniten; Minoxidil; ;MINOXIDIL; Minoxidil Pfizer Bran; Riup; Pfizer Brand of Minoxidil; Regaine			-0.3664520564	4	5		0	-0.82667028					Nc1cc(nc(N)[n+]1[O-])N2CCCCC2	Microsource	01500415	-2.23477407	9.77859779	-0.70789368	-2.78128951	-0.82667028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159510-05	Aripiprazole	170465392	5-HT1A/2A Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	129722-12-9	 Abilify;;Aripiprazole; ;ARIPIPRAZOLE; Aripiprazole			-3.5763831629	4	5		0	-0.23038352			3356	HTR2A	Clc4cccc(N3CCN(CCCCOc1ccc2CCC(=O)Nc2c1)CC3)c4Cl	Microsource	01505851	-1.2524558	1.24231242	-0.38733805	-2.40202276	-0.23038352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095161-05	Rebamipide	170465891	Free Radical Scavenger	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90098-04-7	 ; Rebamipida;REBAMIPIDE; REBAMIPIDE; Rebamipide; Mucosta			-1.5953997122	4	5		0	3.40154492				CAT	Clc1ccc(cc1)C(=O)NC(CC3=CC(=O)Nc2ccccc23)C(=O)O	Microsource	01505310	0.12278978	-1.90651907	-2.41752371	-1.9216182	3.40154492											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249919-01	Nandrolone furylpropionate	170465918		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	7642-64-0		0.0446683592	-7.35	15.6804862005	4	5		-12.766194736	4.78384605	0.0663440482	0.9973074167			O=C4C=C5CC[C@@H]2[C@H](CC[C@]3(C)[C@@H](OC(=O)CCc1ccco1)CC[C@@H]23)[C@H]5CC4	GVK	FFS-11-286-NCI-187	9.65127701	-1.02091021	-1.05516228	-0.53097345	4.78384605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163150-07	Clenbuterol	170465955	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	37148-27-9				-9.7958750987	4	5		0	-1.92522321					Clc1cc(cc(Cl)c1N)C(O)CNC(C)(C)C	Enzo	AC174	-1.92355423	-2.10003818	-1.42679041	-3.32528828	-1.92522321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167521-02	Tenatoprazole	170465931	Potassium-transporting ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	113712-98-4				-8.8164521584	4	5		0	-1.953125				IDO1	Cc3c(OC)c(C)cnc3CS(=O)c1nc2nc(ccc2n1)OC	Sequoia	SRP011927t	-2.07247456	-2.48186331	-1.98088378	-0.56315366	-1.953125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091414-07	Salicylamide	170465496		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	65-45-2				-11.2035256777	4	5		0	-1.06026786					O=C(N)c1ccccc1O	Vitas	STK301812	-2.66815587	-1.03092783	-3.75398255	-3.03030303	-1.06026786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016636-05	Flavoxate hydrochloride	170466285	Muscarinic acetylcholine receptors; M1 & M2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3717-88-2				-3.3443130573	4	5		0	-0.5859375					Cl.O=C(OCCN1CCCCC1)c4cccc2c4OC(=C(C)C2=O)c3ccccc3	Prestwick	Prestw-242	1.30305287	-3.78006873	-2.95054717	-0.88495575	-0.5859375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00043225-04	Disodium 2-hydroxybutanedioate	170465632		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	676-46-0				-8.7613690572	4	5		0	-2.67857143					[Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O	Specs	AE-562/J255939	-1.72499379	0.06363752	-1.50990442	-3.64709037	-2.67857143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015482-07	Gallamine triethiodide	170465398	Muscarinic M2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	65-29-2	 Triethiodide, Gallamin; ;Gallamine triethiodide; Gallamine triethiodide; Gallamine Triethyl Iodide; Triethyl Iodide, Gallamin;GALLAMINE TRIETHIODIDE; Triethioduro de galamina; Iodide, Gallamoniu; Triethochloride, Gallamin; Iodide, Gallamine Triethy; Gallamine Triethochloride; Flaxedil			-5.5576059121	4	5		0	-0.06775986				ACHE	[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	Enzo	C112	-2.18565815	-0.84870849	-2.44423668	1.2136536	-0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159522-05	Cephalexin	170464982	Cephalosporin antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	15686-71-2				-1.2497120668	4	5		0	1.66689253					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O	SIGMA	33989	-2.48035363	3.99753998	0.22706024	-1.2136536	1.66689253											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159508-04	Rose Bengal disodium	225144230	Free Radical Stimulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94			-4.4384230273	4	5		0	-0.53013393					[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	R3877	-0.26061057	-2.68550337	0.6510597	-3.05711987	-0.53013393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095082-06	Iopanoic acid	170465056		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	96-83-3				-2.236277576	4	5		0	4.35018295					Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O	Microsource	01503923	-3.31532416	3.11193112	-1.02844931	-1.13780025	4.35018295											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263530-01	Lafutidine	170465978	Histamine H2 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	118288-08-7				4.0142617168	4	5		0	4.51280661				HRH2	O=S(CC(=O)NC/C=C\COc2cc(CN1CCCCC1)ccn2)Cc3ccco3	Sequoia	SRP01115l	-1.59626719	2.81672817	-0.5209029	2.85714286	4.51280661											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181915-01	Mepranoprofen arbamel	144206887		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	118635-52-2	Y-23023; 			-10.5198536057	4	5	N,N-DCDBPA;CIPLUS_747910;N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-1-benzopyrano(2,3-b)pyridine-7-acetate;LS-172989;Tilnoprofen Arbamel;TILMICOSIN PHOSPHATE;Mepranoprofen Arbamel;Mepranoprofen arbamel;CIPLUS_741518;TILNOPROFEN ARBAMEL;Y-23023;CIPLUS_3889595;Tilnoprofen arbamel;Tilmicosin Phosphate;Tilmicosin phosphate;tilnoprofenum arbamelum;THYMOSTIMULIN TILNOPROFEN ARBAMEL;Y 23023;MEPRANOPROFEN ARBAMEL;	0	0.06775986					CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1	Pharmaron	PH-NIH-7	-2.92239686	-0.13530135	-3.11206091	-4.12136536	0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016692-05	Bromperidol	170465873	Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	10457-90-6		8.9125093813	-5.05	0.8797119257	4	5		11.4754813719	9.73772321	0.1354478003	0.9252263314			Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Br)cc3	Microsource	01505972	-2.41995532	0.98001782	-2.47956781	-1.23357468	9.73772321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024868-09	Bisoprolol fumarate	170464815	beta1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104344-23-2	;Bisoprolol fumarate; Zebeta; ; Bisoprolol hemifumarate; Bisoprolol Hydrochloride; Bisoprolol fumarate; Bisoprolol hemifumarate salt; Bisoprolol, (+-)-Isomer; Bisoprolol, (-)-Isomer;Bisoprolol hemifumarate salt; 3   Bisoprolol Fumarate; Prestwick-05A11;BISOPROLOL FUMARATE			-6.3049943708	4	5		0	0.50142296			153	ADRB1	O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C	Microsource	01505704	-3.31532416	2.32472325	-2.12368105	-0.9608091	0.50142296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249893-01	Lodoxamide	170465346	type I hypersensitivity Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53882-12-5				6.0224752346	4	5		0	4.16045535					Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O	GVK	FFS-11-286-NCI-60	-0.29469548	1.66051661	1.2154401	2.07332491	4.16045535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016613-10	Antazoline hydrochloride	170464765	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2508-72-7				-7.0574179731	4	5		0	-0.83705357					Cl.C(c1ccccc1)N(CC2=NCCN2)c3ccccc3	Microsource	01500126	-1.27823281	-2.86368843	-1.14974373	-1.79672835	-0.83705357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016612-05	Sulfadoxine	170464751	Dihydropteroate Synthase (DHPS) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2447-57-6	; Sulfadoxine Roche Bran; Ro 4439; Ro 4 439; Sulphorthodimethoxine; Ro 4-4393; Sulphormetoxin; Sulformetoxine; Suldox; Ro 6-2153; Borgal; Sulfadoxin;SULFADOXINE; Fanasil; Fansimef; Sulfadoxina; Sulfadoxine;Sulfadoxine			-2.6796887129	4	5		0	1.69399648					O=S(=O)(Nc1ncnc(OC)c1OC)c2ccc(N)cc2	Microsource	01506086	-1.6453831	-1.93111931	-0.81474556	1.4664981	1.69399648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015708-15	Maprotiline hydrochloride	170464778	Noradrenaline Reuptake Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	10262-69-8	 ; Ciba 34276 Ba;MAPROTILINE HYDROCHLORIDE; Maprotilene Hydrochloride; Maprotiline hydrochloride;Maprotiline hydrochloride; Maprotilline HCl; Ludiomil; Maprotilina;Maprotiline	8.9125093813	-5.05	72.7871736229	3	5		110.6387230321	105.12569832	0.0033846927	0.9983035354		SLC6A2	CNCCCC24CCC(c1ccccc12)c3ccccc34	Vitas	STK711156	-4.18187348	-1.2825302	1.30663085	2.79353994	105.12569832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262929-01	BIBR-1048	170466107	Thrombin Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	211915-06-9	Bibr 1048;BIBR-1048 (Dabigatran);3-((2-((4-Amino((e)-hexyloxycarbonylimino)methyl)-phenylamino)methyl-1-1h-benzoimidazole-5-carbonyl)pyridin-2-yl-amino)propionic acid ethyl ester;Dabigatranum etexilatum;Dabigatran etexilate; Dabigatran etexilate			-0.2645036728	4	5		0	-0.28459141				F2	O=C(OCCCCCC)\N=C(\N)c1ccc(cc1)NCc3nc2cc(ccc2n3C)C(=O)N(CCC(=O)OCC)c4ccccn4	GVK	FFS-12-73-NCI-1548	-0.56483301	-1.83271833	0.62775477	2.62958281	-0.28459141											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015771-13	Orphenadrine dihydrogen citrate	170464910	Muscarinic Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4682-36-4	; ; Mebedrol; Norgesic forte; Orphenadrine citrate salt; Orfenadrina; Orphenadrine Hcl;ORPHENADRINE CITRATE;Orphenadrine dihydrogen citrate; Orphenadrine hydrochloride;Orphenadrine hydrochloride	14.1253754462	-4.85	13.7296289325	4	5		14.599639376	12.69819759	0.2099455326	0.8758553875		CHRM1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C	Microsource	01500447	2.60314342	2.39852399	-1.74969948	-1.49178255	12.69819759											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015110-09	Aminoglutethimide	170465259	Aromatase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	125-84-8	 (S)-(-)-Aminoglutethimide; (+-)-p-Aminoglutethimide;(?)-p-Aminoglutethimide; Glutethimide, para-amino; (?)-p-Aminoglutethimide;AMINOGLUTETHIMIDE; (R)-(+)-Aminoglutethimide;Glutethimide, para-amino;p-Aminoglutethimide; Orimeten; p-Aminoglutethimide; ;Aminoglutethimide (Cytadren); Cytadren;Aminoglutethimide; Aminoglutetimida			6.058721856	4	5		0	3.23892126			1588	CYP19A1	CCC1(CCC(=O)NC1=O)c2ccc(N)cc2	Vitas	STK802074	-0.02455796	-1.19311193	-0.89488447	7.35777497	3.23892126											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249915-01	Bupranolol	170465802	Beta-3 adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14556-46-8				10.1976132059	4	5		0	3.53706464					Clc1ccc(C)cc1OCC(O)CNC(C)(C)C	GVK	FFS-11-286-NCI-172	2.94695481	2.84132841	-0.33391211	0.48040455	3.53706464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016306-08	D-Cycloserine	170465249	NMDA Glycine-Site Receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68-41-7	D-cycloserine;CYCLOSERINE; Cycloserine;CYCLOSERINE (D);D-Cycloserine;(S)-(-)-Cycloserine; (S)-(-)-Cycloserine			-4.8193402703	4	5		0	-0.79608939			2903	GRIN2A	N[C@@H]1CONC1=O	Microsource	01500215	-2.23540146	0.18677624	0.57394065	-0.87298123	-0.79608939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015558-14	Isoprenaline hydrochloride	170464679	beta-Adrenoceptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	7683-59-2	Isoproterenol;Isoproterenol HCl; Isoprenalina; Isopropyl noradrenaline; Isuprel;(-)-Isoproterenol hydrochloride; ;Isoproterenol hydrochloride; Isoproterenol HCl; Isopreterenol sulfate; Isoproterenol ALSO 123; Levisoprenalina; Isoproterenol hydrochloride;(?)-Isoproterenol hydrochloride;ISOPROTERENOL HYDROCHLORIDE; Luf-Iso; Proternol-L; Isoprenaline Hcl; (-)-Isoproterenol hydrochloride; Proternol-S			-4.3074978149	4	5		0	-3.81284916			153	ADRB1	Oc1ccc(cc1O)C(O)CNC(C)C	Microsource	01500357	-0.41058394	-2.22886316	0.47624863	0.75658373	-3.81284916											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016308-06	Isopropamide	170465291	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	7492-32-2				3.0473961345	4	5		0	0.20327958					CC(C)[N+](C)(CCC(c1ccccc1)(C(N)=O)c2ccccc2)C(C)C	Microsource	01500356	1.94007859	-1.63591636	0.68118071	-0.0505689	0.20327958											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159429-03	Coenzyme Q10	225144226	mitochondrial electron transport	SARS-CoV-2_CPE_SRI	2019_NPC-3.2					-5.7897704456	4	5		0	0.50142296				NDUFV3	COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)C\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CCC=C(C)C	Tocris	3003	-2.38212181	-3.30873309	-1.24215307	-2.07332491	0.50142296											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00018100-08	Fasudil hydrochloride	170466011	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	105628-07-7	;HA-1077; Fasudil; Fasudil (HA 1077); HA 1077 hydrochloride; Eril-S;Fasudil; HA-1077 dihydrochloride			-1.5844913338	4	5		0	-2.38826816			6093	ROCK1	Cl.O=S(=O)(c2cccc1cnccc12)N3CCCNCC3	Enzo	EI233	-0.10644769	-0.41090773	0.42740261	0.55288811	-2.38826816											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095042-09	ThioTEPA	225144216	Cytochrome P450 Oxidase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef			-2.9118417113	4	5		0	-1.71787709				CYP2B6	S=[P](N1CC1)(N2CC2)N3CC3	Microsource	01503324	2.11374696	-1.40704769	-0.67163268	3.60832242	-1.71787709											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00261971-01	Mazaticol	170466055		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	42024-98-6	Mazaticol;Mazaticolum;Pentona;Mazaticol	14.1253754462	-4.85	8.811227972	4	5		14.7697511961	12.58379888	0.1401543547	0.9221571138			OC(C(=O)OC1CC2CCC(C)(C)C(C1)N2C)(c3cccs3)c4cccs4	GVK	FFS-11-286-NCI-243	-0.89720195	1.40704769	2.01489803	-1.89145933	12.58379888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164529-04	1-Stearoyl-rac-glycerol	170465522	Phospholipase A2 group IIA Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123-94-4				-2.0631278059	4	5		0	1.41061453					OCC(O)COC(=O)CCCCCCCCCCCCCCCCC	SIGMA	M2015	-2.14416058	0.65994272	0.59836366	-0.02909937	1.41061453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249892-01	Lexiscan	170465244	Adenosine A2a receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	313348-27-5				-7.6872036936	4	5		0	-2.41620112					CNC(=O)c1cn(nc1)c2nc(N)c3ncn(c3n2)[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O	GVK	FFS-11-286-NCI-48	-1.62712895	-1.83040717	-1.91720601	-0.34919249	-2.41620112											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179669-04	Norethindrone	170464683		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68-22-4				4.8474861214	4	5		0	1.42295704					O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4	Prestwick Chemical, Inc.	Prestw-253	-0.58939096	2.12792128	-1.74969948	6.59924147	1.42295704											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014993-12	Nonanedioic acid	170465358	reactive oxygen species biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123-99-9				3.8863238361	4	5		0	2.6426345			7299		O=C(O)CCCCCCCC(=O)O	Microsource	01500648	-1.71905697	4.90774908	-0.97502337	3.36283186	2.6426345											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181913-02	Difeterol	144206884	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14587-50-9	Difeterol; Difeterol Phosphate; Difeterol Hydrochloride; 	12.5892541179	-4.9	70.2129497325	3	5	CIPLUS_783660;DIFETEROL;Difeterol;difeterolum;difeterol;Difeterol Phosphate;Difeterol Hydrochloride;	116.1868119845	99.00837989	0.000332856	0.9998335511			OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3	Pharmaron	PH-NIH-2	-0.56265207	-1.40704769	-2.11259006	-0.40739124	99.00837989											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179308-04	Fluticasone propionate	170464975	Corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80474-14-2	 Flovent;;Fluticasone propionate (Flonase, Veramyst); Cutivate;Fluticasone propionate			-7.3789266735	4	5		0	-3.92458101				NR3C1	O=C(SCF)[C@@]4(OC(=O)CC)[C@H](C)C[C@H]3C2C[C@H](F)C1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Prestwick Chemical, Inc.	Prestw-997	-2.29622871	-0.61013572	0.10990353	0.23279499	-3.92458101											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51773-92-3		1.4125375446	-5.85	63.7435405659	3	5		52.2905482332	-6.46648045	0.0697930983	0.9969847732		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-4.27311436	-0.88407421	2.01489803	49.00334643	-6.46648045											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015748-17	Nifedipine	170465006	Voltage-gated L-type calcium channel alpha-1C subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	21829-25-4				0.3125282146	4	5		0	-3.50558659					CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2[N+]([O-])=O)C(=O)OC	Specs	AN-153/I100964	-1.47506083	-1.60627568	7.38795946	2.32794995	-3.50558659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181031-03	Hydroxycitronellal	225144317	Transient receptor potential cation channel subfamily M member 8 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	107-75-5				-6.7020862351	4	5		0	0.78125					CC(CCCC(C)(C)O)CC=O	SIGMA	82934	-1.74981385	-0.0127275	-2.17481646	-3.59345669	0.78125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091338-06	4-Chloro-3-methylphenol	170466134		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59-50-7				0.6425176449	4	5		0	1.72991071					Oc1ccc(Cl)c(C)c1	Microsource	01500178	1.52643336	-0.95456281	-1.37138108	-2.65486726	1.72991071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016305-11	Silver sulfadiazine		Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	68-35-9	; Diazin; Silver Sulphadiazine; Ditrim; Sulphadiazine; Sulfadiazine sodium salt; Perfringens Supplement I;Sulfadiazine; ;SULFADIAZINE; Tibirox; Diaziprim Forte; Silver(I) sulfadiazine; SPS Agar Supplement; Tribrissen; Zinc Sulfadiazine; Sulfadiazina sodica; Sulfazine; Triglobe; Silvadene; Sterinor; Sulfadiazine; Sulfadiazina; Sulfazin; Sulfadiazine, Zin			-13.9269738825	4	5		0	-1.3671875					NC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC=CC=N2	SIGMA	S8626	-3.56167784	-4.39098893	-1.53760909	-3.08393671	-1.3671875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159477-05	Phenylacetic acid	170465102		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103-82-2		0.2818382931	-6.55	5.0764347681	4	5		6.427530816	-1.18715084	0.7239017788	0.4183047955			OC(=O)Cc1ccccc1	Vitas	STK297835	-0.53223844	-1.60627568	10.22102821	0.02909937	-1.18715084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249918-01	Estriol tripropionate	170465876		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2236-31-9				-1.3928507758	4	5		0	0.43296089					CCC(=O)Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2C[C@@H](OC(=O)CC)[C@@H]1OC(=O)CC)c4cc3	GVK	FFS-11-286-NCI-183	0.77554745	-1.85531067	-2.45451215	-0.20369562	0.43296089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178317-03	Foscarnet trisodium	170465060	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63585-09-1				-5.9379996812	4	5		0	-1.18715084					[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O	Microsource	01502019	-2.23540146	-1.0833022	-0.03663451	-0.17459625	-1.18715084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016281-11	Phenacetin	170465554	Prostaglandin G/H synthase 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	62-44-2				-6.2019552212	4	5		0	-3.29241071			403544	PTGS1	CCOc1ccc(cc1)NC(C)=O	Vitas	STK011463	-1.87391412	2.91459845	-2.81202383	-0.48270314	-3.29241071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095166-04	Clopidol	170465668		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2971-90-6				-9.6900462538	4	5		0	-2.79017857					Oc1c(Cl)c(C)nc(C)c1Cl	Vitas	STK802181	-1.97319434	-3.75461372	-1.53760909	0	-2.79017857											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00024842-05	Clomethiazole	170466516		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	533-45-9				-1.621178067	4	5		0	-0.92075893					ClCCc1scnc1C	Tocris	0881	-1.00521221	-5.35827924	2.50727248	4.18342719	-0.92075893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016246-09	Chlorhexidine	170464748	N-Acetyltransferase Eis (Mycobacterium tuberculosis) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane			-3.1076823639	4	5		0	-2.27653631			4312	MMP1	Clc2ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)cc2	Vitas	STK089248	-0.22810219	-2.22886316	4.1396996	-3.31732868	-2.27653631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024715-05	L-Arginine	170465748		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74-79-3				5.3037710137	4	5		0	0.74022346					N[C@@H](CCCNC(=N)N)C(=O)O	Tocris	0663	-1.01885645	1.2825302	2.67431921	3.02633493	0.74022346											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00167488-08	Sorafenib	170465175	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar			5.8655187325	4	4		0	-2.72142504			2321	FLT1	O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1	Sequoia	284461-73-0	2.31996133	2.68870252	2.54533885	-2.72142504												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024778-02	Bifemelane	170465900	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	90293-01-9		12.5892541179	-4.9	100.0308597255	3	4		115.2326794394	92.77585354	0.0221111272	0.9996983454			CNCCCCOc2ccccc2Cc1ccccc1	Tocris	0767	0.19333011	-0.41933892	-1.71810372	92.77585354												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00532497-01	CEFPODOXIME			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.9113226721	4	4		0	-0.28653295					COC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)C3=CSC(=N3)N)C2=O)C(O)=O	Alfa Aesar	J66225	-0.93676815	-1.37753911	-0.48952951	-0.28653295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179240-04	Levocabastine hydrochloride	170465061	Neurotensin receptor type 2 Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	79547-78-7				-1.240246231	4	4		0	-0.19102197			23620	NTSR2	Cl.Fc1ccc(cc1)[C@@]2(CC[C@H](CC2)N3CC[C@@]([C@H](C)C3)(c4ccccc4)C(=O)O)C#N	Prestwick Chemical, Inc.	Prestw-1039	-0.23419204	0.21013308	-0.92466685	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262957-01	Tobicillin	170466044		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	151287-22-8	Tobicillinum;Tobicilline;Tobicillin			-4.0938255817	4	4		0	-1.1938873					CC(C)C(=O)OCc4cc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C)ccc4	GVK	FFS-11-286-NCI-195	-0.84309133	-0.30352557	-1.19662769	-1.1938873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015774-06	Oxatomide	170466059	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60607-34-3		10	-5	68.1735485299	3	5		99.957734783	92.97486034	0.0006836683	0.9996580399	3269	HRH1	O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4	Enzo	EI114	-1.38381995	0.53542523	-1.1356698	2.3861487	92.97486034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015691-06	Cysteamine hydrochloride	170466795	Protein-glutamine gamma-glutamyltransferase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	156-57-0				-3.9989889419	4	5		0	-0.68435754			7052	TGM2	Cl.NCCS	Microsource	01504226	-4.12104623	3.74797659	1.06240078	1.1348756	-0.68435754											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182987-01	Esonarimod	144206833	cytokine production involved in inflammatory response Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	101973-77-7	Esonarimod; 			-2.7720161921	4	5	LS-171798;Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-;esonarimod;ESONARIMOD;CIPLUS_704625;KE-298;2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid;(?)-3-MERCAPTO-2-(P-METHYLPHENACYL)PROPIONIC ACID ACETATE;esonarimodum;KE 298;Esonarimod;	0	-1.41061453					Cc1ccc(cc1)C(=O)CC(CSC(C)=O)C(=O)O	Pharmaron	PH-NIH-151652	-1.01885645	0.06225875	0.94028575	-0.75658373	-1.41061453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015611-18	Lidocaine	170464729	Sodium channel protein type IX alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	137-58-6				-0.4858648357	4	5		0	-2.69553073					O=C(Nc1c(C)cccc1C)CN(CC)CC	Vitas	STK552033	-1.77919708	2.05453866	0.86701673	3.98661429	-2.69553073											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015959-09	Sanguinarine	170466353	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2447-54-3				-2.7865581956	4	5		0	-6.38268156			100009298	PPP1CA	C[n+]2cc1c6OCOc6ccc1c3ccc4cc5OCOc5cc4c23	Tocris	2302	3.20863747	-2.72693313	0.89143974	0.29099374	-6.38268156											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00095150-08	Telmisartan	170464873	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	144701-48-4	; Telmisartan and diuretics;Telmisartan; Telmisartan; Micardis; Telmisartan Sodium;TELMISARTAN			0.3733238785	4	5		0	5.09776536			189	AGT	O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(C)c4nc3CCC)c6nc5ccccc5n6C	Microsource	01505261	-2.50912409	-1.38214419	2.30797411	0.81478248	5.09776536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015594-09	LOXOPROFEN SODIUM			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80382-23-6				-5.3451870782	4	5		0	-2.44413408					CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1	Sequoia	80382-23-6	-1.35340633	-0.13696924	-1.16009281	-0.14549687	-2.44413408											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182987-01	Esonarimod	144206833	cytokine production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	101973-77-7	Esonarimod; 			2.6583915241	4	4	LS-171798;Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-;esonarimod;ESONARIMOD;CIPLUS_704625;KE-298;2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid;(?)-3-MERCAPTO-2-(P-METHYLPHENACYL)PROPIONIC ACID ACETATE;esonarimodum;KE 298;Esonarimod;	0	-0.15835313					Cc1ccc(cc1)C(=O)CC(CSC(C)=O)C(=O)O	Pharmaron	PH-NIH-151652	-0.11770245	3.27070285	0.72894168	-0.15835313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016551-04	Meprylcaine hydrochloride	170466009	"Sodium channel alpha subunits; brain (Types I, II, III) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	956-03-6				-0.6348853147	4	4		0	0.79176564					Cl.CC(C)(COC(=O)c1ccccc1)NCCC	Prestwick Chemical, Inc.	Prestw-1064	-0.96516008	-0.27835769	0.45896328	0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160387-04	Clothiapine	170465938	GABA-A receptor; benzodiazepine site Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2058-52-8		11.220184543	-4.95	12.2911108693	4	4		10.837160748	8.60385326	0.4159385415	0.8773418138			CN1CCN(CC1)C3=Nc4ccccc4Sc2ccc(Cl)cc23	Enzo	D108	2.2834275	-1.53096729	-0.29697624	8.60385326												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016009-19	Tolazamide	170465136	ATP-sensitive inward rectifier potassium channel 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1156-19-0				-2.0337731697	4	4		0	-0.36949063					Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2	Enzo	KC135	-0.40018832	-0.41753653	-0.56695464	-0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015856-10	Prochlorperazine dimaleate	170464761	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	84-02-6	; ;Prochloperazine dimaleate; Proclorperazina; Prochlorperazine dimaleate; Compazine syrup;Prochlorperazine; Compro; Compazine;Prochlorperazine dimaleate; Maleate, Prochlorperazin	8.9125093813	-5.05	113.0818938205	3	4		129.3326258642	104.77698601	0.0042099371	0.9999890683	1813	DRD2	O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Prestwick Chemical, Inc.	Prestw-399	-0.82391714	-0.90466249	0.29697624	104.77698601												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178782-04	Dicloxacillin sodium salt monohydrate	170465296	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	13412-64-1				-3.7107728092	4	4		0	-1.20098039					[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(Cl)cccc1Cl)[C@H]4SC3(C)C	Microsource	01500238	-0.47883065	0.1029601	-2.37828763	-1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179652-04	Nalbuphine hydrochloride		Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	23277-43-2				2.9012198353	4	4		0	-1.05392157					O[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CCC6	Axon Medchem	1577	1.38608871	-0.20592021	0.41969782	-1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181307-01	Febantel	144206335		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	58306-30-2	Febantel; Bayer brand of febantel; Rintal; Armadose; 			-4.6498529998	4	4	N-{2-[2,3-Bis-(methoxycarbonyl)-guanido]-5-(phenylthio)-phenyl}-2-methoxyacetamide;Bayer brand of febantel;febantel;DIMETHYL ((2-(2-METHOXYACETAMIDO)-4-(PHENYLTHIO)PHENYL)IMIDOCARBONYL)DICARBAMATE;BAY H 5757;FEBANTEL / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / IMIDACLOPRID / IVERMECTIN / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / PYRANTEL EMBONATE;CARBAMIC ACID, ((2-((METHOXYACETYL)AMINO)-4-(PHENYLTHIO)PHENYL)CARBONIMIDOYL)BIS-, DIMETHYL ESTER;Febantel;febantelum;Bay Vh 5757;LS-50021;((2-((methoxyacetyl)amino)-4-(phenylthio)phenyl)carbonimidoyl)bis(carbamic acid), dimethyl ester;Febantelum;2'-(2,3-bis(methoxycarbonyl)guanidino)-5'-phenylthio-2-methoxyacetanilide;Rintal;BAY VH 5757;dimethyl 2-(methoxyacetyl)amino-4-(phenylthio)phenyl(carbonimidoyl)bis(carbamate);CIPLUS_183199;FEBANTEL;Armadose;	0	-2.42647059					O=C(OC)N/C(NC(=O)OC)=N\c2ccc(Sc1ccccc1)cc2NC(=O)COC	FLUKA	33981	-0.63004032	-0.72072072	-1.03525462	-2.42647059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167423-01	Bevonium metilsulfate	144205980	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	5205-82-3	BEVONIUM METILSULFATE; Acabel; Metilsulfato de bevonio; 			-4.6797506301	4	4	Bevonii metilsulfas;Bevonium Methylsulfate;bevonii metilsulfas;bevonium;CIPLUS_213756;metilsulfate de bevonium;Metilsulfate de bevonium;LS-116671;Bevonium methylsulfate;Benzilsaeure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat (German);piribenzil methyl sulfate;bevonium methyl sulfate;BEVONIUM METHYLSULFATE;2-(HYDROXYMETHYL)-1,1-DIMETHYLPIPERIDINIUM METHYLSULFATE, BENZILATE;BEVONIUM METILSULFATE;CG 201;2-(hydroxymethyl)-N,N-dimethylpiperidinium benzilate;Bevonium metilsulfate;Metilsulfato de bevonio;CIPLUS_3883657;CIPLUS_173844;Acabel;bevonium methylsulfate;bevonium sulfate (1:1);Piperidinium, 2-hydroxymethyl-1,1-dimethyl-, methanesulfonate, benzilate;	0	0.17156863					[O-]S(=O)(=O)OC.OC(C(=O)OCC1CCCC[N+]1(C)C)(c2ccccc2)c3ccccc3	Apollo	OR3501T	-1.43649194	-0.87516088	-0.75545607	0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390564-03	GS-7340			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	379270-37-8				-1.3978338277	4	4		0	-1.59313725					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	MedChem Express	HY-15232	0.02520161	-0.36036036	-0.02797985	-1.59313725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015646-05	Fomepizole	170465026	Alcohol Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	56010-88-9	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			-0.4886488718	4	4		0	-0.09896091			124	ADH1	Cl.Cc1cnnc1	Microsource	01505432	-0.33832769	-0.12333498	0.31816736	-0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181914-01	Alloclamide	144206889		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5486-77-1	Alloclamide; Aloclamida; Hexacol; 			-2.891644341	4	4	ALLOCLAMIDE HYDROCHLORIDE;Hexacol;Alloclamide;Alloclamidum;alloclamidum;alloclamide hydrochloride;alloclamide;ALLOCLAMIDE;2-allyloxy-4-chloro-N-(2-diethylaminoethyl)benzamide;264 CE;Aloclamida;LS-25294;CIPLUS_774246;CIPLUS_214111;Alloclamide hydrochloride;Benzamide, 2-(allyloxy)-4-chloro-N-(2-(diethylamino)ethyl)-;	0	-0.49480455					O=C(NCCN(CC)CC)c1ccc(Cl)cc1OCC=C	Pharmaron	PH-NIH-93	-0.8699855	0.66600888	-1.14540248	-0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095048-06	Pipobroman	170465158	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	54-91-1				-0.9477282908	4	4		0	0.13154433					O=C(CCBr)N1CCN(CC1)C(=O)CCBr	Microsource	01503393	0.24213075	-1.25470514	-0.63339245	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164526-02	Camylofin	170465936	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	54-30-8				5.617858489	4	4		0	1.86792949					CC(C)CCOC(=O)C(NCCN(CC)CC)c1ccccc1	Labotest	LT03328450	0.968523	1.05395232	0.98809222	1.86792949												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015523-13	Hydroquinone	170464661		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123-31-9				2.9490052582	4	4		0	0.79168728					Oc1ccc(O)cc1	Vitas	STK397446	1.54664089	-0.17266897	-0.63633471	0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159387-03	Laureth 10s	170465561		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	13081-34-0				-5.3859714695	4	4		0	-1.97921821					OCCOCCSCCCCCCCCCCCC	Labotest	LT00000347	-1.06331561	-1.1100148	-0.4454343	-1.97921821												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015074-14	Acetazolamide	170464692	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59-66-5				1.8144882791	4	4		0	4.00791687					O=S(N)(=O)c1nnc(NC(C)=O)s1	Specs	AN-153/I110543	-0.09666506	-0.76467686	-1.78173719	4.00791687												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00248905-02	(1S,2R,5S)-(+)-Menthol	225144344	Transient receptor potential cation channel subfamily A member 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	15356-60-2				-3.104520075	4	4		0	-0.76408787			8989	TRPA1	CC(C)[C@H]1CC[C@H](C)C[C@@H]1O	SIGMA	224464	-1.07728337	0.25682933	0.05439217	-0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386699-01	Fluphenazine decanoate dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	2376-65-0		12.5892541179	-4.9	51.8805791464	3	4		83.0065191295	69.67526266	0.0135501763	0.9998867561			CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1	Axon Medchem	2127	-0.51522248	0.35022181	1.25101985	69.67526266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184998-02	Dopexamine	170466408	D(2) dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	86197-47-9				-5.107699578	4	4		0	-1.05392157			1813	DRD2	Oc2ccc(CCNCCCCCCNCCc1ccccc1)cc2O	APAC	877916	-1.63810484	0	-0.19585898	-1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160621-08	Dextrose			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	50-99-7				-0.9889718763	4	4		0	0.41666667					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	MedChem Express	HY-B0389	-0.12600806	-0.30888031	-1.09121433	0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347676-02	Schisandrol B		MAPK signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	58546-54-6				-1.4566055343	4	4		0	3.94607843					COC1=CC2=C(C(=C1OC)OC)C3=C(OC)C4=C(OCO4)C=C3C[C@H](C)[C@@](C)(O)C2	MedChem Express	HY-N0692	-1.63810484	-0.51480051	0.19585898	3.94607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378997-07	Micafunginsodium			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	208538-73-2				3.1295304423	4	4		0	1.49509804					CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)C5[C@@H](O)[C@@H](C)CN5C(=O)C(NC(=O)C(NC(=O)C6C[C@@H](O)CN6C(=O)C(NC4=O)[C@@H](C)O)[C@H](O)[C@@H](O)C7=CC=C(O)C(=C7)O[S+](O)([O-])=O)[C@H](O)CC(N)=O	Bio Vision	2585	-0.27721774	1.02960103	2.09848909	1.49509804												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00024025-05	Dehydrocholic acid	170465502	bile acid secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	81-23-2				-2.1945594698	4	4		0	0.60510392			1045		O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)C(=O)C[C@H]2[C@H]3C(=O)C[C@@H]1CC(=O)CC[C@@]12C	Prestwick	Prestw-123	-1.21065375	0.30112923	-0.78540664	0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015826-13	Perphenazine	170464834	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	58-39-9		12.5892541179	-4.9	106.2828109905	3	4		120.5381646602	97.42173112	0.0155698918	0.9998504532	1128	CHRM1	OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Microsource	01503934	0.3874092	-0.45169385	-0.93742083	97.42173112												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022819-04	Ipratropium bromide		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	66985-17-9	; Berodual; Atrovent; Bronchodual;Ipratropium bromide; fenoterol-ipratropium IK6; Duovent; Bromuro de ipratropio; Ipratroprium bromide; Iprafen			7.3397745843	4	4		0	3.56259278					CC(C)[N+]1(C)[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	SIGMA	I1637	2.27162881	0.12333498	-0.82723513	3.56259278												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094906-06	Nefopam hydrochloride	170465579	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	23327-57-3				-2.6389376725	4	4		0	-0.84116774					Cl.CN1Cc3ccccc3C(OCC1)c2ccccc2	Microsource	01501137	-0.28999517	-1.20868278	-0.31816736	-0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00522020-01	Butropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	29025-14-7				-0.4635199925	4	4		0	0.42979943					CCCCOC1=CC=C(C[N+]2(C)C3CCC2CC(C3)OC(=O)[C@H](CO)C4=CC=CC=C4)C=C1	Toronto Research	B690080	-1.03044496	-0.02334812	2.66521621	0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182066-02	Fluprednidene acetate	144206681		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1255-35-2	fluprednidene acetate; Decoderm; 			-3.1796776417	4	4	LS-172629;SQ-20918;9A-FLUORO-16-METHYLENEPREGNA-1,4-DIENE-11B,17A,21 TRIOL-3,20-DIONE,21 ACETATE;Decoderm;Fluprednidene acetate;fluprednylidene acetate;CIPLUS_157986;fluprednidene acetate;FLUPREDNIDENE ACETATE;Hermal brand of fluprednidene acetate;Boots brand of fluprednidene acetate;	0	-0.6127451					CC(=O)OCC(=O)[C@@]4(O)C(=C)CC3C2CCC1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Kemprotec	1255-35-2	-0.78125	-1.23552124	0.19585898	-0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159423-03	Phytonadione	170464798	Vitamin K epoxide reductase complex subunit 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	84-80-0				3.0510860885	4	4		0	0.56372549			79001	VKORC1	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O	Labotest	LT00452032	0.63004032	0.25740026	1.20313374	0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165883-04	Rufinamide	170465202	Sodium channel protein type IX alpha subunit Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	106308-44-5				0.0821963921	4	4		0	0.51470588					NC(=O)c2cn(Cc1c(F)cccc1F)nn2	Tocris	3828	0.02520161	-0.72072072	0.19585898	0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-13	MK-4827			DPI_SARS-CoV-2_General	2019_NPC-5_CPE			12.5892541179	-4.9	52.6415029519	3	4		81.2647058816	68.50490196	0.0093676887	0.9999458809			NC(=O)C1=CC=CC2=CN(N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	Bio Vision	9462-5	0.07560484	0.41184041	1.37101287	68.50490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163469-03	Monensin sodium salt			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	22373-78-0		0.4466835922	-6.35	54.2435189542	4	4		20.5	21.00490196	0.1951435461	0.9758483059			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	SIGMA	M5273	3.80544355	10.86229086	22.97146055	21.00490196												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00093358-08	Cefotaxime sodium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	64485-93-4				2.4360046031	4	4		0	-0.71078431					CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)COC(C)=O)C3=CSC(=N3)N	SIGMA	C7039	1.33568548	-0.1029601	-0.53161724	-0.71078431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094754-05	Phenacemide	170465322	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	63-98-9				3.1895928456	4	4		0	0.97342805					O=C(Cc1ccccc1)NC(N)=O	Microsource	01500472	0.5811138	-1.20451694	1.79883456	0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023654-13	Captopril	170464644	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	62571-86-2				3.8952738869	4	4		0	1.60484083					OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)CS	Vitas	STK802012	0.92009685	0.80301129	-0.12667849	1.60484083												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167446-02	Methyclothiazide	170465243	Sodium-(potassium)-chloride cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	135-07-9				0.7377888855	4	4		0	0.13154433					NS(=O)(=O)c2cc1c(NC(CCl)N(C)S1(=O)=O)cc2Cl	Bosche	M5731	-1.1622276	0.70263488	2.15353433	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164604-10	Fluvastatin Na			DPI_SARS-CoV-2_General	2019_NPC-2_CPE			11.220184543	-4.95	21.1053826358	4	4		21.5238393999	18.49513286	0.1008873493	0.9936927475			CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C3=CC=C(F)C=C3	Sequoia	SRP01980f	0.92009685	-0.8531995	-0.27869268	18.49513286												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00522017-01	rac Alminoprofen		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	39718-89-3				-0.8087517006	4	4		0	0.36764706					CC(C(O)=O)C1=CC=C(NCC(C)=C)C=C1	Toronto Research	A575150	0.17641129	-0.82368082	-1.37101287	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015883-11	Risperidone	170464925	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	106266-06-2	 ; Risperdal;Risperidone; Risperidone; Risperidal; Risperdal Consta; Consta, Risperda			-0.3545029341	4	4		0	0.22058824			1813	DRD2	CC=5N=C1CCCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	2865	0.47883065	-0.61776062	-1.87465025	0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181019-01	Testosterone isocaproate	144206222		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	15262-86-9	Testosterone isocaproate; Ambosex; Mixogen; 			7.8980223737	4	4	Testosterone 4-methylvalerate;TESTOSTERONE ISOCAPROATE;estrandron;Testosterone Isocaproate;Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-;4-Androsten-17beta-ol-3-one 17-(4-methylpentanoate);Ambosex;testosterone isocaproate;CIPLUS_662693;Testosterone isocaproate;CIPLUS_750718;	0	4.87745098					CC(C)CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	BB_NC-1398	0.68044355	3.34620335	0.25181869	4.87745098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159559-03	Eplerenone	170465283	Mineralocorticoid Receptor (MR) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	107724-20-9	;Eplerenone; ; 9   Eplerenone; Inspra; Eplerenone			-0.9888381492	4	4		0	-1.05392157			4306	NR3C2	O=C(OC)[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@@]65O[C@@H]6C[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45	Tocris	2397	0.17641129	-1.18404118	0.25181869	-1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253601-01	Calcium undecylenate	170465553		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1322-14-1				2.2658494619	4	5		0	0.48681542					[Ca+2].[O-]C(=O)\C=C\CCCCCCCC.[O-]C(=O)\C=C\CCCCCCCC	GVK	FFS-11-286-NCI-082	1.05006105	-0.4045512	0.14803849	0.19143336	0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167467-03	Vecuronium bromide	170465295	Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50700-72-6	 ; Vecuronium bromide;Vecuronium bromide;Vecuronium Bromide; Bromuro de vecuronio; Norcuron			0.9846862214	4	5		0	1.54158215					[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O	Prestwick	Prestw-1359	0.21978022	-0.505689	0.59215396	-0.90930845	1.54158215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091519-09	p-Cresol	170465495		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	106-44-5				-3.483534435	4	5		0	-0.64908722					Cc1ccc(O)cc1	Microsource	01500209	-0.17094017	-1.3147914	-1.08561559	-1.43575018	-0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178404-03	Triamcinolone	170465188		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	124-94-7				1.2120807858	4	5		0	1.70385396					OCC(=O)[C@@]3(O)[C@H](O)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C	Microsource	01500586	0.51282051	-0.9102402	-0.39476931	-0.14357502	1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179366-03	Florfenicol	170465648		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	73231-34-2				1.3438899123	4	5		0	3.0831643					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl	Prestwick Chemical, Inc.	Prestw-955	-0.12210012	-0.4551201	-0.69084629	0.09571668	3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091502-11	Coumarin	170465665	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	91-64-5				0.0080907526	4	5		0	0.16227181					O=C1C=Cc2ccccc2O1	Vitas	STK066167	0.31746032	-0.7079646	1.28300025	-1.5793252	0.16227181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093976-08	Idarubicin hydrochloride	170464627	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57852-57-0	 ; Idarubicina; Idamycin; Idarubicin hydrochloride;Idarubicin HCl; Idarubicin Hcl; 4 Desmethoxydaunorubici; IDARUBICIN HCl; 4 Demethoxydaunorubici; 4-Desmethoxydaunorubicin;Idarubicin; Idarubicin; Hydrochloride, Idarubici;Idarubicin?HCl			-0.9285273048	4	5		0	2.83975659			7153	TOP2A	Cl.CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2ccccc2C(=O)c3c(O)c5C4	Sequoia	57852-57-0	-0.31746032	-0.6573957	-1.38169257	-1.48360852	2.83975659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023064-05	Medroxyprogesterone	170466063		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	520-85-4				0.4642285009	4	5		0	3.65111562					CC(=O)[C@@]3(O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	SIGMA	M6013	-0.36630037	-0.9102402	-0.59215396	-0.76573343	3.65111562											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091231-04	Quinidine hydrochloride monohydrate	170465031	Antimalarial Agents; Cytochrome P450 Cyp2d6 Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	6151-40-2		7.9432823472	-5.1	11.2019142941	4	5		17.684307924	16.71399594	0.0061039129	0.9969468452		CYP2D6	[H][C@@]1(CC2CCN1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12	Prestwick	Prestw-280	0.07326007	-0.9102402	-0.98692327	-0.14357502	16.71399594											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018123-07	Acetylcholine chloride	170464783	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60-31-1				0.4790226505	4	4		0	1.5522231					[Cl-].C[N+](C)(C)CCOC(=O)C	Microsource	01500104	-0.33898305	0.25094103	-0.73473524	1.5522231												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159455-09	Gefitinib	170464828	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	184475-35-2	;Iressa/ZD-1839;Gefitinib; Iressa; Gefitinib			-7.942225044	4	4		0	-2.8676664			1956	EGFR	Fc1ccc(cc1Cl)Nc2ncnc3cc(OC)c(cc23)OCCCN4CCOCC4	Tocris	3000	-1.11380145	-0.75282309	-2.10286293	-2.8676664												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095978-06	Lufenuron	170465736		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	103055-07-8				2.9359980099	4	4		0	2.72142504					Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F	Microsource	01505355	-0.04833253	-0.41933892	0.31816736	2.72142504												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178286-05	Pralidoxime chloride	170465059	Butyrylcholinesterase Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-15-0				-1.0097434592	4	4		0	-0.14844137					[Cl-].O\N=C\c1cccc[n+]1C	Prestwick Chemical, Inc.	Prestw-943	-0.48332528	-0.024667	0.06363347	-0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164571-14	Dutasteride			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	164656-23-9				-0.6421908363	4	4		0	-0.09551098					[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)C3CC[C@]12C)C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	APExBIO	A1659	-0.09367681	-0.25682933	-0.21756867	-0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-09	Belinostat	404904701	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	414864-00-9				-7.5371613084	4	4		0	-1.81470869				HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	MedChem Express	HY-10225	-1.59250585	-1.28414663	-1.74054936	-1.81470869												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013556-15	Liothyronine Sodium		Thyroid hormone receptor beta-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1955-6-1				-5.0947894296	4	4		0	-0.85959885					N[C@@H](CC1=CC(=C(OC2=CC(=C(O)C=C2)I)C(=C1)I)I)C(O)=O	APExBIO	B1779	-1.07728337	-1.23745039	-1.19662769	-0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178575-05	Morantel tartrate	170465696	Neuronal acetylcholine receptor; alpha3/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	26155-31-7				-1.4472594632	4	4		0	-1.05062082					Cc2ccsc2\C=C\C1=NCCCN1C.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503931	-0.42154567	1.51762783	-0.92466685	-1.05062082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179642-03	Isoconazole nitrate	170466012	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	27523-40-6	;Isoconazole; Isoconazol; Travocort; Adestan-G;Isoconazole nitrate (Travogen)			5.0444580967	4	4		0	3.15186246					Clc3ccc(C(OCc1c(Cl)cccc1Cl)Cn2ccnc2)c(Cl)c3	Prestwick Chemical, Inc.	Prestw-127	0.28103044	-0.44361429	3.26353005	3.15186246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016013-06	Trimipramine maleate	170465260	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	521-78-8		10	-5	83.9433123169	3	5		123.4066955573	109.77687627	0.0000984839	0.9999507596			O=C(O)/C=C\C(=O)O.CN(C)CC(C)CN2c3ccccc3CCc1ccccc12	Microsource	01503117	-0.31746032	-1.1630847	-0.78953861	5.50370902	109.77687627											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348365-01	INDOCYANINE GREEN			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3599-32-4				0.7926025524	4	5		0	1.94726166					CC1(C)C(=C\C=C\C=C\C=C\C2=[N+](/CCCC[S]([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)/N(CCCC[S]([O-])(=O)=O)C5=CC=C6C=CC=CC6=C15	SIGMA	I2633	-0.07326007	-0.505689	-0.29607698	0.04785834	1.94726166											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023648-04	Desoximetasone	170464795	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	382-67-2				1.0802920655	4	5		0	4.05679513					OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	SIGMA	D6038	-0.46398046	-1.0619469	-0.69084629	0.19143336	4.05679513											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023699-09	Cephalothin	170465101	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	153-61-7				2.8531449273	4	5		0	-0.32454361			10864	SLC22A7	O=C(O)C=2N3C(=O)[C@@H](NC(=O)Cc1cccs1)[C@H]3SCC=2COC(C)=O	Microsource	01500166	0.9035409	-0.4551201	3.10880829	-0.62215841	-0.32454361											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178054-06	Clarithromycin		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	81103-11-9	;CLARITHROMYCIN;Clarithromycin (Biaxin, Klacid); 6-O-Methylerythromycin; 14-OH-clarithromycin; Claritromicina;Clarithromycin; Erythromycin, 6-O-methyl-; Biaxin			2.0709793309	4	5		0	1.86612576					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	SIGMA	C9742	0.65934066	-0.8091024	-0.69084629	0.71787509	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167540-03	3-Methylindole	170465747	Aryl hydrocarbon receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	83-34-1				-2.0063116986	4	4		0	0.43930636					Cc2cnc1ccccc12	Vitas	STK033388	-0.71979434	-0.02606882	-0.68439063	0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346550-02	Lumacaftor		CFTR Channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	936727-05-8				6.2588261134	4	4		0	3.30635838				CFTR	CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O	Selleck	S1565	0.92544987	-1.12095933	3.15872598	3.30635838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017048-03	Levopropoxyphene napsylate		Kappa Opioid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	5714-90-9				-2.2120200815	4	4		0	0.20809249					O[S+]([O-])(=O)C1=CC=C2C=CC=CC2=C1.CCC(=O)O[C@](CC3=CC=CC=C3)([C@@H](C)CN(C)C)C4=CC=CC=C4	Prestwick	Prestw-1054	-0.71979434	-0.5995829	-0.1579363	0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378916-02	MK-5172			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1350514-68-9				3.7333267517	4	4		0	4					COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	0.15424165	-0.02606882	0.52645433	4												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091110-01	Glutaraldehyde	144204634		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	111-30-8	Glutaraldehyde (Glutaric dialdehyde)			2.9971675488	4	4	glutaral;polyglutaraldehyde;glutaralum;poly(glutaraldehyde);CIPLUS_151232;Glutaral;Sterihyde L;Glutaraldehyde (Glutaric dialdehyde);GLUTARALDEHYDE;pentanedial, homopolymer;Sonacide;Glutaraldehyde solution;CIPLUS_690280;Glutaralum;Glutaric dialdehyde solution;Pentanedial;AB07944785-01;Pentane-1,5-dial;Glutaraldehyde;CIPLUS_765795;GLUTARAL;	0	-0.76300578					O=CCCCC=O	NIEHS	AB07944785	0.15424165	1.38164755	3.15872598	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181134-04	Haloprogin			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	777-11-7		12.5892541179	-4.9	14.4557892594	4	4		20.308483292	18.33526012	0.0939472664	0.9945387872			[Cl]C1=CC(=C([O][CH2][C]#[C][I])C=C1[Cl])[Cl]	Prestwick	Prestw-1269	-0.25706941	1.27737226	0.73703606	18.33526012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	5.0118723363	-5.3	58.5333787648	3	4		60.3321271339	54.80136806	0.0114127372	0.9999196815			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-1.2590799	-0.55207026	1.08943501	54.80136806												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159513-03	Cefprozil	225144231	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	92665-29-7	 ;Cefprozil hydrate; Cefprozilo; Cefprozil monohydrate;CEFPROZIL; cis-Cefprozil			1.9380568908	4	4		0	-0.71033938					C/C=C/C1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O	Selleck	S2544 	1.40435835	0.50188206	0.38003547	-0.71033938												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00017326-05	(1S,9R)-beta-Hydrastine	170465706	GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	29617-43-4				-3.2475230995	4	4		0	0.92081031					CN2CCc1cc5OCOc5cc1[C@H]2[C@@H]4OC(=O)c3c(OC)c(ccc34)OC	Microsource	01500687	-1.4527845	-0.60225847	-1.08943501	0.92081031												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090766-07	Prednisone	170464847	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53-03-2	 Prednisona; ; Dehydrocortisone; Prednisone;Prednisone;; Deltasone;Prednisone (Adasone); 1-Cortisone; Meticorten; Kortancyl; Deltamid			0.5954733982	4	4		0	0.28939753				NRC31	OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Prestwick Chemical, Inc.	Prestw-77	-0.0968523	-0.9033877	1.03876362	0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095133-06	Famciclovir	170464774	antiviral	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104227-87-4	; ; Famciclovir; FAMCICLOVIR;FAMCICLOVIR;Famciclovir			-0.6494614329	4	4		0	-0.4453241					CC(=O)OCC(COC(C)=O)CCn2cnc1cnc(N)nc12	Microsource	01505201	0.77332044	-0.46867292	-1.20903595	-0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015252-12	Cyproheptadine hydrochloride	170465127	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	129-03-3	; ; Cyproheptadine hydrochloride;Cyproheptadine hydrochloride; Dihexazin; 1   Cyprohetadine;Cyproheptadine;CYPROHEPTADINE HYDROCHLORIDE; Viternum; 9   Cyproheptadine; Ciproheptadina; Periactin; Peritol; Antergan	3.9810717055	-5.4	82.2014283838	3	4		79.3065744949	77.48639287	0.0060013223	0.9999777877	9704	HRH1	CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23	Vitas	STK802098	-0.8699855	-1.30735076	-0.25453388	77.48639287												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389841-01	LINACLOTIDE (1 mg/ml)		Heat-stable enterotoxin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	851199-59-2				-4.6110481214	4	4		0	-1.09837631					C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(O)=O)NC(=O)[C@H](CC5=CC=C(O)C=C5)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C)C(=O)N2	Microsource	01504425	-1.07728337	-0.77048798	-0.70709818	-1.09837631												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166037-04	beta-Glycerol phosphate disodium salt pentahydrate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	13408-09-8				1.0486468577	4	4		0	0.02312139					OCC(CO)OP([O-])([O-])=O	SIGMA	50020	0.30848329	-0.65172054	1.00026323	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179493-03	Solanine alpha		Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	20562-02-1				-0.510768149	4	4		0	0.11560694					C[C@H]1CC[C@@H]2[C@@H](C)[C@H]3[C@H](C[C@H]4[C@@H]5C\C=C6\C[C@H](CC[C@]6(C)[C@H]5CC[C@]34C)O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)N2C1	Prestwick	Prestw-NAT-0174	-0.25706941	-0.5995829	0.68439063	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182058-01	Doxercalciferol			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	54573-75-0				5.4647358143	4	4		0	4.04624277					[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3/CC(=C)[C@@H](O)C[C@@H]3O)[C@H](C)\C=C\C(C)C(C)C	Axon Medchem	1746	0	0.9645464	2.52698078	4.04624277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182972-01	Hexocyclium	144206775	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	115-63-9	4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium; Metilsulfato de hexociclo; 			-3.0972573617	4	4	HEXOCYCLIUM METHYLSULFATE;Hexocyclium Methylsulfate;Metilsulfato de hexociclo;4-(.BETA.-CYCLOHEXYL-.BETA.-HYDROXYPHENETHYL)-1,1-DIMETHYLPIPERAZINUM METHYLSULFATE;LS-113656;LS-113657;4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium;Hexocyclium metilsulfate;hexocyclii metilsulfas;Hexocyclii metilsulfas;Tral;hexocyclium;metilsulfate d'hexocyclium;Metilsulfate d'hexocyclium;hexociclium;CIPLUS_679015;CIPLUS_669959;CIPLUS_3863310;hexocyclium methylsulfate;CIPLUS_166714;TRAL;Hexocyclium;HEXOCYCLIUM METILSULFATE;	0	-0.43930636					OC(CN1CC[N+](C)(C)CC1)(c2ccccc2)C3CCCCC3.[O-]S(=O)(=O)OC	NCI	NSC_30256	-0.97686375	-0.2346194	-0.1579363	-0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161327-01	Calcitriol	26754891	Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	32222-06-3	; ;Calcitriol (Rocaltrol); Receptors, Calcitriol; 1(alpha),25-DIHYDROXYVITAMIN D3;Calcitriol; Calcitriol			2.0723753343	4	4	Receptors, Calcitriol;Calcitriolum;9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-;1alpha,25-Dihydroxyvitamin D3;RO-21-5535;CIPLUS_177636;Calcitriol;1,25-dihydroxyvitamin D3 monoglucuronide;1(alpha),25-DIHYDROXYVITAMIN D3;calcitriol glycoside;1,25-DIHYDROXY VITAMIN D3;CIPLUS_701127;1,25-DVDMG;calcitriolum;NCGC00161327-02;NCGC00161327-03;1 alpha,25-dihydroxy-previtamin D(3);1,25-dihydroxycholecalciferol glycoside;beta-D-Glucopyranosiduronic acid, (1alpha,3beta,5Z,7E)-dihydroxy-9,10-secocholesta-5,7,10(19)-trienyl;1,25-DIHYDROXYCHOLECALCIFEROL;HS_1248;LS-53093;CIPLUS_710322;1,25-dihydroxy-previtamin D(3);1,25-dihydroxytachysterol;1alpha,25-Dihydroxycholecalciferol;HS_234;9,10-secocholesta-5(10),6,8-triene-1,3,25-triol, (1 alpha,3 beta,6Z)-;Rocaltrol;CALCITRIOL;rocaltrol;1,25-dihydroxy-previtamin D(3), (1alpha,3alpha,6Z)-isomer;CIPLUS_682461;calcitriol;	0	1.0867052			7421	VDR	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC\C2=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	BIOMOL	BIOMOL_DM200	-0.71979434	1.64233577	2.79020795	1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095158-08	Secnidazole		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3366-95-8				15.6985201479	4	4		0	1.85185185					CC(O)C[N]1C(=NC=C1[N+]([O-])=O)C	Prestwick	Prestw-1340	4.29389313	1.75026123	1.99004975	1.85185185												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00167460-03	CeftizoximNa		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	68401-82-1				0.1106976288	4	4		0	-0.55055055					[H][C@@]2(NC(=O)C(=N\OC)\C1=CSC(N)=N1)C(=O)N3C(=CCS[C@]23[H])C([O-])=O	Enzo	AC3053	-0.90648855	-0.07836991	4.13720869	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386241-01	Avanafil		Phosphodiesterase 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	330784-47-9				1.0412388674	4	4		0	-0.1001001					COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N3CCC[C@H]3CO)C(=O)NCC4=NC=CC=N4)C=C1	Selleck	S4019	0.71564885	-1.43678161	0.41895784	-0.1001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345885-04	Etravirine		P-glycoprotein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	269055-15-4				-3.0883247958	4	4		0	-0.7007007					CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	MedChem Express	HY-90005	-0.38167939	-1.43678161	-0.83791568	-0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263544-01	Dexrazoxane hydrochloride	170464709	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	24584-09-6	Dexrazoxane hydrochloride;Dexrazoxane Hydrochloride			-0.8913584601	4	4		0	-0.54428501			7153	TOP2A	O=C2CN(C[C@H](C)N1CC(=O)NC(=O)C1)CC(=O)N2	Tocris	3857	-0.38666022	-1.20868278	1.20903595	-0.54428501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015254-20	Clozapine	170464853	Dopamine D4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5786-21-0	;Clozapine; ; clozapine N-glucuronide;CLOZAPINE; Leponex; Clozaril; Clozapine; Clozapina; Clo-Glu	12.5892541179	-4.9	19.9413718805	4	4		26.172605788	21.87036121	0.1513917856	0.9856267238	1815	DRD4	CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23	Enzo	D107	-1.30497825	1.01134682	-2.22717149	21.87036121												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183016-01	Cefteram	144206853		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	82547-58-8	Cefteram; Ro 19-5247; Cefteram Pivoxil; Ro-19-5247; 			-2.1289979847	4	4	7-(2-(2-amino-4-thiazoyl)-2-(methoxyimino)acetamido)-3-((5-methyl-2H-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene carboxylic acid;ceftetrame;CIPLUS_213480;cefteram;Ro 19-5247;CEFTERAM;Cefteram Pivoxil;Ro-19-5247;cefteramum;Cefteram;LS-177691;	0	0.69272637					Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(Cn2nc(C)nn2)CS[C@@H]34)C(=O)O	Pharmaron	PH-NIH-169126	-1.06331561	0.024667	-0.8908686	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015479-19	Genistein	170466848	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein			-1.6032526838	4	4		0	-0.89064819			7153	TOP2A	Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O	Vitas	STK801619	-0.28999517	-0.22200296	0.06363347	-0.89064819												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015036-11	Amantadine hydrochloride	170464860	Dopamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	768-94-5	 Adamantamine fumarate;Adamantamine fumarate;AMANTADINE HYDROCHLORIDE; 1-Adamantylamine;AMANTIDINE; ; Symmetrel; Ambroxol Hydrochloride;Amantadine hydrochloride; Amantadine hydrochloride; 1-Aminoadamantane; Midantan; Amantadina;Amantadine; Adamantine hydrochloride			5.3776553836	4	4		0	1.23701138			1812	DRD1	NC13CC2CC(CC(C1)C2)C3	Vitas	STK298781	-0.19333011	-0.32067094	4.39070951	1.23701138												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015870-27	Quercetin	170466817	Flavone	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6151-25-3	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal			-3.0848500273	4	4		0	-1.58353127				CYP75A12	O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O	Vitas	STK365650	-0.96516008	0.83507307	-0.1349892	-1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00351599-02	Abemaciclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1231930-82-7		7.9432823472	-5.1	38.4531722489	2.2	4		59.4401166243	47.51671442	0.0215812944	0.9997127709		CDK4	CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2	Selleck	S7158	-2.06088993	-0.39691805	12.12945336	47.51671442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408838-01	Piroheptine Hydrochloride		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	16378-22-6				0.6085335007	4	4		0	5.73065903					CCN1CCC(C1C)=C2C3=CC=CC=C3CCC4=CC=CC=C24	Glixx	GLXC-06115	-1.07728337	-0.39691805	-0.92466685	5.73065903												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159503-02	Methylprednisolone acetate	144205275		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	53-36-1	Methylprednisolone acetate; Depo-Medrol; Depo-medrol; Depo-Medrone; 			-1.4941383934	4	4	methylprednisolone acetate, (11beta,16alpha)-isomer;6alpha-METHYLPREDNISOLONE ACETATE;methylprednisolone acetate;NCGC00095841-01;Methylprednisolone Acetate;Methylprednisolone acetate;methylprednisolone acetate, (11beta,16beta)-isomer;6-Methyl Prednisolone Acetate;LS-118505;METHYLPREDNISOLONE ACETATE;11.BETA.,17,21-TRIHYDROXY-6.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE;PREGNA-1,4-DIENE-3,20-DIONE, 21-(ACETYLOXY)-11,17-DIHYDROXY-6-METHYL-,   (6.ALPHA.,11.BETA.)-;Depo-medrol;acetyl-methylprednisolone;(6.ALPHA.,11.BETA.)-11,17-DIHYDROXY-6-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-21-YL ACETATE;Depo-Medrone;methylprednisolone-21-acetate;Depo-Medrol;CIPLUS_148680;	0	0					CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	SigmaAldrich	R201170	-0.32786885	0.25682933	-1.19662769	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167445-02	Eprazinone dihydrochloride	170465851	Neurokinin 1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	10402-53-6				4.1608190513	4	4		0	1.48042025					Cl.Cl.O=C(c1ccccc1)C(C)CN3CCN(CC(OCC)c2ccccc2)CC3	Bosche	E5680	0.74941452	2.40485641	-1.08784335	1.48042025												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00319020-01	NCGC00319020-01	225144374	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-2.988145944	4	4		0	0.48554913					CCCCC[C@@H](O)CC[C@@H]1[C@@H](O)C[C@H]2CC3=C(C[C@@H]12)C=CC=C3OCC(O)=O	GVK	FFS-11-286-NCI-96	-1.23393316	-0.33889468	0.05264543	0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166076-07	Arbutin	170465722	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	497-76-7	Arbutin;ARBUTIN; 0   Arbutin; p-Arbutin;			0.0668983346	4	4		0	1.87283237					Oc1ccc(cc1)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O	SIGMA	A4256	-0.51413882	0.2346194	-0.26322716	1.87283237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179636-04	Clindamycin hydrochloride		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	21462-39-5				6.4292503547	4	4		0	1.59537572					CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Prestwick	Prestw-137	1.79948586	0.33889468	0.57909976	1.59537572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179359-04	Penbutolol sulfate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	38363-32-5		1.77827941	-5.75	37.9606136739	4	4		32.097686376	-1.8265896	1	0.9999354805			CC(C)(C)NCC(O)COC1=C(C=CC=C1)C2CCCC2	Prestwick	Prestw-1043	-1.74807198	-0.9645464	29.79731508	-1.8265896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346667-02	Lornoxicam		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	70374-39-9				0.1454984608	4	4		0	1.04046243				PTGS1	CN1\C(=C(O)/C2=C(C=C(Cl)S2)[S+]1([O-])=O)C(=O)NC3=NC=CC=C3	Selleck	S2047	-0.15424165	-0.13034411	-0.21058173	1.04046243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183865-01	Flugestone	144206781		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	337-03-1				-3.5982015272	4	4	CIPLUS_160491;Flugestonum;CIPLUS_679087;FLUROGESTONE ACETATE;Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-;Fluorogestone acetate;Flurogestone acetate;FLUGESTONE;Flugestona;flugestonum;flugestone;Flugestone;Flurogestone Acetate;Flugestone acetate;LS-118677;	0	-0.11560694					CC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)C1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	NCI	NSC_79327	-1.43958869	0.18248175	0.05264543	-0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159505-03	Octadecanoic acid, monoester with 1,2-propanediol	29215477		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		PROPYLENE GLYCOL MONOSTEARATE; 			-5.5554380792	4	4	CERASYNT PA;CIPLUS_158145;PROPYLENE GLYCOL STEARATE SE;PROPYLENE GLYCOL MONOSTEARATE;CIPLUS_679055;PROPYLENE GLYCOL STEARATE;	0	-2.05205205					CCCCCCCCCCCCCCCCCC(=O)OCC(C)O	SigmaAldrich	S591173	-1.14503817	-1.17554859	-0.78554595	-2.05205205												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165924-04	(S)-Mephenytoin	170465368	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	70989-04-7				4.5019919895	4	4		0	2.15215215					CC[C@]1(NC(=O)N(C)C1=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-1108	1.52671756	-0.86206897	-0.57606703	2.15215215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179009-06	Phenethicillin potassium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	132-93-4				-2.4621143779	4	4		0	0.25025025					CC(OC1=CC=CC=C1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O	Prestwick	Prestw-723	-0.71564885	-1.17554859	0	0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344531-01	Droxidopa	170465890	Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	23651-95-8				-1.5545691227	4	4		0	-0.75075075					Oc1ccc(cc1O)[C@H](O)[C@H](N)C(=O)O	SIGMA	D2384	0.33396947	-1.38453501	-1.25687353	-0.75075075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249891-01	Bromodiphenhydramine	170465292	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	118-23-0		12.5892541179	-4.9	51.0604931172	3	4		82.3326131799	73.52352352	0.0083391488	0.9999571111			Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2	GVK	FFS-11-286-NCI-046	-0.85877863	-1.38453501	-1.04739461	73.52352352												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179306-04	Zuclopenthixol (-)-10-Camphorsulfonic Acid Salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	53772-83-1				-5.0697596459	4	4		0	-2.49184909					OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1	Toronto Research	Z701495	-0.85492228	-0.6094588	-0.85577649	-2.49184909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378669-02	Boldenone Undecylenate			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	13103-34-9				0.3462303522	4	4		0	-0.11644155					C[C@]12CC[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C	MedChem Express	HY-17434	0.07772021	-0.26816187	0.60407752	-0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095121-16	NATEGLINIDE			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	105816-04-4				-3.2584561759	4	4		0	-0.11644155					CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O	Microsource	01504258	-1.37305699	-0.02437835	0.50339794	-0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018218-10	Edaravone	170465935	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	89-25-8	;MCI-186; Developer Z; N-demethylantipyrine; Radicut;1-Phenyl-3-methyl-5-pyrazolone			-0.3639679845	4	4		0	-1.37239377				NT5E	O=C2CC(C)=NN2c1ccccc1	Vitas	STK201315	1.34180791	-0.34794711	-1.05291577	-1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00096014-03	Salsalate	170465545	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	552-94-3				-1.3989917984	4	4		0	0.36949063					O=C(Oc1ccccc1C(=O)O)c2ccccc2O	Specs	AN-153/I262078	-0.4472693	-0.13917884	-0.83693305	0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182990-01	Tandospirone	144206869	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	87760-53-0	Tandospirone citrate; Sediel; 			10.1028341151	4	4	LS-178008;TANDOSPIRONE;Sediel;CIPLUS_196843;CIPLUS_667992;TANDOSPIRONE CITRATE;tandospirone;Tandospirone;tandospironum;SM-3997;sm 3997;(3A-A,4B,7B,7A-A)-HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-BUTYL)-4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE DIHYDROGEN CITRATE;SM 3997;Tandospirone citrate;LS-90979;4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione;	0	0.89733439					O=C4N(CCCCN1CCN(CC1)c2ncccn2)C(=O)[C@@H]5[C@H]3CC[C@H](C3)[C@H]45	Pharmaron	PH-NIH-172250	3.22504708	2.01809325	1.64686825	0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016272-05	Guanethidine sulfate	170464954		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	60-02-6				3.062602281	4	4		0	1.37239377					O=S(=O)(O)O.O=S(=O)(O)O.N=C(N)NCCN1CCCCCCC1	Vitas	STK895063	-0.21186441	-0.90466249	-0.45896328	1.37239377												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00178069-05	Cloperastine hydrochloride	170465832		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	14984-68-0		3.1622776602	-5.5	32.5671841587	3	4		33.5876826719	31.98733175	0.0326392399	0.9993430948			Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-793	-0.87099812	-1.73973556	0.29697624	31.98733175												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016934-06	Nizatidine	170464780	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	76963-41-2				0.0032727889	4	4		0	1.84745315					CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1	Microsource	01505985	-0.6826742	-0.55671538	-0.35097192	1.84745315												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015096-17	Amiodarone hydrochloride	170464920	Muscarinic M3 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1951-25-3	; Ancaron; Kordaron; Amiodarone;Amiodarone; Amiodarona;Amiodarone hydrochloride;Amiodarone?HCl	11.220184543	-4.95	88.6970441534	3	4		93.8476860096	80.60174188	0.0246663299	0.9996245798		CHRM3	CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC	Microsource	02300165	0.87099812	-0.48712596	-0.94492441	80.60174188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094721-07	Methimazole	170464856	Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	60-56-0				-1.3047184403	4	4		0	-0.42227501					S=C1NC=CN1C	Vitas	STK802184	-0.49435028	-0.90466249	0.674946	-0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00161599-09	Troglitazone	170465091	CCL2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	97322-87-7	; Rezulin;GR-92132X;Troglitazone; Troglitazone; Prelay;CS-045;CI-991	10	-5	28.17786975	4	4		19	19.05515967	0.1336694663	0.9888656459	6347	CCL2	Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4	Prestwick Chemical, Inc.	Prestw-1467	1.85969868	3.4098817	1.37688985	19.05515967												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016403-06	Mafenide hydrochloride	170465055	Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	138-37-4				7.9783231157	4	5		0	0.77246239					Cl.O=S(N)(=O)c1ccc(CN)cc1	Vitas	STK083032	-0.09823183	1.46371464	4.58127421	4.80404551	0.77246239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018097-06	Paroxypropione	170465896	Succinate semialdehyde dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	70-70-2				-7.5123556572	4	5		0	2.85946605					O=C(CC)c1ccc(O)cc1	Labotest	LT00855519	-3.53634578	-1.19311193	-1.9901162	-1.23893805	2.85946605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164601-02	Liranaftate	170466057	Fungal Squalene Monooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	88678-31-3	 ;LIRANAFTATE; Liranaftate;Liranaftate; Zefnart; Liranaftato	12.5892541179	-4.9	10.5633454859	4	5		16.534381136	13.7010435	0.2542526684	0.8430331339			COc1cccc(n1)N(C)C(=S)Oc2cc3CCCCc3cc2	Sequoia	SRP01523l	-2.11198428	0.01230012	4.68812609	1.3653603	13.7010435											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263574-01	Diflucortolone valerate	170465700	Annexin A1 Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59198-70-8				-1.9245750765	4	5		0	1.45006098			301	ANXA1	CCCCC(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Sequoia	59198-70-8	-0.78585462	-0.38130381	-1.02844931	-0.8091024	1.45006098											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015703-06	Mecamylamine	170465225	Neuronal acetylcholine receptor; alpha4/beta2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60-40-2				-10.2610899367	4	5		0	-1.06026786					CNC2(C)C1CCC(C1)C2(C)C	Enzo	AC741	-2.91635642	-3.75461372	-0.06926167	-1.98444623	-1.06026786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161602-06	Doxycycline	170465097	Matrix Metalloproteinase (MMP) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	10592-13-9	; ; Monodox;DOXYCYCLINE HYDROCHLORIDE; Doryx; 1   Doxycycline Mono; Doxycycline hydrochloride; Doxycycline SSa; Atridox;Doxycycline; Doxiciclina; Vibramycin; Vibra-Tabs;Doxycycline hydrochloride; 0   Doxycycline Hyclate; Periostat			-5.2257241728	4	5		0	1.07060577			4312	MMP1	Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@H](C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick	Prestw-1399	-3.21709234	-0.97170972	1.2154401	-0.32869785	1.07060577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016418-15	Methoxsalen	170465041	Cytochrome P450 CYP1A2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	298-81-7	 ;METHOXSALEN; Methoxsalen, 8-;Methoxy-8-psoralen; Ammoidin;Methoxsalen;8-Methoxypsoralen; Methoxy-8-psoralen			-7.900657897	4	5		0	0.5859375			1544	CYP1A2	COc1c3occc3cc2C=CC(=O)Oc12	Microsource	01500400	-2.0476545	-2.58368334	-0.34630835	-3.56663985	0.5859375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159469-04	Methoxyphenamine	170465530	Adrenergic receptor beta Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	93-30-1				1.1022397054	4	5		0	2.23607535					COc1ccccc1CC(C)NC	ASDI	500012445	0.56483301	-0.50430504	-0.01335648	-1.79519595	2.23607535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103766-25-2	Gimeracil			4.1438113224	4	5		0	2.66973845			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	-1.15422397	0.03690037	-0.60104181	6.70037927	2.66973845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran	10	-5	78.6702333866	3	5		107.9911737419	100.94866071	0.004475565	0.9977549524		CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	2.76743609	-2.73641339	-2.14711179	2.14534728	100.94866071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015216-17	Chlorpropamide	170464898	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-20-2				5.6089829705	4	5		0	0.3387993					O=S(=O)(NC(=O)NCCC)c1ccc(Cl)cc1	Microsource	01500185	1.8172888	3.18573186	-0.54761587	0.2022756	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164576-04	Lopinavir	170464773	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	192725-17-0	;ABT-738; Lopinavir/Ritonavir;Lopinavir;LOPINAVIR; Lopinavir	12.5892541179	-4.9	40.2883090186	3	5		61.2733887719	55.44111668	0.0158269027	0.9919945775			CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O	Bosche	L2844	-0.76129666	-1.9803198	3.61960732	-1.2642225	55.44111668											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159331-07	CHOLECALCIFEROL		Vitamin D receptor Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	67-97-0				1.027548562	4	5		0	5.81379591					CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	C9756	-1.44891945	1.14391144	-0.20034727	-1.84576485	5.81379591											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160628-03	Rutin trihydrate	170465691	Aldose reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	153-18-4				-8.057812908	4	5		0	-0.75334821					Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O	Enzo	NP266	-2.37031521	-3.90734377	-0.92810639	0.40225261	-0.75334821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015501-09	Apresoline	170464806	Smooth Muscle Relaxant	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			5.7549912239	4	5		0	2.37165179				SMO	Cl.NNc2nncc1ccccc12	Microsource	01500334	0.01241003	1.38729795	0.92810639	2.33306516	2.37165179											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00164615-02	Prulifloxacin	170465849	Antibacterial	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123447-62-1	 ;Prulifloxacin; Prulifloxacin; Sword			7.222289632	4	5		0	4.18755929					CC=5OC(=O)OC=5CN1CCN(CC1)c2cc3c(cc2F)C(=O)C(=C4SC(C)N34)C(=O)O	Bosche	P2859	2.1611002	1.43911439	-1.72298651	0.4045512	4.18755929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015496-08	N,N,N,N',N',N'-Hexamethylhexane-1,6-diaminium	170465837		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60-26-4				-6.7592446611	4	5		0	-0.36590324					C[N+](C)(C)CCCCCC[N+](C)(C)C	Enzo	AC740	-2.92239686	0.87330873	-1.10858822	-1.28950695	-0.36590324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016012-12	Triflupromazine hydrochloride	170465325	Muscarinic acetylcholine receptor M2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1098-60-8		11.220184543	-4.95	57.8312329859	3	5		97.7181634441	78.69630031	0.0032926556	0.9983499331	1129	CHRM2	Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Microsource	01503118	-2.87328094	-0.23370234	1.10858822	5.33501896	78.69630031											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159418-05	Tegafur	170465809	Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	37076-68-9	; S-1 compound; S-1 (combination); ; Tegafur (Ftorafur); UFT protocol; Tegafur; 1-UFT protocol; Franroze; Tegafur-Uracil; TS-1 cpd; S 1 (combination);Tegafur; S-1 cpd; Atillon			10.7179779073	4	5		0	-1.15921788				TYMS	FC1=CN(C(=O)NC1=O)C2CCCO2	Labotest	LT00138127	-0.13686131	7.68272942	7.21699841	2.03695621	-1.15921788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015817-14	Promethazine	170465107		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60-87-7		10	-5	71.876138093	3	5		109.5401033853	97.09987803	0.0004088816	0.9997955235			CN(C)C(C)CN1c3ccccc3Sc2ccccc12	Enzo	AC765	-1.03143418	-1.29151292	-2.23053292	5.25916561	97.09987803											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159474-03	Fluprednisolone	170465086	Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53-34-9				-0.0267810084	4	5		0	-0.0948638					OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	SIGMA	34206	1.32612967	-1.04551046	-0.38733805	-2.02275601	-0.0948638											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160654-06	Ethylparaben	170465715		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	120-47-8				-3.25703532	4	5		0	-2.55586592					Oc1ccc(cc1)C(=O)OCC	Vitas	STK070911	-2.41788321	0.68484622	3.30931738	0.49468936	-2.55586592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016760-08	Carbimazole	170465583		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	22232-54-8				-0.1482657518	4	5		0	-2.38826816					S=C1N(C=CN1C)C(=O)OCC	Microsource	01505323	1.62712895	-1.1331092	0.52509464	-1.3676706	-2.38826816											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249931-01	Docarpamine	170465850	Dopamine D1 receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74639-40-0				-1.3250498019	4	5		0	-3.6452514					CC(=O)N[C@@H](CCSC)C(=O)NCCc1cc(OC(=O)OCC)c(cc1)OC(=O)OCC	GVK	FFS-11-286-NCI-235	-1.04927007	1.50666169	2.55220418	0.72748436	-3.6452514											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182988-01	Acreozast	144206850		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123548-56-1	Acreozast; Acreozst; Adeozast; 			1.484154643	4	5	LS-172573;Acetamide, N,N'-(2-chloro-5-cyano-1,3-phenylene)bis(2-(acetyloxy))-;Acreozst;CIPLUS_706509;TYB-2285;TYB 2285;Acreozast;acreozast;Adeozast;ACREOZAST;acreozastum;3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile;	0	1.50426887					Clc1c(cc(cc1NC(=O)COC(C)=O)C#N)NC(=O)COC(C)=O	Pharmaron	PH-NIH-154940	-2.21021611	2.47232472	1.42914385	2.47787611	1.50426887											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025018-10	Yohimbine	170465467	alpha2-Adrenoceptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	146-48-5	; ; Yohimbine HCL; YOHIMBINE;Yohimbine hydrochloride;YOHIMBINE HYDROCHLORIDE; Yohimbine hydrochloride			12.2007835895	4	5		0	3.83520802			150	ADRA2A	O=C(OC)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23	Microsource	01500663	6.36051081	-0.55350553	-1.85655136	-1.1125158	3.83520802											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090693-11	D-Nicotine	170464932	Neuronal acetylcholine receptor; alpha4/beta2 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	25162-00-9		0.5623413252	-6.25	2.9641799006	4	5		-5.8520859719	-1.04350183	0.5293203136	0.5486249558			CN2CCC[C@@H]2c1cnccc1	Microsource	02300259	0.22102161	8.22878229	-1.08187525	-2.37673831	-1.04350183											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179460-03	Medrysone	170465194	Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2668-66-8				-1.2983779861	4	5		0	3.95251397					CC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3[C@@H](C)C[C@H]12	Prestwick Chemical, Inc.	Prestw-743	-1.47506083	-1.70588968	0.52509464	-0.98937873	3.95251397											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024596-08	Carbidopa	225144194	decarboxylase inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	28860-95-9				-6.3513965184	4	5		0	-0.88087817				DDC	C[C@@](CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	Prestwick	Prestw-1177	-2.03831041	0.52890529	-1.72298651	-1.54235145	-0.88087817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016642-04	Piperacetazine	170465363		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3819-00-9		12.5892541179	-4.9	82.2648471785	3	5		115.9873767406	102.24962732	0.0160625696	0.9918716581			CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-1048	-0.51571709	8.64698647	-1.82983839	2.90771176	102.24962732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167488-08	Sorafenib	170465175	VEGFR-1/2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar	3.1622776602	-5.5	74.6048239495	3	5		42.9608090972	-1.69399648	0.1980497149	0.9750258851	2321	FLT1	O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1	Sequoia	284461-73-0	8.32514735	1.95571956	4.20729264	37.92667509	-1.69399648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00068236-07	Gatifloxacin	170465592	DNA Topoisomerase IV Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	112811-59-3	; Tequin;GATIFLOXACIN;Gatifloxacin; Gatifloxacin Anhydride; Gatifloxacin hydrate; Gatifloxacin Hydrate; Gatiflo; Zymar			1.4846536172	4	5		0	1.82960894			7155	TOP2B	CC1CN(CCN1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK801620	-0.34975669	-0.01245175	-0.69605568	1.80416121	1.82960894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095239-05	1,3,5-Trimethoxybenzene	170465963		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	621-23-8				2.7210962663	4	5		0	1.80167598					COc1cc(cc(OC)c1)OC	Microsource	00231043	0.04562044	-0.26148674	1.99047503	0.1163975	1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095836-05	Guaiazulene	170465862	lipid oxidation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	489-84-9				-0.056199026	4	5		0	5.65642458					CC(C)c1ccc(C)c2ccc(C)c2c1	Microsource	01502249	-1.99209246	-1.95492467	0.50067163	0.61108686	5.65642458											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263583-01	Temocapril hydrochloride	170465944	Angiotensin-I Converting Enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	110221-44-8		0.5623413252	-6.25	18.1374496605	4	5		-15.00152772	-0.65642458	0.6201487372	0.3784281002		ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	Sequoia	110221-44-8	-0.31934307	28.02888806	0.72047869	-1.2512731	-0.65642458											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164544-02	Lanoconazole	170465886	Lanosterol 14-alpha demethylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	101530-10-3				-0.4606332356	4	5		0	1.47716493			3641571	ERG11	N#C\C(=C1/SCC(S1)c2ccccc2Cl)n3ccnc3	Sequoia	SRP01160l	-1.0805501	0.7503075	1.26886603	-1.39064475	1.47716493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183861-01	(2R)-2-Propyloctanoic acid	144206875	S100 beta biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	185517-21-9				-1.9893596423	4	5	Arundic Acid;Acido ar?ndico;(R)-2-Propyloctanoic acid;acidum arundicum;arundic acid;(R)-(-)-2-propyloctanoic acid;CIPLUS_783758;Acide arundique;ONO-2506;Arundic acid;ONO2506;Acidum arundicum;	0	-0.82667028					O=C(O)[C@@H](CCCCCC)CCC	Pharmaron	PH-NIH-183336	1.44891945	-2.0295203	-2.31067183	-1.4664981	-0.82667028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167564-03	8-Bromotheophylline	170465479		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	10381-75-6				-10.1621001936	4	5		0	-0.85195531					O=C2c1nc(Br)nc1N(C)C(=O)N2C	Vitas	STK803299	-3.81690998	-1.70588968	-1.64855294	-0.14549687	-0.85195531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095838-04	Sumatriptan	170465377	5-HT1B Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103628-46-2	; ;SUMATRIPTAN; Sumatriptan; Imigran;Sumatriptan succinate;SUMATRIPTAN SUCCINATE; Succinate, Sumatripta; Imitrex	3.1622776602	-5.5	11.5040030887	4	5		-6.9245810079	-1.18715084	0.6453565926	0.325536993	3351	HTR1B	CNS(=O)(=O)Cc1cc2c(cc1)ncc2CCN(C)C	Microsource	01505372	0.59306569	2.60241564	13.49371108	0.05819875	-1.18715084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164528-04	GLYCERYL LAURATE	225144258	Toxic shock syndrome toxin-1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	142-18-7				9.9485173985	4	5		0	-0.47431901			3552	tst	CCCCCCCCCCCC(=O)OCC(O)CO	SIGMA	M1765	3.978389	3.13653137	0.44076399	0.6068268	-0.47431901											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017324-07	Simvastatin	170464984	HMG-CoA Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	79902-63-9	; Zocor;Simvastatin;SIMVASTATIN	2.8183829313	-5.55	17.0499223179	4	5		14.915520628	5.6240683	0.334081369	0.9247345487	3156	HMGCR	CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801938	-1.59626719	2.64452645	-0.33391211	12.71807838	5.6240683											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181103-02	Propiverine hydrochloride	170466036	Muscarinic acetylcholine receptor Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54556-98-8		12.5892541179	-4.9	50.5984486417	3	5		73.8283103939	66.60794146	0.0026472304	0.998674123			Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3	Sequoia	54556-98-8	0.95776031	-0.35670357	0.54761587	-1.5676359	66.60794146											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015989-17	Thalidomide	170465323	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-35-1	(?)-Thalidomide; ; (+)-Thalidomide; Sedoval; Thalidomide;Thalidomide; Thalomid;thalidomide;THALIDOMIDE; Talidomida; (-)-Thalidomide; (+/-)-Thalidomide; (R)-(+)-Thalidomide; (S)-(-)-Thalidomide; (?)-Thalidomide			-3.2736423196	4	5		0	-3.58938547			7124	TNF	O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O	Microsource	01503607	-2.44829684	2.87635413	2.45451215	0.32009312	-3.58938547											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024309-17	(+)-Diltiazem	170464699	Ca2+ channel blocker, similar pharmacology to verapamil	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	42399-41-7				-9.5749787013	4	5		0	-2.84598214					CN(C)CCN1c3ccccc3S[C@H]([C@@H](OC(C)=O)C1=O)c2ccc(OC)cc2	Enzo	CA205	-2.09729461	-1.8454881	-1.2605624	-1.98444623	-2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015385-18	Dipyridamole	170464694	Phosphodiesterase PDE3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-32-2	; ; Prandiol; Dipyridamole;DIPYRIDAMOLE; Asasantin; Dipiridamol;Dipyridamole; Persantine			-1.0513494676	4	5		0	-0.90782123			8654	PDE5A	OCCN(CCO)c2nc1c(nc(nc1c(n2)N3CCCCC3)N(CCO)CCO)N4CCCCC4	Enzo	EI127	-1.5663017	1.33233719	-0.18317255	2.47344682	-0.90782123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167737-02	Lazabemide hydrochloride	170466038	Monoamine oxidase B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103878-83-7				1.3465913337	4	5		0	0.26536313					Cl.Clc1cnc(cc1)C(=O)NCCN	Tocris	2460	-2.81326034	-1.03349521	4.40835267	5.73257675	0.26536313											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015162-10	Buspirone	170464909	Serotonin 1a (5-HT1a) receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	36505-84-7				7.137949771	4	5		0	-0.79608939					O=C4CC1(CCCC1)CC(=O)N4CCCCN2CCN(CC2)c3ncccn3	Enzo	AC526	2.47871046	-2.10434566	0.30528758	6.28546486	-0.79608939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164593-02	Enalapril acid	170464938		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	76420-72-9				9.1450031057	4	5		0	0.40502793					OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@H](CCc1ccccc1)C(=O)O	Sequoia	76420-72-9	4.42518248	2.22886316	-0.47624863	-0.84388186	0.40502793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013289-09	Pridinol	170465865	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	511-45-5				-2.6813528939	4	5		0	-2.5					OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3	Specs	AG-680/20240026	-2.08333333	1.75569668	1.03797778	1.57136622	-2.5											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093347-05	Mestranol	170465357	Estrogen Receptor (ER) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72-33-3	; Sequens;Mestranol; Infecundin; Aconcen;Ethynylestradiol 3-methyl ether; Norinyl 1-50; Angravid; Estirona; Orthonovin; Bisecurin I; Ovosiston; Ovaras; Ortho Novum; Sequence-Ovosiston; Bisecurin; Sesquelan; ; Ovulen; Ortho-Novum; Norinyl; Femigen; C-quens; Gestranol; Mestranol; Enovid-E			-7.579337408	4	5		0	-2.67857143			2099	ESR1	COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick Chemical, Inc.	Prestw-846	-0.83147183	-2.20185822	-1.39908575	-2.17216412	-2.67857143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016866-11	Pipemidic acid	170465767		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51940-44-4				-10.4424661435	4	5		0	-0.69754464					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCNCC3	Microsource	01502024	-3.38793745	-1.03092783	-2.61809115	-1.55537678	-0.69754464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253579-01	Bolandiol dipropionate	170465909	Androgen Receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1986-53-4				-1.8043267712	4	5		0	-0.11160714					CCC(=O)O[C@H]2CCC3C4CCC1(C)C(CC[C@@H]1OC(=O)CC)C4CCC3=C2	GVK	FFS-11-286-NCI-219	-0.6825515	-1.15820288	0.34630835	0.16090105	-0.11160714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183871-04	N-Acetyl sulfamethoxazole	170466005		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	21312-10-7				-4.3113853475	4	5		0	-0.01396648					Cc2cc(NS(=O)(=O)c1ccc(NC(C)=O)cc1)no2	Specs	AA-504/07985056	-2.78284672	0.03735525	0.3785566	0.81478248	-0.01396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091544-18	Estradiol		Estrogen Receptor (ER) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-28-2		4.4668359215	-5.35	8.5116048114	4	5		13.780450548	10.49107143	0.1379239313	0.9235952697	2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-441	0.16133035	-3.98370879	-0.12467101	4.63931349	10.49107143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182059-03	Febuxostat	170465220	Xanthine Oxidase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	144060-53-7	 ; Febuxostat;Febuxostat			0.0546742994	4	5		0	3.3203125			7498	XDH	CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O	Tocris	4427	-1.05485232	-3.6782487	-0.37401302	3.37892196	3.3203125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016367-08	Succinylsulfathiazole	170465721		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	116-43-8				3.7649511953	4	5		0	0.80915179					O=S(=O)(Nc1nccs1)c2ccc(NC(=O)CCC(=O)O)cc2	Vitas	STK079059	2.56887565	-3.09278351	0.20778501	0.5899705	0.80915179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160527-03	Mosapride citrate	170466008	5-HT4 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	112885-42-4	; Gasmotin; ;Mosapride citrate; Mosapride citrate;AS-4370			-0.7224742244	4	5		0	0.72544643			3360	HTR4	O=C(O)C(O)(CC(=O)O)CC(=O)O.Clc1cc(c(OCC)cc1N)C(=O)NCC3CN(Cc2ccc(F)cc2)CCO3	Vitas	STK711184	-1.30305287	0.44546264	0.29089902	0.91177259	0.72544643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018163-10	Bithionol	170465515	Adenylate cyclase type 10 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	97-18-7		10	-5	12.75972833	2.4	5		32.73062238	28.76674107	0.0061572004	0.9969111246			Oc2c(Sc1cc(Cl)cc(Cl)c1O)cc(Cl)cc2Cl	Specs	AN-153/J117612	-2.271035	-3.52551865	-1.39908575	-1.55537678	28.76674107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095188-05	Pantoprazole	170466337	H+/K+-ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE			5.7180419773	4	5		0	1.82960894				ATP4A	COc3c(OC)ccnc3CS(=O)c1nc2cc(ccc2n1)OC(F)F	Microsource	01505818	2.63077859	-1.73079318	-1.06240078	2.03695621	1.82960894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185770-01	Sucrose octasulfate, sodium salt	144207173		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74135-10-7				-5.4188610879	4	5		0	-0.46089385					[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)O[C@H]1[C@H](O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]1OS([O-])=O)O[C@]2(COS([O-])=O)O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]2OS([O-])=O	Toronto Research	S699020	-0.9580292	-1.83040717	-2.6254732	-0.26189437	-0.46089385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015430-06	Fenoterol hydrobromide	170465657		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1944-12-3				-10.0572687239	4	5		0	-2.58379888					Br.Oc1cc(cc(O)c1)C(O)CNC(C)Cc2ccc(O)cc2	Microsource	01501007	-4.66849148	-1.97982817	1.86836	0.87298123	-2.58379888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016283-04	Diphemanil methylsulfate	170464876	antimitotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	62-97-5	 Vagophemanil; ; Diphemanil; Prantal;Diphemanil methylsulfate; Diphemanil methylsulfate			4.9473265861	4	5		0	-1.06026786					[O-]S(=O)(=O)OC.C[N+]1(C)CC\C(CC1)=C(\c2ccccc2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-79	1.12931248	-2.1509482	7.68804544	-0.32180209	-1.06026786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095152-09	Alfuzosin hydrochloride	170465022	alpha1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	81403-68-1	; Uroxatral ER; ; ALFLUZOCIN;ALFUZOSIN HYDROCHLORIDE; Uroxatral; Alfuzosin Hcl (Uroxatral);Alfuzosin hydrochloride; Afluzosin;ALFLUZOSIN			5.5733211623	4	5		0	-0.16741071			148	ADRA1A	Cl.O=C(NCCCN(C)c2nc1cc(OC)c(OC)cc1c(N)n2)C3CCCO3	Microsource	01505263	5.19980144	-0.39455263	-1.89776977	-3.35210512	-0.16741071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095787-05	(-)-Inosine			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	58-63-9				-4.4863514671	4	5		0	-3.29241071					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=O	Bosche	I0819	0.75701167	-2.53277332	-0.01385233	-2.35988201	-3.29241071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263949-02	Piperacillin sodium salt	170465380	Penicillin-binding protein 2B Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59703-84-3				-4.1305208163	4	5		0	-0.61383929			933948	penA	[Na+].O=C([O-])[C@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)[C@H]4SC3(C)C	Microsource	01500489	-0.4095309	-4.11098384	2.03629312	-2.0917136	-0.61383929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015508-16	Hydrochlorothiazide	170465005	Hypertension treatment	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-93-5	; Moduretic; Dyazide;HYDROCHLOROTHIAZIDE; ; Tenesor; Capozide; Slimin; Hydrochlorothiazide; Esidrix; HydroDIURIL; Tolerzide; Oretic; Sectrazide; Triampur compositum; Spiridazide; Esidrex; Triampur (combination); Hypothiazide; Dihydrochlorothiazide; Hydrochlorothiazid;Hydrochlorothiazide; Dichlothiazide; Maxzide; Triampur; Hidroclorotiazida; Moducren			3.1500506914	4	5		0	1.38268156				SLC12A3	NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl	Specs	AN-153/I107325	2.02250608	0.13696924	-1.28220784	-1.19307435	1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015257-14	Clofibrate	170465329	PPARalpha Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	637-07-0	 ; Aluminium clofibrate; Miscleron; Athromidin; Atromid-S; Atromid S; Miskleron; Clofibrate;Clofibrate; Clofibrato; Atromid;CLOFIBRATE			9.9890191916	4	5		0	-1.9972067			5465	PPARA	Clc1ccc(OC(C)(C)C(=O)OCC)cc1	Microsource	01503429	3.39111922	3.77288009	2.2591281	1.39676997	-1.9972067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181774-02	Chrysarobin	170465659		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	491-59-8		11.220184543	-4.95	7.7071560899	4	5		29.920432224	24.35289335	0.0169140201	0.99144916			Oc2c3c(cc1cccc(O)c12)cc(C)cc3O	Sequoia	491-59-8	-3.68369352	-2.84132841	-0.65446774	-1.74462705	24.35289335											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024357-07	Scopolamine hydrobromide	170464830	Muscarinic Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	114-49-8				-10.1945167345	4	5		0	-0.33482143				CHRM1	Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34	Prestwick Chemical, Inc.	Prestw-877	-4.23181931	-1.36184294	1.23285774	-2.86940198	-0.33482143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183108-01	Propamidine	144206602		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104-32-5	Propamidine; DAPP-Br; Propamidina; 			6.321414562	4	5	Propamidine;Propamidinum;propamidinum;Propamidina;LS-171900;1,3-di-(p-amidinophenoxymethyl)-propane;propamidine;4,4'-(trimethylenedioxy)dibenzamidine dihydrochloride;CIPLUS_209523;DAPP-H;4,4'-(TRIMETHYLEDEDIOXY)DIBENZAMIDINE;CIPLUS_657475;CIPLUS_206886;propamidine diisethionate;1,3-bis(p-amidinophenoxy)propane;1,3-di-(4-amidinophenoxy)propane;PROPAMIDINE;propamidine isethionate;LS-27580;propamidine dihydrochloride;DAPP-Br;4,4'-(trimethylenedioxy)dibenzamidine;	0	2.72394633					N=C(N)c1ccc(cc1)OCCCOc2ccc(cc2)C(=N)N	Beta Pharma	86-41342	0.44204322	-0.50430504	3.56618138	1.89633375	2.72394633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015997-10	Taurine	170465726	Antioxidant	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	107-35-7	L-Taurine;Taurine;l-Taurine; Taurine;TAURINE			-3.4645903768	4	5		0	-0.66404662				CAT	NCCS(=O)(=O)O	Microsource	01505463	-1.15422397	0.92250922	-1.80312542	-0.3034134	-0.66404662											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164034-05	Triclocarban	170465481		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	101-20-2		3.9810717055	-5.4	3.094918477	4	5		16.333581528	9.90513393	0.0233034438	0.9882406069			Clc2ccc(NC(=O)Nc1ccc(Cl)cc1)cc2Cl	Specs	AN-153/I101902	-3.61131794	-1.31093293	-0.12467101	4.85384822	9.90513393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet			-12.8914135	4	5		0	-2.45535714			7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-3.18937702	-2.63459336	-2.11940712	-2.60123357	-2.45535714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015563-13	Imipramine	170464777	Serum paraoxonase/arylesterase 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-49-7		8.9125093813	-5.05	17.215494721	3	5		44.8120263172	34.26339286	0.000164787	0.9999176738	5444	PON1	CN(C)CCCN2c3ccccc3CCc1ccccc12	Enzo	AC813	-3.636138	-3.27096856	-2.97825184	3.88844194	34.26339286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263565-01	Gestodene	170466131	Progestogen hormone	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60282-87-3	Gestodene			1.7374784966	4	5		0	-0.94866071			5241	PGR	O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2C=C[C@@]1(O)C#C)=C4	Bosche	G2883	2.07247456	-1.89639812	0.5679457	-0.67042102	-0.94866071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095133-06	Famciclovir	170464774	antiviral	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104227-87-4	; ; Famciclovir; FAMCICLOVIR;FAMCICLOVIR;Famciclovir			4.5679675807	4	5		0	0.06775986					CC(=O)OCC(COC(C)=O)CCn2cnc1cnc(N)nc12	Microsource	01505201	0.12278978	-0.38130381	7.7066916	-1.18836915	0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095045-05	Sulfanitran	170466141	Eimeria tenella Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	122-16-7				-4.4654321443	4	5		0	-1.98102679					O=S(=O)(Nc1ccc(cc1)[N+]([O-])=O)c2ccc(NC(C)=O)cc2	Microsource	01503339	0.33507074	-0.19091256	-1.48219975	-3.48618933	-1.98102679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024667-14	Methyldopa	170464643	DOPA decarboxylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	41372-08-1	; L-alpha-Methyl DOPA;METHYLDOPA; L-alpha-Methyl-DOPA;Methyldopa; ; DL-alpha-Methyl-DOPA; Methoplain; Metildopa;L-alpha-Methyl DOPA; alpha-Methyl-L-DOPA; L(-)-alpha-Methyldopa;Methyldopa sesquihydrate; Methyldopa (L,-);Methyldopa (L,-); L-Methyldopa; Methyldopa sesquihydrate; Aldomet; L-Alphamethyl Dopa			-3.0249792744	4	5		0	-2.26004464			1644	DDC	O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1	Microsource	01500403	-3.13973691	3.19460354	5.66560465	-2.44033253	-2.26004464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018125-05	Tripelennamine citrate	170465118	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6138-56-3				-3.91420529	4	5		0	-1.3547486					O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCN(Cc1ccccc1)c2ccccn2	Microsource	01500597	-1.65754258	2.17905616	-0.62278667	-1.30947185	-1.3547486											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178754-06	Primaquine diphosphate	174006623	antimalarial	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63-45-6				-5.1225085138	4	5		0	-1.82960894					O=P(O)(O)O.O=P(O)(O)O.CC(CCCN)Nc1cc(cc2cccnc12)OC	Microsource	01500500	-2.72201946	0.21167974	0.94028575	0.69838498	-1.82960894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178480-03	(+)-Tubocurarine chloride hydrochloride	170464882	Small conductance calcium-activated potassium channel protein 2 Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-94-3				-6.4629507387	4	5		0	0.01355197			1135		[Cl-].Cl.Oc7ccc1cc7Oc5cc6[C@H](Cc4ccc(Oc2c3[C@@H](C1)[N+](C)(C)CCc3cc(OC)c2O)cc4)N(C)CCc6cc5OC	Microsource	01500602	-2.40667976	0.25830258	-0.20034727	-2.93299621	0.01355197											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015428-15	(+/-) -Fluoxetine	170465374	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	54910-89-3		4.4668359215	-5.35	102.9158634807	3	4		96.2234766766	92.9242949	0.0021167327	0.9999972365			FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2	Vitas	STK734483	-0.19333011	-0.27133695	1.46356984	92.9242949												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091345-04	Hexanedioic acid	170465352		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	124-04-9				-4.6330676677	4	4		0	-0.79168728					OC(=O)CCCCC(=O)O	Specs	AE-562/J262759	-1.25664572	-0.71534287	-0.8908686	-0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159459-04	Mycophenolate mofetil	170464859	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	7.9432823472	-5.1	29.1663408712	4	4		32.4971751399	28.45077857	0.077905006	0.9962434945	727833	IMPDH1	Oc3c1C(=O)OCc1c(C)c(OC)c3C\C=C(/C)CCC(=O)OCCN2CCOCC2	Sequoia	115007-34-6	-1.24764595	0.83507307	-0.29697624	28.45077857												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164283-07	Hexadecyltrimethylammonium bromide	170465714	Cell membrane Interacts	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-09-0		3.9810717055	-5.4	-7.1518855502	4	5		-7.092178768	-6.32681564	0.5871185938	0.4498969168			[Br-].C[N+](C)(C)CCCCCCCCCCCCCCCC	Microsource	01503200	-1.29257908	-3.10048562	6.26450116	-3.20093118	-6.32681564											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015747-09	Nicardipine	170465173	Ca channel blocker - DHP class	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	55985-32-5	 ;Nicardipine hydrochloride; YC-93 hydrochloride; Dagan;Nicardipine?HCl;Nicardipine; Nicardipine; Cardene/SR; Nicardipino	12.5892541179	-4.9	37.5360623414	3	5		55.001406505	49.20720965	0.0094711039	0.995232938			CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC	Enzo	AC108	1.9891945	-1.26691267	-1.08187525	-1.84576485	49.20720965											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166323-02	Trifluridine	170464911	thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	70-00-8	 ; Viroptic; Trifluridina; Trifluridine;Trifluridine;Trifluridine (Viroptic)			-7.7990344782	4	5		0	-3.61837647			7298	TYMS	FC(F)(F)C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1056	-1.03143418	0.89790898	-1.90997729	-3.53982301	-3.61837647											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021569-09	Enalapril maleate	170464969	Angiotensin-I Converting Enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	75847-73-3	 Enalaprila;;Enalapril; 7   Enalapril; Enalapril; ; Vasotec; Maleate, Enalapri; Renitec; 8   Enalapril maleate;Enalapril maleate; Enalapril maleate salt; Renitek;ENALAPRIL MALEATE; Renivace			6.5805802939	4	5		0	-2.10893855			1636	ACE	OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	Microsource	01501214	4.02980535	-1.35724069	-0.10990353	2.44434745	-2.10893855											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013565-03	D-Leucine	170465492	Mammalian target of Rapamycin (mTORC1) Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	328-38-1				-3.6971145581	4	5		0	-1.69399648					CC(C)C[C@@H](N)C(=O)O	Bosche	L0932	-1.79273084	0.84870849	2.28395886	-1.89633375	-1.69399648											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00183012-01	Penflutizide	144206843	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1766-91-2	Penflutizide; Penflutizida; 			-5.0805506434	4	5	LS-40450;Penflutizida;Penflutizidum;FT-124;Penflutizide;PENFLUTIZIDE;2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 3,4-DIHYDRO-3-PENTYL-6-(TRIFLUOROMETHYL)-, 1,1-DIOXIDE;3-n-pentyl-6-trifluoromethyl-7-sulfamyl-3,4- dihydro-1,2,4-benzothiadiazine-1,1-dioxide;penflutizidum;penfluzide;3-PENTYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE;penflutizide;CIPLUS_214081;	0	-1.77530831					FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)CCCCC	Pharmaron	PH-NIH-153110	-0.88408644	0.40590406	-2.44423668	-0.98609355	-1.77530831											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022003-06	Diflorasone diacetate	170465294		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33564-31-7		14.1253754462	-4.85	1.0660052265	4	5		10.5741952719	7.49424041	0.1453427125	0.9194186167			CC(=O)OCC(=O)[C@@]4(OC(C)=O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-619	0.02455796	-0.99630996	-2.97849606	-2.57901391	7.49424041											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161643-05	Fluorescein sodium	170464991		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	518-47-8				-2.7133848994	4	5		0	-2.10893855					[Na+].[Na+].[O-]c4cc5Oc1cc([O-])ccc1C3(OC(=O)c2ccccc23)c5cc4	Microsource	01505396	0.41058394	-2.40318765	-0.72047869	0.40739124	-2.10893855											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090851-10	5-Azacitidine	170465076	DNA Methyltransferase (DNMT) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	320-67-2	 ;AZACITIDINE; Azacytidine, 5-; Ladakamycin;Azacitidina; Azacytidine-5; 5-Azacitidine;5-Azacitidine; 5 Azacytidin; Azacytidine; Vidaza; ara-5-aza-Cyd;5-azacytidine;5-Azacytidine			-8.272502101	4	5		0	-1.53137281			1786	DNMT1	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01502111	-1.20333988	0.03690037	-2.36409777	-4.67762326	-1.53137281											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164140-07	Dioctyl sulfosuccinate sodium salt	225144252		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	577-11-7				5.7674541622	4	5		0	3.89664804					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	SIGMA	323586	-0.74513382	0.73465322	4.01758456	1.30947185	3.89664804											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249933-01	Nitrogen mustard N-oxide	170465894		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	126-85-2				-7.797296302	4	5		0	-2.13687151					[O-][N+](C)(CCCl)CCCl	GVK	FFS-11-286-NCI-237	-2.93491484	1.85531067	-0.23201856	-2.70624182	-2.13687151											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015155-11	Bepridil	170465240	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64706-54-3	 ; Bepridil, (-)-Isomer; Bepridil;Bepridil; Vascor;Bepridil hydrochloride; Bepridil, (+)-Isomer	8.9125093813	-5.05	68.266808115	3	5		98.5911351179	89.81843575	0.00274087	0.9986269547		KCNT1	CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3	BIOMOL	AC104	-0.25851581	-3.82268709	-0.18317255	6.31456424	89.81843575											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015801-12	Pentoxifylline	170465384	"3',5'-cyclic phosphodiesterase Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6493-05-6				-3.3197605505	4	5		0	-2.16480447					CC(=O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O	Vitas	STK177321	-2.20498783	-0.46071473	3.99316156	-0.1163975	-2.16480447											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022248-04	Hydrocortisone 21-hemisuccinate sodium salt	170465053		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	125-04-2				12.7128092755	4	4		0	4.11718131					[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Sequoia	125-04-2	2.47175141	0.83507307	2.8887689	4.11718131												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091886-04	Denatonium benzoate	170464678	Glycolysis / Gluconeogenesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	3734-33-6				5.0810092857	4	4		0	4.90894695					O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1	Vitas	STK301730	-0.54143126	0.55671538	0.29697624	4.90894695												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095116-05	Metaxalone	170465241		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1665-48-1				-2.7410010338	4	4		0	0.63341251					Cc1cc(cc(C)c1)OCC2CNC(=O)O2	Microsource	01504229	-1.20056497	-0.06958942	-1.10691145	0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166245-04	Proflavin hemisulfate	170466523	RNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1811-28-5				-1.3137923508	4	4		0	1.00290314					O=S(=O)(O)O.Nc1cc2nc3cc(N)ccc3cc2cc1.Nc1cc2nc3cc(N)ccc3cc2cc1	Vitas	STK380650	-0.40018832	-0.97425191	-0.94492441	1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167525-02	Tazarotene	170464671	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	118292-40-3	 ; Tazarotene;Tazarotene; Zorac; Tazorac;Tazarotene (Avage)			7.8490763467	4	4		0	0.68619689			5915	RARB	O=C(OCC)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2	Sequoia	SRP01178t	0.63559322	0.97425191	4.99460043	0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00484844-01	Cilastatin		Renal dipeptidase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	81129-83-1				-3.8674919538	4	4		0	0.12254902					CC1(C)C[C@H]1C(=O)N\C(=C/CCCCSC[C@@H](N)C(O)=O)C(O)=O	Enzo	PI153	-1.13407258	-0.20592021	-1.31505316	0.12254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159352-14	ETIDRONATE DISODIUM			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7414-83-7				-0.4775204596	4	4		0	-1.15196078					CC(O)(P(O)(O)=O)P(O)(O)=O	Microsource	01505537	-0.07560484	-0.15444015	0.97929491	-1.15196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024822-03	EVANS BLUE		Serum albumin Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	314-13-6				5.0548716403	4	4		0	5.23546435			6339		CC1=C(C=CC(=C1)C2=CC=C(\N=N\C3=C(O)C4=C(C=C3)C(=CC(=C4N)[S]([O-])(=O)=O)[S]([O-])(=O)=O)C(=C2)C)/N=N/C5=C(O)C6=C(N)C(=CC(=C6C=C5)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	206334	-0.14527845	0.35131744	-0.63339245	5.23546435												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344542-01	Transfluthrin	225144388	Cytochrome P450 3A2 Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	118712-89-3				-4.1114783673	4	4		0	-0.86819258					CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=C(F)C(=CC(=C2F)F)F	SIGMA	46114	-0.82324455	-0.8531995	-0.98809222	-0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167538-02	Clorprenaline hydrochloride	170466032	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	6933-90-0				-0.3047158129	4	4		0	1.34175217					Cl.OC(CNC(C)C)c1ccccc1Cl	Sequoia	SRP036805c	-0.62953995	-0.30112923	-0.38003547	1.34175217												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262961-01	Cromoglicate lisetil	170465975	mast cell activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	110816-79-0	O			5.6347510323	4	4		0	-0.55248619					O=C(OCC)C=4Oc3cccc(OCC(OC(=O)[C@@H](N)CCCCN)COc1cccc2OC(=CC(=O)c12)C(=O)OCC)c3C(=O)C=4	GVK	FFS-11-286-NCI-234	-0.04842615	0.05018821	6.00456043	-0.55248619												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00063561-03	4,5-Diphenylimidazole	170465946		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	668-94-0				1.0112262274	4	4		0	0.0789266					c1ccc(cc1)c2ncnc2c3ccccc3	Labotest	LT03333454	0	0.75282309	0.38003547	0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018163-10	Bithionol	170465515	Adenylate cyclase type 10 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	97-18-7		11.220184543	-4.95	29.0646236756	4	4		31.9761844439	27.86108919	0.075196373	0.9965015136			Oc2c(Sc1cc(Cl)cc(Cl)c1O)cc(Cl)cc2Cl	Specs	AN-153/J117612	0.04842615	0.20075282	-1.64682037	27.86108919												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016260-13	Ethacrynic acid	170465426	Sodium/potassium-transporting ATPase subunit alpha-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	58-54-8				3.1877449811	4	4		0	4.6566693			476	ATP1A1	Clc1c(ccc(OCC(=O)O)c1Cl)C(=O)C(=C)CC	Specs	AN-153/J108037	-0.82324455	-0.75282309	0.12667849	4.6566693												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167962-06	Quinapril hydrochloride	170465312	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	82586-55-8				0.1144568751	4	4		0	0					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O	Microsource	01503076	-0.19333011	-0.46867292	0.76360165	0												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00271789-02	Actinomycin D	170464668	DNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-76-0				-5.7064892422	4	5		0	-3.70111732				PRKDC	CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O	SIGMA	A1410	-0.31934307	2.60241564	-3.89546953	-2.06605558	-3.70111732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016401-09	Hydroflumethiazide	170465082	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	135-09-1				1.6620279201	4	5		0	-0.01396648					FC(F)(F)c1cc2NCNS(=O)(=O)c2cc1S(N)(=O)=O	Microsource	01500341	0.47141119	-0.65994272	3.43143241	-1.62956496	-0.01396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015122-11	Bupropion hydrochloride	170464747	Dopamine Transporter (DAT) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	31677-93-7	; ;Bupropion hydrochloride; 3   Bupropion Hcl; Bupropion hydrochloride; Bupropine HCl; Amfebutamonum;BUPROPION; Amfebutamona; Bupropion hydrocloride;Bupropion?HCl; Wellbutrin			-16.0487070309	4	5		0	-2.31584821			6531	SLC6A3	Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C	Microsource	01504174	-4.57930007	-3.65279369	-0.87269705	-3.80799142	-2.31584821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016740-18	Prazosin	170465415	alpha1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	19216-56-9	Prazosin hydrochloride;PRAZOSIN HYDROCHLORIDE;PRAZOSIN; Polypress;; ; Pratsiol;Terazosin hydrochloride; Prazosina; Justac; Minipress;Prazosin; Prazosin hydrochloride; Furazosin hydrochloride			0.0011430946	4	5		0	-2.91899441			148	ADRA1A	O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)c4ccco4	Vitas	STK301545	-0.04562044	6.01419499	-1.03797778	-0.49468936	-2.91899441											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00261968-01	Bufetolol	170465825	Adrenergic receptor beta Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53684-49-4	1-Tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol;B			-6.8973004801	4	5		0	-0.89285714					CC(C)(C)NCC(O)COc2ccccc2OCC1CCCO1	GVK	FFS-11-286-NCI-171	-0.78183172	-2.99096347	-0.81728771	-3.03030303	-0.89285714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015264-13	Clomipramine hydrochloride	170464702	Serotonin Transporter (SERT) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	303-49-1	 7   Clomipramine; ; Chlomipramine;; Hydiphen;CLOMIPRAMINE HYDROCHLORIDE; Anafranil;Clomipramine; Anafranil hydrochloride; Chloripramine;Clomipramine?HCl; Clomipramina; 8   Clomipramine Hcl;Clomipramine hydrochloride; Clomipramine hydrochloride	7.9432823472	-5.1	65.9607477184	3	5		94.4590525915	87.41629464	0.0000424685	0.9999787685	6532	SLC6A4	CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12	Microsource	02300061	-1.70017374	-1.76912307	-1.7038371	8.87637436	87.41629464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159453-05	Zileuton	170465222	5-Lipoxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	111406-87-2	;Zileuton; Zileuton; Zyflo;A-64077/ABT-077			-1.3324303418	4	5		0	-1.27094972			240	ALOX5	NC(=O)N(O)C(C)c1cc2ccccc2s1	Prestwick Chemical, Inc.	Prestw-1365	-1.04927007	0.93388121	2.84528025	-1.54226684	-1.27094972											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015116-13	Aniracetam	170465854	AMPA receptor modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72432-10-1	; ; Aniracetamun; Aniracetam;Aniracetam; Ro 13-5057; 3   Aniracetam			3.7472568555	4	5		0	-2.87388393				GRIA1	O=C2CCCN2C(=O)c1ccc(OC)cc1	Enzo	AC439	3.04045669	-1.71821306	4.39118992	-2.30624832	-2.87388393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021575-05	Fluorometholone	170464629	Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	426-13-1				-8.07573158	4	5		0	-0.79608939					CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-718	-2.69160584	-3.4242311	0.94028575	-1.07667685	-0.79608939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182711-02	Picosulfate sodium	225144334		SARS-CoV-2_CPE_SRI	2019_NPC-3.2					6.5365415208	4	5		0	1.32681564					[O-][S](=O)(=O)OC1=CC=C(C=C1)C(C2=CC=C(O[S]([O-])(=O)=O)C=C2)C3=CC=CC=N3	APAC	877841	0.62347932	1.2825302	1.79509098	3.20093118	1.32681564											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092310-06	Amisulpride	170466480	Dopamine D2/D3 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	71675-85-9	; Amisulprida;Amisulpride; Deniban			2.9187125888	4	5		0	2.51116071			1813	DRD2	CCN2CCCC2CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	Tocris	2132	-1.20377265	-3.42369861	3.22759385	4.88066506	2.51116071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263961-02	Ceftriaxone disodium trihydrate	170465387	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	104376-79-6				-2.6750895849	4	5		0	2.23214286			9376	SLC22A8	[Na+].[Na+].O.O.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC2=NC(=O)C([O-])=NN2C)CS[C@@H]34)C([O-])=O	Microsource	01503111	-1.72499379	-1.15820288	0.54024103	-1.01903996	2.23214286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249909-01	Fenbutrazate	170465618	Monoamine transporters; Norepinephrine & dopamine Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4378-36-3				-6.7913528416	4	5		0	-4.03631285					CCC(c1ccccc1)C(=O)OCCN2CCOC(C2C)c3ccccc3	GVK	FFS-11-286-NCI-142	-1.4446472	-2.35338065	1.1356698	-0.34919249	-4.03631285											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090808-04	Amphotericin B		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1397-89-3	 Amphotericin B trihydrate; L-AmB; Amphotericinum B; PAME amphotericin B ester; Abelcet; ; liposomal amphotericin B; Ambisome; amphotericinum B; Amphocil; D-AmB cpd; AmBisome;Amphotericin B;Amphotericin B (Abelcet); Amphotericin B solution; amphotericin??B; HAmB-DOC; Amphozone; Amfotericina B; Fungizone; Amphotericin B; Amphotericine B			1.9649392174	4	4		0	0.84116774					C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	SIGMA	A9528	0.53165781	0.27133695	-0.12726694	0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015442-15	Fluorouracil	170464762	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-21-8	 5-Fluorouracil;FLUOROURACIL;5-Fluorouracil			-6.062843967	4	4		0	-1.83077684				TYMS	FC1=CNC(=O)NC1=O	Vitas	STK297802	-1.15998067	-0.81401085	-1.27266942	-1.83077684												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00161602-06	Doxycycline	170465097	Matrix Metalloproteinase (MMP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	10592-13-9	; ; Monodox;DOXYCYCLINE HYDROCHLORIDE; Doryx; 1   Doxycycline Mono; Doxycycline hydrochloride; Doxycycline SSa; Atridox;Doxycycline; Doxiciclina; Vibramycin; Vibra-Tabs;Doxycycline hydrochloride; 0   Doxycycline Hyclate; Periostat			-2.6474721964	4	4		0	-0.64324592			4312	MMP1	Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@H](C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick	Prestw-1399	-0.28999517	-0.86334484	-0.76360165	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017324-07	Simvastatin	170464984	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	79902-63-9	; Zocor;Simvastatin;SIMVASTATIN			4.7232835801	4	4		0	3.26571004			3156	HMGCR	CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801938	-0.48332528	-0.61667489	2.35443843	3.26571004												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178357-03	BUCLADESINE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	362-74-3				-2.3881699346	4	4		0	0.14326648					CCCC(=O)NC1=C2N=C[N](C3O[C@@H]4CO[P](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1	Microsource	01503043	-0.93676815	0.07004436	-0.21756867	0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538144-01	NCGC00538144-01		Taenia pisiformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE			12.5892541179	-4.9	9.7196363556	4	4		19.8054120199	17.28748806	0.0677311665	0.9971711031			CC1CCCC(C)N1C(=S)NC2=CC(=CC=C2)C(F)(F)F	Pharmaron	PH-NIH-2017-009-L1-6-0	-0.93676815	-0.07004436	-1.08784335	17.28748806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182849-01	Epristeride	144206545	3-oxo-5-alpha-steroid 4-dehydrogenase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	119169-78-7	Epristeride; 			-3.803991715	4	4	SK&F 105657;EPRISTERIDE;CIPLUS_210870;17-N-t-butylcarboxamide androst-3,5-diene-3-carboxylic acid;SKF 105657;LS-19325;ONO 9302;Epristeride;ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID, 17-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-, (17B)-;epristeride;ONO-9302;epristeridum;17B-(TERT-BUTYLCARBAMOYL)ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID;SK&F-105657;	0	0.22058824			6716	SRD5A2	CC(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C1C=C(CC[C@]1(C)[C@H]4CC[C@]23C)C(=O)O	APAC	816099	-1.18447581	-0.87516088	-0.47565753	0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522503-01	Velpatasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1377049-84-7				-3.9718532647	4	4		0	-1.69117647					COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	MedChem Express	HY-12530	-0.9828629	1.64736165	-1.93060996	-1.69117647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263874-02	BLEOMYCIN (bleomycin B2 shown)			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	9041-93-4, 11056-06-7 [bleomycin]				-2.3961745964	4	4		0	-1.74019608					CC[C@@H]1OC(OC(C(NC(=O)C2=NC(=NC(=C2C)N)C(CC(N)=O)NCC(N)C(N)=O)C(=O)NC(C)C(O)C(C)C(=O)NC(C(C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCCCNC(N)=N)C5=C[NH]C=N5)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]6O)[C@@H](C)[C@@H]1C	Microsource	01503692	0.63004032	-1.02960103	-1.81869054	-1.74019608												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166248-03	Green S			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	3087-16-9				0.0246202377	4	4		0	-0.90686274					CN(C)C1=CC=C(C=C1)C(=C/2\C=C/C(/C=C2)=[N+](C)C)C3=C4C=CC(=CC4=CC(=C3O)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	199583	-1.23487903	1.23552124	4.28091774	-0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090964-04	Tetraethylenepentamine	170464940	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	112-57-2				0.890603627	4	4		0	0.18416206					NCCNCCNCCNCCN	Prestwick	Prestw-1387	-0.5811138	-0.10037641	1.2414492	0.18416206												6.4E-9	3.2E-8	1.6E-7	0.000004											
NCGC00180889-03	Flunixin meglumine	170466598	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	42461-84-7				5.1579018242	4	4		0	3.92002105			791253	PTGS2	CNC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.FC(F)(F)c2cccc(Nc1ncccc1C(=O)O)c2C	Microsource	01505113	0.43583535	-0.80301129	0.58272105	3.92002105												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015149-16	Bumetanide	170464735	Loop Diuretics	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	28395-03-1	; ;BUMETANIDE;bumetanide; Bumex; Bumethanide; Bumetanida;Bumetanide; Bumetanide			-6.7790789631	4	5		0	-0.85195531				SLC12A2	O=S(N)(=O)c2cc(cc(NCCCC)c2Oc1ccccc1)C(=O)O	Microsource	01502004	-3.57360097	0.33619724	-0.42740261	0.78568311	-0.85195531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183026-01	Dicethiamine hydrochloride	144206821		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	616-96-6	Cetotiamine; Cetotiamine Hydrochloride; O,S-dicarbethoxythiamine; Cetotiamina; 			-1.6491681705	4	4	Cetotiamine Hydrochloride;Cetotiamine;O,S-dicarbethoxythiamine;CETOTIAMINE;CIPLUS_210876;Cetotiaminum;Cetotiamina;CIPLUS_697013;O,S-bis(ethoxycarbonyl)thiamine;cetotiamine;cetotiaminum;	0	0.02630887					Cl.Nc1nc(C)ncc1CN(C=O)C(/C)=C(/CCOC(=O)OCC)SC(=O)OCC	Pharmaron	PH-NIH-149305	-1.01694915	-0.65244667	0.63339245	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160450-03	4-Acetylaminophenylacetic acid	170465954		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	18699-02-0				-1.3592903227	4	4		0	-0.02630887					O=C(C)Nc1ccc(cc1)CC(=O)O	Specs	AE-562/J260765	0.0968523	-0.60225847	-1.03876362	-0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095255-08	dl-alpha-Tocopheryl acetate	170465444		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52225-20-4				-0.5885586605	4	4		0	0.65772165					CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	Microsource	00310040	-0.92009685	0.30112923	0.17734989	0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00346457-02	Copanlisib		PI3K alpha/delta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1032568-63-0				-5.9315635119	4	4		0	-0.66857689				PIK3CA	COC1=C(OCCCN2CCOCC2)C=CC\3=C1/N=C(/NC(=O)C4=CN=C(N)N=C4)N5CC/N=C35	Selleck	S2802	-1.68618267	-1.37753911	-1.25101985	-0.66857689												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00188430-01	Moperone	144207164	Serotonin 2a (5-HT2a) receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1050-79-9				3.4746711924	4	4	Moperone	0	5.68290353					O=S(=O)(O)O.Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(C)cc3	Toronto Research	M610500	-1.21779859	1.33084287	2.0125102	5.68290353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016529-07	Pramoxine hydrochloride	170465004	Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	637-58-1				3.9333875216	4	4		0	-1.00490196					Cl.CCCCOc1ccc(cc1)OCCCN2CCOCC2	Microsource	01501139	1.08366935	4.16988417	-1.42697258	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025195-06	Ozagrel hydrochloride	170466054	Thromboxane Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	78712-43-3	; ; Ozagrel hydrochloride;Ozagrel hydrochloride; Ozagrel HCL; OZAGREL HCl; Ozapen;Ozagrel			2.7347995015	4	4		0	1.20098039			6915	TBXA2R	Cl.O=C(O)/C=C/c2ccc(Cn1ccnc1)cc2	Prestwick	Prestw-979	0.32762097	-0.05148005	1.48293229	1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-02	Camostat	170465784	Serine Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	59721-29-8	 ; Camostat mesylate;Camostat mesylate; Camostat Mesylate; Foipan; Foy-305;Camostat			-2.0537748719	4	4		0	-1.15196078				PRSS1	O=C(Oc1ccc(cc1)CC(=O)OCC(=O)N(C)C)c2ccc(NC(=N)N)cc2.CS(=O)(=O)O	Sequoia	SRP01202c	-1.48689516	1.23552124	2.49020705	-1.15196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183103-01	Tocophersolan	144206517		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	9002-96-4	TOCOFERSOLAN; Tocofersolano; vitamin E-TPGS; 	14.1253754462	-4.85	16.8202674609	4	4	Tocofersolanum;tocofersolanum;dl-a-Tocopherol Polyethylene Glycol  Succinate;Tocophersolan;tocofersolan;tocopheryl poly(ethylene glycol) 1000 succinate;Tocofersolano;VITAMIN E POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E POLYETHYLENE GLYCOL SUCCINATE;TOCOFERSOLAN;vitamine E PEG-1000-succinate;CIPLUS_698430;TPGS;CIPLUS_213643;ALPHA-TOCOPHERYL PEG-20 SUCCINATE, D-;A-TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E TPGS;vitamin E-TPGS;.ALPHA.-(4-(((2R)-3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-YL)OXY)-1,4-DIOXOBUTYL)-.OMEGA.-HYDROXY-POLY(OXY-1,2-ETHANEDIYL);alpha-tocopheryl polyethylene glycol succinate;TOCOPHERSOLAN;tocophersolan, (2R-(2R*(4R*,8R*)))-isomer;tocophersolan;	21.712367096	19.24019608	0.3136465595	0.9341856529			O=C(OCCO)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	ACC	V-00037	0.17641129	4.27284427	-1.42697258	19.24019608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179566-03	Ritodrine hydrochloride	225144308	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	23239-51-2				-2.7898720302	4	4		0	-0.66176471				ADRB2	C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2	Prestwick	Prestw-349	-0.47883065	-0.05148005	-1.48293229	-0.66176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015678-10	Moxisylyte hydrochloride	170465759	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	964-52-3				0.2919025763	4	4		0	2.08333333					Cl.CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	Prestwick Chemical, Inc.	Prestw-42	-0.22681452	-0.61776062	-0.36373811	2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181167-01	Isoniazid sodium methanesulfonate	144206321		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	3804-89-5	Methaniazide; Neoiscotin; Metaniazida; 			-2.9063045273	4	4	CIPLUS_739573;Isoniazid Sodium Methanesulfonate Anhydride;Methaniazide;CIPLUS_207620;Isoniazid sodium methanesulfonate;Neoiscotin;Methaniazidum;LS-172896;METHANIAZIDE;methaniazide, sodium salt;isoniazid methanesulfonate;Isoniazid Sodium Methanesulfonate;Metaniazida;ISONICOTINIC ACID 2-(SULFOMETHYL)HYDRAZINE;CIPLUS_162545;methaniazidum;isoetam;methaniazide;ISONIAZID SODIUM METHANESULFONATE;	0	-0.75980392					[Na+].O=C(NNCS([O-])(=O)=O)c1ccncc1	NCI	NSC-81103	-0.78125	-0.46332046	-0.02797985	-0.75980392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179596-03	Butoconazole nitrate	170464901	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	64872-77-1	 Butoconazol;;Butoconazole nitrate; Femstat			14.4007957503	4	4		0	8.44514601					[O-][N+](=O)O.Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3	Prestwick Chemical, Inc.	Prestw-408	1.98547215	0.9033877	0.78540664	8.44514601												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181909-01	Sulcaine	144206885		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	41653-21-8	Ethyl piperidinoacetylaminobenzoate; Sulcain; Nichicaine; 			2.5508683841	4	4	Ethyl Piperidinoacetylaminobenzoate;CIPLUS_3838938;P-(PIPERIDINOACETAMIDE)BENZOIC ACID ETHYL ESTER;Nichicaine;ETHYL PIPERIDINOACETYLAMINOBENZOATE;CIPLUS_196504;CIPLUS_180054;Sulcain;Ethyl piperidinoacetylaminobenzoate;	0	3.44646146					O=C(CN1CCCCC1)Nc2ccc(cc2)C(=O)OCC	Pharmaron	PH-NIH-22	-0.0968523	-0.55207026	-0.63339245	3.44646146												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262959-01	Difethialone	170465892		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104653-34-1	2H-1-benzothiopyran-2-one,			-2.6581485501	4	4		0	-1.08857001					Brc1ccc(cc1)c2ccc(cc2)C4Cc3ccccc3C(C4)C5=C(O)c6ccccc6SC5=O	GVK	FFS-11-286-NCI-261	-1.59497342	0.41933892	1.14540248	-1.08857001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015316-05	Eflornithine Hydrochloride	170465007	Ornithine Decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	96020-91-6	 ; 1   Eflornithine; DFMO hydrochloride; Ornidyl; DL-alpha-Difluoromethylornithine hydrochloride;DFMO;Eflornithine Hydrochloride;DL-alpha-Difluoromethylornithine hydrochloride			-1.3986453344	4	4		0	0.59376546			89874	ODC1	Cl.FC(F)C(N)(CCCN)C(=O)O	Bosche	E2777	-0.38666022	-0.66600888	-0.82723513	0.59376546												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00510891-01	Cefacetrile			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	10206-21-0				-6.0391948099	4	4		0	0.09551098					CC(=O)OC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)CC#N)C2=O)C(O)=O	SantaCruz Bio	sc-396239	-2.10772834	-0.44361429	-0.59831384	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181334-04	DIBUNATE SODIUM	225144323		DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-0.525393342	4	4		0	0.36764706					CC(C)(C)C1=CC=C2C(=C1)C=CC(=C2[S]([O-])(=O)=O)C(C)(C)C	Bosche	D6477	-1.68850806	1.75032175	3.27364298	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508820-02	Dalfopristin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	112362-50-2				-1.2007029851	4	4		0	1.00490196					CCN(CC)CC[S+]([O-])(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(=C\[C@@H](O)CC(=O)CC3=NC(=CO3)C2=O)C	MedChem Express	HY-A0241_cm1	-1.13407258	0.87516088	0.47565753	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178768-03	POLYMYXIN B SULFATE		Peptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1405-20-5, 1404-26-8 [polymyxin B]				-0.1627920565	4	4		0	3.06372549					CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCN)NC1=O)C(C)O	Microsource	01500492	-1.38608871	0.61776062	-0.97929491	3.06372549												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00023016-07	Cefmetazole sodium	170465052	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	56796-39-5				-6.4874375335	4	4		0	-0.41666667					[Na+].N#CCSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C([O-])=O	Prestwick	Prestw-700	-1.89012097	-1.28700129	-0.64353665	-0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274270-01	NCGC00274270-01			DPI_SARS-CoV-2_General	2019_NPC-5_CPE					5.7790938293	4	4		0	2.57352941					COC1[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/C(O)[C@H](C)C[C@H](CC=O)C1OC2OCC(OC3CC(C)(O)C(O)C(C)O3)C(C2O)N(C)C	GVK	FFS-11-286-NCI-160	0.73084677	1.6988417	1.14717403	2.57352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-26	MELOXICAM SODIUM			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	71125-38-7				-0.2637175569	4	4		0	0.90686274					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	01504150	-0.42842742	1.02960103	-0.81141578	0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510315-02	Finafloxacin			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	209342-40-5				-3.4935337952	4	4		0	-0.41666667					OC(=O)\C1=C\N(C2CC2)C3=C(C#N)C(=C(F)C=C3C1=O)N4C[C@@H]5NCCO[C@H]5C4	MedChem Express	HY-13451	-0.83165323	-0.92664093	-0.58757694	-0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015703-06	Mecamylamine	170465225	Neuronal acetylcholine receptor; alpha4/beta2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60-40-2				2.4250462069	4	4		0	-0.81557485					CNC2(C)C1CCC(C1)C2(C)C	Enzo	AC741	1.0653753	-1.00376412	1.95084875	-0.81557485												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	108852-90-0				6.3665625032	4	4		0	1.28913444				TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	1.40435835	2.40903388	0.63339245	1.28913444												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249893-01	Lodoxamide	170465346	type I hypersensitivity Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	53882-12-5				2.5897926484	4	4		0	0.74220683					Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O	GVK	FFS-11-286-NCI-60	1.06331561	-0.5673409	0.19090041	0.74220683												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015436-11	Fluphenazine hydrochloride	170465375	Nicotinic alpha7 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	69-23-8	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S			-8.1187126498	4	4		0	-3.16674913			1813	DRD2	FC(F)(F)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2	Vitas	STK050763	-1.54664089	-1.1100148	-0.95450207	-3.16674913												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00510497-02	Eribulin mesylate		Tubulin Polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	441045-17-6				-0.6661115644	4	4		0	0.71633238				TUBB	CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C	MedChem Express	HY-13442A	-0.14051522	-0.77048798	-0.43513734	0.71633238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091015-01	Phenolphthalin	17389504		DPI_SARS-CoV-2_General	2019_NPC-7_CPE		Phenolphthalin; 			-3.9722775871	4	4	PHENOLATHALAIN, YELLOW;2-(Bis[4-hydroxyphenyl]methyl)benzoic acid;PHENOLPHTHALEIN;Phenolphthalin;NCGC00091015-02;CIPLUS_208575;AB07944344-01;phenolphthalin;	0	-0.47755492					OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C3=C(C=CC=C3)C(O)=O	NIEHS	AB07944344	-1.12412178	-0.63039925	-0.43513734	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510940-01	Kebuzone		Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	853-34-9				-1.6689840529	4	4		0	3.55392157					CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	SantaCruz Bio	sc-488996	-1.33568548	-0.72072072	-0.58757694	3.55392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091902-11	Malathion	170465311	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	121-75-5				-1.7816673624	4	5		0	-1.13590264					CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	Microsource	00330021	-0.07326007	0.1011378	-1.4803849	0.2392917	-1.13590264											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164533-02	Buformin	170465982	"AMP-activated protein kinase, AMPK Activator"	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	692-13-7				-0.8811502516	4	5		0	-0.40567951					NC(=N)NC(=N)NCCCC	Labotest	LT02684528	0.02442002	-0.2022756	-0.64150012	-0.04785834	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018242-07	Sulfacetamide	170464944	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	144-80-9				-3.1629207849	4	5		0	-0.89249493					Nc1ccc(cc1)S(=O)(=O)NC(C)=O	Labotest	LT00053160	-0.26862027	-1.0619469	-0.83888478	-0.95716679	-0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274061-01	Trilostane	174007161	Estrogen Receptor (ER) beta Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	13647-35-3	Trilostane			3.5448192513	4	5		0	8.11359026			2099	ESR1	N#CC=2C[C@]4(C)[C@H]5CC[C@]1(C)[C@@H](O)CC[C@H]1[C@@H]5CC[C@@]34O[C@@H]3C=2O	Selleck	S1404	-0.36630037	-0.9608091	-1.4803849	-0.19143336	8.11359026											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159388-05	Pentaerythritol tetranitrate	225144224	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE					-3.2905516362	4	5		0	-0.40567951					[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O	Labotest	LTBB004589	0.02442002	-1.5676359	-1.43103874	-1.3400335	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249900-01	Glyceryl 1-(2-aminobenzoate)	170465551		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	71574-35-1				3.1417864749	4	5		0	2.35294118					Nc1ccccc1C(=O)OCC(O)CO	GVK	FFS-11-286-NCI-90	2.02686203	-1.3653603	-0.78953861	-1.24431682	2.35294118											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091470-05	Isoeugenol	170465654	Tyrosyl-DNA phosphodiesterase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	97-54-1				-0.1060828795	4	5		0	1.54158215					Oc1ccc(cc1OC)C=CC	Bosche	I1325	-0.31746032	-0.1011378	-1.43103874	0.57430007	1.54158215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159351-05	Cholesterol	225144221	Transient receptor potential cation channel subfamily V member 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57-88-5				3.0671559447	4	5		0	2.35294118			7442	TRPV1	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	362794	0.46398046	-0.7079646	0.29607698	0.2392917	2.35294118											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00249935-01	Phenylacetylglycine dimethylamide	170465887		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3738-06-5				0.194491313	4	5		0	0.24340771					CN(C)C(=O)CN(C(C)=O)c1ccccc1	GVK	FFS-11-286-NCI-239	-0.36630037	-0.7585335	-0.74019245	2.48863364	0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018153-10	Dienestrol	170465362	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	84-17-3	 (E,E)-Dienestrol; Ortho Dienestrol; Dienestrol, (Z,E)-Isomer; Dienoestrol; Ortho Brand of Dienestrol; Dienestrol, (E,E)-Isomer; Dienestrol, (Z,Z)-Isomer; Oestrasid;DIENESTROL; Synestrol;Dienestrol;			3.867133511	4	5		0	6.49087221			2099	ESR1	Oc1ccc(cc1)C(=C\C)/C(=C/C)c2ccc(O)cc2	Microsource	01500241	-0.26862027	-0.2528445	-0.39476931	-0.04785834	6.49087221											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016765-09	Diflunisal	170464956	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	22494-42-4				-0.4202434986	4	5		0	2.43407708					OC(=O)c1cc(ccc1O)c2ccc(F)cc2F	Microsource	01500245	-0.21978022	-1.2136536	-0.64150012	-0.76573343	2.43407708											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091120-13	Griseofulvin	170465739	Tubulin beta chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	126-07-8				4.2382193758	4	5		0	-0.0811359				TUB2	O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC	Prestwick	Prestw-226	2.02686203	-0.9102402	0.24673082	1.43575018	-0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00261968-01	Bufetolol	170465825	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53684-49-4	1-Tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol;B			-1.4476957731	4	4		0	-0.0789266					CC(C)(C)NCC(O)COc2ccccc2OCC1CCCO1	GVK	FFS-11-286-NCI-171	-0.92009685	0	0.32936407	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016636-05	Flavoxate hydrochloride	170466285	Muscarinic acetylcholine receptors; M1 & M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3717-88-2				0.7328969265	4	4		0	2.49934228					Cl.O=C(OCCN1CCCCC1)c4cccc2c4OC(=C(C)C2=O)c3ccccc3	Prestwick	Prestw-242	-0.6779661	-0.20075282	-0.58272105	2.49934228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183856-01	Phenyl 11-iodo-10-undecynoate	144206805		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2020-25-9				1.0339003086	4	4	Phenyliodoundecynoate;PHENYLIODOUNDECYNOATE;CIPLUS_3885239;CIPLUS_3845000;10-UNDECYNOIC ACID, 11-IODO-, PHENYL ESTER;11-IODOUNDECYNOIC ACID PHENYL ESTER;002020259;	0	4.60168234					O=C(Oc1ccccc1)CCCCCCCCC#CI	Pharmaron	PH-NIH-102558	-1.11164814	-0.024667	-1.84537066	4.60168234												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015496-08	N,N,N,N',N',N'-Hexamethylhexane-1,6-diaminium	170465837		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	60-26-4				9.8915367373	4	4		0	1.4349332					C[N+](C)(C)CCCCCC[N+](C)(C)C	Enzo	AC740	0.96665056	1.60335471	5.15431117	1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167473-02	Capreomycin IB	174006669		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	33490-33-4				4.4679949178	4	4		0	0.4453241					NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2	Bosche	C2304	0.77332044	1.45535274	1.71810372	0.4453241												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00167973-02	Eperisone hydrochloride	170465796	skeletal muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	56839-43-1				13.308526739	4	4		0	6.11270296					Cl.CC(CN1CCCCC1)C(=O)c2ccc(CC)cc2	Bosche	E3497	1.45199063	2.35816017	4.84090291	6.11270296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167558-02	Fleroxacin	170466056	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	79660-72-3	 Ro 23-6240; ; Ro 23624; Quinodis; Megalocin; Fleroxacin;Fleroxacin; fleroxacin N-oxide; Megalone; Ro 23 624			0.2330011968	4	5		0	-0.40567951					CN1CCN(CC1)c2c(F)c3c(cc2F)C(=O)C(=CN3CCF)C(=O)O	Prestwick	Prestw-1414	0.65934066	-1.1125158	-0.44411547	0.57430007	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016268-08	Niacin	170465044	Nicotinic acid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59-67-6	NIACIN;Niacin; ; Niacin; Niacin-d4 (ring-d4);Nicotinic acid			-0.9233798832	4	5		0	-1.37931034				HCAR3	O=C(O)c1cccnc1	Vitas	STK301803	0.12210012	-1.4664981	1.72711572	-0.43072505	-1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179408-03	Iodixanol	170464924		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	92339-11-2				3.4776891242	4	5		0	4.46247465					OCC(O)CNC(=O)c1c(I)c(c(I)c(C(=O)NCC(O)CO)c1I)N(CC(O)CN(C(C)=O)c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(C)=O	SIGMA	D1556	-0.41514042	1.9721871	0.09869233	-0.76573343	4.46247465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016338-10	Dibucaine	170464829	Sodium channel protein type X alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	85-79-0		12.5892541179	-4.9	91.9012578944	3	5		124.4693306303	114.72616633	0.0001682277	0.9999158837			CCN(CC)CCNC(=O)c1cc(OCCCC)nc2ccccc12	Microsource	01500236	1.83150183	1.6687737	0.78953861	1.48360852	114.72616633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160617-03	Thiamine pyrophosphate			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	154-87-0				3.8875044659	4	5		0	2.43407708					CC1=NC=C(C[N+]2=CSC(=C2C)CCO[P](O)(=O)O[P](O)(O)=O)C(=N1)N	SIGMA	C8754	-0.21978022	-1.3147914	-1.4803849	-1.1007418	2.43407708											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00274064-01	Betamethasone valerate	174007479	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	33755-46-3	Betamethasone valerate			-1.5863406566	4	5		0	1.29817444				NRC31	OCC(=O)[C@@]4(OC(=O)CCCC)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1690	0.07326007	-1.1125158	-1.97384653	-0.76573343	1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165966-06	Vinorelbine tartrate 			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	125317-39-7		11.220184543	-4.95	15.9301883806	4	5		26.1238937999	22.15010142	0.0139740118	0.9929559607			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@@]7([H])CN(CC(CC)=C7)CC8=C6NC9=C8C=CC=C9)C(=O)OC	Bosche	V5183	0.61050061	-1.7699115	-0.88823094	0.14357502	22.15010142											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015199-20	Chlorambucil	170464770	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	305-03-3	; ;CHLORAMBUCIL; Chlorambucil;Chlorambucil; Leukeran; Clorambucilo			-1.8508707845	4	5		0	-0.73022312				H2AFX	O=C(O)CCCc1ccc(cc1)N(CCCl)CCCl	Microsource	01500171	-0.21978022	-1.4664981	-0.29607698	0.47858339	-0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093362-05	Betahistine mesylate	170465694	Histamine H3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	54856-23-4				-2.6747091811	4	5		0	-0.56795132					CS(=O)(=O)O.CNCCc1ccccn1	Prestwick Chemical, Inc.	Prestw-543	0.17094017	-1.6182048	-1.4803849	-0.57430007	-0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166217-02	1-Bromoheptadecafluorooctane	170465144		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	423-55-2				-1.3612159545	4	5		0	0.0811359					FC(F)(C(F)(F)C(Br)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	SIGMA	343862	0.21978022	-1.3147914	-0.34542314	-0.95716679	0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015471-08	Ganciclovir	170464961	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	82410-32-0	 ; Gancyclovir; UL97 protein, HCMV; Biolf 62;Ganciclovir; Cytovene; Vitrasert; Ganciclovir			-0.3145561578	4	5		0	2.19066937				UL54	OCC(CO)OCn2cnc1c2N=C(N)NC1=O	Prestwick	Prestw-839	-0.61050061	0.0505689	-0.88823094	-0.33500838	2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181131-04	Epothilone B		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	152044-54-7				-2.7212010996	4	4		0	2.05780347				TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A10360	-1.1311054	-1.32950991	-0.6317452	2.05780347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249415-01	Fabesetron	144206751	5-hydroxytryptamine receptor 4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	129300-27-2				1.1639501686	4	4		0	0.11560694			3360	HTR4	Cc4ncnc4C[C@H]3CCc2c(C)c1ccccc1n2C3=O	NCGCChem	DJM10-012	0	1.17309698	0.36851803	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092321-03	Tetrabenazine Mesylate		Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	804-53-5				-0.308100427	4	4		0	-1.54913295				SLC18A2	COC1=C(OC)C=C2[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CCC2=C1	Glixx	GLXC-06104	0.15424165	0.5995829	0.05264543	-1.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242497-12	Vismodegib		Hedgehog Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	879085-55-9				-2.1434164903	4	4		0	-1.2716763				SHH	C[S+]([O-])(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3	ActiveBioChem	A-1113	-0.10282776	-1.17309698	-0.1579363	-1.2716763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015725-15	Nimesulide	170465612	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51803-78-2	; ;NIMESULIDE; Nimesulide;Nimesulide; Nimesulida			2.9966993983	4	4		0	1.92054722			5743	PTGS2	[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O	Vitas	STL018679	0.43583535	-0.30112923	0.27869268	1.92054722												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253586-01	Isalon	170465491		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	5579-81-7				-2.7860514343	4	4		0	-0.0789266					O=C(N)NC1N=C(O[Al](O)O)NC1=O	GVK	FFS-11-286-NCI-89	-0.7748184	-0.55207026	-0.83607803	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021146-09	Ketanserin	170466645	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	74050-98-9	Ketanserin tartrate;Ketanserin;KETANSERIN TARTRATE			3.6723749625	4	4		0	2.34148908			3356	HTR2A	Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4	Enzo	NS515	0.3874092	-0.70263488	0.83607803	2.34148908												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00096077-06	Olanzapine	170465009	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	132539-06-1	; ;OLANZAPINE; Zyprexa; OLANZAPINE;Olanzapine; Olanzapine; Lilly brand of olanzapine			4.9352532092	4	4		0	5.13022889			1813	DRD2	CN1CCN(CC1)C2=Nc4ccccc4Nc3sc(C)cc23	SIGMA	O1141	0.24213075	-0.15056462	-0.98809222	5.13022889												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016012-12	Triflupromazine hydrochloride	170465325	Muscarinic acetylcholine receptor M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1098-60-8		12.5892541179	-4.9	53.6942178794	3	4		63.1093304009	50.66798615	0.01641789	0.9998337778	1129	CHRM2	Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Microsource	01503118	-0.77332044	0.024667	-0.4454343	50.66798615												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00186658-01	Dexpanthenol	170464647		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	81-13-0				4.2752185765	4	4		0	0.64324592					CC(C)(CO)[C@@H](O)C(=O)NCCCO	Labotest	LT00244791	1.15998067	0.024667	1.3363029	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00522015-01	Pirlimycin Hydrochloride		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	78822-40-9				-0.0386590915	4	4		0	-0.09551098					CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Toronto Research	P509300	-0.42154567	1.09736166	0.48952951	-0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014602-05	L-Penicillamine		Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1113-41-3				1.1862021117	4	4		0	0.85959885				CAT	CC(C)(S)[C@H](N)C(O)=O	Enzo	NP226	0.09367681	0.21013308	-0.87027468	0.85959885												1.6E-8	8E-8	4E-7	0.000002											
NCGC00178433-02	HYDROXYAMPHETAMINE HYDROBROMIDE		Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	306-21-8, 1518-86-1 [hydroxyamphetamine]				-0.6756887842	4	4		0	1.52817574					CC(N)CC1=CC=C(O)C=C1	Microsource	00211425	-1.17096019	-0.77048798	2.44764754	1.52817574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091532-06	Clorophene	170465725		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	120-32-1				-1.4671365002	4	5		0	-0.40567951					Oc2ccc(Cl)cc2Cc1ccccc1	Bosche	B0598	-0.70818071	-1.1125158	1.13496176	0.19143336	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185753-04	Etoposide  Phosphate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	117091-64-2				-0.77111541	4	4		0	0.71676301					COC1=C(O[P](O)(O)=O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26)OC	Glixx	GLXC-06447	-0.82262211	-0.39103233	1.52671756	0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522030-01	Budralazine		adrenergic receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	36798-79-5				-1.1190298091	4	4		0	-1.05105105					CC(C)=C\C(C)=N/NC1=NN=CC2=C1C=CC=C2	Toronto Research	B689515	0.04770992	-1.38453501	0.73317622	-1.05105105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378604-01	ABT-333			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1132935-63-7		12.5892541179	-4.9	39.4890463855	3	4		62.1761226879	53.75375375	0.0135078045	0.9998874842			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	-0.47709924	0.18286311	0.57606703	53.75375375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179276-04	Etilefrine hydrochloride	225144301		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	534-87-2				-3.528811791	4	4		0	1.3013013					CCNCC(O)C1=CC(=CC=C1)O	Prestwick	Prestw-1017	-1.24045802	-1.38453501	-0.5236973	1.3013013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262578-03	Flucloxacillin sodium		Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1847-24-1				-3.2587734529	4	4		0	-0.75075075					CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@H](N3C2=O)C([O-])=O)C(=NO1)C4=C(Cl)C=CC=C4F	Prestwick	Prestw-1011	-0.62022901	-1.59352142	0	-0.75075075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024357-07	Scopolamine hydrobromide	170464830	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	114-49-8				0.1417637274	4	4		0	-1.28913444				CHRM1	Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34	Prestwick Chemical, Inc.	Prestw-877	0.7748184	-0.55207026	0.48137826	-1.28913444												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015501-09	Apresoline	170464806	Smooth Muscle Relaxant	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			17.6616693265	4	4		0	6.55090766				SMO	Cl.NNc2nncc1ccccc12	Microsource	01500334	2.90556901	3.16185696	1.69749177	6.55090766												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00018284-06	MEPIVACAINE HYDROCHLORIDE		Sodium channel protein type X alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1722-62-9				-1.5503829966	4	4		0	1.33597229					CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C	SIGMA	M3189	-0.67665539	-0.41933892	-1.39993637	1.33597229												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389453-01	Chlortetracycline HCl		translation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	64-72-2 				-1.2628995308	4	4		0	-2.29226361					CN(C)C1C2CC3\C(=C(O)/C4=C(O)C=CC(=C4C3(C)O)Cl)C(=O)C2(O)\C(=C(C(N)=O)/C1=O)O	APExBIO	B1699	-0.46838407	0.72379173	1.63176503	-2.29226361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390702-02	Efinaconazole		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	164650-44-6				8.1241506105	4	4		0	0.42979943					C[C@@H](N1CCC(=C)CC1)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-15660	1.63934426	4.41279477	0.76149035	0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378640-03	Alvimopan		mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1383577-62-5				0.2544396765	4	4		0	-0.85959885				OPRM1	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(O)=O	MedChem Express	HY-76657	0.51522248	-0.49031053	-0.10878433	-0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386509-01	Fluticasone furoate	384569143	Glucocorticoid Receptor (GR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	397864-44-7				1.1979116118	4	4		0	2.38150289				NRC31	C[C@@H]1CC2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)SCF	Axon Medchem	1172	-1.28534704	0.65172054	3.21137141	2.38150289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178852-05	Tobramycin	225144300	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	32986-56-4	 Nebcin; Tobrex; Obracin;TOBRAMYCIN; Tobramycin Sulphate;; Sulfate, Tobramyci; Brulamycin;Tobramycin; Tobramycin Base; Tobramicina; Tobracin; Nebicin			1.685184762	4	4		0	-0.20809249					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	Microsource	01500579	0.30848329	0.39103233	1.63200842	-0.20809249												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00185745-01	Cefroxadine	144206693		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	51762-05-1				-2.404882301	4	4		0	-0.9017341					N[C@H](C1=CCC=CC1)C(=O)N[C@@H]3C(=O)N2C(=C(OC)CS[C@@H]23)C(=O)O	Kemprotec	51762-05-1	-0.41131105	-0.02606882	-0.94761779	-0.9017341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167427-02	Epoprostenol sodium	124893308	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	61849-14-7				1.3957992899	4	4	PROSTAGLANDIN I2 Na	0	-0.71676301			64805		CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC([O-])=O	BIOMOL	PG011	-1.02827763	3.51929093	3.00078968	-0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181122-01	2-Dodecylisoquinolinium tosylate	144206285		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5412-37-3	CIPLUS_189611; 			-7.576942008	4	4	CIPLUS_160386;CIPLUS_150169;Lauryl isoquinolinium bromide;CIPLUS_164262;CIPLUS_189611;LAURYL ISOQUINOLINIUM BROMIDE;LAURYL ISOQUINOLINIUM SACCHARINATE;	0	-3.1031031					[O-]S(=O)(=O)c1ccc(C)cc1.CCCCCCCCCCCC[n+]1cc2ccccc2cc1	NCI	NSC-4486	-1.19274809	-1.69801463	-1.46635245	-3.1031031												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532510-01	PREDNISOLONE VALERATE ACETATE			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					3.6505249323	4	4		0	2.05205205					CCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Biosynth	Q-101384	0.33396947	-0.65308255	2.46137732	2.05205205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179313-05	Imidazolidinyl urea		T-lymphocyte activation antigen CD86 Activator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	39236-46-9				-4.2125062363	4	4		0	-1.6016016					OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O	MedChem Express	HY-B1158	-0.85877863	-0.70532915	-0.47132757	-1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186014-02	Paliperidone	170464996	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	144598-75-4				2.8107516331	4	4		0	-0.3003003					CC=5N=C1[C@H](O)CCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	4493	1.57442748	-0.0261233	-0.57606703	-0.3003003												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00253596-01	Ethchlorvynol	170464750	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	113-18-8				-4.5674190377	4	4		0	-0.4004004					C#CC(O)(/C=C\Cl)CC	GVK	FFS-11-286-NCI-036	-1.90839695	-0.70532915	1.57109191	-0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178860-06	Ethopropazine hydrochloride	170465065	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1094-08-2		12.5892541179	-4.9	32.0511543516	3	4		35.5	30.58058058	0.0400076361	0.9990129955			Cl.CCN(CC)C(C)CN1c3ccccc3Sc2ccccc12	Microsource	01500293	2.43320611	1.38453501	2.88033517	30.58058058												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521081-01	Cycrimine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	126-02-3				-3.0183271641	4	4		0	1.95195195					OC(CCN1CCCCC1)(C2CCCC2)C3=CC=CC=C3	Toronto Research	C991450	-1.0019084	-1.80250784	-0.94265515	1.95195195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095303-04	Cloxyquin	170465523	Mycobacterium tuberculosis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	130-16-5				0.0738353624	4	4		0	0.15835313					Oc1ccc(Cl)c2cccnc12	Vitas	STK015543	0.07062147	-0.20876827	-0.08099352	0.15835313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016261-08	Pyridoxine	170464634	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	65-23-6				2.909090219	4	4		0	0.26392188					Oc1c(CO)c(cnc1C)CO	Vitas	STK177324	-0.25894539	3.82741823	0.4049676	0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164140-07	Dioctyl sulfosuccinate sodium salt	225144252		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	577-11-7				-0.2055775976	4	4		0	1.42517815					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	SIGMA	323586	-0.58851224	-1.2526096	0.18898488	1.42517815												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249912-01	Floctafenine	170465681	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	23779-99-9				-1.6465158318	4	4		0	-0.49480455			5743	PTGS2	OCC(O)COC(=O)c3ccccc3Nc1ccnc2c(cccc12)C(F)(F)F	GVK	FFS-11-286-NCI-159	-0.8699855	-0.32067094	0.69996818	-0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016308-06	Isopropamide	170465291	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	7492-32-2				2.4902072433	4	4		0	0.84116774					CC(C)[N+](C)(CCC(c1ccccc1)(C(N)=O)c2ccccc2)C(C)C	Microsource	01500356	-0.57999033	2.54070054	0.82723513	0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00185778-04	Nitisinone		4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	104206-65-7				-0.2332275721	4	4		0	-0.66857689				HPD	[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	MedChem Express	HY-B0607	0.04683841	0.21013308	0	-0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015159-13	Betaxolol HCl		Beta1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	63659-19-8				-3.4065386498	4	4		0	0.28653295				ADRB1	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1	Selleck	S1827	-1.21779859	-0.35022181	-0.38074517	0.28653295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480770-01	MK-3102		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1226781-44-7				1.4853577099	4	4		0	4.32369942					C[S+]([O-])(=O)[N]1C=C2CN(CC2=N1)[C@H]3CO[C@@H]([C@@H](N)C3)C4=C(F)C=CC(=C4)F	Adooq	A13310	-0.82262211	-0.70385819	1.21084496	4.32369942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390666-01	Opicapone		Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	923287-50-7				-0.2922008958	4	4		0	1.8265896					CC1=C(Cl)C(=[N+]([O-])C(=C1C2=NOC(=N2)C3=CC(=C(O)C(=C3)O)[N+]([O-])=O)Cl)C	MedChem Express	HY-14896	-0.66838046	0.86027112	-0.7896815	1.8265896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160584-01	Chlorphenesin	144207103		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	104-29-0	1,2-Propanediol, 3-(4-chlorophenoxy)-; Mycil; Clorfenesina; Chlorphenesin carbamate; 			-3.7740421723	4	4	CIPLUS_150785;CHLORPHENESIN;Clorfenesina;1,2-Propanediol, 3-(4-chlorophenoxy)-;chlorphenesinum;Chlorphenesin carbamate;4-CHLOROPHENYL GLYCERYL ETHER;Mycil;Chlorphenesinum;1,2-PROPANEDIOL, 3-(4-CHLOROPHENOXY);LS-120277;3-(P-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesine;chlorphenesine;3-(4-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesin;	0	2.33526012					Clc1ccc(OCC(O)CO)cc1	SigmaAldrich	S427640	-1.38817481	-0.49530761	-0.05264543	2.33526012												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00344561-01	Norgestimate	170464733	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	35189-28-7		14.1253754462	-4.85	13.0471966148	4	4		23.116966584	19.6300578	0.0356613227	0.9992173328			CC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(\CC[C@@H]1[C@H]4CC[C@@]23CC)=N\O	Prestwick	Prestw-1452	-0.51413882	-0.13034411	-0.3158726	19.6300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386347-01	Ospemifene		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	128607-22-7		12.5892541179	-4.9	20.0616446759	2.4	4		32.0655930839	28.52852853	0.0201498549	0.9997498647	2100	ESR2	OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3	Selleck	S4285	-0.28625954	-0.28735632	-0.47132757	28.52852853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179305-04	Lymecycline			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	992-21-2				0.3416006243	4	4		0	0.35035035					CN(C)[C@H]\1[C@@H]2C[C@H]3\C(=C(\O)[C@]2(O)C(=O)\C(=C1O)C(=O)NCNC(CCCCN)C(O)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-1000	0.52480916	-1.48902821	-0.31421838	0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261970-01	BEMOTRIZINOL	225144355		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Tinosorb s;Bemotrizinol;Bis-ethylhexyloxyphenol methoxyphenyl			-4.9544726249	4	4		0	-2.15215215					CCCCC(CC)COC1=CC(=C(C=C1)C2=NC(=NC(=N2)C3=C(O)C=C(OCC(CC)CCCC)C=C3)C4=CC=C(OC)C=C4)O	GVK	FFS-11-286-NCI-081	-0.23854962	-0.28735632	-0.89028542	-2.15215215												1.6E-8	8E-8	4E-7	0.000002											
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	6452-73-9				0.5042000742	4	4		0	-0.85085085					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	0.23854962	-0.13061651	0.89028542	-0.85085085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159498-03	Metipranolol	29215466	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Metipranolol; Disorat; 			-5.0657995896	4	4	Trimepranol;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE HYDROCHLORIDE;LS-122351;Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate;CIPLUS_173566;TRIMEPRANOL;METIPRANOLOL HYDROCHLORIDE;1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE -DL;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE;Disorat;Metipranololum;Methypranol;metipranololum;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE, HYDROCHLORIDE;1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol;metipranolol;Metipranolol;METIPRANOLOL;Metipranolol (4-(2-Hydroxy-3-(isopropylamino)propoxy)-2,3,6-trimethylphenyl acetate);METHYPRANOL;	0	-0.85085085					CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C	SigmaAldrich	R736139	-1.09732824	-1.3322884	-0.89028542	-0.85085085												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00094932-04	NCGC00094932-04			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					9.4205774309	4	4		0	1.15115115					CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	SIGMA	L2261	2.67175573	0.70532915	1.78057083	1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00085849-02	MEBHYDROLIN		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	524-81-2				-2.9803588975	4	4		0	0.5005005					CN1CCC2=C(C1)C3=CC=CC=C3[N]2CC4=CC=CC=C4	Microsource	01501116	-1.04961832	-1.85475444	0.89028542	0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229511-10	Tofacitinib		Jak1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	477600-75-2				-2.3141262291	4	4		0	-1.32743363				JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N	XcessBio	M60033-2s	-0.59585492	-0.26816187	0.55373773	-1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346540-03	FESOTERODINE FUMARATE		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	286930-03-8				2.7108961244	4	4		0	2.16581276				CHRM1	CC(C)N(CC[C@H](C1=CC=CC=C1)C2=C(OC(=O)C(C)C)C=CC(=C2)CO)C(C)C	Microsource	01504374	0.44041451	0.6582155	-0.70475711	2.16581276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188433-02	Hygromycin B		Ribosome-associated ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	31282-04-9				1.4372151845	4	4		0	0.67536097			947998	rbbA	CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O)O[C@H]23)[C@@H]1O	MedChem Express	HY-B0490	0.23316062	-0.12189176	0.60407752	0.67536097												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183879-01	Bisbentiamine	144206468		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	2667-89-2				-1.1358351154	4	4	BISBENTIAMINE;Bisbentiamina;Beston;CIPLUS_213921;bisbentiaminum;Bisbentiamine;bisbentiamine;Bisbentiaminum;	0	-0.62878435					Nc4nc(C)ncc4CN(C=O)C(/C)=C(/CCOC(=O)c1ccccc1)SSC(/CCOC(=O)c2ccccc2)=C(/C)N(C=O)Cc3cnc(C)nc3N	ACC	Bisbentiamine	-0.02590674	-0.70697221	-0.15101938	-0.62878435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015558-14	Isoprenaline hydrochloride	170464679	beta-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	7683-59-2	Isoproterenol;Isoproterenol HCl; Isoprenalina; Isopropyl noradrenaline; Isuprel;(-)-Isoproterenol hydrochloride; ;Isoproterenol hydrochloride; Isoproterenol HCl; Isopreterenol sulfate; Isoproterenol ALSO 123; Levisoprenalina; Isoproterenol hydrochloride;(?)-Isoproterenol hydrochloride;ISOPROTERENOL HYDROCHLORIDE; Luf-Iso; Proternol-L; Isoprenaline Hcl; (-)-Isoproterenol hydrochloride; Proternol-S			-0.5370826589	4	4		0	-0.2111375			153	ADRB1	Oc1ccc(cc1O)C(O)CNC(C)C	Microsource	01500357	0.4472693	0.76548365	-1.59287257	-0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018121-07	Proxyphylline	170465953	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	603-00-9				-1.0216079535	4	4		0	-0.26392188					CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Microsource	01505915	0.54143126	-0.90466249	-1.05291577	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263655-01	Huperzine A	170466837	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	102518-79-6				1.7453106954	4	4		0	-0.26392188				ACHE	CC2=C[C@H]\3CC=1NC(=O)C=CC=1[C@@](N)(C2)C/3=C\C	Enzo	C117	0.63559322	1.67014614	-0.29697624	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015692-08	Methoxamine hydrochloride	225144174		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	61-16-5				-0.7120005419	4	4		0	-0.26392188					COC1=CC(=C(OC)C=C1)C(O)C(C)N	Prestwick	Prestw-535	-0.63559322	0.06958942	0.674946	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015801-12	Pentoxifylline	170465384	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6493-05-6				1.9429133506	4	4		0	1.3196094					CC(=O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O	Vitas	STK177321	0.58851224	-0.97425191	0.08099352	1.3196094												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015730-11	Neostigmine bromide	170465765	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	114-80-7				10.7068281334	4	4		0	2.37529691					[Br-].O=C(Oc1cccc(c1)[N+](C)(C)C)N(C)C	Enzo	AC743	1.67137476	4.52331246	1.75485961	2.37529691												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165862-02	Pamidronic acid	170464689	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	40391-99-9				-1.7567881558	4	4		0	-0.63341251					OC(CCN)(P(O)(=O)O)P(=O)(O)O	Selleck	S1311	-1.01224105	1.53096729	-0.24298056	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023373-03	Clobetasol propionate	170465385	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	25122-46-7	Clobetasol propionate			3.6400286893	4	4		0	1.84745315				NR3C1	ClCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-781	-0.58851224	-0.13917884	2.67278618	1.84745315												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00271789-02	Actinomycin D	170464668	DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	50-76-0				-6.0165967403	4	4		0	-0.05278438				PRKDC	CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O	SIGMA	A1410	-1.10640301	-2.71398747	-1.91684665	-0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181093-01	Metrizoate sodium	144206262		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	7225-61-8	Isopaque; Metrizoate; Isopaque cerebral; Isopaque coronar; Metrizoato sodico; Sodium, Metrizoat; 			-4.0419764151	4	4	Isopaque;natrii metrizoas;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MAGNESIUM SALT (2:1);CIPLUS_166229;MEGLUMINE METRIZOATE;Natrii metrizoas;Sodium, Metrizoat;methylglucamine metrizoate calcium;Isopaque cerebral;Sodium Metrizoate;Metrizoate Sodium;Metrizoate sodium;Triosil;CIPLUS_159326;METRIZOATE MEGLUMINE;SODIUM 3-ACETAMIDO-2,4,6-TRIIODO-5-(N-METHYLACETAMIDO)BENZOATE;methylglucamine metrizoate;CIPLUS_166216;Benzoic acid, 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodo-;METRIZOIC ACID;TRIOSIL;METRIZOATE MAGNESIUM;Isopaque coronar;CIPLUS_172535;Metrizoato sodico;metrizoate de sodium;METRIZOATE SODIUM;Metrizoate de sodium;Metrizoic acid;1-deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-5-(acetyl methylamino)-2,4,6-triiodobenzoate(salt) mixt. with 3-(acetylamino)-5-(acetylmethylamino)-2,4,6,- triiodobenzoic acid calcium salt (2:1);BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MONOSODIUM SALT;Metrizoate;SODIUM METRIZOATE;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, COMPD. WITH D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)- (1:1);sodium meglumine calcium metrizoate;meglumine metrizoate;meglumine calcium metrizoate;Sodium metrizoate;	0	0.81184336					[Na+].Ic1c(NC(C)=O)c(I)c(c(I)c1N(C)C(C)=O)C([O-])=O	NCI	NSC-107431	-1.54566745	-1.00396918	0	0.81184336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179556-03	Cefadroxil	170464658	Solute carrier family 15 member 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	50370-12-2				-4.6088248066	4	4		0	0.38204394					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccc(O)cc1)C=3C(=O)O	Vitas	STK801939	-2.01405152	-1.00396918	1.35980419	0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090868-06	HALOTHANE		GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	151-67-7				-0.9061082634	4	4		0	-0.14326648					FC(F)(F)C(Cl)Br	Microsource	01505434	-0.42154567	0.39691805	0	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521952-01	ROMURTIDE		TNF-alpha Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	78113-36-7				3.5447371326	4	4		0	7.00578035			3557		CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(O)=O	Carbosynth	FA110464	-1.02827763	0.5995829	0.73703606	7.00578035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532504-01	CARNIDAZOLE		Trichomonas Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.9484213976	4	4		0	-0.20809249					COC(=S)NCC[N]1C(=NC=C1[N+]([O-])=O)C	SIGMA	32671	-0.5655527	-0.13034411	-0.36851803	-0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166139-03	3-Hydroxy-4-butyrophenetidide	170465885		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1083-57-4				-3.3941043553	4	4		0	-0.02312139					CCOc1ccc(cc1)NC(=O)CC(C)O	SIGMA	B4027	-1.1311054	-1.22523462	0.52645433	-0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379007-02	Retapamulin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	224452-66-8		12.5892541179	-4.9	33.6056839993	3	4		51.8537105158	46.9132948	0.0221793682	0.999696615			C[C@@H]1CCC23CCC(=O)[C@H]2C1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4C[C@@H]5CC[C@H](C4)N5C	MedChem Express	HY-17010	-0.46272494	0.13034411	-0.52645433	46.9132948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161827-01	NCGC00161827-01	26755462	Xanthine dehydrogenase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					4.9217942536	4	4		0	1.001001			6821		[O-][Mo]([O-])(=O)=O	SigmaAldrich	MFCD00049622	1.24045802	-0.28735632	1.62346164	1.001001												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178579-04	Levobupivacaine hydrochloride	170465452	Sodium channel protein type IV alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	27262-48-2				-3.3764752166	4	4		0	-1.2012012					Cl.Cc2cccc(C)c2NC(=O)[C@@H]1CCCCN1CCCC	Specs	AN-153/I154112	-0.76335878	-0.86206897	0.10473946	-1.2012012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378832-01	Eldecalcitol			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	104121-92-8				2.4454879383	4	4		0	-1.3013013					C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)[C@@H](OCCCO)[C@H](O)C3=C	MedChem Express	HY-A0020	1.43129771	-0.65308255	0.31421838	-1.3013013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185000-22	Afatinib (BIBW2992)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	439081-18-2				-6.8904151421	4	4		0	-2.85285285					CN(C)C\C=C\C(=O)NC1=CC2=C(NC3=CC(Cl)=C(F)C=C3)N=CN=C2C=C1O[C@H]4CCOC4	APExBIO	A8247	-0.8110687	-2.11598746	-1.7282011	-2.85285285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179312-03	Cyclopenthiazide	170466046	Solute carrier family 12 member 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	742-20-1				-2.2333837422	4	4		0	-0.65065065			6559	SLC12A3	NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)CC2CCCC2)cc3Cl	Prestwick Chemical, Inc.	Prestw-994	-0.47709924	-1.22779519	0.47132757	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167490-03	Lumefantrine	170465388	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	82186-77-4	;benflumetol, (+-)-isomer;Lumefantrine; Lumefantrine			-1.9782840597	4	4		0	0.75075075					CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2	SIGMA	L5420	-0.42938931	-1.80250784	-0.26184865	0.75075075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186637-01	Chromomycin A<SUB>3</SUB> from Streptomyces griseus	124897824		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	7059-24-7				0.0595761363	4	4	CHROMOMYCIN A3	0	-1.97950629					CO[C@H]1[C@@H](O)CC(O[C@H]1C)O[C@H]2CC(O[C@@H](C)[C@H]2OC(C)=O)OC3=CC4=CC5=C(C(=C4C(=C3C)O)O)C(=O)[C@@H](OC6C[C@@H](OC7C[C@H](OC8C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O8)[C@@H](O)[C@H](C)O7)[C@H](O)[C@@H](C)O6)[C@@H](C5)[C@@H](OC)C(=O)[C@@H](O)[C@H](C)O	BIOMOL	GR302	0.49222798	-0.80448562	1.20815505	-1.97950629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181170-02	Bendamustine	170465340	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	16506-27-7	Bendamustine HCL;Bendamustine;Inno-P08001; Bendamustine;SyB L-0501;SDX-105			1.7653655254	4	4		0	-0.2561714			7515	XRCC1	ClCCN(CCCl)c1cc2nc(CCCC(=O)O)n(C)c2cc1	Sequoia	3543-75-7	0.18134715	0.07313506	2.06393154	-0.2561714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159507-02	Alclofenac	144205279	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	22131-79-9	Alclofenac; Mervan; Prinalgin; Alclofenaco; 			-1.5716693783	4	4	NCGC_ALDRICH_L129054;mervan ethanolamine salt;NCGC00159507-03;Acetic acid, 4-allyloxy-3-chlorophenyl-, compd. with 2-aminoethanol;CIPLUS_758519;Alclofenaco;Benzeneacetic acid, 3-chloro-4-(2-propenyloxy)-;Alclofenacum;Prinalgin;alclofenacum;CIPLUS_173003;epinal;Mervan;CIPLUS_785326;Acetic acid, 4-allyloxy-3-chlorophenyl-;alclofenac;LS-10937;LS-10936;4-allyloxy-3-chlorophenylacetic acid;Alclofenac;ALCLOFENAC;CIPLUS_174183;	0	-0.06986493					Clc1cc(ccc1OCC=C)CC(=O)O	SigmaAldrich	T100277	-0.44041451	0.85324232	-1.25849484	-0.06986493												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00021569-09	Enalapril maleate	170464969	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	75847-73-3	 Enalaprila;;Enalapril; 7   Enalapril; Enalapril; ; Vasotec; Maleate, Enalapri; Renitec; 8   Enalapril maleate;Enalapril maleate; Enalapril maleate salt; Renitek;ENALAPRIL MALEATE; Renivace			0.5279894444	4	4		0	1.10847189			1636	ACE	OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	Microsource	01501214	0.21186441	-0.69589422	-0.56695464	1.10847189												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249895-01	Bornelone	170465560		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2226-11-1				-1.5582824267	4	4		0	2.16415941					CC2(C)C(=C\C=C\C(C)=O)/C1CCC2C1	GVK	FFS-11-286-NCI-70	-1.15348399	-0.90466249	-1.10691145	2.16415941												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3			-1.3646671474	4	4		0	0.84455001			5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-0.02354049	-1.8789144	-0.89092873	0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016528-05	Proguanil hydrochloride	170464800	DHFR inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	637-32-1	Proguanil hydrochloride; Chlorguanide; ; Proguanil hydrochloride;Proguanil hydrochloride; Chlorguanide; ;Proguanil hydrochloride;CHLOROGUANIDE HYDROCHLORIDE			0.3700221335	4	4		0	2.79757192					Cl.Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1	Prestwick Chemical, Inc.	Prestw-999	-1.24764595	-0.34794711	-0.1349892	2.79757192												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016395-06	Diphenylpyraline hydrochloride	170464816	Histamine H1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	132-18-3		8.9125093813	-5.05	21.5433451581	4	4		24.457883372	22.2750066	0.0337745001	0.999297442			Cl.CN3CCC(OC(c1ccccc1)c2ccccc2)CC3	Microsource	01500258	-0.63559322	-0.6263048	-1.21490281	22.2750066												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015735-11	Niclosamide	170465184	STAT-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	50-65-7	 Yomesan;Niclosamide; Niclosamida;NICOLSAMIDE; ; Bayluscide;NICLOSAMIDE; Niclocide; Phenasal; Fenasal; Niclosamid; Radewerm; Bayer 73; Bayer 2353; Niclosamide; Clonitralide; Niclosamidel; Devermine; Niclosamide-olamine; Tr??d??mine	0.1412537545	-6.85	77.9951139335	2.4	4		34.9261753979	22.75006598	0.4809454903	0.8232520006	6774	STAT3	Clc2cc(ccc2NC(=O)c1cc(Cl)ccc1O)[N+]([O-])=O	Vitas	STK396676	-0.54143126	0.34794711	44.62742981	22.75006598												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00015562-25	Indomethacin	170464705	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	53-86-1	 Indocin;; Cu salt; Indocid; Al salt; Indocin I.V.; ; Li salt; Cu(2+) salt; Metindol; Mg salt; Indomethacin; Ca salt; Osmosin; Cu-IMCC; Zn salt; Combiflex;Indomethacin; Indomet 140; Amuno; NH4 salt;INDOMETHACIN; Indometacina			1.8238209658	4	4		0	-0.31670625				PTGS2	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC	Microsource	01500350	1.29472693	0.27835769	-0.4049676	-0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159346-04	Terbinafine	170465174	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	91161-71-6	 ;Terbinafine; terbinafine, (Z)-isomer; Lamasil;TERBINAFINE HYDROCHLORIDE; Terbinafine; TERBINAFINE HCl;Terbinafine?HCl; Terbinafine HCl			1.511968839	4	4		0	3.32541568					CC(C)(C)C#C\C=C\CN(C)Cc2cccc1ccccc12	Vitas	STK802069	-0.96516008	-1.18302018	0.45896328	3.32541568												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091666-04	1,8-Cineol	170465483	tumor necrosis factor production Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	470-82-6				-2.6406375471	4	5		0	5.46875					CC2(C)OC1(C)CCC2CC1	Labotest	LT00440774	-1.27823281	-3.65279369	-3.14447984	0.56315366	5.46875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015520-11	Hydroxyurea	170465025	Ribonucleoside-Diphosphate Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	127-07-1	 Hydroxyurea;HYDROXYUREA;Hydroxyurea			-7.1617092788	4	5		0	3.10340154			6240	RRM1	NC(=O)NO	Microsource	01500344	-2.77504912	-2.12792128	-2.17710699	-1.89633375	3.10340154											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090797-12	Digoxin		Steroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	20830-75-5	; ; 12beta-Hydroxydigitoxin; Card-Cosaldon; Lanoxin;Digoxin; Digoxin			3.3797523724	4	5		0	1.45006098				RORC	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Prestwick	Prestw-437	0.85952849	-0.06150062	1.72298651	-0.6573957	1.45006098											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159417-05	Triclosan	170464936	Bacterial enoyl-[acyl-carrier-protein] reductase Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3380-34-5				-1.370988879	4	5		0	-2.26317929					Clc2cc(Cl)ccc2Oc1ccc(Cl)cc1O	Labotest	LT02056532	0.14734774	2.00492005	-1.00173634	-0.93552465	-2.26317929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253598-01	Sulfacytine	170465286	Dihydropteroate synthetase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	17784-12-2				-9.4365634863	4	5		0	-3.04919366					O=C1N=C(C=CN1CC)NS(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-041	-3.33988212	-2.54612546	3.16548684	-1.99747155	-3.04919366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179596-03	Butoconazole nitrate	170464901	Antifungal Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	64872-77-1	 Butoconazol;;Butoconazole nitrate; Femstat			11.2656583432	4	5		0	8.25892857					[O-][N+](=O)O.Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3	Prestwick Chemical, Inc.	Prestw-408	-0.4095309	-1.03092783	6.82920072	2.57441673	8.25892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263893-02	Lactitol	170465917	Maltase-glucoamylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	585-86-4				-4.0033487357	4	5		0	-0.55803571					OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	Microsource	01505436	-1.97319434	-2.30367825	0.26319435	2.14534728	-0.55803571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159370-04	Docosanol	124892111	Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	661-19-8	; ; Tadenan;DOCOSANOL; Docosanol (Abreva); Abreva; Doconsanol; 1-Docosanol			-9.4207431311	4	5		0	-3.29241071					CCCCCCCCCCCCCCCCCCCCCCO	Labotest	LTBB001507	-2.271035	2.43095329	0.15237568	-1.98444623	-3.29241071											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00162150-04	Cilnidipine	170465867	Voltage-gated N-type calcium channel alpha-1B subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	132203-70-4		11.220184543	-4.95	26.7843144691	3	5		57.6285621437	45.92633929	0.0005309264	0.9997345771			CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3	Prestwick	Prestw-1376	-2.59369571	-2.73641339	-1.84236044	0.67042102	45.92633929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015080-08	Methylatropine nitrate	170465893	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	52-88-0				-6.1039950466	4	5		0	2.56132267					C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3.[O-][N+]([O-])=O	Vitas	STK108600	-3.90471513	-0.82410824	1.96340323	-2.25031606	2.56132267											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178024-05	Metaraminol bitartrate	170465256	Adrenergic receptor alpha-1 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33402-03-8				8.2953671232	4	5		0	0.82667028					O[C@H](c1cc(O)ccc1)[C@H](C)N.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503251	0.83497053	-1.85731857	7.92039535	2.70543616	0.82667028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091297-05	Anilinium nitrate	170465650		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	542-15-4				3.0765163279	4	5		0	2.07345169					O[N+]([O-])=O.[NH3+]c1ccccc1	Vitas	STK301792	-0.63850688	-2.05412054	1.48256979	4.45006321	2.07345169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023945-12	3'-Azido-3'-deoxythymidine	170464737	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	30516-87-1	3'-Azido-3'-deoxythymidine; ; 3'-Azido-3'-deoxythymidine (AZT); Zidovudine, AZT;; 3'-Azido-3'-deoxythymidine; Antiviral AZ; AZT Antiviral; Retrovir; AZTMP-MAN-SA conjugate; 3' Azido 3' deoxythymidin; bis(t-butyl-SATE)-AZTMP; zidovudine (ZDV or AZT);Zidovudine; AZT, Antiviral;Zidovudine, AZT;ZIDOVUDINE [AZT]			-3.5288193051	4	5		0	-1.78571429			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2	Vitas	STK801891	-1.25341276	2.20185822	-0.54024103	-1.47492625	-1.78571429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015443-17	Flecainide acetate	170464874	Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	54143-55-4	Tambocor; Flecainide, (R)-Isomer; Flecainide acetate salt; ; Flecainide, (S)-Isomer;Flecainide; Flecainide; Flecainida;Flecainide acetate			-9.1451242952	4	5		0	-3.26450893			6331	SCN5A	FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2	Enzo	AC130	-2.74261603	-1.74366807	-2.36874913	1.79672835	-3.26450893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168774-02	Rasagiline mesylate	170465410	MAO-B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	161735-79-1	 ; Azilect; N-2-propynyl-1-indanamine;Rasagiline mesylate; Rasagiline mesylate			-6.3964060988	4	5		0	-0.93508605			4129	MAOB	CS(=O)(=O)O.C#CCN[C@@H]2CCc1ccccc12	Tocris	4308	-2.87328094	-1.31611316	3.16548684	-2.37673831	-0.93508605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094817-05	Flopropione	170465817	Catechol O-methyltransferase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2295-58-1				4.3837256872	4	5		0	-2.72394633			1312	COMT	O=C(CC)c1c(O)cc(O)cc1O	Microsource	01500629	5.20628684	1.43911439	-3.08534794	-2.98356511	-2.72394633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024027-09	Methysergide	170464684	Serotonin 7 (5-HT7) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	361-37-5		12.5892541179	-4.9	1.1798971375	4	5		8.479371316	6.95216154	0.498539107	0.5942183777			CC[C@@H](CO)NC(=O)[C@@H]3C=C2c4cccc1c4c(cn1C)C[C@H]2N(C)C3	Enzo	AC577	-3.73280943	3.45633456	0.60104181	0.1011378	6.95216154											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096122-05	Thioinosine	170465903	Serine/threonine-protein kinase N1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	574-25-4		0.4466835922	-6.35	4.0922088789	4	5		-5.9448677079	-0.92075893	0.6288085701	0.3645627764	29355	Pkn1	Sc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	SIGMA	852686	-0.85629188	10.67837597	-1.62072309	0.05363368	-0.92075893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164595-02	Voglibose	170465993		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	83480-29-9				-8.3929548401	4	5		0	-2.09263393					O[C@H]1[C@@H](NC(CO)CO)C[C@](O)(CO)[C@@H](O)[C@@H]1O	Sequoia	SRP01065v	-3.01563663	-0.0127275	1.7038371	-3.45937249	-2.09263393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164431-01	Terpineol	144205671	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	8000-41-7	(S)-p-Menth-1-en-8-ol; (-)-alpha-Terpineol; D-alpha-terpineol; (R)-p-Menth-1-en-8-ol; Terpineol mixed isomers; DL-alpha-terpineol; (+)-alpha-Terpineol; 			3.531704384	4	4	ALPHA-TERPINEOL;CIPLUS_658650;alpha,alpha,4-trimethyl-3-cyclohexene-1-methanol;alpha-terpineol, sodium salt;DL-alpha-terpineol;CIPLUS_160295;CIPLUS_168066;NCGC00164431-01;1-alpha-terpineol;3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-;(+)-alpha-Terpineol;CIPLUS_167185;CIPLUS_197210;(S)-2-(4-Methyl-3-cyclohexenyl)-2-propanol;TERPINEOL;alpha-terpineol;D-alpha-terpineol;(R)-2-(4-Methyl-3-cyclohexenyl)isopropanol;Terpineol mixed isomers;Terpineol;(R)-p-Menth-1-en-8-ol;CIPLUS_167234;CIPLUS_687752;CIPLUS_688650;alpha-Terpineol;(-)-alpha-Terpineol;(S)-p-Menth-1-en-8-ol;CIPLUS_167096;	0	0.80924855					CC1=CCC(CC1)C(O)(C)C	SigmaAldrich	MFCD00166983	1.02827763	0.5995829	-0.26322716	0.80924855												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00025167-02	Formoterol hemifumarate		Voltage-Gated K(V) 7 (KCNQ) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1448				-0.6133491209	4	4		0	0.06936416					COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC(=C(O)C=C2)NC=O)C=C1	Tocris	1448	-0.41131105	0.18248175	0.36851803	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166309-02	Altrenogest	170465646		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	850-52-2				-0.6740106139	4	4		0	-0.25433526					O=C3C=C4CC[C@@H]2C(C=C[C@@]1(C)[C@H]2CC[C@@]1(O)CC=C)=C4CC3	SIGMA	33994	-0.15424165	-0.28675704	0.1579363	-0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182059-03	Febuxostat	170465220	Xanthine Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	144060-53-7	 ; Febuxostat;Febuxostat			4.5176918447	4	4		0	6.65614312			7498	XDH	CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O	Tocris	4427	-1.1622276	-0.10037641	-0.53204966	6.65614312												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091888-09	3,3,5-Trimethylcyclohexyl salicylate	170465478		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	118-56-9				-0.6832403789	4	4		0	1.34175217					O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O	Microsource	01505020	-1.40435835	0.30112923	0.22802128	1.34175217												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016692-05	Bromperidol	170465873	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	10457-90-6		11.220184543	-4.95	12.3974346341	4	4		12.8073220121	11.81268087	0.3497129951	0.9168162242			Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Br)cc3	Microsource	01505972	-0.72639225	2.76035132	-1.08943501	11.81268087												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166413-02	Argatroban	170464871	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	74863-84-6	; 2   Argatroban; Argatroban Anhydride; Argipidine monohydrate; Acova; Novastan;Argatroban			8.6992873161	4	4		0	5.54181098				F2	C[C@H]1C[C@H](C(=O)O)N(CC1)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c3cccc2C[C@@H](C)CNc23	Sequoia	SRP07170a	0.38666022	0.81401085	1.27266942	5.54181098												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00186464-03	Aliskiren hemifumarate	170465199	Renin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	173399-03-6	ALISKIREN HEMIFUMARATE;Aliskiren hydrochloride			-4.624891522	4	4		0	-1.28649184				REN	Cl.NC(=O)C(C)(C)CNC(=O)[C@@H](C[C@H](O)[C@@H](N)C[C@H](Cc1cc(OCCCOC)c(cc1)OC)C(C)C)C(C)C	Microsource	01505710	-0.67665539	-0.32067094	-1.65447025	-1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015606-06	LOBELINE HYDROCHLORIDE		Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	90-69-7				4.9236290512	4	4		0	3.77268386					CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(O)C3=CC=CC=C3	Microsource	01500758	0.6088993	0.35022181	0.43513734	3.77268386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386213-04	Rupatadine (Fumarate)		Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	182349-12-8		12.5892541179	-4.9	18.6961628555	2.4	4		35.2956298239	29.71098266	0.0427631459	0.9988718979			CC1=CN=CC(=C1)CN2CCC(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C35	MedChem Express	HY-13511A	-1.07969152	-0.13034411	-0.94761779	29.71098266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181341-02	Emedastine difumarate	170465197	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	87233-62-3				-2.7556138093	4	4		0	-1.25125125			3269	HRH1	CN1CCCN(CC1)c3nc2ccccc2n3CCOCC.O=C(O)\C=C\C(=O)O.O=C(O)\C=C\C(=O)O	Prestwick	Prestw-1274	-1.04961832	0.18286311	1.04739461	-1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181340-02	Azosemide	170465933		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	27589-33-9				-0.5757541739	4	4		0	0.15015015					NS(=O)(=O)c2cc(c(NCc1cccs1)cc2Cl)c3nnnn3	APAC	814905	0.38167939	-1.75026123	-0.62843676	0.15015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159339-10	Streptomycin sulfate		30s Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3810-74-0				-5.3577234591	4	4		0	-1.45145145					CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)C=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Prestwick	Prestw-321	-1.09732824	-1.85475444	0.10473946	-1.45145145												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00179357-05	PREDNICARBATE		Glucocorticoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	73771-04-7				-3.7309679871	4	4		0	2.3023023					CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	Microsource	01503876	-1.66984733	-1.22779519	-0.47132757	2.3023023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091056-05	Styrene	225144204		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	100-42-5				-1.1899142409	4	4		0	-0.9009009					C=CC1=CC=CC=C1	SIGMA	S4972	0.04770992	-1.3322884	0.41895784	-0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178060-03	Tolperisone hydrochloride	170465769	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3644-61-9				10.3166406096	4	4		0	7.70849776					Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2	Microsource	01501194	1.0653753	-0.05018821	-0.07600709	7.70849776												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159456-11	Imatinib	170465393	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	220127-57-1	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	5.6234132519	-5.25	102.7290954835	3	4		100.0691578298	94.63299132	0.0071119676	0.9999688029	25	ABL1	CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5	Prestwick	Prestw-1290	-0.3874092	-1.00376412	0.32936407	94.63299132												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181023-03	NOLATREXED HCL			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	152946-68-4				-6.9725895143	4	4		0	-2.07840042					CC1=C(SC2=CC=NC=C2)C3=C(C=C1)N=C(N)N=C3O	Sequoia	152946-68-4	-1.30750605	-1.15432873	-1.39346339	-2.07840042												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015500-19	Haloperidol	170464841	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	52-86-8	; ;Haloperidol; Haloperidol hydrochloride; Haloperidol Lact;Haloperidol..HCl; Vesadol;HALOPERIDOL;Haloperidol?HCl;Haloperidol hydrochloride; Haloperidol metabolite II; Haloperidol Dec; Haldol	11.220184543	-4.95	29.4402404126	3	4		34.2908049679	30.62840178	0.0481372924	0.9985697935	1813	DRD2	Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3	Enzo	AC250	-0.96665056	-0.51800691	-1.90900414	30.62840178												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00186054-01	Tannic acid	124896727	Beta-secretase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE			7.9432823472	-5.1	0.9246084865	4	4		11.1920374679	8.2139446	0.0537008842	0.99824391			OC1=CC(=CC(=C1O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3O[C@@H](OC(=O)C4=CC(=C(O)C(=C4)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)[C@H](OC(=O)C6=CC(=C(O)C(=C6)OC(=O)C7=CC(=C(O)C(=C7)O)O)O)[C@@H](OC(=O)C8=CC(=C(O)C(=C8)OC(=O)C9=CC(=C(O)C(=C9)O)O)O)[C@@H]3OC(=O)C%10=CC(=C(O)C(=C%10)OC(=O)C%11=CC(=C(O)C(=C%11)O)O)O	SIGMA	16201	-1.82669789	-1.33084287	0.54392168	8.2139446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166409-02	Sodium 2,3-dimercaptopropanesulfonate monohydrate	225144282	reactive oxygen species metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	207233-91-8				-5.52175081	4	4		0	-0.14326648					O.[Na+].[O-][S](=O)(=O)CC(S)CS	SIGMA	38530	-1.68618267	-0.77048798	-0.81588251	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249888-01	Vitamin B12	170464872		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	68-19-9				-0.9462203506	4	4		0	-1.62368672					NC(=O)CC[C@@H]8C=2N=C(C(C)=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co+]C#N)[C@@H]7N=C(C(C)=C3N=C(C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O)[C@@]8(C)CC(N)=O	GVK	FFS-11-286-NCI-25	0.18735363	0.67709549	-0.97905902	-1.62368672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390241-07	LX1606 (Hippurate)		5-HT Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1137608-69-5		12.5892541179	-4.9	13.9536922983	4	4		22.1744730681	19.05444126	0.0941206237	0.9945161927		TPH1	CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(Cl)C=C3)[N]4C=CC(=N4)C)C(F)(F)F	MedChem Express	HY-13055	-0.56206089	1.09736166	0.54392168	19.05444126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183867-06	ALOIN			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	5133-19-7				2.3203090349	4	4		0	0.48554913					[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	Microsource	01503427	0.51413882	-0.07820647	1.00026323	0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242596-02	Pralatrexate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	146464-95-1				140.0413789455	4	4		0	19.76878613					NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1	Selleck	S1497	34.75578406	22.86235662	29.37615162	19.76878613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522014-01	Zolazepam Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	33754-49-3				-1.6260216197	4	4		0	1.2716763					C[N]1N=C(C)C2=C1N(C)C(=O)C\N=C2\C3=CC=CC=C3F	Toronto Research	Z613500	-1.1311054	0.13034411	0.3158726	1.2716763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179584-05	Ceftazidime		Penicillin-binding protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	72558-82-8				4.5760007518	4	4		0	0.67052023					CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)C[N+]3=CC=CC=C3)C4=CSC(=N4)N)C(O)=O	Enzo	DL348	1.07969152	1.85088634	0.21058173	0.67052023												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167980-02	Pranoprofen	170465811	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	52549-17-4				-0.6247258251	4	4		0	-0.55055055					O=C(O)C(C)c1cc2Cc3cccnc3Oc2cc1	Prestwick	Prestw-1318	-0.33396947	0.60083595	0.31421838	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522023-01	Paliperidone Palmitate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	199739-10-1				2.4164191352	4	4		0	1.3013013					CCCCCCCCCCCCCCCC(=O)OC1CCCN\2C(=O)/C(=C(C)\N=C12)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Toronto Research	P141020	1.0019084	-1.07105538	-0.5236973	1.3013013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016797-11	Amoxicillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	26787-78-0				-0.2929456485	4	4		0	0.25025025					CC1(C)S[C@H]2[C@H](NC(=O)[C@@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O	Selleck	S3015	0.19083969	-1.64576802	0.26184865	0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373220-03	CEFMENOXIME HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	75738-58-8				6.1371044131	4	4		0	0.9009009					CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4	Microsource	01502422	1.86068702	0.91431557	0.10473946	0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179382-03	Hexylcaine hydrochloride	170465088	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	532-76-3				-0.7157996769	4	4		0	-0.47505938					Cl.CC(CNC1CCCCC1)OC(=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-788	0.4472693	-0.69589422	-0.51295896	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016324-09	Sulfamethoxypyridazine	170466374		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	80-35-3				-1.7262327307	4	4		0	-1.26682502					O=S(=O)(Nc1ccc(OC)nn1)c2ccc(N)cc2	Microsource	01501156	0.35310734	-0.48712596	-0.62095032	-1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164529-04	1-Stearoyl-rac-glycerol	170465522	Phospholipase A2 group IIA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	123-94-4				-3.7425088984	4	4		0	-1.00290314					OCC(O)COC(=O)CCCCCCCCCCCCCCCCC	SIGMA	M2015	-1.01224105	-0.48712596	-0.4049676	-1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263583-01	Temocapril hydrochloride	170465944	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	110221-44-8				-2.6551955076	4	4		0	-0.26392188				ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	Sequoia	110221-44-8	-1.01224105	0.55671538	-0.83693305	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015925-12	Sulfaphenazole	170465185	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	526-08-9	; ; Sulphaphenazole; Sulfaphenazole;Sulfaphenazole; Sulfafenazol; Sulfabid;SULFAPHENAZOLE			-0.1402232124	4	4		0	0.52784376					Nc1ccc(cc1)S(=O)(=O)Nc3ccnn3c2ccccc2	Specs	AN-153/I226112	-0.40018832	-0.97425191	0.4049676	0.52784376												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00016490-12	Flufenamic acid	170465857	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	530-78-9				0.9331235691	4	4		0	0.29688273					FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O	Vitas	STK985630	0.53165781	0.22200296	-0.50906777	0.29688273												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016786-15	Mycophenolic acid	170465182	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	24280-93-1	; ; Acido micofenolico; Acid, Mycophenoli; Mycophenolic acid;Mycophenolic acid;MYCOPHENOLIC ACID	6.3095734448	-5.2	32.0029564819	4	4		30.637989372	28.35230084	0.082264967	0.9958093031	727833	IMPDH1	O=C(O)CCC(\C)=C\Cc1c(O)c2C(=O)OCc2c(C)c1OC	Microsource	01500674	-0.53165781	1.6526887	0.69996818	28.35230084												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183273-04	Chloroprocaine HCl		"Sodium Channel Alpha Subunits; Brain (types I, Ii, Iii) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	3858-89-7				2.8008777421	4	4		0	0.95510984					CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1	APExBIO	B4870	0.42154567	0.30352557	1.14223552	0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160454-01	Felbinac ethyl	144205377		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	14062-23-8	ethyl 4-biphenyl acetate; BPAA-Et; 			-1.9062076813	4	4	BPAA-Et;Felbinac Ethyl;FELBINAC ETHYL;ethyl 4-biphenyl acetate;Felbinac ethyl;LS-44075;4-biphenylylacetic acid ethyl ester;CIPLUS_169170;LM-001;ethyl 4-biphenylacetate;felbinac ethyl ester;LM 001;	0	1.00286533					O=C(OCC)Cc1ccc(cc1)c2ccccc2	Enamine	T5544767	-0.79625293	0.53700677	-0.65270601	1.00286533												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00094048-01	Iofetamine hydrochloride	144204790		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	82691-32-5	Iofetamine hydrochloride; Iofetamine; Spectamine; iofetaminum (123I); 			7.2075616978	4	4	(123I)(+/-)-N-ISOPROPYL-P-IODOAMPHETAMINE;Spectamine;NCGC00162226-01;BENZENEETHANAMINE, 4-(IODO-(SUP 123) I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, HYDROCHLORIDE;IOFETAMINE HYDROCHLORIDE I-123;IOFETAMINE (123 I);CIPLUS_733786;NCGC00015533-01;N-Isopropyl-p-Iodoamphetamine(123I) Hydrochloride;Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-;CIPLUS_192774;Iofetamine hydrochloride;M123 I-123;(+/-)-2-(N-Isopropyl)amino-4'-iodophenylpropane;NCGC_SIGMA_I120;N-ISOPROPYL-1-(4-IODOPHENYL)-2-PROPYLAMINE HYDROCHLORIDE, I-123, DL-;N-Isopropyl-p-iodoamphetamine(123I) hydrochloride;IOFETAMINE HYDROCHLORIDE I 123;IPRIOFENAMINE HYDROCHLORIDE, I-123;iofetaminum (123I);WHO NO. 5526;Iofetamine hydrochloride I 123;CIPLUS_210740;(+/-)-P-IODO-123I-N-ISOPROPYL-.ALPHA.-METHYLPHENETHYLAMINE;Iofetamine;iofetamine (123 I);N-Isopropyl-p-iodoamphetamine hydrochloride;RO-22-6303/001, I-123;NCGC00094048-01;IOFETAMINE I-123;BENZENEETHANAMINE, 4-(IODO-123I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, (+/-)-;	0	7.14450867					Cl.Ic1ccc(CC(C)NC(C)C)cc1	SigmaAldrich	Lopac-I-120	0.66838046	0.70385819	-0.4738089	7.14450867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015595-14	Labetalol HCl		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	32780-64-6				0.0347577486	4	4		0	2.61271676					CC(CCC1=CC=CC=C1)NCC(O)C2=CC(=C(O)C=C2)C(N)=O	APExBIO	B4795	-1.1311054	0.70385819	0.68439063	2.61271676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262549-02	Ajmaline		Voltage-gated potassium channel subunit Kv4.3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	12/7/4360				5.154043328	4	4		0	1.13294798					CC[C@@H]1[C@@H](O)N2[C@H]3CC1C4[C@@H](O)[C@]5(C[C@@H]24)[C@H]3N(C)C6=CC=CC=C56	Prestwick	Prestw-NAT-0151	0.77120823	-0.18248175	3.52724401	1.13294798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094207-05	Pentolinium bitartrate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	52-62-0				2.7881237163	4	4		0	0.20809249					C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	Prestwick	Prestw-188	0.71979434	-0.49530761	1.63200842	0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166115-02	Dibutyltin dilaurate	170466843		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	77-58-7				3.854331861	4	4		0	1.54913295					O=C(O[Sn](CCCC)(OC(=O)CCCCCCCCCCC)CCCC)CCCCCCCCCCC	SIGMA	291234	0.46272494	1.7987487	0.36851803	1.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015009-23	4-Aminopyridine		Voltage-gated potassium channel subunit Kv1.3 Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	504-24-5				-3.1491969584	4	4		0	-0.85085085					NC1=CC=NC=C1	MedChem Express	HY-B0604	-0.47709924	-1.12330199	-0.89028542	-0.85085085												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00274083-01	Loxiglumide	170465971	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	107097-80-3				-2.5742694963	4	4		0	0.1001001					Clc1ccc(cc1Cl)C(=O)NC(CCC(=O)O)C(=O)N(CCCCC)CCCOC	SIGMA	SML0130	-1.0019084	-0.54858934	0.41895784	0.1001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378574-01	Brexpiprazole		Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	913611-97-9		11.220184543	-4.95	38.5332484857	3	4		66.8058134454	59.10910911	0.0062910112	0.9999755951			O=C\1NC2=C(\C=C1)C=CC(=C2)OCCCCN3CCN(CC3)C4=C5C=CSC5=CC=C4	MedChem Express	HY-15780	-1.71755725	-1.48902821	-0.31421838	59.10910911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090714-01	Sodium xylenesulfonate	144204551		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1300-72-7	PENTOSAN POLYSULFATE SODIUM; Sodium xylenesulfonate; 			-4.5460858614	4	4	XYLANPOLYSULFATE SODIUM;ELMIRON;Sodium xylenesulfonate;AB02509377-01;PENTOSAN POLYSULFATE SODIUM;CIPLUS_158001;	0	-0.45045045					[Na+].Cc1ccc(cc1C)S(=O)([O-])=O	NIEHS	AB02509377	-1.09732824	-1.22779519	-0.78554595	-0.45045045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167536-03	Tosufloxacin toluenesulfonic acid	170466053	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	115964-29-9				-0.2397898274	4	4		0	-0.1001001					O=S(=O)(O)c1ccc(C)cc1.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3CCC(N)C3)c4ccc(F)cc4F	Sequoia	SRP02535t	0.14312977	-0.18286311	-0.57606703	-0.1001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261967-01	Prednisolone farnesylate	170466045	Glucocorticoid and meneralocorticoid receptor agonists/antagonists Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	118244-44-3	No2-cbl;Nitritocobalamin;Nitrocobalamin			1.6930754886	4	4		0	2.4024024					C/C(C)=C\CCC(\C)=C\CCC(/C)=C/C(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-185	-0.04770992	-0.60083595	0.62843676	2.4024024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345881-04	Conivaptan hydrochloride		Vasopressin (AVP) V1a/V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	168626-94-6				1.7520455975	4	4		0	4.45445445				AVPR1A	CC1=NC2=C([NH]1)C3=CC=CC=C3N(CC2)C(=O)C4=CC=C(NC(=O)C5=CC=CC=C5C6=CC=CC=C6)C=C4	APExBIO	A8402	0.04770992	-1.80250784	-0.62843676	4.45445445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532508-01	DROMETRIZOLE TRISILOXANE			DPI_SARS-CoV-2_General	2019_NPC-9_CPE					6.7592256385	4	4		0	2.58500233					CC(CC1=CC(=CC(=C1O)[N]2N=C3C=CC=CC3=N2)C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C	SIGMA	68790	0.90673575	1.29205266	0.85577649	2.58500233												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00274057-01	Phenylpropanolamine hydrochloride	170465627	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	154-41-6				-1.2829165774	4	4		0	0.2561714					Cl.O[C@H]([C@@H](C)N)c1ccccc1	Microsource	02300253	-0.23316062	-0.80448562	-0.45305814	0.2561714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181784-01	Iloprost	144207135	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	78919-13-8	Iloprost; 			1.3746124855	4	4	LS-101845;ZK 3637;i1oprost;iloprostum;ZK 36 374;ZK-36374;ZK-00036374;Ventavis;ZK3637;CIPLUS_190653;Iloprost;(5E)-5-((3AS,4R,5R,6AS)-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYLOCT-1-EN-6-YN-1-YL)HEXAHYDROPENTALEN-2(1H)-YLIDENE)PENTANOIC ACID;CIPLUS_191919;Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-;ILOPROST;VENTAVIS;5-((E)-(1S,5S,6R 7R)-7-HYDROXY-6((E)-(3S,4RS)-3-HYDROXY-4-METHYL-1-OCTEN-6-INYL)-BICYLO (3,3,0)-OCTAN-3-YLIDENE)-PENTANOIC ACID;CoTherix Brand of Iloprost;PENTANOIC ACID, 5-((3AS,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-2(1H)-PENTALENYLIDENE)-, (5E)-;	0	-0.06986493					O[C@@H]2C[C@@H]1C/C(C[C@@H]1C2/C=C/[C@@H](O)C(C)CC#CC)=C\CCCC(=O)O	Tocris	Tocris-2038	0.18134715	0.17064846	1.20815505	-0.06986493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163470-27	FK-506		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	109581-93-3				2.8089433742	4	4		0	1.32743363				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Microsource	01503968	0.59585492	0.17064846	0.25169897	1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167477-01	Fidarestat	144206034	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	136087-85-9	SNK-860; Aldos; 			-5.7540991915	4	4	LS-145864;fidarestatum;fidarestat;Aldos;SNK-860;Fidarestat;FIDARESTAT;(2S,4S)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide;6-FLUORO-2',5'-DIOXOSPIRO(CHROMAN-4,4'-IMIDAZOLIDINE)-2-CARBOXAMIDE, 2S,4S, D-;CIPLUS_737489;Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2',5'-dioxo-, (2S-cis)-;SNK 860;fedarestat;	0	-1.60689334					NC(=O)[C@@H]2C[C@]1(NC(=O)NC1=O)c3cc(F)ccc3O2	Chemical Block	A4376/0186841	-1.16580311	-1.09702584	-1.15781525	-1.60689334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014810-01	Pirbuterol hydrochloride	144203612	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	38029-10-6	Pirbuterol hydrochloride; Maxair; 			0.2042185082	4	4	6-(2-(tert-butylamino)-1-hydroxyethyl)-3-hydroxy-2-pyridinemethanol dihydrochloride;CIPLUS_3865153;CIPLUS_749202;pirbuterol sulfate;PIRBUTEROL HYDROCHLORIDE;Maxair;CIPLUS_210786;CP-24315-1;LS-176467;Pirbuterolum;pirbuterol acetate;Pirbuterol Hydrochloride;LS-66540;PIRBUTEROL;cp-24,314-14;CP 24315-1;pirbuterol acetate salt;LS-176523;CP-24,314-1;Pirbuterol Acetate;2-HYDROXYMETHYL-3-HYDROXY-6-(1-HYDROXY-2-TERT-BUTYLAMINOETHYL)-PYRIDINE, ACETATE;pirbuterolum;pyrbuterol;pirbuterol;PIRBUTEROL ACETATE;CIPLUS_179342;Pirbuterol acetate;LS-131417;Pirbuterol hydrochloride;pirbuterol dihydrochloride;Pirbuterol;2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride;	0	0.48905449					Cl.Oc1ccc(nc1CO)C(O)CNC(C)(C)C	NCI		-0.02590674	0.31691858	-0.45305814	0.48905449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249924-01	Ibuprofen piconol	170465895		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	64622-45-3				2.115895135	4	4		0	-2.16415941					CC(C)Cc1ccc(cc1)C(C)C(=O)OCc2ccccn2	GVK	FFS-11-286-NCI-203	0.4472693	0.41753653	3.21274298	-2.16415941												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095838-04	Sumatriptan	170465377	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	103628-46-2	; ;SUMATRIPTAN; Sumatriptan; Imigran;Sumatriptan succinate;SUMATRIPTAN SUCCINATE; Succinate, Sumatripta; Imitrex			-0.8078313242	4	4		0	-0.47505938			3351	HTR1B	CNS(=O)(=O)Cc1cc2c(cc1)ncc2CCN(C)C	Microsource	01505372	0.77683616	-0.48712596	-1.32289417	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253597-01	Isosulfan blue	170464639		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	68238-36-8				1.0546081315	4	4		0	0.84455001					[Na+].CC/[N+](CC)=C1\C=C/C(C=C1)=C(/c2ccc(cc2)N(CC)CC)c3cc(ccc3S([O-])(=O)=O)S([O-])(=O)=O	GVK	FFS-11-286-NCI-038	0.07062147	0.76548365	-0.51295896	0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262526-04	CINCHONIDINE		Alkaloid; P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	485-71-2				4.0783457084	4	4		0	-0.14326648				ABCB1	O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C3=CC=NC4=C3C=CC=C4	Microsource	01500839	1.17096019	0.35022181	1.35980419	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167984-01	Tiquizium bromide	144206157		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	71731-58-3	Tiquizium bromide; Bromuro de tiquizio; 			0.0915905166	4	4	CIPLUS_214419;tiquizium bromide;thiaton;Bromuro de tiquizio;Tiquizium Bromide;bromide (cis)-isomer;Tiquizii bromidum;LS-176911;tiquizii bromidum;TIQUIZIUM BROMIDE;bromure de tiquizium;Tiquizium bromide;3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;3-(Di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;LS-142883;Thiaton;Bromure de tiquizium;HSR 902;HSR-902;	0	-0.16184971					[Br-].C[N@@+]14CCCC[C@@H]4CC\C(C1)=C(/c2sccc2)c3cccs3	Bosche	T6489	0.20565553	-0.02606882	-0.42116346	-0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015572-06	MIBG			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103346-16-3				-1.2362947992	4	4		0	-0.76300578					NC(=N)NCC1=CC=CC(=C1)I	Axon Medchem	1750	-0.5655527	1.90302398	-0.7896815	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181755-01	Delapril hydrochloride	144206480		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	83435-67-0	Delapril hydrochloride; Adecut; 			5.2012500227	4	4	Delapril Hydrochloride;Delapril hydrochloride;RHC-6000-A;RO-16-3037;N-(2,3-DIHYDRO-1H-INDEN-2-YL)-N-(N-((1S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)GLYCINE HYDROCHLORIDE;CIPLUS_192483;derapril;USV 6000-A(SS);delapril;N-(2,3-dihydro-1H-inden-2-yl)-N-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)alanyl)glycine;CV 3317;N-(1-(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-(S)-ALANYL-N-(2-INDANYL)GLYCINE HYDROCHLORIDE;N-(N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl)-N-(indan-2-yl)glycine hydrochloride;DELAPRIL;LS-72517;DELAPRIL HYDROCHLORIDE;delaprilum;CV-3317;CIPLUS_667977;Delapril;LS-177754;Adecut;	0	0.99421965					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C2Cc3ccccc3C2	ACC	DELAPRIL HYDROCHLORIDE	1.95372751	-0.39103233	-0.36851803	0.99421965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179358-04	Methacycline hydrochloride	170465224	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	3963-95-9				2.8955247159	4	4		0	1.14112715					Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1C(=C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick Chemical, Inc.	Prestw-964	-0.12953368	0.07313506	3.32242638	1.14112715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381723-02	Taltirelin		Thyrotropin-Releasing Hormone (TRH) Analogs	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103300-74-9				-2.1270933018	4	4		0	0.16184971				TRHR	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=C[NH]C=N2)C(=O)N3CCC[C@H]3C(N)=O	MedChem Express	HY-B0596	-0.97686375	-1.06882169	1.42142669	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274062-01	Zosuquidar trihydrochloride	174006281	P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	167465-36-3	LY335979			1.8938648335	4	4		0	3.25325325				ABCBA	Cl.Cl.Cl.FC3(F)[C@@H]2c7ccccc7[C@H](c1ccccc1[C@@H]23)N4CCN(CC4)C[C@@H](O)COc6cccc5ncccc56	Selleck	S1481	-0.62022901	-1.75026123	3.24692328	3.25325325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00531790-01	JTT-501		Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	170861-63-9				-3.1112982037	4	4		0	-0.65065065			5468	PPARG	CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C4=CC=CC=C4	Glixx	GLXC-08947	-0.47709924	-1.59352142	-0.41895784	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346533-09	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1009119-65-6				4.2831340478	4	4		0	0					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	Glixx	GLXC-90137	1.09732824	0.91431557	1.2045038	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159409-08	myo-Inositol			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	87-89-8				2.6488918653	4	4		0	-0.8008008					O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O	SIGMA	57569	1.90839695	-1.85475444	-0.47132757	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181021-02	Bufogenin	124893634	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE			2.8183829313	-5.55	33.0338165024	4	4	CIPLUS_153297;resibufogenin;Bufogeninum;Bufogenine;Bufogenina;BUFOGENIN;14,15 beta-epoxy-3 beta-hydroxy-5 beta-bufa-20,22-dienolide;Bufogenin;bufogenine;bufogeninum;RESIBUFOGENIN;bufogenin;Resibufogenin;LS-45295;	21.0329153561	2.25225225	1	0.982561348			C[C@]12CC[C@H](O)C[C@H]1CCC3C2CC[C@]4(C)[C@H](C[C@H]5O[C@@]345)C/6=C/OC(=O)/C=C6	Sequoia	RESIBUFOGENIN	2.29007634	-0.44409613	19.0102121	2.25225225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262943-01	Tocanfil	170466061		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5634-42-4	Tocamphylum;Tocanfil;Tocamphyl			-2.0731136708	4	4		0	0.25025025					CC1(CCC(C(=O)O)C1(C)C)C(=O)OC(C)c2ccc(C)cc2.OCCNCCO	GVK	FFS-11-286-NCI-206	-0.76335878	-0.18286311	-0.26184865	0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167979-01	Methenolone enanthate	144206153		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	303-42-4	Methenolone enanthate; Metenolone enanthate; Metenolone Enanthate; Primobolan Depot; Primobolan depot; 			7.935718988	4	4	Primobolan Depot;LS-174294;Primobolan depot;Methenolone Enanthate;CIPLUS_152547;methenolone oenanthate;Schering brand of methenolone enanthate;Metenolone Enanthate;Methenolone enanthate;methenolone enanthate, (17beta)-isomer;methenolone enanthate, (17alpha)-isomer;methenolone enanthate;methenolone heptanoate;METHENOLONE ENANTHATE;Metenolone enanthate;	0	4.40149045					CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]1CC(=O)C=C(C)[C@]1(C)[C@H]4CC[C@]23C	Bosche	M5729	2.30569948	-0.31691858	-1.45985401	4.40149045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168251-01	Ethylmorphine	144206163	Opioid receptors; mu/kappa/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	76-58-4	Ethylmorphine hydrochloride; Veralgin; Dionin; Morphine 3-ethyl ether; 			-2.979589923	4	4	Dionin;LS-91899;CIPLUS_781610;Veralgin;Morphine 3-ethyl ether;Ethylmorphine;LS-91901;LS-91902;LS-91903;CIPLUS_173377;CIPLUS_165781;O-Ethylmorphine hydrochloride;CIPLUS_730767;CIPLUS_149399;ETHYLMORPHINE HYDROCHLORIDE;Ethylmorphine hydrochloride;Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-ethoxy-17-methyl-, hydrochloride,dihydrate;ethyl-alpha-isomorphine;CIPLUS_3884309;Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, (5alpha,6alpha)-;Ethylmorphine Hydrochloride;ETHYLMORPHINE;	0	0.58220773					CCOc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45	SigmaAldrich	E8512	-1.11398964	-0.46318869	-0.35237856	0.58220773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183049-01	Zelandopam	144206852		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	139233-53-7	ZELANDOPAM; 			0.3222209459	4	4	ZELANDOPAM;CIPLUS_3879393;zelandopamum;	0	-0.52784376					Cl.Oc1ccc(cc1O)[C@H]3CNCc2c3ccc(O)c2O	Pharmaron	PH-NIH-155132	0.11770245	-0.27835769	0.83693305	-0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181002-04	Cinacalcet hydrochloride	170465336	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	364782-34-3	 Cinacalcet;Cinacalcet;Cinacalcet hydrochloride; Sensipar; 			-8.3144023573	4	4		0	-2.95592505			846	CASR	Cl.FC(F)(F)c3cccc(CCCN[C@H](C)c2cccc1ccccc12)c3	Selleck	S1260	-1.38888889	-0.69589422	-1.91684665	-2.95592505												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015748-17	Nifedipine	170465006	Voltage-gated L-type calcium channel alpha-1C subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	21829-25-4				1.6120465756	4	4		0	-2.05859066					CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2[N+]([O-])=O)C(=O)OC	Specs	AN-153/I100964	-0.30602637	1.04384134	3.53671706	-2.05859066												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159477-05	Phenylacetic acid	170465102		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	103-82-2				-1.3448252722	4	4		0	-0.84455001					OC(=O)Cc1ccccc1	Vitas	STK297835	-0.07062147	-0.20876827	-0.1349892	-0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017291-17	Riboflavin			DPI_SARS-CoV-2_General	2019_NPC-4_CPE	 83-88-5				0.2119098061	4	4		0	-0.58062813					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Selleck	S2540 	-0.40018832	-0.27835769	1.75485961	-0.58062813												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00015226-12	Mitotane	170464927	Antineoplastic Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53-19-0	 ; ortho,para DD;Mitotane; Lysodren; Chlodithane; Mitotano; 2,4'-DDD solution; Khloditan;MITOTANE;1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; Mytotan;o,p'-DDD; Chloditan	7.0794578438	-5.15	8.9933534064	4	5		9.7720598439	8.34263393	0.4191015866	0.6912589505		CYP11B1	Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1	Microsource	00330082	3.43757756	-2.63459336	-3.56004987	1.01903996	8.34263393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182994-01	Anacolin	144206808		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	21216-78-4	Diphenylpiperidinomethyldioxolan iodide; Gastrophyllin-A; 			-2.954316229	4	5	Gastrophyllin-A;N-(2,2-diphenyl-1,3-dioxolan-4-ylmethyl)-N-methylpiperidinium;anacoline;Diphenylpiperidinomethyldioxolan Iodide;Diphenylpiperidinomethyldioxolan iodide;anacoline iodide;DIPHENYLPIPERIDINOMETHYLDIOXOLAN IODIDE;CIPLUS_770363;CIPLUS_784768;	0	-1.31138393					[I-].C[N+]1(CCCCC1)CC2COC(O2)(c3ccccc3)c4ccccc4	Pharmaron	PH-NIH-117094	0.01241003	-0.54728268	-0.31860368	-1.42129257	-1.31138393											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00274084-01	DL-Isoleucine	170465505		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	443-79-8				1.7009620866	4	5		0	6.0577314					CC(CC)C(N)C(=O)O	SIGMA	I2752	-3.36444008	-2.20172202	6.47789502	0.6068268	6.0577314											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024504-09	Kainic acid	170465818	Glutamate receptor ionotropic kainate 5 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	487-79-6				-1.2791252403	4	5		0	-0.66404662					CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O	Enzo	EA123	-2.1611002	1.53751538	2.92507012	0.1517067	-0.66404662											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016777-08	Probucol	170464772	Serine Protease Hepsin Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	23288-49-5	 Bisbid; Aventis Brand of Probucol; Panavir; Lorelco; Biphenabid;PROBUCOL; Probucol; Superlipid;Probucol; Lurselle; Hoechst Brand of Probucol; 			5.0981531779	4	5		0	7.14285714				ABCA1	CC(C)(C)c2cc(SC(C)(C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)cc(c2O)C(C)(C)C	Microsource	01501109	-2.07247456	1.41275296	0.87269705	2.86940198	7.14285714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183008-01	Israpafant	144206851	Interleukin-5 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	117279-73-9	ISRAPAFANT; 			-1.8864060445	4	5	6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-(2-(4-(2-methylpropyl)phenyl)ethyl)-;4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;Y 24180;CIPLUS_695838;(+/-)-4-(O-CHLOROPHENYL)-2-(P-ISOBUTYLPHENETHYL)-6,9-DIMETHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;israpafant;ISRAPAFANT;Israpafant;Y-24180;israpafantum;	0	-4.18755929					CC(C)Cc1ccc(cc1)CCc2cc5c(s2)n3c(C)nnc3C(C)N=C5c4ccccc4Cl	Pharmaron	PH-NIH-155125	0.81041257	0.13530135	-0.25377321	-0.2528445	-4.18755929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095129-06	Valdecoxib	170465163	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	181695-72-7				13.0945781673	4	5		0	0.98929394				COX2	NS(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	SIGMA	PZ0179	3.68369352	4.34194342	2.97849606	0.58154235	0.98929394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018130-09	Phenazopyridine hydrochloride	170465267		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	136-40-3		14.1253754462	-4.85	0.373941909	4	5		13.969843632	10.51897321	0.1349957097	0.9253950293			Cl.Nc2nc(N)ccc2/N=N/c1ccccc1	Microsource	01500473	-2.89153636	1.08183785	-1.87006511	-2.25261464	10.51897321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017326-05	(1S,9R)-beta-Hydrastine	170465706	GABA-A receptor; anion channel Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	29617-43-4				-10.3740756999	4	5		0	-1.59040179					CN2CCc1cc5OCOc5cc1[C@H]2[C@@H]4OC(=O)c3c(OC)c(ccc34)OC	Microsource	01500687	-2.41995532	-1.28547792	-2.64579582	-2.78895146	-1.59040179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016229-14	Propylthiouracil	170464965	Antithyroid Drugs	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51-52-5	; ; 6 Propyl 2 Thiouraci;Propylthiouracil;6-Propyl-2-thiouracil; Propiltiouracilo;PROPYLTHIOURACIL; Propylthiouracil	11.220184543	-4.95	-1.3047059632	4	5		11.99427262	6.89174107	0.2131142645	0.8745319668	7173	TPO	S=C1NC(CCC)=CC(=O)N1	Microsource	01500515	-1.67535369	-4.16189385	0.041557	-0.67042102	6.89174107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015802-18	Pimozide	170464864	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2062-78-4				-9.7103794588	4	5		0	-4.51280661					Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5	NCGCChem	NCGC00015802-17pur	-1.42436149	-0.82410824	-1.42914385	-3.03413401	-4.51280661											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090814-07	4-Chlorophenol	170465673	macrophage activation involved in immune response Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	106-48-9				-5.8307148811	4	5		0	0.31169535					Oc1ccc(Cl)cc1	Microsource	01500460	-2.65225933	-1.29151292	-1.50928276	1.1630847	0.31169535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091641-12	MERCAPTOPURINE			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6112-76-1, 50-44-2 [anhydrous]				-6.8537736224	4	5		0	1.96503591					S=C1NC=NC2=C1NC=N2	Microsource	01500387	-3.29076621	-1.93111931	-1.74969948	0.505689	1.96503591											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167468-02	Benorylate	170466237	prostaglandin biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5003-48-5				-1.4387191676	4	5		0	4.91936577					O=C(C)Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1	Bosche	B1551	-1.91552063	0.799508	0.68118071	-3.71681416	4.91936577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018256-06	Oxyphenonium bromide	170465282	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-10-2				-5.5412332117	4	5		0	0.5859375					[Br-].OC(C(=O)OCC[N+](C)(CC)CC)(c1ccccc1)C2CCCCC2	SIGMA	O5501	-2.46959543	-1.87094311	2.20252112	-2.33306516	0.5859375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016323-09	Sulfachloropyridazine	170466574	Salmonella Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	80-32-0				4.6628860475	4	5		0	2.87388393					O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2	Microsource	01501142	2.271035	-0.82728777	0.67876437	-2.27943148	2.87388393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016925-11	Omeprazole	170465443	ABCC3 Expression Enhancer	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	73590-58-6	 ; Omeprazole ER; Zegerid; Prilosec;AGI-010/DM-3458;Omepral; ESOMEPRAZOLE Mg; Losec sodium; Esomeprazole;Omeprazole; Omeprazole; Omeprazol; Nexium; Losec			-4.925440899	4	5		0	-2.76227679			8714	ABCC3	Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC	Microsource	01505693	0.4095309	-2.35458827	-0.70646904	-2.11853044	-2.76227679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015897-08	Ranolazine	170465435	Sodium channel Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	95635-55-5	 ;RANOLAZINE;Ranolazine dihydrochloride; Ranolazine dihydrochloride; Ranexa;Ranolazine			-6.8138720234	4	5		0	-1.09770972			6335	SCN9A	OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC	Microsource	01505366	-2.23477407	2.81672817	-2.60451449	-2.85714286	-1.09770972											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094960-06	Anthraquinone	170466833	Beta amyloid A4 protein Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	84-65-1				12.4327032435	4	5		0	3.9436238					O=C2c1ccccc1C(=O)c3ccccc23	Vitas	STK398385	3.14341847	2.9397294	-1.2154401	3.16055626	3.9436238											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00178286-05	Pralidoxime chloride	170465059	Butyrylcholinesterase Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-15-0				-3.4573475066	4	5		0	-0.47431901					[Cl-].O\N=C\c1cccc[n+]1C	Prestwick Chemical, Inc.	Prestw-943	-1.37524558	0.18450184	-0.49418993	-0.48040455	-0.47431901											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162116-04	Cephapirin sodium	170465306	Bacterial penicillin-binding protein Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	24356-60-3				0.4434532753	4	5		0	-0.20327958					[Na+].[O-]C(=O)C=2N3C(=O)[C@@H](NC(=O)CSc1ccncc1)[C@H]3SCC=2COC(C)=O	Microsource	01500167	-1.32612967	4.07134071	-0.78803259	1.08723135	-0.20327958											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016064-12	Terfenadine	170465598		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50679-08-8		3.1622776602	-5.5	11.1648558394	4	5		12.908990164	-6.41741071	0.2773278371	0.9500003016			CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01503708	0.01241003	-0.11454754	-2.42415847	8.93000804	-6.41741071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249921-01	Omoconazole	170465847		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74512-12-2		14.1253754462	-4.85	20.3224876914	2.4	5		34.5390362399	27.24860335	0.0075457597	0.9962118762			C\C(=C(\OCCOc1ccc(Cl)cc1)c2ccc(Cl)cc2Cl)n3ccnc3	GVK	FFS-11-286-NCI-199	0.56265207	-1.2825302	0.13432654	-0.40739124	27.24860335											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023234-05	Flurandrenolide	170465298		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1524-88-5				-6.259228929	4	5		0	-0.40502793					OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-645	-2.35705596	-0.51052173	0.13432654	-1.89145933	-0.40502793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025176-02	Etomidate	170465117	GABAA Receptor Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33125-97-2	 Etomidato; ; Radenarkon; Ethomidate;ETOMIDATE; Etomidate;Etomidate; Amidate	0.2238721139	-6.65	2.2572234447	4	5		8.485401464	-1.29888268	0.6395741147	0.6171506329	2554	GABRA1	CC(c1ccccc1)n2cncc2C(=O)OCC	Microsource	01505599	-2.90450122	-1.65608268	10.12333618	1.19307435	-1.29888268											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165740-05	Benazepril	170465003	Angiotensin-I Converting Enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	86541-74-4	; Briem; Benazepril Free base; BENAZEPRIL HCl; Lotensin HCT 20/12.5mg;Benzapril; Labopal; Benazepril Hcl; Cibacen; Lotensin; Benzapril;Benazepril hydrochloride; Cibac???ne	12.5892541179	-4.9	68.6616544323	3	5		96.1527295174	88.56213579	0.0116211984	0.994139217	1636	ACE	Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@H]3CCc2ccccc2N(CC(=O)O)C3=O	Microsource	01505200	-0.95776031	1.88191882	5.78335782	-1.59292035	88.56213579											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090726-12	Ribavirin	170464657	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	36791-04-5	; ;Ribavirin; Levovirin; Ribavirin; Virazole;RIBAVIRIN; Ribavirina; Drug:  Ribavirin			-5.7812342499	4	5		0	-2.16480447			727833	IMPDH1	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503938	-0.86678832	-2.07944216	-1.11124679	-0.46558999	-2.16480447											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016564-06	Metformin	170464804	AMPK Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			-0.1937349722	4	5		0	0.5726257			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	-1.59671533	2.00473166	0.20759555	1.1348756	0.5726257											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091616-03	2-Ethoxybenzamide	170465775		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	938-73-8		0.177827941	-6.75	6.22869146	4	5		7.5839416079	2.44413408	0.5290087173	0.5478979948			CCOc1ccccc1C(N)=O	Specs	AN-153/I166787	-2.56995134	0.46071473	10.26987422	2.3861487	2.44413408											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015704-09	Methapyrilene hydrochloride	170465531		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	135-23-9				6.2703321224	4	5		0	4.4273743					Cl.CN(C)CCN(Cc1cccs1)c2ccccn2	Microsource	01503229	1.62712895	0.38600423	0.84259372	-1.30947185	4.4273743											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016542-06	Levonordefrin	170464794	Adrenergic receptor alpha-2 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	829-74-3				-6.7509311432	4	5		0	-2.15476352					Oc1ccc(cc1O)[C@@H](O)[C@H](C)N	Enzo	AC1038	-2.28388998	-0.99630996	-2.49766262	2.19974716	-2.15476352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024778-02	Bifemelane	170465900	Monoamine oxidase B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90293-01-9		12.5892541179	-4.9	19.9883720594	3	5		34.623772104	31.18308714	0.1097227553	0.940238943			CNCCCCOc2ccccc2Cc1ccccc1	Tocris	0767	-2.60314342	-1.66051661	5.94363564	-2.12389381	31.18308714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095312-04	Deracoxib	170465679	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	169590-41-4				-4.9678419373	4	5		0	-2.04634774			791253	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(OC)c(F)c2)C(F)F	Microsource	01505222	0.24557957	-1.51291513	-0.46747696	-3.59039191	-2.04634774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188962-02	Pravastatin sodium	174007284	HMG-CoA Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	81131-70-6	Pravastatin			-3.8099961255	4	5		0	-2.52793296			3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	Prestwick	Prestw-1319	-1.53588808	1.53156518	-0.3785566	0.17459625	-2.52793296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095606-02	(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone	170465578	TNF-alpha Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14073-97-3				-5.9271772812	4	5		0	-2.86312849					CC(C)[C@@H]1CC[C@@H](C)CC1=O	SIGMA	63680	-2.96532847	-0.70974972	1.35547686	1.80416121	-2.86312849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate			-4.3866180442	4	5		0	-2.58379888			7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	-1.87043796	0.65994272	2.33239712	-1.54226684	-2.58379888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091125-07	Gallic acid	170465633	intrinsic apoptotic signaling pathway in response to oxidative stress Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	149-91-7		8.9125093813	-5.05	6.3905616958	4	5		-8.175977648	-3.89664804	0.5334516572	0.5419024076			Oc1cc(cc(O)c1O)C(=O)O	Vitas	STK298718	0.22810219	8.2555099	1.91720601	2.53164557	-3.89664804											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015819-15	Propafenone hydrochloride	170464755	Potassium Channel Subfamily K Member 3 (TASK-1; KCNK3) Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54063-53-5	Propafenona; ;Propafenone; Propafenone Hcl; Propafenone;Propafenone hydrochloride; Rythmol;Propafenone?HCl; Propafenone, (S)-Isomer; Rhythmol; Propafenone, (R)-Isomer	12.5892541179	-4.9	68.3982884295	3	5		119.0703291306	101.04748603	0.0018668765	0.9990653633		KCNK3	CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1	SigmaAldrich	P-4670	-2.14416058	-3.79778359	0.13432654	-0.84388186	101.04748603											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016794-13	Gemfibrozil	170464998	PPARalpha Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil	0.1	-7	14.1630926782	4	5		-9.331858412	-0.22321429	0.1122572352	0.939560428	5465	PPARA	O=C(O)C(C)(C)CCCOc1cc(C)ccc1C	Vitas	STK618740	8.32712832	0.42000764	0.34630835	-2.35988201	-0.22321429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090903-11	Sulfasalazine	170464716	NFKB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine			13.0056094732	4	5		0	1.32681564			4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	Microsource	01500552	6.25	1.48175819	1.77066797	-2.64804307	1.32681564											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178069-05	Cloperastine hydrochloride	170465832		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14984-68-0		14.1253754462	-4.85	33.4160421035	4	5		28.5	27.08100559	0.0718970435	0.9620672822			Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-793	4.33394161	5.56593201	1.55086091	0.23279499	27.08100559											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015014-11	Acetohexamide	170465411	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	968-81-0				2.1199099841	4	5		0	-0.50223214					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O	Microsource	01505425	0.65773145	-2.43095329	2.67350048	1.58219362	-0.50223214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015418-09	Ethosuximide	170464802	T-Type Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	77-67-8	 Etosuximida; ; Suxilep;ETHOSUXIMIDE;Ethosuximide; Ethosuximide; Zarontin			-8.5697713949	4	5		0	-3.79464286				CACNA1G	CC1(CC)CC(=O)NC1=O	Microsource	01502196	-1.67535369	-2.17640321	-2.89513783	1.31402521	-3.79464286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024499-06	D-Aspartic acid	225144192	Isoaspartyl peptidase/L-asparaginase Interacts	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	56-84-8				-3.0841710069	4	5		0	0.33482143			80150	ASRGL1	N[C@@H](CC(O)=O)C(O)=O	Enzo	AC367	-0.43435096	-4.36553392	1.12203906	-1.47492625	0.33482143											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00253586-01	Isalon	170465491		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	5579-81-7				-10.4378545976	4	5		0	0.08370536					O=C(N)NC1N=C(O[Al](O)O)NC1=O	GVK	FFS-11-286-NCI-89	-2.46959543	-4.13643884	-2.59038648	-1.74309466	0.08370536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094721-07	Methimazole	170464856	Thyroid peroxidase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60-56-0		0.7943282347	-6.1	9.8157656024	4	5		13.3029197079	-0.15363128	0.0260858267	0.9995846883			S=C1NC=CN1C	Vitas	STK802184	-2.75243309	-1.45685469	3.89546953	9.13720355	-0.15363128											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090820-03	4-Acetamidobenzoic acid	170466207	immune response Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	556-08-1				-6.6214643903	4	5		0	-1.55027933					O=C(C)Nc1ccc(cc1)C(=O)O	Specs	AE-562/J256200	-3.29987835	-2.07944216	1.47759189	1.54226684	-1.55027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091695-03	Triethylenetetramine	170465257	Copper Chelating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	112-24-3				-6.6026801885	4	5		0	1.53459821					NCCNCCNCCN	Labotest	LTBB000434	-3.66095805	-3.27096856	-1.45449508	3.35210512	1.53459821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166153-02	Climbazole	170465557		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	38083-17-9				-8.2779669836	4	5		0	-0.390625					CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2	Bosche	C1228	-2.99081658	-0.52182767	-1.81465577	-1.15312416	-0.390625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178831-03	Acriflavine hydrochloride	170465670	Hypoxia-inducible factor 1 alpha Interacts	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	69235-50-3				-1.8901439995	4	5		0	-3.50558659					[Cl-].C[n+]1c3cc(N)ccc3cc2ccc(N)cc12.Nc1cc2nc3cc(N)ccc3cc2cc1	Microsource	01500618	0.77554745	-1.40704769	1.81951398	-1.42586934	-3.50558659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014993-12	Nonanedioic acid	170465358	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123-99-9				-0.6021479395	4	4		0	0			7299		O=C(O)CCCCCCCC(=O)O	Microsource	01500648	0.14499758	0.5673409	-1.20903595	0												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017013-05	Thiamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	67-03-8				-4.3274108249	4	4		0	-0.76408787					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	Prestwick	Prestw-631	-1.03044496	-0.63039925	-0.97905902	-0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-01	Tigecycline	124894296	glycylcycline antibiotics	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	220620-09-7	Tigecycline; ; Tigecycline; Tygacil			-2.7624737473	4	4	Tigecycline;tigecycline;TIGECYCLINE;TetX protein, Bacillus fragilis;tigecycline 11a-hydroxylase, Bacillus fragilis;GAR-936;CL-346635;4,6-BIS(DIMETHYLAMINO)-9-((((DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-2-NAPHTHACENECARBOXAMIDE;2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-((((1,1-DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-;TBG-MINO;CIPLUS_736709;GAR 936;WAY-156936;9-(tert-butylglycylamido)minocycline;Tygacil;	0	0.66857689					CC(C)(C)NCC(=O)Nc1cc(N(C)C)c2C[C@H]3C[C@H]4[C@@H](C(O)=C(C(=O)[C@@]4(O)C(O)=C3C(=O)c2c1O)C(N)=O)N(C)C	ACC	API-03922	-1.35831382	0.02334812	0.27196084	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181152-02	Nedaplatin			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	95734-82-0				-2.2149555737	4	4		0	-0.52531041					O=C1C[O-][Pt++][O-]1	MedChem Express	HY-13700	-1.264637	0.44361429	1.25101985	-0.52531041												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00017147-02	CEFEPIME HYDROCHLORIDE		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	123171-59-5				-3.0669804309	4	4		0	-1.09837631					CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)C[N+]3(C)CCCC3)C4=CSC(=N4)N	Microsource	01502420	-0.74941452	-0.9105767	0.43513734	-1.09837631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164555-03	Entacapone	170464850	NCI-H1299 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	130929-57-6				2.1904965908	4	4		0	2.11137503					Oc1cc(\C=C(/C#N)C(=O)N(CC)CC)cc([N+]([O-])=O)c1O	Sequoia	SRP10885e	-0.40018832	-1.18302018	1.37688985	2.11137503												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018200-12	Phenolphthalein	170465559	store-operated calcium entry Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	77-09-8				8.8704348557	4	4		0	4.8033782					Oc1ccc(cc1)C3(OC(=O)c2ccccc23)c4ccc(O)cc4	Vitas	STK029876	0.4472693	1.2526096	1.80885529	4.8033782												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167447-02	Prosultiamine	170465884	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	59-58-5				-3.4782080678	4	4		0	-1.44607843					Nc1nc(C)ncc1CN(C=O)C(C)=C(CCO)SSCCC	Bosche	P5775	-0.52923387	0.15444015	-1.65081142	-1.44607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261966-01	NCGC00261966-01			DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Selamectin	1.1220184543	-5.95	13.9868216886	4	4		10.6350806439	-3.06372549	1	0.9991900105			CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	GVK	FFS-11-286-NCI-104	-0.52923387	0.92664093	10.15668719	-3.06372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379009-01	Octreotide acetate		Growth Hormone Release Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	79517-01-4				-1.5031423813	4	4		0	-0.12254902				SSTR1	CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=C[NH]C5=C4C=CC=C5)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1	MedChem Express	HY-17365	-0.27721774	-0.20592021	-0.86737549	-0.12254902												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet			-3.5735085287	4	4		0	-1.60484083			7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-0.1937046	-1.05395232	-0.68406385	-1.60484083												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164520-02	L-Threonine	170465476		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72-19-5				0.0782564623	4	4		0	-0.71033938					O=C(O)[C@@H](N)[C@@H](C)O	Labotest	LTBB004859	0.14527845	-0.65244667	1.2414492	-0.71033938												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00090730-03	D-Camphor	170465497		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	464-49-3				-4.1852302495	4	4		0	-0.34201526					CC2(C)[C@H]1CC(=O)[C@]2(C)CC1	Vitas	STK803534	-0.7748184	-1.30489335	-1.39346339	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016032-11	alpha-Lipoic acid	170465713		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1077-28-7				-2.0517273612	4	4		0	0.39463299					O=C(O)CCCCC1CCSS1	Vitas	STK801969	-1.79176755	0.40150565	0.53204966	0.39463299												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00168785-03	Diclazuril		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	101831-37-2	 ; Diclazuril;Diclazuril;DICLAZURIL			8.2468976383	4	4		0	7.81373323					ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	FLUKA	34057	0.0968523	-0.15056462	-0.38003547	7.81373323												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165856-03	Orlistat	170464663	Fatty acid synthase inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	96829-58-2				6.8350137304	4	4		0	7.47154874				FASN	O=C(O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC)C(CC(C)C)NC=O	Sequoia	96829-58-2	-1.25664572	-0.61667489	1.3363029	7.47154874												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159417-05	Triclosan	170464936	Bacterial enoyl-[acyl-carrier-protein] reductase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3380-34-5				0.6974755389	4	4		0	-1.18753093					Clc2cc(Cl)ccc2Oc1ccc(Cl)cc1O	Labotest	LT02056532	-0.24166264	1.30735076	1.46356984	-1.18753093												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160421-03	Tetrabenazine	170464675	Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	58-46-8	 ; Nitoman;Tetrabenazine; Tetrabenazine; Tetrabenazina; Xenazine			1.0790109086	4	4		0	0.49480455			6571	SLC18A2	CC(C)CC2CN3CCc1cc(OC)c(OC)cc1C3CC2=O	Chemical Block	A2708/0115225	0.53165781	0.024667	-0.4454343	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167436-02	Azelnidipine	174006618	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123524-52-7	 ; Calblock;Azelnidipine; Azelnidipine			-2.8247107787	4	4		0	-1.92973775					[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC(C)C)=C(C)NC(N)=C2C(=O)OC3CN(C3)C(c4ccccc4)c5ccccc5	Bosche	A2998	0.04833253	0.86334484	-1.3363029	-1.92973775												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183861-01	(2R)-2-Propyloctanoic acid	144206875	S100 beta biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	185517-21-9				-2.3454052038	4	4	Arundic Acid;Acido ar?ndico;(R)-2-Propyloctanoic acid;acidum arundicum;arundic acid;(R)-(-)-2-propyloctanoic acid;CIPLUS_783758;Acide arundique;ONO-2506;Arundic acid;ONO2506;Acidum arundicum;	0	0.09896091					O=C(O)[C@@H](CCCCCC)CCC	Pharmaron	PH-NIH-183336	-0.96665056	-0.46867292	-0.31816736	0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00241101-09	Neratinib		EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	698387-09-6				-7.4921454839	4	4		0	-1.62368672				EGFR	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(=C(C=N2)C#N)NC3=CC=C(OCC4=CC=CC=N4)C(=C3)Cl	Glixx	GLXC-90246	-1.54566745	-1.19075414	-2.06690237	-1.62368672												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00388389-01	N-acetyl-D-Glucosamine			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7512-17-6				-2.4594854413	4	4		0	0.12254902					CC(=O)NC(C=O)C(O)C(O)[C@H](O)CO	Cayman	13136	-0.5796371	-0.72072072	-0.81141578	0.12254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016382-07	Oxethazaine	170465643		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	126-27-2		14.1253754462	-4.85	12.4750101059	4	4		26.7399193559	21.34803922	0.0216446515	0.999711687			CC(C)(Cc1ccccc1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2	Microsource	01503279	-1.03326613	-0.61776062	-0.58757694	21.34803922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274274-01	Benzquinamide	170465138	Dopamine D2 receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	63-12-7				-3.3005635314	4	4		0	1.18389897					CCN(CC)C(=O)C2CN3CCc1cc(OC)c(OC)cc1C3CC2OC(C)=O	GVK	FFS-11-286-NCI-037	-1.59806295	-0.40150565	-1.2921206	1.18389897												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095787-05	(-)-Inosine			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	58-63-9				-2.487973259	4	4		0	-1.49960537					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=O	Bosche	I0819	-0.2905569	-0.8531995	0.27869268	-1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017354-07	Spectinomycin dihydrochloride	170465149	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	21736-83-4	; Trobicin sulfate; Spectinomycin Sulfate; Espectinomicina;SPECTINOMYCIN HYDROCHLORIDE; Spectam; Stanilo;Spectinomycin dihydrochloride; Spectinomycin Sulphate			9.8729393897	4	4		0	1.23701138					Cl.Cl.C[C@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@H](NC)[C@H](O)[C@H](NC)[C@H]3O[C@@]2(O)C(=O)C1	Microsource	01500538	3.62493958	0.37000493	1.46356984	1.23701138												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015760-12	Octopamine	170465959	Dopamine transporter Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104-14-3				-5.6788141923	4	4		0	-1.48441366					OC(CN)c1ccc(O)cc1	Vitas	STK801377	-0.8699855	-0.81401085	-1.78173719	-1.48441366												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249929-01	Neticonazole	170466035	ergosterol biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	130726-68-0				7.419140963	4	4		0	3.77268386					CS\C=C(/c1ccccc1OCCCCC)n2ccnc2	GVK	FFS-11-286-NCI-232	1.17096019	1.37753911	0.92466685	3.77268386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181009-02	Timepidium bromide	170465823	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	35035-05-3				-1.7440171222	4	4		0	3.05635148					[Br-].COC1C\C(C[N+](C)(C)C1)=C(/c2sccc2)c3cccs3	Bosche	T3573	-1.68618267	0.39691805	0	3.05635148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182709-03	Landiolol hydrochloride	170465910	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	144481-98-1				-0.7550483745	4	4		0	-0.22058824					Cl.CC3(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N1CCOCC1)cc2)O3	APAC	877817	-0.32762097	-0.51480051	0.86737549	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249110-03	Sucralose	170466823		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	56038-13-2				6.8572859931	4	4		0	2.18137255					O[C@H]1[C@H](O[C@H](CO)[C@H](Cl)[C@@H]1O)O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O	Microsource	01505953	1.38608871	0.87516088	1.538892	2.18137255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167479-01	Bicisate dihydrochloride	144206036		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	14344-58-2	Technetium tc 99m bicisate; 99mTc-ECD; Tc-ethyl cysteinate dimer; Tc-99m-L,L-ECD; Tc-99m ECD; Tc-99m-ECD; Tc-99m-bicisate; 			-0.9205107481	4	4	BICISATE DIHYDROCHLORIDE;N,N'-1,2-ETHYLENEDIYLBIS-CYSTEINE, DIETHYL ESTER DIHYDROCHLORIDE;	0	2.67156863					Cl.Cl.O=C(OCC)C(CS)NCCNC(CS)C(=O)OCC	Epsilon	INVP_51441657	-1.53729839	0.46332046	0.97929491	2.67156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249906-01	Nicoboxil	170465989	positive regulation of vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	13912-80-6		3.9810717055	-5.4	11.7979971004	4	4		15.0108958799	12.39147593	0.0849683775	0.9955564531			O=C(OCCOCCCC)c1cccnc1	GVK	FFS-11-286-NCI-130	-1.2590799	-0.10037641	0.58272105	12.39147593												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167356-07	Raltegravir			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	871038-72-1				-0.7333764318	4	4		0	1.3943699					CN1C(=O)C([O-])=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3	Selleck	S2005	-0.24213075	-0.20075282	-1.59614897	1.3943699												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015876-11	Ranitidine	170465134	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	66357-35-5				-3.1950804827	4	4		0	0.02630887			3274	HRH2	[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1	Microsource	01501151	-1.11380145	-0.25094103	-0.93742083	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090782-06	Nelfinavir mesylate	170465351	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	159989-65-8	 Mesylate, Nelfinavi;; ; Viracept; Nelfinavir mesylate;Nelfinavir mesylate;Nelfinavir; Viracept 250mg; Nelfinavir mesilate; Nelfinavir Mesilate			-3.5103671544	4	4		0	-2.02578269					CS(=O)(=O)O.Oc1cccc(c1C)C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C	Tocris	3766	-1.11380145	-1.05395232	1.44413479	-2.02578269												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179573-03	Tiaprofenic acid	170465577	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	33005-95-7				-1.53494357	4	4		0	-0.34636319					O=C(c1ccc(s1)C(C)C(=O)O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-496	-0.48332528	-0.37000493	0	-0.34636319												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167438-02	Trospium chloride	174006890	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	10405-02-4	Trospium chloride; Cloruro de trospio; Trospium chloride; Spasmoplex; 			-0.1948085137	4	4		0	1.8802573					[Cl-].OC(c1ccccc1)(c2ccccc2)C(=O)O[C@@H]3C[C@@H]5CC[C@H](C3)[N+]45CCCC4	Selleck	S2549	-0.43499275	0.024667	-1.39993637	1.8802573												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178737-05	Trimeprazine tartrate	170465278	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	4330-99-8		12.5892541179	-4.9	102.8850718575	3	4		112.5777832791	89.26274122	0.0108855461	0.9999269117			O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12	Microsource	01500593	1.20831319	1.99802664	1.27266942	89.26274122												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274079-01	Sodium urate	170465686		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1198-77-2				-2.3132928769	4	4		0	-0.52531041					[Na+].O=C1NC(=O)NC=2[N-]C(=O)NC1=2	SIGMA	U0881	-1.12412178	-0.81718422	1.57737286	-0.52531041												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00386235-04	Cobicistat		Cytochrome P450 3A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1004316-88-4		14.1253754462	-4.85	10.4925245335	4	4		13.174870824	10.88825215	0.2524051608	0.9589490996			CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Glixx	GLXC-90002	1.45199063	-0.95727294	-0.97905902	10.88825215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095105-05	Acetrizoic acid	170465154	Solute carrier organic anion transporter family member 1B1 Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	85-36-9				6.3373163635	4	4		0	-0.0245098					O=C(C)Nc1c(I)c(c(I)cc1I)C(=O)O	Microsource	01504142	2.04133065	0.82368082	0.81141578	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522534-01	Quinagolide (hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	94424-50-7				-0.1620483794	4	4		0	-0.41666667					CCCN1C[C@H](C[C@@H]2CC3=C(O)C=CC=C3C[C@@H]12)N[S+]([O-])(=O)N(CC)CC	MedChem Express	HY-13736A	-0.37802419	1.28700129	0.3077784	-0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095157-05	Oxfendazole	170466223	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	53716-50-0	; OXFENDAZOLE;OXFENDAZOLE;Oxfendazole; ; Synanthic; Oxfendazol			-5.9168976379	4	4		0	-1.44607843				TUBB	O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3	Vitas	STK378905	-1.99092742	0.1029601	0.25181869	-1.44607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167476-02	Calcium hopantenate	50112729		DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Calcium hopantenate; Hopate; Acido hopantenico; 			-3.8538128661	4	4	Calcium hopantenate;Hopate;acide hopantenique;CIPLUS_171572;CIPLUS_170762;Acide hopantenique;Acidum hopantenicum;Calcium Hopantenate;Hopantenic acid;CALCIUM HOPANTENATE;HOPANTENIC ACID;Calcium Hopantenate Anhydride;pantogab;CIPLUS_159419;Acido hopantenico;CIPLUS_685059;acidum hopantenicum;	0	1.00490196					CC(C)(CO)C(O)C(=O)NCCCC([O-])=O	InterBioScreen	STOCK1N-30476	-1.28528226	-1.08108108	-0.81141578	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164556-02	Fudosteine	170465764	Mucin-5AC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	13189-98-5				-1.1030594413	4	4		0	-0.28939753			4586	MUC5AC	OCCCSC[C@H](N)C(=O)O	Sequoia	SRP02575f	-1.1622276	-0.05018821	1.08943501	-0.28939753												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00182992-01	Fasoracetam	144206891	GABA-B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	110958-19-5	FASORACETAM; Fasoracetam Anhydride; Fasoracetam Hydrate; 			-3.2540694456	4	4	FASORACETAM;Fasoracetam Anhydride;CIPLUS_775811;CIPLUS_3849428;Fasoracetam;fasoracetam;(+)-1-(((R)-5-OXO-2-PYRROLIDINYL)CARBONYL)PIPERIDINE;Fasoracetam Hydrate;	0	-0.28939753					O=C([C@H]1CCC(=O)N1)N2CCCCC2	Pharmaron	PH-NIH-97984	-1.0653753	-0.65244667	-0.48137826	-0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090757-06	Melphalan	170464727	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	148-82-3	; Mustard, Phenylalanin; Melfalano;Melphalan; ; Sarcolisina; L-Phenylalanine mustard;MELPHALAN; Melphalan			-5.0057671867	4	4		0	-1.3943699				H2AFX	O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl	Microsource	01500382	-1.50121065	-1.10414053	0.07600709	-1.3943699												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090770-09	5-Bromo-2'-deoxyuridine	170465870	base conversion or substitution editing Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59-14-3				-0.1692336527	4	4		0	1.81531176					BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Bosche	B0691	-0.8716707	0.55207026	-0.88674943	1.81531176												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018269-05	Trimebutine maleate	170465734		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	34140-59-5				0.0686352218	4	4		0	1.65745856					COc1c(cc(cc1OC)C(=O)OCC(CC)(c2ccccc2)N(C)C)OC.O=C(O)/C=C\C(=O)O	Microsource	01505011	-0.8716707	0	-0.12667849	1.65745856												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160445-02	Bromisovalum	170465828		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	496-67-3				-0.6487223003	4	4		0	0.60510392					CC(C)C(Br)C(=O)NC(N)=O	Labotest	LT00134620	-0.8716707	0.8531995	-0.27869268	0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016385-08	Sulfabenzamide	170465133		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	127-71-9				2.4099617455	4	4		0	-0.69272637					Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2	Vitas	STK985629	-0.28999517	-0.51800691	3.88164174	-0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015656-12	Mianserin	170465596	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	24219-97-4	; ; Org GB 94;Mianserin; Mianserin Hcl;Mianserin hydrochloride; Mianserin hydrochloride; Mianserina;MIANSERIN HYDROCHLORIDE; Mianserine hydrochloride; Mianserine Hcl;Mianserin..HCl;Mianserine hydrochloride; Lerivon; Bolvidon; Tetramide; Hydrochloride, Mianseri; Tolvon			-1.9860031449	4	4		0	1.08857001			3356	HTR2A	CN1CC2N(CC1)c4ccccc4Cc3ccccc23	Enzo	AC554	-1.35331078	-0.86334484	-0.06363347	1.08857001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183283-01	Iomeprol	144207160		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	78649-41-9				-0.7489801249	4	4	Iomeprol;Iomeron 300;IOMEPROL;iomeprol 350;Iomeprolum;iomeprol 400;iomeprol;iomeprolum;Altana Pharma brand of iomeprol;Rovi brand of iomeprol;Imeron;CIPLUS_191882;Iomeron;N,N'-BIS(2,3-DIHYDROXYPROPYL)-5-((HYDROXYACETYL)METHYLAMINO)-2,4,6-TRIIODO-1,3-BENZENEDICARBOXAMIDE;	0	0.0245098					Ic1c(c(I)c(c(I)c1N(C)C(=O)CO)C(=O)NCC(O)CO)C(=O)NCC(O)CO	Toronto Research	I730500	-0.17641129	-0.25740026	-0.19585898	0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159448-05	4-Methoxycinnamic acid	225144227		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	943-89-5				4.1575627163	4	5		0	3.24543611					COC1=CC=C(\C=C\C(O)=O)C=C1	SIGMA	M13807	1.14774115	-1.2136536	0.78953861	-0.14357502	3.24543611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018234-07	Sulfaguanidine	170465708		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57-67-0				11.5615735848	4	5		0	5.59837728					Nc1ccc(cc1)S(=O)(=O)NC(=N)N	Specs	AT-084/J157969	1.73382173	1.8204804	2.17123119	1.96219191	5.59837728											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179367-03	Iopromide	170465023		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	73334-07-3				-0.9494260516	4	5		0	0.73022312					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)N(C)CC(O)CO)C(=O)NCC(O)CO)COC	Prestwick Chemical, Inc.	Prestw-872	-0.51282051	0.9608091	-0.5428078	-1.19645848	0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163886-05	Fenchlorphos	170466415	Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	299-84-3				2.0937489895	4	5		0	-0.89249493					Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl	Microsource	01505668	0.70818071	0.1011378	0.24673082	1.72290022	-0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091058-11	Linolenic acid	225144205	Fatty acid desaturase 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	463-40-1				6.2290384207	4	5		0	2.92089249			9415	FADS2	CC\C=C/C/C=C\C\C=C/CCCCCCCC(O)=O	SIGMA	62160	2.07570208	0.6573957	-1.38169257	1.00502513	2.92089249											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013058-02	Malachite green oxalate	170465712		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	2437-29-8				0.4777777198	4	5		0	-3.40770791					C/[N+](C)=C1\C=C/C(C=C1)=C(/c2ccccc2)c3ccc(cc3)N(C)C.[O-]C(=O)C(=O)O.[O-]C(=O)C(=O)O.O=C(O)C(=O)O.CN(C)c1ccc(cc1)C(\c2ccccc2)=C3/C=C/C(C=C3)=[N+](/C)C	SIGMA	38800	0.17094017	-0.3539823	0.5428078	3.68509213	-3.40770791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091390-04	4-Methoxyphenol	170464687	Tyrosinase Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	150-76-5				-0.8780241989	4	5		0	0.56795132					Oc1ccc(OC)cc1	Bosche	M0306	0.02442002	-1.2642225	0.19738465	-0.86145011	0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179541-03	Carteolol hydrochloride	170465122	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	51781-21-6				0.4256420041	4	5		0	0.0811359					Cl.CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	Prestwick Chemical, Inc.	Prestw-446	0.46398046	-0.8091024	0.14803849	-0.04785834	0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159447-07	8-Quinolinol Salicylic acid (1:1)	170465482	Trichophyton Interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	2439-07-8				-4.073007185	4	5		0	-0.56795132					O=C(O)c1ccccc1O.Oc1cccc2cccnc12	Specs	AE-562/J262360	-0.65934066	-1.4664981	-1.38169257	-0.62215841	-0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178213-05	Nafronyl oxalate	170465616	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3200-06-4		7.0794578438	-5.15	15.9048571937	4	4		16.55054472	15.75901079	0.0942916113	0.9945026241			O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3	Microsource	01503419	0.1937046	-0.55207026	-1.2921206	15.75901079												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018130-09	Phenazopyridine hydrochloride	170465267		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	136-40-3				3.2577842773	4	4		0	5.9721126					Cl.Nc2nc(N)ccc2/N=N/c1ccccc1	Microsource	01500473	-1.11380145	-0.50188206	-0.83607803	5.9721126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249052-02	Calcium levulinate	170465651		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5743-49-7				2.8859565039	4	4		0	0.24740228					[Ca+2].O.O.O=C([O-])CCC(C)=O.CC(=O)CCC([O-])=O	SIGMA	L2009	0.82165297	1.75135668	-0.12726694	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181000-02	Suplatast tosylate	170465881	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	94055-76-2	 ;IPD-1151T; Tosilato de suplatast; Suplatast;Suplatast tosylate; Suplatast tosylate			-0.7654680861	4	4		0	1.4349332					Cc1ccc(cc1)S(=O)([O-])=O.C[S+](C)CCC(=O)Nc1ccc(OCC(O)COCC)cc1	Tocris	3543	-0.82165297	0.07400099	-0.82723513	1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00168747-01	Methoxyflurane	144206179	synaptic transmission Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	76-38-0				1.3212574325	4	4	Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-;CIPLUS_149389;METHOXYFLURANE;Penthrane;Pentrane;methoxyflurane;Methoxyflurane;methoxyfluranum;LS-1693;Methoxyfluranum;Anecotan;Metoxiflurano;	0	1.62368672					ClC(Cl)C(F)(F)OC	Alfa Aesar	L17285	-0.42154567	0.1167406	1.57737286	1.62368672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378877-01	Methylnaltrexone Bromide			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	73232-52-7				-3.2212123702	4	4		0	0.71633238			4988	OPRM1	[H][C@]12OC3=C4C(C[C@@H]5[C@](O)(CCC1=O)[C@]24CC[N+]5(C)CC6CC6)=CC=C3O	MedChem Express	HY-75766	-1.31147541	-0.25682933	-0.32635301	0.71633238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344556-01	Epitiostanol	225144391		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	2363-58-8				-2.6480024106	4	4		0	1.33715377					C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-1006	-1.17096019	-0.07004436	-0.87027468	1.33715377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017244-16	ENOXOLONE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	471-53-4		14.1253754462	-4.85	9.1206736242	4	4		15.6096002199	12.46418338	0.1200851491	0.9910690062			[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]3(C)C2=CC(=O)[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	01500990	0.37470726	-0.72379173	-0.92466685	12.46418338												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185755-03	Cefatrizine			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	51627-14-6				0.411257269	4	4		0	-0.47755492					[H][C@](N)(C(=O)N[C@]1([H])C(=O)N2\C(C(O)=O)=C(CSC3=CNN=N3)/CS[C@]12[H])C4=CC=C(O)C=C4	DC Chemicals	DC9221	-0.37470726	3.01190754	-0.54392168	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016411-10	Butacaine	170465459		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	149-16-6				-0.9567867751	4	5		0	0.89249493					Nc1ccc(cc1)C(=O)OCCCN(CCCC)CCCC	Microsource	01503914	-0.02442002	-1.011378	-1.67776955	0.43072505	0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015861-09	Propentofylline	170465624	Adenosine receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	55242-55-2				-0.9062319758	4	5		0	-0.81135903					CC(=O)CCCCN2C(=O)c1n(cnc1N(C)C2=O)CCC	SIGMA	P9689	0.75702076	-1.3653603	-0.64150012	-0.43072505	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017245-10	Ellagic acid	170466649	Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	476-66-4	; Elagostasine; Acid, Ellagi; Acido elagico;ELLAGIC ACID; Acid, Benzoari;Ellagic Acid; EADME cpd;Ellagic acid; Ellagic acid hydrate			7.4059575503	4	5		0	7.62677485			231	AKR1B1	Oc1c4OC(=O)c2cc(O)c(O)c3OC(=O)c(cc1O)c4c23	Vitas	STK801964	-0.12210012	-0.2022756	0.39476931	-0.76573343	7.62677485											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00091268-12	Oxytetracycline	225144208	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	79-57-2	; ; Oxytetracycline hydrochloride; Terramycin hydrochloride; Oxitetraciclina;Oxytetracycline hydrochloride;OXYTETRACYCLINE; Oxytetracycline Base;Oxytetracycline; Riomitsin;Oxytetracycline dihydrate; Oxytetracycline HCl; Oxytetracycline base; Oxytetracycline dihydrate; oxycort A; Terramycin			2.9362102938	4	5		0	2.75862069					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@H]3\C(=C(O)/[C@]2(O)C(=O)\C(=C1O)C(N)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-307	0.51282051	-0.1517067	-0.19738465	0.2392917	2.75862069											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016991-05	Proparacaine	170465400	Sodium Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5875-06-9	; ;PROPARACAINE HYDROCHLORIDE; Alcaine; Proximetacaina; Proparacaine hydrochloride;Proparacaine hydrochloride			-2.1447739417	4	5		0	-1.70385396				SCN10A	Cl.CCN(CC)CCOC(=O)c1ccc(OCCC)c(N)c1	Vitas	STK520616	0.65934066	-0.7079646	-1.28300025	-1.00502513	-1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025262-02	Cisapride	170465200		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	81098-60-4				0.2950021128	4	5		0	1.46044625					Clc1cc(c(OC)cc1N)C(=O)NC3CCN(CCCOc2ccc(F)cc2)CC3OC	Tocris	1695	-1.1965812	2.17446271	0.14803849	-0.28715004	1.46044625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00180892-03	CLAVULANATE LITHIUM	225144312	Beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE					-0.2319613205	4	5		0	1.13590264					[Li].OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O	Microsource	01505124	-0.51282051	-1.6182048	0.14803849	0.57430007	1.13590264											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00178500-07	Streptozotocin	170464827	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	18883-66-4				15.0568936843	4	5		0	4.46247465				H2AFX	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O	Microsource	01500543	3.34554335	2.78128951	2.86207747	2.24934195	4.46247465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016391-13	Clioquinol	170465019		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	130-26-7		10	-5	48.9311995457	3	5		66.5491381248	62.39350913	0.0010330565	0.999483239			Oc1c(I)cc(Cl)c2cccnc12	Microsource	01505114	1.001221	-0.4551201	-0.5428078	1.62718354	62.39350913											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018187-09	Cinnarizine	170465920	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	298-57-7				1.6142102726	4	5		0	1.78498986					c1ccccc1C(c2ccccc2)N3CCN(CC3)C/C=C/c4ccccc4	Prestwick	Prestw-278	-0.56166056	-0.6068268	-1.28300025	3.78080881	1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091250-12	Reserpine	170465405	Alkaloid anitpsychotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-55-5		11.220184543	-4.95	74.3197842853	3	5		106.4287387469	98.90466531	0.0000727369	0.9999636342		SLC18A2	COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	Vitas	STK801975	-0.17094017	0.2528445	0.04934616	0.71787509	98.90466531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015321-11	Dobutamine	170465050	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	34368-04-2	 ; Dobutamine, (-)-Isomer;Dobutamine hydrochloride; Dobutamine hydrochloride;Dobutamine; Dobutamina; Dobutaminum; Dobutamine HCl; Dobutamine (+)-Isomer			0.3521593547	4	5		0	-1.37931034			153	ADRB1	Oc2ccc(CCNC(C)CCc1ccc(O)cc1)cc2O	Tocris	0515	1.53846154	-1.2136536	-0.9375771	0.04785834	-1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162445-05	Misoprostol	225144248	Prostanoid EP3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59122-46-2				-1.4210685312	4	5		0	-0.56795132					CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	Prestwick	Prestw-1443	0.17094017	-0.1011378	-0.24673082	-1.53146686	-0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00379039-02	Tiotropium (Bromide)		Muscarinic M3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	136310-93-5				1.3682507786	4	4		0	0.94797688					C[N+]1(C)[C@H]2CC(C[C@@H]1[C@H]3O[C@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-17360	0.05141388	0.75599583	0	0.94797688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023282-21	AMPICILLIN SODIUM			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	69-52-3, 69-53-4 [ampicillin]				-1.4217889061	4	4		0	-0.94797688					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O	Microsource	01500123	-0.25706941	0.2346194	-0.3158726	-0.94797688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182999-01	Flomoxef	144206879	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	99665-00-6	FLOMOXEF; 			0.735045506	4	4	CIPLUS_207906;LS-178431;FLOMOXEF;Flomoxef;flomoxefum;flomoxef;'(-)-(6R,7R)-7-(2-((DIFLUOROMETHYL)THIO)ACETAMIDO)-3-(((1-(2-HYDROXYETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-7-METHOXY-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID;flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];Flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];S 6315;	0	0.58062813					O=C2N1C(=C(CO[C@H]1[C@@]2(OC)NC(=O)CSC(F)F)CSc3nnnn3CCO)C(=O)O	Pharmaron	PH-NIH-183450	-0.72975518	-0.06958942	1.43088553	0.58062813												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091533-10	Ethinylestradiol	170464983	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	57-63-6	;ETHINYL ESTRADIOL; Minulet; Ovulen 50; Conova 30; Oviol; Ovoresta M; Ovostat; Serial C; Varnoline;Ethinyl Estradiol; ; Trikvilar; Desogen (contraceptive); Practil 21; Yermonil (CIBA); Ministat; Oraconal; Mircette; Modicon; Valdys;17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol; Cilest; Novacyclin 22;Ethinylestradiol; Ethinyl estradiol;Ethinyl estradiol; Ortho-Cept; Fisioquens; Femovan; Diane-35; Etinilestradiol; Ethynyl estradiol; Femodene; Gynatrol; Diane; Lestrin; Tri-Ervonum; Bisecurin II; Ovulen-50; Ovidol;17alpha-Ethynylestradiol; Estinyl; Oracon; Demulen; Triregol			13.3615191775	4	4		0	6.01741884			2099	ESR1	Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick	Prestw-1405	1.95386064	2.01809325	1.64686825	6.01741884												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023193-06	Triamcinolone acetonide	170464660	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	76-25-5	; ; Cinonide; Kenalog; Pevisone; Kenacort A; Acetonide, Triamcinolon; A, Kenacor; Azmacort; Tricort 4;Triamcinolone acetonide; Kenalog 40; 40, Kenalo; Tricort4;TRIAMCINOLONE ACETONIDE; Triamcinolone acetonide; Monacort; Tricort-40			9.5925015282	4	4		0	0.63341251				NRC31	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	76-25-5	3.31920904	2.50521921	0.94492441	0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160397-04	Irsogladine maleate	170465947	M1 Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	84504-69-8	; ;Irsogladine maleate; Irsogladine maleate;irsogladine; Gaslon N			-0.3329953784	4	4		0	0.05278438			1128	CHRM1	Nc1nc(nc(N)n1)c2cc(Cl)ccc2Cl.O=C(O)/C=C\C(=O)O	Enzo	PD141	0.07062147	-0.13917884	-0.4049676	0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016610-07	Tolnaftate	170465508	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2398-96-1	; ; Separin;TOLNAFTATE; Tolnafrate;Tolnaftate; Tolnaftate; Tolnaftato; Tinactin			0.5028579104	4	4		0	-0.47505938					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3ccccc3c2	Prestwick Chemical, Inc.	Prestw-70	-0.35310734	0.41753653	1.32289417	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016872-12	Ticlopidine hydrochloride	170464698	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	55142-85-3	 Ticlid; Ticlopidina;Ticlopidine; ;; Ticlodone; Ticlopidine Hcl;TICLOPIDINE HYDROCHLORIDE; Ticlopidine hydrochloride; Hydrochloride, Ticlopidin;Ticlopidine hydrochloride			-2.5324892101	4	4		0	-0.58062813			64805	P2RY12	Clc3ccccc3CN1CCc2sccc2C1	Vitas	STK589340	-0.02354049	-2.36604036	-0.18898488	-0.58062813												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016348-15	Ethoxyquin		Heat shock protein HSP 90-beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	91-53-2				-3.2446611725	4	4		0	-0.19102197			3326	HSP90AB1	CCOC1=CC\2=C(NC(C)(C)\C=C2C)C=C1	Prestwick	Prestw-765	-1.49882904	0.35022181	1.25101985	-0.19102197												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00185765-02	Encainide hydrochloride		Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	66794-74-9				1.8999895961	4	4		0	0.02312139					COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C	SIGMA	E9156	0.41131105	-0.65172054	1.84259016	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389662-01	Luteinizing hormone releasing hormone human acetate salt (LHRH)		Putative gonadotropin-releasing hormone II receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	71447-49-9				-0.6819875547	4	4		0	0.11560694				GNRHR2	CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(CC4=CN=C[NH]4)NC(=O)C5CCC(=O)N5)C(=O)NC(CCCN=C(N)N)C(=O)N6CCCC6C(=O)NCC(N)=O	APExBIO	A1147	-0.92544987	0.86027112	1.42142669	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183050-01	Bethanidine sulfate (2:1)	144206760	adrenergic receptor signaling pathway involved in heart process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	114-85-2	Betanidine sulfate; Betanidin; Batel; Sulfate, Bethanidin; Benzaidin; Tenathan; Betanidina; 			-0.359210364	4	4	BETHANIDINE SULFATE;LS-73259;Bethanidine;Bethanidine, Sulfate (2:1);BETHANIDINE;Tenathan;Betanidine Sulfate;Betanidine sulfate;BETANIDINE SULFATE;Betanidinum;Batel;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-, SULFATE (2:1);betanidine;Betanidina;CIPLUS_151384;Wellcome Brand of Betanidine Sulfate;1-BENZYL-2,3-DIMETHYLGUANIDINE SULFATE (2:1);Bethanidine sulfate;Betanidine;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-;betanidinum;Betanidin;Sulfate, Bethanidin;Bethanidine Sulfate;Benzaidin;BETANIDINE;1-BENZYL-2,3-DIMETHYLGUANIDINE;CIPLUS_3728831;Guanidine, N,N'-dimethyl-N''-(phenylmethyl)-;CIPLUS_148752;LS-73261;	0	0.02312139					O=S(=O)(O)O.C\N=C(/NC)NCc1ccccc1.C\N=C(\NCc1ccccc1)NC	NCI	NSC_106563	-0.41131105	1.01668405	-0.05264543	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386281-05	Fidaxomicin			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	873857-62-6				1.8098066007	4	4		0	2.1021021					CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3=C(CC)C(=C(O)C(=C3O)Cl)Cl)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(C)\C=C(C)\[C@@H]1O[C@@H]4OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]4O)[C@@H](C)O	Glixx	GLXC-90140	0.42938931	-1.43678161	0.20947892	2.1021021												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179623-04	Lisinopril dihydrate	170464907	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	83915-83-7				-0.8579400304	4	4		0	0.05005005					O.O.OC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)N[C@@H](CCc1ccccc1)C(=O)O	Microsource	01501217	0.14312977	-1.22779519	-0.57606703	0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346741-02	Travoprost		Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	157283-68-6				0.0590313906	4	4		0	-0.5005005				TBXA2R	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC2=CC(=CC=C2)C(F)(F)F	MedChem Express	HY-B0584	0.33396947	-0.75757576	0.15710919	-0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022678-23	Rifampicin			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	[13292-46-1]				7.9015588742	4	4		0	0					CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(\C=N\N5CCN(C)CC5)=C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C	Tocris	4121	3.67366412	-1.80250784	-0.31421838	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182977-01	Trimethoquinol	144206771	Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	18559-59-6	Tretoquinol; Tetroquinol; Trimetoquinol; Inolin; Tretoquinol-(S) HCl; Tretoquinol-(R); 			-5.6448903807	4	4	CIPLUS_207808;AQ11;1,2,3,4-TETRAHYDRO-1-(3,4,5-TRIMETHOXYBENZYL)-6,7-ISOQUINOLINEDIOL MONOHYDRATE HYDROCHLORIDE;TRETOQUINOL;Tretoquinol Hydrochloride, (S)-Isomer;CIPLUS_169251;Inolin;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, (S)-;TETRAHYDROISOQUINOLINE;tretoquinol;Trimetoquinol hydrochloride;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, hydrochloride, (S)-;AQ-110;Tetroquinol;Trimetoquinol Hydrochloride Anhydride;Tretoquinolum;AQL 20;Tretoquinol;Tretoquinol-(S) HCl;LS-173897;AQ 11;Trimetoquinol;LS-85640;CV 70;Tretoquinol-(R);CIPLUS_171514;CIPLUS_171515;Trimetoquinol Hydrochloride;tretoquinolum;AQL-208;CV-705;CIPLUS_171513;TRIMETOQUINOL HYDROCHLORIDE;l-trimetoquinol;AQL20;CV70;	0	-1.35135135					Cl.COc1cc(cc(OC)c1OC)C[C@@H]2NCCc3cc(O)c(O)cc23	NCI	NSC_288748	-1.33587786	-1.64576802	-0.10473946	-1.35135135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386547-01	Difluprednate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	23674-86-4				-0.8871423948	4	4		0	-0.25025025					CCCC(=O)O[C@@]1(CC[C@H]2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Axon Medchem	1428	0.04770992	-1.01880878	-0.15710919	-0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181039-02	Ethyl linoleate	170466006	regulation of prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	6114-21-2				-1.0816353745	4	4		0	-0.35035035					O=C(CCCCCCC/C=C\C/C=C\CCCCC)OCC	SIGMA	L6253	-0.71564885	-0.65308255	2.09478921	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263951-01	CEPHRADINE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					4.3515095908	4	4		0	0.45045045					CC/1=C(/N2[C@@H](SC1)[C@H](NC(=O)[C@H](N)/C3=C/C/C=C\C3)C2=O)C(O)=O	Microsource	MS-01500168	0.90648855	1.2800418	1.15213407	0.45045045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346433-07	Peramivir		Influenza Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	330600-85-6				-4.3189207085	4	4		0	-1.7017017				NEU1	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	Adooq	A11124	-0.38167939	-0.18286311	0.99502488	-1.7017017												1.6E-9	8E-9	4E-8	2E-7											
NCGC00091398-01	Nitrobenzene	17389793	Glutathione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE		Nitrobenzene; Nitrobenzene-d5; Pentadeuteronitrobenzene; 			-1.5964109714	4	4	Nitrobenzene;CIPLUS_150482;NCGC00091398-02;CIPLUS_699787;Nitrobenzene-13C6;1,2-dinitrobenzene;ortho-dinitrobenzene;AB07993089-01;o-dinitrobenzene;nitrobenzene;Nitrobenzene-d5;CIPLUS_763567;Pentadeuteronitrobenzene;CIPLUS_174736;Nitrobenzene-15N;	0	0.34932464					[O-][N+](=O)C1=CC=CC=C1	NIEHS	AB07993089	-0.59585492	0.07313506	-0.55373773	0.34932464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180997-01	Ethylphenylacetylurea	144206203		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	90-49-3	Pheneturide; Feneturida; Benuride; 			-2.6231444013	4	4	Ethylphenacemide;2-PHENYLBUTYRYLUREA;CIPLUS_778068;N-(AMINOCARBONYL)-2-PHENYLBUTANAMIDE;(2-phenylbutyryl)urea;2-Phenylbutyrylurea;PHENETURIDE;CIPLUS_778163;LS-7390;CIPLUS_778164;phenylethylacetylurea;ethylphenacemide, (+-)-isomer;BENZENEACETAMIDE, N-(AMINOCARBONYL)-.ALPHA.-ETHYL-;Benuride;ETHYLPHENACEMIDE;LS-28470;ethyl phenacemide;ethylphenacemide;pheneturide;Feneturida;CIPLUS_214323;ethylphenylacetylurea;Pheneturidum;Pheneturide;pheneturidum;	0	-0.72193759					CCC(C(=O)NC(N)=O)c1ccccc1	SigmaAldrich	MFCD00069050	-0.85492228	-0.51194539	0.65441732	-0.72193759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-04	2-Deoxyglucose		sugar	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	154-17-6				-0.3317617668	4	4		0	-1.65346996					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	Cayman	14325	0.28497409	0.75572891	-0.50339794	-1.65346996												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024494-02	D-Alanine	170465038	Alanine aminotransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	338-69-2				-3.1359840813	4	4		0	0.47505938					C[C@@H](N)C(=O)O	Tocris	0205	-1.15348399	-0.83507307	-0.89092873	0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181028-02	D-Pantethine	225144316	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	16816-67-4				-2.147693018	4	4		0	-0.05278438					CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	SIGMA	P2125	-0.82391714	0.20876827	-0.674946	-0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253737-01	Istradefylline	174007485	Adenosine A2A Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	155270-99-8	Istradefylline			5.2100217284	4	4		0	3.0614938			135	ADORA2A	COc1ccc(cc1OC)/C=C/c3nc2c(C(=O)N(CC)C(=O)N2CC)n3C	GVK	FFS-12-73-NCI-1738	0.96516008	0.69589422	-0.4049676	3.0614938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164547-06	Zafirlukast	174007053	Leukotriene CysLT1 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	107753-78-6	 ; Zafirlukast;Zafirlukast			11.6305878592	4	4		0	6.07020322			10800	CYSLTR1	Cc1ccccc1S(=O)(=O)NC(=O)c5ccc(Cc3cn(C)c2ccc(cc23)NC(=O)OC4CCCC4)c(OC)c5	Sequoia	SRP00200z	0.25894539	-0.41753653	4.56263499	6.07020322												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249887-01	Indecainide	170465192	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	74517-78-5				-1.1534367089	4	4		0	-0.36949063					NC(=O)C3(CCCNC(C)C)c1ccccc1c2ccccc23	GVK	FFS-11-286-NCI-023	-0.30602637	0.83507307	-0.72894168	-0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016740-18	Prazosin	170465415	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	19216-56-9	Prazosin hydrochloride;PRAZOSIN HYDROCHLORIDE;PRAZOSIN; Polypress;; ; Pratsiol;Terazosin hydrochloride; Prazosina; Justac; Minipress;Prazosin; Prazosin hydrochloride; Furazosin hydrochloride			1.2644581582	4	4		0	1.84745315			148	ADRA1A	O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)c4ccco4	Vitas	STK301545	-0.77683616	-1.2526096	0.72894168	1.84745315												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00164594-02	Loteprednol etabonate	170465195	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	82034-46-6	Loteprednol etabonate; Lotemax; Loteprednol etabonate; Alrex; 			3.8749022373	4	4		0	3.58933756				NR3C1	O=C(OCCl)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	SRP01583l	1.01224105	-1.60055672	-0.78293736	3.58933756												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179034-07	Pentamidine isethionate	170464786	PRL Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	140-64-7	 cis-Pt(II) pentamidine; Pentamidin; Pt-pentamidine complex; platinum(II) pentamidine;4,4 -(Pentane-1,5-diylbis(oxy))dibenzimidamide; Pentam 300; Pt-pent; cis-Pt pentamidine iodide;Pentamidine isethionate;			0.4644085765	4	4		0	1.58353127				PTP4A1	OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N	Prestwick Chemical, Inc.	Prestw-553	-0.9180791	-1.53096729	1.43088553	1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00247735-02	Varenicline tartrate	174007164	Nicotinic alpha3beta4 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	230615-23-3	Varenicline dihydrochloride;Varenicline tartrate			-5.3906519118	4	5		0	1.7578125			1136	CHRNA3	Cl.c1c4c(cc2nccnc12)C3CC4CNC3	Selleck	S1440	-1.10449243	-2.99096347	-1.98088378	-1.68946098	1.7578125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166310-02	Marbofloxacin	170465732	Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	115550-35-1	 ;Marbofloxacin; Marbofloxacin; Zeniquin;MARBOFLOXACIN; Marbofloxacino; Marbocyl; Marbocyl FD; Dexamethasone			1.4729821802	4	5		0	-0.27901786					CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)N(C)COc34	Sequoia	115550-35-1	0.43435096	0.9291078	0.87269705	-0.24135157	-0.27901786											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00253867-02	Prucalopride	170466188	5-HT4 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	179474-81-8	Resolor;R093877;R 093877;Prucalopride; Prucalopride;Prucalopridum			-7.2905151238	4	5		0	-0.28459141			3360	HTR4	COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23	GVK	FFS-12-73-NCI-2606	-1.69449902	-1.95571956	-1.80312542	-1.8710493	-0.28459141											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091517-06	L-Ascorbic acid	170464728		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-81-7				15.3318253109	4	5		0	6.38297872					OC=1C(=O)O[C@H]([C@@H](O)CO)C=1O	Microsource	01502230	4.39587426	2.22632226	2.23053292	-1.011378	6.38297872											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160451-02	Ibufenac	170465922		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1553-60-2				-1.6246427732	4	5		0	-2.39955357					CC(C)Cc1ccc(cc1)CC(=O)O	Enamine	Z104507406	1.55125341	-0.77637775	-2.53497714	-0.56315366	-2.39955357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015043-10	GABA	225144171	GABA-A receptor; anion channel Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2					4.5498871366	4	5		0	-0.17617563					NCCCC(O)=O	Vitas	STK301748	3.85559921	-0.28290283	0.30719915	-1.8204804	-0.17617563											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00249938-01	Glymidine sodium	170465939		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3459-20-9				-6.2295680196	4	5		0	1.12481366					[Na+].O=S(=O)([N-]c1ncccn1)c2cc(OCCOC)ccc2	GVK	FFS-11-286-NCI-256	-2.40667976	0.01230012	-3.53946841	-0.2022756	1.12481366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183858-01	Blonanserin	144206818	Serotonin 2a (5-HT2a) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	132810-10-7		5.6234132519	-5.25	34.7100779356	3	5	AD-5423;BLONANSERIN;blonanserin;AD 5423;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[B]PYRIDINE;blonanserinum;Blonanserin;blonanserine;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;CIPLUS_702318;	49.344556051	43.77790179	0.0007450719	0.9996274678			CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3	Pharmaron	PH-NIH-148160	-3.06527674	-3.7037037	-2.72890982	-2.76213462	43.77790179											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00163157-05	Mesoridazine	170465272	D(2) dopamine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	5588-33-0		10	-5	66.0460157941	3	5		89.2350137275	83.51004464	0.0076301631	0.9961636314	1813	DRD2	CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2	Prestwick Chemical, Inc.	Prestw-529	3.06527674	-3.3727886	-1.20515307	1.6358273	83.51004464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094906-06	Nefopam hydrochloride	170465579	Serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	23327-57-3				-8.3894971884	4	5		0	-1.12481366					Cl.CN1Cc3ccccc3C(OCC1)c2ccccc2	Microsource	01501137	-2.40667976	0.20910209	-1.10858822	-3.51453856	-1.12481366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016951-05	Clebopride maleate	170465853	Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	84370-95-6				-0.5918870285	4	5		0	0.47433036					O=C(O)/C=C\C(=O)O.Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3	Prestwick	Prestw-380	0.63291139	-0.44546264	-1.67613243	-0.91177259	0.47433036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015444-07	Fenoldopam	170465321	Dopamine D1 Receptor (DRD1) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	67227-56-9	 ;FENOLDOPAM MESYLATE;Fenoldopam; Fenoldopam bromide;Fenoldopam bromide; Fenoldopam mesilate; Hydrobromide, Fenoldopa; Fenoldopam Hydrobromide; Fenoldopam hydrochloride;Fenoldopam hydrochloride			-8.2210240824	4	5		0	-2.20424107			1812	DRD1	Oc1ccc(cc1)C3CNCCc2c3cc(O)c(O)c2Cl	Sequoia	67227-57-0	-1.94837429	-1.43820797	0.18008034	-2.97666935	-2.20424107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021125-03	Diclofenac sodium	170464642	Cyclooxygenase-1/2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	15307-79-6				-3.1863476731	4	5		0	0.39300718				PTGS1	[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O	Vitas	STK984493	-1.57170923	2.27552276	-1.6428476	-1.44121365	0.39300718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253576-01	Amelometasone	170465753		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123013-22-9				-0.7372951443	4	5		0	0.25748746					COCC(=O)[C@]3(OC(=O)CC)[C@@]4(C)C[C@H](O)C2(F)[C@@H](CCC1=CC(=O)C=C[C@@]12C)[C@@H]4C[C@@H]3C	GVK	FFS-11-286-NCI-162	-0.81041257	-0.35670357	0.49418993	0.68268015	0.25748746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025125-18	Colchicine	170465011	Tubulin polymerization Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64-86-8	; ; Colchicine;COLCHICINE; Colchicine derivatives; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer;Colchicine			-4.3226219035	4	5		0	-0.55563084			203068	TUBB	CC(=O)N[C@H]2CCc3cc(OC)c(OC)c(OC)c3C1=CC=C(OC)C(=O)C=C12	Prestwick Chemical, Inc.	Prestw-363	-1.96463654	3.16113161	-0.68118071	-2.85714286	-0.55563084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090764-04	2-Ethylhexyl 4-(dimethylamino)benzoate	170465499		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	21245-02-3				-8.3346349319	4	5		0	1.953125					CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC	Bosche	E2279	-4.05807893	-1.13274787	-1.89776977	-0.21453473	1.953125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162179-08	cis-Flupentixol	170465964		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53772-82-0				-8.3024601178	4	5		0	-6.36160714					FC(F)(F)c2cc3C(=C\CCN1CCN(CCO)CC1)/c4ccccc4Sc3cc2	Tocris	4057	-2.19657483	-0.03818251	-1.67613243	2.46714937	-6.36160714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018249-05	Ethoxzolamide	170465083	Carbonic anhydrase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	452-35-7				0.6978051078	4	5		0	-0.44721507					NS(=O)(=O)c1nc2ccc(cc2s1)OCC	Labotest	LT00453128	-1.52259332	1.80811808	-2.28395886	5.99241466	-0.44721507											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160484-02	Etafenone	170466000	vascular smooth muscle contraction Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90-54-0		14.1253754462	-4.85	2.7762890076	4	5		15.564475352	11.83087139	0.0497352083	0.9743439651			CCN(CCOc2ccccc2C(=O)CCc1ccccc1)CC	Vitas	STK321191	-1.91552063	-0.92250922	-0.12020836	-2.55372946	11.83087139											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182047-03	Fludarabine phosphate	170464764	Purine Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	21679-14-1	 ; Fludarabine phosphate; F-ara-AMP;Fludarabine phosphate; Fludara;FLUDARABINE PHOSPHATE			-3.6016268212	4	5		0	0.02790179				HPRT1	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	Microsource	01505705	-1.05485232	0.49637266	-2.42415847	-0.4558863	0.02790179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181795-02	Lumiracoxib	170465597	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	220991-20-8				4.7174173432	4	5		0	1.84151786					Clc2cccc(F)c2Nc1ccc(C)cc1CC(=O)O	Sequoia	220991-20-8	3.98361876	-4.26371389	0.48483169	-2.01126307	1.84151786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016003-10	Trihexyphenidyl hydrochloride	170464756	Muscarinic acetylcholine receptor M5 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52-49-3		5.0118723363	-5.3	5.6051136187	4	5		15.969843632	12.36049107	0.0154828851	0.9922173845			Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500592	-2.89153636	-1.48911798	-0.59565037	4.55886297	12.36049107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016523-05	Iodipamide	170464888	Complement factor B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	606-17-7				4.846952054	4	5		0	4.70253422					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Prestwick Chemical, Inc.	Prestw-939	0.36836935	2.81672817	0.38733805	-2.27560051	4.70253422											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095978-06	Lufenuron	170465736		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103055-07-8		11.220184543	-4.95	28.1115533123	3	5		38.0884086441	30.7223201	0.0158438428	0.9919944735			Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F	Microsource	01505355	-0.07367387	0.30750308	3.031922	4.22250316	30.7223201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249052-02	Calcium levulinate	170465651		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5743-49-7				-4.6638314314	4	5		0	-1.20612549					[Ca+2].O.O.O=C([O-])CCC(C)=O.CC(=O)CCC([O-])=O	SIGMA	L2009	0.41748527	-3.2595326	-2.49766262	-0.73324905	-1.20612549											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018210-05	Oxyphencyclimine hydrochloride	170465276	Muscarinic acetylcholine receptor M4 Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	125-52-0				-11.5711601337	4	5		0	-3.29241071					Cl.CN3CCCN=C3COC(=O)C(O)(c1ccccc1)C2CCCCC2	Microsource	01503932	-2.56887565	-3.62733868	-2.59038648	0	-3.29241071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00186658-01	Dexpanthenol	170464647		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	81-13-0				-2.5810675184	4	5		0	2.80525817					CC(C)(CO)[C@@H](O)C(=O)NCCCO	Labotest	LT00244791	-1.2524558	-2.07872079	-0.25377321	-1.03666245	2.80525817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179578-03	Mometasone furoate	170464666	Corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	83919-23-7	; 2-Furoate;Mometasone furoate; Nasonex; Mometasone Fuorate; Elocon; Sch 32088	12.5892541179	-4.9	19.0281998117	3	5		34.9459724919	30.66811221	0.007750525	0.9961070381		CYP3A4	ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23	Prestwick Chemical, Inc.	Prestw-572	-2.03831041	-0.13530135	0.20034727	-0.22756005	30.66811221											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015452-20	Flutamide	170464921	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	13311-84-7	Flutamide; ; Eulexin; 2-Methyl-N-(4-nitro-3-;FLUTAMIDE; Flutamide; Flutamida			-6.831799433	4	5		0	-1.72110042			374	AR	O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C	Microsource	01500995	-2.03831041	2.07872079	-1.69627354	-2.90771176	-1.72110042											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015036-11	Amantadine hydrochloride	170464860	Dopamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	768-94-5	 Adamantamine fumarate;Adamantamine fumarate;AMANTADINE HYDROCHLORIDE; 1-Adamantylamine;AMANTIDINE; ; Symmetrel; Ambroxol Hydrochloride;Amantadine hydrochloride; Amantadine hydrochloride; 1-Aminoadamantane; Midantan; Amantadina;Amantadine; Adamantine hydrochloride			-7.990066341	4	5		0	0.01355197			1812	DRD1	NC13CC2CC(CC(C1)C2)C3	Vitas	STK298781	-2.18565815	-2.64452645	0.84145853	-3.84323641	0.01355197											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00142624-05	Lactulose	170464861	Synthetic sugar	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4618-18-2	; Cephulac; Lactulosa; Chronulac; Duphalac;LACTULOSE; Amivalex; Normase;Lactulose			-1.5561872598	4	5		0	-0.3387993					O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@]2(O)CO	Microsource	01500363	-2.1611002	0.30750308	1.13530119	2.42730721	-0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015836-12	Pirenzepine	170465793	Muscarinic acetylcholine receptor M1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	28797-61-7				1.9794616655	4	5		0	0.12196775			1128	CHRM1	O=C(CN1CCN(C)CC1)N4c2ccccc2C(=O)Nc3cccnc34	Enzo	AC220	-2.7259332	1.16851169	3.8065981	0.88495575	0.12196775											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00160424-02	Clobenzorex hydrochloride	170465619		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5843-53-8				-6.7436937972	4	5		0	-3.95251397					Cl.Clc2ccccc2CNC(C)Cc1ccccc1	Specs	AN-153/I197377	-0.98844282	-0.46071473	-1.08682379	-1.2512731	-3.95251397											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263447-01	alpha-Santonin	170465728		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	481-06-1				-7.4822694582	4	5		0	-2.5					O=C1C=C[C@]2(C)CC[C@H]3[C@H](C)C(=O)O[C@@H]3C2=C1C	Specs	AE-562/J257885	-2.35705596	-0.78446022	-0.81817072	-0.17459625	-2.5											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016322-13	Dapsone	170464895	Bacterial dihydropteroate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80-08-0				-8.7782827215	4	5		0	-3.17039106					Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2	Vitas	STK387118	-3.4823601	-2.25376665	-0.06105752	2.3861487	-3.17039106											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159429-03	Coenzyme Q10	225144226	mitochondrial electron transport	DPI_SARS-CoV-2_General	2019_NPC-3_CPE					-0.0931739522	4	4		0	1.38545275				NDUFV3	COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)C\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CCC=C(C)C	Tocris	3003	-1.30497825	0.07400099	-1.84537066	1.38545275												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00249912-01	Floctafenine	170465681	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	23779-99-9				0.9920244982	4	5		0	0.20327958			5743	PTGS2	OCC(O)COC(=O)c3ccccc3Nc1ccnc2c(cccc12)C(F)(F)F	GVK	FFS-11-286-NCI-159	-1.84184676	-1.31611316	3.48604247	3.91908976	0.20327958											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013895-08	Benzbromarone	170465792	Xanthine dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3562-84-3				-5.5994252516	4	5		0	-1.52234637					Brc1cc(cc(Br)c1O)C(=O)c2c3ccccc3oc2CC	Labotest	LT00134669	-2.63077859	-1.68098618	2.91854927	-0.64018624	-1.52234637											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018213-06	Cyclopentolate hydrochloride	170464720	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5870-29-1				-3.7832612662	4	5		0	-1.29888268					Cl.OC1(CCCC1)C(C(=O)OCCN(C)C)c2ccccc2	Microsource	01500212	-1.0796837	-0.75955672	0.79374771	-1.19307435	-1.29888268											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015859-14	Procainamide	170464952	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-06-9				-4.8217034641	4	5		0	-2.29028324					O=C(NCCN(CC)CC)c1ccc(N)cc1	Enzo	AC127	-2.1611002	3.13653137	0.60104181	-2.45259166	-2.29028324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018302-07	Trichlormethiazide	170464812	Diuretic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	133-67-5	;Trichlormethiazide; Esmalorid; Naqua; Triclormetiazida; Esmaloride; Triazide;TRICHLORMETHIAZIDE			7.3336111619	4	5		0	-0.23038352				SLC12A3	NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)C(Cl)Cl)cc2Cl	Prestwick Chemical, Inc.	Prestw-825	3.04518664	-1.31611316	4.58127421	-0.6068268	-0.23038352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263584-01	Tirofiban hydrochloride monohydrate	170465092	Integrin alpha-IIb/beta-3 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	150915-40-5				-0.2388957832	4	5		0	0.60055866					Cl.O.O=C(O)[C@@H](NS(=O)(=O)CCCC)Cc1ccc(cc1)OCCCCC2CCNCC2	Sequoia	142373-60-2	-1.74878345	3.77288009	-0.3785566	0.26189437	0.60055866											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263910-02	Aminopentamide sulfate	170466283	Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	20701-77-3				-2.4320463319	4	5		0	-0.79608939					O=S(=O)(O)O.NC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2	Microsource	01505650	-0.10644769	-2.07944216	0.40297961	-0.66928561	-0.79608939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018218-10	Edaravone	170465935	Free Radical Scavenger	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	89-25-8	;MCI-186; Developer Z; N-demethylantipyrine; Radicut;1-Phenyl-3-methyl-5-pyrazolone			-4.9895842659	4	5		0	-3.22625698				NT5E	O=C2CC(C)=NN2c1ccccc1	Vitas	STK201315	-1.5663017	-0.68484622	-0.62278667	1.77506184	-3.22625698											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160508-03	Isosorbide	170465187		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	652-67-5				-5.0123234881	4	5		0	-3.61731844					O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	Vitas	STK801813	-1.47506083	-2.07944216	1.5264379	1.16397497	-3.61731844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016089-06	Nonivamide	170466476	Vanilloid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2444-46-4				-7.3822848513	4	5		0	-2.58379888					Oc1ccc(cc1OC)CNC(=O)CCCCCCCC	Specs	AN-153/I105041	-2.35705596	0.95878471	-2.50335816	0	-2.58379888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091038-04	Sodium deoxycholate monohydrate	225144203		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	145224-92-6				-5.6378322291	4	5		0	-0.87988827					C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	D5670	-2.17457421	-0.26148674	0.0122115	-1.10577623	-0.87988827											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093926-05	Doxifluridine	170465861	thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3094-09-5	 ;5'dFUrd; Ro 21-9738; Furtulon; 5'dFUrd;Doxifluridine; Doxifluridine; Doxifluridina; 5-Fluro-5??-Deoxyuridine;5-fluoro-5'-deoxyuridine; 5-fluoro-5'-deoxyuridine			4.4974827731	4	5		0	-0.62849162			7298	TYMS	FC1=CN(C(=O)NC1=O)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Bosche	D1649	0.07603406	-0.06225875	4.11527659	2.85173869	-0.62849162											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249884-01	Sulfisoxazole acetal	170465159	Bacterial dihydropteroate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	80-74-0				-6.4502420042	4	5		0	-2.23214286					Cc1c(onc1C)N(C(C)=O)S(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-17	-3.76023827	1.51457299	-1.7038371	3.32528828	-2.23214286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			-1.2694626672	4	5		0	-2.89106145				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	-0.47141119	0.06225875	2.40566614	0.05819875	-2.89106145											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164499-03	DL-alpha Tocopheryl nicotinate	170465780	platelet aggregation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	43119-47-7				-2.4510355496	4	5		0	0.65642458					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc3c(O1)c(C)c(C)c(OC(=O)c2cccnc2)c3C	Labotest	LT00772349	-1.80961071	-1.55646868	2.52778117	-0.37829187	0.65642458											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164544-02	Lanoconazole	170465886	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	101530-10-3				1.1129483062	4	4		0	1.28649184			3641571	ERG11	N#C\C(=C1/SCC(S1)c2ccccc2Cl)n3ccnc3	Sequoia	SRP01160l	-0.82165297	3.28071041	-1.01813554	1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095125-05	Losartan	170465135	Angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	114798-26-4				3.3119882375	4	4		0	2.3255814					OCc4c(Cl)nc(CCCC)n4Cc1ccc(cc1)c2ccccc2c3nnnn3	Microsource	01504268	-0.48332528	0.27133695	1.39993637	2.3255814												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021123-03	Diatrizoic acid dihydrate	170464638		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	50978-11-5				-0.6858331576	4	4		0	-1.18753093					O.O.O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O	Bosche	D0803	0.48332528	0.17266897	-0.38180083	-1.18753093												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00371130-03	Vilazodone Hydrochloride		Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	163521-08-2		10	-5	61.7116138703	3	4		89.5433268648	86.58070678	0.0407911458	0.9989723886	6532	SLC6A4	NC(=O)C1=CC2=CC(=CC=C2O1)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3	APExBIO	A3919	-1.82669789	1.56432407	0.81588251	86.58070678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-10	Maraviroc			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[376348-65-1]				8.151392044	4	4		0	4.63228271					CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Tocris	3756	0.51522248	0.58370301	4.24258907	4.63228271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182708-01	Pipecuronium bromide	144206565	Muscle-type nicotinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	52212-02-9	Pipecuronium bromide; Arduan; Pipecuronium; Bromuro de pipecuronio; 			11.6419021533	4	4	CIPLUS_188694;Arduan;LS-113699;Bromuro de pipecuronio;pipecuronii bromidum;4,4'-(3A,17B-DIHYDROXY-5A-ANDROSTAN-2B,16B-YLENE)BIS-(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE,DIACETATE;bromure de pipecuronium;Pipecuronium Dibromide, (3 beta)-Isomer;pipecuronio bromuro (spanish);CIPLUS_207311;4,4'-(3.ALPHA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTAN-2.BETA.,16.BETA.-YLENE)BIS(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE, DIACETATE (ESTER);Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl);LS-177113;Pipecuronium;PIPECURONIUM BROMIDE;LS-172842;Pipecuronium Dibromide, (16 alpha)-Isomer;Bromure de pipecuronium;Pipecuronium Dibromide, (17 alpha)-Isomer;Pipecuronii bromidum;Pipecuronium bromide;LS-176664;LS-172841;CIPLUS_188695;PIPERAZINIUM, 4,4'-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)ANDROSTANE-2,16-DIYL)BIS(1,1-DIMETHYL-, DIBROMIDE;	0	2.48328558					[Br-].[Br-].C[N+]1(C)CCN(CC1)[C@H]6C[C@@]5(C)[C@@H](CC[C@@H]3[C@@H]5CC[C@]2(C)[C@@H](OC(C)=O)[C@H](C[C@H]23)N4CC[N+](C)(C)CC4)C[C@@H]6OC(C)=O	APAC	872548	3.18501171	1.33084287	1.03345118	2.48328558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166312-02	Closantel	170466628		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	57808-65-8		10	-5	17.8884303651	4	4		19.545197744	17.52441277	0.1342291206	0.9887664475			Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2	Vitas	STK378904	-0.87099812	1.2526096	-0.56695464	17.52441277												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016066-14	Urapidil hydrochloride	170466013	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	64887-14-5				0.4948259625	4	4		0	3.00870942			3350		Cl.COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2	Microsource	01503100	-0.77683616	-1.18302018	-0.51295896	3.00870942												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016936-04	Aztreonam	170465110	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	78110-38-0	; ;Aztreonam; Aztreonam; Aztreonam lysinate;AZTREONAM; Azactam			-1.9135342162	4	4		0	-0.73898126					Nc1nc(cs1)/C(=N\OC(C)(C)C(=O)O)C(=O)N[C@@H]2C(=O)N([C@H]2C)S(=O)(=O)O	Microsource	01505122	0.07062147	-0.34794711	-0.94492441	-0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015149-16	Bumetanide	170464735	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	28395-03-1	; ;BUMETANIDE;bumetanide; Bumex; Bumethanide; Bumetanida;Bumetanide; Bumetanide			-0.1163965307	4	4		0	0.84455001				SLC12A2	O=S(N)(=O)c2cc(cc(NCCCC)c2Oc1ccccc1)C(=O)O	Microsource	01502004	-0.63559322	1.53096729	-0.89092873	0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015766-13	Oxymetazoline hydrochloride	170464916	alpha2A(2D)-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1491-59-4	; ; Oximetazolina;Oxymetazoline;OXYMETAZOLINE HYDROCHLORIDE; Afrazine; 3-[(4,5-Dihydro-; Afrin;OXYMETAZOLINE;Oxymetazoline..HCl;Oxymetazoline hydrochloride; Oxymetazoline hydrochloride			3.7043009667	4	4		0	1.5307469			148	ADRA1A	CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2O	Enzo	AC138	0.4472693	1.67014614	0.02699784	1.5307469												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023902-09	4-Androstene-3,17-dione	170465907	Cytochrome P450 19A1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63-05-8				3.1310106137	4	4		0	3.43098443					O=C2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801871	0.4472693	-1.32219903	-0.51295896	3.43098443												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167421-02	Sevoflurane	225144283	GABA-B receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-4.4044033552	4	4		0	-1.10294118			2890		FCOC(C(F)(F)F)C(F)(F)F	Alfa Aesar	L16891	-1.08366935	-0.46332046	-0.69949636	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161599-09	Troglitazone	170465091	CCL2 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	97322-87-7	; Rezulin;GR-92132X;Troglitazone; Troglitazone; Prelay;CS-045;CI-991	1.2589254118	-5.9	26.6560132802	4	5		18.732162864	16.07541899	0.0485271917	0.9748786757	6347	CCL2	Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4	Prestwick Chemical, Inc.	Prestw-1467	-0.19768856	-0.61013572	1.62412993	20.45686018	16.07541899											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015100-15	Altretamine	170464714	DNA Alkylating Drugs	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	645-05-6	; ; Altretamine; Hexamethylmelamine;ALTRETAMINE; Melamine, hexamethyl-; Hexalen; Altretamina;Altretamine			-4.8256621631	4	5		0	-2.98549107				H2AFX	CN(C)c1nc(nc(n1)N(C)C)N(C)C	Microsource	01503065	-0.08687019	-2.40549828	-1.34367641	0.26816841	-2.98549107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164375-03	1-Phenoxy-2-propanol	170465645		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	770-35-4				-9.4754949438	4	5		0	-1.67410714					CC(O)COc1ccccc1	SIGMA	484423	-2.49441549	-1.41275296	-1.48219975	-2.25261464	-1.67410714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090705-15	2',3'-Dideoxycytidine	170465128	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	7481-89-2	; ; 2',3' Dideoxycytidin; Cytidine, 2',3'-dideoxy-; 2',3'-dideoxycytidine;2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine; Hivid; 2';Zalcitabine;2',3'-dideoxycytidine; Dideoxycytidine-3H; HIVID Roche; Zalcitibine			-10.1642375206	4	5		0	-3.65513393			7015	TERT	NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1037	-1.89873418	-2.43095329	-2.9228425	-0.24135157	-3.65513393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015455-10	Felodipine	170464849	Voltage-gated calcium channel alpha2/delta subunit 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	72509-76-3		11.220184543	-4.95	12.5477112661	4	5		20.658573028	18.08659218	0.0378954799	0.9805686707			CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(Cl)c2Cl)C(=O)OC	Specs	AE-641/11429675	-0.77554745	-1.38214419	1.67297594	0.37829187	18.08659218											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183026-01	Dicethiamine hydrochloride	144206821		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	616-96-6	Cetotiamine; Cetotiamine Hydrochloride; O,S-dicarbethoxythiamine; Cetotiamina; 			4.6110071688	4	5	Cetotiamine Hydrochloride;Cetotiamine;O,S-dicarbethoxythiamine;CETOTIAMINE;CIPLUS_210876;Cetotiaminum;Cetotiamina;CIPLUS_697013;O,S-bis(ethoxycarbonyl)thiamine;cetotiamine;cetotiaminum;	0	5.58035714					Cl.Nc1nc(C)ncc1CN(C=O)C(/C)=C(/CCOC(=O)OCC)SC(=O)OCC	Pharmaron	PH-NIH-149305	-0.38471085	-1.38729795	4.83446461	-1.79672835	5.58035714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249886-01	Prednisolone tebutate	170465430		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	7681-14-3				-6.8137921649	4	5		0	3.48772321					CC(C)(C)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-19	-1.7746339	-4.3146239	-1.34367641	-3.11075355	3.48772321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093985-11	Metolazone	170464665	Carbonic Anhydrase Type VII Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	17560-51-9	; Metolazona; Microx;Metolazone; Metolazone; ; Diulo; Zaroxolyn;METOLAZONE; METOLAZONE			-1.6238222382	4	5		0	-1.5625			766	CA7	NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C	Microsource	02300325	0.75701167	-1.76912307	-3.14447984	2.25261464	-1.5625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016279-05	Aminohippuric acid	170465155		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	61-78-9				-5.9664070291	4	5		0	2.65066964					O=C(NCC(=O)O)c1ccc(N)cc1	Vitas	STK801822	-2.91635642	-1.13274787	-1.42679041	-1.07267364	2.65066964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013683-06	Chlorprothixene	170465069	Serotonin (5-HT) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	113-59-7		3.5481338923	-5.45	89.3760564188	2.1	5		83.6759348836	80.88727679	0.0042561107	0.9978655115	3269		CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12	Microsource	01503203	0.45917101	-3.52551865	-0.54024103	44.22097077	80.88727679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025355-12	Paroxetine	170465075	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	61869-08-7	;Paroxetine;Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetina; ; Paroxetine Base;PAROXETINE HYDROCHLORIDE; Paxil; Paroxetine maleate;Paroxetine?HCl;Paroxetine Hydrochloride	14.1253754462	-4.85	6.9922494236	4	4		17.2495802999	13.21078431	0.1205133395	0.9909907213	3350	HTR1A	Fc1ccc(cc1)[C@@H]4CCNC[C@H]4COc2ccc3OCOc3c2	Microsource	01504085	-0.27721774	-1.23552124	-1.87465025	13.21078431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016285-05	Sulfanilamide	170464653	Carbonic Anhydrase Type I/II/IX Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	63-74-1	 ; p-Aminobenzenesulfonamide; Sulfonamide CS61; Trikolpon; Sulfanilamida;SULFANILAMIDE; Sulfanilamide;Sulfanilamide			1.9852550562	4	4		0	-0.26960784			759	CA1	Nc1ccc(cc1)S(=O)(N)=O	Labotest	LT00847607	0.9828629	-0.15444015	-0.3077784	-0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016035-13	Trazodone hydrochloride	170465234	alpha2-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	25332-39-2	; ;Trazodone hydrochloride; Desyrel; Trazodone hydrochloride;TRAZODONE HYDROCHLORIDE; Trazodona;Trazodone?HCl			-5.172350353	4	4		0	-0.92081031			150	ADRA2A	Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O	Microsource	01503121	-0.72639225	-1.40526976	-1.74816316	-0.92081031												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016059-13	Thioridazine	170465080	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-52-2				-4.770607283	4	4		0	-2.55196001					CN4CCCCC4CCN1c3ccccc3Sc2ccc(SC)cc12	Enzo	NS835	-0.0968523	-0.8531995	-1.14010641	-2.55196001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167466-02	Lomustine	170464967	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	13010-47-4	 ;Lomustine (CeeNU); CeeBU; CeeNU; Lomustina; Lomustine;Lomustine			2.2372000602	4	4		0	4.18310971				H2AFX	O=C(NC1CCCCC1)N(CCCl)N=O	Bosche	L0449	-0.82324455	0.15056462	-0.88674943	4.18310971												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253598-01	Sulfacytine	170465286	Dihydropteroate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	17784-12-2				-4.9917620334	4	4		0	-1.92973775					O=C1N=C(C=CN1CC)NS(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-041	-0.77332044	-1.01134682	-0.69996818	-1.92973775												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160540-03	Ethiazide	170465925		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1824-58-4				-5.4581708182	4	4		0	-1.68233548					NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CC)cc2Cl	Menai	H2748	-1.20831319	-0.91267884	-0.69996818	-1.68233548												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249937-01	Amidoflumet	170465981		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	84466-05-7				9.6197040964	4	4		0	1.00490196					Clc1cc(c(NS(=O)(=O)C(F)(F)F)cc1)C(=O)OC	GVK	FFS-11-286-NCI-248	2.64616935	0.97812098	2.04252938	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253567-01	Talbutal	170465408	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	115-44-6				0.6576727306	4	4		0	0.0245098					O=C1NC(=O)NC(=O)C1(CC=C)C(C)CC	GVK	FFS-11-286-NCI-35	0.78125	-1.18404118	-0.75545607	0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093985-11	Metolazone	170464665	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	17560-51-9	; Metolazona; Microx;Metolazone; Metolazone; ; Diulo; Zaroxolyn;METOLAZONE; METOLAZONE			-0.9606374327	4	4		0	-0.97342805			766	CA7	NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C	Microsource	02300325	0.43583535	0.25094103	-0.83607803	-0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025179-12	Mifepristone	170465151	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	84371-65-3	RU-486; ;VX-410;RU-38486;VGX-410C;VGX-410;Mifepristone (Mifeprex); Corlux; Mifepristone;C-1073;CI-1073;Mifepristone; Mifeprex	2.2387211386	-5.65	30.1808732058	4	4		22.4033877081	21.86266772	0.1296398041	0.9895200938	5241	PGR	CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45	Prestwick	Prestw-299	1.5496368	-0.75282309	3.67367621	21.86266772												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016798-11	(S)-Timolol	170465062	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	26839-75-8				9.104056683	4	4		0	1.92973775					O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C	Enzo	AC172	1.25664572	1.60335471	3.37257397	1.92973775												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015043-10	GABA	225144171	GABA-A receptor; anion channel Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE					0.3408699707	4	4		0	1.97921821					NCCCC(O)=O	Vitas	STK301748	-0.91831803	-0.66600888	-0.50906777	1.97921821												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00253611-01	Isoaminile	170465846		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	77-51-0				7.5719737597	4	4		0	0.64324592					CC(C)C(C#N)(CC(C)N(C)C)c1ccccc1	GVK	FFS-11-286-NCI-202	1.06331561	4.71139615	1.52720331	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018172-09	Indapamide	170465366	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	26807-65-8	; Veroxil;Indapamide; Indapamida; Lozol;INDAPAMIDE; Natrix; Indapamide Anhydride			2.0044911532	4	4		0	0.79168728			766	CA7	NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C	Microsource	01500349	-0.28999517	-0.46867292	1.90900414	0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00538142-01	NCGC00538142-01		vasoconstriction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					5.0988907219	4	4		0	5.49188157					CCCCCCC(COC(=O)C1=CN=CC=C1)(COC(=O)C2=CN=CC=C2)COC(=O)C3=CN=CC=C3	Pharmaron	PH-NIH-2017-009-L1-20-0	-0.37470726	1.05066542	1.74054936	5.49188157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509861-02	Auristatin PE		microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	149606-27-9				22.5813385249	4	4		0	3.30882353					CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCC2=CC=CC=C2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	MedChem Express	HY-14672	6.98084677	0.1029601	3.16172356	3.30882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510316-02	Ombitasvir			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1258226-87-7				-1.8391723532	4	4		0	0.17156863					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	-0.37802419	-0.56628057	-0.86737549	0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263824-02	GENTAMICIN SULFATE	225144365	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1405-41-0, 1403-66-3 [gentamicin]				-5.0084223951	4	4		0	-1.78921569					CN[C@H](C)[C@@H]1CC[C@@H](N)[C@H](O1)O[C@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O	Microsource	01500314	-1.08366935	0	-0.58757694	-1.78921569												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00183106-01	NCGC00183106-01	124894306	Aeromonas salmonicida Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Nifurpirinol; Furanace; 			-0.6788520165	4	4	P 7138;LS-131753;nifurpirinol;Nifurpirinolum;NIFURPIRINOL;Furanace;nifurpirinolum;6-(2-(5-nitro-2-furanyl)ethenyl)-2-pyridinemethanol;CIPLUS_208451;Nifurpirinol;6-hydroxymethyl-2-(2-(5-nitro-2-furyl)vinyl)pyridine;	0	-0.31862745					OCC1=CC=CC(\C=C\C2=CC=C(O2)[N+]([O-])=O)=N1	APAC	877864	-0.78125	2.41956242	-0.19585898	-0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016618-04	Dimethisoquin hydrochloride	170465516	Neuronal acetylcholine receptor; alpha4/beta4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2773-92-4		12.5892541179	-4.9	41.4954390882	3	4		52.9823529407	47.37745098	0.0166521743	0.9998290198			Cl.CN(C)CCOc2nc(cc1ccccc12)CCCC	Prestwick Chemical, Inc.	Prestw-630	1.58770161	1.02960103	1.87465025	47.37745098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183009-01	Pranazepide	144206813	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	150408-73-4	Panazepide; 	14.1253754462	-4.85	23.4764070879	4	4	PANAZEPIDE;PRANAZEPIDE;FK480;FR120480;CIPLUS_709224;1H-Indole-2-carboxamide, N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-, (S)-;Panazepide;LS-173385;FR 120480;FK 480;Pranazepide;N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxo-pyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-1H-indole-2-carboxamide;FR-120480;pranazepide;pranazepidum;	25.0168482441	19.81057616	0.0782212183	0.9962199923			Fc6ccccc6C3=N[C@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45	Pharmaron	PH-NIH-126867	0.92009685	0.70263488	-0.43070687	19.81057616												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	2.2387211386	-5.65	10.0627463658	4	4		12.3249686359	11.28650355	0.0557142077	0.9980978988	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-0.53268765	-1.10414053	-0.53204966	11.28650355												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091021-01	Trichloroacetic acid	17388684		DPI_SARS-CoV-2_General	2019_NPC-7_CPE		Trichloroacetic acid			-2.5799762419	4	4	TCA sodium salt;Rubidium Trichloroacetate;CIPLUS_695902;Sodium trichloroacetate;Trichloroacetic acid-1-13C;Acid, Trichloroaceti;Acetic acid, trichloro-;TRICHLOROACETIC ACID;AB07944365-01;CIPLUS_665666;TRICHLOROACETIC-ACID;Sodium Trichloroacetate;CIPLUS_3745296;CIPLUS_166806;Trichloroacetic acid;Trichloroacetate, Rubidiu;CIPLUS_155922;CIPLUS_664828;CIPLUS_149367;Trichloroacetic acid solution;Trichloroacetic Acid;Trichloroacetate, Sodiu;AB07944376-01;CIPLUS_3859089;	0	1.05062082					OC(=O)C(Cl)(Cl)Cl	NIEHS	AB07944365	-0.79625293	-1.1440579	-0.76149035	1.05062082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-12	Papaverine hydrochloride	170465687	Phosphodiesterase X (PDE10) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	61-25-6	; ;Papaverine?HCl;PAPAVERINE HYDROCHLORIDE; Pavatym; Cerespan;Papaverine hydrochloride; Albatran; Omnopon-Scopolamine; Hydrochloride, Papaverin; Cepaverin; Papaverine hydrochloride; Papaverine Hcl; Pavabid			-0.7477429155	4	4		0	2.72058824			10846	PDE10A	Cl.COc1ccc(cc1OC)Cc3nccc2cc(OC)c(cc23)OC	Vitas	STK039035	-1.53729839	0.15444015	1.48293229	2.72058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181099-01	Siccanin	144206268		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	22733-60-4	Siccanin; Ladar; Sicanina; Piadar; 	12.5892541179	-4.9	38.2333298332	3	4	Siccaninum;LS-173961;siccanine;Siccanine;Siccanin;Ladar;SICCANIN;CIPLUS_214175;Sicanina;Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester, mixt. with (4aS-(4aalpha,6aalpha,11balpha,13aR*,13balpha))-1,2,3,4,4a,5,6,6a,11b,13b-decahydro-4,4,6a,9-tetramethyl-13H-benzo(a)furo(2,3,4-mn)xanthen-11-ol;CIPLUS_769555;siccaninum;Piadar;siccanin;	58.1163425019	52.62254902	0.0349479376	0.9992462103			Cc1cc2O[C@@]4(C)CC[C@H]5C(C)(C)CCCC53CO[C@@H](c2c(O)c1)[C@H]34	NCI	NSC-135048	-0.63004032	0.92664093	-0.19585898	52.62254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263955-02	TYLOSIN TARTRATE			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	74610-55-2				-3.9291342403	4	4		0	-0.66176471					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33847	-1.08366935	-0.92664093	-0.02797985	-0.66176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-05	Megestrol acetate	170465406	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	595-33-5	; Novacyclin 22; Serial C; Megeron; Megace;Megestrol acetate; Megestrol 17-acetate;Megestrol Acetate; Oraconal; Me-quingestanol			0.0315579815	4	4		0	4.68137255			5241	PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick Chemical, Inc.	Prestw-956	-1.08366935	0.25740026	-1.25909345	4.68137255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	915087-33-1				-2.9693057346	4	4		0	-0.0245098				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-0.88205645	-0.41184041	-0.58757694	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386200-02	Vildagliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	274901-16-5				-4.7807969793	4	4		0	-0.85784314					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Axon Medchem	1631	-1.58770161	-0.20592021	0.08393956	-0.85784314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094851-05	Iodamide	170465213		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	440-58-4				1.2083336231	4	4		0	0.85784314					O=C(C)Nc1c(I)c(c(I)c(CNC(C)=O)c1I)C(=O)O	Microsource	01500772	-0.37802419	0.20592021	1.98656967	0.85784314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	11.220184543	-4.95	32.5576762088	3	4		42.7176470624	39.28921569	0.017432479	0.9998126657	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	0.88205645	0.30888031	1.03525462	39.28921569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161326-08	Calcifediol (monohydrate)			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	63283-36-3				5.2005724126	4	4		0	3.55392157					C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)CCC3=C	MedChem Express	HY-32351A	1.08366935	0.77220077	-1.09121433	3.55392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015094-22	Allopurinol			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	315-30-0				-1.4300808427	4	4		0	-0.17156863					OC1=C2C=NNC2=NC=N1	APExBIO	A8360	-0.5796371	0.51480051	-0.08393956	-0.17156863												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00420878-02	Dalbavancin			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	171500-79-1				-1.6948414098	4	4		0	-0.41666667					CN[C@H]1C(=O)N[C@@H]2CC3=CC=C(OC4=CC5=CC(=C4O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6NC(=O)CCCCCCCCC(C)C)C(O)=O)OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)C9=C(Cl)C(=CC(=C9)OC%10=C(O)C=CC1=C%10)O)C%11=CC=C(O)C(=C%11)C%12=C(O[C@H]%13O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%13O)C=C(O)C=C%12[C@H](NC8=O)C(=O)NCCCN(C)C)C=C3	MedChem Express	HY-17586	0.12600806	-1.33848134	-0.86737549	-0.41666667												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015833-15	Pyrazinamide	170464703	Fatty Acid Synthase (FAS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	98-96-4	Pyrazinecarboxamide;PYRAZINAMIDE; Pyrazinamide;Pyrazinamide; Pyrazinecarboxamide			-1.9788515139	4	4		0	-0.71033938			2194	FAS	NC(=O)c1cnccn1	Vitas	STK801661	-0.43583535	-1.05395232	0.32936407	-0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015245-10	Bethanechol chloride	170464912	Muscarinic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	590-63-6	; ;Carbamyl-b-Methylcholine Cl; Urecholine; Bethanechol chloride;BETHANECHOL CHLORIDE;Bethanechol chloride			-0.8736276185	4	4		0	-1.23651671				CHRM2	[Cl-].C[N+](C)(C)CC(C)OC(=O)N	Enzo	AC912	0.24213075	-1.05395232	0.73473524	-1.23651671												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163150-07	Clenbuterol	170465955	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	37148-27-9				-2.2370524838	4	4		0	0.76295712					Clc1cc(cc(Cl)c1N)C(O)CNC(C)(C)C	Enzo	AC174	-1.5496368	-0.55207026	0.17734989	0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021226-04	Dexamethasone 21-phosphate disodium salt	225144188	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2392-39-4				0.3818947275	4	4		0	1.18389897					C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[P]([O-])([O-])=O	SIGMA	D1159	-0.6779661	-0.65244667	-0.48137826	1.18389897												6.4E-9	3.2E-8	1.6E-7	0.000004											
NCGC00253590-01	Variotin	170465957		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	19504-77-9				-1.0693350769	4	4		0	2.47402276					O=C1CCCN1C(=O)/C=C/C=CC(\C)=C\C(O)CCCC	GVK	FFS-11-286-NCI-227	-1.64330594	0.66600888	-1.14540248	2.47402276												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015755-10	Nimustine	170466029	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	42471-28-3				2.8354180677	4	4		0	-0.39584364					Nc1nc(C)ncc1CNC(=O)N(CCCl)N=O	Microsource	01504151	1.64330594	0.22200296	0.06363347	-0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024868-09	Bisoprolol fumarate	170464815	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104344-23-2	;Bisoprolol fumarate; Zebeta; ; Bisoprolol hemifumarate; Bisoprolol Hydrochloride; Bisoprolol fumarate; Bisoprolol hemifumarate salt; Bisoprolol, (+-)-Isomer; Bisoprolol, (-)-Isomer;Bisoprolol hemifumarate salt; 3   Bisoprolol Fumarate; Prestwick-05A11;BISOPROLOL FUMARATE			2.4559787449	4	4		0	1.13805047			153	ADRB1	O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C	Microsource	01505704	0.91831803	-0.51800691	-0.12726694	1.13805047												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179590-04	Syrosingopine			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	84-36-6		14.1253754462	-4.85	16.2734324872	4	4		30.078063792	24.14215686	0.0578370228	0.9979353567			CCOC(=O)OC1=C(OC)C=C(C=C1OC)C(=O)O[C@@H]2C[C@@H]3CN4CCC5=C([NH]C6=C5C=CC(=C6)OC)[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC	Glixx	GLXC-06136	-0.27721774	-0.20592021	-1.31505316	24.14215686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178127-02	Ramipril	170464731	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	87333-19-5	;RAMIPRIL;Ramipril (Altace);Ramipril; Tritace; Altace; Ramipril and diuretics			0.4243133304	4	4		0	-0.6127451			1636	ACE	O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@@H]3CCC[C@H]23)C(=O)O	Vitas	STK801937	-0.68044355	-0.30888031	4.0570789	-0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181161-03	Ethyl salicylate	170466844		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	118-61-6				0.3567899168	4	5		0	0					Oc1ccccc1C(=O)OCC	Labotest	LT02097419	0.65934066	-0.9608091	0.29607698	-0.57430007	0											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016741-09	Tinidazole	170465196		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	19387-91-8				4.1732673803	4	5		0	-1.78498986					O=S(=O)(CCn1c(cnc1C)[N+]([O-])=O)CC	Vitas	STK801761	1.92918193	0.5562579	1.67776955	0.52644173	-1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263571-01	Bendazac sodium	170465952	Xanthine dehydrogenase/oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	23255-99-4				0.3759665764	4	5		0	0.89249493					[Na+].[O-]C(=O)COc3nn(Cc1ccccc1)c2ccccc23	Sequoia	20187-55-7	0.12210012	0.0505689	-0.83888478	0.04785834	0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015948-10	Spironolactone			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	52-01-7				-2.1352742724	4	5		0	-0.73022312					[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]4([H])[C@@]2([H])[C@@]([H])(CC5=CC(=O)CC[C@]45C)SC(C)=O	Prestwick	Prestw-128	0.21978022	-1.2136536	-0.5428078	-1.1007418	-0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249934-01	Tolciclate	170465866		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50838-36-3		8.9125093813	-5.05	7.7453887833	4	5		13.894892676	12.49492901	0.0275446695	0.986035245			Cc1cc(ccc1)N(C)C(=S)Oc2ccc4c(c2)C3CCC4C3	GVK	FFS-11-286-NCI-238	0.31746032	-1.1125158	-1.57907723	-0.43072505	12.49492901											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016569-09	TRANEXAMIC ACID	225144181	Tissue-type Plasminogen Activator Inhibitor (tpa) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1197-18-8	; ;TRANEXAMIC ACID; cis-AMCHA; Cyklokapron; Tranexamic acid; Acido tranexamico; Transamin; Rikavarin;Tranexamic acid			-0.974508991	4	5		0	0.32454361			5054	SERPINE1	NC[C@H]1CC[C@@H](CC1)C(O)=O	Microsource	01502026	0.02442002	-1.011378	0.19738465	-1.29217516	0.32454361											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00159361-06	Menthyl Anthranilate			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	134-09-8		11.220184543	-4.95	12.2250928414	4	5		21.76007326	17.28194726	0.0106712425	0.9946439089			CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2N	SigmaAldrich	437387	-1.05006105	0.505689	-0.04934616	1.3400335	17.28194726											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015260-22	CEFACLOR			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	70356-03-5, 53994-73-3 [anhydrous]				12.4772360407	4	5		0	7.30223124					N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3	Microsource	01500771	0.31746032	-0.6068268	-0.04934616	2.87150036	7.30223124											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00014483-16	Pamelor		Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	894-71-3		12.5892541179	-4.9	111.2188320256	3	4		122.1980268385	96.79031834	0.0126848414	0.9999007469			CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	N7261	1.5496368	1.85696361	0.83607803	96.79031834												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran	12.5892541179	-4.9	98.9764938592	3	4		117.0868011018	90.94975007	0.0176209068	0.999808452		CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	0.0968523	0.25094103	-1.08943501	90.94975007												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017256-17	Galanthamine		Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	357-70-0				3.2743238785	4	4		0	1.95797517				ACHE	COC1=CC=C2CN(C)CC[C@@]34\C=C/[C@H](O)C[C@@H]3OC1=C24	MedChem Express	HY-76299	0.23419204	1.51762783	0.21756867	1.95797517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390187-02	Delafloxacin (meglumine)		Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	352458-37-8				-2.1942129127	4	4		0	-0.38204394					NC1=C(F)C=C(F)C(=N1)N2\C=C(C(O)=O)/C(=O)C3=CC(=C(N4CC(O)C4)C(=C23)Cl)F	MedChem Express	HY-14814A	-0.88992974	-0.02334812	0.54392168	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090793-05	NAPHTHALENE, ZONE REFINED	225144198	Metabolism of xenobiotics by cytochrome P450 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	91-20-3				-2.3288912469	4	5		0	-1.29817444					C1=CC=C2C=CC=CC2=C1	SIGMA	147141	0.12210012	-0.7079646	-0.9375771	-0.62215841	-1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348363-01	ARABITOL(D)		sugar alcohol	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	488-82-4				-1.1448485372	4	5		0	2.43407708					OC[C@@H](O)C(O)[C@H](O)CO	SIGMA	A3381	-0.41514042	-1.0619469	-0.64150012	-1.43575018	2.43407708											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094363-07	D-SERINE		Serine palmitoyltransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	312-84-5				-1.1384893574	4	5		0	-1.70385396					N[C@H](CO)C(O)=O	SIGMA	S4250	0.51282051	-1.1630847	-0.14803849	0.14357502	-1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021277-04	Hydrocortisone acetate	170466796		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	50-03-3				0.6634118473	4	5		0	1.86612576					CC(=O)OCC(=O)[C@@]4(O)CCC3C2CCC1=CC(=O)CC[C@]1(C)C2[C@@H](O)C[C@@]34C	Prestwick	Prestw-1486	0.46398046	-1.1125158	-0.5428078	-0.62215841	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015054-12	Tacrine hydrochloride	170465420	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	321-64-2	 THA hydrochloride hydrate; THA hydrochloride; 9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;Tacrine hydrochloride hydrate; ;TACRINE HYDROCHLORIDE;Tetrahydroaminoacridine Monohydrate;Tacrine hydrochloride;Tacrine (hydrochloride);Tacrine; Tetrahydroaminacrin;1,2,3,4-Tetrahydro-9-acridinamine hydrochloride; Tacrina; Cognex;Tacrin?HCl			4.5802883872	4	5		0	1.78498986			43	ACHE	Nc1c3ccccc3nc2CCCCc12	Vitas	STK101308	0.56166056	-0.5562579	2.417962	1.29217516	1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164492-02	Sulfisomidine	170465986		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	515-64-0				-0.5918234855	4	5		0	2.43407708					Cc2cc(NS(=O)(=O)c1ccc(N)cc1)nc(C)n2	Labotest	LT00452030	-0.70818071	-1.3147914	-0.5428078	0.28715004	2.43407708											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274271-01	Dimethisteron	170465914		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	79-64-1				11.7302587727	4	4		0	3.16763006					C[C@H]3C[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#CC)[C@@]4(C)CCC(=O)C=C34	GVK	FFS-11-286-NCI-184	2.57069409	2.47653806	1.52671756	3.16763006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229704-01	Raltitrexed	124939249	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	112887-68-0	Raltitrexed			2.6724912707	4	4	Raltitrexed	0	-1.50289017			7298	TYMS	O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc(s1)N(C)Cc2ccc3N=C(C)NC(=O)c3c2	Waterstone	WS10046	1.95372751	-0.39103233	-1.31613583	-1.50289017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389454-01	IMEXON		Ribonucleoside-Diphosphate Reductase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	59643-91-3				5.5905917277	4	4		0	3.44508671				RRM1	N=C1NC(=O)N2CC12	Microsource	01506181	0.61696658	1.22523462	2.05317189	3.44508671												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345812-02	Ingenol mebutate		PKC Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	75567-37-2		14.1253754462	-4.85	31.3552306656	4	4		-10.749710988	-0.20809249	0.4389490835	0.8602262053		PRKCA	C\C=C(C)/C(=O)O[C@H]1C(=C/C23[C@H](C)C[C@@H]4[C@H](C(\C=C(CO)/[C@@H](O)[C@]12O)C3=O)C4(C)C)\C	MedChem Express	HY-B0719	6.58097686	10.08863399	10.95025007	-0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159369-04	1-Octadecanol	170465526		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	112-92-5				-1.9271224561	4	4		0	-1.34175217					CCCCCCCCCCCCCCCCCCO	Labotest	LTBB001505	0.33898305	-0.75282309	-0.53204966	-1.34175217												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015099-11	Alprenolol	170465812	Beta-adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	13655-52-2				-3.90729541	4	4		0	-0.60510392					CC(C)NCC(O)COc1ccccc1CC=C	Enzo	AC812	-0.6779661	-0.9033877	-1.2921206	-0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090764-04	2-Ethylhexyl 4-(dimethylamino)benzoate	170465499		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	21245-02-3				-0.4162793713	4	4		0	1.02604578					CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC	Bosche	E2279	-1.01694915	0.15056462	0.22802128	1.02604578												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016612-05	Sulfadoxine	170464751	Dihydropteroate Synthase (DHPS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2447-57-6	; Sulfadoxine Roche Bran; Ro 4439; Ro 4 439; Sulphorthodimethoxine; Ro 4-4393; Sulphormetoxin; Sulformetoxine; Suldox; Ro 6-2153; Borgal; Sulfadoxin;SULFADOXINE; Fanasil; Fansimef; Sulfadoxina; Sulfadoxine;Sulfadoxine			0.3894390976	4	4		0	0.64324592					O=S(=O)(Nc1ncnc(OC)c1OC)c2ccc(N)cc2	Microsource	01506086	-0.14499758	0.12333498	-0.12726694	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015834-19	Primidone	170464846	Anticonvulsant agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	125-33-7	; ;Primaclone; Primidona;Primidone; Primidone; 2-Desoxyphenobarbital; Primaclone; Mysoline;Primidone (primaclone); Primidone (primaclone);PRIMIDONE			-0.6485966742	4	4		0	-0.09896091				GABRA1	CCC1(C(=O)NCNC1=O)c2ccccc2	Specs	AN-153/I262077	0.04833253	0.91267884	-1.20903595	-0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179363-03	Ursodiol	225144303	Steroid	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	128-13-2	; Urosiol; Ursodexycholic Acid; Antigall; Chenique Acid; Acido chenodeoxicholico;Urosiol; Sodium chenodeoxycholate; Litursol; Acido ursodeoxicolico; Urso;Ursodiol (Actigal Urso); UDCA-menthol; Ursodeoxy cholic acid; Chenodesoxycholic acid;URSODIOL; Ursometh; Acide chenodeoxycholique			-0.189136027	4	4		0	0.62082139				NR14H	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Prestwick	Prestw-958	-0.84309133	0.67709549	1.46858852	0.62082139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188437-01	Sultamicillin tosylate	144206543	Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	83105-70-8				-0.5175848581	4	4	Sultamicillintosilate	0	-0.42979943					O=S(=O)(O)c1ccc(C)cc1.O=C1C[C@@H]5N1[C@@H](C(=O)OCOC(=O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@H](N)c2ccccc2)[C@H]4SC3(C)C)C(C)(C)S5(=O)=O	APAC	812244	-0.18735363	-0.30352557	0.70709818	-0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159479-05	Methyl nicotinate	170465506		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	93-60-7				2.3399188308	4	5		0	5.92292089					COC(=O)c1cccnc1	Vitas	STK803258	-0.21978022	-1.1630847	-1.43103874	0.19143336	5.92292089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00484900-01	Estramustine PhosphateNa		Dna Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	52205-73-9				0.0878857304	4	4		0	1.91907514				H2AFX	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P](O)(O)=O	Enzo	AC1524	-0.82262211	0.02606882	1.05290866	1.91907514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182029-01	Fosfluconazole	144206487	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	194798-83-9	Fosfluconazole; Prodif; 			-2.7569569976	4	4	Fosfluconazole;fosfluconazole;fosfluconazolum;CIPLUS_787926;FOSFLUCONAZOLE;Prodif;	0	-0.76300578					Fc1ccc(c(F)c1)C(OP(=O)(O)O)(Cn2cncn2)Cn3cncn3	ACC	Fosfluconazole	-1.23393316	1.59019812	-0.21058173	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182544-01	Triamcinolone hexacetonide	144206532		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	5611-51-8	Triamcinolone hexacetonide; Aristospan; 			-0.2534208652	4	4	hexacetonide de triamcinolone;CL-34433;TATBA;Hexacetonide de triamcinolone;9-fluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-(3,3-dimethylbutyrate);triamcinolone hexacetonide;Tiamcinoloni hexacetonidum;Aristospan;Hexacetonido de triancinolona;CIPLUS_164534;triamcinoloni hexacetonidum;TRIAMCINOLONE ACETONIDE 21-T-BUTYLACETATE;Triamcinolone hexacetonide;LS-1379;SQ-21360;Triamcinoloni hexacetonidum;TRIAMCINOLONE HEXACETONIDE;(11 beta, 16 alpha)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy)) pregna-1,4-diene-3,20-dione;Triamcinolone Hexacetonide;	0	-0.48554913					CC(C)(C)CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	555785	-0.05141388	-0.2346194	0.57909976	-0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390569-01	Netupitant	363680908		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	290297-26-6				-0.6518043838	4	4		0	-2.75144509					CN1CCN(CC1)C2=CC(=C(C=N2)N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=C(C)C=CC=C4	MedChem Express	HY-16346	0.41131105	-0.70385819	1.21084496	-2.75144509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387409-02	Ertapenem		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	153832-46-3				-3.6504243867	4	4		0	-1.55155155			944799	ftsI	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(O)=O)S[C@@H]3CN[C@@H](C3)C(=O)NC4=CC=CC(=C4)C(O)=O	Glixx	GLXC-05077	-0.52480916	-1.48902821	-0.15710919	-1.55155155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378920-01	Falecalcitriol			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	83805-11-2				4.5128542404	4	4		0	0.6006006					C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32342	1.38358779	-0.0261233	0.78554595	0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182991-01	Glybuzole	144206873	insulin secretion Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1492-02-0	Glybuzole; Gludiase; Glibuzol; 			-1.9370671995	4	4	CIPLUS_216125;Glibuzol;desaglybuzole;LS-31372;glybuzole;Gludiase;N-(5-tert-butyl-1,3,4- thiadiazol-2-yl)benzenesulfonamide;GLYBUZOLE;Benzenesulfonamide, N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-;TH-1395;glybuzolum;Glybuzolum;Glybuzole;	0	0.55248619					O=S(=O)(Nc1nnc(s1)C(C)(C)C)c2ccccc2	Pharmaron	PH-NIH-183235	-0.2905569	-0.8531995	-1.34279199	0.55248619												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015542-07	Ibudilast	170466049	Phosphodiesterase 4A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50847-11-5				-7.083939754	4	4		0	-1.86792949					CC(C)C(=O)c1c2ccccn2nc1C(C)C	Prestwick	Prestw-1286	-1.50121065	-1.05395232	-1.44413479	-1.86792949												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018157-13	Flurbiprofen		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	5104-49-4	 R-(-)-Flurbiprofen;;FLURBIPROFEN;(?)-Flurbiprofen;Flurbiprofen; Anside; Flurbiprofeno; (R)-2-Flurbiprofen; Ansaid; (S)-(+)-Flurbiprofen; S-(+)-Flurbiprofen; Ocufen			1.351823201	4	4		0	1.18389897				PTGS2	CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	SIGMA	F8514	-0.1937046	0.55207026	0.0253357	1.18389897												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016600-08	Clofazimine	387065713	DNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2030-63-9		3.5481338923	-5.45	30.3337348609	2.4	4		31.4527844999	28.91344383	0.0149924273	0.9998615396			CC(C)\N=C\1/C=C\2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)\N=C2\C=C1NC5=CC=C(Cl)C=C5	SIGMA	C8895	-1.21065375	-0.70263488	1.2921206	28.91344383												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163160-04	Talipexole	170466015	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	101626-70-4				1.0343954543	4	4		0	0.60510392					C=CCN1CCc2sc(N)nc2CC1	Tocris	2759	-0.53268765	2.05771644	-0.07600709	0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160624-04	Ethopabate	170466827	folic acid biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59-06-3				-0.947862738	4	4		0	1.13805047					CCOc1cc(ccc1C(=O)OC)NC(C)=O	SIGMA	00275	-1.06331561	-0.32067094	0	1.13805047												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00485328-01	(6R)-5,6,7,8-Tetrahydrobiopterin dihydrochloride	363681287	Phenylalanine-4-hydroxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	69056-38-8				-3.0940673277	4	4		0	-0.76300578					C[C@H](O)[C@H](O)[C@H]1CNC\2=C(N1)\C(=O)N\C(=N2)N	SIGMA	T4425	-1.07969152	0.86027112	-0.52645433	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016446-17	Metronidazole		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	443-48-1				-0.0668635107	4	4		0	-0.43930636					CC1=NC=C([N]1CCO)[N+]([O-])=O	Enzo	DL447	0.41131105	-0.33889468	-0.7896815	-0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166270-02	1,3,5-Trihydroxybenzene dihydrate	225144277	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	6099-90-7				10.3746623647	4	4		0	1.68786127					OC1=CC(=CC(=C1)O)O	SIGMA	P38005	2.21079692	1.43378519	3.52724401	1.68786127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379027-01	(24S)-24,25-Dihydroxyvitamin D3		Vitamin D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	55700-58-8				-1.3816651074	4	4		0	0.80924855			7421	VDR	C[C@H](CC[C@H](O)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	MedChem Express	HY-15439	-0.77120823	-0.18248175	0.1579363	0.80924855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183121-01	Zinc pyrithione	144206950		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	13463-41-7				-1.7649832362	4	4	pyrithionum zincicum;LS-784;Pyrithione zincique;PYRITHIONE ZINC;pyrithione zinc;Zinc Pyrithione;Zinc pyrithione;NCGC00094659-02;ZINC OMADINE;NCGC00094659-01;CIPLUS_168786;ZINC DI(2-PYRIDINETHIOL-1-OXIDE);Piritionato cincico;zinc pyrithione;ZINC PYRION;AB07944716-01;Finecide ZPT;Pyrithione zinc;VANCIDE ZP;Pyrithionum zincicum;Sebulon shampoo;2-Mercaptopyridine N-oxide zinc salt Pyrithione zinc;(T-4)-bis(1-hydroxy-2(1H)- pyridinethionato-O,S)zinc;2-Mercaptopyridine N-oxide zinc salt;	0	-2.61271676					[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]	SIGMA	H6377	1.02827763	-1.32950991	-2.15846275	-2.61271676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181135-02	Pentamycin	144206785		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	6834-98-6	Pentamycin; 			-1.8189328486	4	4	lagosin;NSC-277813;CIPLUS_3864474;PENTAMYCIN;fungichromin;pentamycin;LS-69889;Pentamycin;cogomycin;CIPLUS_215789;	0	-0.71676301					CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O	NCI	NSC-276732	-0.92544987	0.80813347	0.73703606	-0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025325-03	Vapiprost hydrochloride	174006925	Prostanoid TP Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	87248-13-3	GR 32191 hydrochloride; Vapiprost hydrochloride;GR-32191B; 			-2.8782570423	4	4		0	-1.9019019			6915	TBXA2R	O[C@H]1C[C@H](OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4	SIGMA	G5044	-0.47709924	0.28735632	-0.62843676	-1.9019019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167429-04	Temozolomide	170464968	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	85622-93-1	Temozolomide; ; Temodar;; Temozolomide			-1.2601175138	4	4		0	-0.65065065			7153	TOP2A	NC(=O)c1ncn2C(=O)N(C)N=Nc12	Prestwick	Prestw-1183	-0.38167939	0.28735632	0	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182543-02	Xipamide	170466623	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	14293-44-8				-5.9778544985	4	4		0	-0.8008008					O=S(N)(=O)c1cc(c(O)cc1Cl)C(=O)Nc2c(C)cccc2C	APAC	555772	-1.38358779	-1.43678161	-1.2045038	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389390-01	Abiraterone acetate		Cytochrome P450 17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	154229-18-2		11.220184543	-4.95	10.9474834373	4	4		20.658307208	16.31631632	0.0166231197	0.9998303403			CC(=O)OC1CCC\2(C)C3CCC\4(C)C(C\C=C4C5=CN=CC=C5)C3C\C=C2C1	APExBIO	A8202	-0.52480916	-0.54858934	0.68080649	16.31631632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344520-01	L-Valine	225144376	tryptophan transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	72-18-4				-0.4858298683	4	4		0	1.8018018					CC(C)[C@H](N)C(O)=O	SIGMA	94620	-0.23854962	-1.75026123	0	1.8018018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094358-05	Isotretinoin	26753641	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	4759-48-2	; Panretin; Retinoic acid, all-trans-; RETINOIC ACID, 9-cis-; Retinoic acid, trans; Roaccutane; "RETINOIC ACID, 13-cis-"; 9-cis-Tretinoin;13-cis-retinoic acid; Retinoic acid, 13-cis-; Tretinoin Potassium Salt; Retin A; 13 cis Retinoic Aci; ISOTRETINON; 9,13-di-cis-RA; Tretinoin Zinc Salt; Velac; 13-cis-retinoic acid; 13-cis-Retinoic acid; RETINOIC ACID, 13-cis-; Ro 4 378; ; Ro 4378; Ro 4-3780; Tretinoine;ISOTRETINON; Tretinoina;13-cis Retinoic acid; Isotretinoino; Tretinoino; Retinoic acid; Vesanoid; Tretinoin Tocoferil; Isotretinoin Anisatil; 9cRA compound;Isotretinoin			4.3776182962	4	4	TRETINOIN;Tretinoinum;RETINOIC ACID, 9-cis-;9,13-di-cis-RA;Retinoic acid, trans;13-CIS-RETINOIC ACID;Tretinoina;ISOTRETINOIN;NCGC00161590-04;Panretin;9-cis-retinoic acid;ALL-TRANS-RETINOIC ACID;LG-100057;Isotrex;Tretinoin Tocoferil;CIPLUS_152537;9-cis-Retinoic acid;9-cis,13-cis-retinoic acid;9,13-di-cis-retinoic acid;Accutane;isotretinoine;Vitamin A acid;NCGC00161590-03;9-CIS-RETINOIC ACID;Velac;Retinoic acid, all-trans-;Tretinoin;SOLAGE;Tretinoin (Retinoic acid, all trans);NCGC00015890-01;RO-4-3780;CIPLUS_163676;NCGC00015890-02;TRETINOIN ZINC;NCGC00015890-03;NCGC00015890-04;Tretinoin Potassium Salt;LS-173936;Isotretinoin;Ro 4-3780;CIPLUS_711531;NCGC_Prestw-256;NCGC00021808-06;13 cis Retinoic Aci;NCGC00021808-05;NCGC_Prestw-257;Isotretinoinum;Isotretinoine;Isotretinoin Zinc Salt, 13-cis-Isomer;Isotretinoino;tretinoine retinoic acid;Tretinoine;Tretinoino;NCGC00021808-02;NCGC00021808-04;RETINOIC ACID, 13-cis-;Isotretinoin Anisatil;CIPLUS_660447;9cRA compound;CIPLUS_725243;13-cis-Retinoic acid;Vesanoid;alitretinoinum;tretinoin;CIPLUS_164122;alitretinoin;Isotretinoin (13-cis-retinoic acid);VITAMIN A ACID;CIPLUS_710508;9-cis-Tretinoin;CIPLUS_710507;ALITRETINOIN;LS-1328;LS-178647;NCGC00021808-14;9,13-retinoic acid;Retinoic acid, 13-cis-;Retin A;all-trans-Retinoic acid;ACCUTANE;ISOTREX;NSC-122758;Tretinoin,all-trans-retinoie acid;clindamycin phosphate - tretinoin formulation;Alitretinoin;isotretinoinum;13-cis-retinoic acid;Isotretinoin Zinc Salt, 13 cis Isome;VITAMIN A ACID, 13-CIS-;CIPLUS_3881593;Ro 4378;RETINOIC ACID, ALL-TRANS;NCGC00094358-02;NCGC00094358-01;NCGC00094358-04;Isotretinoin,13-cis-retinoic acid;NCGC00094358-03;NCGC00094358-06;NCGC00094358-08;NCGC00094358-07;Roaccutane;NCGC00094358-09;ISOTRETINON;Ro 4 378;Retinoic acid;CIPLUS_711632;LGD-1057;ATRA;LS-143465;LS-1154;tretinoinum;Ligand brand of alitretinoin;TRETINON;	0	0.55055055			5915	RARB	CC/1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1	BIOMOL	GR102	0.85877863	1.3322884	1.2045038	0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015919-14	Sotalol		beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	959-24-0				-2.9394992065	4	4		0	0.15015015				ADRB1	CC(C)NCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0437	-0.71564885	-1.22779519	-0.5236973	0.15015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094792-18	Tioguanine		Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	154-42-7				2.8880452963	4	4		0	8.20820821				HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	Cayman	15774	-0.62022901	-1.43678161	-0.94265515	8.20820821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017258-08	Methergine	170465383	Serotonin 2b (5-HT2b) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	113-42-8				5.4359602589	4	4		0	0.95011876					CC[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34	Enzo	AC576	0.49435028	2.01809325	1.97084233	0.95011876												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015234-19	Carbamazepine	170464712	Sodium channel protein type 5 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	298-46-4				-1.9713283014	4	4		0	-0.26392188			6331	SCN5A	NC(=O)N2c3ccccc3C=Cc1ccccc12	Vitas	STK177357	-0.02354049	-0.27835769	-1.37688985	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164572-02	Rimonabant	170465599	Cannabinoid CB1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	168273-06-1	 ; Rimonabant;Rimonabant; Rimonabant Base; Rimonabant(Nlt); Rimonabant HCL			0.2154137685	4	4		0	0.89733439			56144	CNR1	O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c4C	Sequoia	SRP01287r	-0.58851224	1.8789144	-0.94492441	0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159450-04	Parethoxycaine	170465538		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	94-23-5				0.1666161861	4	4		0	-0.47505938					CCOc1ccc(cc1)C(=O)OCCN(CC)CC	Specs	AO-365/40892107	1.15348399	0.06958942	-1.43088553	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	56776-01-3				-4.5639287753	4	4		0	-0.69272637					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-1.30497825	0.024667	-1.3363029	-0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015408-05	RACEPHEDRINE HYDROCHLORIDE		Norepinephrine Transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	134-71-4, 90-81-3 [racephedrine]				-0.577602503	4	4		0	0.16184971					CNC(C)C(O)C1=CC=CC=C1	Microsource	01500525	-0.66838046	0.54744526	0.89497236	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179332-03	Naftifine hydrochloride	170464903	Squalene monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	65473-14-5				0.8484874165	4	4		0	0.57803468			3646509		Cl.CN(C\C=C\c1ccccc1)Cc3cccc2ccccc23	Prestwick	Prestw-1063	-1.18251928	0.65172054	4.26428007	0.57803468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387800-02	AHU-377			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	149709-62-6				3.3263885479	4	4		0	0.16184971					CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(O)=O	Aobious	AOB2046	1.49100257	-0.75599583	-0.10529087	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183846-01	Toborinone	144206841	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	143343-83-3				-1.6428959007	4	4	toborinone;OPC 18790;6-(3-(3,4-DIMETHOXYBENZYLAMINO)-2-HYDROXYPROPOXY)-2(1H)-QUINOLINONE,DL-;torborinone;CIPLUS_208056;Toborinone;LS-141868;OPC-18790;TOBORINONE;2(1H)-Quinolinone, 6-(3-(((3,4-dimethoxyphenyl)methyl)amino)-2-hydroxypropoxy)-, (+-)-;6-(3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy)-2(1H)-quinolinone;toborinonum;taborinone;CIPLUS_197035;CIPLUS_698797;	0	0.02312139					COc1ccc(cc1OC)CNCC(O)COc2ccc3NC(=O)C=Cc3c2	Pharmaron	PH-NIH-152870	-0.51413882	-0.33889468	-0.1579363	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247716-01	(+)-Pentazocine succinate	144206429		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	124819-26-7				-0.7656397703	4	4		0	1.36416185					O=C(O)CCC(=O)O.C/C(C)=C\CN2CC[C@]1(C)c3cc(O)ccc3C[C@H]2[C@H]1C	RTI	9709-002	-0.66838046	0.02606882	0.73703606	1.36416185												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00248275-02	S-Hydroprene	225144342		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	65733-18-8				9.2096875026	4	4		0	1.75175175					CCOC(=O)\C=C(C)\C=C\C[C@@H](C)CCCC(C)C	SIGMA	46426	1.8129771	3.26541275	1.41398272	1.75175175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182974-01	Improsulfan tosylate	144206762		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	32784-82-0	NSC-140117; Improsulfano; 			1.6793104788	4	4	Improsulfano;improsan hydrochloride;LS-1222;NSC-102627;3,3'-IMINO BIS(DIMETHANESULFONATE)1-PROPANOL HYDROCHLORIDE;IMPROSULFAN TOSILATE;improsan tosylate;Improsulfan;iminodipropyl dimethanesulfonate 4-toluenesulphonate;alkylating agent 864;yoshi 864;dimesyloxydipropylamine tosylate;improsulfan;CIPLUS_161918;Improsulfanum;bis(3-mesyloxypropyl)amine;3,3'-iminobis-1-propanol dimethanesulfonate;864 T;improsan;LS-122362;LS-122363;CIPLUS_168735;improsulfanum;IMPROSULFAN;3,3'-iminodi-1- propanol dimethanesulfonate;NSC-140117;Improsulfan Tosilate;Improsulfan tosilate;CIPLUS_731133;	0	-0.55055055					Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)OCCCNCCCOS(C)(=O)=O	NCI	NSC_140117	0.38167939	0.18286311	1.41398272	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344562-01	Celiprolol hydrochloride	170465958	Beta-2 adrenergic receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	57470-78-7				0.506458199	4	4		0	0.05005005					Cl.CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O	Prestwick	Prestw-1132	0.62022901	-1.01880878	-0.57606703	0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090708-11	OXYQUINOLINE HEMISULFATE		Trichophyton interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	134-31-6				-1.6349330371	4	4		0	1.65346996					OC1=CC=CC2=CC=CN=C12	Microsource	01500456	-1.16580311	-0.80448562	0.95645608	1.65346996												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183137-01	Sulfadiazine silver	144207020		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	22199-08-2				4.2842584807	4	4	Silver Sulfadiazine;Silver(I) sulfadiazine;Sulfadiazine silver;	0	2.95761528					[Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2	SigmaAldrich	481181	0.69948187	0.51194539	-0.10067959	2.95761528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532507-01	INOSITOL NIACINATE			DPI_SARS-CoV-2_General	2019_NPC-9_CPE					9.9664575075	4	4		0	3.23707499					O=C(O[C@@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C3=CC=CN=C3)[C@@H](OC(=O)C4=CN=CC=C4)[C@H](OC(=O)C5=CC=CN=C5)[C@H]1OC(=O)C6=CC=CN=C6)C7=CC=CN=C7	SIGMA	MFCD00006387	1.21761658	2.9985373	1.6108734	3.23707499												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00166301-04	SODIUM TETRADECYL SULFATE		Vitamin K-dependent protein S Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	139-88-8				-0.5549077418	4	4		0	-1.04797392			5627	PROS1	CCCCC(CC)CCC(CC(C)C)O[S]([O-])(=O)=O	Microsource	01300042	0.49222798	-0.41443198	-1.05713567	-1.04797392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164620-02	Nadifloxacin	170465882	DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	124858-35-1				-0.4743637092	4	4		0	0.36949063					O=C(O)C3=CN2C(C)CCc1c(c(F)cc(c12)C3=O)N4CCC(O)CC4	Sequoia	SRP00810n	-0.02354049	0.6263048	-1.21490281	0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091585-05	Octocrylene	170464719	photosensitizer	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE			4.5766361982	4	4		0	4.11718131				CAT	CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	0.35310734	0	-0.56695464	4.11718131												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015045-09	Methacholine chloride	170464971	Muscarinic acetylcholine receptor M2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	62-51-1				1.8550254702	4	4		0	1.00290314					[Cl-].C[N+](C)(C)CC(C)OC(=O)C	Microsource	01500391	0.16478343	0.27835769	0.24298056	1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262958-01	Bravavir	170466041		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	77181-69-2	Bravavir;5-(2-Bromovinyl)uridine;2,4(1H,3h)-pyrimidinedione,			-4.454108643	4	4		0	-1.10294118					Br\C=C/C1=CN(C(=O)NC1=O)[C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	GVK	FFS-11-286-NCI-260	-1.78931452	1.5958816	-0.25181869	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091019-23	Dexamethasone		Antiinflammatory agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	50-02-2				-4.0412354607	4	4		0	-0.75980392				NR3C1	C[C@@H]1C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	Microsource	01500230	-1.23487903	-0.20592021	-0.25181869	-0.75980392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167553-02	Norphenylephrine hydrochloride	225144293	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	4779-94-6				-4.7233848746	4	4		0	-1.34803922					NCC(O)C1=CC=CC(=C1)O	SIGMA	113727	-1.23487903	-0.72072072	-0.08393956	-1.34803922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181149-01	3-Anilinopropan-1-ol	144206306		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	31121-11-6	PHENYLPROPANOLAMINE MALEATE; 			-1.3903714999	4	4	PHENYLPROPANOLAMINE MALEATE;	0	-0.22058824					OCCCNc1ccccc1	NCI	NSC-29092	0.22681452	-0.87516088	-1.70677112	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016373-08	Benzethonium chloride	170465473		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	121-54-0				-3.3097403515	4	4		0	-2.23625362					[Cl-].CC(C)(C)CC(C)(C)c2ccc(OCCOCC[N+](C)(C)Cc1ccccc1)cc2	Microsource	01500138	-1.0653753	0.80301129	0.53204966	-2.23625362												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091575-03	2-Ethyl-1,3-hexanediol	170465521		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	94-96-2				0.3187142341	4	4		0	1.3943699					CCCC(O)C(CC)CO	SIGMA	E29125	-1.1622276	0.40150565	0.63339245	1.3943699												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018210-05	Oxyphencyclimine hydrochloride	170465276	Muscarinic acetylcholine receptor M4 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	125-52-0				-1.9747110728	4	4		0	0.49986846					Cl.CN3CCCN=C3COC(=O)C(O)(c1ccccc1)C2CCCCC2	Microsource	01503932	-0.2905569	-1.20451694	-1.08943501	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274280-01	Pixantronemaleate	225144373	DNA Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE					0.060539759	4	4		0	0.28939753					NCCNC1=C2C(=O)C3=C(C=NC=C3)C(=O)C2=C(NCCN)C=C1	GVK	FFS-12-73-NCI-2833	0.5811138	-0.35131744	-1.03876362	0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164601-02	Liranaftate	170466057	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	88678-31-3	 ;LIRANAFTATE; Liranaftate;Liranaftate; Zefnart; Liranaftato			8.8787844019	4	4		0	8.85700148					COc1cccc(n1)N(C)C(=S)Oc2cc3CCCCc3cc2	Sequoia	SRP01523l	0.33832769	-0.5673409	-1.01813554	8.85700148												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018243-09	Sulfamethazine	170464893	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	57-68-1				-1.2804491568	4	4		0	0.49480455					O=S(=O)(Nc1nc(C)cc(C)n1)c2ccc(N)cc2	Vitas	STK097514	-1.01498308	-1.06068081	0.76360165	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389552-01	CEFONICID SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	71420-79-6				4.7394407375	4	4		0	-0.62082139					O[C@@H](C(=O)N[C@@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)CSC3=NN=N[N]3C[S]([O-])(=O)=O)C4=CC=CC=C4	Microsource	01505474	2.38875878	-0.30352557	-0.97905902	-0.62082139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263218-07	Teriflunomide		DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	108605-62-5				-5.4433224412	4	4		0	-1.00490196				DHODH	C\C(O)=C(C#N)\C(=O)NC1=CC=C(C=C1)C(F)(F)F	Bio Vision	1973	-1.43649194	-0.20592021	-1.25909345	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379053-02	Desmopressin (Acetate)		Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	62288-83-9				-0.2394990269	4	4		0	-0.0245098					NC(=N)NCCCC(NC(=O)C1CCCN1C(=O)C2CSSCCC(=O)NC(CC3=CC=C(O)C=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-17370	0.42842742	-0.87516088	-0.81141578	-0.0245098												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00095135-05	Almotriptan	170465288	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	154323-57-6	; ; ALMOTRIPTAN; Almogran; Almotriptan;ALMOTRIPTAN; Axert			1.4212625121	4	4		0	-1.34803922			3351	HTR1B	O=S(=O)(Cc1ccc2ncc(CCN(C)C)c2c1)N3CCCC3	Microsource	01505204	0.93245968	0.82368082	-0.75545607	-1.34803922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015786-16	Pindolol	170464892	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	13523-86-9				3.6274561729	4	4		0	1.5522231					CC(C)NCC(O)COc2cccc1nccc12	Enzo	AC181	0.3874092	1.00376412	0.48137826	1.5522231												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095911-06	Quetiapine	170465146	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	111974-69-7				-4.2451786218	4	4		0	-1.33597229					OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23	Microsource	01505187	-0.09666506	-0.66600888	-2.03627108	-1.33597229												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018200-12	Phenolphthalein	170465559	store-operated calcium entry Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77-09-8				4.5957817993	4	5		0	-1.01955307					Oc1ccc(cc1)C3(OC(=O)c2ccccc23)c4ccc(O)cc4	Vitas	STK029876	0.74513382	0.31129374	0.10990353	5.26698676	-1.01955307											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159376-04	Methylparaben	170465480	canonical glycolysis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	99-76-3				5.8207323083	4	4		0	0.19792182					Oc1ccc(cc1)C(=O)OC	Labotest	LTBB002210	3.52827453	0.46867292	-1.20903595	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183008-01	Israpafant	144206851	Interleukin-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	117279-73-9	ISRAPAFANT; 			-3.4435977405	4	4	6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-(2-(4-(2-methylpropyl)phenyl)ethyl)-;4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;Y 24180;CIPLUS_695838;(+/-)-4-(O-CHLOROPHENYL)-2-(P-ISOBUTYLPHENETHYL)-6,9-DIMETHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;israpafant;ISRAPAFANT;Israpafant;Y-24180;israpafantum;	0	-2.91934686					CC(C)Cc1ccc(cc1)CCc2cc5c(s2)n3c(C)nnc3C(C)N=C5c4ccccc4Cl	Pharmaron	PH-NIH-155125	-0.57999033	-0.71534287	1.27266942	-2.91934686												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00532514-01	FLUPENTIXOL DECANOATE		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-4.0928291388	4	4		0	0.52531041					CCCCCCCCCC(=O)OCCN1CCN(CC\C=C2/C3=CC=CC=C3SC4=CC=C(C=C24)C(F)(F)F)CC1	SynInnova	SL-1062	-1.21779859	-1.42423535	-0.54392168	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168776-03	Delavirdine	170464664	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	136817-59-9				-1.9726848313	4	4		0	-0.6127451					O=C(c1cc2cc(NS(C)(=O)=O)ccc2n1)N3CCN(CC3)c4ncccc4NC(C)C	Sequoia	147221-93-0	-0.68044355	1.8018018	-1.48293229	-0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091112-09	Methylrosaniline chloride	170464787	TNFR1 (p55/CD120a) Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	548-62-9	; Triple Dye; Basic Violet 3; ; Methyl violet 2B; Hexamethyl-p-rosaniline chloride (Gentian violet); Crystal Violet;GENTIAN VIOLET; Genapax; Methyl Violet 10B; Gentian violet; Crystal violet solution;Gentian violet			-3.6598294975	4	4		0	-3.16176471				TNFR1	[Cl-].C/[N+](C)=C1\C=C\C(C=C1)=C(/c2ccc(cc2)N(C)C)c3ccc(cc3)N(C)C	Microsource	01500315	0.32762097	-0.61776062	-2.43424734	-3.16176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016244-15	Isoniazid	170466877	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	54-85-3	 Isoniazid; Phthivazide;ISONIAZID; ;; Fintosid; Thiazina; Tubazide; Ftivazide; Pasiniazida;Isoniazid; Isoniazida; Isonex; Isonicotinic hydrazide			-3.4802353401	4	4		0	-0.90686274				CYP1A2	O=C(NN)c1ccncc1	Vitas	STK086288	-1.63810484	2.05920206	-0.08393956	-0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167518-09	Temsirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	162635-04-3				-8.6462267124	4	4		0	-2.18137255				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(C)(CO)CO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10906	-1.68850806	-1.38996139	-2.26636821	-2.18137255												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182996-01	Pamicogrel	144206832	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	101001-34-7	KBT-3022; 	11.220184543	-4.95	17.5113562121	4	4	KB-3022;KB 3022;pamicogrel;1H-Pyrrole-1-acetic acid, 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-, ethyl ester;LS-136537;CIPLUS_207912;PAMICOGREL;Pamicogrel;ETHYL 2-(4,5-BIS(P-METHOXYPHENYL)-2-THIAZOLYL)PYRROLE-1-ACETATE;pamicogrelum;ethyl 2-(4,5-bis(4-methoxyphenyl)thiazol-2-yl)pyrrol-1-ylacetate;KBT-3022;	24.211693548	19.53431373	0.1009492102	0.9936860968			O=C(OCC)Cn1cccc1c2nc(c(s2)c3ccc(OC)cc3)c4ccc(OC)cc4	Pharmaron	PH-NIH-151650	-0.17641129	1.64736165	3.16172356	19.53431373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167439-03	Trenbolone (acetate)		Progesterone receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	10161-34-9				-4.8775045531	4	4		0	-0.66176471					CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CCC4=C3/C=C\[C@]12C	MedChem Express	HY-12360	-1.48689516	0.30888031	-1.14717403	-0.66176471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182993-01	Betiatide	144206816		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	103725-47-9	Betiatide; 			0.8328122721	4	4	CIPLUS_762860;MP-600;BETIATIDE;THIOBENZOIC ACID, S-ESTER WITH N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE;Betiatide;betiatidum;N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE BENZOATE (ESTER);GLYCINE, N-(N-(N-((BENZOYLTHIO)ACETYL)GLYCYL)GLYCYL)-;betiatide;BENZOYLMERCAPTOACETYLGLYCYLGLYCYLGLYCINE;	0	1.7100763					O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1	Pharmaron	PH-NIH-137963	-0.24213075	0.10037641	-0.63339245	1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091666-04	1,8-Cineol	170465483	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	470-82-6				4.5679146947	4	4		0	0.71033938					CC2(C)OC1(C)CCC2CC1	Labotest	LT00440774	0.92009685	2.40903388	0.38003547	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160451-02	Ibufenac	170465922		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1553-60-2				-1.7198643405	4	4		0	0.92081031					CC(C)Cc1ccc(cc1)CC(=O)O	Enamine	Z104507406	-0.72639225	-1.10414053	-0.58272105	0.92081031												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016759-04	Naproxen sodium	170465301	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	26159-34-2	NAPROXEN(+); ; Naprosin; Synflex; Anaprox; 2   Dl-Naproxen;(S)-Naproxen; (S)-Naproxen; Proxen; Naproxeno; (R) -Naproxen sodium salt; (-)-Naproxen sodium; DL-Naproxen;Naproxen; Naprosyn; Aleve; Naproxen			4.1547863308	4	4		0	2.22662048			5743	PTGS2	[Na+].[O-]C(=O)[C@@H](C)c1ccc2cc(ccc2c1)OC	Microsource	01500425	0.19333011	0.12333498	1.20903595	2.22662048												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00348372-01	LINDANE		GABA-A receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	58-89-9				-1.8821311747	4	4		0	-0.24740228					[Cl][C@H]1[C@H]([Cl])[C@H]([Cl])[C@@H]([Cl])[C@H]([Cl])[C@@H]1[Cl]	SigmaAldrich	233390	-0.14499758	-1.06068081	-0.57270124	-0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167958-05	Imipenem	170464934	Penicillin-binding protein 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	64221-86-9				3.7930722821	4	4		0	1.58337457			945240	mrdA	O[C@H](C)[C@H]2C(=O)N1C(=C(C[C@@H]12)SCCNC=N)C(=O)O	Prestwick Chemical, Inc.	Prestw-519	1.25664572	-1.06068081	0.4454343	1.58337457												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179274-03	Tribenoside	170465999		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	10310-32-4				-3.9307316079	4	4		0	0.66857689					O[C@@H]2[C@@H](OCc1ccccc1)[C@H](O[C@H]2OCC)C(COCc3ccccc3)OCc4ccccc4	Prestwick	Prestw-1019	-0.98360656	-1.33084287	-1.41419636	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167433-05	Rocuronium bromide		Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	119302-91-9				-1.6529788357	4	4		0	2.00573066					CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C	MedChem Express	HY-17440	-1.07728337	0.67709549	-1.25101985	2.00573066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183285-15	Nilotinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	641571-10-0				12.1329869075	4	4		0	1.67144222				ABL1	CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC(=CC=N4)C5=CC=CN=C5)C(F)(F)F	Glixx	GLXC-90226	1.49882904	5.90707448	4.1881969	1.67144222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167574-03	Xaliproden hydrochloride	170465603	Serotonin 1a (5-HT1a) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	90494-79-4				-0.3504065355	4	4		0	0.36764706					Cl.FC(F)(F)c1cccc(c1)C4=CCN(CCc2cc3ccccc3cc2)CC4	Tocris	2491	-0.5796371	1.6988417	-0.47565753	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016561-05	Meticrane	170465801	Translocator protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1084-65-7				-1.8090935659	4	4		0	-1.00490196					NS(=O)(=O)c2cc1c(CCCS1(=O)=O)cc2C	Microsource	01506077	-0.32762097	0.1029601	-0.41969782	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018158-09	Doxazosin mesylate	170465395	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	77883-43-3	; Doxazosin Mesilate; Doxazosin mesylate salt;Doxazosin mesylate; Doxazosin mesilate; Doxazosin hydrochloride;DOXAZOSIN MESYLATE	12.5892541179	-4.9	81.5172528984	3	4		115.0095588257	100.6127451	0.0307730648	0.9994154789	148	ADRA1A	CS(=O)(=O)O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4	Microsource	01505976	1.13407258	3.24324324	1.65081142	100.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164551-05	Biapenem			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	120410-24-4				-1.734329988	4	4		0	0.31862745					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(\N2C1=O)C([O-])=O)/SC3C[N]4C=NC=[N+]4C3	MedChem Express	HY-13573	-1.28528226	-0.20592021	0.47565753	0.31862745												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00185750-01	Astromicin	144206938	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	55779-06-1				1.2280383547	4	4		0	0.71078431					NCC(=O)N(C)[C@H]2[C@@H](O)[C@H](O[C@H]1O[C@@H](CC[C@H]1N)[C@H](C)N)[C@@H](N)[C@H](O)[C@@H]2OC	Sequoia	ASTROMICIN SULPHATE	-0.02520161	0.66924067	0.41969782	0.71078431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378682-03	Pasireotide (ditrifluoroacetate)		Somatostatin receptor 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					2.6784832928	4	4		0	2.08333333					NCCCC[C@@H]1NC(=O)[C@@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@H](CN4C(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC6=CC=C(OCC7=CC=CC=C7)C=C6)NC1=O)OC(=O)NCCN)C8=CC=CC=C8	MedChem Express	HY-79135	-1.03326613	-0.41184041	4.44879687	2.08333333												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182622-03	EFLOXATE			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	119-41-5				-0.5439806502	4	4		0	-1.05392157					CCOC(=O)COC1=CC=C2C(=O)\C=C(/OC2=C1)C3=CC=CC=C3	Microsource	01504518	-0.32762097	-0.72072072	2.26636821	-1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018186-07	Procyclidine hydrochloride	170464805	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1508-76-5		14.1253754462	-4.85	22.3023178739	4	4		28	22.32843137	0.0605807005	0.9977364086			Cl.OC(CCN1CCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500507	1.03326613	2.21364221	2.04252938	22.32843137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015150-04	Betaine	174007375	Nitric Oxide (NO) Donors	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	590-46-5	Betaine-trimethyl-d9  hydrochloride; ;Betaine hydrochloride; Betaine hydrochloride;Betaine			-1.8014197641	4	4		0	-0.0245098					[Cl-].C[N+](C)(C)CC(=O)O	Selleck	S2580	-0.9828629	-0.05148005	1.09121433	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167480-02	N-Hydroxymethylsuccinimide	225144289		DPI_SARS-CoV-2_General	2019_NPC-5_CPE					2.7568964739	4	4		0	-0.12254902					OCN1C(=O)CCC1=O	Innovapharm	BBS-00004790	0.02520161	0.20592021	3.77728036	-0.12254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091034-10	Captan	225144202		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	133-06-2				-0.8205729777	4	4		0	-0.07352941					ClC(Cl)(Cl)SN1C(=O)C2C\C=C/CC2C1=O	SIGMA	32054	0.02520161	-0.82368082	-0.36373811	-0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249917-01	Cloxazolam	170465787	GABA-A receptor; benzodiazepine site Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	24166-13-0				2.5410688086	4	4		0	0.95588235					Clc1ccccc1C34OCCN4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-177	-0.93245968	3.80952381	2.21040851	0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			7.2586755242	4	4		0	1.5522231				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	1.1622276	1.25470514	2.40689131	1.5522231												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263530-01	Lafutidine	170465978	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	118288-08-7				-0.4872853822	4	4		0	-0.19792182				HRH2	O=S(CC(=O)NC/C=C\COc2cc(CN1CCCCC1)ccn2)Cc3ccco3	Sequoia	SRP01115l	0.04833253	-0.41933892	-0.06363347	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00168774-02	Rasagiline mesylate	170465410	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	161735-79-1	 ; Azilect; N-2-propynyl-1-indanamine;Rasagiline mesylate; Rasagiline mesylate			2.7401173703	4	4		0	0.24740228			4129	MAOB	CS(=O)(=O)O.C#CCN[C@@H]2CCc1ccccc12	Tocris	4308	2.02996617	-0.51800691	-0.8908686	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164615-02	Prulifloxacin	170465849	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	123447-62-1	 ;Prulifloxacin; Prulifloxacin; Sword			-0.5642421577	4	4		0	3.61207323					CC=5OC(=O)OC=5CN1CCN(CC1)c2cc3c(cc2F)C(=O)C(=C4SC(C)N34)C(=O)O	Bosche	P2859	-1.01498308	-1.1100148	-1.78173719	3.61207323												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090987-05	1-Naphthaleneacetic acid	170466030	Fusarium oxysporum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	86-87-3				-1.5802993501	4	4		0	-0.84116774					O=C(O)Cc2cccc1ccccc12	Specs	AE-562/J257199	-0.77332044	-0.32067094	0.95450207	-0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00386194-01	Clindamycin palmitate HCl		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	25507-04-4				-5.2547754109	4	4		0	-1.14613181					CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C2CC(CCC)CN2C)C(C)Cl	Selleck	S2596	-1.17096019	-1.1440579	-0.87027468	-1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390804-01	Goserelin (acetate)		LNCaP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	145781-92-6				2.6822234357	4	4		0	0.6127451					CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@H](CC4=CN=C[NH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O	MedChem Express	HY-13673A	0.37802419	0.72072072	0.97929491	0.6127451												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00161336-01	Potassium ricinoleate	26754911	Prostanoid EP3 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE		Ricinoleic acid; 12-Hydroxyoleic acid; 			-3.9085548057	4	4	ricinelaidic acid;ricinoleic acid, (R-(E))-isomer;LS-195;12-oxooctadecanoic acid;Ricinoleic acid;RICINOLEIC ACID, SODIUM SALT;CIPLUS_658255;CIPLUS_680366;12-hydroxy-9-octadecenic acid;CIPLUS_750550;RICINOLEIC ACID;CIPLUS_671898;CIPLUS_166631;12-hydroxy-9-octadecenoic acid;CIPLUS_151987;CIPLUS_663822;CIPLUS_3886623;Ricinelaidic acid sodium salt;(R)-12-Hydroxy-9(E)-octadecenoic acid;kyselina 12-hydroxy-9-oktadecenova (czech);12-Hydroxyoleic acid;CIPLUS_661801;CIPLUS_164143;12-ketostearate;CIPLUS_689393;(R)-12-Hydroxy-cis-9-octadecenoic acid;Potassium ricinoleate;CIPLUS_686506;ricinoleic acid;CIPLUS_689370;CIPLUS_664600;LS-143811;HSDB 4280;CIPLUS_684810;POTASSIUM RICINOLEATE;CIPLUS_666567;12-HYDROXY-9-OCTADECENOIC ACID;	0	0.17156863					CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O	BIOMOL	BIOMOL_AL-112	-0.88205645	-0.56628057	-1.98656967	0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274082-01	Sodium dodecyl sulfate	170465474		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	151-21-3				-3.263258154	4	4		0	-2.08333333					[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC	SIGMA	61749	-1.13407258	0.05148005	1.65081142	-2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014925-06	Topotecan hydrochloride	170465137	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	119413-54-6	; Hycamtamine; Topotecane; Nogitecan hydrochloride;Nogitecan hydrochloride/NSC-609699;Topotecan hydrochloride; Topotecan hydrochloride;TOPOTECAN HYDROCHLORIDE; Nogitecan Hydrochloride; Hycamtin			-7.5262298588	4	5		0	-2.19066937			7150	TOP1	Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O	Prestwick	Prestw-1196	-1.05006105	-1.4664981	-1.87515421	-2.29720029	-2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015966-10	Levosulpiride	170465834	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	23672-07-3	(?)-Sulpiride;SULPIRIDE; Sulpirida; Dogmatyl; Levosulpirida; Sulpiride (+/-)-; (?)-Sulpiride; (-)-Sulpiride;Sulpiride; (RS)-(+/-)-Sulpiride;(RS)-(+/-)-Sulpiride;(RS)-SULPIRIDE; ; (S)-(-)-Sulpiride			-0.2848793574	4	5		0	1.29817444			1813	DRD2	CCN2CCC[C@H]2CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	Prestwick	Prestw-56	-0.07326007	-0.8596713	-0.78953861	0.04785834	1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014670-17	Domperidone	170465594	Dopamine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57808-66-9	 ; Motilium; 5   Domperidone; Prestwick-06G02;Domperidone; Domperidona; Domperidone; TFMP domperidone;DOMPERIDONE; Domperidone Maleate (1:1)	12.5892541179	-4.9	16.1300640336	4	5		28.4102401999	24.25963489	0.0009704614	0.9995154018	1812	DRD1	Clc4cc5NC(=O)N(C3CCN(CCCN1c2ccccc2NC1=O)CC3)c5cc4	Microsource	02300212	-0.46398046	-0.7585335	-0.44411547	-0.43072505	24.25963489											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015061-13	Aciclovir	170464640	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59277-89-3	; ; Acyclovir Sod; Zovirax; Acycloguanosine;ACYCLOVIR; ACVbetaglc; Acyclovir;Acyclovir; Acyclovir-side chain-2-3H; Zovirax sodium			3.8249723426	4	5		0	3.0020284					NC2=Nc1c(ncn1COCCO)C(=O)N2	Microsource	01503603	0.9035409	0.4045512	-0.44411547	-0.09571668	3.0020284											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023037-08	Pancuronium bromide	225144191	Steroid non-depolarizing Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	15500-66-0	; ;Pancuronium bromide; Pancuronium bromide; Bromide, Pancuroniu; Pancuronium Organon; Pancuronium dibromide; Pancuronium Curamed; Bromuro de pancuronio; Pavulon			3.4452025324	4	5		0	3.0831643					CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6	Prestwick	Prestw-1034	0.31746032	-0.5562579	0.19738465	1.14860014	3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348375-01	TILMICOSIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	108050-54-0				-0.8752720306	4	5		0	1.78498986					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN3C[C@H](C)C[C@H](C)C3)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33864	-1.0989011	-0.2528445	-1.33234641	1.3400335	1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181031-03	Hydroxycitronellal	225144317	Transient receptor potential cation channel subfamily M member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	107-75-5				-0.1926161982	4	4		0	0.76295712					CC(CCCC(C)(C)O)CC=O	SIGMA	82934	-0.53268765	-0.40150565	0.22802128	0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016866-11	Pipemidic acid	170465767		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51940-44-4				-1.9399455047	4	4		0	1.34175217					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCNCC3	Microsource	01502024	-1.0653753	-1.10414053	-0.63339245	1.34175217												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167521-02	Tenatoprazole	170465931	Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	113712-98-4				-3.4068785476	4	4		0	-0.86819258				IDO1	Cc3c(OC)c(C)cnc3CS(=O)c1nc2nc(ccc2n1)OC	Sequoia	SRP011927t	-1.30750605	0.45169385	-0.32936407	-0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015754-16	Nilutamide	170465021	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	63612-50-0	 ;Nilutamide; Nilutamide;NILUTAMIDE; Nilandron			-3.2241774467	4	4		0	-0.97342805			374	AR	FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O	Microsource	01504152	-0.8716707	-0.05018821	-0.48137826	-0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023945-12	3'-Azido-3'-deoxythymidine	170464737	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	30516-87-1	3'-Azido-3'-deoxythymidine; ; 3'-Azido-3'-deoxythymidine (AZT); Zidovudine, AZT;; 3'-Azido-3'-deoxythymidine; Antiviral AZ; AZT Antiviral; Retrovir; AZTMP-MAN-SA conjugate; 3' Azido 3' deoxythymidin; bis(t-butyl-SATE)-AZTMP; zidovudine (ZDV or AZT);Zidovudine; AZT, Antiviral;Zidovudine, AZT;ZIDOVUDINE [AZT]			9.0460819539	4	4		0	3.07813733			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2	Vitas	STK801891	1.59806295	1.85696361	1.34279199	3.07813733												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159383-04	Propyl benzoate	170465563		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2315-68-6				-0.3299918735	4	4		0	-0.29688273					O=C(OCCC)c1ccccc1	Labotest	LTBB003527	-0.48332528	-1.1100148	1.59083678	-0.29688273												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016523-05	Iodipamide	170464888	Complement factor B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	606-17-7				2.256115918	4	4		0	0.69272637					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Prestwick Chemical, Inc.	Prestw-939	0	0.51800691	1.08176901	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164552-06	Bromfenac Na			DPI_SARS-CoV-2_General	2019_NPC-3_CPE					-1.3688100631	4	4		0	0.59376546					NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	Sequoia	SRP034005b	-0.82165297	0.91267884	-1.08176901	0.59376546												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179250-03	Halofantrine	170465140	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	36167-63-2	; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine	11.220184543	-4.95	64.1602570533	3	4		103.60639383	86.91499522	0.0072087896	0.9999679486			Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F	Prestwick Chemical, Inc.	Prestw-1031	-0.98360656	-1.1440579	3.58988306	86.91499522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016384-15	Sulfisoxazole	170464636	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	127-69-5	; ;SULFISOXAZOLE; Sulfisoxazole; Sulfafurazole(SIZ);Sulfisoxazole			4.4697511159	4	5		0	0.48681542					Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C	Microsource	01500555	1.24542125	1.011378	0.88823094	0.67001675	0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094557-06	2-Chloro-4-nitrobenzamide	170466191		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3011-89-0				1.071366801	4	5		0	-1.37931034					O=C(N)c1ccc(cc1Cl)[N+]([O-])=O	Vitas	STK061509	0.46398046	-1.1125158	2.17123119	0.71787509	-1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025345-02	Atomoxetine hydrochloride	170465067	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	82248-59-7				1.6469288442	4	5		0	4.38133874			24409		Cl.Cc2ccccc2O[C@H](CCNC)c1ccccc1	Tocris	2011	-0.26862027	0.2022756	-1.57907723	-0.2392917	4.38133874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249913-01	Isoniazid pyruvate	170465758	Isocitrate lyase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1081-50-1				-0.9036269066	4	5		0	0.56795132					O=C(N\N=C(\C)C(=O)O)c1ccncc1	GVK	FFS-11-286-NCI-164	0.12210012	-1.3147914	0	-0.90930845	0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159324-04	2-Ethylhexyl salicylate	170465498		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	118-60-5				-3.2193543003	4	5		0	-0.89249493					Oc1ccccc1C(=O)OCC(CC)CCCC	Bosche	E1869	0.02442002	-1.6182048	-1.33234641	-0.76573343	-0.89249493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095264-04	Chloroxine	170465084	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	773-76-2	; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine	12.5892541179	-4.9	62.2036718039	3	5		94.7936817316	85.27383367	0.0000756083	0.9999622001			Oc1c(Cl)cc(Cl)c2cccnc12	Vitas	STK075368	-0.26862027	-0.505689	-0.5428078	-0.43072505	85.27383367											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016255-10	SULFINPYRAZONE	170464677	Canalicular Multispecific Organic Anion Transporter 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	57-96-5				1.5797136162	4	5		0	3.0831643					O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1	Microsource	01500554	0.36630037	-1.5676359	-0.34542314	-0.09571668	3.0831643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091501-06	Resorcinol	170465462	leukotriene B4 biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	108-46-3				2.2652010617	4	5		0	4.86815416					Oc1cccc(O)c1	Specs	AE-562/J255633	0.41514042	-1.517067	-0.59215396	-0.95716679	4.86815416											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015659-14	Mexiletene hydrochloride	170464740		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5370-01-4				5.2157298796	4	5		0	4.38133874					Cl.CC(N)COc1c(C)cccc1C	Microsource	01503929	0.65934066	-1.1125158	1.13496176	1.00502513	4.38133874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090965-07	Propyl-4-hydroxybenzoate			DPI_SARS-CoV-2_General	2019_NPC-1_CPE	94-13-3				-0.2719680712	4	5		0	-0.16227181					CCCOC(=O)C1=CC=C(O)C=C1	SigmaAldrich	P53357	0.85470085	-1.4664981	-0.39476931	-0.62215841	-0.16227181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094571-08	Crotamiton	170464851	antipruritic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	483-63-6	; Eurax;CROTAMITON;Crotamiton; ; CROTAMITON; 7   Crotamiton; Veteusan			1.060797843	4	5		0	0.97363083					CCN(C(=O)C=CC)c1ccccc1C	Microsource	01505271	0.75702076	-0.9608091	0.09869233	-0.67001675	0.97363083											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183881-09	Moxifloxacin hydrochloride		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	186826-86-8				-1.012672845	4	4		0	-1.36416185				TOP2B	COC1=C(N2C[C@@H]3CCCN[C@@H]3C2)C(=CC4=C1N(\C=C(\C(O)=O)C4=O)C5CC5)F	MedChem Express	HY-66011	0.05141388	-0.65172054	0.4738089	-1.36416185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386382-03	Lurasidone (Hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	367514-88-3		14.1253754462	-4.85	7.379991226	4	4		16.3844432719	13.01734104	0.0595977337	0.9978184246			O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)C6=NSC7=C6C=CC=C7	MedChem Express	HY-B0032	-0.66838046	-0.18248175	-0.73703606	13.01734104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014617-01	Benzylhydrochlorothiazide	144203604		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1824-50-6	Benzylhydrochlorothiazide; Behyd; BHCTh; 			1.1459177224	4	4	6-Chloro-3,4-dihydro-3-(phenylmethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;Behyd;Benzylhydrochlorothiazide;LS-40438;BENZYLHYDROCHLOROTHIAZIDE;BHCTh;CIPLUS_208144;benzylhydrochlorothiazide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(phenylmethyl)-, 1,1-dioxide;	0	0.16184971					NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)Cc2ccccc2)cc3Cl	NCI		0.20565553	-0.44316997	1.15819953	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016605-08	Nifenazone	170466050		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2139-47-1				-0.2604554368	4	4		0	2.49934228					O=C3C(NC(=O)c1cccnc1)=C(C)N(C)N3c2ccccc2	Microsource	01503230	-1.40435835	-0.15056462	-0.27869268	2.49934228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015256-12	Chloroquine	170464753	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-63-5	 ;Chloroquine (CQ); Chloroquine (CQ); Aralen hydrochloride;Chloroquine Diphosphate; Aralen; Chloroquine Sulphate; Cloquiante; Contramibial;Arequin; Cloroquina; Khingamin; Chlorochin; Arechine; Aralen phosphate; Cloquinato; Chingamin;Chloroquine diphosphate; ChloroquineSulphate; Sulfate, Chloroquin; Sulphate, Chloroquin	3.9810717055	-5.4	139.7114654783	3	4		116.6121546915	98.15837937	0.0068766359	0.9999708332			O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Specs	AN-153/J116554	0.43583535	0.05018821	1.69749177	98.15837937												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00073457-04	Metomidate hydrochloride	170466159	Cytochrome P450 2A5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	35944-74-2				7.7357646839	4	4		0	3.28860826					Cl.CC(c1ccccc1)n2cncc2C(=O)OC	Vitas	STK331722	2.51815981	0.25094103	-0.68406385	3.28860826												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016509-06	Trimethobenzamide hydrochloride	170465132	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	554-92-7				0.1510788973	4	4		0	2.52350322					Cl.COc1c(cc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2)OC	Microsource	01500594	-1.25664572	-0.12333498	-0.19090041	2.52350322												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263906-02	Rolitetracycline	170465919		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	751-97-3				-2.3407020684	4	4		0	-0.19792182					O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O	Microsource	01505684	-1.15998067	1.94869265	-1.27266942	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094561-06	Phenothrin	170465585		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	26002-80-2				-3.1794002322	4	4		0	-1.48441366					C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C	Microsource	01504098	-0.43499275	0.27133695	-0.8908686	-1.48441366												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182981-01	Proxazole citrate	144206776		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	132-35-4	Proxazole; Proxazol; 			-3.2695842487	4	4	CIPLUS_151746;proxazole, (+)-isomer;Proxazole;LS-99108;PROXAZOLE;pirecin;Proxazole citrate;LS-175790;3 alpha-phenylpropyl-5 beta- diethylaminoethyl-1,2,4-oxadiazole;proxazole, (+-)-isomer;3-(alpha-ethylbenzyl)-5-(2-diethylaminoethyl)- 1,2,4-oxadiazole;toness;CIPLUS_210763;Proxazol;Proxazole Citrate;N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate;Proxazolum;CIPLUS_177396;CIPLUS_177395;CIPLUS_177394;proxazolum;propazoline;proxazole, (-)-isomer;Toness;PROXAZOLE CITRATE;1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate;proxazole;	0	0.04775549					CCC(c1nc(CCN(CC)CC)on1)c2ccccc2.O=C(O)C(O)(CC(=O)O)CC(=O)O	NCI	NSC_303872	-1.07728337	-0.30352557	-0.48952951	0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182063-03	Cadralazine	170466021		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	64241-34-5				1.9491771892	4	4		0	1.14613181					O=C(OCC)NNc1ccc(nn1)N(CC(C)O)CC	Kemprotec	64241-34-5	0.74941452	-0.95727294	-0.21756867	1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021145-11	Loxapine succinate	170465094	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	27833-64-3		10	-5	28.8708430644	3	5		48.1377540847	42.59634888	0.0010097854	0.9994950606	1128	CHRM1	O=C(O)CCC(=O)O.CN1CCN(CC1)C3=Nc4ccccc4Oc2ccc(Cl)cc23	Microsource	02300242	-0.9035409	-1.8710493	-0.78953861	0.81359177	42.59634888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095175-08	Cefditoren (Pivoxil)		Cephalosporin Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	117467-28-4				7.294131629	4	4		0	4.69364162					[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C4=CSC(N)=N4)C(=O)OCOC(=O)C(C)(C)C	MedChem Express	HY-17452A	1.38817481	-0.28675704	0.6317452	4.69364162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-05	Apixaban		Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	503612-47-3				3.5346167261	4	4		0	0.85549133				F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	APExBIO	A4341	0.92544987	0.2346194	0.52645433	0.85549133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179867-02	NCGC00179867-02			DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-2.8744113423	4	4		0	-1.22543353					O[C@@H]1[C@@H](COC(=O)C2=CC(=C(O)C(=C2)O)O)O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O)[C@H]1OC(=O)C4=CC(=C(O)C(=C4)O)O	Analyticon	NP-005114	-0.61696658	-0.49530761	-0.05264543	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386545-01	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	126544-47-6				4.9743393366	4	4		0	8.95895896				NR3C1	CC(C)C(=O)OCC(=O)[C@@]12OC(O[C@@H]1C[C@H]3[C@@H]4CCC\5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	Axon Medchem	1426	-0.8110687	-0.96656217	1.46635245	8.95895896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013037-01	Thanite	144203555		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	115-31-1	isobornyl thiocyanoacetate; 			-2.0942362977	4	4	CIPLUS_151404;isobornyl thiocyanoacetate;CIPLUS_745354;ISOBORNYL THIOCYANOACETATE;thanite;isobornyl thiocyanoacetate, (exo)-isomer;	0	-0.3003003					N#CSCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C	NCI		-0.09541985	-1.69801463	-0.62843676	-0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263129-08	Palbociclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	571189-11-2				-6.5531297132	4	4		0	-2.4024024				CDK4	CC(=O)C\1=C(/C)C2=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N=C2N(C5CCCC5)C1=O	Axon Medchem	1505	-1.52671756	-0.80982236	-0.41895784	-2.4024024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181911-01	Bucolome	144206890	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	841-73-6	Bucolome; Bucolom; Paramidine; Paramidin; Bucolomo; 			-1.7441985415	4	4	Paramidine;2,4,6(1H,3H,5H)-Pyrimidnetrione, 5-butyl-1-cyclohexyl-;Barbituric acid, 5-butyl-1-cyclohexyl-;bucolome;CIPLUS_156649;LS-23912;Bucolomo;Paramidin;Bucolomum;Bucolome;bucolomum;1-cyclohexyl-5-butylbarbituric acid;Bucolom;BUCOLOME;CIPLUS_165895;	0	0.49986846					O=C2C(CCCC)C(=O)NC(=O)N2C1CCCCC1	Pharmaron	PH-NIH-95	-0.7748184	-0.50188206	-0.48137826	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00096056-02	Ethacridine lactate hydrate	170465798		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	6402-23-9				-1.9573990117	4	4		0	-0.23677979					O.O=C(O)C(C)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	Labotest	LT00244813	0.14527845	-1.10414053	-1.14010641	-0.23677979												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015771-13	Orphenadrine dihydrogen citrate	170464910	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	4682-36-4	; ; Mebedrol; Norgesic forte; Orphenadrine citrate salt; Orfenadrina; Orphenadrine Hcl;ORPHENADRINE CITRATE;Orphenadrine dihydrogen citrate; Orphenadrine hydrochloride;Orphenadrine hydrochloride	3.1622776602	-5.5	35.8244351485	3	4		32.062407504	31.7169718	0.0271269172	0.9995464115		CHRM1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C	Microsource	01500447	0.33832769	-0.46867292	0.69996818	31.7169718												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016526-07	Berberine	170465752	Protein Tyrosine Phosphatase (PTP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	633-65-8	 ; Natural Yellow- 18; Berberine bisulfate; Berberine chloride form; Erben; Umbellatine; Berberine sulphate;Berberine chloride; Berberine chloride; 0   Berberin Sulfate;BERBERINE CHLORIDE; Kyoberin; Natural Yellow 18; Berberine Tannate			-0.3155408253	4	4		0	0.69272637			7803	PTP4A1	[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC	Labotest	LT00440956	-0.04833253	-0.07400099	-0.8908686	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016978-04	Repaglinide	225144184	Insulin Secretagogues	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	135062-02-1	; ; Prandin; Repaglinide;Repaglinide; Repaglinida; Novonorm			7.0825262899	4	4		0	3.46363187				INS	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	Prestwick	Prestw-1046	1.739971	0.27133695	-0.12726694	3.46363187												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093350-05	Amikacin	174006656	30S ribosomal protein S12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	37517-28-5				-2.5018463853	4	4		0	-0.52531041					NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O	Vitas	STK039706	-1.264637	-0.02334812	-0.48952951	-0.52531041												1.6E-9	8E-9	4E-8	2E-7											
NCGC00182980-01	Fominoben hydrochloride	144206774		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	24600-36-0	Fominoben; Noleptan; 			-1.739166829	4	4	Fominoben;fominoben;Noleptan;VNC-3;LS-173706;fominobene;CIPLUS_3734982;fominobenum;Fominobenum;3'-CHLORO-1-(METHYL((MORPHOLINOCARBONYL)METHYL)-AMINO)-O-BENZOTOLUIDIDE;Fominobene;FOMINOBEN;CIPLUS_171289;PB-89;	0	-0.66857689					Cl.O=C(CN(C)Cc2c(NC(=O)c1ccccc1)cccc2Cl)N3CCOCC3	NCI	NSC_293901	-0.51522248	0.16343684	-0.05439217	-0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274275-01	Tripamide	170466047	Solute carrier family 12 member 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	73803-48-2				6.4848241062	4	4		0	1.54913295					NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN3C[C@@H]4C2CC[C@@H](C2)[C@@H]4C3	GVK	FFS-11-286-NCI-189	0.87403599	2.11157456	2.31639905	1.54913295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167452-03	Pirenoxine Sodium	225144286	maintenance of lens transparency Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	51410-30-1				-3.0383422131	4	4		0	-1.22543353					OC1=C2C(=NC(=C1)C([O-])=O)C(=O)/C=C\3OC4=CC=CC=C4\N=C23	Bosche	P6175	-0.82262211	0.49530761	-0.52645433	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183001-01	Tolvaptan	124894207	Vasopressin (AVP) V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	150683-30-0	 ; Tolvaptan;Tolvaptan			-3.4838969245	4	4	OPC 41061;OPC-41061;7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;tolvaptan;TOLVAPTAN;Tolvaptan;7-CHLORO-5-HYDROXY-1-(2-METHYL-4-(2-METHYLBENZOYLAMINO)BENZOYL)-2,3,4,5-TETRAHYDRO-1H-BENZAPINE, DL-;CIPLUS_789421;tolvaptanum;	0	0.16184971			554	AVPR2	Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34	Pharmaron	PH-NIH-116369	-1.49100257	-0.02606882	0.3158726	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387997-02	ValganciclovirHCl		Viral Dna Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	175865-59-5				1.8857917289	4	4		0	1.31791908					CC(C)[C@H](N)C(=O)OCC(CO)OC[N]1C=NC2=C1N\C(=N/C2=O)N	Enzo	AC3286	-0.51413882	1.85088634	1.31613583	1.31791908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483046-01	SCE 2174			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	95789-30-3				1.1587757268	4	4		0	2.55255255					CC(OC(=O)OC1CCCCC1)OC(=O)\C2=C(CS[C@@H]3[C@H](NC(=O)CC4=CSC(=N4)N)C(=O)N23)/CSC5=NN=N[N]5CCN(C)C	DC Chemicals	DC9200	0	-0.80982236	-0.26184865	2.55255255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181785-03	Aprepitant			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	170729-80-3				4.2407537762	4	4		0	-0.95095095					C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	Prestwick	Prestw-1600	2.29007634	-0.23510972	-1.04739461	-0.95095095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164626-02	Tiagabine hydrochloride	170465153	GAT-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	145821-59-6				-2.5963629397	4	4		0	-0.5005005				SLC6A1	Cl.Cc3ccsc3C(=C\CCN1CCC[C@H](C1)C(=O)O)\c2sccc2C	Sequoia	SRP023505t	-1.04961832	-0.28735632	0.94265515	-0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182026-02	Tiludronate disodium salt hydrate	225144329	Osteoclasts Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	89987-06-4				-4.4856667557	4	4		0	-1.45145145					O[P]([O-])(=O)C(SC1=CC=C(Cl)C=C1)[P](O)([O-])=O	SIGMA	T4580	-0.14312977	-1.38453501	0.78554595	-1.45145145												1.6E-9	8E-9	4E-8	2E-7											
NCGC00159502-03	N-Cyclohexyl-2-benzothiazolesulfenamide	29215472	Aryl hydrocarbon receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE		N-cyclohexyl-2-benzothiazylsulfenamide; 			-6.8007690599	4	4	N-Cyclohexyl-2-benzothiazolesulfenamide;N-CYCLOHEXYLBENZOTHIAZYLSULFENAMIDE;N-cyclohexyl-2-benzothiazylsulfenamide;CIPLUS_150281;N-cyclohexyl-2-benzothiazyl sulfenamide;N-cyclohexyl-2-benzothiazolesulfenamide;thiohexam;	0	-1.7017017					C1CCC(CC1)NSC2=NC3=CC=CC=C3S2	SigmaAldrich	S365971	-1.43129771	-1.85475444	-0.94265515	-1.7017017												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00183599-01	NCGC00183599-01	124894454		DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-6.5153277443	4	4	CIPLUS_736638;Uvinul-T-150;Uvinul T150;octyl triazone;CIPLUS_741452;Uvinul T 150;	0	-0.9009009					CCCCC(CC)COC(=O)C1=CC=C(NC2=NC(=NC(=N2)NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)NC4=CC=C(C=C4)C(=O)OCC(CC)CCCC)C=C1	USP	1265537	-1.6221374	-1.48902821	-0.94265515	-0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165791-04	Epinastine hydrochloride	170465284	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	108929-04-0				-1.0315359554	4	4		0	-1.45145145					Cl.NC2=NCC3c4ccccc4Cc1ccccc1N23	SIGMA	E5156	0	0.96656217	-0.89028542	-1.45145145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016912-06	Terconazole			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	67915-31-5				-3.7568315246	4	4		0	-2.95295295					CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2	Prestwick	Prestw-495	-0.71564885	-1.95924765	2.35663786	-2.95295295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016902-04	Etifenin	170466635		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63245-28-3				-0.9272342267	4	4		0	1.63631565					O=C(Nc1c(cccc1CC)CC)CN(CC(=O)O)CC(=O)O	Prestwick Chemical, Inc.	Prestw-504	-0.82391714	-0.69589422	-0.674946	1.63631565												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253581-01	Indomethacin farnesil	170466014		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	85801-02-1				1.404843572	4	4		0	0.26392188					Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)c3C)OC	GVK	FFS-11-286-NCI-252	0.07062147	1.04384134	0.24298056	0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159368-05	1-Hexadecanol	170465348	Fatty aldehyde dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	36653-82-4				-5.0375306172	4	4		0	-2.00580628			224	ALDH3A2	CCCCCCCCCCCCCCCCO	Labotest	LTBB001504	-0.58851224	-1.80932498	-0.45896328	-2.00580628												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249892-01	Lexiscan	170465244	Adenosine A2a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	313348-27-5				-0.572075533	4	4		0	-0.79176564					CNC(=O)c1cn(nc1)c2nc(N)c3ncn(c3n2)[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O	GVK	FFS-11-286-NCI-48	-0.11770245	0.69589422	0.02699784	-0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013687-03	Pyrophosphoric acid			DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2466-09-3				1.1929989392	4	4		0	-0.63341251					O[P](O)(=O)O[P](O)(O)=O	SIGMA	433314	1.71845574	-0.76548365	-0.72894168	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015513-11	Histamine dihydrochloride	170465001	Histamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-45-6	Histamine dihydrochloride;Histamine;HISTAMINE DIHYDROCHLORIDE;HISTAMINE; Histamine dihydrochloride			-1.64368016	4	4		0	-0.79168728			9704	HRH1	NCCc1cncn1	Vitas	STK346752	-0.43499275	-0.81401085	0.57270124	-0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00351603-13	Ceritinib		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1032900-25-6		10	-5	66.6811917917	3	4		94.7604329543	89.06399236	0.0069143877	0.999970513		ALK	CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4	MedChem Express	HY-15656	-0.56206089	-0.07004436	2.28447104	89.06399236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182030-01	Sulbenicillin disodium	144206509		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	28002-18-8	Sulbenicillin; Lilacillin; I.M., Kedacilli; Sulbenicilina; Kedacillin I.M.; 			-2.5548797413	4	4	Hormona Brand of Sulbenicillin Sodium Salt;Disodium alpha-Sulfobenzylpenicillin;CIPLUS_711187;Sulbenicillin;alpha-Sulfobenzylpenicillin, Disodiu;Sulbenicillin sodium;Sulbenicillinum;SULBENICILLIN SODIUM;Sulbenicilina;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylsulfoacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-;sulbenicillinum;I.M., Kedacilli;CIPLUS_180114;Disodium alpha Sulfobenzylpenicilli;SULBENICILLIN;Sulbenicilline;LS-174908;Sulbenicillin Sodium;Kedacillin I.M.;Lilacillin;sulbenicilline;	0	-0.23877746					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)S([O-])(=O)=O)[C@H]3SC2(C)C	ACC	SULBENICILLIN DISODIUM	-0.70257611	-1.05066542	0.21756867	-0.23877746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178214-04	BENZALKONIUM CHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	8001-54-5				-2.2479537681	4	4		0	-2.33526012					CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1	Microsource	01503610	0.15424165	-0.75599583	-0.52645433	-2.33526012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164554-06	Mupirocin			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	12650-69-0				-2.7016664637	4	4		0	0.48554913					C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O	Prestwick	Prestw-1795	-0.71979434	-0.91240876	-0.84232693	0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182074-03	Nicomolol	170465790	Cholesterol biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	27959-26-8				16.2165167317	4	4		0	7.56069364			311849		O=C(OCC4(COC(=O)c1cccnc1)CCCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)C4O)c5cccnc5	Kemprotec	27959-26-8	2.10796915	3.57142857	3.84311661	7.56069364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179612-03	Neomycin sulfate	225144310	30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1405-10-3				0.2493881743	4	4		0	-0.8008008					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O	Prestwick	Prestw-158	1.0019084	-0.39184953	0.5236973	-0.8008008												1.6E-8	8E-8	4E-7	0.000002											
NCGC00185743-02	Cloflucarban	170465550		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	369-77-7				21.211629923	4	4		0	4.05405405					FC(F)(F)c1cc(ccc1Cl)NC(=O)Nc2ccc(Cl)cc2	Enamine	Z124030490	2.52862595	4.51933124	12.25451689	4.05405405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250406-02	Tipifarnib		Farnesyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	192185-72-1				6.9302864473	4	4		0	0.95095095				COX10	C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3	Selleck	S1453	1.66984733	1.80250784	0.99502488	0.95095095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510931-01	Mavacoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	170569-88-7				-2.1159214817	4	4		0	1.25125125					N[S+]([O-])(=O)C1=CC=C(C=C1)[N]2N=C(C=C2C3=CC=C(F)C=C3)C(F)(F)F	SantaCruz Bio	sc-488033	-1.0019084	-0.91431557	0.20947892	1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378902-03	Toceranib		VEGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	[356068-94-5]				-2.1396934217	4	4		0	0.95095095				FLT1	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4	Tocris	3909	-1.33587786	-0.33960293	0.15710919	0.95095095												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00160575-01	Uracil mustard	144205464	DNA Interacts	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	66-75-1	Uracil Mustard; Uramustina; Uracil Mustard Capsules; Mustard, Uraci; 			-3.0942060235	4	4	5-(Bis(2-chloroethyl)amino)-2,4-(1H,3H)pyrimidinedione;URACIL MUSTARD;LS-285;Uramustina;Mustard, Uraci;uramustinum;uramustine;URAMUSTINE;Uramustine;Uracil Mustard;CIPLUS_149101;2,4(1H,3H)-PYRIMIDINEDIONE, 5-(BIS(2-CHLOROETHYL)AMINO)-;2,4(1H,3H)-Pyrimidinedione, 5-(bis(2-chloroethyl)amino)-;Uracil Mustard Capsules;5-(BIS(2-CHLOROETHYL)AMINO)URACIL;Uracil mustard;Uramustinum;	0	-0.9009009					O=C1NC(=O)NC=C1N(CCCl)CCCl	SigmaAldrich	S375063	-0.66793893	-1.01880878	-0.10473946	-0.9009009												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164253-04	LITHIUM CITRATE			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	6080-58-6, 919-16-4 [anhydrous]				1.1182260713	4	4		0	-0.39590126					OC(CC([O-])=O)(CC([O-])=O)C([O-])=O	Microsource	01504269	0.85492228	-0.99951243	-0.10067959	-0.39590126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181096-01	Chlophedianol	144206265		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	791-35-5	CHLOPHEDIANOL HYDROCHLORIDE; Coldrin; Baltix; 			-3.7991452468	4	4	sl 501;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)- .ALPHA.-PHENYL;CHLOPHEDIANOL;Clofedanol hydrochloride;2-chloro-alpha-(2-dimethylaminoethyl)benzhydrol;clofedanol;Clofedanolum;clofedanol hydrochloride;Baltix;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL;2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZHYDROL HYDROCHLORIDE;CIPLUS_660723;chlophedianol;CLOFEDANOL;CHLOPHEDIANOL HYDROCHLORIDE;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-.ALPHA.-PHENYL-, HYDROCHLORIDE;Coldrin;1-Phenyl-1-(o-chlorophenyl)-3-dimethylaminopropanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-, hydrochloride;Chlophedianol;Clofedanol Hydrochloride;chlophendianol hydrochloride;clofedanolum;Clofedanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-;CIPLUS_156451;Chlophedianol hydrochloride;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL HYDROCHLORIDE;LS-32307;LS-32306;	0	-1.5137401					OC(CCN(C)C)(c1ccccc1Cl)c2ccccc2	NCI	NSC-113595	-0.44041451	-0.99951243	-1.20815505	-1.5137401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167537-02	Donepezil hydrochloride	170464858	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	120011-70-3				-1.9097806023	4	4		0	0.11644155					Cl.COc1cc2C(=O)C(Cc2cc1OC)CC4CCN(Cc3ccccc3)CC4	Sequoia	SRP04573d	-1.32124352	0.5607021	1.40951422	0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506887-01	Sodium aurothiomalate(I)		Prostaglandin E synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	12244-57-4				2.2604069908	4	4		0	0.16301816					OC(=O)CC(S[Au])C([O-])=O	Alfa Aesar	39740	0.38860104	-0.75572891	2.71834885	0.16301816												1.6E-8	8E-8	4E-7	0.000002											
NCGC00160620-02	L-Methionine	225144244	S-adenosylmethionine synthetase (MAT 1 and MAT 2) Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63-68-3				1.8682699663	4	4		0	0					CSCC[C@H](N)C(O)=O	SIGMA	64320	0.96516008	0.48712596	0.02699784	0												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00160424-02	Clobenzorex hydrochloride	170465619		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	5843-53-8				7.0268562573	4	4		0	4.75059382					Cl.Clc2ccccc2CNC(C)Cc1ccccc1	Specs	AN-153/I197377	0.58851224	0.34794711	0.45896328	4.75059382												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159441-03	Deslanoside	170465236	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	17598-65-1	Deslanoside; Cedilanid; Cedilanid-D; Cedilanid-d; C, Desacetyllanatosid; Lanatoside, Desacety; Deslanatoside C; C, Deslanatosid; C, Desacetyldigilanid; Desacetyl Lanatoside; Deslanosido; 			8.1235552407	4	4	Cedilanid-d;Cedilanid-D;C, Desacetyllanatosid;deslanoside;Cedilanid;LS-87553;C, Deslanatosid;Lanatoside, Desacety;CIPLUS_171064;Deslanatoside C;deslanosidum;Deslanosido;C, Desacetyldigilanid;CARD-20(22)-ENOLIDE, 3-((O-.BETA.-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3B,5B,12B)-;Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-;DEACETYLANATOSIDE C;Desacetyl Lanatoside;deacetyllanatoside c;DESLANOSIDE;Deslanosidum;Deslanoside;	0	1.00290314					O=C1C=C(CO1)[C@H]2CC[C@@]9(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]9CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]8O[C@H](C)[C@@H](O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)C6)[C@@H](O)C7)[C@@H](O)C8	ChemDiv	N045-0007	0.30602637	3.68823939	3.6987041	1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00386356-02	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	190786-44-8				-1.146651953	4	4		0	0.76408787					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	-0.46838407	-0.25682933	-0.48952951	0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167576-02	Aprindine hydrochloride	170465842	Calmodulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	33237-74-0		8.9125093813	-5.05	33.2536350169	3	4		50.5921669784	47.70773639	0.009480107	0.9999445901			Cl.CCN(CC)CCCN(c1ccccc1)C2Cc3ccccc3C2	Key Organics	KS-1222	-1.07728337	-0.86388046	1.35980419	47.70773639												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178032-03	CITICOLINE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	987-78-0				-3.5947016611	4	4		0	-0.90735435					C[N+](C)(C)CCO[P]([O-])(=O)O[P](O)(=O)OC[C@H]1OC([C@H](O)[C@@H]1O)N2\C=C/C(=N\C2=O)N	Microsource	01505244	0.56206089	-0.77048798	-1.25101985	-0.90735435												1.6E-9	8E-9	4E-8	2E-7											
NCGC00183832-01	Ro 22-9194	144206801	Thromboxane A2 receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	106134-33-2				-3.1557548659	4	4	(-)-(R)-2-AMINO-N-(3-(3-PYRIDYL)PROPYL)-2',6'-PROPIONOXYLIDIDE;Milacainide Tartrate;CIPLUS_3853846;milacainide;MILACAINIDE TARTRATE;CIPLUS_705772;Ro 22-9194;MILACAINIDE;Ro-22-9194;Milacainide tartrate;Milacainide;milacainidum;2-amino-N-(2,6-dimethylphenyl)-N-(3-(3-pyridyl)propyl)propionamide;	0	-0.95510984					Cl.Cl.CC(N)C(=O)N(CCCc1cccnc1)c2c(C)cccc2C	Pharmaron	PH-NIH-100499-100	-0.6557377	-1.42423535	0.32635301	-0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022185-14	Progesterone		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[57-83-0]		14.1253754462	-4.85	14.1411265051	4	4		23.2179766079	19.67526266	0.0844705055	0.9955877231		PGR	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	Tocris	2835	-0.28103044	0.81718422	-0.59831384	19.67526266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509905-01	Eliglustat (Tartrate)		Ceramide glucosyltransferase Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	491833-29-5		12.5892541179	-4.9	27.6202226097	3	4		41.2511389728	35.02890173	0.0499044408	0.9984623546	7357	UGCG	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C2=CC=C3OCCOC3=C2	Selleck	S7852	-0.10282776	1.43378519	1.00026323	35.02890173												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163732-03	Moxidectin			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	113507-06-5		1	-6	24.7544835109	4	4		12	-2.3023023	1	0.9995304807			CO\N=C/1C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C\4CO[C@@H]5[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]45O)C)O2)O[C@@H]([C@H]1C)\C(C)=C\C(C)C	MedChem Express	HY-B0777	1.09732824	4.20585162	13.1448023	-2.3023023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179594-03	Cefotiam hydrochloride	170465103	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	66309-69-1				-4.3143476123	4	4		0	-1.15115115					Cl.Nc1scc(n1)CC(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2CCN(C)C)CS[C@@H]34)C(=O)O	Prestwick	Prestw-482	-0.71564885	-1.48902821	-0.83791568	-1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022787-04	Oxacillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1173-88-2				-1.2441268802	4	4		0	1.001001					CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4	Prestwick	Prestw-1475	-0.85877863	0.39184953	-0.10473946	1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522040-01	Carpipramine Dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	7075-03-8				0.0221263415	4	4		0	-2.95295295					NC(=O)C1(CCN(CCCN2C3=CC=CC=C3CCC4=C2C=CC=C4)CC1)N5CCCCC5	Toronto Research	C184320	0.04770992	-1.59352142	4.60853627	-2.95295295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179291-04	Fursultiamine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2105-43-3				4.6392823771	4	4		0	1.55155155					CC1=NC(=C(CN(C=O)C(/C)=C(\CCO)SSCC2CCCO2)C=N1)N	Prestwick	Prestw-1007	1.52671756	-1.17554859	0.57606703	1.55155155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522018-01	Echothiophate Iodide		Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	513-10-0				-4.4575823236	4	4		0	-0.95095095					CCO[P](=O)(OCC)SCC[N+](C)(C)C	Toronto Research	E325800	-1.28816794	-0.13061651	-0.5236973	-0.95095095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167543-05	CEFTIOFUR HYDROCHLORIDE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	80370-57-6				-0.8466013485	4	4		0	-0.62878435					CO\N=C(\C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N	Microsource	01504832	-0.02590674	-1.04826914	0.60407752	-0.62878435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178896-05	Mepenzolate bromide	170465214	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	76-90-4				1.1136147675	4	4		0	-0.02328831					[Br-].O=C(OC1CCC[N+](C)(C)C1)C(O)(c2ccccc2)c3ccccc3	Microsource	01500383	-0.44041451	0.6094588	2.61766927	-0.02328831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013369-07	Pamoic acid disodium salt			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	[6640-22-8]				-0.0605581222	4	4		0	-0.86166744					OC(=O)C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1	Tocris	4298	0.18134715	0.12189176	0.05033979	-0.86166744												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164605-02	Ampiroxicam	170466020	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	99464-64-9				0.2713373345	4	4		0	1.95302191					O=C(OCC)OC(C)OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Sequoia	SRP05637a	-0.87099812	-0.48712596	0.08099352	1.95302191												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018251-05	Methyl delta-aminolevulinate hydrochloride	225144187	Porphyrin and chlorophyll metabolism Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	79416-27-6				7.2214498707	4	4		0	3.85325944					COC(=O)CCC(=O)CN	SIGMA	A5575	0.4472693	1.11343076	1.32289417	3.85325944												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091505-07	Nitrofurantoin	170464739	Probable pyruvate-flavodoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	67-20-9				6.2998667945	4	4		0	-0.10556875			946587	ydbK	O=[N+]([O-])c2ccc(/C=N/N1CC(=O)NC1=O)o2	Labotest	LT00134625	2.0480226	0.6263048	2.07883369	-0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164582-02	Feprazone	170465969		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	30748-29-9				4.0671262256	4	4		0	1.21404064					C/C(C)=C\CC2C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Sequoia	SRP00472f	1.62429379	1.18302018	-1.05291577	1.21404064												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183871-04	N-Acetyl sulfamethoxazole	170466005		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	21312-10-7				0.6456623355	4	4		0	0.89733439					Cc2cc(NS(=O)(=O)c1ccc(NC(C)=O)cc1)no2	Specs	AA-504/07985056	0.21186441	0.20876827	-0.83693305	0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013841-09	Cyclobenzaprine hydrochloride	170464953	5-HT2A Receptor Ligands	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	6202-23-9	 Lisseril; ; Flexeril; Ciclobenzaprina;CYCLOBENZAPRINE HYDROCHLORIDE; Cyclobenzaprine hydrochloride;Cyclobenzaprine hydrochloride	10	-5	55.6217861264	3	5		91.92540022	81.4453125	0.0013257685	0.9993365786	3356	HTR2A	Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12	Microsource	01503207	-3.11491685	-0.44546264	-1.59301842	2.78895146	81.4453125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164634-02	Balsalazide disodium	170465305	agents for IBS and constipation	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80573-04-2	Balsalazide; Balsalazide; ;Balsalazide disodium; balsalzide Disodium; Colazide; Balsalazide sodium			8.8988168966	4	5		0	-0.0948638				ADORA1	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC(=O)O	Sequoia	SRP00900b	3.58546169	-0.72570726	6.37104314	-2.32616941	-0.0948638											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015439-11	Flumazenil	170464960	GABA(A) BZ Site Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	78755-81-4	 Lanexat; Anexate; Romazicon; ; Ro- 15-1788; Flumazenil;Flumazenil; Roche Brand of Flumazenil;FUMAZENIL; Ro 15178;FlUMAZENIL; Ro 15-1788; Ro 15 178			2.1540908936	4	5		0	0.74535845			2554	GABRA1	O=C(OCC)c3ncn2c3CN(C)C(=O)c1cc(F)ccc12	Microsource	01505701	-0.7367387	-1.24231242	0.14692133	5.33501896	0.74535845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015243-10	Clemizole hydrochloride	170465924	Histamine H1 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1163-36-6		14.1253754462	-4.85	3.6785891296	4	5		10.715607404	8.56584821	0.2426287712	0.8527516367		HRH1	Cl.Clc1ccc(cc1)Cn3c4ccccc4nc3CN2CCCC2	Microsource	01505990	-0.60809134	1.13274787	0.09696634	-3.51300617	8.56584821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090757-06	Melphalan	170464727	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	148-82-3	; Mustard, Phenylalanin; Melfalano;Melphalan; ; Sarcolisina; L-Phenylalanine mustard;MELPHALAN; Melphalan			-6.714683025	4	5		0	-1.61830357				H2AFX	O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl	Microsource	01500382	-1.62571358	-2.81277841	0.45712703	-1.20675784	-1.61830357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015340-14	Desipramine hydrochloride	170465424	Serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-28-6		12.5892541179	-4.9	54.1402205085	3	5		72.724983384	67.36685188	0.0266430011	0.986410114			Cl.CNCCCN2c3ccccc3CCc1ccccc12	Microsource	01500227	-0.24557957	6.58056581	2.07025511	-2.57901391	67.36685188											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015519-11	Dopamine hydrochloride	170464942	Neurotransmitter	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-61-6	 ; Tensophoril; Actopamin; Dopamine hydrobromide;DOPAMINE HYDROCHLORIDE; 8   Dopamine; Hydrochloride, Dopamin; Dopamina; Dopamine hydrochloride;Dopamine hydrochloride; Intropin;Dopamine;3-HYDROXYTYRAMINE			-0.3065678068	4	5		0	-1.47716493				DRD2	Oc1ccc(CCN)cc1O	Vitas	STK301601	1.03143418	0.72570726	-3.4593295	1.13780025	-1.47716493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168759-05	PTC-124	170466862	CFTR-G542X nonsense allele Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	775304-57-9	Ataluren;PTC124			-7.6688739575	4	5		0	0.06775986			1080	CFTR	O=C(O)c1cccc(c1)c2nc(on2)c3ccccc3F	Selleck	S6003	-2.5540275	-2.25092251	-1.53599573	-0.48040455	0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021226-04	Dexamethasone 21-phosphate disodium salt	225144188	Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2392-39-4				-5.0391970047	4	5		0	1.25558036					C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[P]([O-])([O-])=O	SIGMA	D1159	-4.10771904	0.06363752	-1.12203906	-1.95762939	1.25558036											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00249905-01	Phthalofyne	170466477		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	131-67-9				2.063896694	4	5		0	-1.00446429					O=C(O)c1ccccc1C(=O)OC(C)(C#C)CC	GVK	FFS-11-286-NCI-120	3.21419707	-3.62733868	-1.75924643	0.88495575	-1.00446429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183853-01	Mosapramine	144206880	Dopamine D4 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	89419-40-9		15.8489319246	-4.8	-4.6732242022	4	5	MOSAPRAMINE HYDROCHLORIDE;LS-178090;Cremin;3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine;Spiro(imidazo(1,2-a)pyridine-3(2H),4'-piperidin)-2-one, 1'-(3-(3-chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)hexahydro-, dihydrochloride;CIPLUS_3853867;mosapraminum;CIPLUS_703731;Mosapramine hydrochloride;Y 516;(+/-)-1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F]AZEPIN-5-YL)PROPYL)HEXAHYDROSPIRO(IMIDAZO(1,2-A)PYRIDINE-3(2H),4'-PIPERIDIN)-2-ONE;Mosapramine Hydrochloride;Mosapramine;mosapramine;Y-516;MOSAPRAMINE;	-8.4285714319	-5.35714286	0.5973521791	0.4317823355			Clc5ccc6CCc1ccccc1N(CCCN2CCC4(CC2)C(=O)NC3CCCCN34)c6c5	Pharmaron	PH-NIH-183543	-2.76743609	1.38729795	-0.92810639	5.92652186	-5.35714286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095304-05	Furazolidone	170464641	DNA Crosslinking Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	67-45-8				-12.5964037351	4	5		0	-2.00892857					[O-][N+](=O)c2oc(/C=N/N1CCOC1=O)cc2	Vitas	STK388219	-3.16455696	-3.88188876	-1.28826707	-2.30624832	-2.00892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016634-04	Acetopromazine maleate	170465731		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3598-37-6		12.5892541179	-4.9	62.1559951071	3	5		105.40061253	93.73898902	0.0004346079	0.9997826548			O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Prestwick Chemical, Inc.	Prestw-576	-2.25933202	-1.80811808	-1.08187525	-2.42730721	93.73898902											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016055-16	Trimethoprim	170464633	Bacterial dihydrofolate reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	738-70-5				-2.0794111719	4	5		0	0.61383929					Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1	Vitas	STK177322	0.48399106	-0.54728268	-2.83972849	-1.52855994	0.61383929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181023-03	NOLATREXED HCL			SARS-CoV-2_CPE_SRI	2019_NPC-2.2	152946-68-4				-13.49905326	4	5		0	-4.79910714					CC1=C(SC2=CC=NC=C2)C3=C(C=C1)N=C(N)N=C3O	Sequoia	152946-68-4	-1.92355423	-4.56917398	-2.17481646	-2.33306516	-4.79910714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090987-05	1-Naphthaleneacetic acid	170466030	Fusarium oxysporum Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	86-87-3				1.1950024446	4	5		0	-1.69399648					O=C(O)Cc2cccc1ccccc12	Specs	AE-562/J257199	0.46660118	3.2103321	-1.02844931	0.1011378	-1.69399648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159486-06	Hippuric acid	170464791	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	495-69-2				-3.6579510578	4	5		0	2.69684239					O=C(NCC(=O)O)c1ccccc1	Vitas	STK011394	-2.48035363	-1.48831488	-2.07025511	2.02275601	2.69684239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090730-03	D-Camphor	170465497		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	464-49-3				-3.3297561054	4	5		0	0.80915179					CC2(C)[C@H]1CC(=O)[C@]2(C)CC1	Vitas	STK803534	0.38471085	-2.55822833	-0.90040172	-3.19120408	0.80915179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166413-02	Argatroban	170464871	Thrombin Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74863-84-6	; 2   Argatroban; Argatroban Anhydride; Argipidine monohydrate; Acova; Novastan;Argatroban			-0.4517849545	4	5		0	0.60983873				F2	C[C@H]1C[C@H](C(=O)O)N(CC1)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c3cccc2C[C@@H](C)CNc23	Sequoia	SRP07170a	-0.9086444	-1.11931119	3.67303326	-1.44121365	0.60983873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015834-19	Primidone	170464846	Anticonvulsant agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	125-33-7	; ;Primaclone; Primidona;Primidone; Primidone; 2-Desoxyphenobarbital; Primaclone; Mysoline;Primidone (primaclone); Primidone (primaclone);PRIMIDONE			1.7667548813	4	5		0	3.45575281				GABRA1	CCC1(C(=O)NCNC1=O)c2ccccc2	Specs	AN-153/I262077	0.85952849	0.35670357	-0.46747696	-3.33754741	3.45575281											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090874-06	Piperonyl butoxide	170464741		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51-03-6				-11.9199697159	4	5		0	-4.24107143					CCCc1cc2OCOc2cc1COCCOCCOCCCC	SIGMA	45626	-1.2285927	-4.36553392	-2.47956781	-2.41351569	-4.24107143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016893-04	Clorsulon	170466229	antiparasitic agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60200-06-8				-5.0105624585	4	5		0	0.3387993					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	Prestwick Chemical, Inc.	Prestw-540	-1.89096267	1.90651907	-1.56270869	-2.85714286	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179475-03	Halcinonide	170465389		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3093-35-4				3.792566668	4	5		0	1.66201117					ClCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-655	0.34975669	0.56032873	-2.08816705	4.24850866	1.66201117											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249924-01	Ibuprofen piconol	170465895		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64622-45-3				7.6096357274	4	5		0	-4.25977654					CC(C)Cc1ccc(cc1)C(C)C(=O)OCc2ccccn2	GVK	FFS-11-286-NCI-203	5.30717762	-0.90897771	2.96739529	-0.69838498	-4.25977654											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182999-01	Flomoxef	144206879	Streptococcus pneumoniae Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	99665-00-6	FLOMOXEF; 			-1.0812339521	4	5	CIPLUS_207906;LS-178431;FLOMOXEF;Flomoxef;flomoxefum;flomoxef;'(-)-(6R,7R)-7-(2-((DIFLUOROMETHYL)THIO)ACETAMIDO)-3-(((1-(2-HYDROXYETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-7-METHOXY-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID;flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];Flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];S 6315;	0	-3.92458101					O=C2N1C(=C(CO[C@H]1[C@@]2(OC)NC(=O)CSC(F)F)CSc3nnnn3CCO)C(=O)O	Pharmaron	PH-NIH-183450	-0.22810219	4.14643257	-0.89143974	0	-3.92458101											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091051-04	4-Aminobenzoic acid	170466660	Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	150-13-0				0.0036547498	4	5		0	-0.74022346					OC(=O)c1ccc(N)cc1	Specs	AE-562/J257681	0.19768856	-1.1082057	2.13701307	-0.75658373	-0.74022346											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249903-01	Dexamethasone isonicotinate	170466851		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2265-64-7				-1.4963558303	4	5		0	-1.9972067					O=C1C=C2CC[C@@H]5[C@@](F)([C@@]2(C)C=C1)[C@@H](O)C[C@@]4(C)[C@H]5C[C@@H](C)[C@]4(O)C(=O)COC(=O)c3ccncc3	GVK	FFS-11-286-NCI-109	0.28892944	-0.73465322	1.94162901	-1.97875746	-1.9972067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164605-02	Ampiroxicam	170466020	Cyclooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	99464-64-9				4.0477313701	4	5		0	-1.74581006					O=C(OCC)OC(C)OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Sequoia	SRP05637a	-1.17092457	1.48175819	1.74624496	7.53673796	-1.74581006											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090974-06	Diethyl phthalate	225144200	Androgen receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	84-66-2				17.6398539947	4	5		0	0.87988827			367	AR	CCOC(=O)C1=CC=CC=C1C(=O)OCC	SIGMA	524972	6.06751825	3.92230108	4.65258273	-0.37829187	0.87988827											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096081-04	beta-Carotene	225144219	Vitamin/Supplement	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	7235-40-7	; ;BETA-CAROTENE; Solatene; Provitamin A; beta,beta-Carotene; Ro 8-8427; Ro-8-8427;beta-CAROTENE; Betacaroteno; beta-Carotene			20.2965923938	4	5		0	6.96927374				CAT	CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Microsource	01500143	1.6879562	-1.60627568	3.16277934	-0.75658373	6.96927374											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00018257-08	Methocarbamol	170464808	Muscle relaxant	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	532-03-6	 Metocarbamol;;METHOCARBAMOL; Robaxin;Methocarbamol			2.4398508286	4	5		0	3.26602521					NC(=O)OCC(O)COc1ccccc1OC	Microsource	01500397	-1.44891945	-1.63591636	-0.38733805	5.86599241	3.26602521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182983-01	Fezatione	144206829		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	15387-18-5	Fezatione; 			-3.456358084	4	5	Fezatione;FEZATIONE;fezationum;fezatione;3-((P-METHYLBENZYLIDENE)AMINO)-4-PHENYL-4-THIAZOLINE-2-THIONE;CIPLUS_789398;	0	1.77374302					S=C2SC=C(N2/N=C/c1ccc(C)cc1)c3ccccc3	Pharmaron	PH-NIH-150803	-3.39111922	0.93388121	-0.98913176	2.21155245	1.77374302											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3			-12.6796334219	4	5		0	-3.22625698			5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-4.18187348	-2.42809115	-2.03932104	0.87298123	-3.22625698											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016868-12	Acemetacin	170466043	Cyclooxygenase-1/2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53164-05-9	; ; Acemetacina; Rantudil;ACEMETACIN; Acemetacin;Acemetacin	11.220184543	-4.95	7.2072415959	4	5		11.94160584	8.86871508	0.1251950187	0.9319809725	5742	PTGS1	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OCC(=O)O)c3C)OC	Microsource	01500666	-1.2013382	0.43581123	1.74624496	1.83326058	8.86871508											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015529-15	Ibuprofen lysine	170464979	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	15687-27-1	; Ibuprofen, Aluminum Salt; Ibuprofen, (R)-Isomer;Ibuprofen Lysine (NeoProfen); Doctrin; Dexibuprofeno; (S)-(+)-Ibuprofen; Ibuprofen, Calcium Salt; Ibuprofen, (+-)-Isomer; Naproxen;IBUPROFEN; S-(+)-Ibuprofen; ; (?)-Ibuprofen; S(+)-Ibuprofen; Ibuprofen, Potassium Salt; ibuprofen-Lys; S-(+)-ibuprofen;(?)-Ibuprofen; Saren; Advil; Ibuprofen sodium salt; Ibuprofene; Arflamin;Ibuprofen; Ibufen; Ibuprofen, Magnesium Salt; Ibuprofeno			-6.4200645416	4	5		0	1.66201117			5742	PTGS1	CC(C(=O)O)c1ccc(CC(C)C)cc1	Vitas	STK177358	-2.99574209	-0.46071473	-0.57394065	-1.97875746	1.66201117											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016961-06	Atovaquone	170464681	Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	95233-18-4	 ; Atovaquone;Atovaquone; Mepron	14.1253754462	-4.85	7.5700004725	4	5		20.7477876119	16.03198265	0.082291899	0.9562971566		PFF0160c	Clc1ccc(cc1)[C@H]2CC[C@@H](CC2)C=4C(=O)c3ccccc3C(=O)C=4O	Bosche	A2953	-0.19646365	0.40590406	-2.65794043	-3.53982301	16.03198265											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021123-03	Diatrizoic acid dihydrate	170464638		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50978-11-5				-5.0029655847	4	5		0	0.25748746					O.O.O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O	Bosche	D0803	-2.62770138	0.4305043	0.12020836	-1.011378	0.25748746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167436-02	Azelnidipine	174006618	Ca channel blocker - DHP class	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123524-52-7	 ; Calblock;Azelnidipine; Azelnidipine	3.1622776602	-5.5	42.222833107	4	5		28.663750504	-4.64832633	0.4635756018	0.838835889			[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC(C)C)=C(C)NC(N)=C2C(=O)OC3CN(C3)C(c4ccccc4)c5ccccc5	Bosche	A2998	0.66306483	9.38499385	-1.80312542	24.67762326	-4.64832633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015692-08	Methoxamine hydrochloride	225144174		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	61-16-5				0.3051252971	4	5		0	-2.69553073					COC1=CC(=C(OC)C=C1)C(O)C(C)N	Prestwick	Prestw-535	-1.6879562	0.43581123	2.35682012	5.00509239	-2.69553073											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253606-01	Mexazolam	170465840		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	31868-18-5				-1.6678708192	4	4		0	-0.4453241					Clc1ccccc1C34OCC(C)N4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-217	-1.11164814	-0.07400099	0.8908686	-0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016961-06	Atovaquone	170464681	Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	95233-18-4	 ; Atovaquone;Atovaquone; Mepron			12.6989932185	4	4		0	3.16674913				PFF0160c	Clc1ccc(cc1)[C@H]2CC[C@@H](CC2)C=4C(=O)c3ccccc3C(=O)C=4O	Bosche	A2953	4.05993233	1.94869265	0.31816736	3.16674913												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181082-01	Benzactyzine methobromide	144206254	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	3166-62-9	Methylbenactyzium bromide; 			1.3153034344	4	4	diethyllachesine;diethyllachesine bromide;Methylbenactyzium Bromide;Methylbenactyzium bromide;CIPLUS_777361;diethyllachesine iodide;Ethanaminium, N,N-diethyl-2-((hydroxydiphenylacetyl)oxy)-N-methyl-;methylbenactyzium bromide;METHYLBENACTYZIUM BROMIDE;BENACTYZINE METHOBROMIDE;CIPLUS_161517;Bromure de methylbenactyzium;filcilin;methylbenactyzii bromidum;CIPLUS_3883265;bromure de methylbenactyzium;Methylbenactyzii bromidum;CIPLUS_157705;2-diethylaminoethyldiphenylglycolate methylbromide;Bromuro de metilbenacticio;(2-benziloyloxyethyl)diethylmethylammonium iodide;	0	0.5730659					OC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2.BrC	NCI	NSC-11525	-0.74941452	3.24538875	0.76149035	0.5730659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016362-05	Benzonatate	170465391	Slowly adapting pulmonary stretch receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	104-31-4				2.7385435688	4	4		0	1.26682502					O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1	Prestwick	Prestw-12	0.25894539	-0.41753653	1.10691145	1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095169-05	Miltefosine	170465622		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58066-85-6				-2.5073949647	4	4		0	-1.05568752					C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCC	Microsource	01505329	-0.49435028	0.06958942	-0.45896328	-1.05568752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00065934-05	Oxcarbazepine	170464811	Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	28721-07-5	; Oxcarbazepina; Oxcarbazepine;Oxcarbazepine;OXCARBAZEPINE; Timox; Trileptal; Oxacarbazepine			-2.4810246968	4	4		0	-1.26682502					NC(=O)N3c1ccccc1C(=O)Cc2ccccc23	Vitas	STK594696	-0.07062147	-1.2526096	-0.08099352	-1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00185741-02	Nepafenac	170465203	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	78281-72-8	Nepafenac			5.5969828996	4	4		0	2.5245098			5743	PTGS2	Nc1c(cccc1CC(N)=O)C(=O)c2ccccc2	Selleck	S1255	0.73084677	0.87516088	1.76273083	2.5245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094856-05	Adenine	170465950	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	73-24-5				-2.1932493253	4	4		0	-1.00490196					Nc1ncnc2ncnc12	Microsource	01500807	-0.42842742	0.25740026	-0.75545607	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179492-03	Flunisolide	170465331	Corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3385-03-3				-8.057623359	4	5		0	-1.55027933				NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-643	-2.08333333	-2.72693313	-1.06240078	-0.55288811	-1.55027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165862-02	Pamidronic acid	170464689	Farnesyl diphosphate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	40391-99-9				-0.5187434223	4	5		0	-2.27653631					OC(CCN)(P(O)(=O)O)P(=O)(O)O	Selleck	S1311	-0.25851581	-0.68484622	1.40432287	1.65866434	-2.27653631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182082-03	Tesaglitazar	170466025		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	251565-85-2				2.8682749045	4	5		0	4.97357365					O=S(C)(=O)Oc1ccc(cc1)CCOc2ccc(C[C@@H](OCC)C(=O)O)cc2	Tocris	3965	-1.35068762	-1.04551046	2.15039402	1.2642225	4.97357365											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091367-05	Danthron	170465532	DNA topoisomerase II alpha Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	117-10-2				6.4925809606	4	5		0	-2.10893855					Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23	Labotest	LT00455159	3.78649635	-0.38600423	1.18451581	0.69838498	-2.10893855											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016872-12	Ticlopidine hydrochloride	170464698	P2Y12 (P2T) Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	55142-85-3	 Ticlid; Ticlopidina;Ticlopidine; ;; Ticlodone; Ticlopidine Hcl;TICLOPIDINE HYDROCHLORIDE; Ticlopidine hydrochloride; Hydrochloride, Ticlopidin;Ticlopidine hydrochloride			1.4998600611	4	5		0	-2.91899441			64805	P2RY12	Clc3ccccc3CN1CCc2sccc2C1	Vitas	STK589340	3.23905109	-1.78060017	0.40297961	-1.94965808	-2.91899441											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091330-07	Anthralin	170466655		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1143-38-0				7.8400355382	4	5		0	0.34916201					Oc2cccc1Cc3cccc(O)c3C(=O)c12	Microsource	01500127	4.42518248	-3.10048562	2.40566614	-0.20369562	0.34916201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094616-07	Chlorthalidone	170464745	renal sodium excretion Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77-36-1				-2.1174237673	4	5		0	-2.6396648					NS(=O)(=O)c1cc(ccc1Cl)C3(O)NC(=O)c2ccccc23	Microsource	01500187	0.71472019	-2.37828415	1.5264379	-1.2512731	-2.6396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263570-01	Sivelestat sodium hydrate	170465996	Neutrophil Elastase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	201677-61-4				9.0728133943	4	5		0	0.79608939				ELANE	O.O.O.O.[Na+].CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC([O-])=O	Bosche	S3046	4.69890511	-1.35724069	0.98913176	0.02909937	0.79608939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094981-07	Benzyl benzoate	170465382		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	120-51-4				7.5122853701	4	5		0	-2.22067039					O=C(OCc1ccccc1)c2ccccc2	Microsource	01503002	5.82420925	-1.50666169	-1.08682379	0.26189437	-2.22067039											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167531-02	Rivastigmine tartrate	170464721	Acetylcholinesterase Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	129101-54-8	Rivastigmine tartrate;Rivastigmine tartrate (Exelon); Rivastigmine tartrate; ;RIVASTIGMINE			-8.2016316384	4	5		0	-3.18080357			43	ACHE	O=C(Oc1cc(ccc1)[C@H](C)N(C)C)N(C)CC.O=C(O)[C@@H](O)[C@H](O)C(=O)O	Sequoia	SRP01333r	-0.28543063	-2.68550337	-1.53760909	-3.35210512	-3.18080357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016834-07	Fenbufen	170465799	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	36330-85-5		0.2818382931	-6.55	0.0994133414	4	5		6.291970808	-1.96927374	0.6646771927	0.5692175303	5743	PTGS2	O=C(CCC(=O)O)c1ccc(cc1)c2ccccc2	Microsource	01501008	-2.32664234	-2.10434566	7.99853462	0.20369562	-1.96927374											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091326-06	Acetanilide	170465493		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	103-84-4				0.6005524416	4	5		0	-3.67318436					O=C(C)Nc1ccccc1	Vitas	STK046402	1.17092457	-0.58523223	0.40297961	1.86235996	-3.67318436											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344583-01	Vinblastine sulfate	170464976	Tubulin Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	18556-44-0				-4.4580382021	4	5		0	-1.80167598				TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@@H]4C[C@@](O)(CC)C[N@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]6(O)C(=O)OC)[C@H]78	SIGMA	V1377	1.90085158	-3.5985556	-3.62681646	-2.2697512	-1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095048-06	Pipobroman	170465158	DNA Crosslinking Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	54-91-1				-3.6457399569	4	5		0	2.09263393					O=C(CCBr)N1CCN(CC1)C(=O)CCBr	Microsource	01503393	-0.01241003	-3.42369861	-0.45712703	-3.53982301	2.09263393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016936-04	Aztreonam	170465110	beta-lactam antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	78110-38-0	; ;Aztreonam; Aztreonam; Aztreonam lysinate;AZTREONAM; Azactam			2.3658652553	4	5		0	0.99162011					Nc1nc(cs1)/C(=N\OC(C)(C)C(=O)O)C(=O)N[C@@H]2C(=O)N([C@H]2C)S(=O)(=O)O	Microsource	01505122	1.23175182	-2.00473166	1.5264379	-0.46558999	0.99162011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016868-12	Acemetacin	170466043	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	53164-05-9	; ; Acemetacina; Rantudil;ACEMETACIN; Acemetacin;Acemetacin			-1.0045849099	4	4		0	1.16125627			5742	PTGS1	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OCC(=O)O)c3C)OC	Microsource	01500666	-0.77683616	-0.34794711	-0.56695464	1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015704-09	Methapyrilene hydrochloride	170465531		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	135-23-9				-0.4764594253	4	4		0	1.05568752					Cl.CN(C)CCN(Cc1cccs1)c2ccccn2	Microsource	01503229	-0.4472693	-0.13917884	-0.674946	1.05568752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	657-27-2				-1.9119605814	4	4		0	-0.64324592					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-0.91831803	0.76467686	-0.12726694	-0.64324592												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00167514-02	Ethylestrenol	170465211	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	965-90-2		14.1253754462	-4.85	12.3522902519	4	4		14.3441084481	11.6300578	0.1745374204	0.9809257617			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC	Sequoia	965-90-2	1.43958869	-0.28675704	0.26322716	11.6300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510033-02	Distigmine Bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	15876-67-2				13.3862198237	4	4		0	5.38728324					CN(CCCCCCN(C)C(=O)OC1=C[N+](=CC=C1)C)C(=O)OC2=C[N+](=CC=C2)C	SantaCruz Bio	sc-482341	2.8277635	2.05943691	1.00026323	5.38728324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166142-04	Diperodon hydrochloride	170465536	sodium ion transmembrane transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	537-12-2		14.1253754462	-4.85	11.4060227574	4	4		12.2580942401	10.56647399	0.2539199522	0.9584828015			Cl.O=C(Nc1ccccc1)OCC(OC(=O)Nc2ccccc2)CN3CCCCC3	Prestwick	Prestw-300	1.6966581	-0.54744526	-0.6317452	10.56647399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166141-06	Carbinoxamine maleate	170465237	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3505-38-2				-3.9583762572	4	4		0	-0.3003003					O=C(O)/C=C\C(=O)O.Clc1ccc(cc1)C(OCCN(C)C)c2ccccn2	Specs	AN-153/I210051	-0.95419847	-1.3322884	-0.5236973	-0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159467-03	(-)-Cocaine hydrochloride	144206436	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	53-21-4				0.2863577969	4	4		0	-0.25025025					Cl.CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)OC	RTI	9041-001	0.62022901	-1.3322884	-0.62843676	-0.25025025												3.18E-7	0.00000159	0.00000794	0.0000397											
NCGC00483033-01	Tildipirosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	328898-40-4				10.0810658146	4	4		0	3.4034034					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](OC2OC(C)C(O)C(C2O)N(C)C)[C@@H](CCN3CCCCC3)C[C@@H](C)C(=O)\C=C\C(=C\[C@@H]1CN4CCCCC4)C	DC Chemicals	DC8853	2.09923664	0.80982236	2.30426813	3.4034034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347131-03	D(-)-Tartaric acid			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	526-83-0				-0.8475257654	4	4		0	-0.7007007					OC(C(O)C(O)=O)C(O)=O	DC Chemicals	DCJ-065	-0.04770992	0.39184953	-0.68080649	-0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016549-05	Dosulepin hydrochloride		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	897-15-4		12.5892541179	-4.9	61.7354812147	3	4		91.438375273	83.30228225	0.0108389976	0.9999275369			CN(C)CC\C=C1/C2=C(CSC3=C1C=CC=C3)C=CC=C2	Prestwick	Prestw-488	-0.38860104	0.41443198	0.25169897	83.30228225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182551-01	Cythioate	144206631	Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	115-93-5	Cythioate; Cyflee; 			9.3024932162	4	4	Cyflee;CIPLUS_151430;CYTHIOATE;Cythioate;cythioate;O,O-dimethyl-O-(p-sulfamoylphenyl)-phosphorothioate;	0	1.83977643					O=S(N)(=O)c1ccc(OP(=S)(OC)OC)cc1	Chemos	10702	2.0984456	2.31594344	1.35917443	1.83977643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379061-01	Umeclidinium bromide		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	869113-09-7				-2.1686659748	4	4		0	-0.53563111			1131	CHRM3	OC(C1=CC=CC=C1)(C2=CC=CC=C2)C34CC[N+](CCOCC5=CC=CC=C5)(CC3)CC4	MedChem Express	HY-12100	-0.59585492	-0.75572891	0.40271835	-0.53563111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177995-02	Sarafloxacin hydrochloride	170466185	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	91296-87-6	;Sarafloxacin hydrochloride;SARAFLOXACIN HYDROCHLORIDE;Sarafloxacin HCl; Sarafloxacin Hcl; Sarafloxacin HCl; Sarafloxacino			7.4889500616	4	4		0	5.89194224					Cl.Fc1ccc(cc1)N2C=C(C(=O)O)C(=O)c3cc(F)c(cc23)N4CCNCC4	Vitas	STK713346	0.12953368	0.80448562	0.65441732	5.89194224												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00379079-03	Cefoselis (sulfate)		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	122841-12-7				-0.7268440232	4	4		0	1.93292967					CO\N=C(/C(=O)N[C@H]1[C@H]2SC/C(=C(N2C1=O)/C(O)=O)CN3\C=C/C(=N)N3CCO)C4=CSC(=N4)N	MedChem Express	HY-B0186B	-1.47668394	0.07313506	2.21495092	1.93292967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179475-03	Halcinonide	170465389		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	3093-35-4				1.4432580604	4	4		0	1.26682502					ClCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-655	-0.25894539	2.50521921	-1.16090713	1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344532-01	Mucic acid	170464883		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	526-99-8				1.2003988554	4	4		0	0.73898126					O[C@@H]([C@H](O)[C@H](O)[C@@H](O)C(=O)O)C(=O)O	SIGMA	M89617	0.4472693	0.6263048	-0.83693305	0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091051-04	4-Aminobenzoic acid	170466660	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	150-13-0				-3.0690504014	4	4		0	-0.26392188					OC(=O)c1ccc(N)cc1	Specs	AE-562/J257681	-1.01224105	-0.27835769	-0.674946	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179460-03	Medrysone	170465194	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2668-66-8				2.5449011001	4	4		0	3.00870942					CC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3[C@@H](C)C[C@H]12	Prestwick Chemical, Inc.	Prestw-743	-0.96516008	2.08768267	-0.4049676	3.00870942												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263533-01	Penciclovir	170464955	Human herpesvirus 1 DNA polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	39809-25-1				8.7455837314	4	4		0	1.58353127			1487316		OCC(CO)CCn2cnc1c2NC(N)=NC1=O	Sequoia	SRP01095p	2.09510358	3.13152401	0.89092873	1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249926-01	Pirmenol	170466004		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	68252-19-7				0.7795981898	4	4		0	-0.42227501					C[C@H]3CCC[C@@H](C)N3CCCC(O)(c1ccccc1)c2ccccn2	GVK	FFS-11-286-NCI-216	-0.77683616	1.53096729	1.53887689	-0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160530-13	Toremifene citrate		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	89778-27-8				13.7087999191	4	4		0	0.33428844				ESR1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0005	3.18501171	2.77842634	4.84090291	0.33428844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166061-02	L-Cysteine ethyl ester hydrochloride	225144266		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	868-59-7				10.3852037859	4	4		0	2.33526012					CCOC(=O)[C@@H](N)CS	SIGMA	C121908	2.41645244	2.1637122	1.36878126	2.33526012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538148-01	NCGC00538148-01			DPI_SARS-CoV-2_General	2019_NPC-8_CPE					8.281160263	4	4		0	1.41040462					OCCN(CCO)CCOC(=O)C1=CC=CC=C1O	Pharmaron	PH-NIH-2017-009-L1-9-0	1.64524422	1.48592284	2.84285338	1.41040462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	129618-40-2				-1.0549415127	4	4		0	-0.30057803				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	-0.10282776	-0.39103233	-0.42116346	-0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183040-01	NCGC00183040-01	124894246		DPI_SARS-CoV-2_General	2019_NPC-8_CPE		Betamethasone benzoate; Uticort; 	14.1253754462	-4.85	12.6271373433	4	4	LS-118426;betamethasone 17-benzoate;9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-BENZOATE;BETAMETHASONE 17-BENZOATE;BETAMETHASONE BENZOATE;W 5975;Betamethasone benzoate;CIPLUS_173148;PREGNA-1,4-DIENE-3,20-DIONE, 17-(BENZOYLOXY)-9-FLUORO-11,21-DIHYDROXY-16-METHYL-, (11.BETA.,16.BETA.)-;Betamethasone Benzoate;Uticort;Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-,(11-beta,16-beta)-;	16.5	14.31213873	0.0731557749	0.9967064318			C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CC=C5)C(=O)CO	USP	1067307	0.71979434	0.02606882	0.10529087	14.31213873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167781-12	CETIRIZINE HYDROCHLORIDE		Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	83881-52-1				1.9736898421	4	4		0	0.3003003				HRH1	OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	Microsource	01505371	0.76335878	-0.75757576	0.47132757	0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164633-02	Nisoldipine	170465320	Ca2+ channel blocker (dihydropyridine)	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	63675-72-9	Nisoldipine;Nisoldipine; Sular; Bay K 5552; Nisoldipino; ; Nisoldipine;NISOLDIPINE	12.5892541179	-4.9	28.9427721887	4	4		32.5	26.92692693	0.0589738954	0.9978531136			CC=1NC(C)=C(C(C=1C(=O)OCC(C)C)c2ccccc2[N+]([O-])=O)C(=O)OC	Sequoia	SRP03410n	2.38549618	1.07105538	2.82796544	26.92692693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	41468-25-1				-0.7574986461	4	4		0	-0.5005005					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	-0.14312977	-0.23510972	0.20947892	-0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166000-04	Iohexol	170464962		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	66108-95-0				-2.2893680995	4	4		0	-1.05105105					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-512	-0.23854962	-1.3322884	0.05236973	-1.05105105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378990-02	Ledipasvir (GS 5885)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1256388-51-8				-2.6794059831	4	4		0	-1.75175175					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	Adooq	A13155	0.42938931	-1.17554859	-1.41398272	-1.75175175												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182081-04	Zotepine	170465934	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	26615-21-4		12.5892541179	-4.9	32.8995654569	3	4		46.7270091463	39.58958959	0.046792434	0.9986481312	3269	HRH1	CN(C)CCOC1=Cc3ccccc3Sc2ccc(Cl)cc12	Prestwick	Prestw-1368	1.14503817	-0.60083595	1.15213407	39.58958959												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181320-01	Mersalyl acid	144206341		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	486-67-9	2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid; Salyrganic acid; Mersalyl acid; 			1.5081369243	4	4	Mersalyl acid;2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid;2-[N-(3-Hydroxymercuri-2-methoxypropyl)carbamoyl]phenoxyacetic acid;Salyrganic acid;	0	-1.14112715					O[Hg]CC(OC)CNC(=O)c1ccccc1OCC(=O)O	SIGMA	M9784	0.54404145	0.07313506	2.76868865	-1.14112715												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00356592-02	Ergotamine tartrate			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	379-79-3				-3.3981234286	4	4		0	-0.53563111					CN1C[C@@H](\C=C2/[C@H]1CC3=C[NH]C4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O	Prestwick	Prestw-NAT-0314	-1.21761658	0.51194539	-0.35237856	-0.53563111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165979-06	CINNAMIC ACID			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	621-82-9				1.7282373022	4	4		0	0.81509082					OC(=O)\C=C\C1=CC=CC=C1	Microsource	00270092	0.33678756	0.07313506	0.50339794	0.81509082												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00162137-02	Dehydroepiandrosterone Sulfate (sodium salt)		Estrogen receptor alpha Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1099-87-2				2.8082567291	4	4		0	2.91103866					C[C@]12CC[C@H]3[C@@H](C\C=C4\C[C@H](CC[C@]34C)O[S]([O-])(=O)=O)[C@@H]1CCC2=O	Cayman	15873	-0.02590674	0.99951243	0	2.91103866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164632-02	Tibolone	170465874	Steryl-sulfatase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	5630-53-5				-1.1316547254	4	4		0	0.47505938				AR	O=C1CC=2C[C@@H](C)[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(C)CC[C@@H]3C=2CC1	Sequoia	SRP02352t	0.02354049	-1.2526096	-0.78293736	0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090887-04	Phenyl salicylate	170465501	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	118-55-8				-1.0694786573	4	4		0	-1.37239377					Oc2ccccc2C(=O)Oc1ccccc1	Specs	AT-084/J165064	-0.58851224	1.73973556	0.29697624	-1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016296-07	Dicumarol	170465275	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	66-76-2				3.1538455773	4	4		0	1.5307469					OC=3c4ccccc4OC(=O)C=3CC1=C(O)c2ccccc2OC1=O	Vitas	STK801287	1.34180791	0.69589422	-1.43088553	1.5307469												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018100-08	Fasudil hydrochloride	170466011	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	105628-07-7	;HA-1077; Fasudil; Fasudil (HA 1077); HA 1077 hydrochloride; Eril-S;Fasudil; HA-1077 dihydrochloride			-0.9800816209	4	4		0	-1.37239377			6093	ROCK1	Cl.O=S(=O)(c2cccc1cnccc12)N3CCCNCC3	Enzo	EI233	-0.11770245	2.15727209	-0.72894168	-1.37239377												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091330-07	Anthralin	170466655		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1143-38-0				4.5701710066	4	4		0	2.05859066					Oc2cccc1Cc3cccc(O)c3C(=O)c12	Microsource	01500127	-0.58851224	1.67014614	2.13282937	2.05859066												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016016-18	Triamterene	170464706	Heart phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	396-01-0		7.0794578438	-5.15	49.530150469	3	4		49.9090140562	46.92531011	0.0235680021	0.9996574175			Nc2nc(N)nc1nc(N)c(nc12)c3ccccc3	Vitas	STK300348	-0.87099812	0.13917884	-0.4049676	46.92531011												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249918-01	Estriol tripropionate	170465876		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2236-31-9				1.5425402434	4	4		0	2.00580628					CCC(=O)Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2C[C@@H](OC(=O)CC)[C@@H]1OC(=O)CC)c4cc3	GVK	FFS-11-286-NCI-183	0.02354049	-1.04384134	0.02699784	2.00580628												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091038-04	Sodium deoxycholate monohydrate	225144203		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	145224-92-6				3.8613008445	4	4		0	2.58643442					C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	D5670	1.43596987	-0.76548365	-1.05291577	2.58643442												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013289-09	Pridinol	170465865	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	511-45-5				-1.3912468741	4	4		0	1.21404064					OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3	Specs	AG-680/20240026	-1.20056497	0.6263048	-0.89092873	1.21404064												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181010-02	Mabuterol hydrochloride	170465921	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54240-36-7				-2.6224996058	4	4		0	0.2111375					Cl.Nc1c(cc(cc1Cl)C(O)CNC(C)(C)C)C(F)(F)F	Bosche	M5723	-0.77683616	-1.2526096	-0.51295896	0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016410-13	Thiabendazole	170464939	Methionine Aminopeptidase-1 (MetAP1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	148-79-8	;THIABENDAZOLE; ; Omnizole;Thiabendazole; Thibendole; Mintezol; Tiabendazole;Tiabendazole; Mintesol			-0.6464015755	4	4		0	0.52784376				METAP1	n1c3ccccc3nc1c2cscn2	Labotest	LT00134862	-0.54143126	0.69589422	-0.674946	0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164569-02	Capecitabine	170464779	Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	154361-50-9	Capecitabine;Capecitabine (Xeloda); Xeloda; Capecitabine; 			-5.2086651402	4	5		0	5.32924107				TYMS	O=C(OCCCCC)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Sequoia	SRP01237c	-2.94117647	-2.12549319	-0.51253636	-2.70850094	5.32924107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016347-07	Benzthiazide	170465246	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	91-33-8				-10.2010899744	4	5		0	-2.42745536					NS(=O)(=O)c3cc1c(N=C(NS1(=O)=O)CSCc2ccccc2)cc3Cl	Microsource	01500141	-2.99081658	-0.85274278	-1.01122039	-2.19898096	-2.42745536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024025-05	Dehydrocholic acid	170465502	bile acid secretion Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	81-23-2				-7.9171401151	4	5		0	-2.51116071			1045		O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)C(=O)C[C@H]2[C@H]3C(=O)C[C@@H]1CC(=O)CC[C@@]12C	Prestwick	Prestw-123	-2.39513527	0.54728268	-1.81465577	-1.01903996	-2.51116071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164612-02	Propyphenazone	170465821	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	479-92-5				-7.5785016597	4	5		0	-2.84598214					CC(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Specs	AE-562/J258456	-1.07967238	-3.95825379	1.75924643	-2.73531778	-2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182992-01	Fasoracetam	144206891	GABA-B receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	110958-19-5	FASORACETAM; Fasoracetam Anhydride; Fasoracetam Hydrate; 			-5.9392585414	4	5	FASORACETAM;Fasoracetam Anhydride;CIPLUS_775811;CIPLUS_3849428;Fasoracetam;fasoracetam;(+)-1-(((R)-5-OXO-2-PYRROLIDINYL)CARBONYL)PIPERIDINE;Fasoracetam Hydrate;	0	1.84151786					O=C([C@H]1CCC(=O)N1)N2CCCCC2	Pharmaron	PH-NIH-97984	-3.28865724	-3.34733359	-1.31597174	2.92303567	1.84151786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094754-05	Phenacemide	170465322	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	63-98-9				-6.9057232425	4	5		0	-2.84598214					O=C(Cc1ccccc1)NC(N)=O	Microsource	01500472	-3.51203773	-2.20185822	1.81465577	2.86940198	-2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253593-01	Bitolterol	170465239	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	30392-40-6		14.1253754462	-4.85	14.7759410902	4	5		20.86662452	17.84794688	0.0542638741	0.9718205045			O=C(Oc2cc(ccc2OC(=O)c1ccc(C)cc1)C(O)CNC(C)(C)C)c3ccc(C)cc3	GVK	FFS-11-286-NCI-028	0.93320236	-0.01230012	1.56270869	-1.9721871	17.84794688											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178318-04	Sodium 2-mercaptoethanesulfonate	170464862	Antineoplastic Enhancing Agents	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	19767-45-4				-1.2171837442	4	5		0	1.66689253				CAT	[Na+].[O-]S(=O)(=O)CCS	Microsource	01502014	-1.27701375	2.6199262	-1.6428476	-1.1125158	1.66689253											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095911-06	Quetiapine	170465146	Serotonin 2a (5-HT2a) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	111974-69-7				-7.6105282432	4	5		0	-2.26317929					OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23	Microsource	01505187	0.1719057	-1.34071341	-3.51275544	-4.07079646	-2.26317929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178213-05	Nafronyl oxalate	170465616	Serotonin 2 (5-HT2) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3200-06-4		12.5892541179	-4.9	23.5755749528	3	5		55.8658320879	45.5078125	0.000938001	0.9995309239			O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3	Microsource	01503419	-3.06527674	-1.8454881	-2.72890982	-2.2257978	45.5078125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016265-08	Folic acid	170464833	folic acid-containing compound metabolic process Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59-30-3				-4.5378800648	4	5		0	0.390625					O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2	Microsource	01502020	-0.93075205	-4.06007382	-0.5679457	0.18771789	0.390625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091737-05	Sorbic acid			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	110-44-1		0.4466835922	-6.35	8.2790508247	4	5		-6.9135835439	-0.60983873	0.6050172265	0.4133364034			C/C=C/C=C/C(O)=O	SIGMA	S1626	0.19646365	12.50922509	-0.76131962	0.22756005	-0.60983873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015760-12	Octopamine	170465959	Dopamine transporter Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104-14-3				-8.7174108506	4	5		0	2.29028324					OC(CN)c1ccc(O)cc1	Vitas	STK801377	-2.33300589	-2.10332103	-2.17710699	-4.45006321	2.29028324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016799-08	Suxibuzone	170465972	Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	27470-51-5				2.7852811431	4	5		0	4.3772869			791253	PTGS2	O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Prestwick Chemical, Inc.	Prestw-658	-2.38212181	3.38253383	4.34085749	-2.09860936	4.3772869											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023339-16	Pilocarpine	170464845	Muscarinic acetylcholine receptor M3 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	92-13-7				-9.4536344172	4	5		0	-1.81361607			1131	CHRM3	Cn2cncc2C[C@H]1COC(=O)[C@H]1CC	Enzo	AC214	-2.69297592	-2.04912817	-2.23022579	-0.16090105	-1.81361607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249907-01	Sulthiame	170465788	Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	61-56-3		0.0446683592	-7.35	11.2129093675	4	5		-10.643025344	-0.69754464	0.0694298894	0.9638885622			O=S2(=O)CCCCN2c1ccc(cc1)S(N)(=O)=O	GVK	FFS-11-286-NCI-132	7.90518739	-1.74366807	-2.20252112	-0.24135157	-0.69754464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167438-02	Trospium chloride	174006890	Muscarinic Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	10405-02-4	Trospium chloride; Cloruro de trospio; Trospium chloride; Spasmoplex; 			0.8441046589	4	5		0	1.26033338					[Cl-].OC(c1ccccc1)(c2ccccc2)C(=O)O[C@@H]3C[C@@H]5CC[C@H](C3)[N+]45CCCC4	Selleck	S2549	-0.54027505	1.68511685	-0.46747696	0.07585335	1.26033338											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090766-07	Prednisone	170464847	Glucocorticoid steroid	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53-03-2	 Prednisona; ; Dehydrocortisone; Prednisone;Prednisone;; Deltasone;Prednisone (Adasone); 1-Cortisone; Meticorten; Kortancyl; Deltamid			-1.2956854533	4	5		0	-0.44642857				NRC31	OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Prestwick Chemical, Inc.	Prestw-77	-2.44477538	-1.89639812	3.17218451	3.83480826	-0.44642857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018157-13	Flurbiprofen		non-steroidal antiinflammatory	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	5104-49-4	 R-(-)-Flurbiprofen;;FLURBIPROFEN;(?)-Flurbiprofen;Flurbiprofen; Anside; Flurbiprofeno; (R)-2-Flurbiprofen; Ansaid; (S)-(+)-Flurbiprofen; S-(+)-Flurbiprofen; Ocufen			-3.4774473077	4	5		0	1.42299107				PTGS2	CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	SIGMA	F8514	-2.64333582	-1.15820288	1.64842776	0.02681684	1.42299107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159456-11	Imatinib	170465393	Bcr-Abl Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	220127-57-1	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	12.5892541179	-4.9	66.1926949897	3	5		103.61185532	92.99665179	0.0018335268	0.9990821039	25	ABL1	CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5	Prestwick	Prestw-1290	-0.6825515	0.95456281	-2.03629312	-1.85036203	92.99665179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016329-07	Phenindione	170465130	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	83-12-5				-5.1621696879	4	5		0	3.45575281					O=C2c1ccccc1C(=O)C2c3ccccc3	Specs	AN-153/I102301	-3.31532416	-0.99630996	-0.20034727	-1.08723135	3.45575281											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024822-03	EVANS BLUE		Serum albumin Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	314-13-6				1.9539201413	4	5		0	5.80357143			6339		CC1=C(C=CC(=C1)C2=CC=C(\N=N\C3=C(O)C4=C(C=C3)C(=CC(=C4N)[S]([O-])(=O)=O)[S]([O-])(=O)=O)C(=C2)C)/N=N/C5=C(O)C6=C(N)C(=CC(=C6C=C5)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	206334	-2.12211467	2.81277841	1.1774484	-1.7699115	5.80357143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015996-10	Tiapride hydrochloride	170465877	Dopamine D3 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51012-33-0				-8.9858895562	4	5		0	-0.93508605					Cl.O=S(C)(=O)c1cc(c(OC)cc1)C(=O)NCCN(CC)CC	Microsource	01503086	-2.87328094	-0.99630996	-1.6428476	-1.59292035	-0.93508605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181000-02	Suplatast tosylate	170465881	Mediator Release Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94055-76-2	 ;IPD-1151T; Tosilato de suplatast; Suplatast;Suplatast tosylate; Suplatast tosylate	0.5623413252	-6.25	-1.8710896756	4	5		-5.6106194719	-1.96503591	0.5770461721	0.469035675			Cc1ccc(cc1)S(=O)([O-])=O.C[S+](C)CCC(=O)Nc1ccc(OCC(O)COCC)cc1	Tocris	3543	-1.32612967	7.83517835	-1.88326432	-3.00884956	-1.96503591											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016509-06	Trimethobenzamide hydrochloride	170465132	Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	554-92-7		14.1253754462	-4.85	11.6880221822	4	5		13.094816692	11.5869359	0.4173173555	0.6921707213			Cl.COc1c(cc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2)OC	Microsource	01500594	1.15422397	-1.88191882	5.72993188	-2.57901391	11.5869359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024494-02	D-Alanine	170465038	Alanine aminotransferase 1 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	338-69-2				2.6963690972	4	5		0	3.19832402					C[C@@H](N)C(=O)O	Tocris	0205	-2.35705596	9.52558835	-1.23336183	-1.60046559	3.19832402											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015467-20	Glybenclamide	170464964	Sulfonylurea receptor 2 Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	10238-21-8				-2.1749004027	4	5		0	-0.29329609					O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3	Enzo	KC120	-0.98844282	-4.09662558	-0.64720967	4.56860178	-0.29329609											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094857-05	9-Aminoacridine, monohydrochloride, monohydrate	170465046		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	52417-22-8				-6.7809893653	4	5		0	-5.15363128					Cl.O.Nc1c3ccccc3nc2ccccc12	Vitas	STK387428	-3.45194647	3.4491346	2.6254732	-1.10577623	-5.15363128											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159412-04	Tromethamine	170464686	calcium ion transport Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77-86-1				0.6772693395	4	5		0	-3.28212291					OCC(N)(CO)CO	Labotest	LT03329109	1.11009732	-1.90511767	5.06777384	-1.62956496	-3.28212291											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253581-01	Indomethacin farnesil	170466014		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	85801-02-1				-4.0430455625	4	5		0	-0.48882682					Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)c3C)OC	GVK	FFS-11-286-NCI-252	-1.93126521	-1.83040717	-0.25644157	1.94965808	-0.48882682											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015234-19	Carbamazepine	170464712	Sodium channel protein type 5 subunit alpha Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	298-46-4				-2.5996667592	4	5		0	-2.47206704			6331	SCN5A	NC(=O)N2c3ccccc3C=Cc1ccccc12	Vitas	STK177357	-1.5663017	-2.02963516	-0.62278667	5.73257675	-2.47206704											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018121-07	Proxyphylline	170465953	"3',5'-cyclic phosphodiesterase Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	603-00-9				11.7046308326	4	5		0	3.36592179					CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Microsource	01505915	1.90085158	2.87635413	3.48027842	1.74596246	3.36592179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091585-05	Octocrylene	170464719	photosensitizer	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE			-1.7843812203	4	5		0	-1.38268156				CAT	CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	-1.59671533	2.57751214	0.06105752	0.52378874	-1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016251-13	Probenecid	170464839	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-66-9				-2.6890217853	4	5		0	0.60983873					O=S(=O)(N(CCC)CCC)c1ccc(cc1)C(=O)O	Microsource	01500502	-0.98231827	0.40590406	-3.031922	0.73324905	0.60983873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018113-07	Sodium 4-phenylbutyrate	170465108	Glutamine Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1716-12-7				3.9786794518	4	5		0	4.35018295					[Na+].[O-]C(=O)CCCc1ccccc1	Microsource	00306001	-0.51571709	6.11316113	-0.9483104	-2.75600506	4.35018295											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249895-01	Bornelone	170465560		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2226-11-1				3.046224962	4	5		0	-1.38268156					CC2(C)C(=C\C=C\C(C)=O)/C1CCC2C1	GVK	FFS-11-286-NCI-70	1.4446472	3.29971361	0.15874954	-1.45496872	-1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	657-27-2				16.0576553698	4	5		0	5.56986041					NCCCC[C@H](N)C(O)=O	Bosche	L1919	0.31925344	4.4895449	-2.20381995	-1.3653603	5.56986041											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00166104-04	alpha-Lipoic acid amide	170465868	apoptotic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	940-69-2				8.8117608766	4	5		0	4.10624746					NC(=O)CCCCC1CCSS1	Microsource	01505740	1.32612967	7.26937269	-1.05516228	-1.517067	4.10624746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022662-05	Dexamethasone acetate	170466872	Mineralocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1177-87-3				-4.5673459846	4	5		0	0.0948638					CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-130	-2.28388998	-0.97170972	0.54761587	-0.1517067	0.0948638											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164534-02	4-Phenolsulfonic acid	170465916		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	98-67-9				-7.0991232528	4	5		0	-0.90798211					Oc1ccc(cc1)S(O)(=O)=O	Labotest	LT03353562	-1.30157171	-1.3899139	-1.05516228	-3.28697851	-0.90798211											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015821-10	Piracetam	170465901	"Glutamate receptor ionotropic, AMPA 3 Positive Allosteric Modulator"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	7491-74-9				-1.4150738248	4	5		0	0.12569832					O=C1CCCN1CC(=O)N	Specs	AE-641/30117005	-3.23905109	0.28639024	5.04335084	1.10577623	0.12569832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016324-09	Sulfamethoxypyridazine	170466374		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80-35-3				-6.565831296	4	5		0	-0.48882682					O=S(=O)(Nc1ccc(OC)nn1)c2ccc(N)cc2	Microsource	01501156	-2.29622871	-3.72307309	2.28355111	-1.33857122	-0.48882682											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00177979-05	Azelastine hydrochloride	170465172	Histamine H1 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	79307-93-0	; Astelin; Azelastina;AZELASTINE HYDROCHLORIDE; Azelastine Hydrchloride	11.220184543	-4.95	47.5547665069	3	5		83.8655213059	64.49383385	0.002196325	0.9989003593	9704	HRH1	Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4	Microsource	01505340	-2.67681729	-0.57810578	-0.22706024	6.97850822	64.49383385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182997-01	Melinamide	144206837	Acyl coenzyme A:cholesterol acyltransferase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14417-88-0	Melinamide; Artes; Melinamida; 			-7.8096541612	4	5	MELINAMIDE;LS-173854;N-(2-methylbenzyl)linoleamide;(z,z)-n-(1-phenylethyl)-9,12-octadecadienamide;melinamide;melinamidum;CIPLUS_214142;Artes;Melinamidum;LS-88004;Melinamida;N-(2-methylbenzyl)linoleamide, (S-(Z,Z))-isomer;Melinamide;	0	-2.12765957					CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)c1ccccc1	Pharmaron	PH-NIH-152054	-2.7259332	0.23370234	-0.28048618	-1.6182048	-2.12765957											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024994-06	Selegiline hydrochloride	170464993	MAO-B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14611-52-0	; ; (R)-(-)-Deprenyl hydrochloride; Selegiline, (R,S)-Isomer;Selegiline hydrochloride; Selegiline, (S)-Isomer;Selegiline; Selegilina; Selegiline Hcl; Deprenyl; Jumex			4.2837014829	4	5		0	4.24176718			4129	MAOB	Cl.C#CCN(C)[C@H](C)Cc1ccccc1	Prestwick Chemical, Inc.	Prestw-552	1.03143418	-1.75891759	0.38733805	0.22756005	4.24176718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167499-02	Roxatidine acetate hydrochloride	170465941		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	93793-83-0				-7.0322565073	4	5		0	-0.60983873					Cl.CC(=O)OCC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Prestwick Chemical, Inc.	Prestw-428	-3.02062868	2.66912669	-1.50928276	-2.55372946	-0.60983873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263533-01	Penciclovir	170464955	Human herpesvirus 1 DNA polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	39809-25-1				5.9950430836	4	5		0	-3.17039106			1487316		OCC(CO)CCn2cnc1c2NC(N)=NC1=O	Sequoia	SRP01095p	3.14781022	0.36110073	1.62412993	1.62956496	-3.17039106											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164553-02	Clofarabine	170465145	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	123318-82-1	 Clofarabine; ; Clolar;Clofarabine			-10.423483282	4	5		0	-5.2734375				POLA1	Nc3nc(Cl)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	Sequoia	SRP03671c	-2.5440556	-2.25276823	4.52971326	-4.80021453	-5.2734375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091493-09	Anethole	170465678	TNF signaling pathway Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	104-46-1				-14.0196831571	4	5		0	-0.78125			4313		COc1ccc(C=CC)cc1	Microsource	01503705	-4.20699926	-3.95825379	-2.03629312	-2.06489676	-0.78125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164581-02	Estramustine	170466403	Estrogen receptor beta Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2998-57-4		10	-5	13.929732345	4	5		25.756257004	19.62290503	0.010172766	0.994890494	4130		ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	Sequoia	SRP01725e	-0.86678832	-1.88021417	0.0122115	3.11363306	19.62290503											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015608-11	Loperamide hydrochloride	170464852	mu-Opioid Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53179-11-6	 ;LOPERAMIDE; Hydrochloride, Loperamid;Loperamide; Loperamide Hcl;Loperamide hydrochloride; Loperamide hydrochloride; Loperamida	8.9125093813	-5.05	67.7757425152	3	5		100.5592639613	95.23743017	0.0029857705	0.998503969	4988	OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4	Enzo	ALX-550-253	-3.02615572	1.55646868	-1.28220784	2.88083806	95.23743017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016311-19	Phentolamine mesilate	170464866	alpha-Adrenoceptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-60-2	 Regitine;Phentolamine mesylate;Phentolamine;PHENTOLAMINE; ; Regitin;Phentolamine hydrochloride; Regitin mesylate; Vasomax;PHENTOLAMINE HYDROCHLORIDE; Phentolamine hydrochloride; Fentolamina;			13.2780195413	4	5		0	0.82402235			148	ADRA1A	Cc1ccc(cc1)N(CC2=NCCN2)c3cc(O)ccc3	Vitas	STK802099	4.91180049	1.85531067	2.67431921	0.55288811	0.82402235											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183029-02	Troxipide	170465889	reactive oxygen species biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	30751-05-4				4.5643940253	4	5		0	3.68303571					O=C(NC1CCCNC1)c2cc(OC)c(OC)c(OC)c2	Sequoia	30751-05-4	1.57607347	-1.61639303	0.40171769	-0.37543577	3.68303571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015399-16	Etodolac	170464915	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	41340-25-4	; ; Etodolac;Etodolac; Etodolaco; 6-OH etodolac glucuronide;ETODOLAC; Etodolac, (+-)-Isomer; Lodine; Etodolac, Monosodium Salt			3.3669952819	4	5		0	-1.82960894			5743	PTGS2	O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC	Microsource	01501005	3.69525547	-2.57751214	0.62278667	-1.07667685	-1.82960894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016530-07	Sulfameter	170465428	Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	651-06-9	; Sulfametoxidine; Sulfamethoxydine; 5-Methoxysulfadiazine; ;Sulfameter; Sulfameter;SULFAMETER; Sulfametoxidiazina; Sulla; Sulfamethoxydiazine; Sulphamethoxydiazine			1.5632533585	4	5		0	-2.55586592					O=S(=O)(Nc1ncc(cn1)OC)c2ccc(N)cc2	Microsource	01501155	-2.14416058	1.1082057	4.60373672	4.94689364	-2.55586592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274280-01	Pixantronemaleate	225144373	DNA Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2					-5.9210417283	4	5		0	-1.33928571					NCCNC1=C2C(=O)C3=C(C=NC=C3)C(=O)C2=C(NCCN)C=C1	GVK	FFS-12-73-NCI-2833	-0.31025068	-0.24182258	-1.89776977	-4.07615983	-1.33928571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016059-13	Thioridazine	170465080	Serotonin 2c (5-HT2c) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-52-2				-8.2407517722	4	5		0	-6.38950893					CN4CCCCC4CCN1c3ccccc3Sc2ccc(SC)cc12	Enzo	NS835	-1.27823281	-3.22005855	-0.67876437	2.33306516	-6.38950893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015823-17	Piroxicam	170464817	Cyclooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	36322-90-4	; ;Piroxicam; Piroxicam cyclodextrin;PIROXICAM; Piroxicam;piroxicam; Feldene			-4.8533278348	4	5		0	1.10335196			5742	PTGS1	OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Vitas	STK177288	-3.90815085	1.45685469	0.20759555	0.58198749	1.10335196											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262940-01	Iodoxamic Acid	170465432		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	31127-82-9	Acide iodoxamique;Iodoxamate meglumine;Iodoxamic acid			-6.0643520938	4	5		0	-1.19977679					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCOCCOCCOCCOCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	GVK	FFS-11-286-NCI-61	-1.9980144	-2.86368843	-0.59565037	1.36765889	-1.19977679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178395-04	Piperidolate hydrochloride	170465927		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	129-77-1				-8.0705338597	4	5		0	-2.84598214					Cl.CCN3CCCC(OC(=O)C(c1ccccc1)c2ccccc2)C3	Prestwick Chemical, Inc.	Prestw-1055	-1.25341276	-4.49280896	0.81728771	-1.50174309	-2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090955-06	Dicyclohexylamine	170466864	spermidine biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	101-83-7				-5.5212132577	4	5		0	-2.12053571					C1CCCCC1NC2CCCCC2	Vitas	STK379549	-1.10449243	-2.88914344	-0.40171769	0.5899705	-2.12053571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159384-04	6-Chlorothymol	170465546	Estrogen receptor Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	89-68-9				-5.9466263688	4	5		0	-2.81808036					Oc1cc(C)c(Cl)cc1C(C)C	Labotest	LTBB003695	-1.62571358	-2.32913326	-1.39908575	2.54759989	-2.81808036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091835-10	Chlormethine	170465017	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	55-86-7	 Nitrogen mustard HCl;Nitrogen mustard HCl;Nitrogen mustard hydrochloride; Nitrogen mustard hydrochloride;MECHLORETHAMINE			4.6544197049	4	5		0	-3.0027933				H2AFX	Cl.ClCCN(C)CCCl	Microsource	01500375	1.38381995	-0.11206575	3.13835633	3.17183181	-3.0027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022043-06	Deoxycorticosterone acetate	170465334	Mineralocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	56-47-3		8.9125093813	-5.05	14.4022290509	4	5		15.3735524881	13.98044693	0.0158551796	0.9920337331			CC(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	SIGMA	D7000	1.04927007	-0.31129374	0.47624863	2.70624182	13.98044693											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181160-01	Ecabet	144206316	Urease subunit alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	33159-27-2	Ecabet; 			0.5597636605	4	4	LS-174407;CIPLUS_207819;ECABET;ecabet sodium;TA-2711;ecabetum;12-sulfodehydroabietic acid;Ecabet Sodium;Ecabetum;Ecabet;TA 2711;CIPLUS_3872531;ecabet;1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt;	0	1.71919771				ureC	CC(C)c2cc3CC[C@@H]1[C@](C)(CCC[C@@]1(C)C(=O)O)c3cc2S(=O)(=O)O	NCI	NSC-659804	-1.12412178	0.02334812	3.04596138	1.71919771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344330-02	Elaidic Acid		SiHa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	112-79-8				-1.7296989063	4	4		0	1.00286533					CCCCCCCC/C=C/CCCCCCCC(O)=O	Cayman	90250	-1.07728337	0.1167406	0.27196084	1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181094-01	Sodium tyropanoate	144206263		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	7246-21-1	TYROPANOATE SODIUM; Bilopaque; Tyropanoate; Tyropanoic acid; Sodium, Tyropanoat; Tiropanoato sodico; Tyropanoate, Sodiu; 			-5.2453969703	4	4	Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-;Bilopaque;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-;natrii tyropanoas;Tyropanoate de sodium;Sodium, Tyropanoat;Sodium tyropanoate;Natrii tyropanoas;WIN 8851;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-, MONOSODIUM SALT;Tyropanoate sodium;TYROPANOATE SODIUM;Tyropanoic acid;WIN8851;Tyropanoate;WIN-88512;Tiropanoato sodico;CIPLUS_166239;SODIUM TYROPANOATE;2-(3-(BUTYRYLAMINO)-2,4,6-TRIIODOBENZYL)BUTANOIC ACID;Tyropanoate Sodium;CIPLUS_175604;Tyropanoate, Sodiu;TYROPANIC ACID;Sodium Tyropanoate;tyropanoate de sodium;	0	-1.33715377					[Na+].O=C(Nc1c(I)c(CC(CC)C([O-])=O)c(I)cc1I)CCC	NCI	NSC-107434	-1.54566745	-0.21013308	-0.21756867	-1.33715377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274078-01	Fludrocortisone	170464959		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	127-31-1				-1.3781993468	4	4		0	1.22543353					OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@]1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	F6127	-1.07969152	-0.44316997	1.10555409	1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188442-01	Estradiol enanthate	144206583		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	4956-37-0				0.7889349626	4	4	ESTRADIOLENANTHATE	0	1.78034682					CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C	APAC	877917	-0.46272494	0.5995829	0.3158726	1.78034682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182073-03	Nedocromil	170464978	mast cell degranulation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	69049-73-6				-0.0255484348	4	4		0	1.6416185					O=C(O)C2=CC(=O)c3cc1c(OC(=CC1=O)C(=O)O)c(CCC)c3N2CC	Kemprotec	69049-73-6	-0.41131105	-0.02606882	-0.26322716	1.6416185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386215-04	ALOGLIPTIN BENZOATE			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	850649-62-6				-0.3265717062	4	4		0	-1.001001					CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	Microsource	01506318	0	-0.39184953	0.99502488	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185766-04	Esmolol hydrochloride	170465277	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	81161-17-3				5.1131162897	4	4		0	-0.55055055					Cl.CC(C)NCC(O)COc1ccc(cc1)CCC(=O)OC	Prestwick	Prestw-1137	2.09923664	0.44409613	-0.20947892	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181325-03	Menaquinone		bone resorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	11032-49-8				-1.4171293017	4	4		0	2.9029029					CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/1=C(C)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0236	-1.24045802	-1.07105538	0.47132757	2.9029029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167465-02	Calcipotriene	170464710	Vitamin D receptor Activator	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	112965-21-6				7.5833745238	4	4		0	-0.05005005					C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@@H](O)C4CC4	Prestwick Chemical, Inc.	Prestw-1257	2.14694656	1.85475444	1.2045038	-0.05005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506889-01	Sugammadex			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	343306-71-8				-1.001508423	4	4		0	-1.15115115					O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]4O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]5O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]6O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]7O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]8O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]9O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]1O[C@@H]2CSCCC([O-])=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O	Proactive Molecular	P283-1548	0.23854962	-0.07836991	-0.99502488	-1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017020-06	NCGC00017020-06			DPI_SARS-CoV-2_General	2019_NPC-2_CPE					-3.4870644575	4	4		0	-0.71033938					CCCC1=NC=C(C[N+]2=C(C)C=CC=C2)C(N)=N1	Vitas	STL018669	-0.4842615	-0.80301129	-1.19077781	-0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164595-02	Voglibose	170465993		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	83480-29-9				0.4659411206	4	4		0	1.34175217					O[C@H]1[C@@H](NC(CO)CO)C[C@](O)(CO)[C@@H](O)[C@@H]1O	Sequoia	SRP01065v	0.24213075	-0.9033877	-0.78540664	1.34175217												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164034-05	Triclocarban	170465481		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	101-20-2		5.6234132519	-5.25	21.7384382022	4	4		16.5	15.81162852	0.0548941327	0.99814801			Clc2ccc(NC(=O)Nc1ccc(Cl)cc1)cc2Cl	Specs	AN-153/I101902	1.2590799	0.55207026	1.59614897	15.81162852												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan			-1.8686014365	4	4		0	0.54428501					CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	-1.01498308	0.024667	-0.57270124	0.54428501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015747-09	Nicardipine	170465173	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	55985-32-5	 ;Nicardipine hydrochloride; YC-93 hydrochloride; Dagan;Nicardipine?HCl;Nicardipine; Nicardipine; Cardene/SR; Nicardipino	10	-5	60.2978956323	3	4		63.5876565971	56.50667986	0.0228457618	0.9996780414			CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC	Enzo	AC108	-0.04833253	-0.46867292	-1.20903595	56.50667986												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00387269-01	Rifaximin		Pregnane X Receptor (PXR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[80621-81-4]				2.4062439861	4	4		0	1.81470869				rpoB	CO[C@H]1\C=C/O[C@@]2(C)OC3=C(C)C(=C4C(=C(NC(=O)\C(=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=C(N=C6C=C(C)C=C[N]56)C4=C3C2=O)O)O	Tocris	5359	-0.23419204	2.03128648	0.32635301	1.81470869												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183007-01	Risarestat	144206824	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	79714-31-1	CT-112; Risrestat; 			-4.2693722577	4	4	LS-151322;CT-112;Risarestat;risarestatum;5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione;RISARESTAT;5-(3-ETHOXY-4-PENTYLOXYPHENYL)-2,4-THIAZOLIDINEDIONE;Risrestat;CIPLUS_709552;2,4-Thiazolidinedione, 5-(3-ethoxy-4-(pentyloxy)phenyl)-;CT 112;	0	0.66857689					CCCCCOc1ccc(cc1OCC)C2SC(=O)NC2=O	Pharmaron	PH-NIH-149775	-1.68618267	-1.42423535	0.76149035	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094476-03	Terguride	144204835	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	37686-84-3	R(+)-Terguride; S(+)-Terguride; Teluron; 			-4.5471598771	4	4	Teluron;R(+)-TERGURIDE;transdihydrolisuride;CIPLUS_3867987;S(+)-N,N-Diethyl-N'([8alpha]-6-methylergolin-8-yl)urea;TERGURIDE;NCGC00016838-01;NCGC00015990-01;Terguride;N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea;NCGC00016838-02;CIPLUS_739798;S(+)-Terguride;S(-)-terguride hydrogen maleate;terguride;VUFB 6638;dironyl maleate (1:1);NCGC00094476-01;trans-9,10-dihydrolisuride hydrogen maleate;LS-159804;NCGC00094476-03;LS-159803;NCGC00094476-02;R(+)-Terguride;R(+)-N,N-Diethyl-N'[(8alpha)-6-methylergolin-8-yl]urea;S(+)-Terguride (5R, 8S, 10R);CIPLUS_179126;1,1-DIETHYL-3-(6-METHYL-ERGOLIN-8A-YL)UREA;terguridum;dironyl;urea, N,N-diethyl-N'-((8 alpha)-6-methylergolin-8-yl)-, (Z)-2-butenedioate (1:1);	0	-1.38490926					CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C)C1)c34	BIOMOL	AC-839	-1.12412178	-0.53700677	-0.38074517	-1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507799-01	Flumethasone acetate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2823-42-9				-2.3760493973	4	4		0	-0.57803468					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	Carbosynth	FF23330	-0.66838046	-0.28675704	-0.05264543	-0.57803468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-03	Idoxuridine	170465014	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	54-42-2	Idoxuridine			-0.3284855485	4	4		0	0.25433526					IC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick	Prestw-18	-0.15424165	-0.5995829	0.42116346	0.25433526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179767-02	NCGC00179767-02	363676967	lipid metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					1.1103847233	4	4		0	1.04046243					CC(=O)OC(C)(C)\C=C\C(=O)[C@](C)(O)[C@H]1C(O)C[C@@]2(C)[C@@H]3C\C=C4/[C@@H](/C=C(/O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-005666	0	0.39103233	-0.6317452	1.04046243												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00024379-29	EMETINE DIHYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	316-42-7, 483-18-1 [emetine]		2.5118864315	-5.6	27.1061963106	4	4		-15.9687861279	-2.47398844	0.7516388435	0.9999543091			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	Microsource	01500272	35.83547558	8.47236705	2.00052645	-2.47398844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016267-06	Isocarboxazid		Monoamine oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	59-63-2				4.0308295292	4	4		0	1.17919075					CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Prestwick	Prestw-795	1.59383033	-0.49530761	-1.00026323	1.17919075												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00522560-01	Tasimelteon		Melatonin receptor type 1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	609799-22-6				-3.8317702836	4	4		0	-1.45145145			4544	MTNR1B	CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2	MedChem Express	HY-14803	-0.8110687	-0.86206897	-0.10473946	-1.45145145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522029-01	Zuclopenthixol Decanoate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	64053-00-5				-0.3803674439	4	4		0	-1.25125125					CCCCCCCCCC(=O)OCCN1CCN(CC\C=C/2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1	Toronto Research	Z701490	0.09541985	-0.0261233	0.47132757	-1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181290-01	Furazabol	144206325		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1239-29-8	Furazabol; Miotolan; 			5.0387128225	4	4	androfurazanol;Miotolan;CIPLUS_157956;17 alpha-methyl-5 alpha-androstano(2,3-c)furazan-17 beta-ol;furazabol;FURAZABOL;LS-19413;Furazabol;17-METHYL-5.ALPHA.-ANDROSTANO(2,3-C)FURAZAN-17.BETA.-OL;Furazabolum;furazabolum;17-methyl-5 alpha-androstano(2,3-c)(1,2,5)oxadiazol-17 beta-ol;5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl-;	0	3.55355355					C[C@]5(O)CC[C@@H]4[C@]5(C)CC[C@H]1[C@H]4CC[C@H]2Cc3nonc3C[C@]12C	ACC	furazabol	0.38167939	0.75757576	1.25687353	3.55355355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015954-04	Sobuzoxane	90341303	DNA topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-0.3609587249	4	4		0	-0.8008008					CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O	SigmaAldrich	Lopac-S-4692	-0.14312977	0.54858934	0.31421838	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496851-01	NCGC00496851-01			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	207300-70-7				-2.6667472796	4	4		0	-0.3003003					OC1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O	SIGMA	G8645	-0.76335878	-0.75757576	0.10473946	-0.3003003												1.92E-7	9.6E-7	0.0000048	0.000024											
NCGC00166079-02	C.I. Solvent Red 24	170465710		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	85-83-6				-5.3039859442	4	4		0	-0.65065065					Cc4ccccc4/N=N/c3ccc(/N=N/c1c2ccccc2ccc1O)c(C)c3	SIGMA	198102	-1.47900763	-1.43678161	-0.05236973	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018098-07	Iodoquinol	170465640		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	83-73-8		4.4668359215	-5.35	55.9035118101	3	4		55.7884912158	51.62311956	0.010853067	0.999927371			Oc1c(I)cc(I)c2cccnc12	Vitas	STK070581	-1.10640301	-0.48712596	1.59287257	51.62311956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179244-03	Dorzolamide hydrochloride	170465119	Carbonic Anhydrase Type II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	130693-82-2	; Trusopt; 1   Dorzolamide;Dorzolamide HCL;Dorzolamide hydrochloride			-4.4327673461	4	4		0	-0.63341251			760	CA2	Cl.NS(=O)(=O)c1cc2[C@H](C[C@H](C)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-1116	-0.9180791	-0.76548365	-1.43088553	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090970-03	Maleic acid	170465983	"NADP-dependent malic enzyme, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	110-16-7				4.3906875008	4	4		0	0.73898126					O=C(O)/C=C\C(=O)O	SIGMA	M0375	1.01224105	0.20876827	1.48488121	0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015836-12	Pirenzepine	170465793	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	28797-61-7				-5.1558804923	4	4		0	-1.48441366			1128	CHRM1	O=C(CN1CCN(C)CC1)N4c2ccccc2C(=O)Nc3cccnc34	Enzo	AC220	-0.28999517	-0.46867292	-1.39993637	-1.48441366												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00091455-09	Celecoxib	170464693	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	169590-42-5	; 5   Celecoxib (Celebrex);Celecoxib; Celecoxib; Celebrex;CELECOXIB	10	-5	67.794684184	3	4		71.4170672538	63.43394359	0.0366335302	0.9991715304	5743	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(C)cc2)C(F)(F)F	Microsource	01503678	0.38666022	-0.81401085	-1.84537066	63.43394359												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344524-01	Benzylhexadecyldimethylammonium chloride	170465465		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	122-18-9				-5.9137392382	4	4		0	-2.3400191					[Cl-].C[N+](C)(Cc1ccccc1)CCCCCCCCCCCCCCCC	SIGMA	13400	-1.49882904	-0.53700677	0.05439217	-2.3400191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181048-02	Dolasetron mesylate hydrate	225144319	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	115956-13-3				-0.7102495536	4	4		0	0.04775549					O=C1CN2[C@H]3CC(C[C@@H]2CC1C3)OC(=O)C4=C[NH]C5=CC=CC=C45	SIGMA	D9571	-0.51522248	-0.49031053	1.30541202	0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532505-01	N,N-DIMETHYLGLYCINE HYDROCHLORIDE		Glutamate [NMDA] receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-3.4523070913	4	4		0	-1.04046243					CN(C)CC(O)=O	SIGMA	MFCD00012610	-0.66838046	-1.06882169	-0.3158726	-1.04046243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094558-09	CACODYLIC ACID			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	75-60-5				-4.8072072173	4	4		0	0.9009009					C[As](C)(O)=O	Microsource	01503947	-1.38358779	-1.90700104	0.10473946	0.9009009												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178027-08	VALSARTAN		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	137862-53-4				1.181753211	4	4		0	0.25025025					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	Microsource	01505209	0.09541985	-0.39184953	1.46635245	0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532500-01	GABAPENTIN ENACARBIL			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-0.4816013491	4	4		0	-0.8008008					CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(O)=O	AdvChemBlocks	G-5813	-0.47709924	0.49634274	1.41398272	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346691-02	Canagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	842133-18-0				9.487769471	4	4		0	1.55155155				SCL5A2	CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	Selleck	S2760	2.6240458	0.96656217	1.36161299	1.55155155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181104-04	Dithiazanine chloride	124893646		DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-2.3629522377	4	4		0	-1.75175175					CCN1C(/SC2=C1C=CC=C2)=C/C=C/C=C/C3=[N+](CC)C4=C(S3)C=CC=C4	NCI	NSC-221154	0.23854962	-1.64576802	-0.73317622	-1.75175175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510944-01	Cyclopentamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	538-02-3				-0.896027275	4	4		0	0.7007007					CNC(C)CC1CCCC1	SantaCruz Bio	sc-500096	0.09541985	-1.2800418	-1.09976434	0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386381-04	Besifloxacin Hydrochloride		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	405165-61-9				1.0938688947	4	4		0	0.9009009					N[C@@H]1CCCCN(C1)C2=C(Cl)C3=C(C=C2F)C(=O)\C(=C/N3C4CC4)C(O)=O	Glixx	GLXC-06708	0.57251908	-1.07105538	-0.41895784	0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182975-01	Amoebicon	144206766		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	116-49-4	Glycobiarsol; Glicobiarsol; 			7.7074451543	4	4	GLYCOBIARSOL;LS-172304;Glicobiarsol;Glycobiarsol;glycobiarsolum;Glycobiarsolum;CIPLUS_151450;glycobiarsol;	0	-0.55055055					O=C(Nc1ccc(cc1)[As](O)(=O)O[Bi]=O)CO	NCI	NSC_221709	2.67175573	1.90700104	-0.05236973	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319175-03	Rilpivirine			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	500287-72-9				-1.512509932	4	4		0	1.32743363					CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	APExBIO	A3765	-0.38860104	-0.80448562	-1.35917443	1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263884-02	Zolmitriptan	170464875	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	139264-17-8	ZOLMITRIPTAN;Zolmitriptan (Zomig)			-0.0490508012	4	4		0	-1.0013973			3351	HTR1B	CN(C)CCc2cnc1ccc(cc12)C[C@@H]3NC(=O)OC3	Microsource	01505281	0.69948187	-0.95075573	-0.60407752	-1.0013973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182982-01	Dalcotidine	144206834	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	120958-90-9	Dalcotidine; 			-0.24561494	4	4	dalcotidine;KU-1257;CIPLUS_705874;DALCOTIDINE;dalcotidinum;N-ethyl-N'-(3-(3-(piperidinomethyl)phenoxy)propyl)urea;Dalcotidine;KU 1257;	0	-0.52784376			3274	HRH2	CCNC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Pharmaron	PH-NIH-151679	-0.72975518	0.34794711	1.37688985	-0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166020-03	Ethyl 3-aminobenzoate methanesulfonic acid salt	170465717	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	886-86-2				-4.2096919669	4	4		0	-1.42517815					Nc1cc(ccc1)C(=O)OCC.CS(=O)(=O)O	Vitas	STK344228	-0.9180791	-0.90466249	-0.29697624	-1.42517815												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	165800-03-3				-1.06705381	4	4		0	-0.85549133				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-0.10282776	-0.07820647	-0.1579363	-0.85549133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181306-04	Docetaxel	170464919	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	114977-28-5	 Docetaxolum; Docetaxel Hydrate; ; AE-docetaxel;DOCETAXEL; 5   Docetaxel; Docetaxel hydrate; Docetaxel Anhydrous; Docetaxel Trihydrate; Docetaxel;Docetaxel; Taxoltere metro			-3.7430944215	4	4		0	0.80924855			203068	TUBB	CC(C)(C)OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](O)C(=C5C)C6(C)C	Alfa Aesar	J60174	-1.59383033	0.28675704	-0.68439063	0.80924855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344565-01	Mizolastine	170465604	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	108612-45-9				4.8671738889	4	4		0	6.77456647				HRH1	O=C1C=CN=C(N1)N(C)C2CCN(CC2)c4nc5ccccc5n4Cc3ccc(F)cc3	Prestwick	Prestw-1506	-0.25706941	-0.02606882	0.68439063	6.77456647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371080-02	Dexmedetomidine		Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	113775-47-6				3.0655280393	4	4		0	-0.39306358					C[C@H](C1=CN=C[NH]1)C2=C(C)C(=CC=C2)C	Selleck	S3075	0.71979434	0.86027112	1.31613583	-0.39306358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161605-02	L-Ascorbyl 6-palmitate			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	137-66-6				0.9649102129	4	4		0	-0.71676301					CCCCCCCCCCCCCCCC(=O)OCC(O)C\1OC(=O)\C(=C1O)O	APExBIO	B2105	0.5655527	-0.18248175	0.26322716	-0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178692-04	N-METHYL (-)EPHEDRINE [1R,2S]		Beta-1 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	552-79-4				-0.2095915396	4	4		0	0.94797688					C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C	Microsource	02300220	-0.30848329	0.2346194	-0.42116346	0.94797688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-12	Ponatinib		FGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1114544-31-8				5.5139181606	4	4		0	-0.6006006				FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Glixx	GLXC-01988	1.8129771	1.75026123	0.15710919	-0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248803-03	DL-Cysteine	170464842		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	3374-22-9				-4.3089323725	4	4		0	-1.55155155					O=C(O)C(N)CS	Bosche	C2088	-0.66793893	-1.38453501	-0.68080649	-1.55155155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262598-02	Atracurium besylate	225144360		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	64228-81-5	Atracurium besylate			-4.2052498102	4	4		0	-0.55055055					COC1=CC2=C(C=C1OC)C(CC3=CC(OC)=C(OC)C=C3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=C(C=C(OC)C(OC)=C5)C4CC6=CC(OC)=C(OC)C=C6)CC2	Prestwick	Prestw-5	-1.19274809	-1.48902821	0.41895784	-0.55055055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095055-13	SALINOMYCIN, SODIUM			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	55721-31-8; 53003-10-4 (acid)		14.1253754462	-4.85	177.1261738885	4	4		-32.320610684	11.71171171	0.5715734907	0.7223098659			[H]C1(CC[C@@](O)(CC)C(C)O1)[C@@]2(C)CC[C@@]3(O2)OC4(OC(C(CC)C(=O)C(C)C(O)C(C)C5OC(CCC5C)C(CC)C([O-])=O)C(C)CC4C)\C=C/C3O	Microsource	01503602	46.27862595	27.29885057	44.51427075	11.71171171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	282526-98-1		10	-5	64.760876802	3	4		96.3569045565	87.88788789	0.0063328164	0.9999752649			CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	-0.71564885	-1.17554859	2.46137732	87.88788789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389431-01	RIBOFLAVIN 5-PHOSPHATE SODIUM		NADH oxidation Oxidative Enzyme	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	130-40-5				-3.5699308242	4	4		0	-1.3013013					CC1=C(C)C=C2N(C[C@@H](O)[C@@H](O)[C@@H](O)CO[P](O)([O-])=O)C\3=N\C(=O)NC(=O)C3=N/C2=C1	Microsource	01505763	-0.19083969	-1.38453501	-0.5236973	-1.3013013												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00167981-03	Isosorbide mononitrate			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	16051-77-7				-3.5929373904	4	4		0	-0.53563111					O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O	Prestwick	Prestw-1294	-1.16580311	0.36567528	-0.40271835	-0.53563111												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00181786-02	Naratriptan hydrochloride	170465423	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	143388-64-1	Naratriptan hydrochloride; Naratriptan hydrochloride; Amerge; 			-3.7119578597	4	4		0	-1.09455054			3351	HTR1B	Cl.CN1CCC(CC1)c2cnc3ccc(CCS(=O)(=O)NC)cc23	SIGMA	N1415	-1.01036269	-0.90199902	0.45305814	-1.09455054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167522-02	Hexoprenaline sulfate	170465755	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	32266-10-7				0.7433110664	4	4		0	2.11137503					Oc1ccc(cc1O)C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2.O=S(=O)(O)O	Sequoia	SRP01560h	-0.40018832	-0.90466249	-0.18898488	2.11137503												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00261971-01	Mazaticol	170466055		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	42024-98-6	Mazaticol;Mazaticolum;Pentona;Mazaticol			4.0533169773	4	4		0	3.2726313					OC(C(=O)OC1CC2CCC(C)(C)C(C1)N2C)(c3cccs3)c4cccs4	GVK	FFS-11-286-NCI-243	0.02354049	2.01809325	-0.94492441	3.2726313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015385-18	Dipyridamole	170464694	Phosphodiesterase PDE3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58-32-2	; ; Prandiol; Dipyridamole;DIPYRIDAMOLE; Asasantin; Dipiridamol;Dipyridamole; Persantine			3.8378032063	4	4		0	3.43098443			8654	PDE5A	OCCN(CCO)c2nc1c(nc(nc1c(n2)N3CCCCC3)N(CCO)CCO)N4CCCCC4	Enzo	EI127	-0.07062147	-0.55671538	0.56695464	3.43098443												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015162-10	Buspirone	170464909	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	36505-84-7				0.434035822	4	4		0	2.48086566					O=C4CC1(CCCC1)CC(=O)N4CCCCN2CCN(CC2)c3ncccn3	Enzo	AC526	-1.43596987	-0.06958942	0.4049676	2.48086566												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	12.5892541179	-4.9	87.1644605315	3	4		100.1675187595	80.39060438	0.020142605	0.9997496961	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	0.35310734	-0.97425191	-0.94492441	80.39060438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016246-09	Chlorhexidine	170464748	N-Acetyltransferase Eis (Mycobacterium tuberculosis) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane			1.3504531573	4	4		0	-1.05568752			4312	MMP1	Clc2ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)cc2	Vitas	STK089248	0.54143126	2.43562978	-0.18898488	-1.05568752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015767-10	Oxybutynin chloride		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1508-65-2	 Oxibutinina; ;; Oxytrol; Tropax;Oxybutynin Chloride; Esoxybutynin Chloride; Ditropan; Oxybutinin;OXYBUTYNIN CHLORIDE; Oxybutynin Hcl; Oxybutynin Chloride;Oxybutynin chloride	3.5481338923	-5.45	33.3501873112	2.4	4		31.4237288079	28.92583795	0.0105633776	0.9999312754		CHRM1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2	SIGMA	O2881	-0.35310734	-0.34794711	2.40280778	28.92583795												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013082-04	trans-Aconitic acid	170466847	Cytoplasmic aconitate hydratase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	4023-65-8				0.6292720156	4	4		0	2.11137503			48	ACO1	OC(=O)C(\CC(=O)O)=C\C(=O)O	Specs	AE-562/J255898	-0.77683616	0.41753653	-0.51295896	2.11137503												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159325-05	Desloratadine	170464781	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	100643-71-8		11.220184543	-4.95	100.5163595501	3	4		105.7789144095	91.31697018	0.0268804625	0.9995540958			Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2	Vitas	STK586537	-0.21186441	1.67014614	-0.4049676	91.31697018												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095099-05	Sildenafil citrate	170465285	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	171599-83-0	 ; Sildenafil(Viagra); SILDENAFIL;SILDENAFIL; Caverta; Viagra;SILDENAFIL CITRATE			-1.4943822718	4	4		0	-0.63341251			8654	PDE5A	CN1CCN(CC1)S(=O)(=O)c4cc(C3=Nc2c(CCC)nn(C)c2C(=O)N3)c(OCC)cc4.O=C(O)C(O)(CC(=O)O)CC(=O)O	Microsource	01504099	0.11770245	-1.73973556	0.18898488	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167456-02	Bisibutiamine	170466019		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3286-46-2				7.9736176681	4	5		0	0.75334821					Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N	Bosche	B6282	0.01241003	3.55097365	1.01122039	6.00697238	0.75334821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095089-10	Fluconazole	170464782	Antifungal Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	86386-73-4	; ;Hexaflumuron; Hexaflumuron; Diflucan; Sonet; Fluconazole;FLUCONAZOLE;Fluconazole; FLUCONAZOLE			7.377499715	4	5		0	3.29241071					OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F	Vitas	STK619301	3.16455696	-2.1509482	2.42415847	-1.6358273	3.29241071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164493-02	Dipyrithione	170465699		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3696-28-4				4.6511799345	4	5		0	-2.9296875					[O-][n+]2ccccc2SSc1cccc[n+]1[O-]	Labotest	LT00452770	4.40555969	-1.43820797	3.33841252	-0.64360418	-2.9296875											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015826-13	Perphenazine	170464834	Muscarinic acetylcholine receptor M1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	58-39-9		12.5892541179	-4.9	61.4982624685	3	5		112.6087260011	98.88392857	0.0003037455	0.9998481108	1128	CHRM1	OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Microsource	01503934	-2.89153636	-3.65279369	-2.72890982	-3.70072405	98.88392857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095109-08	Venlafaxine	170465123	5-HT Reuptake Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	93413-69-5	; ;D,L-Venlafaxine?HCl;VENLAFAXINE HYDROCHLORIDE; Effexor XR; VENLAFAXINE; Effexor;VENLAFAXINE; Venlafaxina;Venlafaxine hydrochloride; Venlafaxine			0.9793408825	4	5		0	0.90798211			3350	HTR1A	OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2	Microsource	01504171	-2.11198428	3.77613776	-0.09349539	2.35145386	0.90798211											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024584-17	BROMOCRIPTINE			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	22260-51-1		14.1253754462	-4.85	-0.6166001541	4	5		12.388473348	9.12047703	0.3993511547	0.7119787971			[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N3C(=O)[C@](NC(=O)[C@H]4CN(C)[C@]5([H])CC6=C(Br)NC7=CC=CC(=C67)C5=C4)(O[C@@]23O)C(C)C	SIGMA	B2134	-2.84872299	3.67773678	-4.07372779	-2.68015171	9.12047703											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015876-11	Ranitidine	170465134	Histamine H2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	66357-35-5				10.1123693365	4	5		0	-3.125			3274	HRH2	[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1	Microsource	01501151	3.61131794	-0.70001273	3.67086854	5.25610083	-3.125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015442-15	Fluorouracil	170464762	Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-21-8	 5-Fluorouracil;FLUOROURACIL;5-Fluorouracil			-6.8086216661	4	5		0	-2.04634774				TYMS	FC1=CNC(=O)NC1=O	Vitas	STK297802	-4.1502947	5.59655597	1.88326432	-4.02022756	-2.04634774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166218-02	4,4'-Dinitrodiphenylurea	170465744		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	587-90-6				7.8885418032	4	5		0	2.85946605					O=C(Nc1ccc(cc1)[N+]([O-])=O)Nc2ccc(cc2)[N+]([O-])=O	Specs	AN-153/I108774	2.8978389	-0.82410824	1.61613463	-0.2528445	2.85946605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016743-08	Piromidic acid	170466042		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	19562-30-2				-5.4441373703	4	5		0	-2.50711479					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCCC3	Microsource	01502045	-2.87328094	6.23616236	-2.41752371	-1.6687737	-2.50711479											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00016798-11	(S)-Timolol	170465062	Beta-2 adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	26839-75-8				-2.096081496	4	5		0	-1.61268465					O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C	Enzo	AC172	-1.0805501	-0.40590406	-2.57780152	4.57648546	-1.61268465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159376-04	Methylparaben	170465480	canonical glycolysis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	99-76-3				-3.2040792526	4	5		0	2.42580295					Oc1ccc(cc1)C(=O)OC	Labotest	LTBB002210	-1.8172888	0.30750308	0.54761587	-3.21112516	2.42580295											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164631-05	Sunitinib malate	170465289	VEGFR-1/2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	341031-54-7	 Sunitinib malate;Sunitinib malate; Sunitinib base; ;Sutent			-11.0695009715	4	5		0	-0.77246239			2321	FLT1	O=C(O)C(O)CC(=O)O.CCN(CC)CCNC(=O)C1C(C)=C(N=C1C)/C=C2/c3cc(F)ccc3NC2=O	Sequoia	SRP01785s	-2.28388998	-0.28290283	-3.4593295	-5.20859671	-0.77246239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262959-01	Difethialone	170465892		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104653-34-1	2H-1-benzothiopyran-2-one,			2.3075665648	4	5		0	0.71825451					Brc1ccc(cc1)c2ccc(cc2)C4Cc3ccccc3C(C4)C5=C(O)c6ccccc6SC5=O	GVK	FFS-11-286-NCI-261	-1.32612967	-1.04551046	1.9901162	5.10745891	0.71825451											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015754-16	Nilutamide	170465021	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	63612-50-0	 ;Nilutamide; Nilutamide;NILUTAMIDE; Nilandron			11.1346785642	4	5		0	2.95758929			374	AR	FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O	Microsource	01504152	4.55448002	-1.00547283	3.72627788	-2.03807991	2.95758929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159393-03	N-Acetyl-L-tyrosine	170465742		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	537-55-3				-0.4564738637	4	5		0	-3.45982143					Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1	Labotest	LT03380081	1.9980144	-2.10003818	-1.06662973	0.91177259	-3.45982143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024846-08	Guanabenz	170465364	Adrenergic receptor alpha-2 Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	5051-62-7				-3.3004902771	4	5		0	-1.06026786					Clc1cccc(Cl)c1/C=N/NC(=N)N	Enzo	AC153	-0.43435096	1.36184294	-0.92810639	-2.86940198	-1.06026786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253607-01	Watanidipine	170465844	calcium ion transmembrane transport Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	116308-55-5				-1.2866700297	4	5		0	0.3387993					[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCc3ccc(cc3)N4CCN(CC4)C(c5ccccc5)c6ccccc6	GVK	FFS-11-286-NCI-247	-3.16797642	3.03813038	2.20381995	0.9608091	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253575-01	Arimoclomol	170465602	Heat shock 70 kDa protein 1 Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	289893-25-0				4.0471697768	4	5		0	2.99498577					O[C@H](CN1CCCCC1)CO\N=C(/Cl)c2ccc[n+]([O-])c2	GVK	FFS-11-286-NCI-145	-1.30157171	1.36531365	-1.2154401	5.89127686	2.99498577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253590-01	Variotin	170465957		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	19504-77-9		3.1622776602	-5.5	20.4995086617	4	5		12.3431948761	-1.85662014	0.5137771133	0.7934002687			O=C1CCCN1C(=O)/C=C/C=CC(\C)=C\C(O)CCCC	GVK	FFS-11-286-NCI-227	4.00294695	-0.52890529	-1.53599573	10.03792667	-1.85662014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015680-18	Melatonin	170465589	NOS2 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	73-31-4	; ;Melatonin;MELATONIN; Melatonin	0.6309573445	-6.2	8.8425771871	4	5		-7.460176992	0.06775986	0.3224531537	0.788284098		MTNR1B	CC(=O)NCCc2cnc1ccc(cc12)OC	Specs	AN-153/I149495	3.41355599	7.17097171	0.06678242	-3.71681416	0.06775986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016393-07	2,2'-Dihydroxy-4-methoxybenzophenone	170465540		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	131-53-3				-0.6304111062	4	5		0	-1.86941964					O=C(c1ccc(cc1O)OC)c2ccccc2O	Microsource	01500255	0.43435096	-1.87094311	1.84236044	-0.02681684	-1.86941964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164512-02	Guaiacol carbonate	170465684		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	553-17-3				2.5745715787	4	5		0	1.03236607					COc2ccccc2OC(=O)Oc1ccccc1OC	Labotest	LT02084807	3.56167784	-2.7618684	-2.28563513	-1.82354519	1.03236607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016049-07	Tetracaine hydrochloride	170465190	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	136-47-0				-11.6068245833	4	5		0	-0.41852679					Cl.CN(C)CCOC(=O)c1ccc(NCCCC)cc1	Microsource	01500564	-2.66815587	-2.63459336	-3.17218451	-3.2716546	-0.41852679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015089-17	Amiloride hydrochloride	170465124	Epithelial Sodium Channels (ENaC) Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2609-46-3	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren			-4.6931802252	4	5		0	-1.69399648			6339	SCNN1D	Clc1nc(C(=O)NC(=N)N)c(N)nc1N	Enzo	CA200	-1.37524558	-0.99630996	0.14692133	-0.4045512	-1.69399648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015578-12	Ketoprofen	170465449	non-steroidal antiinflammatory	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	22071-15-4	 Alrheumat; Orudis; Alrheumum; ; Ketoprofen;Ketoprofen; Ketoprofeno; (S)-(+)-Ketoprofen; (S)-Ketoprofen; Profenid;KETOPROFEN			0.889431071	4	5		0	1.3958531				PTGS1	CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2	Microsource	01501215	0.93320236	-1.09471095	0.54761587	-2.14917826	1.3958531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164625-04	Cerivastatin sodium	170465109	HMG-CoA reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	143201-11-0		2.8183829313	-5.55	14.0299185318	4	5		-13.264873288	-3.97072774	0.6465377056	0.3191421364			[Na+].CC(C)c1nc(c(/C=C/[C@@H](O)C[C@@H](O)CC([O-])=O)c(c1COC)c2ccc(F)cc2)C(C)C	Sequoia	143201-11-0	0.12278978	1.63591636	25.39067717	-3.03413401	-3.97072774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163160-04	Talipexole	170466015	Dopamine D4 receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	101626-70-4				3.3521661406	4	5		0	-0.53013393					C=CCN1CCc2sc(N)nc2CC1	Tocris	2759	0.31025068	2.50731831	0.23548968	1.79672835	-0.53013393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016373-08	Benzethonium chloride	170465473		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	121-54-0				-9.3920740541	4	5		0	-4.85491071					[Cl-].CC(C)(C)CC(C)(C)c2ccc(OCCOCC[N+](C)(C)Cc1ccccc1)cc2	Microsource	01500138	-1.30305287	-1.46366298	-2.06399778	-1.26039153	-4.85491071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015227-08	Dexchlorpheniramine hydrochloride	170466889	Histamine H1 Receptor Antagonists; SNRI	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5502-69-2	 ; Clorfenamina;Chlorpheniramine; Chlor-Trimeton; Mylaramine; Polaramine; Dexclorfeniramina; Chlortrimeton;Chlorpheniramine maleate; Ru-Tuss; Teldrin; Chlorpheniramine; Chlor-trimeton;Chlorpheniramine Maleate			-1.8524778369	4	5		0	2.07345169				HRH1	Cl.Clc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2	Vitas	STK736174	-0.9086444	-0.92250922	-2.44423668	0.9102402	2.07345169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167489-03	Sarpogrelate hydrochloride	174006666	5HT(2A) and 5HT(2B) inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	135159-51-2	 ; Sarpogrelate;Sarpogrelate; Anplag; Sarpogrelate HCl	12.5892541179	-4.9	22.206852227	3	5		45.7546279809	40.20870037	0.01391964	0.992971707			Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C	Tocris	3739	-3.38899804	-0.4797048	0.54761587	-2.30088496	40.20870037											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094561-06	Phenothrin	170465585		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	26002-80-2				-8.9326578933	4	5		0	-1.63978859					C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C	Microsource	01504098	-2.08742633	-3.06273063	-1.13530119	-1.28950695	-1.63978859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024567-03	Ambenonium chloride	170465386	Acetylcholinesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	115-79-7				6.2696942515	4	5		0	1.66201117					[Cl-].[Cl-].Clc2ccccc2C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](Cc1ccccc1Cl)(CC)CC	Tocris	0388	-0.80596107	-0.56032873	6.16680913	3.72471992	1.66201117											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015718-12	Naftopidil	170466026	alpha1-Adrenoceptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57149-07-2	;Naftopidil;Naftopidil dihydrochloride; Flivas; KT-611 dihydrochloride; Naftopidil			-10.386121781	4	5		0	-1.38268156			148	ADRA1A	OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34	Tocris	0597	-4.06021898	0.70974972	-0.98913176	-2.32794995	-1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249914-01	Bencyclane	170465760		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2179-37-5		11.220184543	-4.95	8.6060118705	4	5		19.5628683639	17.38717983	0.0175829643	0.991123912			CN(C)CCCOC1(CCCCCC1)Cc2ccccc2	GVK	FFS-11-286-NCI-166	-1.71905697	0.28290283	-0.78803259	-1.2136536	17.38717983											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253592-01	Menadiol	170465455	regulation of blood coagulation Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	481-85-6				-7.8961214444	4	5		0	-2.0192438					Oc1cc(C)c(O)c2ccccc12	GVK	FFS-11-286-NCI-27	-3.21709234	-0.87330873	0.12020836	0.1517067	-2.0192438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166236-02	Oteracil potassium		Orotate Phosphoribosyltransferase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2207-75-2				-11.6392973413	4	5		0	-3.84078212				UMPS	OC1=NC(=NC(O)=N1)C([O-])=O	Bosche	O3085	-1.93126521	-2.27867015	3.26047136	-1.57136622	-3.84078212											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00189077-01	Methsuximide	144207162	Voltage-gated T-type calcium channel Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77-41-8		1.5848931925	-5.8	14.7302032802	4	5	Methsuximide	10.744525552	2.91899441	0.3958363929	0.8900527849			CC1(CC(=O)N(C)C1=O)c2ccccc2	Toronto Research	M271900	-1.87043796	2.67712614	0.59836366	10.99956351	2.91899441											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263655-01	Huperzine A	170466837	Acetylcholinesterase Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	102518-79-6				-2.9176010288	4	5		0	-0.99162011				ACHE	CC2=C[C@H]\3CC=1NC(=O)C=CC=1[C@@](N)(C2)C/3=C\C	Enzo	C117	-1.0796837	1.2078197	0.08548052	-1.54226684	-0.99162011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015705-07	Memantine hydrochloride	170464999	NMDA Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	19982-08-2	 Namenda; ;Memantine;MEMANTINE HYDROCHLORIDE; Axura;Memantine hydrochloride; Ebixa; Memantine hydrochloride; Memantine HCL; Memantina;Memantine Hydrochloride; Memantin			-4.0267726857	4	5		0	-3.67318436			2903	GRIN2A	CC13CC2(C)CC(N)(C1)CC(C2)C3	Vitas	STK520682	-1.87043796	3.12538912	-0.40297961	0.40739124	-3.67318436											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015714-16	Nimodipine	170466561	Voltage-gated L-type calcium channel Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	66085-59-4				10.0103123447	4	5		0	5.23743017					CC=1NC(C)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OCCOC	SigmaAldrich	N149	1.35340633	2.77674013	1.16009281	1.19307435	5.23743017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016421-07	Cyclizine hydrochloride	170465270	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	303-25-3		14.1253754462	-4.85	5.9365556746	4	5		24.5221238919	18.57975335	0.0539877138	0.9719402403			Cl.Cl.CN1CCN(CC1)C(c2ccccc2)c3ccccc3	Microsource	01500211	-1.44891945	-0.4305043	-2.49766262	-4.60176991	18.57975335											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016261-08	Pyridoxine	170464634	Oxidative Stress Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	65-23-6				8.5505723288	4	5		0	1.29888268					Oc1c(CO)c(cnc1C)CO	Vitas	STK177324	2.81326034	0.95878471	2.47893516	-0.05819875	1.29888268											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013687-03	Pyrophosphoric acid			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2466-09-3				-8.3851873656	4	5		0	-3.61731844					O[P](O)(=O)O[P](O)(O)=O	SIGMA	433314	-4.02980535	1.2825302	0.52509464	0.75658373	-3.61731844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253597-01	Isosulfan blue	170464639		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68238-36-8				3.5616745041	4	5		0	1.63407821					[Na+].CC/[N+](CC)=C1\C=C/C(C=C1)=C(/c2ccc(cc2)N(CC)CC)c3cc(ccc3S([O-])(=O)=O)S([O-])(=O)=O	GVK	FFS-11-286-NCI-038	0.13686131	0.63503922	2.08816705	0.26189437	1.63407821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249899-01	Cinoxate	170465555		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	104-28-9				-4.3591882233	4	5		0	-0.36590324					COc1ccc(C=CC(=O)OCCOCC)cc1	GVK	FFS-11-286-NCI-86	-2.01375246	1.3899139	-0.62775477	-1.2642225	-0.36590324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023373-03	Clobetasol propionate	170465385	Corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	25122-46-7	Clobetasol propionate			-8.9362550303	4	5		0	-1.01955307				NR3C1	ClCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-781	-3.78649635	-2.22886316	1.59970692	-1.0184781	-1.01955307											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253737-01	Istradefylline	174007485	Adenosine A2A Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	155270-99-8	Istradefylline			-2.7985418062	4	5		0	0.37709497			135	ADORA2A	COc1ccc(cc1OC)/C=C/c3nc2c(C(=O)N(CC)C(=O)N2CC)n3C	GVK	FFS-12-73-NCI-1738	-1.38381995	-1.85531067	0.30528758	0.81478248	0.37709497											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249887-01	Indecainide	170465192	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	74517-78-5				-0.4725055406	4	5		0	-3.22625698					NC(=O)C3(CCCNC(C)C)c1ccccc1c2ccccc23	GVK	FFS-11-286-NCI-023	0.62347932	-1.00859171	1.57528392	0.55288811	-3.22625698											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015713-13	Nitrendipine	170465897	Intermediate conductance calcium-activated potassium channel protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	39562-70-4		0.316227766	-6.5	-0.9636720823	4	5		6.9138984399	-2.31584821	0.662361335	0.5733478064			CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(c2)[N+]([O-])=O)C(=O)OC	SigmaAldrich	N144	-2.07247456	-3.6782487	7.96509212	-0.08045052	-2.31584821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016271-05	Tolazoline hydrochloride	170465219	Adrenergic receptor alpha-1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59-97-2				-9.5608193231	4	5		0	0.04189944					Cl.c2cc(CC1=NCCN1)ccc2	Specs	AT-139/J221336	-3.75608273	-3.17519611	0.3785566	-0.96027935	0.04189944											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016241-10	Furosemide	170464879	Loop Diuretics	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54-31-9	 ; Diumide-K; Frusemid;FUROSEMIDE; Errolon; Lasix; Furosemide;Furosemide; Furosemide and potassium; Furosemida; Furantral; Furosemide solution; Fusid; Diumide-K continus; Furanthril			5.3997939331	4	5		0	-2.33240223					NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O	Vitas	STK177334	4.45559611	-0.90897771	-0.40297961	-0.29099374	-2.33240223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018102-12	Flunarizine	170466037	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52468-60-7	Sibelium; ; Flu Narizine;Flunarizine dihydrochloride; Hydrochloride, Flunarizin;Flunarizine; Flunarizin; Flunarizina; Flunarizine	12.5892541179	-4.9	58.233704945	3	5		109.9366356875	90.09486607	0.0022701402	0.9988631618			Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4	Enzo	CA225	-3.636138	-3.01641848	-0.01385233	-0.34861893	90.09486607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016542-06	Levonordefrin	170464794	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	829-74-3				-1.8638027227	4	4		0	1.48441366					Oc1ccc(cc1O)[C@@H](O)[C@H](C)N	Enzo	AC1038	-0.8699855	0.27133695	-1.97263761	1.48441366												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389304-01	Clindamycin Phosphate		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	24729-96-2				-3.3891784964	4	4		0	-0.19102197					CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O[P](O)(O)=O)C(O)C2O	APExBIO	B1708	-0.98360656	-0.95727294	-0.43513734	-0.19102197												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263117-05	Panobinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	404950-80-7				-11.7159263766	4	4		0	-2.62655205				HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Selleck	S1030	-2.57611241	-2.31146393	-2.23007887	-2.62655205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182711-02	Picosulfate sodium	225144334		DPI_SARS-CoV-2_General	2019_NPC-4_CPE					17.0199844075	4	4		0	5.48957509					[O-][S](=O)(=O)OC1=CC=C(C=C1)C(C2=CC=C(O[S]([O-])(=O)=O)C=C2)C3=CC=CC=N3	APAC	877841	3.46045198	4.24495477	1.53887689	5.48957509												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015594-09	LOXOPROFEN SODIUM			DPI_SARS-CoV-2_General	2019_NPC-4_CPE	80382-23-6				5.038357022	4	4		0	3.4837688					CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1	Sequoia	80382-23-6	-0.25894539	1.73973556	0.45896328	3.4837688												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094087-05	Mizoribine	170466027	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	50924-49-7	; ;Mizoribine (Bredinin);MIZORIBINE; Mizoribine;Mizoribine; Mizoribina			-4.2116028243	4	4		0	0.73898126			727833	IMPDH1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2O	Sequoia	50524-49-7	-1.24764595	-1.80932498	-1.37688985	0.73898126												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091285-03	Tricaprylin	170465841		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	538-23-8				3.8945984214	4	4		0	-0.46568627					O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC	SIGMA	91039	1.18447581	0.87516088	0.86737549	-0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015409-11	Edrophonium chloride	170464801	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	116-38-1				1.4316513987	4	4		0	0.95588235					[Cl-].C[N+](C)(CC)c1cccc(O)c1	Microsource	02300219	0.17641129	1.08108108	-0.69949636	0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161621-03	Cepharanthine	170465994		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	481-49-2		1.995262315	-5.7	118.3200811268	3	4		83.6376608872	5.80882353	1	0.9999948551			COc8ccc1cc8Oc7ccc(C[C@H]4c5c(Oc3cc2c(CCN(C)[C@@H]2C1)cc3OC)c6OCOc6cc5CCN4C)cc7	Vitas	STK801907	0.63004032	2.36808237	79.54672636	5.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167419-03	ENZACAMENE			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	36861-47-9				-2.8831964734	4	4		0	-1.10294118					CC1=CC=C(C=C1)\C=C/2C3CCC(C)(C2=O)C3(C)C	SIGMA	78551	-0.83165323	1.18404118	-1.09121433	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095045-05	Sulfanitran	170466141	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	122-16-7				-2.737865002	4	4		0	-1.28913444					O=S(=O)(Nc1ccc(cc1)[N+]([O-])=O)c2ccc(NC(C)=O)cc2	Microsource	01503339	-0.33898305	-0.65244667	-0.22802128	-1.28913444												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181774-02	Chrysarobin	170465659		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	491-59-8		2.8183829313	-5.55	13.4842226675	4	4		11.154415396	10.88570015	0.1897852869	0.9773569168			Oc2c3c(cc1cccc(O)c12)cc(C)cc3O	Sequoia	491-59-8	1.01498308	-0.96201283	0.31816736	10.88570015												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183000-01	Lanperisone hydrochloride	144206892	Sodium channel alpha subunit Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	116287-13-9	Lanperisone; 			-2.2200051395	4	5	Lanperisone hydrochloride;lanperisone;LANPERISONE HYDROCHLORIDE;Lanperisone Hydrochloride;CIPLUS_775823;CIPLUS_3846316;LANPERISONE;Lanperisone;lanperisonum;	0	-2.84598214					C[C@H](CN1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F	Pharmaron	PH-NIH-98442	-0.16133035	-1.92185312	0.98351572	1.23357468	-2.84598214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023643-15	Estrone	170465020	Steroid hormone	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	53-16-7				2.8183575942	4	5		0	1.42299107				ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)c4cc3	Vitas	STK801833	0.06205014	-3.24551355	1.67613243	3.91525878	1.42299107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013082-04	trans-Aconitic acid	170466847	Cytoplasmic aconitate hydratase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4023-65-8		0.1584893192	-6.8	12.0634947823	4	5		13.255474452	-1.2150838	0.3064224246	0.9383775253	48	ACO1	OC(=O)C(\CC(=O)O)=C\C(=O)O	Specs	AE-562/J255898	-2.29622871	3.00087162	4.21296862	7.79863233	-1.2150838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00063561-03	4,5-Diphenylimidazole	170465946		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	668-94-0				-4.1331011966	4	5		0	-4.63169643					c1ccc(cc1)c2ncnc2c3ccccc3	Labotest	LT03333454	0.83147183	-1.43820797	0.041557	-1.7699115	-4.63169643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015580-13	Ketotifen	170465378	Histamine H1 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	34580-13-7	Ketotifen; Zaditor;Ketotifen fumarate; Ketotifen fumarate;; ; Fumarate, Ketotife; Ketotiphen;KETOTIFEN FUMARATE; Zaditen; Ketotifen fumarate salt; Ketotifen Maleate; Ketotiphene; Ketotifeno			-6.6646088025	4	5		0	-2.69553073			9704	HRH1	CN1CC/C(CC1)=C3\c4ccccc4CC(=O)c2sccc23	Vitas	STK048448	-0.74513382	-2.00473166	-0.10990353	-2.56074494	-2.69553073											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095116-05	Metaxalone	170465241		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1665-48-1		1	-6	1.9285681768	4	5		10.142335764	0.48882682	0.0730751491	0.9967390288			Cc1cc(cc(C)c1)OCC2CNC(=O)O2	Microsource	01504229	-3.45194647	-2.77674013	0.18317255	7.01294922	0.48882682											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00142615-08	Epinephrine	170464973	alpha/beta-adrenoceptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51-43-4	 TEC solution;;(-)-Epinephrine bitartrate; L-Epinephrine; DL-Adrenaline; 4-(1-Hydroxy-2-; ; (+/-)-Adrenalin; TAC combination; L-(-)-EPINEPHRINE; Epinephrin; Asmatane mist; (+/-)-Epinephrine; Epinephrine; Epinefrina; (-)-Epinephrine bitartrate; dl-Adrenaline; (-)-Adrenalin; Adrenaline-L Bitartrate; Adrenalin chloride; Piladren; Sphygmogenin; Racepinephrine Hcl;Epinephrine; Levorenone; Racepinefrina; (-)-Epinephrine			-8.2575833214	4	5		0	-3.01339286			148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CNC	Labotest	LT03210011	-1.57607347	-0.08909253	-2.11940712	-1.58219362	-3.01339286											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015766-13	Oxymetazoline hydrochloride	170464916	alpha2A(2D)-Adrenoceptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1491-59-4	; ; Oximetazolina;Oxymetazoline;OXYMETAZOLINE HYDROCHLORIDE; Afrazine; 3-[(4,5-Dihydro-; Afrin;OXYMETAZOLINE;Oxymetazoline..HCl;Oxymetazoline hydrochloride; Oxymetazoline hydrochloride			-2.8286283126	4	5		0	1.15921788			148	ADRA1A	CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2O	Enzo	AC138	-3.26946472	0.38600423	1.11124679	1.89145933	1.15921788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181912-01	Iomazenil	144206800	GABAergic synapse Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	127985-21-1				0.2854031033	4	4	IOMAZENIL (123I);iomazenilum (123I);iomazenil (123 I);Ro 16-0154;Iomazenil(123I);Ro-16-0154;IOMAZENIL (123 I);CIPLUS_208012;Iomazenil (123I);Benzodine;ethyl 7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;iomazenil;Iomazenil ((sup 123)I);(123I)iomazenil;	0	2.07840042					O=C(OCC)c3ncn2c3CN(C)C(=O)c1c(I)cccc12	Pharmaron	PH-NIH-10	-0.82324455	-0.25094103	-0.27869268	2.07840042												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263560-01	6-Aminopenicillanic acid	225144362		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	551-16-6				0.1787436258	4	4		0	-1.07866351					CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O	Bosche	A0928	0.04842615	0.05018821	2.25487712	-1.07866351												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00262940-01	Iodoxamic Acid	170465432		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	31127-82-9	Acide iodoxamique;Iodoxamate meglumine;Iodoxamic acid			-1.196033819	4	4		0	1.86792949					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCOCCOCCOCCOCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	GVK	FFS-11-286-NCI-61	-0.62953995	-0.50188206	-1.64682037	1.86792949												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163468-05	Mitomycin C	170464814	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	50-07-7	; ; Ametycine; Mitomycin-C;Mitomycin C;Mitomycin; Mutamycin; MITOMYCIN C; Mitocin;MITOMYCIN C; Mitocin-C; Muamycin			0.4162268358	4	4		0	-0.84116774				H2AFX	NC(=O)OC[C@@H]3C=1C(=O)C(N)=C(C)C(=O)C=1N2C[C@@H]4N[C@@H]4[C@@]23OC	Sequoia	50-07-7	-0.24166264	-1.35668476	2.60897232	-0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016637-10	Diloxanide furoate	170466783		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	3736-81-0				2.1900976843	4	4		0	-0.19792182					ClC(Cl)C(=O)N(C)c1ccc(cc1)OC(=O)c2ccco2	Microsource	01505532	1.35331078	0.61667489	-0.50906777	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253593-01	Bitolterol	170465239	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	30392-40-6		3.5481338923	-5.45	26.376048594	4	4		25.4504193359	24.49282533	0.0511614406	0.9983854152			O=C(Oc2cc(ccc2OC(=O)c1ccc(C)cc1)C(O)CNC(C)(C)C)c3ccc(C)cc3	GVK	FFS-11-286-NCI-028	-0.09666506	-1.20868278	0.50906777	24.49282533												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166005-02	L-Cysteine methyl ester hydrochloride	225144264		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	18598-63-5				-2.3998525853	4	4		0	0.51470588					COC(=O)[C@@H](N)CS	SIGMA	410209	-1.18447581	0.87516088	-0.53161724	0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164549-02	Dofetilide	170465418	K(V)11.1 (erg1) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	115256-11-6	; 2   Dofetilide; Tikosyn; Dofetilide;Dofetilide; Dofetilida			0.4782764682	4	4		0	2.08333333				KCNH2	CS(=O)(=O)Nc1ccc(cc1)CCN(C)CCOc2ccc(cc2)NS(C)(=O)=O	Sequoia	SRP045723d	-0.5796371	0.15444015	0.41969782	2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095152-09	Alfuzosin hydrochloride	170465022	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	81403-68-1	; Uroxatral ER; ; ALFLUZOCIN;ALFUZOSIN HYDROCHLORIDE; Uroxatral; Alfuzosin Hcl (Uroxatral);Alfuzosin hydrochloride; Afluzosin;ALFLUZOSIN			2.1934919793	4	4		0	1.44698763			148	ADRA1A	Cl.O=C(NCCCN(C)c2nc1cc(OC)c(OC)cc1c(N)n2)C3CCCO3	Microsource	01505263	0.6779661	0.70263488	-1.08943501	1.44698763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167456-02	Bisibutiamine	170466019		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3286-46-2				-0.7467120155	4	4		0	0.13154433					Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N	Bosche	B6282	0.04842615	-0.30112923	-0.73473524	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015798-11	Dexpropranolol	170464682	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5051-22-9		10	-5	18.3658204056	4	4		18.905993228	16.92231569	0.0599962355	0.9977834348			CC(C)NC[C@@H](O)COc2cccc1ccccc12	Specs	AN-153/I110481	-0.33832769	0.61667489	0	16.92231569												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091737-05	Sorbic acid			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	110-44-1				-1.2118923995	4	4		0	-0.19792182					C/C=C/C=C/C(O)=O	SIGMA	S1626	-0.33832769	0.71534287	-0.82723513	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00538147-01	NCGC00538147-01			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-2.2195569244	4	4		0	-0.19102197					CCCCCCCCNC(=N)NC(=N)NCC1=CC(=C(Cl)C=C1)Cl	Pharmaron	PH-NIH-2017-009-L1-5-0	-0.46838407	-0.77048798	-0.48952951	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188440-01	Zinc dibutyldithiocarbamate	144206589		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	136-23-2				-5.3677461894	4	4	ZINC DIBUTYLDITHIOCARBAMATE	0	-2.81757402					[Zn+2].[S-]C(=S)N(CCCC)CCCC.CCCCN(CCCC)C([S-])=S	APAC	878050	-1.35831382	0.35022181	-0.05439217	-2.81757402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159491-04	Rimantadine	170465164	M2 Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1501-84-4	; Flumadine; Riamantadine;Rimantadine hydrochloride; Rimantadina; ; Hydrochloride, Rimantadin; Flumadine Oral; Roflual;RIMANTADINE HYDROCHLORIDE; Rimantadine hydrochloride; Rimantadine Hcl			0.7084944396	4	4		0	1.15196078					Cl.CC(N)C12CC3CC(C1)CC(C2)C3	Vitas	STK177253	0.37802419	-1.23552124	-0.36373811	1.15196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016018-11	Tetrahydrozoline HCl		Adrenergic receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	522-48-5				-3.9290841654	4	4		0	1.59313725					C1CC(\C2=N\CCN2)C3=C(C1)C=CC=C3	Selleck	S4043	-1.68850806	-1.18404118	0.02797985	1.59313725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090686-11	Nitrofurazone	170464946	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	59-87-0	; ;Nitrofurazone; Furacilin; Nitrofurazone solution; Furacillin;NITROFURAZONE; Nitrofurazone;Nitrofural; Furacin			-1.1614501067	4	4		0	0.26960784					O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1	Microsource	01500434	-0.88205645	-0.15444015	1.42697258	0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018268-08	Itraconazole			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	84625-61-6		2.5118864315	-5.6	21.6325994366	4	4		15	4.9754902	1	0.9998051356			CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Selleck	S2476	0.63004032	0.56628057	13.57022943	4.9754902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183363-01	Sincalide	144207030	Cholecystokinin A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	25126-32-3				-1.0623625543	4	4	Sincalide;ASP-TYR(SO3-H)-MET-GLY-TRP-MET-ASP-PHE-NH2;Sincalida;(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide;sincalidum;SINCALIDE;Pancreozymin C-terminal octapeptide;NTOC00000205-01;CCK Octapeptide, sulfated;sincalide;Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-;Cholecystokinin octapeptide;SQ-19844;Sincalidum;CCK-8;CIPLUS_174725;	0	1.00490196					NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc2ccc(OS(=O)(=O)O)cc2)NC(=O)[C@@H](N)CC(=O)O)Cc4cnc3ccccc34	SigmaAldrich	C2175	-0.68044355	-0.36036036	0.25181869	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179445-03	Dydrogesterone	170465104	signaling/transport	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	152-62-5				3.4945845463	4	4		0	5.34069982					CC(=O)[C@H]2CC[C@H]3[C@@H]4C=CC1=CC(=O)CC[C@@]1(C)[C@@H]4CC[C@]23C	Prestwick Chemical, Inc.	Prestw-671	-0.7748184	-0.45169385	-0.58272105	5.34069982												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166310-02	Marbofloxacin	170465732	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	115550-35-1	 ;Marbofloxacin; Marbofloxacin; Zeniquin;MARBOFLOXACIN; Marbofloxacino; Marbocyl; Marbocyl FD; Dexamethasone			-1.5485988991	4	4		0	-0.34201526					CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)N(C)COc34	Sequoia	115550-35-1	-0.33898305	0.55207026	-0.88674943	-0.34201526												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00017331-08	(-)-Epicatechin	170465932	superoxide anion generation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	490-46-0				3.1434144378	4	4		0	3.60431465					Oc1ccc(cc1O)[C@H]2Oc3cc(O)cc(O)c3C[C@H]2O	Microsource	00210205	0.33898305	-0.65244667	-0.93742083	3.60431465												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095112-05	Avobenzone	170464749	UVA ray absorber	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	70356-09-1	; ; Avobenzona; AVOBENZONE;AVOBENZONE; Shade uvaguard; Photoplex;Avobenzone; 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione			-4.0517011502	4	4		0	-0.9896091				CAT	COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C	Microsource	01504190	-1.15998067	-1.35668476	0.12726694	-0.9896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016799-08	Suxibuzone	170465972	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	27470-51-5				0.1430461367	4	4		0	0.64324592			791253	PTGS2	O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Prestwick Chemical, Inc.	Prestw-658	0.04833253	-0.07400099	-0.57270124	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00070736-03	Imiquimod	170464691	TLR 7 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	99011-02-6	; ; 3M Brand of Imiquimod; Aldara; Imiquimod;Imiquimod			2.9399294082	4	4		0	1.38545275			51284	TLR7	CC(C)Cn3cnc2c(N)nc1ccccc1c23	Vitas	STK583860	0.62832286	-1.01134682	0.69996818	1.38545275												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00271596-03	Exemestane	170464628	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	107868-30-4	Exemestane			4.3724576101	4	4		0	8.30945559			1588	CYP19A1	O=C3C=C4C(=C)C[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)[C@@]4(C)C=C3	Tocris	3759	-0.6557377	-0.72379173	0.48952951	8.30945559												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182039-02	Cilazapril	225144330	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					0.3783040712	4	4		0	2.14899713					CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(O)=O	APAC	500074	-0.79625293	1.42423535	-0.27196084	2.14899713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346688-03	Alectinib (CH5424802)		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1256580-46-7				-4.2847195293	4	4		0	-1.33715377				ALK	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N	Axon Medchem	1884	-0.84309133	-0.53700677	-0.87027468	-1.33715377												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00522464-01	Lusutrombopag		Thrombopoietin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1110766-97-6		1.2589254118	-5.9	17.6314263776	4	4		15.360887096	-3.01470588	1	0.9994938789			CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C2=CSC(=N2)NC(=O)C3=CC(=C(/C=C(C)/C(O)=O)C(=C3)Cl)Cl	MedChem Express	HY-19883	-1.13407258	0.82368082	13.79406827	-3.01470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181750-01	Cefozopran hydrochloride	144206474	Bacterial penicillin-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	113981-44-5	Cefozopran; Firstcin; 			7.6883312527	4	4	Cefozopran Hydrochloride;CEFOZOPRAN;LS-172220;Cefozopran;CEFOZOPRAN HYDROCHLORIDE;CIPLUS_766339;SCE-2787;CZOP;Firstcin;cefozopranum;SCE 2787;cefozopran;CIPLUS_214061;Cefozopran hydrochloride;	0	4.3872549					Cl.CO\N=C(/c1nc(N)sn1)C(=O)N[C@@H]5C(=O)N4C(C([O-])=O)=C(C[n+]3ccn2ncccc23)CS[C@@H]45	ACC	CEFOZOPRAN HYDROCHLORIDE	1.08366935	2.26512227	0.08393956	4.3872549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390266-01	Nalfurafine hydrochloride		Kappa opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	152658-17-8				-2.0077553992	4	4		0	-0.22058824					CN([C@@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CC6)C(=O)\C=C\C7=COC=C7	Adooq	A12579	-0.83165323	0.20592021	0.19585898	-0.22058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095107-09	Gliclazide	170465698	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	21187-98-4	; ; Gliclazida;Gliclazide; GLICLAZIDE; Glimicron;GLICLAZIDE			-1.7519439779	4	4		0	-0.17156863				KCNJ8	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	Vitas	STK803142	-0.63004032	-0.72072072	0.69949636	-0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017366-08	Pergolide methanesulfonate	170465250	Dopamine D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	66104-23-2				1.5857862954	4	4		0	-0.0245098					CS(=O)(=O)O.CSC[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CCC)c34	Enzo	AC755	0.52923387	0.66924067	-0.3077784	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263540-04	Asenapine		Dopamine D1/D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	65576-45-6				-4.938178641	4	4		0	-1.59313725				HTR2A	CN1C[C@@H]2[C@@H](C1)C3=C(OC4=C2C=CC=C4)C=CC(=C3)Cl	MedChem Express	HY-10121	-1.08366935	-0.92664093	-0.47565753	-1.59313725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160408-06	Benziodarone			DPI_SARS-CoV-2_General	2019_NPC-5_CPE					2.4347811084	4	4		0	4.24019608					CCC1=C(C(=O)C2=CC(=C(O)C(=C2)I)I)C3=CC=CC=C3O1	Bionet	KS-1133_CM2	-0.17641129	-0.15444015	-0.25181869	4.24019608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390625-02	Maropitant		Substance-P receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	147116-67-4		11.220184543	-4.95	64.5271735143	3	4		109.181356726	87.5245098	0.0139517825	0.9998799307	403815	TACR1	COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)(C)C	MedChem Express	HY-10053	-1.68850806	-0.61776062	5.51203134	87.5245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185767-01	Spiramycin II	144207139	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	24916-51-6		12.5892541179	-4.9	66.4091709032	3	4		107.996831121	92.62254902	0.0055792554	0.999980801			CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C	Toronto Research	A187800	-1.03326613	-0.56628057	0.3077784	92.62254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263444-01	Metocurine iodide	170465111		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	7601-55-0				-1.9532195525	4	4		0	0.71033938					[I-].[I-].COc7ccc1cc7Oc6cc5c(CC[N+](C)(C)[C@H]5Cc4ccc(Oc3c2c(CC[N+](C)(C)[C@@H]2C1)cc(OC)c3OC)cc4)cc6OC	Specs	AE-562/J259582	-1.1622276	0.20075282	-0.68406385	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164576-04	Lopinavir	170464773	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	192725-17-0	;ABT-738; Lopinavir/Ritonavir;Lopinavir;LOPINAVIR; Lopinavir	12.5892541179	-4.9	56.8551345962	3	4		66.5594527409	53.53785255	0.0267242806	0.9995593942			CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O	Bosche	L2844	0	-0.86334484	-1.20903595	53.53785255												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183108-01	Propamidine	144206602		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	104-32-5	Propamidine; DAPP-Br; Propamidina; 			2.4809126365	4	4	Propamidine;Propamidinum;propamidinum;Propamidina;LS-171900;1,3-di-(p-amidinophenoxymethyl)-propane;propamidine;4,4'-(trimethylenedioxy)dibenzamidine dihydrochloride;CIPLUS_209523;DAPP-H;4,4'-(TRIMETHYLEDEDIOXY)DIBENZAMIDINE;CIPLUS_657475;CIPLUS_206886;propamidine diisethionate;1,3-bis(p-amidinophenoxy)propane;1,3-di-(4-amidinophenoxy)propane;PROPAMIDINE;propamidine isethionate;LS-27580;propamidine dihydrochloride;DAPP-Br;4,4'-(trimethylenedioxy)dibenzamidine;	0	-0.14844137					N=C(N)c1ccc(cc1)OCCCOc2ccc(cc2)C(=N)N	Beta Pharma	86-41342	0.14499758	1.01134682	1.59083678	-0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016329-07	Phenindione	170465130	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	83-12-5				0.7393311745	4	4		0	-0.19792182					O=C2c1ccccc1C(=O)C2c3ccccc3	Specs	AN-153/I102301	1.15998067	-0.46867292	-0.82723513	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094772-04	PYRVINIUM PAMOATE		Cryptosporidium parvum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-5.1975612588	4	4		0	-2.19675263					CN(C)C1=CC=C2C(=C1)C=CC(=[N+]2C)/C=C/C3=C(C)[N](C(=C3)C)C4=CC=CC=C4.OC(=O)C5=CC6=CC=CC=C6C(=C5O)CC7=C(O)C(=CC8=CC=CC=C78)C([O-])=O	Microsource	MS-01500521	-0.98360656	-1.00396918	-0.48952951	-2.19675263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181109-03	Decoquinate	170466244	Antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	18507-89-6				-2.9979763826	4	4		0	0.04775549					O=C(OCC)c1cnc2cc(OCC)c(cc2c1O)OCCCCCCCCCC	Microsource	01505356	-1.31147541	-1.00396918	-0.48952951	0.04775549												1.6E-8	8E-8	4E-7	0.000002											
NCGC00510884-01	Tylvalosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	63409-12-1				1.5867880622	4	4		0	-0.85959885					CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	SantaCruz Bio	sc-473950	1.07728337	-0.25682933	-0.48952951	-0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263156-14	Nintedanib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	928326-83-4				-3.8371426289	4	4		0	-2.76981853			2324	FLT1	COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5	APExBIO	A8252	-0.37470726	-0.72379173	-0.43513734	-2.76981853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015462-14	Glipizide	170465089	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	29094-61-9	; ; Glucotrol;Glipizide; Glipizide; Glypidizine; Glipizida; Samarium(III) ionophore I;GLIPIZIDE			2.8146062631	4	4		0	0.46568627				KCNJ8	Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3	Enzo	AC120	0.5796371	2.11068211	-0.69949636	0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015288-09	Cyclothiazide	170465274	renal sodium ion absorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	2259-96-3				2.0539235404	4	4		0	-1.20098039					NS(=O)(=O)c4cc1c(NC(NS1(=O)=O)C3CC2C=CC3C2)cc4Cl	Microsource	01503263	0.5796371	1.85328185	0.25181869	-1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164624-02	Adefovir dipivoxil	170464742	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	142340-99-6	 ;Hepsera;Adefovir Dipivoxil (Preveon, Hepsera);Adefovir dipivoxil; Preveon; Adefovir dipivoxil; Adefovir pivoxil; Adefovir Pivoxil			-0.7749342967	4	4		0	-1.74019608					CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)COCCn2cnc1c(N)ncnc12	Sequoia	SRP02645a	-0.27721774	0.61776062	1.14717403	-1.74019608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159430-04	Hexobarbital	170465860	GABA-A receptor; benzodiazepine site Activator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56-29-1				0.8231786464	4	5		0	-2.10953347					CC1(C(=O)N=C(O)N(C)C1=O)C2=CCCCC2	Labotest	LT00244803	2.61294261	-1.3147914	-1.03626943	-1.14860014	-2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166006-02	L-Cystine	170465457	Cystine/glutamate transporter Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56-89-3				8.6966602254	4	5		0	3.89452333					N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O	Bosche	C0896	-0.41514042	-0.9102402	-0.83888478	-0.90930845	3.89452333											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00016394-10	2-Hydroxy-4-methoxybenzophenone	170465010		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	131-57-7				-1.1303169211	4	5		0	-1.05476673					O=C(c1ccc(cc1O)OC)c2ccccc2	Vitas	STK057962	-0.61050061	0.2528445	0.5428078	0.33500838	-1.05476673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014711-14	Oxaprozin	170464987	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	21256-18-8				-1.8901874482	4	4		0	1.18389897					OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3	Microsource	01505267	-0.62953995	-0.95357591	-1.2921206	1.18389897												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015014-11	Acetohexamide	170465411	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	968-81-0				9.6817852865	4	4		0	7.4454091					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O	Microsource	01505425	0.8716707	0.65244667	-0.53204966	7.4454091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091238-03	2,2'-Dithiobisbenzothiazole	170465723		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	120-78-5				0.9169158786	4	4		0	-0.14844137					c1cccc2sc(nc12)SSc3nc4ccccc4s3	Bosche	D1170	-0.28999517	-0.41933892	1.78173719	-0.14844137												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00015996-10	Tiapride hydrochloride	170465877	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51012-33-0				-1.7184540756	4	4		0	1.03908956					Cl.O=S(C)(=O)c1cc(c(OC)cc1)C(=O)NCCN(CC)CC	Microsource	01503086	-1.15998067	-1.01134682	0	1.03908956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167529-02	Itopride hydrochloride	170465974	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	122892-31-3				-4.4841880032	4	4		0	-0.66857689			43	ACHE	Cl.COc1cc(ccc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2	Sequoia	SRP02400i	-1.63934426	0.72379173	-0.43513734	-0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167487-15	BICALUTAMIDE		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	90357-06-5				0.8170348416	4	4		0	4.15472779				AR	C[C@](O)(C[S+]([O-])(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	Microsource	01504827	-0.84309133	0.35022181	-0.54392168	4.15472779												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018099-09	Dyphylline	170465316	Xanthine Derivative	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	479-18-5	; Major Brand of Dyphylline;Diprophylline; Lufyllin; Dilin; Hauck Brand of Dyphylline; Dilor Brand of Dyphylline;Dyphylline; Dylix;DYPHYLLINE; Diprofilina; Diphylline			4.5425129557	4	5		0	4.05679513				XDH	OCC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Vitas	STK796769	1.05006105	-0.7585335	-0.34542314	0.47858339	4.05679513											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263839-02	Pentisomicin	170465779	Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	55870-64-9				2.834192529	4	5		0	4.54361055					N[C@@H]3CC=C(CN)O[C@@H]3O[C@H]2[C@@H](O)[C@@H](O[C@H]1OC[C@@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	Microsource	01500536	0.65934066	-1.011378	-0.34542314	-1.19645848	4.54361055											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015208-19	Caffeine	170464929	Chitinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	69-22-7	; Annaca; Sig 8304;Caffeine; Vincents Powder; Spalt-tablette; Norgesic forte; Impletol; ; Fioricet; Syndol; Bex Powder; Dolomo; Caffeine solution; Sedalgin; Caffeine, Anhydrous; Synalgos; Caffeine-13C3 solution; Caffeine-sodium benzoate; Cerebyx; Midol; Theobromine, 1-methyl-; Caffeine benzoate sodium; Amidochin; impletol depot Bayer; Triaminicin; Caffeine, citrated; Caffeine-trimethyl-13C3; Sig-8304; Fiorinal; Elsinore pill; Doleron; Caffeine; 3   Caffeine; Migraine-Kranit;Caffeine, citrated;CAFFEINE; Rectoval; Propain; Cafcit			-0.5060482223	4	5		0	-0.81135903				ADORA2B	O=C(O)C(O)(CC(=O)O)CC(=O)O.O=C2c1n(C)cnc1N(C)C(=O)N2C	Enzo	AC1295	-0.70818071	-0.7079646	1.67776955	1.05288346	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015251-13	Clotrimazole	170464807	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	23593-75-1	 ; Bay b 5097; Clotrimazole;Clotrimazole; b 5097, F; Clotrimazol; Kanesten; Baycuten; Canesten; Canesten HC; FB b 5097; b 5097, Ba; Baycuten SD; Lotrimin; Mycelex; Klotrimazole;CLOTRIMAZOLE; 5097, Bay	14.1253754462	-4.85	13.7374938759	4	5		24.9120603	20.20283976	0.0194879656	0.9901392028	1595	CYP51A1	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	Vitas	STK700023	0.51282051	-0.7079646	-0.59215396	-2.01005025	20.20283976											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015610-17	Leflunomide	170464823	DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	75706-12-6	; Arava;Leflunomide; Leflunomida; Leflunomide;HWA-486/RS-34821			-1.0114450825	4	5		0	-1.13590264			3716	DHODH	Cc2oncc2C(=O)Nc1ccc(cc1)C(F)(F)F	Selleck	S1247	1.34310134	-1.517067	-0.98692327	-1.29217516	-1.13590264											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016087-11	Vigabatrin	225144175	Gamma-amino-N-butyrate transaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	[60643-86-9]				-1.588929146	4	5		0	1.13590264					NC(CCC(O)=O)C=C	Tocris	0808	-0.31746032	-1.4664981	-1.13496176	-0.67001675	1.13590264											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00188429-02	Acitazanolast	170466060	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	114607-46-4	Acitazanolast			-1.8313635258	4	5		0	0.24340771					O=C(O)C(=O)Nc1cccc(c1)c2nnnn2	Life Chemicals	F2119-0003	0.56166056	-0.9102402	-2.07253886	-1.38789184	0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00242597-01	Saxagliptin	124950715	DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	361442-04-8	Saxagliptin			8.0864670555	4	5		0	2.59634888			1803	DPP4	O=C([C@@H](N)C13CC2CC(C1)CC(O)(C2)C3)N5[C@H](C#N)C[C@@H]4C[C@@H]45	ACC	API0007051	1.29426129	1.5676359	1.92450037	1.86647523	2.59634888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159320-04	Triamcinolone diacetate	170464837		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	67-78-7				-2.4325294799	4	5		0	-2.19066937					CC(=O)OCC(=O)[C@@]3(O)[C@@H](C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C)OC(C)=O	Sequoia	67-78-7	0.12210012	-1.2642225	-0.19738465	0	-2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249898-01	Sodium 3, 4-dimethylphenyl-glyoxylate	170465549		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	81632-85-1				0.9904285637	4	5		0	0.64908722					[Na+].Cc1ccc(cc1C)C(=O)C([O-])=O	GVK	FFS-11-286-NCI-75	0.70818071	-1.0619469	0.04934616	-0.14357502	0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024452-04	Miglustat	170464950	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	72599-27-0				10.0064041553	4	5		0	2.27180527					OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCC	Tocris	3117	2.22222222	1.4664981	2.417962	2.10576693	2.27180527											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00264003-02	(2R,3R)-2,3-Dimercaptosuccinic acid	170465255	Lead Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	27887-84-9				0.5551607936	4	5		0	0.32454361					O=C(O)[C@@H](S)[C@H](S)C(O)=O	Microsource	01505007	0.21978022	-0.5562579	-0.34542314	0.76573343	0.32454361											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00264001-02	CALCIUM GLUCEPTATE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	299-28-5				-1.69750067	4	4		0	0.53179191					OC[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)C([O-])=O	Microsource	01300012	-0.41131105	-0.5995829	-0.89497236	0.53179191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167527-03	Grepafloxacin hydrochloride	170466148	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	161967-81-3				-4.7763441686	4	4		0	-0.71676301					Cl.CC1CN(CCN1)c4cc2c(C(=O)C(=CN2C3CC3)C(=O)O)c(C)c4F	Sequoia	SRP02578g	-1.33676093	-0.13034411	-1.05290866	-0.71676301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181767-03	Tolcapone	170465081	catechol-O-methyltransferase (COMT)	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	134308-13-7	 ; Roche brand of tolcapone; Tasmar;TOLCAPONE; Tolcapone;Tolcapone	12.5892541179	-4.9	15.6258759358	4	4		26.863753208	23.0982659	0.0531086546	0.9982603965	1312	COMT	Oc1cc(cc([N+]([O-])=O)c1O)C(=O)c2ccc(C)cc2	Sequoia	134308-13-7	-0.71979434	0.39103233	-0.10529087	23.0982659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390731-01	Tafamidis		Transthyretin Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	594839-88-0				5.0740194787	4	4		0	0.99421965					OC(=O)C1=CC=C2N=C(OC2=C1)C3=CC(=CC(=C3)Cl)Cl	MedChem Express	HY-14852	0.77120823	1.74661105	1.63200842	0.99421965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178319-06	Thiamphenicol	170465845	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	15318-45-3	;THIAMPHENICOL; Thiomycetin; Thiamcol;Thiamphenicol (Thiophenicol);Thiamphenicol; Vicemycetin; Tiamfenicol; Raceophenidol; Urfamycin; Armai; Thiocymetin			-0.3338589221	4	4		0	0.34682081					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl	Microsource	01503136	0.20565553	-0.5995829	-1.00026323	0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015100-15	Altretamine	170464714	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	645-05-6	; ; Altretamine; Hexamethylmelamine;ALTRETAMINE; Melamine, hexamethyl-; Hexalen; Altretamina;Altretamine			-0.1470231628	4	4		0	1.18389897				H2AFX	CN(C)c1nc(nc(n1)N(C)C)N(C)C	Microsource	01503065	-0.3874092	-1.15432873	0.07600709	1.18389897												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090705-15	2',3'-Dideoxycytidine	170465128	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	7481-89-2	; ; 2',3' Dideoxycytidin; Cytidine, 2',3'-dideoxy-; 2',3'-dideoxycytidine;2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine; Hivid; 2';Zalcitabine;2',3'-dideoxycytidine; Dideoxycytidine-3H; HIVID Roche; Zalcitibine			-1.9315514427	4	4		0	-0.0789266			7015	TERT	NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1037	-0.82324455	-1.40526976	0.63339245	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00017112-10	Ciclopirox	170464708	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	41621-49-2	; Dafnegin-CSC;Ciclopirox ethanolamine; Ciclopirox ethanolamine; Penlac;Ciclopirox; Batrafen; Loprox;ciclopirox; ciclopirox	12.5892541179	-4.9	57.4336685031	3	4		72.3782991978	55.43278085	0.0272778815	0.999540925		CAT	CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO	Microsource	01500189	-1.2590799	0	-0.98809222	55.43278085												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159377-04	4-tert-Butylphenol	170465689	UDP-glucuronosyltransferase 1-6 Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	98-54-4				-1.8176522497	4	4		0	-1.07866351					CC(C)(C)c1ccc(O)cc1	Labotest	LTBB002519	-0.6779661	0.8531995	0.0253357	-1.07866351												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091208-09	4-Hexylresorcinol	170465471	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	136-77-6				-1.3245037689	4	4		0	-1.18753093					Oc1cc(O)ccc1CCCCCC	Microsource	01500330	-0.43499275	1.50468673	-0.25453388	-1.18753093												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024643-10	Ifenprodil	170465791	Kir3.1/Kir3.4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	23210-56-2				-1.7586817158	4	4		0	0.69272637					OC(C(C)N1CCC(CC1)Cc2ccccc2)c3ccc(O)cc3	SigmaAldrich	I-2892	-1.06331561	0.17266897	-0.63633471	0.69272637												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159411-02	Triethanolamine	144206717		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	102-71-6	trolamine salicylate; Tris(2-hydroxyethyl)amine; Solupront; Thiofaco T-35; Myoflex; texapon TH; 			0.7035043137	4	4	CIPLUS_734310;CIPLUS_3747852;CIPLUS_740704;CIPLUS_752482;CIPLUS_750425;CIPLUS_737530;CIPLUS_737531;Triethanolamine aluminate barium salt;CIPLUS_749510;CIPLUS_686266;triethanolamine salicylate;TRIETHANOL AMMONIUM CHLORIDE;CIPLUS_740747;CIPLUS_3755473;CIPLUS_732537;CIPLUS_739845;CIPLUS_749773;CIPLUS_749544;CIPLUS_749685;CIPLUS_740695;CIPLUS_3889761;CIPLUS_745468;CIPLUS_691861;CIPLUS_753415;CIPLUS_740654;CIPLUS_3730238;CIPLUS_175532;CIPLUS_3749955;NCGC_FLUKA_90290;CIPLUS_739743;LS-173901;2,2',2''-Nitrilotriethanol hydrochloride;CIPLUS_749503;CIPLUS_738415;trolamine salicylate;CIPLUS_752427;CIPLUS_752428;CIPLUS_3756040;NCGC00159411-04;CIPLUS_666794;CIPLUS_3885762;Tris(2-hydroxyethyl)amine hydrochloride;CIPLUS_193084;CIPLUS_748749;CIPLUS_3755605;CIPLUS_3733577;CIPLUS_740728;Myoflex;CIPLUS_739153;CIPLUS_3745711;CIPLUS_3755043;Trolamine (Triethanolamine hydrochloride);CIPLUS_736952;CIPLUS_687637;Triethanolamine;CIPLUS_732449;CIPLUS_3749677;CIPLUS_746627;CIPLUS_3753376;CIPLUS_668732;CIPLUS_193079;CIPLUS_667351;Triethanolamine Hydrochloride;CIPLUS_193078;Tris(2-hydroxyethyl)amine;CIPLUS_3887736;CIPLUS_749757;CIPLUS_737348;CIPLUS_738912;CIPLUS_767549;Trolamine salicylate;2,2',2''-Nitrilotriethanol;CIPLUS_753583;Triethanolamine hydrochloride;CIPLUS_750558;CIPLUS_3752239;CIPLUS_3745729;	0	-0.52531041					OCCN(CCO)CCO	Labotest	LT03329084	-0.32786885	-0.1167406	2.88278488	-0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181297-01	Mebrofenin	144206328		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	78266-06-5	Mebrofenin; Mebrofenino; 			-2.7623610251	4	4	Technetium (99mTc) mebrofenin;TECHNETIUM TC-99M MEBROFENIN KIT;mebrofeninum;Mebrofenin;Mebrofenine;CIPLUS_191790;technetium Tc 99m mebrofenin;MEBROFENIN;Technetium Tc 99m Mebrofenin;2,2'-((2-((3-BROMO-2,4,6-TRIMETHYLPHENYL)-AMINO)-2-OXOETHYL)IMINO)DIACETIC ACID;Mebrofenin ((3-Bromo-2,4,6-trimethylphenylcarbamoyl) methyliminodiacetic acid);Mebrofeninum;mebrofenine;Mebrofenino;SQ-26962;	0	-0.09551098					Cc1cc(C)c(Br)c(C)c1NC(=O)CN(CC(=O)O)CC(=O)O	ACC	mebrofenin	-0.6088993	-0.86388046	-0.76149035	-0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016879-06	Torsemide	170465279	Loop Diuretics	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	56211-40-6	 ;Torsemide (Demadex); Torasemida;TORSEMIDE; Luprac; Demadex;Torsemide; Torsemide			9.7611383933	4	5		0	4.12946429					O=S(=O)(NC(=O)NC(C)C)c2cnccc2Nc1cc(C)ccc1	Prestwick	Prestw-1030	5.94440308	-2.58368334	-2.70120515	-0.93858943	4.12946429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179573-03	Tiaprofenic acid	170465577	Cyclooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	33005-95-7				-1.3418772623	4	5		0	-0.5285269					O=C(c1ccc(s1)C(C)C(=O)O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-496	-1.62082515	-2.12792128	5.75664485	-0.68268015	-0.5285269											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178737-05	Trimeprazine tartrate	170465278	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4330-99-8		8.9125093813	-5.05	45.3801801057	3	5		74.7747290807	69.88751863	0.0010862664	0.9994565574			O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12	Microsource	01500593	-2.65225933	-0.84870849	-2.60451449	0.68268015	69.88751863											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015898-15	Rolipram	170465962	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	61413-54-5	; ;Rolipram; Rolipram; (R)-(+)-Rolipram; (S)-(-)-Rolipram			6.3820336354	4	5		0	4.86515788			5141	PDE4A	COc2ccc(cc2OC1CCCC1)C3CC(=O)NC3	Prestwick Chemical, Inc.	Prestw-924	2.38212181	1.90651907	-3.08534794	-1.2136536	4.86515788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016916-11	Norfloxacin	170464769	DNA Topoisomerase IV Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	70458-96-7	; ; Norfloxacin-d5;NORFLOXACIN; Norfloxacino; Noroxin; Norfloxacin;Norfloxacin; Norfloxacin Glutamate			8.3303026439	4	5		0	1.74820436			7155	TOP2B	O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3	Vitas	STK177250	-0.12278978	-0.38130381	11.76706291	-1.011378	1.74820436											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183856-01	Phenyl 11-iodo-10-undecynoate	144206805		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2020-25-9		14.1253754462	-4.85	4.9560976609	4	5	Phenyliodoundecynoate;PHENYLIODOUNDECYNOATE;CIPLUS_3885239;CIPLUS_3845000;10-UNDECYNOIC ACID, 11-IODO-, PHENYL ESTER;11-IODOUNDECYNOIC ACID PHENYL ESTER;002020259;	17.4059040599	12.91502914	0.0233661491	0.9881813251			O=C(Oc1ccccc1)CCCCCCCCC#CI	Pharmaron	PH-NIH-102558	-1.12966601	-2.00492005	-0.20034727	-1.517067	12.91502914											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016600-08	Clofazimine	387065713	DNA Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2030-63-9		6.3095734448	-5.2	40.8793815389	2.2	5		35.5223214332	33.81696429	0.0427639584	0.977935948			CC(C)\N=C\1/C=C\2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)\N=C2\C=C1NC5=CC=C(Cl)C=C5	SIGMA	C8895	1.72499379	5.2310042	0.18008034	12.33574685	33.81696429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188943-03	Orotic acid	170465761	metabolite	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	65-86-1	Orotic acid;Orotic acid (6-Carboxyuracil)			-15.7899468814	4	5		0	-3.85044643				DHODH	OC(=O)c1cc(O)nc(O)n1	Vitas	STK301771	-3.83469844	-4.06007382	-2.11940712	-2.11853044	-3.85044643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091575-03	2-Ethyl-1,3-hexanediol	170465521		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	94-96-2				-4.2438998612	4	5		0	-1.81361607					CCCC(O)C(CC)CO	SIGMA	E29125	-0.85629188	-1.46366298	0.59565037	-0.99222312	-1.81361607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00186464-03	Aliskiren hemifumarate	170465199	Renin Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	173399-03-6	ALISKIREN HEMIFUMARATE;Aliskiren hydrochloride			-1.4440082554	4	5		0	0.3387993				REN	Cl.NC(=O)C(C)(C)CNC(=O)[C@@H](C[C@H](O)[C@@H](N)C[C@H](Cc1cc(OCCCOC)c(cc1)OC)C(C)C)C(C)C	Microsource	01505710	-2.50491159	2.69372694	1.32229197	0.2022756	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094646-04	Dibenzothiophene	170465511	Cytochrome P450 2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	132-65-0				0.492546053	4	5		0	0.90782123					c1cccc2sc3ccccc3c12	Vitas	STK367232	0.92761557	0.38600423	-2.35682012	-0.75658373	0.90782123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167500-02	Etretinate	170465372	Retinoic acid receptor alpha Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54350-48-0				-9.1320426912	4	5		0	-4.2877095					Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)OCC)c(C)cc1OC	LKT Lab	E7668	-2.17457421	-2.02963516	1.5020149	-2.18245308	-4.2877095											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015252-12	Cyproheptadine hydrochloride	170465127	Histamine H1 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	129-03-3	; ; Cyproheptadine hydrochloride;Cyproheptadine hydrochloride; Dihexazin; 1   Cyprohetadine;Cyproheptadine;CYPROHEPTADINE HYDROCHLORIDE; Viternum; 9   Cyproheptadine; Ciproheptadina; Periactin; Peritol; Antergan	12.5892541179	-4.9	62.4898965782	3	5		103.3218310111	91.9230248	0.0016363088	0.9991809565	9704	HRH1	CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23	Vitas	STK802098	-0.93320236	-1.29151292	-1.50928276	-3.61567636	91.9230248											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00177979-05	Azelastine hydrochloride	170465172	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	79307-93-0	; Astelin; Azelastina;AZELASTINE HYDROCHLORIDE; Azelastine Hydrchloride			2.7571751442	4	4		0	5.1954478			9704	HRH1	Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4	Microsource	01505340	-1.11164814	0.17266897	-0.95450207	5.1954478												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095312-04	Deracoxib	170465679	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	169590-41-4				2.0153623184	4	4		0	0.64324592			791253	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(OC)c(F)c2)C(F)F	Microsource	01505222	1.69163847	-0.41933892	-1.46356984	0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00386567-02	FLIBANSERIN		Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	167933-07-5				1.6899707204	4	4		0	-0.19102197					FC(F)(F)C1=CC(=CC=C1)N2CCN(CC2)CCN3C(=O)NC4=CC=CC=C34	SIGMA	SML0797	0.32786885	1.42423535	0	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183836-01	Emiglitate	144206827	Maltase-glucoamylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	80879-63-6				7.8801959416	4	5	N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin;Emiglitate;BAY-o-1248;EMIGLITATE;BAY-o 1248;BAY o 1248;LS-177593;N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin;CIPLUS_214267;emiglitate;emiglitatum;	0	0.25748746					O=C(OCC)c2ccc(OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)cc2	Pharmaron	PH-NIH-150421	4.34675835	1.02091021	1.40243088	-2.95828066	0.25748746											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262942-01	Etifelmine hydrochloride	170465899		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1146-95-8	Etifelmine;Etifelmine	14.1253754462	-4.85	15.4631492555	4	5		12.892111372	10.76815642	0.2325653755	0.8601337318			Cl.CCC(\CN)=C(/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-209	3.54318735	1.75569668	-1.16009281	0.61108686	10.76815642											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167523-03	Ormetoprim	170465718	Folate biosynthesis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6981-18-6				-4.5410686445	4	5		0	-4.09217877					Nc2nc(N)ncc2Cc1cc(OC)c(OC)cc1C	Sequoia	SRP01245o	-2.81326034	1.60627568	-0.59836366	4.33580678	-4.09217877											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00142384-03	Cholic Acid		Bile acid receptor FXR Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	81-25-4				-5.4884100396	4	5		0	-2.61173184					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	C1129	-3.05656934	2.75183663	0.79374771	-0.49468936	-2.61173184											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	56776-01-3				2.8621103042	4	5		0	5.0006776					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-0.78585462	1.3899139	1.16201416	-1.7193426	5.0006776											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164632-02	Tibolone	170465874	Steryl-sulfatase  Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5630-53-5				10.7239437172	4	5		0	2.41620112				AR	O=C1CC=2C[C@@H](C)[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(C)CC[C@@H]3C=2CC1	Sequoia	SRP02352t	5.70255474	-0.08716225	-1.81951398	-0.46558999	2.41620112											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016786-15	Mycophenolic acid	170465182	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	24280-93-1	; ; Acido micofenolico; Acid, Mycophenoli; Mycophenolic acid;Mycophenolic acid;MYCOPHENOLIC ACID	5.0118723363	-5.3	19.7612589756	4	5		27.708695068	24.70524461	0.0050625057	0.9974638141	727833	IMPDH1	O=C(O)CCC(\C)=C\Cc1c(O)c2C(=O)OCc2c(C)c1OC	Microsource	01500674	-1.30157171	-1.53751538	-2.25724589	9.10240202	24.70524461											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164603-04	Ebastine	170465995	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90729-43-4		1	-6	13.1335443117	4	5		11.87638376	-4.64832633	0.0847841906	0.9955839957	3269	HRH1	CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4	Sequoia	SRP00750e	-1.15422397	-1.9803198	1.90997729	10.59418458	-4.64832633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025158-02	(S)-(+)-Dimethindene maleate	170465880	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1217457-81-2				7.4463554767	4	5		0	3.21181732					C[C@@H](C=1c2ccccc2CC=1CCN(C)C)c3ccccn3.O=C(O)/C=C\C(=O)O	Tocris	1425	0.39292731	0.06150062	2.52437558	3.59039191	3.21181732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179392-03	Beclomethasone	170464981		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4419-39-0				3.5331232948	4	5		0	2.83519553					OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-855	0.34975669	-2.22886316	1.25778483	2.06605558	2.83519553											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164572-02	Rimonabant	170465599	Cannabinoid CB1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	168273-06-1	 ; Rimonabant;Rimonabant; Rimonabant Base; Rimonabant(Nlt); Rimonabant HCL			-2.1493952643	4	5		0	1.46648045			56144	CNR1	O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c4C	Sequoia	SRP01287r	-0.50182482	-3.4242311	2.52778117	-2.41524807	1.46648045											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160662-02	Ambrisentan	170465143	Endothelin ETA Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	177036-94-1				5.5370333574	4	5		0	0.46089385				EDNRA	O=C(O)[C@@H](Oc1nc(C)cc(C)n1)C(OC)(c2ccccc2)c3ccccc3	Prestwick	Prestw-1497	2.93491484	-0.46071473	1.06240078	-0.96027935	0.46089385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015237-07	Carbachol	170464972	Acetylcholinesterase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-83-2				-2.0105673482	4	5		0	2.66973845					[Cl-].C[N+](C)(C)CCOC(=O)N	Enzo	AC911	-2.11198428	1.14391144	-0.84145853	-0.42983565	2.66973845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017325-06	Kojic acid	170466814	Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	501-30-4		3.1622776602	-5.5	12.6607624766	4	5		-6.064245812	-2.13687151	0.6295268508	0.3637607028			O=C1C=C(CO)OC=C1O	Labotest	LT00068503	5.36800487	-2.12924916	8.63353279	-0.34919249	-2.13687151											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016344-07	5-Aminosalicylic acid	170464840	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	89-57-6				9.0984199571	4	4		0	1.68910003			16534		OC(=O)c1cc(N)ccc1O	Vitas	STK301678	4.16666667	-0.48712596	-0.1349892	1.68910003												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015822-15	Pyrilamine	170464656	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	91-84-9				-0.8403544732	4	4		0	-1.47796252					COc1ccc(cc1)CN(CCN(C)C)c2ccccn2	Enzo	AC277	0.30602637	-0.6263048	0.62095032	-1.47796252												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166266-03	1,3-Bis(4-carboxyphenoxy)propane	170466646		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	3753-81-9				-0.6465599199	4	4		0	-1.10294118					O=C(O)c1ccc(cc1)OCCCOc2ccc(cc2)C(=O)O	SIGMA	655538	-0.73084677	0.15444015	2.7700056	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091023-06	Cetylpyridinium bromide	170465500		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	140-72-7				-2.846368476	4	4		0	-3.06372549					[Br-].CCCCCCCCCCCCCCCC[n+]1ccccc1	Vitas	STK177346	-0.02520161	1.33848134	-2.04252938	-3.06372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018254-08	Bifonazole	170465826	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	60628-96-8				8.8939746937	4	4		0	8.89705882					c1cc(ccc1c2ccccc2)C(c3ccccc3)n4ccnc4	Microsource	01505309	0.73084677	1.18404118	-0.64353665	8.89705882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186628-02	Butylscopolamine bromide	170465685	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	149-64-4	Butylscopolammonium Br			-3.8464765719	4	4		0	-0.0245098			1128	CHRM1	[Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)CCCC	Enzo	NP527	-1.38608871	-0.72072072	0.3077784	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160615-03	Sucrose octaacetate	170465525		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	126-14-7				4.6337535648	4	4		0	2.02578269					CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O	SIGMA	252603	1.6464891	-0.65244667	-0.17734989	2.02578269												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00142615-08	Epinephrine	170464973	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51-43-4	 TEC solution;;(-)-Epinephrine bitartrate; L-Epinephrine; DL-Adrenaline; 4-(1-Hydroxy-2-; ; (+/-)-Adrenalin; TAC combination; L-(-)-EPINEPHRINE; Epinephrin; Asmatane mist; (+/-)-Epinephrine; Epinephrine; Epinefrina; (-)-Epinephrine bitartrate; dl-Adrenaline; (-)-Adrenalin; Adrenaline-L Bitartrate; Adrenalin chloride; Piladren; Sphygmogenin; Racepinephrine Hcl;Epinephrine; Levorenone; Racepinefrina; (-)-Epinephrine			5.0070880596	4	4		0	1.34175217			148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CNC	Labotest	LT03210011	1.30750605	1.00376412	0.38003547	1.34175217												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00092310-06	Amisulpride	170466480	Dopamine D2/D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	71675-85-9	; Amisulprida;Amisulpride; Deniban			-2.0355946098	4	4		0	-0.34201526			1813	DRD2	CCN2CCCC2CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	Tocris	2132	-0.24213075	-0.25094103	-0.98809222	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179384-10	Chlorcyclizine		Hepatitis C virus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	GRT00368		12.5892541179	-4.9	44.1286053344	3	4		75.7372153727	64.53431373	0.0323510742	0.9993540558			CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	SIGMA	SMl1473	-1.48689516	0.25740026	-0.69949636	64.53431373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532513-01	ADRENOCHROME MONOAMINOGUANIDINE MESILATE ANHYDROUS			DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-3.237399545	4	4		0	-0.46568627					CN1CC(O)C/2=C/C(=N/NC(N)=N)C(=O)/C=C12	Carbosynth	FA17227	-0.42842742	-1.02960103	-1.538892	-0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167453-02	Clinofibrate	174007296	treatment of lipoprotein diseases	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	30299-08-2	 ; Lipoclin;Clinofibrate; Clinofibrate; Clinofibrato			-2.8396095527	4	4		0	-0.34201526				HMGCR	O=C(O)C(C)(CC)Oc1ccc(cc1)C2(CCCCC2)c3ccc(OC(C)(CC)C(=O)O)cc3	Selleck	S2664	-0.82324455	-1.45545797	0.07600709	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015226-12	Mitotane	170464927	Antineoplastic Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53-19-0	 ; ortho,para DD;Mitotane; Lysodren; Chlodithane; Mitotano; 2,4'-DDD solution; Khloditan;MITOTANE;1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; Mytotan;o,p'-DDD; Chloditan			5.9939716174	4	4		0	7.91896869				CYP11B1	Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1	Microsource	00330082	-1.2590799	-0.8531995	0.22802128	7.91896869												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179680-05	Clonidine	170464900	alpha1-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	4205-90-7				-0.7906431744	4	4		0	-1.13805047				ADRA1A	Clc2cccc(Cl)c2\N=C1/NCCN1	Enzo	AC152	0.96665056	-0.76467686	-0.76360165	-1.13805047												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178024-05	Metaraminol bitartrate	170465256	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	33402-03-8				-3.0523960095	4	4		0	-0.14844137					O[C@H](c1cc(O)ccc1)[C@H](C)N.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503251	-0.72498792	0.27133695	-1.65447025	-0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160397-04	Irsogladine maleate	170465947	M1 Muscarinic acetylcholine receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	84504-69-8	; ;Irsogladine maleate; Irsogladine maleate;irsogladine; Gaslon N			-6.0863730643	4	5		0	-2.5			1128	CHRM1	Nc1nc(nc(N)n1)c2cc(Cl)ccc2Cl.O=C(O)/C=C\C(=O)O	Enzo	PD141	-1.3229927	-2.45299465	0.59836366	-0.66928561	-2.5											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00184993-03	Amfenac Sodium	225144335	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2					1.2303304773	4	5		0	-0.18156425					NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=CC=C2	APAC	872965	0.25851581	1.1829162	1.45316888	-1.3676706	-0.18156425											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091612-09	Triacetin	170465543		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	102-76-1				-5.9784822074	4	5		0	0.9765625					O=C(C)OC(COC(C)=O)COC(=O)C	Microsource	01500585	-1.42715314	-2.43095329	-2.11940712	-1.26039153	0.9765625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159319-04	Zonisamide	174006630	Na channel blocker, T-type Ca channel blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	68291-97-4	 ; Zonisamide sodium salt; Elan brand of zonisamide; Excegran; Zonegran; Zonisamide;Zonisamide; Zonisamide sodium			-1.4625675889	4	5		0	0.47433036					NS(=O)(=O)Cc2noc1ccccc12	Vitas	STK711131	-0.75701167	-2.02367316	3.28300319	-1.85036203	0.47433036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016272-05	Guanethidine sulfate	170464954		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	60-02-6				-4.5463627305	4	5		0	-1.88547486					O=S(=O)(O)O.O=S(=O)(O)O.N=C(N)NCCN1CCCCCCC1	Vitas	STK895063	1.6879562	-2.12924916	1.69739895	0.49468936	-1.88547486											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00249904-01	Butamisole	170466389	Nicotinic acetylcholine receptor alpha subunit Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54400-59-8				-7.4843922446	4	5		0	-2.61173184					CC(C)C(=O)Nc1cccc(c1)C2N=C3SCCN3C2	GVK	FFS-11-286-NCI-117	-1.5663017	1.1082057	-2.77201123	-2.09515495	-2.61173184											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159460-04	Indinavir sulfate	170465228	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	157810-81-6	 ;Indinavir sulfate salt hydrate; Crixivan; Indivanir Sulfate; Indinavir, Sulfate (1:1);Indinavir;Indinavir Sulfate; Indinavir sulfate; Sulfate, Indinavi			16.6195617014	4	5		0	6.63407821					O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O	Bosche	I2146	1.04927007	5.8398705	2.21028209	5.84897425	6.63407821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178376-05	Sulfaquinoxaline	170465653		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59-40-5				-2.3297841329	4	5		0	-3.29241071					Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2	Microsource	01501145	-2.19657483	5.71464936	2.28563513	-1.98444623	-3.29241071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159369-04	1-Octadecanol	170465526		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	112-92-5				-6.7350607238	4	5		0	1.22767857					CCCCCCCCCCCCCCCCCCO	Labotest	LTBB001505	-2.94117647	-3.29642357	1.81465577	-1.66264414	1.22767857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164583-02	Amdinocillin	170465354		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	32887-01-7				-5.331080496	4	5		0	-0.86495536					OC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C	Sequoia	SRP01690m	-1.05485232	-2.73641339	-0.84499238	-0.32180209	-0.86495536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016353-08	Butyl 4-aminobenzoate	170465735		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	94-25-7				-5.3783057089	4	5		0	-2.48325893					Nc1ccc(cc1)C(=O)OCCCC	Specs	AE-562/J257667	-0.70737156	-3.57642866	0.78958304	-0.37543577	-2.48325893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090698-06	1,3-Diphenylguanidine	170465656		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	102-06-7				-11.9933849384	4	5		0	-4.12946429					N=C(Nc1ccccc1)Nc2ccccc2	Vitas	STK802182	-2.91635642	-2.22731322	-1.73154176	-1.0458568	-4.12946429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164582-02	Feprazone	170465969		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	30748-29-9				-2.7269034459	4	5		0	-0.40502793					C/C(C)=C\CC2C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Sequoia	SRP00472f	-2.26581509	-0.01245175	-0.96470876	3.5210243	-0.40502793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274269-01	NCGC00274269-01	225144370		SARS-CoV-2_CPE_SRI	2019_NPC-3.2			7.0794578438	-5.15	13.8906803344	4	5		14.23357664	12.91899441	0.0995090175	0.9466092602			CCCCCCCCCCCCNCCNCCNCC(O)=O	GVK	FFS-11-286-NCI-158	-1.4446472	2.10434566	1.1356698	0.46558999	12.91899441											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00018193-11	Fluvoxamine	170464809	5-HT Reuptake Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54739-18-3	;FLUVOXAMINE MALEATE;Fluvoxamine; Fluvoxamina;Fluvoxamine maleate; Fluvoxamine, (Z)-Isomer	12.5892541179	-4.9	10.277674938	4	5		18.7127243879	15.87988827	0.0373057046	0.9808917715	3350	HTR1A	FC(F)(F)c1ccc(cc1)C(\CCCCOC)=N\OCCN	Tocris	1033	0.80596107	-1.2327232	-1.84393699	-1.33857122	15.87988827											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167565-06	Carbazochrome sodium sulfonate		Hemostatics	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	51460-26-5				4.0128715554	4	4		0	-0.5730659					CN1C(CC\2=C\C(=N\NC(N)=O)C(=O)\C=C12)[S]([O-])(=O)=O	MedChem Express	HY-B0491A	1.8735363	-0.81718422	0.32635301	-0.5730659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263467-03	2-Pyrrolidone-5-carboxylic acid	225144361		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	149-87-1				0.4189412475	4	4		0	-0.07352941					OC(=O)C1CCC(=O)N1	SIGMA	292915	-0.47883065	3.29472329	-0.86737549	-0.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182985-01	Trolnitrate	144206882	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7077-34-1	TROLNITRATE PHOSPHATE; Trolnitrato; Angitrit; 			-5.1382798991	4	4	trolnitratum;Trolnitratum;Trolnitrate;TROLNITRATE PHOSPHATE;2,2',2''- nitrilotrisethanol, trinitrate (ester);Trolnitrate Phosphate;Trolnitrate phosphate;LS-66974;trolnitrate;Trolnitrato;Ethanol, 2,2',2''-nitrilotris-, trinitrate (ester), phosphate (1:2) (salt) (9CI);Angitrit;CIPLUS_154803;Ethanol, 2,2',2''-nitrilotri-, trinitrate (ester), phosphate (1:2);trolnitrate phosphate (1:2);CIPLUS_658463;triethanolamine trinitrate;TROLNITRATE;	0	-0.95588235					O=[N+]([O-])OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O	Pharmaron	PH-NIH-183589	-1.33568548	-1.02960103	-0.41969782	-0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163355-05	Indigo	170465746		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	482-89-3				-2.7700112673	4	4		0	-0.56372549					O=C3c4ccccc4N/C3=C2/Nc1ccccc1C2=O	Enzo	AC1057	-0.88205645	0.61776062	-0.75545607	-0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016710-05	Clemastine fumarate	170465318	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	14976-57-9	 ;CLEMASTINE FUMARATE; Clemastine fumarate salt; Meclastine;Clemastine fumarate; Corto-Tavegil; Clemastine fumarate; Tavist; Tavegyl;CLEMASTINE; Clemastina	11.220184543	-4.95	67.3097320761	3	4		104.2022058803	90.07352941	0.0084070202	0.9999564069	9704	HRH1	CN3CCC[C@@H]3CCO[C@](C)(c1ccccc1)c2ccc(Cl)cc2.O=C(O)/C=C/C(=O)O	Microsource	01500191	-0.78125	-0.1029601	2.93788472	90.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253670-01	Meropenem	170466350	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	96036-03-2				3.2382279342	4	4		0	2.92028414					O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@H](NC1)C(=O)N(C)C)[C@H](C)[C@@H]23)C(=O)O	GVK	FFS-12-73-NCI-194	0.43583535	0.45169385	-1.03876362	2.92028414												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182049-02	Nitroscanate	225144331	ATP biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-0.8058201567	4	4		0	2.03431373					[O-][N+](=O)C1=CC=C(OC2=CC=C(C=C2)N=C=S)C=C1	Oakwood	8991	-0.83165323	-0.20592021	-0.08393956	2.03431373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182986-01	Acetylpheneturide	144206817		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	13402-08-9	ACETYLPHENETURIDE; Crampol; 			-0.1307071723	4	4	CIPLUS_669097;ACETYLPHENETURIDE;Crampol;Urea, 1-acetyl-3-(2-phenylbutyryl)-;Acetylpheneturide;LS-158754;acetylpheneturide;	0	2.5245098					CCC(C(=O)NC(=O)NC(C)=O)c1ccccc1	Pharmaron	PH-NIH-148128	-1.33568548	0.56628057	1.42697258	2.5245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00487176-01	EAA-090			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	144912-63-0				-1.8805675114	4	4		0	-0.71078431					O[P](O)(=O)CCN1CCCN/C2=C1/C(=O)C2=O	SIGMA	SML0206	-0.42842742	-0.51480051	0.02797985	-0.71078431												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00183003-01	Depolipon	144206803		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	16488-48-5	p-Butylaminobenzoyldiethylaminoethyl hydrochloride; Calvital liquid; T cain; 			-0.1295242995	4	4	P-BUTYLAMINOBENZOYLDIETHYLAMINOETHYL HYDROCHLORIDE;Calvital liquid;T cain;CIPLUS_170427;p-Butylaminobenzoyldiethylaminoethyl Hydrochloride;p-Butylaminobenzoyldiethylaminoethyl hydrochloride;CIPLUS_162500;	0	1.78921569					[Cl-].CC[NH+](CC)CCOC(=O)c1ccc(NCCCC)cc1	Pharmaron	PH-NIH-101688	0.17641129	-1.5958816	-1.14717403	1.78921569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263532-01	Olopatadine hydrochloride	170465181	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	140462-76-6	Olopatadine HCl;Olopatadine hydrochloride (Opatanol)			-3.3061460387	4	4		0	-1.20098039				HRH1	Cl.O=C(O)Cc1ccc2OCc3ccccc3C(=C\CCN(C)C)\c2c1	Sequoia	SRP01210o	-0.17641129	-0.92664093	-1.87465025	-1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178756-05	LEUCOVORIN CALCIUM	225144299	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1492-18-8				-1.8294814769	4	4		0	-0.56372549				TYMS	N\C1=N\C(=O)\C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N2C=O)/N1	Microsource	01500364	0.27721774	-0.25740026	-0.36373811	-0.56372549												1.6E-9	8E-9	4E-8	2E-7											
NCGC00522306-02	Valbenazine			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1025504-45-3		12.5892541179	-4.9	18.2412189007	4	4		28.453629028	22.18137255	0.0906734953	0.9949090518			COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1	MedChem Express	HY-16771	-0.37802419	1.49292149	2.26636821	22.18137255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090905-12	Busulfan	170465232	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	55-98-1	Busulfan; 4   Busulfan; Busulfex;; ; Busulfan;BUSULFAN; Myleran; Busulfano			-0.5898234684	4	4		0	0.26960784				H2AFX	O=S(C)(=O)OCCCCOS(C)(=O)=O	Microsource	01500152	-0.42842742	1.13256113	-0.69949636	0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094619-06	Chloramphenicol sodium succinate	170465429	Bacterial 70S ribosome Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	982-57-0				-2.3285927455	4	5		0	1.38268156					[Na+].O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl	SIGMA	C3787	-3.4823601	4.39546756	1.11124679	-1.07667685	1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167466-02	Lomustine	170464967	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	13010-47-4	 ;Lomustine (CeeNU); CeeBU; CeeNU; Lomustina; Lomustine;Lomustine	0.2818382931	-6.55	-3.6934800798	4	5		5.333524248	-1.78571429	0.7159681181	0.443833234		H2AFX	O=C(NC1CCCCC1)N(CCCl)N=O	Bosche	L0449	-2.22139489	-3.19460354	6.96772406	-1.52855994	-1.78571429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023902-09	4-Androstene-3,17-dione	170465907	Cytochrome P450 19A1 Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63-05-8				-2.9970800684	4	5		0	1.15921788					O=C2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801871	-3.93856448	2.77674013	0.72047869	1.42586934	1.15921788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179580-04	Biotin	170464763		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-85-5				-7.0941935726	4	5		0	-2.55586592					O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1	Vitas	STK801941	-1.99209246	-2.70202964	2.2591281	-1.68776371	-2.55586592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00378610-02	Topiroxostat		Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					3.3819869448	4	4		0	1.8872549					[N]#[C]C1=NC=CC(=C1)C2=N[NH]C(=N2)C3=CC=NC=C3	APExBIO	B1192	0.47883065	-0.41184041	1.48293229	1.8872549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183096-01	Cefcapene pivoxil hydrochloride	144206464	Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	147816-23-7	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-; Flomox; 			-3.5139971554	4	4	Cefcapene pivoxil hydrochloride;S-1108;CIPLUS_3875022;CEFCAPENE PIVOXIL HYDROCHLORIDE;LS-171990;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-;Flomox;Cefcapene Pivoxil Hydrochloride;S 1108;CIPLUS_695832;	0	-0.56372549					Cl.Nc1scc(n1)\C(=C\CC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(N)=O)CS[C@@H]23)C(=O)OCOC(=O)C(C)(C)C	ACC	API-04911	-0.9828629	0.25740026	-1.09121433	-0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160481-02	Tioxidazole	124892286	microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-3.7277546894	4	4		0	-1.00490196					CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1	Chembridge	5175278	-0.5796371	-0.15444015	-1.98656967	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-03	Telaprevir (VX-950)		HCV NS3 NS4A Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	402957-28-2				-3.7500789274	4	4		0	0.56372549					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	Selleck	S1538	-1.08366935	-1.02960103	-0.97929491	0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164543-02	Lomerizine dihydrochloride	170466010	Ca channel blocker - benzhydryl class	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	101477-54-7	 ; Terranas; Lomerizine HCl; LOMERIZINE DiHCl;Lomerizine; Lomerizine	11.220184543	-4.95	27.8921067109	2.4	4		35.611350388	28.38726651	0.0309753684	0.9994085985			Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC	Sequoia	SRP01568l	-0.72639225	-0.70263488	-1.34279199	28.38726651												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160631-02	Famphur	170466840	Trichostrongylus axei Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52-85-7				-1.3383816376	4	4		0	-0.13154433					O=S(=O)(N(C)C)c1ccc(OP(=S)(OC)OC)cc1	SIGMA	34341	-0.14527845	-0.75282309	-0.38003547	-0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095122-05	Irbesartan	170464670		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	138402-11-6				4.087528774	4	4		0	2.77090549					CCCCC5=NC1(CCCC1)C(=O)N5Cc2ccc(cc2)c3ccccc3c4nnnn4	Microsource	01504259	0.09666506	-0.66600888	1.27266942	2.77090549												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178714-04	Topiramate	170464746	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	97240-79-4	 Ortho brand of topiramate; ; Topamax;Topiramate; Topiramate; Epitomax; McN 4853; Cilag brand of topiramate; Topiramato			-3.7673895882	4	4		0	-0.76408787					NS(=O)(=O)OC[C@]23OC[C@H]1OC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2	Microsource	01505801	-1.68618267	1.42423535	0.1631765	-0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168771-03	Fosamprenavir (Calcium Salt)			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	226700-81-8				-2.947299907	4	4		0	-0.85959885					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17431	-0.84309133	0.16343684	-0.38074517	-0.85959885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178810-03	Novobiocin sodium	170465360	Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1476-53-5				3.5897093934	4	4		0	-0.51470588				HSP90AB1	[Na+].C/C(C)=C\Cc1cc(ccc1O)C(=O)NC3=C([O-])c4ccc(O[C@@H]2OC(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@H]2O)c(C)c4OC3=O	Microsource	01500444	0.52923387	0.92664093	2.8259653	-0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164637-02	Nifekalant	170465960	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	130636-43-0	NIFEKALANT HCl; ; Nifekalant;Nifekalant; Shinbit			5.4707716143	4	4		0	0.90686274				KCNH2	Cl.CN1C(=CC(=O)N(C)C1=O)NCCN(CCCc2ccc(cc2)[N+]([O-])=O)CCO	Sequoia	SRP034084n	1.13407258	1.28700129	1.42697258	0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485883-01	Forodesine (hydrochloride)	363681392	Purine nucleoside phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	284490-13-7				1.8216408325	4	4		0	1.93627451					OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C2=C[NH]C3=C2\N=C/NC3=O	MedChem Express	HY-16209	0.52923387	-0.97812098	-0.41969782	1.93627451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091635-09	Fenthion	170466807	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	55-38-9				-0.9800705187	4	5		0	-1.29817444					Cc1cc(ccc1SC)OP(=S)(OC)OC	Bosche	F1401	-0.41514042	0.2022756	0.78953861	0.09571668	-1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183830-01	Lemildipine	144206840	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	94739-29-4		12.5892541179	-4.9	29.5187602735	3	5	CIPLUS_208006;NPK 1886;isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;lemildipine;Lemidipine;Lemildipine;LS-131203;LEMILDIPINE;NB-818;NPK-1886;CIPLUS_701996;NB 818;lemildipinum;	46.9011356419	41.94726166	0.0006748032	0.999662661			O=C(OC)C1=C(C)NC(COC(N)=O)=C(C1c2cccc(Cl)c2Cl)C(=O)OC(C)C	Pharmaron	PH-NIH-152804	-0.26862027	-0.6573957	-0.29607698	-0.95716679	41.94726166											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013109-03	Phenol red	170465805	amyloid fibril formation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	143-74-8				-1.9895625606	4	5		0	-0.16227181					Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc(O)cc4	Labotest	LT00455865	-0.41514042	-0.0505689	-1.23365408	-0.28715004	-0.16227181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319018-01	Exametazime	170465570		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	105613-48-7				-0.9177128454	4	5		0	2.27180527					C/C(=N\O)[C@@H](C)NCC(C)(C)CN[C@H](C)C(\C)=N\O	GVK	FFS-11-286-NCI-100	-0.51282051	-0.6573957	-1.62842339	-0.09571668	2.27180527											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274268-01	NCGC00274268-01	225144369		DPI_SARS-CoV-2_General	2019_NPC-1_CPE					6.064910508	4	5		0	2.35294118					CCCCCCCC\C=C\CCCCCCCC(=O)NCCOC(=O)CC(C([O-])=O)[S]([O-])(=O)=O	GVK	FFS-11-286-NCI-103	2.36874237	-0.505689	-0.04934616	0.43072505	2.35294118											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016570-06	Mephentermine hemisulfate	170465271		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1212-72-2				-1.4893441529	4	5		0	-1.29817444					O=S(=O)(O)O.CC(C)(NC)Cc1ccccc1.CC(C)(NC)Cc1ccccc1	Microsource	01503250	-0.41514042	-1.0619469	-0.49346163	1.91433357	-1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00238452-03	Enzastaurin	170465609	PKCa, PKCb, PKCg inhbitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	170364-57-5	 Enzastaurin;LY-317615;Enzastaurin	12.5892541179	-4.9	39.0405173894	3	5		63.926945707	54.60446247	0.0002304044	0.9998848253	5578	PRKCA	Cn2cc(c1ccccc12)C=3C(=O)NC(=O)C=3c7cn(C5CCN(Cc4ncccc4)CC5)c6ccccc67	Selleck	S1055	-0.31746032	-0.7585335	-0.83888478	-0.09571668	54.60446247											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263909-02	Tadalafil	170464819	Phosphodiesterase V (PDE5) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	171596-29-5				1.0634228363	4	5		0	2.83975659				PDE5A	O=C6N(C)CC(=O)N4[C@@H]6Cc1c5ccccc5nc1[C@H]4c2ccc3OCOc3c2	Microsource	01505639	-0.36630037	-1.5676359	0.64150012	0.38286671	2.83975659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015191-13	Chlormezanone	170465161	GABA Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	80-77-3	 ; Beserol;CHLORMEZANONE; Chlormezanone; Trancopal; Lobak; Clormetazon; Clormezanona;Chlormezanone			-2.615645672	4	5		0	-0.64908722			2554	GABRA1	O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2	Microsource	02300062	-1.0989011	-1.2136536	-0.64150012	1.72290022	-0.64908722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021925-03	Prednisolone acetate	170464632	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	52-21-1	; Pred forte;PREDNISOLONE ACETATE;Prednisolone acetate (Omnipred); Supercortyl;Prednisolone acetate			1.0471654	4	5		0	1.62271805				NRC31	CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Bosche	P0845	0.31746032	-0.0505689	-0.78953861	-0.2392917	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016386-06	Sulfamerazine	170464738	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	127-79-7				-3.1404608873	4	5		0	-2.10953347					O=S(=O)(Nc1nc(C)ccn1)c2ccc(N)cc2	Vitas	STK520614	-0.61050061	-1.1125158	-1.03626943	1.53146686	-2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181034-03	Liarozole	170465610	Cytochrome P450 CYP17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	145858-50-0				-1.0814069933	4	5		0	0.73022312				CYP17A1	Cl.Clc1cc(ccc1)C(c2ccc3ncnc3c2)n4ccnc4	Tocris	2705	-0.17094017	-0.7079646	-0.59215396	-0.57430007	0.73022312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164553-02	Clofarabine	170465145	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	123318-82-1	 Clofarabine; ; Clolar;Clofarabine			-5.3431961974	4	4		0	-0.76295712				POLA1	Nc3nc(Cl)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	Sequoia	SRP03671c	-1.0653753	-1.60602258	-1.34279199	-0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091338-06	4-Chloro-3-methylphenol	170466134		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59-50-7				-0.0771156905	4	4		0	0.55248619					Oc1ccc(Cl)c(C)c1	Microsource	01500178	0	0.20075282	-0.78540664	0.55248619												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021122-08	Alverine citrate	170466248		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	5560-59-8		5.0118723363	-5.3	40.8991674437	3	4		43.4155953599	37.27966325	0.039583301	0.9990331895			O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2	Microsource	01500109	-1.3559322	0.30112923	2.20420573	37.27966325												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091596-05	Octadecanoic acid	170465630		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	57-11-4				-1.259552674	4	4		0	0.13154433					O=C(O)CCCCCCCCCCCCCCCCC	Specs	AE-562/J263018	-0.4842615	0.15056462	-0.58272105	0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164625-04	Cerivastatin sodium	170465109	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	143201-11-0		0.3981071706	-6.4	31.7943566553	4	4		15	-1.8802573	1	0.9996807342			[Na+].CC(C)c1nc(c(/C=C/[C@@H](O)C[C@@H](O)CC([O-])=O)c(c1COC)c2ccc(F)cc2)C(C)C	Sequoia	143201-11-0	0.67665539	1.50468673	13.74482978	-1.8802573												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024622-05	Dantrolene sodium	170464793	Ryanodine receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	14663-23-1				5.629438339	4	4		0	1.92973775			6261	RYR1	[Na+].[O-][N+](=O)c1ccc(cc1)c3ccc(/C=N/N2CC(=O)[N-]C2=O)o3	Enzo	AC100	2.41662639	-0.81401085	-0.38180083	1.92973775												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015897-08	Ranolazine	170465435	Sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	95635-55-5	 ;RANOLAZINE;Ranolazine dihydrochloride; Ranolazine dihydrochloride; Ranexa;Ranolazine			-1.2439044795	4	4		0	1.33597229			6335	SCN9A	OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC	Microsource	01505366	-0.77332044	-1.06068081	-0.50906777	1.33597229												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018194-08	Bendroflumethiazide	170465156	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	73-48-3				0.7322466057	4	4		0	-0.64324592					FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)Cc3ccccc3	Microsource	01503104	-0.57999033	-0.22200296	2.54533885	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183866-01	Oxypertine hydrochloride	144206763	Adenylate cyclase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	17506-66-0				-4.0458518934	4	4	OXYPERTINE;LS-82918;oxypertine;CIPLUS_152240;Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxipertina;Equipertine;Forit;CIPLUS_179718;Oxypertinum;Oxypertin;oxypertinum;1H-Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxypertine;	0	-1.52817574					Cl.COc3cc4nc(C)c(CCN1CCN(CC1)c2ccccc2)c4cc3OC	NCI	NSC_169107	-0.70257611	-1.42423535	-0.1631765	-1.52817574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165752-04	Eslicarbazepine (acetate)		Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	236395-14-5				-4.4233245283	4	4		0	-1.14613181					CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C3=C1C=CC=C3	MedChem Express	HY-B0703	-1.45199063	-0.07004436	0.27196084	-1.14613181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159372-04	Butanedioic acid	170465738		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	110-15-6				4.0323912379	4	5		0	-0.48681542					O=C(O)CCC(=O)O	Labotest	LTBB001662	1.44078144	2.62958281	-0.64150012	0.47858339	-0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160456-03	2-Iodohippuric acid	170465302	renal filtration Interacts	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	147-58-0				4.2467028298	4	5		0	2.35294118					O=C(NCC(=O)O)c1ccccc1I	SIGMA	106577	0.75702076	-1.1125158	1.03626943	1.62718354	2.35294118											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249922-01	Estriol benzoate diacetate	170465998		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	2508-47-6				3.3806595858	4	5		0	4.78701826					CC(=O)O[C@@H]4C5(C)CCC2C(CCc3cc(OC(=O)c1ccccc1)ccc23)C5C[C@H]4OC(C)=O	GVK	FFS-11-286-NCI-200	0.36630037	-0.9102402	-0.29607698	-0.04785834	4.78701826											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179456-04	Glycopyrrolate bromide	170465427		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	596-51-0				1.5865661601	4	5		0	2.51521298					[Br-].C[N+]3(C)CCC(OC(=O)C(O)(c1ccccc1)C2CCCC2)C3	Prestwick Chemical, Inc.	Prestw-746	-0.36630037	0.7585335	-0.49346163	0.28715004	2.51521298											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021141-05	Phenyltoloxamine citrate	170465477	Histamine H1 receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1176-08-5		14.1253754462	-4.85	10.37968112	4	5		20.952620248	16.79513185	0.0148906957	0.9925007174			O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc2ccccc2Cc1ccccc1	SIGMA	P8404	-0.07326007	-0.2022756	-1.08561559	-1.62718354	16.79513185											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091106-05	Methyl salicylate	225144206		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	90045-28-6				0.0066036147	4	5		0	1.46044625					COC(=O)C1=C(O)C=CC=C1	SIGMA	84330	-0.56166056	-0.1517067	-0.19738465	0.28715004	1.46044625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018237-09	Trichlorfon	170465707	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	52-68-6				3.3088212427	4	5		0	5.35496957					OC(C(Cl)(Cl)Cl)P(=O)(OC)OC	Prestwick	Prestw-51	-0.17094017	-0.2022756	-0.04934616	-0.28715004	5.35496957											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094574-15	Fipronil	170465992		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	120068-37-3				-3.7834266657	4	5		0	-1.78498986					FC(F)(F)S(=O)c1c(N)n(nc1C#N)c2c(Cl)cc(cc2Cl)C(F)(F)F	Microsource	01505354	-0.07326007	-0.505689	-0.9375771	-1.86647523	-1.78498986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018258-10	Econazole nitrate	170465422	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	24169-02-6	; Pevisone; Spectazole;Econazole nitrate;ECONAZOLE NITRATE; Econazole nitrate salt	14.1253754462	-4.85	7.9748403232	4	5		16.9120602999	13.63083164	0.0278831788	0.9858434958			[O-][N+](=O)O.Clc3ccc(C(OCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501185	0.07326007	-0.7585335	-0.59215396	-2.01005025	13.63083164											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025357-04	Nicorandil	170465582	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	65141-46-0	;Nicorandil; Nicorandil; ; Sigmart			2.1570519508	4	5		0	4.94929006				KCNJ8	O=C(NCCO[N+]([O-])=O)c1cccnc1	Prestwick	Prestw-106	-0.26862027	0.2022756	-0.69084629	-1.00502513	4.94929006											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263517-03	BORNEOL			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	507-70-0				-0.4969291238	4	4		0	0.9017341					CC1(C)C2CCC1(C)C(O)C2	Microsource	01505747	-0.66838046	-0.33889468	1.10555409	0.9017341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348215-03	Bedaquiline (TMC-207)		ATP synthase subunit c Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	843663-66-1				-0.1678833957	4	4		0	1.04046243			886937	atpE	COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C3=CC=CC=C3)[C@@](O)(CCN(C)C)C4=CC=CC5=C4C=CC=C5	Adooq	A12327	-0.61696658	2.05943691	-1.15819953	1.04046243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263546-01	Moexipril hydrochloride	170465131	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	82586-52-5				6.2942217888	4	4		0	2.05780347					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O	Tocris	2691	1.43958869	0.80813347	0.73703606	2.05780347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183869-01	Gusperimus trihydrochloride	144206777	Heat shock protein HSP90 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	85468-01-5				12.6960812367	4	4	CIPLUS_667980;15-DEOXYSPERGUALIN TRIHYDROCHLORIDE;LS-171915;Gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)-;gusperimus trihydrochloride;gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;Gusperimus Hydrochloride;deoxyspergualin;LS-74249;CIPLUS_667979;LS-74248;NKT-01;CIPLUS_756341;NSC-356894;1-amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione;(-)-15-Deoxyspergualin;BMY-42215-1;gusperimusum;Gusperimus trihydrochloride;Gusperimus hydrochloride;GUSPERIMUS TRIHYDROCHLORIDE;15-deoxyspergualin;3HCl of gusperimus;GUSPERIMUS;gusperimus, (+-)-isomer;Spanidin;DEOXYSPERGUALIN;CIPLUS_192812;	0	1.91907514			3303		Cl.Cl.Cl.O=C(NCCCCNCCCN)C(O)NC(=O)CCCCCCNC(=N)N	NCI	NSC_356894	2.72493573	2.99791449	3.15872598	1.91907514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017360-04	Aconitine			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	302-27-2				-0.7543715656	4	4		0	0.67052023					CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34C5C[C@]6(O)[C@@H](OC)[C@H](O)[C@](OC(C)=O)(C([C@H](OC)C23)[C@@H]14)C5[C@H]6OC(=O)C7=CC=CC=C7	Prestwick	Prestw-NAT-0127	-0.77120823	0.54744526	0.4738089	0.67052023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510028-01	Amezinium methylsulfate		Amine oxidase [flavin-containing] B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	30578-37-1				3.6242295939	4	4		0	2.19653179			403451	MAOB	COC1=CC(=CN=[N+]1C2=CC=CC=C2)N	Ark Pharm	AK396807	-0.30848329	1.17309698	2.79020795	2.19653179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167531-02	Rivastigmine tartrate	170464721	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	129101-54-8	Rivastigmine tartrate;Rivastigmine tartrate (Exelon); Rivastigmine tartrate; ;RIVASTIGMINE			-1.3454741535	4	4		0	0.39463299			43	ACHE	O=C(Oc1cc(ccc1)[C@H](C)N(C)C)N(C)CC.O=C(O)[C@@H](O)[C@H](O)C(=O)O	Sequoia	SRP01333r	-0.53268765	0.35131744	-0.98809222	0.39463299												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159508-04	Rose Bengal disodium	225144230	Free Radical Stimulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94			-0.6220213476	4	4		0	-0.13154433					[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	R3877	0	1.25470514	-1.2921206	-0.13154433												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016049-07	Tetracaine hydrochloride	170465190	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	136-47-0				0.8467198124	4	4		0	1.44698763					Cl.CN(C)CCOC(=O)c1ccc(NCCCC)cc1	Microsource	01500564	-0.0968523	0.45169385	-0.83607803	1.44698763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094748-07	Oxyphenbutazone	170465310		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	129-20-4				1.1274597106	4	4		0	1.4349332					Oc1ccc(cc1)N3C(=O)C(CCCC)C(=O)N3c2ccccc2	Microsource	01500455	-0.72498792	0.61667489	0.4454343	1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00014482-03	Methdilazine hydrochloride	124878446	ion channel	DPI_SARS-CoV-2_General	2019_NPC-7_CPE			7.0794578438	-5.15	61.2062248712	2.2	4	Methdilazine hydrochloride	75.9371778316	67.76504298	0.029536217	0.9994616522			CN1CC[C@@H](C1)CN2C3=C(SC4=C2C=CC=C4)C=CC=C3	NCGC	NSC-169091	-0.04683841	-1.09736166	16.37204243	67.76504298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178851-03	Moxalactam disodium	170465353	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	64953-12-4				10.5413434181	4	5		0	2.19066937					[Na+].[Na+].O=C3N1C(=C(CO[C@@H]1[C@]3(OC)NC(=O)C(c2ccc(O)cc2)C([O-])=O)CSc4nnnn4C)C([O-])=O	Microsource	01500418	2.75946276	1.0619469	1.57907723	2.77578368	2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00532496-01	P-T-BUTYL-M-CRESOL			DPI_SARS-CoV-2_General	2019_NPC-8_CPE			2.5118864315	-5.6	49.6998945655	3	4		40.7418265899	0.30057803	1	0.9999917981			CC1=CC(=CC=C1C(C)(C)C)O	SIGMA	A000011660	-0.35989717	-0.02606882	35.00921295	0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247988-03	Cochineal	170466801	Solute carrier organic anion transporter family member 1B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1343-78-8				-3.4951192408	4	4		0	0.48554913					O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O	SIGMA	229253	-1.1311054	-0.80813347	-0.57909976	0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167584-01	Nicametate citrate	144206129	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1641-74-3	Buffer solution from sodium citrate; Citric acid ammonium salt; Advil PM; Citric acid disodium salt; Euclidan; Alka-Seltzer; Sodium citrate buffer; Ammonium citrate dibasic; Sodium citrate monobasic; Citrate, Calciu; Tectlol; Pectamol; Citric acid-2,2,4,4-d4; Tc-99m-citrate; Citrate standard for IC; Bryrel; Astomatop; Pax??ladine; Caffeine, citrated; Antepar; Etoheptazina; Bismuth(III) citrate; Citric acid-13C6; DACH-Pt(II)citrate; Isoaminilo; Chemosol; Peracon; Aciletten; Tussimol; (239)Pu citrate; Tripelenamina; Anhydrous Citric Acid; Alverine citrate salt; Tritec; Tripelennamine Maleate; Toness; Citrato de galio (67 Ga); Cafcit; Oseltamivir citrate; Ferriseltz; Ammonium bismuth citrate; Citric acid solution; Ga-67 citrate; Sodium dihydrogencitrate; Pentoxyverine citrate; Tricalcium dicitrate; Silver citrate hydrate; Uralyt U; Zinc citrate dihydrate; Ascarex Syrup; Sinutab; Sodium dihydrogen citrate; DN 1417, (S)-isomer; Pyribenzamine; Tipepidina; AD 1308, citrate; Naldecon; U, Uraly; Oxeladin citrate salt; Citrate, Potassiu; 0.5 citrate CPD; Ammonium hydrogencitrate; Raniberl; technetium Tc 99m citrate; Citric acid lead salt; Citric acid calcium salt; Azanplus; Pentoxyverine Citrate; Citracal; Citric acid-2,4-13C2; Neoscan; Azaron; Citrates, Calciu; copper(II) citrate; Toclase; Citra ph; Citrate Solution; Banminth D; Oxeladina; Anhydrous citric acid; ethoheptazine HCl; Citric acid-1,5-14C; Clinitest; Oxeladin Tannate; Lithium citrate hydrate; Citric acid-1,5-13C2; Pylorid; Asverin; Tripotassium citrate; Alka Seltzer; DN 1417 citrate (1:1); Hetrazan; Butethamate citrate salt; DADP-PrD; ACD-A solution; Tri-lithium citrate; Gallii (67 Ga) citras; Citric acid zinc salt; Citric acid barium salt; Carricide citrate; gallii (67Ga) citras; Potassium hydroxycitrate; 67Ga-labeled; Negram-Citrat; Provasan; Banmint D; ACD solution; Iron(III) citrate; Mictral; Platinex; Acid, Citri; Trisodium citrate hydrate; Perogan; Norgesic forte; Orfenadrina; Citric Acid (Renacidin); Ammonium citrate tribasic; Magurlit; Sinecod; Cerebyx; Tetrodotoxin citrate; Dietilcarbamazina; 			4.9865267196	4	4	Nicametate Citrate;2-(diethylamino)ethyl nicotinate;nicametatum;NICAMETATE CITRATE;Nicametate citrate;Nicotinic acid, 2-(diethylamino)ethyl ester;3-(diethylaminoethoxycarbonyl)pyridine citrate;LS-96550;Nicametate;Provasan;Euclidan;NICAMETATE;nicametate;Nicametatum;2-(diethylaminoethyl)nicotinate citrate;LS-96549;CIPLUS_213922;CIPLUS_669827;	0	6.31213873					O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CC)CCOC(=O)c1cccnc1	SigmaAldrich	R288020	-0.10282776	0.33889468	0.42116346	6.31213873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181743-02	Lypressin	144206977	Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	50-57-7				3.4240012933	4	4	8-L-LYSINEVASOPRESSIN;CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1,6-DISULFIDE);Lypressin;Lyspressin;VASOPRESSIN, 8-LYSINE;Lysyl Vasopressin;Lipresina;Lypressinum;CIPLUS_148560;LYPRESSIN;LS-161412;Lysipressin;lypressine;Lypressine;Vasopressin, 8-Lysin;lypressinum;Lysine Vasopressin;[Lys8]-Vasopressin;VASOPRESSIN PIG;Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2, cyclic 1-6 disulfide;Lys Vasopressi;L-CYSTEINYL-L-TYROSYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)-DISULFIDE;Lysine vasopressin;8 Lysine Vasopressi;8-Lysine Vasopressin;Lys-Vasopressin;8-l-lysine vasopressin;VASOPRESSIN, 8-L-LYSINE;Vasopressin, Lysy;Postacton;Diapid;Vasopressin, 8-L-lysine-;	0	1.8018018					NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	Sigma DiscoveryCPR	CPY6754	0.47709924	0.75757576	0.47132757	1.8018018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179290-03	Pivampicillin	170466065		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	33817-20-8				3.4651743301	4	4		0	1.25125125					CC(C)(C)C(=O)OCOC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C	Prestwick	Prestw-1009	0.8110687	-0.75757576	1.41398272	1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160567-01	Acetomenaphthone	144205458		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	573-20-6	Acetomenaphtone; Acetomenaphthone; Menadiol diacetate; Vitamin K4; 			-4.8904442198	4	4	Menadiol diacetate;ACETOMENAPHTONE;Acetomenaphtone;Vitamin K4;Acetomenaphthone (2-Methyl-1,4-naphthalenediol diacetate);Acetomenaphthone;CIPLUS_154611;	0	-1.9019019					CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12	SigmaAldrich	S353078	-0.85877863	-1.43678161	-0.83791568	-1.9019019												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178711-03	Gemifloxacin mesylate	170465333	Topoisomerase IV subunit A  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	204519-65-3				-0.2650687095	4	4		0	1.2012012					CS(=O)(=O)O.CO\N=C1/CN(CC1CN)c2nc3c(cc2F)C(=O)C(=CN3C4CC4)C(=O)O	Microsource	01505802	-0.04770992	-1.3322884	-0.15710919	1.2012012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248587-03	METHYLPHENIDATE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	298-59-9, 113-45-1(base)				-5.2226683862	4	4		0	-0.8008008					COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Microsource	01505907	-1.28816794	-0.86206897	-1.04739461	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389765-01	DIBEKACIN			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	34493-98-6				1.7621514353	4	4		0	-1.9019019					NC[C@@H]1CC[C@@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O	Microsource	01503114	1.43129771	-0.80982236	1.57109191	-1.9019019												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00160628-03	Rutin trihydrate	170465691	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	153-18-4				-3.5858297027	4	4		0	-0.86819258					Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O	Enzo	NP266	-0.3874092	-0.95357591	-1.19077781	-0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182047-03	Fludarabine phosphate	170464764	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	21679-14-1	 ; Fludarabine phosphate; F-ara-AMP;Fludarabine phosphate; Fludara;FLUDARABINE PHOSPHATE			-0.1060104437	4	4		0	-0.18416206				HPRT1	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	Microsource	01505705	0.33898305	-1.10414053	0.22802128	-0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016893-04	Clorsulon	170466229	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	60200-06-8				-2.3216964536	4	4		0	-0.64324592					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	Prestwick Chemical, Inc.	Prestw-540	-0.24166264	0.71534287	-1.59083678	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016278-10	Mefenamic acid	170464813	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	61-68-7				-0.5731942597	4	4		0	0.49480455					O=C(O)c2ccccc2Nc1cccc(C)c1C	Vitas	STK666691	-0.72498792	0.51800691	-0.12726694	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249902-01	Epsiprantel	170465737	calcium ion homeostasis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	98123-83-2				2.4380472842	4	4		0	0.09896091					O=C2CN(CC1c3ccccc3CCCN12)C(=O)C4CCCCC4	GVK	FFS-11-286-NCI-105	-1.20831319	-0.71534287	4.83614381	0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018139-07	Ipriflavone	170466811	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone			13.3246881211	4	4		0	6.53142009					CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	SIGMA	381551	1.739971	2.09669462	1.39993637	6.53142009												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166213-02	2-Octyl-1-dodecanol	170465533		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	5333-42-6				-1.3161686177	4	4		0	1.43266476					CCCCCCCCC(CCCCCCCCCC)CO	SIGMA	464481	-0.74941452	-0.67709549	0	1.43266476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167505-03	Eptifibatide		Integrin alpha-IIb/beta-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	188627-80-7				-5.4470580391	4	4		0	-0.76408787					NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=C[NH]C4=CC=CC=C34)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O	MedChem Express	HY-B0686	-1.59250585	-0.07004436	-1.08784335	-0.76408787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164566-09	Pitavastatin Calcium			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	147526-32-7		1.1220184543	-5.95	29.102162055	4	4		22.1299765839	-0.14326648	1	0.9996755069			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	APExBIO	A8504	-1.35831382	3.15199626	20.99537667	-0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183859-01	Prifinium bromide	144206846	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	4630-95-9				-1.2437991369	4	4	Pyrrolidinium, 1,1-diethyl-3-diphenylmethylene-2-methyl-, bromide;Prifinium Bromide;PRIFINIUM BROMIDE;Prifinium bromide;CIPLUS_213773;Bromuro de prifinio;Prifinii bromidum;pyrodifenium bromide;CIPLUS_163551;Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide;3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide;prifinii bromidum;prifinium;Bromure de prifinium;prifinium bromide;bromure de prifinium;Padrin;LS-138326;	0	0.19102197					[Br-].CC[N+]3(CC)CC/C(=C(\c1ccccc1)c2ccccc2)C3C	Pharmaron	PH-NIH-153498	-0.23419204	-0.9105767	-0.21756867	0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181006-02	1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride	225144314		DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-1.9033438049	4	4		0	0					CNC(C)[C@@H](O)C1=CC=C(O)C=C1	SIGMA	CDS014222	-0.6088993	-0.77048798	0.27196084	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181323-02	Squalene	225144321	Steroid biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	111-02-4				1.8040974356	4	4		0	0.23877746					CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C	SIGMA	85634	1.07728337	-0.95727294	-0.65270601	0.23877746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167454-02	Pilsicainide	170465988	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	88069-67-4				-5.3722689051	4	4		0	-0.42979943					Cc3cccc(C)c3NC(=O)CC12CCCN2CCC1	SIGMA	P0026	-1.49882904	-1.42423535	-0.32635301	-0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181308-01	Sorbitan monohexadecanoate	144206336		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	26266-57-9	Sorbitan monopalmitate; Span 40; Palmitato de sorbitano; 			-1.5400099713	4	4	sorbitan monopalmitate;SPAN-40;CIPLUS_158227;Palmitato de sorbitano;sorbitan monohexadecanoate;Span 40;SORBITAN PALMITATE;Palmitate de sorbitan;SORBITAN MONOPALMITATE;Sorbitani palmitas;sorbitan palmitate;CIPLUS_204868;palmitate de sorbitan;Sorbitan monopalmitate;sorbitani palmitas;	0	0.23877746					O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O	SigmaAldrich	388920	-0.46838407	-0.9105767	0.1631765	0.23877746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262575-02	Cyproterone acetate	170465682	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	427-51-0		10	-5	19.9021307754	4	4		28.870179948	24.06936416	0.0442983026	0.9987906032		AR	CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C	Prestwick	Prestw-1074	-0.30848329	0.70385819	3.15872598	24.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483049-02	Gamithromycin			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	145435-72-9				-0.1069149627	4	4		0	0.85549133					CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@H]1C	Ark Pharm	AK105038	-0.71979434	-0.91240876	2.47433535	0.85549133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167496-03	Methylene blue	170465461	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	61-73-4	; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue			-0.4448172505	4	4		0	1.73410405				MAOA	[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	Labotest	LT00032971	-0.71979434	-0.75599583	0.89497236	1.73410405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485920-01	Tofogliflozin (hydrate)	363681416	Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1201913-82-7				3.3053644536	4	4		0	5.61849711					CCC1=CC=C(CC2=CC3=C(CO[C@]34O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C2)C=C1	MedChem Express	HY-13413	-0.25706941	-0.2346194	-0.10529087	5.61849711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263918-08	Epirubicin hydrochloride		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	56390-09-1				6.4669023211	4	4		0	-1.85185185				TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	MedChem Express	HY-13624A	4.05534351	-1.64576802	-1.93768002	-1.85185185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388518-02	Ticarcillin sodium			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	74682-62-5				0.9008709554	4	4		0	0.95095095					CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)C3=CSC=C3)C(=O)N2[C@H]1C([O-])=O	Prestwick	Prestw-1067	0.38167939	-1.48902821	0.36658811	0.95095095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182965-05	Biperiden	170465324	Anticholinergic	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1235-82-1	 ; Biperideno;BIPERIDEN;Biperiden hydrochloride; Akineton lactate; Akineton hydrochloride; Hydrochloride, Biperide;Biperiden; Biperidine; Biperiden hydrochloride; Tasmolin; 2   Biperiden Hcl; Beperiden; Akineton	8.9125093813	-5.05	12.1283762332	4	4		24.474921624	20.47047047	0.0356232674	0.9992187126		CHRNA2	Cl.OC(CCN1CCCCC1)(c2ccccc2)C4CC3C=CC4C3	Microsource	01505514	-1.04961832	-1.64576802	0.94265515	20.47047047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016914-06	CEFOTETAN		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	6971256-7				1.5160949979	4	4		0	-0.8008008					CO[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O	Microsource	01502424	0.62022901	-0.0261233	0.78554595	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016819-05	Gliquidone	170465581	Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	33342-05-1				3.8501145482	4	4		0	1.47796252					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3cc(ccc3C(C)(C)C4=O)OC	Prestwick Chemical, Inc.	Prestw-991	0.40018832	1.60055672	0.35097192	1.47796252												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159412-04	Tromethamine	170464686	calcium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	77-86-1				-0.5578972007	4	4		0	-0.42227501					OCC(N)(CO)CO	Labotest	LT03329109	0.11770245	-0.97425191	0.35097192	-0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159391-03	Sulfobromophthalein	170465816	Solute carrier organic anion transporter family member 1B1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	71-67-0				6.9620164153	4	4		0	8.18157825					[Na+].[Na+].[O-]S(=O)(=O)c1cc(ccc1O)C3(OC(=O)c2c(Br)c(Br)c(Br)c(Br)c23)c4ccc(O)c(c4)S([O-])(=O)=O	Labotest	LT03378988	-0.54143126	-0.83507307	-0.4049676	8.18157825												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095056-04	Retinyl palmitate	225144218		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	79-81-2				4.5239808757	4	4		0	1.10847189					CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)\CCCC1(C)C	SIGMA	R1512	0.25894539	0.76548365	2.18682505	1.10847189												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263584-01	Tirofiban hydrochloride monohydrate	170465092	Integrin alpha-IIb/beta-3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	150915-40-5				1.9290911129	4	4		0	1.90023753					Cl.O.O=C(O)[C@@H](NS(=O)(=O)CCCC)Cc1ccc(cc1)OCCCCC2CCNCC2	Sequoia	142373-60-2	-0.54143126	2.22686152	-0.674946	1.90023753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00142624-05	Lactulose	170464861	Synthetic sugar	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	4618-18-2	; Cephulac; Lactulosa; Chronulac; Duphalac;LACTULOSE; Amivalex; Normase;Lactulose			-1.7187989761	4	4		0	0.39584364					O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@]2(O)CO	Microsource	01500363	-0.67665539	-0.61667489	-0.4454343	0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164603-04	Ebastine	170465995	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	90729-43-4				-2.3241823737	4	4		0	-2.77090549			3269	HRH1	CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4	Sequoia	SRP00750e	1.01498308	-0.71534287	-0.63633471	-2.77090549												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183012-01	Penflutizide	144206843	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1766-91-2	Penflutizide; Penflutizida; 			-2.8725310643	4	4	LS-40450;Penflutizida;Penflutizidum;FT-124;Penflutizide;PENFLUTIZIDE;2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 3,4-DIHYDRO-3-PENTYL-6-(TRIFLUOROMETHYL)-, 1,1-DIOXIDE;3-n-pentyl-6-trifluoromethyl-7-sulfamyl-3,4- dihydro-1,2,4-benzothiadiazine-1,1-dioxide;penflutizidum;penfluzide;3-PENTYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE;penflutizide;CIPLUS_214081;	0	-0.4453241					FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)CCCCC	Pharmaron	PH-NIH-153110	-0.19333011	-0.32067094	-1.71810372	-0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022003-06	Diflorasone diacetate	170465294		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	33564-31-7				5.5550927799	4	4		0	2.67194458					CC(=O)OCC(=O)[C@@]4(OC(C)=O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-619	-0.19333011	-0.12333498	2.92713968	2.67194458												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249890-01	Mebutamate	170465233		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	64-55-1				-1.3995010004	4	4		0	-0.28653295					O=C(N)OCC(C)(COC(=O)N)C(C)CC	GVK	FFS-11-286-NCI-34	-0.32786885	-0.44361429	-0.05439217	-0.28653295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164248-05	Sucrose		Starch and sucrose metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	57-50-1				10.3585081916	4	4		0	1.96531792					OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCZ-038	1.6966581	3.57142857	2.94814425	1.96531792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178839-08	NAD+			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	53-84-9				0.5051630697	4	4		0	0.02312139					NC(=O)C1=C[N+](=CC=C1)[C@@H]2O[C@H](CO[P]([O-])(=O)O[P](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C(N)N=CN=C45)[C@@H](O)[C@H]2O	Adooq	A11679	-0.46272494	0.70385819	1.68465386	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016508-04	Methazolamide		Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	554-57-4				2.272045862	4	4		0	-0.39306358					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	Selleck	S4039	0.20565553	0.2346194	2.68491708	-0.39306358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183097-01	Beraprost sodium	144206467	Thyroid hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	88475-69-8	Beraprost sodium; Procylin; 			-2.1430888149	4	4	TRK-100;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-, monosodium salt;beraprost;4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate;BERAPROST;CIPLUS_685106;beraprost sodium;Procylin;Beraprost sodium;TRK 100;Beraprost Sodium;CIPLUS_193198;Beraprostum;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-;Beraprost;trk-100;BERAPROST SODIUM;ML-1129;2,3,3A,8B-TETRAHYDRO-2-HYDROXY-1((E)-(3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-1H-CYCLOPENTA(B)BENZOFURAN-5-BUTYRIC ACID SODIUM SALT;LS-57735;beraprostum;LS-57736;	0	0.94797688			19222		[Na+].CC(CC#CC)[C@H](O)/C=C/[C@H]2[C@H](O)C[C@@H]3Oc1c(cccc1CCCC([O-])=O)[C@H]23	ACC	BERAPROST SODIUM	-0.82262211	-0.49530761	-0.57909976	0.94797688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163699-07	Fumagillin		Methionine Aminopeptidase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	23110-15-8				-3.2052843987	4	4		0	-0.48554913					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	MedChem Express	HY-B0751	-0.71979434	-1.12095933	-0.3158726	-0.48554913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387803-01	Atosiban		Oxytocin receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	90779-69-4				5.6603604421	4	4		0	2.05205205					CCOC1=CC=C(CC2NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(NC2=O)C(C)CC)C(C)O)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)C=C1	ChemieTek	CT-ATOS	1.33587786	-0.91431557	1.93768002	2.05205205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345789-05	Venetoclax (ABT-199)		Bcl-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	8444499-71-4				-2.1553788618	4	4		0	-0.25025025				BCL2	CC1(C)CCC(=C(\C1)C2=CC=C(Cl)C=C2)/CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S+]([O-])(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7	ChemieTek	CT-A769	-0.47709924	-0.23510972	-0.83791568	-0.25025025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532503-01	BUNITROLOL		Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-4.2879505923	4	4		0	-0.35035035			154	ADRB2	CC(C)(C)NCC(O)COC1=CC=CC=C1C#N	UkrOrg	BBV-45651151	-1.24045802	-1.07105538	-0.15710919	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179247-04	Nomegestrol acetate		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	58652-20-3				5.6419363338	4	4		0	8.15815816					CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	SIGMA	SML0133	-0.14312977	-0.80982236	0.68080649	8.15815816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510907-01	Etafedrine hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5591-29-7				-1.9026712897	4	4		0	-1.25125125			154	ADRB2	CCN(C)C(C)C(O)C1=CC=CC=C1	SantaCruz Bio	sc-497331	-0.14312977	-1.22779519	0.36658811	-1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378845-01	Trelagliptin succinate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1029877-94-8				-1.6968447286	4	4		0	-0.65065065					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	-0.52480916	-0.91431557	1.09976434	-0.65065065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165774-05	Cloprostenol (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	55028-72-3				2.0056085625	4	4		0	1.32743363					O[C@@H](COC1=CC(=CC=C1)Cl)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC([O-])=O	Cayman	16764	0.18134715	-0.21940517	1.00679587	1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181020-01	Zeaxanthin	144206223	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	144-68-3	Lutein; alpha-Carotene-3,3'-diol; gamma Lutein; Lutein, gamm; Lutein G; Lutein F; 			-3.3649623768	4	4	XANTHOPHYLL;zeaxanthin;beta, epsilon-carotene;ZEAXANTHIN;(3R,3'R)-beta,beta- carotene-3,3'-diol;Lutein G;beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-;meso-zeaxanthin;Lutein F;CIPLUS_173450;LUTEIN A;alpha-Carotene-3,3'-diol;LUTEIN;beta,epsilon-Carotene-3,3'-diol, (3R,3'R,6'R)-;CIPLUS_758859;CIPLUS_668195;beta,beta-Carotene-3,3'-diol;Xanthophyll;gamma Lutein;Lutein;Lutein, gamm;B,B-CAROTENE-3,3'-DIOL, (3R,3'R), TRANS;Zeaxanthin;B,E-CAROTENE-3,3'-DIOL, (3R,3'R,6'R), TRANS;beta, epsilon-carotene-3,3'-diol;CIPLUS_759357;beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-;beta-carotene-3,3'-diol;	0	-0.81509082					CC2(C)C[C@H](O)CC(C)=C2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C	Sequoia	SRP00500Z	-0.59585492	-0.6582155	-1.10747546	-0.81509082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187598-03	Amaranth			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	915-67-3				1.4608142013	4	4		0	0.53563111					OC1=C(N=NC2=CC=C(C3=CC=CC=C23)[S]([O-])(=O)=O)C4=CC=C(C=C4C=C1[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	06409	0.44041451	-1.04826914	0.95645608	0.53563111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179663-03	(-)-(5S,8R)-Lisuride	170465966	Dopamine D5 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	159701-44-7				2.9582054089	4	4		0	0.31670625					CCN(CC)C(=O)N[C@@H]2C=C1c3cccc4ncc(C[C@@H]1N(C)C2)c34	Tocris	4052	0.11770245	1.60055672	1.21490281	0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00274056-01	Risedronate sodium	170464992	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	115436-72-1				-1.181103524	4	4		0	-0.47505938				FDPS	[Na+].[Na+].[O-]P(=O)(O)C(O)(Cc1cccnc1)P([O-])(=O)O	Microsource	01505944	-0.07062147	0.41753653	-0.78293736	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249903-01	Dexamethasone isonicotinate	170466851		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2265-64-7				-0.9339124085	4	4		0	-0.47505938					O=C1C=C2CC[C@@H]5[C@@](F)([C@@]2(C)C=C1)[C@@H](O)C[C@@]4(C)[C@H]5C[C@@H](C)[C@]4(O)C(=O)COC(=O)c3ccncc3	GVK	FFS-11-286-NCI-109	0.40018832	-1.53096729	-0.08099352	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182973-01	Chromonar hydrochloride	144206761	Platelet Aggregation (Plug Formation) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	655-35-6	Carbocromene; Intercordin; Carbocromeno; Cardiocap; Carbocromen Hydrochloride; Carbochromene; Carbocromen hydrochloride; Intensain; Hydrochloride, Chromona; 			-0.9337749995	4	4	Carbocromenum;Carbocromen hydrochloride;NSC-110430;Chromonar;Intensain;Carbocromen;Carbocromen Hydrochloride;carbocromene;Intercordin;((3-(2-(DIETHYLAMINO)ETHYL)-4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-YL)-OXY)ACETIC ACID ETHYL ESTER HYROCHLORIDE;Chromonar Hydrochloride;Hydrochloride, Chromona;chromonar;Carbocromeno;Carbochromene;carbocromenum;Acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester;Cardiocap;Chromonar hydrochloride;Carbocromene;CHROMONAR HYDROCHLORIDE;CIPLUS_155933;LS-11691;LS-11690;CIPLUS_156471;CARBOCROMEN;	0	0.42979943					Cl.O=C(OCC)COc1ccc2c(c1)OC(=O)C(CCN(CC)CC)=C2C	NCI	NSC_110430	-0.6557377	1.1440579	-0.54392168	0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183107-01	NCGC00183107-01	124894307		DPI_SARS-CoV-2_General	2019_NPC-8_CPE		Carbetocin; Depotocin; Carbetocino; 			2.7877150121	4	4	carbetocin;1-BUTYRIC ACID-2-(3-(4-METHOXYPHENYL)-ALANINE)OXYTOCIN;oxytocin, 1-desamino-1-monocarba-(Tyr(OMe))(2)-;1-Carbaoxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)-;Carbetocino;Depotocin;dcomot;oxytocin, 1-desamino-1-monocarba-(tyrosine(O-methyl))(2)-;LS-174644;carbetocinum;Carbetocinum;1-deamino-1-monocarba-2-(Tyr(OMe))-oxytocin;CIPLUS_213985;carbetocine;Carbetocin;CARBETOCIN;	0	-0.02312139					CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)N(C)C(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	APAC	877872	0.97686375	0.33889468	0.10529087	-0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386257-02	Aclidinium (Bromide)		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	320345-99-1				3.0579456099	4	4		0	0.76300578					OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-14144	-0.51413882	1.17309698	4.26428007	0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183837-01	Monatepil	124894552	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103377-41-9	Monatepil; Monatepil	12.5892541179	-4.9	71.4809550633	3	4	CIPLUS_696267;AJ 2615;MONATEPIL;monatepil, (S)-isomer;monatepil, (+-) monatepil;LS-172819;LS-172817;Monatepil Maleate;monatepil maleate;LS-173001;maleate;LS-171860;11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate;1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1);CIPLUS_3853864;MONATEPIL MALEATE;monatepil;Monatepil maleate;CIPLUS_197056;monatepil x maleate;monatepil, (R)-isomer;monatepilum;LS-173055;AJ-2615;N-(6,11-DIHYDRODIBENZO(B.E)THIEPIN-11-YL)-4-(4-FLUOROPHENYL)-1-PIPERAZINEBUTYRAMIDE MALEATE, DL-;LS-173056;	103.5671282691	94.26589595	0.0113333089	0.9999207729			Fc1ccc(cc1)N2CCN(CC2)CCCC(=O)NC3c5ccccc5SCc4ccccc34	Pharmaron	PH-NIH-152406	0.30848329	0.39103233	-0.05264543	94.26589595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167459-02	Doxapram hydrochloride	170465313	Potassium channel subfamily K member 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	113-07-5				-0.8158600693	4	4		0	-1.001001					Cl.O=C4N(CC)CC(CCN1CCOCC1)C4(c2ccccc2)c3ccccc3	Sequoia	113-07-5	-0.62022901	1.80250784	0.36658811	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181107-01	Arotinolol hydrochloride	144206274	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	68377-91-3	5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide; Almarl; 			-1.5534369111	4	4	arotinolol, (+-)-isomer;LS-175382;AROTINOLOL HYDROCHLORIDE;CIPLUS_732431;CIPLUS_211026;arotinololum;s 596;Arotinolol Hydrochloride;S 596;5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide;2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride;S-596;arotinolol;LS-176661;LS-152938;AROTINOLOL;Arotinolol hydrochloride;Almarl;arotinolol hydrochloride;Arotinolol;CIPLUS_695770;	0	1.4014014					Cl.OC(CSc1nc(cs1)c2ccc(s2)C(N)=O)CNC(C)(C)C	NCI	NSC-317940	-0.66793893	-0.96656217	-0.31421838	1.4014014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249416-01	Oberadilol	144206753	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	114856-44-9				-4.3143352315	4	4		0	-1.25125125					Clc3cc(OCC(O)CNC(C)(C)CNc1ccc(cc1)C2=NNC(=O)CC2C)c(C#N)cc3	NCGCChem	DJM10-028	-1.0019084	-1.80250784	0.62843676	-1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532495-01	Sizofilan			DPI_SARS-CoV-2_General	2019_NPC-6_CPE					1.2218532326	4	4		0	-1.001001					OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O)O[C@H](CO)[C@H]3O)[C@H](O)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	Kemprotec	TC838	-0.09541985	0.54858934	2.61848651	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183031-08	D-Pantothenic acid			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	79-83-4				7.5190506047	4	4		0	1.37401025					[H][C@](O)(C(=O)NCCC(O)=O)C(C)(C)CO	Selleck	S2498	1.11398964	2.85226719	2.3659703	1.37401025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182042-04	Propylhexedrine (hydrochloride)		Trace amine-associated receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1007-33-6				-4.4706413635	4	4		0	-0.62878435					CNC(C)CC1CCCCC1	Cayman	12058	-1.37305699	-0.26816187	-0.25169897	-0.62878435												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00274077-01	Hydrocortisone 17-butyrate	170465456		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	13609-67-1				-0.0293505625	4	4		0	0.44247788					OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5270	-0.44041451	1.19453925	-0.10067959	0.44247788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166257-03	NCGC00166257-03	50111747		DPI_SARS-CoV-2_General	2019_NPC-9_CPE					-3.2440134405	4	4	Mn3O4;Manganese(II,III) oxide;hausmannite;manganese oxide;manganous-manganic oxide;CIPLUS_158079;manganese oxide, hydrate;	0	-0.90824406					O=[Mn]O[Mn]O[Mn]=O	SigmaAldrich	377473	-1.16580311	-0.31691858	0.90611628	-0.90824406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-07	Ammonium Glycyrrhizinate			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	1407-03-0				11.4146241356	4	4		0	-0.11644155					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Selleck	S2376	2.8238342	2.41345685	3.72514473	-0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167426-03	Caramiphen edisylate	170465518		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	125-86-0				-0.9212011704	4	4		0	0.06986493					O=S(=O)(O)CCS(=O)(=O)O.CCN(CC)CCOC(=O)C1(CCCC1)c2ccccc2.CCN(CCOC(=O)C1(CCCC1)c2ccccc2)CC	ASDI	100028134	-0.12953368	-0.36567528	-0.55373773	0.06986493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346470-02	ZilpaterolHCl		beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	119520-06-8				-5.1570617305	4	4		0	-1.93292967				ADRB1	CC(C)N[C@@H]1CCN2C(=O)NC3=CC=CC(=C23)[C@H]1O	Enzo	AR113	-1.21761658	-0.5607021	-0.30203876	-1.93292967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094881-07	Glafenine hydrochloride	170465943		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	65513-72-6				1.0508430984	4	4		0	3.85325944					Cl.OCC(O)COC(=O)c3ccccc3Nc1ccnc2cc(Cl)ccc12	Microsource	01500996	-0.82391714	-1.18302018	-0.78293736	3.85325944												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249901-01	Thiocyanoacetic acid sodium salt	170465517		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63906-52-5				8.5756612825	4	4		0	1.58353127					[Na+].[O-]C(=O)CSC#N	GVK	FFS-11-286-NCI-92	1.62429379	2.92275574	1.70086393	1.58353127												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183829-01	Minodronic acid	144206806	Geranylgeranyl pyrophosphate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	180064-38-4				-0.9024733149	4	4	Minodronic Acid;MINODRONIC ACID;acidum minodronicum;CIPLUS_707422;acide minodronique;YM 529;Minodronic Acid Hydrate;	0	-0.15835313					O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O	Pharmaron	PH-NIH-115451	-0.16478343	-1.60055672	0.72894168	-0.15835313												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00015603-08	Lomefloxacin hydrochloride	170465262	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	98079-52-8	 ; Maxaquin;LOMEFLOXACIN HYDROCHLORIDE; Lomefloxacin hydrochloride;Lomefloxacin hydrochloride; Lemofloxacin			-2.4993160235	4	4		0	0.68619689					Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3	Microsource	01502037	-1.34180791	0.48712596	-1.05291577	0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095042-09	ThioTEPA	225144216	Cytochrome P450 Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef			-3.2104547316	4	4		0	-1.42517815				CYP2B6	S=[P](N1CC1)(N2CC2)N3CC3	Microsource	01503324	-0.11770245	1.73973556	0.02699784	-1.42517815												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00095239-05	1,3,5-Trimethoxybenzene	170465963		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	621-23-8				-0.7213178233	4	4		0	-0.2111375					COc1cc(cc(OC)c1)OC	Microsource	00231043	0.54143126	-1.04384134	-0.72894168	-0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164588-02	Malotilate	170465879	Liver Protein Metabolism	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	59937-28-9	 Kantec; Malotilate; Malotilato;Malotilate; 			-0.4566114726	4	4		0	0.10556875				MMP1	CC(C)OC(=O)C(/C(=O)OC(C)C)=C1/SC=CS1	Sequoia	SRP01140m	-0.9180791	1.2526096	0.24298056	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015608-11	Loperamide hydrochloride	170464852	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	53179-11-6	 ;LOPERAMIDE; Hydrochloride, Loperamid;Loperamide; Loperamide Hcl;Loperamide hydrochloride; Loperamide hydrochloride; Loperamida	5.6234132519	-5.25	108.1855148224	3	4		103.1170135449	98.12615466	0.0065718949	0.9999733611	4988	OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4	Enzo	ALX-550-253	-0.02354049	-0.48712596	0.89092873	98.12615466												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093926-05	Doxifluridine	170465861	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	3094-09-5	 ;5'dFUrd; Ro 21-9738; Furtulon; 5'dFUrd;Doxifluridine; Doxifluridine; Doxifluridina; 5-Fluro-5??-Deoxyuridine;5-fluoro-5'-deoxyuridine; 5-fluoro-5'-deoxyuridine			-0.3823245842	4	4		0	-0.58062813			7298	TYMS	FC1=CN(C(=O)NC1=O)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Bosche	D1649	0.11770245	-0.06958942	0.08099352	-0.58062813												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159453-05	Zileuton	170465222	5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	111406-87-2	;Zileuton; Zileuton; Zyflo;A-64077/ABT-077			-1.3577192699	4	4		0	1.00290314			240	ALOX5	NC(=O)N(O)C(C)c1cc2ccccc2s1	Prestwick Chemical, Inc.	Prestw-1365	-0.58851224	-2.15727209	0.1349892	1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016530-07	Sulfameter	170465428	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	651-06-9	; Sulfametoxidine; Sulfamethoxydine; 5-Methoxysulfadiazine; ;Sulfameter; Sulfameter;SULFAMETER; Sulfametoxidiazina; Sulla; Sulfamethoxydiazine; Sulphamethoxydiazine			0.4568689807	4	4		0	-0.63341251					O=S(=O)(Nc1ncc(cn1)OC)c2ccc(N)cc2	Microsource	01501155	0.40018832	0.6263048	-0.02699784	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093351-06	Cefoxitin	170465105	Penicillin-binding protein 2B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	35607-66-0				0.203484813	4	4		0	0.47505938			933948	penA	O=C(O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O	Microsource	01502031	-0.21186441	-0.90466249	0.674946	0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022653-09	Cefazolin	170465254	Bacterial penicillin-binding protein Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	25953-19-9				-1.677320248	4	5		0	-3.62723214					O=C(O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nnc(C)s2	Microsource	01500164	1.40233309	-2.40549828	2.17481646	-2.01126307	-3.62723214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091050-09	Phenylmercuric acetate	170465524		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	62-38-4		3.1622776602	-5.5	17.6485037138	4	5		16.0913556041	-4.67543028	0.3740947854	0.9031085704			CC(=O)O[Hg]c1ccccc1	Microsource	01500644	-1.32612967	3.23493235	-0.62775477	12.64222503	-4.67543028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163468-05	Mitomycin C	170464814	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-07-7	; ; Ametycine; Mitomycin-C;Mitomycin C;Mitomycin; Mutamycin; MITOMYCIN C; Mitocin;MITOMYCIN C; Mitocin-C; Muamycin			1.796634748	4	5		0	3.9436238				H2AFX	NC(=O)OC[C@@H]3C=1C(=O)C(N)=C(C)C(=O)C=1N2C[C@@H]4N[C@@H]4[C@@]23OC	Sequoia	50-07-7	-0.56483301	3.18573186	-1.10858822	-2.22503161	3.9436238											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179295-03	Meptazinol hydrochloride	170466363	Mu opioid receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59263-76-2				-7.6195155005	4	5		0	0.77246239					Cl.CN1CCCCC(CC)(C1)c2cccc(O)c2	Prestwick Chemical, Inc.	Prestw-1004	-3.61001965	0.18450184	-0.36062508	-1.9721871	0.77246239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090782-06	Nelfinavir mesylate	170465351	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	159989-65-8	 Mesylate, Nelfinavi;; ; Viracept; Nelfinavir mesylate;Nelfinavir mesylate;Nelfinavir; Viracept 250mg; Nelfinavir mesilate; Nelfinavir Mesilate	1.5848931925	-5.8	120.4638433046	3	5		86.0006346274	13.75558036	0.0545986508	0.998157005			CS(=O)(=O)O.Oc1cccc(c1C)C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C	Tocris	3766	0.83147183	-3.42369861	3.36611719	82.24725127	13.75558036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164556-02	Fudosteine	170465764	Mucin-5AC Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	13189-98-5				-4.4137642536	4	5		0	-1.89732143			4586	MUC5AC	OCCCSC[C@H](N)C(=O)O	Sequoia	SRP02575f	-2.49441549	-1.20911289	3.33841252	-0.05363368	-1.89732143											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00018243-09	Sulfamethazine	170464893	Bacterial dihydropteroate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-68-1				-4.6200011808	4	5		0	0.74535845					O=S(=O)(Nc1nc(C)cc(C)n1)c2ccc(N)cc2	Vitas	STK097514	-1.05599214	0.38130381	-1.74969948	-3.23640961	0.74535845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091149-21	VALPROATE SODIUM			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1069-66-5, 99-66-1 [valproic acid]				-1.7074821242	4	5		0	1.99213986					CCCC(CCC)C(O)=O	Microsource	01500606	-1.54715128	-0.35670357	0.5209029	-0.63211125	1.99213986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094937-04	Carprofen	170464799	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	53716-49-7				-4.5311882475	4	5		0	1.17902155					O=C(O)C(C)c1ccc2c3cc(Cl)ccc3nc2c1	Microsource	01502006	-2.28388998	0.25830258	0.33391211	-2.27560051	1.17902155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			-4.2581110845	4	5		0	-3.40401786				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	-1.10449243	1.97276314	-0.18008034	-1.31402521	-3.40401786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014483-16	Pamelor		Norepinephrine transporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	894-71-3		12.5892541179	-4.9	72.3955049877	3	5		111.8218556134	100.08370536	0.0026387407	0.9986781736			CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	N7261	0.85629188	-0.54728268	-1.98088378	-3.19120408	100.08370536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021122-08	Alverine citrate	170466248		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	5560-59-8		5.0118723363	-5.3	20.4110505793	2.4	5		32.26116838	24.63727679	0.0073181606	0.9963272576			O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2	Microsource	01500109	-2.02283445	-3.55097365	0.48483169	11.28989005	24.63727679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091596-05	Octadecanoic acid	170465630		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	57-11-4				3.7619568356	4	5		0	-0.30691964					O=C(O)CCCCCCCCCCCCCCCCC	Specs	AE-562/J263018	1.82427401	0.80183276	1.7038371	-1.6358273	-0.30691964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015798-11	Dexpropranolol	170464682	Adrenergic receptor beta Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	5051-22-9		14.1253754462	-4.85	21.8614921039	4	5		11.36662452	11.28879252	0.4858911991	0.6086255832			CC(C)NC[C@@H](O)COc2cccc1ccccc12	Specs	AN-153/I110481	7.26915521	1.63591636	0.25377321	-1.9721871	11.28879252											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015893-06	Ropinirole	170465139	Dopamine D3 receptor Partial Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	91374-21-9				-7.1575041863	4	5		0	-2.07345169					CCCN(CCC)CCc1cccc2NC(=O)Cc12	Microsource	01505178	-0.1719057	-3.08733087	-2.20381995	-2.27560051	-2.07345169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159455-09	Gefitinib	170464828	EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	184475-35-2	;Iressa/ZD-1839;Gefitinib; Iressa; Gefitinib			-10.8852190608	4	5		0	-5.71986607			1956	EGFR	Fc1ccc(cc1Cl)Nc2ncnc3cc(OC)c(cc23)OCCCN4CCOCC4	Tocris	3000	0.03723008	-3.78006873	-1.56531376	-4.21024403	-5.71986607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015519-11	Dopamine hydrochloride	170464942	Neurotransmitter	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-61-6	 ; Tensophoril; Actopamin; Dopamine hydrobromide;DOPAMINE HYDROCHLORIDE; 8   Dopamine; Hydrochloride, Dopamin; Dopamina; Dopamine hydrochloride;Dopamine hydrochloride; Intropin;Dopamine;3-HYDROXYTYRAMINE			-3.0731769069	4	4		0	-0.64324592				DRD2	Oc1ccc(CCN)cc1O	Vitas	STK301601	-0.53165781	0.12333498	-1.39993637	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095933-04	Phenyl 4-aminosalicylate	170465273		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	133-11-9				-1.5363972355	4	4		0	-0.34636319					Oc2cc(N)ccc2C(=O)Oc1ccccc1	Microsource	00305025	-1.06331561	-0.07400099	0.82723513	-0.34636319												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00390365-01	Delamanid			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	681492-22-8				-0.1546327692	4	4		0	-1.38490926					CC1(COC2=CC=C(C=C2)N3CCC(CC3)OC4=CC=C(OC(F)(F)F)C=C4)C[N]5C=C(N=C5O1)[N+]([O-])=O	Bio Vision	2280	0.23419204	0.02334812	0.38074517	-1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274273-01	NCGC00274273-01	225144371	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-2.4929546813	4	4		0	2.05348615					C[C@@]12CCCCC[C@@H](CC3=C1C=C(O)C=C3)[C@@H]2N	GVK	FFS-11-286-NCI-03	-1.21779859	-0.1167406	-1.19662769	2.05348615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018261-06	Perhexiline	170466435	mitochondrial carnitine palmitoyltransferase-1 inhbitior	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	6724-53-4	Perhexiline;rac Perhexiline Maleate; Perhexiline	3.1622776602	-5.5	20.7828654308	4	4		15.1119691161	0.41666667	1	0.9622539306		CPT1A	O=C(O)\C=C/C(=O)O.C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3	Microsource	01503227	1.68850806	-0.92664093	11.83547846	0.41666667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167547-02	Agaric acid	170465652		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	666-99-9				0.7407961236	4	4		0	4.9754902					O=C(O)C(CCCCCCCCCCCCCCCC)C(O)(CC(=O)O)C(=O)O	SIGMA	A7384	-0.93245968	-0.15444015	-0.69949636	4.9754902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159406-12	Noradrenaline bitartrate monohydrate	170465227	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	69815-49-2	; Norepinephrine bitartrate; Noreinefrina; L-(-)-NOREPINEPHRINE; L-Arterenol; NET protein, human; SLC6A2 protein, human; ;Norepinephrine bitartrate;L(-)-Norepinephrine bitartrate; Arterenol hydrochloride; Slc6a2 protein, mouse; (-)-Norepinephrine; Receptors, Adrenergic; (-)Arterenol; (-)-Arterenol bitartrate; Receptor, Adrenergi; Arterenol; Epinephrine Receptors; L(-)-Norepinephrine bitartrate; Norepinephrine Receptors;NOREPINEPHRINE; Noradrenaline bitartrate; Slc6a2 protein, rat; D-Norepinephrine Tartrate;(+/-)-NOREPINEPHRINE; Net protein, rat; Adrenergic Receptor; Norepinephrine; L-Arterenol hydrochloride; Noradrenaline Bitartrate			3.5582119313	4	4		0	-1.20098039			148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CN.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O	Microsource	01500436	1.99092742	0.36036036	-1.25909345	-1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182710-02	Flurbiprofen axetil	144206486		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	91503-79-6				-4.6052154239	4	4	Flurbiprofen Axetil;CIPLUS_701423;Flurbiprofen axetil;FLURBIPROFEN AXETIL;Ropion;FP83;FP 83;FP-83;1-acetoxyethyl-2-(2-fluoro-4-biphenyl)propionate;	0	-1.25					Fc2cc(ccc2c1ccccc1)C(C)C(=O)OC(C)OC(C)=O	ACC	Flurbiprofen Axetil	-1.28528226	0.92664093	-1.48293229	-1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521080-01	Digitoxin 3'''-Acetate		Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1111-39-3				10.070622676	4	4		0	0.36764706					CC1OC(CC(OC(C)=O)C1O)OC2C(O)CC(OC2C)OC3C(O)CC(OC3C)OC4CCC5(C)C(CCC6C5CCC7(C)C(CCC67O)\C8=C\C(=O)OC8)C4	Toronto Research	D445385	3.15020161	1.75032175	0.75545607	0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263541-01	Reboxetine mesylate	170465620		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	98769-84-7				4.1906476398	4	4		0	2.44672455					CS(=O)(=O)O.CCOc3ccccc3O[C@H](c1ccccc1)[C@H]2CNCCO2	Prestwick Chemical, Inc.	Prestw-1328	0.62953995	0.9033877	-0.27869268	2.44672455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253585-01	Cyclomethycaine	170465528		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	139-62-8		12.5892541179	-4.9	96.061368535	3	4		114.6904388916	89.05551171	0.0068712306	0.9999708798			CC3CCCCN3CCCOC(=O)c2ccc(OC1CCCCC1)cc2	GVK	FFS-11-286-NCI-76	-0.33898305	-0.70263488	-0.48137826	89.05551171												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00188435-01	2-Hydroxyethyl octadecanoate	144206587		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	111-60-4				-2.6532775299	4	4	Polyoxyl40Stearate	0	0.33428844					O=C(CCCCCCCCCCCCCCCCC)OCCO	APAC	878043	-1.45199063	0.77048798	0.38074517	0.33428844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167509-02	Pipethanate ethylbromide	170465967	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	23182-46-9				0.5721066083	4	4		0	0.52531041					[Br-].CC[N+]3(CCOC(=O)C(O)(c1ccccc1)c2ccccc2)CCCCC3	Sequoia	23182-46-9	0.18735363	-0.21013308	-0.21756867	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253591-01	Nepaprazole	170465906		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	156601-79-5				0.8782923917	4	4		0	-0.56372549					COc4ccnc1c4CCCCC1S(=O)c2nc3ccccc3n2	GVK	FFS-11-286-NCI-253	-0.52923387	1.75032175	2.04252938	-0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181026-02	Robenidine	170465629	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	25875-51-8				-5.9634662202	4	4		0	-2.86764706					Clc2ccc(/C=N/NC(=N)N\N=C/c1ccc(Cl)cc1)cc2	SIGMA	33979	-1.53729839	1.8018018	-1.65081142	-2.86764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024928-23	Tamoxifen	170465425	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	54965-24-1	Soltamox; "Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife	1.77827941	-5.75	42.4545190064	3	4		32.9375	-2.86764706	1	0.9998462371	2099	ESR1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc1ccc(cc1)/C(c2ccccc2)=C(/CC)c3ccccc3	Microsource	01500557	-0.78125	0.30888031	30.58198097	-2.86764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015623-10	Proglumide	170465774	Cholecystokinin B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	6620-60-6				7.3125888412	4	4		0	0.90686274				CCKBR	O=C(NC(CCC(=O)O)C(=O)N(CCC)CCC)c1ccccc1	Microsource	01501119	2.49495968	-0.15444015	0.53161724	0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253588-01	Gimatecan	170465615		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	292618-32-7				-10.8355557619	4	4		0	-1.39705882					CC(C)(C)O\N=C\c1c3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccccc12	GVK	FFS-11-286-NCI-141	-2.79737903	-1.8018018	-1.98656967	-1.39705882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024995-43	Paclitaxel		Tubulin Depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	33069-62-4				-1.3864514175	4	4		0	0.6127451				TUBB	CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7	Aobious	AOB5558	-0.07560484	-0.82368082	-1.538892	0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387301-01	Timiperone		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE			10	-5	36.7572984942	3	4		48.9294117632	45.75980392	0.0104491487	0.9999326879			FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)N3C(=S)NC4=C3C=CC=C4	Toronto Research	T443110	0.32762097	0.36036036	2.09848909	45.75980392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090814-07	4-Chlorophenol	170465673	macrophage activation involved in immune response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	106-48-9				-2.8260931729	4	4		0	0.19792182					Oc1ccc(Cl)cc1	Microsource	01500460	-1.30497825	1.20868278	-1.39993637	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159392-05	1,1,1-Trichloro-2-methyl-2-propanol	170465458		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	57-15-8				0.7900957676	4	4		0	0.89064819					ClC(Cl)(Cl)C(C)(C)O	Labotest	LT03378907	1.06331561	-0.32067094	-1.84537066	0.89064819												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159519-14	Tolterodine Tartrate 			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	124937-52-6		12.5892541179	-4.9	45.7885855815	3	4		73.622537065	65.47277937	0.0200444448	0.9997521546			[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O	Bosche	T0008	-0.46838407	-1.37753911	-1.41419636	65.47277937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183833-01	Bimosiamose	144206811	Selectin E Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	187269-40-5				-0.9203828073	4	4		0	-0.47755492					O=C(O)Cc1cccc(c1)c3cc(ccc3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)CCCCCCc5ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(c5)c6cccc(CC(=O)O)c6	Pharmaron	PH-NIH-124707	1.35831382	-1.65771655	1.14223552	-0.47755492												1.6E-9	8E-9	4E-8	2E-7											
NCGC00263905-04	TOLTRAZURIL			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	69004-03-1				-1.5481848537	4	4		0	1.44607843					CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(SC(F)(F)F)C=C3)C(=C2)C	Microsource	01505681	-0.73084677	0	-1.09121433	1.44607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181100-01	Ormeloxifene	144206269	Estrogen receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	31477-60-8	Levormeloxifene; Compound 672; Compound 67-20; Compound 67 2; Centchroman; 			-1.933041523	4	4	ORMELOXIFENE;levormeloxifenum;Centchroman;(-)-3,4-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane;CIPLUS_3865012;LEVORMELOXIFENE;LEVORMELOXIFENE FUMARATE;CIPLUS_676257;CIPLUS_709447;1-(2-(p-(trans-7-methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine;CIPLUS_3853907;ormeloxifenum;Compound 67-20;CIPLUS_3847290;Compound 672;NNC-46-0020 FUMARATE;CIPLUS_177424;CIPLUS_731807;Compound 67 2;Ormeloxifene;LS-137582;Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-;ormeloxifene;levormeloxifene;trans-2,2-Dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman;LS-137965;Levormeloxifene Fumarate;7-METHOXY-2,2-DIMETHYL-3-PHENYL-4-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)CHROMANE FUMARATE, TRANS-3R,4R, L-;Levormeloxifene;	0	-2.81862745					COc1ccc2c(c1)OC(C)(C)[C@H]([C@@H]2c4ccc(OCCN3CCCC3)cc4)c5ccccc5	NCI	NSC-147956	-1.23487903	-0.36036036	5.12031337	-2.81862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161414-03	Tropisetron	170466432	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	89565-68-4	 ;Tropisetron hydrochloride; Tropisetron hydrochloride;Navoban			0.2402511245	4	4		0	2.62254902			3359	HTR3A	CN4[C@H]1CC[C@@H]4CC(C1)OC(=O)c3cnc2ccccc23	Bosche	T0234	-0.52923387	-0.05148005	-0.47565753	2.62254902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262941-01	Ipenoxazone hydrochloride	170465754	Glutamate [NMDA] receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	118635-68-0	2-Oxazolidinone,	12.5892541179	-4.9	13.9619287309	4	4		18.100727472	16.69117647	0.134374897	0.9887509883			Cl.CC(C)C[C@H]3N(CCCN1CCCCCC1)C(=O)O[C@H]3c2ccccc2	GVK	FFS-11-286-NCI-165	0.12600806	1.75032175	-0.08393956	16.69117647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263480-01	Medroxyprogesterone acetate	170464622	Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	71-58-9				4.5665844139	4	4		0	8.01470588				PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Vitas	STK801943	-0.47883065	0.41184041	-0.69949636	8.01470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021301-06	Fluocinolone acetonide	170464630	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	67-73-2	; ; Fluocet; Synalar-C; Acetonida de fluocinolona; Sinalar; Synandone; Fluocinolone acetonide;Fluocinolone acetonide			-1.5359088841	4	5		0	1.05476673				NRC31	OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-1419	-0.41514042	-1.6182048	-1.03626943	0.43072505	1.05476673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016360-06	Monobenzone	170464724	topical medical depigmentation treatment	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	103-16-2	; ; 4-(Benzyloxy)phenol;4-(Benzyloxyl)phenol; 4-(Benzyloxyl)phenol; Benoquin;MONOBENZONE;Monobenzone; Monobenzona; Novo-depigman; ICN brand of monobenzone			-4.9031911783	4	5		0	-2.10953347				TYR	Oc2ccc(OCc1ccccc1)cc2	Microsource	01503031	-0.46398046	-1.8710493	-0.98692327	-0.67001675	-2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092377-04	Apafant	170466052	Platelet activating factor receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	105219-56-5				0.653148315	4	5		0	-1.54158215					Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CCC(=O)N5CCOCC5	Tocris	2339	0.56166056	-1.5676359	2.51665433	0.14357502	-1.54158215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090827-07	Guaiacol	225144199	intestine smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	90-05-1				6.2572989546	4	5		0	1.62271805					COC1=C(O)C=CC=C1	Prestwick	Prestw-1268	1.97802198	-0.3539823	0.83888478	1.48360852	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016737-04	Epirizole	170465827		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	18694-40-1				3.7615575483	4	5		0	3.73225152					Cc1cc(nc(n1)n2nc(C)cc2OC)OC	Prestwick	Prestw-32	-0.17094017	0	-0.74019245	2.58435032	3.73225152											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165810-02	Indoramin hydrochloride	170466233	Alpha-1d adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	38821-52-2		7.9432823472	-5.1	7.6679416701	4	5		13.30594184	12.00811359	0.0317932045	0.9838403811			Cl.O=C(NC3CCN(CCc1cnc2ccccc12)CC3)c4ccccc4	SigmaAldrich	I2909	0.02442002	-1.9216182	-0.44411547	0.43072505	12.00811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168085-05	Vorinostat (SAHA)	170465180	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	149647-78-9	 ;MK-0683;SAHA; SAHA cpd; Vorinostat;Vorinostat; M344 compound;Zolinza			-4.8584791537	4	5		0	-3.32657201			3065	HDAC1	O=C(Nc1ccccc1)CCCCCCC(=O)NO	Prestwick Chemical, Inc.	Prestw-1362	0.70818071	-0.8596713	-1.92450037	-2.48863364	-3.32657201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016010-09	Terbutaline hemisulfate	170464990	cAMP biosynthetic process Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	23031-32-5				-2.9692158891	4	5		0	0.48681542					Oc1cc(cc(O)c1)C(O)CNC(C)(C)C.O=S(=O)(O)O.CC(C)(C)NCC(O)c1cc(O)cc(O)c1	Microsource	01500558	-1.05006105	-2.02275601	-0.24673082	0.28715004	0.48681542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018241-07	Betamipron	170466040	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3440-28-6				0.7416749604	4	5		0	1.29817444			9376	SLC22A8	O=C(NCCC(=O)O)c1ccccc1	Vitas	STK288042	-0.02442002	-0.9608091	-0.64150012	1.3400335	1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016305-11	Silver sulfadiazine		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	68-35-9	; Diazin; Silver Sulphadiazine; Ditrim; Sulphadiazine; Sulfadiazine sodium salt; Perfringens Supplement I;Sulfadiazine; ;SULFADIAZINE; Tibirox; Diaziprim Forte; Silver(I) sulfadiazine; SPS Agar Supplement; Tribrissen; Zinc Sulfadiazine; Sulfadiazina sodica; Sulfazine; Triglobe; Silvadene; Sterinor; Sulfadiazine; Sulfadiazina; Sulfazin; Sulfadiazine, Zin			3.0204924164	4	4		0	4.18310971					NC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC=CC=N2	SIGMA	S8626	-0.14527845	-0.45169385	-0.93742083	4.18310971												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178241-04	Dichloro(ethylenediamine)platinum(II)	170466890	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	14096-51-6				0.5453224432	4	4		0	-0.49986846					[Cl-][Pt]1([Cl-])NCCN1	Microsource	01502107	1.01694915	0.65244667	-1.19077781	-0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016504-09	Droperidol	170464722	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	548-73-2				3.8092858107	4	4		0	1.65745856					Fc1ccc(cc1)C(=O)CCCN2CC=C(CC2)N3c4ccccc4NC3=O	Microsource	01501002	0.72639225	0.35131744	0.38003547	1.65745856												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094614-06	4-Chloro-3,5-dimethylphenol	170465503		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	88-04-0				-4.7773560679	4	4		0	0.02630887					Oc1cc(C)c(Cl)c(C)c1	Microsource	01500182	-1.6464891	-1.40526976	-0.73473524	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015443-17	Flecainide acetate	170464874	Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	54143-55-4	Tambocor; Flecainide, (R)-Isomer; Flecainide acetate salt; ; Flecainide, (S)-Isomer;Flecainide; Flecainide; Flecainida;Flecainide acetate			0.9472722216	4	4		0	-0.55248619			6331	SCN5A	FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2	Enzo	AC130	-0.14527845	1.50564617	0.73473524	-0.55248619												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163128-08	Pioglitazone hydrochloride	170465116	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	112529-15-4	Pioglitazona; Pioglitazone HCl;AA-10090;Pioglitazone HCl;PIOGLITAZONE HYDROCHLORIDE; ;Zactos;Actos;U-72107A;Glustin			3.7620405955	4	4		0	5.44285007			5468	PPARG	Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3	Microsource	01504401	-0.82165297	-0.024667	-0.63633471	5.44285007												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016697-04	Trimetazidine dihydrochloride	170465797	"Trifunctional enzyme subunit beta, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	13171-25-0				-2.449837998	4	4		0	-1.4349332			3032	HADHB	Cl.Cl.COc2ccc(CN1CCNCC1)c(OC)c2OC	Vitas	STK315643	0.38666022	-0.37000493	-1.27266942	-1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094960-06	Anthraquinone	170466833	Beta amyloid A4 protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	84-65-1				3.9903552323	4	4		0	1.13805047					O=C2c1ccccc1C(=O)c3ccccc23	Vitas	STK398385	-0.04833253	-0.46867292	2.67260579	1.13805047												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00181168-01	Trifluomeprazine 2-butenedioate	144206322		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	71609-19-3	Trifluomeprazine; Trifluomeprazina; 	10	-5	61.9339042712	3	4	Trifluomeprazinum;Trifluomeprazine;CIPLUS_214394;trifluomeprazine;TRIFLUOMEPRAZINE;trifluomeprazinum;Trifluomeprazina;TRIFLUOMEPRAZINE MALEATE;	92.7925320277	86.67621777	0.0138554868	0.9998815827			O=C(O)C=CC(=O)O.FC(F)(F)c1cc2N(CC(C)CN(C)C)c3ccccc3Sc2cc1	NCI	NSC-170991	-1.45199063	-0.35022181	1.57737286	86.67621777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179506-05	Kanamycin (sulfate)		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	25389-94-0				1.5904113122	4	4		0	0.47755492					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	MedChem Express	HY-16566A	0.37470726	-0.02334812	0.27196084	0.47755492												1.6E-8	8E-8	4E-7	0.000002											
NCGC00390805-02	Icatibant		Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	130308-48-4				0.895710154	4	4		0	0.19102197					N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CS3)C(=O)N[C@@H](CO)C(=O)N4CC5=C(C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C5	MedChem Express	HY-17446	0.14051522	-1.1440579	1.68615719	0.19102197												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181296-02	Seratrodast	170465940	Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	112665-43-7	 Bronica; (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid;Seratrodast;AA 2414; 			0.0383134051	4	4		0	1.52817574			6915	TBXA2R	O=C2C(C)=C(C)C(=O)C(C)=C2C(CCCCCC(=O)O)c1ccccc1	Tocris	3025	-0.51522248	-0.02334812	0.32635301	1.52817574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016855-10	Fenbendazole	170465647	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	43210-67-9	; ; Phenbendasol; Fenbendazole; Panacur;FENBENDAZOLE; Fenbendazol;Fenbendazole			-1.7837899169	4	5		0	-1.62271805				CYP3A4	O=C(OC)Nc1nc2cc(ccc2n1)Sc3ccccc3	Vitas	STK378581	1.68498168	-2.22503161	-1.57907723	-1.48360852	-1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022680-05	Chlormadinone acetate	170465776	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	302-22-7		12.5892541179	-4.9	25.2247404267	3	5		43.1838038448	36.34888438	0.0005442934	0.999727993	367	AR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1374	-0.56166056	-0.6573957	-0.34542314	-0.28715004	36.34888438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179435-06	Ifomide	170464854	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3778-73-2	 Isofamide (Ifosfamide?);Ifosfamide; Asta Z 4942; Ifosfamida;; Holoxan; Iso Endoxa;IFOSFAMIDE; Iphosphamide; Iso-Endoxan; Ifosfamide Sterile			1.8329079394	4	5		0	4.38133874				H2AFX	O=P1(NCCCl)OCCCN1CCCl	Microsource	01505480	-0.31746032	-0.2528445	-0.34542314	-0.62215841	4.38133874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094887-05	Fenoprofen calcium salt dihydrate	170465299	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	71720-56-4				1.540573906	4	5		0	0					[Ca+2].O.O.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2	Microsource	01501011	1.1965812	0.3539823	-1.08561559	-0.2392917	0											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179669-04	Norethindrone	170464683		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	68-22-4				-1.8098575085	4	4		0	-0.04948046					O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4	Prestwick Chemical, Inc.	Prestw-253	-0.57999033	0.17266897	-0.76360165	-0.04948046												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00507976-02	Derquantel			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	187865-22-1				-3.0316378075	4	4		0	0.62082139					CN1C(=O)[C@]23C[C@H]4C(C)(C)[C@]5(CNC6=C7O\C=C/C(C)(C)OC7=CC=C56)C[C@]14CN2CC[C@@]3(C)O	SantaCruz Bio	sc-391516	-1.45199063	0.30352557	0	0.62082139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483038-01	TAK-599			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	400827-46-5				-2.4889466648	4	4		0	-1.00286533					CCO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)SC3=NC(=CS3)C4=CC=[N+](C)C=C4)C5=NSC(=N5)N[P](O)(O)=O	DC Chemicals	DC7923	-0.79625293	0.58370301	-0.1631765	-1.00286533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015455-10	Felodipine	170464849	Voltage-gated calcium channel alpha2/delta subunit 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	72509-76-3				7.0100726791	4	4		0	5.17286883					CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(Cl)c2Cl)C(=O)OC	Specs	AE-641/11429675	0.49435028	1.53096729	-0.62095032	5.17286883												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015611-18	Lidocaine	170464729	Sodium channel protein type IX alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	137-58-6				-0.6322493511	4	4		0	-0.89733439					O=C(Nc1c(C)cccc1C)CN(CC)CC	Vitas	STK552033	-0.87099812	-1.11343076	2.6187905	-0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094810-04	Warfarin sodium	170464790	Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2610-86-8	 ; Coumafene;WARFARIN; (S)-(-)-Warfarin;Warfarin; Warfarin; WARFARIN;Potassium warfarin; (R)-(+)-Warfarin; Warfarina; Warfarin Sodium Clathrate; actosin P; Coumadin; Athrombin-K;(?)-Warfarin			-4.8473112939	4	4		0	-1.26682502			79001	VKORC1	[K+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3	Labotest	LT00771738	-1.24764595	0.34794711	-1.32289417	-1.26682502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179676-03	Lynestrenol	170465984		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	52-76-6		12.5892541179	-4.9	19.4197307337	2.4	4		32.426640924	28.45588235	0.0190317428	0.9997768604			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C	Prestwick Chemical, Inc.	Prestw-95	-0.42842742	-0.77220077	-0.3077784	28.45588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163127-04	Acitretin	225144249	retinoid	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	55079-83-9	Acitretin; ; Acitretin; ACITRETIN; Soriatane			13.7374825449	4	4		0	8.50490196				RXRA	COC1=C(C)C(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1)C)C	Prestwick	Prestw-1165	1.13407258	2.47104247	3.94515949	8.50490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024667-14	Methyldopa	170464643	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	41372-08-1	; L-alpha-Methyl DOPA;METHYLDOPA; L-alpha-Methyl-DOPA;Methyldopa; ; DL-alpha-Methyl-DOPA; Methoplain; Metildopa;L-alpha-Methyl DOPA; alpha-Methyl-L-DOPA; L(-)-alpha-Methyldopa;Methyldopa sesquihydrate; Methyldopa (L,-);Methyldopa (L,-); L-Methyldopa; Methyldopa sesquihydrate; Aldomet; L-Alphamethyl Dopa			-1.0188708901	4	4		0	0.97342805			1644	DDC	O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1	Microsource	01500403	-0.33898305	-0.45169385	-1.08943501	0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160514-02	Idebenone	170465611	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	58186-27-9	 ;Idebenone;IDEBENONE; Idebenone			1.180146866	4	4		0	0.49986846					COC1=C(OC)C(=O)C(C)=C(CCCCCCCCCCO)C1=O	Vitas	STK801942	0.62953995	-0.65244667	-0.07600709	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164057-03	2-Bromo-2-nitro-1,3-propanediol	225144251	reactive oxygen species biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52-51-7				-4.7189092067	4	4		0	-1.92054722					OCC(Br)(CO)[N+]([O-])=O	SIGMA	134708	-0.2905569	-1.10414053	-1.2414492	-1.92054722												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016640-06	Todralazine hydrochloride	170465782	histone acetylation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3778-76-5				-5.1800666163	4	4		0	-0.18416206					Cl.O=C(OCC)NNc2nncc1ccccc12	Microsource	01501174	-1.3559322	-1.05395232	-1.64682037	-0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159510-05	Aripiprazole	170465392	5-HT1A/2A Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	129722-12-9	 Abilify;;Aripiprazole; ;ARIPIPRAZOLE; Aripiprazole			-1.7061639074	4	4		0	0.19792182			3356	HTR2A	Clc4cccc(N3CCN(CCCCOc1ccc2CCC(=O)Nc2c1)CC3)c4Cl	Microsource	01505851	-0.38666022	-0.96201283	-0.50906777	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015340-14	Desipramine hydrochloride	170465424	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	58-28-6		11.220184543	-4.95	100.6893235938	3	4		105.9692424286	91.24195943	0.0164395104	0.9998332813			Cl.CNCCCN2c3ccccc3CCc1ccccc12	Microsource	01500227	0.43499275	0.66600888	-0.63633471	91.24195943												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00379087-02	Tipranavir			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	174484-41-4		10	-5	13.8788113606	4	4		17	13.94460363	0.0972406575	0.9941700087			CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	0.18735363	1.37753911	2.88278488	13.94460363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521078-02	Cephaloglycin		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	3577-01-3				1.7755187697	4	4		0	0.38204394					CC(=O)OCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O	Toronto Research	C258000	-0.23419204	2.1713752	0.81588251	0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183013-01	Doranidazole	144206845	Apoptosis Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	149838-23-3	DORANIDAZOLE; 			3.6034891955	4	4	Doranidazole;RP 343;1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole;doranidazolum;(2RS,3SR)-3-((2-NITROIMIDAZOL-1-YL)METHOXY)BUTANE-1,2,4-TRIOL;RP-343;1,2,4-Butanetriol, 3-((2-nitro-1H-imidazol-1-yl)methoxy)-, (R*,S*)-;CIPLUS_741927;DORANIDAZOLE;	0	2.4754902			81656		OC[C@@H](O)[C@H](CO)OCn1ccnc1[N+]([O-])=O	Pharmaron	PH-NIH-153447	0.02520161	1.49292149	0.9233352	2.4754902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183864-01	Adesulfone sodium	144206768	Dihydropteroate synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	144-75-2				-1.213060924	4	4	DIASONE;Aldesulfone sodique;aldesulfone sodique;aldesulfonum natricum;SULFOXONE SODIUM;Adesulfone Sodium;METHANESULFINIC ACID, (SULFONYLBIS(4,1-PHENYLENEIMINO))BIS-;SULFOXONE;(SULFONYLBIS(4,1-PHENYLENEIMINO))DIMETHANESULFINIC ACID;Methanesulfinic acid, (sulfonylbis(p-phenyleneimino))di-, disodium salt;DISODIUM (SULFONYLBIS(P-PHENYLENEIMINO))DIMETHANESULFINATE;(sulfonylbis(p-phenyleneimino))dimethanesulfinic acid disodium salt;ALDESULFONE SODIUM;aldesulfon sodium;sulfoxone, disodium salt;CIPLUS_152107;Aldesulfonum natricum;CIPLUS_152108;LS-90060;Sulfoxone;METHANESULFINIC ACID, (SULFONYLBIS(1,4-PHENYLENEIMINO))BIS-, DISODIUM SALT;Sulfoxone sodium;sulfoxone;sulfoxone sodium;Diasone;Aldesulfona sodica;	0	-0.56372549					[Na+].[Na+].O=S(=O)(c1ccc(NCS([O-])=O)cc1)c2ccc(NCS([O-])=O)cc2	NCI	NSC_27222	-0.47883065	0.30888031	0.3077784	-0.56372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095089-10	Fluconazole	170464782	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	86386-73-4	; ;Hexaflumuron; Hexaflumuron; Diflucan; Sonet; Fluconazole;FLUCONAZOLE;Fluconazole; FLUCONAZOLE			1.5911825732	4	4		0	0.86819258					OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F	Vitas	STK619301	0.8716707	-0.75282309	-0.43070687	0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00378622-03	Osimertinib mesylate		EGFR (Thr790Met Mutant) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1421373-65-0				5.990393299	4	4		0	-0.67052023				EGFR	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Axon Medchem	2342	1.18251928	0.80813347	4.15898921	-0.67052023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179607-03	Chlorphensin carbamate	225144309		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	886-74-8				-1.4397229074	4	4		0	-0.11560694					NC(=O)OCC(O)COC1=CC=C(Cl)C=C1	Prestwick	Prestw-234	-0.30848329	-0.70385819	-0.10529087	-0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165722-03	Plerixafor hydrochloride		Chemokine CXCR4 (SDF-1 Receptor) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	155148-31-5				2.4048881962	4	4		0	-0.16184971				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	Selleck	S3013	0.87403599	1.95516163	-0.05264543	-0.16184971												1.6E-8	8E-8	4E-7	0.000002											
NCGC00183658-01	Quadrisol	144207184	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	71109-09-6				-2.6126308906	4	4	CIPLUS_214418;Vedaprofen;vedaprofen;VEDAPROFEN;vedaprofenum;2-(4-cyclohexyl-1-naphthalenyl)propanoic acid;	0	-1.0867052			791253	PTGS2	O=C(O)C(C)c2ccc(c1ccccc12)C3CCCCC3	Toronto Research		-0.77120823	-0.49530761	0.73703606	-1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263521-01	Deflazacort	170466610	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	14484-47-0	Deflazacort;Deflazacort (Calcort)			-1.8081850555	4	4		0	0.53179191				NR3C1	CC(=O)OCC(=O)[C@@]54N=C(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	14484-47-0	-1.02827763	0.44316997	0.1579363	0.53179191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388369-01	Prednisolone Phosphate (sodium salt)		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	125-02-0				-0.1678026879	4	4		0	-0.30057803					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO[P]([O-])([O-])=O	Cayman	15933	0.41131105	-0.13034411	-0.57909976	-0.30057803												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00090698-06	1,3-Diphenylguanidine	170465656		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	102-06-7				1.0175140285	4	4		0	-1.07866351					N=C(Nc1ccccc1)Nc2ccccc2	Vitas	STK802182	1.21065375	0.05018821	-0.07600709	-1.07866351												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181337-03	2,4-Dichlorobenzyl alcohol	170465574		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1777-82-8				9.6780280211	4	4		0	2.92028414					OCc1ccc(Cl)cc1Cl	Bosche	D0540	0.72639225	2.50941029	3.21763365	2.92028414												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016892-04	Iopamidol	170464646		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60166-93-0				-1.7753514126	4	4		0	0.65772165					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO)[C@H](C)O	Prestwick	Prestw-871	-0.43583535	-0.40150565	-1.34279199	0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00093802-06	Dehydroepiandrosterone	170465614	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53-43-0	 DHEA phosphatide; ; Prasterona; DHEA sulfotransferase; Androstenolone; Dehydroepiandrosterone;Dehydroepiandrosterone; DHEA receptor;Dehydroepiandrosterone (DHEA); 5a-Androstanedione; Prasterone, 3 alpha Isome; trans-Dehydroandrosterone;trans-Dehydroandrosterone; DHEA sulphotransferase; 5-Androsten-3-ol-17-one;; 7   Androstanedione;DHEA; 5 Androsten 3 ol 17 on			1.8893661941	4	4		0	0.97342805				HSD11B1	O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Labotest	LT03329654	-1.11380145	1.20451694	1.95084875	0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091320-05	Decanoic acid	225144209	Peroxisome proliferator-activated receptor gamma Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	334-48-5				-0.6823934013	4	4		0	-0.0789266			5468	PPARG	CCCCCCCCCC(O)=O	SIGMA	D1653	-0.3874092	1.50564617	-0.88674943	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163778-09	Imazalil sulfate	170466809	O75469|||Q9UJ26 REC20 - 20% relative effective concentration; the concentration of the test compound showing 20% of the agonistic activity of 1 _ 10_5 M rifampicin via hPXR	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	58594-72-2				-2.6863043713	4	4		0	-1.63285502					O=S(=O)(O)O.Clc2ccc(C(OCC=C)Cn1ccnc1)c(Cl)c2	Prestwick Chemical, Inc.	Prestw-963	-0.43499275	-0.22200296	0.06363347	-1.63285502												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021382-07	ERYTHROMYCIN ETHYLSUCCINATE		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1264-62-6, 114-07-8 [erythromycin]				6.8151384911	4	4		0	1.71919771					CCOC(=O)CCC(=O)O[C@@H]1[C@H](C[C@@H](C)O[C@H]1O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500279	0.88992974	3.89913612	0.76149035	1.71919771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	526-18-1				-2.6553404788	4	4		0	0.95510984					OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	-1.40515222	1.56432407	-1.25101985	0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091396-05	Benzoin	170465507		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	119-53-9				-3.2127328795	4	5		0	-1.70385396					OC(C(=O)c1ccccc1)c2ccccc2	Vitas	STK358785	-1.0989011	-0.1517067	0.19738465	0.09571668	-1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017253-03	Ergobasine	124882896	Serotonin (5-HT) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	129-51-1				0.2587527917	4	4	ERGONOVINE MALEATE	0	0.11560694					C[C@@H](CO)NC(=O)[C@H]\1CN(C)[C@@H]\2CC3=C[NH]C4=CC=CC(=C34)C2=C1	BIOMOL	AC824	0.46272494	-0.39103233	-1.05290866	0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378691-02	Asunaprevir (BMS-650032)		Solute carrier organic anion transporter family member 2B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	630420-16-5				-0.5408267342	4	4		0	0.43930636					COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(=CC=C15)Cl	Adooq	A11295	-0.82262211	0.18248175	1.57936299	0.43930636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167559-01	Androstenone	144206107		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	18339-16-7	5A-ANDROSTA-16-ENE-3-ONE; Androstenone; 			5.619136113	4	4	3-Keto-5alpha,16-androstene;5 alpha-androst-16-en-3-one;CIPLUS_663558;androsta-5,16-dien-3 beta-ol;5,16-androstadien-3 beta-ol;ANDROSTAENEONE;andien-beta;androstadienol;CIPLUS_728432;5A-ANDROSTA-16-ENE-3-ONE;androst-16-en-3-one;androst-16-en-3-one, (5beta)-isomer;16-(5alpha)Androsten-3-one;Androstenone;5alpha-Androst-16-en-3-one;	0	6.86705202					O=C2C[C@@H]3CC[C@H]1[C@@H]4CC=C[C@@]4(C)CC[C@@H]1[C@@]3(C)CC2	SigmaAldrich	A8008	0.41131105	-0.9645464	0.1579363	6.86705202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185748-01	Paramethasone acetate	144206683	Glucocorticoid receptor Interacts	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1597-82-6				3.0937694421	4	4		0	4.32369942					CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Kemprotec	1597-82-6	-0.10282776	0.5995829	-0.42116346	4.32369942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166414-11	Pemetrexed Disodium heptahydrate		Thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	150399-23-8				-2.1240093333	4	4		0	-1.35135135					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Aobious	AOB2160	-0.42938931	-0.49634274	0.47132757	-1.35135135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179297-04	Azapropazone		interleukin-1 alpha production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	13539-59-8				-0.1604875111	4	4		0	-0.65065065					CCCC1C(=O)N2N(C1=O)\C(=N/C3=C2C=C(C)C=C3)N(C)C	Prestwick	Prestw-1003	-0.19083969	1.48902821	-0.5236973	-0.65065065												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			-3.1917849033	4	4	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	0.6006006					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	-0.66793893	-1.54127482	-0.68080649	0.6006006												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00179546-05	Bambuterol hydrochloride	170466370	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	81732-46-9				-0.4174650829	4	4		0	0.49986846					Cl.O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C	Microsource	01505173	-0.72639225	-0.10037641	0.43070687	0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253600-01	Iothalamate sodium	170465058		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1225-20-3				6.0303732594	4	4		0	1.97316496					[Na+].O=C(C)Nc1c(I)c(c(I)c(c1I)C([O-])=O)C(=O)NC	GVK	FFS-11-286-NCI-047	0.92009685	1.45545797	1.08943501	1.97316496												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023230-10	Noscapine	170465539	Tubulin polymerization inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	128-62-1				-1.5452443037	4	4		0	-0.97342805				TUBB	COc3c5OCOc5cc4CCN(C)[C@@H]([C@H]2OC(=O)c1c(OC)c(ccc12)OC)c34	Vitas	STK054401	-0.14527845	0.65244667	-0.63339245	-0.97342805												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164589-02	Phenprobamate	170465902		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	673-31-4				4.0370939905	4	4		0	-0.94012865					NC(=O)OCCCc1ccccc1	Sequoia	SRP014251p	1.93330111	-0.07400099	1.46356984	-0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00390779-02	Brivaracetam		Synaptic vesicle glycoprotein 2A Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	357336-20-0				13.8793243218	4	4		0	5.24855491					CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1	MedChem Express	HY-14449	2.57069409	1.74661105	3.10608055	5.24855491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016682-06	ESTROPIPATE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	7280-37-7				-1.9674110213	4	4		0	1.04046243					C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O[S+](O)([O-])=O)=C4)[C@H]1CCC2=O	Microsource	01505116	-1.43958869	1.06882169	0.26322716	1.04046243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250399-08	Vemurafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1029872-54-5				15.4272206709	4	4		0	1.95195195				BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4	Bio Vision	2235	2.8148855	6.08672936	3.61351139	1.95195195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166022-02	D-(-)-Mandelic acid	170465573		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	611-71-2				1.7573332356	4	4		0	-1.65165165					O[C@@H](C(=O)O)c1ccccc1	SIGMA	154210	1.47900763	-1.22779519	0.10473946	-1.65165165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378907-01	Edoxaban tosylate monohydrate		Coagulation Factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1229194-11-9				-1.9707459842	4	4		0	0.5005005					CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	MedChem Express	HY-10264B	-0.95419847	-0.18286311	0.31421838	0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179501-03	Aurantiamarin (Methyl Hesperidin)	225144305	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	11013-97-1	; Aurantiamarin; Hesperitin-7-rutinoside;Vitamin P; Hesperetin-7-Rutinoside;Methyl-Hesperidin;Hesperidin; Hesperetin 7 Rutinosid			-3.560092076	4	4		0	-0.5005005					COC1=C(O)C=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-400	-0.8110687	-0.96656217	-0.62843676	-0.5005005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016878-04	Piretanide	170465869	Cystic fibrosis transmembrane conductance regulator Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	55837-27-9				-2.0040041093	4	4		0	-0.2111375					O=C(O)c2cc(c(Oc1ccccc1)c(c2)N3CCCC3)S(N)(=O)=O	Prestwick Chemical, Inc.	Prestw-1047	-0.4472693	-0.41753653	-0.62095032	-0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095836-05	Guaiazulene	170465862	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	489-84-9				-1.4689632806	4	4		0	-0.47505938					CC(C)c1ccc(C)c2ccc(C)c2c1	Microsource	01502249	0.02354049	-0.48712596	-0.62095032	-0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160518-03	Orbifloxacin	170465644	DNA gyrase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	113617-63-3				-1.3423921686	4	4		0	-0.79168728					C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(F)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	SIGMA	34041	-0.67665539	-0.07400099	0.82723513	-0.79168728												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00178417-03	Ribostamycin sulfate	170465814	Protein disulfide-isomerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	53797-35-6				-3.3950961645	4	4		0	-0.47755492			5034	P4HB	O=S(=O)(O)O.N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@@H]2[C@@H](N)C[C@@H](N)C(O)[C@H]2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Microsource	01503939	-1.07728337	-0.30352557	-0.70709818	-0.47755492												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00178734-06	Sitagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	654671-77-9				-0.5893043262	4	4		0	-0.34682081				DPP4	N[C@@H](CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F	Adooq	A10848	-0.30848329	0.33889468	0.3158726	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-06	Telbivudine		DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	3424-98-4				3.9137656767	4	4		0	3.35260116				P	CC/1=C/N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	Enzo	AC3257	0.61696658	0.28675704	-0.52645433	3.35260116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181354-02	Tocoretinate	225144326	Retinoic acid receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	40516-48-1				-1.5993164531	4	4		0	0.20809249			1282		CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(=C(C)C(=C2C)OC(=O)\C=C(C)\C=C\C=C(C)\C=C\C3=C(/C)CCCC3(C)C)C	Bosche	T3082	-1.18251928	-0.44316997	0.26322716	0.20809249												1.6E-8	8E-8	4E-7	0.000002											
NCGC00017041-05	Dobesilate Calcium			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	20123-80-2 (anhydrous)				0.7373799968	4	4		0	-1.8265896					OC1=CC(=C(O)C=C1)[S+](O)([O-])=O	SIGMA	SML0488	0.87403599	0.07820647	-0.26322716	-1.8265896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167515-03	Enocitabine		cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	55726-47-1 				-5.6708853159	4	4		0	-1.3013013					CCCCCCCCCCCCCCCCCCCCCC(=O)NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	Glixx	GLXC-05978	-1.33587786	-1.2800418	-0.57606703	-1.3013013												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182044-02	Toltrazuril (sulfone)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	69004-04-2				-3.7949417439	4	4		0	-0.8008008					CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(C=C3)[S+]([O-])(=O)C(F)(F)F)C(=C2)C	MedChem Express	HY-17008	-1.14503817	-1.2800418	0.89028542	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264046-02	Glutathione	170465600	"Glutathione reductase, mitochondrial Substrate"	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	70-18-8				7.9222874105	4	4		0	1.65165165			2936	GSR	O=C(NCC(=O)O)[C@@H](NC(=O)CC[C@H](N)C(=O)O)CS	Microsource	01502248	0.90648855	3.63113898	2.30426813	1.65165165												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167430-04	Tioconazole	170465343	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	65899-73-2	 ; Vagistat-1;Tioconazole; Tioconazol;TIOCONAZOLE; Tioconazole	12.5892541179	-4.9	9.0939238911	4	4		18.963730572	15.48672566	0.0320021363	0.9993710176			Clc3sccc3COC(Cn1ccnc1)c2ccc(Cl)cc2Cl	Microsource	01505581	-0.80310881	-0.41443198	-0.20135917	15.48672566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389470-01	Dirithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	62013-04-1				-1.3673484797	4	4		0	1.32743363					CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C4NC(COCCOC)OC(C4C)C1(C)O	APExBIO	B1731	-0.85492228	-0.75572891	0.50339794	1.32743363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249931-01	Docarpamine	170465850	Dopamine D1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	74639-40-0				-0.1896576285	4	4		0	-0.31670625					CC(=O)N[C@@H](CCSC)C(=O)NCCc1cc(OC(=O)OCC)c(cc1)OC(=O)OCC	GVK	FFS-11-286-NCI-235	0.35310734	0.13917884	-0.56695464	-0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015860-06	Prilocaine hydrochloride	170464697	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1786-81-8				11.3189499207	4	4		0	1.63631565					Cl.O=C(Nc1ccccc1C)C(C)NCCC	Microsource	01503270	3.46045198	2.7835769	1.10691145	1.63631565												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249885-01	Estradiol acetate	170465258		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	4245-41-4				4.3876003266	4	4		0	4.11718131					CC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	GVK	FFS-11-286-NCI-18	-0.02354049	0	-0.08099352	4.11718131												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179419-05	Guanadrel sulfate		Norepinephrine transporter Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	22195-34-2				-3.8378934404	4	4		0	-1.43266476					NC(=N)NCC1COC2(CCCCC2)O1	Prestwick	Prestw-767	-1.12412178	0.25682933	-0.10878433	-1.43266476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522037-01	Oxitropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	30286-75-0				-0.153005165	4	4		0	0.66857689					CC[N@@+]1(C)C2C[C@@H](CC1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	Toronto Research	O847165	-0.32786885	-0.1167406	0.38074517	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538143-01	NCGC00538143-01		surfactant homeostasis Activator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-1.4551360037	4	4		0	-0.47755492					O[C@H]1CC[C@@H](CC1)NCC2=CC(=CC(=C2O)Br)Br	Pharmaron	PH-NIH-2017-009-L1-3-0	-0.23419204	-0.44361429	-0.27196084	-0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263138-19	Regorafenib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	835621-07-3				8.5072769614	4	4		0	2.33526012				KDR	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F	MedChem Express	HY-13308	1.1311054	1.27737226	4.26428007	2.33526012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179341-04	Ondansetron	170464701	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	99614-02-5	; ; Ondansetron, (R)-Isomer; Zofran;Ondansetron hydrochloride; Methoxamine HCl;Ondansetron Hydrochloride; Zofran ODT; Ondansetron, (S)-Isomer; Ondansetron; Ondansetron, (+,-)-Isomer			-1.7646427541	4	4		0	1.6416185			3359	HTR3A	O=C1C(CCc3c1c2ccccc2n3C)Cn4ccnc4C	Prestwick	Prestw-1058	-1.33676093	0.18248175	0.42116346	1.6416185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346701-07	Laquinimod		Immunomodulators	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	248281-84-7				-0.9056953316	4	4		0	-0.76300578				BDNF	CCN(C(=O)C/1=C(O)/C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3	MedChem Express	HY-13010	-0.30848329	1.12095933	-0.4738089	-0.76300578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160478-02	Menadione sodium bisulfite	225144239	NQO1 protein Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	130-37-0				-5.500671946	4	4		0	-1.4014014					CC1(CC(=O)C2=CC=CC=C2C1=O)[S]([O-])(=O)=O	SIGMA	M5750	-0.90648855	-1.80250784	-1.25687353	-1.4014014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390707-01	Oclacitinib		Tyrosine-protein kinase JAK3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1208319-26-9				-4.5920736753	4	4		0	-2.4024024					CN[S+]([O-])(=O)C[C@H]1CC[C@@H](CC1)N(C)C2=C3C=C[NH]C3=NC=N2	MedChem Express	HY-13577	-0.28625954	-1.64576802	-1.30924326	-2.4024024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344555-01	Proscillaridin	170465956	Steroid	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	466-06-8				13.6231918252	4	4		0	1.15115115				ATP1A1	O=C1C=CC(=CO1)[C@H]6CC[C@@]5(O)[C@]6(C)CC[C@H]3[C@H]5CCC2=C[C@H](CC[C@@]23C)O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O	Prestwick	Prestw-986	3.95992366	1.90700104	1.88531029	1.15115115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00531792-01	PYRETHRIN II		Plasmodium falciparum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	121-29-9				1.7383848687	4	4		0	0.9009009					COC(=O)C(/C)=C/[C@H]1[C@H](C(=O)O[C@@H]2CC(=O)/C(=C2/C)C\C=C\C=C)C1(C)C	Toronto Research	P991240	-0.04770992	1.69801463	0	0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164607-01	Bentiromide sodium	144205782		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	41748-47-4	Bentiromide; N-benzoyl-L-tyrosyl-PABA; Bentiromido; benzoyl-tyrosyl-PABA; PABA-peptide; 			2.00210455	4	4	N-Benzoyl-L-tyrosyl-4-aminobenzoic acid sodium salt;benzoyl-tyrosyl-PABA;bentiromidum;bentiromide;CIPLUS_3741566;NCGC00164607-02;N-BENZOYL-L-TYROSYL-P-AMINOBENZOIC ACID;N-Benzoyl-L-tyrosine p-amidobenzoic acid sodium salt;Bentiromidum;BENTIROMIDE;PABA-peptide;NCGC00164607-01;N-benzoyl-L-tyrosyl-PABA;4-((2-(BENZOYLAMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPYL)AMINO)BENZOIC ACID;Bentiromide (N-Benzoyl-L-tyrosyl-p-aminobenzoic acid (bentiromide);Bentiromide;CIPLUS_178986;Bentiromido;NCGC_FLUKA_13135;N-benzoyl-L-tyrosyl-p-aminobenzoic acid;	0	0.48905449					[Na+].Oc3ccc(C[C@H](NC(=O)c1ccccc1)C(=O)Nc2ccc(cc2)C([O-])=O)cc3	Labotest	LT00645584	0.28497409	-0.51194539	1.81223257	0.48905449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090991-02	N,N-Dimethylbenzylamine	144207006		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	103-83-3				-2.4450727558	4	4	Zephiran chloride;CIPLUS_150764;Drapolene;Cloruro de benzalconio;N,N-Dimethylbenzylamine;N-benzyl-N,N-dimethylamine hydrochloride;CIPLUS_167204;N-benzyl-N,N-dimethylamine nitrate;Benzalkonium chloride;Compounds, Benzalkoniu;CIPLUS_776792;Germex;Osvan;ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE;N,N-dimethylbenzylamine;NCGC00095057-01;Alkyl* dimethyl benzyl ammonium chloride *(50%C12, 30%C14, 17%C16, 3%C18);chlorure de benzalkonium;BENZALKONIUM CHLORIDE;Alkyldimethylbenzylammonium Chloride;AB07944111-01;ALKYLBENZYL TRIMETHYL AMMONIUM CHLORIDE;N-Benzyldimethylamine;Chloride, Alkyldimethylbenzylammoniu;BTC212;Zephiran;NCGC00095057-02;N-benzyl-N,N-dimethylamine;DMBA;BTC-2125;NCGC00164245-01;benzalkonii chloridum;Chloride, Benzalkoniu;Asepsol;CIPLUS_718497;CIPLUS_159160;benzyldimethylamine;N-benzyl-N,N-dimethylamine hydrobromide;Benzalkonium Chloride;Benzalkonii chloridum;Chlorure de benzalkonium;BTC 212;ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE;BDMA;Benzalkonium Compounds;ALKYL ETHYLBENZYL DIMETHYL AMMONIUM CHLORIDE;	0	-0.72193759					CN(C)Cc1ccccc1	SigmaAldrich	136921	-0.69948187	-0.17064846	0	-0.72193759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013364-03	Vitamin B6			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	8059-24-3				6.1943966115	4	4		0	0.16301816					CC1=C(O)C(=C(CO[P](O)(O)=O)C=N1)C	DC Chemicals	DCZ-121	1.01036269	1.92588981	3.07072741	0.16301816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183110-02	Imidafenacin		potassium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	170105-16-5				8.9769805102	4	4		0	2.63157895					CC1=NC=C[N]1CCC(C(N)=O)(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0662	1.7357513	1.92588981	1.76189278	2.63157895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263447-01	alpha-Santonin	170465728		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	481-06-1				1.194216051	4	4		0	0.42227501					O=C1C=C[C@]2(C)CC[C@H]3[C@H](C)C(=O)O[C@@H]3C2=C1C	Specs	AE-562/J257885	0.54143126	-1.32219903	0.62095032	0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015714-16	Nimodipine	170466561	Voltage-gated L-type calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	66085-59-4				6.1299206045	4	4		0	4.43388757					CC=1NC(C)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OCCOC	SigmaAldrich	N149	-0.72975518	2.08768267	1.10691145	4.43388757												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015156-15	Baclofen	170465099	GABA-B receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1134-47-0				-1.490233208	4	4		0	-0.26392188					Clc1ccc(cc1)C(CN)CC(=O)O	Vitas	STK535284	-0.9180791	-0.13917884	-0.24298056	-0.26392188												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00182983-01	Fezatione	144206829		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	15387-18-5	Fezatione; 			2.7981894891	4	4	Fezatione;FEZATIONE;fezationum;fezatione;3-((P-METHYLBENZYLIDENE)AMINO)-4-PHENYL-4-THIAZOLINE-2-THIONE;CIPLUS_789398;	0	3.32541568					S=C2SC=C(N2/N=C/c1ccc(C)cc1)c3ccccc3	Pharmaron	PH-NIH-150803	-0.6826742	0.06958942	0.35097192	3.32541568												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094616-07	Chlorthalidone	170464745	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	77-36-1				5.1492185908	4	4		0	1.05568752					NS(=O)(=O)c1cc(ccc1Cl)C3(O)NC(=O)c2ccccc23	Microsource	01500187	0.77683616	4.17536534	-0.35097192	1.05568752												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023509-13	Lovastatin	170464913	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	75330-75-5	; ; Lovastatin (Mevinolin); Monacolin K; Mevacor;LOVASTATIN; Mevinolin (lovastatin); 6-Methylcompactin; 6 Methylcompacti; Lovastatin;Lovastatin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin	11.220184543	-4.95	9.0813253225	4	4		12.133909292	10.45130641	0.1037903254	0.9933681603	3156	HMGCR	C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801953	-0.77683616	0.06958942	-0.94492441	10.45130641												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016401-09	Hydroflumethiazide	170465082	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	135-09-1				-0.5851242017	4	4		0	-0.79176564					FC(F)(F)c1cc2NCNS(=O)(=O)c2cc1S(N)(=O)=O	Microsource	01500341	0.49435028	0.83507307	-1.16090713	-0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091595-07	Sodium 2-phenylphenate tetrahydrate	170465724		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6152-33-6				0.2008726805	4	4		0	0.52784376					[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1	Vitas	STK177354	-0.02354049	0.69589422	-0.78293736	0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024715-05	L-Arginine	170465748		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	74-79-3				-0.2528300564	4	4		0	0.31670625					N[C@@H](CCCNC(=N)N)C(=O)O	Tocris	0663	-0.96516008	0.55671538	-0.45896328	0.31670625												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00015774-06	Oxatomide	170466059	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	60607-34-3		12.5892541179	-4.9	78.6036406499	3	4		91.7079333799	73.7925574	0.0082026852	0.9999585035	3269	HRH1	O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4	Enzo	EI114	-0.63559322	-0.48712596	-0.78293736	73.7925574												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164071-03	Isopropyl tetradecanoic acid	170465683		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	110-27-0				7.2956512532	4	4		0	6.07020322					CC(C)OC(=O)CCCCCCCCCCCCC	SIGMA	172472	-0.63559322	0.20876827	1.59287257	6.07020322												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015691-06	Cysteamine hydrochloride	170466795	Protein-glutamine gamma-glutamyltransferase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	156-57-0				6.7881453363	4	4		0	1.7418844			7052	TGM2	Cl.NCCS	Microsource	01504226	1.38888889	0.41753653	1.91684665	1.7418844												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160450-03	4-Acetylaminophenylacetic acid	170465954		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	18699-02-0				-1.3582033161	4	5		0	-0.61383929					O=C(C)Nc1ccc(cc1)CC(=O)O	Specs	AE-562/J260765	-1.84909407	-0.3181876	5.30544397	-1.36765889	-0.61383929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182993-01	Betiatide	144206816		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	103725-47-9	Betiatide; 			-4.6361520386	4	5	CIPLUS_762860;MP-600;BETIATIDE;THIOBENZOIC ACID, S-ESTER WITH N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE;Betiatide;betiatidum;N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE BENZOATE (ESTER);GLYCINE, N-(N-(N-((BENZOYLTHIO)ACETYL)GLYCYL)GLYCYL)-;betiatide;BENZOYLMERCAPTOACETYLGLYCYLGLYCYLGLYCINE;	0	-1.00446429					O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1	Pharmaron	PH-NIH-137963	-1.7746339	-0.42000764	-2.11940712	1.68946098	-1.00446429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024714-11	Triprolidine	170464931	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	486-12-4				5.0626680953	4	5		0	1.17902155					Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3	SigmaAldrich	T6764	-1.17878193	6.900369	0.89488447	1.3147914	1.17902155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183009-01	Pranazepide	144206813	Cholecystokinin A receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	150408-73-4	Panazepide; 	12.5892541179	-4.9	2.9858415464	4	5	PANAZEPIDE;PRANAZEPIDE;FK480;FR120480;CIPLUS_709224;1H-Indole-2-carboxamide, N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-, (S)-;Panazepide;LS-173385;FR 120480;FK 480;Pranazepide;N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxo-pyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-1H-indole-2-carboxamide;FR-120480;pranazepide;pranazepidum;	14.6807942	10.82589286	0.0958881924	0.9486814899			Fc6ccccc6C3=N[C@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45	Pharmaron	PH-NIH-126867	0.26061057	-3.0673285	-2.75661449	-2.17216412	10.82589286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016853-06	Nabumetone	170464970	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	42924-53-8				-5.9680362502	4	5		0	-2.06473214					CC(=O)CCc1ccc2cc(ccc2c1)OC	Microsource	01503650	-1.70017374	-3.7037037	1.48219975	0.40225261	-2.06473214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253611-01	Isoaminile	170465846		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	77-51-0				-7.2067518455	4	5		0	-0.50142296					CC(C)C(C#N)(CC(C)N(C)C)c1ccccc1	GVK	FFS-11-286-NCI-202	-1.71905697	-3.45633456	1.42914385	-3.18584071	-0.50142296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159387-03	Laureth 10s	170465561		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	13081-34-0				-8.2430295363	4	5		0	-1.04350183					OCCOCCSCCCCCCCCCCCC	Labotest	LT00000347	-1.76817289	-1.63591636	-1.66956057	-2.68015171	-1.04350183											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014017-03	L-Proline	225144170		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	147-85-3				-4.3878946772	4	5		0	0.72544643					OC(=O)[C@@H]1CCCN1	SIGMA	81710	-3.31347729	-2.30367825	6.05347001	-2.01126307	0.72544643											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016759-04	Naproxen sodium	170465301	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	26159-34-2	NAPROXEN(+); ; Naprosin; Synflex; Anaprox; 2   Dl-Naproxen;(S)-Naproxen; (S)-Naproxen; Proxen; Naproxeno; (R) -Naproxen sodium salt; (-)-Naproxen sodium; DL-Naproxen;Naproxen; Naprosyn; Aleve; Naproxen			4.4219529137	4	5		0	6.32877084			5743	PTGS2	[Na+].[O-]C(=O)[C@@H](C)c1ccc2cc(ccc2c1)OC	Microsource	01500425	-1.44891945	2.17712177	2.36409777	-1.13780025	6.32877084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094779-05	Salicyl alcohol	170465547		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	90-01-7		12.5892541179	-4.9	2.0000637263	4	5		9.8753340919	7.64508929	0.1304254264	0.9286362412			OCc1ccccc1O	Microsource	01500531	0.18615041	-2.81277841	-0.98351572	-2.01126307	7.64508929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090997-11	Dichlorvos	170466226	Butyrylcholinesterase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	62-73-7				-2.7637812588	4	5		0	3.01339286					COP(=O)(OC)O\C=C(\Cl)Cl	Microsource	00330018	-0.6825515	-1.18365788	-2.03629312	-2.14534728	3.01339286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167958-05	Imipenem	170464934	Penicillin-binding protein 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64221-86-9				-1.2674189207	4	5		0	2.91367394			945240	mrdA	O[C@H](C)[C@H]2C(=O)N1C(=C(C[C@@H]12)SCCNC=N)C(=O)O	Prestwick Chemical, Inc.	Prestw-519	-1.2524558	-2.20172202	-1.85655136	2.45259166	2.91367394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016385-08	Sulfabenzamide	170465133		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	127-71-9				3.4261966378	4	5		0	2.75105028					Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2	Vitas	STK985629	-0.51571709	3.92373924	-0.49418993	-0.1011378	2.75105028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015755-10	Nimustine	170466029	DNA Crosslinking Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	42471-28-3				-5.929835779	4	5		0	-0.96219					Nc1nc(C)ncc1CNC(=O)N(CCCl)N=O	Microsource	01504151	-1.12966601	1.46371464	-2.6846534	-3.23640961	-0.96219											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183011-01	Itasetron	144206831	Serotonin 3 (5-HT3) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	123258-84-4	Itasetron; DAU 6215 hydrochloride; 			-7.1971166473	4	5	itasetronum;itasetron;DAU 6215 hydrochloride;ITASETRON HYDROCHLORIDE HYDRATE;(endo-N-8-methyl-8-azabicyclo(3.2.1.)-oct-3-yl)-2,3-dihydro-2-oxo-1H-benzimidazol-1-carboxamide;Itasetron Hydrochloride Hydrate;U-98079A;CIPLUS_197009;Itasetron;DAU 6215;CIPLUS_3881158;LS-32715;N-(8-methyl-8-azabicyclo (3.2.1.)oct-3-yl)2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxamide;ENDO-2,3-DIHYDRO-N-((8-METHYL)-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO-1H-BENZIDAZOLE-1-CARBOXAMIDE HYDROCHLORIDE HYDRATE;2-OXO-N-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-YL-1-BENZIMIDAZOLINE-1-CARBOXAMIDE;ITASETRON;LS-172560;1H-BENZIMIDAZOLE-1-CARBOXAMIDE, 2,3-DIHYDRO-N-(8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO, ENDO-;	0	-0.64174107					CN4[C@@H]1CC[C@H]4C[C@H](C1)NC(=O)N2c3ccccc3NC2=O	Pharmaron	PH-NIH-151623	-3.11491685	-0.42000764	-0.84499238	-0.08045052	-0.64174107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178060-03	Tolperisone hydrochloride	170465769	Voltage-gated calcium channel Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3644-61-9				-9.3233024264	4	5		0	-0.9765625					Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2	Microsource	01501194	-2.19657483	-3.16914853	-1.20515307	-2.0917136	-0.9765625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016035-13	Trazodone hydrochloride	170465234	alpha2-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	25332-39-2	; ;Trazodone hydrochloride; Desyrel; Trazodone hydrochloride;TRAZODONE HYDROCHLORIDE; Trazodona;Trazodone?HCl			-6.0478346153	4	5		0	-1.81361607			150	ADRA2A	Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O	Microsource	01503121	-1.20377265	-1.20911289	-1.37138108	-0.93858943	-1.81361607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094736-05	Nitromide	170466818	Eimeria tenella Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	121-81-3				5.6927122603	4	5		0	3.78100014					O=[N+]([O-])c1cc(cc(c1)[N+]([O-])=O)C(N)=O	Microsource	01500435	0.12278978	4.02214022	-0.12020836	-0.12642225	3.78100014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021318-08	Budesonide		Glucocorticoid steroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51333-22-3				-0.0323773291	4	5		0	0.3387993				NR3C1	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	SIGMA	B7777	2.13654224	-0.03690037	-3.031922	-3.00884956	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015238-13	Chlorzoxazone	170464957	Intermediate conductance calcium-activated potassium channel protein 4 Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	95-25-0				3.3119311491	4	5		0	2.10893855					Clc1cc2NC(=O)Oc2cc1	Vitas	STK071582	-1.6879562	-0.11206575	1.42874588	5.64527863	2.10893855											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016902-04	Etifenin	170466635		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63245-28-3				19.0817858027	4	5		0	8.84078212					O=C(Nc1c(cccc1CC)CC)CN(CC(=O)O)CC(=O)O	Prestwick Chemical, Inc.	Prestw-504	5.33759124	2.57751214	-0.98913176	2.09515495	8.84078212											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249897-01	Nitromersol	170465514		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	133-58-4		14.1253754462	-4.85	11.1236082562	4	5		-12.826815644	-6.52234637	0.3384058763	0.7724098589			Cc1ccc(c2[Hg]Oc12)[N+]([O-])=O	GVK	FFS-11-286-NCI-74	3.20863747	0.93388121	8.14507266	5.29608613	-6.52234637											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183016-01	Cefteram	144206853		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	82547-58-8	Cefteram; Ro 19-5247; Cefteram Pivoxil; Ro-19-5247; 			-3.4636553374	4	5	7-(2-(2-amino-4-thiazoyl)-2-(methoxyimino)acetamido)-3-((5-methyl-2H-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene carboxylic acid;ceftetrame;CIPLUS_213480;cefteram;Ro 19-5247;CEFTERAM;Cefteram Pivoxil;Ro-19-5247;cefteramum;Cefteram;LS-177691;	0	-0.69115056					Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(Cn2nc(C)nn2)CS[C@@H]34)C(=O)O	Pharmaron	PH-NIH-169126	-2.18565815	2.17712177	0.9483104	-1.54235145	-0.69115056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018139-07	Ipriflavone	170466811	Treatment of Osteoporosis	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone			11.1286418859	4	5		0	4.78384605					CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	SIGMA	381551	2.43123772	6.08856089	-0.97502337	-0.7585335	4.78384605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090887-04	Phenyl salicylate	170465501	Estrogen receptor alpha Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	118-55-8				-7.4593347474	4	5		0	-1.80167598					Oc2ccccc2C(=O)Oc1ccccc1	Specs	AT-084/J165064	-2.29622871	-1.60627568	0.52509464	-1.57136622	-1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016296-07	Dicumarol	170465275	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	66-76-2				3.4368772949	4	5		0	-1.49441341					OC=3c4ccccc4OC(=O)C=3CC1=C(O)c2ccccc2OC1=O	Vitas	STK801287	2.35705596	-0.85917071	0.30528758	0.81478248	-1.49441341											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015603-08	Lomefloxacin hydrochloride	170465262	Quinoline Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	98079-52-8	 ; Maxaquin;LOMEFLOXACIN HYDROCHLORIDE; Lomefloxacin hydrochloride;Lomefloxacin hydrochloride; Lemofloxacin			0.9570407195	4	5		0	-1.80167598					Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3	Microsource	01502037	0.44099757	2.92616113	-1.06240078	0.26189437	-1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091325-09	Dichlorophen	170465475	"Indoleamine 2,3-dioxygenase Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	97-23-4		6.3095734448	-5.2	18.3106515587	4	5		26.875250428	22.88928039	0.004157633	0.9979194095			Oc2ccc(Cl)cc2Cc1cc(Cl)ccc1O	Microsource	01500626	-0.93320236	-1.16851169	-1.56270869	6.92793932	22.88928039											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160518-03	Orbifloxacin	170465644	DNA gyrase Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	113617-63-3				-3.1325653625	4	5		0	0.69115056					C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(F)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	SIGMA	34041	-0.9086444	1.04551046	-2.47094965	-2.07332491	0.69115056											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00167832-06	Carvedilol tartrate	170465440	beta1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	NOCAS_45916	; carvedilol, 14C-labeled; 8   Carvedilol;Carvedilol; Coreg; carvedilol, (S)-isomer; Carvedilol; carvedilol, (R)-isomer	11.220184543	-4.95	72.7566063295	3	5		107.0251447276	92.41089579	0.0090583894	0.9954404835	153	ADRB1	O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23	Microsource	01504257	-0.02455796	4.41574416	-3.29905169	4.22250316	92.41089579											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015925-12	Sulfaphenazole	170465185	Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	526-08-9	; ; Sulphaphenazole; Sulfaphenazole;Sulfaphenazole; Sulfafenazol; Sulfabid;SULFAPHENAZOLE			12.9530669563	4	5		0	3.22625698					Nc1ccc(cc1)S(=O)(=O)Nc3ccnn3c2ccccc2	Specs	AN-153/I226112	4.36435523	0.01245175	4.06643058	-0.08729812	3.22625698											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00159441-03	Deslanoside	170465236	Sodium/potassium-transporting ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	17598-65-1	Deslanoside; Cedilanid; Cedilanid-D; Cedilanid-d; C, Desacetyllanatosid; Lanatoside, Desacety; Deslanatoside C; C, Deslanatosid; C, Desacetyldigilanid; Desacetyl Lanatoside; Deslanosido; 			1.7330814047	4	5	Cedilanid-d;Cedilanid-D;C, Desacetyllanatosid;deslanoside;Cedilanid;LS-87553;C, Deslanatosid;Lanatoside, Desacety;CIPLUS_171064;Deslanatoside C;deslanosidum;Deslanosido;C, Desacetyldigilanid;CARD-20(22)-ENOLIDE, 3-((O-.BETA.-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3B,5B,12B)-;Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-;DEACETYLANATOSIDE C;Desacetyl Lanatoside;deacetyllanatoside c;DESLANOSIDE;Deslanosidum;Deslanoside;	0	-1.01955307					O=C1C=C(CO1)[C@H]2CC[C@@]9(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]9CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]8O[C@H](C)[C@@H](O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)C6)[C@@H](O)C7)[C@@H](O)C8	ChemDiv	N045-0007	-0.19768856	0.46071473	1.16009281	2.47344682	-1.01955307											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018117-17	Theophyllamine	170466874	Adenosine Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	58-55-9	; Theocolin; 1,3-Dimethylxanthine; Choledyl-SA; Quadrinal; Theophylline solution; Novurite; Mercurofilina; Guaithylline; Choledyl; oxtripylline-SA;Theophylline; Guaifilina; Mercumatilina sodica; Aminofilina; Elixophyllin;Aminophylline ethylenediamine;THEOPHYLLINE; Teofilinato de colina; Mercumatiline sodique;Aminophylline; Brondecon; Theobret; Aminophylline, dihydrate; Brondaxin; Butaphyllamine; Tedral; Theodur G; Theophylline-[8-3H]; Mercumatilinum natricum; Euspirax; Novurit; Somophyllin;Theophylline monohydrate			-2.9269279321	4	5		0	-1.33928571			134	ADORA1	O=C2c1ncnc1N(C)C(=O)N2C	Labotest	LT00000171	-2.09729461	-2.55822833	2.23022579	3.13757039	-1.33928571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016806-13	Mebendazole	170464914	Tubulin depolymerization Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	31431-39-7	; ; Vermox;Mebendazole; Mebendazol; Mebendazole;MEBENDAZOLE			-14.3223735972	4	5		0	-1.72991071			203068	TUBB	O=C(OC)Nc1nc2cc(ccc2n1)C(=O)c3ccccc3	Microsource	01501110	-3.18937702	-2.30367825	-5.13921596	-2.73531778	-1.72991071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095795-06	5,7-Dichloro-8-hydroxy-2-methylquinoline	170465701	Botulinum neurotoxin type A Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72-80-0				-0.4102487995	4	5		0	-0.44642857					Oc1c(Cl)cc(Cl)c2ccc(C)nc12	Microsource	00212151	2.74261603	-4.51826397	-2.06399778	-0.80450523	-0.44642857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091595-07	Sodium 2-phenylphenate tetrahydrate	170465724		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6152-33-6				0.9857096197	4	5		0	-0.18156425					[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1	Vitas	STK177354	-2.17457421	4.34566057	2.03932104	0.98937873	-0.18156425											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164385-05	Clomifene citrate	170464951	Selective Estrogen Receptor Modulators (SERM)	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	911-45-5	; Zuclomifeno; Clomifeno; Clomiphene citrate (Z,E);CLOMIPHENE CITRATE; Clomifene Citrate; ; Clomiphene Hydrochloride; Clomid; Clomiphene citrate salt; (E)-isomer, HCl; Clomifen; cis-Clomiphene citrate; Clomifene citrate; Enclomifeno; (Z)-isomer, citrate; Clomiphene citrate			-10.52285288	4	5		0	-4.23184358			2099	ESR1	CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC	Microsource	01500196	-2.47871046	-1.65608268	-2.06374405	-0.23279499	-4.23184358											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249927-01	Simetride	170466023		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	154-82-5		0.316227766	-6.5	7.7496334747	4	5		5.3896152399	1.80167598	0.7331763342	0.3911958105			O=C(COc1ccc(CCC)cc1OC)N2CCN(CC2)C(=O)COc3ccc(CCC)cc3OC	GVK	FFS-11-286-NCI-224	0.59306569	-1.1580127	9.70814507	0.46558999	1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018291-03	Procaterol	170465820	beta2-Adrenoceptor Agonists	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	72332-33-3				-4.1328207611	4	5		0	-2.37165179				ADRB2	CC(C)N[C@@H](CC)[C@H](O)c2ccc(O)c1NC(=O)C=Cc12	Bosche	P2505	-0.60809134	1.10729286	-1.28826707	-1.58219362	-2.37165179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015725-15	Nimesulide	170465612	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	51803-78-2	; ;NIMESULIDE; Nimesulide;Nimesulide; Nimesulida			7.7382232595	4	5		0	4.15736607			5743	PTGS2	[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O	Vitas	STL018679	2.46959543	4.74735904	-3.19988918	-1.47492625	4.15736607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016934-06	Nizatidine	170464780	Histamine H2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	76963-41-2				-3.4078450342	4	5		0	-1.57821229					CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1	Microsource	01505985	-1.29257908	3.69816959	-2.84528025	-0.61108686	-1.57821229											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015096-17	Amiodarone hydrochloride	170464920	Muscarinic M3 Receptor Ligands	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1951-25-3	; Ancaron; Kordaron; Amiodarone;Amiodarone; Amiodarona;Amiodarone hydrochloride;Amiodarone?HCl	10	-5	69.7360452507	3	5		107.6667267403	90.96368715	0.0017009366	0.9991485772		CHRM3	CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC	Microsource	02300165	-2.66119221	0.46071473	-0.03663451	9.13720355	90.96368715											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159380-05	Benzoyl peroxide	170464986		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-36-0				-3.3173346339	4	5		0	2.69553073					O=C(OOC(=O)c1ccccc1)c2ccccc2	Labotest	LTBB002750	-3.29987835	0.28639024	-0.06105752	0.90208061	2.69553073											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015767-10	Oxybutynin chloride		Muscarinic Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1508-65-2	 Oxibutinina; ;; Oxytrol; Tropax;Oxybutynin Chloride; Esoxybutynin Chloride; Ditropan; Oxybutinin;OXYBUTYNIN CHLORIDE; Oxybutynin Hcl; Oxybutynin Chloride;Oxybutynin chloride	12.5892541179	-4.9	21.5846706961	3	5		49.5701586239	40.5726257	0.0039359152	0.998027569		CHRM1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2	SIGMA	O2881	-2.60036496	-0.80936372	-2.23470509	-2.56074494	40.5726257											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164594-02	Loteprednol etabonate	170465195	Corticosteroid	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	82034-46-6	Loteprednol etabonate; Lotemax; Loteprednol etabonate; Alrex; 			-1.9865233248	4	5		0	-3.81284916				NR3C1	O=C(OCCl)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	SRP01583l	0.38017032	0.95878471	-0.35413359	-0.37829187	-3.81284916											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016344-07	5-Aminosalicylic acid	170464840	reactive oxygen species biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	89-57-6				0.8431713774	4	5		0	-0.85195531			16534		OC(=O)c1cc(N)ccc1O	Vitas	STK301678	0.10644769	-1.85531067	1.62412993	2.06605558	-0.85195531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015848-09	Tranylcypromine hydrochloride			SARS-CoV-2_CPE_SRI	2019_NPC-2.2					-2.6612802377	4	5		0	-1.45089286					N[C@@H]1C[C@H]1C2=CC=CC=C2	Tocris	3852	-0.70737156	-2.20185822	1.23285774	0.5899705	-1.45089286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090964-04	Tetraethylenepentamine	170464940	Oxidative Stress Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	112-57-2		3.1622776602	-5.5	17.7137733037	4	5		11.52493966	9.84933036	0.3917555582	0.7209513947			NCCNCCNCCNCCN	Prestwick	Prestw-1387	1.7746339	4.34007891	0.20778501	-2.52078305	9.84933036											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00016801-05	Levobunolol hydrochloride	170464743	Beta-2 adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	27912-14-7				-2.0184414225	4	5		0	1.64620536					Cl.CC(C)(C)NC[C@H](O)COc2cccc1c2CCCC1=O	Prestwick Chemical, Inc.	Prestw-847	-2.29585505	-1.76912307	5.2777393	-2.06489676	1.64620536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344584-01	Verapamil	170464904	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	52-53-9		14.1253754462	-4.85	10.1000162059	4	5		11.58402444	10.46089385	0.2953304986	0.8107397317		DRD2	COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C	SIGMA	V106	0.38017032	0.63503922	3.7733545	-2.1533537	10.46089385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015964-17	Spiperone	170465856	Dopamine D4 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	749-02-0		7.9432823472	-5.1	57.2339844264	2.2	5		76.510351054	65.96368715	0.0050647654	0.9974587063			Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3	Enzo	AC807	0.98844282	-2.17905616	-2.30797411	13.21111596	65.96368715											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015646-05	Fomepizole	170465026	Alcohol Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	56010-88-9	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			-0.446132731	4	5		0	0.55563084			124	ADH1	Cl.Cc1cnnc1	Microsource	01505432	0.7367387	-1.93111931	0.38733805	-1.64348925	0.55563084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346829-03	Fotemustine		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	92118-27-9				-0.9295522619	4	4		0	-0.20959478				H2AFX	CCO[P](=O)(OCC)C(C)NC(=O)N(CCCl)N=O	SIGMA	F7307	-1.16580311	-0.21940517	3.37276617	-0.20959478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248247-02	Dimethyl maleate	170466784	NFkappaB-inducing kinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	624-48-6				8.6827341603	4	4		0	5.23986959				NFE2L2	COC(=O)/C=C\C(=O)OC	GVK	FFS-12-73-NCI-3423	1.32124352	1.43832277	0.55373773	5.23986959												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015339-07	Dequalinium dichloride	225144172	Protein kinase C beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	522-51-0				-0.1512099748	4	4		0	1.26682502					CC1=CC(=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)N	Prestwick	Prestw-388	-0.87099812	-0.20876827	-1.21490281	1.26682502												6.4E-9	3.2E-8	1.6E-7	0.000004											
NCGC00016959-06	Ciprofloxacin	170464757	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	93107-08-5	 ;CIPROFLOXACIN; Bay0986; Ciprofloxacin hydrochloride; Bay 0986; Cipro IV;Ciprofloxacin; Ciprobay; Cipro; Ciprofloxacino; Ciprofloxacin Lactate; Ciprofloxacin Hcl; Ciprinol; Ciloxan;Ciprofloxacin hydrochloride; Bay-09867; Ciprofloxacin Base			1.8725153023	4	4		0	3.43098443			7155	TOP2B	Cl.O=C(O)C2=CN(c1cc(c(F)cc1C2=O)N3CCNCC3)C4CC4	Vitas	STK021082	-1.24764595	-0.97425191	1.05291577	3.43098443												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00142384-03	Cholic Acid		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	81-25-4				-0.4809967658	4	4		0	0.05278438					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	C1129	-0.16478343	-1.67014614	0.89092873	0.05278438												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181913-02	Difeterol	144206884	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	14587-50-9	Difeterol; Difeterol Phosphate; Difeterol Hydrochloride; 	12.5892541179	-4.9	116.8719872309	3	4	CIPLUS_783660;DIFETEROL;Difeterol;difeterolum;difeterol;Difeterol Phosphate;Difeterol Hydrochloride;	127.9080902002	104.77698601	0.0288572168	0.9994860361			OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3	Pharmaron	PH-NIH-2	0.11770245	2.50521921	-0.02699784	104.77698601												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182046-04	Efonidipine hydrochloride monoethanolate			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[111011-76-8]				16.9925152462	4	4		0	10.79274117					CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(Cc4ccccc4)c5ccccc5	Tocris	3733	2.20140515	1.84450152	2.88278488	10.79274117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420892-01	NKH477		Adenylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-8_CPE			11.220184543	-4.95	18.5919711011	2.4	4		36.665809772	28.55491329	0.0385819539	0.9990821323			CN(C)CCC(=O)OC1C(OC(C)=O)C2(C)OC(C)(CC(=O)C2(O)C3(C)C(O)CCC(C)(C)C13)C=C	Bio Vision	9427-5	-1.38817481	-0.44316997	1.57936299	28.55491329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253603-01	Mibolerone	170466095	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	3704-09-4				-0.7393776685	4	4		0	0.20809249					C[C@@H]3CC1=CC(=O)CC[C@@H]1[C@H]4CC[C@@]2(C)[C@@H](CC[C@]2(C)O)[C@H]34	GVK	FFS-11-286-NCI-098	-0.61696658	0.02606882	0.94761779	0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389632-02	Tipiracil		Thymidine Phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	183204-72-0				1.0093466297	4	4		0	-0.39306358				TYMP	ClC\1=C(/CN2CCCC2=N)NC(=O)NC1=O	Adooq	A13098	0.46272494	1.06882169	-0.89497236	-0.39306358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371144-02	AWD 131-138			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	188116-07-6				-0.1455765953	4	4		0	0.80924855					ClC1=CC=C(C=C1)N2CC(=N/C2=O)\N3CCOCC3	MedChem Express	HY-14953	-0.35989717	-0.44316997	0.68439063	0.80924855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386206-03	Azilsartan (TAK-536)		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	147403-03-0				0.1434433675	4	4		0	-0.11560694					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Adooq	A11775	0.05141388	-0.9645464	1.10555409	-0.11560694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274276-01	NCGC00274276-01	225144372	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-0.0384810091	4	4		0	-0.30057803					CC(CC1=CC2=C(OCO2)C=C1)NCC(O)C3=CC(=C(O)C=C3)O	GVK	FFS-11-286-NCI-024	-0.20565553	0.91240876	0.10529087	-0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344541-01	Adrenochrome semicarbazone	225144387		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	69-81-8				5.1337062447	4	4		0	0.06936416					CN1CC(O)C\2=C\C(=N/NC(N)=O)C(=O)\C=C12	SIGMA	A5877	1.07969152	1.74661105	1.57936299	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091099-01	Dibromomannitol	17389938	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Mitobronitol; Dibromomannitol; 			-1.2908011185	4	4	NSC 9410;MITOBRONITOL;mitobronitol;CIPLUS_725146;R 54;mitobronitolum;Mitolactolum;Mitolactol;elobromol;NCGC00091099-02;Mitobronitolum;Mitobronitol (1,6-Dibromo-1,6-dideoxy-D-mannitol);Galactitol, 1,6-dibromo-1,6-dideoxy-;CIPLUS_167927;NSC-94,100;Dibromodulcitol;NSC-94100;DIBROMODULCITOL;NSC9410;CIPLUS_153526;NCGC_SIGMA_D4393;1,6-Dibromo-1,6-dideoxy-D-mannitol;NSC94,10;NSC-104800;D-Mannitol, 1,6-dibromo-1,6-dideoxy-;AB07944772-01;mitolactol;NSC 10480;LS-369;Myelobromol;NSC10480;LS-1295;Dibromomannitol;MITOLACTOL;mitolactolum;Mitobronitol;NSC 94,10;MYELOBROMOL;1,6-DIBROMO-1,6-DIDEOXY-D-GALACTITOL;	0	-0.35035035					O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr	NIEHS	AB07944772	0.04770992	-1.38453501	-0.26184865	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185003-01	NCGC00185003-01	124896579		DPI_SARS-CoV-2_General	2019_NPC-6_CPE					3.4821557851	4	4	PPIX;NCGC00094273-03;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid;protoporphyrin IX;NCGC00094273-02;NCGC00094273-01;CIPLUS_213719;Ooporphyrin disodium salt;Cobalt Protoporphyrin;Protoporphyrin disodium;CIPLUS_732479;Ooporphyrin;Prolmon;Protoporphyrin IX disodium salt;PROTOPORPHYRIN IX;Protoporphyrin;Protoporphyrin IX;NCGC00015844-01;NCGC00162303-01;Zinc ionophore II;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid disodium salt;PROTOPORPHYRIN DISODIUM;NCGC00166283-01;Kammerer's porphyrin;NCGC_FLUKA_30157;MgProto;CIPLUS_154404;CIPLUS_744647;Mg protoporphyrin;Protoporphyrin IX disodium;divinyl-Mg-protoporphyrin;protoporphyrin IX, disodium salt;protoporphyrin IX dihydride;magnesium protoporphyrin;CIPLUS_736051;Depocolin-S;Protoporphyrin Disodium;	0	0.2002002					CC1=C2[NH]C(=C1C=C)C=C\3N=C(C=C\4N=C(C=C5[NH]C(=C2)C(=C5C)C=C)\C(=C4CCC([O-])=O)C)\C(=C3C)CCC([O-])=O	FLUKA	30157	1.8129771	-1.43678161	-0.41895784	0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183281-03	Valeric acid			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	109-52-4				0.0985676801	4	4		0	0.4004004					CCCCC(O)=O	SIGMA	110140	0.42938931	-1.38453501	-0.47132757	0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188864-02	Iloperidone	170465198	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	133454-47-4	Iloperidone	12.5892541179	-4.9	59.5424655361	3	4		95.8793441059	85.86399627	0.0046976281	0.9999863896	1813	DRD2	CC(=O)c4ccc(OCCCN1CCC(CC1)c3noc2cc(F)ccc23)c(OC)c4	Bosche	I2337	-1.32124352	-1.04826914	-0.7550969	85.86399627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167420-01	Perflenapent	144205977		DPI_SARS-CoV-2_General	2019_NPC-9_CPE	678-26-2	QW-7437; 2H,3H-perfluoropentane; 			-2.8646058933	4	4	CIPLUS_156010;QW7437;perfluoropentane;DODECAFLUOROPENTANE;dodecafluoropentane;QW-7437;2H,3H-perfluoropentane;perflenapentum;QW 7437;PERFLUOROPENTANE;PERFLENAPENT;Perflenapent;	0	1.93292967					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F	Alfa Aesar	L16969	-1.37305699	-1.04826914	-0.10067959	1.93292967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168777-04	Etonogestrel		contraceptive	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	54048-10-1				1.4600171317	4	4		0	0.11644155					CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0652	0.33678756	-0.12189176	0.85577649	0.11644155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167457-02	Gestrinone	170466364	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	16320-04-0				12.4780095764	4	4		0	4.49464369			5241	PGR	O=C3C=C4CC[C@@H]2C(C=C[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4CC3	Bosche	G6427	1.68393782	2.41345685	4.48024163	4.49464369												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166294-03	Sparfloxacin	170465370	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	110871-86-8	; Esparfloxacino;Sparfloxacin; Zagam			3.7845261218	4	4		0	2.7713088			7155	TOP2B	C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK802067	0.28497409	-0.36567528	0.70475711	2.7713088												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00344182-03	5-trans Prostaglandin F2?		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	36150-01-3				-2.1000918697	4	4		0	-1.0013973					CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C\CCCC(O)=O	Cayman	16210	-0.59585492	-0.51194539	0.7550969	-1.0013973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017030-10	Fusidic Acid (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	751-94-0				2.7062972236	4	4		0	1.42058687					C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]3(C)[C@H]2[C@H](O)C[C@H]4\C([C@H](CC34C)OC(C)=O)=C(CCC=C(C)C)/C([O-])=O	Cayman	14825	0.33678756	0.31691858	0.8054367	1.42058687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178783-03	HYOSCYAMINE		M1 Muscarinic acetylcholine receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	101-31-5				7.9021765269	4	4		0	1.60689334				CHRM1	CN1C2CC[C@@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3	Microsource	01500346	1.7357513	1.58459288	1.66121319	1.60689334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253658-01	Dapoxetine	170466555	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	119356-77-3	Dapoxetine hydrochloride (Priligy);Dapoxetine	12.5892541179	-4.9	68.3678746408	3	4		100.8036795534	87.91336749	0.0206081752	0.9997379804	6532	SLC6A4	CN(C)[C@@H](CCOc2cccc1ccccc12)c3ccccc3	GVK	FFS-12-73-NCI-1987	0.18134715	1.68210629	1.45985401	87.91336749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181917-01	Carbenicillin indanyl	144206652	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	35531-88-5	Carbenicillin indanyl			1.280135645	4	4	Geocillin;Carbenicillin Indanyl Sodium;carindacillinum;Carindacillin;CARINDACILLIN;LS-149775;CARINDACILLIN SODIUM;CIPLUS_670161;Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-, 1-(5-indanyl) ester, monosodium salt;CARBENICILLIN INDANYL SODIUM;CIPLUS_175403;carbenicillin indanyl;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S,5R,6R)-;LS-88733;Carindacilline;1-(5-INDANYL)(2S,5R,6R)-N-(2-CARBOXY-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPT-6-YL)-2-PHENYLMALONAMATE MONOSODIUM SALT;Carindacilina;CIPLUS_197131;SODIUM (2S,5R,6R)-6-((3-(2,3-DIHYDRO-1H-INDEN-5-YLOXY)-3-OXO-2-PHENYLPROPANOYL)AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE;Carindacillin sodium;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1H-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2-alpha,5-alpha,6-beta))-;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.))-.;carindacilline;Carbenicillin indanyl sodium;Carindacillinum;Carindacillin Sodium;	0	0.48905449					OC(=O)[C@@H]4N5C(=O)[C@@H](NC(=O)C(c1ccccc1)C(=O)Oc2cc3CCCc3cc2)[C@H]5SC4(C)C	GVK	GVK-NIH-11	0.02590674	-0.95075573	2.16461112	0.48905449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090726-12	Ribavirin	170464657	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	36791-04-5	; ;Ribavirin; Levovirin; Ribavirin; Virazole;RIBAVIRIN; Ribavirina; Drug:  Ribavirin			-4.4066026071	4	4		0	-1.16125627			727833	IMPDH1	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503938	-0.9180791	-1.60055672	-0.29697624	-1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00068236-07	Gatifloxacin	170465592	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	112811-59-3	; Tequin;GATIFLOXACIN;Gatifloxacin; Gatifloxacin Anhydride; Gatifloxacin hydrate; Gatifloxacin Hydrate; Gatiflo; Zymar			-3.1294127476	4	4		0	-0.84455001			7155	TOP2B	CC1CN(CCN1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK801620	-0.82391714	0.20876827	-0.78293736	-0.84455001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00273481-01	Metixene hydrochloride	170465287	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1553-34-0				-2.2048460043	4	4		0	-2.48086566					Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23	Prestwick Chemical, Inc.	Prestw-491	-0.02354049	-1.18302018	1.32289417	-2.48086566												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00160508-03	Isosorbide	170465187		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	652-67-5				-1.7508361151	4	4		0	-0.2111375					O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	Vitas	STK801813	-0.6826742	0.97425191	-0.89092873	-0.2111375												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016602-04	Benperidol	170466409	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	2062-84-2				-2.763714866	4	4		0	-0.52784376					Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=O	Prestwick Chemical, Inc.	Prestw-484	-0.72975518	-1.39178845	0.1349892	-0.52784376												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164385-05	Clomifene citrate	170464951	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	911-45-5	; Zuclomifeno; Clomifeno; Clomiphene citrate (Z,E);CLOMIPHENE CITRATE; Clomifene Citrate; ; Clomiphene Hydrochloride; Clomid; Clomiphene citrate salt; (E)-isomer, HCl; Clomifen; cis-Clomiphene citrate; Clomifene citrate; Enclomifeno; (Z)-isomer, citrate; Clomiphene citrate			-4.3985538372	4	4		0	-3.11427817			2099	ESR1	CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC	Microsource	01500196	0.54143126	-0.69589422	-1.43088553	-3.11427817												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249927-01	Simetride	170466023		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	154-82-5				-0.4269679215	4	4		0	0.89733439					O=C(COc1ccc(CCC)cc1OC)N2CCN(CC2)C(=O)COc3ccc(CCC)cc3OC	GVK	FFS-11-286-NCI-224	-0.82391714	-0.27835769	0.29697624	0.89733439												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016241-10	Furosemide	170464879	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54-31-9	 ; Diumide-K; Frusemid;FUROSEMIDE; Errolon; Lasix; Furosemide;Furosemide; Furosemide and potassium; Furosemida; Furantral; Furosemide solution; Fusid; Diumide-K continus; Furanthril			-0.8127254412	4	4		0	0.47505938					NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O	Vitas	STK177334	-0.4472693	0.69589422	-0.94492441	0.47505938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164499-03	DL-alpha Tocopheryl nicotinate	170465780	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	43119-47-7				1.2188352832	4	4		0	3.2726313					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc3c(O1)c(C)c(C)c(OC(=O)c2cccnc2)c3C	Labotest	LT00772349	-1.15348399	-0.69589422	0.24298056	3.2726313												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022304-21	ACETYLCYSTEINE			DPI_SARS-CoV-2_General	2019_NPC-4_CPE	616-91-1				-1.504215796	4	4		0	1.16125627					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-1.29472693	-0.41753653	-0.08099352	1.16125627												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015580-13	Ketotifen	170465378	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	34580-13-7	Ketotifen; Zaditor;Ketotifen fumarate; Ketotifen fumarate;; ; Fumarate, Ketotife; Ketotiphen;KETOTIFEN FUMARATE; Zaditen; Ketotifen fumarate salt; Ketotifen Maleate; Ketotiphene; Ketotifeno			-0.6336165724	4	4		0	0.31670625			9704	HRH1	CN1CC/C(CC1)=C3\c4ccccc4CC(=O)c2sccc23	Vitas	STK048448	-0.21186441	-1.04384134	0.1349892	0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015786-16	Pindolol	170464892	Serotonin 1a (5-HT1a) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	13523-86-9				-4.2089637798	4	5		0	-2.56696429					CC(C)NCC(O)COc2cccc1nccc12	Enzo	AC181	-0.70737156	-3.34733359	-0.73417371	2.6816841	-2.56696429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179445-03	Dydrogesterone	170465104	signaling/transport	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	152-62-5				-1.3818728077	4	5		0	3.87834821					CC(=O)[C@H]2CC[C@H]3[C@@H]4C=CC1=CC(=O)CC[C@@]1(C)[C@@H]4CC[C@]23C	Prestwick Chemical, Inc.	Prestw-671	-0.50881112	-0.36909762	-2.3133398	-2.0917136	3.87834821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092386-13	Sertraline hydrochloride	170465121	Selective Seratonin Reuptake Inhibitor (SSRI)	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	79559-97-0		2.8183829313	-5.55	8.2884300104	4	5		15.844788092	-6.25	0.0739090328	0.9966395841		SLC6A4	Cl.Clc1ccc(cc1Cl)[C@@H]3CC[C@H](NC)c2ccccc23	Microsource	01505262	-2.0476545	-2.78732341	-2.72890982	11.02172164	-6.25											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249932-01	Emorfazone	170465843		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	38957-41-4				-6.2553154823	4	5		0	-1.70200893					CCOC1=C(C=NN(C)C1=O)N2CCOCC2	GVK	FFS-11-286-NCI-236	-2.51923554	-4.46735395	2.09170245	1.93081255	-1.70200893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018204-13	Vinpocetine	170465859	Na channel blocker, also PDE1, IKK inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	42971-09-5	;Vinpocetine; Cavinton	0.2238721139	-6.65	6.7032668873	4	5		8.239685664	1.85662014	0.660825322	0.5750632456			O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC	Prestwick Chemical, Inc.	Prestw-268	-1.86640472	-0.72570726	11.55335916	1.79519595	1.85662014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015273-19	Chlorpromazine	170465371	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-53-3		8.9125093813	-5.05	50.8658837634	3	5		70.4732862024	67.09581244	0.0032864225	0.9983531854			CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12	Vitas	STK182870	0.19646365	0.60270603	-2.55108855	2.45259166	67.09581244											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090808-04	Amphotericin B		Macrolide Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1397-89-3	 Amphotericin B trihydrate; L-AmB; Amphotericinum B; PAME amphotericin B ester; Abelcet; ; liposomal amphotericin B; Ambisome; amphotericinum B; Amphocil; D-AmB cpd; AmBisome;Amphotericin B;Amphotericin B (Abelcet); Amphotericin B solution; amphotericin??B; HAmB-DOC; Amphozone; Amfotericina B; Fungizone; Amphotericin B; Amphotericine B			-1.2023894731	4	5		0	4.51280661					C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	SIGMA	A9528	-2.62770138	1.58671587	0.76131962	-1.9216182	4.51280661											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016637-10	Diloxanide furoate	170466783		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3736-81-0				-8.2201176449	4	5		0	0.3387993					ClC(Cl)C(=O)N(C)c1ccc(cc1)OC(=O)c2ccco2	Microsource	01505532	-3.70825147	-1.95571956	-2.57780152	2.25031606	0.3387993											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090770-09	5-Bromo-2'-deoxyuridine	170465870	base conversion or substitution editing Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59-14-3				3.4425433296	4	5		0	6.08258929					BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Bosche	B0691	-0.06205014	2.60913835	-1.28826707	-2.73531778	6.08258929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018271-07	Homochlorcyclizine	170465786		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	848-53-3		11.220184543	-4.95	65.468545621	3	5		104.6863056079	84.765625	0.0051902445	0.9973951883			Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3	Enzo	AC927	0.23579052	-4.11098384	0.98351572	5.52426924	84.765625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179680-05	Clonidine	170464900	alpha1-Adrenoceptor Agonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	4205-90-7				-5.3791544239	4	5		0	-0.79956634				ADRA1A	Clc2cccc(Cl)c2\N=C1/NCCN1	Enzo	AC152	-3.38899804	1.58671587	0.8681715	-0.3034134	-0.79956634											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182995-01	Etomidoline	144206828		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	21590-92-1	Etomidoline; Smedolin; Etomidolina; 			-0.2152913782	4	5	Etomidolina;2-ethyl-3-(p-(beta-piperidinoethoxy)phenylamino)-isoindoline-1-one;Etomidolinum;K-2680;2-ETHYL-3-(.BETA.-PIPERIDINO-P-PHENETIDINO)PHTHALIMIDINE;K 2680;Phthalimidine, 2-ethyl-3-(beta-piperidino-p-phenetidino)-;etomidolinum;Etomidoline;LS-109527;CIPLUS_213965;Smedolin;ETOMIDOLINE;amidoline;1h-isoindol-1-one, 2-ethyl-2,3-dihydro-3-((4-(2-(1-piperidinyl)ethoxy)phenyl)amino)- (9ci);etomidoline;	0	3.67258436					O=C4c1ccccc1C(Nc3ccc(OCCN2CCCCC2)cc3)N4CC	Pharmaron	PH-NIH-150630	-1.76817289	-0.25830258	-1.05516228	1.7699115	3.67258436											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263444-01	Metocurine iodide	170465111		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	7601-55-0				1.0707281517	4	5		0	4.4921875					[I-].[I-].COc7ccc1cc7Oc6cc5c(CC[N+](C)(C)[C@H]5Cc4ccc(Oc3c2c(CC[N+](C)(C)[C@@H]2C1)cc(OC)c3OC)cc4)cc6OC	Specs	AE-562/J259582	-2.99081658	1.13274787	0.15237568	3.37892196	4.4921875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160631-02	Famphur	170466840	Trichostrongylus axei Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52-85-7				-0.7025546549	4	5		0	-0.11160714					O=S(=O)(N(C)C)c1ccc(OP(=S)(OC)OC)cc1	SIGMA	34341	-0.83147183	0.11454754	-2.11940712	3.32528828	-0.11160714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160445-02	Bromisovalum	170465828		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	496-67-3				-4.2379088028	4	5		0	-2.12053571					CC(C)C(Br)C(=O)NC(N)=O	Labotest	LT00134620	-2.271035	0.72546774	3.86480122	-2.35988201	-2.12053571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015316-05	Eflornithine Hydrochloride	170465007	Ornithine Decarboxylase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	96020-91-6	 ; 1   Eflornithine; DFMO hydrochloride; Ornidyl; DL-alpha-Difluoromethylornithine hydrochloride;DFMO;Eflornithine Hydrochloride;DL-alpha-Difluoromethylornithine hydrochloride			-1.865464299	4	5		0	1.91082803			89874	ODC1	Cl.FC(F)C(N)(CCCN)C(=O)O	Bosche	E2777	-1.79273084	1.04551046	-0.04006945	-0.9608091	1.91082803											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016973-06	Letrozole	225144183	Aromatase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	112809-51-5	 Letrozole; F??mara;Letrozole; ;Femara; Femara;CGS-20267;FEM-345?			5.7791028796	4	5		0	3.32023309			1588	CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Prestwick	Prestw-1025	1.00687623	2.12792128	-1.295579	1.2136536	3.32023309											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016498-08	Dyclonine hydrochloride	170464776	Sodium channel protein type II alpha subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	536-43-6		5.0118723363	-5.3	8.3779755986	4	5		12.402214028	10.82802548	0.0067626202	0.9966338819			Cl.CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2	Microsource	01500268	-0.44204322	-1.16851169	-0.84145853	3.59039191	10.82802548											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183014-01	Sulfamethomidine	144206847	Bacterial dihydrofolate reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3772-76-7	Sulfametomidine; Sulfametomidina; Sulfametomidine Anhydride; 			-2.6606762855	4	5	LS-147802;sulfamethomidine;Sulfametomidina;sulfamidine;Sulfanilamide, N(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)-;Sulfametomidine Anhydride;SULFAMETOMIDINE;CIPLUS_162501;Sulfamethomidine;Sulfametomidine;Sulfametomidinum;sulfametomidine;4-sulfanilamido-2-methyl-6-methoxypyrimidine;sulfametomidinum;	0	-2.00892857					Cc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Pharmaron	PH-NIH-154290	-0.73219161	-3.14369352	1.95317911	1.47492625	-2.00892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016352-07	Benzocaine	170465463	Sodium channel protein type 10 subunit alpha Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-09-7				-5.1396191447	4	5		0	-0.74535845			6336	SCN10A	Nc1ccc(cc1)C(=O)OCC	Vitas	STK043620	0.34381139	-2.300123	-2.79150528	-2.37673831	-0.74535845											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096077-06	Olanzapine	170465009	Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	132539-06-1	; ;OLANZAPINE; Zyprexa; OLANZAPINE;Olanzapine; Olanzapine; Lilly brand of olanzapine			-3.4441316115	4	5		0	1.39508929			1813	DRD2	CN1CCN(CC1)C2=Nc4ccccc4Nc3sc(C)cc23	SIGMA	O1141	-2.0476545	-3.34733359	-0.37401302	2.73531778	1.39508929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015436-11	Fluphenazine hydrochloride	170465375	Nicotinic alpha7 Receptor Ligands	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	69-23-8	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	3.1622776602	-5.5	33.9566150315	4	5		26.5355282481	-4.64832633	0.2177257521	0.9696619824	1813	DRD2	FC(F)(F)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2	Vitas	STK050763	2.67681729	0.06150062	-1.69627354	20.83438685	-4.64832633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095122-05	Irbesartan	170464670		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	138402-11-6				2.4558109074	4	5		0	7.08768126					CCCCC5=NC1(CCCC1)C(=O)N5Cc2ccc(cc2)c3ccccc3c4nnnn4	Microsource	01504259	-2.45579568	-1.09471095	2.23053292	1.3147914	7.08768126											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091238-03	2,2'-Dithiobisbenzothiazole	170465723		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	120-78-5				-0.4404407579	4	5		0	0.5285269					c1cccc2sc(nc12)SSc3nc4ccccc4s3	Bosche	D1170	1.32612967	-0.30750308	-1.50928276	-2.55372946	0.5285269											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00018181-12	Nalidixic acid	170465215	Quinoline Antibiotic	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	389-08-2	; Negram-Citrat;NALIDIXIC ACID; Sodium, Nalidixat; Nevigramon; Acid, Nalidixi; Acido nalidixico; Nalidixic acid sodium; Mictral;Nalidixic acid; NegGram; Prestwick-03C08			-9.3804914487	4	5		0	-1.25558036					O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O	Vitas	STK735579	-3.16455696	-2.73641339	1.06662973	-2.01126307	-1.25558036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015344-16	NCGC00015344-16			SARS-CoV-2_CPE_SRI	2019_NPC-2.2					-2.3186806186	4	5		0	6.16629464					CN(C)CC\C=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2	Microsource	01500264	-2.24621494	-3.65279369	0.31860368	-0.61678734	6.16629464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091208-09	4-Hexylresorcinol	170465471	Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	136-77-6				-1.3209495618	4	5		0	1.88372408					Oc1cc(O)ccc1CCCCCC	Microsource	01500330	-0.49115914	0.4797048	-2.52437558	-0.5562579	1.88372408											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024643-10	Ifenprodil	170465791	Kir3.1/Kir3.4 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	23210-56-2		0.0501187234	-7.3	12.0473351579	4	5		-13.008537748	-2.50711479	0.0489101279	0.9748417163			OC(C(C)N1CCC(CC1)Cc2ccccc2)c3ccc(O)cc3	SigmaAldrich	I-2892	9.52848723	-2.47232472	-2.3373848	-0.5562579	-2.50711479											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182552-02	Atazanavir	170465290	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	198904-31-3	 ;ATAZANAVIR SULFATE; Atazanavir;Atazanavir sulfate; Reyataz			2.8523801805	4	5		0	-1.171875					CC(C)(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc2ccc(cc2)c3ccccn3	Sequoia	229975-97-7	-3.61131794	13.834797	3.19988918	-2.11853044	-1.171875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167472-03	Amlexanox	170465365	Mediator Release Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68302-57-8	 3   Amlexanox; ; Solfa;Amlexanox; Aphthasol; Amlenanox			-3.1397093659	4	5		0	0.01396648				IL3	CC(C)c1cc2C(=O)c3cc(c(N)nc3Oc2cc1)C(=O)O	Bosche	A2169	-3.57360097	5.61573901	-0.3785566	-0.26189437	0.01396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00042523-03	N-Oxydiethylenebenzothiazole-2-sulfenamide	170465568		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	102-77-2				-5.5300302491	4	5		0	-4.70670391					c1cccc2sc(nc12)SN3CCOCC3	Labotest	LT00078541	-1.59671533	0.38600423	1.99047503	-1.0184781	-4.70670391											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018098-07	Iodoquinol	170465640		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	83-73-8		10	-5	22.6085806361	3	5		42.3545304418	33.50558659	0.0258692137	0.9868235748			Oc1c(I)cc(I)c2cccnc12	Vitas	STK070581	-3.4823601	0.98368821	0.52509464	4.24850866	33.50558659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015831-06	Pheniramine maleate	170464902	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	132-20-7				-8.0532890897	4	5		0	-2.75139665					[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2	Microsource	01500478	-2.72201946	-0.70974972	-0.64720967	0	-2.75139665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164620-02	Nadifloxacin	170465882	DNA gyrase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	124858-35-1				-0.0103866304	4	5		0	0.99162011					O=C(O)C3=CN2C(C)CCc1c(c(F)cc(c12)C3=O)N4CCC(O)CC4	Sequoia	SRP00810n	-0.62347932	1.00859171	-0.72047869	0.29099374	0.99162011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274059-01	Nelarabine	170464759	Antimetabolite	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	121032-29-9				0.9727406474	4	5		0	0.58273479				HPRT1	Nc3nc2c(ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O)c(OC)n3	Selleck	S1213	0	0.65190652	2.41752371	-2.30088496	0.58273479											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018284-06	MEPIVACAINE HYDROCHLORIDE		Sodium channel protein type X alpha subunit Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1722-62-9				5.4214534238	4	5		0	-0.31169535					CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C	SIGMA	M3189	0.66306483	2.89052891	-1.16201416	4.60176991	-0.31169535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015500-19	Haloperidol	170464841	Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	52-86-8	; ;Haloperidol; Haloperidol hydrochloride; Haloperidol Lact;Haloperidol..HCl; Vesadol;HALOPERIDOL;Haloperidol?HCl;Haloperidol hydrochloride; Haloperidol metabolite II; Haloperidol Dec; Haldol			-9.2677806772	4	5		0	-0.14907169			1813	DRD2	Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3	Enzo	AC250	-2.23477407	-2.05412054	-0.8681715	-4.24778761	-0.14907169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016978-04	Repaglinide	225144184	Insulin Secretagogues	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	135062-02-1	; ; Prandin; Repaglinide;Repaglinide; Repaglinida; Novonorm	14.1253754462	-4.85	19.2616826402	4	5		21.625158032	18.66106518	0.1519431373	0.9143924719		INS	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	Prestwick	Prestw-1046	4.17485265	0.18450184	-1.05516228	-2.60429836	18.66106518											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022858-08	Sodium cromoglycate	170464887	Mediator Release Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	15826-37-6	;CROMOLYN SODIUM; Nasalcrom; Cromolyn sodium salt; Cromoglycate; Cromoglycic Acid; Cromolyn disodium salt; Cromoglycate, Disodiu; Aarane; Intal;Cromolyn disodium salt; Cromoglycate, Sodiu; Sodium Cromoglicate; Opticrom; Gastrocrom; Cromoglycic acid; Sodium cromoglicate; 6   Cromolyn Sodium; Acido cromoglicico; Lomudal; Vicrom; Disodium chromoglycate; Nalcrom; Bicromat Spray			-6.6275242725	4	5		0	1.85662014				KCNMA1	[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4	Microsource	01500210	-2.03831041	-1.3899139	-1.96340323	-2.70543616	1.85662014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274056-01	Risedronate sodium	170464992	Farnesyl diphosphate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	115436-72-1				3.2960677915	4	5		0	-1.2150838				FDPS	[Na+].[Na+].[O-]P(=O)(O)C(O)(Cc1cccnc1)P([O-])(=O)O	Microsource	01505944	1.35340633	-0.95878471	4.75027476	-1.3676706	-1.2150838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016421-07	Cyclizine hydrochloride	170465270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	303-25-3				8.5115706809	4	4		0	5.24492825					Cl.Cl.CN1CCN(CC1)C(c2ccccc2)c3ccccc3	Microsource	01500211	-0.53165781	-0.37000493	3.81800827	5.24492825												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090851-10	5-Azacitidine	170465076	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	320-67-2	 ;AZACITIDINE; Azacytidine, 5-; Ladakamycin;Azacitidina; Azacytidine-5; 5-Azacitidine;5-Azacitidine; 5 Azacytidin; Azacytidine; Vidaza; ara-5-aza-Cyd;5-azacytidine;5-Azacytidine			-2.4070072976	4	4		0	0.4453241			1786	DNMT1	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01502111	-0.96665056	-0.81401085	-0.50906777	0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00346501-07	Bleomycin sulfate		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	9041-93-4				-5.1562998148	4	4		0	-2.3400191					C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(=NC(=N1)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)N)C(O[C@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C	Selleck	S1214	-1.03044496	0.63039925	-1.74054936	-2.3400191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095188-05	Pantoprazole	170466337	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE			0.7919301023	4	4		0	0.36949063				ATP4A	COc3c(OC)ccnc3CS(=O)c1nc2cc(ccc2n1)OC(F)F	Microsource	01505818	0.72975518	-0.20876827	-0.78293736	0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091835-10	Chlormethine	170465017	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	55-86-7	 Nitrogen mustard HCl;Nitrogen mustard HCl;Nitrogen mustard hydrochloride; Nitrogen mustard hydrochloride;MECHLORETHAMINE			-2.9156257025	4	4		0	-0.79176564				H2AFX	Cl.ClCCN(C)CCCl	Microsource	01500375	-0.49435028	-1.2526096	-0.24298056	-0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090957-05	Octanoic acid		Solute carrier family 22 member 8 Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	124-07-2				-2.0354825106	4	4		0	2.07840042					CCCCCCCC(O)=O	SIGMA	C2875	-1.01694915	-0.8531995	-1.74816316	2.07840042												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015673-13	Minoxidil	170464704	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	38304-91-5	Minoxidil; Loniten; Minoxidil; ;MINOXIDIL; Minoxidil Pfizer Bran; Riup; Pfizer Brand of Minoxidil; Regaine			-1.1441518966	4	4		0	-0.94012865					Nc1cc(nc(N)[n+]1[O-])N2CCCCC2	Microsource	01500415	-0.38666022	-0.5673409	0.95450207	-0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183017-01	Ethyl 4-nitrophenyl ethylphosphonate	144206877		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	546-71-4	Ethyl-p-Nitrophenyl Ethylphosphonate; Armin; Armine; 			-2.5960191628	4	5	ETHYL 4-NITROPHENYL-ETHYL PHOSPHONATE;Armine;p-Nitrophenyl-O-ethyl ethylphosphonate;ETHYL 4-NITROPHENYL ETHYLPHOSPHONATE;Ethyl 4-nitrophenyl ethylphosphonate;LS-106606;CIPLUS_208139;Ethyl-p-Nitrophenyl Ethylphosphonate;Ethyl 4-Nitrophenyl Ethylphosphonate;Armin;	0	-0.14907169					[O-][N+](=O)c1ccc(OP(=O)(OCC)CC)cc1	Pharmaron	PH-NIH-183377	-2.28388998	4.56334563	-0.89488447	-1.1630847	-0.14907169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015841-11	Pargyline hydrochloride	170465066	Monoamine oxidase B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	306-07-0				5.0752227711	4	5		0	2.85946605					Cl.CN(Cc1ccccc1)CC#C	Microsource	01500462	1.22789784	-3.11193112	2.81821824	1.23893805	2.85946605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095124-08	Rosiglitazone	170465417	PPARgamma Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	122320-73-4	; ;Rosiglitazone;ROSIGLITAZONE MALEATE; Avandia; ROSIGLTAZONE HCl; Rosiglitazone; rosiglitazone (Avandia); ROSIGLITAZONE;ROSIGLITAZONE	6.3095734448	-5.2	35.3046174757	4	5		27.1642066361	24.37999729	0.0525193612	0.9727296997	5468	PPARG	CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3	Microsource	01504263	3.41355599	-0.55350553	4.60798718	11.32743363	24.37999729											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094516-08	Coumaphos	170466302		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	56-72-4				-1.7259341372	4	5		0	0.01396648					CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	Microsource	00330012	-0.59306569	-1.73079318	-0.25644157	1.07667685	0.01396648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159368-05	1-Hexadecanol	170465348	Fatty aldehyde dehydrogenase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	36653-82-4				0.0667323569	4	5		0	-4.20391061			224	ALDH3A2	CCCCCCCCCCCCCCCCO	Labotest	LTBB001504	1.93126521	0.11206575	0.25644157	-0.90208061	-4.20391061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249896-01	Cinnamedrine	170465535		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	90-86-8		7.9432823472	-5.1	0.8554552672	4	5		11.448905108	7.44413408	0.0994199805	0.9470993244			OC(C(C)N(C)C/C=C/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-72	-2.87408759	-0.26148674	-0.7693247	1.92055871	7.44413408											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015620-17	NCGC00015620-17			SARS-CoV-2_CPE_SRI	2019_NPC-3.2					0.3444582681	4	5		0	-1.55847676					C1CN2CC(N=C2S1)C3=CC=CC=C3	Vitas	STL019093	1.94007859	-0.89790898	0.38733805	-2.47787611	-1.55847676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164578-02	Etoricoxib	170465621	Cyclooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	202409-33-4				-1.0524002612	4	5		0	1.13128492			5743	PTGS2	CS(=O)(=O)c1ccc(cc1)c3cc(Cl)cnc3c2cnc(C)cc2	Sequoia	SRP02700e	0.71472019	0.51052173	-2.50335816	-2.61894369	1.13128492											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016257-10	4-Dimethylaminoantipyrine	170465863		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	58-15-1				4.7538071045	4	5		0	0.46089385					CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Microsource	01500621	-0.9580292	2.52770514	0.79374771	5.52888113	0.46089385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018251-05	Methyl delta-aminolevulinate hydrochloride	225144187	Porphyrin and chlorophyll metabolism Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	79416-27-6				1.3829574802	4	5		0	-1.55027933					COC(=O)CCC(=O)CN	SIGMA	A5575	-0.19768856	0.38600423	-0.79374771	4.56860178	-1.55027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183015-01	Temoporfin	144206848	cell proliferation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	122341-38-2	Temoporfin; 			-0.6172627429	4	5	M-THPC;CIPLUS_197002;5,10,15,20-TETRA(3-HYDROXYPHENYL)-CHLORIN;TEMOPORFIN;Temoporfin;LS-172529;temoporfinum;	0	6.72433036					Oc1cccc(c1)c9c2CCc(n2)c(c3cccc(O)c3)c4ccc(n4)c(c5cccc(O)c5)c6C=Cc(n6)c(c7cccc(O)c7)c8ccc9n8	Pharmaron	PH-NIH-154455	-2.86671631	2.32913326	-1.48219975	-1.31402521	6.72433036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015735-11	Niclosamide	170465184	STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50-65-7	 Yomesan;Niclosamide; Niclosamida;NICOLSAMIDE; ; Bayluscide;NICLOSAMIDE; Niclocide; Phenasal; Fenasal; Niclosamid; Radewerm; Bayer 73; Bayer 2353; Niclosamide; Clonitralide; Niclosamidel; Devermine; Niclosamide-olamine; Tr??d??mine	0.1	-7	56.7538806028	4	5		28.350364964	20.0698324	0.1250827957	0.9309875479	6774	STAT3	Clc2cc(ccc2NC(=O)c1cc(Cl)ccc1O)[N+]([O-])=O	Vitas	STK396676	-3.20863747	3.17519611	30.66308463	24.38527572	20.0698324											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016026-10	Terazosin hydrochloride	170465073	Alpha1-adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	63074-08-8	; ; Terazosin hydrochloride;TERAZOSIN HYDROCHLORIDE; Hytrin; Terazosina;Terazosin hydrochloride			-0.3908195946	4	5		0	-1.9972067			148	ADRA1A	Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1	Vitas	STK567029	1.99209246	-3.4242311	-0.86701673	0.58198749	-1.9972067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093351-06	Cefoxitin	170465105	Penicillin-binding protein 2B Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	35607-66-0				-3.6141450433	4	5		0	-1.07541899			933948	penA	O=C(O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O	Microsource	01502031	-3.14781022	-0.80936372	2.40566614	2.73534119	-1.07541899											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	57-41-0				-0.5545109756	4	4		0	-0.60510392					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	1.40435835	-1.55583438	-1.34279199	-0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091050-09	Phenylmercuric acetate	170465524		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	62-38-4				-0.3954572879	4	4		0	-2.62246413					CC(=O)O[Hg]c1ccccc1	Microsource	01500644	-0.09666506	0.37000493	2.29080496	-2.62246413												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090797-12	Digoxin		Steroid	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	20830-75-5	; ; 12beta-Hydroxydigitoxin; Card-Cosaldon; Lanoxin;Digoxin; Digoxin			2.8738123683	4	4		0	1.73181593				RORC	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Prestwick	Prestw-437	-0.28999517	1.20868278	0.63633471	1.73181593												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015620-17	NCGC00015620-17			DPI_SARS-CoV-2_General	2019_NPC-3_CPE					6.2644589996	4	4		0	1.28649184					C1CN2CC(N=C2S1)C3=CC=CC=C3	Vitas	STL019093	2.9482842	-1.35668476	0.31816736	1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018302-07	Trichlormethiazide	170464812	Diuretic	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	133-67-5	;Trichlormethiazide; Esmalorid; Naqua; Triclormetiazida; Esmaloride; Triazide;TRICHLORMETHIAZIDE			3.8766942118	4	4		0	2.12765957				SLC12A3	NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)C(Cl)Cl)cc2Cl	Prestwick Chemical, Inc.	Prestw-825	1.01498308	0.46867292	-0.63633471	2.12765957												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159497-02	Allylestrenol	144205271	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	432-60-0	Allylestrenol; Allyloestrenol; Turinal; Gestanon; Alilestrenol; Gestanin; Perselin; 			1.1046121993	4	4	Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-;Organon Brand of Allylestrenol;allylestrenolum;CIPLUS_153117;allylestrenol;Perselin;Allylestrenolum;Turinal;Gestanon;LS-64837;Alilestrenol;Gestanin;Allylestrenol Organon Bran;ALLYLESTRENOL;Allyloestrenol;Allylestrenol;ALLYL ESTRENOL;	0	-1.83823529					C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC=C	SigmaAldrich	R187755	-0.02520161	0.92664093	1.93060996	-1.83823529												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00182033-01	Felypressin	144206485	Vasopressin V1a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	56-59-7	Felypressin; Octopressin; Felipresina; 			-0.0966147744	4	4	LS-175689;Felypressine;Felypressin;Felypressinum;felypressine;H-CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2  (1-6);PLV-2;Phenylalanyl-Lysyl Vasopressi;Vasopressin, 2-L-phenylalanine-8-L-lysine-;Lysine Vasopressin, Phenylalanin;Vasopressin, Phenylalanine Lysin;Vasopressin, Phenylalanyl Lysy;felypressinum;FELYPRESSIN;CIPLUS_148784;Octopressin;Felipresina;	0	1.05392157					NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	ACC	FELYPRESSIN	-1.08366935	0.87516088	1.81869054	1.05392157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389674-01	Apremilast (CC-10004)		Phosphodiesterase 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	608141-41-9				-6.1199204664	4	4		0	-1.00490196					CCOC1=C(OC)C=CC(=C1)C(C[S+](C)([O-])=O)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(C)=O	APExBIO	A4317	-1.33568548	-0.92664093	-1.87465025	-1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016801-05	Levobunolol hydrochloride	170464743	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	27912-14-7				-3.346775106	4	4		0	-0.49986846					Cl.CC(C)(C)NC[C@H](O)COc2cccc1c2CCCC1=O	Prestwick Chemical, Inc.	Prestw-847	-0.6779661	-1.25470514	-0.63339245	-0.49986846												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091149-21	VALPROATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-3_CPE	1069-66-5, 99-66-1 [valproic acid]				0.6066919462	4	4		0	0.39584364					CCCC(CCC)C(O)=O	Microsource	01500606	0.67665539	0.07400099	-1.08176901	0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249919-01	Nandrolone furylpropionate	170465918		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	7642-64-0				4.3711521894	4	4		0	1.33597229					O=C4C=C5CC[C@@H]2[C@H](CC[C@]3(C)[C@@H](OC(=O)CCc1ccco1)CC[C@@H]23)[C@H]5CC4	GVK	FFS-11-286-NCI-187	0.43499275	0.61667489	1.59083678	1.33597229												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00484907-01	(-)-Scopolamine N-oxide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	6106-81-6				-1.0758937882	4	4		0	0.09551098					C[N+]1([O-])[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)C(CO)C4=CC=CC=C4	Enzo	NP278	-0.51522248	0.02334812	0.21756867	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389499-01	TELITHROMYCIN		Ketolide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	191114-48-4				2.2799202335	4	4		0	5.44412607					CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]3N(CCCC[N]4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC	Microsource	01505265	-0.37470726	-1.19075414	0	5.44412607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178815-03	Tolmetin sodium dihydrate	170465216	Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	64490-92-2				-7.5871638927	4	5		0	-0.5859375					[Na+].O.O.O=C([O-])Cc2ccc(C(=O)c1ccc(C)cc1)n2C	Microsource	01500582	-1.15413254	-1.8454881	-2.42415847	-2.89621883	-0.5859375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253573-01	Tepoxalin	170466265	platelet aggregation Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	103475-41-8		10	-5	12.0620206314	4	5		17.5212211519	15.20647321	0.0200636292	0.9898716595			CN(O)C(=O)CCc2cc(c1ccc(Cl)cc1)n(n2)c3ccc(OC)cc3	GVK	FFS-11-286-NCI-124	-0.43435096	1.18365788	-0.42942236	1.39447573	15.20647321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091070-02	Diisopropylamine	170466002	Pyruvate dehydrogenase kinase isoform 4 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	108-18-9				-2.4397409546	4	5		0	2.16480447					CC(C)NC(C)C	Labotest	LTBB000412	-2.41788321	3.05067862	-1.16009281	-1.28037247	2.16480447											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091886-04	Denatonium benzoate	170464678	Glycolysis / Gluconeogenesis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	3734-33-6				11.2205046365	4	5		0	-1.38268156					O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1	Vitas	STK301730	5.94586375	2.50280164	0.18317255	-0.93117998	-1.38268156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274274-01	Benzquinamide	170465138	Dopamine D2 receptor Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	63-12-7				-9.5854449851	4	5		0	-2.06473214					CCN(CC)C(=O)C2CN3CCc1cc(OC)c(OC)cc1C3CC2OC(C)=O	GVK	FFS-11-286-NCI-037	-3.21419707	-0.08909253	-1.84236044	-1.0458568	-2.06473214											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181137-01	Sulfathiourea	144206297		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	515-49-1	Sulfatolamide; Marbadal; Sulfatolamida; Sulfanilthiocarbamide; Sulfatiourea; 			-5.0156357391	4	4	LS-160708;Sulfatolamida;Sulfanilthiocarbamide;Sulfatolamidum;CIPLUS_210321;sulfathiouree;Urea, 1-sulfanilyl-2-thio-;sulfatolamidum;sulfathiourea;LS-172308;Sulfatolamide;SULFATHIOUREA;sulphatolamide;SULFATOLAMIDE;CIPLUS_213879;Sulfathiouree;Marbadal;1-sulfanilyl-2-thiourea compound with alpha-amino-p-toluenesulfonamide (1:1) marbalettes;sulfatolamide;1-sulfanilyl-2-thiourea;Sulfatiourea;Sulfathiourea;	0	-0.95588235					Nc1ccc(cc1)S(=O)(=O)NC(N)=S	NCI	NSC-108228	-1.63810484	-0.30888031	0.13989927	-0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015368-11	Dicyclomine	170464896	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	77-19-0		11.220184543	-4.95	22.5656762675	3	4		34.07459678	30.80882353	0.0407912857	0.9989736576			CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2	Microsource	01500240	-0.47883065	0.66924067	0.41969782	30.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021125-03	Diclofenac sodium	170464642	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	15307-79-6				3.2327498678	4	4		0	-0.64324592				PTGS1	[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O	Vitas	STK984493	1.06331561	-0.81401085	2.41807191	-0.64324592												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095029-08	NCGC00095029-08		Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE			0.2238721139	-6.65	68.3634129512	1.4	4		36.0147093192	-1.33715377	1	0.9128862659			CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]2CC[C@](O)(CC)[C@H](C)O2)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC3=C(C([O-])=O)C(=C(C)C=C3)O	Analyticon	NP-009923	1.40515222	37.52042961	26.65216209	-1.33715377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160594-03	IPROHEPTINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	13946-02-6				0.0871932694	4	4		0	0.90686274					CC(C)CCCC(C)NC(C)C	Microsource	01506195	0.37802419	-0.46332046	-1.76273083	0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183005-01	Zanapezil fumerate	144206802	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	263248-42-6	CIPLUS_775863; Zanapezil Fumarate; 	11.220184543	-4.95	70.0167219468	3	4	CIPLUS_775863;ZANAPEZIL;Zanapezil Fumarate;CIPLUS_3882440;CIPLUS_3882439;zanapezilum;	100.7720303677	91.98529412	0.012922948	0.9998969867			O=C(O)/C=C/C(=O)O.O=C(CCC2CCN(Cc1ccccc1)CC2)c3ccc4CCCCNc4c3	Pharmaron	PH-NIH-100582	-0.22681452	0.87516088	1.76273083	91.98529412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160469-01	Gamolenic acid	144205388	prostanoid metabolic process Interacts	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	506-26-3	Gamolenic acid; 			-3.3317447566	4	4	CIS,CIS,CIS-6,9,12-OCTADECATRIENOIC ACID;GAMMA-LINOLENIC ACID (18:3 N-6);CIPLUS_710725;gamma-Linolenic Acid;cis,cis,cis-6,9,12-Octadecatrienoic acid;GAMMA-LINOLENIC ACID;GAMMA-LINOLENIC ACID (18:3 n-6);CIS-LINOLEIC ACID/GAMMA-LINOLENIC ACID;GAMOLENIC ACID;NCGC00160469-03;EVENING PRIMROSE OIL;6,9,12-Octadecatrienoic acid, (Z,Z,Z)-;acide gamolenique;Gamolenic acid;acidum gamolenicum;CIPLUS_153754;gamma-Linolenic acid;	0	-0.6127451					O=C(O)CCCC\C=C/C/C=C\C/C=C\CCCCC	FLUKA	FLUKA_62172	-1.13407258	-0.05148005	0.3077784	-0.6127451												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1446502-11-9		4.4668359215	-5.35	16.3263467873	4	4		21.421370972	17.5245098	0.0099077599	0.9999397147		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	-1.18447581	0.41184041	8.53385562	17.5245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159462-04	Ritonavir	170464891	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	155213-67-5				-0.5833087579	4	4		0	-1.15196078					CC(C)c4nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)C(C)C)cs4	Bosche	R1692	0.37802419	0.05148005	-1.03525462	-1.15196078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184994-02	Cidofovir	225144336	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	113852-37-2	Cidofovir;CIDOFOVIR;Cidofovir (Vistide)			5.3395947876	4	4		0	0.66176471					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	Sequoia	113852-37-2	2.04133065	2.16216216	1.25909345	0.66176471												1.6E-9	8E-9	4E-8	2E-7											
NCGC00181118-01	Sulfabromomethazine	144206282		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	116-45-0	CIPLUS_654340; 			4.8108503371	4	4	CIPLUS_654340;CIPLUS_151449;SULFABROMOMETHAZINE;SULFABROMOMETHAZINE SODIUM;	0	1.00490196					O=S(=O)(Nc1nc(C)c(Br)c(C)n1)c2ccc(N)cc2	NCI	NSC-5874	1.38608871	-0.51480051	1.25909345	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522551-01	Monepantel			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	887148-69-8		12.5892541179	-4.9	8.3674715604	4	4		18.1633064519	15.07352941	0.1435320785	0.987145546			C[C@](COC1=CC(=CC=C1C(F)(F)F)C#N)(NC(=O)C2=CC=C(SC(F)(F)F)C=C2)C#N	MedChem Express	HY-14774	-1.38608871	0.72072072	0.19585898	15.07352941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	81840-15-5				-2.1086100198	4	4		0	-0.51470588				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	-0.63004032	0.92664093	-1.09121433	-0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091449-10	Eugenol	170465464	reactive oxygen species biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	97-53-0				-3.5214653494	4	4		0	-0.44725072					Oc1ccc(cc1OC)CC=C	Microsource	01500296	-0.5811138	-0.55207026	-1.49480618	-0.44725072												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249883-01	Hydrocortamate	170465314	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	76-47-1				-1.6024074167	4	4		0	0.09896091					CCN(CC)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-02	-0.8699855	-0.61667489	0.31816736	0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166215-05	2-Phenylethanol	170466787		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	60-12-8				-2.6149635575	4	4		0	-0.90735435					OCCc1ccccc1	Microsource	01505398	-1.12412178	-0.35022181	1.68615719	-0.90735435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371122-04	Betrixaban		Coagulation factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	330942-05-7				-0.2428706108	4	4		0	0.52531041					COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	-1.12412178	2.54494513	0.65270601	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159492-03	Perazine	29215457	Cytochrome P450 1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE		Perazine; Perazine Maleate (1:1); Perazine Maleate (1:2); Maleate, Perazin; Taxilan; Dihydrochloride, Perazin; Perazine Dihydrochloride; Perazine Fendizoate; 			-1.6626357996	4	4	CIPLUS_744600;Perazine Fendizoate;LS-172810;CIPLUS_776815;PERAZINE DIMALONATE;Maleate, Perazin;10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-;Perazine Dihydrochloride;Dihydrochloride, Perazin;CIPLUS_666528;10-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine dihydrochloride;Perazine Dimalonate;CIPLUS_660985;Perazine Maleate (1:1);Perazine Maleate;10h-phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-, (z)-2-butenedioate;CIPLUS_777988;PERAZINE MALEATE;LS-105591;LS-105593;pernazine;LS-173237;Perazine maleate;Pernazine;Perazine Maleate (1:2);Perazine;LS-105589;Perazine dimalonate;CIPLUS_149789;Cinchonan-9-ol, 6'-methoxy-, (9S)-, sulfate (2:1) (salt), mixt. with 5,5-diphenyl-2,4-imidazolidinedione and 10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (Z)-2-butenedioate (1:2);Taxilan;CIPLUS_769544;phenrytmat;	0	-2.57879656					CN1CCN(CCCN2C3=CC=CC=C3SC4=CC=CC=C24)CC1	AKos	AKJ-93711	-1.21779859	-0.49031053	4.73211857	-2.57879656												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00167550-08	Narasin		Nf-kappa B Signaling Pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	55134-13-9		0.5011872336	-6.3	115.1443438269	2.4	4		43.6695675854	-2.24450812	1	0.9999405238			CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C)C(O)=O	Enzo	NP198	16.01873536	27.76091525	37.91134077	-2.24450812												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160431-02	2-[(4-Chloro-3-methylphenyl)amino]benzoic acid			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.1384734031	4	4		0	0.47755492					CC1=CC(=CC=C1Cl)NC2=CC=CC=C2C(O)=O	Scientific Exchange	F-137102	-0.88992974	-0.77048798	-0.97905902	0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183860-01	Mefruside	144206878	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7195-27-9				0.6301753871	4	4	LS-30042;Mefrusida;Mefrusidum;1,3-Benzenedisulfonamide, 4-chloro-N1-methyl-N1-((tetrahydro-2-methyl-2-furanyl)methyl)-;CIPLUS_166167;fda 1902;Mefruside;MEFRUSIDE;mefruside;Baycaron;mefrusidum;	0	0.26960784					CC2(CN(C)S(=O)(=O)c1ccc(Cl)c(c1)S(N)(=O)=O)CCCO2	Pharmaron	PH-NIH-183408	0.27721774	-0.87516088	0.47565753	0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015073-05	Amifostine	170465179	Alkaline phosphatase placental-like Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	20537-88-6				-1.8087225595	4	5		0	0					OP(=O)(O)SCCNCCCN	Prestwick	Prestw-1489	-0.41514042	0.3539823	-0.19738465	-2.05790859	0											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00016374-05	Carbarsone	170466507		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	121-59-5				-3.8879842068	4	5		0	-1.37931034					O=C(N)Nc1ccc(cc1)[As](O)(O)=O	Prestwick Chemical, Inc.	Prestw-413	-0.95238095	-0.7079646	0.29607698	-1.14860014	-1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095164-04	Protionamide	170465795	tuberculosis treatment	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	14222-60-7	; ; Trevintix; Peteha; PROTHIONAMIDE; Prothionamide; Protionamida;PROTHIONAMIDE;PROTIONAMIDE;Prothionamide			-1.0394350588	4	5		0	-2.02839757					CCCc1cc(ccn1)C(N)=S	Vitas	STK366469	1.05006105	0.0505689	-1.62842339	-0.52644173	-2.02839757											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159422-04	Tiopronin	170465217	Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1953-02-2	 Dextiopronin; Meprin (detoxicant); ; Tiopronino;Tiopronin; Tiopronin; Thiopronine			1.1951511581	4	5		0	1.05476673				MPO	OC(=O)CNC(=O)C(C)S	Labotest	LT00451995	1.14774115	-1.2642225	-1.67776955	0.47858339	1.05476673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167471-02	Anethole trithione	170465669		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	532-11-6				4.5267195763	4	5		0	1.37931034					COc1ccc(cc1)C2=CC(=S)SS2	Prestwick	Prestw-1223	0.95238095	-0.9102402	-0.44411547	3.82866715	1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015971-05	Succinylcholine chloride	170464625	Muscle-type nicotinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	71-27-2				1.0414020645	4	5		0	1.62271805					[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Vitas	STK177290	1.001221	-0.9608091	-0.88823094	-1.05288346	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159414-01	p-Menthane-1,8-diol monohydrate	225144225		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	2451-01-6				-0.1888436505	4	5		0	3.89452333					CC(C)(O)C1CCC(C)(O)CC1	SIGMA	M4031	-0.41514042	-1.6687737	-1.23365408	-0.43072505	3.89452333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319022-01	Octotiamine	170465976		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	137-86-0				-0.3707638689	4	5		0	1.54158215					Nc1nc(C)ncc1CN(C=O)C(\C)=C(/CCO)SSCCC(CCCCC(=O)OC)SC(C)=O	GVK	FFS-11-286-NCI-250	-0.75702076	-1.1125158	-0.49346163	1.43575018	1.54158215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016781-08	Ambroxol hydrochloride	225144182	surfactant homeostasis Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	23828-92-4				3.8958368732	4	5		0	4.94929006					NC1=C(CNC2CCC(O)CC2)C=C(Br)C=C1Br	Prestwick	Prestw-366	-0.21978022	-0.8091024	-0.04934616	1.72290022	4.94929006											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159437-03	Clobutinol hydrochloride	170466051	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1215-83-4				1.097149762	4	5		0	1.86612576					Cl.Clc1ccc(CC(C)(O)C(C)CN(C)C)cc1	Prestwick	Prestw-1380	0.9035409	-1.1125158	-1.18430792	-0.52644173	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274069-01	Nandrolone phenpropionate	170465193	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	62-90-8				-1.1825261147	4	5		0	0.0811359				AR	O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	Selleck	S1310	-0.26862027	-0.6068268	-0.9375771	0.47858339	0.0811359											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164602-03	RACTOPAMINE HYDROCHLORIDE		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	90274-24-1				2.9152245018	4	5		0	2.43407708					CC(CCC1=CC=C(O)C=C1)NCC(O)C2=CC=C(O)C=C2	FLUKA	34198	1.14774115	-0.5562579	-0.39476931	-0.52644173	2.43407708											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025060-15	Methotrexate	170464688	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	59-05-2	 Methylaminopterin; Antifolan; Amethopterin (R,S); Mtx-1 protein, rat; Dl-Amethopterin; Methotrexate Hydrate;Abitrexate (Methotrexate); (+/-)Amethopterin; ; D-Methotrexate; (-)Amethopterin; Mexate; methotrexate; Methotrexate hydrate; Metotrexato; Slc19a1 protein, rat; L-Amethopterin hydrate; (+)-Amethopterin hydrate; Methotrexate; 8   D-(-)-Amethopterin;Methotrexate hydrate; DL-Amethopterin; MTXGlu3; Methotrexate Pres-Fre; (+)-Amethopterin;Methotrexate			1.3518785042	4	5		0	3.40770791			1719	DHFR	O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)nc(N)nc3N	Prestwick	Prestw-135	-0.41514042	-0.6068268	-0.04934616	0.04785834	3.40770791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023212-14	Stavudine	170464820	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3056-17-5	 2',3'-didehydro-3'-deoxythymidine; ; Zerit; Dideoxydidehydrothymidine;; Stavudine;Stavudine; 2',3'-Anhydrothymidine; stavudine (d4T);2',3'-didehydro-3'-deoxythymidine; D4T (2',3'-Didehydro-3'-deoxythymidine); Sanilvudine; Estavudina; 2',3'-Didehydro-3'-deoxythymidine; Estavudina (INN-Spanish);2',3'-Didehydro-3'-deoxythymidine			-0.4079006878	4	5		0	2.27180527			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@@H](CO)O2	Prestwick	Prestw-1279	0.12210012	-1.011378	-0.9375771	-1.38789184	2.27180527											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274060-01	Posaconazole	170464963	Lanosterol 14alpha-demethylase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	171228-49-2		2.2387211386	-5.65	53.7894756782	3	5		39.4159387288	10.14198783	0.0428719703	0.9988656833		CYP51A1	C[C@H](O)[C@H](CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OCC6C[C@@](Cn5cncn5)(OC6)c7ccc(F)cc7F	Selleck	S1257	0.51282051	-0.6573957	1.28300025	36.22876286	10.14198783											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183015-01	Temoporfin	144206848	cell proliferation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	122341-38-2	Temoporfin; 			-5.1062493485	4	4	M-THPC;CIPLUS_197002;5,10,15,20-TETRA(3-HYDROXYPHENYL)-CHLORIN;TEMOPORFIN;Temoporfin;LS-172529;temoporfinum;	0	-2.49934228					Oc1cccc(c1)c9c2CCc(n2)c(c3cccc(O)c3)c4ccc(n4)c(c5cccc(O)c5)c6C=Cc(n6)c(c7cccc(O)c7)c8ccc9n8	Pharmaron	PH-NIH-154455	-0.7748184	-0.30112923	-0.68406385	-2.49934228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091414-07	Salicylamide	170465496		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	65-45-2				0.0311492002	4	4		0	2.18363589					O=C(N)c1ccccc1O	Vitas	STK301812	-0.72639225	-0.20075282	-0.83607803	2.18363589												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159393-03	N-Acetyl-L-tyrosine	170465742		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	537-55-3				-0.8737028952	4	4		0	-0.18416206					Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1	Labotest	LT03380081	-0.2905569	0	-0.12667849	-0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183014-01	Sulfamethomidine	144206847	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3772-76-7	Sulfametomidine; Sulfametomidina; Sulfametomidine Anhydride; 			4.805931772	4	4	LS-147802;sulfamethomidine;Sulfametomidina;sulfamidine;Sulfanilamide, N(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)-;Sulfametomidine Anhydride;SULFAMETOMIDINE;CIPLUS_162501;Sulfamethomidine;Sulfametomidine;Sulfametomidinum;sulfametomidine;4-sulfanilamido-2-methyl-6-methoxypyrimidine;sulfametomidinum;	0	3.23599053					Cc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Pharmaron	PH-NIH-154290	1.3559322	-1.15432873	-0.43070687	3.23599053												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167507-04	Lapatinib	170465125	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	231277-92-2	;Lapatinib; Lapatinib;GW-572016F?; Lapatinib base;LAPATINIB DITOSYLATE; Tykerb;Tykerb			-6.2487267442	4	4		0	-2.37506185			1956	EGFR	Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5	Sequoia	231277-92-2	-0.8699855	-0.51800691	-1.59083678	-2.37506185												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00165864-04	Pipamperone dihydrochloride	170465949	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2448-68-2				-0.5399273608	4	4		0	1.78129639					Cl.Cl.Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(C(N)=O)N3CCCCC3	Microsource	01505690	-0.48332528	-0.5673409	-1.14540248	1.78129639												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015227-08	Dexchlorpheniramine hydrochloride	170466889	Histamine H1 Receptor Antagonists; SNRI	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	5502-69-2	 ; Clorfenamina;Chlorpheniramine; Chlor-Trimeton; Mylaramine; Polaramine; Dexclorfeniramina; Chlortrimeton;Chlorpheniramine maleate; Ru-Tuss; Teldrin; Chlorpheniramine; Chlor-trimeton;Chlorpheniramine Maleate			-1.3132112511	4	4		0	-1.68233548				HRH1	Cl.Clc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2	Vitas	STK736174	-0.67665539	-1.35668476	2.60897232	-1.68233548												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167455-02	Zofenopril	170465605		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	81872-10-8				-0.770232528	4	4		0	1.52817574					O=C([C@@H](C)CSC(=O)c1ccccc1)N3C[C@@H](Sc2ccccc2)C[C@H]3C(=O)O	Bosche	Z6238	-1.17096019	-0.81718422	1.19662769	1.52817574												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016981-05	Troleandomycin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	311074				-4.5707130585	4	4		0	-1.67144222					CO[C@@H]1C[C@@H](O[C@H](C)[C@H]1OC(C)=O)O[C@H]2[C@H](C)[C@H](O[C@@H]3O[C@@H](C)C[C@H]([C@H]3OC(C)=O)N(C)C)[C@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@H](C)[C@H](C)OC(=O)[C@@H]2C	Enzo	EI249	-0.98360656	-0.39691805	-0.76149035	-1.67144222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164344-04	Symclosene	170465634		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	87-90-1				1.6934445745	4	5		0	4.13793103					ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O	SIGMA	176125	-0.85470085	-0.7585335	0.64150012	0.38286671	4.13793103											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015862-07	Pyridostigmine bromide	170464878	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	101-26-8				1.2671735894	4	5		0	1.21703854					[Br-].O=C(Oc1ccc[n+](C)c1)N(C)C	Specs	AQ-776/42801589	0.07326007	-1.3653603	0.24673082	1.43575018	1.21703854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159404-04	Sulisobenzone	170465489		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	4065-45-6				-0.4617824204	4	5		0	0.56795132					OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2	Labotest	LT03210147	0.51282051	-0.8596713	-1.52973106	-0.2392917	0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182057-03	Detomidine hydrochloride	170465639	Alpha-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	90038-01-0				4.5627191507	4	5		0	4.54361055					Cl.Cc2cccc(Cc1cncn1)c2C	Selleck	S1579	0.36630037	-0.6068268	0.39476931	0.90930845	4.54361055											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160482-02	Sulfalene	170465930	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	152-47-6				0.7848607116	4	5		0	1.62271805					COc2nccnc2NS(=O)(=O)c1ccc(N)cc1	Vitas	STK386859	-0.07326007	-0.4045512	-0.44411547	0.43072505	1.62271805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263585-01	Zaltoprofen	170465838	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	74711-43-6				10.8904012534	4	5		0	3.0020284				PTGS2	O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1	Sequoia	74711-43-6	2.71062271	2.02275601	1.4803849	1.67504188	3.0020284											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015806-06	Pirfenidone	170465606		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	53179-13-8				3.9050460605	4	5		0	2.83975659					CC2=CN(c1ccccc1)C(=O)C=C2	Sequoia	53179-13-8	0.41514042	-0.2022756	0.78953861	0.86145011	2.83975659											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015851-10	Protriptyline hydrochloride	170465077	Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1225-55-4		12.5892541179	-4.9	75.0906268781	3	5		118.0639172875	101.33874239	0.0001520062	0.9999239974			Cl.CNCCCC2c3ccccc3C=Cc1ccccc12	Microsource	01505984	-0.07326007	-1.011378	-0.49346163	0.76573343	101.33874239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274070-01	Perindopril	170464836	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	82834-16-0				1.1775193995	4	5		0	3.48884381				ACE	O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O	Selleck	S1506	-0.31746032	-0.5562579	-0.83888478	0.19143336	3.48884381											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162129-06	Tocainide hydrochloride	170465114	Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	35891-93-1				1.7126836212	4	5		0	1.29817444					Cl.O=C(Nc1c(C)cccc1C)C(C)N	Prestwick	Prestw-1027	0.36630037	0.2022756	-0.5428078	0.43072505	1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167440-02	Bosentan	170465245	"Endothelin receptor, ET-A/ET-B Antagonist"	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	147536-97-8				3.2850824084	4	5		0	4.21906694					CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c4ncccn4	Prestwick	Prestw-1244	-0.07326007	-1.0619469	0.29607698	1.14860014	4.21906694											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179344-04	Pivmecillinam			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	32886-97-8				0.9304914779	4	4		0	0.62427746					CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N3CCCCCC3)C2=O	SIGMA	SML0817	-0.35989717	-0.44316997	2.42168992	0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532517-01	OZENOXACIN		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.3639059621	4	4		0	-0.30057803					CNC1=C(C)C=C(C=N1)C2=CC=C3C(=O)\C(=C/N(C4CC4)C3=C2C)C(O)=O	NanjingKaimubo Pharm	KB-80783	-0.25706941	-0.49530761	-0.1579363	-0.30057803												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00164789-04	Fulvestrant	170464917	Estrogen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	129453-61-8	; Faslodex;Fulvestrant;Fulvestrant (Faslodex)			14.3816065195	4	4		0	4.83236994			2099	ESR1	FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23	Prestwick	Prestw-1424	2.41645244	2.78936392	3.79047118	4.83236994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166289-02	Hydroxystilbamidine bis(methanesulfonate)	124893257		DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-6.7549229835	4	4		0	-0.57803468					NC(=N)C1=CC=C(C=C1)/C=C/C2=CC=C(C=C2O)C(N)=N	FLUKA	39286	-2.21079692	-0.49530761	-0.4738089	-0.57803468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166124-03	Benzyl cinnamate	170465584		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103-41-3				2.1355640353	4	4		0	-0.57803468					O=C(OCc1ccccc1)C=Cc2ccccc2	SIGMA	234214	1.02827763	0.44316997	-0.52645433	-0.57803468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016353-08	Butyl 4-aminobenzoate	170465735		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	94-25-7				10.3750762529	4	4		0	4.07787424					Nc1ccc(cc1)C(=O)OCCCC	Specs	AE-562/J257667	2.22760291	1.35508156	0.78540664	4.07787424												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023643-15	Estrone	170465020	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	53-16-7				2.3291759756	4	4		0	4.81452249				ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)c4cc3	Vitas	STK801833	-1.40435835	0.30112923	-0.53204966	4.81452249												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015202-08	Ciprofibrate	170466356	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52214-84-3				-1.6939241508	4	4		0	-0.0789266				PPARA	ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1	Vitas	STK624758	-0.72639225	0.50188206	-0.58272105	-0.0789266												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015444-07	Fenoldopam	170465321	Dopamine D1 Receptor (DRD1) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	67227-56-9	 ;FENOLDOPAM MESYLATE;Fenoldopam; Fenoldopam bromide;Fenoldopam bromide; Fenoldopam mesilate; Hydrobromide, Fenoldopa; Fenoldopam Hydrobromide; Fenoldopam hydrochloride;Fenoldopam hydrochloride			-6.2608959007	4	4		0	-1.13128124			1812	DRD1	Oc1ccc(cc1)C3CNCCc2c3cc(O)c(O)c2Cl	Sequoia	67227-57-0	-1.50121065	-0.65244667	-1.69749177	-1.13128124												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016393-07	2,2'-Dihydroxy-4-methoxybenzophenone	170465540		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	131-53-3				-1.1857650425	4	4		0	0.02630887					O=C(c1ccc(cc1O)OC)c2ccccc2O	Microsource	01500255	-0.5811138	0.60225847	-0.53204966	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00263922-02	Darifenacin hydrobromide	170465079	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	133099-07-7				-0.6067976444	4	4		0	1.03908956			1131	CHRM3	Br.NC(=O)C(c1ccccc1)(c2ccccc2)[C@@H]3CCN(C3)CCc4cc5CCOc5cc4	Microsource	01505714	-0.57999033	0.5673409	-1.01813554	1.03908956												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159518-05	Rabeprazole	170464736	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole			0.7428677315	4	4		0	0.49480455				ATP4A	[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Microsource	01505943	-0.33832769	-1.01134682	1.46356984	0.49480455												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183020-01	Minopafant	144206826	Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	128420-61-1	Menopafant; Minopafant; 			-2.673728534	4	4	E-5880;E 5880;1-ethyl-2-(N-(2-methoxy)benzoyl-N-(2-methoxy-3-(4-octadecylcarbamoyloxy)piperidinocarbonyloxypropyloxy)carbonyl)aminomethylpyridinium chloride;MENOPAFANT;CIPLUS_707454;Minopafant;Menopafant;minopafantum;	0	-1.8802573					[Cl-].COc1ccccc1C(=O)N(Cc2cccc[n+]2CC)C(=O)OC[C@@H](COC(=O)N3CCC(CC3)OC(=O)NCCCCCCCCCCCCCCCCCC)OC	Pharmaron	PH-NIH-150353	-0.8699855	-0.66600888	1.39993637	-1.8802573												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00480885-01	INT-747 (Obeticholic acid)		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	459789-99-2				2.6349299874	4	4		0	0.81184336					CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14	Glixx	GLXC-05527	0.70257611	0.44361429	-0.10878433	0.81184336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018239-11	ISOETHARINE MESYLATE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	7279-75-6				-1.2626327091	4	4		0	-1.43266476					CCC(NC(C)C)C(O)C1=CC=C(O)C(=C1)O	Microsource	01505977	-0.42154567	-0.58370301	1.8493337	-1.43266476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178529-06	Levofloxacin		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	100986-85-4				-0.7049596017	4	4		0	0.16184971				TOP2B	C[C@H]1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0330	-0.61696658	0.70385819	0.36851803	0.16184971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179625-03	Thioproperazine dimethanesulfonate	170465871	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2347-80-0		11.220184543	-4.95	62.219633058	3	4		95.6807001815	80.53179191	0.0053522488	0.9999823326			CS(=O)(=O)O.CS(=O)(=O)O.CN(C)S(=O)(=O)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-149	-0.30848329	-0.13034411	4.15898921	80.53179191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263579-01	rac Nebivolol hydrochloride	170465208	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	169293-50-9				1.4954673003	4	4		0	-2.19653179				ADRB1	Cl.Fc1cc2CC[C@@H](Oc2cc1)[C@@H](O)CNC[C@H](O)[C@@H]3CCc4cc(F)ccc4O3	Sequoia	99200-09-6	0.87403599	-0.54744526	1.84259016	-2.19653179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179430-04	Iocetamic acid			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	16034-77-8				-0.4035567406	4	4		0	1.8265896					CC(CN(C(C)=O)C1=C(I)C(=C(I)C=C1I)N)C(O)=O	Prestwick	Prestw-838	-0.51413882	-0.5995829	-0.05264543	1.8265896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166226-02	4-Propylbenzoic acid	225144274		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2438-05-3				7.8701572577	4	4		0	0.94797688					CCCC1=CC=C(C=C1)C(O)=O	SIGMA	332976	1.85089974	1.74661105	1.73729929	0.94797688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166271-02	Pregnenolone acetate			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1778-02-5				-0.5120982008	4	4		0	3.2032032					CC(=O)O[C@H]1CC[C@]\2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4C(C)=O)[C@@H]3C\C=C2C1	SIGMA	P49902	-0.71564885	-0.65308255	-0.89028542	3.2032032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181030-02	Uracil	170465915	Dihydropyrimidine dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	66-22-8				-2.0335410637	4	4		0	0.2002002					O=C1C=CNC(=O)N1	Specs	AC-907/30002021	-1.04961832	-1.80250784	2.51374705	0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160502-01	NCGC00160502-01	29216184		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Kliostom; 			-2.8520732668	4	4	CIPLUS_3884272;Kliostom;	0	-1.05105105					CC1=NC=C(N1CCOC(=O)C2=CC=CC=C2)[N+]([O-])=O	InterBioScreen	STOCK1S-09026	-1.09732824	0.49634274	0.57606703	-1.05105105												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00250402-09	Dapagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	461432-26-8				1.2734387929	4	4		0	1.45145145				SCL5A2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C1	DC Chemicals	DC6904	0.95419847	-1.90700104	-1.30924326	1.45145145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181097-01	Dimefline hydrochloride	144206266		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2740-04-7	Dimefline hydrochloride; Dimeflina; Remeflin; Reanimil; 			-3.5238215669	4	4	Flavone, 8-(dimethylaminomethyl)-7-methoxy-3-methyl-;4H-1-BENZOPYRAN-4-ONE, 8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYL-2-PHENYL-;dimeflinum;LS-68986;Dimeflina;Dimefline hydrochloride;dimefline;4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl-, hydrochloride;3-methyl-7-methoxy-8-dimethylamino-methylflavone;Flavone, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-, hydrochloride;Reanimil;dimefline hydrochloride;CIPLUS_157700;Remeflin;8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYLFLAVONE;LS-68987;DIMEFLINE HYDROCHLORIDE;DIMEFLINE;CIPLUS_160797;Dimeflinum;	0	0.2002002					Cl.CN(C)Cc3c(ccc1c3OC(=C(C)C1=O)c2ccccc2)OC	NCI	NSC-114650	-0.85877863	-1.22779519	-0.89028542	0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016613-10	Antazoline hydrochloride	170464765	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2508-72-7				0.4444625551	4	4		0	0.28939753					Cl.C(c1ccccc1)N(CC2=NCCN2)c3ccccc3	Microsource	01500126	-0.8716707	0.10037641	1.59614897	0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015818-14	Praziquantel	170464906	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	55268-74-1	; ; Praziquantel, (R)-Isomer; Praziquantel, (+-)-Isomer;PRAZIQUANTEL;Praziquantel; Praziquantel, (S)-Isomer; Biltricide; Praziquantel			-0.8732270376	4	4		0	-0.76295712					O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4	Vitas	STK030186	0.0968523	-0.80301129	0.32936407	-0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00262603-04	Idelalisib		PI3Kdelta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	870281-82-6				-2.067692475	4	4		0	0.14326648				PIK3CD	CC[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=N/C4=C(C(=CC=C4)F)C(=O)N3C5=CC=CC=C5	Axon Medchem	2170	-0.98360656	0.21013308	0.27196084	0.14326648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356590-01	Arsenic trioxide 			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	1327-53-3				-1.9232068192	4	4		0	-0.67052023					[O]1[As]2[O][As]1[O]2	Enzo	AC2011	-0.46272494	0.18248175	-0.52645433	-0.67052023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168248-02	Benzoylecgonine	144206406		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	519-09-5				3.9772242209	4	4		0	-0.25433526					CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)O	RTI	9180-001	1.28534704	-0.39103233	0.7896815	-0.25433526												3.96E-7	0.00000198	0.00000991	0.0000496											
NCGC00181745-03	Bimatoprost		prostaglandin	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	155206-00-1				-4.6241633821	4	4		0	-0.34682081				PTGER1	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC2=CC=CC=C2	Enzo	RA121	-1.64524422	-0.28675704	0.05264543	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167432-05	FosinoprilNa		Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	98048-97-6				10.7251643053	4	4		0	2.01156069					CCC(=O)O[C@@H](O[P](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C([O-])=O)C3CCCCC3)C(C)C	Enzo	DL155	2.46786632	2.63295099	2.00052645	2.01156069												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00531794-01	Cimicoxib			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	265114-23-6				-1.0572759465	4	4		0	1.25125125					COC1=CC=C(C=C1F)C2=C(Cl)N=C[N]2C3=CC=C(C=C3)[S+](N)([O-])=O	Toronto Research	C441690	-0.42938931	-0.49634274	-0.78554595	1.25125125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346629-02	Dolutegravir (GSK1349572)		HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1051375-16-6				1.478175527	4	4		0	1.2012012					C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	Selleck	S2667	-0.23854962	0.07836991	1.62346164	1.2012012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183838-01	Perisoxal citrate	144206844		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	14838-45-0				9.0309423409	4	4	Perisoxal Citrate;perisoxal, (S)-isomer;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-, citrate (2:1);LS-115490;perisoxal citrate (2:1);Perisoxalum;CIPLUS_213305;CIPLUS_744614;LS-115487;perisoxal citrate;3-(1-hydroxy-2-piperidinoaethyl)-5-phenyl-isoxazol (german);Isoxal;CIPLUS_791151;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-;3-(1-hydroxy-2-piperidinoethyl)-5-phenylisoxazole;PERISOXAL;perisoxal citrate (1:1);perisoxal;perisoxalum;31252-S;isoxal;alpha-(5-phenyl-3-isoxazolyl)-1-piperidineethanol;Perisoxal citrate;perisoxal, (R)-isomer;PERISOXAL CITRATE;CIPLUS_742412;perisoxal, (+-)-isomer;Perisoxal;	0	2.6026026					OC(CN1CCCCC1)c2cc(on2)c3ccccc3.O=C(O)C(O)(CC(=O)O)CC(=O)O	Pharmaron	PH-NIH-153178-6	1.90839695	1.3322884	1.83294056	2.6026026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179264-03	Tiletamine Hydrochloride		Glutamate [NMDA] receptor subunit epsilon 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	14176-50-2				-4.0777512244	4	4		0	-1.55155155					CCNC1(CCCCC1=O)C2=CC=CS2	USP	1667359	-0.47709924	-1.43678161	-0.99502488	-1.55155155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164507-02	Nifuroxime	124893124		DPI_SARS-CoV-2_General	2019_NPC-6_CPE					-5.4675102545	4	4		0	-0.9009009					[O-][N+](=O)C1=CC=C(CN=O)O1	Enamine	T1302-8796 	-1.38358779	-1.12330199	-0.68080649	-0.9009009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023234-05	Flurandrenolide	170465298		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1524-88-5				-2.2596383104	4	4		0	-0.26392188					OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-645	-0.16478343	-1.53096729	-0.56695464	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159418-05	Tegafur	170465809	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	37076-68-9	; S-1 compound; S-1 (combination); ; Tegafur (Ftorafur); UFT protocol; Tegafur; 1-UFT protocol; Franroze; Tegafur-Uracil; TS-1 cpd; S 1 (combination);Tegafur; S-1 cpd; Atillon			2.5066730335	4	4		0	0.10556875				TYMS	FC1=CN(C(=O)NC1=O)C2CCCO2	Labotest	LT00138127	0.6826742	2.7835769	-0.78293736	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016257-10	4-Dimethylaminoantipyrine	170465863		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	58-15-1				6.2935248091	4	4		0	-0.10556875					CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Microsource	01500621	2.42467043	-0.13917884	1.91684665	-0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166323-02	Trifluridine	170464911	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	70-00-8	 ; Viroptic; Trifluridina; Trifluridine;Trifluridine;Trifluridine (Viroptic)			-3.1505986365	4	4		0	-1.18753093			7298	TYMS	FC(F)(F)C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1056	-0.43499275	0.41933892	-1.27266942	-1.18753093												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015701-06	Metyrosine	170465112	Tyrosine 3-hydroxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	672-87-7				-0.3791128272	4	4		0	-0.29688273					Oc1ccc(C[C@](C)(N)C(=O)O)cc1	Vitas	STK272180	0.33832769	1.6526887	-1.14540248	-0.29688273												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00183017-01	Ethyl 4-nitrophenyl ethylphosphonate	144206877		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	546-71-4	Ethyl-p-Nitrophenyl Ethylphosphonate; Armin; Armine; 			-1.1488450081	4	4	ETHYL 4-NITROPHENYL-ETHYL PHOSPHONATE;Armine;p-Nitrophenyl-O-ethyl ethylphosphonate;ETHYL 4-NITROPHENYL ETHYLPHOSPHONATE;Ethyl 4-nitrophenyl ethylphosphonate;LS-106606;CIPLUS_208139;Ethyl-p-Nitrophenyl Ethylphosphonate;Ethyl 4-Nitrophenyl Ethylphosphonate;Armin;	0	-0.19792182					[O-][N+](=O)c1ccc(OP(=O)(OCC)CC)cc1	Pharmaron	PH-NIH-183377	-0.57999033	-0.27133695	0.31816736	-0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015643-11	Metoclopramide	170464848	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	364-62-5				3.2732277985	4	4		0	1.48441366					Nc1cc(OC)c(cc1Cl)C(=O)NCCN(CC)CC	Enzo	AC840	-0.38666022	-1.01134682	2.92713968	1.48441366												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389762-01	D-(+)-MALTOSE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	69-79-4				3.3107407896	4	4		0	-0.30057803					OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O	Microsource	01301024	1.23393316	0.28675704	0.26322716	-0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390656-02	Pimavanserin			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	706779-91-1				0.4123809696	4	4		0	-2.70520231					CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C3CCN(C)CC3)C=C1	MedChem Express	HY-14557	0.41131105	-0.5995829	2.57962622	-2.70520231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386317-11	Ribociclib (LEE011)		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-2.9050859825	4	4		0	-0.67052023				CDK4	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5	Bio Vision	9481-5	-0.51413882	-0.70385819	-0.7896815	-0.67052023												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00185769-02	Stiripentol		"Gaba Synthesis, Release, Reuptake And Degradation Modulator"	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.9476497801	4	4		0	-0.34682081					CC(C)(C)C(O)C=CC1=CC=C2OCOC2=C1	APExBIO	A8704	-0.41131105	-0.86027112	-0.05264543	-0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182064-02	Ceftezole sodium	144206691	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	41136-22-5	Ceftezole; Celoslin; Falomesin; 			-4.6595751737	4	4	CEFTEZOLE SODIUM;LS-150087;LS-174169;Ceftezol;ceftezolum;Falomesin;Celoslin;ceftezol;Ceftezole sodium;Ceftezolum;Ceftezole;CIPLUS_748000;ceftezole;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, monosodium salt, (6R-trans)-;demethylcefazolin;Ceftezole Sodium;CIPLUS_207790;CEFTEZOLE;ceftezol, sodium salt;	0	-0.7007007					[Na+].[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nncs2	Kemprotec	41136-22-5	-1.09732824	-1.43678161	-0.47132757	-0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178697-04	Irinotecan	170464824	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	100286-90-6	;Irinotecan hydrochloride trihydrate;Irinotecan; Campto;Irinotecan hydrochloride			9.6139515488	4	4		0	-0.35035035			7150	TOP1	Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O	Prestwick	Prestw-1494	3.67366412	-0.33960293	1.04739461	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181916-01	Sulfaethoxypyridazine	144206640		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	963-14-4	CIPLUS_157090; 			-3.4233304798	4	4	SULFAETHOXYPYRIDAZINE;sulfaethoxypyridazine;CIPLUS_157090;N-1-(6-ethoxy-3-pyridazinyl)sulfanilamide;	0	-1.001001					O=S(=O)(Nc1ccc(OCC)nn1)c2ccc(N)cc2	FLUKA	02743	-0.52480916	-0.65308255	-1.25687353	-1.001001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016886-04	Ioxaglic Acid		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	59017-64-0				-4.0545702494	4	4		0	-1.6016016					CNC(=O)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(=O)NC2=C(I)C(=C(I)C(=C2I)C(O)=O)C(=O)NCCO)N(C)C(C)=O	USP	1345159	-0.52480916	-1.07105538	-1.09976434	-1.6016016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346655-02	Linagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	668270-12-0				-2.0297192724	4	4		0	1.35135135				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	Selleck	S3031	-1.52671756	0.80982236	0.41895784	1.35135135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179658-04	Acenocoumarol	170465636	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	152-72-7				-2.2064180609	4	4		0	0.3003003					[O-][N+](=O)c1ccc(cc1)C(CC(C)=O)C2=C(O)c3ccccc3OC2=O	Prestwick	Prestw-110	-0.85877863	-0.0261233	-0.31421838	0.3003003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385183-01	NCGC00385183-01		Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-4.2598782274	4	4		0	-0.43930636					OC[C@H]1O[C@@H](OC2=CC=CC3=C2C(=O)C4=C(C=C(C=C4O)C(O)=O)[C@@H]3[C@@H]5C6=C(C(=O)C7=C5C=C(C=C7O)C(O)=O)C(=CC=C6)O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-010759	-1.33676093	-0.44316997	-0.68439063	-0.43930636												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182548-02	Flutropium bromide	170465904	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	63516-07-4				3.5776784653	4	4		0	0.02312139					[Br-].[Br-].C[N+]2(CCF)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(O)(c3ccccc3)c4ccccc4	APAC	871826	0.92544987	-0.18248175	1.89523559	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161419-07	Trimetrexate	404904680	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	[82952-64-5]		10	-5	36.2687965247	3	4		56.053389264	48.3983984	0.0131485696	0.9998934025	1719	DHFR	COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC	NCGCChem	NCGC00161419-05pur	-0.57251908	-0.54858934	2.77559571	48.3983984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346580-04	Vinflunine (Tartrate)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1201898-17-0				9.7240868178	4	4		0	3.25325325					[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)\C=C/C3)C(=O)OC)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=C8C=CC=C9)C(C)(F)F)C(=O)OC	MedChem Express	HY-B0628A	2.57633588	0.13061651	0.89028542	3.25325325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390740-04	Avibactam sodium			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	1192491-61-4				-0.4177000975	4	4		0	2.15215215					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	Glixx	GLXC-04187	-0.71564885	-1.54127482	1.25687353	2.15215215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 			-1.7616764948	4	4		0	1.68233548				KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	-0.48332528	-1.1100148	-1.84537066	1.68233548												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015452-20	Flutamide	170464921	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	13311-84-7	Flutamide; ; Eulexin; 2-Methyl-N-(4-nitro-3-;FLUTAMIDE; Flutamide; Flutamida			-5.5356110535	4	4		0	-2.02869866			374	AR	O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C	Microsource	01500995	-0.57999033	-0.71534287	-1.65447025	-2.02869866												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183836-01	Emiglitate	144206827	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	80879-63-6				-7.0839546938	4	4	N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin;Emiglitate;BAY-o-1248;EMIGLITATE;BAY-o 1248;BAY o 1248;LS-177593;N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin;CIPLUS_214267;emiglitate;emiglitatum;	0	-1.83077684					O=C(OCC)c2ccc(OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)cc2	Pharmaron	PH-NIH-150421	-1.25664572	-1.15934879	-1.84537066	-1.83077684												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025018-10	Yohimbine	170465467	alpha2-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	146-48-5	; ; Yohimbine HCL; YOHIMBINE;Yohimbine hydrochloride;YOHIMBINE HYDROCHLORIDE; Yohimbine hydrochloride			0.6134343058	4	4		0	0.24740228			150	ADRA2A	O=C(OC)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23	Microsource	01500663	1.11164814	-0.07400099	-1.59083678	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023673-10	Adenosine		Adenosine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	[58-61-7]				11.5988970244	4	4		0	0.38204394				ADORA1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Tocris	3624	3.46604215	1.89119776	1.63176503	0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482904-01	Capromorelin		Ghrelin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	193273-66-4				8.7935784261	4	4		0	0.62427746					CN1\N=C2\CCN(C[C@]2(CC3=CC=CC=C3)C1=O)C(=O)[C@H](COCC4=CC=CC=C4)NC(=O)C(C)(C)N	DC Chemicals	DC7615	2.36503856	1.7987487	1.47407212	0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142611-02	D-HISTIDINE	26754413	Histidine decarboxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_CPE		Histidine; L-Histidine hydrochloride; Cu-His; Zn(His)2; Histidine, L isome; DL-Histidine; L-Histidine-ul-13C,15N; Cu(His)2; poly(L-histidine); polyhistidine, (D)-isomer; Zn-His(2); L-Histidine-2,5-3H; D-His; Histidina; D-His-OH; L-isomer Histidin; L-Histidine-15N3; Fe(II)-histidinate; Levadial; L-Histidine-13C6,15N3; Poly-L-histidine; Pt(His)(adenine); PRu-Hi; Histidine, L-isomer; poly-(alpha-L-histidine); 			-1.5506373104	4	4	CIPLUS_688453;CIPLUS_670571;L-Histidine Monohydrochloride Monohydrate;L-Histidine monohydrochloride monohydrate;DL-Histidine monohydrochloride monohydrate;L-Histidine-15N3;Poly-L-histidine;L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE;CIPLUS_208166;polyhistidine;HISTIDINE, DL-;CIPLUS_163873;CIPLUS_213264;DL-Histidine;L-Histidine Monohydrochloride;poly-(alpha-L-histidine);CIPLUS_207332;(+/-)-2-Amino-3-(4-imidazolyl)propionic acid;S(+)-alpha-Amino-1H-imidazole-4-propanoic acid hydrochloride;HISTIDINE;L-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;NCGC00093950-01;Histidine, L isome;L-HISTIDINE;(R)-2-Amino-3-(4-imidazolyl)propionic acid;CIPLUS_3885719;NCGC00162189-01;L-Histidine hydrochloride;D-His;L-isomer Histidin;polyhistidine, (D)-isomer;D-HISTIDINE;L-Histidine;D-Histidine;D-alpha-Amino-beta-(4-imidazolyl)propionic acid;histidinum;CIPLUS_166016;CIPLUS_742841;Histidina;DL-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;D-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;L-Histidine dihydrochloride;(S)-2-Amino-3-(4-imidazolyl)propionic acid;L-Histidine Monohydrochloride Anhydride;L-Histidine-13C6,15N3;D-His-OH;CIPLUS_215801;CIPLUS_3886763;CIPLUS_149204;L-Histidine-2,5-3H;poly(L-histidine);L-Histidine hydrochloride solution;NCGC00015518-01;Histidinum;D-Histidine monohydrochloride monohydrate;Histidine, L-isomer;CIPLUS_214867;HISTIDINE, L-;L-HISTIDINE MONOHYDROCHLORIDE;L-Histidine monohydrochloride;CIPLUS_3887315;Histidine;CIPLUS_750166;histidine;L-Histidine-ul-13C,15N;NCGC00142611-02;Poly-L-histidine hydrochloride;CIPLUS_711628;	0	0.06936416			3067	HDC	N[C@H](CC1=CNC=N1)C(O)=O	BIOMOL	BIOMOL_AC-1014	-0.46272494	-0.33889468	-0.26322716	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386518-01	Cannabidiol	377020361	Cannabinoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	13956-29-1		8.9125093813	-5.05	20.9136737202	4	4		27.906673616	25.78034682	0.0264698626	0.9995684588		CNR1	CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O	Axon Medchem	1234	0.10282776	-0.33889468	2.31639905	25.78034682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183276-01	Hydrocortisone buteprate	144206491		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	72590-77-3				0.1002733639	4	4	PANDEL;TS-408;HYDROCORTISONE PROBUTATE;Pandel;CIPLUS_189796;hydrocortisone 17-butyrate 21-propionate;LS-54998;Hydrocortisone Butyrate Propionate;Hydrocortisone butyrate propionate;HYDROCORTISONE BUTEPRATE;Hydrocortisone probutate;hydrocortisone buteprate;17-BUTYRYLOXY-21-PROPIONYLOXY-HYDROCORTISONE;Hydrocortisone buteprate;	0	-0.9017341					CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	ACC	HYDROCORTISONE PROBUTATE	0.30848329	-0.18248175	0.68439063	-0.9017341												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00344535-01	5alpha-Cholestan-3beta-ol	225144382	Sterol regulatory element-binding protein cleavage-activating protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	80-97-7				-2.7264700252	4	4		0	-2.15215215			22937	SCAP	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	D6128	0.28625954	-0.96656217	-0.62843676	-2.15215215												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	923604-59-5				-3.7955586974	4	4		0	-2.9029029					COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-0.71564885	-0.18286311	0.47132757	-2.9029029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159403-03	Nandrolone decanoate	26754490		DPI_SARS-CoV-2_General	2019_NPC-6_CPE		Nandrolone decanoate; Deca-durabolin; Retabolyl; Decadurobolin; Decadurabolin; Retabolil; Deca-Durabol; 			-0.6119982426	4	4	CIPLUS_152890;Decadurabolin;Nandrolone Decanoate;Decadurobolin;Retabolil;Retabolyl;17 beta-hydroxyestr-4-en-3-one 17-decanoate;Deca-durabolin;LS-64854;NCGC00159403-03;Nandrolone decanoate;NANDROLONE DECANOATE;nandrolone decanoate;19-nor-4-androstene-17 beta-ol-3-one 17-decanoate;19-nortestosterone decanoate;Deca-Durabol;	0	-0.6006006					[H]C1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCC	Labotest	LT01138619	-0.14312977	-0.65308255	0.94265515	-0.6006006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167500-02	Etretinate	170465372	Retinoic acid receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	54350-48-0				-3.1043240431	4	4		0	-0.36949063					Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)OCC)c(C)cc1OC	LKT Lab	E7668	-0.82391714	-1.39178845	-0.18898488	-0.36949063												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025176-02	Etomidate	170465117	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	33125-97-2	 Etomidato; ; Radenarkon; Ethomidate;ETOMIDATE; Etomidate;Etomidate; Amidate			-3.8634761255	4	4		0	-0.63341251			2554	GABRA1	CC(c1ccccc1)n2cncc2C(=O)OCC	Microsource	01505599	-1.20056497	0.06958942	-0.94492441	-0.63341251												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091616-03	2-Ethoxybenzamide	170465775		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	938-73-8				3.132425602	4	4		0	4.06439694					CCOc1ccccc1C(N)=O	Specs	AN-153/I166787	-0.63559322	1.53096729	-1.16090713	4.06439694												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018257-08	Methocarbamol	170464808	Muscle relaxant	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	532-03-6	 Metocarbamol;;METHOCARBAMOL; Robaxin;Methocarbamol			1.8715797252	4	4		0	0.4453241					NC(=O)OCC(O)COc1ccccc1OC	Microsource	01500397	0.33832769	0.22200296	0.57270124	0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095124-08	Rosiglitazone	170465417	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	122320-73-4	; ;Rosiglitazone;ROSIGLITAZONE MALEATE; Avandia; ROSIGLTAZONE HCl; Rosiglitazone; rosiglitazone (Avandia); ROSIGLITAZONE;ROSIGLITAZONE			7.4700259657	4	4		0	4.35428006			5468	PPARG	CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3	Microsource	01504263	-0.62832286	0.27133695	3.49984092	4.35428006												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024994-06	Selegiline hydrochloride	170464993	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	14611-52-0	; ; (R)-(-)-Deprenyl hydrochloride; Selegiline, (R,S)-Isomer;Selegiline hydrochloride; Selegiline, (S)-Isomer;Selegiline; Selegilina; Selegiline Hcl; Deprenyl; Jumex			-0.9434118901	4	4		0	0.09896091			4129	MAOB	Cl.C#CCN(C)[C@H](C)Cc1ccccc1	Prestwick Chemical, Inc.	Prestw-552	-0.19333011	-0.41933892	-0.38180083	0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181749-01	Cefminox sodium	144206473	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	75498-96-3	Cefminox; Tencef; Meicelin; Alteporina; 			2.1703552553	4	4	cefminox Sodium;Alter brand of cefminox sodium;Tedec Meiji brand of cefminox sodium;CEFMINOX;Cefminox sodium;Alteporina;Cefminox Sodium;cefminox;MT 141;CEFMINOX SODIUM;Cefminox;CIPLUS_685509;cefminox sodium;Tencef;CIPLUS_733759;cefminoxum;LS-177815;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-;CIPLUS_213346;Meicelin;MT-141;	0	1.62368672					[Na+].[O-]C(=O)[C@H](N)CSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C(=O)O	ACC	CEFMINOX SODIUM	-0.09367681	1.00396918	0.70709818	1.62368672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179239-05	Clocortolone pivalate			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	34097-16-0				-3.803416599	4	4		0	0.52531041					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	Prestwick	Prestw-1119	-1.82669789	1.37753911	-0.70709818	0.52531041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263855-02	CEFAMANDOLE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	34444-01-4				-1.666969284	4	4		0	-0.38204394					C[N]1N=NN=C1SCC/2=C(/N3C(SC2)[C@@H](NC(=O)C(O)C4=CC=CC=C4)C3=O)C([O-])=O	Microsource	01502038	-0.88992974	0.35022181	0.92466685	-0.38204394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182037-01	Alacepril	124893756	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	74258-86-9	Alacepril; ; Alacepril			-2.2093756283	4	4	N-(1-(3-(acetylthio)-2-methyl-1-oxopropyl)-L-prolyl)-L-phenylalanine;CIPLUS_214255;aracepril;alacepril;ALACEPRIL;DU-1219;Alacepril;DU 1219;cetapril;alaceprilum;LS-105750;Cetapril;	0	0.47755492			1636	ACE	O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O	ACC	ALACEPRIL	-0.74941452	-0.77048798	-0.1631765	0.47755492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016834-07	Fenbufen	170465799	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	36330-85-5				10.673632359	4	4		0	5.64792821			5743	PTGS2	O=C(CCC(=O)O)c1ccc(cc1)c2ccccc2	Microsource	01501008	1.24764595	0.6263048	1.64686825	5.64792821												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00163736-04	Imidacloprid	170465741		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	138261-41-3				-2.8590179702	4	4		0	-0.31670625					[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1	Vitas	STK786692	-1.01224105	0.34794711	-0.83693305	-0.31670625												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095150-08	Telmisartan	170464873	Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	144701-48-4	; Telmisartan and diuretics;Telmisartan; Telmisartan; Micardis; Telmisartan Sodium;TELMISARTAN			2.1997272588	4	4		0	4.27553444			189	AGT	O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(C)c4nc3CCC)c6nc5ccccc5n6C	Microsource	01505261	-1.20056497	-0.41753653	0.02699784	4.27553444												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166222-04	N,N'-Dibenzylethane-1,2-diamine dihydrochloride	170465030	F-box only protein 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	3412-76-8				-1.0913499632	4	4		0	1.00490196			26273	FBXO3	Cl.Cl.C(NCc1ccccc1)CNCc2ccccc2	SIGMA	D35201	-1.53729839	0.15444015	2.8259653	1.00490196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262945-01	Rivaroxaban	170466121	Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	366789-02-8	Bay 59-7939;Rivaroxaban (Xarelto);5-Chloro-n-(((5s)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;Rivaroxaban;Rivaroxabanum; Rivaroxaban			-2.9153148295	4	4		0	0.6127451			83541	F10	O=C(NCC3CN(c1ccc(cc1)N2CCOCC2=O)C(=O)O3)c4ccc(Cl)s4	GVK	FFS-12-73-NCI-1931	-0.68044355	-1.08108108	-1.25909345	0.6127451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522533-01	Olodaterol		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	868049-49-4				-3.784501495	4	4		0	-0.46568627			154	ADRB2	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(=C2)O)C=C1	MedChem Express	HY-14301	-1.68850806	0.72072072	0.53161724	-0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159379-04	BETA-HYDROXYETHYL SALICYLATE	225144223		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	87-28-5				-2.5475737189	4	4		0	-0.0245098					OCCOC(=O)C1=CC=CC=C1O	SIGMA	172049	-1.33568548	1.9047619	-0.64353665	-0.0245098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522453-01	MLN9708		Proteasome subunit beta type-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1239908-20-3				-0.5153969804	4	4		0	0.75980392			5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	-0.17641129	-1.49292149	0.58757694	0.75980392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015686-11	Gallopamil hydrochloride	170465991	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	16662-46-7				0.4174354641	4	4		0	1.7100763					Cl.COc1c(cc(cc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C)OC	Enzo	AC103	0.04842615	-0.20075282	-1.34279199	1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016764-04	Benfotiamine	170465987		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	22457-89-2				-1.8420244738	4	4		0	-0.55248619					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCOP(=O)(O)O)SC(=O)c1ccccc1	SIGMA	B9636	0.0968523	-0.60225847	-0.32936407	-0.55248619												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00095109-08	Venlafaxine	170465123	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	93413-69-5	; ;D,L-Venlafaxine?HCl;VENLAFAXINE HYDROCHLORIDE; Effexor XR; VENLAFAXINE; Effexor;VENLAFAXINE; Venlafaxina;Venlafaxine hydrochloride; Venlafaxine			-3.6385363619	4	4		0	-0.39584364			3350	HTR1A	OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2	Microsource	01504171	-0.96665056	0.27133695	-1.52720331	-0.39584364												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164634-02	Balsalazide disodium	170465305	agents for IBS and constipation	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	80573-04-2	Balsalazide; Balsalazide; ;Balsalazide disodium; balsalzide Disodium; Colazide; Balsalazide sodium			-4.2502863033	4	4		0	0.24740228				ADORA1	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC(=O)O	Sequoia	SRP00900b	-1.15998067	-0.81401085	-1.71810372	0.24740228												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018295-05	Isoxsuprine hydrochloride	170465968		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	579-56-6				-1.4761801023	4	4		0	-1.73181593					Cl.Oc1ccc(cc1)C(O)C(C)NC(C)COc2ccccc2	Prestwick Chemical, Inc.	Prestw-68	-0.67665539	-0.27133695	1.78173719	-1.73181593												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091400-02	Allylthiourea	170465680		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	109-57-9				2.762070986	4	4		0	-0.9896091					NC(=S)NCC=C	Labotest	LT00025093	1.64330594	-0.76467686	1.27266942	-0.9896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182082-03	Tesaglitazar	170466025		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	251565-85-2				4.6992892301	4	4		0	0.4453241					O=S(C)(=O)Oc1ccc(cc1)CCOc2ccc(C[C@@H](OCC)C(=O)O)cc2	Tocris	3965	0.43499275	-0.66600888	3.69074133	0.4453241												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00161345-07	DOCONEXENT		Voltage-gated L-type calcium channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	6217-54-5				7.5486529003	4	4		0	0.81184336					CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/C\C=C/CCC(O)=O	Microsource	01503885	1.77985948	1.47093159	1.95811803	0.81184336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386387-01	Buclizine HCl		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	129-74-8		12.5892541179	-4.9	42.8836231596	3	4		71.0949282979	63.41929322	0.0087147552	0.9999531642			CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)C=C1	Selleck	S4140	-1.264637	-0.86388046	-0.97905902	63.41929322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015207-12	Cilostazol	170465347	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	73963-72-1	Cilostazol;CILOSTAZOL;; ; Pletal; Pletaal; Cilostazole; Cilostazol			11.719704936	4	4		0	0.17156863			5139	PDE3A	O=C1CCc2cc(ccc2N1)OCCCCc4nnnn4C3CCCCC3	Microsource	01505230	3.09979839	3.55212355	1.70677112	0.17156863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015146-17	Brompheniramine (maleate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	980-71-2				-2.3168874029	4	4		0	2.72058824					CN(C)CCC(C1=CC=C(Br)C=C1)C2=CC=CC=N2	MedChem Express	HY-B0480	-1.33568548	-0.30888031	-1.03525462	2.72058824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090955-06	Dicyclohexylamine	170466864	spermidine biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	101-83-7				-6.2254459729	4	4		0	-1.49960537					C1CCCCC1NC2CCCCC2	Vitas	STK379549	-1.0653753	-1.10414053	-1.74816316	-1.49960537												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016913-14	Astemizole	170465888	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	68844-77-9				-4.3340922145	4	4		0	-2.81504867					Fc1ccc(cc1)Cn4c5ccccc5nc4NC3CCN(CCc2ccc(OC)cc2)CC3	Enzo	NH101	0.5811138	-0.70263488	-1.74816316	-2.81504867												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178483-14	Limonin			DPI_SARS-CoV-2_General	2019_NPC-2_CPE	1180-71-8				1.1076165926	4	4		0	0.92081031					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	1.11380145	-0.95357591	-1.2414492	0.92081031												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015970-11	Sulindac	170464648	ABCC1 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac			-1.3649801636	4	4		0	0.71033938				ABCC1	CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C	Microsource	01500556	-0.53268765	-0.55207026	-0.73473524	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253587-01	Sitaxentan	170465720	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	184036-34-8	Sitaxentan			3.2527723103	4	4		0	-0.54428501				EDNRA	O=C(Cc1cc2OCOc2cc1C)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl	GVK	FFS-11-286-NCI-102	0.38666022	-0.86334484	3.56347439	-0.54428501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182995-01	Etomidoline	144206828		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	21590-92-1	Etomidoline; Smedolin; Etomidolina; 			-4.511514631	4	4	Etomidolina;2-ethyl-3-(p-(beta-piperidinoethoxy)phenylamino)-isoindoline-1-one;Etomidolinum;K-2680;2-ETHYL-3-(.BETA.-PIPERIDINO-P-PHENETIDINO)PHTHALIMIDINE;K 2680;Phthalimidine, 2-ethyl-3-(beta-piperidino-p-phenetidino)-;etomidolinum;Etomidoline;LS-109527;CIPLUS_213965;Smedolin;ETOMIDOLINE;amidoline;1h-isoindol-1-one, 2-ethyl-2,3-dihydro-3-((4-(2-(1-piperidinyl)ethoxy)phenyl)amino)- (9ci);etomidoline;	0	-0.94012865					O=C4c1ccccc1C(Nc3ccc(OCCN2CCCCC2)cc3)N4CC	Pharmaron	PH-NIH-150630	-0.72498792	-0.76467686	-1.52720331	-0.94012865												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00346455-05	Cobimetinib		Mek Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1453848-26-4				-5.6888475474	4	4		0	0.04775549				MAP2K1	OC1(CN(C1)C(=O)C2=C(NC3=C(F)C=C(I)C=C3)C(=C(F)C=C2)F)[C@@H]4CCCCN4	ActiveBioChem	A-1318	-1.77985948	-0.81718422	-0.87027468	0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094740-05	NORETHYNODREL		Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	68-23-5				0.534991708	4	4		0	-0.5730659					C[C@]12CCC\3C(CCC\4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C	Microsource	01500439	0.42154567	0.81718422	-0.97905902	-0.5730659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179431-03	Carbenoxolone sodium	170465951	gap junction assembly Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7421-40-1				-1.0976043323	4	4		0	1.20098039					[Na+].[Na+].[O-]C(=O)CCC(=O)O[C@H]4CC[C@]3(C)[C@H]5C(=O)C=C1[C@@](C)(CC[C@@]2(C)CC[C@@](C)(C[C@@H]12)C([O-])=O)[C@]5(C)CC[C@H]3C4(C)C	Prestwick Chemical, Inc.	Prestw-837	-0.52923387	-0.66924067	-0.25181869	1.20098039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379034-03	Caspofungin Acetate			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	179463-17-3				-3.5687972432	4	4		0	-0.56372549					CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN	Selleck	S3073	-1.13407258	-1.08108108	0.47565753	-0.56372549												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159341-18	Lamivudine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	134678-17-4				2.759067705	4	4		0	0.85784314				TERT	NC\1=N\C(=O)N(\C=C1)[C@@H]2CS[C@H](CO)O2	SIGMA	L1295	1.08366935	-0.1029601	-0.9233352	0.85784314												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00160596-03	Aluminum monostearate	225144243		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	7047-84-9				1.3775490239	4	4		0	1.34175217					CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O	SIGMA	06270	0.14527845	-1.05395232	-0.78540664	1.34175217												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00249932-01	Emorfazone	170465843		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	38957-41-4				3.5396810707	4	4		0	2.70981321					CCOC1=C(C=NN(C)C1=O)N2CCOCC2	GVK	FFS-11-286-NCI-236	0.92009685	-0.45169385	-0.78540664	2.70981321												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159425-09	ZINC UNDECYLENATE		Fatty Acid Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	557-08-4				2.2573537479	4	4		0	2.70981321					OC(=O)CCCCCCCCC=C	Microsource	01505467	-0.53268765	0.55207026	-1.03876362	2.70981321												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00016498-08	Dyclonine hydrochloride	170464776	Sodium channel protein type II alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	536-43-6				3.9951679652	4	4		0	4.25531915					Cl.CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2	Microsource	01500268	-0.09666506	-0.41933892	-0.19090041	4.25531915												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095082-06	Iopanoic acid	170465056		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	96-83-3				12.7456495688	4	4		0	2.8698664					Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O	Microsource	01503923	1.69163847	1.70202269	5.02704423	2.8698664												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00379052-01	Ticagrelor		Purinergic receptor P2Y12 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	274693-27-5				5.0164614174	4	4		0	7.0678128					CCCSC1=NC(=C2N=N[N]([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1)N[C@@H]4C[C@H]4C5=CC=C(F)C(=C5)F	MedChem Express	HY-10064	0.32786885	-0.81718422	-0.76149035	7.0678128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181342-02	Imidapril hydrochloride	170466024		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	89396-94-1				-3.1108045507	4	4		0	0.23877746					Cl.OC(=O)[C@@H]2CN(C)C(=O)N2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	SIGMA	SML0148	-1.31147541	-0.02334812	0.10878433	0.23877746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532516-01	IOBITRIDOL			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-3.2971558758	4	4		0	0.95510984					CN(CC(O)CO)C(=O)C1=C(I)C(=C(I)C(=C1I)NC(=O)C(CO)CO)C(=O)N(C)CC(O)CO	Carbosynth	FI24594	-1.54566745	1.05066542	-1.14223552	0.95510984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-06	Bortezomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	179324-69-7				-2.5387992722	4	4		0	0.09551098				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	Axon Medchem	1810_cm1	-1.07728337	-0.39691805	0.59831384	0.09551098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390657-02	Lesinurad (sodium)		Solute carrier family 22 member 12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1151516-14-1				1.0509623597	4	4		0	0					[Na]OC(=O)CSC1=NN=C(Br)[N]1C2=C3C=CC=CC3=C(C=C2)C4CC4	MedChem Express	HY-15258A	-1.40515222	0.81718422	5.81996193	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016242-05	Metyrapone	170465268	Cytochrome P450 11B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	54-36-4				-4.8212775286	4	4		0	-0.31862745					CC(C)(c1cccnc1)C(=O)c2cccnc2	Prestwick Chemical, Inc.	Prestw-904	-1.48689516	-0.25740026	-0.86737549	-0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522025-01	Mepitiostane (Contains ~15% 3a,4a-Epithio isomer)		Estrogen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	21362-69-6				-1.6322971762	4	4		0	0.95588235					COC1(CCCC1)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]5C[C@@H]6S[C@@H]6C[C@]5(C)[C@H]4CC[C@]23C	Toronto Research	M224920	-0.27721774	-1.02960103	-1.31505316	0.95588235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00273482-01	Nafcillin sodium monohydrate	170465253		DPI_SARS-CoV-2_General	2019_NPC-5_CPE	7177-50-6				-3.742066861	4	4		0	-1.10294118					[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c1c2ccccc2ccc1OCC)[C@H]4SC3(C)C	Prestwick Chemical, Inc.	Prestw-843	-0.83165323	-0.77220077	-0.36373811	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015938-05	Salmeterol xinafoate	170465397	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	94749-08-3				-1.5488148692	4	4		0	0.31862745					OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2.O=C(O)c2ccc1ccccc1c2O	Prestwick Chemical, Inc.	Prestw-945	-0.12600806	-0.66924067	-1.42697258	0.31862745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249905-01	Phthalofyne	170466477		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	131-67-9				3.8387873716	4	4		0	-0.34201526					O=C(O)c1ccccc1C(=O)OC(C)(C#C)CC	GVK	FFS-11-286-NCI-120	2.13075061	-0.80301129	0.78540664	-0.34201526												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094817-05	Flopropione	170465817	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2295-58-1				-0.3282108195	4	4		0	0.09896091			1312	COMT	O=C(CC)c1c(O)cc(O)cc1O	Microsource	01500629	0.53165781	-0.22200296	-1.20903595	0.09896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00022398-05	Fluocinonide	170464717	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	356-12-7	;Fluocinonide; Lidex; Fluocinonido;Fluocinonide (Vanos)			1.7587433391	4	4		0	0.51470588				NRC31	CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-774	1.08366935	-0.56628057	-1.42697258	0.51470588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346442-02	Phenprocoumon		Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	435-97-2				-3.8074531552	4	4		0	-0.90686274					CCC(C1=CC=CC=C1)C/2=C(\O)C3=CC=CC=C3OC2=O	Adooq	A10656	-1.48689516	-0.36036036	1.31505316	-0.90686274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178065-03	TENIPOSIDE		DNA Topoisomerase II Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	29767-20-2				-8.6980593351	4	4		0	-2.27941176				TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@H](OC5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7)OC	Microsource	01504094	-2.09173387	-1.44144144	-0.9233352	-2.27941176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095227-06	Alizarin	170465641	Calcium Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	72-48-0				-2.5240547408	4	4		0	-0.80882353					O=C3c1ccccc1C(=O)c2c3ccc(O)c2O	Vitas	STK801841	-0.83165323	-0.46332046	0.75545607	-0.80882353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016101-10	Xylometazoline hydrochloride	170465470	alpha2A/B/C-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1218-35-5	; Otrivine-Antistin; ;XYLOMETAZOLINE HYDROCHLORIDE;Xylometazoline hydrochloride; Xylometazoline hydrochloride; Neo-Synephrine II; Xilometazolina; Otrivin hydrochloride	14.1253754462	-4.85	21.8364652509	2.4	5		34.09117014	27.99188641	0.0095517107	0.9951971943	150	ADRA2A	Cl.CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2	Microsource	01500614	1.1965812	-0.8091024	-0.14803849	-0.90930845	27.99188641											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016927-11	Enoxacin	170465263	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	74011-58-8	; ; Enoxiacin Gluconate;Enoxacin; Penetrex; Enoxacin;ENOXACIN; 2   Enoxacin			-0.3580024603	4	5		0	-1.21703854					O=C(O)C2=CN(CC)c1nc(c(F)cc1C2=O)N3CCNCC3	Microsource	01503215	-0.12210012	-0.9102402	0.44411547	1.5793252	-1.21703854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159515-03	Eszopiclone	170465445	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	138729-47-2	Eszopiclone; ; Estorra; Eszopiclone; Zopiclona;Zopiclone; Amoban			0.1042741153	4	5		0	3.32657201			2554	GABRA1	CN1CCN(CC1)C(=O)O[C@H]4c2nccnc2C(=O)N4c3ccc(Cl)cn3	Bionet	KS-1055	0.02442002	-1.5676359	-1.28300025	-0.62215841	3.32657201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094916-06	Suprofen	170465412	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	40828-46-4				-4.0724377313	4	5		0	-0.32454361			5743	PTGS2	O=C(c1ccc(cc1)C(C)C(=O)O)c2cccs2	SIGMA	s9894	-0.85470085	-1.517067	-0.64150012	-1.05288346	-0.32454361											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262960-01	Resocortol butyrate	170466824	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	76738-96-0	Resocortol			1.5788856646	4	5		0	3.1643002					CCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-149	0.12210012	-1.1125158	-1.62842339	1.29217516	3.1643002											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274063-01	Pimobendan	174007050	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	77469-98-8	Pimobendan(Vetmedin)			-1.2123611677	4	5		0	-1.29817444			5139	PDE3A	Cl.COc1ccc(cc1)c2nc3ccc(cc3n2)C4=NNC(=O)CC4C	Selleck	S1550	0.36630037	0.1517067	-1.13496176	-0.33500838	-1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016506-07	Naphazoline hydrochloride	170464797	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	550-99-2				-3.6820467481	4	5		0	-2.27180527					Cl.c2cc(CC1=NCCN1)cc3ccccc23	Vitas	STK300042	-0.46398046	-0.5562579	-1.52973106	0.47858339	-2.27180527											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016372-07	4-Hydroxy-3-nitrophenylarsonic acid	170465666		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	121-19-7				-0.0855968322	4	5		0	1.86612576					O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O	Microsource	01500530	-0.61050061	-1.0619469	-0.34542314	0.90930845	1.86612576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016065-11	Tropicamide	170464754	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1508-75-4				-1.6400157494	4	5		0	-1.70385396					OCC(c1ccccc1)C(=O)N(CC)Cc2ccncc2	Enzo	AC222	0.21978022	-1.2136536	0.34542314	-0.2392917	-1.70385396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024309-17	(+)-Diltiazem	170464699	Ca2+ channel blocker, similar pharmacology to verapamil	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	42399-41-7				-5.5211198111	4	4		0	-0.65772165					CN(C)CCN1c3ccccc3S[C@H]([C@@H](OC(C)=O)C1=O)c2ccc(OC)cc2	Enzo	CA205	-1.8401937	-0.50188206	-0.98809222	-0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159319-04	Zonisamide	174006630	Na channel blocker, T-type Ca channel blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	68291-97-4	 ; Zonisamide sodium salt; Elan brand of zonisamide; Excegran; Zonegran; Zonisamide;Zonisamide; Zonisamide sodium			0.8523120751	4	4		0	1.76269403					NS(=O)(=O)Cc2noc1ccccc12	Vitas	STK711131	-0.5811138	-0.80301129	0.53204966	1.76269403												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018102-12	Flunarizine	170466037	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	52468-60-7	Sibelium; ; Flu Narizine;Flunarizine dihydrochloride; Hydrochloride, Flunarizin;Flunarizine; Flunarizin; Flunarizina; Flunarizine	11.220184543	-4.95	79.5137993311	3	4		92.8882720404	76.00631413	0.0287771827	0.9994889373			Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4	Enzo	CA225	-1.50121065	0.40150565	-1.2921206	76.00631413												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00178376-05	Sulfaquinoxaline	170465653		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59-40-5				2.9779635315	4	4		0	0.02630887					Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2	Microsource	01501145	0.14527845	3.11166876	0.48137826	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016265-08	Folic acid	170464833	folic acid-containing compound metabolic process Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	59-30-3				-4.5473696884	4	4		0	-0.81557485					O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2	Microsource	01502020	-1.2590799	-0.25094103	-1.08943501	-0.81557485												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00023339-16	Pilocarpine	170464845	Muscarinic acetylcholine receptor M3 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	92-13-7				-1.7893046747	4	4		0	0.28939753			1131	CHRM3	Cn2cncc2C[C@H]1COC(=O)[C@H]1CC	Enzo	AC214	-0.82324455	0.65244667	-0.98809222	0.28939753												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249907-01	Sulthiame	170465788	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	61-56-3				-2.2283994388	4	4		0	-1.44698763					O=S2(=O)CCCCN2c1ccc(cc1)S(N)(=O)=O	GVK	FFS-11-286-NCI-132	-0.5811138	-0.40150565	0.68406385	-1.44698763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253608-01	Chlorexolone	170466039		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	2127-01-7				-0.8510555419	4	4		0	-0.14844137					NS(=O)(=O)c1cc2C(=O)N(Cc2cc1Cl)C3CCCCC3	GVK	FFS-11-286-NCI-259	-0.67665539	0.71534287	0.06363347	-0.14844137												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018238-09	Oxibendazole	170465661	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	20559-55-1	OXIBENDAZOLE;Oxibendazole; Loditac; Oxibendazolo;			-2.0559240635	4	4		0	0.79168728				POLB	O=C(OC)Nc1nc2cc(ccc2n1)OCCC	Microsource	01503373	-0.33832769	-0.51800691	-1.84537066	0.79168728												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159451-06	Tinoridine	170465864	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	24237-54-5				-5.6681550983	4	4		0	-1.18753093					O=C(OCC)c1c2CCN(Cc2sc1N)Cc3ccccc3	Vitas	STK036143	-1.30497825	0.27133695	-2.03627108	-1.18753093												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094736-05	Nitromide	170466818	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	121-81-3				1.5765192183	4	4		0	-0.84116774					O=[N+]([O-])c1cc(cc(c1)[N+]([O-])=O)C(N)=O	Microsource	01500435	1.49830836	0.17266897	-0.38180083	-0.84116774												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253602-01	Thenyldiamine	170465520		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	91-79-2				-0.1872810107	4	4		0	-0.04775549					CN(C)CCN(Cc1ccsc1)c2ccccn2	GVK	FFS-11-286-NCI-087	0.28103044	-0.21013308	-1.03345118	-0.04775549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241107-02	Bosutinib	170466788	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	918639-10-8	 Bosutinib;Bosutinib;PF-5208763/SKI-606			-4.743343439	4	4		0	-1.81470869			25	ABL1	CO.COc4cc(Nc3c(C#N)cnc2cc(OCCCN1CCN(C)CC1)c(OC)cc23)c(Cl)cc4Cl	Sequoia	380843-75-4	-0.56206089	-1.70441279	-1.08784335	-1.81470869												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179265-03	Netilmicin sulfate	170465142	Lysosomal phospholipase A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56391-57-2				0.5198637356	4	5		0	0					O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.NC3CC=C(CN)OC3O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H]2O.NC3CC=C(CN)OC3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](NCC)C[C@@H]2N	Bosche	N2413	1.0989011	0.3034134	-0.44411547	0.33500838	0											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00016309-06	Sulfathiazole	170465454	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	72-14-0				-1.7627639998	4	5		0	1.21703854					O=S(=O)(Nc1nccs1)c2ccc(N)cc2	Labotest	LT00114899	-0.95238095	-1.6687737	-0.34542314	0.71787509	1.21703854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016383-05	Trimethadione	225144178	Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	127-48-0				-0.7776678792	4	5		0	2.10953347					CN1C(=O)OC(C)(C)C1=O	Prestwick	Prestw-515	-0.51282051	-1.2136536	-0.9375771	0.14357502	2.10953347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181356-02	Oxapium iodide	170465824		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	6577-41-9				1.4422983425	4	5		0	0					[I-].C[N+]1(CCCCC1)CC2COC(O2)(C3CCCCC3)c4ccccc4	APAC	877482	0.70818071	-1.1630847	0.24673082	1.1007418	0											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178238-05	Midodrine hydrochloride	170464672	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	3092-17-9				12.7447347004	4	5		0	3.97565923					Cl.COc1ccc(cc1C(O)CNC(=O)CN)OC	Microsource	01503257	3.24786325	1.011378	3.10880829	1.24431682	3.97565923											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025349-05	Apomorphine	170465297	D2-like dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	58-00-4				-0.0444673048	4	5		0	2.19066937					Oc3ccc2C[C@@H]1c4c(CCN1C)cccc4c2c3O	Specs	AE-562/J258166	-0.26862027	-0.7079646	-0.9375771	-0.04785834	2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167533-02	Vardenafil	170465607	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1193386-64-9	 ;Levitra;Vardenafil citrate; Vardenafil citrate; Vardenafil Hcl; Vardenafil HCLTrihydrate;Vardenafil Hydrochloride Trihydrate (Vivanza			-3.2649364176	4	5		0	-0.40567951			8654	PDE5A	O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN1CCN(CC1)S(=O)(=O)c4cc(C2=NC(=O)c3c(C)nc(CCC)n3N2)c(OCC)cc4	Sequoia	SRP01005v	-0.85470085	-1.3653603	-0.98692327	0.38286671	-0.40567951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183844-01	Sitafloxacin hydrate	124894559	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	127254-12-0	Sitafloxacin			1.9043349182	4	4	DU-6859A;Sitafloxacin Hydrate;sitafloxacin;sitafloxacinum;SITAFLOXACIN;CIPLUS_215256;Sitafloxacin;3-Quinolinecarboxylic acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, (1R-(1alpha(S*),2alpha))-;SITAFLOXACIN SESQUIHYDRATE;sitafloxacine;CIPLUS_3818295;	0	0.85549133			7155	TOP2B	N[C@H]2CN(CC12CC1)c3c(F)cc4c(c3Cl)[N@@](C=C(C4=O)C(=O)O)C5C[C@H]5F	Pharmaron	PH-NIH-183573	-0.35989717	0.80813347	2.31639905	0.85549133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182053-03	Acrivastine		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	87848-99-5				-0.6866576426	4	4		0	1.04046243					CC1=CC=C(C=C1)\C(=C/CN2CCCC2)C3=CC=CC(=N3)\C=C\C(O)=O	Enzo	AC3005	-0.82262211	1.12095933	-0.21058173	1.04046243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016281-11	Phenacetin	170465554	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	62-44-2				0.4541364188	4	4		0	0.60510392			403544	PTGS1	CCOc1ccc(cc1)NC(C)=O	Vitas	STK011463	0.43583535	-0.05018821	-0.93742083	0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015418-09	Ethosuximide	170464802	T-Type Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	77-67-8	 Etosuximida; ; Suxilep;ETHOSUXIMIDE;Ethosuximide; Ethosuximide; Zarontin			-0.6683096562	4	4		0	1.28913444				CACNA1G	CC1(CC)CC(=O)NC1=O	Microsource	01502196	-0.968523	-0.9033877	0.32936407	1.28913444												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249928-01	Eicosapentaenoic acid ethyl ester	170466007		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	73310-10-8				-1.1271361446	4	4		0	1.97316496					O=C(/C=C\C=C/C=C\C=C/C=C\CCCCCCCCC)OCC	GVK	FFS-11-286-NCI-230	-1.5496368	0.20075282	-0.53204966	1.97316496												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018277-06	Mebeverine hydrochloride	170466168		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	2753-45-9				4.9042972799	4	4		0	7.55064457					Cl.COc1cc(ccc1OC)C(=O)OCCCCN(CC)C(C)Cc2ccc(OC)cc2	Microsource	01501117	-1.01694915	-0.65244667	-0.98809222	7.55064457												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00018256-06	Oxyphenonium bromide	170465282	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50-10-2				1.3306914307	4	4		0	1.44698763					[Br-].OC(C(=O)OCC[N+](C)(CC)CC)(c1ccccc1)C2CCCCC2	SIGMA	O5501	0.04842615	0.15056462	-0.43070687	1.44698763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016055-16	Trimethoprim	170464633	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	738-70-5				-1.5375232732	4	4		0	-0.02630887					Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1	Vitas	STK177322	-0.53268765	-0.25094103	-0.32936407	-0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164512-02	Guaiacol carbonate	170465684		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	553-17-3				-4.1185155503	4	4		0	0.65772165					COc2ccccc2OC(=O)Oc1ccccc1OC	Labotest	LT02084807	-1.937046	-0.15056462	-1.08943501	0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015092-10	Aminocaproic acid	170465057	PAI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	60-32-2	 6-Aminohexanoic acid;6-Aminohexanoic acid;AMINOCAPROIC ACID;6-AMINOCAPROIC ACID;Aminocaproic acid; 6-Aminocaproic acid			2.4299209335	4	4		0	0.76295712			5054	SERPINE1	NCCCCCC(=O)O	Microsource	01500114	-0.0968523	1.05395232	0.98809222	0.76295712												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183104-02	Nizofenone	170466022		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	54533-86-7				-3.746783714	4	4		0	0.23877746					Clc1ccccc1C(=O)c2cc(ccc2n3ccnc3CN(CC)CC)[N+]([O-])=O	APAC	556416	-1.03044496	-1.1440579	-0.70709818	0.23877746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182048-01	Pipothiazine palmitate	144206970	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	37517-26-3	Pipotiazine palmitate; Pipotiazin Retard; Piportil depot; 			14.9468044978	4	4	Hexadecanoic acid, 2-(1-(3-(2-((dimethylamino)sulfonyl)-10H-phenothiazin-10-yl)propyl)-4-piperidinyl)ethyl ester;Pipotiazine palmitate;pipotiazine palmitate;pipothiazin palmitate;Pipotiazin Retard;LS-74847;CIPLUS_179082;Piportil depot;pipothiazine palmitate;PIPOTIAZINE PALMITATE;19552 RP;	0	1.33715377					CN(C)S(=O)(=O)c2cc3N(CCCN1CCC(CCOC(=O)CCCCCCCCCCCCCCC)CC1)c4ccccc4Sc3cc2	Sigma - DiscoveryCPR	CSZ6713	3.46604215	1.79780528	5.49360892	1.33715377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378598-01	PSI-7976		RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1190308-01-0				0.6981860914	4	4		0	0.62082139					CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005A	0.23419204	0.02334812	-0.54392168	0.62082139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179542-03	Brinzolamide	170464926	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	138890-62-7				-2.4402511895	4	5		0	-0.81135903					NS(=O)(=O)c1cc2[C@H](CN(CCCOC)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-365	0.36630037	-1.5676359	-0.59215396	-1.43575018	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389663-01	Empagliflozin (BI 10773)		Sodium/glucose cotransporter 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	864070-44-0				3.6481162964	4	4		0	0.30057803					OCC1OC(C(O)C(O)C1O)C2=CC(=C(Cl)C=C2)CC3=CC=C(OC4CCOC4)C=C3	APExBIO	A4601	0.97686375	1.38164755	-0.05264543	0.30057803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167510-02	Doripenem	170465085	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	148016-81-3				-2.3637282153	4	4		0	-1.22543353				DPEP1	O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@@H](CNS(N)(=O)=O)NC1)[C@H](C)[C@@H]23)C(=O)O	Sequoia	148016-81-3	-0.35989717	-0.70385819	-0.05264543	-1.22543353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159521-09	Zoledronic acid monohydrate		Farnesyl Pyrophosphate Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	118072-93-8				1.8041105744	4	4		0	0.02312139				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	APExBIO	A1352	-0.35989717	-0.18248175	4.05369834	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507698-01	Talaporfin sodium			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	220201-34-3				4.0444704517	4	4		0	5.47976879					CCC1=C2[NH]C(=C1C)C=C3[NH]C(=CC4=NC(=C(CC(=O)N[C@@H](CC(O)=O)C(O)=O)C\5=NC(=C2)\C(=C5C(O)=O)C)[C@@H](CCC(O)=O)[C@@H]4C)C(=C3C=C)C	MedChem Express	HY-16477	-0.25706941	0.28675704	0.57909976	5.47976879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263164-17	Cabozantinib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	849217-68-1				2.9274100899	4	4		0	0.02312139				KDR	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3	MedChem Express	HY-13016	0.35989717	2.11157456	0.73703606	0.02312139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015841-11	Pargyline hydrochloride	170465066	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	306-07-0				5.0227963159	4	4		0	1.23701138					Cl.CN(Cc1ccccc1)CC#C	Microsource	01500462	1.11164814	0.86334484	0.95450207	1.23701138												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015859-14	Procainamide	170464952	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	51-06-9				-1.5674176797	4	4		0	1.13805047					O=C(NCCN(CC)CC)c1ccc(N)cc1	Enzo	AC127	-0.43499275	-1.06068081	-1.20903595	1.13805047												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094969-05	Anisindione	170465379	Vitamin K-dependent gamma-carboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	117-37-3				-0.5652303814	4	4		0	0.19792182					COc1ccc(cc1)C3C(=O)c2ccccc2C3=O	Microsource	01502198	-0.38666022	-0.66600888	0.38180083	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344578-01	Flavin adenine dinucleotide disodium salt hydrate	225144395	oxidative phosphorylation Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	84366-81-4				-5.2475816425	4	4		0	-1.05062082					O.[Na+].[Na+].CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO[P]([O-])(=O)O[P]([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C4N=CN=C5N)C\6=N\C(=O)NC(=O)C6=N/C2=C1	SIGMA	F8384	-1.45199063	-0.81718422	-0.43513734	-1.05062082												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00018185-23	Tranilast		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	53902-12-8				0.2830817626	4	4		0	-1.09837631				TNF	COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC	Enzo	CT110	0.6557377	-0.16343684	-0.65270601	-1.09837631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408835-01	Frovatriptan succinate		Serotonin 1d (5-HT1d) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	158930-09-7				-1.9429736826	4	4		0	-0.19102197					CN[C@@H]1CCC2=C(C1)C3=C([NH]2)C=CC(=C3)C(N)=O	Glixx	GLXC-06564	-0.74941452	-0.49031053	0.65270601	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181355-02	Carpronium chloride	225144327	Muscarinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE					-1.1142794557	4	4		0	0.66857689					COC(=O)CCC[N+](C)(C)C	APAC	877481	-0.93676815	1.33084287	-0.21756867	0.66857689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166122-01	Perflexane	144205881		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	355-42-0	Perflexane; Imavist; Imagent; 			8.638018384	4	4	perflexane;perfluorohexane;NCGC_FLUKA_77273;perflexanum;PERFLEXANE;PERFLUOROHEXANE;Perflexane;NCGC00166122-01;Tetradecafluorohexane;AF0150;AFO 150;CIPLUS_152856;Imavist;TETRADECAFLUOROHEXANE;Perfluorohexane;Imagent;perfluoro-n-hexane;	0	2.43553009					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F	FLUKA	FLUKA-77273	1.54566745	2.63833761	1.46858852	2.43553009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263198-04	Lenvatinib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	417716-92-8				-0.6111344205	4	4		0	1.48042025				FLT1	COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O	APExBIO	A2174	-0.14051522	-0.9105767	-1.03345118	1.48042025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507798-01	Drostanolone propionate		Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	521-12-0				5.0278884308	4	4		0	1.67144222					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C	Carbosynth	FD22623	1.63934426	-0.25682933	-0.32635301	1.67144222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378665-02	Ixabepilone		Microtubule-Stabilizing Agents	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	219989-84-1				-9.0810326541	4	4		0	-2.23039216				TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A11449	-1.94052419	-1.6988417	-1.81869054	-2.23039216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015344-16	NCGC00015344-16			DPI_SARS-CoV-2_General	2019_NPC-2_CPE			11.220184543	-4.95	12.2567041304	4	4		16.4289333719	13.97000789	0.0381942909	0.9991044576			CN(C)CC\C=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2	Microsource	01500264	-0.6779661	-0.80301129	-1.19077781	13.97000789												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016064-12	Terfenadine	170465598		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	50679-08-8				-6.6470905638	4	4		0	-2.92028414					CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01503708	-0.33898305	-1.40526976	-1.74816316	-2.92028414												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024714-11	Triprolidine	170464931	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	486-12-4				0.3662391033	4	4		0	1.38545275					Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3	SigmaAldrich	T6764	-0.14499758	-0.024667	-0.82723513	1.38545275												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253867-02	Prucalopride	170466188	5-HT4 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	179474-81-8	Resolor;R093877;R 093877;Prucalopride; Prucalopride;Prucalopridum			0.9100443253	4	4		0	3.01830777			3360	HTR4	COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23	GVK	FFS-12-73-NCI-2606	-1.30497825	0.12333498	-0.06363347	3.01830777												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00015116-13	Aniracetam	170465854	AMPA receptor modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	72432-10-1	; ; Aniracetamun; Aniracetam;Aniracetam; Ro 13-5057; 3   Aniracetam			-2.5839763594	4	4		0	-0.86819258				GRIA1	O=C2CCCN2C(=O)c1ccc(OC)cc1	Enzo	AC439	-0.82324455	1.10414053	-0.83607803	-0.86819258												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00253573-01	Tepoxalin	170466265	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	103475-41-8		2.5118864315	-5.6	15.9029921756	4	4		16.7045169439	16.02209945	0.0523575792	0.9983133296			CN(O)C(=O)CCc2cc(c1ccc(Cl)cc1)n(n2)c3ccc(OC)cc3	GVK	FFS-11-286-NCI-124	-0.1937046	-1.00376412	-0.58272105	16.02209945												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00091695-03	Triethylenetetramine	170465257	Copper Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	112-24-3				5.0217070565	4	4		0	2.8676664					NCCNCCNCCN	Labotest	LTBB000434	0.43583535	3.16185696	-1.08943501	2.8676664												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021202-03	Famotidine	170464877	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	76824-35-6				-3.7304569908	4	4		0	-0.9896091				HRH2	N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1	Enzo	AC925	-1.44997583	1.20868278	-0.76360165	-0.9896091												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166105-04	BENZYL NICOTINATE	225144269		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	94-44-0				3.6350253365	4	4		0	1.4349332					O=C(OCC1=CC=CC=C1)C2=CN=CC=C2	SIGMA	72351	0.8699855	-0.12333498	0.50906777	1.4349332												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021152-06	Hydroxyzine	170464958	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	68-88-2				-3.0649972812	4	4		0	-0.46568627					Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO	Microsource	01500345	-0.5796371	-0.56628057	-1.20313374	-0.46568627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162106-17	Cefsulodin Sodium Salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	52152-93-9				-5.0025111439	4	4		0	-0.26960784					NC(=O)C1=CC=[N+](CC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@@H](C4=CC=CC=C4)[S]([O-])(=O)=O)C3=O)C([O-])=O)C=C1	Glixx	GLXC-08405	-1.53729839	-0.72072072	-0.53161724	-0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016279-05	Aminohippuric acid	170465155		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	61-78-9				4.3520231919	4	4		0	0.71033938					O=C(NCC(=O)O)c1ccc(N)cc1	Vitas	STK801822	0.72639225	2.15809285	0.68406385	0.71033938												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179521-03	Cefixime		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	125110-14-7				0.9921469288	4	4		0	0.92081031					NC1=NC(=CS1)\C(=N\OCC(O)=O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	FLUKA	18588	0.7748184	-0.9033877	-0.78540664	0.92081031												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016743-08	Piromidic acid	170466042		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	19562-30-2				3.5342661788	4	4		0	2.17714003					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCCC3	Microsource	01502045	-0.28999517	0.41933892	-0.31816736	2.17714003												6.4E-9	3.2E-8	1.6E-7	0.000004											
NCGC00094937-04	Carprofen	170464799	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	53716-49-7				-3.7714572053	4	4		0	0.19792182					O=C(O)C(C)c1ccc2c3cc(Cl)ccc3nc2c1	Microsource	01502006	-1.06331561	0.07400099	-1.97263761	0.19792182												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00389455-01	Penicillin G Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	69-57-8				-2.3795448034	4	4		0	1.48042025					CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C([O-])=O	APExBIO	B1678	-1.17096019	-1.47093159	0.76149035	1.48042025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015787-09	PINACIDIL		"Sulfonylurea receptor 2, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	85371-64-8, 60560-33-0 [anhydrous]				-1.5036943899	4	4		0	-1.38490926					CC(N\C(NC1=CC=NC=C1)=N\C#N)C(C)(C)C	Microsource	02300270	-0.18735363	-0.9105767	0.92466685	-1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-10	Ivermectin		Glutamate-gated Chloride Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	70288-86-7				3.084250732	4	4		0	1.43266476					[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	APExBIO	A2813	-0.46838407	-0.30352557	4.89529508	1.43266476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167443-02	Afloqualone			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	56287-74-2				-3.5680805392	4	4		0	-1.38490926					CC1=CC=CC=C1N2C(=O)C3=C(C=CC(N)=C3)N=C2CF	DC Chemicals	DC9026	-0.6557377	-0.30352557	-0.92466685	-1.38490926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238451-11	Olaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	763113-22-0				13.0484434007	4	4		0	3.06372549				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Adooq	A10111	1.13407258	4.16988417	7.07890319	3.06372549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164574-06	Erlotinib	170465434	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	183321-74-6	 ;CP-358774; Erlotinib hydrochlorid;Erlotinib hydrochlorid;OSI-774; erlotinib HCl; Erlotinib HCL;RG-1415;Tarceva;Ro-50-8231;NSC-718781			-8.0260065501	4	4		0	-2.37745098			1956	EGFR	C#Cc1cc(ccc1)Nc3ncnc2cc(OCCOC)c(cc23)OCCOC	Sequoia	SRP01330e	-1.63810484	-1.08108108	-1.87465025	-2.37745098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509859-03	ABT-450			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	1221573-85-8				0.4774696859	4	4		0	2.42647059					CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCCC=C[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	Glixx	GLXC-90367	-0.47883065	-1.02960103	0.86737549	2.42647059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164493-02	Dipyrithione	170465699		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	3696-28-4		4.4668359215	-5.35	37.2944427747	2.4	4		33.4636135479	27.28229413	0.0271733124	0.9995450422			[O-][n+]2ccccc2SSc1cccc[n+]1[O-]	Labotest	LT00452770	-0.0968523	-0.80301129	-0.12667849	27.28229413												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00162143-03	Clodronate	225144247	ADP/ATP translocase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	22560-50-5				2.4942281056	4	4		0	0.0789266			293	SLC25A6	O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O	Prestwick	Prestw-1381	0.14527845	2.65997491	0.32936407	0.0789266												3.2E-9	1.6E-8	8E-8	0.000002											
NCGC00015219-07	Choline Chloride			DPI_SARS-CoV-2_General	2019_NPC-7_CPE	67-48-1				1.0712942489	4	4		0	1.24164279					C[N+](C)(C)CCO	Selleck	S4171	0	0.95727294	-0.21756867	1.24164279												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00386236-02	TAK 438		Potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	881681-01-2				1.2054505943	4	4		0	6.73352436					CNCC1=C[N](C(=C1)C2=CC=CC=C2F)[S+]([O-])(=O)C3=CC=CN=C3	Axon Medchem	1971	-0.93676815	-1.23745039	-0.81588251	6.73352436												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015060-18	Azathioprine	170464989	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	446-86-6	 Azathiopurine;Azathioprine; Imurel; Imuran; ; Azatioprina; Immuran; Azathioprine Sulfate; Azathioprine Sodium Salt; Azathioprine;AZATHIOPRINE; Azothioprine			1.9934402021	4	4		0	4.3872549				HPRT1	O=[N+]([O-])c3ncn(C)c3Sc2ncnc1ncnc12	Specs	AG-670/36150031	-0.42842742	0.25740026	-0.53161724	4.3872549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167435-07	Nilvadipine		Voltage-gated L-type calcium channel alpha-1C subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	75530-68-6				-1.3532694086	4	4		0	0.26960784					COC(=O)C\1=C(\N\C(=C(/C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C)C#N	MedChem Express	HY-14284	-0.42842742	-0.46332046	-0.19585898	0.26960784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181120-02	Acetophenazine Maleate		Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	5714-00-1				-0.9597358042	4	4		0	3.94607843					[CH3][C](=[O])C1=CC=C2[S]C3=C(C=CC=C3)[N]([CH2][CH2][CH2][N]4[CH2][CH2][N]([CH2][CH2][OH])[CH2][CH2]4)C2=C1	USP	1007000	-1.33568548	0.15444015	-0.86737549	3.94607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160529-06	Tizanidine hydrochloride	170465419	alpha2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	51322-75-9	;Tizanidine hydrochloride; Tizanadine; ; Tizanidina; TIZANIDINE; Tizanidine;Tizanidine; Tizanidine Hcl; Zanaflex			-2.9395447766	4	4		0	-0.36764706			150	ADRA2A	Clc2ccc3nsnc3c2NC1=NCCN1	Vitas	STK711168	-1.08366935	-0.72072072	0.86737549	-0.36764706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017246-10	PICROTIN			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	21416-53-5				-0.6023504073	4	4		0	-1.10294118					[H][C@@]12OC(=O)[C@@]([H])([C@]1([H])C(C)(C)O)[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@@]2([H])[C@]35C	Microsource	00100346	0.07560484	-0.15444015	0.19585898	-1.10294118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-12	Cyclosporine A	170466812	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	59865-13-3	 Antibiotic S 7481F1; ; 11-me-Leu-CsA;Cyclosporin A; cyclosporin A synthetase;; Cyclophilins; F-7-62 cyclosporin; CYCLOSPORIN A;CYCLOSPORINE; Cyclosporine; cyclosporin O; CYCLOSPORINE; Cyclosporin A; cyclosporin metabolite M1; H-7-94 cyclosporin; cyclosporin A-SPTP; 3-MeAla-7-Phe-8-Ser-CsA; Cs29 (cyclosporin); M1 cyclosporin metabolite; Cyclosporin SG			1.7149451909	4	4		0	-1.44607843				PPP3CC	C[C@H](C\C=C\C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C)C(C)C	Microsource	01502202	1.03326613	0.30888031	-0.08393956	-1.44607843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166015-02	C.I. Basic Violet 14	124893209		DPI_SARS-CoV-2_General	2019_NPC-5_CPE					-1.9424098878	4	4		0	2.08333333					CC1=CC(=CC=C1N)C(C2=CC=C(N)C=C2)=C/3\C=C/C(=N)/C=C3	SigmaAldrich	B0904	-1.18447581	0.41184041	-1.09121433	2.08333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163125-06	Pregnenolone	170465558	Steroid	DPI_SARS-CoV-2_General	2019_NPC-5_CPE	145-13-1	; ; 5-Pregnen-3beta-ol-20-one; Allopregnandione; Allopregnane-3,20-dione; Pregnenolona; Pregnenolone acetate; PREGNENOLONE; 5 Pregnen 3 beta ol 20 on;Pregnenolone; Pregnenolone			-0.3497819093	4	4		0	2.03431373					CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-546	-1.68850806	0.05148005	3.4415221	2.03431373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379082-01	Anidulafungin			DPI_SARS-CoV-2_General	2019_NPC-5_CPE	166663-25-8		5.6234132519	-5.25	82.8432446784	3	4		87.136923687	79.19117647	0.0092106594	0.9999476761			CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC=C(O)C=C7)C(C)O	MedChem Express	HY-13553	-0.07560484	-0.72072072	0.69949636	79.19117647												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179602-03	Testosterone propionate	170464835	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	57-85-2				10.0731560767	4	4		0	2.55196001				AR	CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801834	2.51815981	1.25470514	1.64682037	2.55196001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00182994-01	Anacolin	144206808		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	21216-78-4	Diphenylpiperidinomethyldioxolan iodide; Gastrophyllin-A; 			0.8078743801	4	4	Gastrophyllin-A;N-(2,2-diphenyl-1,3-dioxolan-4-ylmethyl)-N-methylpiperidinium;anacoline;Diphenylpiperidinomethyldioxolan Iodide;Diphenylpiperidinomethyldioxolan iodide;anacoline iodide;DIPHENYLPIPERIDINOMETHYLDIOXOLAN IODIDE;CIPLUS_770363;CIPLUS_784768;	0	1.23651671					[I-].C[N+]1(CCCCC1)CC2COC(O2)(c3ccccc3)c4ccccc4	Pharmaron	PH-NIH-117094	-0.8716707	0.05018821	0.38003547	1.23651671												1.6E-8	8E-8	4E-7	0.0000099999999999											
NCGC00164584-03	Cetraxate hydrochloride	170465783	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	27724-96-5				4.4627643527	4	4		0	0.65772165					Cl.NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2	Sequoia	SRP02040c	0.24213075	1.55583438	2.10286293	0.65772165												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00181154-03	Nitarsone	170465716		DPI_SARS-CoV-2_General	2019_NPC-3_CPE	98-72-6				3.8978035578	4	4		0	2.27610094					O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O	Vitas	STK368450	0.67665539	-0.17266897	0.25453388	2.27610094												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166322-02	PROTIRELIN		Thyrotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	24305-27-9				7.7543292497	4	4		0	5.01432665					NC(=O)C1CCCN1C(=O)C(CC2=CN=C[NH]2)NC(=O)C3CCC(=O)N3	Microsource	01506101	0.98360656	1.05066542	1.08784335	5.01432665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015453-08	Fexofenadine hydrochloride	170464669	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	153439-40-8				6.4285906784	4	5		0	-0.24340771					Cl.O=C(O)C(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01504179	2.56410256	0.9102402	0.69084629	1.05288346	-0.24340771											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021268-04	Hydroxyprogesterone caproate	170465210		DPI_SARS-CoV-2_General	2019_NPC-1_CPE	630-56-8		7.9432823472	-5.1	41.7479891573	3	5		56.3946527502	52.65720081	0.0004778545	0.9997610971			CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Bosche	H1727	-0.07326007	-0.7585335	-0.98692327	5.360134	52.65720081											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016511-08	Chlorotrianisene	170465394	Estrogen receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	569-57-3		11.220184543	-4.95	4.5850040996	4	5		14.06321112	9.49290061	0.0142187488	0.992897359			COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3	Prestwick	Prestw-757	-0.65934066	-1.7193426	-0.88823094	0.76573343	9.49290061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164617-04	Adapalene	170464674	topical retinoid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	106685-40-9	 ; Differin; Alcon brand of adapalene; Differine; Adapalene;Adapalene; Adapalene (Differin); Adaferin; Adapaleno			6.1227731148	4	5		0	0.81135903				RARB	O=C(O)c1ccc2cc(ccc2c1)c3cc(c(OC)cc3)C46CC5CC(CC(C4)C5)C6	Tocris	2852	1.14774115	1.1125158	1.62842339	2.10576693	0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015007-14	R-(+)-Atenolol	170464744	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	56715-13-0				0.483065046	4	5		0	-1.29817444					CC(C)NC[C@@H](O)COc1ccc(cc1)CC(N)=O	Vitas	STK528649	0.36630037	-0.4551201	2.61534666	-1.05288346	-1.29817444											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091493-09	Anethole	170465678	TNF signaling pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	104-46-1				1.3255439844	4	4		0	2.34148908			4313		COc1ccc(C=CC)cc1	Microsource	01503705	-0.43583535	0.10037641	-0.48137826	2.34148908												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183853-01	Mosapramine	144206880	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	89419-40-9				-3.997802115	4	4	MOSAPRAMINE HYDROCHLORIDE;LS-178090;Cremin;3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine;Spiro(imidazo(1,2-a)pyridine-3(2H),4'-piperidin)-2-one, 1'-(3-(3-chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)hexahydro-, dihydrochloride;CIPLUS_3853867;mosapraminum;CIPLUS_703731;Mosapramine hydrochloride;Y 516;(+/-)-1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F]AZEPIN-5-YL)PROPYL)HEXAHYDROSPIRO(IMIDAZO(1,2-A)PYRIDINE-3(2H),4'-PIPERIDIN)-2-ONE;Mosapramine Hydrochloride;Mosapramine;mosapramine;Y-516;MOSAPRAMINE;	0	-2.76243094					Clc5ccc6CCc1ccccc1N(CCCN2CCC4(CC2)C(=O)NC3CCCCN34)c6c5	Pharmaron	PH-NIH-183543	0.0968523	0.75282309	-1.59614897	-2.76243094												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00043225-04	Disodium 2-hydroxybutanedioate	170465632		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	676-46-0				-2.9968152896	4	4		0	0.02630887					[Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O	Specs	AE-562/J255939	-0.968523	-0.20075282	-1.03876362	0.02630887												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00166238-02	Benznidazole	170466539	Pyruvate:ferredoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	22994-85-0				-0.4116869827	4	4		0	1.62368672					O=C(Cn1ccnc1[N+]([O-])=O)NCc2ccccc2	SIGMA	419656	-0.18735363	-0.77048798	-0.87027468	1.62368672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022735-06	Methylprednisolone	170465051	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	83-43-2	; Medrone; Metipred;Methylprednisolone, 6-alpha; 6alpha-Methylprednisolone; Urbason;6alpha-Methylprednisolone; 6 Methylprednisolon; Medrol Veriderm; Medrol; Metilprednisolona;Methylprednisolone; 6-Methylprednisolone; Methylprednisolone Base; 6-alfa-Methylprednisolone			-2.0960750939	4	5		0	-0.81135903				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-279	0.31746032	-1.8204804	-0.14803849	-1.00502513	-0.81135903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167441-02	Pramipexole hydrochloride	170465264	Dopamine D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	104632-26-0	 ; PRAMIPEXOLE HCl; pramipexol, (R)-isomer;Pramipexole; Pramipexole; Pramipexole Hcl; Mirapex;Pramipexole (Mirapex)			-1.1848907885	4	5		0	2.19066937			1814	DRD3	CCCN[C@@H]1Cc2sc(N)nc2CC1	Prestwick Chemical, Inc.	Prestw-1316	-0.41514042	-1.517067	-1.03626943	-0.38286671	2.19066937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016667-04	Benoxinate hydrochloride	170464771	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5987-82-6				4.1439243667	4	5		0	4.46247465					Cl.CCN(CC)CCOC(=O)c1cc(OCCCC)c(N)cc1	Vitas	STK520615	0.46398046	-0.9102402	0.74019245	0.09571668	4.46247465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159340-05	Tazobactam sodium	170465148	Bacterial beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	89785-84-2				4.9967021067	4	5		0	0.56795132					[Na+].O=S3(=O)[C@@](C)(Cn1ccnn1)[C@@H](N2C(=O)C[C@H]23)C([O-])=O	Prestwick	Prestw-1349	1.24542125	-1.4664981	2.0231927	2.680067	0.56795132											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015882-15	Riluzole	170464928	Glutamate Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	1744-22-5	 ; Rilutek;PK-26124/RP-54274/Rilute;Riluzol; Prestwick-03A08;Riluzole; Riluzole; Riluzole hydrochloride			-3.6004419696	4	5		0	-1.37931034			2911	GRM1	FC(F)(F)Oc1ccc2nc(N)sc2c1	Vitas	STK503686	-0.9035409	-0.2528445	-0.69084629	-0.33500838	-1.37931034											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024674-14	NCGC00024674-14			DPI_SARS-CoV-2_General	2019_NPC-1_CPE					-0.6181024577	4	5		0	1.46044625					OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC=C	Microsource	01500422	-0.46398046	-1.2642225	0.04934616	0	1.46044625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015437-17	Fenofibrate	170464718	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	49562-28-9	; Fenofibrato; Tricor; ;FENOFIBRATE; Fenofibrate;Fenofibrate; Lipofene; Lipantil; Procetofen; Fenofibrate micronised			17.1134734393	4	5		0	9.81744422			5465	PPARA	O=C(c1ccc(Cl)cc1)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2	Microsource	01501010	2.90598291	0.7585335	3.60226992	1.91433357	9.81744422											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159458-05	Atorvastatin calcium	170465113	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	134523-03-8				5.8612927283	4	5		0	6.32860041					[Ca+2].O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC([O-])=O.[O-]C(=O)C[C@H](O)C[C@H](O)CCn4c(c1ccc(F)cc1)c(c2ccccc2)c(C(=O)Nc3ccccc3)c4C(C)C	Prestwick	Prestw-1232	0.21978022	-0.3034134	-0.04934616	1.38789184	6.32860041											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090753-06	Azithromycin		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	83905-01-5	; Azithromycin hydrate; ADES azithromycin; N-desmethylazithromycin; Zitromax; Zithromax  (azithromycin); NDES azithromycin;Azithromycin (AZ);Azithromycin; Azithromycin (AZ); Azithromycin Hydrate	11.220184543	-4.95	53.9245169871	3	5		83.5884989023	73.59026369	0.0005869764	0.9997064497			CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	FLUKA	57947	-0.21978022	-1.6182048	-0.39476931	1.05288346	73.59026369											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016666-06	Hydrocotarnine hydrobromide	170465806	Cytochrome P450 3A4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_CPE	5985-00-2				-5.1132632654	4	5		0	-2.35294118					Br.CN1Cc2c(OC)c3OCOc3cc2CC1	Vitas	STK802005	-0.36630037	-0.7079646	-1.87515421	-1.24431682	-2.35294118											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182065-02	Dimemorfan phosphate	144206689		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	36304-84-4	dimemorfan; Astomin; Dimemorfano; Dimemorfane; Dastosin; 			4.2847345619	4	4	LS-174594;Dimemorfano;DIMEMORFAN;CIPLUS_789081;Dimemorfane;3,17-dimethylmorphinan;Astomin;CIPLUS_775315;Dastosin;LS-174593;dimemorfanum;CIPLUS_739426;CIPLUS_207834;dimemorfan, (9alpha,13alpha,14alpha)-isomer;Yamanouchi brand of dimemorfan phosphate;Dimemorfan Phosphate;at-17;dinemorphan;Dimemorfan;(+)-3,17-DIMETHYLMORPHINAN;dimemorfan phosphate;dimemorfan phosphate (1:1) salt;dimemorfan;d-3-methyl-N-methylmorphinan;LS-174853;DIMEMORFAN PHOSPHATE;Dimemorfan phosphate;AT 17;LS-91711;Dimemorfanum;	0	4.83236994					O=P(O)(O)O.Cc3ccc4C[C@@H]1N(C)CC[C@]2(CCCC[C@H]12)c4c3	Kemprotec	36304-84-4	0.25706941	0.28675704	-0.26322716	4.83236994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174736-02	Uridine triacetate	174006168	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	4105-38-8	Uridine triacetate			2.0094236236	4	4		0	1.0867052				TYMS	CC(=O)OC[C@@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2\C=C/C(=O)NC2=O	SIGMA	T6001	0.10282776	0.54744526	0.7896815	1.0867052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188399-06	Fingolimod hydrochloride		Sphingosine Kinase 1 (SphK1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE					-1.2662382589	4	4		0	-2.75144509				SPHK1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1	Selleck	S5002	0	0.13034411	1.00026323	-2.75144509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024842-05	Clomethiazole	170466516		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	533-45-9				1.3701389346	4	4		0	-0.44725072					ClCCc1scnc1C	Tocris	0881	1.59806295	-0.55207026	-0.68406385	-0.44725072												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016624-05	Diphenidol	170465280	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	972-02-1				2.8542366699	4	4		0	5.44593528					OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3	Prestwick	Prestw-252	-1.2590799	-0.55207026	-0.38003547	5.44593528												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164375-03	1-Phenoxy-2-propanol	170465645		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	770-35-4				-4.1221379506	4	4		0	-0.18416206					CC(O)COc1ccccc1	SIGMA	484423	-0.92009685	-1.30489335	-1.2414492	-0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021148-08	Metoprolol tartrate	170464652		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	56392-17-7				0.7229967	4	4		0	0.55248619					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC	Microsource	01500411	0.0968523	0.10037641	-0.12667849	0.55248619												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016229-14	Propylthiouracil	170464965	Antithyroid Drugs	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	51-52-5	; ; 6 Propyl 2 Thiouraci;Propylthiouracil;6-Propyl-2-thiouracil; Propiltiouracilo;PROPYLTHIOURACIL; Propylthiouracil			-3.9531830506	4	4		0	-1.7100763			7173	TPO	S=C1NC(CCC)=CC(=O)N1	Microsource	01500515	-0.72639225	-0.70263488	-0.22802128	-1.7100763												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00024846-08	Guanabenz	170465364	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	5051-62-7				-1.0450342264	4	4		0	0.18416206					Clc1cccc(Cl)c1/C=N/NC(=N)N	Enzo	AC153	-0.04842615	-0.40150565	-0.83607803	0.18416206												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159474-03	Fluprednisolone	170465086	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	53-34-9				1.2500398029	4	4		0	0.04948046					OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	SIGMA	34206	1.01498308	-0.12333498	-0.57270124	0.04948046												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167492-03	Lercanidipine hydrochloride	170465587	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	132866-11-6		11.220184543	-4.95	29.2663983561	3	4		41.3252148971	36.10315186	0.0208895377	0.9997310169			Cl.CC=3NC(C)=C(C(C=3C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c2ccccc2)c4cccc(c4)[N+]([O-])=O)C(=O)OC	Sequoia	132866-11-6	0.09367681	0.58370301	2.3388632	36.10315186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507682-01	Emodepside		synaptic transmission Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	155030-63-0		7.0794578438	-5.15	53.2913352765	2.2	4		67.7479259279	61.747851	0.0281426025	0.9995113164	174419		CC(C)C[C@@H]1N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC2=CC=C(C=C2)N3CCOCC3)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC4=CC=C(C=C4)N5CCOCC5)OC1=O	AdvChemBlocks	M15352	-0.37470726	-1.47093159	13.05412021	61.747851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167586-03	Piroctone Olamine	225144295		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	68890-66-4		7.9432823472	-5.1	46.2149283186	3	4		57.4078612692	53.34104046	0.0144712938	0.9998708638			CC(CC/1=C/C(=C\C(=O)N1O)C)CC(C)(C)C	Bosche	P6136	0.35989717	0.02606882	7.73887865	53.34104046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263897-02	PREDNISOLONE HEMISUCCINATE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2920-86-7				-2.4636092778	4	4		0	0.06936416					C[C@]12C[C@H](O)C3C(CCC/4=C/C(=O)/C=C\[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	Microsource	01505450	-0.71979434	-0.49530761	-0.4738089	0.06936416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178520-03	Bromhexine hydrochloride	170465803	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	611-75-6	; Amiorel;abiadin;Bromhexine hydrochloride;Bromhexine HCl;BROMHEXINE HYDROCHLORIDE; Amyorel	11.220184543	-4.95	24.9767393596	4	4		30.6564129321	25.68786127	0.0723427244	0.9967650282			Cl.CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2	Vitas	STK177356	1.49100257	-0.13034411	2.94814425	25.68786127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249414-01	Fonazine	144206752	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	7456-24-8		28.1838293126	-4.55	38.787368402	3	4		103.7806715257	88.25433526	0.0145565763	0.9998692928	3269		CN(C)S(=O)(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1	NCGCChem	DJM10-019	-0.41131105	0.75599583	0.05264543	88.25433526												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00174007-04	Pyrantel tartrate	170465676	Antiparasitic Agent	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	33401-94-4				3.5978128351	4	4		0	-0.20809249					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2CCCN=C2/C=C/c1cccs1	Vitas	STK676402	1.23393316	0.70385819	0.1579363	-0.20809249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095086-04	PERICIAZINE		Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	2622-26-6		10	-5	47.2293407745	3	4		63.8079322836	57.13294798	0.0361352434	0.9991940208			OC1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(C=C24)C#N)CC1	Microsource	MS-01503936	1.02827763	-0.86027112	3.57988944	57.13294798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142423-06	Phlorizin		SGLT-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	60-81-1				1.3454754018	4	4		0	0.7007007				SCL5A2	OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(=CC(=C2)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-NAT-0295	0.71564885	-0.54858934	-0.89028542	0.7007007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094852-04	L-Thyroxine		synthetic hormone	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	51-48-9				2.5962754015	4	4		0	-0.65065065				THRA	NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O	APExBIO	B2107	1.43129771	0.33960293	-0.26184865	-0.65065065												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510144-01	Gestonorone			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2137-18-0				4.3024224023	4	4		0	0.4004004					CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@@H]4[C@H]3CC[C@]12C	Glixx	GLXC-08149	1.57442748	-0.60083595	0.57606703	0.4004004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344522-01	Gluconolactone	170465327	Calcium Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	90-80-2				4.1572830119	4	4		0	-0.95095095					O[C@H]1[C@H](O)[C@@H](O)C(=O)O[C@@H]1CO	SIGMA	G2164	2.09923664	-0.96656217	0.26184865	-0.95095095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015661-12	Molsidomine	170465872		DPI_SARS-CoV-2_General	2019_NPC-2_CPE	25717-80-0				-3.2214668938	4	4		0	-0.60510392					O=C(OCC)[N-]c1c[n+](no1)N2CCOCC2	Microsource	01500673	-0.82324455	-0.75282309	-0.48137826	-0.60510392												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183011-01	Itasetron	144206831	Serotonin 3 (5-HT3) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_CPE	123258-84-4	Itasetron; DAU 6215 hydrochloride; 			-0.6662167926	4	4	itasetronum;itasetron;DAU 6215 hydrochloride;ITASETRON HYDROCHLORIDE HYDRATE;(endo-N-8-methyl-8-azabicyclo(3.2.1.)-oct-3-yl)-2,3-dihydro-2-oxo-1H-benzimidazol-1-carboxamide;Itasetron Hydrochloride Hydrate;U-98079A;CIPLUS_197009;Itasetron;DAU 6215;CIPLUS_3881158;LS-32715;N-(8-methyl-8-azabicyclo (3.2.1.)oct-3-yl)2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxamide;ENDO-2,3-DIHYDRO-N-((8-METHYL)-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO-1H-BENZIDAZOLE-1-CARBOXAMIDE HYDROCHLORIDE HYDRATE;2-OXO-N-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-YL-1-BENZIMIDAZOLINE-1-CARBOXAMIDE;ITASETRON;LS-172560;1H-BENZIMIDAZOLE-1-CARBOXAMIDE, 2,3-DIHYDRO-N-(8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO, ENDO-;	0	2.55196001					CN4[C@@H]1CC[C@H]4C[C@H](C1)NC(=O)N2c3ccccc3NC2=O	Pharmaron	PH-NIH-151623	-1.59806295	-0.45169385	-0.17734989	2.55196001												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249915-01	Bupranolol	170465802	Beta-3 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	14556-46-8				10.6777222661	4	4		0	1.28649184					Clc1ccc(C)cc1OCC(O)CNC(C)(C)C	GVK	FFS-11-286-NCI-172	2.80328661	2.09669462	2.48170538	1.28649184												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00344544-01	Cabergoline	170464667	Serotonin 2b (5-HT2b) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	81409-90-7		12.5892541179	-4.9	68.7258613304	3	4		102.3549074395	88.57803468	0.0113706363	0.9999202518			CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CC=C)c34	SIGMA	C0246	0.71979434	-0.2346194	1.21084496	88.57803468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-14	ANCITABINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_CPE	10212-25-6				-6.2971800462	4	4		0	-2.10404624					[H][C@]1(CO)O[C@@]2([H])N3C=CC(=N)N=C3O[C@@]2([H])[C@]1([H])O	Microsource	01504137	-1.18251928	-0.91240876	-1.52671756	-2.10404624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167561-03	D-alpha-Tocopherol succinate	225144294		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	4345-03-3		7.0794578438	-5.15	10.3098339059	4	4		13.808483292	11.39884393	0.0160511112	0.9998428257			CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(=O)CCC(O)=O	SIGMA	T3126	-0.25706941	0.07820647	3.42195315	11.39884393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017063-07	Amodiaquin dihydrochloride dihydrate		Antimalarial; Histamine N-methyl Transferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	6398-98-7		1.5848931925	-5.8	126.3810264273	1.3	4		87.3953906497	69.56956957	0.326532376	0.9278682669			CCN(CC)CC1=C(O)C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl	Prestwick	Prestw-309	1.52671756	-1.01880878	101.85912543	69.56956957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183598-02	Ximelagatran		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	192939-46-1				1.8954240863	4	4		0	1.4014014					CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)\C(N)=N\O	DC Chemicals	DC7647	-0.04770992	0.13061651	1.25687353	1.4014014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484056-01	Testosterone (undecanoate)			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	5949-44-0				0.6847781404	4	4		0	-0.8008008					CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0626	-0.19083969	2.84743992	-0.31421838	-0.8008008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263538-01	Trovafloxacin mesylate	170465074	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	147059-75-4				-0.107204808	4	4		0	-0.35035035					CS(=O)(=O)O.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3C[C@H]4[C@H](N)[C@H]4C3)c5ccc(F)cc5F	Tocris	3863	0.23854962	-1.85475444	1.2045038	-0.35035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179514-05	Ceforanide		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	60925-61-3				-4.0352519237	4	4		0	0.2002002					NCC1=C(CC(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4CC(O)=O)C=CC=C1	Prestwick	Prestw-470	-1.57442748	-0.18286311	-0.05236973	0.2002002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160603-02	4-Styrylpyridine	144205483		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	103-31-1	4-styrylpyridine; 4-stilbazole, (E)-isomer; 4-stilbazole, (Z)-isomer; 			-3.3667610875	4	4	CIPLUS_714835;4-stilbazole, (E)-isomer;STYRYLPYRIDINIUM CHLORIDE;CIPLUS_679001;4-STYRYLPYRIDINIUM CHLORIDE;4-stilbazole;4-styrylpyridine;4-stilbazole, (Z)-isomer;4-stilbazole monohydrochloride, (E)-isomer;4-stilbazole monohydrochloride;	0	-0.4004004					C(=Cc1ccncc1)c2ccccc2	Maybridge	JFD 00085	-1.09732824	0.39184953	-0.47132757	-0.4004004												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178754-06	Primaquine diphosphate	174006623	antimalarial	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63-45-6				12.9451567901	4	4		0	8.287147					O=P(O)(O)O.O=P(O)(O)O.CC(CCCN)Nc1cc(cc2cccnc12)OC	Microsource	01500500	1.34180791	2.15727209	-0.1349892	8.287147												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00095049-04	Exalamide	170465990		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	53370-90-4				-2.4762093816	4	4		0	-0.26392188					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-0.87099812	-0.69589422	-0.08099352	-0.26392188												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00164283-07	Hexadecyltrimethylammonium bromide	170465714	Cell membrane Interacts	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	57-09-0				-4.7290439727	4	4		0	-2.79757192					[Br-].C[N+](C)(C)CCCCCCCCCCCCCCCC	Microsource	01503200	-0.21186441	-1.04384134	-0.51295896	-2.79757192												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016564-06	Metformin	170464804	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			0.8900251555	4	4		0	2.05859066			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	0.02354049	-0.27835769	-1.16090713	2.05859066												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00249933-01	Nitrogen mustard N-oxide	170465894		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	126-85-2				1.3825786429	4	4		0	0.79176564					[O-][N+](C)(CCCl)CCCl	GVK	FFS-11-286-NCI-237	-0.11770245	0.27835769	0.51295896	0.79176564												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090691-03	2',3'-Dideoxyinosine	174006954	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	69655-05-6	 Videx; Didanosina;Didanosine; ; didanosine (ddI);2',3'-Dideoxyinosine; didanosine??(ddI); 0   Didanosine; ddIno; 2',3' Dideoxyinosin; NunclonD multidishes; 2',3'-Dideoxyinosine (ddI); Inosine, 2',3'-dideoxy-			-1.2570947377	4	4		0	0.04948046			7015	TERT	O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1	Prestwick	Prestw-153	-0.53165781	-0.37000493	-0.06363347	0.04948046												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00183024-01	Proglumetacin	144206876	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	57132-53-3	Proglumetacin; Miridacin; Proglumetacina; 	12.5892541179	-4.9	105.5738805061	3	4	LS-82118;proglumetacine;Proglumetacinum;proxil;Proglumetacina;Proglumetacin Maleate;Proglumetacin;Proglumetacine;CIPLUS_182770;proglumetacin;Proglumetacin maleate;METACINE-P;LS-175816;Miridacin;PROGLUMETACIN MALEATE;PROTACINE;3'-(4-(2-(1-p-chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate;PROGLUMETACIN;proglumetacinum;CIPLUS_685564;3-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)PROPYL DL-4-BENZAMIDO-N,N-DIPROPYLGLUTARAMATE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETATE;	120.095250761	97.08065314	0.0216422145	0.9997110056			CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5	Pharmaron	PH-NIH-183347	0.04833253	0.5673409	-1.3363029	97.08065314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016270-09	Levodopa	225144176	Dopamine Precursors	DPI_SARS-CoV-2_General	2019_NPC-3_CPE	59-92-7	 beta Hydroxytyrosin; Dopaflex; 3-Hydroxy-DL-tyrosine; 3,4 Dihydroxyphenylalanin; DL-Tyrosine, 3-hydroxy-; Dihydroxyphenylalanine; DL-3-Hydroxytyrosine; ;L-3,4-Dihydroxyphenyl-alanine; Levopa; Sinemet CR4;LEVODOPA; L-3-Hydroxytyrosine; 3 Hydroxy DL tyrosin; Sinemet CR; Roberts Brand of Levodopa; 3 Hydroxy L tyrosin; Levodopa;L-3,4-Dihydroxyphenylalanine; beta-Hydroxytyrosine; Ro 8-0576-12;Levodopa; 3-Hydroxy-L-tyrosine;L-Dopa; Nakom; Larodopa; L-DOPA-ring-d3; Dopar; Maipedopa; Roche Brand of Levodopa; Ro 8-0576-7; L Dop; Ro 8-0576; D-3-Hydroxytyrosine			5.7171618397	4	4		0	0.79168728				DRD1	N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	AC1036	2.17496375	2.34336458	0.82723513	0.79168728												3.2E-10	1.6E-9	8E-9	2E-7											
NCGC00164564-06	Emtricitabine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	143491-57-0				1.3961472626	4	4		0	4.63228271				TERT	NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	Adooq	A10349	-0.79625293	-0.21013308	0.1631765	4.63228271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344534-01	Indigo carmine	225144381		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	860-22-0				-2.626783234	4	4		0	0.42979943					[O-][S](=O)(=O)C1=CC2=C(NC(\C2=O)=C/3NC4=CC=C(C=C4C3=O)[S]([O-])(=O)=O)C=C1	SIGMA	131164	-1.264637	-0.95727294	1.35980419	0.42979943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532512-01	HYDROCORTISONE ACEPONATE			DPI_SARS-CoV-2_General	2019_NPC-7_CPE					0.7445591974	4	4		0	1.43266476					CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	BOC Sciences	74050-20-7	0.18735363	-0.77048798	-0.38074517	1.43266476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167544-02	2,2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]	225144291		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	103597-45-1				0.7669619083	4	4		0	0.9017341					CC(C)(C)CC(C)(C)C1=CC(=C(O)C(=C1)[N]2N=C3C=CC=CC3=N2)CC4=CC(=CC(=C4O)[N]5N=C6C=CC=CC6=N5)C(C)(C)CC(C)(C)C	SIGMA	407941	-0.15424165	-0.18248175	-0.6317452	0.9017341												1.6E-8	8E-8	4E-7	0.000002											
NCGC00166125-02	Meglumine	170465359	amino sugar	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	6284-40-8	 hypaque(M)90; Isopaque coronar; N-Methyl-D-glucamine; Isteropac; Banamine; Urovist; Isopaque cerebral;Meglumine; Renovue-65; ; Uropolinum Polfa; Vascoray; Uropolin; Renovist II; Conraxin-H; Hypaque 76; Telebrix 350; Salicylate Meglumine; Uromiron; Meglumine iotalamate; Meglumine; Fortombrine; Sch 14714 meglumine; N-Methyl-D-Glucamine; Vasurix; Visotrast; Meglumina			-0.065012191	4	4		0	0.62427746				GLUT1	O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO	Prestwick	Prestw-884	0	-0.28675704	-0.4738089	0.62427746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346570-04	Tebipenem pivoxil		Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	161715-24-8				0.4928624861	4	4		0	-0.39306358					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(=O)OCOC(=O)C(C)(C)C)SC3CN(C3)/C4=N/CCS4	MedChem Express	HY-B0396	0.61696658	-0.33889468	-0.7896815	-0.39306358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021305-19	Sirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	(53123-88-9)				-3.5767943353	4	4		0	3.5035035				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	SynKinase	SYN-1185	-1.57442748	-1.85475444	-1.25687353	3.5035035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181130-02	Eletriptan	170465317	5-hydroxytryptamine receptor 1F Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	143322-58-1				-1.7205450792	4	4		0	-0.48905449			3355	HTR1F	CN4CCC[C@@H]4Cc2cnc3ccc(CCS(=O)(=O)c1ccccc1)cc23	Sequoia	143322-58-1	-0.44041451	0.07313506	-0.40271835	-0.48905449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485994-01	Bivalirudin (Trifluoroacetate)			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	128270-60-0				4.2571560019	4	4		0	1.04797392					CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CCCN3C(=O)[C@@H](N[2H])CC4=CC=CC=C4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(O)=O	MedChem Express	HY-15664	0.18134715	1.7796197	1.66121319	1.04797392												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00164557-11	Eprosartan mesylate		urate transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	144143-96-4				0.3741817936	4	4		0	-0.02328831				AGTR1	CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	SIGMA	E2535	0.23316062	-1.09702584	0.8054367	-0.02328831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188962-02	Pravastatin sodium	174007284	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	81131-70-6	Pravastatin			0.59084176	4	4		0	0.10556875			3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	Prestwick	Prestw-1319	0.25894539	-0.69589422	0.45896328	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00179492-03	Flunisolide	170465331	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	3385-03-3				-0.9056700066	4	4		0	0.68619689				NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-643	-0.07062147	-1.73973556	-0.29697624	0.68619689												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00483012-01	Phytic acid		lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	83-86-3				-3.8660640761	4	4		0	-0.19102197					O[P](O)(=O)OC1C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C1O[P](O)(O)=O	DC Chemicals	DCZ-023	-1.12412178	-0.02334812	-1.19662769	-0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-06	Masitinib		FGFR 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1048007-93-7		2.5118864315	-5.6	14.4695516505	4	4		14.511709596	12.79847182	0.0223336826	0.9996946904		FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	Axon Medchem	1419	-0.84309133	1.28414663	8.81153114	12.79847182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181132-01	Halofuginone hydrochloride	144206292		DPI_SARS-CoV-2_General	2019_NPC-7_CPE	1217623-74-9	halofuginone; Halofuginona; Stenorol; 			-4.0484077337	4	4	halofunginone;LS-176413;Halofuginone hydrobromide;halofuginone;LS-140372;HALOFUGINONE;RU-19110;Halofuginonum;4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-;7-bromo-6-chlorofebrifugine;Halofuginone Hydrobromide;HALOFUGINONE HYDROBROMIDE;CIPLUS_205078;7-bromo-6-chloro- 3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)- quinazolinone;CIPLUS_205079;Halofuginona;halofuginone lactate;LS-173665;Stenorol;halofuginonum;7-bromo-6-chloro-3,3-(3-hydroxy-2-piperidyl)acetonyl-4(3H)-quinazolinone-hydrolactate;Halofuginone;CIPLUS_205081;CIPLUS_205080;	0	-2.00573066					Cl.O[C@@H]3CCCN[C@H]3CC(=O)CN2C=Nc1cc(Br)c(Cl)cc1C2=O	Toronto Research	H102500	-0.70257611	-0.21013308	-0.87027468	-2.00573066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183876-03	Tenofovir disoproxil fumarate	170465338	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_CPE	202138-50-9	Tenfovir disoproxil fumarate;TENOFOVIR DISOPROXIL FUMARATE			-0.0850020728	4	4		0	0.19102197			7015	TERT	O=C(O)C=CC(=O)O.CC(C)OC(=O)OCOP(=O)(OCOC(=O)OC(C)C)CO[C@H](C)Cn2cnc1c(N)ncnc12	Sequoia	202138-50-9	0.14051522	-0.02334812	-0.81588251	0.19102197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390584-01	Exatecan	384569198	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_CPE	169869-90-3				-9.1553797831	4	4		0	-0.85549133				TOP1	CC[C@@]1(O)C(=O)OC/C2=C1/C=C3\N(CC4=C5[C@@H](N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O	MedChem Express	HY-13631A	-2.46786632	-1.7987487	-1.36878126	-0.85549133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166249-03	Erythrosin B	170465719		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	15905-32-5				-0.9988265367	4	4		0	0.34682081					Ic4c5Oc1c(I)c(O)c(I)cc1C3(OC(=O)c2ccccc23)c5cc(I)c4O	SIGMA	200964	-0.87403599	0.18248175	1.21084496	0.34682081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160570-01	Butonate	144205461		DPI_SARS-CoV-2_General	2019_NPC-8_CPE	126-22-7	Butonate; Butonato; Pedix PE 50; 			0.2341380624	4	4	Pedix PE 50;Tribufon;butonatum;0,0,dimethyl-2,2,2-trichloro-1-n-butyryloxyethyl phosphonate;CIPLUS_173408;LS-47987;Butonate;BUTONATE;butonate;tribuphon;tribufon;Butonatum;Butonato;	0	-0.67052023					O=P(OC)(OC)C(OC(=O)CCC)C(Cl)(Cl)Cl	SigmaAldrich	S360910	-0.05141388	0.07820647	0.89497236	-0.67052023												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00166059-02	Aluminum acetate, basic			DPI_SARS-CoV-2_General	2019_NPC-6_CPE	142-03-0				6.8449440213	4	4		0	3.3033033					CC(=O)O[Al](O)OC(C)=O	SIGMA	289825	0.90648855	-0.91431557	1.46635245	3.3033033												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00388420-02	Pentostatin	363680730	Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_CPE	53910-25-1				-3.3903956737	4	4		0	0.15015015				ADA	OC[C@H]1O[C@H](C[C@@H]1O)[N]2C=NC3=C2N\C=N/C[C@H]3O	MedChem Express	HY-A0006	-0.90648855	-1.12330199	-0.57606703	0.15015015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344533-01	Nalpha-Acetyl-L-glutamine	170465810		DPI_SARS-CoV-2_General	2019_NPC-6_CPE	2490-97-3				4.5932473266	4	4		0	3.35335335					O=C(C)NC(CCC(N)=O)C(=O)O	SIGMA	A9125	-0.04770992	3.57889237	-0.41895784	3.35335335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182979-02	Perlapine		Histamine H1 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_CPE	[1977-11-3]				10.2506428014	4	4		0	2.21238938					CN1CCN(CC1)C/2=N/C3=C(CC4=C2C=CC=C4)C=CC=C3	Tocris	5549	2.56476684	2.02340322	0.90611628	2.21238938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179245-04	Alcuronium chloride			DPI_SARS-CoV-2_General	2019_NPC-9_CPE	15180-03-7				7.7098419956	4	4		0	3.70284117					OC\C=C1/C[N@@+]2(CC[C@@]34[C@@H]2C[C@@H]1\C5=C\N6C7\C(=C/N(C35)C8=C4C=CC=C8)[C@H]\9C[C@H]%10[C@@]7(CC[N@@+]%10(CC=C)CC9=C\CO)C%11=C6C=CC=C%11)CC=C	Prestwick	Prestw-1036	0.85492228	1.68210629	2.26529071	3.70284117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018125-05	Tripelennamine citrate	170465118	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	6138-56-3				-0.8990929485	4	4		0	0.10556875					O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCN(Cc1ccccc1)c2ccccn2	Microsource	01500597	-0.35310734	-0.06958942	-0.29697624	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094818-09	Hexestrol	170466031	17-betahydroxysteroid dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	84-16-2	; ; Hexoestrolum; Hexestrol, (R*,S*)-Isomer;Hexestrol; Dihydrodiethylstilbestrol;meso-Hexestrol;HEXESTROL; HEXESTROL			1.6202399378	4	4		0	4.38110319			1645	AKR1C1	Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2	Microsource	01500632	-1.20056497	-0.27835769	-0.72894168	4.38110319												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00094516-08	Coumaphos	170466302		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	56-72-4				-0.8915724847	4	4		0	0.10556875					CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	Microsource	00330012	-0.77683616	0.41753653	0.1349892	0.10556875												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00013895-08	Benzbromarone	170465792	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	3562-84-3				8.0547330627	4	4		0	7.864872					Brc1cc(cc(Br)c1O)C(=O)c2c3ccccc3oc2CC	Labotest	LT00134669	-0.07062147	-0.34794711	-0.18898488	7.864872												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016271-05	Tolazoline hydrochloride	170465219	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	59-97-2				-1.7100498754	4	4		0	0.58062813					Cl.c2cc(CC1=NCCN1)ccc2	Specs	AT-139/J221336	-0.49435028	-1.60055672	-0.29697624	0.58062813												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00167737-02	Lazabemide hydrochloride	170466038	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	103878-83-7				-0.3459900662	4	4		0	2.11137503					Cl.Clc1cnc(cc1)C(=O)NCCN	Tocris	2460	-1.34180791	0.27835769	-0.35097192	2.11137503												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00021193-03	AMCINONIDE			DPI_SARS-CoV-2_General	2019_NPC-4_CPE	51022-69-6				0.939056396	4	4		0	1.63631565					CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]4[C@@H]5CCC/6=C/C(=O)/C=C\[C@]6(C)[C@@]5(F)[C@@H](O)C[C@]24C	FLUKA	A2428	-0.49435028	0.20876827	-0.08099352	1.63631565												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00159380-05	Benzoyl peroxide	170464986		DPI_SARS-CoV-2_General	2019_NPC-4_CPE	94-36-0				-3.5062460769	4	4		0	-0.42227501					O=C(OOC(=O)c1ccccc1)c2ccccc2	Labotest	LTBB002750	-0.87099812	-0.13917884	-1.26889849	-0.42227501												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00090820-03	4-Acetamidobenzoic acid	170466207	immune response Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	556-08-1				-1.0572934004	4	4		0	-1.00290314					O=C(C)Nc1ccc(cc1)C(=O)O	Specs	AE-562/J256200	-0.49435028	0.76548365	0.4049676	-1.00290314												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00016026-10	Terazosin hydrochloride	170465073	Alpha1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_CPE	63074-08-8	; ; Terazosin hydrochloride;TERAZOSIN HYDROCHLORIDE; Hytrin; Terazosina;Terazosin hydrochloride			-3.9301668623	4	4		0	-1.42517815			148	ADRA1A	Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1	Vitas	STK567029	-0.58851224	-0.97425191	-0.56695464	-1.42517815												3.2E-8	1.6E-7	8E-7	0.000019999999999											
NCGC00025179-12	Mifepristone	170465151	Progesterone Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	84371-65-3	RU-486; ;VX-410;RU-38486;VGX-410C;VGX-410;Mifepristone (Mifeprex); Corlux; Mifepristone;C-1073;CI-1073;Mifepristone; Mifeprex	6.3095734448	-5.2	23.5067222353	4	5		31.069873996	25.25111607	0.1198501458	0.9342177088	5241	PGR	CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45	Prestwick	Prestw-299	-1.79945396	-2.55822833	5.970356	7.99141861	25.25111607											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095255-08	dl-alpha-Tocopheryl acetate	170465444		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52225-20-4				-4.2605127459	4	5		0	-1.5625					CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	Microsource	00310040	-1.20377265	-4.39098893	3.64316387	-0.48270314	-1.5625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166298-02	Melengestrol acetate	170465702		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2919-66-6				-1.5950393942	4	5		0	4.01785714					CC(=O)[C@@]3(OC(C)=O)C(=C)C[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1435	-1.89873418	-3.50006364	0.48483169	1.47492625	4.01785714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165856-03	Orlistat	170464663	Fatty acid synthase inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	96829-58-2		11.220184543	-4.95	16.650347929	4	5		26.9430255441	21.26304377	0.0061752182	0.9969069349		FASN	O=C(O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC)C(CC(C)C)NC=O	Sequoia	96829-58-2	-0.78585462	0.13530135	0.70789368	2.32616941	21.26304377											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167962-06	Quinapril hydrochloride	170465312	Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	82586-55-8				6.1773793048	4	5		0	1.28743732					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O	Microsource	01503076	1.84184676	4.39114391	-0.1736343	-1.64348925	1.28743732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181909-01	Sulcaine	144206885		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	41653-21-8	Ethyl piperidinoacetylaminobenzoate; Sulcain; Nichicaine; 			-7.788644345	4	5	Ethyl Piperidinoacetylaminobenzoate;CIPLUS_3838938;P-(PIPERIDINOACETAMIDE)BENZOIC ACID ETHYL ESTER;Nichicaine;ETHYL PIPERIDINOACETYLAMINOBENZOATE;CIPLUS_196504;CIPLUS_180054;Sulcain;Ethyl piperidinoacetylaminobenzoate;	0	0.16741071					O=C(CN1CCCCC1)Nc2ccc(cc2)C(=O)OCC	Pharmaron	PH-NIH-22	-2.59369571	-0.3181876	-1.84236044	-2.27943148	0.16741071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167546-03	S-(5 -Adenosyl)-L-methionine p-toluenesulfonate salt	225144292	S-adenosylmethionine synthase isoform type-2 Binding Agent	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	17176-17-9				-2.8423938029	4	5		0	-1.86941964					C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N	SIGMA	A2408	-2.29585505	2.17640321	5.3608533	-3.51300617	-1.86941964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167446-02	Methyclothiazide	170465243	Sodium-(potassium)-chloride cotransporter 2 Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	135-07-9				-5.6076534467	4	5		0	-2.1484375					NS(=O)(=O)c2cc1c(NC(CCl)N(C)S1(=O)=O)cc2Cl	Bosche	M5731	-3.71059816	-2.53277332	3.0059565	3.64709037	-2.1484375											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095933-04	Phenyl 4-aminosalicylate	170465273		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	133-11-9				-0.7508980001	4	5		0	-0.47431901					Oc2cc(N)ccc2C(=O)Oc1ccccc1	Microsource	00305025	0.58939096	-0.35670357	0.62775477	-2.40202276	-0.47431901											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015523-13	Hydroquinone	170464661		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	123-31-9				-4.7256607045	4	5		0	-1.91082803					Oc1ccc(O)cc1	Vitas	STK397446	-1.2524558	-1.80811808	-1.48256979	1.89633375	-1.91082803											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164604-10	Fluvastatin Na			SARS-CoV-2_CPE_SRI	2019_NPC-2.2			10	-5	4.4904259948	4	5		20.940919792	17.02008929	0.0071228177	0.9964313696			CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C3=CC=C(F)C=C3	Sequoia	SRP01980f	-1.60089352	-2.86368843	-2.86743316	-1.79672835	17.02008929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024683-23	Parthenolide			SARS-CoV-2_CPE_SRI	2019_NPC-3.2	20554-84-1		0.316227766	-6.5	22.1020748192	4	5		11.6107011079	17.14324434	0.5602811356	0.4936342172			C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	SIGMA	P0667	0.29469548	-1.75891759	13.58354481	0.68268015	17.14324434											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093560-05	Finasteride	170464818	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	98319-26-7	; ; Propecia; Proscar; Finasterida;Finasteride; Finasteride			-0.4515723671	4	5		0	-0.79956634			374	AR	CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C	Prestwick Chemical, Inc.	Prestw-717	-1.62082515	-2.300123	3.69974623	3.10998736	-0.79956634											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00070736-03	Imiquimod	170464691	TLR 7 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	99011-02-6	; ; 3M Brand of Imiquimod; Aldara; Imiquimod;Imiquimod	3.1622776602	-5.5	4.3553667475	4	5		12.7131630599	10.7196097	0.0450371919	0.9768767265	51284	TLR7	CC(C)Cn3cnc2c(N)nc1ccccc1c23	Vitas	STK583860	-3.09430255	-1.93111931	-0.76131962	-0.27812895	10.7196097											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00159481-03	Sofalcone	170466017	Prostaglandin Synthesis and Regulation Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	64506-49-6		8.9125093813	-5.05	26.9158328786	4	5		22.947499648	21.26116071	0.0704163871	0.9629372465			C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C	Bionet	KS-1141	3.85951849	1.38729795	-0.78958304	4.93429874	21.26116071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091195-08	Hexachlorophene	170464690	Glucose-6-phosphate dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	70-30-4		0.2238721139	-6.65	80.1334900623	1.2	5		39.6264268287	33.7890625	0.0224904	0.9885698122			Clc2c(Cc1c(O)c(Cl)cc(Cl)c1Cl)c(O)c(Cl)cc2Cl	Vitas	STK377478	-2.46959543	9.73654066	36.44549107	38.88441942	33.7890625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015092-10	Aminocaproic acid	170465057	PAI Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60-32-2	 6-Aminohexanoic acid;6-Aminohexanoic acid;AMINOCAPROIC ACID;6-AMINOCAPROIC ACID;Aminocaproic acid; 6-Aminocaproic acid			-2.2250961536	4	5		0	-2.65066964			5054	SERPINE1	NCCCCCC(=O)O	Microsource	01500114	-0.03723008	-5.07827415	1.28826707	3.53982301	-2.65066964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021146-09	Ketanserin	170466645	5-HT2A Antagonists?	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	74050-98-9	Ketanserin tartrate;Ketanserin;KETANSERIN TARTRATE	12.5892541179	-4.9	15.9312903826	2.4	5		30.386597936	23.18638393	0.0194776453	0.9901382877	3356	HTR2A	Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4	Enzo	NS515	0.01241003	-2.40549828	0.29089902	0.08045052	23.18638393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182991-01	Glybuzole	144206873	insulin secretion Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	1492-02-0	Glybuzole; Gludiase; Glibuzol; 			-0.5306370638	4	5	CIPLUS_216125;Glibuzol;desaglybuzole;LS-31372;glybuzole;Gludiase;N-(5-tert-butyl-1,3,4- thiadiazol-2-yl)benzenesulfonamide;GLYBUZOLE;Benzenesulfonamide, N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-;TH-1395;glybuzolum;Glybuzolum;Glybuzole;	0	0.78125					O=S(=O)(Nc1nnc(s1)C(C)(C)C)c2ccccc2	Pharmaron	PH-NIH-183235	0.53363117	-4.13643884	3.75398255	-2.62805042	0.78125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015542-07	Ibudilast	170466049	Phosphodiesterase 4A Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50847-11-5				-8.1706479461	4	5		0	-4.4921875					CC(C)C(=O)c1c2ccccn2nc1C(C)C	Prestwick	Prestw-1286	-0.28543063	-2.02367316	-1.31597174	-2.78895146	-4.4921875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015838-06	Propionylpromazine hydrochloride	170466841	Trypanothione reductase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	7681-67-6		10	-5	24.6511842881	3	5		46.4796364696	40.98772321	0.0232531874	0.9881750776			Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	SIGMA	P7780	-3.85951849	-1.18365788	1.89776977	0.96540628	40.98772321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159392-05	1,1,1-Trichloro-2-methyl-2-propanol	170465458		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	57-15-8				5.7696474301	4	5		0	-0.69115056					ClC(Cl)(Cl)C(C)(C)O	Labotest	LT03378907	3.0697446	-1.95571956	1.13530119	1.6687737	-0.69115056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024622-05	Dantrolene sodium	170464793	Ryanodine receptor 1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14663-23-1		3.9810717055	-5.4	4.8427867017	4	5		20.979371316	12.12901477	0.4202889003	0.6883866149	6261	RYR1	[Na+].[O-][N+](=O)c1ccc(cc1)c3ccc(/C=N/N2CC(=O)[N-]C2=O)o3	Enzo	AC100	-3.73280943	-2.66912669	6.07720048	0.4551201	12.12901477											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165864-04	Pipamperone dihydrochloride	170465949	Serotonin 2c (5-HT2c) receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	2448-68-2				15.0578648706	4	5		0	2.07345169					Cl.Cl.Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(C(N)=O)N3CCCCC3	Microsource	01505690	1.27701375	5.0799508	1.37571791	9.48166877	2.07345169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018238-09	Oxibendazole	170465661	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	20559-55-1	OXIBENDAZOLE;Oxibendazole; Loditac; Oxibendazolo;			-13.5932915151	4	5		0	-0.82667028				POLB	O=C(OC)Nc1nc2cc(ccc2n1)OCCC	Microsource	01503373	-3.29076621	-2.76752768	-4.20729264	-2.85714286	-0.82667028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096056-02	Ethacridine lactate hydrate	170465798		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	6402-23-9		0.4466835922	-6.35	3.9836877938	4	5		-8.2095165519	-1.47879464	0.561315511	0.4936359597			O.O=C(O)C(C)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	Labotest	LT00244813	-0.16133035	11.95112638	-2.25793046	-1.98444623	-1.47879464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015686-11	Gallopamil hydrochloride	170465991	Voltage-gated L-type calcium channel Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	16662-46-7				-2.6335797167	4	5		0	3.01339286					Cl.COc1c(cc(cc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C)OC	Enzo	AC103	-2.44477538	5.2310042	-2.78431916	-2.94985251	3.01339286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095303-04	Cloxyquin	170465523	Mycobacterium tuberculosis Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	130-16-5				1.5687755167	4	5		0	-1.13128492					Oc1ccc(Cl)c2cccnc12	Vitas	STK015543	1.23175182	1.30743369	0.15874954	-1.28037247	-1.13128492											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016892-04	Iopamidol	170464646		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60166-93-0				-1.0407401299	4	5		0	-1.72991071					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO)[C@H](C)O	Prestwick	Prestw-871	-1.05485232	2.27822324	1.14974373	-0.26816841	-1.72991071											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094874-05	Esculin hydrate	225144214	tumor necrosis factor production Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	66778-17-4				3.1833224991	4	5		0	-3.25418994					OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)\C=C/C3=C2)[C@H](O)[C@@H](O)[C@@H]1O	SIGMA	E8250	0.28892944	5.914581	0.30528758	1.04757748	-3.25418994											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274075-01	1-Octacosanol		PI3K-Akt signaling pathway Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	557-61-9				1.1823520878	4	5		0	1.13128492					CCCCCCCCCCCCCCCCCCCCCCCCCCCCO	SIGMA	O3379	-1.4446472	-1.80550367	1.11124679	-1.33857122	1.13128492											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00021623-05	Nadolol	170464945	Beta-2 adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	42200-33-9				-7.324083607	4	5		0	-2.12765957					CC(C)(C)NCC(O)COc2cccc1C[C@@H](O)[C@@H](O)Cc12	Microsource	01503260	-3.73280943	-0.65190652	1.2154401	1.13780025	-2.12765957											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094812-05	Acetarsol	170466503		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	97-44-9				-6.8082703044	4	5		0	-1.31454127					Oc1ccc(cc1NC(C)=O)[As](O)(O)=O	Microsource	01500616	-2.08742633	0.1599016	0.28048618	-3.23640961	-1.31454127											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164568-04	Montelukast sodium	170465230	Cysteinyl leukotriene receptor 1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	151767-02-1		5.6234132519	-5.25	0.422859737	4	5		-7.245810056	-4.37150838	0.5652433745	0.4904218575			[Na+].CC(C)(O)c5ccccc5CC[C@@H](SCC1(CC([O-])=O)CC1)c2cccc(c2)/C=C/c3ccc4ccc(Cl)cc4n3	Sequoia	SRP06641m	-1.53588808	1.95492467	7.02161436	0.37829187	-4.37150838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015004-13	Amoxapine	170465376	5-HT2A Antagonists?	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	14028-44-5	 Amoxapina; ; Asendin; Amoxapine; 2   Amoxapine;Amoxapine;AMOXAPINE;	10	-5	53.8874786237	3	5		66.2592178779	59.03631285	0.0016741627	0.9991621919	3356	HTR2A	Clc1ccc2Oc4ccccc4N=C(c2c1)N3CCNCC3	Enzo	AC814	2.08333333	1.2078197	0.30528758	6.9256511	59.03631285											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016526-07	Berberine	170465752	Protein Tyrosine Phosphatase (PTP) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	633-65-8	 ; Natural Yellow- 18; Berberine bisulfate; Berberine chloride form; Erben; Umbellatine; Berberine sulphate;Berberine chloride; Berberine chloride; 0   Berberin Sulfate;BERBERINE CHLORIDE; Kyoberin; Natural Yellow 18; Berberine Tannate			-3.6158810845	4	5		0	2.29028324			7803	PTP4A1	[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC	Labotest	LT00440956	-2.06286837	-1.83271833	0.9483104	-1.2642225	2.29028324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan			-5.6061324384	4	5		0	1.42295704					CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	-3.68369352	-0.799508	2.97849606	-1.94690265	1.42295704											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094854-07	Allantoin	170465460	Allantoinase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	97-59-6				-6.0877484782	4	5		0	-1.63978859			854845	DAL1	O=C1NC(=O)NC1NC(=O)N	Specs	AE-562/J258555	-2.08742633	1.31611316	-0.76131962	-1.9721871	-1.63978859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182982-01	Dalcotidine	144206834	Histamine H2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	120958-90-9	Dalcotidine; 	0.0446683592	-7.35	4.2423520842	4	5	dalcotidine;KU-1257;CIPLUS_705874;DALCOTIDINE;dalcotidinum;N-ethyl-N'-(3-(3-(piperidinomethyl)phenoxy)propyl)urea;Dalcotidine;KU 1257;	8.058394164	-2.75139665	0.6124442827	0.6669447717	3274	HRH2	CCNC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Pharmaron	PH-NIH-151679	-2.96532847	7.50840493	3.35816339	1.48406809	-2.75139665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094881-07	Glafenine hydrochloride	170465943		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	65513-72-6		12.5892541179	-4.9	3.2587496123	4	5		18.67883212	15.43296089	0.0549385628	0.9714650555			Cl.OCC(O)COC(=O)c3ccccc3Nc1ccnc2cc(Cl)ccc12	Microsource	01500996	-3.4823601	-0.28639024	-0.45182562	-1.86235996	15.43296089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179248-03	Articaine hydrochloride	170464825	Sodium channel alpha subunit Blocker	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	23964-57-0				-2.5354509155	4	5		0	0.85195531					Cl.O=C(Nc1c(scc1C)C(=O)OC)C(C)NCCC	Prestwick Chemical, Inc.	Prestw-1032	-1.87043796	-0.16187274	2.33239712	-1.74596246	0.85195531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015156-15	Baclofen	170465099	GABA-B receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	1134-47-0				22.4083025779	4	5		0	6.63407821					Clc1ccc(cc1)C(CN)CC(=O)O	Vitas	STK535284	-0.04562044	5.814967	1.20893882	-1.0184781	6.63407821											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00183049-01	Zelandopam	144206852		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	139233-53-7	ZELANDOPAM; 			-6.610237353	4	5	ZELANDOPAM;CIPLUS_3879393;zelandopamum;	0	-2.38826816					Cl.Oc1ccc(cc1O)[C@H]3CNCc2c3ccc(O)c2O	Pharmaron	PH-NIH-155132	-1.80961071	-0.31129374	-0.45182562	-1.33857122	-2.38826816											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015513-11	Histamine dihydrochloride	170465001	Histamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	51-45-6	Histamine dihydrochloride;Histamine;HISTAMINE DIHYDROCHLORIDE;HISTAMINE; Histamine dihydrochloride			1.3621109505	4	5		0	2.94077788			9704	HRH1	NCCc1cncn1	Vitas	STK346752	-0.56483301	-0.4305043	-0.70789368	1.44121365	2.94077788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016270-09	Levodopa	225144176	Dopamine Precursors	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	59-92-7	 beta Hydroxytyrosin; Dopaflex; 3-Hydroxy-DL-tyrosine; 3,4 Dihydroxyphenylalanin; DL-Tyrosine, 3-hydroxy-; Dihydroxyphenylalanine; DL-3-Hydroxytyrosine; ;L-3,4-Dihydroxyphenyl-alanine; Levopa; Sinemet CR4;LEVODOPA; L-3-Hydroxytyrosine; 3 Hydroxy DL tyrosin; Sinemet CR; Roberts Brand of Levodopa; 3 Hydroxy L tyrosin; Levodopa;L-3,4-Dihydroxyphenylalanine; beta-Hydroxytyrosine; Ro 8-0576-12;Levodopa; 3-Hydroxy-L-tyrosine;L-Dopa; Nakom; Larodopa; L-DOPA-ring-d3; Dopar; Maipedopa; Roche Brand of Levodopa; Ro 8-0576-7; L Dop; Ro 8-0576; D-3-Hydroxytyrosine			7.6760349728	4	5		0	1.31454127				DRD1	N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	AC1036	-0.7367387	-1.58671587	4.63470015	3.13527181	1.31454127											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00015643-11	Metoclopramide	170464848	Muscarinic acetylcholine receptor M3 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	364-62-5				4.2209323265	4	5		0	4.43149478					Nc1cc(OC)c(cc1Cl)C(=O)NCCN(CC)CC	Enzo	AC840	-1.74361493	4.39114391	-2.25724589	3.79266751	4.43149478											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015428-15	(+/-) -Fluoxetine	170465374	Serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	54910-89-3		10	-5	61.1688454287	3	5		96.0197294853	89.02290283	0.0027505429	0.9986220983			FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2	Vitas	STK734483	-2.8978389	1.04551046	-2.15039402	1.1125158	89.02290283											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249916-01	Dimorpholamine	170465773	skeletal muscle contraction Activator	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	119-48-2				14.011316843	4	5		0	-0.82402235					O=C(N(CCCC)CCN(CCCC)C(=O)N1CCOCC1)N2CCOCC2	GVK	FFS-11-286-NCI-176	5.73296837	0.46071473	6.06911711	-0.81478248	-0.82402235											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094819-07	Hexetidine	170465729		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	141-94-6		14.1253754462	-4.85	0.4602636852	4	5		14.8217446319	10.55698604	0.0088167921	0.9955976456			CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1	Microsource	01500633	-1.86640472	-1.3899139	-1.93669026	-2.35145386	10.55698604											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181776-02	Dicyclopentamethylenethiuram disulfide	170465709		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	94-37-1				6.5497891071	4	5		0	5.90782123					S=C(SSC(=S)N1CCCCC1)N2CCCCC2	Labotest	LT00159442	-0.68430657	-0.80936372	5.678349	0	5.90782123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090970-03	Maleic acid	170465983	"NADP-dependent malic enzyme, mitochondrial Inhibitor"	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	110-16-7				-2.9219770075	4	5		0	0.0698324					O=C(O)/C=C\C(=O)O	SIGMA	M0375	-1.74878345	-0.85917071	2.08816705	-0.84388186	0.0698324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015870-27	Quercetin	170466817	Flavone	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	6151-25-3	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal			-5.1399088851	4	5		0	0.60055866				CYP75A12	O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O	Vitas	STK365650	-2.02250608	1.43195119	-1.96605202	-2.09515495	0.60055866											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249926-01	Pirmenol	170466004		SARS-CoV-2_CPE_SRI	2019_NPC-3.2	68252-19-7				-4.918956215	4	5		0	-0.32122905					C[C@H]3CCC[C@@H](C)N3CCCC(O)(c1ccccc1)c2ccccn2	GVK	FFS-11-286-NCI-216	-1.26216545	-1.80550367	-1.30663085	-0.23279499	-0.32122905											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016528-05	Proguanil hydrochloride	170464800	DHFR inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	637-32-1	Proguanil hydrochloride; Chlorguanide; ; Proguanil hydrochloride;Proguanil hydrochloride; Chlorguanide; ;Proguanil hydrochloride;CHLOROGUANIDE HYDROCHLORIDE			10.4844449528	4	5		0	2.94692737					Cl.Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1	Prestwick Chemical, Inc.	Prestw-999	2.96532847	-0.56032873	0.52509464	4.01571366	2.94692737											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181002-04	Cinacalcet hydrochloride	170465336	Calcium-Sensing Receptor (CaSR) Agonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	364782-34-3	 Cinacalcet;Cinacalcet;Cinacalcet hydrochloride; Sensipar; 	15.8489319246	-4.8	-8.5480530546	4	5		-7.860335196	-6.55027933	0.5821898868	0.4613787074	846	CASR	Cl.FC(F)(F)c3cccc(CCCN[C@H](C)c2cccc1ccccc12)c3	Selleck	S1260	-1.87043796	-2.02963516	-2.77201123	4.5395024	-6.55027933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091505-07	Nitrofurantoin	170464739	Probable pyruvate-flavodoxin oxidoreductase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	67-20-9				-0.4997933271	4	5		0	-1.80167598			946587	ydbK	O=[N+]([O-])c2ccc(/C=N/N1CC(=O)NC1=O)o2	Labotest	LT00134625	-2.47871046	-1.60627568	7.24142142	2.1533537	-1.80167598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018123-07	Acetylcholine chloride	170464783	Acetylcholinesterase Substrate	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	60-31-1		7.9432823472	-5.1	0.4844402245	4	5		7.841542572	6.27790179	0.3184033251	0.7923840223			[Cl-].C[N+](C)(C)CCOC(=O)C	Microsource	01500104	-0.73219161	-4.03461881	0.76187838	-0.80450523	6.27790179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015256-12	Chloroquine	170464753	antimalarial agents	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	50-63-5	 ;Chloroquine (CQ); Chloroquine (CQ); Aralen hydrochloride;Chloroquine Diphosphate; Aralen; Chloroquine Sulphate; Cloquiante; Contramibial;Arequin; Cloroquina; Khingamin; Chlorochin; Arechine; Aralen phosphate; Cloquinato; Chingamin;Chloroquine diphosphate; ChloroquineSulphate; Sulfate, Chloroquin; Sulphate, Chloroquin	3.9810717055	-5.4	65.4432442441	3	5		64.111411435	62.36049107	0.0040441942	0.9979724107			O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Specs	AN-153/J116554	-2.07247456	1.36184294	-0.20778501	3.53982301	62.36049107											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00159346-04	Terbinafine	170465174	Fungal Squalene Monooxygenase Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	91161-71-6	 ;Terbinafine; terbinafine, (Z)-isomer; Lamasil;TERBINAFINE HYDROCHLORIDE; Terbinafine; TERBINAFINE HCl;Terbinafine?HCl; Terbinafine HCl			-4.1854053351	4	5		0	-0.74022346					CC(C)(C)C#C\C=C\CN(C)Cc2cccc1ccccc12	Vitas	STK802069	-1.47506083	-2.10434566	2.01489803	-1.19307435	-0.74022346											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016410-13	Thiabendazole	170464939	Methionine Aminopeptidase-1 (MetAP1) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	148-79-8	;THIABENDAZOLE; ; Omnizole;Thiabendazole; Thibendole; Mintezol; Tiabendazole;Tiabendazole; Mintesol			-0.2911137819	4	5		0	3.1424581				METAP1	n1c3ccccc3nc1c2cscn2	Labotest	LT00134862	-2.53953771	0.70974972	-0.13432654	2.3861487	3.1424581											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159325-05	Desloratadine	170464781	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	100643-71-8		12.5892541179	-4.9	43.775216334	3	5		78.4495942576	64.84636871	0.0000948606	0.9999525799			Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2	Vitas	STK586537	-1.41423358	-1.38214419	-1.40432287	-0.17459625	64.84636871											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016624-05	Diphenidol	170465280	Muscarinic acetylcholine receptor M5 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	972-02-1				-1.9312137065	4	5		0	5.10602679					OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3	Prestwick	Prestw-252	-3.21419707	0.85274278	2.59038648	-3.13757039	5.10602679											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274272-01	Iobenzamic acid	170465948		SARS-CoV-2_CPE_SRI	2019_NPC-2.2	3115-05-7				2.0212838232	4	5		0	0.11160714					Ic1cc(I)c(N)c(I)c1C(=O)N(CCC(=O)O)c2ccccc2	GVK	FFS-11-286-NCI-258	0.4095309	-2.22731322	-0.48483169	4.39796192	0.11160714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263559-01	Carbocysteine	170465800	regulation of mucus secretion Modulator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	2387-59-9				-10.0071883582	4	5		0	-2.00892857					OC(=O)C(N)CSCC(O)=O	Bosche	S0868	-3.13973691	-1.38729795	0.09696634	-2.54759989	-2.00892857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166113-04	Diphenylcyclopropenone	170465593	immune system process Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	886-38-4				-5.3897505295	4	5		0	-1.171875					O=C2C(=C2c1ccccc1)c3ccccc3	Vitas	STK289679	-1.5016133	-2.63459336	1.2605624	-1.09949048	-1.171875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160514-02	Idebenone	170465611	Free Radical Scavenger	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	58186-27-9	 ;Idebenone;IDEBENONE; Idebenone			-9.0242031102	4	5		0	-0.80915179					COC1=C(OC)C(=O)C(C)=C(CCCCCCCCCCO)C1=O	Vitas	STK801942	-2.14693472	0.49637266	-3.14447984	-3.70072405	-0.80915179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164057-03	2-Bromo-2-nitro-1,3-propanediol	225144251	reactive oxygen species biosynthetic process Activator	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	52-51-7				-7.2002558472	4	5		0	-2.62276786					OCC(Br)(CO)[N+]([O-])=O	SIGMA	134708	-1.40233309	0.85274278	-2.59038648	-2.03807991	-2.62276786											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016066-14	Urapidil hydrochloride	170466013	Adrenergic receptor alpha-1 Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	64887-14-5				1.1579520966	4	5		0	0.09776536			3350		Cl.COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2	Microsource	01503100	-0.50182482	0.06225875	3.57797045	-0.75658373	0.09776536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094908-06	Mephenesin	170466586	Glutamate NMDA receptor Antagonist	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	59-47-2				-6.8550181079	4	5		0	-2.48325893					OCC(O)COc1ccccc1C	Microsource	01501140	-2.39513527	-0.49637266	1.92547444	-2.2257978	-2.48325893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167491-04	Lenalidomide	170465201	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-2.2	191732-72-6	; IMiD3 cpd; Lenalidomide;Lenalidomide;ENMD-0997; Revimid;CC-5013; Lenalidomide(Revlimid);Revlimid; Revlimid			-4.4273458055	4	5		0	0.30691964			7124	TNF	O=C1NC(=O)CCC1N3Cc2c(cccc2N)C3=O	Selleck	S1029	-0.18615041	-3.32187858	-0.54024103	-2.30624832	0.30691964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094087-05	Mizoribine	170466027	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2019_NPC-3.2	50924-49-7	; ;Mizoribine (Bredinin);MIZORIBINE; Mizoribine;Mizoribine; Mizoribina			-2.2805091417	4	5		0	-1.43854749			727833	IMPDH1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2O	Sequoia	50524-49-7	-1.04927007	-0.61013572	1.23336183	0.43649062	-1.43854749											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016343-13	Gramine	376241757		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	87-52-5				0.8618924226	4	4		0	-3.03690788					CN(C)CC1=C[NH]C2=C1C=CC=C2	CANVASS	578ff292f1709662a82ed8de	1.87517893	-1.49812734	-0.87209302	-3.03690788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346932-04	SB-3CT	384568968	MMP2/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	292605-14-2				-5.7466534498	4	4		0	-4.34466725				MMP2	[O-][S+](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2	MedChem Express	HY-12354	-1.3312339	2.03745318	-0.749694	-4.34466725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388427-02	Tizoxanide		Trichomonas vaginalis Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	173903-47-4		3.1622776602	-5.5	50.1852151096	1.4	4		39.30635415	39.59604766	0.0575455221	0.997953411			OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O	MedChem Express	HY-12687	-0.55825938	1.67790262	29.81946144	39.59604766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093846-07	3-Deazaadenosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6736-58-9				-7.4165563819	4	4		0	-4.05405405					NC1=NC=CC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Bio Vision	2771	-0.04294303	-3.65543071	-2.46328029	-4.05405405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015436-09	Fluphenazine hydrochloride	124880096	Nicotinic alpha7 Receptor Ligands	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	146-56-5	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	1	-6	23.3594728606	4	4	FLUPHENAZINE 2HCl	13	-4.7224644	1	0.9996666775	1813	DRD2	OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	BIOMOL	AC753	0.38648726	3.92509363	13.57099143	-4.7224644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346529-03	Safinamide		Sodium channel inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	133865-89-1				-5.0041750528	4	4		0	-3.99593142					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	-0.3006012	-2.96629213	1.17809058	-3.99593142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018261-09	Perhexiline	384568001	mitochondrial carnitine palmitoyltransferase-1 inhbitior	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6724-53-4, 6621-47-2 [perhexiline]		2.8183829313	-5.55	43.2535199256	3	4		41.1123196716	-6.96018599	1	0.9998933702			C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3	Microsource	01503227	-1.58889207	-1.61797753	33.49143207	-6.96018599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165961-04	FTI-277 hydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-0.1418229315	4	4		0	-2.33943621					COC(=O)[C@H](CCSC)NC(=O)C1=CC=C(NC[C@@H](N)CS)C=C1C2=CC=CC=C2	Bio Vision	2874-5	1.24534784	-2.78651685	0.53549572	-2.33943621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-05	Cyclocytidine		antiviral	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	10212-25-6				-1.6674769087	4	4		0	-4.08311537					OC[C@H]1O[C@@H]2[C@@H](OC/3=N/C(=N)/C=C\N23)[C@@H]1O	Enzo	DL369	2.50501002	-3.08614232	-4.08506732	-4.08311537												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241099-04	Saracatinib	384568470	cSRC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	379231-04-6				-12.9533966342	4	4		0	-6.05928509				SRC	CN1CCN(CCOC2=CC3=NC=NC(=C3C(=C2)OC4CCOCC4)NC5=C6OCOC6=CC=C5Cl)CC1	Selleck	S1006	-1.47437733	-3.80524345	-2.86107711	-6.05928509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346841-07	LY-411575	384568950	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	209984-57-6				-11.0167631611	4	4		0	-4.02499273				NOTCH1	C[C@H](NC(=O)[C@@H](O)C1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-50752	-1.50300601	-3.62546816	-2.34088127	-4.02499273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370683-05	GI254023X			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	260264-93-5				-5.4786937859	4	4		0	-1.03167684					CNC(=O)[C@@H](NC(=O)[C@H](CCCC1=CC=CC=C1)[C@H](C)N(O)C=O)C(C)(C)C	SIGMA	SML0789	-2.10420842	1.97752809	-1.0250918	-1.03167684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-08	Trametinib	384568648	Mek 1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	871700-17-3				-18.7038214738	4	4		0	-2.38912732				MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	APExBIO	A3018	-4.18404026	-4.32440303	-4.59406537	-2.38912732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164561-11	Zanamivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	139110-80-8				-5.3030718382	4	4		0	-1.55937053					[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(NC(N)=N)[C@@]1([H])NC(C)=O)C(O)=O	Enzo	AC3291	-0.99209202	-0.7134537	-1.58156349	-1.55937053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346565-08	Elvitegravir		HIV Integrase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	697761-98-1				-4.4326380141	4	4		0	-3.47639485					COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	APExBIO	A4070	-0.50323508	0.94641817	-1.73218858	-3.47639485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379154-03	U-104	363678388	Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	178606-66-1				-8.4314023594	4	4		0	-1.3304721					N[S+]([O-])(=O)C1=CC=C(NC(=O)NC2=CC=C(F)C=C2)C=C1	APExBIO	A4358	-3.06254493	3.30518346	-2.75643922	-1.3304721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	908112-43-6		0.7943282347	-6.1	47.4783962055	4	4		31.1370142138	23.99141631	0.3488683642	0.9166152309		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	-1.39468009	12.79848573	34.56845911	23.99141631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178086-06	AMINOLEVULINIC ACID HYDROCHLORIDE		DNA Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	5451-09-2				-3.4386541748	4	4		0	-2.28131357					NCC(=O)CCC(O)=O	Microsource	01504184	-0.18608646	-0.9588015	-0.84149327	-2.28131357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164564-09	Emtricitabine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	143491-57-0				6.9600971126	4	4		0	-2.04882302					NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	MedChem Express	HY-17427	4.1654738	-3.14606742	0.07649939	-2.04882302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381559-05	Resminostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1187075-34-8				-13.6446263536	4	4		0	-6.55332752				HDAC1	CN(C)CC1=CC=C(C=C1)[S+]([O-])(=O)[N]2C=CC(=C2)\C=C\C(=O)NO	MedChem Express	HY-14718A	-1.7320355	-1.94756554	-4.2380661	-6.55332752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126027-01	NCGC00126027-01	24401410		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	25.4674652841	3	4		43.3509961499	39.11144578	0.1422859684	0.9873107545			COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCCC5=C(C)C=CC=C5	Sytravon	E859-1228	-1.79224579	2.88771621	-1.72703653	39.11144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164600-15	Artesunate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	88495-63-0				3.996862293	4	4		0	4.56325301					C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	MedChem Express	HY-N0193	0.40234089	-0.24919378	-0.38208773	4.56325301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137848-01	NCGC00137848-01	24413231		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.2921841529	4	4	methylethyl 2-{[5-phenyl-7-(trifluoromethyl)-8-hydropyrazolo[1,5-a]pyrimidin-2 -yl]carbonylamino}-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate;	0	2.00301205					CC(C)OC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=CC=C4)SC5=C1CCCC5	Sytravon	K061-0473	0.54864667	-1.92025799	-2.64404707	2.00301205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	59721-29-8				-2.8455760795	4	4		0	1.06927711					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-0.01219215	-2.77044855	-2.39951093	1.06927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165783-04	Vadimezan		Interferon Inducer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	117570-53-3				-4.4094752282	4	4		0	-0.27181688					CC1=C(C)C2=C(C=C1)C(=O)C3=C(O2)C(=CC=C3)CC(O)=O	APExBIO	A8233	-0.1581596	-2.11124054	-3.32881458	-0.27181688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168108-06	AG-14361		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	328543-09-5		14.1253754462	-4.85	27.8772783211	4	4		15.5	15.26466381	0.2447062825	0.9614965354		PARP1	CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O	APExBIO	A4158	4.9604601	2.16948165	3.26856454	15.26466381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016280-11	Zoxazolamine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	61-80-3				-13.1111152877	4	4		0	-1.50214592					NC1=NC2=C(O1)C=CC(=C2)Cl	APExBIO	B1871	-3.09130122	-3.10133955	-2.75643922	-1.50214592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421080-01	NCGC00421080-01	375803636		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.8820884553	4	4		0	6.67168675					CC(=O)C1=CC=C(NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)[N]4N=NN=C4C5=CC=C(CN6CCOCC6)C=C5)C=C1	Analyticon	NAT6-296454	-1.49963424	-1.83230724	-1.08512915	6.67168675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399644-01	NCGC00399644-01	375804384		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.4050580743	4	4		0	-5.9186747					COC1=CC=C(C=C1OC)C2=N[N](C)C(=C2)[C@H]3CN4CC[C@H]3C[C@@H]4COC(=O)NC5=CC=C(C=C5)C(C)C	Analyticon	NAT13-339048	1.96293587	-2.91703313	-2.79688216	-5.9186747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125763-01	NCGC00125763-01	24401146		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.5551409437	4	4		0	-0.61746988					CC1=CC(=CC=C1)NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC=CC=C25	Sytravon	E842-0144	0.28041941	-1.07006743	-2.94971725	-0.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-0.6877832469	4	4		0	-2.73247496					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	0.61826024	0.5678509	-0.88868806	-2.73247496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00493059-01	NCGC00493059-01	375825413		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.0345525376	4	4		0	5.88855422					COC1=CC=CC(=C1)C2=CC=CC(=C2)C(=O)N3CCCC3C(=O)N4CCN(CC4)CC5=CC=CC=C5	ChemRoutes	CA-207-256	-1.45086564	-2.8583993	0.38208773	5.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-08	Telaprevir (VX-950)	384568831	HCV NS3 NS4A Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	402957-28-2				-4.3558417967	4	4		0	-3.20783133					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	APExBIO	A4031	0.59741526	-1.3925535	-3.59162464	-3.20783133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346463-01	Nesbuvir	174007343	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	691852-58-1	Nesbuvir			-5.1243096213	4	4		0	-2.1602289					CNC(=O)C1=C(OC2=CC(=C(C=C12)C3CC3)N(CCO)[S+](C)([O-])=O)C4=CC=C(F)C=C4	Chemscene	CS-0689	-1.56721783	2.28596389	-1.58156349	-2.1602289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091162-09	Aminothiazole			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	96-50-4				-8.7744453032	4	4		0	-0.64377682					NC1=NC=CS1	APExBIO	B1659	-1.99856219	-1.64531159	-2.33468896	-0.64377682												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00244248-01	NCGC00244248-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-6.6853989081	4	4		0	-1.41630901					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	-1.53846154	-2.05299942	-0.37656274	-1.41630901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	52-86-8		14.1253754462	-4.85	13.2869687442	4	4		13.0307275199	11.14449213	0.4773869368	0.8278179547			OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	2.97627606	-0.42224811	-3.3589396	11.14449213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106481-02	NCGC00106481-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.4921931025	4	4		0	0.9186747					CC1=CC=CC(=C1)NC(=O)CN2C(=O)N(CC3=CC=C(C=C3)C(=O)NCC4=CC=C5OCOC5=C4)C(=O)C6=CC=CC=C26	Chemdiv	C260-1157	-0.74372104	-2.50659631	-2.1855418	0.9186747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137717-01	NCGC00137717-01	24413100		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	34.9614941027	3	4		62.609850488	51.25	0.0280538676	0.9995144489			FC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)C4=CC5=C([NH]4)C=CC=C5	Sytravon	G883-0849	-0.62179956	-2.00820874	-0.5043558	51.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123513-01	NCGC00123513-01	24398896		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.2791398278	4	4		0	2.09337349					CC1=CC=CC(=C1)[S+]([O-])(=O)/C2=C/N(CC3=CC=C(F)C=C3)C4=CC(=C(F)C=C4C2=O)N5CCCCC5	Sytravon	E599-0593	-2.15801024	-2.00820874	-1.32966529	2.09337349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346475-02	Birinapant	384568790	IAP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1260251-31-7				-1.475151495	4	4		0	0.24320458				XIAP	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC2=C([NH]C3=C2C=CC(=C3)F)C4=C(C[C@@H]5C[C@H](O)CN5C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C6=C([NH]4)C=C(F)C=C6	Selleck	S7015	-0.64701653	0.82993593	-1.22006326	0.24320458												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00242597-10	Saxagliptin		DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	709031-78-7				-7.1647928583	4	4		0	-0.95851216				DPP4	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	DC Chemicals	DCAPI1568	-1.42343638	-2.08211998	-1.94306371	-0.95851216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015898-28	Rolipram	384567905	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	61413-54-5				-9.5752962632	4	4		0	0.10014306				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3	MedChem Express	HY-16900	-3.12005751	-1.82003494	-0.58743787	0.10014306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107289-02	NCGC00107289-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.297919367	4	4		0	0.64759036					FC(F)(F)C1=CC=CC(=C1)N2CCN(CC2)C(=O)C3=CC=C(NC4=NC5=C(C=CC=C5)[N]6N=NN=C46)C=C3	Chemdiv	C301-4561	-0.64618386	-1.45118733	-0.1681186	0.64759036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163489-05	Shikonin		Drugs Acting on Chemokine Receptors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	517-89-5				-5.5104965446	4	4		0	-1.64520744				CCR5	CC(C)=CC[C@@H](O)C/1=C/C(=O)C2=C(O)C=CC(=C2C1=O)O	Cayman	14751	-0.90582315	-2.22772277	-0.58743787	-1.64520744												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-21	INCB018424			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	941678-49-5				-8.5781139986	4	4		0	-3.39055794					N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	-1.3659238	-1.41234712	-2.2443139	-3.39055794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386200-01	Vildagliptin (LAF-237)	363680148	Dipeptidyl peptidase IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	274901-16-5				-1.9068934804	4	4		0	-0.84406295					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Selleck	S3033	-0.7620417	1.90739662	-0.94893809	-0.84406295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481568-01	AZD3839			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					11.0203313819	4	4		0	2.67525036					FC(F)C1=NC=CC(=C1)[C@@]2(NC(=N)C3=C2C=CC=C3F)C4=CC=CC(=C4)C5=CN=CN=C5	APExBIO	B5951	0.73328541	9.1875364	1.03931315	2.67525036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482516-02	Ginsenoside Rb2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	11021-13-9				-7.2596692636	4	4		0	3.39055794					CC(C)=CCC[C@](C)(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0040	-3.92523364	-1.15026209	-1.67193854	3.39055794												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00163662-01	NCGC00163662-01	26757041		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-1.8106387703	4	4	schisandrin A;deoxyschisandrin;Schizandrin A;CIPLUS_183967;SCHISANDRIN A, R(+)-;Deoxyschizandrin;schizandrin A;Dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer;CIPLUS_732662;NCGC00163662-01;	0	1.24463519					COC1=C(OC)C(OC)=C2C(C[C@H](C)[C@H](C)CC3=CC(OC)=C(OC)C(OC)=C23)=C1	BIOMOL	NP-455	0.38820992	-2.40244613	-2.93718934	1.24463519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510921-01	Lucanthone	384569494	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	548-57-2		3.1622776602	-5.5	10.347120499	4	4		14.200000004	-7.04736995	1	0.9684551296		TOP2A	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1	SantaCruz Bio	sc-396381	-0.44374463	-2.66666667	9.22582619	-7.04736995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159521-16	Zoledronic acid monohydrate	384568184	Farnesyl Pyrophosphate Synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	165800-06-6				1.4648701081	4	4		0	0.56669573				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	MedChem Express	HY-13777A	1.38849127	-1.19850187	-1.20869033	0.56669573												1.6E-8	8E-8	4E-7	0.000002											
NCGC00136000-01	NCGC00136000-01	24411383		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.7603364203	4	4		0	-1.85240964					COC1=CC=C(C=C1)N2CCN(CC2)C(CNC(=O)C3=C(F)C=CC=C3F)C4=CC5=C(OCO5)C=C4	Sytravon	G856-4236	-0.91441112	-1.92025799	-2.43007795	-1.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017063-13	Amodiaquine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	86-42-0		8.9125093813	-5.05	83.3822514238	2.1	4		109.7081952953	88.33188027	0.0109751598	0.9999257048			CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1	Cayman	15954_cm1	0.58688806	1.25842697	21.43512852	88.33188027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346587-16	Bergenin monohydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	477-90-7				-7.8688567966	4	4		0	-1.61144578					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	-1.7678615	-0.98211668	-2.09384075	-1.61144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482790-01	tetrahydroxyl diphenylethylene-2-o-glucoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	82373-94-2				-3.8638886974	4	4		0	1.06927711					OC[C@H]1O[C@@H](OC2=C(O)C=C(O)C=C2\C=C\C3=CC=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCS-029	-1.23140697	-2.09615948	-0.07641755	1.06927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140029-01	NCGC00140029-01	24415412		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-8.9574695714	4	4		0	-2.84638554					CC1=C(OC2=CC=C(C=C12)[S+]([O-])(=O)N3CCC4(CC3)OCCO4)C(=O)NC5=CC=C(F)C(=C5)F	Sytravon	K786-1599	-2.08485735	1.07006743	-3.22482042	-2.84638554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178332-02	Genkwanin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	437-64-9				-1.8978885716	4	4		0	1.12951807					COC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC=C(O)C=C3	DC Chemicals	DCY-091	0.08534504	-2.47727939	-1.75760355	1.12951807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482601-01	Patchouli alcohol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	5986-55-0				-0.242105638	4	4		0	-2.48474281					C[C@H]1CC[C@@]2(O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@H]1C3	DC Chemicals	DC6504	1.10220441	-2.03745318	0.32129743	-2.48474281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346399-01	NCGC00346399-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.1663171158	4	4		0	-2.21385542					CC1=CC=CC=C1C(=O)N2CCC3=CC(=CC=C23)N4CCCC(C4)NC(=O)CC5=CC=CC=C5	NCGCChem	LLI13-090	-1.32894416	1.9495749	-0.68775791	-2.21385542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-01	NCGC00241103-01	124950162		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	790299-79-5	 Masitinib;Masitinib;AB-1010?	14.1253754462	-4.85	-0.7895444337	4	4		-8.6566265039	-4.71385542	0.6525639927	0.5942226662	3815	FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	Toronto Research	M197500	-1.45086564	3.32746995	5.884151	-4.71385542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163589-02	LUTEOLIN-7-GLUCOSIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					4.4647181059	4	4		0	2.97878524					OC[C@H]1O[C@@H](OC2=CC(=C3C(=O)\C=C(/OC3=C2)C4=CC=C(O)C(=C4)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-001730	0.1002004	-0.26966292	3.10587515	2.97878524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-12	NCGC00159456-12			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	152459-95-5	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	158.4893192461	-3.8	12.4503880952	4	4		-12.536144576	-3.78012048	0.8495168039	0.4817911886	25	ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	AK Scientific	69412	0.23165082	95.294635	12.2726578	-3.78012048												0.0000016	0.000008	0.000039999999999	0.00019999999999											
NCGC00160217-03	Sophocarpine	363676600	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6483-15-4				-8.5089682101	4	4		0	-3.44376635				KCNH2	O=C1\C=C/C[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34	Selleck	S2405	-1.90380762	-1.88764045	0.35189718	-3.44376635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165862-04	Pamidronate Disodium		Farnesyl diphosphate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	57248-88-1				-3.4339866943	4	4		0	-1.38041267					NCCC(O)([P](O)([O-])=O)[P](O)([O-])=O	APExBIO	A2456	-0.04294303	-1.88764045	-1.39228886	-1.38041267												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163572-01	ISORHAMNETINE	26756952		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			12.5892541179	-4.9	7.6548855152	4	4	ISOHAMNETIN:3'-METHOXY-3,4',5,7-TETRAHYDRO-XY-FLAVONE;3'-Methoxy-3,4',5,7-tetrahydroxyflavone;3-methyl-quercetin;3-methylquercetin;isorhamnetin;CIPLUS_153428;isorhamnetine;NCGC00163572-01;iso-rhamnetin;3'-methoxyquercetin;TAMARIXETINE;NCGC00163572-02;Isorhamnetin;3,4',5,7-tetrahydroxy-3'-methoxyflavone;ISORHAMNETIN;LS-69043;ISORHAMNETINE;CIPLUS_155089;3,4',5,7-tetrahydroxy-3'-methoxy-flavone;	14.910392216	11.08689334	0.1352086916	0.9886791235			COC1=CC(=CC=C1O)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	BIOMOL_NP-148	-0.75866018	0.65917603	1.20869033	11.08689334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378668-01	PD 144418 oxalate	363678143	Sigma opioid receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[154130-99-1]				5.5465251803	4	4		0	8.70386516					CCCN1CC\C=C(/C1)C2=CC(=NO2)C3=CC=C(C)C=C3	Tocris	2606	-0.04294303	-1.13857678	-0.07649939	8.70386516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402337-02	BGP-15	384569215	Insulin Sensitizers	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	66611-37-8				-0.9911204268	4	4		0	-0.85730892				PARP1	N\C(=N/OCC(O)CN1CCCCC1)C2=CN=CC=C2	Glixx	GLXC-05825	0.32922989	-1.16853933	-0.53549572	-0.85730892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095122-14	Irbesartan			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	138402-11-6				-4.1846754721	4	4		0	-1.21602289					CCCCC/1=N/C2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5	MedChem Express	HY-B0202	-1.50970525	0.42224811	0.40668775	-1.21602289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246968-07	Olmesartan	384568514	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	144689-24-7				-5.120425502	4	4		0	-1.35908441				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	MedChem Express	HY-17004	-1.59597412	-0.53873034	0.49706281	-1.35908441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346533-07	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1009119-64-5				9.280382907	4	4		0	-2.775356					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	MedChem Express	HY-10466	4.53764672	-0.8988764	0.56609547	-2.775356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250390-07	ISOX		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1045792-66-2				-8.4176625853	4	4		0	-5.6795422				HDAC6	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	Axon Medchem	1645	-0.1581596	-0.88817705	-4.50369031	-5.6795422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161679-13	MG-132			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	133407-82-6				7.7879649716	4	4		0	-3.9668701					CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	APExBIO	A2585	3.3638706	1.97752809	1.11689106	-3.9668701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-17	Emetine dihydrochloride hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	7083-71-8		6.3095734448	-5.2	49.6694266254	4	4		-19.045064376	-4.62088698	0.7854546822	0.9998865372			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375	51.286844	14.10891089	10.34794397	-4.62088698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371131-03	NMS-873		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1418013-75-8				-10.4739845949	4	4		0	-6.8148794				VCP	CC1=C(C=CC(=C1)OCC2=NN=C(SC3CCCC3)[N]2C4=CN=CC=C4)C5=CC=C(C=C5)[S+](C)([O-])=O	Selleck	S7285	-1.15946178	-1.97752809	-1.48408813	-6.8148794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390740-02	Avibactam (sodium)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1192491-61-4				5.0115573767	4	4		0	1.18975904					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	MedChem Express	HY-14879A 	1.20702268	-1.92025799	3.40822253	1.18975904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-24	Papaverine hydrochloride		Phosphodiesterase X (PDE10) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					6.9155434465	4	4		0	2.93674699				PDE10A	COC1=C(OC)C=C(CC2=C3C=C(OC)C(=CC3=CC=N2)OC)C=C1	Analyticon	NP-014100	-0.57303097	6.14189387	2.70518111	2.93674699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094931-06	Lapachol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	84-79-7				-4.7619893493	4	4		0	-2.7560241					CC(C)=CCC/1=C(O)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0052	-0.20726652	-1.71503958	-2.49121198	-2.7560241												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00159462-20	Ritonavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	155213-67-5				-5.7412978439	4	4		0	-2.98998569					[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	-1.68224299	-1.29586488	2.42506402	-2.98998569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00124402-01	NCGC00124402-01	24399785		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			7.0794578438	-5.15	33.4688279043	2.4	4		44.4217879419	37.33433735	0.0556663064	0.998085626			CC1=CC(=NC2=CC=C(NC(=O)CC3=CC=CC(=C3)C(F)(F)F)C=C12)NC4=CC(=CC=C4)Cl	Sytravon	E683-0301	-0.30480371	-1.33391967	10.40806969	37.33433735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133175-01	NCGC00133175-01	24408558		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	38.9803518674	3	4		63.4326031829	56.09939759	0.0654912153	0.997345964			FC1=C(C=CC=C1)N2CCN(CCCNC(=O)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3)CC2	Sytravon	G706-0928	0.08534504	-1.24596892	-3.28595446	56.09939759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094792-17	Tioguanine		Purine Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	154-42-7		14.1253754462	-4.85	30.3898573939	2.4	4		30.5	28.53915663	0.0286908697	0.999492868		HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	MedChem Express	HY-13765	2.27993172	2.50659631	2.12440776	28.53915663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510002-01	GLPG0187	384569406	Integrin Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	298708-81-3				0.8313484053	4	4		0	5.10729614					COC(=O)\C1=C(C)\N=C(N[C@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029	-0.81955428	1.23762376	-2.51543907	5.10729614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509914-02	NMS-P118		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1262417-51-5				8.0093308055	4	4		0	5.07868383				PARP1	NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F	MedChem Express	HY-18954	0.53199137	1.23762376	2.84681428	5.07868383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165875-04	PB-28	384568294	sigma1/2 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	172907-03-8		10	-5	64.5727576776	3	4		91.190944837	83.36194564	0.0245686781	0.9996275443		SIGMAR1	COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1	Axon Medchem	1272	0.50323508	-1.38322656	2.78656424	83.36194564												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483210-07	NCGC00483210-07			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.4712081686	4	4		0	-2.18373494					CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	0.23165082	-1.74435649	-3.16368638	-2.18373494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238681-01	NCGC00238681-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.0256714188	4	4		0	1.21987952					OC(=O)C1=CC(=CC=C1Br)[S+]([O-])(=O)N2CCN(CC2)[S+]([O-])(=O)C3=CC=C4C=CC=CC4=C3	NCGCChem	MLS002156571-02pur	-1.67032431	-0.24919378	0.71832493	1.21987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134138-01	NCGC00134138-01	24409521		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.3126307969	4	4		0	-2.36445783					CC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)NC5=CC(=CC=C5C)Cl)\N=C3S2	Sytravon	G768-1156	-0.81687393	0.21987687	-2.30780987	-2.36445783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167474-06	Candesartan	363676659	Type-1 angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	139481-59-7				-1.5872216426	4	4		0	-2.73247496					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(O)=O	Selleck	S1578	-1.02084831	3.1304601	1.25018828	-2.73247496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346504-07	Avagacestat	384568808	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1146699-66-2				-1.8417715203	4	4		0	-3.50903614				NOTCH1	NC(=O)[C@@H](CCC(F)(F)F)N(CC1=C(F)C=C(C=C1)C2=NOC=N2)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-50845	2.25554743	-3.56200528	-3.56105762	-3.50903614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111245-01	NCGC00111245-01	24385824		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.3886855969	4	4		0	-0.76807229					COC1=CC=CC(=C1)N2CCN(CC2)C(=O)C3CCCN(C3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0080	0.23165082	-0.42509528	6.67889347	-0.76807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508866-01	MK-1439			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1338225-97-0				-3.1408550297	4	4		0	0.84406295					CN\1C(=O)N\N=C1CN2\C=C/C(=C(OC3=CC(=CC(=C3)C#N)Cl)\C2=O)C(F)(F)F	Bio Vision	B1250	-0.70452912	-0.27664531	-2.54556409	0.84406295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090726-30	Ribavirin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	36791-04-5				4.8333767808	4	4		0	2.98998569					NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Bio Vision	2199	1.19338605	-0.59697146	-0.04518753	2.98998569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016612-14	Sulfadoxine		Dihydropteroate Synthase (DHPS) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	2447-57-6				-4.2815047618	4	4		0	-1.13018598					COC1=NC=NC(=C1OC)N[S+]([O-])(=O)C2=CC=C(N)C=C2	SIGMA	S7821	-1.71099928	1.49970879	-0.1656876	-1.13018598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482751-01	Casticin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	479-91-4				-9.4761469643	4	4		0	-3.35843373					COC1=C(O)C=C(C=C1)\C2=C(/OC)C(=O)C3=C(O)C(=C(OC)C=C3O2)OC	DC Chemicals	DCM-037	-0.89002682	-3.82585752	-2.88858322	-3.35843373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387769-02	Gardiquimod	363680656	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1020412-43-4		8.9125093813	-5.05	5.1109766487	4	4		13.4484272159	9.68373494	0.0489426857	0.9985390185	51284	TLR7	CCNCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N	Bio Vision	2002	-1.20702268	-0.51304603	1.87987162	9.68373494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015156-28	Baclofen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1134-47-0				3.4914025717	4	4		0	-1.43072289					NCC(CC(O)=O)C1=CC=C(Cl)C=C1	MedChem Express	HY-B0007_cm1	0.329188	0.77689827	5.30337766	-1.43072289												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346662-06	Geniposide		P2Y purinoceptor 14 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	24512-63-8				-4.5217575178	4	4		0	0.27181688			171108	P2ry14	COC(=O)C/1=C/O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]\3[C@@H]1C\C=C3CO	Glixx	GLXC-06546	-1.53846154	1.58707047	-2.7263142	0.27181688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356069-06	GSK1324726A		Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1300031-52-0				-7.9197479919	4	4		0	1.10157368			23476	BRD4	C[C@H]1C[C@@H](NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O	MedChem Express	HY-13960	-2.68871316	-0.74257426	-1.94306371	1.10157368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483135-03	CPI-0610	384569263	Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1380087-89-7				0.3832123211	4	4		0	-4.48997384					CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(N)=O)C4=CC=C(Cl)C=C4	ChemieTek	CT-C0610_cm2	3.22072717	-4.01498127	-2.40208078	-4.48997384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137860-02	NCGC00137860-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.2293602253	4	4		0	-0.88855422					FC(F)(F)C1=CC(=NC2=CC(=N[N]12)C(=O)NC3=C(C#N)C4=C(CCCC4)S3)C5=CC=C(Br)C=C5	Chemdiv	K061-0771	0.71933675	-3.4154207	-1.45193336	-0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100267-01	NCGC00100267-01	24273965		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.4794199417	4	4		0	3.56927711					CC1=CC=C(C=C1)C/2=N/N(CC(=O)NC3=CC=CC(=C3)C(F)(F)F)C(=O)C4=CC=CC=C24	Sytravon	5498-2707	-1.20702268	-0.68894752	0.59605685	3.56927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119660-01	NCGC00119660-01	24394239		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.2044473786	4	4		0	1.61144578					COC1=CC=C(C=C1)C2\C=C(/NC3=NC(=N[N]23)NC(=O)/C=C/C4=C(Cl)C=CC=C4)C5=CC=CC=C5	Sytravon	D413-0074	-1.28017557	-2.47727939	2.27724285	1.61144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104967-01	NCGC00104967-01	24268312		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	57.9454448423	3	4		75.0132530079	66.15963855	0.0301915421	0.999437482			ClC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0340	2.54815899	1.36323659	1.48250038	66.15963855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347894-01	NCGC00347894-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.4193882542	4	4		0	3.78012048					CC(C)C1=CC=CC=C1C(=O)N2CCC3=CC(=CC=C23)C4=C(C)SC(=N4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	LLI015-025	-0.30480371	-1.30460276	-1.02399511	3.78012048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017401-02	NCGC00017401-02	144206666		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	17479-19-5		12.5892541179	-4.9	22.2061161809	3	4	Dihydroergocristine methanesulfonate salt;Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19alpha)-, mixt. with (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)ergotaman-3',6',18-trione;Dihydroergocristine methanesulfonate;CIPLUS_751524;Iskedyl;CIPLUS_773547;Kristepin;NCGC00016137-01;CIPLUS_3884556;Dihydroergocristine;P 3007;Ersilan;CIPLUS_774402;NCGC00025380-01;NCGC00025380-02;dihydroergotoxine ethansulfonate;NCGC00023148-05;NCGC00023148-02;CIPLUS_740293;CIPLUS_684973;Dihydroergocristine mesylate;CIPLUS_3885160;Brinerdine;PF 50;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-;DIHYDROERGOTOXINE-MESYLATE;LS-175603;Dihydroergotoxine mesylate;Crystepin CH;Chrystepin CH;Briserin;P-3007;CIPLUS_3884046;defluina;	44.0519402239	38.11746988	0.0546496788	0.9981547371			CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C	InterBioScreen	STOCK1N-23631	-1.49963424	-0.80621519	-2.70518111	38.11746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390283-02	Vesatolimod		Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1228585-88-3				-1.623503252	4	4		0	-2.13600697				TLR7	CCCCOC1=NC2=C(NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4)C(=N1)N	MedChem Express	HY-15601	0.18608646	-1.46816479	0.749694	-2.13600697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00396904-01	NCGC00396904-01	375800439		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					5.1296312284	4	4		0	6.94277108					COC1=CC=C(NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)N[S+]([O-])(=O)C4=CC5=CC=CC=C5C=C4)C=C1	Analyticon	NAT6-270303	-0.81687393	4.41219584	-1.5130674	6.94277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	282526-98-1		1	-6	14.1385831148	4	4		9.160936356	8.29819277	0.1912929361	0.9770405776			CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	-0.13411363	1.80299033	10.04126547	8.29819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522453-02	IXAZOMIB CITRATE		Proteasome subunit beta type-5 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-6.9792427316	4	4		0	-3.85062482			5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	0.04294303	-3.7752809	-2.24908201	-3.85062482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016961-11	ATOVAQUONE		Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	95233-18-4				2.9243759914	4	4		0	-3.47282767					O\C1=C(/C2CCC(CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O	Microsource	01504210	4.42313198	-5.03370787	-3.22827417	-3.47282767												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182080-04	Valpromide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2430-27-5				-0.8910297973	4	4		0	-4.31560593					CCCC(CCC)C(N)=O	SIGMA	V3640	1.07357572	-2.33707865	-0.56609547	-4.31560593												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164975-01	NCGC00164975-01	29216729		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.9865216107	4	4		0	-0.2560241					COC1=CC=C(Cl)C=C1NC(=O)C2=NN3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C5OCOC5=C4	Sytravon	A0001410	-0.93879542	-2.1254764	-2.73574813	-0.2560241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390564-04	GS7340			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	379270-37-8				-0.2026193271	4	4		0	0.10171462					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	Glixx	GLXC-07981	0.3006012	-2.27715356	0.78029376	0.10171462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388362-02	Glycitin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	40246-10-4				0.5657062281	4	4		0	-2.33943621					COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C3O\C=C(/C(=O)C3=C1)C4=CC=C(O)C=C4	Prestwick	Prestw-NAT-0037	-0.12882909	-0.11985019	3.90146879	-2.33943621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345839-16	Baricitinib		Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1187594-09-7				-10.1006585856	4	4		0	-5.15838419				JAK2	CC[S+]([O-])(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-15315	-1.04494704	-3.2659176	-1.85128519	-5.15838419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184994-11	Cidofovir	384568422	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	113852-37-2				-4.8014096836	4	4		0	-1.93257774					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	MedChem Express	HY-17438	0.24334383	-3.74531835	0.22949816	-1.93257774												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00370733-05	Retro-2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1429192-00-6				-1.0592658346	4	4		0	-1.64196455					CC1=CC=C(S1)C2NC3=C(C=CC=C3)C(=O)N2C4=CC=CC=C4	Glixx	GLXC-02449	0.87317492	-3.02621723	0.07649939	-1.64196455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378845-08	Trelagliptin (succinate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1029877-94-8				12.7701827871	4	4		0	-0.91543156					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	5.85456628	-0.80898876	-1.33108935	-0.91543156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356067-12	OTX-015			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	202590-98-5				-0.3086197044	4	4		0	-2.57192677					CC1=NN=C2[C@H](CC(=O)NC3=CC=C(O)C=C3)N=C(C4=C(SC(C)=C4C)N12)C5=CC=C(Cl)C=C5	APExBIO	A3692	1.07357572	0.32958801	-1.94308446	-2.57192677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538163-01	NCGC00538163-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-3.2426356283	4	4		0	2.30329041					CC1=C(N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CC[S+]([O-])(=O)CC4)C(=CC=C1)C	Pharmaron	PH-NIH-2017-009-L2-30-0	-1.39468009	-0.33488643	-1.67193854	2.30329041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485878-01	Nucleoside-Analog-2	363681388	NS5B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	876708-01-9				-5.9133777703	4	4		0	0.50071531					OC[C@]1(O[C@H]([C@@H](O)[C@@H]1O)N2\C=C/C(=O)NC2=O)N=[N+]=[N-]	MedChem Express	HY-77652	-1.88353702	0.16016308	-2.27443892	0.50071531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482591-01	Atractylon			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6989-21-5				-3.7850520333	4	4		0	-3.70531822					CC1=COC2=C1C[C@H]3C(=C)CCC[C@]3(C)C2	DC Chemicals	DCZ-188	-1.04494704	-0.20973783	1.17809058	-3.70531822												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00095133-09	Famciclovir	384568149	antiviral	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	104227-87-4				-3.9640702438	4	4		0	-0.24320458					CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O	APExBIO	B1942	-1.53846154	1.79091439	-1.58156349	-0.24320458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346542-10	Hesperadin		Aurora Kinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	422513-13-1		12.5892541179	-4.9	1.8255225888	2.4	4		30.7659286	23.8769671	0.0493226239	0.9984988714		AURKA	CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1	Glixx	GLXC-03283	-3.69518332	-4.61560862	-4.8049405	23.8769671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379005-02	Silvestrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	697235-38-4		5.6234132519	-5.25	26.0748970493	4	4		32.3146067439	28.90148213	0.1556279732	0.9847799398			CO[C@@H]1OC[C@@H](O[C@H]1OC2=CC(=C3C(=C2)O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)C5=CC=CC=C5)C6=CC=C(OC)C=C6)OC)[C@H](O)CO	MedChem Express	HY-13251	0.38648726	-3.59550562	8.58323133	28.90148213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162073-12	H-89	384568218	AKT Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	130964-39-5		10	-5	21.0263964943	3	4		41.3094767984	36.29470672	0.0090897459	0.9999490782		AKT1	[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23	MedChem Express	HY-15979A	-1.85478073	-1.90739662	-0.04518753	36.29470672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091208-11	HEXYLRESORCINOL		Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	136-77-6				-8.7963018262	4	4		0	0.38626609					CCCCCCC1=C(O)C=C(O)C=C1	Microsource	01500330	-2.37239396	-2.83925451	-1.49118843	0.38626609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379250-01	ME 0328		Poly [ADP-ribose] polymerase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[1445251-22-8]		7.0794578438	-5.15	13.7746511139	4	4		9.10337798	8.48354793	0.5262020938	0.7813737089			C[C@H](NC(=O)CCC/1=N/C2=CC=CC=C2C(=O)N1)C3=CC=CC=C3	Tocris	5054	2.71746945	-2.16948165	2.8769393	8.48354793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161826-02	Phenylmercuric borate	124892360	platelet aggregation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			1.2589254118	-5.9	24.0130553034	4	4		22.7433501079	-5.76537911	1	0.9997591264			[Hg+]C1=CC=CC=C1	SigmaAldrich	S366137	-2.28612509	1.03377985	20.13857509	-5.76537911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163363-01	N'-NITROSONORNICOTINE	26756720		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-1.1511890082	4	4	N'-nitrosonornicotine, (S)-isomer;nitrosonornicotine;Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (S)-;N-nitrosonor-nicotine;N'-nitrosonornicotine;CIPLUS_675838;N'-NITROSONORNICOTINE;NCGC00163363-01;N'-nitrosonornicotine, (+-)-isomer;N-nitrosonornicotine;CIPLUS_170449;CIPLUS_199562;	0	-1.26416739					O=NN1CCCC1C2=CN=CC=C2	BIOMOL	BIOMOL_AC-1066	-0.01431434	0.62921348	-0.87209302	-1.26416739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180420-04	Picroside 2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	39012-20-9				-3.3662309614	4	4		0	0.39232781					COc1cc(ccc1O)C(=O)O[C@@H]2[C@@H]3O[C@]3(CO)[C@@H]4[C@H]2C=CO[C@H]4O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O	DC Chemicals	DCH-008	-1.13083309	-0.59925094	-0.50489596	0.39232781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161634-09	Artemisinin	384568213	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	63968-64-9				1.0937093127	4	4		0	3.21127579				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S1282	-0.87317492	0.47940075	0.84149327	3.21127579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263102-06	Degrasyn	384568591	Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	856243-80-6		1.995262315	-5.7	57.8870014415	3	4		49.629033456	-5.6795422	1	0.9999871143		JAK2	CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-13264	-2.60244428	-2.02387886	45.594216	-5.6795422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386235-06	Cobicistat		Cytochrome P450 3A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1004316-88-4		12.5892541179	-4.9	23.5358885699	4	4		32.741912288	29.68526466	0.2017281473	0.9740677324			CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Cayman	13433	-0.61826024	4.35352359	-0.1656876	29.68526466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139527-01	NCGC00139527-01	24414910		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.6374754924	4	4		0	3.4186747					CC1=CC=C(C)C(=C1)N2CCN(CC2)[S+]([O-])(=O)C3=C(F)C=CC(=C3)C(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4	Sytravon	K781-7785	-0.98756401	-0.57167986	-1.81873758	3.4186747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180911-03	Pyrvinium pamoate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	3546-41-6				-9.9349701019	4	4		0	-5.70815451					CN(C)c1ccc2[n+](C)c(\C=C/c3cc(C)n(c3C)-c4ccccc4)ccc2c1.Oc5c(cc6ccccc6c5Cc7c(O)c(cc8ccccc78)C([O-])=O)C([O-])=O	Prestwick	Prestw-1040	-0.81955428	-1.03377985	-4.08194005	-5.70815451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092327-05	4-HQN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[491-36-1]				-0.45396918	4	4		0	6.22317597					OC1=NC=NC2=C1C=CC=C2	Tocris	2192	-2.83249461	1.70355271	1.34056334	6.22317597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140567-02	NCGC00140567-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-9.3943456292	4	4		0	-1.61144578					COC1=CC(=CC=C1)N[S+]([O-])(=O)C2=CC=C3N\C=C(C(=O)NCCC4=CC=C(C)C=C4)/C(=O)C3=C2	Chemdiv	K788-1747	-2.15801024	-3.29815303	-0.53492282	-1.61144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133970-01	NCGC00133970-01	24409353		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.0301949399	4	4		0	0.97891566					CC1=C(C=CC=C1)C(=O)NC2=CC=CC(=C2)OCC\3=C\C(=O)N4/C=C\C=C(C)/C4=N3	Sytravon	G756-0565	-1.98732017	1.68572266	-1.23796424	0.97891566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126021-02	NCGC00126021-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.0811340617	4	4		0	-1.43072289					COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=CC=C5C	Chemdiv	E859-1199	-1.32894416	1.24596892	-3.56105762	-1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480778-01	Scutellarin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	27740-01-8				-0.1902892779	4	4		0	-0.55793991					O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)/C=C(OC3=C2)/C4=CC=C(O)C=C4)O	Adooq	A12117	0.30194105	-0.13104252	-0.6476879	-0.55793991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522288-01	PERETINOIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					4.0112207122	4	4		0	2.84692418					CC(C)=CCC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(O)=O	Ark Pharm	AK162192	-0.10064702	2.92661619	0.13556258	2.84692418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510316-01	ombitasvir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1258226-87-7				-1.8663887811	4	4		0	-1.43072289					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	-0.54864667	-1.62708883	2.49121198	-1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126519-01	NCGC00126519-01	24401902		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	47.1295626504	3	4		80.8941482031	61.00903614	0.0338793764	0.9992915708			FC1=CC=C(C=C1)C2=NOC\3=C2C(=O)N(CCC(=O)NC4=CC=CC(=C4)C(F)(F)F)\C=N3	Sytravon	E910-0008	-1.67032431	0.54236294	7.74873911	61.00903614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090782-17	Nelfinavir Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	159989-65-8		3.1622776602	-5.5	157.9656368011	3	4		148.695203974	3.47639485	1	0.9999870644			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	-1.25089863	-1.23762376	112.01988251	3.47639485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024415-61	Doxorubicin		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	23214-92-8				-10.4058118074	4	4		0	0.04291845				TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(=C3C2=O)O	Microsource	01505483	-2.2573688	-3.53814793	-3.14806447	0.04291845												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00434879-01	NCGC00434879-01	375875258		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.908847714	4	4		0	0.97891566					OC1=CC=C(CCC(=O)N[C@H]2CC[C@@H](C2)NC3=NC(=CC=N3)C4=CN=CC=C4)C=C1	Chembridge	15174553	-1.45086564	-1.30460276	2.82744918	0.97891566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356145-10	CB-839	384569029	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1439399-58-2				-12.1846565079	4	4		0	-4.62088698				GLS	FC(F)(F)OC1=CC=CC(=C1)CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4)S3)C=C2	MedChem Express	HY-12248	-1.42343638	-3.47990681	-3.81081488	-4.62088698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160539-02	Adefovir	225144241	DNA polymerase/reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	106941-25-7				-2.5436780887	4	4		0	-0.4148784					NC1=NC=NC2=C1N=C[N]2CCOC[P](O)(O)=O	Bosche	A2312	-0.53199137	-1.15026209	-0.43681277	-0.4148784												1.6E-9	8E-9	4E-8	2E-7											
NCGC00164859-01	NCGC00164859-01	29216613		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	10.2440319432	4	4		14.1081794199	11.85240964	0.1519417674	0.9856158455			CCOC(=O)C1=C(NC(=O)CSC2=CN(CCNC(=O)C3=CC=C(OC)C=C3)C4=C2C=CC=C4)SC5=C1CCCC5	Sytravon	C064-0045	0.84125823	-0.92348285	-0.1681186	11.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105405-01	NCGC00105405-01	24268750		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.6907634966	4	4		0	-2.15361446					CC1=CC=C(C=C1)C2=NC(=NO2)/C3=C/C4=CC=CC(=C4OC3=O)OCC5=CC=CC(=C5)C	Sytravon	C200-5366	-0.01219215	0.10260921	-1.60476845	-2.15361446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091823-01	Chrysophanol	17389107	VEGFR-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	481-74-3	CHRYSOPHANOL;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone)			0.8202865772	4	4	chrysophanic acid, ion (1-);Chrysophanic acid;chrysophanic acid;1,8-Dihydroxy-3-methylanthraquinone;CHRYSOPHANOL;NCGC00160154-01;Chrysophanol:9,10-Anthracenedione,1,8-dihydroxy-3-methyl;CHRYSOPHANIC ACID;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone);AB08582917-01;2-methyl-4,5-dihydroxyanthraquinone;chrysophanol 8-O-(6'-galloyl)glucopyranoside;1,8-Dihydroxy-3-methyl-anthraquinone;chrysophanol;CIPLUS_153453;3-methyl-1,8-dihydroxyanthraquinone;Chrysophanic Acid;NCGC00091823-02;chrysophanol 8-O-GGlc;	0	6.19456366			2321	FLT1	CC1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	NIEHS	AB08582917	-1.07836089	-0.74257426	-0.76818798	6.19456366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263192-04	Silmitasertib	384568656	Casein Kinase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1009820-21-6 (parent)				-0.1789729182	4	4		0	-3.59084406				CSNK2A1	OC(=O)C1=CC2=C(C=C1)C3=CN=CC=C3C(=N2)NC4=CC=CC(=C4)Cl	Axon Medchem	1965	-1.73975557	3.53814793	6.4015665	-3.59084406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346623-04	BMS-378806	384568863	HIV Attachment Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	357263-13-9				-8.9675849084	4	4		0	-1.67381974					COC1=C2C(=NC=C2C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C4=CC=CC=C4)[NH]C=C1	MedChem Express	HY-14134	-2.19985622	-2.02387886	-0.97906311	-1.67381974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510442-01	Abametapir	384569434	MMP-9 (Gelatinase B) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			12.5892541179	-4.9	19.3486352535	4	4		27.7189866	23.81974249	0.1270795165	0.9899270899		MMP	CC1=CN=C(C=C1)C2=NC=C(C)C=C2	SIGMA	513040	1.10711718	-1.8491555	0.01506251	23.81974249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090753-20	Azithromycin	384568081	50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	83905-01-5				-2.3052485131	4	4		0	-1.10157368					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MedChem Express	HY-17506	0.33069734	-2.19860221	-1.12968821	-1.10157368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105393-01	NCGC00105393-01	24268738		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.8448970134	4	4		0	-0.61746988					COC1=CC=C(NC(=O)CSC2=NC3=C(C=N2)[S+]([O-])(=O)N(CC4=CC=C(C)C=C4)C5=CC=CC=C35)C=C1Cl	Sytravon	C200-5334	0.25603511	3.47405453	0.32095369	-0.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00490219-01	NCGC00490219-01	375820855		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.134176985	4	4		0	-2.30421687					COC1=CC=C(NC2=NC(=NC=C2)N3CCCC(C3)C(=O)NCCC4=CC=C(Cl)C=C4)C=C1	ChemRoutes	CA-182-221	0.62179956	0.30782762	0.07641755	-2.30421687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00130409-01	NCGC00130409-01	24405792		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.5556691635	4	4		0	0.01506024					CC1=CC=C(C=C1C)C/2=N/C3=C(C=CC=C3)N(CC(=O)NC4=CC=CC=C4F)C(=O)C2	Sytravon	G353-0232	2.08485735	0.92348285	-3.46935656	0.01506024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253627-01	Pleconaril	170466405	Human rhinovirus A protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	153168-05-9				-8.965736881	4	4		0	-3.50903614			1461213		Cc1cc(on1)CCCOc2c(C)cc(cc2C)c3nc(on3)C(F)(F)F	GVK	FFS-12-73-NCI-1186	-1.67032431	-0.54236294	-2.43007795	-3.50903614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00400099-01	NCGC00400099-01	375800320		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.7872645064	4	4		0	-0.76807229					C[N]1C=CC=C1C(=O)N[C@H]2C[C@H](N(C2)C(=O)CSCC(=O)N3C[C@H](C[C@H]3C(O)=O)NC(=O)C4=CC=CS4)C(O)=O	Analyticon	NAT3-206772	-1.98732017	-1.9495749	0.32095369	-0.76807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165722-19	Plerixafor hydrochloride	384568275	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.2148152044	4	4		0	0.28614458			7852	CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	NCGCChem	AED021-093	-1.7678615	2.62386397	3.83616078	0.28614458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016055-11	Trimethoprim	124881736	Bacterial dihydrofolate reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					4.8819880771	4	4	trimet;tridoxine;LS-31253;sulfaton;CIPLUS_751110;CN-3123;2,4-PYRIMIDINEDIAMINE, 5-((3,4,5-TRIMETHOXYPHENYL)METHYL)-, MONOHYDROCHLORIDE;kelfiprim;Proloprim;trimethoprim sulfamethizole;2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine;TRIMETHOPRIM LACTATE;syraprim;WHO NO. 1047;co-trimazine;berlocombin;NCGC_Prestw-208;cotrifamol;2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE SULFATE;Quam;Borgal;potrox;HS_1413;SULFAMETHOXAZOLE;LS-175750;CIPLUS_3886364;Trimethoprim-Sulfamethoxazole Combination;co-trifamole;Trimethoprim Sulfate;Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimithoprime;Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;BACTRIM;sulfamoxole and trimethoprim;Trimethoprimum;TRIMETHOPRIM HYDROCHLORIDE;Co-soltrim;Tribrissen;CIPLUS_167341;Potesept;CIPLUS_732710;lidaprim;Trimethoprim sulfate;Trimethoprim lactate;CIPLUS_3883816;Supristol;trimerazine;CIPLUS_206865;CIPLUS_206866;CIPLUS_206868;CIPLUS_206867;CIPLUS_206869;benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimethoprim-sulfadiazine mixture;TRIMETHOPRIM SULFATE;NCGC00024707-08;sulfatroxazole-trimethoprim combination;LS-178642;BW-72U;NCGC00024707-06;NCGC00024707-04;Trimpex;NCGC00024707-05;NCGC00024707-01;cotrifamole;CIPLUS_206870;CIPLUS_156267;CIPLUS_206871;CIPLUS_206872;Trimetoprima;Trimethoprime;Trimethoprim;Co-trimadine;4-amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, mixt. with 5-((3,4,5-trimethoxyphenyl)meth yl)-2,4-pyrimidinediamine;LS-178650;2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-;Ditrim;Diaziprim Forte;PHENAZOPYRIDINE HYDROCHLORIDE;LS-1627;trimethoprimum;trimethoprim-sulfadoxine;SEPTRA;CIPLUS_740266;NCGC00016055-02;CN 3123;NCGC00016055-01;sulfadiazine-trimethoprim mixture;TRIMETHOPRIM;Linaris;BISPORIN;LS-2191;CIPLUS_748857;Poteseptyl;Bactrim;Triglobe;AB07944729-01;Ro 6-2153;	0	4.69340308					COC1=CC(=CC(=C1OC)OC)CC2=C(N)N=C(N)N=C2	SIGMA	T7883	-0.15745777	-2.21722846	4.75826193	4.69340308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015529-22	Ibuprofen lysine	384567862	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	15687-27-1				1.1126915727	4	4		0	2.45568149				PTGS1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	APExBIO	A8446	-1.15946178	-0.02996255	4.78886169	2.45568149												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00124418-01	NCGC00124418-01	24399801		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.6654003062	4	4		0	-1.52108434					[O-][S+](=O)(CC1=CC=C(F)C=C1)C2=C[N](CC(=O)NCCC3=CC=CC=C3)C4=C2C=CC=C4	Sytravon	E690-0710	-1.45086564	2.6824978	-2.43007795	-1.52108434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138211-01	NCGC00138211-01	24413594		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.9383376959	4	4		0	-1.21987952					CC(=O)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C(CN4C(=O)NC5=CC=CC=C5C4=O)C=C3	Sytravon	K221-2840	-1.64594001	0.24919378	-2.8580162	-1.21987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095049-04	Exalamide	170465990		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	53370-90-4				0.1373111946	4	4		0	-1.61144578					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	0.42672519	-0.57167986	0.93229405	-1.61144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017351-07	Psoralen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	66-97-7				-3.4209703701	4	4		0	-2.10694566					O=C\1OC2=CC3=C(C=CO3)C=C2\C=C1	MedChem Express	HY-N0053	-0.95906098	-0.98876404	1.85128519	-2.10694566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408830-04	BRD73954			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1440209-96-0				-3.6424396796	4	4		0	-3.6762569					ONC(=O)C1=CC(=CC=C1)C(=O)NCCC2=CC=CC=C2	Tocris	6284	0.47237332	-1.82771536	-1.17809058	-3.6762569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163432-05	Calpeptin		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	117591-20-5		0.316227766	-6.5	263.5027683724	1.3	4		110.3452484768	112.85963383	0.1015543991	0.9935848048			CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Cayman	14593	14.58631549	99.2659176	103.74847001	112.85963383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482596-01	Germacrone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6902-91-6				-5.5332187263	4	4		0	-1.78727114					CC(C)=C1C\C=C(/C)CC\C=C(/C)CC1=O	DC Chemicals	DCJ-025	-0.75866018	-2.63670412	-0.59669523	-1.78727114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386712-02	TMP195			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1314891-22-9		5.0118723363	-5.3	10.5716226092	4	4		15.190510424	11.45922747	0.0916196397	0.9948434819			CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4	Selleck	S8502	-0.99209202	1.2085032	5.2869408	11.45922747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182549-04	Vicriviroc (SCH-417690)	384568410	Chemokine CCR5 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	541503-81-5		7.9432823472	-5.1	4.2563343799	4	4		9.0227140319	7.48211731	0.3148507735	0.9345549508		CCR5	COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F	Adooq	A10971	0.18691589	-2.51892836	-0.07531255	7.48211731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250401-11	Flavopiridol	384568550	CDK1/2/4/6/7/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	146426-40-6		0.2238721139	-6.65	27.1224671628	4	4		12.5	10.77253219	0.3176457052	0.9328969726		CDK1	CN1CC[C@H]([C@@H](O)C1)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	MedChem Express	HY-10005	1.13587347	13.14793244	9.98644374	10.77253219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024683-20	NCGC00024683-20			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			10	-5	62.3883764339	3	4		89.9937384229	83.85643708	0.014633197	0.9998679153			C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	BIOMOL	T-113	-0.15745777	-1.19850187	1.36168911	83.85643708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261043-01	Desipramine hydrochloride	312344483	Serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			8.9125093813	-5.05	18.9506911869	3	4		38.6968819487	33.55129323	0.0387619596	0.9990730459			Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	D 3900	-1.67477813	-2.90636704	0.26009792	33.55129323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346708-03	Aloperine		Mediator Release Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	56293-29-9				4.8046255183	4	4		0	0.36326649					C1CCN2C[C@H]3C[C@H](\C=C/4CCCN[C@@H]34)[C@H]2C1	APExBIO	B1654	0.98768966	-0.74906367	3.62607099	0.36326649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356072-01	N/A	363677795	Lysine-specific histone demethylase 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-4.5926107132	4	4		0	-0.75822604					N[C@H]1C[C@H]1C2=CC=C(C=C2)C3=CC=CC(=C3)O	Selleck	S7237	-1.91229331	0.24752475	0.97906311	-0.75822604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168771-04	Fosamprenavir Calcium Salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	226700-81-8				2.710353313	4	4		0	3.81974249					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	APExBIO	A3421	0.99209202	-0.7134537	-3.11793945	3.81974249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015735-22	Niclosamide		STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	50-65-7				126.0255260792	4	4		0	25.45064378				STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	MedChem Express	HY-B0497	27.16031632	25.43680839	28.42295526	25.45064378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485478-02	Oritavancin (diphosphate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	192564-14-0				-4.4315033779	4	4		0	1.01573677					[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	-1.56721783	-0.48048923	-1.22006326	1.01573677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095709-02	Tanshinone IIA	50107688	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	568-72-9	TANSHINONE IIA			-6.9619877131	4	4	Tanshinone Iia;tanshinone;Tanshinone IIA;CIPLUS_762550;1,6-dimethylphenanthro(1,2-b)furan-10,11-dione;NCGC00095709-01;Tanshinon I;NCGC00095709-02;tanshinone IIB;tanshinone IIA;LS-175776;TANSHINONE IIA;tanshinone II A;CIPLUS_742126;tanshinone II B;	0	-2.51380413			7124	TNF	CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C	Prestwick Chemical, Inc.	GPN1A_01G09	-1.5316347	-2.45692884	0.78029376	-2.51380413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	165800-03-3				4.9471830275	4	4		0	0.13077594				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-0.78728886	1.10861423	8.70563035	0.13077594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482789-01	8-O-Acetylharpagide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6926-14-3				-5.949683393	4	4		0	-1.43853531					CC(=O)O[C@@]1(C)C[C@@H](O)[C@]2(O)\C=C/O[C@@H](OC3OC(CO)C(O)C(O)C3O)[C@H]12	DC Chemicals	DCY-112	-1.01631835	-2.78651685	-0.47429621	-1.43853531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384199-05	4SC-202	384569106	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	910462-43-0				-12.0906582592	4	4		0	-5.94303981				HDAC1	C[N]1C=C(C=N1)C2=CC=C(C=C2)[S+]([O-])(=O)[N]3C=CC(=C3)/C=C/C(=O)NC4=C(N)C=CC=C4	MedChem Express	HY-16012A	-0.52963069	-4.49438202	-4.51346389	-5.94303981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163544-09	E-64			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	66701-25-5		10	-5	3.6958802902	4	4		14.3461538479	10.40057225	0.0705968799	0.9969459116			CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(O)=O)C(=O)NCCCCNC(N)=N	Selleck	S7379	-1.53846154	-0.80081538	0.58743787	10.40057225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263207-01	NCGC00263207-01	137276051		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1217444-15-9	QS11	10	-5	17.4117978068	4	4		22.2487198241	18.23795181	0.1535338697	0.9852428012	442334	ARF1	OC[C@H](CC1=CC=CC=C1)NC2=NC(=NC3=C2N=C[N]3CC4=CC=C(C=C4)C5=CC=CC=C5)OC6=CC7=C(CCC7)C=C6	Tocris	3324	-0.20726652	2.36001173	3.80559376	18.23795181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00441105-01	NCGC00441105-01	375840228		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					5.7880315879	4	4		0	0.73795181					COC1=CC=C(NC(=O)N2CC(C2)OC3=CC=C(C=C3)C4=NC(=NO4)C5=CC=CC=C5)C=C1	Chemdiv	S050-0185	-0.23165082	6.61096453	1.72703653	0.73795181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345014-01	NCGC00345014-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.2592146352	4	4		0	0.88855422					CC1=C(C=CC=C1)C(=O)N2CCC3=C2C=CC(=C3)C4=CC=CC(=N4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	JMR03-081	-1.08510119	-0.04397537	-1.60476845	0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346556-07	Semagacestat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	425386-60-3				-13.1566601589	4	4		0	-3.39055794					CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=C(CCN(C)C1=O)C=CC=C2	DC Chemicals	DC7496	-2.48741912	-2.7810134	-3.32881458	-3.39055794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	126544-47-6				5.7770847939	4	4		0	7.31044349					CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	1.3659238	-1.93651718	-2.60581413	7.31044349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025297-10	Gabexate mesilate		NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	56974-61-9				-5.1986893019	4	4		0	-1.46084337				NFKB1	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	MedChem Express	HY-B0385	-0.96317971	-1.36323659	-0.99342809	-1.46084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246387-06	Arbidol		antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	131707-23-8		12.5892541179	-4.9	68.5555674087	3	4		100.7029216829	87.39457831	0.0046974808	0.9999863905			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	0.62179956	0.65963061	1.69646951	87.39457831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091011-20	CHLORAMPHENICOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	56-75-7				-4.9993268876	4	4		0	-0.87267525					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Microsource	MS-01500174	-0.87706686	-2.54804892	-0.46693779	-0.87267525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133169-02	NCGC00133169-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					6.826246452	4	4		0	4.23192771					ClC1=CC(=CC=C1)N2CCN(CCCNC(=O)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3)CC2	Chemdiv	G706-0916	1.57278713	-1.77367341	1.26853125	4.23192771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160628-18	RUTOSIDE  (rutin)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	153-18-4				-5.8637645299	4	4		0	-2.67525036					[H][C@@]1(C)O[C@@]([H])(OC[C@@]2([H])O[C@@]([H])(OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC=C(O)C(O)=C5)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	MS-00300607	-3.00503235	2.69365172	2.75643922	-2.67525036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651741-01	2,2 -Cyclouridine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	3736-77-4		0.4466835922	-6.35	21.1404961594	4	4		-11.244635192	-2.70386266	0.217230303	0.9700365859			OC[C@H]1O[C@@H]2[C@@H](OC3=NC(=O)C=C[N@@]23)[C@@H]1O	Selleck	S4984	9.50395399	-1.2085032	-0.37656274	-2.70386266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016435-06	HARMINE	124882259		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					6.7742163	4	4	LS-133548;HARMINE;HARMINE HYDROCHLORIDE;NCGC00094869-01;NCGC00094869-02;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole;CIPLUS_711790;9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-;Harmine hydrochloride;Harmine;CIPLUS_153150;harmine;CIPLUS_165046;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole hydrochloride;CIPLUS_758970;NCGC00016435-01;NCGC00094869-04;CIPLUS_152786;NCGC00094869-05;NCGC_Prestw-613;Harmine Hydrochloride;	0	1.64520744					COC1=CC2=C(C=C1)C3=CC=NC(=C3[NH]2)C	BIOMOL	AC-1053	1.25089863	1.2085032	2.15393885	1.64520744												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00124334-01	NCGC00124334-01	24399717		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	17.307952862	3	4		35.3929390159	30.94879518	0.1251552319	0.9902240017			CC1=C(C=CC=C1)C(=O)NC2=CC=C3N=C(NC4=CC(=CC=C4)C(F)(F)F)C=C(C)C3=C2	Sytravon	E683-0130	-1.7434772	0.86484902	-2.82744918	30.94879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134170-01	NCGC00134170-01	24409553		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.6481189477	4	4		0	-1.46084337					COC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)NC5=CC(=CC=C5C)C)\N=C3S2	Sytravon	G768-1619	-0.23165082	-0.74758135	-2.06327373	-1.46084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686694-01	Remdesivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1809249-37-3		8.9125093813	-5.05	97.7626435346	3	4		133.0922101341	126.93848355	0.0216015412	0.9997120749			CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	0.35945363	-2.14036109	4.9555656	126.93848355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378657-01	Simeprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	923604-59-5				-12.1329361692	4	4		0	-5.19313305					COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-2.11358735	-2.14036109	-1.94306371	-5.19313305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378806-01	Nucleozin	363678210		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	341001-38-5				-3.9737760195	4	4		0	1.18741059					CC1=C(C(=O)N2CCN(CC2)C3=C(Cl)C=C(C=C3)[N+]([O-])=O)C(=NO1)C4=CC=CC=C4	MedChem Express	HY-50001	-1.13587347	-0.77169482	-2.03343877	1.18741059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344933-01	NCGC00344933-01	161004144		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	59.7794798814	3	4		87.8713654019	79.11144578	0.0325228102	0.9993471062			[O-][S+](=O)(NC1=CN=CC=C1C(=O)NC2=NC(=CS2)C3=CC=CC=C3)C4=CC(=C(F)C=C4)F	NCGCChem	RAP12-060	0.86564253	-1.3925535	-0.840593	79.11144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00121463-01	NCGC00121463-01	24396042		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	29.7626800529	3	4		47.5795753592	42.96686747	0.0350481368	0.9992420554			CCC1CN(C(=O)N2CCC(CC2)C(=O)N3CCN(CC3)C4=CC=CC(=C4C)C)C5=CC=CC=C5O1	Sytravon	E216-5396	-1.10948549	0.33714453	0.35152071	42.96686747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125549-01	NCGC00125549-01	24400932		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.1388464286	4	4		0	4.05120482					CC1=C(Cl)C=CC=C1NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC6=C(OCO6)C=C25	Sytravon	E843-0235	-1.30455986	-1.21665201	1.8493046	4.05120482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			3.6648539938	4	4	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	0.70783133					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	2.03608876	-2.65318089	-0.87116002	0.70783133												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00017338-03	Antimycin A	124883057	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1397-94-0	Antimycin A;ANTIMYCIN A1			-18.598941847	4	4	Antimycin- A from Streptomyces sp.;Antimycin A1;NCGC00016578-01;9   Antimycin A (A3+A4 >90%);ANTIMYCIN A;ANTIMYCIN A (A1 shown);NCGC00142516-03;NCGC_Prestw-222;NCGC00095884-01;ANTIMYCIN A1;Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester;LS-86460;CIPLUS_155874;Antimycin A;NCGC00142516-02;CIPLUS_158270;	0	-1.58798283					CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)C2=C(O)C(=CC=C2)NC=O)[C@@H](C)OC1=O	BIOMOL	NP-009	-4.58662832	-4.64472918	-3.50956469	-1.58798283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-25	MELOXICAM SODIUM		Neuropharmacol 39: 1653 (2000)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	71125-38-7				0.6873449578	4	4		0	-2.80441732					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	MS-01504150	1.13083309	0.53932584	-0.68849449	-2.80441732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346433-06	Peramivir		Influenza Infection Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	330600-85-6				7.660734078	4	4		0	3.03690788					CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	APExBIO	A3709	1.30260521	-2.66666667	0.65789474	3.03690788												1.6E-9	8E-9	4E-8	2E-7											
NCGC00399536-01	NCGC00399536-01	375805932		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.8026711679	4	4		0	1.34036145					COC1=CC=C(NC(=O)N[C@H]2CO[C@@H]3[C@@H](CO[C@H]23)OC(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4)C=C1	Analyticon	NAT6-270098	-0.23165082	-2.59454705	-2.00213969	1.34036145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128419-02	NCGC00128419-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.1653792579	4	4		0	7.60542169					CC(=O)C1=CC(=CC=C1)NC(=O)CSC2=NC3=C(C=N2)[S+]([O-])(=O)N(CC4=CC=CC=C4)C5=CC=C(Cl)C=C35	Chemdiv	G071-1348	-0.42672519	-2.36001173	-1.11569616	7.60542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163699-10	Fumagillin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	23110-15-8		6.3095734448	-5.2	-0.5533726207	4	4		9.3447669319	6.40060241	0.3080793965	0.9376047083			[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	-1.0363326	-3.62063911	-0.22925264	6.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025208-05	Splitomicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	5690-03-9				-7.071589217	4	4		0	-2.48474281					O=C1CCC2=C3C=CC=CC3=CC=C2O1	Enzo	GR-331	-1.41711995	-1.28838951	-0.99449204	-2.48474281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507869-01	LY-3314814	384569343	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1383982-64-6				4.4564815899	4	4		0	-1.32229003				BACE1	CO[C@H]1CC[C@]2(CC1)CC3=C(C=C(C=C3)C4=CN=CC(=C4)C#CC)[C@@]2/5\N=C(C)/C(=N5)N	Selleck	S8193	1.84655024	0.56928839	0.47429621	-1.32229003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346477-02	Emricasan	384568791	Caspase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	254750-02-2		1.5848931925	-5.8	23.7094979813	4	4		15.5	13.96396396	0.109290956	0.9926228734		CASP3	C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F	MedChem Express	HY-10396	0.1002004	1.67790262	5.00305998	13.96396396												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00390255-01	Maslinic acid	384569181	Glycogen Phosphorylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	4373-41-5				-1.7498942483	4	4		0	-6.11740773				PYGL	CC1(C)CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Adooq	A12089	2.21872316	-3.68539326	-0.38249694	-6.11740773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346877-07	Batimastat	384568955	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	130370-60-4				-4.3653655995	4	4		0	-5.04213891				MMP1	CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC2=CC=CS2)C(=O)NO	MedChem Express	HY-13564	1.21671915	-3.35580524	-1.94308446	-5.04213891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371106-01	()-PPCC oxalate	363678033	Sigma-1 receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[932736-91-9]				3.1392154589	4	4		0	-0.0726533					COC(=O)[C@]1(C[C@H]1CN2CCC(O)(CC2)C3=CC=CC=C3)C4=CC=C(C)C=C4	Tocris	3870	1.70340681	-0.62921348	-1.0250918	-0.0726533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095987-05	NCGC00095987-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			12.5892541179	-4.9	6.3714592976	2.4	4		35.53370786	26.37314734	0.0255300103	0.9995983174			CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C	Analyticon	NP-007859	-3.53564271	-4.19475655	-3.93206854	26.37314734												1.44E-7	7.2E-7	0.0000036	0.000018											
NCGC00163523-01	CATALPOL	26756908		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					7.2000829692	4	4	NCGC00163523-01;CIPLUS_668279;CATALPOL;catalpol;	0	0.9735542					[H][C@@]12C=CO[C@@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@]1([H])[C@@]4(CO)O[C@H]4[C@H]2O	BIOMOL	BIOMOL_NP-046	3.24935585	-1.67790262	-0.93329253	0.9735542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522278-01	Oglufanide		VEGF Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					2.1182559193	4	4		0	3.64719558				FLT1	N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=CC=CC=C12)C(O)=O	Combi-Blocks	QM-5596	0.04294303	-1.37827715	0.35189718	3.64719558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091023-07	CETYLPYRIDINIUM CHLORIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	6004-24-6, 123-03-5 [anhydrous]				-4.9330813491	4	4		0	-5.70815451					CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1	Microsource	MS-01500169	1.27965492	-1.00465929	-4.62419039	-5.70815451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090548-05	Deferiprone		Iron Chelating Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	30652-11-0				4.7865855026	4	4		0	0.01453066					CN/1\C=C/C(=O)/C(=C1C)O	APExBIO	B1723	1.18809047	0.08988764	2.40208078	0.01453066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371119-04	S1RA	363678035	Sigma opioid receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	878141-96-9				-5.959668877	4	4		0	-2.89160128					CC1=CC(=N[N]1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4	Glixx	GLXC-90073	-1.04494704	-2.39700375	0.78029376	-2.89160128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370887-06	AC-55541			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	916170-19-9		5.0118723363	-5.3	24.0216836339	4	4		25.5101123639	24.16448707	0.090289703	0.9949497657			C\C(=N/NC(=O)C(NC(=O)C1=CC=CC=C1)C/2=N/NC(=O)C3=CC=CC=C23)C4=CC=CC(=C4)Br	MedChem Express	HY-14350	0.32922989	-1.25842697	8.58323133	24.16448707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390686-01	NBD-557	363680970	Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	333352-59-3				-2.0777546131	4	4		0	-2.07439199					CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Br)C=C2	MedChem Express	HY-76649	-0.58950395	2.22772277	-0.82843802	-2.07439199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096023-03	3,4 -DIHYDROXYFLAVONE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	14919-49-4		0.3981071706	-6.4	16.7783791821	4	4		-11.993025284	-3.32752107	0.1525195065	0.9855548191			OC1=CC=C(C=C1)C/2=C(O)/C(=O)C3=C(O2)C=CC=C3	Microsource	01505138	8.11623246	-0.32958801	-1.75948592	-3.32752107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	12.5892541179	-4.9	56.3507380599	3	4		101.7667516447	84.1761116	0.0163959553	0.9998341674	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-2.30460922	-1.04868914	0.07649939	84.1761116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379085-03	Kaempferide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	491-54-3				-0.9373371449	4	4		0	-3.8215635					COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C=C3O2	MedChem Express	HY-15449	0.70140281	0.74906367	-0.56609547	-3.8215635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345799-06	Oprozomib	384568748	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	935888-69-0				-19.4188547473	4	4		0	-3.64806867				PSMD1	COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@@]3(C)CO3	MedChem Express	HY-12113	-4.32782171	-4.47000582	-3.59993975	-3.64806867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263184-03	MK-0752		g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	471905-41-6				-8.5674235014	4	4		0	0.75822604				NOTCH1	OC(=O)CCC1CCC(CC1)(C2=CC(=CC=C2F)F)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	Adooq	A11194	-2.37239396	-2.54804892	-1.85268866	0.75822604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137795-01	NCGC00137795-01	24413178		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			10	-5	3.8688482578	4	4		18.53108998	14.83433735	0.0412927663	0.9989519094			CC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)C4=CC=C(Br)C=C4	Sytravon	G883-0331	-2.10924165	-1.59777191	-1.02399511	14.83433735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139425-01	NCGC00139425-01	24414808		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.0372980723	4	4		0	7.84638554					CC1=CC(=CC=C1)N2C(=N/C3=C(C=CC=C3)C2=O)\C=C\C4=C5C=CC=CC5=CC=C4	Sytravon	K505-0626	-1.67032431	2.50659631	-1.87987162	7.84638554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398199-01	NCGC00398199-01	375801055		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.1777175734	4	4		0	2.81626506					COC1=CC=C(NC(=O)N[C@H]2C[C@H](N(C2)C(=O)C3CC3)C(=O)N[C@H](CC4=C[NH]C5=C4C=CC=C5)C(N)=O)C=C1	Analyticon	NAT3-155438	-1.0363326	-3.44473761	-1.75760355	2.81626506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398354-01	NCGC00398354-01	375798676		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	61.6903520206	3	4		97.5665242537	87.18373494	0.0158013246	0.9998459783			[O-][S+](=O)(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC5=C(OCO5)C=C4)C6=CC7=CC=CC=C7C=C6	Analyticon	NAT6-319064	-0.54864667	-1.45118733	-1.5130674	87.18373494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379032-06	Tasquinimod	384569088	S100A9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	254964-60-8				-5.4731225977	4	4		0	-0.34638554			6280	S100A9	COC1=CC=CC2=C1C(=C(/C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)C(=O)N2C)/O	MedChem Express	HY-10528	-1.23140697	-2.24274406	-0.71832493	-0.34638554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1502654-87-6				-2.6935427877	4	4		0	-4.20180723					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	2.10924165	-2.74113163	-4.32523307	-4.20180723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159461-08	Amprenavir		HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	161814-49-9				-5.8729196801	4	4		0	-3.39055794					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17430	-1.07836089	0.68433314	-1.52131345	-3.39055794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137632-01	NCGC00137632-01	24413015		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.1088232237	4	4		0	7.72590361					FC1=C(CNC(=O)C2CCN(CC2)CC3=CC4=CC=CC=C4[N]3CC5=CC(=CC=C5)Cl)C=CC=C1	Sytravon	G907-0444	-0.67056815	-1.12870126	-1.66590249	7.72590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162178-02	NCGC00162178-02	144207066		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	208993-54-8		12.5892541179	-4.9	56.1009605524	3	4		90.2764959348	80.49698795	0.0201189271	0.9997502833			Cl.COc1cccc2OC[C@H]3CN(C[C@H]3c12)CCCCN5C(=O)Nc4c6nc(cnc6sc4C5=O)c7ccccc7	SigmaAldrich	Lopac-F-4303	-0.71933675	-1.24596892	-1.94100565	80.49698795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344588-04	I-BET151		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					2.9060855068	4	4		0	-3.10443491				BRD4	COC1=CC2=C(C=C1C3=C(C)ON=C3C)N=CC4=C2N([C@H](C)C5=CC=CC=N5)C(=O)N4	Tocris	4650	3.78145219	-2.28596389	-4.05181503	-3.10443491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163413-03	Lycorine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	2188-68-3		2.2387211386	-5.65	84.7412567866	3	4		61.7444252236	11.20171674	1	0.9993686288			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	-0.07189073	2.40244613	57.55384847	11.20171674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390668-02	()-BI-D			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1416258-16-6				-7.5365236542	4	4		0	1.58798283					CC1=NC2=C(C=CC=C2)C(=C1C(OC(C)(C)C)C(O)=O)C3=CC4=C(OCCC4)C=C3	MedChem Express	HY-18601	-2.91876348	-0.59697146	-1.22006326	1.58798283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346719-03	LY-2811376	384568932	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1194044-20-6				-3.7294538944	4	4		0	-1.70180723				BACE1	C[C@]\1(CCS\C(=N1)N)C2=CC(=C(F)C=C2F)C3=CN=CN=C3	Axon Medchem	2225	-0.96317971	1.36323659	-1.36023231	-1.70180723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165009-01	NCGC00165009-01	29216763		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.6379133074	4	4		0	-1.76204819					CC1CCC2=C(C1)SC(NC(=O)C3=NN4C(=C3)N=C(C=C4C(F)(F)F)C5=CC=C(Cl)C=C5)=C2C#N	Sytravon	A0005724	1.69470861	-2.82908238	-0.56548984	-1.76204819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180681-03	Isochlorogenic acid C			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	32451-88-0				11.7550932927	4	4		0	6.40060241					O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H]1OC(=O)\C=C\c3ccc(O)c(O)c3)C(O)=O	DC Chemicals	DCY-070	2.15801024	4.76399883	-2.67461409	6.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015801-17	Pentoxifylline	363676463	"3',5'-cyclic phosphodiesterase Inhibitor"	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	6493-05-6				-3.3442109474	4	4		0	-0.78683834					C[N]1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C	MedChem Express	HY-B0715	-0.47447879	-2.31508445	0.10543757	-0.78683834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601813-01	Bictegravir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1611493-60-7				-10.3620971488	4	4		0	-3.0472103					OC1=C2N(CC3OC4CCC(C4)N3C2=O)C=C(C(=O)NCC5=C(F)C=C(F)C=C5F)C1=O	Selleck	S5911	-3.09130122	1.79091439	-2.06356379	-3.0472103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016403-11	Mafenide (Acetate)		Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	13009-99-9				-5.2722711692	4	4		0	-1.18741059					NCC1=CC=C(C=C1)[S+](N)([O-])=O	MedChem Express	HY-B0614A	-2.34363767	-1.73267327	4.02169001	-1.18741059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346487-05	Quisinostat	385842041	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	807640-87-5				-19.2550113518	4	4		0	-5.64759036				HDAC1	C[N]1C=C(CNCC2CCN(CC2)C3=NC=C(C=N3)C(=O)NO)C4=CC=CC=C14	ActiveBioChem	A-1162	-2.86515484	-5.58487247	-5.45621275	-5.64759036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015992-01	Tyrphostin A9	11111849		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			4.4668359215	-5.35	46.9476881608	4	4	NCGC00015992-01;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile;SF6847;Malonoben;CIPLUS_168096;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]-propanedinitrile;NCGC00094494-01;TYRPHOSTIN 9;NCGC00094494-02;NCGC00094494-03;NCGC00094494-04;SF 6847;3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile;SF-6847;tyrphostin A9;Tyrphostin A9;	24.5	27.7560241	0.0377883921	0.9991205609			CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)C#N	SigmaAldrich	Lopac-T-182	4.69397708	4.76399883	15.57389577	27.7560241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263117-14	Panobinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	404950-80-7				-19.3018872571	4	4		0	-5.79819277				HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Aobious	AOB87727	-2.96269203	-4.67604808	-5.91471802	-5.79819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379171-01	NCGC00379171-01	363678396		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	[479232-57-0]				-7.3297763942	4	4		0	1.21987952					CN1CCCN(CC1)C(=S)[C@@H]2CCCN2C(=O)NCC3=CC=C(C=C3C)C(=O)N4CC5=C(NC6=C4C=CC=C6)[N](C)N=C5	Tocris	4625	-2.13362594	-1.62708883	-2.36894391	1.21987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481318-01	NCGC00481318-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	12.0502084639	4	4		15.5	11.79216867	0.0491775518	0.998522416			CN1C(=O)N(C)C2=C([N](CC(=O)NC3=CC=C(N=N3)C4=CC=CC=C4)C=N2)C1=O	MedChem Express	HY-18988	0.23165082	0.86484902	2.91915024	11.79216867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398316-01	NCGC00398316-01	375800526		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.5694485652	4	4		0	-0.16566265					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C(C=C4)[N]5C=CN=C5)NC6=CC=C(OC7=CC=CC=C7)C=C6	Analyticon	NAT6-298623	-1.91416728	-1.36323659	0.56548984	-0.16566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162068-04	Opipramol dihydrochloride	144206704	Serotonin 2 (5-HT2) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	909-39-7	Opipramol dihydrochloride; Insidon; Hydrochloride, Opipramo; 			-5.0428427909	4	4	NCGC00093619-01;opipramol hydrochloride;Opipramol;1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-;NCGC00093619-02;CIPLUS_152628;Opipramolum;opipramolum;Opipramol Hydrochloride;OPIPRANMOL DIHYDROCHLORIDE;LS-112246;4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol;LS-112248;OPIPRAMOL;OPIPRAMOL HYDROCHLORIDE;opipramol;Opipramol hydrochloride;Insidon;Hydrochloride, Opipramo;CIPLUS_213844;NCGC00162068-02;Opipramol dihydrochloride;4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol dihydrochloride;NCGC00162068-01;	0	4.64949928					Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Kemprotec	909-39-7	-2.05607477	-3.33430402	-1.34056334	4.64949928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511370-02	ACY-738		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1375465-91-0				-17.3746502655	4	4		0	-5.6223176				HDAC1	ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1	MedChem Express	HY-19327	-2.71746945	-3.47990681	-5.4375659	-5.6223176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246971-04	Polydatin	363677157	V/ICAM1 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	65914-17-2				-10.6864210517	4	4		0	-0.38626609				ICAM1	OC[C@H]1O[C@@H](OC2=CC(=CC(=C2)/C=C/C3=CC=C(O)C=C3)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2390	-3.49388929	-0.80081538	-1.31043832	-0.38626609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132517-01	NCGC00132517-01	24407900		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			10	-5	19.4602992575	4	4		31.3021214279	23.96084337	0.090509601	0.994925475			CC1CN(CCN1C2=CC=CC(=C2)C)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=C(ON=C4C)/C=C/C5=CC=C(C)C=C5	Sytravon	G637-0523	-1.08510119	1.21665201	4.96714046	23.96084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119897-01	NCGC00119897-01	24394476		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.0604688024	4	4		0	-1.94277108					CC(N1C(=O)\C(=N/C2=C1C=CC=C2)C3=CC=CC=C3NC(C)=O)C(=O)NC4=CC(=CC=C4C)Cl	Sytravon	D384-0046	-1.64594001	-0.16124304	-1.8493046	-1.94277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350780-13	NCGC00350780-13			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	942183-80-4				-10.2172516939	4	4		0	-3.29819277				MAPK7	O=C(CN1CC[C@H](C1)C(=O)NC2=CC3=C([NH]N=C3C4=CC=NC=C4)C=C2)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	MedChem Express	HY-50846	-1.30455986	-2.21342715	-4.11126395	-3.29819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023945-24	Zidovudine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	30516-87-1				-0.9298748578	4	4		0	3.41917024					C\C1=C\N([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O	MedChem Express	HY-17413	-0.61826024	-1.26674432	-1.46106341	3.41917024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164319-07	EPIGALLOCATECHIN-3-MONOGALLATE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	989-51-5				2.9832352239	4	4		0	5.56524266					OC1=CC(=C2C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC2=C1)C4=CC(=C(O)C(=C4)O)O)O	Microsource	MS-00210239	0.87317492	-3.23595506	-1.6370869	5.56524266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347890-01	NCGC00347890-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	58.9505957097	3	4		89.055913042	70.49698795	0.0667845374	0.9972394254			CC1=C(N=C(NC(=O)CC2=CC=C(C=C2)C(F)(F)F)S1)C3=CC=C4N(CCC4=C3)[S+]([O-])(=O)C5=CC=CC=C5C	NCGCChem	LLI015-018	-1.18263838	3.35678687	9.9189974	70.49698795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00098694-01	NCGC00098694-01	24272392		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.8290705608	4	4		0	-1.40060241					COC1=CC=C(C=C1)C2=NC3=CC(=N[N]3C(=C2)C(F)(F)F)C(=O)NC4=C(C(=O)OC(C)C)C5=C(CC(C)CC5)S4	Sytravon	3209-0156	1.69470861	3.82585752	-3.04141831	-1.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346506-05	LY-2886721	384568809	beta-Secretase 1/2 (BACE1/2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1262036-50-9				6.8561711941	4	4		0	-0.74106364				BACE1	NC/1=N/[C@]2(COC[C@H]2CS1)C3=CC(=CC=C3F)NC(=O)C4=NC=C(F)C=C4	MedChem Express	HY-13240	2.93444031	-2.3071161	2.1878825	-0.74106364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025291-03	Arctigenin		tumor necrosis factor biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1777				-3.9183564706	4	4		0	-0.9735542					COC1=C(O)C=CC(=C1)C[C@@H]2[C@H](COC2=O)CC3=CC(=C(OC)C=C3)OC	Tocris	1777	-0.24334383	-3.41573034	-0.26009792	-0.9735542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163654-01	HARRINGTONINE	26757033		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			14.1253754462	-4.85	42.4542283611	4	4	Harringtonine;harringtonine hydrochloride;CIPLUS_701701;HARRINGTONINE;LS-52750;NCGC00163654-01;LS-177419;LS-176258;harringtonine, (S)-isomer;harringtonin;CIPLUS_214594;harringtonine;harringtonine, (R)-isomer;LS-176636;	-24.050566692	-5.04213891	0.794553191	0.683288764			[H][C@]12[C@H](OC(=O)[C@](O)(CCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]13CCCN3CCC4=CC5=C(OCO5)C=C24	BIOMOL	BIOMOL_NP-435	7.429144	58.03745318	23.51591187	-5.04213891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399500-01	NCGC00399500-01	375799043		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.0815967504	4	4		0	1.28012048					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=C(C=C4)C5=CC=CC=C5)NC6=CC=C(OC7=CC=CC=C7)C=C6	Analyticon	NAT6-321094	-0.329188	0.04397537	-1.75760355	1.28012048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133197-01	NCGC00133197-01	24408580		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	32.4231422215	3	4		53.8367511766	44.35240964	0.0216230171	0.9997116763			O=C(NCCCN1CCN(CC1)C2=CC=CC=C2)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3	Sytravon	G706-0942	-0.91441112	-0.19055995	2.49121198	44.35240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-06	NCGC00183128-06			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	11052-19-0				-1.8701488711	4	4		0	-1.18975904					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	SigmaAldrich	S369039	-0.74372104	0.01465846	1.29909827	-1.18975904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00401264-01	NCGC00401264-01	375801833		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.4016104766	4	4		0	0.55722892					C[N]1C=CC=C1C(=O)N[C@H]2C[C@H](N(C2)C(=O)CSCC(=O)N3C[C@H](C[C@H]3C(O)=O)NC(=O)C4=CC=C[N]4C)C(O)=O	Analyticon	NAT3-206800	-1.10948549	-1.36323659	-0.04585053	0.55722892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025146-05	NU-1025			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	90417-38-2		1.1220184543	-5.95	18.1025472448	4	4		10.5	2.80441732	1	0.9985477901			CC/1=N/C2=C(C=CC=C2O)C(=O)N1	SIGMA	N7287	0.3006012	2.60674157	10.7252142	2.80441732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093656-03	Brivudine	90341813	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	69304-47-8	(E)-5-(2-Bromovinyl)-2'-deoxyuridine;Brivudine			5.8981204132	4	4		0	1.08979948			7015	TERT	OC[C@H]1O[C@H](C[C@@H]1O)N2/C=C(/C=C/Br)C(=O)NC2=O	SigmaAldrich	Lopac-B-9647	1.56026338	1.58801498	-0.01529988	1.08979948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378916-02	MK-5172			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1350514-68-9		14.1253754462	-4.85	7.2695245893	4	4		15.4353507519	12.03313253	0.0547695239	0.9981606311			COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	-0.3535723	-0.39577836	-0.77945896	12.03313253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM			-0.6591288619	4	4		0	0.88855422			217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-0.06096074	-1.68572266	0.01528351	0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398391-01	NCGC00398391-01	375801564		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					5.1110473782	4	4		0	-0.0753012					O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)O[C@@H]3CO[C@@H]4[C@H](CO[C@H]34)NC5=NC(=CC=N5)C6=CC=CC(=C6)C#N	Analyticon	NAT6-322408	-0.76810534	5.2623864	4.93657344	-0.0753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508898-01	UCPH 101			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[1118460-77-7]				2.1153631847	4	4		0	3.26939843					COC1=CC=C(C=C1)C\2C(=C(/N)O\C3=C2C(=O)CC(C3)C4=C5C=CC=CC5=CC=C4)/C#N	Tocris	3490	-0.73003149	-0.4494382	2.64687882	3.26939843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346532-04	VX-222			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1026785-59-0				5.1947614528	4	4		0	-0.42138913					C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]2CC[C@H](O)CC2)C3=C(SC(=C3)C#CC(C)(C)C)C(O)=O	MedChem Express	HY-75800	2.59089608	-1.10861423	-0.47429621	-0.42138913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183682-13	VX-765		Caspase-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	273404-37-8				-5.2599163032	4	4		0	-1.61290323				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C3=CC(=C(N)C=C3)Cl)C(C)(C)C	ChemieTek	CT-VX765	-2.10420842	-3.11610487	5.00305998	-1.61290323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384200-03	HPOB		Histone deacetylase 6 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1429651-50-2				-9.494383096	4	4		0	-5.21650683					OCCN(C(=O)CC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Adooq	A14197	-1.44574864	-0.71910112	-2.00428397	-5.21650683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350413-05	ESI-09			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	263707-16-0		3.9810717055	-5.4	27.5404204708	4	4		19.0955056159	19.16594013	0.3493862975	0.916536901			CC(C)(C)C1=CC(=NO1)C(=O)\C(=N\NC2=CC=CC(=C2)Cl)C#N	MedChem Express	HY-16704	3.47838534	-2.99625468	9.19522644	19.16594013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483024-01	BMS-791325 hydrochloride	377020421		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	958002-36-3		4.4668359215	-5.35	18.1549205435	4	4		9.4022471961	10.09880849	0.4381908141	0.8610972714			COC1=CC2=C(C=C1)C3=C(C4CCCCC4)C5=C(C=C(C=C5)C(=O)N[S+]([O-])(=O)N(C)C)[N]3C[C@]6(C[C@@H]26)C(=O)N7[C@H]8CC[C@@H]7CN(C)C8	DC Chemicals	DC9232	3.02032637	-1.16853933	5.30905753	10.09880849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480790-01	Coptisine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	3486-66-6				-7.9707541301	4	4		0	-2.94972392					C1OC2=C(O1)C=C3C(=C2)CC[N+]4=C3C=C5C=CC6=C(OCO6)C5=C4	Adooq	A14548	-0.95906098	-3.47565543	-1.26988984	-2.94972392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262641-04	S31-201	384568576	STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	501919-59-1				-3.9714591902	4	4		0	-3.87968614				STAT3	CC1=CC=C(C=C1)[S+]([O-])(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O	Selleck	S1155	-0.47237332	0.29962547	-0.10709914	-3.87968614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346536-05	PIK-93		PI3K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	593960-11-3		14.1253754462	-4.85	7.2992811503	4	4		-8.516129032	-3.76344086	0.7056209144	0.4702715828		PIK3CA	CC(=O)NC1=NC(=C(S1)C2=CC(=C(Cl)C=C2)[S+]([O-])(=O)NCCO)C	Adooq	A10731	1.24534784	0.56928839	9.34822521	-3.76344086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378604-04	ABT-333	377020340		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1132935-63-7		10	-5	70.3350255702	3	4		99.6747646481	88.59343214	0.0396560655	0.9990288514			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	0.81591755	-2.33707865	5.24785802	88.59343214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263093-14	Apilimod mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	870087-36-8		12.5892541179	-4.9	431.2339096564	5	4		-72.1831001384	42.44405696	0.4475122166	0.8517424253			CC1=CC=CC(\C=N\NC2=NC(OCCC3=CC=CC=N3)=NC(=C2)N4CCOCC4)=C1	AChemBlock	O33823	93.31520183	104.65917603	125.99449204	42.44405696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356073-10	RVX-208		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-5.3930551601	4	4		0	-4.31560593				BRD4	COC1=CC(=C2C(=O)N\C(=N/C2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC	Bio Vision	9408-5	-0.1002004	-1.61797753	-1.11689106	-4.31560593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178483-14	Limonin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1180-71-8				-2.4255514956	4	4		0	0.79918628					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	-0.84454624	-2.87640449	1.6370869	0.79918628												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091231-18	NCGC00091231-18			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			12.5892541179	-4.9	31.0121293807	3	4		40.8841101734	34.83547926	0.1696339137	0.9818380751			[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	BIOMOL	AC-129	2.8612509	-2.86837507	-0.46693779	34.83547926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371158-09	XEN 445		Endothelial lipase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[1515856-92-4]				-1.8987264464	4	4		0	0.4148784			9388	LIPG	OC(=O)C1=C(C=CC(=C1)C(F)(F)F)N2CC[C@@H](C2)OCC3=CC=CC=N3	Tocris	5839	-0.53199137	-1.41234712	0.19581262	0.4148784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522434-01	DPC-681			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	284661-68-3		0.2238721139	-6.65	19.7520350708	4	4		-13.87977528	9.28509154	1	0.9914956842			CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNCC2=CC=CC(=C2)F)C(C)(C)C)[S+]([O-])(=O)C3=CC(=CC=C3)N	MedChem Express	HY-19400	9.43315202	-2.8164794	-1.6370869	9.28509154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522116-02	Presatovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1353625-73-6				-0.2798421959	4	4		0	2.10694566					CC1=C[N]2N=C(C=C2N=C1N3CC[C@H](N)C3)[C@@H]4CCCCN4C(=O)C5=CC(=CC=C5N[S+](C)([O-])=O)Cl	MedChem Express	HY-16727	-0.93043229	-0.17977528	-0.38249694	2.10694566												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164574-25	Erlotinib		EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	183321-74-6				-13.0638217104	4	4		0	-6.26271433				EGFR	COCCOC1=CC2=NC=NC(=C2C=C1OCCOC)NC3=CC=CC(=C3)C#C	DC Chemicals	DC2101	-1.30260521	-2.99625468	-4.2380661	-6.26271433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016509-08	TRIMETHOBENZAMIDE HYDROCHLORIDE		Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	554-92-7, 138-56-7 [trimethobenzamide]				16.7073975966	4	4		0	-2.10694566					COC1=CC(=CC(=C1OC)OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2	Microsource	01500594	6.08359576	2.96629213	0.96389229	-2.10694566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381566-06	Nexturastat A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1403783-31-2				-11.8581030528	4	4		0	-4.59227468					CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2	MedChem Express	HY-16699	-1.9410496	-1.09202097	-3.87106492	-4.59227468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016535-12	Alprostadil			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	745-65-3				-8.8663212888	4	4		0	-0.75822604					CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	Selleck	S1508	-2.37239396	-2.22772277	-0.97906311	-0.75822604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115775-02	NCGC00115775-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			15.8489319246	-4.8	-2.5860512578	4	4		-8.79468178	-5.24556815	0.6929898645	0.5041836084			CC(C)C[S+]([O-])(=O)C1=C(N=C(O1)C2=CC=C(F)C=C2)[S+]([O-])(=O)C3=CC=CC=C3	Chemdiv	D093-0011	-1.21671915	-0.23970037	6.59424725	-5.24556815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263598-10	Chidamide		Histone deacetylase 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	743420-02-2				-7.9073534897	4	4		0	-6.26271433					NC1=C(NC(=O)C2=CC=C(CNC(=O)/C=C/C3=CN=CC=C3)C=C2)C=C(F)C=C1	MedChem Express	HY-13592	-0.35785857	-0.53932584	-2.76927785	-6.26271433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095522-06	DIMETHYLCAFFEIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	14737-89-4				-2.2184916128	4	4		0	-1.7291485					COC1=CC=C(/C=C/C(O)=O)C=C1OC	Microsource	00210567	0.3006012	-1.88764045	-0.53549572	-1.7291485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371122-02	Betrixaban	363678038	Coagulation factor X Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	330942-05-7				6.3820597192	4	4		0	1.15879828					COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	1.30841121	0.62609202	2.48531405	1.15879828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319175-08	Rilpivirine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	500287-72-9				-3.3516825464	4	4		0	3.33333333					CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	MedChem Express	HY-10574	-1.45219267	-0.53873034	-2.51543907	3.33333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00099110-01	NCGC00099110-01	24272808		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					5.1792640371	4	4		0	1.31024096					OC1=CC=C(NC(=O)C2=CC=C(O2)C3=CC=CC(=C3)Cl)C=C1C4=NC5=C(O4)C=CC=C5	Sytravon	3777-1655	1.40209705	0.71826444	0.1681186	1.31024096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168696-01	NCGC00168696-01	85736118		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.7092972453	4	4		0	-1.18975904					FC(F)(F)C1=CC=C(Cl)C(=C1)NC(=O)C(OC(=O)CNC(=O)C2=CC=C3C=CC=CC3=C2)C4=CC=CC=C4	NCGCChem	DJM02-036-A4	-0.54864667	-1.27528584	-2.1855418	-1.18975904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165833-11	Entinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	209783-80-2				-12.8139830595	4	4		0	-5.67771084				HDAC1	NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=CN=C3)C=C2)C=CC=C1	Selleck	S1053	-1.62155572	-1.92025799	-4.41693413	-5.67771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378881-01	Tegobuvir	363678254		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1000787-75-6				-2.0313961087	4	4		0	-0.67238913					FC1=CC=CC=C1C2=NC3=C[N](CC4=NN=C(C=C4)C5=CC=C(C=C5C(F)(F)F)C(F)(F)F)C=CC3=N2	MedChem Express	HY-10544	0.01437815	0.30576587	-2.54556409	-0.67238913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	192725-17-0		12.5892541179	-4.9	54.4906249369	3	4		91.192987598	80.92989986	0.0475598896	0.9986023912			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	-1.27965492	-0.27664531	-3.63006477	80.92989986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00131816-01	NCGC00131816-01	24407199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.1740774688	4	4		0	-1.25					CC1=C(NC(=O)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CC5=CC=CC=C5)C(=O)N24)C=C(Cl)C=C1	Sytravon	G567-0208	-1.98732017	-1.77367341	0.10698456	-1.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386847-01	NCGC00386847-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.4063078359	4	4		0	-1.67168675					COC1=CC=C(C=C1)C2=CC=C(C=C2)C3=C[N](N=N3)C(=O)N4CCCCC4C5=CC=CC=C5	Evotec	MLS004256815	-1.13386979	-0.68894752	-1.11569616	-1.67168675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			2.8419899815	4	4	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	-1.61144578					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	1.40209705	1.568455	-0.90172704	-1.61144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133280-01	NCGC00133280-01	24408663		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.5240124973	4	4		0	-2.60542169					FC(F)(F)C1=CC(=CC=C1)NC(=O)NCC2=CC=C3N(CCC3=C2)C(=O)C4=CC=CC=C4	Sytravon	G714-0224	-0.23165082	-2.21342715	-0.62662387	-2.60542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00392372-01	NCGC00392372-01	375809155		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.4578311695	4	4		0	-0.73795181					C[C@@H]1[C@H](CC[C@]2(C)CCC([C@H](O)[C@@H]12)[C@H](C)C(=O)N3CCC4=C(C3)C=CC=C4)NC(=O)C5=CN=CC=N5	Analyticon	NAT5-397554	-0.98756401	1.568455	-0.68775791	-0.73795181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015950-14	SB-415286		GSK-3 beta Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	264218-23-7				-7.0463725927	4	4		0	-1.75965665				GSK3B	OC1=C(Cl)C=C(N\C2=C(\C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1	MedChem Express	HY-15438	-1.10711718	-2.69365172	-1.46106341	-1.75965665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00382803-03	Desaminotyrosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	501-97-3				-6.4279541365	4	4		0	-1.93133047					OC(=O)CCC1=CC=C(O)C=C1	MedChem Express	HY-W015346	-1.48094896	-0.77169482	-0.94893809	-1.93133047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					23.2910890297	4	4		0	3.96280401					CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	5.33429188	3.88759464	5.70869107	3.96280401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178864-04	Ethambutol HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1070-11-7				-3.0466647364	4	4		0	-1.64156627					CC[C@@H](CO)NCCN[C@@H](CC)CO	Selleck	S4004	-0.49987808	-1.12870126	0.35152071	-1.64156627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123501-02	NCGC00123501-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					8.3909552646	4	4		0	5.61746988					CC1CCN(CC1)C2=C(F)C=C3C(=O)C(=C/N(CC4=CC=CC=C4)C3=C2)\[S+]([O-])(=O)C5=CC(=CC=C5)C	Chemdiv	E599-0577	1.7678615	-2.09615948	1.63533547	5.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00112475-01	NCGC00112475-01	24387054		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.75539074	4	4		0	-0.34638554					CC1=C(C)C=C(C=C1)[S+]([O-])(=O)\C2=C\N=C(/NC2=O)SCC(=O)NC3=CC=C4OCCOC4=C3	Sytravon	C716-0323	0.10972933	-2.03752565	-0.5043558	-0.34638554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389337-01	Epoxomicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	134381-21-8				-15.006396805	4	4		0	-3.73390558					CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	APExBIO	A2606	-3.49388929	-2.25684333	-2.45518903	-3.73390558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015256-29	Chloroquine		antimalarial agents	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	50-63-5		0.7943282347	-6.1	42.3140652384	4	4		22	20.70783133	0.1062885437	0.992991969			CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	1.84101439	0.01465846	4.66147027	20.70783133												1.6E-8	8E-8	4E-7	0.000002											
NCGC00485882-01	BCX 4430	363681391		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	222631-44-9				-3.0396082678	4	4		0	0.22590361					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	-0.76810534	-0.4544122	-1.32966529	0.22590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420587-01	NCGC00420587-01	375889531		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.5089197969	4	4		0	-1.49096386					OC(=O)COC1=CC=C(C=C1)C2=NC=CC3=C2C(=O)N(CC(CNC(=O)CC4=CC=CC=C4)O3)CC5=C[NH]C6=CC=CC=C56	Charles River	1444_8467_2002	-0.91441112	-1.0114336	-0.5043558	-1.49096386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095192-08	Tegaserod maleate		5-HT4 Partial Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	189188-57-6				-8.5521652077	4	4		0	-5.85585586				HTR4	CCCCCNC(=N)N/N=C/C1=C[NH]C2=C1C=C(OC)C=C2	Cayman	14692	-2.3332379	1.64794007	0.90269278	-5.85585586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	259793-96-9				-5.8156608422	4	4		0	0.61746988					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	-1.25579127	-2.36001173	-2.03270671	0.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159554-09	Salubrinal			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	405060-95-9		12.5892541179	-4.9	44.4737708206	3	4		76.8690173719	65.1409474	0.0071495742	0.999968477			ClC(Cl)(Cl)C(NC(=O)\C=C\C1=CC=CC=C1)NC(=S)NC2=C3N=CC=CC3=CC=C2	SIGMA	SML0951	-1.10220441	-1.52808989	-0.47429621	65.1409474												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522552-01	PI4KIIIbeta-IN-10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1881233-39-1		1.1220184543	-5.95	45.5628687092	4	4		21.5	4.69340308	1	0.999783269			COC1=CC=C(C=C1[S+]([O-])(=O)NC2=CC=C(O)C=C2)C3=C(C)N=C(NC(=O)C(C)(C)C)S3	MedChem Express	HY-100198	2.44775265	7.01123596	23.79130967	4.69340308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162409-10	Bafilomycin A1 from Streptomyces griseus			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	88899-55-2		0.2818382931	-6.55	186.9289973044	5	4		-18.4529463461	31.03915663	0.4101653658	0.8796914916			CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(C)/C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C	SantaCruz Bio	sc-201550B	45.41575226	54.42685429	34.46431301	31.03915663												1.6E-8	8E-8	4E-7	0.000002											
NCGC00346692-04	CUDC-907		PI3K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1339928-25-4				-24.484800608	4	4		0	-6.8148794				PIK3CA	COC1=CC=C(C=N1)C2=NC3=C(SC(=C3)CN(C)C4=NC=C(C=N4)C(=O)NO)C(=N2)N5CCOCC5	Selleck	S2759	-4.70941884	-5.96254682	-4.5746634	-6.8148794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398026-01	NCGC00398026-01	375798682		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.0054264349	4	4		0	3.26807229					COC1=CC=C(NC(=O)N2C[C@@H]3C[C@H](C2)\C4=C\C=C(\N[S+]([O-])(=O)C5=CC=C(NC(C)=O)C=C5)C(=O)N4C3)C=C1	Analyticon	NAT11-292327	-1.79224579	-1.0114336	-1.66590249	3.26807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133986-01	NCGC00133986-01	24409369		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.4389921307	4	4		0	3.96084337					CC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0127	-1.20702268	2.82908238	-0.59605685	3.96084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111803-01	NCGC00111803-01	24386382		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.4431215121	4	4		0	-1.12951807					COC1=CC(=CC=C1)NC(=O)C2=C(NC(=O)C3=CC=C(C=C3)C(F)(F)F)C4=C(O2)C=CC=C4	Sytravon	C686-0308	-2.23116313	-0.16124304	3.16368638	-1.12951807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386421-08	Verdinexor		Exportin-1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1392136-43-4				-8.9325458536	4	4		0	-2.22319093				XPO1	FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)C2=N[N](\C=C/C(=O)NNC3=CC=CC=N3)C=N2	MedChem Express	HY-15970	-1.01631835	-4.16479401	-2.5244798	-2.22319093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091641-16	6-Mercaptopurine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	50-44-2				-0.097266428	4	4		0	0.79918628					S=C1NC=NC2=C1NC=N2	MedChem Express	HY-13677	-0.78728886	-0.02996255	1.9124847	0.79918628												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00400318-01	NCGC00400318-01	375800847		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	75.9361474215	3	4		131.9177233972	111.21987952	0.0176941587	0.9998068448			CC1=NC(=CC(=N1)C2=C(Br)C=CC=C2)[C@H]3CN4CC[C@H]3C[C@@H]4CNC(=O)NC5=CC=C(Cl)C=C5	Analyticon	NAT13-368693	-1.49963424	-3.29815303	-1.5130674	111.21987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	526-18-1				-1.8805366132	4	4		0	3.81024096					OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	-0.89002682	-1.48050425	-2.03270671	3.81024096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160146-02	Cephalotaxlen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	24316-19-6				9.5344396437	4	4		0	2.83347864					COC/1=C/[C@]23CCCN2CCC4=C(C=C5OCOC5=C4)[C@@H]3[C@@H]1O	MedChem Express	HY-N0838	1.50300601	1.70786517	3.4118727	2.83347864												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402247-01	BG45			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	926259-99-6				0.3821400871	4	4		0	-5.97210113					NC1=C(NC(=O)C2=NC=CN=C2)C=CC=C1	SynKinase	SYN-5062	2.64815345	-2.72659176	-0.01529988	-5.97210113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017013-06	Thiamine chloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	59-43-8				7.9448397499	4	4		0	-2.775356					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	DC Chemicals	DCZ-120	3.10621242	4.19475655	-1.20869033	-2.775356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346629-09	GSK1349572		HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1051375-16-6				2.3228356727	4	4		0	-2.36849753					C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	DC Chemicals	DC7273	-0.07157171	-0.59925094	6.71664627	-2.36849753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167328-03	Aloxistatin	363676654	Calpain Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	88321-09-9		7.0794578438	-5.15	41.3143495032	3	4		57.5391355313	53.17596567	0.0143355614	0.9998732728		CAPN1	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	Selleck	S7393	-1.27965492	-1.49970879	8.41994276	53.17596567												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186460-07	Bardoxolone methyl		NF-kappaB signaling Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	218600-53-4				-18.6298172447	4	4		0	-6.98924731				NFKB1	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)\C=C\4[C@@](C)(CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)[C@]3(C)CC2	Adooq	A11323	-2.41912396	-5.09363296	-5.24785802	-6.98924731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016480-10	Kaempferol		flavanoid	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[520-18-3]				9.0730283327	4	4		0	3.26939843					OC1=CC=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O	Tocris	3603	0.32922989	2.66666667	5.61505508	3.26939843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015385-22	Dipyridamole	384567839	Phosphodiesterase PDE3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	58-32-2				-1.0092499367	4	4		0	-2.74629468				PDE5A	OCCN(CCO)C1=NC(=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO)N4CCCCC4	Prestwick	Prestw-142	0.27197252	-1.16853933	1.66768666	-2.74629468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386265-04	TCID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	30675-13-9				1.4024217635	4	4		0	6.17553037					ClC1=C(Cl)C(=C2C(=O)CC(=O)C2=C1Cl)Cl	APExBIO	B1467	-1.01631835	-2.3071161	1.42288862	6.17553037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159459-03	Mycophenolate mofetil	29215410	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	6.3095734448	-5.2	26.5589075179	4	4	Mycophenolate mofetil hydrochloride;mycophenolic acid morpholinoethyl ester;RS 61443;Mycophenolate Mofetil;Mycophenolate Mofetil Hydrochloride;mycophenolate mofetil hydrochloride;MYCOPHENOLATE MOFETIL HYDROCHLORIDE;RS-61443;Cellcept;CIPLUS_196921;mycophenolate mofetil;CIPLUS_739758;2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE;HS_286;LS-172327;Mycophenolate mofetil;LS-172272;MYCOPHENOLATE MOFETIL;CIPLUS_660816;	33.4743739079	29.45636624	0.0744999215	0.9965661967	727833	IMPDH1	COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C3C(=O)OCC3=C1C	AKos	AKJ-92025	-0.21567218	-1.64531159	8.93206808	29.45636624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017222-10	OLEANOIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	508-02-1				-4.4457821062	4	4		0	0.58655222					[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]3(C)C2=CC[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	00100550	-2.22861251	0.59697146	0.55731285	0.58655222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166076-09	Arbutin		Free Radical Scavenger	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	497-76-7				-9.9871360984	4	4		0	3.47639485					OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-1026	-3.1488138	-3.39254514	-0.25606266	3.47639485												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00017325-10	KOJIC ACID		Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	501-30-4				0.9565768082	4	4		0	-2.45568149					OC\C1=C\C(=O)\C(=C/O1)O	Microsource	01504324	-0.04294303	-0.29962547	3.4118727	-2.45568149												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345452-02	Ac-DEVD-CHO			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	184179-08-6				-3.5157753115	4	4		0	-2.74629468					CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N[C@@H](CC(O)=O)C=O	Cayman	10017	-0.67277412	-0.59925094	0.96389229	-2.74629468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183808-18	ML324		JMJ Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			7.9432823472	-5.1	37.6118084742	3	4		43.9694041752	41.78826896	0.0667191398	0.9972462909		JARID2	CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O	NCGCChem	GRB059-084	1.42343638	-1.12114153	5.04594065	41.78826896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384596-01	NCGC00384596-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					2.4471627603	4	4		0	5.39341917					OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C2=C3[C@@H]([C@H](OC3=C(O)C=C2)C4=CC(O)=C(O)C=C4)C(O)=O	Analyticon	NP-017967	-0.01437815	-0.45136867	-1.7623136	5.39341917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-05	Ixazomib	384568528	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1072833-77-2				-12.4752940146	4	4		0	-2.76108727				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Adooq	A10600	-1.91229331	-4.76121142	-3.14806447	-2.76108727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126890-02	NCGC00126890-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.8626266055	4	4		0	2.60542169					[O-][S+](=O)(CC1NC2=C(NC1=O)C=C(C=C2)C(=O)NCC3=CC=C(Cl)C=C3)CC4=C(Cl)C=C(F)C=C4	Chemdiv	K977-0487	-0.74372104	-1.97889182	-2.1855418	2.60542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370745-06	NCGC00370745-06			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.4364849374	4	4		0	4.44277108					CC1=NOC(N[S+]([O-])(=O)C2=CC=C(NC(=O)C3=C4C=C(C)C=C(C)C4=NC(=C3)C5=NC=CC=C5)C=C2)=C1C	NCGCChem	KKW009-092	-0.69495245	-2.30137789	-0.53492282	4.44277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126065-01	NCGC00126065-01	24401448		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.3741514502	4	4		0	1.9126506					CC1=C(NC(=O)C2=CC=CC(=C2)NC(=O)N3CCSC4=NC=CC=C34)C=CC=C1Cl	Sytravon	E867-0334	-1.96293587	0.16124304	0.13755158	1.9126506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389721-01	Q-VD-OPh hydrate	363680840	Irreversible pan-Caspase inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1135695-98-5		0.7943282347	-6.1	28.3433366657	4	4		15.5	13.97711016	0.227405838	0.966880115		CASP3	CC(C)C(NC(=O)C1=NC2=CC=CC=C2C=C1)C(=O)NC(CC(O)=O)C(=O)COC3=C(F)C=CC=C3F	APExBIO	A1901	0.1581596	8.08095515	16.94532309	13.97711016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371133-07	Atglistatin	363678049	Patatin-like phospholipase domain-containing protein 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1469924-27-3				-7.9181291495	4	4		0	-2.07439199			57104	PNPLA2	CN(C)C(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)N(C)C	Glixx	GLXC-04086	-2.48741912	-0.21840419	0.19581262	-2.07439199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015097-03	4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride	90340895		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					1.3947166681	4	4		0	-0.61516452					NCCC1=CC=C(C=C1)[S+]([O-])(F)=O	SigmaAldrich	Lopac-A-8456	-0.01437815	0.16016308	2.54556409	-0.61516452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164557-06	Eprosartan (mesylate)	363676634	urate transport Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	144143-96-4				-3.8995777315	4	4		0	0.70100143					CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	MedChem Express	HY-15834A	-1.56721783	-1.73267327	1.12968821	0.70100143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137466-01	NCGC00137466-01	24412849		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.5031046967	4	4		0	-3.26807229					COC1=C(C=CC=C1)N2CCN(CC2)C(=O)CN3C(=O)[N]4N=C(N=C4C5=CC=CC=C35)C6=CC(=CC=C6)F	Sytravon	G860-0124	-0.49987808	-1.21665201	-2.76631515	-3.26807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133282-01	NCGC00133282-01	24408665		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.3103533048	4	4		0	-1.85240964					CC1=CC(=CC=C1Br)NC(=O)NCC2=CC=C3N(CCC3=C2)C(=O)C4=CC=CC=C4	Sytravon	G714-0225	1.25579127	-0.13192612	-2.91915024	-1.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139554-01	NCGC00139554-01	24414937		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.8515705388	4	4		0	1.79216867					[O-][S+](=O)(N1CCC2(CC1)OCCO2)C3=CC(=CC=C3F)C(=O)NC4=CC(=C(F)C=C4)F	Sytravon	K784-0137	-1.91416728	-0.86484902	-2.43007795	1.79216867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250408-10	NCGC00250408-10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1086062-66-9		1.2589254118	-5.9	15.0231960864	4	4		18.9353562	13.4186747	0.1654474084	0.9828065288		PIK3CA	COC1=C(N[S+]([O-])(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C3=CC=C4N=CC=C(C5=CN=NC=C5)C4=C3	Aobious	AOB87781	-1.86539868	-4.5294635	-3.37765551	13.4186747												1.6E-8	8E-8	4E-7	0.000002											
NCGC00016853-13	Nabumetone		Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	42924-53-8				-0.8964048209	4	4		0	-0.9186747					COC1=CC2=CC=C(CCC(C)=O)C=C2C=C1	Enzo	DL454	0.74372104	-2.36001173	-0.65719089	-0.9186747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017251-06	alpha-MANGOSTIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	6147-11-1		2.2387211386	-5.65	64.2430329751	3	4		45.5027510272	-4.86445783	1	0.9988812026			COC1=C(CC=C(C)C)C2=C(OC3=C(C(=C(CC=C(C)C)C(=C3)O)O)C2=O)C=C1O	Microsource	MS-01504015	0.329188	2.56523014	42.59513984	-4.86445783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015036-23	Amantadine hydrochloride	384567799	Dopamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	665-66-7				-3.1313684887	4	4		0	-0.46686747				DRD1	NC12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0402A	-0.62179956	-2.21342715	0.5043558	-0.46686747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100060-01	NCGC00100060-01	24273758		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.7563955062	4	4		0	1.52108434					CC1=C(NC2=C3C=CC=CC3=C(N=N2)C4=CC(=C(C)C=C4)[S+]([O-])(=O)NCC5CCCO5)C=CC=C1	Sytravon	4903-2163	-1.57278713	-1.53913808	-1.14626318	1.52108434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182490-01	NCGC00182490-01	104223876		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.966242471	4	4		0	2.63554217					CC1=CC=C(NC(=O)CN2C(=O)N\C(=C/C3=CC=CN3C4=CC=C(C=C4)C(=O)N[S+](C)([O-])=O)C2=O)C=C1	NCGCChem	BTM03-098	-0.84125823	-2.79976546	-4.05012991	2.63554217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370866-10	PJ34 Hydrochloride	363677895	Poly [ADP-ribose] polymerase-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	344458-15-7		0.4466835922	-6.35	32.610551481	4	4		15.5	14.98493976	0.0547482089	0.9981580154			CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1	Glixx	GLXC-05505	0.30480371	13.85224274	15.66559682	14.98493976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263556-10	P 22077			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1247819-59-5		2.5118864315	-5.6	1.3587164065	4	4		17.192667148	8.59799714	0.395873495	0.8903511164			CC(=O)C1=CC(=C(S1)SC2=CC=C(F)C=C2F)[N+]([O-])=O	MedChem Express	HY-13865	-3.49388929	2.57716948	2.93718934	8.59799714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-02	Verteporfin		photosensitizer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	129497-78-5				-8.2296697634	4	4		0	-5.05007153					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-0.27318476	-2.22772277	-3.14806447	-5.05007153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116188-01	NCGC00116188-01	24390767		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.1886710733	4	4		0	-1.06927711					CC1=CC=C(CC2=CN=C(NC(=O)C3=CC4=C(C=C3)C(=O)OC(C4)C5=CC=CC=C5)S2)C=C1	Sytravon	D136-0114	-0.03657644	-1.09938434	-2.1855418	-1.06927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017115-04	Thiethylperazine Malate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	52239-63-1		3.1622776602	-5.5	34.7129722744	4	4		34.754177664	-5.94879518	1	0.991628156			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	USP	1657005	0.06096074	-2.71181472	25.2025065	-5.94879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168085-15	Vorinostat (SAHA)		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	149647-78-9				-11.704414986	4	4		0	-5.43674699				HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	Microsource	01502267	-0.79248964	-3.64995602	-4.38636711	-5.43674699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274067-03	NCGC00274067-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			2.5118864315	-5.6	31.8206354858	4	4		28.2003312503	20.82831325	0.3852088379	0.8957318015		MPL	CC1=CC=C(C=C1C)N2/N=C(C)\C(=N/NC3=CC=CC(=C3O)C4=CC=CC(=C4)C(O)=O)C2=O	Toronto Research	E508000	-0.81687393	1.92025799	33.63900352	20.82831325												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00016382-09	Oxethazaine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	126-27-2		12.5892541179	-4.9	10.3204314955	2.4	4		30.2654767279	23.84835479	0.0385109989	0.9990858444			CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2	APExBIO	A8494	-1.68224299	-2.28596389	-2.30456394	23.84835479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485944-01	TAPI-1	363681435	ADAM17 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	163847-77-6				-0.6499474532	4	4		0	-2.87553648					CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)NCCN	MedChem Express	HY-16657	0.4457225	2.4898078	-1.97318873	-2.87553648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132816-01	NCGC00132816-01	24408199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.8588108134	4	4		0	-0.88855422					CC1=CC=C(CNC(=O)C2=CC=C(C=C2)C3=NC(=C(C)O3)CN4CCC5=C4C=CC=C5)C=C1	Sytravon	G659-0754	-1.93855157	0.4544122	0.62662387	-0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253439-03	NCGC00253439-03	384568562		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1089283-49-7		12.5892541179	-4.9	22.1091663341	3	4		37.0453920239	33.11746988	0.035474487	0.99922384		IGFR1	CCC1=CC(=C(OC)C=C1N2CCC(CC2)N3CCN(CC3)[S+](C)([O-])=O)NC4=NC(=CC=N4)C5=C(N=C6C=CC=C[N]56)C7=CC(=C(OC)C=C7)C(=O)NC8=C(F)C=CC=C8F	Selleck	S1093	-0.81687393	0.07329229	-0.87116002	33.11746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249694-01	NCGC00249694-01	144116880		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.8126523549	4	4		0	0.85843373					[O-][S+](=O)(NC1=NC(=NC2=CC=CC=C12)C3=C(C=CC=C3)C(F)(F)F)C4=CC=C(C=C4)C5=CN=CC=C5	NCGCChem	ASR12-076	-0.93879542	0.33714453	-1.8493046	0.85843373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399493-01	NCGC00399493-01	375804029		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.71827589	4	4		0	-1.46084337					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=C(C=C4)C5=CC=CC=C5)C6=CC=C7OCOC7=C6	Analyticon	NAT6-321062	-1.25579127	-2.82908238	-2.06327373	-1.46084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018113-18	Sodium Phenylbutyrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1716-12-7				-8.9771433696	4	4		0	-0.24320458					OC(=O)CCCC1=CC=CC=C1	APExBIO	A4107	-1.50970525	-3.82935352	-3.23843952	-0.24320458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388216-01	Corilagin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	23094-69-1				-0.2453203506	4	4		0	2.1888412					OC1C2COC(=O)C3=CC(=C(O)C(=C3C4=C(O)C(=C(O)C=C4C(=O)OC1C(O)C(O2)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)O)O	Cayman	11832	-0.50323508	0.27664531	-1.12968821	2.1888412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399510-01	NCGC00399510-01	375801344		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			10	-5	45.0820889237	3	4		69.3026342831	62.96686747	0.0072307936	0.9999677577			COC1=CC(=CC(=C1)NC(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=C(C=C5)C6=CC=CC=C6)OC	Analyticon	NAT6-321099	-0.91441112	-1.12870126	1.63533547	62.96686747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00103892-01	NCGC00103892-01	24267237		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-10.2688354356	4	4		0	-2.87650602					CC1=CC=CC(=C1)CC(=O)N2CC(=O)NC3=C(C=C(Br)C=C3)C2C4=CC=C(F)C=C4	Sytravon	C076-0593	-1.67032431	-1.89094107	-3.62219166	-2.87650602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381560-10	RGFP966			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1357389-11-7				-6.3320004654	4	4		0	-2.98998569					NC1=CC(=CC=C1NC(=O)\C=C\C2=C[N](C\C=C\C3=CC=CC=C3)N=C2)F	MedChem Express	HY-13909	-0.87706686	-0.68433314	-1.97318873	-2.98998569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090730-05	Camphor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	76-22-2				-4.0431669358	4	4		0	0.61516452					CC1(C)C2CCC1(C)C(=O)C2	MedChem Express	HY-N0808	-1.25089863	-0.74257426	-1.12968821	0.61516452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-08	Carfilzomib		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	868540-17-4				-16.1902127874	4	4		0	-4.36337625				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Aobious	AOB87759	-4.15528397	-0.80081538	-2.51543907	-4.36337625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522444-01	TAK-220			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	333994-00-6				-4.2982816318	4	4		0	-1.8744551					CC(=O)N1CCC(CC1)C(=O)N(CCCN2CCC(CC2)CC3=CC=C(C=C3)C(N)=O)C4=CC=C(C)C(=C4)Cl	MedChem Express	HY-19974	-1.76066419	-0.35955056	2.64687882	-1.8744551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116054-01	NCGC00116054-01	24390633		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.9044276927	4	4		0	7.63554217					CC1=C2C(=O)/C=C(\C=C(OC(=O)C3=CC=C(C)C=C3)/C2=C(C)O1)C4=CC5=C(OCO5)C=C4	Sytravon	D132-0066	-2.08485735	-1.24596892	-0.59605685	7.63554217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164462-05	NCGC00164462-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.5254202256	4	4		0	-1.61144578					C[C@@H](COc1ccc(Oc2ccccc2)cc1)Oc3ccccn3	EPA	TV000265	1.25579127	-1.77367341	-1.57420144	-1.61144578												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00166291-04	Lycopene		response to oxidative stress Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	502-65-8				-1.1550821411	4	4		0	-0.61746988					CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	Glixx	GLXC-06674	-0.25603511	1.33391967	-1.39079933	-0.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102565-01	NCGC00102565-01	24276263		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.596374651	4	4		0	2.06325301					COC1=CC2=C(OC(=N2)C3=CC(=CC=C3)NC(=O)C4=CC(=CC=C4N5CCOCC5)[N+]([O-])=O)C=C1	Sytravon	7793-4006	0.28041941	-1.71503958	-2.36894391	2.06325301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164126-01	Octyl gallate	26757543		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1034-01-1		22.3872113857	-4.65	18.5130954956	4	4	OCTYL-GALLATE;CIPLUS_197519;NCGC00164126-01;3,4,5-trihydroxybenzoic acid octyl ester;octyl gallate dihydrate;Octyl gallate;octyl gallate;	31.4741573041	29.33740192	0.1140591868	0.991901183			CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1	SigmaAldrich	MFCD00002197	1.9324363	-1.22846442	1.08629131	29.33740192												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00163651-06	DIHYDROTANSHINONE I			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					5.988067387	4	4		0	-2.42662017					C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C	Microsource	01505825	2.963069	0.71910112	-0.38249694	-2.42662017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398412-01	NCGC00398412-01	375799462		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.8135538646	4	4		0	2.48493976					FC(F)(F)C1=CC=CC(=C1)NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC6=C(OCO6)C=C5	Analyticon	NAT6-318363	-2.37746891	-0.80621519	-1.48250038	2.48493976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00121465-02	NCGC00121465-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.1165199949	4	4		0	-3.75					CCC1CN(C(=O)N2CCC(CC2)C(=O)N3CCN(CC3)C4=C(C)C=CC(=C4)C)C5=CC=CC=C5O1	Chemdiv	E216-5397	-0.96317971	-1.45118733	0.22925264	-3.75												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140594-02	NCGC00140594-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			8.9125093813	-5.05	12.4767932142	4	4		15.4045734361	14.02108434	0.060894473	0.9977221923			[O-][S+]1(=O)C2=C(C=C(C=C2)C(=O)N3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F)N(CC5=CC=CC(=C5)Cl)C(=O)C6=C1C=CC=C6	Chemdiv	K788-8584	0.42672519	-0.33714453	1.63533547	14.02108434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345017-01	NCGC00345017-01	170466916		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.6667524923	4	4		0	0.61746988					CC1=C(C=CC=C1)C(=O)N2CCC3=C2C=CC(=C3)C4=CC=CC(=C4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	JMR03-077	0.64618386	-2.41864556	0.35152071	0.61746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378947-03	AMD-070 (hydrochloride)		Human immunodeficiency virus 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	880549-30-4				2.8147527436	4	4		0	-0.79918628					NCCCCN(CC1=NC2=CC=CC=C2[NH]1)[C@H]3CCCC4=CC=CN=C34	MedChem Express	HY-50101A	1.50300601	-2.27715356	1.66768666	-0.79918628												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094916-09	.		Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	GRT01099				0.3341881725	4	4		0	-0.59575705			5743	PTGS2	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2	SIGMA	SML1495	0.58688806	-1.76779026	0.22949816	-0.59575705												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00017159-23	Curcumin	384567975	NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	458-37-7		12.5892541179	-4.9	21.0845953812	3	4		43.229060568	36.89334496	0.0491553565	0.9985079344		NFKB1	COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC	MedChem Express	HY-N0005	-2.10420842	-0.38951311	-1.20869033	36.89334496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015520-13	Hydroxyurea	384567861	Ribonucleoside-Diphosphate Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	127-07-1				-7.20487691	4	4		0	-1.55120482				RRM1	NC(=O)NO	Selleck	S1896	-1.54840283	-2.94635004	-0.04585053	-1.55120482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00099045-01	NCGC00099045-01	24272743		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.5935835236	4	4		0	-1.40060241					CC1=CC2=C(C=C1C)N=C(O2)C3=CC(=CC=C3)NC(=O)C4=C5C=CC=CC5=CC=C4	Sytravon	3729-3012	2.35308461	-1.53913808	-1.8493046	-1.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346546-02	NCGC00346546-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	957116-20-0				-3.7535906426	4	4		0	2.72590361					FC1=CC(=CC(=C1)F)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC=C5C[C@]6(CC5=C4)C(=O)NC7=C6C=CC=N7	Selleck	S1542	-1.54840283	-0.01465846	-2.61348006	2.72590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399481-01	NCGC00399481-01	375799752		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.280773674	4	4		0	6.34036145					FC(F)(F)C1=CC=CC(=C1)NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=C(C=C5)C6=CC=CC=C6	Analyticon	NAT6-318788	-2.40185321	-0.80621519	2.39951093	6.34036145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347708-02	NCGC00347708-02	363677669		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			3.9810717055	-5.4	58.8930908084	3	4		55.102236669	50.13554217	0.0109243878	0.9999264143			CC1CCC2(OC1)OC3CC4C5CCC6C[C@H](CC[C@]6(C)C5CC[C@]4(C)C3C2C)O[C@@H]7O[C@H](CO[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H](O)[C@H]7O	Analyticon	NP-007320	-0.81687393	-0.68894752	-0.77945896	50.13554217												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00022304-23	ACETYLCYSTEINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	616-91-1				-2.278891188	4	4		0	-2.9206626					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-0.1002004	-1.4082397	1.6370869	-2.9206626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384206-05	b-AP15			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1009817-63-3				-9.4636020669	4	4		0	-6.96018599					[O-][N+](=O)C1=CC=C(C=C1)/C=C/2CN(CC(=C/C3=CC=C(C=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	Cayman	11324	-1.04494704	-2.90636704	0.62729498	-6.96018599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347398-04	Ginsenoside Rb1			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	41753-43-9				3.3350182686	4	4		0	-1.00261552					CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0039	2.90581162	-2.21722846	-0.87209302	-1.00261552												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00492296-03	eFT508		MNK1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1849590-01-7				-5.2066940572	4	4		0	-2.94972392				MKNK1	CC/1=C2/N(C(=O)C(=C1)/NC3=CC(=NC=N3)N)C4(CCCCC4)NC2=O	MedChem Express	HY-100022	-0.47237332	-2.21722846	-0.35189718	-2.94972392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016012-08	Triflupromazine hydrochloride	124881619	Muscarinic acetylcholine receptor M2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			7.0794578438	-5.15	61.5805057958	2.4	4	Triflupromazinum;NCGC00094410-03;triflupromazinum;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-;Triflupromazine Hcl;NCGC00094410-02;NCGC00094410-01;CIPLUS_208142;Triflupromazine Hydrochloride;NCGC_Prestw-53;Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-, monohydrochloride;Trifluopromazine;NCGC00016012-02;NCGC00016012-01;NCGC00024300-04;Triflupromazina;TRIFLUPROMAZINE HYDROCHLORIDE;TRIFLUPROMAZINE;TRIFLUPROMAZINE MALEATE;trifluopromazine;Triflupromazine;LS-105501;Vesprin;Triflupromazine hydrochloride;LS-105500;10-3-(DIMETHYLAMINO)PROPYL-2-(TRIFLUOROMETHYL)PHENOTHIAZINE;triflupromazine;Vesprin hydrochloride;10-(3-(DIMETHYLAMINO)PROPYL)-2-(TRIFLUOROMETHYL)PHENOTHIAZINE MONOHYDROCHLORIDE;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE;CIPLUS_170810;10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-;CIPLUS_152129;	75.2518244978	68.36675385	0.0652919635	0.9973618976	1129	CHRM2	CN(C)CCCN1C2=C(SC3=C1C=C(C=C3)C(F)(F)F)C=CC=C2	SIGMA	T-2896	0.75866018	-2.84644195	15.07037944	68.36675385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686697-01	4E2RCat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	432499-63-3		5.6234132519	-5.25	7.5200817585	4	4		10.732584272	8.79104911	0.2957277994	0.9427023264			OC(=O)C1=CC(=CC=C1Cl)C2=CC=C(O2)\C=C3/SC(=S)N(CC4=CC=CC=C4)C3=O	MedChem Express	HY-100733	0.32922989	-2.27715356	2.43268054	8.79104911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-05	Idoxuridine		Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	54-42-2				-4.7850006368	4	4		0	-2.89160128					OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(\I)C(=O)NC2=O	Selleck	S1883	-0.52963069	-1.52808989	-0.29069767	-2.89160128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160391-12	Auranofin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	34031-32-8		1	-6	9.8546303568	4	4		-15.317349604	-6.93112467	0.0252021358	0.9996112103			CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	Cayman	15316	6.91382766	1.43820225	-5.18665851	-6.93112467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522475-03	Verubecestat (MK-8931)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1286770-55-5(free base)				-3.5947653607	4	4		0	-5.10026155					CN1C(N)=N[C@@](C)(C[S+]1([O-])=O)C2=CC(NC(=O)C3=NC=C(F)C=C3)=CC=C2F	Selleck	S8173	0.73003149	-2.15730337	-0.19889841	-5.10026155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-25	Trifluoperazine hydrochloride	384567788	CaMK-II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	440-17-5		3.1622776602	-5.5	7.6757775274	4	4		16.4842696679	-6.58238884	1	0.9975490424		DRD2	CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	MedChem Express	HY-B0532A	-1.98969367	-2.48689139	10.02141983	-6.58238884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-10	Ibandronate sodium hydrate	384568439	Treatment of Osteoporosis	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	138926-19-9				-4.3024056653	4	4		0	-2.89160128					CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	APExBIO	B1772	0.12882909	-0.32958801	1.11689106	-2.89160128												1.6E-8	8E-8	4E-7	0.000002											
NCGC00178734-13	Sitagliptin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	486460-32-6				-3.4085178824	4	4		0	-1.7291485					N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F	DC Chemicals	DC5112	0.01431434	-2.66666667	-0.4130967	-1.7291485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263237-09	JZL-184	384568681	Monoacylglycerol lipase (MAGL) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-6.6111265296	4	4		0	-3.8215635				MGLL	OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC4=C(OCO4)C=C3)C5=CC=C6OCOC6=C5	SIGMA	J3455	-1.10220441	-0.77902622	-0.56609547	-3.8215635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386343-01	PI-1840	363680225	26S proteosome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1401223-22-0				-7.0971339619	4	4		0	-3.56223176					CCCC1=CC=C(OCC(=O)N(CC2=NC(=NO2)C3=CC=CN=C3)C(C)C)C=C1	Selleck	S7462	-0.81955428	-2.43156669	-0.91881307	-3.56223176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482457-02	KDM5A-IN-1	363681129	Lysine-specific demethylase 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1905481-36-8				-6.7610140599	4	4		0	-2.2174535					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@H](C2)NC(=O)C3CC3	MedChem Express	HY-100014	-2.2573688	4.03319744	-3.08781443	-2.2174535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346469-08	Delanzomib		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	847499-27-8				-17.351988794	4	4		0	-3.53361946				PSMD1	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)[C@@H](C)O)B(O)O	Bio Vision	2433	-4.47160316	-2.31508445	-2.394939	-3.53361946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346498-06	Danoprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	850876-88-9				6.1271231557	4	4		0	0.70100143					CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(F)=CC=C5)C(=O)N[S+]([O-])(=O)C6CC6	MedChem Express	HY-10238	2.19985622	-0.27664531	0.25606266	0.70100143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016028-08	Tyrphostin AG 555	90341437		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			14.1253754462	-4.85	11.1501760625	4	4		14.6674157359	11.08689334	0.4740878033	0.8305730938			OC1=C(O)C=C(C=C1)\C=C(/C#N)C(=O)NCCCC2=CC=CC=C2	SigmaAldrich	Lopac-T-4818	2.79129688	-3.05617978	-3.04467564	11.08689334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-02	Glycyrrhizic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1405-86-3				9.3274472458	4	4		0	1.8744551					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Prestwick	Prestw-NAT-0335	1.98969367	0.65917603	3.4118727	1.8744551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378751-01	Balapiravir	377020534		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	690270-29-2				-0.1856272298	4	4		0	0.33420517					CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N2/C=C\C(=N/C2=O)N)N=[N+]=[N-]	MedChem Express	HY-10443	0.35785857	-0.59925094	-1.33108935	0.33420517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate			2.8604043263	4	4		0	-1.81688126			7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	1.73975557	1.44146768	-1.7623136	-1.81688126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247668-03	LDN-57444	384568515	Reversible, competitive Inhibitor of UCH-L1 deubiquitinase	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	668467-91-2		8.9125093813	-5.05	72.0176196091	3	4		109.4476375082	102.81831187	0.0079256136	0.9999612551			CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13	XcessBio	M60204-2s	-2.17109993	-1.61619103	2.63593915	102.81831187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262945-10	Rivaroxaban			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	366789-02-8				-8.163650045	4	4		0	-0.92989986					ClC1=CC=C(S1)C(=O)NC[C@H]2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O	Glixx	GLXC-90151	-1.91229331	-1.06290041	-2.63593915	-0.92989986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188641-04	PLpro inhibitor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1093070-14-4				-0.4405747367	4	4		0	-1.3304721					C[C@@H](NC(=O)C1=C(C)C=CC(=C1)NC(C)=O)C2=C3C=CC=CC3=CC=C2	MedChem Express	HY-17542	0.67577283	1.44146768	-3.11793945	-1.3304721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386282-01	NSC 405020			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	7497-07-6				-3.1064205914	4	4		0	-3.79113019					CCCC(C)NC(=O)C1=CC=C(Cl)C(=C1)Cl	Selleck	S8072	1.6534867	-3.07221899	-3.3589396	-3.79113019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164560-17	Abacavir hemisulfate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[188062-50-2]				2.581745096	4	4		0	-2.33943621					NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	Tocris	4148	1.78929287	-1.917603	1.57588739	-2.33943621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263546-03	Moexipril HCl		Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	82586-52-5				2.2714553419	4	4		0	-2.9206626					CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(OC)C=C3C[C@H]2C(O)=O)OC	Selleck	S2079	2.90581162	-2.63670412	-1.60648715	-2.9206626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346946-03	CDK9 Inhibitor		CDK 9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1415559-43-1				-7.8750725001	4	4		0	-4.69340308				CDK9	CC1=CC=C(NC2=NC=NC(=C2)C3=CC=CC(=C3)N4C(=O)C5=C(C=CC=C5)C4=O)C=C1N[S+](C)([O-])=O	MedChem Express	HY-13231	-1.15946178	-2.51685393	0.50489596	-4.69340308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017376-12	Tetrandrine		Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	518-34-3		1.5848931925	-5.8	63.4688143734	3	4		46.8669677238	-5.6223176	1	0.9999035865			COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(=C(OC)C(=C4)OC)OC5=C(OC)C=C6CCN(C)[C@@H](CC7=CC=C(OC1=C2)C=C7)C6=C5	Prestwick	Prestw-NAT-0181	-0.99209202	1.76179383	44.78084049	-5.6223176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378593-08	Alvelestat (AZD9668			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	848141-11-7				-5.9746830771	4	4		0	0.30042918					CN1N=CC=C1C2=C(C)N(C(=O)C(=C2)C(=O)NCC3=NC=C(C=C3)[S+](C)([O-])=O)C4=CC=CC(=C4)C(F)(F)F	Selleck	S7218	-2.2573688	-0.68433314	-1.03931315	0.30042918												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159352-06	Etidronate		ATP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2809-21-4				-4.0931279203	4	4		0	-1.49665795					CC(O)([P](O)(O)=O)[P](O)(O)=O	Selleck	S1857	-0.38648726	-2.66666667	0.93329253	-1.49665795												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00379057-02	TMC353121		Respiratory syncytial virus Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	857066-90-1		12.5892541179	-4.9	38.0723940149	3	4		52.2540178059	46.97762278	0.0797111652	0.9960623664			CC1=CC=C(CCCO)C(=C1)NCC2=CC=C3N=C(NCCCN4CCOCC4)[N](CC5=NC(=CC=C5O)C)C3=C2	MedChem Express	HY-11097	1.81792156	-1.22846442	-1.17809058	46.97762278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386335-01	SC75741	363680219	Nuclear factor NF-kappa-B complex Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	913822-46-5				1.2988505788	4	4		0	-2.83347864					O=C(NC1=NC2=CC=C(C=C2[NH]1)C(=O)C3=CC=CC=C3)C4=CSC(=N4)C5CCN(CC5)C6=C7SC=CC7=NC=N6	Selleck	S7273	1.61752076	-1.61797753	0.59669523	-2.83347864												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-25	Emetine		antiprotozoal agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	316-42-7		7.0794578438	-5.15	45.1548965217	4	4		-18.510729616	-4.59227468	0.8030052976	0.999565119			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	USP	1235004_cm1	56.49173257	12.74024461	10.22744389	-4.59227468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015412-21	Ebselen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	60940-34-3		12.5892541179	-4.9	47.2471031518	3	4		70.781230047	64.33476395	0.0418600577	0.9989179059			[O]=[C]1[N]([Se]C2=C1C=CC=C2)C3=CC=CC=C3	Bio Vision	2169	-0.73328541	1.64531159	-0.1656876	64.33476395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137854-02	NCGC00137854-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.9331895635	4	4		0	-0.55722892					CCOC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(OC)C=C4)SC5=C1CCC(C)C5	Chemdiv	K061-0670	-0.76810534	-0.86484902	-1.36023231	-0.55722892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601698-01	Glecaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1365970-03-1				1.4046635434	4	4		0	0.94879518					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-0.329188	0.07329229	2.12440776	0.94879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137882-01	NCGC00137882-01	24413265		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.912743718	4	4		0	-0.49698795					COC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(Br)C=C4)SC5=C1CCCC5	Sytravon	K061-0796	3.06022921	-1.97889182	-3.07198533	-0.49698795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128693-01	NCGC00128693-01	24404076		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	16.3531261495	4	4		19.5	16.85240964	0.0990774926	0.9939287777			[O-][S+]1(=O)N(CC2=CC=CC=C2)C3=CC(=CC=C3C4=C1C=NC(=N4)SCC(=O)NC5=CC=CC=C5C(F)(F)F)Cl	Sytravon	G071-0990	0.54864667	1.9495749	1.42136635	16.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165045-01	NCGC00165045-01	29216799		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.4225309546	4	4		0	-1.73192771					FC(F)(F)C1=CC(=NC2=CC(=NN12)C(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C4=CC=C5OCOC5=C4	Sytravon	A0012923	-0.74372104	-2.91703313	-3.13311936	-1.73192771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482644-02	Scutellarein			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	529-53-3				0.2577545304	4	4		0	3.8769671					OC1=CC=C(C=C1)C2=CC(=O)C3=C(O)C(O)=C(O)C=C3O2	MedChem Express	HY-N0752	0.10064702	-2.98485731	-1.15981322	3.8769671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178124-03	LOGANIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	18524-94-2				-5.916484827	4	4		0	-2.27467811					COC(=O)\C1=C\O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]3[C@@H](C)[C@@H](O)C[C@H]13	Microsource	MS-01504066	-1.0496046	-1.79091439	-0.40668775	-2.27467811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346883-02	6-Bromoindirubin-3'-acetoxime	384568960	GSK-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[667463-85-6]				-3.3006823286	4	4		0	-2.38912732				GSK3B	CC(=O)O\N=C1\C(NC2=CC=CC=C12)=C3/C(=O)NC4=C3C=CC(=C4)Br	Tocris	3874	0.18691589	0.53873034	-3.38906462	-2.38912732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018268-05	Itraconazole		cytochrome inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	84625-61-6				11.9377125987	4	4		0	6.40060241					CCC(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Prestwick	Prestw-1139	-0.45110949	3.76722369	8.11554333	6.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402349-02	GN6958	363681035	Sentrin-specific protease 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1392278-32-8				4.3207550257	4	4		0	6.85240964			29843	SENP1	CCOC(=O)C1=CC=CC(=C1)CNC2=CC=C(C=C2)N(C)C(=O)NC3=CC=CC=C3	Glixx	GLXC-02687	0.28041941	0.71826444	-2.88858322	6.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134078-01	NCGC00134078-01	24409461		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.6588426067	4	4		0	-2.39457831					COC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0766	-1.40209705	0.36646145	-0.77945896	-2.39457831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023212-30	Stavudine (d4T)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	3056-17-5				4.9336328686	4	4		0	-1.73104435					CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O	Selleck	S1398	1.71099928	-1.09202097	3.75056484	-1.73104435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095055-08	Salinomycin		Anticoccidial/Antibacterial	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	53003-10-4				-0.7368781338	4	4		0	0.87267525				WNT1	CCC(C1CCC(C)C(O1)C(C)C(O)C(C)C(=O)C(CC)C2OC\3(O[C@]4(CC[C@@](C)(O4)C5CC[C@@](O)(CC)C(C)O5)C(O)\C=C3)C(C)CC2C)C([O-])=O	Enzo	NP267	-1.99856219	-2.34420501	-0.55731285	0.87267525												1.6E-9	8E-9	4E-8	2E-7											
NCGC00013216-05	2,3-Dimercapto-1-propanol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	59-52-9				0.330550738	4	4		0	2.04577969					OC[C@H](S)CS	SIGMA	D1129	-1.02084831	0.10192196	1.9129387	2.04577969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162368-03	NCGC00162368-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	153190-29-5				-4.6117752283	4	4		0	-0.5873494					C[C@]12C\C=C3/[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8	Cayman	75860	-1.54840283	-1.27528584	-0.41265475	-0.5873494												1.6E-8	8E-8	4E-7	0.000002											
NCGC00134114-01	NCGC00134114-01	24409497		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.7287962196	4	4		0	-1.43072289					COC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0979	-0.57303097	-2.30137789	-0.840593	-1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123293-01	NCGC00123293-01	24397872		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.9013573373	4	4		0	0.22590361					CCOC(=O)C1=CC=CC=C1NC(=O)CSC2=C[N](CC(=O)N3CCOCC3)C4=C2C=CC=C4	Sytravon	E587-0338	-1.81663009	-0.86484902	-2.61348006	0.22590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166323-16	Trifluorothymidine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[70-00-8]				-4.5521918272	4	4		0	-4.78058704					[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N2C=C(C(=O)NC2=O)C(F)(F)F	Tocris	4460	-0.1002004	0.4494382	-1.48408813	-4.78058704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250410-11	GSK-650394	384568558	SGK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	890842-28-1		7.9432823472	-5.1	36.3065044883	3	4		51.6044640138	44.59459459	0.025924765	0.9995854826		SGK1	OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5	MedChem Express	HY-15192	-0.67277412	-1.34831461	8.0630355	44.59459459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388311-01	Z-VAD(OH)-FMK			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	161401-82-7				0.5595846174	4	4		0	6.17553037					CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF	Cayman	14467	-1.24534784	-0.77902622	-0.47429621	6.17553037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379028-01	PSI-6130		Hepatitis C virus NS5B RNA-dependent RNA polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	817204-33-4				-3.4645841764	4	4		0	-2.33943621					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10165	0.81591755	-2.66666667	-2.76927785	-2.33943621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165841-02	NH125			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	278603-08-0				-10.5539865697	4	4		0	-7.07643127					CCCCCCCCCCCCCCCC[N+]1=C(C)[N](CC2=CC=CC=C2)C=C1	Selleck	S7436	-0.21471514	-2.84644195	-3.90146879	-7.07643127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016872-19	Ticlopidine hydrochloride	384567964	P2Y12 (P2T) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	53885-35-1				-9.517148376	4	4		0	-3.17771084				P2RY12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	MedChem Express	HY-B0153A	-2.35308461	-0.68894752	-0.93229405	-3.17771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379210-02	LMK235		Histone deacetylase 6 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1418033-25-6				-16.4278965378	4	4		0	-6.87300203			10013	HDAC6	CC1=CC(=CC(=C1)C)C(=O)NOCCCCCC(=O)NO	XcessBio	M60145-2s	-1.7320355	-4.88389513	-4.94186047	-6.87300203												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111425-01	NCGC00111425-01	24386004		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.9943163253	4	4		0	2.18373494					CC1CN(CCN1C2=CC=C(C)C=C2)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0840	-0.96317971	-2.56523014	-0.53492282	2.18373494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163450-06	Ilomastat (GM6001, Galardin)	384568240	MMP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	142880-36-2				-3.6364925166	4	4		0	-3.90874746				MMP1	CNC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO	Selleck	S7157	0.18608646	-2.66666667	0.96389229	-3.90874746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345451-03	A-966492		PARP-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	934162-61-5				36.528197778	4	4		0	10.85440279					NC(=O)C1=C2N=C([NH]C2=CC=C1)C3=C(F)C=C(C=C3)[C@@H]4CCCN4	MedChem Express	HY-10614	4.30861723	12.04494382	12.86719706	10.85440279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510185-01	CCT365623			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	N/A				-6.225293324	4	4		0	-2.97878524					C[S+]([O-])(=O)C1=CC(=CC(=C1)C2=CC=CC=C2)[S+]([O-])(=O)C3=CC=C(CN)S3	Glixx	GLXC-10154	-0.12882909	-2.75655431	-2.49388005	-2.97878524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135612-01	NCGC00135612-01	24410995		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.2757001208	4	4		0	5.67771084					CC(=O)N1CCCC2=C1C=CC(=C2)[S+]([O-])(=O)N3CCCC(C3)C(=O)N4CCN(CC4)C5=CC=CC=C5F	Sytravon	G855-6099	-0.81687393	-1.50982117	-1.97157267	5.67771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106735-02	NCGC00106735-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.1974682091	4	4		0	-0.04518072					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=C(C)C=C(C)C=C4)C5=CC=CC=C5C3=O)C=C2)C=C1	Chemdiv	C260-2769	-0.49987808	-0.77689827	2.36894391	-0.04518072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371134-02	PR-619		Ubiquitin carboxyl-terminal hydrolase isozyme L3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2645-32-1		6.3095734448	-5.2	14.5557655788	4	4		20.3078651719	17.88724208	0.1769960893	0.9802422674	7347	UCHL3	NC1=NC(=C(SC#N)C=C1SC#N)N	Selleck	S7130	0.24334383	-2.75655431	3.56487148	17.88724208												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164624-11	Adefovir dipivoxil	377020406	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	142340-99-6				-0.188696108	4	4		0	-3.90874746					CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	MedChem Express	HY-B0255	2.16146579	-1.73782772	-2.24908201	-3.90874746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371045-07	AMD-3465	384569040	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	185991-07-5				9.6136343902	4	4		0	6.00116245				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CNCC3=NC=CC=C3)C=C2	MedChem Express	HY-15971	1.21671915	0	2.89167687	6.00116245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093674-07	CYCLOSERINE (L)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	339-72-0				-0.32265073	4	4		0	-3.26939843					[H][C@]1(N)CONC1=O	Microsource	01506178	0.47237332	-0.86891386	0.56609547	-3.26939843												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178317-04	Foscarnet Sodium		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	63585-09-1				3.1006422073	4	4		0	-0.77012496					[O-][C](=[O])[P]([O-])([O-])=[O]	Selleck	S3076	2.73403951	-2.8164794	-1.9124847	-0.77012496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00685392-02	Cenicriviroc Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	497223-28-6		8.9125093813	-5.05	46.7356166112	3	4		68.3349725215	64.85033421	0.0076999081	0.9999634375			CCCCOCCOC1=CC=C(C=C1)C2=CC=C3N(CC(C)C)CCCC(=CC3=C2)C(=O)NC4=CC=C(C=C4)[S@@+]([O-])CC5=CN=CN5CCC	MedChem Express	HY-14882A	-0.87317492	-0.8988764	1.60648715	64.85033421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090791-01	2'	17389408		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-2.6031230088	4	4	NCGC00090791-02;Kolibri-D 002;NCGC00090791-03;2',3'-Dideoxyadenosine;2',3'-Dideoxyadenosine (ddA);2',3' Dideoxyadenosin;2',3'-DIDEOXYADENOSINE;Adenosine, 2',3'-dideoxy-;Dideoxyadenosine;CIPLUS_162883;LS-112;NunclonD multidishes;AB02911402-01;	0	-1.52571927					NC1=NC=NC2=C1N=C[N]2[C@H]3CC[C@@H](CO)O3	NIEHS	AB02911402	-0.75866018	0.4494382	0.22949816	-1.52571927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163409-07	Betulinic acid	384568234	Caspase 3/8 Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	472-15-1				-7.4781913304	4	4		0	-2.24606581				CASP3	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	Prestwick	Prestw-NAT-0019	-2.22861251	-1.61619103	1.46106341	-2.24606581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164566-08	Pitavastatin calcium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[147526-32-7]		1.5848931925	-5.8	26.1915378444	4	4		24.3876324039	-1.99070038	1	0.9999337871			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	Tocris	4942	-1.98969367	-1.19850187	22.2001224	-1.99070038												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480786-05	Brequinar sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[96201-88-6]				-6.2411226981	4	4		0	-1.99070038					CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C3=CC=C(C=C3)C4=CC=CC=C4F	Tocris	6196	-0.52963069	-2.15730337	-2.70807834	-1.99070038												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386432-07	BLZ945			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	953769-46-5				-1.2312030615	4	4		0	1.38769671					CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(N[C@@H]4CCCC[C@H]4O)S3)=C1	MedChem Express	HY-12768_cm2	-0.38820992	-1.17938264	-0.6476879	1.38769671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018158-11	Doxazosin Mesylate		alpha1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	77883-43-3		12.5892541179	-4.9	72.0228809425	3	4		109.6921262765	98.81258941	0.0619871001	0.9976226185			COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N	Selleck	S1324	-0.35945363	2.11124054	-3.41918964	98.81258941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00490649-01	NCGC00490649-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-2.8644270317	4	4		0	1.93133047					CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	-0.70452912	-2.4898078	-1.09956319	1.93133047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651745-01	ABBV-744			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2138861-99-9				-12.1564230306	4	4		0	-6.17553037					CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C3=C(OC4=C(C)C=C(F)C=C4C)C=CC(=C3)C(C)(C)O	Selleck	S8723	-2.10420842	-1.67790262	-1.42288862	-6.17553037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095191-16	Oseltamivir phosphate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	204255-11-8				-6.0032634971	4	4		0	-2.83347864					CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	APExBIO	B1803	-0.75866018	-2.03745318	-0.749694	-2.83347864												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378617-04	XL 413 hydrochloride	384569057	Serine/threonine-protein kinase PIM1  Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[1169562-71-3]				-5.4216444616	4	4		0	-3.87968614					ClC1=CC=C2OC3=C(\N=C(NC3=O)\[C@@H]4CCCN4)C2=C1	Tocris	5493	-0.24334383	-3.80524345	1.08629131	-3.87968614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161662-08	Calpain Inhibitor I, ALLN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	110044-82-1		1.1220184543	-5.95	154.5061179793	1.3	4		97.9947689664	102.07788434	0.0849778176	0.9955195093			CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C=O	APExBIO	A2602	0.501002	16.71910112	93.34455324	102.07788434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	41468-25-1				-7.130171301	4	4		0	-0.10014306					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	-1.59597412	-1.29586488	-2.96731435	-0.10014306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00087387-05	Droxinostat	384568077	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	99873-43-5				-3.0430545258	4	4		0	4.04864092				HDAC6	CC1=CC(=CC=C1OCCCC(=O)NO)Cl	Selleck	S1422	-1.45219267	0.10192196	-3.47943967	4.04864092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482529-01	Epigoitrin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1072-93-1				-4.2266462377	4	4		0	0.10542169					C=C[C@@H]1CNC(=S)O1	DC Chemicals	DCB-014	-1.28017557	-1.07006743	-0.41265475	0.10542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421347-01	NCGC00421347-01	375798736		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-9.684951279	4	4		0	-2.45481928					O[C@@H]1CCCN(C[C@H]1NC(=O)C2=CC=C(OCC3=CC=CC=C3)C=C2)C(=O)NC4=CC(=CC=C4)C(F)(F)F	Analyticon	NAT10-367732	-1.84101439	-1.15801818	-3.34708849	-2.45481928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263639-15	Tacedinaline		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-9.6163226869	4	4		0	-4.83433735				HDAC1	CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(N)C=CC=C2	SIGMA	C0621	-0.98756401	-1.48050425	-3.49992358	-4.83433735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263219-03	Elacridar	384568673	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	143664-11-3				6.2712631571	4	4		0	-1.58798283				ABCBA	COC1=C2NC3=C(C=CC=C3C(=O)NC4=CC=C(CCN5CCC6=C(C5)C=C(OC)C(=C6)OC)C=C4)C(=O)C2=CC=C1	Selleck	S7772	1.82602444	4.58648806	-0.58743787	-1.58798283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346581-06	AZ-960		Jak2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	(905586-69-8)				-15.3687953273	4	4		0	-4.70672389				JAK2	C[C@H](NC1=NC(=C(F)C=C1C#N)NC2=N[NH]C(=C2)C)C3=CC=C(F)C=C3	SynKinase	SYN-1015	-2.17109993	-3.9167152	-5.10619069	-4.70672389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165041-01	NCGC00165041-01	29216795		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					12.7802555602	4	4		0	-2.99698795					COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=C(C=C(Cl)C=C4)C(F)(F)F	Sytravon	A0012890	6.79102658	-1.68572266	-1.63533547	-2.99698795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016032-14	THIOCTIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1077-24-7				2.769191825	4	4		0	-0.55793991					OC(=O)CCCCC1CCSS1	Microsource	01503941	1.71099928	-2.46068725	0.76818798	-0.55793991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095125-15	Losartan potassium		Angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	124750-99-8				18.898843562	4	4		0	1.81688126					CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[NH]4)Cl	Glixx	GLXC-05212	6.59956866	3.77111241	-2.78656424	1.81688126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510505-01	WT-161	384569466	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1206731-57-8				-17.0819789084	4	4		0	-3.76251788				HDAC1	ONC(=O)CCCCCCC(=O)N\N=C\C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-100871	-4.12652768	-0.65521258	-4.68444043	-3.76251788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346512-02	BMS-707035	363677435	HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	729607-74-3				-5.1367190314	4	4		0	-3.0472103					CN\1C(=O)/C(=C(\N=C1N2CCCC[S+]2([O-])=O)C(=O)NCC3=CC=C(F)C=C3)O	Selleck	S1366	-1.02084831	-1.76179383	1.40081338	-3.0472103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247542-02	Amentoflavone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1617-53-4				-3.2915723326	4	4		0	-1.94277108					OC1=CC=C(C=C1)\C2=C\C(=O)C3=C(O2)C(=C(O)C=C3O)C4=C(O)C=CC(=C4)\C5=C\C(=O)C6=C(O5)C=C(O)C=C6O	DC Chemicals	DCS-044	-0.45110949	-1.30460276	0.32095369	-1.94277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168725-01	NCGC00168725-01	85736143		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.0071881943	4	4		0	-0.5873494					FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)C(CC2=CC=CC=C2)OC(=O)CNC(=O)C3=CC=CC=C3	NCGCChem	BTM01-083	-0.23165082	0.07329229	1.39079933	-0.5873494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134146-01	NCGC00134146-01	24409529		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.5235572474	4	4		0	1.70180723					CC1=C(Cl)C=CC=C1NC(=O)N2CCN(CC2)CC\3=C\C(=O)N\4\N=C(/SC4=N3)C5=C(F)C=CC=C5	Sytravon	G768-1351	-0.64618386	-0.2785107	-1.36023231	1.70180723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165856-15	Orlistat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	96829-58-2		0.2238721139	-6.65	11.3918485727	4	4		12.070812368	7.28183119	0.1239832682	0.990521226			[H]C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC	APExBIO	A8492	-2.14234364	8.43040186	7.90781744	7.28183119												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346443-01	Rupintrivir	174007383	HRV 3C Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	223537-30-2	AG-7088 (Rupintrivir)	7.9432823472	-5.1	3.6832653823	4	4		11.035585904	9.08440629	0.0809160901	0.9959973742			CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C2=NOC(=C2)C)C(C)C)CC3=CC=C(F)C=C3	Axon Medchem	1571	-1.27965492	-0.5678509	0.798313	9.08440629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344901-01	NCGC00344901-01	161004131		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.7766153746	4	4		0	3.35843373					[O-][S+](=O)(NC1=NC(=CS1)C2=CC=CC=C2)C3=CC=C(NC(=O)C4=CC=C5C=CC=CC5=C4)C=C3	NCGCChem	RAP12-043	-1.84101439	-1.42187042	-2.27724285	3.35843373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-15	NCGC00263152-15	384568626		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	943319-70-8				-12.3086267216	4	4		0	-5.67771084				FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Selleck	S1490	-1.10948549	-3.4154207	-6.03698609	-5.67771084												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00386403-01	Z-DEVD-FMK	363680258	Caspase-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	210344-95-9				-3.9396793709	4	4		0	0.64377682			836	CASP3	COC(=O)CC[C@@H](CC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)OC)C(=O)CF	Selleck	S7312	-1.02084831	-0.74257426	-1.85268866	0.64377682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386434-02	GSK744 (S/GSK1265744)	363680286	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1051375-10-0				-6.2284371062	4	4		0	-2.30329041					C[C@H]1CO[C@@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	APExBIO	A8566	-1.27965492	-1.00465929	-0.76818798	-2.30329041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015471-09	Ganciclovir	384567853	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	82410-32-0				1.2221129763	4	4		0	-2.39457831					N\C1=N\C2=C(N=C[N]2COC(CO)CO)C(=O)N1	Selleck	S1878	-0.71933675	5.05716799	1.87987162	-2.39457831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347888-01	NCGC00347888-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	60.2604361787	3	4		93.1570523847	83.84036145	0.0147037297	0.9998666385			CC1=C(N=C(NC(=O)CC2=CC(=CC=C2)C(F)(F)F)S1)C3=CC=C4N(CCC4=C3)[S+]([O-])(=O)C5=CC=CC=C5C	NCGCChem	LLI015-016	-0.91441112	0.16124304	-0.25981965	83.84036145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00141392-03	NCGC00141392-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.8175808387	4	4		0	-1.79216867					COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=C(C)C=C5	Chemdiv	E859-1146	0.93879542	-0.54236294	0.19868562	-1.79216867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378746-04	NBD 556		Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[333353-44-9]				-7.8245809619	4	4		0	2.50357654					CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Cl)C=C2	Tocris	5811	-2.65995687	-0.10192196	-4.05181503	2.50357654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390606-01	TNKS-656	363680925	Tachykinin NK2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1419949-20-4				-1.0442525521	4	4		0	2.00301205				TACR2	COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)C\C4=N\C5=C(\COCC5)C(=O)N4	MedChem Express	HY-13990	0.40234089	-2.1254764	-2.98028427	2.00301205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126025-02	NCGC00126025-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.8667919675	4	4		0	-1.31024096					CCC1=CC=C(CNC(=O)C2CCCN(C2)C3=NN=C(C)C4=C(C)[N](N=C34)C5=CC=C(OC)C=C5)C=C1	Chemdiv	E859-1203	-1.0363326	-1.50982117	-1.69646951	-1.31024096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109199-01	NCGC00109199-01	24383778		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.6693053893	4	4		0	1.40060241					COC1=CC=C(C=C1)\C=C/C2=C(C(=NO2)C)[S+]([O-])(=O)N3CCC(CC3)C(=O)NC4=CC(=C(C)C=C4)F	Sytravon	C514-0081	-0.71933675	-1.74435649	-3.80559376	1.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102146-01	NCGC00102146-01	24275844		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.3261888485	4	4		0	-2.87650602					CC1=C(C=CC=C1NC(=O)C2=CC=C(O2)C3=CC(=CC=C3)[N+]([O-])=O)C4=NC5=C(O4)C=CC(=C5)Cl	Sytravon	7645-1552	-1.79224579	2.03752565	2.82744918	-2.87650602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399579-01	NCGC00399579-01	375800879		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.2041118557	4	4		0	5.64759036					COC1=CC=C(C=C1)C(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=CC(=C5)F	Analyticon	NAT6-324238	-0.18288222	-2.03752565	-3.04141831	5.64759036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164555-10	Entacapone		NCI-H1299 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	130929-57-6				3.8492787055	4	4		0	3.44778255					CCN(CC)C(=O)/C(=C/C1=CC(=C(O)C(=C1)[N+]([O-])=O)O)C#N	MedChem Express	HY-14280	-1.42343638	-0.04368084	7.06431692	3.44778255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241102-05	Midostaurin		PKC/flt3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	120685-11-2				-14.2296381393	4	4		0	-4.90701001				PRKCA	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N3C4=CC=CC=C4C5=C6CNC(=O)C6=C7C8=CC=CC=C8N2C7=C35)N(C)C(=O)C9=CC=CC=C9	MedChem Express	HY-10230	-1.27965492	-4.87769365	-5.55806597	-4.90701001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00650297-01	Biphenyl-4-sulfonyl chloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1623-93-4				-9.1288655085	4	4		0	-1.87410587					[O-][S+](Cl)(=O)C1=CC=C(C=C1)C2=CC=CC=C2	Selleck	S5438	-2.31488138	-0.62609202	-1.97318873	-1.87410587												1.6E-7	8E-7	0.000004	0.000019999999999											
MLS000543798-03	MLS000543798-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			7.0794578438	-5.15	337.2469282561	5	4		-46.9248905279	42.82185411	0.633612577	0.6246470822			C1CN(CCO1)C2=NC(NC3=CC=CC=C3)=NC(N\N=C\C4=CNC5=C4C=CC=C5)=N2	Specs	AG-205/33155024	67.5207558	108.76404494	81.25764994	42.82185411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387111-01	TMCB			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[905105-89-7]				-0.6413255496	4	4		0	3.47282767					CN(C)C1=NC2=C(Br)C(=C(Br)C(=C2[N]1CC(O)=O)Br)Br	Tocris	3675	-0.21471514	-2.57677903	-1.26988984	3.47282767												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095707-04	SOLANESOL		tobacco isoprenoid alcohol	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	13190-97-1				-8.80203015	4	4		0	-1.93257774					CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO	Microsource	01505325	-2.10420842	-3.3258427	0.4130967	-1.93257774												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00485610-01	NCGC00485610-01	363681369		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	222036-17-1 (principal component)				-6.3333700933	4	4		0	-2.06325301					[O-][S+](=O)(NC1=NC=CC=C1)C2=CC=C(N/C=C/3C(=O)NC4=C3C5=C(C=C4)N=CS5)C=C2	SIGMA	G7791	-1.0363326	-0.86484902	-1.1768302	-2.06325301												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00482578-01	D-Pinitol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	10284-63-6				-3.7336526007	4	4		0	0.0753012					COC1[C@@H](O)[C@@H](O)C(O)[C@H](O)[C@H]1O	DC Chemicals	DCS-033	-0.52426237	-3.06361771	-0.44322176	0.0753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182552-14	Atazanavir		Human immunodeficiency virus type 1 protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	198904-31-3				-4.233597737	4	4		0	-1.29322871					COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	SIGMA	SML1796	-1.21671915	-2.90636704	2.67747858	-1.29322871												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686671-01	Brincidofovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	444805-28-1				-0.3765543517	4	4		0	-1.12951807					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	1.64594001	-2.1254764	-0.44322176	-1.12951807												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00140656-02	NCGC00140656-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.9528278352	4	4		0	6.43072289					COC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC4=C(C=C3)[S+]([O-])(=O)C5=C(C=CC=C5)C(=O)N4CC6=CC=CC(=C6)Cl	Chemdiv	K788-8633	-0.71933675	-0.01465846	1.42136635	6.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262306-24	ML323		USP1/UAF1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1572414-83-5		15.8489319246	-4.8	0.6761007942	4	4		-8.1089799479	-4.25748329	0.7244398006	0.4186111125		USP1	CC(C)C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NCC3=CC=C(C=C3)[N]4C=CN=N4	MedChem Express	HY-17543	-0.1002004	-1.22846442	7.11444308	-4.25748329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420698-02	BPTES	384569223	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[314045-39-1]				-5.834742845	4	4		0	-2.71723336				GLS	O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2	Tocris	5301	-0.67277412	-1.4082397	-1.57588739	-2.71723336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371093-04	Marimastat	384569041	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	154039-60-8				-4.4001126495	4	4		0	-3.32752107				MMP1	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	MedChem Express	HY-12169	-0.1002004	-2.90636704	0.53549572	-3.32752107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399716-01	NCGC00399716-01	375799743		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.1072812397	4	4		0	-0.2560241					C[N]1N=C(C=C1[C@H]2CN3CC[C@H]2C[C@@H]3COC(=O)NC4=CC(=CC=C4)C(F)(F)F)C5=CC=CS5	Analyticon	NAT13-331659	0.67056815	4.26561126	-0.56548984	-0.2560241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246187-06	Pyronaridine Tetraphosphate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	76748-86-2		15.8489319246	-4.8	19.2377324147	4	4		-16.852659112	-5.71054926	0.6744398432	0.54368035			COC1=CC=C2NC3=C(C=CC(Cl)=C3)C(N=C4C=C(CN5CCCC5)C(=O)C(CN6CCCC6)=C4)=C2N1	AvaChem	1554_cm1	4.90981964	0.98876404	14.70318237	-5.71054926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137821-01	NCGC00137821-01	24413204		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			0.8912509381	-6.05	43.4882827188	4	4		35.565471832	7.66566265	1	0.9998941981			COC1=CC=C2C=C([NH]C2=C1)C(=O)NCC3=CC=C4N(CCC4=C3)C(=O)C5=CC=C(C)C=C5	Sytravon	G883-0400	-1.30455986	11.85869247	26.63915635	7.66566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00070736-17	Imiquimod	384568073	TLR 7 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	99011-02-6				-6.1368281027	4	4		0	-2.28131357				TLR7	CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12	MedChem Express	HY-B0180	-0.73003149	-1.8576779	-1.14749082	-2.28131357												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00522593-01	RSV604 (R enantiomer)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	932108-20-8				-5.8739951067	4	4		0	-4.69340308					FC1=CC=CC=C1NC(=O)N[C@@H]2\N=C(C3=CC=CC=C3)/C4=CC=CC=C4NC2=O	MedChem Express	HY-12993B	-0.81591755	1.01872659	-1.42288862	-4.69340308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538156-01	NCGC00538156-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-2.7352129788	4	4		0	-2.0197617					CN(C)C1=C2C=CC=C(C2=CC=C1)[S+]([O-])(=O)NC3=CC=C(NC(=O)C(C)(C)CO)C=C3	Pharmaron	PH-NIH-2017-009-L2-56-0	-0.21471514	0.23970037	-1.20869033	-2.0197617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347066-11	KUC105555N	384568981	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	177355-84-9		15.8489319246	-4.8	-8.1652246198	4	4		-8.2244986879	-6.43708224	0.7211556962	0.4281079785		VCP	C(NC1=NC2=CC=CC=C2C(=N1)NCC3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-15945	-1.7320355	-3.56554307	5.09485924	-6.43708224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163638-01	TUBERCIDIN	26757019		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			3.5481338923	-5.45	7.4618920007	4	4	NCGC00163638-01;CIPLUS_740558;7-DEAZAADENOSINE;Sparsomycin A;CIPLUS_158314;CIPLUS_149167;7 Deazaadenosin;xylotubercidin hydrochloride;7-Deazaadenosine;LS-139541;Tubercidin;4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine;Deazaadenosine;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-;ara-tubercidin;TUBERCIDIN;CIPLUS_701898;xylotubercidin;	-14.6551874439	-5.12932287	0.7213667677	0.4210354159			NC1=C2C=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	BIOMOL	BIOMOL_NP-327	-1.01631835	20.19475655	-0.32129743	-5.12932287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390587-03	G-007-LK		Tachykinin NK1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-2.4461298747	4	4		0	-1.18741059			80351	TACR1	C[S+]([O-])(=O)C1=CC=C(N=C1)C2=NN=C(\C=C\C3=NN=C(O3)C4=CC=C(C=C4)C#N)[N]2C5=C(Cl)C=CC=C5	APExBIO	B5830	-0.33069734	-0.94641817	-0.07531255	-1.18741059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346486-03	Abexinostat	384568795	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	783355-60-2				-17.4658774537	4	4		0	-6.69863412				HDAC1	CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO	Selleck	S1090	-2.1328371	-5.21348315	-4.81946144	-6.69863412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016623-07	Moroxydine HCl		antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	3160-91-6				-2.1473146013	4	4		0	-3.35658239					NC(=N)NC(=N)N1CCOCC1	Selleck	S2486	0.55825938	-3.95505618	2.43268054	-3.35658239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387092-01	PF 429242		cholesterol biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[947303-87-9]				1.396419679	4	4		0	2.22319093					CCN(CC)CC1=CC=C(C=C1)C(=O)N(CCC2=CC=CC=C2OC)[C@@H]3CCNC3	Tocris	3354	-1.41711995	1.01872659	3.77906977	2.22319093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510887-02	Celgosivir (hydrochloride)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	141117-12-6		14.1253754462	-4.85	14.0233882036	4	4		29.071531272	22.1888412	0.3926866785	0.8912006403			CCCC(=O)O[C@H]1C[N@]2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O	MedChem Express	HY-16134A	-2.97627606	5.8386721	1.37068836	22.1888412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164140-08	DOCUSATE SODIUM			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	577-11-7				2.7696949546	4	4		0	0.32904149					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	Microsource	01503881	-1.42343638	2.19860221	6.61244163	0.32904149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092388-15	Conessine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	546-06-5				1.0637937394	4	4		0	-0.24320458					[H][C@]12CC[C@@]3([H])[C@]4([H])CC=C5C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]13CN(C)[C@H]2C)N(C)C	Enzo	NP495	-0.64701653	3.30518346	0.43681277	-0.24320458												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00021305-27	Sirolimus		mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	53123-88-9				-18.5699467076	4	4		0	-2.81831187				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Enzo	A275	-4.47160316	-2.98485731	-4.23256515	-2.81831187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345885-02	Etravirine (TMC125)		P-glycoprotein 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	269055-15-4				-2.1341079412	4	4		0	-2.775356					CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	Selleck	S3080	-0.01431434	-2.03745318	2.00428397	-2.775356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479258-01	NCGC00479258-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-5.5507158123	4	4		0	-1.14792212					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-050_2nd_pos	-1.50300601	-0.77902622	-0.44369645	-1.14792212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015061-29	Acyclovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[59277-89-3]				-8.3060810415	4	4		0	-2.71723336					NC1=NC2=C(N=CN2COCCO)C(=O)N1	Tocris	2513	-1.18809047	-2.8164794	-1.82068543	-2.71723336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390568-02	Bevirimat		Gag-Pol polyprotein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	174022-42-5		6.3095734448	-5.2	13.8164206636	4	4		19.6707865159	16.81197326	0.2357621969	0.9642184712			CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	MedChem Express	HY-N0842	0.41511595	-3.47565543	3.74847001	16.81197326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015067-24	Aspirin		HMG-CoA Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	50-78-2				-9.6832227511	4	4		0	-0.12875536				HMGCR	CC(=O)OC1=C(C=CC=C1)C(O)=O	Enzo	DL313	-2.89000719	-2.7810134	-0.37656274	-0.12875536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	6452-73-9				-7.326120652	4	4		0	-2.87553648					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	-0.93457944	-1.29586488	-2.69618919	-2.87553648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017236-16	Baicalein	384567977	Cyp2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	491-67-8		3.1622776602	-5.5	20.6460292675	4	4		14.5528089839	1.55478059	1	0.8839691398		CYP2C9	OC1=CC2=C(C(=O)\C=C(/O2)C3=CC=CC=C3)C(=C1O)O	APExBIO	N1858	2.41912396	-2.12734082	11.03121175	1.55478059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024246-18	Daunorubicin		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	23541-50-6				-12.0309248487	4	4		0	0.67238913				TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(=C3C2=O)O	APExBIO	B2285	-2.89000719	-3.71287129	-3.66018979	0.67238913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160338-03	Oxymatrine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	16837-52-8				-10.7633475301	4	4		0	2.01716738					[O-][N@+]12CCC[C@@H]3C[N@@]4[C@H](CCCC4=O)[C@H](CCC1)[C@H]23	Selleck	S2338	-3.49388929	-2.57716948	-2.21418888	2.01716738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017331-07	CIANIDANOL		superoxide anion generation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	154-23-4				-5.7133213576	4	4		0	4.16309013					O[C@H]1CC2=C(O[C@@H]1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O	Microsource	MS-00210205	-2.94751977	-2.05299942	0.19581262	4.16309013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017352-31	Resveratrol		Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-8.0646004083	4	4		0	-1.75965665				PTGS2	OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O	Analyticon	NP-012969	-1.50970525	-2.22772277	-1.9129387	-1.75965665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109194-01	NCGC00109194-01	24383773		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.6346935238	4	4		0	0.10542169					CCN1\C=C(C(=O)NCCC2=CC=C(Cl)C=C2)/C(=O)C3=CC(=CC=C13)[S+]([O-])(=O)N4CCC(C)CC4	Sytravon	C519-1832	-1.37771275	-0.89416593	-2.24667584	0.10542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00395168-01	NCGC00395168-01	375800199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-9.6855605968	4	4		0	-1.97289157					CN(C)C1=CC=C(C=C1)C2=NN=N[N]2[C@H]3CO[C@@H]4[C@@H](CO[C@H]34)OC(=O)NC5=CC=C(OC6=CC=CC=C6)C=C5	Analyticon	NAT6-296297	-2.01170446	-2.24274406	-2.15497478	-1.97289157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159447-01	Sodium Salicylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	54-21-7				2.1641818605	4	4		0	-0.79819277					OC(=O)C1=CC=CC=C1O	MedChem Express	HY-B0167A_cm1	1.35332846	1.09938434	-2.09384075	-0.79819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183680-01	NCGC00183680-01	87544174		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.3426463978	4	4		0	1.00903614					CC(C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C#N	NCGCChem	mbb07-52	-0.81687393	-3.06361771	-2.67461409	1.00903614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247556-02	Fangchinoline			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	436-77-1		2.8183829313	-5.55	70.614430278	3	4		52.8345269302	-5.6223176	1	0.9958170329			COC1=C2OC3=CC=C(C[C@@H]4N(C)CCC5=CC(=C(OC6=C(O)C(=CC7=C6[C@H](CC(=C2)C=C1)N(C)CC7)OC)C=C45)OC)C=C3	DC Chemicals	DCF-007	2.2573688	-0.94641817	45.29296581	-5.6223176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263621-06	I-BET762		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1260907-17-2				-6.0753138191	4	4		0	-3.10443491				BRD4	CCNC(=O)C[C@@H]1\N=C(C2=CC=C(Cl)C=C2)/C3=C(C=CC(=C3)OC)[N]4C(=NN=C14)C	Cayman	10676	-0.38820992	-2.40244613	-1.55143847	-3.10443491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386028-03	BAICALIN		prolyl endopeptidase inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	21967-41-9				-4.4769516975	4	4		0	0.98712446					O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)\C=C(/OC3=C2)C4=CC=CC=C4)O	Microsource	01505040	-2.45866283	0.42224811	1.09956319	0.98712446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-07	Tigecycline	384568415	glycylcycline antibiotics	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	220620-09-7				0.3254211021	4	4		0	3.50500715					CN(C)[C@H]\1[C@@H]2C[C@@H]\3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)/[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Enzo	AC3268	-1.30841121	0.24752475	1.25018828	3.50500715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163510-01	Aloe-emodin	26756894	Caspase 3 Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	481-72-1	ALOE-EMODINE;Aloe-emodin			-0.635729543	4	4	ALOE-EMODINE;Aloe Emodin;aloe-emodin;ALOE-EMODIN;LS-2202;aloe-emodin 1-O-glucopyranoside;Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,;Aloe-emodin;ALOE EMODIN;Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-;NCGC00163510-02;NCGC00163510-01;aloe-emodin 1-O-Glc;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;CIPLUS_153452;	0	0.16566265			836	CASP3	OCC1=CC(O)=C2C(=O)C3=C(C=CC=C3O)C(=O)C2=C1	BIOMOL	BIOMOL_NP-005	-0.59741526	1.53913808	-0.44322176	0.16566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686699-01	S(-)-Verapamil hydrochloride hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	36622-28-3 (anhydrous)				-5.4859992768	4	4		0	-0.79819277					COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1	SIGMA	V105	-0.71933675	-2.24274406	-2.12440776	-0.79819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178697-04	Irinotecan	170464824	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	100286-90-6	;Irinotecan hydrochloride trihydrate;Irinotecan; Campto;Irinotecan hydrochloride			-5.6900571797	4	4		0	-1.43072289			7150	TOP1	Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O	Prestwick	Prestw-1494	-1.0363326	-0.42509528	-2.39951093	-1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	56776-01-3				1.3273678832	4	4		0	3.17771084					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-0.06096074	-0.89416593	-0.38208773	3.17771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1190307-88-0				-5.9285683357	4	4		0	-0.87267525					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-1.79726815	0.53873034	-1.52131345	-0.87267525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483052-01	Saikosaponin B2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	58316-41-9				0.6720531467	4	4		0	-3.24749642					C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)C(CC[C@]4(C)[C@@H]3\C=C/C5=C6\CC(C)(C)CC[C@]6(CO)[C@H](O)C[C@]45C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]7O)[C@H]1O	DC Chemicals	DCC-051	0.70452912	1.96563774	-0.10543757	-3.24749642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094614-07	CHLOROXYLENOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	88-04-0				-8.4245357798	4	4		0	-1.73104435					CC1=CC(=CC(=C1Cl)C)O	Microsource	01500182	-2.40115025	-1.354106	-0.07531255	-1.73104435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015798-15	Propranolol HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	318-98-9				-4.9830208252	4	4		0	1.55937053					CC(C)NCC(O)COC1=C2C=CC=CC2=CC=C1	APExBIO	B1346	-2.19985622	-0.68433314	-0.07531255	1.55937053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249377-04	IU1	363677167	Ubiquitin carboxyl-terminal hydrolase 14 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	314245-33-5				-2.514876486	4	4		0	-2.10300429					CC1=CC(=C(C)[N]1C2=CC=C(F)C=C2)C(=O)CN3CCCC3	Selleck	S7134	0.27318476	-0.94641817	-1.40081338	-2.10300429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686698-01	Migalastat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	75172-81-5				-5.9552153437	4	4		0	-3.26807229					OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	SIGMA	D9641	-0.69495245	-1.18733509	-1.29909827	-3.26807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164861-02	NCGC00164861-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-1.4557256636	4	4		0	0.73795181					CCOC(=O)C1=C(NC(=O)CSC2=C[N](CCNC(=O)C3=CC=C(OC)C=C3)C4=C2C=CC=C4)SC5=C1CCC5	Chemdiv	C064-0046	0.30480371	-2.59454705	-1.39079933	0.73795181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165001-01	NCGC00165001-01	29216755		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.9616655852	4	4		0	-1.94277108					COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=C(C#N)C5=C(CC(C)CC5)S4	Sytravon	A0005388	-0.86564253	-1.71503958	-1.57420144	-1.94277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263153-10	AR-42(HDAC-42)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	935881-37-1				-17.6865910187	4	4		0	-5.6509299					CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Bio Vision	2716	-3.17757009	-1.73267327	-5.9195662	-5.6509299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274060-07	Posaconazole			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	171228-49-2		1	-6	16.3579062246	4	4		12.3109273959	9.51359084	0.2929414834	0.9434903416			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	-0.67577283	2.51892836	13.17969574	9.51359084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164951-01	NCGC00164951-01	29216705		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.2867577083	4	4		0	1.79216867					COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=CC(=CC=C4Cl)C(F)(F)F	Sytravon	A0001277	-1.49963424	-1.36323659	-1.20739722	1.79216867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139531-02	NCGC00139531-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			10	-5	35.6596090691	3	4		61.0768893588	55.43674699	0.0266021811	0.9995633942			CC1CN(CCN1C2=CC=CC(=C2)C)[S+]([O-])(=O)C3=C(F)C=CC(=C3)C(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4	Chemdiv	K781-7795	-1.28017557	-2.65318089	-0.93229405	55.43674699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178869-11	Vidarabine	384568366	Adenosine Receptor Agonist; Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	5536-17-4				-0.798007903	4	4		0	-4.83870968					NC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC=N1	MedChem Express	HY-B0277	1.07357572	-1.58801498	1.69828641	-4.83870968												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00112114-02	NCGC00112114-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.0951657601	4	4		0	0.31626506					[O-][S+](=O)(N1CCCCCC1)C2=CC=C3OCC(=O)N(CC(=O)N4CCN(CC4)C5=CC(=CC=C5)C(F)(F)F)C3=C2	Chemdiv	C700-0994	-0.76810534	3.44473761	-0.840593	0.31626506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00396146-01	NCGC00396146-01	375804793		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.0132298902	4	4		0	2.72590361					OC(=O)C1=CC=CC=C1C(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)[N]4N=NN=C4OC5=CC=CC(=C5)N6CCOCC6	Analyticon	NAT6-299670	-2.30431602	-2.00820874	-2.521779	2.72590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091110-02	Glutaraldehyde	124890454		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	111-30-8				5.1432366804	4	4	Glutaraldehyde	0	0.88855422					O=CCCCC=O	SIGMA	NTP-SID_831	1.23140697	-0.4544122	2.21610882	0.88855422												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00090851-14	5-Azacitidine		DNA Methyltransferase (DNMT) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	320-67-2				-9.7640546682	4	4		0	-1.84539378				DNMT1	NC/1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	XcessBio	M60131-5s	-1.35986258	-4.07490637	-2.95287638	-1.84539378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018257-16	Methocarbamol		Muscle relaxant	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	532-03-6				2.2809392709	4	4		0	-0.10171462					COC1=C(OCC(O)COC(N)=O)C=CC=C1	MedChem Express	HY-B0262	1.10220441	-1.58801498	0.93329253	-0.10171462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345492-06	PCI-34051	384568736	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	950762-95-5		11.220184543	-4.95	6.9740661276	4	4		20.0937589479	17.24789305	0.1312156942	0.9892695398		HDAC8	COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1	Selleck	S2012	-2.16146579	0.14981273	-0.71909425	17.24789305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095802-05	Flavanone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	487-26-32				-5.1070368266	4	4		0	-4.25748329					O=C1CC(OC2=CC=CC=C12)C3=CC=CC=C3	Enzo	AC1548	-1.21671915	-2.54681648	4.2380661	-4.25748329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095003-07	Tioxolone	384568140	Carbonic Anhydrase Type I Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	4991-65-5				-5.2955291659	4	4		0	-4.11217669				CA1	OC1=CC2=C(SC(=O)O2)C=C1	Selleck	S2603	0.61551675	-3.05617978	-2.37148103	-4.11217669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167465-07	Calcipotriol		Vitamin D receptor Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	112965-21-6		12.5892541179	-4.9	68.5735118405	3	4		96.1917771066	83.93072289	0.0132224555	0.9998921596			C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(CCC[C@]23C)=C\C=C/4C[C@@H](O)C[C@H](O)C4=C	MedChem Express	HY-10001	1.52401853	1.24596892	1.54363442	83.93072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00076924-03	Salicylanilide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	87-17-2				4.3680059719	4	4		0	4.38253012					OC1=CC=CC=C1C(=O)NC2=CC=CC=C2	Selleck	S4187	0.89002682	0.89416593	-2.58291304	4.38253012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015442-24	Fluorouracil		Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	51-21-8				-2.9589635381	4	4		0	-4.19936065				TYMS	F\C1=C\NC(=O)NC1=O	MedChem Express	HY-90006	1.47437733	-2.69662921	-2.43268054	-4.19936065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263625-09	AnacardicAcid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	16611-84-0		2.2387211386	-5.65	155.6943843923	1.1	4		108.4163033951	109.19790758	0.0030372923	0.9999943099			CCCCCCCCCCCCCCCC1=C(C(O)=O)C(=CC=C1)O	Bio Vision	1849	0.90180361	2.48689139	100.19889841	109.19790758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015074-17	ACETAZOLAMIDE		Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	59-66-5				-3.1051904773	4	4		0	-0.13554217					CC(=O)NC1=NN=C(S1)[S+](N)([O-])=O	Microsource	01500102	-0.25603511	-2.15479332	-1.20739722	-0.13554217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164571-04	Dutasteride	384568256	Steroid 5alpha-Reductase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.2203330561	4	4		0	1.49096386					C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	Selleck	S1202	-1.32894416	-2.53591322	-3.10255235	1.49096386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188640-01	NCGC00188640-01	124899261		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					3.686889003	4	4		0	1.84539378					C[C@@H](NC(=O)C1=CC(N)=CC=C1C)C2=CC=CC3=CC=CC=C23	Acesys	A9608	-0.35785857	2.69662921	2.86107711	1.84539378												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1446502-11-9		7.0794578438	-5.15	19.9437712766	4	4		23	18.58471375	0.0237053545	0.9996548024		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	0.18608646	1.01872659	6.96144431	18.58471375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-43	Cyclosporin A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	59865-13-3				5.1850369682	4	4		0	2.28131357					CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	Selleck	S2286	1.04494704	1.37827715	-0.749694	2.28131357												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan			-4.9656078823	4	4		0	-0.28614458					CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	-1.20702268	-1.33391967	-1.05456213	-0.28614458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161670-08	Pepstatin	384568214	Aspartyl Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	26305-03-3				-4.7675599407	4	4		0	-3.6762569					CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	Prestwick	Prestw-405	-1.70340681	0.80898876	2.5244798	-3.6762569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479257-01	NCGC00479257-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					3.2583608145	4	4		0	-1.43853531					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-049_1st_neg	2.79129688	-2.66666667	-1.33108935	-1.43853531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015693-13	Mitoxantrone		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	70476-82-3				-12.9854757972	4	4		0	2.48474281				TOP2A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	Selleck	S1889	-3.44975666	-4.91385768	-3.71787026	2.48474281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015818-25	Praziquantel	384567893	antiparasitic agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	55268-74-1				-0.7330122976	4	4		0	-2.60098808					O=C1CN(CC2N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4	MedChem Express	HY-B0244	-0.501002	-1.34831461	4.91126071	-2.60098808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016441-03	(Z)-Capsaicin	124882263		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	25775-90-0				-1.1896827032	4	4	TRPV Cation Channels;CAPSAICIN (E);Zucapsaicin;LS-96940;Cation Channels, TRP;Zostrix;6-nonenamide, 8-methyl-n-vanillyl-, (z)- (8ci);CAPSAICIN (Z)-;TRANS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-;Z-Capsaicin;Receptors, Vanilloi;zucapsaicin;CIS-CAPSAICIN;LS-2138;CIPLUS_213626;Capsaicin;CIPLUS_153053;8-Methyl-N-vanillyl-trans-6-nonenamide;Vanilloid Receptors;NCGC_Prestw-879;TRPV1 protein, mouse;capsaicin;AB07930300-01;civamide;Channels, TRPV Catio;NCGC00016441-01;transient receptor potential cation channel V1, mouse;capsaicin receptor, mouse;NCGC00090853-02;CAPSAICIN;Receptors, Capsaici;CAPSAICIN OLEORESIN;CIS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (Z)-;N-1107;transient receptor potential cation channel, subfamily V, member 1 protein, mouse;zucapsaicinum;ZUCAPSAICIN;NCGC00024601-01;NCGC00024601-02;vanilloid receptor 1 receptor, mouse;Capsaicin Receptors;NCGC00090853-03;CIVAMIDE;E-CAPSAICIN;NCGC00090853-07;NCGC00090853-08;trans-n-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide;	0	-1.64196455					COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1	Tocris	Tocris-0463	-0.3006012	-0.20973783	1.36168911	-1.64196455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274063-04	Pimobendan		Phosphodiesterase III (PDE3) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	74150-27-9				-8.248262353	4	4		0	-4.5771578				PDE3A	COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)/C4=N/NC(=O)CC4C	Adooq	A10733	-1.38849127	-0.83895131	-0.99449204	-4.5771578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189220-03	UNC-0638	363677129	EHMT2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1255580-76-7	UNC0638;UNC-0638			-8.0198617418	4	4		0	-5.36480687			10919	EHMT2	COC1=C(OCCCN2CCCC2)C=C3N=C(N=C(NC4CCN(CC4)C(C)C)C3=C1)C5CCCCC5	SGC	UNC0638 	-2.48741912	2.43156669	0.91881307	-5.36480687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179542-09	Brinzolamide		Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	138890-62-7				4.1761949778	4	4		0	-0.53763441					CCN[C@H]1CN(CCCOC)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0588	0.44374463	4.94382022	-0.01529988	-0.53763441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166142-07	Diperodon HCl		sodium ion transmembrane transport Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	537-12-2		12.5892541179	-4.9	6.1887055699	4	4		20.721542228	17.18977042	0.0337670708	0.9992986328			O=C(NC1=CC=CC=C1)OCC(CN2CCCCC2)OC(=O)NC3=CC=CC=C3	APExBIO	A8413	-1.7320355	-1.34831461	-1.85128519	17.18977042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161621-13	Cepharanthine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	481-49-2		2.2387211386	-5.65	130.1301083372	3	4		96.0783047704	-6.90206335	1	0.9999987388			[H][C@@]12CC3=CC(OC4=CC=C(C[C@]5([H])N(C)CCC6=C5C(OC7=CC1=C(CCN2C)C=C7OC)=C8OCOC8=C6)C=C4)=C(OC)C=C3	APExBIO	N2771	0.04294303	0.8988764	89.45838433	-6.90206335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-12	Megestrol acetate	384568021	Progesterone Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	595-33-5				3.315140592	4	4		0	6.65236051				PGR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	MedChem Express	HY-13676	-0.01437815	-1.79091439	-0.52718783	6.65236051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599701-01	BDD   BFD   DDB   alpha-DDB   Bifendate Biphenyldimethyldicarboxylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-7.8171755331	4	4		0	-1.15879828					COC(=O)C1=C(C2=C(OCO2)C(OC)=C1)C3=C(C=C(OC)C4=C3OCO4)C(=O)OC	BLD Pharma	BD40653	-2.17109993	0.7134537	-2.7263142	-1.15879828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386395-01	YYA-021	363680252	Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	144217-65-2		2.8183829313	-5.55	1.1301166752	4	4		-5.969957076	-2.47496423	0.7039799829	0.4765725227		env	CC1=CC=C(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)C=C1	Selleck	S7487	-0.58950395	7.84799068	-1.43093839	-2.47496423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189073-04	Selumetinib	384568456	Mek1/2 inibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	606143-52-6				-17.5403383059	4	4		0	-3.39055794				MAP2K1	C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=CC=C(Br)C=C3Cl	Selleck	S1008	-3.81020848	-2.98485731	-4.56394035	-3.39055794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016777-10	Probucol	384567958	Serine Protease Hepsin Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	23288-49-5				9.0991385858	4	4		0	1.58384191					CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	Selleck	S2119	0.3006012	1.88764045	8.33843329	1.58384191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165733-10	Apicidin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	183506-66-3				-15.6897150672	4	4		0	-5.56509299					CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=C[N](OC)C3=CC=CC=C23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O	Enzo	GR-340	-1.85478073	-3.80023296	-5.9195662	-5.56509299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095095-04	SENNOSIDE A		Helv Chim Acta 33: 313 (1950)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	81-27-6				6.0168806698	4	4		0	-0.472103					[H][C@@]1(C2=CC(=CC(O)=C2C(=O)C3=C1C=CC=C3O[C@@H]4OC(CO)C(O)C(O)C4O)C(O)=O)[C@@]5([H])C6=CC(=CC(O)=C6C(=O)C7=C5C=CC=C7O[C@@H]8OC(CO)C(O)C(O)C8O)C(O)=O	Microsource	MS-01504078	3.17757009	-1.87827606	-0.61756289	-0.472103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522503-02	VELPATASVIR		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-3.6904183979	4	4		0	-5.24556815					COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	Astatech	40127	1.61752076	-1.64794007	-3.93206854	-5.24556815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-13	Bortezomib	384568504	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	179324-69-7				-14.9190405931	4	4		0	-4.24892704				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	ActiveBioChem	A-1014	-3.63767074	-3.01397787	-0.49706281	-4.24892704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179623-07	Lisinopril		Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	83915-83-7				0.6446894236	4	4		0	-0.24320458					NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O	Prestwick	Prestw-301	-0.41696621	2.57716948	-0.04518753	-0.24320458												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00015793-12	Palmitoylethanolamide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[544-31-0]				-7.321279819	4	4		0	0.18597997					CCCCCCCCCCCCCCCC(=O)NCCO	Tocris	0879	-1.82602444	-1.87827606	-2.12381383	0.18597997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00457027-01	NCGC00457027-01	375831663		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.9376620396	4	4		0	-0.04518072					CC1=C(C)C=C(C=C1)C2=N[N]3\C=C/N(CCNC(=O)C4=NC5=C(C=CC=C5)C=C4)C(=O)C3=C2	Chemdiv	S539-0652	-0.03657644	-1.48050425	0.32095369	-0.04518072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263096-16	Iniparib	384568587	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	[160003-66-7]				-4.7341159848	4	4		0	0.88855422				PARP1	NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O	Tocris	5817	-1.52401853	0.36646145	-2.521779	0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166368-01	NCGC00166368-01	29218127		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.3460730101	4	4		0	-0.40662651					COC1=CC=C(C=C1COC2=CC=C(NC(C)=O)C=C2)C3NC4=C(C=CC=C4)C(=O)N3CC5=CC(=CC=C5)C6=CC=CC=C6	NCGCChem	WH-A-014-0001-B5	-1.28017557	0.13192612	-1.23796424	-0.40662651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180626-04	Cephaeline			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	483-17-0		3.1622776602	-5.5	36.4245919753	4	4		-15.755364812	-3.96280401	0.6854939667	0.9996367242			CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O	Carbosynth	FC19891	30.66858375	12.04135119	0.3163127	-3.96280401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116379-01	NCGC00116379-01	24390958		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			10	-5	2.2523079478	4	4		12.2968337719	8.62951807	0.1668153647	0.9826613961			CC1=C2C(=O)/C=C(\C=C(OC(=O)C3=C(Cl)C=CC=C3)/C2=C(C)O1)C4=CC5=C(OCO5)C=C4	Sytravon	D132-0061	-0.79248964	-2.33069481	-0.77945896	8.62951807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398410-01	NCGC00398410-01	375800513		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	14.8030021139	4	4		34.8562585919	28.20783133	0.1363006568	0.9883798251			COC1=CC=C(C=C1)C2=CC=NC(=N2)N[C@H]3CO[C@@H]4[C@@H](CO[C@H]34)OC(=O)NC5=CC(=CC=C5)C(F)(F)F	Analyticon	NAT6-318838	-1.93855157	0.89416593	-2.79688216	28.20783133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167803-13	GSI-IX	384568339	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	208255-80-5				-7.0221095018	4	4		0	-3.99141631				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@H](C(=O)OC(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-13027	-0.12940331	-2.51892836	-2.78656424	-3.99141631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023595-03	Loxistatin Acid (E-64C)	363676526		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	76684-89-4		12.5892541179	-4.9	3.9248921224	4	4		18.2609633399	13.80543634	0.2517233825	0.9590057899			CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O	Selleck	S7392	-2.71746945	0.94641817	-0.1656876	13.80543634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601824-01	UPGL00004			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1890169-95-5				-16.7574315412	4	4		0	-2.04577969					O=C(CC1=CC=CC=C1)NC2=NN=C(NC3CCN(CC3)C4=NN=C(NC(=O)CC5=CC=CC=C5)S4)S2	Selleck	S8778	-4.0690151	-2.83925451	-4.08194005	-2.04577969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00098652-01	NCGC00098652-01	24272350		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.9587166824	4	4		0	1.82228916					COC1=CC(=CC=C1)C(=O)NC2=CC=C3OC(=NC3=C2)C4=CC=C5C=CC=CC5=C4	Sytravon	3205-0102	1.18263838	-2.56523014	-0.90172704	1.82228916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.0223872114	-7.6499999999	22.7125502407	4	4		-11.480211084	6.5813253	1	0.8128327964	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	10.32674957	-2.06684257	3.31652147	6.5813253												1.6E-8	8E-8	4E-7	0.000002											
NCGC00120966-01	NCGC00120966-01	24395545		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.734202554	4	4		0	0.85843373					CCOC1=C2OC(=O)C(=C/C2=CC=C1)\C3=N\C4=C(C(=O)N3)C(=C(S4)C(=O)NC5=CC=C(C)C=C5)C	Sytravon	E210-0056	-1.96293587	0.71826444	-1.23796424	0.85843373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162241-09	N6-Methyladenosine		DNA oxidative demethylase ALKBH1 Substrate	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1867-73-8				-4.3259291766	4	4		0	-2.47496423			8846	ALKBH1	CNC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	MedChem Express	HY-N0086	-0.24442847	-1.79091439	-0.85856304	-2.47496423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166276-06	N-ACETYLNEURAMIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	131-48-6				-5.0142272884	4	4		0	-2.07439199					CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO	Microsource	MS-02300147	-0.53199137	-2.6354106	-0.37656274	-2.07439199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167356-14	Raltegravir Potassium		Human immunodeficiency virus type 1 integrase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	871038-72-1				-0.3923791914	4	4		0	3.0758226					CN1C(=O)\C(=C(/N=C1/C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]	Glixx	GLXC-90403	-2.17109993	-0.42224811	4.50369031	3.0758226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138593-02	NCGC00138593-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.7745040211	4	4		0	-1.34036145					ClC1=CC(=CC=C1)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CC(=O)NCC5=CC=C6OCOC6=C5)C(=O)N24	Chemdiv	K279-1495	-1.47524994	1.04075051	0.38208773	-1.34036145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128071-01	NCGC00128071-01	24403454		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.6895161643	4	4		0	-2.60542169					CC(=O)C1=CC=C(NC(=O)C2CCC(CC2)CN[S+]([O-])(=O)C3=CC4=C(NC(=O)CCC4)C=C3)C=C1	Sytravon	G017-0209	-0.59741526	2.38932864	-1.26853125	-2.60542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510496-01	VLX-1570	384569458	Ubiquitin C-terminal Hydrolase L5 (UCH-L5) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1431280-51-1				-11.6102043057	4	4		0	-5.73676681				UCHL5	[O-][N+](=O)C1=CC(=CC=C1F)/C=C/2CCN(CC(=C/C3=CC=C(F)C(=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	MedChem Express	HY-12471	-1.48094896	-0.74257426	-4.3229402	-5.73676681												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389319-01	NCGC00389319-01	363680766		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	957116-20-0				-3.596490481	4	4		0	0.16566265					FC1=CC(=CC(=C1)F)C2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC5=C(CC6(C5)C(=O)NC7=C6C=CC=N7)C=C4	APExBIO	B1436	-0.13411363	-1.36323659	-3.46935656	0.16566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484060-01	NM107	363681153	Picornaviridae Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	20724-73-6				-8.0371181295	4	4		0	0.85843373					C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10468	-1.7190929	-2.56523014	-2.46064496	0.85843373												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00163163-01	NCGC00163163-01	144205574		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	17479-19-5	Dihydroergocristine methanesulfonate; Brinerdine; Iskedyl; Chrystepin CH; Kristepin; Ersilan; Crystepin CH; Briserin; 	12.5892541179	-4.9	49.6882839315	3	4	Dihydroergocristine methanesulfonate salt;Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19alpha)-, mixt. with (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)ergotaman-3',6',18-trione;Dihydroergocristine methanesulfonate;CIPLUS_751524;Iskedyl;CIPLUS_773547;Kristepin;NCGC00016137-01;CIPLUS_3884556;Dihydroergocristine;P 3007;Ersilan;CIPLUS_774402;NCGC00025380-01;NCGC00025380-02;dihydroergotoxine ethansulfonate;NCGC00023148-05;NCGC00023148-02;CIPLUS_740293;CIPLUS_684973;Dihydroergocristine mesylate;CIPLUS_3885160;Brinerdine;PF 50;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-;DIHYDROERGOTOXINE-MESYLATE;LS-175603;Dihydroergotoxine mesylate;Crystepin CH;Chrystepin CH;Briserin;P-3007;CIPLUS_3884046;defluina;	86.862254382	77.21385542	0.0455209022	0.9987198824			CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C	BIOMOL	BIOMOL_NS-108	-2.23116313	-0.10260921	-3.22482042	77.21385542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-08	Apixaban	363677453	Coagulation Factor Xa Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	503612-47-3				-5.1902879748	4	4		0	0.0753012				F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	Glixx	GLXC-90058	-2.25554743	-0.01465846	0.74889195	0.0753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090705-24	Zalcitabine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	7481-89-2				-0.7181570717	4	4		0	-0.52932761					NC/1=N/C(=O)N(/C=C1)[C@H]2CC[C@@H](CO)O2	MedChem Express	HY-17392	-0.41696621	-0.21840419	1.2803133	-0.52932761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138198-01	NCGC00138198-01	24413581		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.2409308068	4	4		0	-1.94277108					CCOC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(OC)C=C4)SC(=C1C)C	Sytravon	K061-0044	-0.81687393	-1.07006743	-2.79688216	-1.94277108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510794-01	KIN1408			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1903800-11-2		1.1220184543	-5.95	121.5311893879	2.4	4		77.4533821304	-2.87553648	1	0.999897904			COC1=CC=C2SC(=NC2=C1)NC(C3=CC=C(OC(F)F)C=C3)C4=CC=C5C=CC=NC5=C4O	SIGMA	SML1866	-0.30194105	15.85614444	76.89411056	-2.87553648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378713-01	Nirogacestat	363678166	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1290543-63-3		12.5892541179	-4.9	20.2662723663	3	4		38.8721047449	33.40486409	0.0707921125	0.9968992233		NOTCH1	CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C	MedChem Express	HY-15185	-0.81955428	-0.97553873	-2.75643922	33.40486409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163469-10	Sodium Monensin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	22373-78-0		0.1122018454	-6.95	110.0042825992	2.4	4		34.2689718459	16.2598082	1	0.9998330258			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	Selleck	S2324	4.82393358	11.44569288	38.63219094	16.2598082												1.6E-8	8E-8	4E-7	0.000002											
NCGC00123753-01	NCGC00123753-01	24399136		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	14.5032887221	4	4		30.5628152239	24.98493976	0.1056648473	0.9930624			CC1=CC(=C(C=C1)[S+]([O-])(=O)/C2=C/N(CC3=CC=CC=C3)C4=CC(=C(F)C=C4C2=O)N5CCCC5)C	Sytravon	E599-0377	-0.93879542	0.01465846	-2.55234602	24.98493976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398287-01	NCGC00398287-01	375804744		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.414550784	4	4		0	-2.15361446					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C5OCOC5=C4)NC6=CC=CC7=CC=CC=C67	Analyticon	NAT6-298378	-1.67032431	-1.3925535	-0.81002598	-2.15361446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346836-01	NCGC00346836-01	174006487		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1227911-45-6	GSK-2334470	14.1253754462	-4.85	6.9332103085	4	4		28.649701972	22.27409639	0.1030405378	0.9934075236	5170	PDPK1	CNC1=NC(=CC(=N1)C2=CC3=C(C=C2)C(=N[NH]3)N)N4C[C@H](CC[C@H]4C)C(=O)NC5CCCCC5	SIGMA	SML0217	-2.74323336	-0.8355321	-3.04141831	22.27409639												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160670-08	Mecarbinate	384568202	antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	15574-49-9				-4.3137528158	4	4		0	-1.70008718					CCOC(=O)C1=C(C)[N](C)C2=CC=C(O)C=C12	MedChem Express	HY-B0376	-0.98768966	-0.20973783	-0.53549572	-1.70008718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262963-03	Fiacitabine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	69123-90-6				3.2290829243	4	4		0	-2.54286545					NC\1=N\C(=O)N(\C=C1I)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F	MedChem Express	HY-50735	2.21872316	-2.06741573	1.3004896	-2.54286545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345794-11	MLN-4924	384568745	NEDD8-Activating Enzyme (NAE) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	905579-51-3		1.4125375446	-5.85	43.9939552723	4	4		30.5	11.29032258	1	0.9999929019		NAE1	N[S+]([O-])(=O)OC[C@@H]1C[C@H](C[C@@H]1O)[N]2C=CC3=C2N=CN=C3N[C@H]4CCC5=C4C=CC=C5	ChemieTek	CT-M4924	1.27397652	9.49812734	23.57711138	11.29032258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159460-01	INDINAVIR SULFATE	363676591	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	0157810-81-6				-4.1921832029	4	4		0	-0.33420517					CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=CC=CC=C34)CC5=CC=CN=C5	Microsource	01506401	-1.10220441	-1.10861423	-0.50489596	-0.33420517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104965-01	NCGC00104965-01	24268310		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					13.2230947403	4	4		0	5.73795181					CC1=CC(=C(C)C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0338	1.62155572	1.89094107	4.96714046	5.73795181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165007-01	NCGC00165007-01	29216761		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-0.0766495492	4	4		0	-1.12951807					CC1CCC2=C(C1)SC(NC(=O)C3=NN4C(=C3)N=C(C=C4C(F)(F)F)C5=CC=C(C)C=C5)=C2C#N	Sytravon	A0005592	-0.71933675	-1.36323659	5.08940853	-1.12951807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161626-04	Euphobiasteroid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	28649-59-4				1.9098489504	4	4		0	6.11740773					[H][C@]12CC[C@@]3(CO3)[C@@H](OC(C)=O)[C@@]4([H])[C@@H](OC(=O)CC5=CC=CC=C5)[C@@H](C)C[C@]4(OC(C)=O)C(=O)\C(C)=C\[C@@]1([H])C2(C)C	DC Chemicals	DCQ-059	-0.04294303	-1.64794007	-2.00428397	6.11740773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164615-05	Prulifloxacin	384568265	Antibacterial	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	123447-62-1				-0.3656863249	4	4		0	-1.08979948					CC1SC/2=C(C(O)=O)/C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)C\C5=C(C)\OC(=O)O5)F	Glixx	GLXC-06577	0.58688806	-2.03745318	0.53549572	-1.08979948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167491-06	Lenalidomide		TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	191732-72-6				-1.2447078147	4	4		0	-1.55478059				TNF	NC1=CC=CC2=C1CN([C@H]3CCC(=O)NC3=O)C2=O	Selleck	S1029	1.13083309	-3.7752809	-0.47429621	-1.55478059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390251-01	Isochlorogenic acid A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2450-53-5				-1.72210065	4	4		0	-3.32752107					OC1[C@@H](CC(O)(C[C@H]1OC(=O)\C=C\C2=CC(O)=C(O)C=C2)C(O)=O)OC(=O)\C=C\C3=CC(O)=C(O)C=C3	Adooq	A12072	-0.1002004	-0.32958801	1.79008568	-3.32752107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00169833-02	Aucubin	363676896	TNF-alpha Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-6.7917771334	4	4		0	-1.70008718					OC[C@H]1O[C@@H](O[C@@H]2O\C=C/[C@H]3[C@H](O)\C=C(\CO)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-009911	-1.04494704	-3.59550562	-0.32129743	-1.70008718												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00408803-01	Bicyclol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	118159-48-1				-7.6322243668	4	4		0	-2.57192677					COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3CO)OC	Glixx	GLXC-06162	-1.81792156	-2.27715356	0.749694	-2.57192677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378981-01	RO-9187			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	876708-03-1		0.2238721139	-6.65	15.273375832	4	4		-9.6556233679	-3.87968614	0.5925887185	0.6960893296			NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O	MedChem Express	HY-10870	7.11422846	-2.57677903	2.58567931	-3.87968614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161602-07	Doxycycline		Matrix Metalloproteinase (MMP) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[1293992-19-4]				3.1553179766	4	4		0	3.76344086				MMP1	C[C@@H]1[C@H]\2[C@H](O)[C@H]3[C@H](N(C)C)\C(=C(C(N)=O)/C(=O)[C@@]3(O)\C(=C2C(=O)C4=C(O)C=CC=C14)O)O	Tocris	4090	0.64414543	-0.86891386	-0.99449204	3.76344086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00169121-02	Neochlorogenic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-2.2986002626	4	4		0	0.24320458					O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\C2=CC(=C(O)C=C2)O)[C@H]1O)C(O)=O	Analyticon	NP-000060	-0.38820992	-0.24752475	-1.88281368	0.24320458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015034-21	INO-1001		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	3544-24-9				-2.1904121381	4	4		0	4.70672389				PARP1	NC(=O)C1=CC(=CC=C1)N	MedChem Express	HY-12022	-1.45219267	-0.88817705	-1.97318873	4.70672389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1370468-36-2				8.1000024297	4	4		0	3.56001162					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	2.87718294	-1.8576779	-0.87209302	3.56001162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510523-01	Pimodivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1629869-44-8				-0.5465446098	4	4		0	1.87410587					OC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC3=NC(=NC=C3F)C4=C[NH]C5=NC=C(F)C=C45	MedChem Express	HY-12353A	-0.27318476	-1.44146768	-0.34643772	1.87410587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346526-03	PHA-680632	384568820	Aurora-A/B/c Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	398493-79-3				3.5769559141	4	4		0	-5.53618134				AURKA	CCC1=CC=CC(=C1NC(=O)N2CC3=C(C2)C(=N[NH]3)NC(=O)C4=CC=C(C=C4)N5CCN(C)CC5)CC	Selleck	S1454	4.22273118	-2.93632959	-1.45348837	-5.53618134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370899-04	Golgicide A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1139889-93-2		15.8489319246	-4.8	4.7292001404	4	4		-7.950643776	-2.87553648	0.7082920373	0.4672009551			[H][C@@]12CC=C[C@]1([H])C3=C(NC2C4=CN=CC=C4)C(F)=CC(F)=C3	APExBIO	B1385	0.53199137	0.74257426	7.15469197	-2.87553648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599698-01	4-Butylresorcinol Rucinol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-0.7115503878	4	4		0	-1.58798283					CCCCC1=C(O)C=C(O)C=C1	BLD Pharma	BD66959	0.58950395	-0.0728014	-1.40081338	-1.58798283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017254-11	Cyanein	404904668	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	20350-15-6		0.2238721139	-6.65	12.9616335033	4	4		-14.5037856719	-4.16309013	0.1476116081	0.9864327404		GBF1	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	APExBIO	B1400	8.35370237	-4.58648806	-2.93718934	-4.16309013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378589-01	Merimepodib	363678106	Inosine-5'-monophosphate dehydrogenase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	198821-22-6		12.5892541179	-4.9	54.0600191459	3	4		72.2779169889	62.93228713	0.0703232135	0.9969380478			COC1=CC(=CC=C1C2=CN=CO2)NC(=O)NC3=CC(=CC=C3)CNC(=O)O[C@H]4CCOC4	MedChem Express	HY-13986	2.93444031	-0.71910112	0.04589963	62.93228713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346637-05	Odanacatib	384568871	Cathepsin K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	603139-19-1				-4.7353798856	4	4		0	-3.24033711				CTSK	CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C2=CC=C(C=C2)[S+](C)([O-])=O)C(F)(F)F)C(=O)NC3(CC3)C#N	MedChem Express	HY-10042	-0.38648726	-2.12734082	0.22949816	-3.24033711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094565-03	Hinokitiol	26753708		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-0.3461568886	4	4	beta-Thujaplicin;hinokitiol;4-isopropyltropolone;alpha-thujaplicin;NCGC00094565-03;NCGC00094565-01;NCGC00094565-02;4-Isopropyltropolone;2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one;CIPLUS_153635;HINOKITIOL;Hinokitiol;beta-thujaplicin;beta-thujaplicin, sodium salt;LS-56183;LS-173664;2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one;	0	2.96137339					CC(C)C\1=C\C=C/C(=O)\C(=C1)O	BIOMOL	FR-110	-0.70452912	-2.51892836	1.43093839	2.96137339												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095649-07	Trigonelline hydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	6138-41-6				-2.7628378218	4	4		0	-0.04291845					C[N+]1=CC(=CC=C1)C([O-])=O	Prestwick	Prestw-NAT-0039	-0.33069734	-2.98485731	0.28618768	-0.04291845												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095150-16	Telmisartan	384568151	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	144701-48-4				-0.2988792234	4	4		0	3.79113019				AGT	CCCC1=NC2=C(C=C(C=C2C)C3=NC4=CC=CC=C4[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O	Enzo	DL511	-0.99209202	-0.48048923	-0.37656274	3.79113019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168902-03	Hyperoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-8.783547302	4	4		0	-0.30042918					OC[C@H]1O[C@@H](O\C2=C(\OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC(=C(O)C=C4)O)[C@H](O)[C@@H](O)[C@H]1O	Analyticon	NP-001009	-2.8612509	-2.19860221	0.40668775	-0.30042918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104961-01	NCGC00104961-01	24268306		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.1322509467	4	4		0	3.44879518					FC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0322	1.59717142	-2.77044855	-0.840593	3.44879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378998-01	HIV-1 integrase inhibitor 2	363678307	Human immunodeficiency virus type 1 integrase Negative Allosteric Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	957890-42-5				-9.2167176276	4	4		0	-0.70100143					CCCC(C(O)=O)C1=C(C2=CC=CC=C2)C3=CC(=CC=C3N=C1C)Cl	MedChem Express	HY-10522	-2.05607477	-2.19860221	-2.7263142	-0.70100143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	53-86-1				-4.7847763257	4	4		0	-2.36051502				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	-1.56721783	-0.53873034	1.94306371	-2.36051502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	3.1622776602	-5.5	54.3032346233	2.2	4		53.1627864329	50.40057225	0.0179419326	0.9998014672			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-2.28612509	-2.75189284	34.89983431	50.40057225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132097-01	NCGC00132097-01	24407480		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.6753704144	4	4		0	1.52108434					CC1=C(Cl)C=C(C=C1)[S+]([O-])(=O)\C2=C\N=C(/NC2=O)SCC(=O)NC3=CC=C4OCCOC4=C3	Sytravon	G605-0145	0.3779566	-0.16124304	-1.87987162	1.52108434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378896-04	MP-513   Tenelia   Tenglyn   Teneligliptin hydrobromide hydrate (Prop INNM)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-6.9956666598	4	4		0	-2.33190272					CC1=NN(C(=C1)N2CCN(CC2)[C@@H]3CN[C@@H](C3)C(=O)N4CCSC4)C5=CC=CC=C5	BLD Pharma	BD627730	-2.14234364	-2.92661619	3.23843952	-2.33190272												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379165-02	IT1t dihydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1092776-63-0		3.9810717055	-5.4	100.3553124861	2.3	4		85.819713651	84.24892704	0.0730544732	0.9966940547			CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C4CCCCC4)=CSC2=N1	Glixx	GLXC-01713	2.45866283	-1.15026209	45.65446603	84.24892704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132638-01	NCGC00132638-01	24408021		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			6.3095734448	-5.2	24.9217532189	2.4	4		30.650835528	27.78614458	0.0249765825	0.9996157149			COC1=CC=CC(=C1)N2CCN(CC2)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=C(ON=C4C)/C=C/C5=C(F)C=CC=C5	Sytravon	G637-0917	-0.329188	-0.54236294	7.68760507	27.78614458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00113556-01	NCGC00113556-01	24388135		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.6450594714	4	4		0	-0.5873494					CCC1=CC=C(CNC(=O)C2=CC=C(CSC3=NC4=CC=NC=C4[N]3CC5=CC=C(OC)C=C5)C=C2)C=C1	Sytravon	C797-0831	-0.96317971	-0.04397537	-1.02399511	-0.5873494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	10	-5	25.0777027044	3	4		40.1809244016	35.06437768	0.0221021346	0.9996988684	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	-0.50323508	-1.17938264	1.40081338	35.06437768												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250412-15	JQ1		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1268524-70-4				-8.1053905201	4	4		0	-0.75822604				BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	-1.16462976	-3.68375073	-2.84681428	-0.75822604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091502-16	COUMARIN		Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	91-64-5				-7.3468973917	4	4		0	-2.56080114					O=C\1OC2=C(C=CC=C2)\C=C1	Microsource	01400208	-1.42343638	-2.05299942	-1.00918813	-2.56080114												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346655-06	Linagliptin	384568886	DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	668270-12-0				6.6139905146	4	4		0	-0.16566265				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	MedChem Express	HY-10284	1.52401853	5.58487247	-1.5130674	-0.16566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107850-02	NCGC00107850-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	11.592195543	4	4		17.0261347999	14.83433735	0.2350463141	0.9644829968			ClC1=CC(=CC=C1)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CCC(=O)N5CCN(CC5)C6=CC=CC=C6)C(=O)N24	Chemdiv	C336-0175	1.0363326	-0.54236294	-2.521779	14.83433735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115742-01	NCGC00115742-01	24390321		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	11.8968611636	4	4		19.31178358	16.85240964	0.0196001574	0.9997640348			CC1=CC2=C(C=C1C)C(=O)\C=C(/O2)C(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)NC4=C(C)C(=NO4)C	Sytravon	D103-1958	-0.15849793	-0.16124304	-0.25981965	16.85240964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379189-01	P005091			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[882257-11-6]		10	-5	1.9218842793	4	4		16.0194104919	11.17310443	0.1461537929	0.9867047233			CC(=O)C1=CC(=C(S1)SC2=CC=CC(=C2Cl)Cl)[N+]([O-])=O	Tocris	4733	-2.51617541	-0.7134537	0.70793794	11.17310443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107780-01	NCGC00107780-01	24271125		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.9247493921	4	4		0	0.79819277					FC1=C(NC(=O)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CCC(=O)NCC5=CC=CC=C5)C(=O)N24)C=CC=C1	Sytravon	C336-0111	0.42672519	0.60099678	-0.25981965	0.79819277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347064-06	KUC107871N		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1346527-98-7				-6.1473101683	4	4		0	-7.04736995				VCP	COC1=C2N=C(N=C(NCC3=CC=CC=C3)C2=CC=C1)[N]4C(=NC5=C4C=CC=C5)N	SIGMA	SML1071	1.84655024	-2.72659176	-5.27845777	-7.04736995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166328-02	Ammonium diethyldithiocarbamate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	21124-33-4		2.8183829313	-5.55	33.2110123357	4	4		32.1966292119	-2.97878524	1	0.9982815742			CCN(CC)C(S)=S	SIGMA	359548	-1.01631835	-2.24719101	25.84149327	-2.97878524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263182-04	Mocetinostat	384568650	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	726169-73-9				-12.3302120873	4	4		0	-6.29177565				HDAC1	NC1=C(NC(=O)C2=CC=C(CNC3=NC(=CC=N3)C4=CC=CN=C4)C=C2)C=CC=C1	Selleck	S1122	-0.81591755	-3.29588015	-4.63586291	-6.29177565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378559-03	Maribavir		Serine/threonine protein kinase UL97 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	176161-24-3				6.5166994721	4	4		0	1.67102586				UL97	CC(C)NC1=NC2=CC(=C(Cl)C=C2[N]1[C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)Cl	MedChem Express	HY-16305	1.24534784	2.72659176	0.26009792	1.67102586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482045-01	NCGC00482045-01	375815951		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-2.1571888653	4	4		0	3.50903614					FC(F)(F)C1=CC=CC(=C1)C2=CC(=N[N]3C=NN=C23)C(=O)NCC4=CC=C5OCOC5=C4	ChemRoutes	CA-37-245	-1.25579127	-0.98211668	-1.26853125	3.50903614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346705-02	PMSF	384568924	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	329-98-6				-0.7508723558	4	4		0	1.06927711					[O-][S+](F)(=O)CC1=CC=CC=C1	Selleck	S3025	-0.45110949	0.4544122	-1.02399511	1.06927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346833-03	PD-151746			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	179461-52-0				-1.6292722027	4	4		0	-3.50188899					OC(=O)/C(S)=C/C1=C[NH]C2=C1C=C(F)C=C2	Glixx	GLXC-06766	1.56026338	-3.47565543	-0.81089351	-3.50188899												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105403-01	NCGC00105403-01	24268748		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.236070612	4	4		0	-1.37048193					CC1=CC=C(C=C1)C2=NC(=NO2)/C3=C/C4=CC=CC(=C4OC3=O)OCC5=CC=C(F)C=C5	Sytravon	C200-5363	-0.30480371	-1.50982117	-1.97157267	-1.37048193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386359-03	Santacruzamate A (CAY10683)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1477949-42-0				-4.5074851121	4	4		0	0.0753012					CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1	APExBIO	B4794	-2.18239454	3.4154207	-1.97157267	0.0753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179244-11	Dorzolamide hydrochloride	384568369	Carbonic Anhydrase Type II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	130693-82-2				-3.0890931988	4	4		0	-1.8744551				CA2	CCN[C@H]1C[C@H](C)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0109A	0.27197252	-3.02621723	-0.38249694	-1.8744551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346654-11	INK-128	384568885	mTORC1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	?1224844-38-5				-6.6289904308	4	4		0	-5.56524266				MTOR	CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14	ActiveBioChem	A-1023	-1.24534784	3.2659176	-2.24908201	-5.56524266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181337-01	2,4-Dichlorobenzyl alcohol	144206349		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1777-82-8	DICHLOROBENZYL ALCOHOL; 			2.2971843267	4	4	2,4-Dichlorobenzyl alcohol;DICHLOROBENZYL ALCOHOL;2,4-DICHLOROBENZYL ALCOHOL;CIPLUS_158985;	0	-2.57192677					OCc1ccc(Cl)cc1Cl	SigmaAldrich	146668	1.9324363	-0.08988764	-0.93329253	-2.57192677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238451-08	Olaparib		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	763113-22-0		3.1622776602	-5.5	36.8134745854	4	4		10.5	4.78058704	1	0.7136320284		PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Axon Medchem	1464	7.17148583	1.67790262	11.97980416	4.78058704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178913-14	Celastrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[34157-83-0]		0.7943282347	-6.1	32.344549419	4	4		-24.1778552799	-6.8148794	0.831674553	0.9998764561			CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O	Tocris	3203	14.7580876	68.13483146	-5.15605875	-6.8148794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345802-01	ACY-1215	174006356	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1316214-52-4	ACY-1215			-2.770649031	4	4		0	-5.59430398			10013	HDAC6	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	ChemieTek	CT-ACY12	1.67477813	-2.15730337	-1.94308446	-5.59430398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390751-02	SPK-601			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1096687-52-3				6.0815016612	4	4		0	-3.03690788					[K]SC(=S)O[C@H]1C[C@H]2C[C@@H]1[C@@H]3CCC[C@H]23	MedChem Express	HY-70083	3.13484111	-0.98876404	1.48408813	-3.03690788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346531-06	Oligomycin A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	579-13-5		3.1622776602	-5.5	131.67228243	3	4		127.2844677038	29.27927928	1	0.9993146089			[H][C@@]1(C)[C@@H]2CC[C@@H](CC)\C=C/C=C\C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@]([H])(O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)\C=C\C(=O)O[C@H]1[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O2	APExBIO	A5588	-0.95906098	-3.74531835	94.5379437	29.27927928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370995-10	SRPIN340	363677983	Serine/threonine-protein kinase SRPK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	218156-96-8				-2.901375499	4	4		0	-0.61516452					FC(F)(F)C1=CC(=C(C=C1)N2CCCCC2)NC(=O)C3=CC=NC=C3	Glixx	GLXC-02516	-0.56074766	-0.04368084	-1.40081338	-0.61516452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163431-06	CA-074 Me	384568238	Cathepsin B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	147859-80-1		7.9432823472	-5.1	17.9337188103	4	4		23.792012596	18.46846847	0.0096062193	0.9999433256		CTSB	CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC	APExBIO	A8239	-0.24334383	0.5093633	6.28824969	18.46846847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386253-01	Valganciclovir HCl	363680169	Human herpesvirus 5 DNA polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	175865-59-5				1.6409980143	4	4		0	-0.59575705					CC(C)[C@H](N)C(=O)OCC(CO)OCN1\C=N/C2C1\N=C(N)/NC2=O	Selleck	S4050	1.3312339	-1.58801498	-0.29069767	-0.59575705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247490-02	3-Hydroxy-4-methoxycinnamic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					2.9739203617	4	4		0	-4.34466725					COC1=C(O)C=C(\C=C\C(O)=O)C=C1	Analyticon	NP-013745	2.36186659	-1.67790262	0.26009792	-4.34466725												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00488726-01	NCGC00488726-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-7.8328279837	4	4		0	-1.53075823					NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ005-090	-2.45866283	-0.45136867	-0.13556258	-1.53075823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346534-07	MC-1568		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	852475-26-4				-6.9476640471	4	4		0	-3.27610873				HDAC2	C[N]1C=C(/C=C/C(=O)C2=CC=CC(=C2)F)C=C1\C=C\C(=O)NO	Adooq	A10560	-1.22214234	0.39312755	-2.36481398	-3.27610873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016925-21	Omeprazole	384567968	ABCC3 Expression Enhancer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	73590-58-6				4.8052312088	4	4		0	6.19456366				ABCC3	COC1=CC2=C([NH]C(=N2)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC)C=C1	MedChem Express	HY-B0113	1.16462976	-1.82003494	-2.18406387	6.19456366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00537955-01	GSK2838232			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1443460-91-0				-5.1652677007	4	4		0	-5.33275211					CC(C)\C1=C2/[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC6=CC=C(Cl)C=C6	DC Chemicals	LL-510	-0.38648726	-0.71910112	0.44369645	-5.33275211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386258-01	Deoxyarbutin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	53936-56-4				-6.4740706488	4	4		0	-3.6762569					OC1=CC=C(OC2CCCCO2)C=C1	Selleck	S4132	-0.3006012	-1.67790262	-2.55507956	-3.6762569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-06	Imatinib	124892208	Bcr-Abl Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	152459-95-5	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	10	-5	69.5955315743	3	4	STI571;Imatinib mesilate;IMATINIB;CIPLUS_700313;Imatinib Mesilate;4-(4-(4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-PHENYL)BENZAMIDE MESYLATE;CIPLUS_670910;Imatinib mesylate;HS_649;imatinib;CPG-57148B;Glivec;Imatinib base;Genpharm brand of imatinib mesylate;IMATINIB MESILATE;Gleevec;CGP-57148;CGP 57148;imatinib mesylate;Imatinib;IMATINIB MESYLATE;CGP57148B;STI 571;imatinibum;Imatinib base(IMA-3);Novartis brand of imatinib mesylate;STI-571;	92.0991085737	86.32664923	0.0335326995	0.9993058726	25	ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	Sequoia	IMATINIB	1.5316347	-1.16853933	2.83047736	86.32664923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095143-05	Rosuvastatin Calcium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	147098-20-2				-0.5366572692	4	4		0	5.82679454					CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Selleck	S2169	-0.47237332	-3.14606742	-2.12668299	5.82679454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390769-01	HIV-1 integrase inhibitor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	544467-07-4				1.9396556777	4	4		0	1.46759663					OC(=O)\C(O)=C\C(=O)C1=CC=CC(=C1)CN=[N+]=[N-]	MedChem Express	HY-13025	-0.3006012	-1.13857678	3.44247246	1.46759663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094960-07	ANTHRAQUINONE		Beta amyloid A4 protein Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	84-65-1				-8.1428205567	4	4		0	-0.35765379					O=C1C2=C(C=CC=C2)C(=O)C3=CC=CC=C13	Microsource	MS-01502103	-2.31488138	-1.49970879	-1.31043832	-0.35765379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	917389-32-3		10	-5	23.535423859	3	4		42.0325871774	33.63376252	0.0317756253	0.999377399	3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-1.42343638	-0.42224811	3.32881458	33.63376252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164524-02	D-Glucuronolactone	50111689		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			-1.1632858619	4	4	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	-2.36051502					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	0.70452912	-0.24752475	-2.78656424	-2.36051502												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00378968-01	Lersivirine	363678296	Reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	473921-12-9				9.6911116271	4	4		0	3.50500715					CCC1=N[N](CCO)C(=C1OC2=CC(=CC(=C2)C#N)C#N)CC	MedChem Express	HY-14267	2.74622574	0.18928363	-0.10543757	3.50500715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183867-02	Aloin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1415-73-2				-1.2617826135	4	4		0	0.42138913					[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	APExBIO	N2491	0.64414543	-2.69662921	-1.9124847	0.42138913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263617-13	M-344	384568694	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	251456-60-7				-17.304667723	4	4		0	-7.01830863				HDAC1	CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-13506	-2.1328371	-4.79400749	-4.66646267	-7.01830863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018100-16	Fasudil hydrochloride	384567990	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	105628-07-7				-1.155991605	4	4		0	-3.21888412				ROCK1	[O-][S+](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2	MedChem Express	HY-10341	0.47447879	0.16016308	-0.10543757	-3.21888412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480888-01	STING agonist G10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	702662-50-8				-6.1170570637	4	4		0	-0.64377682					FC1=C(CN2C(=O)CSC3=CC=C(C=C23)C(=O)NCC4=CC=CO4)C(=CC=C1)Cl	Glixx	GLXC-07341	-2.22861251	-2.28596389	2.36481398	-0.64377682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250404-15	ABT-888			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	912445-05-7				40.7543969621	4	4		0	13.17596567					C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(N)=O	ChemieTek	CT-A888	6.80086269	5.22714036	14.14369634	13.17596567												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016360-07	Monobenzone	384567934	topical medical depigmentation treatment	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	103-16-2				-7.1944574032	4	4		0	-2.5753012					OC1=CC=C(OCC2=CC=CC=C2)C=C1	Selleck	S1652	-0.86564253	-1.30460276	-3.07198533	-2.5753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015142-02	Benzamide	124879383		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-1.4923301602	4	4	Benzamide-15N;Benzamide-13C1 (carbonyl-13C);NCGC00015142-01;Benzoylamide;AB07990186-01;Benzamide;benzamide;NCGC00091355-03;CIPLUS_148736;Benzoic acid amide;Benzamide-alpha-13C;NCGC00091355-02;	0	3.9341917					NC(=O)C1=CC=CC=C1	NIEHS	AB07990186	-2.68871316	1.26674432	2.21418888	3.9341917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091367-08	DANTHRON		DNA topoisomerase II alpha Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	117-10-2				3.317644814	4	4		0	-1.13018598					OC1=CC=CC2=C1C(=O)C3=C(O)C=CC=C3C2=O	Microsource	MS-00211468	0.12940331	0.01456028	5.46769092	-1.13018598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	51773-92-3		15.8489319246	-4.8	-2.4023966485	4	4		-9.8841201719	-5.73676681	0.6975296481	0.491226489		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-1.30841121	-0.18928363	7.66681729	-5.73676681												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094932-06	LANATOSIDE C			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	17575-22-3				15.3790748084	4	4		0	3.13304721					CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	Microsource	MS-01501205	2.74622574	4.26616191	4.35306522	3.13304721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182416-01	NCGC00182416-01	87225661		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.5429148095	4	4		0	-1.67168675					[O-][S+](=O)(N1CCN(CC1)[S+]([O-])(=O)C2=CC3=C(CCN(C3)C(=O)C(F)(F)F)C=C2)C4=CC=C5OCCOC5=C4	NCGCChem	mbb01-82	-1.23140697	-0.16124304	-1.48250038	-1.67168675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263107-01	NCGC00263107-01	137275951		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1252806-86-2	GB 83	0.7079457844	-6.15	13.5100736417	4	4		10.977688364	6.06927711	0.5246798378	0.7815248233	55065	PAR2	CC[C@@H](C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C2=CC=NO2)C(=O)N3CCC4(CC3)CCC5=C4C=CC=C5	ChemAxon	Axon 1622	-1.23140697	4.88126649	12.45605991	6.06927711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016508-03	Methazolamide		Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	554-57-4				-4.456296377	4	4		0	-0.27181688					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	MedChem Express	HY-B0553	-0.56074766	-1.76179383	-2.27443892	-0.27181688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601806-01	TH34			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	2196203-96-8				-6.1999061855	4	4		0	0.70100143					CC1=CC=C(C=C1NCC2=CC=CC=C2)C(=O)NO	Selleck	S8773	-1.76851186	-0.13104252	-3.02756439	0.70100143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116616-01	NCGC00116616-01	24391195		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.9213230914	4	4		0	1.43072289					FC1=CC=C(C=C1)C/2=N/C(=N\C3=C(N2)C=CC=C3)C4=CC=CC(=C4)C(F)(F)F	Sytravon	D165-0058	-0.59741526	-0.77689827	5.60904784	1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168285-02	NCGC00168285-02	85736016		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	9.6239541047	4	4		26.939248052	21.43072289	0.0552072428	0.9981199524			FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)[C@@H](NC(=O)CNC(=O)C2=CC=CC=C2)C3=CC=CC=C3	NCGCChem	BTM01-55	-1.69470861	-0.92348285	-2.03270671	21.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345539-05	Dacinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	404951-53-7				-24.7224402439	4	4		0	-5.42203147				HDAC1	OCCN(CCC1=C[NH]C2=C1C=CC=C2)CC3=CC=C(\C=C\C(=O)NO)C=C3	Selleck	S1095	-5.07548526	-5.13977868	-5.88944118	-5.42203147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371120-06	Dapivirine?TMC-120	363678036	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	244767-67-7		14.1253754462	-4.85	-1.8866095871	4	4		17.223678264	11.23032904	0.1858631015	0.9782012863			CC1=CC(=C(NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C(=C1)C)C	Glixx	GLXC-04864	-1.82602444	-3.68375073	-4.35306522	11.23032904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-01	NCGC00347284-01	174006574		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	651031-01-5	XL-647			-16.8486233166	4	4		0	-5.9186747			1956	EGFR	COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	SantaCruz Bio	sc-364659	-2.32870032	-4.14834359	-5.11997555	-5.9186747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344564-03	NCGC00344564-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.192423404	4	4		0	-0.70783133				AHR	COC1=CC=C(C=C1O)C/2=C/C(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Analyticon	NP-010617	0.06096074	-2.33069481	-3.13311936	-0.70783133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	17321-77-6		11.220184543	-4.95	73.8266874201	3	4		107.4539361255	101.3304721	0.0069445177	0.9999702542		SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	-0.79079799	-0.16016308	0.3163127	101.3304721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182390-05	NCGC00182390-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			11.220184543	-4.95	38.9356978789	3	4		69.9342313999	52.6037196	0.0251754908	0.9996090281			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	-1.76851186	-0.30576587	6.22081639	52.6037196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178714-18	Topiramate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	97240-79-4				-4.0412312374	4	4		0	0.27181688					CC1(C)O[C@@H]2CO[C@@]3(CO[S+](N)([O-])=O)OC(C)(C)O[C@H]3[C@@H]2O1	DC Chemicals	DC9074	-1.50970525	1.29586488	-1.85268866	0.27181688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387263-05	Oltipraz		Nuclear Factor Erythroid 2-Related Factor 2 (NFE2-Related Factor 2; NFE2L2; NRF2) Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	64224-21-1				9.5196278482	4	4		0	3.99141631				NRF2	C\C1=C(\SSC1=S)C2=CN=CC=N2	SIGMA	O9389	0.79079799	1.29586488	5.16644073	3.99141631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091914-04	Cichoric Acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.2142049102	4	4		0	1.03915663					OC(=O)[C@H](OC(=O)\C=C\C1=CC(=C(O)C=C1)O)[C@@H](OC(=O)\C=C\C2=CC=C(O)C(=C2)O)C(O)=O	Analyticon	NP-015790	0.86564253	-0.30782762	2.06327373	1.03915663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017388-08	(+)-Usniacin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	7562-61-0				-1.7786010406	4	4		0	1.38769671					CC(=O)C1=C(O)C(C)=C(O)C2=C1OC3=CC(=O)C(C(C)=O)=C(O)[C@@]23C	DC Chemicals	DCS-001	-1.30841121	-0.82993593	1.58156349	1.38769671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399585-01	NCGC00399585-01	375805247		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.8796152141	4	4		0	-0.34638554					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=CC(=C4)C#N)N5CCOCC5	Analyticon	NAT6-322275	0.71933675	2.06684257	-1.63533547	-0.34638554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181129-22	Dasatinib			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	302962-49-8				-13.9297360854	4	4		0	-1.13018598					CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Selleck	S1021_CM1	-2.60244428	-4.52824694	-4.68444043	-1.13018598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016564-06	Metformin	170464804	AMPK Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			2.6120853264	4	4		0	-0.12875536			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	1.39468009	0.45136867	-1.67193854	-0.12875536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016759-38	Naproxen sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	26159-34-2				7.6528641139	4	4		0	3.26939843					COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O	DC Chemicals	DC9000	2.87718294	-2.21722846	-0.84149327	3.26939843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015202-21	NCGC00015202-21			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					2.6933831227	4	4		0	4.48997384					CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O	SigmaAldrich	C0330	0.501002	-2.45692884	-0.32129743	4.48997384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346566-10	Roflumilast	384568843	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	162401-32-3				-6.8589037964	4	4		0	-3.24033711				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	MedChem Express	HY-15455	-1.5316347	-1.31835206	0.56609547	-3.24033711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-16	Ivermectin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	70288-86-7		1.2589254118	-5.9	62.608486253	3	4		38.0703805588	-5.76807229	1	0.9999623048			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	0.91441112	5.99530929	38.77426257	-5.76807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386356-05	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	190786-44-8				-4.8401724582	4	4		0	-1.38041267					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	-0.81591755	-1.22846442	-1.23929009	-1.38041267												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094857-06	AMINACRINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-3.7712253136	4	4		0	0.27608253					NC1=C2C=CC=CC2=NC3=C1C=CC=C3	Microsource	MS-01500810	0.21471514	-2.72659176	-3.74847001	0.27608253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686670-01	GS-441524			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1191237-69-0		1.77827941	-5.75	145.4119007181	1.1	4		96.3904172384	95.28614458	0.0454648312	0.9987229097			NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	2.15801024	0.98211668	97.27953538	95.28614458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126023-01	NCGC00126023-01	24401406		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.050920217	4	4		0	5.0753012					COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=CC(=C5)F	Sytravon	E859-1200	-1.59717142	-1.09938434	3.01085129	5.0753012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015415-05	N-Ethylmaleimide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	128-53-0				1.8924990987	4	4		0	-0.01453066					CCN1C(=O)\C=C/C1=O	Enzo	PI149	0.15745777	-0.38951311	2.46328029	-0.01453066												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00378626-06	TMP269	363678130	Histone deacetylase 9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1314890-29-3				6.3284786537	4	4		0	-4.28654461			9734	HDAC9	FC(F)(F)C1=NC(=NO1)C2=CC(=CC=C2)C(=O)NCC3(CCOCC3)C4=NC(=CS4)C5=CC=CC=C5	Glixx	GLXC-05455	4.1654738	-1.22846442	-0.35189718	-4.28654461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263103-09	Pelitinib		EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	257933-82-7				-17.5657360607	4	4		0	-7.04736995				EGFR	CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N	MedChem Express	HY-32718	-2.19009447	-5.72284644	-3.87086903	-7.04736995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180407-02	NCGC00180407-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					5.7204726066	4	4		0	2.25225225					CC(=O)C\C1=C\C(=O)C2=C(O1)C(=C(O)C=C2C)C3OC(CO)C(O)C(O)C3O	Analyticon	NP-000313	1.76066419	-0.05992509	-0.59669523	2.25225225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185937-01	NCGC00185937-01	87225716		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	6.2684522675	4	4		11.4025676279	8.71987952	0.2877014797	0.9459509298			CC(=O)NC1=CC(=CC=C1)[S+]([O-])(=O)N2CCCN(CC2)[S+]([O-])(=O)C3=CC4=C(OCCO4)C=C3	NCGCChem	MBB09-018	0.71933675	-0.98211668	-2.00213969	8.71987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263606-06	Tubastatin A	384568693	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1310693-92-5				-8.6423755389	4	4		0	-4.80421687				HDAC6	CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO	Selleck	S2627	-1.01194831	-0.36646145	-3.16368638	-4.80421687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390429-01	Isoxanthohumol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	70872-29-6				-8.2218326824	4	4		0	-4.80964836					COC1=CC(=C(CC=C(C)C)C2=C1C(=O)CC(O2)C3=CC=C(O)C=C3)O	Bio Vision	2529	-0.38648726	-3.3258427	-1.88188494	-4.80964836												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370784-05	Resiquimod	363677855	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	144875-48-9				2.5127799668	4	4		0	-0.01453066				TLR7	CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2[N]1CC(C)(C)O	MedChem Express	HY-13740	-0.18608646	1.8576779	2.43268054	-0.01453066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106733-02	NCGC00106733-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.7596805677	4	4		0	1.37048193					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=C(C)C=C(C)C=C4C)C5=CC=CC=C5C3=O)C=C2)C=C1	Chemdiv	C260-2768	-2.10924165	-1.12870126	-0.87116002	1.37048193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510187-01	BMS-663068			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	864953-29-7				-2.4362890996	4	4		0	-1.1188608					COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[N]3CO[P](O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	Glixx	GLXC-90326	0.52963069	-2.09737828	-2.12668299	-1.1188608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181785-11	Aprepitant			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	170729-80-3				-8.6504758247	4	4		0	-3.6762569					C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	MedChem Express	HY-10052	-1.30260521	-1.49812734	-2.1878825	-3.6762569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378691-05	Asunaprevir (Prop INN; USAN) BMS-650032   Sunvepra  			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-2.9290698426	4	4		0	-0.94449288					COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(Cl)=CC=C15	AK Scientific	Y1367	-0.07157171	-1.58801498	-1.33108935	-0.94449288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00411883-01	NCGC00411883-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			7.0794578438	-5.15	98.3425204583	2.1	4		113.7176581733	104.48997384	0.0355470334	0.9992198487			COCCNC(=O)NC1=CC2=C(C=C1)N=C(C3=CC=CS3)C(=N2)C4=CC=CS4	NCGCChem	MLS000534714-02pur	1.35986258	-0.92883895	24.92350061	104.48997384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016786-25	Mycophenolic acid		Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	24280-93-1		2.8183829313	-5.55	28.1496944566	4	4		25.264705888	23.9341917	0.0315919882	0.999385013		IMPDH1	COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2	MedChem Express	HY-B0421	-0.81955428	-1.47058824	19.14444947	23.9341917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-05	Ponatinib		FGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	943319-70-8		0.3548133892	-6.45	18.537127789	4	4		-19.2124463479	-5.59370529	0.0371226832	0.9991537082		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Axon Medchem	1857	10.85549964	-2.11124054	-5.04594065	-5.59370529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015273-15	Chlorpromazine hydrochloride	124879758	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	69-09-0		8.9125093813	-5.05	38.7829629031	3	4	CHLORPROMAZINE HCl	59.8589457697	53.37625179	0.0199993263	0.9997533132			CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2	BIOMOL	AC749	-1.59597412	-0.65521258	4.89531556	53.37625179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482994-01	20(S)-Ginsenoside Rh2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	67400-17-3		7.9432823472	-5.1	8.0926602193	4	4		15.75952552	13.43347639	0.0339451857	0.9992935925			CC(C)=CCC[C@](C)(O)[C@H]1CC[C@@]2(C)[C@H]1[C@@H](O)CC3[C@@]4(C)CC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)C4CC[C@@]23C	DC Chemicals	DCR-036	-1.0496046	-0.68433314	1.73218858	13.43347639												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165962-02	L-685458			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	292632-98-5				-11.7021704689	4	4		0	-3.58907294					CC(C)C[C@H](NC(=O)[C@@H](C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(N)=O	Glixx	GLXC-06622	-2.10420842	-4.34456929	-0.87209302	-3.58907294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386289-08	Dynasore	387065823	Dynamin-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[304448-55-3]				-5.5890431067	4	4		0	-1.95994278			10059		OC1=C(O)C=C(C=C1)\C=N\NC(=O)C2=C(O)C=C3C=CC=CC3=C2	Tocris	2897	-2.60244428	4.58648806	-0.97906311	-1.95994278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016016-28	Triamterene		Heart phosphodiesterase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	396-01-0				8.6590693322	4	4		0	8.55855856					NC1=NC(=C2N=C(C3=CC=CC=C3)C(=NC2=N1)N)N	MedChem Express	HY-B0575	0.35785857	0.65917603	1.26988984	8.55855856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166414-05	Pemetrexed	384568308	Thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	150399-23-8				-4.2929745394	4	4		0	-1.52571927					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Selleck	S1135	-0.04294303	-3.20599251	-1.14749082	-1.52571927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263533-12	Penciclovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	39809-25-1				3.6661415115	4	4		0	-0.04291845					N\C1=N\C2=C(N=CN2CCC(CO)CO)C(=O)N1	APExBIO	B1809	1.59597412	0.80081538	-1.34056334	-0.04291845												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386215-05	Alogliptin (SYR-322)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	850649-61-5				-8.9018363209	4	4		0	1.3018598					CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	APExBIO	A4038	-2.57368799	-1.87827606	-2.84681428	1.3018598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263570-02	Sivelestat sodium salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	150374-95-1				-4.4497387854	4	4		0	1.50214592					CC(C)(C)C(=O)OC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC=C2C(=O)NCC(O)=O	Tocris	3535	-2.02731848	-0.18928363	-0.37656274	1.50214592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229511-27	Tofacitinib			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	477600-75-2				-0.3824199214	4	4		0	-2.27467811					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	1.33716751	-1.23762376	-1.7623136	-2.27467811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522539-01	Trovirdine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	149488-17-5				-2.7707883635	4	4		0	-5.33275211					BrC1=CN=C(NC(=S)NCCC2=NC=CC=C2)C=C1	MedChem Express	HY-15349	0.78728886	-0.4494382	-0.68849449	-5.33275211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486904-01	MRT-68601 hydrochloride	377020217	IKK-epsilon Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-6.9876698443	4	4		0	-6.32083697				IKBKE	O=C(NCCCNC1=C(C=NC(=N1)NC2=CC=C(C=C2)N3CCOCC3)C4CC4)C5CCC5	Tocris	5067	-0.15745777	-0.68913858	-1.97368421	-6.32083697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00169713-02	Oxyresveratrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-0.2916395689	4	4		0	0.47951177					OC1=CC(=C(C=C1)\C=C\C2=CC(=CC(=C2)O)O)O	Analyticon	NP-003143	-0.35785857	0.23970037	0.1376989	0.47951177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386330-03	Z-FA-FMK			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	197855-65-5		0.316227766	-6.5	299.5043457003	1.1	4		85.5599458208	101.47353362	0.0219880364	0.9997017529			C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)CF	DC Chemicals	DC7567	35.90222861	87.40535818	101.41587588	101.47353362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015673-19	Minoxidil		K(ATP) Channel Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	38304-91-5				2.131645832	4	4		0	0.04291845					NC1=[N+]([O-])C(=NC(=C1)N2CCCCC2)N	MedChem Express	HY-B0112	0.96333573	-0.77169482	0.25606266	0.04291845												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379064-01	R-7128	377020456		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	940908-79-2				-10.7503617345	4	4		0	-2.38912732					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	-2.02731848	-1.8491555	-3.56981473	-2.38912732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398321-01	NCGC00398321-01	375805750		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.925616753	4	4		0	-1.40060241					[O-][S+](=O)(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C(C=C4)[N]5C=CN=C5)C6=CC7=CC=CC=C7C=C6	Analyticon	NAT6-298644	-0.49987808	-2.15479332	-0.13755158	-1.40060241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106464-01	NCGC00106464-01	24269809		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.7585939418	4	4		0	-2.15361446					COC1=C(OC)C=C(CCNC(=O)CCCCN2C(=O)N(CC(=O)NC3=C(C)C=CC=C3C)C4=CC=CC=C4C2=O)C=C1	Sytravon	C260-1456	1.40209705	0.80621519	0.32095369	-2.15361446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388284-12	Darunavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	635728-49-3				-1.2954266793	4	4		0	-1.07296137					[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(CC(C)C)[S+]([O-])(=O)C4=CC=C(N)C=C4	APExBIO	A8206	1.22214234	-1.17938264	-3.99156499	-1.07296137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378984-02	Pritelivir (BAY 57-1293)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	348086-71-5				5.1179105292	4	4		0	0.07153076					CN(C(=O)CC1=CC=C(C=C1)C2=NC=CC=C2)C3=NC(=C(S3)[S+](N)([O-])=O)C	Selleck	S7546	2.77498203	-1.73267327	-1.15981322	0.07153076												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159491-11	Rimantadine		M2 Channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1501-84-4				-6.7797549707	4	4		0	1.44492132					CC(N)C12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0338A	-2.19985622	-0.45136867	-2.75643922	1.44492132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159564-05	Scriptaid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[287383-59-9]				-15.0831299624	4	4		0	-5.56509299					ONC(=O)CCCCCN1C(=O)C2=CC=CC3=C2C(=CC=C3)C1=O	Tocris	2421	-1.56721783	-4.61560862	-5.2869408	-5.56509299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137713-01	NCGC00137713-01	24413096		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.4553110388	4	4		0	-0.67771084					FC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)COC4=CC=CC=C4	Sytravon	G883-0846	-1.47524994	-1.21665201	-0.47378878	-0.67771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023654-26	Captopril			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	62571-86-2 				1.6095512307	4	4		0	-1.73104435					C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	APExBIO	A4078	1.02084831	1.67443215	-1.25018828	-1.73104435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178027-11	Valsartan		Neprilysin Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	137862-53-4				-6.0418569933	4	4		0	-1.24463519					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	MedChem Express	HY-18204	-1.16462976	-0.42224811	-2.63593915	-1.24463519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018130-08	PHENAZOPYRIDINE HYDROCHLORIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	136-40-3, 94-78-0 [phenazopyridine]				-2.4176923308	4	4		0	-1.24463519					NC1=CC=C(\N=N\C2=CC=CC=C2)C(=N1)N	Microsource	MS-01500473	-2.80373832	6.65404776	1.46106341	-1.24463519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263172-02	NCGC00263172-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1020172-07-9		12.5892541179	-4.9	41.977848453	3	4		39.425101365	38.32831325	0.3660537941	0.9070989398		ABL1	CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC(=N[N]3C4=CC5=C(C=C4)N=CC=C5)C(C)(C)C)C=C2)F	Selleck	S2634	3.1577664	10.39284667	-2.8580162	38.32831325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016251-17	Probenecid		Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	57-66-9				3.1943796341	4	4		0	-0.50071531					CCCN(CCC)[S+]([O-])(=O)C1=CC=C(C=C1)C(O)=O	APExBIO	B2014	1.56721783	2.25684333	-2.8769393	-0.50071531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00393868-01	NCGC00393868-01	375809842		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.9870908029	4	4		0	0.94879518					CN(C)C1=CC=CC(=C1)OC2=NN=N[N]2[C@H]3CO[C@@H]4[C@H](CO[C@H]34)NC(=O)NC5=CC=CC6=CC=CC=C56	Analyticon	NAT6-298297	-2.18239454	2.1254764	-0.87116002	0.94879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109256-01	NCGC00109256-01	24383835		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.4211245904	4	4		0	0.22590361					CCN1\C=C(C(=O)NC(C)C2=CC=CC=C2)/C(=O)C3=CC(=CC=C13)[S+]([O-])(=O)N4CCC5=CC=CC=C5C4	Sytravon	C519-2054	-0.81687393	-2.00820874	-1.57420144	0.22590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016246-21	Chlorhexidine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	3697-42-5				-8.8656924242	4	4		0	-3.11746988					ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	APExBIO	B1695	-1.45086564	-0.36646145	-3.68332569	-3.11746988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346888-03	UK-383367	363677552	Procollagen C-Endopeptidase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	348622-88-8		12.5892541179	-4.9	22.571865176	3	4		39.1077891919	33.4620887	0.1482513151	0.9862091582			NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO	Selleck	S2224	-1.6534867	2.86837507	-0.3163127	33.4620887												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166215-04	PHENYLETHYL ALCOHOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	60-12-8				-0.1220369601	4	4		0	2.81831187					OCCC1=CC=CC=C1	Microsource	MS-01505398	-1.13587347	-0.80081538	1.7623136	2.81831187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115610-01	NCGC00115610-01	24390189		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			7.0794578438	-5.15	6.8618839563	4	4		21.332014076	17.36445783	0.0146393131	0.9998682819			CC1=CC2=C(C=C1Cl)C(=C(O2)C(=O)N(CC3=C(F)C=CC=C3)C4CC[S+]([O-])(=O)C4)C	Sytravon	D076-0328	-2.25554743	-2.36001173	1.8493046	17.36445783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115604-01	NCGC00115604-01	24390183		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					0.1202005839	4	4		0	-1.37048193					CC1=CC2=C(OC(=C2C)C(=O)N(CC3=CC(=CC=C3)F)C4CC[S+]([O-])(=O)C4)C=C1	Sytravon	D076-0310	-0.81687393	0.57167986	4.05012991	-1.37048193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263116-12	NCGC00263116-12			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	780757-88-2				-5.867890753	4	4		0	-4.11144578				CREBBP	OC1=CC=C(C[C@@H]2N3[C@H](CN(CC4=CC=CC5=C4C=CC=C5)C2=O)N(CCC3=O)C(=O)NCC6=CC=CC=C6)C=C1	Selleck	S2662	-0.71933675	0.60099678	-1.97157267	-4.11144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	129618-40-2				2.3435753874	4	4		0	-0.22590361				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	1.18263838	0.54236294	-1.26853125	-0.22590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386232-01	Cathepsin Inhibitor 1	363680160		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	225120-65-0		0.2818382931	-6.55	284.348415541	1.3	4		82.1162527344	101.13018598	0.2036143951	0.9735307227			C[N]1N=C(C=C1C(=O)N[C@@H](CC2=CC=CC(=C2)Cl)C(=O)NCC#N)C(C)(C)C	Selleck	S2847	33.74550683	86.56086197	88.82361801	101.13018598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168776-10	Delavirdine (mesylate)		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	147221-93-0				-8.0242770885	4	4		0	2.36051502					CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C([NH]3)C=CC(=C4)N[S+](C)([O-])=O	MedChem Express	HY-10571A	-3.17757009	-2.16948165	-0.22593764	2.36051502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111301-01	NCGC00111301-01	24385880		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.1373800477	4	4		0	-3.44879518					COC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3CCCN(C3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0204	1.01194831	2.47727939	2.00213969	-3.44879518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346683-02	YM-201636	384568907	PIKfyve Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	371942-69-7		1.1220184543	-5.95	54.6042864845	3	4		38.3498485834	8.65963855	1	0.9998854367		PIKFYVE	NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6	Selleck	S1219	-1.20702268	6.40574612	36.78740639	8.65963855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599627-01	Adaptavir   D-Ala1-peptide T-NH2   DAPTA   RAP-101  			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-8.6669263765	4	4		0	-1.50214592					C[C@@H](O)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O	MedChem Express	HY-P1034	-2.77498203	-0.21840419	-0.43681277	-1.50214592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017375-03	Berbamine dihydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6078-17-7		1.4125375446	-5.85	90.2040801398	1.2	4		63.0926461284	62.90322581	0.0229880478	0.9996739742			COC1=CC2=C3C=C1OC4=C(OC)C(=CC5=C4[C@@H](CC6=CC=C(O)C(=C6)OC7=CC=C(C[C@@H]3N(C)CC2)C=C7)N(C)CC5)OC	Prestwick	Prestw-NAT-0350	-1.04494704	5.00374532	60.60281518	62.90322581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346743-03	Givinostat hydrochloride	384568939	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-17.4037544929	4	4		0	-5.67771084				HDAC1	CCN(CC)CC1=CC2=C(C=C1)C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=C2	Bio Vision	9431-5	-2.4262375	-4.32424509	-5.63961486	-5.67771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	57-41-0				-7.7807589929	4	4		0	-1.03915663					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	-1.37771275	-2.03752565	-2.94971725	-1.03915663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390724-02	E-7449	384569209	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1140964-99-3		1.1220184543	-5.95	43.5608417189	4	4		16	21.43072289	0.1687839821	0.9820868062		PARP1	O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13	MedChem Express	HY-12418	3.62106803	7.63705658	18.53889653	21.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111269-02	NCGC00111269-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			11.220184543	-4.95	75.2767308765	3	4		97.7385794628	88.0873494	0.0396302011	0.9990301248			CN1C(=O)OC2=C1C=CC(=C2)[S+]([O-])(=O)N3CCCC(C3)C(=O)N4CCN(CC4)C5=CC=CC(=C5C)C	Chemdiv	C648-0100	2.91392343	-0.33714453	3.1942534	88.0873494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106236-02	NCGC00106236-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			12.5892541179	-4.9	33.870247381	3	4		60.155872039	50.55722892	0.0342800522	0.9992747831			CC1=CC(=CC=C1)CN2C(=O)N(CC3=CC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=CC=C5)C(=O)C6=CC=CC=C26	Chemdiv	C260-1272	-0.59741526	-2.18411023	-1.23796424	50.55722892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095169-07	Miltefosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	58066-85-6				-7.362165156	4	4		0	-3.99593142					CCCCCCCCCCCCCCCCO[P]([O-])(=O)OCC[N+](C)(C)C	Selleck	S3056	0.38648726	-2.87640449	-0.4130967	-3.99593142												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00379087-02	Tipranavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	174484-41-4				10.7161787797	4	4		0	4.69340308					CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	1.18809047	1.917603	4.05446756	4.69340308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109737-01	NCGC00109737-01	24384316		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			1	-6	38.4272620103	4	4		24.8365032919	9.38253012	1	0.9997201974			CC1=CC(=C(C)C=C1)CN2C(=O)C3=C(C=CC=C3)[S+]([O-])(=O)C4=C2C=C(C=C4)C(=O)N5CCN(CC5)C6=CC=CC=C6	Sytravon	C530-1332	-0.28041941	5.93667546	24.1937949	9.38253012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344804-01	NCGC00344804-01	170466906		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.5102501878	4	4		0	3.47891566					CC1=C(N=C(NC(=O)CC2=CC3=C(C=CC=C3)C=C2)S1)C4=CC5=C(C=C4)N(CC5)C(=O)C6=C(C)C=CC=C6	NCGCChem	JMR03-026-A6	-0.20726652	-0.54236294	-0.25981965	3.47891566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126982-01	NCGC00126982-01	24402365		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.6803959585	4	4		0	4.38253012					CC1=CC=CC(=C1)C(=O)NC2=C(OC3=C2C=CC=C3)C(=O)N4CCN(CC4)C5=CC=C(F)C=C5	Sytravon	E957-2050	-1.28017557	1.18733509	1.20739722	4.38253012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388372-01	Angelicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	523-50-2				-7.6591389838	4	4		0	-4.43185121					O=C\1OC2=C(\C=C1)C=CC3=C2C=CO3	Cayman	11683	-0.95906098	-1.70786517	-1.88188494	-4.43185121												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00507862-01	LDC4297 (LDC044297)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1453834-21-3				-1.7402998025	4	4		0	1.81633246					CC(C)C1=C2N=C(OC3CCCNC3)N=C(NCC4=CC=CC=C4[N]5C=CC=N5)[N]2N=C1	Selleck	S7992	-0.95906098	-4.55430712	3.62607099	1.81633246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095703-06	NOBILETIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	478-01-3				19.8964460894	4	4		0	4.95495495					COC1=C(OC)C=C(C=C1)C/2=C/C(=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC	Microsource	01505268	2.81992557	1.55805243	11.30660955	4.95495495												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386206-04	Azilsartan	363680151	Type-1 angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	147403-03-0				-3.9823279979	4	4		0	3.12409183					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Glixx	GLXC-05169	-1.9324363	-1.22846442	-0.749694	3.12409183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00129227-01	NCGC00129227-01	24404610		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.7944700416	4	4		0	-2.54518072					CCOC1=CC=CC=C1CNC(=O)CC2=CC=C(NC(=O)N3CCCCC4=CC=CC=C34)C=C2	Sytravon	G217-1159	-0.89002682	-0.86484902	-1.45193336	-2.54518072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-05	Maraviroc	384568416		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	376348-65-1				-3.6076002151	4	4		0	-1.61290323				CCR5	CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Enzo	AC3169	-0.75866018	-1.10861423	0.44369645	-1.61290323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015508-23	Hydrochlorothiazide	384567858	Hypertension treatment	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	58-93-5				-8.9338505227	4	4		0	-2.39755885					N[S+]([O-])(=O)C1=C(Cl)C=C2NCN[S+]([O-])(=O)C2=C1	Enzo	AC3145	-1.64614944	-3.05617978	-1.14749082	-2.39755885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371259-05	Clevudine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	163252-36-6		3.1622776602	-5.5	14.8543997425	4	4		10.9123595479	-1.96163906	1	0.8160344314			C\C1=C\N([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O	MedChem Express	HY-13859	2.01832236	-2.42696629	7.87943696	-1.96163906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025029-03	U-0126	26752096	Mek 1/2 inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	218601-62-8	U0126;U0126-EtOH;U-0126			-10.7079897957	4	4	1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene;UO126;CIPLUS_753356;U0126 ethanolate;U 0126;UO-126;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene;U0126;U126 cpd;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene ethanolate;NCGC00094462-02;NCGC00094462-01;NCGC00016074-01;UO 126;U-0126;NCGC00025029-03;NCGC00025029-02;NCGC00025029-01;U0126 cpd;	0	-1.8744551			5604	MAP2K1	NC(/SC1=CC=CC=C1N)=C(C#N)\C(C#N)=C(N)\SC2=CC=CC=C2N	BIOMOL	EI282	-2.07557973	-3.11610487	-2.61627907	-1.8744551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163460-03	Leupeptin, Microbial			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	103476-89-7		10	-5	20.8971115515	4	4		32.5134554879	26.75094449	0.0573527884	0.9979695133			[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O	APExBIO	A2570	-0.84454624	0.65917603	3.71787026	26.75094449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482625-01	Dendrobine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2115-91-5				2.6944288453	4	4		0	3.99593142					CC(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@@H]3CC[C@@H]4CN(C)[C@H]2[C@]34C	DC Chemicals	DCS-082	-1.21671915	-0.14981273	4.17686658	3.99593142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090691-14	Didanosine		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	69655-05-6				-6.7661629198	4	4		0	-0.95851216					OC[C@@H]1CC[C@@H](O1)[N]2C=NC3=C2\N=C/NC3=O	MedChem Express	HY-B0249	-2.2573688	0.48048923	-0.88868806	-0.95851216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016672-07	Chloropyramine hydrochloride		Histamine H1 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	6170-42-9				7.013183846	4	4		0	5.24556815					CN(C)CCN(CC1=CC=C(Cl)C=C1)C2=CC=CC=N2	Prestwick	Prestw-807	0.1002004	2.69662921	1.36168911	5.24556815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162225-04	L-tetramisol		Nicotinic Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	16595-80-5	; Vetavia; Hydrochloride, Levamisol; Tetramisol hydrochloride; Levamisol;LEVAMISOLE HYDROCHLORIDE;Tetramisole hydrochloride; ; dexamisole, (R)-isomer; Levomysol; Tetramisol; Decaris; (-)-Tetramisole hydrochloride; Levamisol hydrochloride; Helmoral B; Solaskil; Levamisole Base; Dekaris; Nilverm; Dexamisol; Ergamisol;(-)-Tetramisole hydrochloride			-8.1805479087	4	4		0	-0.472103			1136	CHRNA3	C1CN\2C[C@@H](\N=C2S1)C3=CC=CC=C3	Enzo	AC-1102	-2.40115025	-0.39312755	-2.03343877	-0.472103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482702-01	Dehydroandrographolide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	134418-28-3				-2.0708699981	4	4		0	6.10872675					CC1(CO)C(O)CCC2(C)C(C\C=C3/C=C\OC3=O)C(=C)CCC12	DC Chemicals	DCT-012	-2.31488138	-0.48048923	-0.55731285	6.10872675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385384-01	NCGC00385384-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-3.8416347184	4	4		0	0.30514385					CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)C3C/C=C/4C(C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-015959	-1.84655024	-0.98876404	1.9124847	0.30514385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-12	telbivudine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	3424-98-4				-10.1597549715	4	4		0	-0.18597997					C\C1=C\N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	DC Chemicals	DC4211	-2.89000719	-3.1304601	-0.6476879	-0.18597997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167778-02	ZK 756326			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	[874911-96-3]				-4.3407917446	4	4		0	-0.50071531					OCCOCCN1CCN(CC1)CC2=CC=CC(=C2)OC3=CC=CC=C3	Tocris	2565	-1.42343638	1.52882935	-2.00331375	-0.50071531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178090-03	Pristimerin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1258-84-0		1.1220184543	-5.95	207.416457673	5	4		-75.5924983828	-5.59370529	0.0130276914	0.9998953152			COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)\C4=C\C=C\5\C(=C(\O)C(=O)\C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C	SIGMA	P0020	69.51833214	54.79033197	-6.04006628	-5.59370529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351072-01	ML414			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			1.2589254118	-5.9	116.0850605741	1.3	4		82.0604625711	63.67668097	0.3539015925	0.9138006189			CN(C)[S+]([O-])(=O)C1=CC(=C(C=C1)N2CCCC2)C(=O)NC3=NC=C(C)S3	NCGCChem	YSM004-073	-1.56721783	6.27548049	97.4393734	63.67668097												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263136-04	Pracinostat	363677222	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	929016-96-6 				-18.9529976273	4	4		0	-5.55722892				HDAC1	CCCCC1=NC2=CC(=CC=C2[N]1CCN(CC)CC)/C=C/C(=O)NO	Arking Pharma	SB-939	-3.10899781	-4.23629434	-5.57848082	-5.55722892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	657-27-2				-8.5557148065	4	4		0	-2.30329041					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-2.45866283	-0.74257426	-0.49706281	-2.30329041												1.6E-9	8E-9	4E-8	2E-7											
NCGC00481588-01	ACY-241	384569257		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-10.789786641	4	4		0	-4.44921316				HDAC1	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=C(Cl)C=CC=C3	APExBIO	B5936	-1.76851186	-0.85905649	-3.3589396	-4.44921316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091149-26	Valproic acid sodium salt (Sodium valproate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1069-66-5				-5.6527059712	4	4		0	-0.75822604					CCCC(CCC)C(O)=O	Selleck	S1168	-1.88353702	-1.64531159	1.25018828	-0.75822604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163532-06	Daidzin	384568245	Alcohol Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	552-66-9				-6.9536303906	4	4		0	-0.88855422				ADH1	OC[C@H]1O[C@@H](OC2=CC3=C(C=C2)C(=O)\C(=C/O3)C4=CC=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O	Adooq	A10283	-0.96317971	-2.6824978	-2.79688216	-0.88855422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135267-01	NCGC00135267-01	24410650		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.312443663	4	4		0	2.03313253					COC1=C(NC(=O)C2CCN(CC2)[S+]([O-])(=O)C3=CC4=C(C=C3)N(CCC4)C(C)=O)C=C(C)C=C1	Sytravon	G855-0577	-2.20677883	-1.42187042	-0.29038667	2.03313253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015829-14	PROMAZINE HYDROCHLORIDE		Serotonin 2a (5-HT2a) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	53-60-1, 58-40-2 [promazine]				2.3223407622	4	4		0	-4.87839771					CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2	Microsource	01500509	1.39468009	-1.15026209	4.59406537	-4.87839771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE			7.9432823472	-5.1	0.4753866748	4	4		13.03630482	9.42775393	0.019591955	0.9997657717			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097	-2.11358735	-1.96563774	0.28618768	9.42775393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379006-04	PSI-6206			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	863329-66-2				-1.7697644892	4	4		0	-2.10300429					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2\C=C/C(=O)NC2=O	MedChem Express	HY-15236	-0.7620417	1.73267327	0.76818798	-2.10300429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134056-01	NCGC00134056-01	24409439		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-10.6957623562	4	4		0	-0.64759036					FC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0553	-2.54815899	-3.29815303	-2.00213969	-0.64759036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274056-12	Risedronate sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					-0.2805114378	4	4		0	1.38769671					OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O	Selleck	S1428	-0.50323508	1.354106	-1.40081338	1.38769671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	915087-33-1				-3.5338597767	4	4		0	0.64377682				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-2.63120058	-1.23762376	5.10619069	0.64377682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183912-01	FR-180204	174006438	ERK1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	865362-74-9		0.5011872336	-6.3	14.9289714501	4	4		-12.2898779879	-3.33333333	0.0672632089	0.9972268768	5598	MAPK7	NC1=N[NH]C2=NN=C(C=C12)C3=C4C=CC=C[N]4N=C3C5=CC=CC=C5	NCGCChem	SP01-087	8.32494608	-1.49970879	-3.99156499	-3.33333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024936-06	N-Desmethylclozapine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	6104-71-8		8.9125093813	-5.05	58.9639556478	3	4		87.5218686688	79.87124464	0.0156343734	0.9998492229			ClC1=CC2=C(NC3=C(C=CC=C3)C(=N2)N4CCNCC4)C=C1	Adooq	A13762	-1.71099928	-0.5678509	5.76894111	79.87124464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263173-05	Rucaparib	384568643	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	459868-92-9				20.5505254665	4	4		0	7.48493976				PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	Selleck	S1098	2.86515484	8.19407798	2.73574813	7.48493976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	81840-15-5				7.5899437448	4	4		0	5.05007153				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	1.22214234	-1.73267327	2.7263142	5.05007153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381565-04	RG2833		Histone deacetylase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1215493-56-3				-9.9905270684	4	4		0	-5.10729614			8841	HDAC3	CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC2=CC=CC=C2N	MedChem Express	HY-16425	-0.81955428	-1.06290041	-4.77481548	-5.10729614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100034-02	NCGC00100034-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.2070538103	4	4		0	0.70783133					CC1=C(C=C(C=C1)C2=C3C=CC=CC3=C(NC4=CC=C(O)C=C4)N=N2)[S+]([O-])(=O)NCC5=NC6=C([NH]5)C=CC=C6	Chemdiv	4903-2136	-0.91441112	-2.59454705	-0.840593	0.70783133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015608-22	Loperamide hydrochloride	384567873	mu-Opioid Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	34552-83-5		12.5892541179	-4.9	66.8918880102	3	4		110.1459363173	98.78397711	0.0321979328	0.9993600468		OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-B0418A	-2.57368799	0.48048923	-1.00918813	98.78397711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163470-28	FK-506	384568242	mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	104987-11-3				4.1314297284	4	4		0	3.41917024				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Bio Vision	1563	-0.24442847	3.07221899	0.07531255	3.41917024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263555-02	Spautin-1	174006174	Ubiquitin Specific Peptidase (USP10/13) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1262888-28-7	Spautin-1			-1.4390555176	4	4		0	-4.84978541			84669	USP10	FC1=CC=C(CNC2=C3C=C(F)C=CC3=NC=N2)C=C1	SIGMA	SML0440	0.81955428	3.1304601	-2.99743937	-4.84978541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398345-01	NCGC00398345-01	375798575		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					1.0488130527	4	4		0	1.46084337					O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)O[C@@H]3CO[C@@H]4[C@H](CO[C@H]34)[N]5N=NN=C5C6=CC=C(C=C6)C7=CC=CC=C7	Analyticon	NAT6-296405	0.81687393	-1.68572266	-1.36023231	1.46084337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168284-02	NCGC00168284-02	85736014		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					8.5200793011	4	4		0	1.34036145					FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)[C@H](NC(=O)CNC(=O)C2=CC=CC=C2)C3=CC=CC=C3	NCGCChem	BTM01-69	4.05998537	-1.89094107	-2.1855418	1.34036145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482878-01	VR23			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1624602-30-7				15.0189310669	4	4		0	5.76807229					[O-][N+](=O)C1=CC=C(C(=C1)[N+]([O-])=O)[S+]([O-])(=O)N2CCN(CC2)C3=CC=NC4=CC(=CC=C34)Cl	DC Chemicals	DC8448	3.06022921	-1.0114336	5.15054256	5.76807229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102563-01	NCGC00102563-01	24276261		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.0108394141	4	4		0	-0.82831325					[O-][N+](=O)C1=CC=C(N2CCOCC2)C(=C1)C(=O)NC3=CC=CC(=C3)C4=NC5=C(O4)C=CC=C5	Sytravon	7793-3989	0.64618386	-0.33714453	4.60033624	-0.82831325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421826-01	NCGC00421826-01	363681094		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-3.0381064454	4	4		0	0.67771084					CN1CCCC1CCOC(C2=CC3=C([NH]2)C(=CC=N3)C(O)=O)C4=C(Cl)C=CC=C4	NCGCChem	GRB052-095	-1.01194831	-0.74758135	-0.62662387	0.67771084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482848-01	Orientin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	28608-75-5				5.8030603902	4	4		0	-1.43072289					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC(=C(O)C=C4)O	DC Chemicals	DCH-044	3.30407218	-0.54236294	-1.69646951	-1.43072289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378907-02	Edoxaban 		Coagulation factor X Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	480449-70-5		0.2238721139	-6.65	35.4360653765	4	4		-19.052808984	-1.14792212	0.1079971482	0.9927719834			CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	Glixx	GLXC-90139	14.95848841	-2.12734082	-0.59669523	-1.14792212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484798-01	Anagliptin	363681178	Dipeptidyl peptidase IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	739366-20-2				-3.7770457152	4	4		0	-0.01453066					CC1=N[N]2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	MedChem Express	HY-14877	-1.78929287	1.37827715	-0.22949816	-0.01453066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125765-01	NCGC00125765-01	24401148		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					3.1392793544	4	4		0	2.36445783					ClC1=CC(=CC=C1)NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC=CC=C25	Sytravon	E842-0147	0.28041941	-2.65318089	3.59162464	2.36445783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179135-02	EPICATECHIN MONOGALLATE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	1257-08-5				-0.6261262036	4	4		0	3.47891566					OC1=CC2=C(C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O2)C4=CC(=C(O)C=C4)O)C(=C1)O	Microsource	MS-00210238	-1.52401853	-0.10260921	1.05456213	3.47891566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091469-15	Saquinavir Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	149845-06-7		8.9125093813	-5.05	22.674461638	4	4		27.4674157321	24.16448707	0.0684530977	0.9971056244			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4)[C@@H](C2)C(=O)NC(C)(C)C	Enzo	AC3247	0.98768966	-0.38951311	3.38127295	24.16448707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015897-20	Ranolazine	384567904	Sodium channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	95635-56-6				-6.2185805539	4	4		0	-0.33420517				SCN9A	COC1=C(OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C)C=CC=C1	MedChem Express	HY-17401	-1.38849127	-1.73782772	-1.72888617	-0.33420517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370872-07	UPF1069	363677900	Poly [ADP-ribose] polymerase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1048371-03-4				0.9738239312	4	4		0	2.89160128			10038	PARP2	O=C(COC1=C2\C=C/NC(=O)C2=CC=C1)C3=CC=CC=C3	Glixx	GLXC-06427	-1.21671915	-1.79775281	4.54406365	2.89160128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163567-08	Honokiol		NF-kappaB Activation Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	35354-74-6				-2.9572845485	4	4		0	-1.32229003					OC1=CC=C(C=C1CC=C)C2=CC(=CC=C2O)CC=C	Adooq	A10453	0.1002004	-2.12734082	-1.05569155	-1.32229003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-03	Dabrafenib		Raf kinase B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1195765-45-7		12.5892541179	-4.9	49.332928545	3	4		69.9694914951	58.57308922	0.1032703383	0.9933657679		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	ChemieTek	CT-DABRF	2.70541082	-3.11610487	1.17809058	58.57308922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00395224-01	NCGC00395224-01	375804301		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.4911848018	4	4		0	-0.10542169					COC1=CC=C(C=C1)C(=O)N2C[C@@H]3C[C@H](C2)\C4=C\C=C(\N[S+]([O-])(=O)C5=CC(=CC=C5)C(F)(F)F)C(=O)N4C3	Analyticon	NAT11-274707	-0.59741526	-2.06684257	-2.06327373	-0.10542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00453407-01	NCGC00453407-01	375863775		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-6.9472115753	4	4		0	-1.73192771					O=C(N1CCCC(C1)CC2=NOC(=N2)C3=CC=CN=C3)C4=CC(=N[NH]4)C5=CC=CC=C5	Chemdiv	S427-0496	-1.42648135	-0.65963061	-2.21610882	-1.73192771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164977-01	NCGC00164977-01	29216731		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					4.8916147866	4	4		0	-0.64759036					FC(F)(F)C1=CC=C(Cl)C(NC(=O)C2=NN3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C5OCOC5=C4)=C1	Sytravon	A0001411	2.27993172	-1.50982117	0.87116002	-0.64759036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164563-06	Entecavir (monohydrate)		DNA Polymerase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	209216-23-9				-5.7346312991	4	4		0	-4.37372857					NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	-0.12882909	-2.3071161	-0.749694	-4.37372857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486532-01	NCGC00486532-01	375823985		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-4.9322807001	4	4		0	4.0813253					O=C(NC1CCCC1)N2CCC(CC2)C(=O)N3CCCC3C4=NC5=CN=CC=C5[NH]4	ChemRoutes	CA-177-224	-2.32870032	-1.21665201	-1.69646951	4.0813253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164361-03	Decanedioic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-0.1093798966	4	4		0	1.06073816					OC(=O)CCCCCCCCC(O)=O	Analyticon	NP-002989	-0.52963069	-0.92883895	1.97368421	1.06073816												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	394730-60-0				4.6412456237	4	4		0	-0.53763441					CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	0.73003149	5.57303371	-1.0250918	-0.53763441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-04	Belinostat	384568629	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	414864-00-9				-18.9026174175	4	4		0	-7.04736995				HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	Selleck	S1085	-2.73403951	-4.91385768	-4.60526316	-7.04736995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485876-01	Nucleoside-Analog-1			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	876707-99-2				0.3229129244	4	4		0	-0.85730892					OC[C@]1(O[C@@H]2[C@@H](OC\3=N\C(=O)\C=C/N23)[C@@H]1O)N=[N+]=[N-]	MedChem Express	HY-77651	1.18809047	-2.45692884	-0.50489596	-0.85730892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015817-17	Promethazine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	58-33-3		8.9125093813	-5.05	67.8608520798	3	4		100.814507794	95.40772532	0.0257565133	0.9995906196			CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C	Selleck	S4293	-2.2573688	0.04368084	3.26856454	95.40772532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095196-07	TILORONE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	27591-69-1, 27591-97-5 [tilorone]		10	-5	33.3586429697	3	4		57.5121088082	44.13447783	0.0822842345	0.9958031683			CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	-2.37239396	1.44146768	7.75719235	44.13447783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390932-01	NCGC00390932-01	375807998		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE			14.1253754462	-4.85	8.0346494785	4	4		18.466299864	15.10542169	0.4073120764	0.8818728334			FC1=CC(=CC=C1)C2=CC=NC(=N2)N[C@H]3CO[C@@H]4[C@H](CO[C@H]34)NC(=O)NC5=CC(=CC=C5)C#N	Analyticon	NAT6-324295	-1.47524994	3.62063911	-2.88858322	15.10542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385072-01	Schisandrin C	363679517	<MOA Unknown> | Class: Shikimate | Genus: N/A | Family: N/A | Species: N/A	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE					4.5465438385	4	4		0	-0.50071531					COC1=C2OCOC2=CC3=C1C4=C(CC(C)C(C)C3)C=C5OCOC5=C4OC	Analyticon	NP-015228	2.02731848	0.21840419	0.04518753	-0.50071531												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00378687-03	Verbascoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	61276-17-3				-9.8900334487	4	4		0	-0.4434907					C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(=C(O)C=C3)O)O[C@H](CO)[C@H]2OC(=O)\C=C\C4=CC(=C(O)C=C4)O)[C@H](O)[C@H](O)[C@H]1O	MedChem Express	HY-N0021	-3.23508267	0.53873034	-2.394939	-0.4434907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119654-01	NCGC00119654-01	24394233		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-7.1292259262	4	4		0	-2.63554217					COC1=CC=C(C=C1)C2\C=C(/NC3=NC(=N[N]23)NC(=O)/C=C/C4=CC=CC=C4)C5=CC=CC=C5	Sytravon	D413-0071	-1.10948549	-0.80621519	-2.521779	-2.63554217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00141981-01	NCGC00141981-01	24417364		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-8.2701135517	4	4		0	-1.21987952					CC1=CC=C(CCNC(=O)C2=CNC3=CC=C(C=C3C2=O)S(=O)(=O)NC4=CC(=CC=C4)C(F)(F)F)C=C1	Sytravon	K788-0970	-1.93855157	-2.36001173	-1.08512915	-1.21987952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115987-01	NCGC00115987-01	24390566		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.3391784442	4	4		0	-0.13554217					CC1=CC2=C(OC(=C/C2=O)\C(=O)NC3=C(OC4=C3C=CC=C4)C(=O)NC5=CC=CC=C5)C=C1	Sytravon	D103-1101	-1.7678615	1.33391967	-2.36894391	-0.13554217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-13	Valaciclovir	384568359	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	124832-27-5				3.0304599565	4	4		0	-1.38041267					CC(C)[C@H](N)C(=O)OCCOC[N]1C=NC2=C1\N=C(N)/NC2=O	MedChem Express	HY-17425A	2.81992557	-3.95505618	-0.53549572	-1.38041267												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106729-01	NCGC00106729-01	24270074		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					2.5303940721	4	4		0	4.11144578					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=CC=C(C)C=C4)C5=CC=CC=C5C3=O)C=C2)C=C1	Sytravon	C260-2754	-2.30431602	1.42187042	6.2203882	4.11144578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093560-19	Finasteride		Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[98319-26-7]				-3.8901641841	4	4		0	-3.56001162				AR	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)\C=C/[C@]4(C)[C@H]3CC[C@]12C	Tocris	3293	0.07157171	-2.12734082	0.10709914	-3.56001162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381558-03	AZD-2461		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1174043-16-3				17.6536158003	4	4		0	2.39755885			142	PARP1	COC1CCN(CC1)C(=O)C2=CC(=CC=C2F)CC/3=N/NC(=O)C4=CC=CC=C34	Axon Medchem	2241	3.3638706	6.50187266	3.90146879	2.39755885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481317-01	CB-5083	363681118	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1542705-92-9				-9.5386922513	4	4		0	-6.3789596				VCP	CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC(=C4COCCC4=N3)NCC5=CC=CC=C5	ActiveBioChem	A-1513	0.04294303	-1.88764045	-5.09485924	-6.3789596												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378650-01	Narlaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	865466-24-6				3.8607175501	4	4		0	2.68817204					CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC3(CCCCC3)C[S+]([O-])(=O)C(C)(C)C)C(C)(C)C)C2(C)C)C(=O)C(=O)NC4CC4	MedChem Express	HY-10300	0.52963069	-2.63670412	3.35067319	2.68817204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346694-03	MK-2048		HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	869901-69-9				-9.2463402342	4	4		0	-5.7686719					CCN1C[C@H](C)[N]2C(=C(O)C3=C2\C(=N/N(CC4=CC=C(F)C(=C4)Cl)C3=O)C(=O)NC)C1=O	APExBIO	A4072	-1.07357572	-1.37827715	-1.75948592	-5.7686719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247606-02	Methyl gallate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	99-24-1				7.5576686105	4	4		0	2.775356					COC(=O)C1=CC(=C(O)C(=C1)O)O	DC Chemicals	DCM-014	1.58889207	1.19850187	0.84149327	2.775356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095694-06	Ostol		GABAA Receptor Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE					-11.7325942872	4	4		0	-3.9668701					COC1=C(CC=C(C)C)C2=C(\C=C/C(=O)O2)C=C1	Analyticon	NP-000408	-2.36186659	-2.24719101	-1.66768666	-3.9668701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510231-01	GDC-0077	384569416	PARP inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE			1.995262315	-5.7	52.1226500216	4	4	Pamiparib	-12	5.44899738	0.4863544198	0.8191756423		PARP1	C[C@]12CCCN1C/C3=N/NC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F	ChemGood	C-1286	12.55367879	19.80524345	3.0752754	5.44899738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092314-15	Triciribine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	35943-35-2				-3.0003268567	4	4		0	-1.26416739					CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)C3O)C4=C2C1=NC=N4	MedChem Express	HY-15457	-2.1328371	4.25468165	0.59669523	-1.26416739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159341-20	LAMIVUDINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	134678-17-4				-6.730343039	4	4		0	-1.49665795					[H][C@@]1(CO)O[C@@]([H])(CS1)N2C=CC(N)=NC2=O	Microsource	01503839	-1.21671915	-3.44569288	-0.1376989	-1.49665795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015099-12	Alprenolol hydrochloride		Beta-adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	[13707-88-5]				1.1526165108	4	4		0	-3.38564371					CC(C)NCC(O)COC1=C(CC=C)C=CC=C1	Tocris	2806	1.61752076	-0.83895131	0.19889841	-3.38564371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510789-01	RSV604			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	676128-63-5				6.596090516	4	4		0	-4.63528044					FC1=CC=CC=C1NC(=O)N[C@H]2\N=C(\C3=CC=CC=C3)C4=CC=CC=C4NC2=O	SIGMA	SML1695	3.965073	-0.68913858	0.59669523	-4.63528044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-13	NafamostatMesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	82956-11-4				11.6482810197	4	4		0	-2.50357654					NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC=C3C=C(C=CC3=C2)C(N)=N	Bio Vision	1760	6.02444285	-3.01397787	0.34643772	-2.50357654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015243-17	Clemizole (hydrochloride)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1163-36-6				-4.8289587746	4	4		0	-2.76108727					ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1	MedChem Express	HY-30234A	-0.24442847	-2.02387886	-1.03931315	-2.76108727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480772-03	Oroxylin A	376241613		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	480-11-5				9.3964133465	4	4		0	2.58941345					COC1=C(O)C=C2O\C(=C/C(=O)C2=C1O)C3=CC=CC=C3	CANVASS	57a2faeef1704b5b7a46901d	2.65995687	0.21840419	0.73806296	2.58941345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015989-22	Thalidomide	384567913	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	50-35-1				-8.5357071086	4	4		0	0.64377682				TNF	O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1	Microsource	01503607	-3.06254493	-1.03377985	-0.67781292	0.64377682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379018-02	BMS-626529	363678318	Human immunodeficiency virus 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	701213-36-7		14.1253754462	-4.85	7.7168667637	4	4		22.5969272439	17.72532189	0.1417966726	0.9874331342			COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[NH]3)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	MedChem Express	HY-15440	-1.22214234	-0.45136867	-2.99743937	17.72532189												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167959-12	(+)-Chelidonine		microtubule polymerization Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	476-32-4				1.3013012821	4	4		0	6.69863412					CN1CC2=C(C=CC3=C2OCO3)[C@H]4[C@@H](O)CC5=CC6=C(OCO6)C=C5[C@@H]14	Enzo	NP050	-0.32922989	-0.80898876	-3.28947368	6.69863412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386310-01	Selinexor		Exportin-1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	1393477-72-9				-12.2403798152	4	4		0	-0.30514385				XPO1	FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F	Selleck	S7252	-3.07758374	-4.76404494	-1.17809058	-0.30514385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482709-01	Licochalcone A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	58749-22-7		14.1253754462	-4.85	-0.4998003351	4	4		-11.189625104	-6.40802092	0.5950415415	0.6915112134			COC1=CC(=C(C=C1\C=C\C(=O)C2=CC=C(O)C=C2)C(C)(C)C=C)O	DC Chemicals	DCG-033	-1.30260521	4.91385768	5.98225214	-6.40802092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166236-04	Oxonic acid potassium salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	2207-75-2				11.417983442	4	4		0	-2.22319093					OC1=NC(=NC(O)=N1)C([O-])=O	SIGMA	156124	5.42513599	0.05992509	2.12668299	-2.22319093												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00017363-18	Cycloheximide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_CPE	66-81-9		0.5011872336	-6.3	99.5869536618	1.4	4		32.3919101153	29.25021796	0.5418709935	0.759866349			[H][C@]1(C[C@@H](C)C[C@H](C)C1=O)[C@H](O)CC2CC(=O)NC(=O)C2	SIGMA	1810_cm3	9.23275122	49.07865169	37.01040392	29.25021796												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165993-02	Picolinic acid	170466822		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	98-98-6				0.0740718394	4	4		0	-2.04577969					O=C(O)c1ccccn1	Bosche	P0843	1.3659238	-2.16948165	-0.52718783	-2.04577969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-07	Niraparib	384568775	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1038915-60-4		12.5892541179	-4.9	56.8585226284	3	4		83.908583694	65.19313305	0.0280717426	0.9995137605		PARP1	NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	MedChem Express	HY-10619	0.73328541	2.40244613	6.5521916	65.19313305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180839-02	Penta-O-galloyl--D-glucose hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	14937-32-7 (anhydrous)		7.0794578438	-5.15	22.9982646018	2.4	4		39.5017972719	29.05579399	0.0116060867	0.9999170344			OC1=C(O)C(=CC(=C1)C(=O)OC[C@H]2O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC(=O)C4=CC(=C(O)C(=C4)O)O)[C@@H](OC(=O)C5=CC(=C(O)C(=C5)O)O)[C@@H]2OC(=O)C6=CC(=C(O)C(=C6)O)O)O	SIGMA	G7548	-2.08483106	-0.59697146	10.04669378	29.05579399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-06	2-Deoxyglucose		sugar	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	154-17-6				7.4644635633	4	4		0	0.18597997					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	MedChem Express	HY-13966	2.74622574	1.00465929	-0.55731285	0.18597997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168703-01	NCGC00168703-01	85736125		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					6.5575476221	4	4		0	-1.76204819					FC(F)(F)C1=CC=C(C=C1)C(=O)NCC(=O)OC(C(=O)NC2=CC(=CC=C2Cl)C(F)(F)F)C3=CC=CC=C3	NCGCChem	DJM02-036-B5	2.81638625	3.62063911	-2.64404707	-1.76204819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168784-12	Gemcitabine		Ribonucleotide reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	122111-03-9		3.5481338923	-5.45	-5.7043696665	4	4		10.6086196879	6.30901288	0.1239151906	0.9905241943		RRM2	NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	MedChem Express	HY-B0003	-3.52264558	-4.67384974	2.63593915	6.30901288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013414-04	Procodazole	170466381		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	23249-97-0				8.7713092954	4	4		0	-2.27467811					O=C(O)CCc1nc2ccccc2n1	Vitas	STK387005	3.86772106	2.40244613	-1.55143847	-2.27467811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00487399-01	TAK-779			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	229005-80-5				-1.6842545415	4	4		0	0.24320458					CC1=CC=C(C=C1)C2=CC\3=C(CCC\C(=C3)C(=O)NC4=CC=C(C[N+](C)(C)C5CCOCC5)C=C4)C=C2	SIGMA	SML0911	-1.85478073	0.59697146	3.50956469	0.24320458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509859-02	Paritaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1216941-48-8				-5.9461819597	4	4		0	-2.27467811					CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC\C=C/[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	MedChem Express	HY-12594	-1.71099928	-0.74257426	0.91881307	-2.27467811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180669-03	Gentiopicroside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	20831-76-9				-1.9749305237	4	4		0	2.93276109					OC[C@H]1O[C@@H](O[C@@H]2O\C=C/3C(=O)OC/C=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCL-005	-1.07836089	0.10192196	-2.12381383	2.93276109												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135329-01	NCGC00135329-01	24410712		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.791904758	4	4		0	-2.60542169					COC1=CC=C(CNC(=O)C2CCCN(C2)[S+]([O-])(=O)C3=CC4=C(C=C3)N(CCC4)C(C)=O)C=C1	Sytravon	G855-0851	-1.18263838	0.42509528	-1.60476845	-2.60542169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016622-11	Hycanthone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	3105-97-3		12.5892541179	-4.9	32.391382277	3	4		49.4339701761	42.66566265	0.0154071089	0.9998536517			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	0.15849793	-0.39577836	0.53492282	42.66566265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126637-01	NCGC00126637-01	24402020		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-5.5812129041	4	4		0	-3.81024096					CC1=CC=C(CNC(=O)C2=CC3=C(NC(C[S+]([O-])(=O)CC4=CC=CC(=C4)F)C(=O)N3)C=C2)C=C1	Sytravon	K977-0077	-0.59741526	-0.33714453	-1.39079933	-3.81024096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167535-16	Tenofovir		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE	147127-20-6				-3.1341938569	4	4		0	-2.72590361					C[C@H](C[N]1C=NC2=C1N=CN=C2N)OC[P](O)(O)=O	MedChem Express	HY-13910	-0.67056815	1.568455	-0.68775791	-2.72590361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137432-01	NCGC00137432-01	24412815		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_CPE					-9.5604420668	4	4		0	-3.62951807					CC1=CC=C(C=C1)C2=N[N]3C(=O)N(CC(=O)N4CCN(CC4)C5=CC=C(F)C=C5)C6=CC=CC=C6C3=N2	Sytravon	G860-0093	-1.86539868	-1.04075051	-1.94100565	-3.62951807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651732-01	ROC-325			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_CPE	1859141-26-6				1.9688978305	4	4		0	4.02002861					CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	-0.53199137	1.52882935	-3.02756439	4.02002861												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General		126544-47-6		0.0702306445	-7.1534733462	172.5035489862	3	10		76.3700464588	59.98906805	5.433E-7	0.9941726878			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	-0.5739273	-2.65099754	0.24596884	0.30062859	-2.48701831	-2.37769882	0.13664936	-2.04974037	5.05602624	59.98906805						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485478-02	Oritavancin (diphosphate)			DPI_SARS-CoV-2_General		192564-14-0				24.1015222438	4	10		0	6.75047827					[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	0.1913091	0.62858705	-1.94042088	1.39382345	3.52555343	1.17518448	2.15905985	7.51571468	0.5739273	6.75047827						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346712-02	Verteporfin		photosensitizer	DPI_SARS-CoV-2_General		129497-78-5				1.5111950123	4	10		0	0.68324679					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-2.37769882	-1.17518448	0.79256627	-2.32303908	0.84722602	2.26837934	-1.66712216	0.30062859	0.5739273	0.68324679						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389778-03	NCGC00389778-03			DPI_SARS-CoV-2_General		82956-11-4				5.4332226215	4	10		0	0.02680247					NC(N)=NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N	Bio Vision	1760	2.33181453	-0.67006165	6.62020906	4.58322166	0.77727151	-1.90297507	2.59983919	2.22460466	2.38541946	0.02680247						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015256-29	Chloroquine		antimalarial agents	DPI_SARS-CoV-2_General		50-63-5				21.4087467092	4	10		0	5.44090056					CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	-1.47413562	-1.15250603	-2.43902439	-2.01018494	-1.47413562	1.36692576	-1.90297507	4.79764138	4.20798713	5.44090056						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00483210-07	NCGC00483210-07			DPI_SARS-CoV-2_General				0.0702306445	-7.1534733462	110.8197967289	1.2	20		48.5890865297	39.01069519	9E-10	0.9724033579			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163699-10	Fumagillin			DPI_SARS-CoV-2_General		23110-15-8				11.281288089	4	20		0	3.71657754					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00379064-01	R-7128	377020456		DPI_SARS-CoV-2_General		940908-79-2				13.0540798039	4	20		0	5.27466521					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General		55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	0.0124889709	-7.9034733462	200.44853786	1.1	20		87.5169909061	47.45989305	2.4E-9	0.9771263463			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00181343-04	NCGC00181343-04	384568396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	148849-67-6				-2.58143668	4	4		0	2.03233256				HCN	COC1=C(OC)C=C2CC(=O)N(CCCN(C)C[C@H]3CC4=CC(=C(OC)C=C34)OC)CCC2=C1	Glixx	GLXC-03048	-1.01422736	-2.85540705	0.69434604	2.03233256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263179-09	NCGC00263179-09	377020324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	905281-76-7				6.2539126602	4	4		0	0.27713626				BRAF	OCC[N]1C=C(C2=CC=C\3C(=C2)CCC3=N\O)C(=N1)C4=CC=NC=C4	MedChem Express	HY-50864	-0.73249753	7.68529769	3.64177412	0.27713626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346658-03	NCGC00346658-03	384568889		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	670220-88-9				-8.4541994366	4	4		0	-2.22254931				PDGFRB	CC1(COC1)COC2=CC3=C(C=C2)[N](C=N3)C4=NC5=C(C=CC=C5C=C4)N6CCC(N)CC6	ChemieTek	CT-CREN	-2.09617756	-0.56479927	-1.49566258	-2.22254931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346704-07	NCGC00346704-07	384568923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	183133-96-2				-10.7744036882	4	4		0	2.04592287				TUBB	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)/C(=C(/[C@@H](OC)C(=O)[C@]13C)C5(C)C)C	MedChem Express	HY-15459	-3.52103028	-1.35857121	-3.38019743	2.04592287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346682-08	NCGC00346682-08	384568906		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	187235-37-6				-3.7082313572	4	4		0	-2.45805122					[O-][N+](=O)C1=C[N]2C[C@@H](COC2=N1)OCC3=CC=C(OC(F)(F)F)C=C3	MedChem Express	HY-10844	-1.27414714	0.93115555	1.0469638	-2.45805122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274056-12	Risedronate sodium			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-1.9243183801	4	4		0	-2.51661247					OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O	Selleck	S1428	-0.17965727	2.37329659	-1.7789443	-2.51661247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507851-01	NCGC00507851-01	384569331		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1338540-63-8(free base)		3.1622776602	-5.5	3.2962078078	4	4		-8.979004668	-3.73250389	0.6507996492	0.5958037256		PBK	C[C@@H](CN)C1=CC=C(C=C1)C2=C3C(=C(C)C=C2O)NC(=O)C4=C3C=CS4	Selleck	S7652	0.31785517	9.32475884	-1.7789443	-3.73250389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346614-07	NCGC00346614-07	363677477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	900185-02-6				2.9480192918	4	4		0	-2.37522975				PIK3CA	CC1=C(C=CC=C1)N2C(=O)C3=C(C=CC=C3C)\N=C2\C[N]4N=C(C5=CC(=CC=C5)O)C6=C(N)N=CN=C46	MedChem Express	HY-10303	3.68988391	-3.07762977	-3.64537766	-2.37522975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346877-07	Batimastat	384568955	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	130370-60-4				-14.2199200088	4	4		0	-3.23325635				MMP1	CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC2=CC=CS2)C(=O)NO	MedChem Express	HY-13564	-3.52162276	-1.42770352	-2.5931699	-3.23325635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250388-04	NCGC00250388-04	384568541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	509088-69-1		1.77827941	-5.75	16.0387029864	4	4		12.37188336	-4.58814473	1	0.9999400351		S1PR1	NC(CO)(CO)CCC1=C(Cl)C=C(SC2=CC(=CC=C2)OCC3=CC=CC=C3)C=C1	Axon Medchem	1615	-0.3099028	0.12150668	11.57715743	-4.58814473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250393-01	NCGC00250393-01	137275895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	147159-51-1	CAP-232			-9.5121408175	4	4		0	-4.03387221			6754	SSTR4	CC(O)[C@H](NC(=O)[C@@H]1CSSC[C@H](CC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC4=C[NH]C5=CC=CC=C45)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O	NCGCChem	CAP-232	-2.05662769	-0.57715674	-1.20447782	-4.03387221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351477-05	NCGC00351477-05	384569006		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1431612-23-5		1.995262315	-5.7	13.536139082	4	4		13.5811373039	-6.08461865	1	0.9994556309		EZH1	CCCC\1=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC=C(N=C4)N5CCN(CC5)C(C)C)C(=O)NC(=C1)\C	APExBIO	B1583	-1.31761442	-0.84960501	12.09535021	-6.08461865												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250407-05	NCGC00250407-05	384568555		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	927880-90-8		1.5848931925	-5.8	75.6727823234	3	4		65.689064874	-6.22612141	1	0.9999332955		BRAF	C[N]1C(=NC2=CC(=CC=C12)OC3=CC(=NC=C3)C4=NC(=C[NH]4)C(F)(F)F)NC5=CC=C(C=C5)C(F)(F)F	MedChem Express	HY-10248	-4.03606103	-0.43225518	59.6527369	-6.22612141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167356-11	NCGC00167356-11	384568309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	518048-05-0				6.365719068	4	4		0	-3.84561007					CN1C(=O)\C(=C(/N=C1/C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]	Glixx	GLXC-90212	4.51907131	-1.42397795	-1.86643336	-3.84561007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510476-01	NCGC00510476-01	384569439		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1308672-74-3		12.5892541179	-4.9	38.0635380923	3	4		69.6344037379	60.79110726	0.0336380496	0.9993016056		KDR	CN(C)CCN[S+]([O-])(=O)CC1=CC=CC(=C1)NC2=NC=CC(=N2)OC3=CC4=C([NH]C(=C4)C)C=C3	MedChem Express	HY-12297	-1.30108895	-3.26867267	-2.52669574	60.79110726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015898-28	Rolipram	384567905	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	61413-54-5				-5.375249125	4	4		0	-0.21555042				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3	MedChem Express	HY-16900	-1.83124384	-0.69866343	-0.07085164	-0.21555042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384199-05	4SC-202	384569106	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	910462-43-0				4.9477707888	4	4		0	-1.5848309				HDAC1	C[N]1C=C(C=N1)C2=CC=C(C=C2)[S+]([O-])(=O)[N]3C=CC(=C3)/C=C/C(=O)NC4=C(N)C=CC=C4	MedChem Express	HY-16012A	2.23300971	0.93903711	-0.32371984	-1.5848309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142624-06	NCGC00142624-06	384568168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	4618-18-2				-1.6500121531	4	4		0	-0.33960662					OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O	Microsource	01500363	-0.31900139	0.52168729	-1.35373749	-0.33960662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165811-08	NCGC00165811-08	384568285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	978-62-1		14.1253754462	-4.85	78.6051179625	4	4		-25.601795556	-0.08482963	0.6384298306	0.9721527187		IKBKB	OC1=C(C=C(Cl)C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F	Adooq	A12837	38.15644002	19.18542337	23.27209099	-0.08482963												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166323-05	NCGC00166323-05	384568306		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	70-00-8				-0.171424414	4	4		0	-3.73250389				TYMS	OC[C@H]1O[C@H](C[C@@H]1O)N2/C=C(C(=O)NC2=O)/C(F)(F)F	Selleck	S1778	2.44610282	-3.96570204	-1.22484689	-3.73250389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263193-02	NCGC00263193-02	384568657		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[623142-96-1]				-5.0082776413	4	4		0	-4.92011876				CSF1R	COC1=CC(=CC=C1NC(=O)NC(C)C2=NC=CS2)OC3=CC=NC4=CC(=C(OC)C=C34)OC	Tocris	4481	1.47871752	-4.30255704	-3.00379119	-4.92011876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381751-04	NCGC00381751-04	363679167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	885060-09-3		12.5892541179	-4.9	15.7385633626	3	4		39.5895728039	32.97045101	0.0870651962	0.9952995227		KIF11	CON(C)C(=O)N1/N=C(S[C@@]1(CCCN)C2=CC=CC=C2)/C3=CC(=CC=C3F)F	MedChem Express	HY-15187	-1.3681592	-4.24131067	-3.49956255	32.97045101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379091-01	NCGC00379091-01	363678347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1311367-27-7				-6.3052067457	4	4		0	-4.66562986				RPS6KB2	C[C@@H]1CCNC(=O)C2=CC3=C(C=C(C=C3)C(=O)NC4=NC5=CC=CC=C5[N]4CCCN(C)C)[N]12	MedChem Express	HY-16104	-0.20729685	-0.47465932	-2.79965004	-4.66562986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167767-12	NCGC00167767-12	377020288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	873225-46-8		2.5118864315	-5.6	158.7227283915	3	4		106.7725284297	-6.92775343	1	0.9999959255		IKBKB	O=C(N1CCC(CC1)N2CCCC2)C3=CC=C(NC4=NC=CC(=N4)C5=CC6=C(S5)C=CC=C6)C=C3	MedChem Express	HY-13687	5.01658375	5.8643393	98.04607757	-6.92775343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485046-01	NCGC00485046-01	363681205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE			5.6234132519	-5.25	9.0627060089	4	4		12.848536272	9.7156056	0.1135705856	0.9920847885		ALK	C[C@@H](OC1=C(N)N=CC(=C1)C2=C(C)N=C(S2)[C@](C)(O)CO)C3=C(C=CC(=C3)F)[N]4N=CC=N4	SIGMA	PZ0221	-0.70711356	1.069192	4.09084073	9.7156056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179034-15	NCGC00179034-15	384568368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	140-64-7				6.390997414	4	4		0	-1.66017035					NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	MedChem Express	HY-B0537B	2.29104794	3.39086605	-0.84223191	-1.66017035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263121-03	NCGC00263121-03	384568605		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1243583-85-8		12.5892541179	-4.9	67.1074915883	3	4		75.192057977	70.89288241	0.0896659539	0.9950089369		HAT1	CCCCCCCC1=CC=C(CCC2=CC=CC(=C2C(O)=O)O)C=C1	Axon Medchem	1785	4.34119279	4.66537487	-0.32371984	70.89288241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017338-03	Antimycin A	124883057	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1397-94-0	Antimycin A;ANTIMYCIN A1			-12.8345033326	4	4	Antimycin- A from Streptomyces sp.;Antimycin A1;NCGC00016578-01;9   Antimycin A (A3+A4 >90%);ANTIMYCIN A;ANTIMYCIN A (A1 shown);NCGC00142516-03;NCGC_Prestw-222;NCGC00095884-01;ANTIMYCIN A1;Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester;LS-86460;CIPLUS_155874;Antimycin A;NCGC00142516-02;CIPLUS_158270;	0	0.05655309					CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)C2=C(O)C(=CC=C2)NC=O)[C@@H](C)OC1=O	BIOMOL	NP-009	-2.63957988	-4.60878885	-4.17031204	0.05655309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263104-06	NCGC00263104-06	384568593		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	849217-64-7				-9.3343610302	4	4		0	-6.89947688				KDR	COC1=CC2=C(C=C1OCCCN3CCOCC3)N=CC=C2OC4=CC=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4F	ChemieTek	CT-XL880	-0.40077391	-3.81258613	-0.69991251	-6.89947688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386401-01	NCGC00386401-01	384569132		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1453848-26-4				-4.718776782	4	4		0	0.04330879				ERK	C[N]1N=CC=C1NC2=NC=CC(=N2)C\3=C\C(=O)N(\C=C3)[C@H](CO)C4=CC(=C(Cl)C=C4)F	Selleck	S7554	-0.67882902	-1.03864365	-3.27868852	0.04330879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163329-11	NCGC00163329-11	384568233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	120202-66-6				5.6283026677	4	4		0	-3.59462971				P2RY12	COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3	MedChem Express	HY-17459	3.90326686	-1.16083702	-1.20318845	-3.59462971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159521-16	Zoledronic acid monohydrate	384568184	Farnesyl Pyrophosphate Synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	165800-06-6				-9.1371007049	4	4		0	-3.53688465				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	MedChem Express	HY-13777A	-0.82025173	-0.03054834	-2.37629719	-3.53688465												1.6E-8	8E-8	4E-7	0.000002											
NCGC00015834-27	NCGC00015834-27	384567897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	125-33-7				3.9642036756	4	4		0	-2.17987585					CCC1(C(=O)NCNC1=O)C2=CC=CC=C2	MedChem Express	HY-B0339	2.71531608	0.48877348	-2.4063769	-2.17987585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263212-05	NCGC00263212-05	384568669		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	431979-47-4				5.8740697045	4	4		0	0.20933014				MDM4	CCOC1=CC(=CC(=C1OCC(=O)OC)Cl)/C=C2\C(=N/N(C2=O)C3=CC=CC=C3)C	MedChem Express	HY-16664	1.55184917	3.51305942	-1.00250627	0.20933014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015471-09	Ganciclovir	384567853	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	82410-32-0				-0.4499807142	4	4		0	-1.76435407					N\C1=N\C2=C(N=C[N]2COC(CO)CO)C(=O)N1	Selleck	S1878	-1.05873822	4.52115473	0.58970957	-1.76435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263230-01	NCGC00263230-01	137276074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	910249-49-9	FASN MRK	3.1622776602	-5.5	21.843215109	4	4		27.3716461159	24.0430622	0.0273446222	0.9995394403	2194	FAS	COC1=CC=CC=C1C2=CC=CC(=C2)C/3=C(O)/C4=CC(=C(Cl)C=C4NC3=O)C#N	NCGCChem	FASN MRK	-2.39303843	-0.48877348	14.77222468	24.0430622												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346571-07	NCGC00346571-07	384568845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	940929-33-9				-19.8527205656	4	4		0	-5.7582756				KIF11	CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C/2=C(\CC3=CC=CC=C3)C(=O)C4=C(O2)C=C(Cl)C=C4	MedChem Express	HY-12069	-4.33863924	-4.70838396	-1.68626895	-5.7582756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263575-10	NCGC00263575-10	384568690		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	163222-33-1		14.1253754462	-4.85	20.2150346383	4	4		30.3226002479	23.24865281	0.140782941	0.9876013943			O[C@@H](CC[C@@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4	DC Chemicals	DCAPI1084	1.577687	-1.51883354	-0.18421426	23.24865281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167513-13	NCGC00167513-13	384568321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	443913-73-3				-13.8763515152	4	4		0	-6.31102306				EGFR	COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCC4CCN(C)CC4	Aobious	AOB87780	-2.26074896	-2.57862573	-2.26603885	-6.31102306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162413-14	NCGC00162413-14	384568226		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	30562-34-6				1.0626131797	4	4		0	0.22640441				HSP90AB1	CO[C@H]1C[C@@H](C)C\C2=C(/OC)C(=O)\C=C(\NC(=O)\C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(=C/[C@H](C)[C@H]1O)C)C)C2=O	MedChem Express	HY-15230	1.17891817	-0.96884782	-2.06003531	0.22640441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167429-10	NCGC00167429-10	384568311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	85622-93-1				-10.9356174206	4	4		0	-3.33830104				TOP2A	CN1\N=N/C2=C(N=C[N]2C1=O)C(N)=O	APExBIO	B1399	-3.65411437	-0.05987128	1.3341419	-3.33830104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274062-01	Zosuquidar trihydrochloride	174006281	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	167465-36-3	LY335979	1.5848931925	-5.8	5.4929386336	4	4		8.9786708599	5.18628912	0.3787861378	0.9006897482		ABCBA	Cl.Cl.Cl.FC3(F)[C@@H]2c7ccccc7[C@H](c1ccccc1[C@@H]23)N4CCN(CC4)C[C@@H](O)COc6cccc5ncccc56	Selleck	S1481	-1.28312413	-2.06555905	9.06610067	5.18628912												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510464-01	NCGC00510464-01	384569438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-1.0329315829	4	4		0	-5.00745156				PTK6	FC1=C(NC2=NC(=C[N]3C(=CN=C23)C4=C[NH]N=C4)C5CC5)C=CC(=C1)C(=O)N6CCOCC6	Tocris	6073	0.05578801	2.03562341	1.63735597	-5.00745156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378617-04	XL 413 hydrochloride	384569057	Serine/threonine-protein kinase PIM1  Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[1169562-71-3]				-11.1370514124	4	4		0	-2.61296376					ClC1=CC=C2OC3=C(\N=C(NC3=O)\[C@@H]4CCCN4)C2=C1	Tocris	5493	-2.77188516	-0.30548343	-2.70717401	-2.61296376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390744-01	NCGC00390744-01	363680980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	852391-20-9				2.0937329689	4	4		0	-2.48205742				RIPK1	CN1C(=O)N[C@@H](CC2=C[NH]C3=C2C=CC=C3Cl)C1=O	MedChem Express	HY-14622B	1.11675127	1.89399725	-0.32434026	-2.48205742												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263222-02	NCGC00263222-02	384568676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1018340-07-2				2.1518254801	4	4		0	0.38875598				IDO1	CC1(C)OC/2=C(\[C@H](NCC3=CC=CC=C3)[C@@H]1O)C(=O)C4=CC=CC=C4C2=O	Cayman	16838	0.94271211	0.4276768	-1.20890461	0.38875598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178802-11	NCGC00178802-11	384568364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	138-14-7		8.9125093813	-5.05	4.9728262157	4	4		13.7651077599	9.94611239	0.2669411644	0.9538999561			CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	MedChem Express	HY-B0988	-1.8875898	1.09356015	2.2814227	9.94611239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017291-12	NCGC00017291-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	83-88-5				-3.3423763485	4	4		0	-0.98537336					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Microsource	01505347	-0.7888435	-0.15188335	-0.69434604	-0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507962-02	NCGC00507962-02	384569358		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1415925-18-6				5.8719974746	4	4		0	-1.29330254					CC(C)[N]1C=C(C2=CC3=C(CCN3C)C=C2)C4=C(N[S+]([O-])(=O)C5=N[N](C)C=C5)C=CN=C14	MedChem Express	HY-18950	2.50739541	-0.21263669	0.83604931	-1.29330254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387273-01	NCGC00387273-01	363680607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE			11.220184543	-4.95	32.472715379	3	4		42.360276913	37.30012735	0.2832883717	0.9470373915		MAPK14	[F]C1=CC=C(C=C1)C2=C([NH]C(=N2)C3=C([F])C=CC=C3)C4=CC=NC=C4	Tocris	5384	-1.51178918	8.0339842	4.06121248	37.30012735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242487-08	NCGC00242487-08	384568495		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	896720-20-0				-13.5975326189	4	4		0	-6.67660209				MAPK7	CC1=CN=C(NC2=CC=C(F)C=C2Cl)N=C1C3=C[NH]C(=C3)C(=O)N[C@H](CO)C4=CC=CC(=C4)Cl	MedChem Express	HY-14178	-1.64574616	-2.75407873	-3.54760461	-6.67660209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263019-01	NCGC00263019-01	137275923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	884491-41-2 (diastereomeric mixture)	WAY-204688;SIM-688			3.0600903374	4	4		0	-0.62593145			4790	NFKB1	COC1=C(C=CC=C1)[C@H](C2=C3C=CC=CC3=CC=C2)[C@@](C)(C#N)C(=O)N4CCC(CC4)C5=CC=CC(=C5)C(F)(F)F	NCGCChem	JKJ22-068	1.70153417	-1.04774734	-0.12128563	-0.62593145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263127-03	NCGC00263127-03	363677215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	199850-67-4				-2.7340821022	4	4		0	-0.38748137				MMP13	CC(C)[C@H](C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CC=C(Br)C=C2)C(O)=O	Axon Medchem	1271	-0.80892608	-0.29935638	-0.24257126	-0.38748137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161670-08	Pepstatin	384568214	Aspartyl Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	26305-03-3				-7.3290146821	4	4		0	0.53414176					CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	Prestwick	Prestw-405	-3.30929147	0.70261188	0.33087682	0.53414176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379032-06	Tasquinimod	384569088	S100A9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	254964-60-8				11.3568565947	4	4		0	-1.05384726			6280	S100A9	COC1=CC=CC2=C1C(=C(/C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)C(=O)N2C)/O	MedChem Express	HY-10528	5.06293311	1.37467542	-2.49661603	-1.05384726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021925-05	NCGC00021925-05	363676517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	52-21-1				-6.8172802663	4	4		0	0.1587989				NRC31	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	Selleck	S2570	-1.55564984	-1.86344891	-2.37629719	0.1587989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017244-10	NCGC00017244-10	384567978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	471-53-4				1.6938849997	4	4		0	0.86722488					CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)\C=C/4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O	Enzo	NP116	-0.18854242	2.62715748	-0.44228218	0.86722488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379163-01	NCGC00379163-01	363678393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[130065-61-1]		2.8183829313	-5.55	186.6975170865	3	4		149.6460957478	-6.51913876	1	0.9988223467			CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1	Tocris	4580	1.95794054	-2.77989919	126.96447	-6.51913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159483-06	NCGC00159483-06	363676594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	747-36-4				7.1639807301	4	4		0	4.84449761				MAP1LC3A	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(=CC=C12)Cl	Selleck	S4430	-2.2480058	-0.58041851	3.71517028	4.84449761												1.6E-8	8E-8	4E-7	0.000002											
NCGC00189073-04	Selumetinib	384568456	Mek1/2 inibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	606143-52-6				-12.754247884	4	4		0	-4.15669856				MAP2K1	C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=CC=C(Br)C=C3Cl	Selleck	S1008	-2.2480058	-3.02428593	-2.56523662	-4.15669856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384220-02	NCGC00384220-02	384569107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1401033-86-0				-3.6022915659	4	4		0	-3.16985646				CDK4	C[C@H]1CC[C@@H](CC1)[N]2C3=CN=CC=C3C4=CN=C(NC5=NC6=C(CN(CC6)C(=O)CO)C=C5)N=C24	ChemieTek	CT-AMG925_CM1	1.34880348	1.09974034	-3.2728881	-3.16985646												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00273984-04	NCGC00273984-04	384568706		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-3.8976313448	4	4		0	-2.34026174				MAPK11	CC[N]1C(=NC2=CN=CC(=C12)CNC3CCNCC3)C4=NON=C4N	Tocris	4630	-0.16903789	-1.7618469	-0.69434604	-2.34026174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095129-15	NCGC00095129-15	384568148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	181695-72-7				-3.8669828303	4	4		0	-3.50926843				COX2	CC1=C(C2=CC=C(C=C2)[S+](N)([O-])=O)C(=NO1)C3=CC=CC=C3	MedChem Express	HY-15762	-2.34396671	2.31032941	4.47321954	-3.50926843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095460-08	NCGC00095460-08	384568157		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	517-28-2				-10.1760535826	4	4		0	0.50670641					OC1=CC2=C(C=C1O)C3C4=C(OCC3(O)C2)C(=C(O)C=C4)O	Microsource	00200010	-4.0446304	-0.74839096	0.4244997	0.50670641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178913-11	NCGC00178913-11	384568367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	34157-83-0		1.2589254118	-5.9	71.5668879317	4	4		-31.5476900199	-6.70640835	0.0436058879	0.9988265908		HSP90AB1	CC/1=C(\O)C(=O)\C=C2/C1=C\C=C3/[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O	SIGMA	C0869	25.74616457	20.7453974	-5.2456034	-6.70640835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189074-12	NCGC00189074-12	384568457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	212631-79-3				-4.6118413852	4	4		0	3.85448246				MAP2K1	FC1=C(F)C(=C(C=C1)C(=O)NOCC2CC2)NC3=CC=C(I)C=C3Cl	SIGMA	PZ0181	-2.77188516	-3.3603177	2.76733343	3.85448246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386271-02	NCGC00386271-02	384569119		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1375465-09-0				-6.6944895659	4	4		0	0.99610221				EGFR	COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)NC4CN(CCF)C4	APExBIO	B3227	-0.87682082	-2.59660913	-4.84283351	0.99610221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346832-02	NCGC00346832-02	384568947		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	24150-24-1				0.6003890479	4	4		0	-0.41865165					COC1=C(OC)C=C(C[C@H](C)[C@H](C)CC2=CC(=C(OC)C=C2)OC)C=C1	SIGMA	T3455	0	-1.09974034	2.4063769	-0.41865165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370805-01	NCGC00370805-01	384569036		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	3397				-6.5502537595	4	4		0	-3.39252202				SLC6A9	CN(CCOC1=C(C=C(C=C1)C2=CC3=C(OCO3)C=C2)C(C)(C)C)CC(O)=O	Tocris	3397	-1.72535709	-0.76370857	1.32350729	-3.39252202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378933-01	NCGC00378933-01	363678285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	956136-95-1		5.6234132519	-5.25	11.907474244	4	4		17.9007212559	14.62393533	0.1788947181	0.9798607598		DGAT1	OC(=O)C[C@H]1CC[C@@H](CC1)C2=CC=C(C=C2)C3=NC=C(NC4=CC=C(N=C4)C(F)(F)F)C=C3	MedChem Express	HY-16278	-1.58393438	1.68015885	5.50458716	14.62393533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387872-01	NCGC00387872-01	363680714		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1061353-68-1				-11.9537532372	4	4		0	-5.21149127				ERK2	CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=C[NH]C(=C3)C(=O)NC(CO)C4=CC(=CC=C4)Cl	ChemieTek	CT-VS4718	-1.52736529	-1.52741714	-4.42171755	-5.21149127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346503-01	NCGC00346503-01	174006514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	157716-52-4	Perifosine			3.53103774	4	4		0	-3.42918653			5290	PIK3CA	CCCCCCCCCCCCCCCCCCO[P]([O--])(=O)OC1CC[N+](C)(C)CC1	Selleck	S1037 	4.78284772	-2.28445099	-2.93370945	-3.42918653												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00371019-02	NCGC00371019-02	363677996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1078166-57-0				-7.1880616393	4	4		0	-1.10645933				PTGER2	COC1=CC=C2C=C(OCC3(CN(C3)C(=O)C4=CC=C(F)C=C4)C(O)=O)C=CC2=C1	Axon Medchem	2024	-2.59608412	1.71070719	-1.32684653	-1.10645933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250391-05	NCGC00250391-05	384568544		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	252017-04-2				0.6797881591	4	4		0	4.69497608				PDK2	CN(C)C(=O)C1=CC=C(C=C1)[S+]([O-])(=O)C2=CC=C(NC(=O)[C@@](C)(O)C(F)(F)F)C(=C2)Cl	Glixx	GLXC-05955	-0.47860769	-1.68015885	-0.61919505	4.69497608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386309-03	NCGC00386309-03	384569122		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[1214265-58-3]		2.5118864315	-5.6	10.7992668565	4	4		16.3432563839	-5.63510393	1	0.9998571052		NUAK	CCC(=O)NC1=CC=CC(=C1)OC2=NC(=NC=C2Cl)NC3=C(OC)C=C(C=C3)N4CCN(C)CC4	Tocris	5177	-2.22566559	-2.36938032	12.54073969	-5.63510393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371137-09	NCGC00371137-09	384569042		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	91396-88-2				8.4959250159	4	4		0	0.70823711			6319	SCD1	O=C(NNC1=CC=CC=C1)C2=CC=NC=C2	Glixx	GLXC-01592	3.49344978	-2.39975699	1.0344339	0.70823711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262604-18	NCGC00262604-18	384568575		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	944396-07-0				-6.4575682	4	4		0	3.75331175				PIK3CA	NC1=CC(=C(C=N1)C2=CC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(F)(F)F	Selleck	S2247	-1.63036032	-3.5567089	-3.73915645	3.75331175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346667-07	NCGC00346667-07	384568894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	70374-39-9				0.1893105017	4	4		0	-1.30997939					CN1\C(=C(O)/C2=C(C=C(Cl)S2)[S+]1([O-])=O)C(=O)NC3=NC=CC=C3	MedChem Express	HY-B0367	0.67132484	-0.90062586	0.11965301	-1.30997939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402337-02	BGP-15	384569215	Insulin Sensitizers	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	66611-37-8				0.1506392497	4	4		0	-1.33012594				PARP1	N\C(=N/OCC(O)CN1CCCCC1)C2=CN=CC=C2	Glixx	GLXC-05825	-0.51317614	4.27783574	-0.76515597	-1.33012594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386277-03	NCGC00386277-03	384569120		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	873652-48-3				-0.8179159937	4	4		0	-1.89613697				XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=NS3)C4=CC=CC=C4	MedChem Express	HY-13638	-0.01386963	0.81979431	0.08828723	-1.89613697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390260-01	NCGC00390260-01	363680869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	131179-95-8				-3.0362919224	4	4		0	-2.23546945					CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)C	Adooq	A12323	-0.55788006	2.84388565	-2.75924803	-2.23546945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167811-13	NCGC00167811-13	363676671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	885101-89-3		7.0794578438	-5.15	26.0044322963	4	4		22	21.54992548	0.2402881924	0.9627518235		FFAR1	OC(=O)CCC1=CC=C(NCC2=CC=CC(=C2)OC3=CC=CC=C3)C=C1	MedChem Express	HY-15589	0.69735007	4.7597665	6.85263796	21.54992548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178697-07	NCGC00178697-07	384568360		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	97682-44-5				-14.5066377431	4	4		0	-4.38259265				TOP1	CCC1=C2C=C(OC(=O)N3CCC(CC3)N4CCCCC4)C=CC2=NC\5=C1CN6C(=O)\C7=C(/C=C56)[C@@](O)(CC)C(=O)OC7	Selleck	S1198	-2.14403518	-2.90346352	-5.33145275	-4.38259265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345786-03	NCGC00345786-03	384568741		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1252003-13-6				-4.8623004548	4	4		0	-3.18314624				HDAC6	CN1CCC2=C(C1)[N](CC3=CC=C(C=C3)C(=O)NO)C4=CC=CC=C24	Aobious	AOB87388	-1.01704233	0.84008843	-0.67700987	-3.18314624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263221-03	NCGC00263221-03	384568675		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	168682-53-9				6.0454111435	4	4		0	1.67464115				GSTP1	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@@H](C(=O)OCC)C2=CC=CC=C2	MedChem Express	HY-13634A	1.89992748	1.00809531	-1.0909627	1.67464115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167785-11	NCGC00167785-11	384568336		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	315183-21-2		5.0118723363	-5.3	10.4128484723	4	4		19.76722262	17.34449761	0.075510531	0.9964808527		CASP3	OC1=C(C=CC=C1CC=C)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3	SIGMA	P0115	-2.30601885	-0.88590194	5.66121185	17.34449761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177986-12	NCGC00177986-12	384568351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	70458-95-6				8.0263295214	4	4		0	-1.58492823					CCN1\C=C(C(O)=O)/C(=O)C2=C1C=C(N3CCN(C)CC3)C(=C2)F	MedChem Express	HY-B0147A	2.18999275	3.87963953	1.29736105	-1.58492823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370980-01	NCGC00370980-01	384569038		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	3914				-22.5371034299	4	4		0	-6.45933014				HCK	CN1CCN(CC1)[C@H]2CC[C@@H](CC2)[N]3C=C(C4=CC=C(OC5=CC=CC=C5)C=C4)C6=C(N)N=CN=C36	Tocris	3914	-4.6555475	-3.75744616	-4.57024915	-6.45933014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345173-01	NCGC00345173-01	174006338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1260530-25-3				9.5334683044	4	4		0	-1.04712042				BRD4	CCNC(=O)C[C@H]1/N=C(/C2=CC=C(Cl)C=C2)C3=CC(=CC=C3[N]4C(=NN=C14)C)OC	NCGCChem	PRP01-073_2ND_NEG	3.50901526	0.90922641	1.03001766	-1.04712042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510528-01	NCGC00510528-01	384569475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	653592-04-2				6.3707429474	4	4		0	0.38748137					CSC[C@H]1CN(C[C@@H]1O)CC2=C[NH]C3=C(N)N=CN=C23	MedChem Express	HY-101496	0.75313808	1.91588086	4.03274712	0.38748137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015252-17	NCGC00015252-17	384567832		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	969-33-5		12.5892541179	-4.9	63.9206826831	3	4		107.2590979694	95.20221436	0.0224125281	0.9996900583		HRH1	CN1CCC(CC1)=C2C3=C(C=CC=C3)\C=C/C4=C2C=CC=C4	APExBIO	B3309	-1.37438153	-2.28445099	-3.04654443	95.20221436												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347285-06	NCGC00347285-06	363677575		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1047953-91-2				-9.4071596368	4	4		0	-2.81408581					COCCOC1=N[N](C2=CC=C(NC(=O)CCl)C=C2)C(=N1)C3=CC=C(Cl)C(=C3)Cl	MedChem Express	HY-12276	-1.20945574	-2.81503316	-3.2157969	-2.81408581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379339-01	NCGC00379339-01	377020268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					0.2264813923	4	4		0	-0.9569378					CCCCCCCCCCCCCCCCOCCCO[P](O)(=O)COC(CO)CN1/C=C\C(=N/C1=O)N	NCGCChem	PJM002-071	0.68165337	-1.49686879	0.35382574	-0.9569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510487-01	NCGC00510487-01	384569449		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1402837-78-8				6.8635889234	4	4		0	0.16190757				IDO1	O[C@@H]1CC[C@H](CC1)[C@H](O)C[C@@H]2[N]3C=NC=C3C4=C2C(=CC=C4)F	MedChem Express	HY-18770B	0.94533498	3.73988704	2.45288663	0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159459-08	NCGC00159459-08	384568181		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	115007-34-6		4.4668359215	-5.35	28.8644570056	4	4		27.234163064	26.23461157	0.0893993511	0.995047773		IMPDH1	COC1=C(C/C=C(C)/CCC(=O)OCCN2CCOCC2)C(=C3C(=O)OCC3=C1C)O	Microsource	01504567	0.6518724	-1.02846922	11.88934667	26.23461157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185071-01	NCGC00185071-01	124896608		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1492-18-8				11.6905147011	4	4	N5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid;FOLINIC ACID CALCIUM SALT;CIPLUS_148853;Levoleucovorin Calcium;CALCIUM N-(P-((((6S)-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-L-GLUTAMATE (1:1);5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt;L-Glutamic acid, N-(4-(((2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-;LS-71774;Calcium levofolinate;CALCIUM FOLINATE;L-GLUTAMIC ACID, N-(4-(((2-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-, CALCIUM SALT (1:1), (S)-;Calcium Folinate;Wellcovorin;CIPLUS_682532;CIPLUS_3741774;Calcium folinate;CIPLUS_711792;Levoleucovorin calcium;Citrovorum factor calcium salt;folinate de calcium;5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid calcium salt;Calcium Levofolinate;NCGC00094708-01;NCGC00094708-02;CIPLUS_192127;calcii folinas;Folinic acid calcium salt hydrate;leucovorin;citrovorum;N-(4-(((2-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-GLUTAMIC ACID;NCGC00017055-01;Calcii folinas;Leucovorin Calcium;Leucovorin;LEUCOVORIN CALCIUM;5-HCO-H4PteGlu;CIPLUS_158472;calcii levofolinas;Uzel;CIPLUS_756906;Folinic acid;LS-177560;HS_806;HS_805;NCGC_Prestw-738;LS-175894;Leucovorin calcium;LEVOLEUCOVORIN CALCIUM;LS-176087;Leucovorin calcium salt;Citrovorum factor;LEUCOVORIN;calcium leucovorin;Leucovorin Calcium (pentahydrate);Folinate de calcium;CIPLUS_727061;CALCIUM LEVOFOLINATE;levofolinate de calcium;Folinato calcico;Folinic acid calcium salt;	0	-0.0566011					N/C1=N/C(=O)C/2=C(NC[C@@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N2C=O)\N1	SigmaAldrich	F8259	4.23023578	-0.61111939	1.94231901	-0.0566011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167441-07	NCGC00167441-07	384568313		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	104632-25-9				0.6874259902	4	4		0	0.89418778				DRD3	CCCN[C@H]1CCC2=C(C1)SC(=N2)N	MedChem Express	HY-17355	0.86471409	-1.67639575	-1.45542753	0.89418778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346567-12	NCGC00346567-12	377020162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	869357-68-6				-20.2462581685	4	4		0	-5.4247392				MAP2K1	CN1C(=O)\C(=C/C(=C1/NC2=C(F)C=C(I)C=C2)C(=O)NOCCO)C	MedChem Express	HY-12058	-4.37935844	-3.95150427	-3.21406913	-5.4247392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346685-03	NCGC00346685-03	384568909		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	819812-04-9				-4.1599354231	4	4		0	1.98369983				HSP90AB1	CCC1=C(CC(=O)N(CCOC)CCOC)C(=C(O)C=C1O)C(=O)C2=CC=C(OCCN3CCOCC3)C(=C2)OC	APExBIO	A4062	-1.64925783	-2.01915991	-0.02820874	1.98369983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346663-04	NCGC00346663-04	384568893		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	27741-01-1				4.2215585006	4	4		0	1.04665072					OC[C@H]1O[C@@H](O[C@@H]2O\C=C(/[C@H]3C\C=C(CO)/[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2413	1.02973169	3.63525279	-2.47678019	1.04665072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347905-02	NCGC00347905-02	363677717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[607378-18-7]		12.5892541179	-4.9	4.4102046255	4	4		14.5837563399	10.16746411	0.1148245983	0.9918738233		P2RX7	OCCNCCNC1=NC2=CC=CC(=C2C=C1)NC(=O)CC34CC5CC(CC(C5)C3)C4	Tocris	3323	-1.31979695	-0.18329006	0.44228218	10.16746411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346619-03	NCGC00346619-03	384568861		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1092788-83-4				-19.0583164655	4	4		0	-1.75154548				PDGFRA	NC1=NC=NC2=C1C(=N[N]2C3CCCC3)C4=CN=C5[NH]C=CC5=C4	Selleck	S2622	-4.61707083	-3.70935735	-4.8160335	-1.75154548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507865-01	NCGC00507865-01	384569340		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1439901-97-9				-4.8370733211	4	4		0	-0.54459817				BTK	CC#CC(=O)N1CC[C@H](C1)N2C(=O)N(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C25	Selleck	S8166	-0.56172078	-1.14486338	-3.14089141	-0.54459817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015226-17	NCGC00015226-17	384567827		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	53-19-0				12.7829910523	4	4		0	7.01853686					ClC(Cl)C(C1=CC=C(Cl)C=C1)C2=C(Cl)C=CC=C2	Microsource	00330082	2.37170596	1.11790133	1.00058858	7.01853686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421877-04	NCGC00421877-04	384569229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1448346-63-1				7.5954108213	4	4		0	2.77110137					FC1=CN=CC(=C1)N(C(C(=O)NC2CC(F)(F)C2)C3=C(Cl)C=CC=C3)C(=O)[C@@H]4CCC(=O)N4C5=NC=CC(=C5)C#N	Astatech	41508	2.44610282	-1.1789925	0.14581511	2.77110137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095486-03	NCGC00095486-03	174007452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	57-87-4	ERGOSTEROL			4.7039656791	4	4		0	-0.98967906					CC(C)C(C)/C=C/C(C)C1CCC2\C3=C\C=C/4CC(O)CCC4(C)C3CCC12C	Microsource	MS-00200743	2.44610282	-1.76083295	0.61242345	-0.98967906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091104-10	NCGC00091104-10	384568093		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	22839-47-0				2.2184016757	4	4		0	3.05386682					COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O	MedChem Express	HY-B0361	0.67716971	-1.5158475	-1.04986877	3.05386682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159519-01	NCGC00159519-01			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-0.8694544739	4	4		0	0.65036053					[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O	Microsource	MS-1504402	-0.67716971	2.95513704	-2.42053077	0.65036053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351549-05	NCGC00351549-05	384569011		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1394854-52-4				1.9931554695	4	4		0	1.63934426				KDM6B	OC(=O)CCNC1=CC(=NC(=N1)C2=CC=CN=C2)N3CCC4=C(CC3)C=CC=C4	MedChem Express	HY-15648A	0.55788006	-0.02993564	-0.90964221	1.63934426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015605-13	NCGC00015605-13	384567872		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	84057-84-1				-9.1908813074	4	4		0	-1.10283159					NC1=NC(=C(N=N1)C2=CC=CC(=C2Cl)Cl)N	Selleck	S3024	-3.68200837	0.29935638	1.18253487	-1.10283159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345024-01	NCGC00345024-01	174007010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	603281-31-8				-12.4501247002	4	4		0	-2.77198212			2932	GSK3B	O=C/1NC(=O)C(=C1C2=CN=C3C=CC=C[N]23)/C4=C[N]5CCN(CC6=C5C4=CC=C6)C(=O)N7CCOCC7	NCGCChem	DYD11-007	-3.34728033	-1.46684628	-1.15221346	-2.77198212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384204-04	NCGC00384204-04	363679195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1687736-54-4				2.2160616006	4	4		0	-3.72578241				PRMT3	O=C(NCC(=O)N1CCCC1)NC2=CC3=C(C=C2)C=NC=C3	Aobious	AOB5757	1.89679219	1.37703937	-1.15221346	-3.72578241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242479-03	NCGC00242479-03	363677141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	186497-07-4				-2.3119604966	4	4		0	-0.65789474				EDNRA	COC1=C(N[S+]([O-])(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4)N=CC(=N1)C	Selleck	S1456	-0.47860769	-1.71070719	0.85507887	-0.65789474												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387463-02	NCGC00387463-02	384569159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1125593-20-5				-1.4853831552	4	4		0	-2.24282297				TTK	COC1=C(NC2=NC3=C(C=C[NH]3)C(=C2)NC4=C(C=CC=C4)[S+]([O-])(=O)C(C)C)C=CC(=C1)N5CCC(O)CC5	MedChem Express	HY-13298	0.47860769	-0.03054834	-1.44478844	-2.24282297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509985-02	NCGC00509985-02	384569395		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	308831-61-0		12.5892541179	-4.9	71.6347099796	3	4		77.689447548	74.22248804	0.1345951702	0.9886590571		GNRHR	CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)CC3=CC=CC=C3)C4=C(S2)N(CC5=C(F)C=CC=C5F)C(=O)N(C4=O)C6=CC=CC=C6	Glixx	GLXC-04354	4.07541697	8.55353597	-0.32434026	74.22248804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018218-13	NCGC00018218-13	384567997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	89-25-8				7.883934638	4	4		0	0.39740948					C\C1=N\N(C(=O)C1)C2=CC=CC=C2	Selleck	S1326	4.45266475	-2.15234315	-3.26054442	0.39740948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263235-01	NCGC00263235-01	137276079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	n	ACC1 BMS	1.2589254118	-5.9	55.2964692798	1.4	4		38.7845157528	34.33912276	0.0626917328	0.9975717453	31	ACACA	CC(C)OC1=CC=C(OC2=CC=C(C=C2)C(C)NC(C)=O)C=C1	NCGCChem	ACC1 BMS	2.26058364	18.3941383	29.55429255	34.33912276												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346575-02	NCGC00346575-02	384568848		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	211914-51-1				1.9380797869	4	4		0	1.01795561					C[N]1C(=NC2=CC(=CC=C12)C(=O)N(CCC(O)=O)C3=NC=CC=C3)CNC4=CC=C(C=C4)C(N)=N	Selleck	S2196	1.11940299	-0.62777523	-1.48731409	1.01795561												1.6E-9	8E-9	4E-8	2E-7											
NCGC00346633-02	NCGC00346633-02	384568869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	908112-43-6		0.7079457844	-6.15	93.5908598072	1.4	4		47.9422572224	46.6562986	0.0655839226	0.9973393125		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	APExBIO	A4068	2.55666114	26.81059562	47.85651794	46.6562986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025357-13	NCGC00025357-13	384568070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	65141-46-0				-8.7135478382	4	4		0	-0.02980626					[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1	MedChem Express	HY-B0341	-3.43096234	-0.71845532	0.81867799	-0.02980626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346884-02	NCGC00346884-02	384568961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[412960-54-4]				5.3759547018	4	4		0	4.20268256					CC1(C)C(N(O)C(=O)NC2=CC=C(Cl)C=C2)N(C(=O)N1CC(=O)N\N=C\C=C\C3=CC=C(O3)[N+]([O-])=O)C4=CC=C(Cl)C=C4	Tocris	3922	1.42259414	-0.08980692	-1.91024864	4.20268256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346526-03	PHA-680632	384568820	Aurora-A/B/c Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	398493-79-3				-10.8590851988	4	4		0	-3.40909091				AURKA	CCC1=CC=CC(=C1NC(=O)N2CC3=C(C2)C(=N[NH]3)NC(=O)C4=CC=C(C=C4)N5CCN(C)CC5)CC	Selleck	S1454	-2.94416244	-0.39712846	-0.73713696	-3.40909091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253713-01	NCGC00253713-01	170466486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	72479-26-6	Fenticonazole nitrate;Fenticonazole	14.1253754462	-4.85	6.0738891061	4	4		19.10902256	14.9222488	0.2079167052	0.9724833751			Clc4ccc(C(OCc2ccc(Sc1ccccc1)cc2)Cn3ccnc3)c(Cl)c4	GVK	FFS-12-73-NCI-1907	-1.23277737	0.24438674	-3.0075188	14.9222488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159406-15	NCGC00159406-15	384568174		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	69815-49-2, 51-41-2 [norepinephrine]				-1.0436543527	4	4		0	-1.25598086				ADRA1A	NC[C@H](O)C1=CC=C(O)C(=C1)O	Microsource	01500436	-0.24655547	-0.45822514	1.20890461	-1.25598086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346573-02	NCGC00346573-02	384568846		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	848942-61-0				-15.6967319692	4	4		0	-3.94736842				ERBB2	CNC(=O)CN1CCC(CC1)OC2=C(OC)C=C3N=CN=C(NC4=C(F)C(=CC=C4)Cl)C3=C2	Selleck	S2192	-3.40826686	-2.68825416	-3.09597523	-3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378765-02	NCGC00378765-02	363678186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	624733-88-6				2.5660504909	4	4		0	1.81042096				CCR2	CO[C@@H]1COCC[C@@H]1N[C@@H]2CC[C@](C2)(C(C)C)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F	Adooq	A11127	0.26030963	-1.45016028	1.16661681	1.81042096												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00183656-11	NCGC00183656-11	363677096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	488832-69-5		0.2238721139	-6.65	26.2958828282	4	4		-11.8005648001	2.57580218	0.3805276222	0.8997577982		HSPA2	CN(NC(=O)CC(=O)NN(C)C(=S)C1=CC=CC=C1)C(=S)C2=CC=CC=C2	Selleck	S1052	9.98766954	-1.083804	-0.53843853	2.57580218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345808-01	NCGC00345808-01	174006728		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	n	BP-1-102			2.4988851245	4	4		0	5.65530892			6774	STAT3	CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC=C(C(O)=O)C(=C3)O)[S+]([O-])(=O)C4=C(F)C(=C(F)C(=C4F)F)F	EMD Chemicals	573132	-0.70480929	-1.82207931	1.92475941	5.65530892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242217-09	NCGC00242217-09	384568486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	660868-91-7				-4.5677459868	4	4		0	-2.79937792				PLK1	COC1=CC2=C(C=C1OC)[N](C=N2)C3=CC(=C(S3)C(N)=O)OCC4=C(C=CC=C4)C(F)(F)F	MedChem Express	HY-11003	0.26257601	-3.56760067	-0.93321668	-2.79937792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263145-02	NCGC00263145-02	384568620		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	883065-90-5				-13.4780635154	4	4		0	-6.55737705				MAPK8	OC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)[N]1C3=CC4=C(OCCO4)C=C3	Chemdea	CD0179	-3.51464435	0.50890585	0.06064281	-6.55737705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510234-01	NCGC00510234-01	384569419		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1557268-88-8				-4.4071563908	4	4		0	-6.05067064				EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC(=C4C=C[NH]C4=N3)OC5=CC(=CC=C5)NC(=O)C=C)C=C2F	ChemGood	C-1377	1.81311018	-2.30504416	-4.15403275	-6.05067064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345447-10	NCGC00345447-10	384568734		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	5142-23-4				-8.5748056618	4	4		0	-1.76841458				PIK3CA	C[N]1C=NC(=C2N=CN=C12)N	Enzo	AP502	-1.53930731	-1.63596168	-3.2157969	-1.76841458												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00015466-09	NCGC00015466-09	90340599		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	60142-96-3	 Go 3450;; Gabapentin hydrochloride;Gabapentin hydrochloride; ; Neurontin;Gabapentin; Gabapentino; Gabapentin; gabapentin ISTD			-8.5992119833	4	4		0	-0.53821313					NCC1(CCCCC1)CC(O)=O	SigmaAldrich	Lopac-G-154	-2.3364486	0.899042	-4.09026798	-0.53821313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016345-14	NCGC00016345-14	384567933		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	90-33-5				-2.956690967	4	4		0	-2.53729048				MAOA	C\C1=C\C(=O)OC2=C1C=CC(=C2)O	Microsource	01506174	-0.96206707	0.86956522	1.12834979	-2.53729048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346465-06	NCGC00346465-06	384568786		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1207360-89-1				-1.8664224948	4	4		0	-3.40005888				PIM3	CCNC(=O)NC1=CC=C(C=C1)C2=NC(=C3CCN(CC3=N2)C4COC4)N5CCOC[C@@H]5C	MedChem Express	HY-15248	1.43855323	-1.35857121	-2.93149865	-3.40005888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390611-02	NCGC00390611-02	384569200		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-16.0615051686	4	4		0	-5.72564027					C[N]1N=CC(=C1C2=C(Cl)SC(=C2)C(=O)N[C@H](CN)CC3=CC=C(F)C(=C3)F)Cl	MedChem Express	HY-15966A	-2.7812029	-1.96916501	-4.72629375	-5.72564027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351596-02	NCGC00351596-02	384569014		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1356962-20-3				-7.3468906481	4	4		0	-5.72564027				ALK	COC1=C(NC2=NC(=C(Cl)C=N2)C3=C[NH]C4=C3C=CC=C4)C=CC(=C1)N5CCC(N)CC5	Selleck	S7106	0.04110152	-1.81651656	-2.72210589	-5.72564027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351599-03	NCGC00351599-03	384569017		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1231930-82-7		1.4125375446	-5.85	55.8697666461	1.4	4		38.6386479214	35.89932293	0.1196104745	0.9910759661		CDK4	CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2	APExBIO	A1794	0.01370051	0.93115555	40.56236913	35.89932293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346696-07	NCGC00346696-07	384568916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1373615-35-0 (free base)				1.5052447776	4	4		0	-0.39740948				SMO	CC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CC[S+](C)([O-])=O)C	SIGMA	PZ0217	0.83573092	0.93115555	-1.40592282	-0.39740948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390558-02	NCGC00390558-02	384569192		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1186206-79-0				-12.635873103	4	4		0	-5.54901384				RET	CCN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)NC(=O)C4=CC(=CN=C4)C5=CC=CS5)C=C2C(F)(F)F	MedChem Express	HY-18007	-0.56172078	-4.25889177	-5.83308406	-5.54901384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161327-10	NCGC00161327-10	384568203		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	32222-06-3				12.4370860272	4	4		0	-2.69958135				VDR	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-10002	5.31749399	3.26867267	-2.01534065	-2.69958135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386362-01	NCGC00386362-01	363680233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1095253-39-6				-1.6624754206	4	4		0	-0.82286704				KIF11	NCCCN([C@H](CC#C)C/1=N/C2=C(C=CC(=C2)Cl)C(=O)N1NC3=CC=CC=C3)C(=O)C4=CC=CC(=C4F)Cl	Selleck	S7355	-0.98995899	2.77989919	-0.66175365	-0.82286704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263100-02	NCGC00263100-02	363677201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	252003-65-9		12.5892541179	-4.9	11.4628810339	3	4		42.2704434419	34.08401906	0.0482170709	0.9985644757		KDR	NC(=O)C1=C(NC(=O)NCCCCN2CCCC2)SN=C1OCC3=C(F)C=C(Br)C=C3F	Axon Medchem	1662	-3.22443784	-3.60470444	-4.66235524	34.08401906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370777-10	NCGC00370777-10			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1197160-78-3				-4.0224417145	4	4		0	-0.9380286				PIK3CA	CN(C)C1CCN(CC1)C(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6)C=C2	Selleck	S2628_CM1	-0.76965366	-1.48857774	-0.45133992	-0.9380286												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346497-03	NCGC00346497-03	384568803		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1214265-57-2				-16.7201368414	4	4		0	-6.10487467				EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)SC4=CC(=CC=C4)NC(=O)C=C)C=C2	APExBIO	A1393	-3.02363936	-2.28445099	-4.06205924	-6.10487467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510878-01	NCGC00510878-01	384569492		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	114560-48-4				2.7532007482	4	4		0	2.66031063					C[N]1C(=C(CO)C2=C1C(=O)\C=C(N3CC3)/C2=O)\C=C\CO	SantaCruz Bio	sc-480043	0.71467839	-1.48857774	-0.02820874	2.66031063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345848-02	NCGC00345848-02	363677390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	(913376-84-8)		10	-5	39.1725253622	3	4		64.420904204	53.5291404	0.0115834607	0.9999172631		MET	COC1=CC=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)\C4=C(C)\N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3F	SynKinase	SYN-1143	-1.31940627	-1.34119381	4.96473907	53.5291404												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346826-01	NCGC00346826-01	174006691		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	599150-20-6	HPI-1			-0.9508939678	4	4		0	-4.44410272			54498	SMO	COCCOC(=O)C/1=C(C)/NC/2=C(C1C3=CC=CC(=C3)O)/C(=O)CC(C2)C4=C(OC)C=CC=C4	SIGMA	H1542	0.90709181	-0.48636699	0.56417489	-4.44410272												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509995-02	NCGC00509995-02	384569402		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1639417-53-0				-2.5220389896	4	4		0	-4.3062201				PIK3CD	CC[C@H](NC1=C2[NH]C=NC2=NC=N1)/C3=C(/C(=O)C4=CC=CC=C4O3)C5=CC=CC(=C5)F	MedChem Express	HY-17645_cm1	0.47860769	-0.4276768	-0.32434026	-4.3062201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346460-05	NCGC00346460-05	363677414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	468740-43-4				-10.2598708501	4	4		0	-3.81832179				IGFR1	CC1=C2N=C([NH]C2=CC(=C1)N3CCOCC3)\C4=C(NC[C@@H](O)C5=CC=CC(=C5)Cl)\C=C/NC4=O	MedChem Express	HY-10262	-1.66220594	-1.30619684	-3.2166643	-3.81832179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179619-17	NCGC00179619-17	384568380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	114-07-8				-1.1410131056	4	4		0	1.87836798					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	Selleck	S1635	-1.69037893	-0.97205346	1.9696755	1.87836798												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00420895-01	NCGC00420895-01	384569227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			8.9125093813	-5.05	9.9389246037	4	4		19.397451708	16.76479246	0.0533160887	0.9982504505		HSP90AB1	CC(C)NCCC[N]1C(=NC2=C1N=CN=C2N)SC3=CC(=CC(=C3)Cl)Cl	Bio Vision	9442-5	-1.16454309	-0.32056175	0.8674843	16.76479246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389582-02	NCGC00389582-02	363680807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1286739-19-2				5.6731974758	4	4		0	3.16455696				PAK1	CCN1C(=O)\C(=C/C2=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N=C12)C5=C(Cl)C=C(C=C5)C6=CN=CS6	MedChem Express	HY-15542A	0.3973147	1.75545718	1.52557583	3.16455696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481564-01	NCGC00481564-01	377020339		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					1.5050410507	4	4		0	-4.19487783				MET	CN\1N(C(=O)\C(=C1C)C(=O)NC2=CC=C(OC3=CC=NC4=C3C(=C[NH]4)C5=CC=CC=C5)C(=C2)F)C6=CC=C(F)C=C6	APExBIO	B5947	2.42498972	-1.083804	-1.13670356	-4.19487783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384198-02	NCGC00384198-02	384569105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	685898-44-6				1.5907103234	4	4		0	-1.63379452				HIF1A	N[C@@H](CC1=CC=C(C=C1)[N+]([O-])(CCCl)CCCl)C(O)=O	Selleck	S7612	1.93177148	0.07632423	-3.11097816	-1.63379452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167521-07	NCGC00167521-07	384568324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	113712-98-4				-3.0860993233	4	4		0	0.80953783					COC1=CC=C2[NH]C(=NC2=N1)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC	Enzo	DL169	-2.26058364	0.07632423	2.9015854	0.80953783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347941-04	NCGC00347941-04	363677723		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	425399-05-9				-3.6799145056	4	4		0	-6.84292379				CDC42	OCCNC1CCCC2=C1[NH]C3=C2C=C(C=C3)C4=CC=CC=C4	Glixx	GLXC-04909	-0.04145937	0.04593477	2.15806358	-6.84292379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263218-08	NCGC00263218-08	384568672		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	163451-81-8				-0.6380797927	4	4		0	1.80969885				DHODH	C\C(O)=C(C#N)\C(=O)NC1=CC=C(C=C1)C(F)(F)F	MedChem Express	HY-15405	0.53897181	-1.63834022	-3.17876932	1.80969885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386293-01	NCGC00386293-01	384569121		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1374640-70-6				-9.87341237	4	4		0	-0.32292788				EGFR	COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)N4CCN(CC4)C(C)=O	Selleck	S7284	-2.19901045	-2.10759027	-3.63892807	-0.32292788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015672-15	NCGC00015672-15	384567879		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	6202-27-3	Morin;MORIN			11.7745984518	4	4		0	0.76982294			1544	CYP1A2	OC1=CC(=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O)O	Microsource	MS-01502259	4.36681223	-0.03037667	0.09919229	0.76982294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164588-06	NCGC00164588-06	384568259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	59937-28-9				-2.7762309079	4	4		0	-2.77136259					CC(C)OC(=O)C(C(=O)OC(C)C)=C1S\C=C/S1	Adooq	A10552	-0.3099028	0.78979344	-0.66600538	-2.77136259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481573-01	NCGC00481573-01	377020380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			8.9125093813	-5.05	16.5946309896	4	4		20.604487868	17.82455107	0.0805405054	0.9959954667		MAPK14	CC1=CC=C(C=C1)[N]2N=C(C=C2N\C(O)=N\CC3=CC(=CC=C3OC4=CC=C5[N](CCO)N=CC5=C4)F)C(C)(C)C	APExBIO	B5955	0.69872585	-0.50373989	2.63236614	17.82455107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390634-03	NCGC00390634-03	384569203		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1619903-54-6		0.4466835922	-6.35	50.9327119005	4	4		29.5	26.21235685	0.0619981707	0.9976275634	1025	CDK9	CC(C)C1=C2C=C(C=CC2=N[N]1C)C3=NC(=NC=C3)N[C@H]4CC[C@@H](CC4)NC5CCOCC5	MedChem Express	HY-12293_CM1	1.06412383	16.9499311	24.00116652	26.21235685												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249612-02	NCGC00249612-02	384568529		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1201902-80-8				-18.8050405122	4	4		0	-2.35311101				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B2OC(=O)CC(CC(O)=O)(O2)C(O)=O	Selleck	S2181	-4.61038043	-3.54360776	-4.00060159	-2.35311101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016806-17	NCGC00016806-17	384567961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	31431-39-7				-11.7152216346	4	4		0	-1.276334				TUBB	COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CC=C3	MedChem Express	HY-17595	-2.6937878	-1.57700811	-3.977433	-1.276334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481572-02	NCGC00481572-02	377020298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1394076-92-6				-13.9150669803	4	4		0	1.15331386				MTOR	COC1(COC1)C2=C(C)C3=C(S2)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	MedChem Express	HY-12763	-4.26058274	-2.7266028	-2.84908322	1.15331386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344626-12	NCGC00344626-12	384568727		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1373423-53-0		11.220184543	-4.95	14.1127470457	4	4		18.4733061	15.79676674	0.1968100616	0.9754723642		KDM6A	CCOC(=O)CCNC1=NC(=NC(=C1)N2CCC3=C(CC2)C=CC=C3)C4=CC=CC=N4	Bio Vision	2762	-0.39442175	2.43013366	2.30976336	15.79676674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263130-02	NCGC00263130-02	363677217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	628279-07-2				-5.6211029363	4	4		0	2.00153965				PCK1	CCCCN1C(=O)N(CC2=C(F)C=CC=C2)C(=O)C3=C1[NH]C(=N3)CC4=CC=C(NC(C)=O)C=C4	Axon Medchem	1165	-1.38047612	-2.88578372	-2.25308205	2.00153965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346514-04	NCGC00346514-04	384568814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	887650-05-7		12.5892541179	-4.9	57.5989771081	3	4		81.9947731617	70.69045056	0.0646402596	0.9974144216		ABL1	CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5	MedChem Express	HY-12039	-0.10995052	4.14148858	3.07475317	70.69045056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346606-02	NCGC00346606-02	363677475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	860-79-7		3.1622776602	-5.5	82.6742479746	3	4		68.5806321736	52.96381832	0.1381256829	0.9880491701			CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@H](CC[C@@]45C[C@@]35CC[C@]12C)NC	Selleck	S2402	4.39498521	-2.39975699	-0.58098342	52.96381832												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00161602-13	NCGC00161602-13	384568211		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	24390-14-5				13.5063349869	4	4		0	0.98616426				MMP1	C[C@@H]1[C@H]\2[C@H](O)[C@H]3[C@H](N(C)C)\C(=C(C(N)=O)/C(=O)[C@@]3(O)\C(=C2C(=O)C4=C(O)C=CC=C14)O)O	MedChem Express	HY-N0565B	4.91848198	2.24393222	-1.94436135	0.98616426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015754-17	NCGC00015754-17	384567887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[63612-50-0]				-4.6646516077	4	4		0	-1.13106178				AR	CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O	Tocris	1759	-2.14206744	2.74077477	-0.37911928	-1.13106178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345829-03	NCGC00345829-03	377020285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	260415-63-2				-12.7719099939	4	4		0	-5.42909656				SRC	CSC1=CC(=CC=C1)NC2=NC3=C(C=N2)/C=C(C(=O)N3C)/C4=C(Cl)C=CC=C4Cl	MedChem Express	HY-10395	-0.84300719	-5.12938294	-4.25780111	-5.42909656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263144-09	NCGC00263144-09	384568619		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1213269-23-8				-4.6412093837	4	4		0	-2.03591121				EGFR	COC1=CC(=CC=C1NC2=NC=C(Cl)C(=N2)OC3=CC(=CC=C3)NC(=O)C=C)N4CCN(C)CC4	MedChem Express	HY-12026	0.26257601	-2.71015158	-2.71216098	-2.03591121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160519-13	NCGC00160519-13	384568197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	51037-30-0				13.3977120344	4	4		0	-0.79399451					CC1=[N+]([O-])C=C(N=C1)C(O)=O	MedChem Express	HY-B0283	6.08117664	-0.27493508	-1.92510152	-0.79399451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389197-01	NCGC00389197-01	363680736		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	934343-74-5		1.1220184543	-5.95	142.7148130659	2.4	4		31.292675589	16.41403205	1	0.9998222404		HSP90AB1	COC1=CC=CC(=N1)C2=C(C=CC(=C2)F)C3CC4=C(C(=NC(=N4)N)C)C(=O)N3	APExBIO	B4797	19.99717155	24.68306094	51.43630621	16.41403205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015092-11	NCGC00015092-11	384567807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	60-32-2				4.3112125759	4	4		0	-3.62350224				SERPINE1	NCCCCCC(O)=O	Selleck	S1671	3.3941451	-0.73316023	-1.62430441	-3.62350224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263103-02	NCGC00263103-02	384568592		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	257933-82-7				-21.3165873314	4	4		0	-4.44410272				EGFR	CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N	Selleck	S1392	-4.09565695	-4.40677966	-6.3751763	-4.44410272												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378895-01	NCGC00378895-01	363678262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	863513-91-1				28.7913005497	4	4		0	2.67898383			4987	OPRL1	CN(C)[C@@]1(CC[C@]2(CC1)OCCC3=C2[NH]C4=C3C=C(F)C=C4)C5=CC=CC=C5	MedChem Express	HY-15536	8.00112692	4.82989064	4.26526853	2.67898383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387472-01	NCGC00387472-01	363680628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[879487-87-3]				-14.362692067	4	4		0	-2.03233256				TGBR1	CC1=NC(=CC=C1)C2=N[NH]C=C2C3=CC(=C(F)C=C3)C4=C[N](CCO)N=C4	Tocris	5288	-4.33863924	-0.24301337	-2.2814227	-2.03233256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386668-01	NCGC00386668-01	363680384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	477775-14-7				-0.6850359297	4	4		0	0				AGT	CCCCOC(=O)N[S+]([O-])(=O)C1=C(C=C(CC(C)C)S1)C2=CC=C(C[N]3C=CN=C3)C=C2	Axon Medchem	1969	-0.3099028	0.78979344	-0.63766473	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346807-05	NCGC00346807-05	384568941		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1234480-84-2				6.1753308563	4	4		0	9.05311778				LRRK2	COC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)C(=O)N5CCC(CC5)N6CCN(C)CC6	Glixx	GLXC-02871	-0.02817298	0.12150668	-0.86438997	9.05311778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386432-02	NCGC00386432-02	363680284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	(953769-46-5)				-1.0940193848	4	4		0	-1.20092379				CSF1R	CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(N[C@@H]4CCCC[C@H]4O)S3	SynKinase	SYN-1197	-0.08451895	-1.48845687	1.51622502	-1.20092379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344053-04	NCGC00344053-04	384568716		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	483367-10-8		12.5892541179	-4.9	33.4364632071	3	4		38.39963364	32.8672358	0.1815658854	0.9791236669			C1CCC(CC1)[N]2C=NC3=C2N=C(OC4=CC=CC5=C4C=CC=C5)N=C3NC6=CC=C(C=C6)N7CCOCC7	Selleck	S3042	3.68543636	-1.9996947	1.22644331	32.8672358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017248-18	NCGC00017248-18	384567980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	550-24-3				4.2079114922	4	4		0	-1.07447748				XIAP	CCCCCCCCCCCC/1=C(O)/C(=O)/C=C(O)\C1=O	MedChem Express	HY-17473	-0.26030963	7.34239047	0.77774454	-1.07447748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378854-02	NCGC00378854-02	384569072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	249921-19-5				-6.8358894244	4	4		0	0.92728878					CN(C)N(C)C(=O)[C@]1(CCCN(C1)C(=O)[C@@H](CC2=C[NH]C3=CC=CC=C23)NC(=O)C(C)(C)N)CC4=CC=CC=C4	MedChem Express	HY-14734	-2.64419784	-0.96168524	-0.14956626	0.92728878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346635-10	NCGC00346635-10	377020163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1144068-46-1		6.3095734448	-5.2	22.7025487696	4	4		35.1650082959	29.3510533	0.1798805229	0.9795280886		MTOR	CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7	MedChem Express	HY-10044	-3.05417358	2.83264431	9.41965588	29.3510533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161410-03	NCGC00161410-03	384568207		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[171009-07-7]		12.5892541179	-4.9	59.0720430427	3	4		67.940388998	62.71737594	0.1334710246	0.9888513825		HSP90AB1	CCC1=C(O)C=C(O)C(=C1)C2=N[NH]C(=C2C3=CC4=C(OCCO4)C=C3)C	Tocris	2435	5.48645661	-0.93400704	-1.66229221	62.71737594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509943-03	NCGC00509943-03	384569391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1268454-23-4				-9.5956811609	4	4		0	-4.66291324				PIK3CA	NC1=NC2=C(O1)C=CC(=C2)C3=C[N]4C(=NC=C4C(=O)N5CCOCC5)C=C3	ChemieTek	CT-SERA	-1.10309716	-1.2830304	-3.42908708	-4.66291324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253737-09	NCGC00253737-09	384568566		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	155270-99-8				-4.9138301882	4	4		0	-1.1982099				ADORA2A	CCN1C(=O)N(CC)C2=C([N](C)C(=N2)\C=C\C3=CC=C(OC)C(=C3)OC)C1=O	MedChem Express	HY-10888	-1.95163343	1.80235222	-0.42111596	-1.1982099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095003-07	Tioxolone	384568140	Carbonic Anhydrase Type I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	4991-65-5				3.617864842	4	4		0	-5.09600115				CA1	OC1=CC2=C(SC(=O)O2)C=C1	Selleck	S2603	3.45071418	0.24438674	-2.22589863	-5.09600115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387215-01	NCGC00387215-01	384569154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-11.5746908295	4	4		0	-3.91070054			1956	EGFR	C[C@@H](NC1=C2C=C([NH]C2=NC=N1)C3=CC=C(O)C=C3)C4=CC=CC=C4	Tocris	4941	-1.63403296	-2.79465371	-3.61343347	-3.91070054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346637-05	Odanacatib	384568871	Cathepsin K Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	603139-19-1				-8.1556819026	4	4		0	-0.86220169				CTSK	CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C2=CC=C(C=C2)[S+](C)([O-])=O)C(F)(F)F)C(=O)NC3(CC3)C#N	MedChem Express	HY-10042	-2.31018453	-1.21506683	-1.0911152	-0.86220169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378840-01	NCGC00378840-01	363678229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	867331-82-6				12.7834809173	4	4		0	1.72440339				SRC	CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C5=CC(=CC=C5Cl)OC(=O)C6=CC=CC=C6	MedChem Express	HY-10186	5.52190449	0.27339004	-2.36644466	1.72440339												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00165844-06	NCGC00165844-06	384568289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE			14.1253754462	-4.85	12.8912945682	4	4		11.5	10.78251026	0.182972018	0.9790362822			NC1=NC(=C(N=O)C(=N1)OCC2CCCCC2)N	SIGMA	N4411	1.73370319	0.43225518	0.14714538	10.78251026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-08	Trametinib	384568648	Mek 1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	871700-17-3				-12.8356360229	4	4		0	-4.55638885				MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	APExBIO	A3018	-2.17753121	-3.7114324	-1.82460271	-4.55638885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344622-15	NCGC00344622-15	384568725		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1561178-17-3		0.5011872336	-6.3	12.2623127366	4	4		-12.686571392	-3.90547616	0.1683200346	0.9824202214		DOT1L	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N]3C=C(Br)C4=C3N=CN=C4N	Selleck	S7079	6.17198336	0.7601729	-1.5891701	-3.90547616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344630-02	NCGC00344630-02	384568728		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	437742-34-2		1.4125375446	-5.85	11.5040585314	4	4		15.445908464	3.8771756	1	0.9994604008		PSMD1	C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]\3CCC\C=C3	SIGMA	SML1916	-2.45492372	-0.81979431	12.68393172	3.8771756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242482-11	NCGC00242482-11	377020426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1146618-41-8		5.0118723363	-5.3	-0.7580154424	4	4		12.266998344	8.68089919	0.0178682452	0.9998052994		AURKA	ClC1=CC=CC(=C1)NC(=O)NC2=NC=C(CCNC3=NC=NC4=C3SC=C4)S2	MedChem Express	HY-12003	-2.72249862	-2.40391977	1.98308545	8.68089919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379065-03	NCGC00379065-03	363678334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	625115-55-1				-2.8457522246	4	4		0	-1.34257254				GUCY1A2	COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24	Bio Vision	2644	0.02828454	-2.07728731	-0.66175365	-1.34257254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238621-08	NCGC00238621-08	384568467		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	425637-18-9				-5.664430614	4	4		0	-4.8361484					CN1CCN(CC1)C2=NC3=C(C=CC=C3)C(=N2)C/4=C(/C(=O)NC4=O)C5=C[NH]C6=C5C=CC=C6	MedChem Express	HY-10343	-0.08485363	-0.36658011	-2.25597834	-4.8361484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345083-01	NCGC00345083-01	174007178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	154589-96-5	Stauprimide			-17.4220344	4	4		0	-5.00938357					CO[C@@H]1C(C[C@H]2O[C@]1(C)[N]3C4=C(C=CC=C4)C5=C6C(=O)NC(=O)C6=C7C8=C(C=CC=C8)[N]2C7=C35)N(C)C(=O)C9=CC=CC=C9	LC Labs	S-9344	-2.40418611	-5.00992821	-5.77530456	-5.00938357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379255-03	NCGC00379255-03	384569097		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1232030-35-1		1.1220184543	-5.95	28.4368001894	4	4		20.777574308	16.84372594	0.2715871959	0.9516725327		PAK1	CCN1C(=O)\C(=C/C2=C1N=C(NC3=CC=C(N4CCNCC4)C(=C3)F)N=C2)C5=CC=C(Cl)C=C5Cl	ChemieTek	CT-F486	-0.64797859	2.12636695	22.9134193	16.84372594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378596-08	NCGC00378596-08	384569053		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1229208-44-9				1.0095900681	4	4		0	0.33872209				SYK	C1CN(CCO1)C2=CC=C(NC3=NC(=C[N]4C=CN=C34)C5=CC6=C(C=C5)C=N[NH]6)C=C2	MedChem Express	HY-15968	-0.08451895	0.66828676	0.72268669	0.33872209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161679-02	NCGC00161679-02	26755342		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	133407-82-6	MG-132	3.1622776602	-5.5	56.070921601	4	4	NCGC00161679-02;Z-Leu-Leu-Leu-al;MG132;CIPLUS_684965;MG-132;LS-172868;benzyloxycarbonylleucyl-leucyl-leucine aldehyde;benzyloxycarbonyl-leucyl-leucyl-leucinal;	-20.2941842359	-2.74515353	0.7488713163	0.9997399721	5707	PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	BIOMOL	BIOMOL_PI-102	54.04993065	17.48397675	1.79517363	-2.74515353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346651-08	NCGC00346651-08	384568882		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	170151-24-3				-0.1467708757	4	4		0	1.04712042					NCC/1=C/NC(=S)N1[C@H]2CCC3=C(F)C=C(F)C=C3C2	MedChem Express	HY-13289A	-1.51178918	-0.01490535	4.20835786	1.04712042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242503-02	NCGC00242503-02	384568503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[146362-70-1]				-0.7090136038	4	4		0	-0.28300552				CPA1	COC1=C(C(=CC=C1)OC)C2=CC(=N[N]2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(O)=O	Tocris	3721	-1.01248266	0.01490535	2.97233667	-0.28300552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263182-04	Mocetinostat	384568650	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	726169-73-9				-10.0574674268	4	4		0	-6.36639238				HDAC1	NC1=C(NC(=O)C2=CC=C(CNC3=NC(=CC=N3)C4=CC=CN=C4)C=C2)C=CC=C1	Selleck	S1122	0.36769905	-3.32976936	-5.59482629	-6.36639238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356071-11	NCGC00356071-11	384569026		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1446144-04-2				-4.1555745798	4	4		0	-4.20095279					CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(N)=O)\N=C2C4=CC=C(Cl)C=C4)C	MedChem Express	HY-15846	1.44251167	-2.96318925	-3.7599639	-4.20095279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090753-20	Azithromycin	384568081	50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	83905-01-5				9.6769506444	4	4		0	1.5704388					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MedChem Express	HY-17506	3.38075785	0.82017011	-1.00609324	1.5704388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179817-06	NCGC00179817-06	384568383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	5508-58-7		14.1253754462	-4.85	48.2483509629	3	4		34	30.59289656	0.3461912168	0.9180578316			C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CC[C@H]12	MedChem Express	HY-N0191	9.30651872	0.28320167	2.03060624	30.59289656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167467-03	Vecuronium bromide	170465295	Steroid non-depolarizing neuromuscular Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	50700-72-6	 ; Vecuronium bromide;Vecuronium bromide;Vecuronium Bromide; Bromuro de vecuronio; Norcuron			-0.6641252415	4	4		0	2.5633383					[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O	Prestwick	Prestw-1359	-2.39888424	6.34635534	-1.27349909	2.5633383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246187-03	NCGC00246187-03	384568510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	76748-86-2		3.5481338923	-5.45	50.0191575637	4	4		23	26.37853949	0.26923708	0.9525619298			COC1=CC=C2NC3=C(C=CC(Cl)=C3)C(N=C4C=C(CN5CCCC5)C(=O)C(CN6CCCC6)=C4)=C2N1	Microsource	01502329	6.52719665	1.49678192	18.01091571	26.37853949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485024-02	NCGC00485024-02	384569274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-1.8334685258	4	4		0	-2.89120715				LRRK2	C[N]1C=C(C=N1)C2=C[NH]C3=NC=NC(=C23)N4CCOCC4	SIGMA	PZ0249	-0.64156206	2.93369256	-0.12128563	-2.89120715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018238-11	NCGC00018238-11	384567998		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	20559-55-1				-9.8370923322	4	4		0	3.45026707					CCCOC1=CC=C2[NH]C(=NC2=C1)NC(=O)OC	Prestwick	Prestw-1460	-3.13958422	-4.33786467	-1.95518123	3.45026707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506868-01	NCGC00506868-01	384569320		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[1402438-74-7]				-4.4429846925	4	4		0	-2.49747365				NTRK1	CC(C)(CO)[N]1C=C(C(=O)C2=CN=CC(=C2)NC(=O)CC3=CC=C(Cl)C=N3)C4=CN=C(N)N=C14	Tocris	6115	-0.31112997	-1.46632045	-1.0828696	-2.49747365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346486-03	Abexinostat	384568795	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	783355-60-2				-19.6755094372	4	4		0	-6.42413743				HDAC1	CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO	Selleck	S1090	-2.85673879	-4.8571865	-5.98586254	-6.42413743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481588-01	ACY-241	384569257		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-6.3050313974	4	4		0	-5.35585391				HDAC1	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=C(Cl)C=CC=C3	APExBIO	B5936	0.67882902	-1.83290057	-3.94044217	-5.35585391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00372530-03	NCGC00372530-03	384569044		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-8.8158305178	4	4		0	-5.83133971				LDHA	N[S+]([O-])(=O)C1=CC=C(CC2=C(CC3CC3)[N](N=C2C4=CC(=CC=C4)C5=CC=CC=C5)C6=NC(=CS6)C(O)=O)C=C1	NCGCChem	GRB048-023	0.04350979	-2.26057736	-4.27539437	-5.83133971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346732-02	NCGC00346732-02	384568936		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-4.2690835494	4	4		0	-1.90916089					C[C@@H]1CNC(=O)CC[C@]/2(C)[C@@H](CC(N)=O)[C@H]3N4C2=C(C)/C5=[N]6/C(=C\C7=[N]8\C(=C(C)/C9=[N](/[C@]3(C)[C@@](C)(CC(N)=O)[C@@H]9CCC(N)=O)[Co+]468(O)\[N]%10=C\N([C@H]%11O[C@H](CO)[C@@H](O[P]([O-])(=O)O1)[C@H]%11O)C%12=C%10C=C(C)C(=C%12)C)[C@@](C)(CC(N)=O)[C@@H]7CCC(N)=O)C(C)(C)[C@@H]5CCC(N)=O	Selleck	S1668	0.22538386	-2.12636695	-2.76321383	-1.90916089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480771-01	NCGC00480771-01	384569241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1351635-67-0				-7.8912008179	4	4		0	0.30792918				BTK	NC1=C2N(C(=O)N([C@H]3CCCN(C3)C(=O)C=C)C2=NC=N1)C4=CC=C(OC5=CC=CC=C5)C=C4	Adooq	A15558	-2.11297366	-1.73147023	-2.16806008	0.30792918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510440-01	NCGC00510440-01	384569432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					-6.485959985	4	4		0	-2.97155795				KDM5A	CCC/1=C(/NC2=C(C=N[N]2C1=O)C#N)C3=CC=CC=C3C	Axon Medchem	2622	-1.84466019	0.37263378	0.26486168	-2.97155795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263598-06	NCGC00263598-06	384568691		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	743420-02-2		5.6234132519	-5.25	0.6541675797	4	4		-7.788453372	-3.99037781	0.7019286341	0.4810527566			NC1=C(NC(=O)C2=CC=C(CNC(=O)/C=C/C3=CN=CC=C3)C=C2)C=C(F)C=C1	Glixx	GLXC-05969	-1.04022191	7.88493069	1.11830489	-3.99037781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016361-21	NCGC00016361-21	384567935		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	103-90-2				-8.8342337892	4	4		0	-1.13202207				PTGS1	CC(=O)NC1=CC=C(O)C=C1	MedChem Express	HY-66005	-2.56588072	-0.7005515	-1.35373749	-1.13202207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481107-02	NCGC00481107-02	384569252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE			0.1	-7	22.8118272771	4	4		-20.961935756	-5.80161313	0.3985164023	0.8876561764		CECR2	CCC[S+]([O-])(=O)C1=NC(=CC(=N1)C2=CC3=C(C=C2)[N](C=C3)C4CC(C)(C)NC(C)(C)C4)NC5CC5	SGC	NVS-CECR2-1	14.18862691	-0.46206588	1.23602119	-5.80161313												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00188689-09	NCGC00188689-09	384568450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	85650-56-2		10	-5	65.8017082062	2.1	4		112.6961171959	89.03129657	0.0461489914	0.9986842016		DRD1	CN1C[C@H]2[C@H](C1)C3=CC(=CC=C3OC4=C2C=CC=C4)Cl	MedChem Express	HY-11100	-3.84937238	0.53884149	12.46209824	89.03129657												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016101-17	NCGC00016101-17	384567921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1218-35-5				-1.4913937622	4	4		0	-2.09325826				ADRA2A	CC1=CC(=CC(=C1C\C2=N\CCN2)C)C(C)(C)C	MedChem Express	HY-B0475	0.45255268	1.00809531	-2.55677545	-2.09325826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095133-09	Famciclovir	384568149	antiviral	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	104227-87-4				17.3581546278	4	4		0	-1.34569378					CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O	APExBIO	B1942	6.36693256	0.97754697	2.03449801	-1.34569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263102-06	Degrasyn	384568591	Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	856243-80-6		2.8183829313	-5.55	41.7272972692	3	4		37.4692989119	-6.48923445	1	0.9959634397		JAK2	CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-13264	-0.21754895	-2.47441576	30.42901371	-6.48923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346836-09	NCGC00346836-09	384568948		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1227911-45-6		14.1253754462	-4.85	4.2137750365	4	4		14.3599971599	10.25404157	0.273087044	0.9514101766		PDPK1	CNC1=NC(=CC(=N1)C2=CC3=C(C=C2)C(=N[NH]3)N)N4C[C@H](CC[C@H]4C)C(=O)NC5CCCCC5	MedChem Express	HY-14981	0.02817298	-1.82260024	-3.2166643	10.25404157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263206-04	NCGC00263206-04	384568665		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	882663-88-9				0.7607758211	4	4		0	0.95458045				LCK	CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)C3=CC4=CN=C(NCCN5CCOCC5)N=C4C=C3	Adooq	A13167	1.18326525	-0.27339004	-3.98186198	0.95458045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510506-01	NCGC00510506-01	384569467		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1434048-34-6				-3.7154899068	4	4		0	0.83140878				BTK	C[C@H]1CN(CCN1C2=CN=C(NC/3=C/C(=C\N(C)C3=O)C4=CC=NC(=C4CO)N5CC[N]6C7=C(CC(C)(C)C7)C=C6C5=O)C=C2)C8COC8	MedChem Express	HY-19834	-1.80307086	0	0.38259884	0.83140878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387875-03	NCGC00387875-03	363680715		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	934493-76-2				-10.1519524962	4	4		0	-1.10854503				MTOR	CCN1C(=O)\C(=C/C2=C(C)N=C(N)N=C12)C3=CC=N[NH]3	MedChem Express	HY-15900	-2.70460628	-0.63791009	-2.81989514	-1.10854503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507885-01	NCGC00507885-01	384569350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1872382-47-2				6.5413493646	4	4		0	4.86769492					CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)C(C)(C)C)C(=O)N[C@@H](CO)C(=O)OC	Selleck	S8359	-0.56865465	0.52168729	5.70924073	4.86769492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025099-02	NCGC00025099-02	384568048		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[110283-66-4]				-1.5656441348	4	4		0	1.69803311				SLC6A1	OC(=O)/C1=C/CCN(CCOC(C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F)C1	Tocris	1296	-2.62135922	2.54881502	2.97233667	1.69803311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345840-03	NCGC00345840-03	384568763		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	12847-42-4		15.8489319246	-4.8	14.5693789698	4	4		-17.175109664	-6.39592472	0.6898998889	0.5071255563		AKT1	CCN(CC)CCNC(=O)C1=CC=C2N=C(C3=CC=CC=C3)C(=NC2=C1)C4=CC=C(CN5CCC(CC5)N6C(=O)NC7=CC=CC=C67)C=C4	SynKinase	SYN-1118	3.34257975	0.52168729	14.94997057	-6.39592472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390475-03	NCGC00390475-03	384569185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[83280-65-3]		1.2589254118	-5.9	43.9884999163	4	4		30.582524268	-6.48082638	1	0.9999333673		STAT3	CC(=O)C1=CC2=C(O1)C(=O)C3=C(C=CC=C3)C2=O	Tocris	5522	-0.48543689	3.44313609	29.60565038	-6.48082638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013822-04	NCGC00013822-04	384567789		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[64048-12-0]		8.9125093813	-5.05	24.3776759735	3	4		46.1238481339	35.35022355	0.0360507533	0.9991983166		SHH	S1C(=C(C2=CC=NC=C2)C(=C1C3=CC=NC=C3)C4=CC=NC=C4)C5=CC=NC=C5	Tocris	3889	-2.45467225	-0.74839096	6.79199515	35.35022355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486932-01	NCGC00486932-01	384569281		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1103926-82-4]				3.5115050183	4	4		0	4.29210134			5054	SERPINE1	OC(=O)C1=C(NC(=O)COCC(=O)N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C=CC(=C1)Cl	Tocris	5769	0.08368201	1.7961383	-1.66767738	4.29210134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167512-03	NCGC00167512-03	384568320		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	159351-69-6				-21.4581540644	4	4		0	-3.69597615				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	MedChem Express	HY-10218	-5.49511855	-2.27510852	-4.396604	-3.69597615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016959-17	NCGC00016959-17	384567969		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	85721-33-1				2.6538486983	4	4		0	2.77198212				TOP2B	OC(=O)\C1=C\N(C2CC2)C3=CC(=C(F)C=C3C1=O)N4CCNCC4	MedChem Express	HY-B0356	0.19525802	-2.24517288	-0.21224985	2.77198212												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00250392-01	NCGC00250392-01	137275894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	496791-37-8	AR-C155858			-14.093849148	4	4		0	-1.7585693			6566	SLC16A1	CC(C)CN1C(=O)N(C)C(=O)C2=C1SC(=C2C(=O)N3C[C@H](O)CO3)CC4=C(C)[NH]N=C4C	NCGCChem	AR-C155858	-4.29567643	-1.406975	-1.18253487	-1.7585693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091149-26	Valproic acid sodium salt (Sodium valproate)			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1069-66-5				-0.5090231808	4	4		0	-2.87281651					CCCC(CCC)C(O)=O	Selleck	S1168	0.50912176	-1.80235222	2.28605805	-2.87281651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183677-03	NCGC00183677-03	174006434		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	76958-67-3	Hypothemycin	8.9125093813	-5.05	40.1363634712	3	4		70.8309215263	65.17973149	0.0041779608	0.9999892357	5604	MAP2K1	COC1=CC(=C2C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)CC3OC3C2=C1)O	ChemieTek	CT-HPTM	-2.71531608	-2.59660913	0.24063769	65.17973149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015399-27	NCGC00015399-27			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	41340-25-4				-3.107037638	4	4		0	0.93835715					CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(O)=O	Selleck	S1328	-2.09305614	0.15274171	2.04542036	0.93835715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025297-06	NCGC00025297-06	384568066		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	56974-61-9				-4.279758937	4	4		0	1.76435407				NFKB1	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	Selleck	S2101	-2.2480058	-0.09164503	0.29485478	1.76435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250385-11	NCGC00250385-11	377020424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1234480-50-2		1.2589254118	-5.9	19.7398004308	4	4		-17.02540416	-4.1878368	0.1610643961	0.9838423017		MAPK7	CCOC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)N5CCC(O)CC5	MedChem Express	HY-14443	8.25468376	2.91616039	-0.35425818	-4.1878368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387023-02	NCGC00387023-02	384569148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	319460-94-1		1.5848931925	-5.8	45.6836324459	4	4		21.5	15.8891455	0.5388452858	0.7635480063		FLT1	C[N]1N=C(C)C=C1C(=O)NC2=C(F)C=CC(=C2)NC3=CC4=N[NH]C(=C4C=C3)\C=C\C5=NC=CC=C5	SynKinase	SYN-1004	4.33863924	0.78979344	31.7273629	15.8891455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510498-01	NCGC00510498-01	384569460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1488363-78-5		2.2387211386	-5.65	82.3539229182	3	4		58.1600538435	11.94765204	1	0.9998516702			CC1=C(C(=CC(=C1)O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)C)C3=CC=C(C=C3)C(C)(C)C	MedChem Express	HY-19904	0.84518946	2.33900365	54.31486467	11.94765204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00531749-01	NCGC00531749-01	384569536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1375466-18-4				-5.5915650206	4	4		0	-4.95259658				HDAC1	ONC(=O)C1=CN=C(NC2(CCCCC2)C3=CC(=CC=C3)F)N=C1	MedChem Express	HY-19328	0.5409154	-1.20733343	-3.47263096	-4.95259658												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025125-23	NCGC00025125-23	384568052		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	64-86-8				-11.8012761423	4	4		0	-1.69803311				TUBB	COC/1=C/C=C2\C(=C/C1=O)[C@H](CCC3=CC(=C(OC)C(=C23)OC)OC)NC(C)=O	Microsource	01500205	-2.92649098	-2.78730064	-1.5891701	-1.69803311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016457-02	NCGC00016457-02	124882284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	480-41-1	Naringenine;NARINGENIN			4.5412506528	4	4	4',5,7-trihydroxyflavanone;CIPLUS_727689;naringenin;4',5,7-Trihydroxyflavanone;flavanone 3-dioxygenase;4',5,7-TRIHYDROXYFLAVANONE;BE 14348A;naringenin-7-sulfate;naringenin 7-O-methyltransferase;dimethylallyl diphosphate naringenin 8-dimethylallyltransferase;DMAPP naringenin DMAtransferase;(2S)-flavanone 3-hydroxylase;(+/-)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;Naringenin;flavanone 3-hydroxylase;naringenin monooxygenase;genistein synthase;alhagitin;NCGC00095963-01;CIPLUS_153433;Naringenine;NCGC_Prestw-466;NCGC00163598-01;flavanone 3beta-hydroxylase;NARINGENIN;LS-39547;NCGC00016457-01;(+/-)-Naringenin;naringenin 5-methyl ether 4'-glucoside;NADPH-2'-hydroxydaidzein oxidoreductase;isoflavone synthase;BE-14348A;naringenin 3-dioxygenase;	0	0.48110938			1576	ESR1	OC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	NP-200	2.23300971	-0.96884782	-1.20659211	0.48110938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016083-23	NCGC00016083-23	384567918		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[152-11-4]				-6.3100887774	4	4		0	2.32488823				DRD2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1	Tocris	0654	-2.84518828	-0.20954947	-0.90964221	2.32488823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183682-14	NCGC00183682-14	384568419		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	273404-37-8				-11.4207141107	4	4		0	-0.02980626				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C3=CC(=C(N)C=C3)Cl)C(C)(C)C	MedChem Express	HY-13205	-4.88145049	1.5566532	-0.03032141	-0.02980626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-17	Emetine dihydrochloride hydrate			DPI_SARS-CoV-2_General		7083-71-8		0.0014012856	-8.8534733462	23.0160390545	5	10		-71.479365951	-5.22000547	0.0378869174	0.8856146608			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375	86.99098114	57.69335884	33.86171085	21.78190762	14.94943974	20.74337251	13.09100847	-2.10440011	-4.56408855	-5.22000547						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346475-02	Birinapant	384568790	IAP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1260251-31-7		0.2238721139	-6.65	21.4356420928	4	4		-11.1261646559	2.18301435	0.4410286148	0.8587350342		XIAP	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC2=C([NH]C3=C2C=CC(=C3)F)C4=C(C[C@@H]5C[C@H](O)CN5C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C6=C([NH]4)C=C(F)C=C6	Selleck	S7015	8.7164612	-1.77180388	-1.73964323	2.18301435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346678-15	NCGC00346678-15	384568904		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	888216-25-9		2.8183829313	-5.55	98.091584899	4	4		-31.2559808639	-1.04665072	0.0362984414	0.9991873705		HSP90AB1	CC(C)C1=C(O)C=C(O)C(=C1)C/2=N/NC(=O)N2C3=CC4=C(C=C3)[N](C)C=C4	Selleck	S1159	29.311095	30.27340767	4.0984815	-1.04665072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091585-03	NCGC00091585-03	29215118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE			-0.6117382827	4	4	octocrilenum;UVINUL N-539;CIPLUS_165218;Octocrylene;2-ethylhexyl 2-cyano-3,3-diphenylacrylate;2-ETHYLHEXYL ESTER OF DIPHENYL METHYLIDINE CYANO ACETIC ACID;octocrylene;Octocrileno;2-Ethylhexyl 2-cyano-3,3-diphenylacrylate;2-ETHYLHEXYL 2-CYANO-3,3-DIPHENYLACRYLATE;Octocrilenum;OCTOCRYLENE;AB08080858-01;2-Ethylhexyl-2-cyano-3,3-diphenylacrylate;OCTOCRILENE;	0	-0.43110085					CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	0.42259473	-1.51883354	-0.43928015	-0.43110085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484078-02	NCGC00484078-02	384569270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1297538-32-9				-7.8264568713	4	4		0	-1.17013087				AR	CC(O)C1=CC(=N[NH]1)C(=O)N[C@@H](C)C[N]2C=CC(=N2)C3=CC(=C(C=C3)C#N)Cl	MedChem Express	HY-16985_cm2	-2.47922243	0.91130012	-1.79963157	-1.17013087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250379-21	NCGC00250379-21	377020168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	252917-06-9		3.1622776602	-5.5	35.0788838032	4	4		17.5	-1.32409546	1	0.8890632138		GSK3B	CC1=C[NH]C(=N1)C2=C(N=C(NCCNC3=CC=C(C=N3)C#N)N=C2)C4=CC=C(Cl)C=C4Cl	MedChem Express	HY-10182	5.09930976	0.15188335	15.17642058	-1.32409546												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475739-01	NCGC00475739-01	384569235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1276553-09-3		11.220184543	-4.95	17.0290120866	4	4		36.407451752	29.13010008	0.1207289266	0.990913913		PIK3CA	FC1=CC(=CC=C1C2=C(SC(=C2C#N)N3CCOCC3)C4=NN=C[NH]4)C#N	ActiveBioChem	A-1184	-2.42287646	1.00243013	1.06277455	29.13010008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186047-02	NCGC00186047-02	174006753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	42521-82-4	p21-Activated Kianse Inhibitor III, IPA-3;IPA-3			-5.4513236361	4	4		0	-2.60523992			5585	PAK1	OC1=CC=C2C=CC=CC2=C1SSC3=C4C=CC=CC4=CC=C3O	EMD Chemicals	506106	-1.68516235	2.54922913	-1.40592282	-2.60523992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184994-11	Cidofovir	384568422	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	113852-37-2				2.0982323932	4	4		0	-2.00933918					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	MedChem Express	HY-17438	1.31761442	-0.01490535	3.67863449	-2.00933918												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00346962-03	NCGC00346962-03	377020391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1469988-75-7		3.1622776602	-5.5	61.3663285852	2.2	4		52.9983298222	49.97877459	0.0240042402	0.9996446108		BTK	C[N]1C=C(C=N1)C2=CC=C3N=CC\4=C(N(C(=O)\C=C4)C5=CC6=C(CCN6C(=O)C=C)C=C5)C3=C2	MedChem Express	HY-80003	0.04160888	-0.43225518	13.12536786	49.97877459												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510497-01	NCGC00510497-01	384569459		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	441045-17-6				-9.2881717895	4	4		0	-2.11624441				TUBB	CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C	MedChem Express	HY-13442A	-0.75313808	-2.54452926	-4.3662826	-2.11624441												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00262228-03	NCGC00262228-03	384568571		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-0.9121148713	4	4		0	-1.07302534				HPGD	COC1=CC=C(C=C1)[N]2C=NC3=CC(=CC=C23)C(=O)N4CCCCC4	NCGCChem	DYD028-075	0.47419805	0.7783266	-2.66828381	-1.07302534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015772-20	NCGC00015772-20	384567889		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	82419-36-1				5.1368727107	4	4		0	1.30708904					CC1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0125	0.90709181	3.93515107	-1.29760226	1.30708904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025091-11	NCGC00025091-11	384568047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	112648-68-7				-5.0937905101	4	4		0	0.53827751				PLCG1	COC1=CC=C2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCC2=C1)NCCCCCCN5C(=O)\C=C/C5=O	MedChem Express	HY-13419	-2.85714286	1.13028868	1.44478844	0.53827751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686670-01	GS-441524			DPI_SARS-CoV-2_General		1191237-69-0		0.0044312541	-8.3534733462	439.5393500447	1.1	10		110.9278477621	107.66550523	0.0000063648	0.9880991424			NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	2.1173948	-1.90297507	7.96033235	2.06378987	8.06754221	79.09407665	107.98713482	113.13320826	106.86143125	107.66550523						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686694-01	Remdesivir			DPI_SARS-CoV-2_General		1809249-37-3		0.0222088798	-7.6534733462	360.3653528067	1.1	10		108.5042245956	104.89304813	2.283E-7	0.9954607349			CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	2.1657754	-0.24064171	0.98930481	-0.72192513	4.83957219	4.19786096	8.36898396	61.63101604	107.8342246	104.89304813						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00490649-01	NCGC00490649-01			DPI_SARS-CoV-2_General						12.5714685319	4	10		0	3.07486631					CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	-0.13368984	-0.24064171	0.0802139	-0.82887701	2.48663102	0.24064171	2.43315508	2.54010695	5.53475936	3.07486631						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244248-01	NCGC00244248-01			DPI_SARS-CoV-2_General						-1.7597268286	4	10		0	-1.4171123					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	1.20320856	3.12834225	-1.63101604	-1.52406417	1.36363636	2.59358289	-0.45454545	1.73796791	2.00534759	-1.4171123						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015256-29	Chloroquine		antimalarial agents	DPI_SARS-CoV-2_General		50-63-5		0.0012743412	-8.8947142596	55.7364709191	4	10		9.6497326199	12.96791444	0.0824794654	0.7393177114			CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	-1.79144385	1.4171123	0.34759358	-1.52406417	-1.31016043	1.4171123	2.00534759	12.21925134	3.71657754	12.96791444						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00163413-03	Lycorine HCl			DPI_SARS-CoV-2_General		2188-68-3		0.0019793685	-8.7034733462	153.9805844671	1.4	20		59.0588765638	8.90374332	0.059361172	0.7387819209			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General						45.7538814944	4	20		0	9.11764706					CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686694-01	Remdesivir			DPI_SARS-CoV-2_General		1809249-37-3		0.0222088798	-7.6534733462	357.0193461635	1.1	20		105.9162032052	104.89304813	0	0.99305334			CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016622-11	Hycanthone			DPI_SARS-CoV-2_General		3105-97-3		0.0140128558	-7.8534733462	233.4648188119	1.2	20		75.5172458022	-1.84491979	4.214E-7	0.9523235508			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	DPI_SARS-CoV-2_General		59721-29-8				-1.6831178176	4	20		0	-0.40106952					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00390693-06	NCGC00390693-06	384569207		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1233948-35-0				20.6499904663	4	4		0	1.9138756				TUBB	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C)C3=CC=C(S3)C#N	MedChem Express	HY-16191	6.86004351	-0.36658011	2.80112045	1.9138756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093926-10	NCGC00093926-10	384568120		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	3094-09-5				-8.4656166126	4	4		0	-2.24282297				TYMS	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2\C=C(F)/C(=O)NC2=O	MedChem Express	HY-B0021	-2.04496012	-0.88590194	-1.35633201	-2.24282297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480912-02	NCGC00480912-02	363681114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1652591-81-5		14.1253754462	-4.85	17.7421984643	4	4		26.248368384	21.53110048	0.2751893444	0.9503223231		PADI4	COC1=C2[N](C)C(=NC2=CC(=C1)C(=O)N3CC[C@@H](O)[C@@H](N)C3)C4=CC5=C(C=CC=C5)[N]4CC6CC6	Cayman	17488	-0.62364032	4.49060638	0.14742739	21.53110048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510507-01	NCGC00510507-01	384569468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1415823-73-2				-4.0554866032	4	4		0	0.338534				BTK	NC1=C(C(=NC=N1)NCC2CCN(CC2)C(=O)C=C)C3=CC=C(OC4=CC=CC=C4)C=C3	MedChem Express	HY-101215	-1.32894917	-0.38162113	-0.9273108	0.338534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182055-09	NCGC00182055-09	384568408		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	198481-33-3		3.9810717055	-5.4	59.4218694057	2.4	4		44.5443805083	44.96957691	0.1334962374	0.9888515902		ESR1	CC1=C([N](CC2=CC=C(OCCN3CCCCCC3)C=C2)C4=CC=C(O)C=C14)C5=CC=C(O)C=C5	MedChem Express	HY-A0036	3.70319001	-1.05827992	24.4555621	44.96957691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250381-02	NCGC00250381-02	174006473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	915720-21-7	 AZ-23;AZ-23			-16.6615176063	4	4		0	-5.23560209			4914	NTRK1	CC(C)OC1=CC(=N[NH]1)NC2=C(Cl)C=NC(=N2)N[C@@H](C)C3=CC=C(F)C=N3	Axon Medchem	1610	-2.89875173	-3.20465047	-4.44379046	-5.23560209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345784-11	NCGC00345784-11	384568740		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	898044-15-0				-9.3573208915	4	4		0	-3.50926843				PAK4	CN(C)C[C@@H](NC(=O)N1CC2=C([NH]N=C2NC3=C4SC=CC4=NC(=N3)C)C1(C)C)C5=CC=CC=C5	MedChem Express	HY-13007	-0.29126214	-3.97972872	-4.59093584	-3.50926843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091544-23	NCGC00091544-23	384568097		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	50-28-2				2.8499687532	4	4		0	1.10372152				ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	MedChem Express	HY-B0141	0.12482663	-1.26695484	3.70806357	1.10372152												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017280-37	NCGC00017280-37	384567982		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	302-79-4		0.8912509381	-6.05	9.1734031414	4	4		9.508368204	7.27272727	0.2060736855	0.9732274643		RORB	C/C1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1	MedChem Express	HY-14649	-1.67364017	2.33497979	9.12674348	7.27272727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345843-02	NCGC00345843-02	363677386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	(1003311-62-3)				3.3472201495	4	4		0	-3.90461997				KIT	CC\1=C(C(=O)N(\C=C1)C2=CC=C(C=C2)C3=NC=CO3)/C4=CC5=CN=C(N)N=C5C=C4	SynKinase	SYN-1125	2.59414226	2.1853016	-2.69860522	-3.90461997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371153-09	NCGC00371153-09	363678067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1342278-01-6				-2.2498929212	4	4		0	-3.30849478				ROCK1	OC1=CC(=CC=C1)CNC(=O)NC2=NC(=CS2)C3=CC=NC=C3	Glixx	GLXC-05200	0.27894003	0.20954947	-0.90964221	-3.30849478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263603-10	NCGC00263603-10	384568692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	120964-45-6		0.316227766	-6.5	64.2187317755	4	4		27.5	23.5171386	0.3283158241	0.9271234418		EZH2	NC1=NC=CC2=C1N=C[N]2[C@@H]3\C=C(CO)/[C@@H](O)[C@H]3O	MedChem Express	HY-12186	1.81311018	27.63059422	32.4742268	23.5171386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188866-01	NCGC00188866-01	137275837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	n				10.1073533143	4	4		0	6.78148547			5879	RAC1	FC(F)(F)C1=CC=C2C(SCCCCCO\C3=C\O\C(CN4CCOCC4)=C/C3=O)=CC=NC2=C1	NCGCChem	EHT1864	0.96206707	4.22991894	-0.53596615	6.78148547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241982-07	NCGC00241982-07	384568481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[850664-21-0]		12.5892541179	-4.9	29.1521705754	3	4		66.8552328024	54.51555024	0.0263203406	0.9995726017		ROCK1	CC[N]1C2=C(C=NC(=C2)OC3=CC(=CC=C3)NC(=O)C4=CC=C(OCCN5CCOCC5)C=C4)N=C1C6=NON=C6N	Tocris	4009_CM1	-3.35025381	-2.07728731	-2.27038184	54.51555024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095023-08	NCGC00095023-08	384568141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	434-03-7 				10.5129664384	4	4		0	-2.27272727				PGR	CC\12CCC(=O)\C=C1CCC3C2CCC4(C)C3CCC4(O)C#C	Adooq	A11667	4.2204496	-1.19138537	3.24340262	-2.27272727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386179-04	NCGC00386179-04	363680137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	936890-98-1				-4.4354275924	4	4		0	-3.11004785					COC1=CC=CC2=C1[NH]C(=C2)C3=C4[N](N=CN=C4N)C(=N3)[C@@H]5CC[C@H](CC5)C(O)=O	Glixx	GLXC-90206	0.21754895	-2.01619062	-1.79861418	-3.11004785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016371-06	NCGC00016371-06	363676482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	120-97-8				3.1456514243	4	4		0	-2.72299087				CA1	N[S+]([O-])(=O)C1=CC(=C(Cl)C(=C1)[S+](N)([O-])=O)Cl	Selleck	S2177	0.53431977	0.04579454	5.41429853	-2.72299087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025018-11	NCGC00025018-11	363676536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	65-19-0				0.5628320042	4	4		0	2.42861348				ADRA2A	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([NH]C5=C4C=CC=C5)[C@@H]3C[C@H]12	Selleck	S2373	0.36991369	-2.33552129	-0.80765779	2.42861348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250382-06	NCGC00250382-06	384568538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1218778-77-8				9.645083725	4	4		0	2.66025187				SMO	C[C@H]1CN(C[C@@H](C)O1)C2=NC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C2	MedChem Express	HY-16582	3.86962552	-1.50544045	-1.67745733	2.66025187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163424-11	NCGC00163424-11	384568237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	75747-14-7				33.4491845861	4	4		0	6.16989568				HSP90AB1	CO[C@H]1C[C@H](C)C\C2=C(NCC=C)\C(=O)\C=C(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C/[C@H](C)[C@H]1O)/C)C)/C2=O	MedChem Express	HY-10211	9.87447699	2.5744649	2.60764099	6.16989568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488783-01	NCGC00488783-01	363681476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1369764-02-2				-10.7754388643	4	4		0	-2.92101341				HCRTR1	CC1=NC(=C(OC[C@]2(C[C@H]2C(=O)NC3=NC=C(F)C=C3)C4=CC=CC(=C4)F)C=N1)C	MedChem Express	HY-16725	-2.92887029	-1.13755426	-0.4548211	-2.92101341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181034-04	NCGC00181034-04	384568388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[145858-50-0]				-1.2053239647	4	4		0	0.56631893				CYP17A1	ClC1=CC=CC(=C1)C([N]2C=CN=C2)C3=CC=C4N=C[NH]C4=C3	Tocris	2705	-1.61785216	-0.20954947	3.79017586	0.56631893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091268-11	NCGC00091268-11	174007181		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	79-57-2	; ; Oxytetracycline hydrochloride; Terramycin hydrochloride; Oxitetraciclina;Oxytetracycline hydrochloride;OXYTETRACYCLINE; Oxytetracycline Base;Oxytetracycline; Riomitsin;Oxytetracycline dihydrate; Oxytetracycline HCl; Oxytetracycline base; Oxytetracycline dihydrate; oxycort A; Terramycin			-3.7742229705	4	4		0	-1.01341282					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@H]3\C(=C(O)/[C@]2(O)C(=O)\C(=C1O)C(N)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Microsource	MS-01500457	-0.92050209	1.0178117	-1.97089145	-1.01341282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505021-01	NCGC00505021-01	384569315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	Indotecan hydrochloride				-21.7918934446	4	4		0	-5.21297863				TOP1	COC1=C(OC)C=C2C(=C1)C(=O)N(CCCN3CCOCC3)\C4=C2\C(=O)C5=C4C=C6OCOC6=C5	NCI	NSC743400	-4.70038483	-4.17096536	-4.25952045	-5.21297863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384168-11	NCGC00384168-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	912545-86-9		1.5848931925	-5.8	24.9021573881	4	4		27.82627818	-6.28940489	1	0.9998645471			CN[C@H]1CC[C@@H](CC1)N(CC2=CC=CC(=C2)C3=CC=NC=C3)C(=O)C4=C(Cl)C5=CC=CC=C5S4	DC Chemicals	DC8225	-3.18856515	-2.10759027	23.86459803	-6.28940489												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346548-07	NCGC00346548-07	363677450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	286370-15-8				-7.6067742058	4	4		0	-3.52145164				FLT1	CCCNC(=O)NC1=CC=C(OC2=NC=NC3=CC(=C(OC)C=C23)OC)C=C1Cl	MedChem Express	HY-12060	-0.71467839	-0.16212233	-4.34414669	-3.52145164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181754-07	NCGC00181754-07	384568398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	201530-41-8		14.1253754462	-4.85	12.7344213973	4	4		28.534634412	21.69767799	0.2809550653	0.948056673			OC(=O)C1=CC=C(C=C1)[N]2N=C(N=C2C3=CC=CC=C3O)C4=CC=CC=C4O	MedChem Express	HY-17359	-2.52886201	3.52247605	0.73342736	21.69767799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016229-20	NCGC00016229-20	384567923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	51-52-5				0.1659149534	4	4		0	-2.10671998				TPO	CCC\C1=C\C(=O)NC(=S)N1	MedChem Express	HY-B0346	1.86915888	-2.16654385	-2.17207334	-2.10671998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179578-11	NCGC00179578-11	384568377		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	83919-23-7		11.220184543	-4.95	40.867341154	3	4		59.4683452356	47.45813397	0.0790581958	0.9961272088			C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)CCl	MedChem Express	HY-13693	-0.59463379	2.96318925	6.92908742	47.45813397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345085-02	NCGC00345085-02	384568733		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	90365-57-4		2.2387211386	-5.65	146.8475056354	2.3	4		97.5883132208	94.71592582	0.0647305562	0.9974068936			CC(C)[C@@H]1N(C)C2=C3C(=C[NH]C3=CC=C2)C[C@@H](CO)NC1=O	SIGMA	I0661	4.97328401	3.73988704	48.25007478	94.71592582												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346661-05	NCGC00346661-05	384568892		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	71610-00-9				9.6756892525	4	4		0	2.54636444				TUBB	C/C=C(C)/C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]\1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@H]4[C@@](C)([C@@H](O)C[C@H]5OC[C@@]45OC(C)=O)C(=O)[C@H](OC(C)=O)C(=C1C)/C2(C)C)C6=CC=CC=C6	MedChem Express	HY-77554	3.52103028	1.78598687	-3.52976369	2.54636444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345847-02	NCGC00345847-02	377020179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(951151-97-6)				0.7772833228	4	4		0	-1.25110392				FLT1	CCNC(=O)NC1=C(Cl)C=C(OC2=C(\C=N\OC)C(=NC=N2)N)C=C1	SynKinase	SYN-1133	0.47951774	1.23645245	-0.53843853	-1.25110392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345824-02	NCGC00345824-02	363677371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(888719-03-7)				11.7639798486	4	4		0	3.31174566				MET	FC1=CC=C(C=C1)N2/C=C\C=C(C(=O)NC3=CC=C(OC4=C5C=C[NH]C5=NC=C4)C(=C3)F)/C2=O	SynKinase	SYN-1022	2.94560899	-1.48068997	4.00837571	3.31174566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480775-01	NCGC00480775-01	384569243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	857679-55-1 				-8.7703464041	4	4		0	-2.5633383				CCR2	OC1(CCC(CC1)N[C@H]2CCN(C2)C(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=NC=C(C=C4)C5=NC=CC=N5	Adooq	A11136	-2.34309623	0.23948511	-1.48574894	-2.5633383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386310-03	NCGC00386310-03	363680201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1393477-72-9				-21.3936435148	4	4		0	-2.23546945				XPO1	FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F	Selleck	S7252_CM1	-5.85774059	-2.81395001	-4.00242571	-2.23546945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249389-22	NCGC00249389-22	384568524		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1062368-62-0		2.8183829313	-5.55	-15.01501024	4	4		-6.510432196	-5.84202683	0.7104991189	0.458432026		ACVR1	C1CN(CCN1)C2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6	MedChem Express	HY-12071A	-4.12831241	4.7597665	-4.91206792	-5.84202683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379062-01	NCGC00379062-01	384569090		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	697235-39-5				1.7078922523	4	4		0	-0.11961722					CO[C@@H]1OC[C@@H](O[C@H]1OC2=CC(=C3C(=C2)O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)C5=CC=CC=C5)C6=CC=C(OC)C=C6)OC)[C@@H](O)CO	MedChem Express	HY-15359	-1.08774474	5.0710249	1.47427392	-0.11961722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161634-09	Artemisinin	384568213	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	63968-64-9				-3.3904337664	4	4		0	-1.04665072				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S1282	-0.68165337	-1.77180388	0.53073861	-1.04665072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386723-01	NCGC00386723-01	363680418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1142090-23-0				2.2903962073	4	4		0	4.40094201					CNC1=NC(=NC(=N1)C)N[C@H]2CCC[C@H](C2)C(=O)NCC3=CC=C(C=C3C(F)(F)F)C#N	Axon Medchem	2220	-1.24674613	-0.01526485	3.14089141	4.40094201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092360-02	NCGC00092360-02	384568106		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[73-03-0]				-3.9432921686	4	4		0	4.0182514				HPRT1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)C[C@H]3O	Tocris	2294	-1.90437046	-0.22897268	-2.75201914	4.0182514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346947-02	NCGC00346947-02	363677565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1001409-50-2		14.1253754462	-4.85	14.7620495172	4	4		29.228088544	24.18310274	0.1247063404	0.9903030292		PDPK1	FC1=CC=C(CN2\C=C/C=C(/C(=O)N[C@@H](COC3=CC4=C(NC(=O)N4)C=C3)C5=CC=CC=C5)C2=O)C=C1F	MedChem Express	HY-14440	-0.86313194	0.68691803	-2.27340712	24.18310274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263154-08	NCGC00263154-08	384568628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1173900-33-8				-5.2294890147	4	4		0	-0.95672652				PIK3CB	C[C@@H](NC1=CC=CC=C1C(O)=O)C/2=C/C(=C\N3C(=O)/C=C(\N=C23)N4CCOCC4)C	MedChem Express	HY-10344	-1.02753802	-1.35857121	-1.34609632	-0.95672652												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159453-14	NCGC00159453-14	384568177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	111406-87-2				-2.1921819223	4	4		0	-1.15933833				ALOX5	CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1	MedChem Express	HY-14164	0.26257601	-1.48522431	-1.370662	-1.15933833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253909-02	NCGC00253909-02	137275916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1194961-19-7	PRT-318?; PRT-060318;PRT-060318	12.5892541179	-4.9	48.9534152193	3	4		76.558780021	68.59889721	0.0235738783	0.9996571371	6850	SYK	CC1=CC(=CC=C1)NC2=C(C=NC(=N2)N[C@@H]3CCCC[C@@H]3N)C(N)=O	NCGCChem	DYD07-064	-0.26257601	-0.8421375	-1.51647711	68.59889721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345790-03	NCGC00345790-03	384568743		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	571170-77-9				-5.9192517788	4	4		0	0.62593145				PTGDR	C[S+]([O-])(=O)C1=C2[N](CC3=CC=C(Cl)C=C3)C4=C(CC[C@@H]4CC(O)=O)C2=CC(=C1)F	ChemieTek	CT-LR001_cm1	-1.70153417	-1.52671756	-1.39478472	0.62593145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263234-01	NCGC00263234-01	137276078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	730970-25-9	IDH-001	31.6227766017	-4.5	-0.3204460477	4	4		17.1536930559	11.96172249	0.1264231731	0.9900829588	3417	IDH1	CCCCC1=CC=C(N[S+]([O-])(=O)C2=CC=C(C)C(=C2)C(=O)N3CCN(CC3)C4=CC=CC(=C4C)C)C=C1	NCGCChem	IDH-001	-1.2617839	-0.73316023	-2.21141088	11.96172249												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00378630-01	NCGC00378630-01	363678131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	859853-30-8				-15.921237963	4	4		0	-4.04768914				FLT4	COC1=CC(=CC=C1)NC2=NC=N[N]3C=CC(=C23)CN4CC[C@@H](N)[C@H](O)C4	MedChem Express	HY-10333	-2.80860392	-3.34300107	-4.84594675	-4.04768914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346944-02	NCGC00346944-02	363677562		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	173897-44-4				-4.4594188054	4	4		0	-0.72122461				ROCK1	C[C@@H](N)C1=CC=C(C=C1)C(=O)NC2=C3C=C[NH]C3=NC=C2	MedChem Express	HY-10069	-1.24674613	1.87757594	-2.93149865	-0.72122461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510946-01	NCGC00510946-01	384569495		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	3432-99-3				-6.5536307476	4	4		0	-3.90216316					NC/1=N/C(=O)C/2=C(/NCC3CN(CN23)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	SantaCruz Bio	sc-470660	-0.37313433	-3.16949931	-0.67074949	-3.90216316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390788-02	NCGC00390788-02	384569214		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	27314-97-2				-1.2267619885	4	4		0	-1.64003959					NC1=[N+]([O-])C2=CC=CC=C2[N+](=N1)[O-]	MedChem Express	HY-13767	1.34051962	-2.12831113	-2.77048702	-1.64003959												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480777-01	NCGC00480777-01	384569244		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	552292-08-7				-10.0287616846	4	4		0	-6.64679583				TACR1	C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C3=CC=CC=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	Adooq	A13680	-1.70153417	-0.53884149	-0.48514251	-6.64679583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507863-01	NCGC00507863-01	384569338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1219810-16-8				-1.6084072523	4	4		0	-1.16244411				GPX4	COC(=O)[C@H]1CC2=C([NH]C3=C2C=CC=C3)[C@@H](N1C(=O)CCl)C4=CC=C(C=C4)C(=O)OC	Selleck	S8155	-0.86471409	-0.68851968	2.78956944	-1.16244411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162440-05	NCGC00162440-05	384568227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			11.220184543	-4.95	-6.9425606682	4	4		17.924686188	11.38599106	0.2176516187	0.9697777634			CCC(\C=C\[C@@H]1OC(=O)\C=C/[C@@H]1C)=C\[C@H](C)C/C=C/C(C)=C/[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(O)=O	BioAustralis	BIA-L1046	-4.93723849	-1.7961383	-2.27410552	11.38599106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346577-02	NCGC00346577-02	363677460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	N/A				9.1502529721	4	4		0	-4.54545455				BRAF	FC(F)(F)C1=CN=C([NH]1)C2=CC(=CC=N2)OC3=CC4=C([NH]C(=N4)NC5=CC=C(C=C5)C(F)(F)F)C=C3	Selleck	S2200	3.1182016	3.7879945	2.77163497	-4.54545455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253587-02	NCGC00253587-02	384568564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	210421-74-2	Sitaxentan			-7.6073454263	4	4		0	-4.21650718				EDNRA	CC1=C(CC(=O)C2=C(C=CS2)[S+]([O-])(=O)NC3=C(Cl)C(=NO3)C)C=C4OCOC4=C1	Selleck	S3034	-1.40681653	0.09164503	-1.32684653	-4.21650718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017323-11	NCGC00017323-11	384567983		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	64-75-5		7.0794578438	-5.15	0.0815504728	4	4		9.0804931079	7.47607655	0.3842462668	0.8981061848			CN(C)[C@H]\1[C@@H]2C[C@H]3C(=C(O)\[C@]2(O)C(=O)\C(=C1O)C(N)=O)/C(=O)C4=C(O)C=CC=C4[C@@]3(C)O	Selleck	S2574	-2.56707759	0.76370857	0.73713696	7.47607655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246835-02	NCGC00246835-02	384568512		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-3.3809711506	4	4		0	0.27428901					COC12C(COC(N)=O)\C3=C(/N1CC4C2N4C)C(=O)C(=C(N)/C3=O)\C	NCI	NSC56410	-1.27280441	0.06109669	-0.5414348	0.27428901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510691-01	NCGC00510691-01	384569481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	890405-51-3				0.1425172329	4	4		0	0.8806121					[O-][N+](=O)C1=C(OCC2CC(CC3=CC=CC=C3)C(=O)O2)C=CC=C1	Selleck	S8317	0.79196719	-1.40522377	-2.22589863	0.8806121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163547-01	NCGC00163547-01	26756928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	3604-87-3	ECDYSONE;Ecdysone			4.3769145359	4	4	Ecdysone;NCGC00163547-01;alpha-Ecdysone;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2beta,3beta,5beta,22R)-;CIPLUS_774291;ECDYSONE;2 beta, 3 beta, 14, 22 S, 25-pentahydroxy-5 beta- cholest-7-en-6-one;CIPLUS_162150;2beta,3beta,14alpha,22(R),25-Pentahydroxy-7-cholesten-6-one;22-iso-ecdysone;	0	-0.96878364					[H][C@]12CC[C@]3(C)C(CC[C@@]3(O)C1=CC(=O)[C@]4([H])C[C@@H](O)[C@@H](O)C[C@]24C)[C@H](C)[C@H](O)CCC(C)(C)O	BIOMOL	BIOMOL_NP-089	2.08905992	-2.19602063	1.86177715	-0.96878364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185990-14	NCGC00185990-14	384568431		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	74103-07-4				-6.7684566938	4	4		0	-1.64539443					OC(=O)C1CC[N]2C1=CC=C2C(=O)C3=CC=CC=C3	MedChem Express	HY-B0138	-1.51181968	-0.39793662	-2.00282087	-1.64539443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481577-01	NCGC00481577-01	377020308		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			0.4466835922	-6.35	21.6813577236	4	4		18.155567436	14.56339713	0.0337969973	0.9992969825		AXL	CN(C)[S+]([O-])(=O)C1=CC=CC=C1\N=C/2N\C(=N/C=C2Cl)NC3=CC=C(CN4CCN(C)CC4)C=C3	APExBIO	B5940	-3.35025381	-3.87963953	13.6517765	14.56339713												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263015-01	NCGC00263015-01	137275919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	n	NCGC00263015-01	12.5892541179	-4.9	24.0764222231	3	4		38.020048604	32.11701309	0.1682950856	0.982132204	7099	TLR4	CN(CC(O)COC1=CC=C(Cl)C=C1)CC2=C(C)[N](CC3=C(Cl)C=CC=C3)N=C2C	NCGCChem	BTM10-092	1.60585998	-3.76670717	-1.99801615	32.11701309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185773-02	NCGC00185773-02	124896661		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	25507-04-4	Clindamycin palmitate hydrochloride			-5.8281352668	4	4	CLINDAMYCIN PALMITATE HYDROCHLORIDE	0	-0.27713626					Cl.CS[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl	LKT Lab	C4534	-1.54951402	-0.63791009	-1.74295026	-0.27713626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346701-09	NCGC00346701-09	384568921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	248281-84-7				-7.1987322974	4	4		0	-3.35642802					CCN(C(=O)C/1=C(O)/C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3	MedChem Express	HY-13010	-1.04240034	-2.06561361	-0.83604931	-3.35642802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347303-01	NCGC00347303-01	174006484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	n				-8.6465054715	4	4		0	-0.92378753			5578	PRKCA	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]3CC[C@@H](C)[C@H]3[C@@H]2OC(=O)\C=C\C4=CC=CC=C4	NCI	Englerin A	-2.14114664	-3.43256379	-0.12753295	-0.92378753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346806-06	NCGC00346806-06	384568940		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	112093-28-4				-2.246946175	4	4		0	-5.69620253				PRKCA	CC\C(C1=CC=CC=C1)=C(\C2=CC=C(O)C=C2)C3=CC=C(OCCNC)C=C3	Axon Medchem	2221	0.97273599	-1.6943978	1.01705055	-5.69620253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016889-15	NCGC00016889-15	384567965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	59804-37-4				-0.1554954741	4	4		0	1.8398587					CN1\C(=C(\O)C2=C(C=CS2)[S+]1([O-])=O)C(=O)NC3=CC=CC=N3	MedChem Express	HY-B0440	0.15070558	-0.1679133	-2.57253964	1.8398587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346506-05	LY-2886721	384568809	beta-Secretase 1/2 (BACE1/2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1262036-50-9				-5.7158804687	4	4		0	-1.25110392				BACE1	NC/1=N/[C@]2(COC[C@H]2CS1)C3=CC(=CC=C3F)NC(=O)C4=NC=C(F)C=C4	MedChem Express	HY-13240	-0.97273599	-1.9996947	-1.28626982	-1.25110392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390241-09	NCGC00390241-09	384569180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	11137608-69-5		14.1253754462	-4.85	14.1674291197	4	4		24.2445319359	19.42598614	0.2084503829	0.9722859519			CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(Cl)C=C3)[N]4C=CC(=N4)C)C(F)(F)F	Selleck	S2173	1.06412383	-1.27086204	-3.12044328	19.42598614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263170-02	NCGC00263170-02	384568640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1258861-20-9				4.779379756	4	4		0	-1.49865686				SMO	C[N]1N=CC=C1C2=C3C=CC=CC3=C(N=N2)N4CCC(CC4)N(C)C(=O)C5=C(C=C(F)C=C5)C(F)(F)F	Selleck	S2157	3.35820896	-2.31205022	-1.51647711	-1.49865686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507846-01	NCGC00507846-01	384569327		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	890128-81-1				4.330492113	4	4		0	5.54220274				KDR	OCC1=CC(=NC=N1)OC2=CC=C3C(=C2)C=CC=C3C(=O)NC4=CC(=CC=C4)C(F)(F)F	Selleck	S8188	-0.04145937	-1.27086204	1.69145523	5.54220274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016438-06	NCGC00016438-06	384567940		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	366-70-1				-8.0102638887	4	4		0	-1.57355276					CNNCC1=CC=C(C=C1)C(=O)NC(C)C	Selleck	S1995	-1.95163343	-1.98564228	-0.66175365	-1.57355276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016916-15	NCGC00016916-15	384567967		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	70458-96-7				0.0904918152	4	4		0	-1.34257254				TOP2B	CCN1\C=C(\C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(=C2)F	Prestwick	Prestw-221	-0.02828454	0.91645028	0.75199278	-1.34257254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346679-10	NCGC00346679-10	363677513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	452342-67-5				-10.7482883331	4	4		0	0.47670306				TGBR1	O=C(NC1CCOCC1)C2=CC=C(C=C2)C3=NC=CC(=C3)C4=C[NH]N=C4C5=NC=CC=C5	Glixx	GLXC-04575	-2.91368884	-2.84450995	-2.3977433	0.47670306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246971-04	Polydatin	363677157	V/ICAM1 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	65914-17-2				0.7467463304	4	4		0	-1.57973174				ICAM1	OC[C@H]1O[C@@H](OC2=CC(=CC(=C2)/C=C/C3=CC=C(O)C=C3)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2390	-1.81311018	6.10687023	3.27471195	-1.57973174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165719-16	NCGC00165719-16	384568274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					6.618210648	4	4		0	-1.87779434					NCCCC(O)([P](O)(O)=O)[P](O)([O-])=O	Selleck	S1624	2.84518828	0.74839096	0.33353548	-1.87779434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263194-02	NCGC00263194-02	384568658		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	280744-09-4				4.7800938807	4	4		0	0.33203407				GSK3B	C[N]1C=C(C2=C1C=CC=C2)C/3=C(C(=O)NC3=O)\C4=CC(=CC(=C4)Cl)Cl	SynKinase	SYN-1075	0.56569085	-0.30548343	4.72251466	0.33203407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274064-02	NCGC00274064-02	384568710		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	2152-44-5		14.1253754462	-4.85	3.3821442951	4	4		11.196495716	8.79168471	0.3080509661	0.9373892958		NRC31	CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO	Selleck	S1690	-1.18795078	1.19138537	-1.41374643	8.79168471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484075-02	NCGC00484075-02	384569269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1620576-64-8				-12.6999465549	4	4		0	-3.45026707				PIK3CA	CC[N]1N=C(N=C1C2=NC(=C(N)N=C2)C3=NN=C(O3)C(C)(C)C)C4CCN(CC4)C(=O)CCO	MedChem Express	HY-12869_cm2	-2.00820252	-2.90209256	-4.24123928	-3.45026707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509991-01	NCGC00509991-01	384569399		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	77472-98-1		12.5892541179	-4.9	50.4041930227	3	4		63.5645310099	58.8566479	0.095078476	0.9943841668			C1CC(CCN1)CCC2=CC(=NC3=CC=CC=C23)C4=CC=CC=C4	MedChem Express	HY-100140	2.17790977	2.96318925	-1.74462325	58.8566479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499183-01	NCGC00499183-01	363681481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-8.9858667129	4	4		0	-5.06712863				MST	CN1C(=O)C2=C(C=CS2)N(C)C3=NC(=NC=C13)NC4=CC=C(C=C4)[S+](N)([O-])=O	TruePharmaChem	XMU-MP-1	-0.45255268	-2.53551245	-3.24860881	-5.06712863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-08	Telaprevir (VX-950)	384568831	HCV NS3 NS4A Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	402957-28-2				-16.1789286638	4	4		0	-5.18261874					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	APExBIO	A4031	-3.30929147	-2.62715748	-2.88765228	-5.18261874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346946-02	NCGC00346946-02	363677564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1415559-43-1				3.754055525	4	4		0	-1.76435407				CDK9	CC1=CC=C(NC2=NC=NC(=C2)C3=CC=CC(=C3)N4C(=O)C5=C(C=CC=C5)C4=O)C=C1N[S+](C)([O-])=O	MedChem Express	HY-13231	2.42204496	0.03054834	-1.62170131	-1.76435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163409-07	Betulinic acid	384568234	Caspase 3/8 Activator	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	472-15-1				-12.4622319605	4	4		0	-2.40184758				CASP3	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	Prestwick	Prestw-NAT-0019	-2.84547119	-2.61239368	-2.25308205	-2.40184758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510518-01	NCGC00510518-01	384569471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1610759-22-2				-10.3939930346	4	4		0	-3.41801386				TTK	CC1=CC(=CC=C1C(=O)NC2CC2)C3=C4N=C(OC5=CN=CC=C5)C=C(NC[C@@H]6C[C@](C)(O)C6)[N]4N=C3	MedChem Express	HY-101340	-1.97210875	-1.70109356	-0.24089556	-3.41801386												1.6E-8	8E-8	4E-7	0.000002											
NCGC00015122-14	NCGC00015122-14	363676440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	31677-93-7				-4.9619365723	4	4		0	-0.30792918				SLC6A3	CC(NC(C)(C)C)C(=O)C1=CC=CC(=C1)Cl	Selleck	S2452	-1.40864911	0.5164034	-2.13971943	-0.30792918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016991-07	NCGC00016991-07	384567972		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	5875-06-9				0.8809885565	4	4		0	-2.09424084					CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC	Selleck	S1828	0.62413315	-2.42957222	3.64920541	-2.09424084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263163-11	NCGC00263163-11	384568634		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1022150-57-7				-5.3654572782	4	4		0	4.3219076				MET	C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C=C2)SC4=CC5=C(C=C4)N=CC=C5	MedChem Express	HY-12019	-4.12831241	0.3891633	2.39539115	4.3219076												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	DPI_SARS-CoV-2_General						9.4561001607	4	10		0	2.27563283					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	1.5597034	0.07670672	2.22449501	1.5597034	0.74149834	1.40628995	0.33239581	2.68473536	-0.28125799	2.27563283						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General		1190307-88-0				8.3077042891	4	10		0	2.68473536					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-1.30401432	-1.2528765	-0.63922271	1.5597034	0.38353362	-0.53694707	1.61084122	2.32677065	-1.04832524	2.68473536						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00182390-05	NCGC00182390-05			DPI_SARS-CoV-2_General				0.024918773	-7.6034733462	199.1805499365	1.2	10		67.5443620592	55.97034007	0.0132879892	0.8720536468			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	-0.74149834	-0.63922271	2.88928663	1.45742777	0.63922271	4.78138583	21.96369215	17.25901304	75.19815904	55.97034007						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00246387-06	Arbidol		antiinfluenza drug	DPI_SARS-CoV-2_General		131707-23-8		0.0279593232	-7.5534733462	274.8448954945	1.1	10		95.2658268528	80.27338515	0.0010690704	0.9445753443			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	2.2782096	5.28008577	-0.29482712	0.18761726	-2.17099973	7.74591262	1.79576521	23.82739212	103.26990083	80.27338515						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General		192725-17-0		0.0497194887	-7.3034733462	50.8916616118	4	10		18.961940504	16.858751	0.6069232089	0.9773098985			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	0.99169124	0.18761726	-1.42053069	0.34843206	0.02680247	-0.0804074	-1.63495042	0.34843206	82.36397749	16.858751						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244248-01	NCGC00244248-01			DPI_SARS-CoV-2_General						19.9389516612	4	10		0	6.72741892					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	1.90297507	2.06378987	-1.90297507	-0.77727151	-1.79576521	-0.34843206	2.65344412	-0.50924685	1.20611096	6.72741892						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General		55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	0.0070230644	-8.1534733462	204.3279302593	1.2	10		64.4053475956	47.45989305	0.0020895832	0.9313966169			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-0.82887701	5.58823529	-0.93582888	-0.24064171	0.34759358	20.77540107	49.38502674	67.72727273	79.97326203	47.45989305						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General		97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	0.0702306445	-7.1534733462	223.1950176626	3	10		93.6604278033	74.46524064	4.397E-7	0.9945173138	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	0.6684492	1.14973262	-0.61497326	4.03743316	1.73796791	3.23529412	4.30481283	2.00534759	8.85026738	74.46524064						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090782-17	Nelfinavir Mesylate			DPI_SARS-CoV-2_General		159989-65-8		0.0049719489	-8.3034733462	186.0927240153	1.4	10		70.2033155069	-2.70053476	0.0750508395	0.7816356001			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	-0.72192513	1.04278075	1.31016043	4.2513369	15.10695187	44.03743316	100.18716578	86.01604278	34.51871658	-2.70053476						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00651732-01	ROC-325			DPI_SARS-CoV-2_General		1859141-26-6		0.0075228402	-8.1236181626	272.026556125	1.1	10		98.8067914502	64.19786096	0.0065837524	0.899762345			CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	-0.0802139	0.34759358	-0.0802139	-0.6684492	-1.20320856	-0.6684492	5.7486631	95.16042781	123.23529412	64.19786096						8.682634731E-11	1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8					
NCGC00250412-15	JQ1		Brd4 Inhibitor	DPI_SARS-CoV-2_General		1268524-70-4				6.9781128587	4	20		0	4.1543822				BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General		917389-32-3		0.0702306445	-7.1534733462	68.7756472878	2.4	20		34.327392116	25.6499598	0.0000087843	0.9090636039	3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00246387-06	Arbidol		antiinfluenza drug	DPI_SARS-CoV-2_General		131707-23-8		0.0279593232	-7.5534733462	257.7521762766	1.1	20		85.8519163732	80.27338515	7.61E-8	0.9517134694			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163432-03	NCGC00163432-03	384568239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[117591-20-5]		1.1220184543	-5.95	190.8196528094	1.1	4		91.612702075	101.12394149	0.0336263546	0.9993019755			CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Tocris	0448	8.98718129	37.7582017	94.27518776	101.12394149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016014-09	NCGC00016014-09	124881627		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	133550-30-8	 ;AG-490; Tyrphostin-AG-490; Tyrphostin B42; tyrphostin AG-490;Tyrphostin B42; tyrphostin B42; Tyrphostin AG 490;Tyrphostin AG 490			8.290634037	4	4		0	4.87194583			3717	JAK2	OC1=C(O)C=C(C=C1)\C=C(/C#N)C(=O)NCC2=CC=CC=C2	BIOMOL	EI-272	3.00041102	-0.87009617	-3.44002393	4.87194583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017236-16	Baicalein	384567977	Cyp2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	491-67-8				14.9424679794	4	4		0	6.14121975				CYP2C9	OC1=CC2=C(C(=O)\C=C(/O2)C3=CC=CC=C3)C(=C1O)O	APExBIO	N1858	2.0665742	2.81711134	4.44379046	6.14121975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389085-04	NCGC00389085-04	384569171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1613028-81-1				-6.1833009838	4	4		0	-1.92443753					CC1=CC(=C(C(=C1)C)[S+]([O-])(=O)N(CCC2=CC=CC(=C2)Br)CC3=CC=C(C=C3)C4=CC=CC(=C4)[S+](C)([O-])=O)C	DC Chemicals	DC8279	-1.45631068	-0.87941571	-0.58858152	-1.92443753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093644-09	NCGC00093644-09	384568116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	51264-14-3				-15.6520305741	4	4		0	-4.27338333				TOP2A	COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(=C1)N[S+](C)([O-])=O	MedChem Express	HY-13551	-2.95423024	-3.20465047	-3.82577987	-4.27338333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090504-14	NCGC00090504-14	384568078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	961-29-5				7.6221212414	4	4		0	5.49030706				SIRT1	OC1=CC=C(C=C1)/C=C/C(=O)C2=C(O)C=C(O)C=C2	Selleck	S2404	2.0110957	-0.25339097	-2.06003531	5.49030706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346624-10	NCGC00346624-10	384568864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1166227-08-2				-7.3504560807	4	4		0	-0.20864382				PIK3CA	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(N)=O)C3=CSC(=N3)C(C)(C)C	MedChem Express	HY-13261	-1.84100418	-0.83819787	-2.72892662	-0.20864382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015094-18	NCGC00015094-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	315-30-0		0.2511886432	-6.6	25.7114282754	4	4		-11.008756172	1.66915052	0.3010675204	0.9403556398			OC1=C2C=NNC2=NC=N1	MedChem Express	HY-B0219	9.87447699	-1.25729681	0.18192844	1.66915052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015061-27	NCGC00015061-27	384567804		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	59277-89-3				-1.4888952526	4	4		0	2.68256334					N\C1=N\C2=C(N=C[N]2COCCO)C(=O)N1	MedChem Express	HY-17422	-0.80892608	-1.43691064	-0.60642814	2.68256334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182058-03	NCGC00182058-03	124893779		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	54573-75-0	TSA-840; ; Doxercalciferol; 1alpha(OH)2D2; 1alpha-hydroxyvitamin D2; 1alpha-OHD2;Hectorol	14.1253754462	-4.85	8.6576364009	4	4	1alpha-hydroxyvitamin D2;1A-HYDROXYVITAMIN D2;DOXERCALCIFEROL;doxercalciferolum;doxacalciferol;1 alpha-hydroxyergocalciferol;doxercalciferol;Hectorol;HECTOROL;Bone Care brand of 1 alpha-hydroxyergocalciferol;1alpha-OHD2;1A-HYDROXYERGOCALCIFEROL;CIPLUS_700330;Draxis brand of 1 alpha-hydroxyergocalciferol;1alpha(OH)2D2;	11.192688288	9.58019376	0.4403946223	0.8596188481	7421	VDR	C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@H](C)C(C)C	APAC	555784	-0.57724024	3.4045689	0.84626234	9.58019376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090851-17	NCGC00090851-17	384568089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	320-67-2				-10.2610216312	4	4		0	-0.87651853				DNMT1	NC/1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Adooq	A10105	-1.7042331	-3.25718497	-4.25952045	-0.87651853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165863-16	NCGC00165863-16	384568291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	219580-11-7		14.1253754462	-4.85	12.3737519044	3	4		38.923836384	30.18606797	0.1055113224	0.9930776343		FGFR1	CCN(CC)CCCCNC1=NC=C2C=C(C(=NC2=N1)NC(=O)NC(C)(C)C)C3=CC(=CC(=C3)OC)OC	MedChem Express	HY-10321	-2.06157229	-2.10759027	-4.93653032	30.18606797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022848-25	NCGC00022848-25	384568014		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	50-23-7				-6.9195888222	4	4		0	0.01537752					C[C@]\12CCC(=O)\C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23	MedChem Express	HY-N0583	-1.9791094	0.19159912	-2.87729196	0.01537752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498399-01	NCGC00498399-01	363681480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-8.6538452592	4	4		0	-3.58296171				ADAM10	COC(=O)N1CC2(CC2)C[C@@H]([C@H]1C(=O)N3CCN(CC3)C4=CC=CC=C4)C(=O)NO	NCGCChem	PJM010-074	-1.26443101	-1.19380987	-2.73624824	-3.58296171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346498-01	NCGC00346498-01	174007476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	916881-67-9	Danoprevir			1.9584454649	4	4		0	2.26049516					CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)N[S+]([O-])(=O)C6CC6	Selleck	S1183	-0.38482683	-0.01473839	1.80535966	2.26049516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016306-09	NCGC00016306-09	384567930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	68-41-7				0.5269100011	4	4		0	1.13636364				GRIN2A	N[C@@H]1CONC1=O	Selleck	S1998	-0.39158811	1.58851382	-0.61919505	1.13636364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186028-04	NCGC00186028-04	384568436		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	102767-28-2				-1.1450081203	4	4		0	1.16626794					CC[C@H](N1CCCC1=O)C(N)=O	Selleck	S1356	-0.36258158	0.06109669	-1.62170131	1.16626794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167488-03	NCGC00167488-03	124893321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar	0.7079457844	-6.15	64.434984092	2.4	4	4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAY-439006;sorafenibum;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-, MONO(4-METHYLBENZENESULFONATE);Sorafenib base;BAY 43-9006;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID-4-METHYLBENZENESULFONATE;Nexavar;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N2-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;SORAFENIB;BAY-43-9006 TOSYLATE;Sorafenib Tosilate;BAY-439006 TOSYLATE;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE;sorafenib;CIPLUS_789424;sorafenib tosylate;SORAFENIB TOSYLATE;Sorafenib tosylate;Sorafenib;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;	43.1159497748	-6.54904306	1	0.9998855509	2321	FLT1	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2	Pharmeks	PHAR202191	-0.7106599	19.18435925	36.53250774	-6.54904306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522475-03	Verubecestat (MK-8931)			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1286770-55-5(free base)				-10.9877936281	4	4		0	-3.63556079					CN1C(N)=N[C@@](C)(C[S+]1([O-])=O)C2=CC(NC(=O)C3=NC=C(F)C=C3)=CC=C2F	Selleck	S8173	-2.7812029	-0.56479927	-1.10679031	-3.63556079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347934-09	NCGC00347934-09	363677720		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1355326-35-0				-1.3473832595	4	4		0	-0.78010009				IDH1	CC1=CC=CC=C1C(N(C(=O)C[N]2C=CN=C2C)C3=CC=CC(=C3)F)C(=O)NC4CCCCC4	MedChem Express	HY-18082	0.2055076	-0.22897268	-1.61531558	-0.78010009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346580-05	NCGC00346580-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1201898-17-0				-5.0393859612	4	4		0	0.60347365					[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)\C=C/C3)C(=O)OC)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=C8C=CC=C9)C(C)(F)F)C(=O)OC	MedChem Express	HY-B0628A	0.12330456	-3.19035262	-5.11516602	0.60347365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386295-01	NCGC00386295-01	363680194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1421919-75-6				-15.4331433094	4	4		0	-4.25375331				XPO1	FC1(F)CN(C1)C(=O)\C=C/[N]2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F	Selleck	S7251	-2.58939581	-3.43459014	-4.63655399	-4.25375331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092384-05	NCGC00092384-05	384568110		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[57653-26-6]				25.4184302524	4	4		0	1.13202207				GRM5	CN1CC(=O)\N=C1\NC(=O)NC2=CC(=CC=C2)Cl	Tocris	2386	8.36338419	4.18840364	0.41200706	1.13202207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346709-02	NCGC00346709-02	384568926		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	5289-74-7				0.3847673783	4	4		0	3.1130607					CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C/3=C/C(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C	Selleck	S2417	-1.04022191	2.81711134	-1.79517363	3.1130607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015520-13	Hydroxyurea	384567861	Ribonucleoside-Diphosphate Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	127-07-1				8.5469125295	4	4		0	-0.44709389				RRM1	NC(=O)NO	Selleck	S1896	3.82147838	-1.406975	0.15160703	-0.44709389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024762-06	NCGC00024762-06	384568034		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1185241-83-1]		14.1253754462	-4.85	16.5884091549	4	4		28.260225664	23.29693987	0.0776713132	0.9962687734		ESR1	CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1	Tocris	0743	0.21990104	-0.51584377	-1.46685472	23.29693987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			2.6755633235	4	4		0	-2.7218207				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	1.81418362	0.92851879	-0.8180536	-2.7218207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163128-17	NCGC00163128-17	384568232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	112529-15-4				1.6152910603	4	4		0	5.24373366				PPARG	CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1	Microsource	01504401	-2.30896097	1.10537951	4.03385049	5.24373366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165740-14	NCGC00165740-14	384568277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	86541-74-4				5.1135897754	4	4		0	5.02844841				ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=C(C=CC=C3)N(CC(O)=O)C2=O	MedChem Express	HY-B0093A	0.90709181	-0.16212233	-1.21297602	5.02844841												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386757-02	NCGC00386757-02	384569145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	286936-40-1				-11.4264608516	4	4		0	-3.22966507					CN(C)CCNC(=O)COC1=C2CC3=CC=CC(=C3OCC(=O)NCCN(C)C)CC4=CC=CC(=C4OCC(=O)NCCN(C)C)CC5=CC=CC(=C5OCC(=O)NCCN(C)C)CC1=CC=C2	Axon Medchem	2332	-3.58230602	-0.33603177	0.17691287	-3.22966507												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00389590-05	NCGC00389590-05	363680811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1604810-83-4		0.2238721139	-6.65	13.6473769436	4	4		16.52794904	6.31439505	0.4776739457	0.8270966395		CDK7	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC(=CC=C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=CC=CC=C45	MedChem Express	HY-80013	-3.3566242	11.03648298	13.99940173	6.31439505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496841-01	NCGC00496841-01	384569295		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	935273-79-3				-5.7578054486	4	4		0	-0.4857227				SMO	C[N]1C(=NN=C1C23CCC(CC2)(CC3)C4=NOC(=N4)C5CC(F)(F)C5)C6=CC=CC=C6C(F)(F)F	Selleck	S8200	-1.08234005	-1.96916501	-1.79479509	-0.4857227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263118-02	NCGC00263118-02	384568602		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	329306-27-6				11.0837862416	4	4		0	5.82991368				PDE4A	C[S+]([O-])(=O)OC1=CC=C2C(=C(OC2=C1)C(=O)C3=C(Cl)C=C(Cl)C=C3)NC(N)=O	Axon Medchem	1178	2.17753121	0.40244448	1.26545026	5.82991368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021191-15	NCGC00021191-15	384568005		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	50-04-4				6.4987612165	4	4		0	-0.14150276				NRC31	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	MedChem Express	HY-17461A	2.51040222	-0.16395886	0.44143614	-0.14150276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346718-02	NCGC00346718-02	384568931		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	343787-29-1		11.220184543	-4.95	11.0303123638	4	4		16.8495145681	14.74458752	0.0489491871	0.9985284156		PDGFRB	COCCOC1=CC=C2[N](C=NC2=C1)C3=NC4=C(C=CC=C4C=C3)N5CCC(N)CC5	Selleck	S1536	-0.29126214	0.31301237	0.76515597	14.74458752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475742-01	NCGC00475742-01	363681099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1260533-36-5		2.5118864315	-5.6	15.0433759157	4	4		16.539748956	14.51564829	0.0302853037	0.9994372972		HSP90AB1	CCC1=CC(=CC=C1[N]2N=C(C(C)C)C3=C(C=CN=C23)[N]4C=NC(=C4)C5=C[N](C)N=C5)C(N)=O	ActiveBioChem	A-1924	-1.28312413	1.19742554	9.49060036	14.51564829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521070-01	NCGC00521070-01	384569505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1435467-37-0				-7.9934517072	4	4		0	-1.40089419					COC1=CC=C(Cl)C=C1\C2=C\C(=O)NC(=S)N2CC(N)=O	BOC Sciences	1435467-37-0	-2.0083682	-0.53884149	-2.06185567	-1.40089419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241036-03	NCGC00241036-03	384568468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	n	 NCGC00241036-01;NCGC00241036-01			-8.032468196	4	4		0	1.21482393			3720	JARID2	OC(=O)C1=CC=C(O)C2=NC=C(C=C12)N3CCOCC3	NCGCChem	GRB26-028	-2.99615173	0.72218128	-2.56699577	1.21482393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347938-05	NCGC00347938-05	384568990		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1230487-00-9		8.9125093813	-5.05	11.133041551	4	4		19.538688288	18.06858373	0.0547043857	0.9981563775		S1PR1	CCC1=CC(=CC=C1CN2CC(C2)C(O)=O)\C(C)=N\OCC3=CC=C(C4CCCCC4)C(=C3)C(F)(F)F	MedChem Express	HY-12355	-0.38482683	-1.28224024	-0.70521862	18.06858373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran	11.220184543	-4.95	62.9891141103	3	4		107.9334796318	95.72368421	0.0097345282	0.9999415502		CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	-2.71211022	-1.83290057	-0.50125313	95.72368421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481403-01	NCGC00481403-01	377020458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1609281-86-8				9.8928441757	4	4		0	0.26913876				IKBKB	CC1=C(C(=NO1)C)C2=CC=C(C(=C2)O[C@H]3CCNC3)C4=CC(=C(NC(N)=O)S4)C(N)=O	MedChem Express	HY-19362	3.90137781	-0.12219337	-0.26536931	0.26913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160338-03	Oxymatrine			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	16837-52-8		1.995262315	-5.7	24.2715656427	4	4		18.279490344	1.36885487	1	0.9998987127			[O-][N@+]12CCC[C@@H]3C[N@@]4[C@H](CCCC4=O)[C@H](CCC1)[C@H]23	Selleck	S2338	-0.23290862	0.10685392	17.14029315	1.36885487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475735-01	NCGC00475735-01	377020396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1346242-81-6				-16.1772887531	4	4		0	-5.3723874				FGFR1	COC1=CC(=CC(=C1)N(CCNC(C)C)C2=CC=C3N=CC(=NC3=C2)C4=C[N](C)N=C4)OC	ActiveBioChem	A-1278	-2.91820797	-2.61028851	-4.12802872	-5.3723874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015958-18	NCGC00015958-18	384567910		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	129-56-6				1.4573531471	4	4		0	-4.01526933				MAPK8	[O]=[C]1C2=C(C=CC=C2)C3=N[NH]C4=CC=CC1=C34	MedChem Express	HY-12041	2.25262576	0.62777523	-2.47885681	-4.01526933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090749-19	NCGC00090749-19	384568080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	56-53-1		12.5892541179	-4.9	29.6966673147	3	4		46.8327064936	40.57684151	0.0564125615	0.9980334143		ESR1	CCC(/C1=CC=C(O)C=C1)=C(/CC)C2=CC=C(O)C=C2	MedChem Express	HY-14598	-0.73244887	1.39335477	0.37911928	40.57684151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479176-02	NCGC00479176-02	363681104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1448428-04-3				-10.1858104429	4	4		0	-0.98360656				MAP3K5	CC(C)[N]1C=NN=C1C2=CC=CC(=N2)NC(=O)C3=CC(=C(C)C=C3F)[N]4C=NC(=C4)C5CC5	Sun-shine	100503	-3.06834031	0.50890585	-2.81989084	-0.98360656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015519-15	NCGC00015519-15	384567860		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	62-31-7				-6.2954311792	4	4		0	-1.10391522					NCCC1=CC(=C(O)C=C1)O	Selleck	S2529	-1.68516235	-0.4732102	-1.19653006	-1.10391522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00087387-05	Droxinostat	384568077	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	99873-43-5				6.0080472916	4	4		0	8.99322932				HDAC6	CC1=CC(=CC=C1OCCCC(=O)NO)Cl	Selleck	S1422	-0.56172078	-0.04579454	1.07687706	8.99322932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351608-02	NCGC00351608-02	384569022		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	571203-78-6		12.5892541179	-4.9	43.7338705118	3	4		47.3283779808	44.61289373	0.1933488691	0.9762248018		VDAC2	CCOC1=CC=CC=C1N\2C(=O)C3=C(C=CC=C3)\N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(Cl)C=C5	Selleck	S7242	1.71256336	7.73927645	0.8674843	44.61289373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229735-09	NCGC00229735-09	384568464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	925701-49-1		1.995262315	-5.7	29.0794591174	4	4		11	2.60523992	1	0.9993229192		ATM	C[C@H]1CN(C[C@@H](C)O1)CC(=O)NC2=CC=C3SC4=C(CC3=C2)C=CC=C4\C5=C\C(=O)\C=C(/O5)N6CCOCC6	MedChem Express	HY-12061	2.89080696	3.43459014	13.3413102	2.60523992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370919-02	NCGC00370919-02	363677934		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	524684-52-4				3.9858232905	4	4		0	7.72740654				ESR2	OC1=CC(=C2OC(=NC2=C1)C3=CC=C(O)C(=C3)F)C=C	Axon Medchem	1898	-0.53431977	0.22897268	-0.83757104	7.72740654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015725-27	NCGC00015725-27	384567885		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	51803-78-2				0.3970809556	4	4		0	1.92280503				PTGS2	C[S+]([O-])(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O	MedChem Express	HY-B0363	0.29021559	-2.37329659	-0.17497813	1.92280503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346477-02	Emricasan	384568791	Caspase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	254750-02-2		2.8183829313	-5.55	38.6561387163	2.2	4		51.0722870391	34.99254844	0.019061999	0.9997760648		CASP3	C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F	MedChem Express	HY-10396	-2.73361227	6.46609789	21.40691328	34.99254844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00079434-04	NCGC00079434-04	384568075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[309928-48-1]		12.5892541179	-4.9	14.7223978807	4	4		16.5	14.09836066	0.2938170805	0.9431414543		CRY	C[S+]([O-])(=O)N(CC(O)C[N]1C2=CC=CC=C2C3=CC=CC=C13)CC4=CC=CO4	Tocris	4685	0	3.62221224	2.36506974	14.09836066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346444-07	NCGC00346444-07	363677406		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1232410-49-9		1.1220184543	-5.95	26.4678729362	4	4		12.5	13.49720341	0.0282344556	0.9995132552		ATR	C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CN=C(N)C(=N2)C(=O)NC3=CC=CC=C3	MedChem Express	HY-14731	1.63036032	5.60219814	11.87556087	13.49720341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022037-07	NCGC00022037-07	363676518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	71-58-9		14.1253754462	-4.85	0.7733848194	4	4		12.6178582079	8.49278775	0.0694991515	0.997047348		PGR	C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@@]\4(C)CCC(=O)\C=C14	Selleck	S2567	-1.21934512	-1.75545718	-1.76488184	8.49278775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025220-11	NCGC00025220-11	384568058		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	212844-54-7				11.6891934545	4	4		0	-0.65036053				CDK1	CC(C)[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NC3=CC(=C(C=C3)C(O)=O)Cl	MedChem Express	HY-18299	5.62465451	-2.95513704	-0.17497813	-0.65036053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346719-03	LY-2811376	384568932	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1194044-20-6				0.9410229467	4	4		0	2.20557048				BACE1	C[C@]\1(CCS\C(=N1)N)C2=CC(=C(F)C=C2F)C3=CN=CN=C3	Axon Medchem	2225	-0.12437811	-0.38278977	-0.17497813	2.20557048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024427-09	NCGC00024427-09	384568028		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	16590-41-3				-3.8507750663	4	4		0	4.26229508				OPRM1	OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC6CC6	MedChem Express	HY-76711	-2.11994421	-0.98787607	-1.3341419	4.26229508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241101-10	NCGC00241101-10	384568471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	698387-09-6				-20.625155274	4	4		0	-5.81222057				EGFR	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(=C(C=N2)C#N)NC3=CC=C(OCC4=CC=CC=N4)C(=C3)Cl	Adooq	A10638_CM1	-3.93305439	-3.9814399	-4.94238933	-5.81222057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018139-05	NCGC00018139-05	170465997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone	5.6234132519	-5.25	-3.8730668133	4	4		12.451882844	6.64679583	0.4059687384	0.8843061583			CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	Sequoia	35212-22-7	-3.70990237	0.35922766	0.54578532	6.64679583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346822-02	NCGC00346822-02	377020351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	81267-65-4		7.0794578438	-5.15	0.2266880352	4	4		14.5460250999	10.19374069	0.019583595	0.9997655313		SPHK1	OC1=CC=C(C=C1)C/2=C/C3=C(OC2)C=C(O)C=C3	SIGMA	D7446	-2.53835425	-2.45472235	1.15221346	10.19374069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263093-04	NCGC00263093-04	384568585		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	541550-19-0		0.2511886432	-6.6	437.6818645733	5	4		-10.5	16.60208644	1	0.8785769499		PIKFYVE	CC1=CC=CC(=C1)\C=N\NC2=NC(=NC(=C2)N3CCOCC3)OCCC4=CC=CC=N4	MedChem Express	HY-14644	111.07391911	99.23664122	103.39599757	16.60208644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015082-09	NCGC00015082-09	170466652		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	996-19-0				-1.3190532164	4	4		0	1.95294479				NOS2	NNC(N)=N.NNC(N)=N.OS(O)(=O)=O	Microsource	01505162	-1.31940627	-1.01694915	1.86177715	1.95294479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016831-09	NCGC00016831-09	384567962		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	35543-24-9				-7.6352952863	4	4		0	-0.75349839					COC1=CC(=C(C(=O)CCCN2CCCC2)C(=C1)OC)OC	APExBIO	B1889	-2.22649808	-1.19380987	-0.78984485	-0.75349839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351592-01	NCGC00351592-01	384569012		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	88497-87-4	Manassantin A	3.1622776602	-5.5	66.4071878546	2.4	4		36.468301437	40.52033493	0.1475276729	0.9863426919		HIF1A	COC1=CC=C(C=C1OC)[C@@H](O)[C@@H](C)OC2=C(OC)C=C(C=C2)[C@H]3O[C@@H]([C@H](C)[C@H]3C)C4=CC=C(O[C@H](C)[C@H](O)C5=CC(=C(OC)C=C5)OC)C(=C4)OC	Duke University	Manassantin A	6.04786077	1.09974034	28.48297214	40.52033493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387089-01	NCGC00387089-01	384569152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[148869-05-0]				-3.8288611071	4	4		0	-1.73444976				CYP19A1	BrC1=CC=C(CN([N]2C=NN=C2)C3=CC=C(C=C3)C#N)C=C1	Tocris	3278	-0.85569253	0.12219337	-0.61919505	-1.73444976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510264-02	NCGC00510264-02	384569422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1616392-22-3				-1.8084979635	4	4		0	3.57668531				PRMT5	CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NC[C@H](O)CN3CCC4=C(C3)C=CC=C4	MedChem Express	HY-101563	-2.34278668	3.37353076	-1.22644331	3.57668531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378567-02	NCGC00378567-02	363678092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1001917-37-8				-4.5246411997	4	4		0	-4.35458787				MET	C[N]1C=C(C=N1)C2=CN=C3\C=C/C4=CC=C(C[S+]([O-])(=O)NCC5=NC=CC=C5)C=C4C(=O)C3=C2	MedChem Express	HY-13299	-0.64953013	-2.09768795	2.65383494	-4.35458787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378744-02	NCGC00378744-02	384569067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	81409-90-7		12.5892541179	-4.9	19.4219045993	4	4		26.3563464161	21.46672441	0.1258082613	0.99013691			CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1CC2[C@@H](CC3=C[NH]C4=CC=CC2=C34)N(CC=C)C1	MedChem Express	HY-15296	1.44251167	-1.13028868	0.69183336	21.46672441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351478-06	NCGC00351478-06	384569007		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-1.8573713972	4	4		0	-3.30590443			10927	EHMT2	COC1=CC2=C(C=C1OCCCN3CCCC3)\N=C(N)/C24CCC4	APExBIO	B4947	0.50912176	-1.2830304	0.30079711	-3.30590443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274061-07	NCGC00274061-07	384568709		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	13647-35-3				-6.6339981838	4	4		0	-1.45806265				ESR1	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4\C(=C(/C[C@]35C)C#N)O)[C@@H]1CC[C@@H]2O	MedChem Express	HY-14281	-1.66878801	-1.98564228	0.15039856	-1.45806265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481611-02	NCGC00481611-02	377020235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	939805-30-8		1.4125375446	-5.85	18.4726181763	4	4		22.0623969199	-4.84391819	1	0.9999049137		FGFR1	COCC1=C(CN2CCOCC2)[N]3N=CN=C(N)C3=C1C4=CC=C(NC(=O)NC5=CC(=CC=C5F)C(F)(F)F)C(=C4)F	MedChem Express	HY-16025	-2.9686641	-1.19380987	18.58956276	-4.84391819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018185-20	NCGC00018185-20	363676503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	53902-12-8				-9.2017768911	4	4		0	-1.06104875				TNF	COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC	MedChem Express	HY-B0195	-2.6937878	-1.3706706	-0.8180536	-1.06104875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250384-02	NCGC00250384-02	377020291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	503555-55-3		6.3095734448	-5.2	39.1140808701	2.2	4		55.2439499738	49.94611239	0.0134983185	0.9998876524		IKBKB	CN1CCN(CC1)C2=CC(=C(Cl)C=N2)C(=O)NC3=CC=C4CCC5=C([N](N=C5C(N)=O)C6=CC=C(F)C=C6)C4=C3	Axon Medchem	1651	-1.91576278	-1.91373026	11.46379481	49.94611239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510479-01	NCGC00510479-01	384569442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1365267-27-1		12.5892541179	-4.9	13.0172749395	4	4		17.6081904519	15.73518091	0.3700856654	0.9051268837		ALK	C[C@@H](OC1=CC(=NN=C1N)C(=O)NC2=CC=C(C=C2)C(=O)N3CCN(C)CC3)C4=C(Cl)C=CC(=C4Cl)F	MedChem Express	HY-16590	0.98605437	2.03523694	-3.84015871	15.73518091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482799-01	NCGC00482799-01	384569260		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	N/A				-9.0161968619	4	4		0	-0.69178687				PTK2	CONC(=O)C1=CC=CC=C1NC2=CC(=NC=C2Cl)NC3=CC(=N[N]3C(C)C)C	DC Chemicals	DC8331	-2.15097959	-1.90810563	-2.39306013	-0.69178687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178127-11	NCGC00178127-11	384568353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	87333-19-5				13.2269702546	4	4		0	-0.08482963				ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(O)=O	MedChem Express	HY-B0279	4.74018795	-0.81151432	2.50801983	-0.08482963												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378723-01	NCGC00378723-01	384569065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	193022-04-7		14.1253754462	-4.85	3.4342851344	4	4		11.171078356	8.93604735	0.2863914028	0.9464361641		MMP12	ONC(=O)C1(CCOCC1)C[S+]([O-])(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2	MedChem Express	HY-10398	-0.82025173	0.58041851	-2.22589863	8.93604735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168759-10	NCGC00168759-10	363676681		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	775304-57-9				-3.8744199876	4	4		0	-3.91222752				CFTR	OC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C3=CC=CC=C3F	MedChem Express	HY-14832	0.14142271	1.22193371	-3.09821026	-3.91222752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091014-06	NCGC00091014-06	174007324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	52806-53-8	Hydroxyflutamide;hydroxyflutamide			-6.9895207439	4	4		0	-1.38568129			374	AR	CC(C)(O)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F	SIGMA	H4166	-1.54951402	-1.82260024	-1.0344339	-1.38568129												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162409-08	NCGC00162409-08	384568225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			4.4668359215	-5.35	135.5313757716	4	4		-25.365735116	13.456505	0.8165891766	0.9999374488			CO[C@H]1\C=C/C=C(/C)C[C@H](C)[C@H](O)[C@H](C)\C=C(C)/C=C(/OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C	Analyticon	NP-007111	95.2810255	34.29526124	34.27802182	13.456505												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00024956-17	NCGC00024956-17	384568037		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	183322-45-4				-8.3839506644	4	4		0	-3.84162496				EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=CC(=C3)Br	MedChem Express	HY-12013	-2.45239074	-2.42711036	3.49985043	-3.84162496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015100-16	NCGC00015100-16	384567809		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	645-05-6				-5.2737796442	4	4		0	3.01736827					CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C	Selleck	S1278	-1.54815728	-2.24393222	-2.87167215	3.01736827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00343768-05	NCGC00343768-05	384568714		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	911222-45-2		12.5892541179	-4.9	24.3883735874	3	4		37.0461644479	32.54630284	0.1395818611	0.9878000188		CHEK1	CC1=NC=C(NC(=O)NC2=C(OC[C@@H]3CNCCO3)C=C(C)C(=C2)Br)N=C1	MedChem Express	HY-14720	1.3681592	-2.95513704	-1.95392243	32.54630284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345812-03	NCGC00345812-03	384568756		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	75567-37-2		2.8183829313	-5.55	85.9129856497	4	4		-24.5	1.61176304	0.1770859375	0.9801813949		PRKCA	C\C=C(C)/C(=O)O[C@H]1C(=C/C23[C@H](C)C[C@@H]4[C@H](C(\C=C(CO)/[C@@H](O)[C@]12O)C3=O)C4(C)C)\C	MedChem Express	HY-B0719	23.81149807	28.21926198	5.97841936	1.61176304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346474-01	NCGC00346474-01	174006243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	40675-81-8	1-(1-Naphthylmethyl)piperazine			-5.2220671389	4	4		0	-1.01795561					C1CN(CCN1)CC2=C3C=CC=CC3=CC=C2	SIGMA	651699	-0.34549475	-0.65839841	-4.46194226	-1.01795561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378640-02	NCGC00378640-02	363678135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1383577-62-5				9.9513166254	4	4		0	2.88420755				OPRM1	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(O)=O	MedChem Express	HY-76657	2.0591487	0.59715204	3.03295421	2.88420755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379044-02	NCGC00379044-02	384569089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-9.1295417604	4	4		0	0.24541649				VDR	C[C@H](\C=C\[C@H](C)C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/[CH]=[C]3C[C@@H](O)[CH2][C@H](O)C3	MedChem Express	HY-76585	-3.08301513	-0.97754697	-1.0828696	0.24541649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015482-15	NCGC00015482-15	384567857		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	65-29-2				4.027004412	4	4		0	1.83340551				ACHE	CC[N+](CC)(CC)CCOC1=CC=CC(=C1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC	MedChem Express	HY-B0416	0.42426814	-0.33603177	2.58685517	1.83340551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378564-01	NCGC00378564-01	384569049		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	300353-13-3				2.0603292167	4	4		0	4.28021555				GCK	C[S+]([O-])(=O)C1=CC=C(C=C1)[C@@H](CC2CCCC2)C(=O)NC3=NC=CS3	MedChem Express	HY-10595	-0.56345964	0.27339004	0.1558736	4.28021555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274063-05	NCGC00274063-05	363677311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	74150-27-9				-1.8287638667	4	4		0	-3.28007917				PDE3A	COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)/C4=N/NC(=O)CC4C	MedChem Express	HY-B0204	1.45107794	-1.05649977	-3.35374745	-3.28007917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387826-01	NCGC00387826-01	363680682		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1440898-61-2				-2.876016625	4	4		0	-6.74173524					C1CC(CCN1)C(COC2=CC=C(C=C2)C3=NC4=CC=CC=C4[N]3CC5=CC=CC=C5)[N]6C7=CC=CC=C7N=C6C8=CC=CC=C8	ChemieTek	CT-DELT	1.24451987	-0.54987017	-0.90239134	-6.74173524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015429-18	NCGC00015429-18	384567842		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	25451-15-4				-9.2046059294	4	4		0	-0.38977913				GABRA1	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1	MedChem Express	HY-B0184	-2.80016971	-1.64961051	-0.87231163	-0.38977913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346649-04	NCGC00346649-04	384568880		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1173204-81-3 				-4.0249982874	4	4		0	-3.38722094				PIK3CA	CC[N]1N=NC2=C1N=C(N=C2N3CCOCC3)C4=CC=C(NC(=O)NC5=CC=C(C=C5)C(=O)N6CCN(C)CC6)C=C4	Adooq	A11089	0.14086491	2.09599028	-4.74705966	-3.38722094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346703-08	NCGC00346703-08	384568922		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	262352-17-0				12.6142442816	4	4		0	4.15704388				CETP	CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C3=C1C=CC(=C3)C(F)(F)F	MedChem Express	HY-12089	0.53528666	10.75334143	0.89273062	4.15704388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015888-06	NCGC00015888-06	384567902		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	50-55-5		10	-5	59.9492411157	3	4		95.8151936596	82.43264049	0.0139921937	0.9998792364			COC1C(CC2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)C3CC2C1C(=O)OC)OC(=O)C6=CC(=C(OC)C(=C6)OC)OC	APExBIO	N1867	-1.29595718	-2.2782503	4.63369704	82.43264049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023373-10	NCGC00023373-10	384568017		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	25122-46-7		10	-5	11.9134195259	4	4		11.625204952	10.13159757	0.1668739171	0.9826840617			CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	MedChem Express	HY-13600	1.31761442	-0.10433746	1.50088287	10.13159757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181304-01	NCGC00181304-01	50125901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	59643-91-3	Imexon			0.0498163212	4	4	CIPLUS_210928;4-IMINO-1,3-DIAZABICYCLO(3.1.0)HEXAN-2-ONE;4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one;BM-06002;4-amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one;BM 06002;imexon;LS-176018;Imexon;4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one;IMEXON;imexonum;Imexonum;	0	-1.66973256			6240	RRM1	O=C1N=C(N)C2CN12	ACC	imexon	0.45769764	-0.52168729	0.70629782	-1.66973256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181152-04	NCGC00181152-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	95734-82-0				2.9211334994	4	4		0	0.99051932					O=C1C[O-][Pt++][O-]1	Selleck	S1826	1.20665742	-0.64093009	-0.64743967	0.99051932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165736-13	NCGC00165736-13	384568276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	2627-69-2				5.6018429996	4	4		0	3.76078043				PRKAA1	NC(=O)C1=C(N)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-13417	0.92592593	-0.96463022	1.57480315	3.76078043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347910-01	NCGC00347910-01	174006383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	926319-75-7	CK59			-0.2732349412	4	4		0	-2.58409124			10645	CAMKK2	CC(C)[N]1C=NC2=C(NCCCCCCNC(=O)OC(C)(C)C)N=C(NCCO)N=C12	EMD Chemicals	208922	1.15966624	-1.92454559	0.06015942	-2.58409124												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015508-23	Hydrochlorothiazide	384567858	Hypertension treatment	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	58-93-5				1.6475170637	4	4		0	-0.62261214					N[S+]([O-])(=O)C1=C(Cl)C=C2NCN[S+]([O-])(=O)C2=C1	Enzo	AC3145	-0.90152566	4.90386049	1.41259564	-0.62261214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346747-02	NCGC00346747-02	174007018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	n		11.220184543	-4.95	40.4466464545	3	4		52.8780574046	45.46868373	0.011904347	0.9999126354	4790	NFKB1	CC(O)(C#CC1=CC2=C(CCN2C3=NC(=NC=C3Cl)N)C=C1)C4=NC=CS4	NCGCChem	PRP02-095	1.14704256	1.11774613	3.93700787	45.46868373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-04	Belinostat	384568629	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	414864-00-9				-21.9137927351	4	4		0	-6.0776671				HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	Selleck	S1085	-3.95983595	-4.46005804	-5.92570311	-6.0776671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263229-03	NCGC00263229-03	363677274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	13616-29-0		0.5011872336	-6.3	21.5087694471	4	4		-13.3583802479	-2.38198354	0.0278482301	0.9995270246		FAS	CC1=NC(=NC=C1)N[S+]([O-])(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)NC4=NC(=CC=N4)C)C=C2	SIGMA	G5547	9.07933814	1.86344891	-1.71454354	-2.38198354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408915-01	NCGC00408915-01	363681083		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	870281-34-8				-7.0967595067	4	4		0	-5.12487368				PIK3CD	C[C@H](NC1=NC=NC2=C1[NH]C=N2)\C3=N\C4=C(C=C(F)C=C4)C(=O)N3C5=CC=CC=C5	Glixx	GLXC-90107	-0.02828454	-1.80235222	-2.76733343	-5.12487368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263225-01	NCGC00263225-01	137276069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	199800-49-2	AG-041R	12.5892541179	-4.9	44.6194956801	3	4		49.81418304	46.61469612	0.1089380418	0.9926120657	887	CCKB	CCOC(CN1C(=O)[C@](CC(=O)NC2=CC=C(C)C=C2)(NC(=O)NC3=CC=C(C)C=C3)C4=CC=CC=C14)OCC	Cayman	10010129	3.90326686	0.03054834	-0.30079711	46.61469612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475743-01	NCGC00475743-01	384569237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	926927-61-9				-4.1832957847	4	4		0	0.55427252				TLR8	CCCN(CCC)C(=O)C\1=C\C2=CC=C(C=C2\N=C(N)/C1)C3=CC=C(C=C3)C(=O)N4CCCC4	ActiveBioChem	A-1284	-0.39442175	-2.43013366	-2.70653252	0.55427252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390672-01	NCGC00390672-01	363680966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1610537-15-9		11.220184543	-4.95	48.4209024657	3	4		55.7889196114	49.02232487	0.1208165783	0.9908919944		CYP17A1	CC(C)[C@](O)(C1=CC2=CC(=C(OC(F)F)C=C2C=C1)OC(F)F)C3=C[NH]N=N3	MedChem Express	HY-15996	4.00056346	-1.48845687	3.72679609	49.02232487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496836-02	NCGC00496836-02	384569292		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1228013-30-6				-2.3064120553	4	4		0	4.1878368				MTOR	CO[C@H]1CC[C@@H](CC1)N2C(=O)CNC3=NC=C(N=C23)C4=CN=C(C=C4)C(C)(C)O	Glixx	GLXC-90511	-0.59163262	-2.39975699	-3.2166643	4.1878368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263187-07	NCGC00263187-07	384568654		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1035555-63-5				-3.7824571994	4	4		0	2.80175463				MAP2K1	CN1C(=O)/C(=C(NC2=CC=C(I)C=C2F)\C3=C1\N=C/N(C[C@@H](O)CO)C3=O)F	MedChem Express	HY-13449	-1.98335645	0.07452676	-1.23602119	2.80175463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016103-16	NCGC00016103-16	384567922		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	170632-47-0				9.1916367543	4	4		0	4.27338333				HIF1A	OCC1=CC=C(O1)C2=N[N](CC3=CC=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-14927	1.81692094	-1.11790133	3.0606239	4.27338333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090905-16	NCGC00090905-16	384568090		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	55-98-1				5.036473928	4	4		0	0.93391821					C[S+]([O-])(=O)OCCCCO[S+](C)([O-])=O	Microsource	01500152	1.70596394	1.44581905	-1.4714538	0.93391821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347944-06	NCGC00347944-06	363677725		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1351758-81-0				-1.0489741026	4	4		0	-4.30168388				LRRK2	CNC1=NC(=NC=C1Cl)NC2=CC=C(C=C2OC)C(=O)N3CCOCC3	Glixx	GLXC-02896	0.40221914	-0.28320167	1.91288994	-4.30168388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481596-01	NCGC00481596-01	377020230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					19.4239942078	4	4		0	5.2594373			2322	KIT	FC(F)(F)C1=CC=C(C\N=C/2N\C=C(CC3=C[NH]C4=C3C=CC=N4)/C=C2)C=C1	APExBIO	B5816	6.50912106	0.07655795	-1.69145523	5.2594373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509989-01	NCGC00509989-01	384569397		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	328232-95-7				-4.9693799668	4	4		0	-1.52011922					FC1=CC=CC=C1[N]2C=CC(=N2)NC(=O)[C@H]3CC[C@]4(CC3)OC(=O)C5=C4C=NC=C5	MedChem Express	HY-15411	-0.36262204	-1.94581649	-2.2134627	-1.52011922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182084-01	NCGC00182084-01	124893809		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	60200-06-8	Clorsulon			8.289504758	4	4		0	1.68904288					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	APAC	854922	2.12134069	1.13028868	1.17310874	1.68904288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179649-13	NCGC00179649-13	384568381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	50-24-8				4.5330561589	4	4		0	0.98537336				NRC31	C[C@]12C[C@H](O)[C@H]3[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	MedChem Express	HY-17463	0.73249753	1.15431349	1.60124699	0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164594-08	NCGC00164594-08	384568262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	82034-46-6				-1.9898947007	4	4		0	-0.95458045					CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl	MedChem Express	HY-17358	0.4789407	-2.39975699	-1.17613717	-0.95458045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481546-01	NCGC00481546-01	384569255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					0.7973838686	4	4		0	-1.13933795				EZH2	CC[S+]([O-])(=O)N1CCC(CC1)[C@@H](C)[N]2C(=C(\C(O)=N\CC3=C(OC)C=C(C)N=C3O)C4=CC=CC=C24)C	APExBIO	B4678	0.76067052	-2.24787363	1.82797223	-1.13933795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015897-20	Ranolazine	384567904	Sodium channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	95635-56-6				-10.1353258391	4	4		0	0.40030793				SCN9A	COC1=C(OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C)C=CC=C1	MedChem Express	HY-17401	-2.56374137	-3.28068044	-2.2814227	0.40030793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016270-13	NCGC00016270-13	384567928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	59-92-7				13.507765023	4	4		0	-1.0469592					N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Selleck	S1726	4.64854205	0.69866343	2.76321383	-1.0469592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347940-04	NCGC00347940-04	384568992		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1420071-30-2				5.3378852844	4	4		0	-0.90561766				TNFRSF10B	BrC1=CC=C(C=C1)N2C(=N)S\C(=C/C3=CC=C(O3)C4=CC5=C(C=C4)C(=O)NC5=O)C2=O	Glixx	GLXC-01623	2.0110957	2.1314652	0.38257799	-0.90561766												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166035-05	NCGC00166035-05	384568302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	477-30-5				-6.0189289746	4	4		0	0.0566011				TUBB	CN[C@H]1CCC2=CC(=C(OC)C(=C2C/3=C/C=C(OC)\C(=O)/C=C13)OC)OC	Cayman	15364	-3.06518724	3.11521836	-0.58858152	0.0566011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168109-05	NCGC00168109-05	363676677		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	853625-60-2				-7.8794267013	4	4		0	-1.31147541				ARHGEF1	COC1=N[N](C2=CC=C(NC(=O)CSC3=CC=CC=C3)C=C2)C(=N1)C4=CC=C5OCOC5=C4	Selleck	S7685	-2.70571827	1.22736117	-1.21285628	-1.31147541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242491-03	NCGC00242491-03	384568497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[211096-49-0]				-8.7067901358	4	4		0	-0.35767511				CXCR2	BrC1=CC=CC=C1NC(=O)NC2=C3N=N[NH]C3=C(C=C2)C#N	Tocris	2724	-2.48256625	-2.15536596	-0.84899939	-0.35767511												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016244-21	NCGC00016244-21	384567924		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	54-85-3				-4.1861826788	4	4		0	-1.04321908				CYP1A2	NNC(=O)C1=CC=NC=C1	MedChem Express	HY-B0329	-1.78521618	-0.86813351	2.51667677	-1.04321908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387870-04	NCGC00387870-04	384569165		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1047634-65-0				-12.859535008	4	4		0	-3.76786488					C[N]1N=CC(=C1C2=C(Cl)OC(=C2)C(=O)NC(CN)CC3=CC(=C(F)C=C3)F)Cl	MedChem Express	HY-15965	-1.75364163	-3.32976936	-4.63227553	-3.76786488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242514-13	NCGC00242514-13	384568506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	781661?94?7				-4.9514141991	4	4		0	1.01674641				BIRC5	COCC[N]1C(=[N+](CC2=NC=CN=C2)C3=C1C(=O)C4=CC=CC=C4C3=O)C	ActiveBioChem	A-1061	-2.21899927	3.23812433	-3.30237358	1.01674641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165833-10	NCGC00165833-10	384568288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	209783-80-2				-10.562856593	4	4		0	-5.38876058				HDAC1	NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=CN=C3)C=C2)C=CC=C1	XcessBio	M60174-5s	-1.04240034	-2.12636695	-3.41504889	-5.38876058												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183808-01	NCGC00183808-01	85736407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1222800-79-4	 NCGC00183808-01;NCGC00183808-01	12.5892541179	-4.9	49.2534981976	3	4		61.3739917899	57.0822131	0.0388220282	0.9990695592	3720	JARID2	CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O	NCGCChem	GRB09-026-A4	2.03883495	1.62468326	0.35314891	57.0822131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241108-15	NCGC00241108-15	384568476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	319460-85-0				-2.7975654505	4	4		0	-4.86769492				FLT1	CNC(=O)C1=CC=CC=C1SC2=CC=C3C(=C2)[NH]N=C3\C=C\C4=CC=CC=N4	SIGMA	PZ0193	1.12343967	-0.22358027	-2.67804591	-4.86769492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386324-08	NCGC00386324-08	363680210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1432597-26-6		14.1253754462	-4.85	1.8321955751	4	4		-10.573227672	-6.31102306	0.4434125449	0.8571506767	657	ACVR1	C1CN(CCN1)C2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=CC6=C5C=CC=N6	Glixx	GLXC-03718	0.92926491	1.20733343	4.7675103	-6.31102306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182052-15	NCGC00182052-15	384568407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1001645-58-4				-14.7009926835	4	4		0	-6.39592472				SIRT1	O=C(NC1=CC=CC=C1C2=C[N]3C(=CSC3=N2)CN4CCNCC4)C5=NC6=C(C=CC=C6)N=C5	MedChem Express	HY-15145	-2.84327323	-1.86316888	-1.94231901	-6.39592472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250406-03	NCGC00250406-03	384568554		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	192185-72-1		12.5892541179	-4.9	23.9609045096	3	4		40.469196842	34.2719683	0.3279985828	0.9272314219		COX10	C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3	MedChem Express	HY-10502	-2.92649098	7.70606648	0.61801059	34.2719683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178852-04	NCGC00178852-04	384568365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	32986-56-4	 Nebcin; Tobrex; Obracin;TOBRAMYCIN; Tobramycin Sulphate;; Sulfate, Tobramyci; Brulamycin;Tobramycin; Tobramycin Base; Tobramicina; Tobracin; Nebicin			0.0526784961	4	4		0	-0.2544889					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	Microsource	MS-01500579	0.26257601	-1.5158475	0.90405366	-0.2544889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508859-01	NCGC00508859-01	384569364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1698878-14-6				-18.0739008082	4	4		0	-5.37254348				NAMPT	CC(C)(O)C[S+]([O-])(=O)NC1=CC2=C(CN(CC2)C(=O)COC3=CN=CC=C3)C=C1	Bio Vision	B1171	-2.66721946	-5.52748431	-4.84106153	-5.37254348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522488-01	NCGC00522488-01	384569520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1346528-50-4				-5.1133757958	4	4		0	-2.91248409				FAAH	FC1(F)OC2=CC=C(CN3CCN(CC3)C(=O)NC4=C(Cl)C=CN=C4)C=C2O1	MedChem Express	HY-19636	0.31785517	-1.45460113	-3.90784485	-2.91248409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480794-01	NCGC00480794-01	384569246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	945976-43-2		11.220184543	-4.95	50.5610759453	3	4		90.9269833943	75.49925484	0.0317688522	0.9993770646		TPH2	N[C@@H](CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)C(O)=O	Adooq	A14325	-2.87308229	-0.59871277	2.69860522	75.49925484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507875-01	NCGC00507875-01	384569346		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1234480-46-6		8.9125093813	-5.05	42.9474905534	3	4		69.1667055846	64.08257543	0.0214131245	0.9997171443		TNK2	COC1=CC(=CC=C1NC2=NC3=C(NC(=O)C4=C(C=CC=C4)N3C)C=N2)N5CCN(C)CC5	Selleck	S8272	-2.20619431	-0.88590194	1.8649421	64.08257543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387792-03	NCGC00387792-03	384569161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	502632-66-8				-3.241254114	4	4		0	0.47670306					COC[C@@H]1OC(=O)C(=C\N(CC=C)CC=C)/C2=C(\O)C(=O)\C3=C([C@H](C[C@@]4(C)[C@@H]3CCC4=O)OC(C)=O)/[C@]12C	Bio Vision	1965	-0.96206707	1.07590273	-2.70803949	0.47670306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390733-04	NCGC00390733-04	384569210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1527473-33-1]				-4.8395843077	4	4		0	-2.99861602				LRRK2	N#CC1=CC=CC(=C1)C2=C[NH]C3=NC=NC(=C23)N4CCOCC4	Tocris	5716	-0.16492578	-0.60427413	-2.51057828	-2.99861602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379254-06	NCGC00379254-06	384569096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1472795-20-2				-9.6555102731	4	4		0	-4.50561279				ALK	COC1=CC(=CC=C1NC2=NC(=C(Cl)C=N2)NC3=C(OC)C=C(C=C3)N4CCN(CC4)C(C)=O)N5CCN(CC5)C(C)=O	MedChem Express	HY-12331	-1.67674546	-0.16212233	-2.70803949	-4.50561279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263085-12	NCGC00263085-12	384568580		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1243243-89-1		7.0794578438	-5.15	21.4284628941	4	4		21.5	19.55741627	0.0314304959	0.9993927375		PORCN	CC1=CC(=CC=N1)C2=CC=C(CC(=O)NC3=CC=C(C=C3)C4=CC=CN=C4)C=C2	DC Chemicals	DC7340	0.76867295	1.03864365	5.89709568	19.55741627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484080-01	NCGC00484080-01	363681171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1192189-69-7				7.6910411184	4	4		0	-2.12074085				LIMK1	CN(C)C(=O)OC1=CC=CC(=C1)NC(=O)C2(CN)CCN(CC2)C3=C4C(=C[NH]C4=NC=N3)C	MedChem Express	HY-12659	2.8883361	3.50635431	-0.78740157	-2.12074085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351603-15	NCGC00351603-15	363677773		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1032900-25-6				-5.2006989678	4	4		0	-6.74173524				ALK	CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4	Selleck	S7083	0.7353981	-1.98564228	-0.93247105	-6.74173524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483923-01	NCGC00483923-01	363681142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1173699-31-4				-4.6002121661	4	4		0	-1.4003176				MET	COCCOC1=CN=C2\C=C/N([C@H](C)C3=NN=C4[N]3C=C(C=C4F)C5=C[N](C)N=C5)C(=O)C2=C1	ChemieTek	CT-AMG337	-0.79196719	0.33603177	-2.52669574	-1.4003176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174007-13	NCGC00174007-13	384568350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-3.598726745	4	4		0	2.69106566					CN1CCC\N=C1\C=C\C2=CC=CS2	Microsource	MS-01500517	-2.28147334	-1.01694915	1.325811	2.69106566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386301-06	NCGC00386301-06	363680195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1059734-66-5				-5.4948973396	4	4		0	-5.60431101				SMO	CNCC1=CC(=C(C)C=C1)NC(=O)C2=CC=C(NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5)C=C2	Glixx	GLXC-90164	-0.42259473	-2.09599028	1.77129092	-5.60431101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015735-18	NCGC00015735-18	384567886		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	50-65-7		0.5011872336	-6.3	112.1566065068	4	4		10.5	27.62731822	0.4028999329	0.8859711387		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	Microsource	01503265	20.07124264	26.24026866	31.34908765	27.62731822												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188865-05	NCGC00188865-05	384568453		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	635702-64-6		12.5892541179	-4.9	40.5172725146	3	4		43.6611716249	41.84574625	0.026840232	0.9995557358		FLT1	C[N]1N=C2C=C(C=CC2=C1C)N(C)C3=NC(=NC=C3)NC4=CC=C(C)C(=C4)[S+](N)([O-])=O	Selleck	S1035	2.47979175	2.36605098	1.79479509	41.84574625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510503-01	NCGC00510503-01	384569464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1349723-93-8		2.2387211386	-5.65	73.0347919998	3	4		58.7931797682	-6.84292379	1	0.9999386893		ESR1	CCNCCC1=CC=C(CN(CC)C2=CC(=CC=C2[C@@H]3CCC4=CC(=CC=C4C3)O)OC)C=C1	MedChem Express	HY-19822A	-1.20232172	-0.04593477	52.63925343	-6.84292379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 			-2.3603919452	4	4		0	-0.90484943			846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	-0.59425097	0.81151432	-1.04986877	-0.90484943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522455-01	NCGC00522455-01	384569517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	232931-57-6				2.5150842304	4	4		0	2.31867666					COC1=C(OCCCOC2=C(OC)C=C3C(=O)N4CC(=C)C[C@H]4\C=N/C3=C2)C=C5\N=C/[C@@H]6CC(=C)CN6C(=O)C5=C1	MedChem Express	HY-14573	0.48369265	-1.66896341	1.02070575	2.31867666												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163411-06	NCGC00163411-06	384568235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[38748-32-2]				12.6518255808	4	4		0	5.90443193				POLR2A	CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CC\C6=C(COC6=O)/[C@@H]5C[C@@H]7O[C@]47[C@@H]2O	Tocris	3253	0.36769905	4.30731633	6.13626109	5.90443193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351593-05	NCGC00351593-05	377020510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1168091-68-6				-2.3049362553	4	4		0	5.45034642				MAP2K1	OCCONC(=O)C1=C(NC2=CC=C(I)C=C2F)[N]3C=NC=C3C=C1	MedChem Express	HY-15610	-1.69037893	-1.94410693	-1.00609324	5.45034642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015233-07	NCGC00015233-07	384567828		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	57265-65-3				-9.239079974	4	4		0	-4.31100847				CAMKK2	ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)[N+]3=C[N](CC(OCC4=C(Cl)C=C(Cl)C=C4)C5=C(Cl)C=C(Cl)C=C5)C=C3	Glixx	GLXC-04254	-1.26778419	-2.03523694	-1.94133484	-4.31100847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345789-16	NCGC00345789-16	384568742		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1257044-40-8		3.1622776602	-5.5	12.3672393511	4	4		15.5221948199	14.14483368	0.0307906876	0.9994177693		BCL2	CC1(C)CCC(=C(\C1)C2=CC=C(Cl)C=C2)/CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S+]([O-])(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7	Bio Vision	2253	-1.68516235	-1.23645245	9.96111277	14.14483368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378563-01	NCGC00378563-01	363678091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	892128-60-8				0.7285034261	4	4		0	-4.25375331			6240	RRM2	CCCC(CCC)C(=O)NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	MedChem Express	HY-13672	2.45239074	-0.1679133	-3.20071792	-4.25375331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-30	NCGC00159456-30	384568179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[220127-57-1]		10	-5	69.6151120075	3	4		117.5107086602	97.04510109	0.0140511351	0.99987821		ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	Tocris	5906	-2.39082366	-3.16949931	7.72820064	97.04510109												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346431-02	NCGC00346431-02	384568774		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[200189-97-5]				-4.542882425	4	4		0	-3.36490881				GAPDH	CN(CC#C)C/C1=C/C2=CC=CC=C2OC3=CC=CC=C13	Tocris	2966	0.04145937	-0.71964477	-2.3330417	-3.36490881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165855-05	NCGC00165855-05	384568290		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	151720-43-3				-14.6909476216	4	4		0	-6.5318818					ONC(=O)\C=C\C#CC1=CC=CC(=C1)N[S+]([O-])(=O)C2=CC=CC=C2	Bio Vision	2250	-1.81039248	-1.94457204	-3.44123651	-6.5318818												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00486904-01	MRT-68601 hydrochloride	377020217	IKK-epsilon Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-1.1432808408	4	4		0	-5.0049484				IKBKE	O=C(NCCCNC1=C(C=NC(=N1)NC2=CC=C(C=C2)N3CCOCC3)C4CC4)C5CCC5	Tocris	5067	2.6119403	-2.0058184	-3.82035579	-5.0049484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263164-07	NCGC00263164-07	384568635		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1140909-48-3				-6.904357493	4	4		0	-2.0924643				KDR	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3	ChemieTek	CT-XL184	-0.73244887	-2.89389068	-2.07057451	-2.0924643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346646-02	NCGC00346646-02	363677494		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	186392-40-5				-2.6554008207	4	4		0	-1.4003176				PYGL	CN(C)C(=O)[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC3=CC(=CC=C3[NH]2)Cl	Selleck	S2717	0.67882902	-1.89399725	-2.88765228	-1.4003176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510235-01	NCGC00510235-01	384569420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1702259-66-2				-0.9048805031	4	4		0	-2.17987585					CCN1CCN(CC1)C2=CC=C(NC3=NC=NC(=C3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C(=C2)NC(=O)C=C	ChemGood	C-1373	0.11313817	3.3603177	-2.73725372	-2.17987585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015622-10	NCGC00015622-10	384567876		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[934389-88-5]				-1.4067409451	4	4		0	-1.94889563				PIK3CA	O=C1\C=C(/OC2=C1C=CC=C2C3=CC=CC=C3)N4CCOCC4	Tocris	1130	-1.10309716	4.61279976	-0.51135509	-1.94889563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247954-03	NCGC00247954-03	384568521		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	615571-23-8		12.5892541179	-4.9	41.8462107225	3	4		69.0550724718	61.32729588	0.0348523659	0.9992502244		SLC6A9	FC(F)(F)C1=CC=CC(=C1Cl)C(=O)N[C@H]([C@@H]2CCCCN2)C3=CC=CC=C3	Axon Medchem	1549	-0.5963939	-1.14771203	-2.38375515	61.32729588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345850-02	NCGC00345850-02	384568765		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(848344-36-5)		7.0794578438	-5.15	52.6997600077	2.4	4		52.6466845766	49.65361233	0.0537169181	0.9982169779		MAPK8	N#CC(=C/1NC2=CC=CC=C2S1)\C3=NC(=NC=C3)OCC4=CC=C(CN5CCOCC5)C=C4	SynKinase	SYN-1147	2.50138198	0.5052825	12.65675124	49.65361233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187983-01	NCGC00187983-01	174006432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1226056-71-8				-0.5576590586	4	4		0	1.86227804			6093	ROCK1	O=C(NCC1=CC=CC=C1)C2=CSC(=N2)NC3=CC=NC=N3	NCGCChem	XJB04-071	-0.50912176	0.2138384	-1.14302903	1.86227804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164789-05	NCGC00164789-05	174007328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	129453-61-8	; Faslodex;Fulvestrant;Fulvestrant (Faslodex)			5.9472399595	4	4		0	6.77060777			2099	ESR1	C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4=CC(=CC=C34)O)[C@@H]1CC[C@@H]2O	Selleck	S1191	-0.67882902	1.22193371	2.52669574	6.77060777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025012-06	NCGC00025012-06	384568043		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	164178-33-0				-1.1205418793	4	4		0	1.47806005				CNR2	COC1=CC=C(C=C1)C(=O)C2=C(C)[N](CCN3CCOCC3)C4=C2C=CC(=C4)I	MedChem Express	HY-15421	-0.64797859	-1.39732685	0.58098342	1.47806005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344564-05	NCGC00344564-05	384568723		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	520-27-4				-2.2932848531	4	4		0	0.19793581				AHR	COC1=CC=C(C=C1O)C/2=C/C(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-1503	0.31785517	-2.49578931	-2.15806358	0.19793581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378611-03	NCGC00378611-03	384569055		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-16.1381655303	4	4		0	-4.63404071					CC(C)(C)C[C@H]1N[C@H]([C@H](C2=CC=CC(=C2F)Cl)[C@@]13C(=O)NC4=C3C=CC(=C4)Cl)C(=O)N[C@H]5CC[C@H](O)CC5	APExBIO	B4984	-2.23447886	-4.79608981	-5.17371033	-4.63404071												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507868-01	NCGC00507868-01	384569342		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1884712-47-3				-3.1372436784	4	4		0	-2.74056967				EP300	C[C@@H]1CC(=O)NC2=C(N1)C(=CC=C2)C3=CC4=C(C=C3)[N](C)N=C4C5=C[N](C)N=C5	Selleck	S8190	-0.22538386	1.09356015	-1.82797223	-2.74056967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522580-01	NCGC00522580-01	384569529		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1300118-55-1				-6.7776903814	4	4		0	-0.15396459					CCN1C(=O)C\N=C/2N\C=C(/N=C12)C3=C(C)N=C(C=C3)C4=NN=C[NH]4	MedChem Express	HY-16962A	-1.23961121	-2.97691373	-2.02635681	-0.15396459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164569-08	NCGC00164569-08	384568255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	154361-50-9				-4.8741937302	4	4		0	-1.92280503				TYMS	CCCCCOC(=O)NC\1=N\C(=O)N(\C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	MedChem Express	HY-B0016	-0.12437811	-3.38386158	-1.07903179	-1.92280503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094381-09	NCGC00094381-09	384568130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	194413-58-6				5.491079064	4	4		0	-0.19793581				FLT3	CC1=CC(=C([NH]1)/C=C/2C(=O)NC3=CC=CC=C23)C	Selleck	S2845	2.16970702	2.03644159	-1.89559638	-0.19793581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179308-13	NCGC00179308-13	384568371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	80474-14-2				-1.049817391	4	4		0	-2.46005938					CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF	MedChem Express	HY-B0154	0.89828635	-2.64890522	0.49577136	-2.46005938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183848-01	Troxacitabine	124894563	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	145918-75-8	Troxacitabine			6.7132504324	4	4	2R(-)-cis-HMD-cytosine;Troxacitabine;LS-173247;LS-173246;LS-173400;TROXACITABINE;BCH-4556;BCH 4556, trans-(+-)-isomer;LS-173262;2'-DEOXY-3'-OXACYTIDINE,1'S,4'S,L-;BCH 4556, cis-(+-)-isomer;BCH 4556, (2S-trans)-isomer;BCH 4556, 2R(-)-cis-isomer;LS-173106;troxacitabine;CIPLUS_728716;troxacitabinum;CIPLUS_703293;	0	0.90948463				POLB	OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O	Pharmaron	PH-NIH-148677	2.65874699	0.09164503	-1.17310874	0.90948463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510263-01	NCGC00510263-01	384569421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1640247-87-5				-6.2955310471	4	4		0	-4.98051104				PIK3CD	NC1=NC(=C(C#N)C(=N1)N)N[C@@H](C2CC2)\C3=N\C4=C(C(=CC=C4F)Cl)C(=O)N3C5=CC=CN=C5	ChemieTek	CT-GS9901	0.25456088	-0.58041851	-4.03068131	-4.98051104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346644-04	NCGC00346644-04	384568876		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1038395-65-1		0.2238721139	-6.65	-5.7051999135	4	4		10.390500364	1.22607655	1	0.3542924244		SRC	O=C(CC1=CC=C(C=N1)C2=CC=C(OCCN3CCOCC3)C=C2)NCC4=CC=CC=C4	APExBIO	A3535	-4.07541697	11.30288682	-2.21141088	1.22607655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014352-10	NCGC00014352-10	384567791		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	500579-04-4		5.0118723363	-5.3	24.9918334755	2.4	4		31.222987672	28.91746411	0.0377156175	0.9991230081		SHH	CN(C)C1=C(CN2CCCN(CC3=C(C=CC=C3)N(C)C)C2C4=CC=NC=C4)C=CC=C1	MedChem Express	HY-13901	-1.43582306	-0.15274171	10.23146101	28.91746411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386735-01	NCGC00386735-01	363680425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	911715-90-7				18.3871755387	4	4		0	3.54118553				CX3CR1	CC(C)C[C@H](CO)NC1=C2SC(=NC2=NC(=N1)S[C@@H](C)C3=CC=CC=C3)N	Axon Medchem	2255	5.43738555	1.7618469	0.89273062	3.54118553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-18	NCGC00159322-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					-11.6428176341	4	4		0	-5.03749823					[H][C@]1(CO)O[C@@]2([H])N3C=CC(=N)N=C3O[C@@]2([H])[C@]1([H])O	Selleck	S1973	-1.9556172	-1.59487256	-2.53090053	-5.03749823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346617-03	NCGC00346617-03	384568860		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	602306-29-6		1.4125375446	-5.85	63.0381018254	1.4	4		41.4240729874	36.564313	0.2149180042	0.9703972196		CDK1	CC(C)[N]1C(=NC=C1C2=NC(=NC=C2)NC3=CC=C(C=C3)[S+](C)([O-])=O)C	Selleck	S2621	0.95700416	1.53525116	46.05650383	36.564313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475729-01	NCGC00475729-01	384569232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1401066-79-2				-13.8380634079	4	4		0	-3.15946349					CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)\N=C(C2=CC=CC=C2)/C3=CC=CC=C13	ActiveBioChem	A-1401	-3.09623431	-3.65214788	-1.45542753	-3.15946349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509987-01	NCGC00509987-01	384569396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1346623-17-3				-6.0787727122	4	4		0	-2.72845388					CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C3=CC=C(NC4CCCC4)C=C3)C(=O)C5=C(C)C=CC=C5F)C=C1C(F)(F)F	MedChem Express	HY-17627	-0.98995899	0.2138384	-2.37629719	-2.72845388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510493-01	NCGC00510493-01	384569455		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	865783-99-9				-5.4524080824	4	4		0	-0.6785044				PLK1	COC1=CC(=C(/C=C/[S+]([O-])(=O)CC2=CC(=C(OC)C=C2)O[P](O)(O)=O)C(=C1)OC)OC	MedChem Express	HY-16366	-1.69707255	-2.13838399	1.26334787	-0.6785044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371151-06	NCGC00371151-06	363678065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	354813-19-7		1.5848931925	-5.8	125.6853422186	1.1	4		81.0802742159	81.27990431	0.0346867216	0.9992572066			CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N	Glixx	GLXC-06343	1.60986222	3.60470444	83.4144184	81.27990431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017324-15	NCGC00017324-15	384567984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	79902-63-9				-11.0504850958	4	4		0	-1.10645933				HMGCR	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	Enzo	G244	-3.35025381	-1.64961051	-0.73713696	-1.10645933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163650-04	NCGC00163650-04	384568247		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	35825-57-1				0.1603363602	4	4		0	-2.24282297				STAT3	C[C@H]1COC/2=C1/C(=O)C(=O)C3=C4CCCC(C)(C)C4=CC=C23	Selleck	S2285	0.65264685	0.2138384	0.02948548	-2.24282297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163125-13	NCGC00163125-13	384568230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	145-13-1		14.1253754462	-4.85	21.1452652566	4	4		13.5	13.42703349	0.3184533003	0.9323575091			CC(=O)[C@H]1CC[C@H]2[C@@H]3C/C=C4/C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0151	3.69833212	2.38277073	0	13.42703349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015116-20	NCGC00015116-20	384567811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	72432-10-1				4.2626694382	4	4		0	-0.83140878					COC1=CC=C(C=C1)C(=O)N2CCCC2=O	MedChem Express	HY-10932	1.29595718	-0.42527339	2.67819187	-0.83140878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161599-13	NCGC00161599-13	384568210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	97322-87-7		3.5481338923	-5.45	52.8265858632	4	4		29.5	32.12112636	0.151673303	0.9855588257		CCL2	CC1=C(O)C(=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C)C	Enzo	GR210	5.09015257	1.35638694	21.2772219	32.12112636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095192-05	NCGC00095192-05	170466887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	145158-71-0	; ; Tegaserod;TEGASEROD MALEATE;Tegaserod Maleate;Tegaserod maleate; TEGASEROD	3.1622776602	-5.5	8.6998039485	4	4		13.9786708599	-2.83159463	1	0.9949351625	3360	HTR4	N=C(NCCCCC)N\N=C\c2cnc1ccc(cc12)OC	Bosche	T3499	-1.28312413	-2.06555905	9.27835052	-2.83159463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379068-03	NCGC00379068-03	384569092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	147030-01-1		3.5481338923	-5.45	0.3005370206	4	4		18.052301256	9.92548435	0.0795396694	0.9961133928			CC(C)(C)SC1=C(CC(C)(C)C(O)=O)[N](CC2=CC=C(Cl)C=C2)C3=C1C=C(OCC4=NC5=CC=CC=C5C=C4)C=C3	MedChem Express	HY-50714	-3.79358438	-0.53884149	4.21467556	9.92548435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356746-04	NCGC00356746-04	384569031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-16.5939765348	4	4		0	-5.58683413				NAMPT	[O-][S+](=O)(C1=CC=C(CNC(=O)C2=CC3=C([NH]N=C3)N=C2)C=C1)C4=CC(=CC=C4)C(F)(F)F	NCGCChem	DYD027-070	-2.51732428	-3.72689782	-4.84283351	-5.58683413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499427-02	NCGC00499427-02	384569306		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1622849-58-4				5.7423805346	4	4		0	-2.7573264				RIPK1	CN1C(=O)[C@H](COC2=C1C=CC=C2)NC(=O)C3=NOC(=C3)CC4=CC=CC=C4	Glixx	GLXC-08004	4.69523405	-2.19948068	-3.79004362	-2.7573264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015251-13	Clotrimazole	170464807	Lanosterol 14alpha-demethylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	23593-75-1	 ; Bay b 5097; Clotrimazole;Clotrimazole; b 5097, F; Clotrimazol; Kanesten; Baycuten; Canesten; Canesten HC; FB b 5097; b 5097, Ba; Baycuten SD; Lotrimin; Mycelex; Klotrimazole;CLOTRIMAZOLE; 5097, Bay	14.1253754462	-4.85	8.9868577439	4	4		27.3368382919	21.71052632	0.1463053167	0.9865923669	1595	CYP51A1	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	Vitas	STK700023	-2.36403191	0.51932183	-2.24089636	21.71052632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248064-08	NCGC00248064-08	384568522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	256373-96-3				-9.0029349733	4	4		0	0.9569378					CC(C)(O)C1=COC(=C1)[S+]([O-])(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4	Glixx	GLXC-05963	-3.1182016	-0.15274171	-2.35883827	0.9569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164613-04	NCGC00164613-04	384568264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	82159-09-9				-6.8582643124	4	4		0	-0.14952153				AKR1B1	CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O	Selleck	S2035	-2.62509065	1.61906217	-1.68067227	-0.14952153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246958-03	NCGC00246958-03	363677155		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	58131-57-0				6.5708796545	4	4		0	0.68779904				MDM4	CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+]([O-])=O	Selleck	S2678	1.11675127	1.2830304	3.30237358	0.68779904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510444-01	NCGC00510444-01	384569436		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			1.4125375446	-5.85	46.6883223851	2.4	4		33.8771885478	23.95688992	0.4174775045	0.87435644		CSNK1A1	NC1=NC2=C(N=C(C(=N2)N)C3=CC(=CC=C3)Cl)C(=N1)N	SIGMA	SML1647	0.22538386	-0.66828676	41.02309763	23.95688992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344510-06	NCGC00344510-06	384568720		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	284035-33-2		14.1253754462	-4.85	7.3453841526	4	4		-15.743030984	-6.45252582	0.6634705256	0.5675160639		CASR	CC(C)(CC1=CC=C2C=CC=CC2=C1)NC[C@@H](O)COC3=C(C#N)C(=CC=C3)Cl	MedChem Express	HY-10007	-1.17891817	12.4161574	9.29958799	-6.45252582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263184-06	NCGC00263184-06	384568652		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	471905-41-6				6.9598785996	4	4		0	3.22626291				NOTCH1	OC(=O)CCC1CCC(CC1)(C2=CC(=CC=C2F)F)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	Chemscene	HY-10974	1.56726768	0.13414816	0.64743967	3.22626291												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263220-07	NCGC00263220-07	384568674		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	128517-07-7				-18.427133609	4	4		0	-6.19782086				HDAC1	C\C=C1/NC(=O)[C@H]2CSSCC\C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C	DC Chemicals	DCAPI1434	-2.92649098	-4.18840364	-4.85579753	-6.19782086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378593-02	NCGC00378593-02	384569052		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	848141-11-7				2.9031014809	4	4		0	1.33012594					C[N]1N=CC=C1C/2=C(\C)N(C(=O)C(=C2)/C(=O)NCC3=NC=C(C=C3)[S+](C)([O-])=O)C4=CC=CC(=C4)C(F)(F)F	Glixx	GLXC-90263	0.04160888	0.31301237	2.26603885	1.33012594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510162-01	NCGC00510162-01	384569411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1883423-59-3		11.220184543	-4.95	-2.2997010029	4	4		11.64853556	6.97466468	0.379121963	0.9011736331		CDK8	CC1=N[NH]C2=C1C=C(C=N2)C(=O)N3CCC[C@H]3C4=CC=C(Cl)C=C4	Glixx	GLXC-09132	-3.0404463	0.32929202	0.03032141	6.97466468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346677-02	NCGC00346677-02	384568903		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	252935-94-7		11.220184543	-4.95	26.1554884914	4	4		17	15.9520716	0.1351987098	0.98865974		GSK3B	NC1=NC(=CC=C1[N+]([O-])=O)NCCNC2=NC=C([N]3C=CN=C3)C(=N2)C4=CC=C(Cl)C=C4Cl	Selleck	S2745	2.77188516	4.46005804	5.77530456	15.9520716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274067-09	NCGC00274067-09	384568712		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE			4.4668359215	-5.35	50.8569203031	2.4	4		40.0403374324	39.75088421	0.142906646	0.9871996078		MPL	CC1=CC=C(C=C1C)N2/N=C(C)\C(=N/NC3=CC=CC(=C3O)C4=CC=CC(=C4)C(O)=O)C2=O	Bio Vision	9489-5	3.40846619	-0.95799558	18.75881523	39.75088421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601698-01	Glecaprevir			DPI_SARS-CoV-2_General		1365970-03-1				0.5700580701	4	10		0	-0.1913091					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-1.28450396	1.50314294	4.23613009	-1.06586499	-0.13664936	-0.24596884	-0.46460782	-0.84722602	1.39382345	-0.1913091						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General		97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	0.0702306445	-7.1534733462	177.1338221828	3	10		69.2504690411	57.59849906	7.828E-7	0.993524797	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	3.02867864	2.38541946	2.54623425	1.68855535	4.69043152	6.13776467	2.54623425	3.61833289	9.19324578	57.59849906						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	DPI_SARS-CoV-2_General		59721-29-8				-3.218791327	4	10		0	-1.15250603					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-1.63495042	-3.2967033	2.33181453	-0.61645671	-0.45564192	-0.9380863	1.47413562	-0.24122219	2.92146878	-1.15250603						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686670-01	GS-441524			DPI_SARS-CoV-2_General		1191237-69-0		0.0070230644	-8.1534733462	398.1189353009	1.1	10		99.4131550856	101.25668449	0.0000026232	0.9908055951			NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	2.21925134	-0.18716578	2.48663102	4.67914438	10.72192513	29.75935829	101.25668449	104.35828877	94.19786096	101.25668449						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General		51773-92-3		0.0049719489	-8.3034733462	14.3648931354	4	20		27.0703564739	-3.60962567	0.2521820203	0.3678337418		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485882-01	BCX 4430	363681391		DPI_SARS-CoV-2_General		222631-44-9				17.6086935004	4	20		0	6.44385027					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00182390-05	NCGC00182390-05			DPI_SARS-CoV-2_General				0.024918773	-7.6034733462	208.8696404517	1.2	20		69.8727794544	61.51954086	0.000116277	0.8677790882			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00092381-04	NCGC00092381-04	384568109		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[1188890-28-9]				2.8080519372	4	4		0	-5.02392344				ADK	NC1=C2C(=NC=N1)N=C(C=C2C3=CC(=CC=C3)Br)C4=CN=C(C=C4)N5CCOCC5	Tocris	2372	0.826686	1.71070719	4.65870559	-5.02392344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00070736-17	Imiquimod	384568073	TLR 7 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	99011-02-6				-2.1911593292	4	4		0	1.67464115				TLR7	CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12	MedChem Express	HY-B0180	-1.6968818	-0.88590194	0.70765148	1.67464115												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00091057-08	NCGC00091057-08	384568092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	22888-70-6				8.4067805988	4	4		0	-0.98684211				ABCBA	COC1=C(O)C=CC(=C1)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=C(C(=CC(=C5)O)O)C(=O)[C@@H]4O	Selleck	S2357	1.95794054	2.62715748	3.30237358	-0.98684211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025346-15	NCGC00025346-15	384568069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	85650-52-8				-9.7174641221	4	4		0	-1.20092379				HTR2A	CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3	MedChem Express	HY-B0352	-2.87364418	-0.97205346	-1.14779651	-1.20092379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142605-05	NCGC00142605-05	384568166		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	138-52-3				-1.5225444431	4	4		0	1.04503974					OC[C@H]1O[C@@H](OC2=CC=CC=C2CO)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2351	-1.63036032	0.65638834	2.00418786	1.04503974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351595-02	NCGC00351595-02	363677763		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	4279				1.4213906859	4	4		0	0.16980331				MAPKAPK2	C[C@@H]1CNC2=C(SC3=CC=C4N=C(C=CC4=C23)C5=CC=C(C)N=C5)C(=O)N1	Tocris	4279	-1.01248266	2.57862573	2.97233667	0.16980331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159491-08	NCGC00159491-08	384568182		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	13392-28-4				-1.274452473	4	4		0	-0.50670641					CC(N)C12CC3CC(CC(C3)C1)C2	Selleck	S1964	0.11157601	-0.68851968	-1.00060643	-0.50670641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160391-11	NCGC00160391-11	384568191		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			2.5118864315	-5.6	-3.1133326094	4	4		-10.08345752	-6.7362146	0.4115514909	0.8795436689		TXNRD1	CC[P](CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	SIGMA	A6733_cm1	0.78103208	5.74764257	-5.85203153	-6.7362146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390417-03	NCGC00390417-03	363680893		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1346546-69-7				-8.5276744993	4	4		0	0.05980861				RIPK3	CC(C)[S+]([O-])(=O)C1=CC2=C(C=C1)N=CC=C2NC3=CC4=C(SC=N4)C=C3	Glixx	GLXC-03990	-2.27701233	-2.38277073	-1.56273036	0.05980861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090797-28	NCGC00090797-28	384568087		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[20830-75-5]				10.7387430241	4	4		0	1.67464115			24377		C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Tocris	4583	1.17476432	4.88773484	4.39333628	1.67464115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189144-02	NCGC00189144-02	384568459		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[1320288-17-2]				-3.3545465742	4	4		0	-0.35885167				EHMT2	COC1=C(OCCCN2CCCCC2)C=C3N=C(N=C(NC4CCN(CC4)C5CCCCC5)C3=C1)N6CCCN(CC6)C(C)C	Tocris	4342	-1.31979695	2.35222239	-1.94604157	-0.35885167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384250-02	NCGC00384250-02	384569109		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1496581-76-0		10	-5	1.6860152296	4	4		21.403205916	14.43921107	0.0310276651	0.999408596		MAP3K12	FC1(F)CCN(C1)C2=CC(=CC(=N2)NC3=CC(=CC=N3)C#N)C4CCN(CC4)C5COC5	MedChem Express	HY-12947	-2.83600493	-2.45764005	-0.20939276	14.43921107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167982-11	NCGC00167982-11	384568345		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	72496-41-4				-9.8632820828	4	4		0	-2.48748896				TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@H]6CCCCO6)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Adooq	A10735	-1.63036032	-3.251412	-2.24349387	-2.48748896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346536-06	NCGC00346536-06	363677444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	593960-11-3				17.0785331064	4	4		0	-1.19222844				PIK3CA	CC(=O)NC1=NC(=C(S1)C2=CC(=C(Cl)C=C2)[S+]([O-])(=O)NCCO)C	MedChem Express	HY-12046	3.98684751	4.4725996	6.6706551	-1.19222844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379217-03	NCGC00379217-03	363678425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1216665-49-4		14.1253754462	-4.85	17.1800572942	4	4		13	12.36734116	0.1466097756	0.9866541904		ERN1	C1CC1C2=N[NH]C(=C2)NC3=NC(=NC=C3)NC4=CC5=C(C=C4)N=C[NH]5	Bio Vision	2591	2.45492372	1.29676554	1.08887581	12.36734116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387035-02	NCGC00387035-02	384569149		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1184843-57-9		7.0794578438	-5.15	3.720576345	4	4		11.3378985159	9.32935917	0.1643349189	0.9831673363		CHEK1	C[C@H](CN(C)C)OC1=NC(=CN=C1C#N)NC2=NC=C3C(=CC=CC3=C2)Cl	SynKinase	SYN-1189	-0.80892608	-2.36491543	0.66707095	9.32935917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262641-04	S31-201	384568576	STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	501919-59-1				-7.7348036947	4	4		0	-1.25186289				STAT3	CC1=CC=C(C=C1)[S+]([O-])(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O	Selleck	S1155	-3.48675035	-0.71845532	3.72953305	-1.25186289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016612-13	NCGC00016612-13	384567954		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	2447-57-6				-4.3125683717	4	4		0	-1.43070045					COC1=NC=NC(=C1OC)N[S+]([O-])(=O)C2=CC=C(N)C=C2	MedChem Express	HY-B0439	-1.05997211	-1.61652447	0.84899939	-1.43070045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345791-06	NCGC00345791-06	384568744		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1097917-15-1				-4.6945717826	4	4		0	0.56896817				ALK	COC1=CC(=CC=C1NC2=NC=NC(=N2)NC3=CC=CC=C3[S+]([O-])(=O)C(C)C)N4CCC(CC4)N5CCN(C)CC5	APExBIO	A3193	-0.74216603	-1.34119381	-3.27221439	0.56896817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094571-10	NCGC00094571-10	384568131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	483-63-6				0.4856457506	4	4		0	-2.07596494					CCN(C(=O)\C=C\C)C1=CC=CC=C1C	Microsource	01505271	1.29191864	0.98747237	-2.79266573	-2.07596494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167462-06	NCGC00167462-06	384568315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	77337-73-6		6.3095734448	-5.2	12.1222306465	4	4		12.9060150359	11.30382775	0.287605892	0.9457517976			CC(=O)NCCC[S]([O-])(=O)=O	Microsource	01505711	0.39158811	1.13028868	-2.00501253	11.30382775												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00348107-03	NCGC00348107-03	363677735		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	885704-21-2				0.4246123681	4	4		0	2.04592287				CSF1R	CC1CCN(CC1)C2=CC(=CC=C2NC(=O)C3=CC(=C[NH]3)C#N)N4CCN(C)CC4	MedChem Express	HY-13075	-0.61652281	-0.04579454	0.71791804	2.04592287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166088-10	NCGC00166088-10	384568303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	2353-33-5				-17.0787140155	4	4		0	-2.75242861				DNMT1	NC\1=N\C(=O)N(\C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Adooq	A10292	-3.79504042	-3.61776828	-4.00837571	-2.75242861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356803-11	NCGC00356803-11	384569032		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1338466-77-5				-0.2951562488	4	4		0	-1.69803311				DOT1L	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N]3C=CC4=C3N=CN=C4N	APExBIO	A4170	-1.12343967	3.02578626	2.47204238	-1.69803311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021569-20	NCGC00021569-20	384568008		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	76095-16-4				6.9041147151	4	4		0	-3.62247064				ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O	MedChem Express	HY-B0331A	2.64909847	4.36726785	-0.29429076	-3.62247064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510909-01	NCGC00510909-01	384569493		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	182167-02-8		11.220184543	-4.95	68.0291081497	3	4		111.5578289191	90.4768643	0.0129585225	0.9998964195		ESR1	C\C1=C(\[C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5	SantaCruz Bio	sc-480110	-1.51178918	-0.37263378	6.4743967	90.4768643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161641-05	NCGC00161641-05	363676605		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	115-53-7				-4.0753827679	4	4		0	-2.12254139					COC/1=C/[C@@H]2[C@@H]3CC4=C(C(=C(OC)C=C4)O)[C@]2(CCN3C)CC1=O	Selleck	S2359	-1.12343967	-0.07452676	0.61801059	-2.12254139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346706-07	NCGC00346706-07	363677528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	433967-28-3				-2.4795591733	4	4		0	-1.07542097				GRM5	CCCCOC1=CC=C(C=C1)C(=O)NC2=C(F)C=C(F)C=C2	MedChem Express	HY-15393	-0.79056865	-1.89297958	2.38375515	-1.07542097												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249393-08	NCGC00249393-08	377020310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1218779-75-9				-0.9578455431	4	4		0	1.84798808				FLT1	O=C(NC1=CC=C(C=C1)C2(CCCC2)C#N)C3=CC=CN=C3NCC4=CC=NC=C4	MedChem Express	HY-13342	-1.19944212	-0.35922766	1.39478472	1.84798808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386332-03	NCGC00386332-03	363680217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	585543-15-3		12.5892541179	-4.9	13.9343780624	4	4		16.215549004	13.97816392	0.2432761743	0.9618693391			CC1=C(F)C=C(C=C1C2=CC=C(C=N2)C(=O)NCC(C)(C)C)C(=O)NC3CC3	MedChem Express	HY-10402	1.84167125	-1.42962417	-0.31029619	13.97816392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346702-05	NCGC00346702-05	363677527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1029712-80-8		8.9125093813	-5.05	5.2902674797	4	4		17.3749312799	12.77871751	0.0768686686	0.9963640471		MET	CNC(=O)C1=CC=C(C=C1F)C2=N[N]3C(=CN=C3N=C2)CC4=CC=C5N=CC=CC5=C4	MedChem Express	HY-13404	-1.9791094	-0.84008843	1.97461213	12.77871751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015038-11	NCGC00015038-11	384567800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	54-62-6, 58602-66-7 [aminopterin sodium]				-1.0781022234	4	4		0	0.5997232				DHFR	NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N=C2C(=N1)N	Microsource	01500679	-0.30236394	0.16212233	-1.24118477	0.5997232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183862-01	NCGC00183862-01	144206867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	75820-08-5				-10.3690297169	4	4	N-5-trifluoromethyl-6-methoxy-1-thionaphthoyl-N-methylglycine;Alredase;tolrestatum;tolrestat;AY-27,773;TOLRESTAT;N-((5-(trifluoromethyl)-6-methoxy-1-naphthalenyl)thioxomethyl)-N-methylglycine;CIPLUS_682579;Tolrestat;LS-71766;AY 27773;	0	-1.01674641				AKR1B1	O=C(O)CN(C)C(=S)c2cccc1c2ccc(OC)c1C(F)(F)F	Pharmaron	PH-NIH-172180	-2.88614938	0.30548343	-3.50877193	-1.01674641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263146-04	NCGC00263146-04	384568621		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					7.9711336407	4	4		0	3.52870813				MAPK8	CC1=NC=C(C=C1)C2=N[N](C=N2)C3=CC=C(NC4=NC=CC(=N4)C5=CC(=CC=C5)N6CCOCC6)C=C3	MedChem Express	HY-12829	-0.39158811	6.20131358	2.8600914	3.52870813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015680-33	NCGC00015680-33	384567881		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	73-31-4				4.5050131674	4	4		0	-3.67822966				MTNR1B	COC1=CC2=C([NH]C=C2CCNC(C)=O)C=C1	MedChem Express	HY-B0075	2.91515591	-0.18329006	-0.08845644	-3.67822966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00343773-03	NCGC00343773-03	384568715		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	n				15.1853173102	4	4		0	5.32296651			29943	PADI1	CN(C)C1=CC=C2C=C(C=CC2=C1)C(=O)N[C@@H](CCCNC(=N)CCl)C(=O)NCC3=CC=CC=C3	NCGCChem	JKJ27-003	2.91515591	3.02428593	2.35883827	5.32296651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499575-01	NCGC00499575-01	384569307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1024008-14-7				-15.4424059682	4	4		0	-5.60788931				HDAC1	ONC(=O)C1=CN=C(N=C1)N2C[C@H]3C[C@@H]2CN3C4=CC(=CC=N4)C(F)(F)F	Organix	O-10104	-1.76736539	-4.07571363	-5.56386479	-5.60788931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263195-04	NCGC00263195-04	377020296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	451492-95-8				-23.471025724	4	4		0	-6.64679583				EGFR	CN1CCN(CC1)C(C)(C)C#CC2=C(NC(=O)C=C)C=C3C(=NC=NC3=C2)NC4=CC(=C(F)C=C4)Cl	MedChem Express	HY-10346A	-4.85355649	-4.1311181	-4.60885385	-6.64679583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247879-05	NCGC00247879-05	384568520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	847559-80-2		3.1622776602	-5.5	21.7574574885	4	4		14	15.13157895	0.0720830594	0.9968054993		HSP90AB1	CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C3=CC(=C(Cl)C=C3Cl)OCCN4CCCC4	MedChem Express	HY-10942	0.91370558	1.74125554	3.74465576	15.13157895												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015121-25	NCGC00015121-25	384567812		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	63-92-3				7.7030793303	4	4		0	-0.92728878				ADORA1	CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2	MedChem Express	HY-B0431A	3.13741608	-0.1679133	0.71791804	-0.92728878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090808-05	NCGC00090808-05	384568088		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1397-89-3				-2.8489682751	4	4		0	-0.22078304					C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	Selleck	S1636	-0.31511166	-0.56479927	-2.12384086	-0.22078304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480972-03	NCGC00480972-03	363681115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-0.4327429803	4	4		0	1.8379754				IDH1	COC1=C(C)C=C(NC(=O)C2=N[N](CC3=CC=C(F)C=C3)C4=C2CN(C[C@]4(C)C(N)=O)C(=O)C5=CC=C[NH]5)C=C1C	SGC	GSK864	-0.31785517	-1.20961568	-2.07057451	1.8379754												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00522513-01	NCGC00522513-01	384569522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1233948-61-2				-8.9696160374	4	4		0	-1.69659268				HIF1A	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C)C3=CSC(=C3)C#N	MedChem Express	HY-16187	-2.58430072	0.26029704	-1.83727034	-1.69659268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263215-04	NCGC00263215-04	384568670		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[1222998-36-8]		0.5011872336	-6.3	24.6027123018	4	4		18.5679933679	-0.08482963	1	0.9989000098		MTOR	CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)\C=C/C4=C3C5=CC(=CC=C5N=C4)C6=CN=C7C=CC=CC7=C6)C(F)(F)F	Tocris	4247_cm1	-2.55666114	4.57816567	15.54389035	-0.08482963												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00390670-01	NCGC00390670-01	363680965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1588521-78-1				-1.6086622186	4	4		0	2.5633383				BRD4	CC1=NN=C(C[C@@H]2\C=C(C3=CC=C(Cl)C=C3)/C4=CC=CC=C4[N]5C(=NN=C25)C)O1	MedChem Express	HY-12421 	-0.39051604	-1.76620266	-1.84960582	2.5633383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181336-01	NCGC00181336-01	144206348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	21679-14-1	 ; Fludarabine des-phosphate; Fludarabine;fludarabine; F-ara-A;2-Fluoroadenosine; Fludara; Fludarabine Base			-0.4861523735	4	4	2-fluoroadenosine;2-fluoroadenine arabinoside;FLUDARABINE;9-beta-D-Arabinofuranosyl-2-fluoroadenine;9-.BETA.-D-ARABINOFURANOSYL-2-FLUOROADENINE;2-FLUOROADENOSINE;Fludara;fludarabine;2-Fluoroadenosine;CIPLUS_152133;CIPLUS_172834;9h-purin-6-amine, 9-beta-d-arabinofuranosyl-2-fluoro- (9ci);Fludarabine Base;Fludarabine des-phosphate;F-ara-A;NSC-312887;2-FLUORO-ARA AMP;2-Fluoroadenine-9-beta-D-arabinofuranoside;FLUDARABINE PHOSPHATE SODIUM;LS-15061;2-FLUORO-9-(5-O-PHOSPHONO-BETA-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE;9-beta-D-arabinofuranosyl-2-fluoroadenine;2-Fluoroadenosine(Fludarabine Intermediate);FLUDARABINE PHOSPHATE;Fludarabine;9-D-arubinofuranosyl-2-fluoro-9H-purin-6-amine;9H-purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-;fludarabinum;2-FLUORO-ADENINE ARABINOSIDE-5-PHOSPHATE;	0	-2.86140089			5539	PNP	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	SIGMA	F2773	1.50627615	-1.13755426	-2.00121286	-2.86140089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346891-02	NCGC00346891-02	384568964		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[382180-17-8]				-13.4224595966	4	4		0	-5.4247392				HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CN=C1	Tocris	4403	-2.67782427	-1.49678192	-2.12249848	-5.4247392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346590-02	NCGC00346590-02	363677468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	71939-50-9				-8.0621960049	4	4		0	-0.23923445				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S2290	-1.6968818	-1.069192	-4.01002506	-0.23923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484800-01	NCGC00484800-01	384569272		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-4.2682817644	4	4		0	-1.73444976				DYRK1A	CCOC(=N)C1=NC2=CC=C3N=CN=C(NC4=CC(=C(F)C=C4Cl)F)C3=C2S1	Felicitex	FX-9847	-0.10152284	-1.37467542	-2.50626566	-1.73444976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161327-11	NCGC00161327-11	384568204		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	32222-06-3				4.224854995	4	4		0	-0.338534			7421	VDR	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	Glixx	GLXC-06432	2.56199479	-0.35109144	-2.60245289	-0.338534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483118-01	NCGC00483118-01	363681137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			6.3095734448	-5.2	10.698126753	4	4		17.192718664	14.0859582	0.129997457	0.9894850626		SIRT1	COCCCC1=C(N=C(S1)C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C4=NC5=C(S4)N=CC(=C5)CN6CCCC6	MedChem Express	HY-19758A	-0.47951774	-2.24393222	-2.03410111	14.0859582												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346632-02	NCGC00346632-02	384568868		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	741713-40-6		0.5623413252	-6.25	38.7861092686	4	4		16.5	15.02796585	0.3402639734	0.9214419117		CDK1	COC1=CC=C(F)C(=C1C(=O)C2=C(N)N=C(NC3CCN(CC3)[S+](C)([O-])=O)N=C2)F	Selleck	S2688	1.84956843	12.50190811	20.16153156	15.02796585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092288-05	NCGC00092288-05	363676556		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	856925-71-8				5.864378591	4	4		0	-1.1627907				MYH2	CC1=CC=C2\N=C/3N(CC[C@@]3(O)C(=O)C2=C1)C4=CC=CC=C4	Selleck	S7099	2.39758871	-0.41215082	1.28626982	-1.1627907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386818-01	NCGC00386818-01	363680447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-7.9427835945	4	4		0	-6.05067064					OC1=C(C=CC=N1)C(=O)NCCCNC(=O)C2=NOC(=C2)C3=CC=CC=C3	Evotec	MLS004580709	-0.78103208	0.65858404	-2.69860522	-6.05067064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181771-06	NCGC00181771-06	384568401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	122647-32-9				2.7405176292	4	4		0	0.17883756					CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0387	1.31101813	-0.08980692	-0.97028502	0.17883756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168108-05	NCGC00168108-05	363676676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	328543-09-5				7.3520665142	4	4		0	6.94485842				PARP1	CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O	Selleck	S2178	-1.11576011	1.37703937	5.79138872	6.94485842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510683-01	NCGC00510683-01	384569477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1245603-92-2]				-3.2111889281	4	4		0	-2.02682563				GCK	CN(C)C(=O)C1=NC=C(OC2=C3C=C(C)OC3=CC(=C2)C(=O)NC4=CN=C(C)C=N4)C=N1	Tocris	6049	-0.92050209	0.29935638	0.63674955	-2.02682563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346628-05	NCGC00346628-05	384568867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1234703-40-2				-6.5907455384	4	4		0	-3.67522682				GCK	[O-][S+](=O)(C1CC1)C2=CC=C(C=C2)[C@]3(C[C@H]3C4CCCCC4)C(=O)NC5=NC=C(SCCN6CCCC6)S5	MedChem Express	HY-13529	-1.89664651	3.4045689	-1.97461213	-3.67522682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090774-12	NCGC00090774-12	384568086		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	55981-09-4		11.220184543	-4.95	67.3014271848	3	4		98.3779904283	80.44258373	0.0227441621	0.9996808404			CC(=O)OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O	Enzo	AC3203	0.07251632	1.89399725	8.10850656	80.44258373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499786-01	NCGC00499786-01	384569310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1224964-36-6		14.1253754462	-4.85	2.3213408975	4	4		13.7998673199	10.25717703	0.1792323522	0.9798468516		ADAM10	COCCOC(=O)N1CCN(C(C1)C(=O)NO)[S+]([O-])(=O)C2=CC(=C(OC3=CC=C(Cl)C=C3)C(=C2)F)F	TruePharmaChem	T16012	-1.55184917	-0.06109669	-1.9165561	10.25717703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346539-05	NCGC00346539-05	363677446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	942947-93-5				-11.0517585469	4	4		0	-4.03708134				AURKA	CN(C)C1=CC=C(C=C1)C2=NC3=C(N4CCN(CC4)CC(=O)NC5=NC=CS5)C(=CN=C3[NH]2)Cl	MedChem Express	HY-12049	-2.71211022	-1.22193371	0.20639835	-4.03708134												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00381558-06	NCGC00381558-06	363679154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1174043-16-3		3.5481338923	-5.45	50.439548149	4	4		-16	17.23579629	1	0.6891105353	142	PARP1	COC1CCN(CC1)C(=O)C2=CC(=CC=C2F)CC/3=N/NC(=O)C4=CC=CC=C34	MedChem Express	HY-13536	11.4947253	19.70691497	5.05533952	17.23579629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386436-01	NCGC00386436-01	384569141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1616391-65-				0.9392476606	4	4		0	1.98704739				PRMT5	O[C@@H](CNC(=O)C1=CC(=NC=N1)NC2COC2)CN3CCC4=C(C3)C=CC=C4	Selleck	S7748	-0.23290862	-1.72492749	1.79479509	1.98704739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183362-01	NCGC00183362-01	124894389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	5534-95-2	Pentagastrin			-9.3706265684	4	4	N-t-Boc-beta-Ala-Trp-Met-Asp-Phe amide;Pentagastrin;	0	-1.90916089				CCK2	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CCNC(=O)OC(C)(C)C)Cc3cnc2ccccc23	SigmaAldrich	B1636	-2.39470348	-1.60996355	-1.00609324	-1.90916089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483921-01	NCGC00483921-01	363681140		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1393466-87-9				7.6422527263	4	4		0	0.75066235			673	BRAF	[O-][S+](=O)(NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=C2C=C(C=N3)C4=CN=C(N=C4)C5CC5)N6CC[C@@H](F)C6	MedChem Express	HY-18972	1.30154816	6.24332163	-0.8674843	0.75066235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263168-03	NCGC00263168-03	384568638		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	718630-59-2				-10.7385954095	4	4		0	-4.25375331				CDK1	CC(C)CC(=O)NC1=N[NH]C2=C1CN(C(=O)C3CCN(C)CC3)C2(C)C	Selleck	S1487	-1.68516235	-1.81651656	-2.8417589	-4.25375331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159509-02	NCGC00159509-02	29215484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	82834-16-0	 ; Aceon; Perindopril;Perindopril; Pirindopril; Erbumine, Perindopri; Perindopril and diuretics; cpd with unspecified MF; Perstarium			-3.2460259715	4	4	cpd with unspecified MF;S 9490-3;CIPLUS_196546;LS-82690;1-(2-((1-(ETHOXYCARBONYL)BUTYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID(2S-(1(R*(R*)),2A,3AB,7AB))-2-METHYL-2-PROPANAMINE;S-9490;Perindopril and diuretics;LS-82762;PERINDOPRIL;S 9490;LS-178402;CIPLUS_668001;S949;perindopril;Perindopril;(2S,3(infinity)S,7(infinity)S)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1);PERINDOPRIL ERBUMINE;CIPLUS_685081;HS_6;S 949;PERINDOPRIL T-BUTYLAMINE;Pirindopril;MCN-A-2833-109;perindoprilum;Perindopril erbumine;Aceon;Perindopril Erbumine;1H-Indole-2-carboxylic acid,              1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-;NCGC00095142-01;Perstarium;Erbumine, Perindopri;NCGC00095142-02;1H-Indole-2-carboxylic acid,;	0	-1.01795561			1636	ACE	O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O	Enamine	T5568746	-0.92592593	0.96463022	-1.13735783	-1.01795561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096095-02	NCGC00096095-02	26753806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	34408-14-5				-9.9959041005	4	4	LS-174469;8-chloroadenosine;NCGC00096095-01;Kolibri-C 006;8-Chloroadenosine (8-Cl-Ado);CIPLUS_725292;	0	-1.08271979			7015	TERT	NC1=NC=NC2=C1N=C(Cl)[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Timtec	ST5298846	-2.14962523	-1.68015885	-3.60956535	-1.08271979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262642-10	NCGC00262642-10	384568577		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	857064-38-1		0.2511886432	-6.6	27.5401439021	4	4		-17.1159309559	8.8783023	1	0.998955469		STAT3	C[C@H](NC(=O)/C(=C/C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-15312	12.75632867	-2.59660913	-2.22589863	8.8783023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016480-20	NCGC00016480-20	384567944		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	520-18-3				3.51564991	4	4		0	-0.18767143					OC1=CC=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O	Enzo	NP156	1.07481261	0.67206354	0.63167394	-0.18767143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378692-06	NCGC00378692-06	384569063		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	869886-67-9				-16.8807666678	4	4		0	-1.97074673				ERK	CC(C)NC1=NC=C(Cl)C(=C1)C2=C[NH]C(=C2)C(=O)N[C@H](CO)C3=CC=CC(=C3)Cl	MedChem Express	HY-15816	-3.38075785	-4.86026731	-4.83208162	-1.97074673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093976-15	NCGC00093976-15	384568121		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	57852-57-0				-5.5937352686	4	4		0	3.45266733				TOP2A	C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=C23)O)C(=O)C5=C(C=CC=C5)C4=O)C(C)=O	MedChem Express	HY-17381	-0.84604716	-4.27783574	-4.32607416	3.45266733												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178529-07	NCGC00178529-07	384568358		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	100986-85-4				6.5037874112	4	4		0	3.9304397				TOP2B	C[C@H]1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0330	0.98120509	-0.29092023	1.80810732	3.9304397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015148-12	NCGC00015148-12	384567814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	5072-26-4				5.2324221667	4	4		0	0.87657288				GSS	CCCC[S+]([O-])(=N)CCC(N)C(O)=O	SIGMA	B2640	-0.42841349	7.94671566	0.49577136	0.87657288												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00346507-07	NCGC00346507-07	363677433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1002304-34-8				-0.3877263277	4	4		0	-2.03591121				MET	COC1=CC=C2C(=CC=NC2=C1)OCC3=NN=C4C=CC(=N[N]34)C5=CC=CC=C5	MedChem Express	HY-12035	1.17468214	-1.24023886	-1.42898804	-2.03591121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166125-02	Meglumine	170465359	amino sugar	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	6284-40-8	 hypaque(M)90; Isopaque coronar; N-Methyl-D-glucamine; Isteropac; Banamine; Urovist; Isopaque cerebral;Meglumine; Renovue-65; ; Uropolinum Polfa; Vascoray; Uropolin; Renovist II; Conraxin-H; Hypaque 76; Telebrix 350; Salicylate Meglumine; Uromiron; Meglumine iotalamate; Meglumine; Fortombrine; Sch 14714 meglumine; N-Methyl-D-Glucamine; Vasurix; Visotrast; Meglumina			9.2547366721	4	4		0	-0.5089778				GLUT1	O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO	Prestwick	Prestw-884	4.93366501	-2.98576022	-1.25400992	-0.5089778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016994-20	NCGC00016994-20	384567973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	7689-03-4				-16.7261755312	4	4		0	-2.79937792				TOP1	CC[C@@]1(O)C(=O)OC\C2=C1\C=C\3N(CC4=C3N=C5C=CC=CC5=C4)C2=O	Selleck	S1288	-3.41348811	-3.53697749	-4.9285506	-2.79937792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016311-32	NCGC00016311-32	384567931		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	65-28-1				-5.8029377425	4	4		0	-2.49747365				ADRA1A	CC1=CC=C(C=C1)N(C\C2=N\CCN2)C3=CC=CC(=C3)O	MedChem Express	HY-B0362A	-1.61221892	-0.79425691	1.05278989	-2.49747365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378588-02	NCGC00378588-02	363678105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	939981-37-0				-11.1189943771	4	4		0	-6.25090227				TP53	CCOC1=CC(=CC=C1C/2=N/[C@@](C)(C3=CC=C(Cl)C=C3)[C@](C)(N2C(=O)N4CCN(CC4)CC(=O)N5CCOCC5)C6=CC=C(Cl)C=C6)C(C)(C)C	MedChem Express	HY-70027	0.50912176	-4.79608981	-4.60219582	-6.25090227												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00253439-03	NCGC00253439-03	384568562		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1089283-49-7		1.5848931925	-5.8	7.2911516606	4	4		11.579272948	6.25090227	0.4359408382	0.8616255534		IGFR1	CCC1=CC(=C(OC)C=C1N2CCC(CC2)N3CCN(CC3)[S+](C)([O-])=O)NC4=NC(=CC=N4)C5=C(N=C6C=CC=C[N]56)C7=CC(=C(OC)C=C7)C(=O)NC8=C(F)C=CC=C8F	Selleck	S1093	-1.69707255	-2.56606079	12.51315987	6.25090227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345795-04	NCGC00345795-04	363677359		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1143532-39-1				-11.1539245641	4	4		0	-3.51039261				AKT1	NC1(CCN(CC1)C2=C3C=C[NH]C3=NC=N2)C(=O)N[C@@H](CCO)C4=CC=C(Cl)C=C4	ChemieTek	CT-A5363	-2.14114664	-2.15674362	-2.22474139	-3.51039261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475727-01	NCGC00475727-01	363681098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1313725-88-0				11.5049453783	4	4		0	1.93995381				MET	C[C@H]([N]1N=NC2=C1N=C(C=N2)C3=C[N](C)N=C3)C4=C[N]5C=CN=C5C=C4	ActiveBioChem	A-1316	2.50739541	0.36452005	4.86042228	1.93995381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386394-01	NCGC00386394-01	384569131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1493694-70-4				-6.0340803176	4	4		0	-4.66959106			10461	MERTK	CCCCNC1=NC(=C(C=N1)C2=CC=C(CN3CCOCC3)C=N2)N[C@@H]4CC[C@@H](O)CC4	Selleck	S7342	-0.67961165	3.651811	-3.09005297	-4.66959106												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00475734-01	NCGC00475734-01	384569234		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1037210-93-7		3.1622776602	-5.5	54.3192093499	3	4		44.981814176	-6.30566945	1	0.9851138905		SHH	C[C@@H]1CN[C@H]2[C@@H](C)[C@@]3(CC[C@H]4[C@@H]5CC[C@@H]6C[C@@H](CC[C@]6(C)[C@H]5C\C4=C(C)\C3)N[S+](C)([O-])=O)O[C@@H]2C1	ActiveBioChem	A-1062	2.44610282	-2.37329659	34.3832021	-6.30566945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508861-01	NCGC00508861-01	384569365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1474110-21-8		12.5892541179	-4.9	55.1993606278	3	4		58.824219273	55.08270889	0.1379744001	0.9880755944		RORC	CCC1=CC=C(C=C1)N(CC(C)C)[S+]([O-])(=O)C2=CC=C(OCC3CCOCC3)C(=C2)CO	Bio Vision	B1195	5.48645661	1.48522431	-1.45815106	55.08270889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263189-06	NCGC00263189-06	363677254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	943540-75-8				13.4684410469	4	4		0	5.82496819				MET	C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C(F)(F)C4=CC=C5N=CC=CC5=C4)C=C2	Glixx	GLXC-90142	3.19237148	0.44403614	0.93321668	5.82496819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379071-02	NCGC00379071-02	384569093		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1093403-33-8				4.6419404018	4	4		0	4.86502093				SIRT1	CC1=C(SC(=N1)C2=CC=CN=C2)C(=O)NC3=CC=CC=C3C4=C[N]5C(=CSC5=N4)CN6CCOCC6	MedChem Express	HY-15262	-0.96167444	3.20757599	1.74462325	4.86502093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183031-08	D-Pantothenic acid			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	79-83-4				5.0252594003	4	4		0	0.07218132					[H][C@](O)(C(=O)NCCC(O)=O)C(C)(C)CO	Selleck	S2498	1.8667798	1.40522377	-1.11294932	0.07218132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386704-01	NCGC00386704-01	363680407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1260075-17-9				-1.8396666038	4	4		0	-0.18767143				PKM2	[O-][S+](=O)(NC1=CC=C(C=C1)C(=O)N2CCN(CC2)CC3CC3)C4=CC=CC5=C4N=CC=C5	Axon Medchem	2149	-1.24451987	0.6415152	1.47390585	-0.18767143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263116-09	NCGC00263116-09	384568600		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	847591-62-2				-8.2205782039	4	4		0	-5.11363636				CREBBP	OC1=CC=C(C[C@@H]2N3[C@H](CN(CC4=CC=CC5=C4C=CC=C5)C2=O)N(CCC3=O)C(=O)NCC6=CC=CC=C6)C=C1	Glixx	GLXC-02853	-0.76867295	-0.15274171	-3.33185906	-5.11363636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094810-08	NCGC00094810-08	384568136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	81-81-2				5.1809054609	4	4		0	-0.92703349				VKORC1	CC(=O)CC(C1=CC=CC=C1)C/2=C(O)/C3=CC=CC=C3OC2=O	Cayman	13566	0.59463379	7.05666718	-0.8255934	-0.92703349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379236-08	NCGC00379236-08	363678438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1062368-49-3				5.106096165	4	4		0	3.28947368				ACVR1	COC1=CC=C(C=C1)C2=C[N]3N=CC(=C3N=C2)C4=CC=CC5=C4C=CC=N5	Aobious	AOB4273	-1.55184917	2.32167405	7.13548577	3.28947368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016599-10	NCGC00016599-10	384567951		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	2022-85-7				8.9509822588	4	4		0	5.74162679				TYMS	NC/1=N/C(=O)N/C=C1F	MedChem Express	HY-B0139	0.04350979	8.2175042	-1.71015775	5.74162679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345838-04	NCGC00345838-04	363677381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1033735-94-2				-9.888215324	4	4		0	1.57491905				PIK3CA	CC(C)(O)C1=CC2=C(S1)C(=NC(=N2)C3=CN=C(N)N=C3)N4CCOCC4	Glixx	GLXC-90035	-2.83600493	-3.49564952	-1.9742746	1.57491905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161927-04	NCGC00161927-04	384568217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					-11.1398202219	4	4		0	0.56601104				TUBB	COC1=C(O)C(=CC(=C1)[C@H]2C3C(COC3=O)[C@H](O)C4=C2C=C5OCOC5=C4)OC	Microsource	01505328	-3.17614424	-3.05559696	-1.88346086	0.56601104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387868-06	NCGC00387868-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	891494-64-7				2.6386117864	4	4		0	-0.08490166					CN1C=C(C=N1)C2=C3N=C([C@H]4CCCNC4)C(Br)=C(N)N3N=C2	MedChem Express	HY-15532B	0.40221914	2.1314652	0.26486168	-0.08490166												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025251-08	NCGC00025251-08	384568063		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1664				1.7435520341	4	4		0	1.61313146				PPARG	CN(CCOC1=CC=C(C[C@H](NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C(O)=O)C=C1)C4=CC=CC=N4	Tocris	1664	-1.20665742	5.61931733	-0.44143614	1.61313146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3			-2.7667108446	4	4		0	-1.96721311			5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-0.89260809	-0.89806915	2.30442693	-1.96721311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263088-02	NCGC00263088-02	384568582		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[853910-02-8]		0.7943282347	-6.1	37.3389936371	1.4	4		37.8305439319	28.76304024	0.1244310559	0.9903365384		PIK3CA	CC1=NC2=CN=C3C=CC(=CC3=C2[N]1C4=CC=C(C=C4)C(C)(C)C#N)C#CC5=CN=CC=C5	Tocris	3606	-6.10878661	13.02200269	31.95876289	28.76304024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510682-01	NCGC00510682-01	384569476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1246030-96-5]				1.8633882524	4	4		0	-6.49776453				ITK	CCC1=CC=C2N=C(NC3=NC(=NC(=C3)CC4=CC=CC=C4)N[C@H]5CC[C@H](O)CC5)SC2=C1	Tocris	5401	3.26359833	0.35922766	-2.66828381	-6.49776453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351483-01	NCGC00351483-01	384569010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1251156-08-7				-7.7294721931	4	4		0	-0.78425342				MTOR	CC1=C(F)C(=CC=C1C(=O)N2CCOC3=CC=C(C=C3C2)C4=CC=C(N)N=C4)[S+](C)([O-])=O	Arking Pharma	ARKS-00101	-1.48433205	-1.01694915	-3.77997179	-0.78425342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263621-12	NCGC00263621-12	384568695		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1260907-17-2		1.995262315	-5.7	4.7694266961	4	4		-7.535966148	-2.29125019	0.5820526829	0.710913467		BRD4	CCNC(=O)C[C@@H]1\N=C(C2=CC=C(Cl)C=C2)/C3=C(C=CC(=C3)OC)[N]4C(=NN=C14)C	MedChem Express	HY-13032	1.37438153	8.03242447	-3.77997179	-2.29125019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346882-02	NCGC00346882-02	384568959		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1203680-76-5]				-0.7470632707	4	4		0	4.01353222				INPPL1	C[C@H](NC(=O)C1=C(OCC2=CC=C(Cl)C=C2)C=CS1)C3=CC=CC=C3	Tocris	3718	-0.96206707	0.04421518	-1.8899859	4.01353222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163532-06	Daidzin	384568245	Alcohol Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	552-66-9				1.0927886792	4	4		0	-1.82416268				ADH1	OC[C@H]1O[C@@H](OC2=CC3=C(C=C2)C(=O)\C(=C/O3)C4=CC=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O	Adooq	A10283	0.39158811	4.79608981	-2.71266401	-1.82416268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346837-02	NCGC00346837-02	363677547		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[1210004-12-8]				4.4723854559	4	4		0	0.4784689				MGLL	[O-][N+](=O)C1=CC=C(OC(=O)N2CCN(CC2)CC3=CC=CC(=C3)OC4=CC=CC=C4)C=C1	Tocris	4715	-0.01450326	2.07728731	3.86259767	0.4784689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371045-07	AMD-3465	384569040	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	185991-07-5		4.4668359215	-5.35	8.5892145932	4	4		17.153719692	12.29025611	0.0566668249	0.9980305608		CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CNCC3=NC=CC=C3)C=C2	MedChem Express	HY-15971	-1.79476641	0.22897268	5.47412504	12.29025611												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480774-04	NCGC00480774-04	384569242		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					0.2413246245	4	4		0	-1.16244411				CSF1R	FC(F)(F)C1=NC=C(CNC2=NC=C(CC3=C[NH]C4=C3C=C(Cl)C=N4)C=C2)C=C1	MedChem Express	HY-16749	0	-0.89806915	2.48635537	-1.16244411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159418-07	NCGC00159418-07	384568175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	17902-23-7				-7.3346016045	4	4		0	-0.23845007				TYMS	F\C1=C\N(C2CCCO2)C(=O)NC1=O	APExBIO	B1474	-2.37099024	-0.02993564	-1.54639175	-0.23845007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016610-12	NCGC00016610-12	384567952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	2398-96-1				-4.634834789	4	4		0	4.29032754					CN(C(=S)OC1=CC=C2C=CC=CC2=C1)C3=CC(=CC=C3)C	Microsource	01500583	-1.53930731	-2.52026529	-3.07475317	4.29032754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244250-02	NCGC00244250-02	174006689		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1261496-45-0	NCGC00244250-01; NCGC00244250-01	14.1253754462	-4.85	17.5623623472	4	4		12	12.26076555	0.1343400129	0.9888481433	7297	TYK2	CN(C)C1=CC=C(NC2=N[N](C(=N2)N)C(=O)C3=C(F)C=CC=C3F)C=C1	NCGCChem	DYD03-067	1.92893401	2.96318925	2.00501253	12.26076555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094374-12	NCGC00094374-12	384568129		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	186692-46-6				-6.0638117374	4	4		0	2.63157895				CDK1	CC[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NCC3=CC=CC=C3	Glixx	GLXC-04786	-1.92893401	-1.40522377	-3.03700428	2.63157895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384304-02	NCGC00384304-02	384569110		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1598383-40-4				5.4582311208	4	4		0	0.26913876					CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)C2=C(C)C(=CC(=C2)C#CCN3CCOCC3)C(=O)NC\C4=C(C)\C=C(\C)NC4=O	Aobious	AOB87382	1.23277737	1.13028868	1.88707062	0.26913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159370-10	NCGC00159370-10	384568173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	661-19-8				11.1807861278	4	4		0	-0.25022078					CCCCCCCCCCCCCCCCCCCCCCO	Adooq	A10327	4.97328401	1.48068997	-1.13670356	-0.25022078												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015882-15	Riluzole	170464928	Glutamate Release Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1744-22-5	 ; Rilutek;PK-26124/RP-54274/Rilute;Riluzol; Prestwick-03A08;Riluzole; Riluzole; Riluzole hydrochloride			9.2231583302	4	4		0	-0.51516044			2911	GRM1	FC(F)(F)Oc1ccc2nc(N)sc2c1	Vitas	STK503686	3.63063433	2.39658067	-1.9144481	-0.51516044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242051-10	NCGC00242051-10	384568482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	870483-87-7				-1.6802936366	4	4		0	-1.89613697			1436	CSF1R	COC1=CC=C(COC2=C(OC)C=C(CC3=C(N)N=C(N)N=C3)C=C2)C=C1	MedChem Express	HY-10917	-0.37447989	2.75748994	-1.76574456	-1.89613697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024631-03	NCGC00024631-03	384568030		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[4450-98-0]				-3.4599318217	4	4		0	-3.07004471				AKR1B1	CCOC(=O)C/1=C(O)/C(=O)N(CC2=CC=CC=C2)C1	Tocris	0518	-0.94839609	1.67639575	0.12128563	-3.07004471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347217-03	NCGC00347217-03	377020175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			14.1253754462	-4.85	0.4749725461	4	4		-11.0111773519	-6.25931446	0.6732918379	0.54804065		DDR1	CCC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)CN3CCN(C)CC3)C#CC4=C[N]5N=CC=C5N=C4	NCGCChem	PRP008-041	-0.58577406	0.62864841	8.88417223	-6.25931446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510478-01	NCGC00510478-01	384569441		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1949837-12-0				-6.5812403251	4	4		0	-2.92101341				BRD4	C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]2\N=C(C3=CC=C(Cl)C=C3)/C4=C(SC(=C4C)C)[N]5C(=NN=C25)C)C(C)(C)C)C6=CC=C(C=C6)C7=C(C)N=CS7	MedChem Express	HY-100972	-2.73361227	2.69420745	1.00060643	-2.92101341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484085-01	NCGC00484085-01	363681176		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1643913-93-2				-8.5246857819	4	4		0	-0.63047824				PAK4	NC1=NC=C(C=C1)/C=C/C(=O)NCC2=CC3=CC(=CC(=C3O2)C4=CC=C(F)C=C4)C5=CC=C(C=C5)C(=O)N6CCC(F)(F)CC6	MedChem Express	HY-12793	-1.26443101	-0.78113486	-6.1212976	-0.63047824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378635-03	NCGC00378635-03	384569060		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	38647-11-9		1.77827941	-5.75	14.4354599472	4	4		17.68746564	12.04059665	0.1888932755	0.9775737717			CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CC\C6=C(COC6=O)/[C@@H]5C[C@@H]7O[C@]47C2=O	MedChem Express	HY-32736	-0.9895547	4.17096536	7.22143865	12.04059665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185774-06	NCGC00185774-06	384568426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	84611-23-4				-9.7639409626	4	4		0	-1.09180378					OC(=O)CSCC(=O)NC1CCSC1=O	MedChem Express	HY-B0289	-3.24354041	-0.81061164	-0.14104372	-1.09180378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345796-09	NCGC00345796-09	384568746		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1372540-25-4				-7.9880324907	4	4		0	-1.6146394				PIK3CB	CC1=NC2=C(C=C(C=C2[N]1CC3=CC=CC(=C3C)C(F)(F)F)N4CCOCC4)C(O)=O	Aobious	AOB87319	-1.89664651	-0.51584377	-2.25669958	-1.6146394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480786-02	NCGC00480786-02	384569245		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	96187-53-0				-5.9274349922	4	4		0	-1.76435407				DHODH	CC1=C(N=C2C=CC(=CC2=C1C(O)=O)F)C3=CC=C(C=C3)C4=CC=CC=C4F	DC Chemicals	DC9236	-0.30456853	-2.44386742	-3.03700428	-1.76435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242501-03	NCGC00242501-03	377020171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	347323-96-0				-2.4241728049	4	4		0	-0.75066235				TRIO	CC1=CC(=C(C)[N]1C2=CC=CC=C2)\C=C3\SC4=NC5=C(C=CC=C5)[N]4C3=O	SIGMA	I1411	-1.32894917	2.51869944	-0.32904577	-0.75066235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510200-01	NCGC00510200-01	384569415		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1263131-92-5		12.5892541179	-4.9	65.5538301924	3	4		104.9607751853	90.13725768	0.0136775306	0.9998846039		SHH	COC1=C(OC)C(=CC(=C1)C(=O)NC(=N)NC2=CC=C(C)C(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)OC	Glixx	GLXC-90537	-0.90152566	0.19376956	0.50029429	90.13725768												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386207-07	NCGC00386207-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1433953-83-3				2.1419100074	4	4		0	5.20288421					CCN1C(N)=C(C(=O)NC)C(=O)C2=CC=C(N=C12)C#C[C@@](C)(O)COC	APExBIO	B2301	-0.20729685	-1.36273159	-0.37911928	5.20288421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263123-02	NCGC00263123-02	384568606		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	213252-19-8		0.7943282347	-6.1	1.338005905	4	4		10.0167363959	5.81222057	0.1305830565	0.9894957026		PPARA	COC1=C(C=C(CC2SC(=O)NC2=O)C=C1)C(=O)NCC3=CC=C(C=C3)C(F)(F)F	Axon Medchem	1567	-3.34728033	1.25729681	6.67070952	5.81222057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387263-04	NCGC00387263-04	384569156		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					4.4315715059	4	4		0	2.14605067				NRF2	C\C1=C(\SSC1=S)C2=CN=CC=N2	APExBIO	B5958	0	1.37703937	2.66828381	2.14605067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390283-03	NCGC00390283-03	363680873		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1228585-88-3				-3.9052757447	4	4		0	5.62200957				TLR7	CCCCOC1=NC2=C(NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4)C(=N1)N	Glixx	GLXC-90047	-2.65409717	-2.13838399	0.23588383	5.62200957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018258-12	NCGC00018258-12	384568000		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	24169-02-6				-10.6649852151	4	4		0	-5.20334928					ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C=C1	Selleck	S2535	-2.10297317	0.67206354	-2.68317853	-5.20334928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014650-04	NCGC00014650-04	384567792		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	66547-09-9				11.5654653542	4	4		0	2.93062201				TUBB	CO[C@@H]1/C=C/C=C(C)/CC2=CC(=C(Cl)C(=C2)OC)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]3(C)O[C@@H]3[C@H](C)[C@@H]4C[C@@]1(O)NC(=O)O4	DC Chemicals	DC8241	3.17621465	1.98564228	-0.17691287	2.93062201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168774-04	NCGC00168774-04	384568347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	161735-79-1				6.7236609094	4	4		0	-1.54548131				MAOB	C#CCN[C@@H]1CCC2=C1C=CC=C2	Selleck	S2102	2.28798466	2.79346665	0.11965301	-1.54548131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510160-03	NCGC00510160-03	384569410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1821908-48-8		14.1253754462	-4.85	13.234310717	4	4		25.8049656039	20.4739476	0.1682748456	0.9821653148		PRMT4	C[C@H](N)C(=O)NCC1=CC=C(OC2=CC(=CC(=C2)C)C)C(=C1)C	Selleck	S8340	0.28771065	-0.83956648	-3.17080467	20.4739476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387775-03	NCGC00387775-03	363680662		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	849727-81-7		12.5892541179	-4.9	54.6698948756	3	4		59.0519630871	48.38092434	0.1739556214	0.9808686157		PRKAA1	OC(=O)C1=CC=C(CCCC2=CC=C(OCCC3=CC=C(F)C=C3)C=C2)O1	Bio Vision	2341	6.48033977	-1.083804	3.8887227	48.38092434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186024-12	NCGC00186024-12	384568435		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	356559-20-1				2.8304937677	4	4		0	2.26212357				TGBR1	CC1=NC(=CC=C1)C2=C(N=C([NH]2)C(C)(C)C)C3=CC=C4N=CC=NC4=C3	MedChem Express	HY-12043	1.47871752	-3.56760067	-0.20414115	2.26212357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015590-08	NCGC00015590-08	384567868		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[113168-57-3]				15.3356999252	4	4		0	-0.79174325					O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5	Tocris	1999	4.65726921	2.71015158	3.06211724	-0.79174325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161703-03	NCGC00161703-03	363676607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-13.7861823689	4	4		0	1.40089419				IKBKB	COC1=CC=CC2=C1C(=NC(=N2)C3=CC=CS3)NN4C(=O)\C=C(C)/C4=O	NCGCChem	DYD029-046	-3.79358438	-2.81395001	-4.54821104	1.40089419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179596-11	NCGC00179596-11	384568378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	64872-77-1		14.1253754462	-4.85	25.6462584524	4	4		28.6676249481	24.73086124	0.2001837236	0.9744925572			ClC1=CC=C(CCC(C[N]2C=CN=C2)SC3=C(Cl)C=CC=C3Cl)C=C1	MedChem Express	HY-B0293	3.26323423	-0.70261188	-0.97302079	24.73086124												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017363-15	NCGC00017363-15	384567988		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	66-81-9		0.2511886432	-6.6	114.1531839745	1.4	4		44.3963647483	31.30980861	0.5524846396	0.7468607772		GSK3B	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2	Adooq	A10036	6.0768673	59.69146174	47.94338788	31.30980861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263148-07	NCGC00263148-07	384568623		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	154229-19-3				-1.5112013421	4	4		0	-0.89712919				AR	C[C@]\12CC[C@H](O)CC1=C/C[C@@H]3[C@@H]2CC[C@@]\4(C)[C@H]3C\C=C4C5=CN=CC=C5	MedChem Express	HY-70013	-0.24655547	1.069192	-1.0909627	-0.89712919												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00372509-03	NCGC00372509-03	363678075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	905298-84-2				-6.3400323235	4	4		0	-1.33941713				LIMK1	CCNC(=O)NC1=NC=C(S1)C2=NC(=NC(=C2)C3=C(C)C=C(OC)C=C3C)C4=CN=CC=N4	Axon Medchem	1949	-0.94533498	-2.06075408	-2.12384086	-1.33941713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347945-09	NCGC00347945-09	384568993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	147591-46-6				1.620270301	4	4		0	0.39587162				DYRK1A	COC1=CC=C(C=C1)[N]2C(=C(C3=C2C=C(O)C=C3)[N+]([O-])=O)C	MedChem Express	HY-15838	0.81536761	0.81151432	-1.89559638	0.39587162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015448-06	NCGC00015448-06	384567849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	162520-00-5				1.1612442515	4	4		0	0.44709389				MTOR	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=C(C=CC=C1)C(O)=O	Selleck	S7684	-1.64574616	-0.74839096	7.94420861	0.44709389												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	108852-90-0				4.7607344721	4	4		0	3.21907601				TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	-0.16736402	4.07124682	-0.09096422	3.21907601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015036-23	Amantadine hydrochloride	384567799	Dopamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	665-66-7				-4.6083042902	4	4		0	-0.92399404				DRD1	NC12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0402A	-2.31520223	4.46041012	-1.60703457	-0.92399404												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016643-13	NCGC00016643-13	384567955		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	3902-71-4				2.2724783039	4	4		0	-1.18406889					CC1=CC2=C(O1)C(=C3OC(=O)\C=C(C)/C3=C2)C	Enzo	NP323	1.37438153	-1.54753132	1.04372355	-1.18406889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346669-05	NCGC00346669-05	384568895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1000413-72-8		12.5892541179	-4.9	2.5912069456	4	4		12.2047828519	8.78056282	0.4285430181	0.8682667876			CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC=C4[C@@H](COC4=C3)CC(O)=O)C)OCCC[S+](C)([O-])=O	Glixx	GLXC-04884	-2.25398571	1.96020634	0.59238364	8.78056282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016872-19	Ticlopidine hydrochloride	384567964	P2Y12 (P2T) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	53885-35-1				-2.0448660167	4	4		0	1.36859911				P2RY12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	MedChem Express	HY-B0153A	-1.01704233	-0.899042	0.22566996	1.36859911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386210-03	NCGC00386210-03	384569115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	928037-13-2				-4.9204983368	4	4		0	-5.88958942				KDR	CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4)F	APExBIO	B1439	-0.54975261	-1.04642594	2.31311707	-5.88958942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346436-04	NCGC00346436-04	384568776		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-6.9936608185	4	4		0	-6.25864985				CHEK2	COC1=CC2=NC(=NC(=C2C=C1OC)N[C@@H]3CNC[C@H]3C(C)(C)O)C4=CC(=CC=C4O)F	Tocris	4968	-0.57724024	-0.78113486	-0.42313117	-6.25864985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00077915-02	NCGC00077915-02	384568074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			7.0794578438	-5.15	28.1536158871	4	4		25.2030075241	22.15909091	0.1604552003	0.9838203787		PTP2C	OC(=O)C1=CC=CC=C1C2=CC=C(O2)\C=C3/SC4=NC5=CC(=CN=C5[N]4C3=O)Br	Evotec	MLS002554729	2.30601885	0.61096686	-1.00250627	22.15909091												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00163451-04	NCGC00163451-04	363676620		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	136194-77-9				-8.4232890987	4	4		0	-2.63467766				PRKCA	C[N]1C2=C(C=CC=C2)C3=C4C(=O)NCC4=C5C6=C(C=CC=C6)[N](CCC#N)C5=C13	Selleck	S7119	-2.12357857	-2.70187758	1.22644331	-2.63467766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016564-17	NCGC00016564-17	384567949		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1115-70-4				-1.0238801152	4	4		0	-1.86929644				PRKAA1	CN(C)C(=N)NC(N)=N	MedChem Express	HY-17471A	0.23290862	-0.13738361	-0.17947951	-1.86929644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345810-01	NCGC00345810-01	174007307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	18771-50-1	Tetrahydrouridine	3.1622776602	-5.5	8.8076905829	4	4		13.3178686319	1.0745087	1	0.9278364383	978	CDA	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2CCC(O)NC2=O	EMD Chemicals	584222	-0.29021559	-3.59822386	8.34062409	1.0745087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344620-03	NCGC00344620-03	384568724		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	328968-36-1	C646			9.7145417473	4	4		0	8.08709176				HAT1	CC1=C(C)C=C(C(=C1)C2=CC=C(O2)/C=C3\C(=N/N(C3=O)C4=CC=C(C=C4)C(O)=O)C)[N+]([O-])=O	Selleck	S7152	0.20729685	0.35216659	4.14114902	8.08709176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263553-13	NCGC00263553-13	363677284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1227633-49-9		2.8183829313	-5.55	17.1934234715	4	4		15.251459364	-6.70640835	1	0.9994706815		AHR	CC(C)[N]1C=NC2=C(NCCC3=CC=C(O)C=C3)N=C(N=C12)C4=CSC5=C4C=CC=C5	Glixx	GLXC-04564	-0.027894	-0.20954947	12.03759854	-6.70640835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387310-02	NCGC00387310-02	384569158		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[1982372-88-2]		12.5892541179	-4.9	48.4281266737	3	4		43.9497926579	41.49249338	0.2558223548	0.9573577981			ClC1=C(Cl)C=C2C(=C1)C(=NN=C2C3=CC=NC=C3)NC4CCCC4	Tocris	6167	7.5215783	-1.75545718	-0.80765779	41.49249338												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345022-04	NCGC00345022-04	384568730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-8.5889992093	4	4		0	-0.54459817					OC(=O)CCCCCC(=O)NN=C1CCCC1	Stemgent	04-0027	-2.26058364	-1.083804	-2.36314687	-0.54459817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263198-07	NCGC00263198-07	363677259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	417716-92-8				2.5472892994	4	4		0	1.64003959				FLT1	COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O	Glixx	GLXC-90055	1.28524046	-1.63834022	-1.16652085	1.64003959												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271534-03	NCGC00271534-03	174006849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	105816-04-4	Nateglinide (Starlix)			-3.0018936555	4	4		0	-2.29040011					CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O	Selleck	S2489	-0.95356551	-0.81151432	2.44969379	-2.29040011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421916-03	NCGC00421916-03	384569230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[1301214-47-0]				8.4676974102	4	4		0	7.57811395				ACC	CC(C)[N]1N=CC2=C1C(=O)CC3(CCN(CC3)C(=O)C4=CC=C5[NH]C(=NC5=C4)C)C2	Tocris	5790	1.09176341	-2.28142704	2.30387868	7.57811395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263128-02	NCGC00263128-02	384568609		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	640736-79-4		12.5892541179	-4.9	53.4997160871	3	4		68.856499913	64.16919301	0.1258033054	0.9901118566		CXCR1	CCN(CC)CCCCNC1=NC2=CC(=C(Cl)C=C2N=C1C3=CC=C(S3)C4=CC=CS4)Cl	Axon Medchem	1501	1.55564984	4.82663815	-2.58685517	64.16919301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508901-01	NCGC00508901-01	384569372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[1391076-61-1]				-9.3595371873	4	4		0	-0.41865165				FFAR2	C[C@@]1(CCN1C(=O)C2=CSC3=C2C=CC=C3)C(=O)N(CCCC(O)=O)CC4=CC(=CC=C4)Cl	Tocris	5621	-3.02644605	-1.37467542	-0.51135509	-0.41865165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346496-05	NCGC00346496-05	384568802		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1214265-56-1		2.8183829313	-5.55	0.0115141042	4	4		17.878493968	-3.42139454	1	0.9961517085		EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)OC4=CC(=CC=C4)NC(=O)C=C)C=C2	Adooq	A10990_CM1	-4.29925046	-5.31541164	10.1669424	-3.42139454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510111-01	NCGC00510111-01	384569409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	327031-55-0		2.5118864315	-5.6	100.3245885378	1.2	4		67.8126288817	68.84654251	0.0345928521	0.9992612842			CC1=CC=CC2=C1[NH]C3=C2N=NC(=N3)N\N=C(/C)C4=NC=CC=C4	Glixx	GLXC-06213	2.03648706	-0.18329006	62.6560385	68.84654251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346689-06	NCGC00346689-06	363677518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1185763-69-2				4.3239612018	4	4		0	5.58203906				MET	C[N]1C=C(C=N1)C2=N[N]3C(=CN=C3C=C2)CC4=CC=C5N=CC=CC5=C4	Glixx	GLXC-04408	0.05497526	2.01915991	-2.00282087	5.58203906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346519-04	NCGC00346519-04	384568816		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	61036-62-2		12.5892541179	-4.9	23.1946184561	4	4		30.609432572	26.18791327	0.1378200242	0.9881200398			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	Selleck	S1399	1.92413414	-1.34119381	-0.5077574	26.18791327												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522584-01	NCGC00522584-01	384569530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1093119-54-0				-5.3751491264	4	4		0	0.92378753				ERN1	CN1CCN(CC1)C(=O)C2=CC=C(S2)C3=CC4=C(C=C3)C(=C(O)C=C4)C=O	MedChem Express	HY-19710	-1.01422736	-2.09599028	-2.87657645	0.92378753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492296-02	NCGC00492296-02	384569287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1849590-01-7				-4.3147054641	4	4		0	-1.54548131				MKNK1	CC/1=C2/N(C(=O)C(=C1)/NC3=CC(=NC=N3)N)C4(CCCCC4)NC2=O	Selleck	S8275	-0.17810659	-0.25950237	-3.02123841	-1.54548131												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00384181-09	NCGC00384181-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			2.8183829313	-5.55	60.1236620614	2.2	4		58.5610378759	51.354136	0.0153302129	0.9998550816			C\C(=N/NC(=O)C1=CC=CC(=C1)[S+]([O-])(=O)N2CCOCC2)C3=CC(Cl)=CC=C3O	Bio Vision	9446-5	-2.23318263	5.96855442	33.293449	51.354136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092284-04	NCGC00092284-04	384568102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[125316-60-1]				-7.8605578069	4	4		0	-5.60788931				RARG	OC(=O)C1=CC2=CC=C(C=C2C=C1)C3=CC=C(O)C(=C3)C45CC6CC(CC(C6)C4)C5	Tocris	1549	-0.64392383	-3.46511983	0.56835178	-5.60788931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00487085-02	NCGC00487085-02	384569282		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1338806-73-7		12.5892541179	-4.9	46.4384769001	3	4		93.6380660308	81.23344127	0.0212968811	0.9997201702		PLK4	COC1=CC=C2NC(=O)[C@@]3(C[C@H]3C4=CC5=C(C=C4)C(=N[NH]5)/C=C/C6=CC=C(CN7C[C@@H](C)O[C@@H](C)C7)C=C6)C2=C1	ChemieTek	CT-CFI400_cm1	-3.3566242	-3.5567089	-4.60664074	81.23344127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	103766-25-2	Gimeracil			-6.3968997843	4	4		0	-3.22352609			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	-1.25760088	-0.35216659	-0.75823855	-3.22352609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165880-14	NCGC00165880-14	377020303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	656820-32-5				-11.1332271284	4	4		0	-5.7684151				ADORA3	C1CCC(CC1)NC2=C3N=C[NH]C3=NC(=N2)NC4=CC=C(C=C4)N5CCOCC5	MedChem Express	HY-14711	-1.11940299	-1.79145613	-3.87868183	-5.7684151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390582-04	NCGC00390582-04	384569197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	784210-88-4		4.4668359215	-5.35	89.6854540382	2.4	4		97.2579233582	78.18464584	0.1389976869	0.9878928816		CDK1	COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=N[NH]C4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6	MedChem Express	HY-15504A	-2.66721946	15.66375746	38.78681831	78.18464584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015962-25	NCGC00015962-25	384567911		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	152121-30-7		11.220184543	-4.95	100.0549046156	3	4		117.7283672566	109.38357153	0.0489950119	0.9985164995		MAPK14	OC1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=C(F)C=C3)C4=CC=NC=C4	MedChem Express	HY-10295	2.88502333	7.72873072	7.91096405	109.38357153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263129-31	NCGC00263129-31	384568610		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	827022-33-3		10	-5	0.1209841273	4	4		15.875515508	11.56344738	0.174069845	0.9809542873		CDK4	CC(=O)C\1=C(/C)C2=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N=C2N(C5CCCC5)C1=O	MedChem Express	HY-A0065	-1.64050346	-4.06292959	-2.1356595	11.56344738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015185-06	NCGC00015185-06	384567819		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	28860-95-9		3.1622776602	-5.5	-5.4882247009	4	4		-6.299554052	-3.58296171	0.7253239614	0.4158086806		DDC	CC(CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	MedChem Express	HY-B0311	-2.28147334	6.85335298	-2.53878702	-3.58296171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142483-07	NCGC00142483-07	384568164		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	65-46-3				17.4772631235	4	4		0	1.52511962				CDA	NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-B0158	5.49673677	3.08538262	0.20639835	1.52511962												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167972-02	NCGC00167972-02	384568343		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	126544-47-6		12.5892541179	-4.9	32.4929254675	3	4		58.4587052208	51.67795113	0.0773650218	0.9962914093			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	Prestwick	Prestw-1801	-1.63036032	0.4732102	-3.29045767	51.67795113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508900-01	NCGC00508900-01	384569371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[1206711-14-9]		4.4668359215	-5.35	87.9880086094	3	4		82.6981501851	79.96761849	0.0293828031	0.9994671784		TGFBR1	C1CN(CCO1)CCOC2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6	Tocris	5580	1.16454309	-1.02274462	3.20071792	79.96761849												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346963-01	NCGC00346963-01	174006744		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	n	HMSL10083	11.220184543	-4.95	29.6295737263	3	4		39.1398754752	36.08320362	0.0221539106	0.9996974511	1436	CSF1R	CCN(CC)CCCCNC1=NC=C2CN(C(=O)N(C)C2=N1)C3=C(Cl)C(=CC(=C3Cl)OC)OC	LINCS	HMSL10083	0.7073509	0.01490535	1.20659211	36.08320362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271789-11	NCGC00271789-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	50-76-0				-18.2587545918	4	4		0	-5.03725782					CC(C)C1NC(=O)C(NC(=O)C2=CC=C(C)C3=C2\N=C4/C(O3)=C(C)\C(=O)\C(N)=C\4C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCN7C1=O	Bio Vision	1036	-3.79358438	-2.06555905	-4.27531837	-5.03725782												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00508850-01	NCGC00508850-01	384569362		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	253863-00-2				-15.8162247884	4	4		0	-2.38450075				COX10	ClC1=CC=CC(=C1)N2CCN(CC2=O)CC3=CN=C[N]3CC4=CC=C(C=C4)C#N	Bio Vision	9638	-4.26778243	-2.45472235	-2.03153426	-2.38450075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-05	Maraviroc	384568416		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	376348-65-1				-4.6035966575	4	4		0	-0.92399404				CCR5	CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Enzo	AC3169	-1.33891213	0.71845532	-1.42510612	-0.92399404												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496921-02	NCGC00496921-02	384569298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	N/A				7.2443133626	4	4		0	2.50372578				RIPK1	CC(C)(C)C(=O)N1\N=C/C[C@H]1C2=CC=CC=C2	Glixx	GLXC-08006	2.39888424	1.22736117	-2.30442693	2.50372578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387145-01	NCGC00387145-01	384569153		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1229652-21-4]		0.4466835922	-6.35	14.4753726204	4	4		-10.885049364	5.85883438	1	0.9998989783			OB(O)C1=CC=CC(=C1)COC2=CC=C(C=C2)/C=C/3SC(=O)N(CC4=CC=C(F)C=C4)C3=O	Tocris	4196	7.6415613	-1.3706706	-2.82087447	5.85883438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378894-01	NCGC00378894-01	363678261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	201410-53-9		1.4125375446	-5.85	19.8641988474	4	4		13	12.10210672	0.1192050515	0.9911882247		CYP26A1	CCC(CC)C([N]1C=NC=N1)C2=CC=C(NC3=NC4=CC=CC=C4S3)C=C2	MedChem Express	HY-14531	0.3573392	0.60427413	13.56840621	12.10210672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00415059-02	NCGC00415059-02	384569222		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1448671-31-5				-9.5721946899	4	4		0	-1.70690451				SLC16A7	CC(C)N1C(=O)N(C)C(=O)C2=C1SC(=C2C(=O)N3C[C@](C)(O)CO3)CC4=C(C)[NH]N=C4C(F)(F)F	MedChem Express	HY-12750	-2.00659703	-2.22549742	-2.31311707	-1.70690451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017344-11	NCGC00017344-11	384567986		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	528-48-3				-4.3247298148	4	4		0	0.68779904				SIRT1	OC1=CC2=C(C=C1)C(=O)\C(=C(O2)\C3=CC(=C(O)C=C3)O)O	Adooq	A10388	-2.91515591	2.04673896	1.68067227	0.68779904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386413-01	NCGC00386413-01	363680266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1352608-82-2		8.9125093813	-5.05	-0.1714604856	4	4		16.1153009439	10.64593301	0.0263981954	0.999573544		TGFBR1	CC1=NC(=CC=C1)C2=C(N=C(CNC3=CC=CC=C3F)[NH]2)C4=C[N]5N=CN=C5C=C4	Selleck	S7530	-2.59608412	-2.32167405	0.17691287	10.64593301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346631-02	NCGC00346631-02	363677486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	566939-85-3				-1.0208913857	4	4		0	-0.78010009					CNC(=O)C1=CC=C2C=C(C=CC2=C1)C3(O)CC[N]4C=NC=C34	Selleck	S1195	-0.56172078	1.72492749	-0.29913252	-0.78010009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386417-06	NCGC00386417-06	384569134		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1454846-35-5		1.2589254118	-5.9	8.4178487226	4	4		9.824907524	-2.87017957	1	0.9987403447		ALK	C[C@H]1OC2=C(N)N=CC(=C2)C3=C(C#N)[N](C)N=C3CN(C)C(=O)C4=C1C=C(F)C=C4	ChemieTek	CT-PF0646_cm2	-1.52075627	-0.29003206	8.6449297	-2.87017957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249390-02	NCGC00249390-02	384568525		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	475108-18-0		12.5892541179	-4.9	7.7045281854	4	4		18.0138696279	13.72576765	0.2344337158	0.9647364804		FLT1	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1	Selleck	S1207_cm2	-1.67822469	1.50544045	0.97115951	13.72576765												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346574-04	NCGC00346574-04	384568847		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	917111-44-5				-3.5750758218	4	4		0	-1.24522428				TUBB	CCC[C@H](NC1=C(C)C=NC(=N1)C2=CC(=C(NC(=O)NCC)C=C2)OC)C3=CC=CN=C3	MedChem Express	HY-10498	-1.40083218	4.24802504	-2.91347852	-1.24522428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096077-20	NCGC00096077-20			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	132539-06-1				-3.6635699833	4	4		0	-0.6557377					CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C)S4	Adooq	A10667	-1.36680614	0.11974255	0.33353548	-0.6557377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159356-02	NCGC00159356-02	29215274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	62-90-8	 ; Nerobolil; Durabolin-50; Fenobolin; Nerobolyl; Nandrolone decanoate;Durabolin; Nandrolone phenpropionate			-8.9159934413	4	4	Nandroloni phenylpropionas;ESTR-4-EN-3-ONE, 17-(1-OXO-3-PHENYLPROPOXY)-, (17.BETA.);nortestosterone phenylpropionate;CIPLUS_149019;LS-64857;Nandrolone Phenpropionate;Nandrolone decanoate;Durabolin;NANDROLONE PHENPROPIONATE;LS-171982;norandrolone phenylpropionate;Nandrolone phenpropionate;NANDROLONE PHENYLPROPIONATE;Durabolin-50;Nerobolyl;nandrolone phenpropionate;19-nortestosterone phenylpropionate;Nandrolone Phenylpropionate;nandrolone phenpropionate, (17alpha)-isomer;17 beta-hydroxyestr-4-en-3-one hydrocinnamate;Nerobolil;Fenobolin;NSC-23162E;17.BETA.-HYDROXYESTR-4-EN-3-ONE HYDROCINNAMATE;Nandrolone phenylpropionate;	0	0.63047824					O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	Pharmeks	PHAR048161	-2.88620121	0.13264554	-3.01833568	0.63047824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346489-03	NCGC00346489-03	363677423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	957217-65-1				1.1504856068	4	4		0	2.01445487					CC1COC2(CCN(CC2)C/3=N/C(=O)C4=CC(=CC(=C4S3)[N+]([O-])=O)C(F)(F)F)O1	APExBIO	A5118	-1.75920836	0.86956522	5.0493653	2.01445487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378919-01	NCGC00378919-01	363678276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	894787-30-5				-13.196478395	4	4		0	-3.0601261				MYD88	NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)CC4=CC=C(NC(=O)COC5=CC=C(Cl)C=C5Cl)C=C4)C(=O)N12	MedChem Express	HY-50937	-3.18856515	-0.54532056	-3.41325811	-3.0601261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510494-01	NCGC00510494-01	384569456		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	925206-65-1				-7.7105549044	4	4		0	-3.02937106					[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O	MedChem Express	HY-16438	-1.7042331	-0.81061164	-1.325811	-3.02937106												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00402358-02	NCGC00402358-02	384569216		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1204669-58-8				6.2461836215	4	4		0	2.36244019				IDO1	N[S+]([O-])(=O)NCCNC1=NON=C1\C(NC2=CC(=C(F)C=C2)Br)=N\O	Glixx	GLXC-90193	1.60986222	-0.06109669	0.58970957	2.36244019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263188-03	NCGC00263188-03	363677253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	209984-56-5				-10.0857098927	4	4		0	-2.95849279				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	Selleck	S2711	-1.08234005	-2.85452603	-4.45707448	-2.95849279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164296-05	NCGC00164296-05	363676628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	133-32-4				2.3740164445	4	4		0	-1.51604357					OC(=O)CCCC1=C[NH]C2=CC=CC=C12	Selleck	S2253	0.23290862	4.13677301	0.02991325	-1.51604357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00489873-03	NCGC00489873-03	384569285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1607837-31-9		8.9125093813	-5.05	43.5921162586	2.4	4		58.7855993652	45.26052399	0.0830498738	0.9957244268		CDK8	C[N]1N=CC2=C1C=CC(=C2)C3=CN=C(N)C(=C3N4CCC5(CCNC5=O)CC4)Cl	MedChem Express	HY-19984	-0.75352788	3.67882766	13.04217768	45.26052399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378970-01	NCGC00378970-01	384569079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	852391-19-6				-3.0401037718	4	4		0	0.54459817					CN1C(=O)N[C@H](CC2=C[NH]C3=C(Cl)C=CC=C23)C1=O	MedChem Express	HY-14622	-1.76736539	0.71744772	0.80765779	0.54459817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510078-03	NCGC00510078-03	384569408		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE			3.1622776602	-5.5	55.3207008164	4	4		-23.25081364	-2.2923447	0.4659881994	0.8367044665		CDK6	FC1=CC=CC(=C1)[N]2C=NC3=C2N=C(N=C3NCC4=NC5=C([NH]4)C(=C(F)C=C5)F)N6CCOCC6	Axon Medchem	2547	14.24410541	27.32150842	2.23660977	-2.2923447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507847-01	NCGC00507847-01	384569328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1306760-87-1		12.5892541179	-4.9	13.9167232391	4	4		14.5	12.48054337	0.2761568929	0.9503570872		S1PR1	CC(C)OC1=CC=C(C=C1C#N)C2=NC(=NO2)C3=CC=CC4=C3CC[C@@H]4NCCO	Selleck	S7952	0.29126214	3.23446117	2.26603885	12.48054337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015300-11	NCGC00015300-11	384567836		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[67469-78-7]		8.9125093813	-5.05	6.2681425204	4	4		19.776150628	16.66169896	0.0160644032	0.9998414319			FC1=CC=C(C=C1)C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C4=CC=C(F)C=C4	Tocris	0421	-1.89679219	-1.64646011	-0.27289266	16.66169896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015365-22	NCGC00015365-22	384567838		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	486-66-8				-0.9967837847	4	4		0	-2.5633383				ESR1	OC1=CC=C(C=C1)\C2=C\OC3=C(C=CC(=C3)O)C2=O	Selleck	S1849	0.61366806	1.34710373	-2.27410552	-2.5633383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345830-02	NCGC00345830-02	363677374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	(185039-99-0)				0.8628639953	4	4		0	-2.74217586				SRC	CN1C(=O)C(=C\C2=C1N=C(NC3=CC=CC(=C3)C(O)=O)N=C2)/C4=C(Cl)C=CC=C4Cl	SynKinase	SYN-1062	0.19525802	2.60440054	0.84899939	-2.74217586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182047-14	NCGC00182047-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	75607-67-9				-3.5702686337	4	4		0	-2.05663189					Nc1nc(F)nc2n(cnc12)[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O	Bio Vision	1763	-2.56624826	1.70633139	4.76046089	-2.05663189												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167507-13	NCGC00167507-13	384568319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	231277-92-2				-12.0866772523	4	4		0	-4.01353222				EGFR	C[S+]([O-])(=O)CCNCC1=CC=C(O1)C2=CC3=C(NC4=CC=C(OCC5=CC(=CC=C5)F)C(=C4)Cl)N=CN=C3C=C2	Aobious	AOB5254	-3.54590434	-2.0486367	2.00282087	-4.01353222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390645-03	NCGC00390645-03	384569205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1802175-06-9				-7.7879606082	4	4		0	1.09180378				EZH2	COC/1=C(\CNC(=O)C2=C(C)[N]([C@H](C)C3CCOCC3)C4=CC=CC=C24)C(=O)NC(=C1)/C	MedChem Express	HY-15955	-2.44639912	-1.98968312	-1.38222849	1.09180378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390545-02	NCGC00390545-02	384569188		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	56124-62-0				4.5844111715	4	4		0	-4.45574163				TOP2A	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O	MedChem Express	HY-13772	3.64031907	1.68015885	-3.65619932	-4.45574163												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00494684-01	NCGC00494684-01	384569290		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					8.2398923969	4	4		0	1.31578947				GABRA1	CC1=C(COC2=NC=C(C=C2)C(=O)N3CC[S+]([O-])(=O)CC3)C(=NO1)C4=CC=C(F)C=C4	NCGCChem	PJM010-042	1.1457578	5.19321827	1.00250627	1.31578947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508855-01	NCGC00508855-01	384569363		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	954126-98-8				4.4161283996	4	4		0	3.66499853				CXCR2	CC1=C(NC(=O)NC2=CC=C(Cl)C(=C2O)[S+]([O-])(=O)[C@H]3CCCNC3)C=CC=C1F	Bio Vision	B1103	-0.23290862	1.6943978	1.55548908	3.66499853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159549-16	NCGC00159549-16	384568187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3690-10-6				2.3631176011	4	4		0	-0.67921324				CDA	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2/C=C\C=N/C2=O	SIGMA	Z4775	1.01248266	0.84960501	-0.44143614	-0.67921324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345803-02	NCGC00345803-02	384568751		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	297730-17-7		3.1622776602	-5.5	72.6430883032	2.2	4		72.8405619016	58.56072388	0.0131371536	0.9998935753		IMPDH1	CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC=CC(NC(=O)NC2=CC=C(C3=CN=CO3)C(OC)=C2)=C1	ChemieTek	CT-AVN944_cm1	-1.34051962	10.33532384	35.87051619	58.56072388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346687-10	NCGC00346687-10	384568911		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	702674-56-4				-0.1149779013	4	4		0	-6.05118055				PDPK1	BrC1=CN=C(NC2=CC(=CC=C2)NC(=O)N3CCCC3)N=C1NCCC4=CN=C[NH]4	MedChem Express	HY-11005	1.5063571	2.46516613	-1.66229221	-6.05118055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025212-26	NCGC00025212-26	384568057		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	?56-25-7				10.5693502957	4	4		0	3.87481371					C[C@@]12[C@H]3CC[C@H](O3)[C@]1(C)C(=O)OC2=O	Bio Vision	2510	2.56624826	0.35922766	1.24317768	3.87481371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390724-02	E-7449	384569209	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1140964-99-3		6.3095734448	-5.2	45.1909317547	2.2	4		31.5	30.70044709	0.0145863145	0.9998690128		PARP1	O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13	MedChem Express	HY-12418	3.59832636	4.64002395	14.0388114	30.70044709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510527-02	NCGC00510527-02	384569474		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1622848-92-3				-7.8633528335	4	4		0	-2.62295082				RIPK1	CN1C(=O)[C@H](COC2=CC=CC=C12)NC(=O)C3=NC(=N[NH]3)CC4=CC=CC=C4	Selleck	S8484	-2.81729428	2.51459362	-0.66707095	-2.62295082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159455-27	NCGC00159455-27	384568178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	184475-55-6				-13.0059862503	4	4		0	-3.05023923				EGFR	COC1=CC2=NC=NC(=C2C=C1OCCCN3CCOCC3)NC4=CC=C(F)C(=C4)Cl	MedChem Express	HY-50895A	-2.74111675	-2.38277073	-2.94854784	-3.05023923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510440-02	NCGC00510440-02	384569433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1628214-07-2				-7.5474424097	4	4		0	-3.61842105				KDM5A	CCC/1=C(/NC2=C(C=N[N]2C1=O)C#N)C3=CC=CC=C3C	Axon Medchem	2622	-1.87092096	0.70261188	-0.79610792	-3.61842105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346711-02	NCGC00346711-02	363677531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	851983-85-2				1.7647100334	4	4		0	-5.31351192				AR	C[C@]\12CC[C@H](O)CC1=C/CC3C2CC[C@@]\4(C)C3C\C=C4[N]5C=NC6=C5C=CC=C6	Selleck	S2803	1.73996438	0.50373989	1.34609632	-5.31351192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346695-02	NCGC00346695-02	363677522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	917879-39-1				-4.8902208972	4	4		0	-4.35458787					CN(C[C@@H]1COCCO1)[S+]([O-])(=O)NC2=CC3=C(C=C2)\C=C/C4=C(C=C(C=N4)C5=C[N](C)N=C5)C3=O	Selleck	S2774	0.92592593	-1.66896341	-4.05365996	-4.35458787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402377-02	NCGC00402377-02	384569219		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	871266-63-6				-3.9421901068	4	4		0	6.16989568				F7	NC(=N)C1=CC2=C([NH]C(=N2)C3=C(O)C(=CC(=C3)CC(=O)N[C@@H](CC(O)=O)C(O)=O)C4=C(O)C=CC(=C4)[S+](N)([O-])=O)C=C1	Glixx	GLXC-90209	-3.17991632	-1.28723245	0.66707095	6.16989568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346595-02	NCGC00346595-02	363677470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	28957-04-2		12.5892541179	-4.9	73.4311310898	3	4		119.7536695986	102.86140089	0.0195387335	0.9997644653		NFE2L3	CC1(C)CC[C@H](O)[C@]23CO[C@](O)([C@@H](O)[C@H]12)[C@@]45[C@H](O)[C@@H](CCC34)C(=C)C5=O	Selleck	S2335	-1.36680614	0.23948511	-0.18192844	102.86140089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511383-01	NCGC00511383-01	384569500		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1628838-42-5		12.5892541179	-4.9	46.2651948945	3	4		72.3606358799	65.10167464	0.0237055804	0.9996533043		BRAF	CC1=NC=C(NC(=O)C2=CC(=CC=C2)C(F)(F)F)C=C1C3=CC(=C(OC4CCOCC4)N=C3)N5CCOCC5	Glixx	GLXC-10326	-0.39158811	-0.51932183	-1.47427392	65.10167464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090726-15	NCGC00090726-15	384568079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	36791-04-5				-3.3510326974	4	4		0	-2.13423609				IMPDH1	NC(=O)C1=N[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Selleck	S2504	-0.50691876	-0.83956648	0.17947951	-2.13423609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475741-01	NCGC00475741-01	384569236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1186231-83-3		14.1253754462	-4.85	13.6502591115	4	4		26.0460664079	20.6211363	0.0962702513	0.9942554931		SHH	CCC/1=C/C2=C(C(=O)N1CC(=O)C3=CC=CC=C3)C(=C([N]2C)C(=O)NC4CCN(CC4)C(=O)CO)OCC(F)(F)F	ActiveBioChem	A-1172	0.12330456	-1.26698214	-1.70505534	20.6211363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-25	Trifluoperazine hydrochloride	384567788	CaMK-II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	440-17-5		12.5892541179	-4.9	75.9454388772	3	4		110.4321286107	101.20175315	0.0364837911	0.9991781395		DRD2	CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	MedChem Express	HY-B0532A	-0.67716971	2.61828204	0.29163021	101.20175315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015785-10	NCGC00015785-10	384567890		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	57-83-0		5.6234132519	-5.25	9.4244814208	4	4		20.603648424	17.3052453	0.0209683965	0.99972978		PGR	CC(=O)C1CCC2C3CC\C4=C\C(=O)CCC4(C)C3CCC12C	APExBIO	A8509	-2.16970702	-1.76083295	4.66608341	17.3052453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250403-11	NCGC00250403-11	377020321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	796967-16-3		11.220184543	-4.95	13.5068401078	2.4	4		30.8410041799	23.72578241	0.0236642476	0.9996551758		KDR	CC1=CC=C(F)C(=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=N[NH]C4=CC=C3)N	MedChem Express	HY-50751	-1.53417015	-1.0178117	0.57610673	23.72578241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345783-02	NCGC00345783-02	384568739		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	58053-83-1				-1.9245284313	4	4		0	5.15146855				PIK3CA	COC[C@H]1OC(=O)C2=COC3=C2[C@@]1(C)\C4=C(\[C@@H]5CC[C@H](O)[C@@]5(C)C[C@H]4OC(C)=O)C3=O	Chemdea	CD0278	-1.12699285	-0.28002948	-3.86459803	5.15146855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387475-01	NCGC00387475-01	384569160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[1332331-08-4]		1.77827941	-5.75	27.2268334088	4	4		11	11.27392344	0.3170803237	0.9329021586		FAS	O=C1N\N=C(\C[C@@H]2CCN(C2)C(=O)C3CC3)N1C4=CC=C(C=C4)C5=CC=C6OC=CC6=C5	Tocris	5303	3.20522117	0.91645028	14.27097155	11.27392344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167982-03	NCGC00167982-03	384568344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	72496-41-4				4.9741898917	4	4		0	-4.12679426				TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@H]6CCCCO6)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Glixx	GLXC-06538	3.55329949	-0.2138384	-1.23839009	-4.12679426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351600-04	NCGC00351600-04	384569018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1207456-01-6		0.6309573445	-6.2	40.6078967781	4	4		-19.449661464	-2.45805122	0.0341134123	0.9992849281		PARP1	C[N]1N=CN=C1[C@@H]2[C@H](NC3=CC(=CC4=C3\C2=N/NC4=O)F)C5=CC=C(F)C=C5	MedChem Express	HY-16106	15.52267434	5.51060907	-1.49566258	-2.45805122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00357427-09	NCGC00357427-09	384569034		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-0.343268932	4	4		0	-3.13511922					NCCOC1=CC(=NC(=C1)C(=O)NC2=NC3=CC=CC=C3C(=C2)OCCN)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN	MedChem Express	HY-15176A	-0.47951774	5.51060907	-0.89739755	-3.13511922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347935-08	NCGC00347935-08	363677721		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1432660-47-3				13.6450358077	4	4		0	8.63997645				IDH2	[O-][S+](=O)(NC1CC1)C2=CC=C(C(=C2)NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C4=CSC=C4	Glixx	GLXC-04459	1.5755583	2.70187758	1.82470835	8.63997645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263134-08	NCGC00263134-08	363677221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1255517-76-0				-4.7220426115	4	4		0	-3.10568148				RPS6KB1	CCC1=C(N=CN=C1)N2CCN(CC2)CC3=NC4=C([NH]3)C=CC(=C4)C(F)(F)F	MedChem Express	HY-15773	0.2055076	-0.62585865	-3.55967694	-3.10568148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509912-01	NCGC00509912-01	384569378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1707289-21-1		12.5892541179	-4.9	33.5692240237	3	4		63.8418010088	56.15248749	0.05474314	0.9981475876		FGFR4	COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=C(C=C2)N=C(N[C@@H]4COCC[C@@H]4NC(=O)C=C)N=C3)OC	Selleck	S8503	-2.75380189	0.07632423	-2.03410111	56.15248749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346455-02	NCGC00346455-02	384568780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	934660-93-2				-19.0587128056	4	4		0	-6.89947688				MAP2K1	OC1(CN(C1)C(=O)C2=C(NC3=C(F)C=C(I)C=C3)C(=C(F)C=C2)F)[C@@H]4CCCCN4	MedChem Express	HY-13064	-3.27529022	-5.00689022	-2.91630213	-6.89947688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379063-03	NCGC00379063-03	384569091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	175519-16-1				-13.7307255485	4	4		0	-4.40306049				TOP2A	CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=C\N3C4=NC=CS4)/C(O)=O	MedChem Express	HY-16518	-2.0647716	-2.01619062	-3.03805083	-4.40306049												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00025323-13	NCGC00025323-13	384568067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	58970-76-6				-2.6378457061	4	4		0	-2.84484084				LTA4H	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	MedChem Express	HY-B0134	0.60472787	0.81061164	-3.75176305	-2.84484084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018117-32	NCGC00018117-32	384567991		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	317-34-0				-7.3836595556	4	4		0	1.95294479				ADORA1	CN1C(=O)N(C)C2=C([NH]C=N2)C1=O	MedChem Express	HY-B0140	-2.72127543	0.28002948	-2.99012694	1.95294479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165783-03	NCGC00165783-03	384568283		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	117570-53-3				8.43203373	4	4		0	-2.10479835					CC1=C(C)C2=C(C=C1)C(=O)C3=C(O2)C(=CC=C3)CC(O)=O	Selleck	S1537	4.1512536	-1.45016028	0.59826503	-2.10479835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509990-02	NCGC00509990-02	384569398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1323403-33-3				-10.1717296929	4	4		0	-1.68904288					O=C1CC[C@H](N2CC3=C(C=CC=C3OCC4=CC=C(CN5CCOCC5)C=C4)C2=O)C(=O)N1	MedChem Express	HY-101291	-2.43247065	-0.61096686	-3.24860881	-1.68904288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00081778-05	NCGC00081778-05	384568076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[868224-64-0]				-0.5591075773	4	4		0	7.11979087				NR5A1	CCOC(=O)C(C)OC1=CC=CC2=C1\C=C/N(CC(=O)NC3=CC=C4OCCOC4=C3)C2=O	Tocris	3440	-1.92413414	-1.01694915	-0.36671368	7.11979087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346938-02	NCGC00346938-02	384568972		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	474550-69-1		1.995262315	-5.7	10.2397962874	4	4		11.3264554119	-6.16638475	1	0.9991211417			CCOC1=CC2=C(C(=C1OCC)F)C(=N)N(CC(=O)C3=CC(=C(OC)C(=C3)C(C)(C)C)N4CCOCC4)C2	Axon Medchem	2030	-1.07201759	-1.10537951	9.50634697	-6.16638475												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509994-02	NCGC00509994-02	384569401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1000025-07-9				-1.4947077962	4	4		0	3.6643572					OC(=O)CNC(=O)C1=NC=C(C=C1O)C2=CC=CC(=C2)Cl	MedChem Express	HY-101277	-0.61980561	-2.24787363	-1.54456568	3.6643572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025379-01	NCGC00025379-01	11114298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE		SR 33805; SR 33805			-9.4524377341	4	4	SR 33805 oxalate;NCGC00025379-01;	0	-5.63732705					COC1=CC=C(CCN(C)CCCOC2=CC=C(C=C2)[S+]([O-])(=O)C3=C(C(C)C)C4=CC=CC=C4[N]3C)C=C1OC	Tocris	Tocris-1806	-1.5755583	0.53426958	-2.27340712	-5.63732705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510502-02	NCGC00510502-02	384569463		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1174428-47-7				8.4156491387	4	4		0	3.40005888				PIK3CB	O=C1\C=C(OC2=C1SC=C2C3=CC=C4OCCOC4=C3)\N5CCOCC5	Selleck	S8589	3.52103028	-2.33552129	-2.12384086	3.40005888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387306-01	NCGC00387306-01	384569157		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-3.7232134573	4	4		0	-0.7634667				HIF2A	C[S+]([O-])(=O)C1=CC=C(OC2=CC(=CC(=C2)C#N)F)C3=C1[C@H](O)C(F)(F)C3	NCGCChem	PJM004-004	-0.67716971	-0.81151432	-1.22484689	-0.7634667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015067-22	NCGC00015067-22	384567805		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	50-78-2				2.6729515135	4	4		0	-2.77110137				HMGCR	CC(=O)OC1=C(C=CC=C1)C(O)=O	MedChem Express	HY-14654	1.83803206	1.82207931	-1.74978128	-2.77110137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186006-10	NCGC00186006-10	384568434		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	77191-36-7		0.316227766	-6.5	18.6682812605	4	4		-12.376902972	-2.81408581	0.2851547138	0.9470656829		GABRA1	CC1=C(NC(=O)CN2CCCC2=O)C(=CC=C1)C	MedChem Express	HY-B0340	7.94392523	0.75165807	-0.05641749	-2.81408581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379003-05	NCGC00379003-05	384569085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1431866-33-9				-6.7207888062	4	4		0	-3.42918653				BCL2L1	NCC1=CC=C(OCCCC2=C(N=C(S2)C3=CC\4=C(CCCC4=N\NC5=NC6=C(S5)C=CC=C6)C=C3)C(O)=O)C=C1	Glixx	GLXC-03738	-0.87960418	-1.60648489	-1.12834979	-3.42918653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249391-11	NCGC00249391-11	384568526		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	940310-85-0		1.2589254118	-5.9	194.7323484066	2.3	4		128.9819257104	21.97447332	1	0.9999723684		BRAF	C[N]1N=CC2=C1N=C(N=C2NC3=CC(=CC=C3C)C(=O)NC4=CC=CC(=C4)C(F)(F)F)C5=CC=CN=C5	MedChem Express	HY-13258	-0.19241341	14.9889462	127.72919605	21.97447332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249417-03	NCGC00249417-03	384568527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	254877-67-3		12.5892541179	-4.9	26.8081371547	3	4		52.7499525808	46.55889145	0.0573944111	0.9979636815		GUCY1A2	[O-][S+](=O)(NC1=CC=C(Cl)C=C1C(=O)NC2=CC=C(C=C2)[S+]([O-])(=O)N3CCOCC3)C4=CC=C(Cl)S4	Cayman	16371	-2.78912523	-0.15188335	-1.0911152	46.55889145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164553-07	NCGC00164553-07	384568252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	123318-82-1				4.7409955887	4	4		0	0.98537336					NC1=NC(=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)Cl	MedChem Express	HY-A0005	2.6764333	-0.57715674	-3.4717302	0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091533-17	NCGC00091533-17	384568096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	57-63-6		8.9125093813	-5.05	-6.7277993313	4	4		10.861177628	6.89761355	0.1679150282	0.9824529826		ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)O)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0216	-3.63431469	-2.06561361	-1.6579283	6.89761355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481082-01	NCGC00481082-01	363681116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			0.3548133892	-6.45	155.3151034619	1.4	4		72.6416392439	-5.66676479	1	0.9999772091		CSNK2A1	COC(=O)NC1=CC(=C(Cl)C(=C1)NC2=N[N]3C(=CN=C3C(=C2)NC4CC4)C#N)N5CCN(C)CC5	Piramal	BMS-595 lot1	5.71311139	59.33445276	68.6209991	-5.66676479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016925-21	Omeprazole	384567968	ABCC3 Expression Enhancer	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	73590-58-6				-1.7077460271	4	4		0	-1.92817192				ABCC3	COC1=CC2=C([NH]C(=N2)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC)C=C1	MedChem Express	HY-B0113	-0.23290862	0.29003206	0.17947951	-1.92817192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-09	NCGC00179673-09	384568382		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	54-42-2				8.1645609113	4	4		0	-0.39740948					OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(\I)C(=O)NC2=O	Enzo	DL422	3.74023839	-0.90062586	-0.65809153	-0.39740948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016447-01	NCGC00016447-01	144203993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	466-06-8	 Scillase; Proscillaridin;Proscillaridin; ; Caradrin; Sandoscill; Digitalysat; A, Proscillaridi; Proscillaridin A; Proscilaridina; Talusin; Rhamnoside, Scillareni			16.3249712365	4	4	CIPLUS_168268;Proscillaridin A;Proscillaridin;Caradrin;CIPLUS_153303;3-(6-Deoxy-alpha-L-mannopyranosyloxyl)-14-hydroxybufa-4,20,22-trienolide;Ysatfabrik Brand of Proscillaridin;proscillaridinum;PROSCILLARIDIN;NCGC_Prestw-986;Scillarenin 3beta-rhamnoside;A, Proscillaridi;proscillaridine;Digitalysat;Knoll Brand of Proscillaridin;Proscilaridina;Scillase;LS-125804;Abbott Brand of Proscillaridin;Ziethen Brand of Proscillaridin;NCGC00016447-01;Sandoscill;Talusin;Rhamnoside, Scillareni;Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-;Proscillaridinum;Proscillaridine;	0	2.75242861					O=C1C=CC(=CO1)[C@H]6CC[C@@]5(O)[C@]6(C)CC[C@H]3[C@H]5CCC2=C[C@H](CC[C@@]23C)O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O	Prestwick Chemical, Inc.	CAS-466-06-8	3.49362926	4.74736681	2.9015854	2.75242861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241410-02	NCGC00241410-02	363677139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1044733-37-0				0.076526102	4	4		0	-2.00763467				IRAK1	ClC1=C[N]2C(=NC=C2C3=CC=CC(=N3)NC4CNC4)C=C1	Axon Medchem	1385	1.3681592	-0.93400704	-1.80810732	-2.00763467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00032387-14	NCGC00032387-14	384568071		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	719277-26-6				1.5473758826	4	4		0	-2.20557048				CLK1	CCN1\C(SC2=CC=C(OC)C=C12)=C\C(C)=O	MedChem Express	HY-15338	1.61691542	-0.1684275	-1.16652085	-2.20557048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167490-03	Lumefantrine	170465388	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	82186-77-4	;benflumetol, (+-)-isomer;Lumefantrine; Lumefantrine	14.1253754462	-4.85	20.2513325556	4	4		32.354768156	26.15580376	0.10646211	0.9929557992			CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2	SIGMA	L5420	0.95356551	-0.93400704	-1.54564013	26.15580376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015256-17	NCGC00015256-17	363676447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	50-63-5		1.1220184543	-5.95	52.3721367056	3	4		34.1957515031	34.63259708	0.1237352664	0.9904468023			CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	Selleck	S4157	-1.75364163	2.19948068	5.71514513	34.63259708												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263177-04	NCGC00263177-04	384568646		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1012054-59-9				-21.4625234733	4	4		0	-5.32698138				EGFR	COC1=C(OCCCCCCC(=O)NO)C=C2C(=NC=NC2=C1)NC3=CC(=CC=C3)C#C	Selleck	S1194	-3.67699052	-5.59034672	-5.98586254	-5.32698138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387769-02	Gardiquimod	363680656	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1020412-43-4				-4.1448381039	4	4		0	-0.76512199			51284	TLR7	CCNCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N	Bio Vision	2002	-0.79196719	0.48877348	-2.70717401	-0.76512199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165772-06	NCGC00165772-06	384568281		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	218137-86-1				-1.3770220644	4	4		0	0.67744419				FAS	CCCCCCCCC1OC(=O)C(=C)C1C(O)=O	SIGMA	C5490	-1.15509227	3.09842041	-1.57290633	0.67744419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370842-02	NCGC00370842-02	384569037		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	950912-80-8				2.7285621338	4	4		0	6.86682063				CSNK1E	NC1=NC=CC(=N1)C2=C(N=C[N]2C3CCCCC3)C4=CC=C(F)C=C4	Adooq	A11781	-1.35230314	-1.91373026	3.41504889	6.86682063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509904-02	NCGC00509904-02	384569375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	946128-88-7				-15.2465181781	4	4		0	-3.9304397				BRAF	CN[S+]([O-])(=O)NC1=NC=CC(=C1F)CC/2=C(C)/C3=CC=C(OC4=NC=CC=N4)C=C3OC2=O	MedChem Express	HY-18652	-2.6119403	-4.3638034	-3.7037037	-3.9304397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481108-02	NCGC00481108-02	384569253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1883429-22-8				0.4458349204	4	4		0	-3.47801499				BRD9	COC1=C(CN(C)C)C=C(OC)C(=C1)C/2=C/N(C)C(=O)C3=C2C=CN=C3	MedChem Express	HY-100352	0.98120509	2.43454295	-1.66229221	-3.47801499												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346960-01	NCGC00346960-01	174006727		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	899804-90-1	HMSL10058			-2.8036621319	4	4		0	3.21928685			5599	MAPK8	OC1CCC(CC1)NC2=NC=C3N=C(NC4=C(F)C=C(F)C=C4F)[N]([C@@H]5CCOC5)C3=N2	LINCS	HMSL10058	-2.54560882	2.7188025	-0.87231163	3.21928685												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389632-06	NCGC00389632-06	384569178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	183204-72-0				-6.5572649881	4	4		0	1.11159232					ClC\1=C(/CN2CCCC2=N)NC(=O)NC1=O	MedChem Express	HY-A0063	-2.12134069	-1.46632045	-1.35358701	1.11159232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166414-05	Pemetrexed	384568308	Thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	150399-23-8				4.4101560089	4	4		0	-3.4791396					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Selleck	S1135	3.25272239	-1.22193371	-0.63167394	-3.4791396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163431-06	CA-074 Me	384568238	Cathepsin B Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	147859-80-1		8.9125093813	-5.05	32.1785765343	4	4		22.6038882121	20.84680523	0.3553437469	0.9133293832		CTSB	CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC	APExBIO	A8239	5.24017467	-1.33657351	5.93736715	20.84680523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346955-02	NCGC00346955-02	384568976		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	869748-10-7 				-13.0908746529	4	4		0	-2.34026174				LCK	COC1=CC(=CC=C1NC(=O)C2=CC3=C(C=CC=C3)[N]2C)C4=N[N](C5CCC(CC5)N6CCN(CC6)C(C)=O)C7=NC=NC(=C47)N	Axon Medchem	1698	-2.39470348	-4.37424058	-3.10330169	-2.34026174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013841-13	NCGC00013841-13	384567790		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	6202-23-9, 303-53-7 [cyclobenzaprine]		10	-5	44.2177012083	3	4		80.9093015742	66.38953041	0.025212615	0.9996077932		HTR2A	CN(C)CCC=C1C2=C(C=CC=C2)\C=C/C3=C1C=CC=C3	Microsource	01503207	-2.14114664	-3.49331713	3.58509282	66.38953041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024995-15	NCGC00024995-15	384568039		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	33069-62-4				-1.6704364022	4	4		0	5.06579878				TUBB	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)C2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)\C(=C1/C5(C)C)C	Selleck	S1150	-1.37309293	-0.7303622	-2.06003531	5.06579878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250375-10	NCGC00250375-10	384568536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	867160-71-2				2.0841421512	4	4		0	-0.28300552				IGFR1	C[C@]1(O)CC(C1)C2=NC(=C3[N]2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6	MedChem Express	HY-10191	0.67961165	-0.61111939	1.41259564	-0.28300552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016456-20	NCGC00016456-20	384567941		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	480-40-0				0.0413118401	4	4		0	0.7075138					OC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC=CC=C3	Enzo	NP051	-0.5963939	-0.37263378	1.85403178	0.7075138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263564-04	NCGC00263564-04	384568688		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	141505-33-1				-1.7507515678	4	4		0	1.38672704					C[C@@H]\1CC(=O)N\N=C1C2=CC=C(NN=C(C#N)C#N)C=C2	Microsource	01502356	-1.40083218	-0.22358027	1.35373749	1.38672704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386224-06	NCGC00386224-06	377020161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1204313-51-8				-9.57552811	4	4		0	-5.57047929				EGFR	C#CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C4OCCOCCOCCOC4=C3	MedChem Express	HY-15164	-0.09673853	-3.59822386	-3.79119277	-5.57047929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242227-11	NCGC00242227-11	377020378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	312917-14-9				-12.1299919141	4	4		0	0.19793581				MAPK8	O=C(NC1=C(C#N)C2=C(CCCC2)S1)C3=C4C=CC=CC4=CC=C3	MedChem Express	HY-15881	-2.80541736	-3.29199204	-4.02449694	0.19793581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483922-01	NCGC00483922-01	363681141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1626387-80-1				-16.8266053062	4	4		0	-5.40082002			1956	EGFR	COC1=C(OC(=O)N2CCN(C)C[C@H]2C)C=C3C(=NC=NC3=C1)NC4=CC=CC(=C4F)Cl	MedChem Express	HY-18750	-2.28026534	-5.06813658	-4.89938758	-5.40082002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510232-02	NCGC00510232-02	384569417		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1874276-76-2				-4.2748494465	4	4		0	4.43193302				PRKCA	CC1(N)CCN(CC1)C2=CC=CN=C2NC(=O)C3=NC(=CN=C3N)C4=NC=CC=C4C(F)(F)F	ChemieTek	CT-LXS196	-2.60217791	-1.61906217	0.2707174	4.43193302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015159-22	NCGC00015159-22	384567818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	63659-18-7				-0.6232994859	4	4		0	0.6785044				ADRB1	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1	MedChem Express	HY-B0381	0.22627634	-0.48877348	-1.95518123	0.6785044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262009-03	NCGC00262009-03	377020269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	119139-23-0				-11.1228981016	4	4		0	-3.01717915				CDK4	O=C\1NC(=O)\C(=C1C2=C[NH]C3=C2C=CC=C3)C4=C[NH]C5=C4C=CC=C5	Cayman	13299	-1.64050346	-2.99373759	-3.69980448	-3.01717915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091032-09	NCGC00091032-09	363676548		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	427-51-0				3.7983850387	4	4		0	6.48082638				AR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(Cl)/C4=C/C(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	Selleck	S2042	-1.28987517	-0.46206588	3.67863449	6.48082638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346674-02	NCGC00346674-02	384568900		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	912999-49-6		0.5011872336	-6.3	54.6868564688	4	4		27.5370457439	20.27428248	0.4470482376	0.852305411		HSP90AB1	CC(C)C1=C(O)C=C(O)C(=C1)C(=O)N2CC3=C(C2)C=C(CN4CCN(C)CC4)C=C3	Selleck	S1163	-0.51133223	24.45261063	33.9749198	20.27428248												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182037-01	Alacepril	124893756	Angiotensin-I Converting Enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	74258-86-9	Alacepril; ; Alacepril			0.1254282918	4	4	N-(1-(3-(acetylthio)-2-methyl-1-oxopropyl)-L-prolyl)-L-phenylalanine;CIPLUS_214255;aracepril;alacepril;ALACEPRIL;DU-1219;Alacepril;DU 1219;cetapril;alaceprilum;LS-105750;Cetapril;	0	-3.53456808			1636	ACE	O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O	ACC	ALACEPRIL	0.89828635	-0.78089113	1.45815106	-3.53456808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263918-05	NCGC00263918-05	384568700		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	56390-09-1				-7.3088524803	4	4		0	-4.04354588				TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Selleck	S1223	-0.29021559	-4.54754249	-0.52493438	-4.04354588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238453-16	NCGC00238453-16	384568466		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	761439-42-3				-8.3309485704	4	4		0	-6.78637071				ALK	COC1=CC(=CC=C1NC2=NC(=C(Cl)C=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-10192	0.98120509	-3.23074567	-5.01603966	-6.78637071												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166281-02	NCGC00166281-02	124893255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE		 Kinidin-duretter; Kinilentin; Quinact; Quinine,; Quinidine gluconate salt; Amidochin;Quinidine sulfate; Quinine sulfate anhydrous; Kinidin Durules; Quinaglute; Coco-quinine; Quinidex; Kinidine Durettes; Chinidin-retard-Isis; Chinidin-Duriles; Chinidin duriles; ; Quinine hydrobromide; Quinine, dihydrochloride; Natisedine; Biquin Durules; Quinine; Quinine sulfate dihydrate; Quinine Sulphate; Quindine			0.5937398909	4	4		0	5.17460766					COC1=CC=C2N=CC=C([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)C2=C1	SIGMA	145904	-0.23493643	-1.63834022	-2.1872266	5.17460766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508876-01	NCGC00508876-01	384569369		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1404095-34-6				-3.9724677605	4	4		0	-3.87481371				CHEK1	COC1=CC(=NC=C1C2=C[N](C)N=C2)NC3=CN=C(C#N)C(=N3)O[C@H](C)CN(C)C	SynKinase	SYN-1216	-0.22315202	-0.23948511	-0.48514251	-3.87481371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-12	Megestrol acetate	384568021	Progesterone Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	595-33-5		7.9432823472	-5.1	0.6520623502	4	4		10.570428508	8.44521438	0.0510343021	0.9984125956		PGR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	MedChem Express	HY-13676	-1.72535709	-1.2830304	-0.51135509	8.44521438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015819-17	NCGC00015819-17	384567894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	34183-22-7		12.5892541179	-4.9	59.5574627207	3	4		73.8928565939	67.74938646	0.0984385333	0.9939763563			CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2	Selleck	S2500	4.04468958	0	-2.01534065	67.74938646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510266-01	NCGC00510266-01	384569423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1379545-95-5				-15.2452717344	4	4		0	-4.69178577				AKT1	NC(=O)C1=CC=CC2=C1N=CN=C2NC(CN3CCC3)C4=CC(=C(Cl)C=C4)C(F)(F)F	ChemieTek	CT-M2698	-2.94159242	-4.0018329	-2.04542036	-4.69178577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346492-03	NCGC00346492-03	384568799		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	(956958-53-5)				-3.3168328966	4	4		0	-1.28588517				PIK3CA	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4	SynKinase	SYN-1127	-1.66787527	-1.03864365	3.59722836	-1.28588517												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00387878-04	NCGC00387878-04	384569167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1401966-69-5				2.0339156856	4	4		0	5.17321016				KDM1A	OC(=O)C1=CC=C(CN2CCC(CC2)CN[C@@H]3C[C@H]3C4=CC=CC=C4)C=C1	DC Chemicals	DC8491	-1.26778419	-1.09356015	3.10330169	5.17321016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386713-03	NCGC00386713-03	363680411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1123231-07-1				-6.8100443056	4	4		0	-5.66589684				DKK1	NCC1CCN(CC1)C2=NC=CC(=N2)C3=CC=C4C=CC=CC4=C3	Glixx	GLXC-04604	-0.76067052	-1.0328068	0.12753295	-5.66589684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510496-01	VLX-1570	384569458	Ubiquitin C-terminal Hydrolase L5 (UCH-L5) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1431280-51-1				-9.8625999445	4	4		0	-5.72748268				UCHL5	[O-][N+](=O)C1=CC(=CC=C1F)/C=C/2CCN(CC(=C/C3=CC=C(F)C(=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	MedChem Express	HY-12471	0.05634596	-2.76427704	-5.42723537	-5.72748268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522550-01	NCGC00522550-01	384569525		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	858668-07-2		14.1253754462	-4.85	4.1138557706	4	4		23.5300410959	17.92147806	0.1391131858	0.9879084331		KIF11	CN(C)CCNC(=O)NC[C@H]1CC[C@H]2[C@@H](NC3=C(C=C(C=C3)C(F)(F)F)[C@H]2O1)C4=CC=CC=C4	MedChem Express	HY-15000	-2.50739541	-0.75941677	-3.35836758	17.92147806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345794-11	MLN-4924	384568745	NEDD8-Activating Enzyme (NAE) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	905579-51-3		5.0118723363	-5.3	33.2704397142	4	4		18.5	16.5973826	0.3080938223	0.9371518847		NAE1	N[S+]([O-])(=O)OC[C@@H]1C[C@H](C[C@@H]1O)[N]2C=CC3=C2N=CN=C3N[C@H]4CCC5=C4C=CC=C5	ChemieTek	CT-M4924	3.32441189	8.14094775	9.56497095	16.5973826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165816-04	NCGC00165816-04	384568287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[355025-24-0]				-0.8652649687	4	4		0	2.74056967				LPAR1	CC(OC(=O)NC1=C(ON=C1C)C2=CC=C(CSCCC(O)=O)C=C2)C3=C(Cl)C=CC=C3	Tocris	5056	-0.70432455	-0.33414338	-1.26115913	2.74056967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386129-03	NCGC00386129-03	363680114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	475488-23-4		12.5892541179	-4.9	61.7167394021	3	4		88.113138156	80.37356728	0.0367061095	0.9991681455		IGFR1	NC1=NC=NC2=C1C(=C[N]2[C@@H]3C[C@H](C3)CN4CCCC4)C5=CC(=CC=C5)OCC6=CC=CC=C6	MedChem Express	HY-10252	0.31900139	1.83335818	-0.64743967	80.37356728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263147-03	NCGC00263147-03	384568622		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	(552325-73-2 (free base))		1	-6	31.8622344565	4	4		21.049237168	-0.48110938	1	0.9999231132		AKT1	CC1=N[NH]C2=CC=C(C=C12)C3=CC(=CN=C3)OC[C@@H](N)CC4=CC=CC=C4	SynKinase	SYN-1110	-0.45769764	4.99329259	20.42377869	-0.48110938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165856-14	NCGC00165856-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					33.7287230745	4	4		0	10.78251026					[H]C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC	Microsource	1504300	5.67267684	9.64376211	6.3566804	10.78251026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182965-11	NCGC00182965-11	384568413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1235-82-1		12.5892541179	-4.9	9.4288589101	4	4		12.144382608	11.36133969	0.069314709	0.9970560009			OC(CCN1CCCCC1)(C2CC\3CC2\C=C3)C4=CC=CC=C4	MedChem Express	HY-13204	0.28284542	0.4276768	-0.12031884	11.36133969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166236-04	Oxonic acid potassium salt			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	2207-75-2				-10.1728308398	4	4		0	-4.86502093					OC1=NC(=NC(O)=N1)C([O-])=O	SIGMA	156124	-0.70711356	-0.94699863	-4.03068131	-4.86502093												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263101-07	NCGC00263101-07	363677202		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	383432-38-0				-1.5252166597	4	4		0	-1.465311				ERBB2	COCC(=O)NC/C=C/C1=CC=C2N=CN=C(NC3=CC=C(OC4=CN=C(C)C=C4)C(=C3)C)C2=C1	MedChem Express	HY-14674	0.68165337	-0.27493508	-2.83060593	-1.465311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347949-11	NCGC00347949-11	363677729		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1118807-13-8				9.6371357122	4	4		0	2.8708134				WNT5A	COC1=CC=C(CCC(=O)NC2=NC3=CC=C(Cl)C=C3S2)C=C1OC	Aobious	AOB3874	-0.07251632	4.6433481	6.33937786	2.8708134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492447-02	NCGC00492447-02	384569288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1629268-00-3				11.8110959866	4	4		0	1.4354067				KRAS	CC1(CC1)C2=C(Cl)C=C(O)C(=C2)NCC(=O)N3CCN(CC3)C4CN(C4)C(=O)C=C	MedChem Express	HY-19706	4.13343002	2.44386742	-2.1819254	1.4354067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346805-02	NCGC00346805-02	363677543		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[729605-21-4]				0.6987714828	4	4		0	-3.43899522				TUBB	CC1=N[N](C2=CC=CC=C2)C(=C1)C(=O)N3CCN(CC3)C4=CC(=CC=C4)Cl	Tocris	3101	3.32124728	-3.29922102	-4.15745245	-3.43899522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262603-12	NCGC00262603-12	384568574		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	870281-82-6				-9.1710607678	4	4		0	-3.23325635				PIK3CD	CC[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=N/C4=C(C(=CC=C4)F)C(=O)N3C5=CC=CC=C5	MedChem Express	HY-13026	-1.577687	-1.73147023	-2.16806008	-3.23325635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346592-02	NCGC00346592-02	384568852		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	489-32-7				-2.7530559432	4	4		0	-1.29330254				PDE5A	COC1=CC=C(C=C1)C/2=C(OC3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)/C(=O)C4=C(O2)C(=C(OC5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C=C4O)CC=C(C)C	Selleck	S2312	-0.81701648	-0.15188335	0.58098342	-1.29330254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346730-07	NCGC00346730-07	384568935		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	177036-94-1				1.4278081615	4	4		0	0.28300552				EDNRA	COC([C@H](OC1=NC(=CC(=N1)C)C)C(O)=O)(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-13209	-0.5963939	3.83067521	0.08828723	0.28300552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263111-11	NCGC00263111-11	384568597		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	188591-46-0				3.4450978929	4	4		0	-0.39620773				PPARD	[O-][S+](=O)(CCNC(=O)C1=CC=C(Cl)C=C1)C2=NC=C(C=C2)C(F)(F)F	MedChem Express	HY-15577	1.26213592	1.59487256	-0.8534432	-0.39620773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			-8.9515894567	4	4		0	2.26527571			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	-4.10041841	0.47897021	-0.72771377	2.26527571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263096-16	Iniparib	384568587	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[160003-66-7]				-6.4144156145	4	4		0	-1.54992548				PARP1	NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O	Tocris	5817	-1.47838215	-2.66427182	0.54578532	-1.54992548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247785-11	NCGC00247785-11	384568516		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE			12.5892541179	-4.9	10.5282032606	2.4	4		35.470521888	29.1468168	0.0294916513	0.9994638019			OC1CCC(CC1)N2\C=N/C3=C(C2=N)C(=C([N]3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6	Evotec	MLS003678589	-2.80016971	-2.56606079	-3.30876824	29.1468168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263214-02	NCGC00263214-02	363677270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[883031-03-6]		12.5892541179	-4.9	48.1248328585	3	4		69.8273541509	63.12799043	0.0556735168	0.9980837904		TRPV4	CC1=C(C=C([N]1CCCN2CCOCC2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C(F)(F)F	Tocris	4100	1.05873822	-0.4276768	-2.09346897	63.12799043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162142-06	NCGC00162142-06	384568219		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1670-87-7				-9.3324344242	4	4		0	0.68779904				MAPK14	NC(=O)C1=CC=C2[NH]C=CC2=C1	Cayman	14156	-3.49528644	-0.58041851	-0.73713696	0.68779904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00372956-01	NCGC00372956-01	384569045		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1223498-69-8				1.0574702128	4	4		0	-1.19617225				JAK2	C[C@@H](O)[C@@H](C)OC1=C(C=NC(=N1)NC2=CC=C(C=C2)[S+]([O-])(=N)C3CC3)C(F)(F)F	Adooq	A12742	0.39158811	-0.70261188	2.06398349	-1.19617225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015150-07	NCGC00015150-07	384567816		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	590-46-5		0.2238721139	-6.65	7.5228106263	4	4		10.427031976	0	1	0.578579075			C[N+](C)(C)CC(O)=O	MedChem Express	HY-N0739	-1.60585998	11.08748481	2.67819187	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159438-03	NCGC00159438-03	26754506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3211-76-5	Selenomethionine			0.3847699318	4	4	BUTANOIC ACID, 2-AMINO-4-(METHYLSELENO-(SUP 75)SE)-, (S)-;(S)-2-AMINO-4-(METHYLSELENYL-(SUP 75)SE)BUTYRIC ACID;Sethotope;Selenomethioninum (75 Se);Selenomethionine Hydrochloride, (S)-Isomer;Selenometionina (75 Se);Selenomethionine, (S)-Isomer;NCGC00159438-03;SELENOMETHIONINE, DL-;selenomethionine (75 Se);Butanoic acid, 2-amino-4-(methylseleno)-;SELENOMETHIONINE, SE-75;selenomethioninum (75Se);Selenomethionine, (R)-Isomer;SELENOMETHIONINE, L-;CIPLUS_208331;Seleno-DL-methionine;SELENOMETHIONINE SE 75;CIPLUS_710865;(S)-2-Amino-4-(methylseleno)butyric acid;CIPLUS_682499;CIPLUS_160576;Se 75, Selenomethionin;SELENOMETHIONINE (75 SE);Selenomethionine, (+,-)-Isomer;Selenomethionine se 75;Seleno-D, L-methionine;Selenomethionine;DL-Selenomethionine-13C1 (methyl-13C1);Seleno-L-methionine;CIPLUS_158422;SELENOMETHIONINE, L-, SE-75;	0	-0.42450828					C[Se]CCC(N)C(O)=O	Labotest	LT00441028	0.51317614	0.46206588	-1.73631548	-0.42450828												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00182047-04	NCGC00182047-04	384568405		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	75607-67-9				-4.299375906	4	4		0	-1.43070045				HPRT1	NC1=C2N=C[N]([C@@H]3O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(=N1)F	Selleck	S1229	-1.33891213	2.54452926	-2.27410552	-1.43070045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247877-09	NCGC00247877-09	384568518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	848695-25-0		7.9432823472	-5.1	71.2685136872	2.2	4		62.3467958291	53.56184799	0.0244352229	0.9996317521		HSP90AB1	COC1=C(C)C=NC(=C1C)C[N]2C=NC3=C(Cl)N=C(N)N=C23	MedChem Express	HY-10212	4.32357043	7.42403832	21.46755609	53.56184799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263281-01	NCGC00263281-01	137276089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1309805-49-9	GSK-1995010			4.718614441	4	4		0	0.53414176			2194	FAS	O=C(C1CC1)N2CC[C@H](C2)C[N]3C4=CC=NC=C4N=C3C5=CC=C(C=C5)C6=CC=C7OC=CC7=C6	NCGCChem	JKJ21-051	1.1313817	2.01619062	0.03007971	0.53414176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386948-01	NCGC00386948-01	363680520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1291087-14-3		11.220184543	-4.95	72.2305144767	3	4		103.7041030028	90.24108561	0.0258466782	0.9995877554		FFAR1	CC#C[C@@H](CC(O)=O)C1=CC=C(OCC2=CC(=CC=C2)C3=CC=C(C=C3)C(F)(F)F)C=C1	Axon Medchem	2405	1.10309716	-1.03864365	3.85020304	90.24108561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507884-01	NCGC00507884-01	384569349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	2012607-27-9				-15.0943586906	4	4		0	-3.52145164				WNK1	CC(C)(C)NC(=O)C1=CN=C[N]1C2CCN(CC2)C3=NC=C(C=C3)C4=NN=C(O4)C(F)(F)F	Selleck	S8358	-3.13358988	-1.78334562	-4.59802539	-3.52145164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General		908112-43-6		0.0015722683	-8.8034733462	249.0450771095	1.4	10		52.5882127319	55.25441064	0.0543127928	0.7811647948		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	3.45180261	1.5597034	1.71311685	21.70800307	53.66913833	71.77192534	75.14702122	34.9015597	33.57197648	55.25441064						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General		747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.0063868356	-8.1947142596	58.8602273607	4	10		13.2790379879	15.22273845	0.0443301555	0.7994301219	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	2.48701831	-0.62858705	0.24596884	-1.06586499	-0.30062859	-0.90188576	1.88576114	-0.90188576	-1.06586499	15.22273845						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00483210-07	NCGC00483210-07			DPI_SARS-CoV-2_General				0.0702306445	-7.1534733462	107.0525186799	3	10		48.5419458622	36.79978558	0.000019435	0.983508481			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	1.90297507	-0.83087644	-2.06378987	-2.33181453	-1.95658001	-0.0804074	0.29482712	2.17099973	5.44090056	36.79978558						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General						45.0382754037	4	10		0	9.08603592					CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	8.22835701	6.62020906	7.42428303	5.92334495	5.97694988	6.40578933	7.69230769	8.71080139	9.40766551	9.08603592						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244253-21	INCB018424			DPI_SARS-CoV-2_General		941678-49-5				-6.201930733	4	10		0	-0.93582888					N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	0.45454545	0.29411765	-1.09625668	-1.95187166	-2.00534759	-0.93582888	-1.73796791	-2.32620321	-2.05882353	-0.93582888						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General		1502654-87-6				-8.4771510969	4	20		0	-0.99718742					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General		259793-96-9				6.5586666161	4	20		0	2.43902439					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General		915087-33-1				-3.7690641022	4	20		0	-0.84722602				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General		53-86-1				8.7370972423	4	20		0	3.08228357				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00024379-17	Emetine dihydrochloride hydrate			DPI_SARS-CoV-2_General		7083-71-8		0.0011130807	-8.9534733462	23.1733875899	5	20		-68.479365951	-4.3722833	0.0004660532	0.8882196774			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General		1190307-88-0				9.669516968	4	20		0	4.72806778					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General		97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	0.0702306445	-7.1534733462	200.1644199227	2.2	20		82.2566844881	74.46524064	6E-10	0.9740310141	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00370909-03	NCGC00370909-03	363677927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	217645-70-0				-6.2770837852	4	4		0	-0.76512199				CCR1	C[C@@H]1CN(CCN1C(=O)COC2=CC=C(Cl)C=C2NC(N)=O)CC3=CC=C(F)C=C3	MedChem Express	HY-12080	-1.8667798	-1.22193371	-0.12031884	-0.76512199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167491-14	NCGC00167491-14	384568318		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	191732-72-6				-7.920268749	4	4		0	-3.2770319				TNF	NC1=CC=CC2=C1CN([C@H]3CCC(=O)NC3=O)C2=O	Glixx	GLXC-04181	-1.07481261	-1.31357874	-2.58685517	-3.2770319												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015501-05	NCGC00015501-05	90341825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			5.3015637093	4	4		0	1.70454545				SMO	NNC1=C2C=CC=CC2=CN=N1	SigmaAldrich	Lopac-H-1753	-1.00072516	5.43760501	3.98053958	1.70454545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510350-01	NCGC00510350-01	384569428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			3.1622776602	-5.5	1.6899709822	4	4		11.692225444	-3.94736842	1	0.962179554		TUBB	COC1=CC=C(C=C1)[S+]([O-])(=O)N2CCC3=C2C(=CC=C3)C4=CC=NC=C4	Axon Medchem	2658	-1.84191443	-3.91018787	6.30989238	-3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347280-04	NCGC00347280-04	363677574		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	406209-26-5		10	-5	67.8098823655	2.3	4		97.8607093203	81.72368991	0.0626984616	0.9975677682		IKBKB	NC1=C(C#N)C(=CC(=N1)C2=C(OCC3CC3)C=CC=C2O)C4CCNCC4	MedChem Express	HY-13060	-1.66878801	3.26867267	12.45300045	81.72368991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371093-04	Marimastat	384569041	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	154039-60-8				-1.8564974496	4	4		0	-2.52501925				MMP1	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	MedChem Express	HY-12169	-0.28172982	1.00243013	0.07085164	-2.52501925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242511-04	NCGC00242511-04	384568505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	134404-52-7				1.9972744462	4	4		0	2.83294842				VDR	CCC(O)(CC)/C=C/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCCC12C)=C\C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32341	-1.63403296	0.45565006	5.34221341	2.83294842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-19	NCGC00093704-19	384568118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	59865-13-3				1.7627834185	4	4		0	-2.24788299					CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	DC Chemicals	DC4115	0.70432455	0.63791009	1.71460961	-2.24788299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181002-10	NCGC00181002-10	384568386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	364782-34-3		15.8489319246	-4.8	-5.5567270746	4	4		-8.4468822119	-5.78906851	0.7143050093	0.4485780471		CASR	C[C@@H](NCCCC1=CC=CC(=C1)C(F)(F)F)C2=CC=CC3=CC=CC=C23	MedChem Express	HY-70037A	-1.15509227	-2.82503038	5.2855321	-5.78906851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094358-38	NCGC00094358-38	384568128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	4759-48-2				-5.8929253903	4	4		0	4.28021555				RARB	CC/1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1	Selleck	S1379	-3.85969855	0.03037667	1.06277455	4.28021555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016256-20	NCGC00016256-20	384567926		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	58-14-0		4.4668359215	-5.35	39.8356466933	2.2	4		41.6306179821	39.81524249	0.0463581128	0.9986732262		DHFR	CCC1=C(C(=NC(=N1)N)N)C2=CC=C(Cl)C=C2	Selleck	S2006	-0.4789407	-0.03037667	16.19668414	39.81524249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346940-03	NCGC00346940-03	384568974		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[164658-13-3]		11.220184543	-4.95	142.7028368451	2.4	4		73.1144757271	71.40229234	0.2183585195	0.9694029045		CDK1	OCCCNC1=CC(=CC=N1)C2=NC(=NC=C2)NC3=CC=CC(=C3)Cl	Tocris	5471	17.65603329	28.99090774	34.31430253	71.40229234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189075-02	NCGC00189075-02	363677126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	391210-10-9				-16.6560142053	4	4		0	-4.66959106				MAP2K1	OCC(O)CONC(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(=C(F)C=C1)F	ChemieTek	CT-PD03	-3.4257975	-2.90654345	-3.41377281	-4.66959106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095150-16	Telmisartan	384568151	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	144701-48-4				-1.9983794622	4	4		0	0.79241545				AGT	CCCC1=NC2=C(C=C(C=C2C)C3=NC4=CC=CC=C4[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O	Enzo	DL511	-1.42857143	-0.22358027	1.73631548	0.79241545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510199-01	NCGC00510199-01	384569414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1225037-39-7				-13.1149624729	4	4		0	-0.1587989				PIK3CA	NC1=NC=C(C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(=C1)C(F)(F)F	Glixx	GLXC-90536	-2.60217791	-4.09347793	-4.99323206	-0.1587989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390552-02	NCGC00390552-02	384569191		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1313363-54-0		15.8489319246	-4.8	-3.4335283403	4	4		11.2084523959	5.26923632	0.4826452635	0.8243392723		MDM2	COC1=C(OC(C)C)C=C2[C@@H](N(C(=O)CC2=C1)C3=CC=C(C=C3)N(C)C[C@@H]4CC[C@H](CC4)N5CCN(C)C(=O)C5)C6=CC=C(Cl)C=C6	ChemieTek	CT-CGM097	-0.50912176	-3.51305942	-5.17371033	5.26923632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1190307-88-0				0.450795121	4	4		0	0.86722488					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-0.1595359	1.00809531	-0.70765148	0.86722488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185850-16	NCGC00185850-16	384568428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	935693-62-2				4.1500799153	4	4		0	-6.2295082				EHMT2	COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCCN(C)CC3)NC4CCN(CC4)CC5=CC=CC=C5	MedChem Express	HY-10587	1.78521618	3.7419548	2.33474833	-6.2295082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164615-05	Prulifloxacin	384568265	Antibacterial	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	123447-62-1				1.3975544492	4	4		0	0.29904306					CC1SC/2=C(C(O)=O)/C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)C\C5=C(C)\OC(=O)O5)F	Glixx	GLXC-06577	0.59463379	0.24438674	-0.73713696	0.29904306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346717-12	NCGC00346717-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1217486-61-7				-1.7014810702	4	4		0	-5.2757079					CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C3=CC(=NC=C3)C(C)(C)C(F)(F)F	APExBIO	A8346	1.78521618	-1.58658883	-1.72832019	-5.2757079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344625-13	NCGC00344625-13	363677341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	931398-72-0		14.1253754462	-4.85	1.2548691766	4	4		9.407751164	7.75981524	0.6228105816	0.6483841226		HIF1A	OC(=O)CNC(=O)\C1=C(/O)C2=CC=CC=C2N(CC3=CC=CC=C3)C1=O	Glixx	GLXC-01838	-2.1974926	3.94896719	-2.42312597	7.75981524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263196-01	NCGC00263196-01	137276040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1265789-88-5	S6K-18			0.661399109	4	4		0	-0.29806259			6198	RPS6KB1	CC(C)(C)C1=CC(=C(NC(=O)NC2=CC3=C([NH]N=C3)C=C2)S1)C(O)=O	SynKinase	SYN-1132	-1.28312413	3.95150427	2.00121286	-0.29806259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476204-01	NCGC00476204-01	363681102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[900305-37-5]		10	-5	20.5846707429	3	4		39.276150628	31.29657228	0.0540571887	0.9981955748		BRPF1	COC1=C(C=CC=C1)C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCC4	Tocris	5576	-1.89679219	-0.20954947	3.12310491	31.29657228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386721-01	NCGC00386721-01	363680416		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1262832-74-5				-2.0057474871	4	4		0	-2.92532717				FGFR1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)N4CCCC4	Axon Medchem	2217	-0.33807579	-0.75941677	2.25308205	-2.92532717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181306-04	Docetaxel	170464919	Tubulin depolymerization Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	114977-28-5	 Docetaxolum; Docetaxel Hydrate; ; AE-docetaxel;DOCETAXEL; 5   Docetaxel; Docetaxel hydrate; Docetaxel Anhydrous; Docetaxel Trihydrate; Docetaxel;Docetaxel; Taxoltere metro			-6.32277196	4	4		0	4.27338333			203068	TUBB	CC(C)(C)OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](O)C(=C5C)C6(C)C	Alfa Aesar	J60174	-1.76144244	-3.41332538	-3.76692172	4.27338333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250400-05	NCGC00250400-05	384568549		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[877399-52-5]				-6.0026669728	4	4		0	-4.86769492				MET	C[C@@H](OC1=C(N)N=CC(=C1)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C(=CC=C4Cl)F	Tocris	4368	-1.09570042	1.32657624	-0.70629782	-4.86769492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179244-11	Dorzolamide hydrochloride	384568369	Carbonic Anhydrase Type II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	130693-82-2				-10.9711027953	4	4		0	-3.09088113				CA2	CCN[C@H]1C[C@H](C)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0109A	-3.3260033	-1.31171702	1.0719323	-3.09088113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346535-02	NCGC00346535-02	384568825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	173529-46-9				-3.1281820562	4	4		0	-2.74515353				PLK1	COC1=CC=C(C=C1)[S+]([O-])(=O)N(C(C)=O)C2=C(C=CC=C2)\C=C\C\3=C\C=[N](=O)\C=C3	MedChem Express	HY-12045	0.40221914	0.55149799	-3.56091819	-2.74515353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015830-08	Phenelzine	170465229	MAO Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	156-51-4	 ;PHENELZINE SULFATE;Phenelzine sulfate; Phenelzine sulfate; 2-Phenelzine; Nardil;Phenylethylhydrazine sulfate; Phenylethylhydrazine sulfate; Fenelzina; Felazine			1.6837124031	4	4		0	0.66123328			4128	MAOA	O=S(=O)(O)O.NNCCc1ccccc1	Microsource	01500476	0.57724024	2.66764923	-3.07475317	0.66123328												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350264-01	NCGC00350264-01	384569003		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	n				-6.7132847631	4	4		0	-2.03349282				SUCNR1	FC1=CC=C(C=C1C(F)(F)F)C2=NOC(=C2)CNC(=O)CCCC3=NC4=NC=CC=C4C=C3	NCGCChem	PRP003-062	-1.63886875	0.06109669	-1.5037594	-2.03349282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015439-20	NCGC00015439-20	384567845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	78755-81-4				11.1038159891	4	4		0	0				GABRA1	CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(=C3)F)[N]2C=N1	MedChem Express	HY-B0009	2.30601885	4.27676799	3.18443167	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481604-01	NCGC00481604-01	377020508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-7.0010786108	4	4		0	-3.20246343				BRAF	C\N=C/1NC2=NC(=C(C=C2/C=N1)C3=CC(=C(F)C=C3C)N\C(O)=N\CCC(C)(C)C)C	APExBIO	B5887	-0.59163262	-2.88578372	-1.54456568	-3.20246343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162453-19	NCGC00162453-19	384568228		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	58880-19-6				-21.4327996893	4	4		0	-4.60700618				HDAC1	C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C	Bio Vision	1606	-3.93204549	-5.41902	-5.95273706	-4.60700618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017337-22	NCGC00017337-22	384567985		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	404-86-4				-3.3749462338	4	4		0	1.07447748				NFKB1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1	MedChem Express	HY-10448	-1.13714207	-0.65638834	-1.16661681	1.07447748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025092-02	NCGC00025092-02	174007484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	158848-32-9	GR-159897; GR-159897			-0.7485945631	4	4		0	3.67907174			6865	TACR2	COC1(CCN(CCC2=C[NH]C3=CC=C(F)C=C23)CC1)C[S+]([O-])C4=CC=CC=C4	Axon Medchem	1119	-1.26213592	0.25339097	-0.64743967	3.67907174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347950-07	NCGC00347950-07	363677730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1243244-14-5				2.4192259901	4	4		0	-0.36790717				PORCN	CC1=NC=CC(=C1)C2=NC=C(CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4)C=C2C	MedChem Express	HY-17545	0.84604716	1.02846922	-0.26486168	-0.36790717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-07	Tigecycline	384568415	glycylcycline antibiotics	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	220620-09-7				7.7523935409	4	4		0	1.10372152					CN(C)[C@H]\1[C@@H]2C[C@@H]\3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)/[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Enzo	AC3268	0.73509015	2.34014011	4.8852266	1.10372152												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178734-10	NCGC00178734-10	384568363		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	486460-32-6				16.3978760081	4	4		0	2.83005519				DPP4	N[C@@H](CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F	MedChem Express	HY-13749	5.58945908	-0.10433746	0.1177163	2.83005519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160514-14	NCGC00160514-14	384568196		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	58186-27-9				-4.1657294772	4	4		0	0.77496274					COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)CCCCCCCCCCO	Enzo	FR114	-1.25523013	-0.83819787	-1.36446331	0.77496274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346070-02	NCGC00346070-02	384568773		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1337531-36-8	Perk Inhibitor I, GSK2606414			5.7178557003	4	4		0	1.5282298				EIF2AK3	C[N]1C=C(C2=CC3=C(C=C2)N(CC3)C(=O)CC4=CC(=CC=C4)C(F)(F)F)C5=C1N=CN=C5N	EMD Chemicals	516535	0.09708738	2.04203309	4.14949971	1.5282298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351597-13	NCGC00351597-13	384569015		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1380288-87-8				-9.8697976786	4	4		0	-2.74217586				DOT1L	CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N)[C@@H]4C[C@H](CCC5=NC6=CC(=CC=C6[NH]5)C(C)(C)C)C4	Selleck	S7062	-2.73361227	-0.89806915	-0.30321407	-2.74217586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015480-17	NCGC00015480-17	384567856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	265129-71-3		14.1253754462	-4.85	7.1512980133	4	4		-8.4716840479	-4.14307004	0.592801913	0.6972982585		PPARA	CC(C)(SC1=CC=C(CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3)C=C1)C(O)=O	Cayman	10008613	2.14783821	0.59871277	6.21588842	-4.14307004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159330-04	NCGC00159330-04	363676585		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	69975-86-6				-7.3654726963	4	4		0	-0.44594802				ADORA2	CN1C(=O)N(C)C2=C([N](CC3OCCO3)C=N2)C1=O	Selleck	S4164	-2.11654755	-1.98968312	-0.33850494	-0.44594802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091455-13	NCGC00091455-13	363676552		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	169590-42-5		12.5892541179	-4.9	34.1787796091	3	4		71.2283964703	59.09580194	0.0180667316	0.9997986732		PTGS2	CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S+](N)([O-])=O)C(F)(F)F	Selleck	S1261	-2.91368884	-1.87177598	-1.77715092	59.09580194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263105-06	NCGC00263105-06	363677205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	629664-81-9				-2.9437523815	4	4		0	-1.55312932				NR14H	CC(C)OC(=O)/C1=C/N(CC(C)(C)C2=C1[NH]C3=CC=CC=C23)C(=O)C4=CC=C(F)C(=C4)F	MedChem Express	HY-50911	-0.30236394	-1.8128224	0.36671368	-1.55312932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402250-03	NCGC00402250-03	363680999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1404189-10-1				4.5445982594	4	4		0	-0.72274335				MAPK14	CC1=C(C=CC=C1)N2/N=C(\C=C/C2=O)C3=C4NC[C@@H](CO)C[N]4N=C3C5=CC=C(F)C=C5	Glixx	GLXC-01771	1.45684442	2.43183493	-0.47954866	-0.72274335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182868-16	NCGC00182868-16	384568412		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	658084-64-1				-20.1398114038	4	4		0	-3.55861244				NAMPT	O=C(NCCCCC1CCN(CC1)C(=O)C2=CC=CC=C2)\C=C\C3=CN=CC=C3	MedChem Express	HY-50876	-4.45250181	-3.7879945	-4.95356037	-3.55861244												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348110-01	NCGC00348110-01	384569002		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	n		1.4125375446	-5.85	5.6750376015	4	4		12.254532264	-6.54904306	1	0.9995259021		TNK2	COC(C)(C)CC[N]1N=C(NC2=C(C)C=CC=C2C)C3=CN=C(NC4=CC(=C(OCCN5CCCC5)C=C4)F)N=C13	NCGCChem	PRP003-032	-2.71211022	-1.80235222	9.58278048	-6.54904306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371443-05	NCGC00371443-05	384569043		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-3.8092256909	4	4		0	-0.10303209				KDM5A	CCOC(=O)C1=CC=NC(=C1)CNCC(=O)N(CC)CCN(C)C	XcessBio	M60192-b_cm2	-2.94560899	1.11433369	4.30750823	-0.10303209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263544-04	NCGC00263544-04	384568686		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	149003-01-0				0.3694832669	4	4		0	-2.09330144				TOP2A	C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	Selleck	S1222	-0.01450326	3.08538262	-0.26536931	-2.09330144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160515-01	NCGC00160515-01	29216197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	56180-94-0	; Lasa Brand of Acarbose; Glucobay; Glumida; Bayer Brand of Acarbose; Precose;ACARBOSE; Prandase;Acarbose; Glucor; Acarbosa			-3.8579629148	4	4	Bayer Brand of Acarbose;Precose;acarbose;acarbose 7-phosphotransferase;CIPLUS_182443;D-glucose, O-4,6-dideoxy-4-(((1S-(1 alpha,4 alpha,5 beta,6 alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyr anosyl-(1-4)-;Bay g 5421;HS_1150;NCGC00096061-02;LS-71702;component C, acarbose byproduct;ACARBOSE;acarbose kinase;BAY G 5421;Glucobay;O-4,6-Dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-a-D-glucopyranosyl-(1-4)-O-a-D-glucopyranosyl-(1-4)-D-Glucose;acarbose byproduct, component C;Lasa Brand of Acarbose;O-4,6-DIDEOXY-4-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-D-GLUCOPYRANOSYL-(1,4)-O-D-GLUCOPYRANOSYL-(1,4)-D-GLUCOPYRANOSE;NCGC00096061-01;Glucor;acarbose 7-phosphate;Acarbosa;Prandase;WHO NO. 4527;Acarbose;acarbosum;Acarbosum;acarbose-7-phosphate;Glumida;	0	0.44594802			2548	GAA	[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O[C@]3([H])[C@@]([H])(CO)OC(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]4([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O	InterBioScreen	BB_NC-1311	-1.81418362	2.54974208	-1.91819464	0.44594802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345815-02	NCGC00345815-02	384568758		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	133407-86-0		1.2589254118	-5.9	307.1874609517	5	4		-96.0271659957	3.04680601	0.0468825621	0.998641892		PSMD1	CCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Cayman	15413	96.65707631	83.88032361	-0.77774454	3.04680601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346495-14	NCGC00346495-14	384568801		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[663619-89-4]				-0.2888584961	4	4		0	2.75242861				PIK3CB	CC(NC1=CC=CC=C1)C\2=C\C(=C/N3C(=O)\C=C(/N=C23)N4CCOCC4)C	Tocris	5832	-0.34251267	-1.29751183	-0.80765779	2.75242861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345804-10	NCGC00345804-10	363677367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	606143-89-9				-17.6446167079	4	4		0	-4.64129051				MAP2K1	C[N]1C=NC2=C(F)C(=C(C=C12)C(=O)NOCCO)NC3=CC=C(Br)C=C3F	Glixx	GLXC-04704	-3.92510402	-3.14502907	-2.79576221	-4.64129051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016488-15	NCGC00016488-15	384567945		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	525-79-1				0.9204751942	4	4		0	1.34569378					C(NC1=C2[NH]C=NC2=NC=N1)C3=CC=CO3	APExBIO	A3528	0.04350979	0.39712846	-0.678166	1.34569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094419-03	NCGC00094419-03	26753659		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	402-71-1	Tosyl-Phe-CMK (TPCK);TPCK;N-p-Tosyl-L-phenylalanine chloromethyl ketone			0.0078245695	4	4	(S)-1-Chloro-3-tosylamido-4-phenyl-2-butanone;Tosylphenylalanyl Chloromethyl Ketone;NCGC00016020-01;NCGC00094419-03;TPCK;NCGC00094419-02;Ketone, Tosylphenylalanyl Chloromethy;NCGC00094419-01;CIPLUS_153043;Chloromethyl Ketone, Tosylphenylalany;Tosyl-L-phenylalanyl-chloromethane;Chloromethane, Tosylphenylalany;(S)-1-Chloro-4-phenyl-3-tosylamido-2-butanone;Tosyl-Phe-CMK (TPCK);CIPLUS_675469;LS-154112;Benzenesulfonamide, N-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-4-methyl-, (S)-;N-p-Tosyl-L-phenylalanine chloromethyl ketone;	0	2.96903718					CC1=CC=C(C=C1)[S+]([O-])(=O)N[C@@H](CC2=CC=CC=C2)C(=O)CCl	BIOMOL	PI-122	-0.17965727	-0.29092023	-2.21638962	2.96903718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484799-01	NCGC00484799-01	363681179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1338545-07-5				6.1118115997	4	4		0	-4.47148719					C[C@@H](CN(C)C)C1=CC=C(C=C1)C2=C(O)C=C(C)C3=C2C4=C(SC=C4)C(=O)N3	ChemieTek	CT-OTS964	3.95284327	0.87941571	-1.79517363	-4.47148719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253867-11	NCGC00253867-11	384568568		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	179474-85-2				14.7927084463	4	4		0	-0.02980626				HTR4	COCCCN1CCC(CC1)NC(=O)C2=CC(=C(N)C3=C2OCC3)Cl	MedChem Express	HY-12694	4.40725244	4.69989523	0.39417829	-0.02980626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015242-16	NCGC00015242-16	384567829		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	58-94-6				-1.1783515227	4	4		0	1.98103863					N[S+]([O-])(=O)C1=C(Cl)C=C2\N=C/N[S+]([O-])(=O)C2=C1	Microsource	01500180	-1.42857143	-0.96884782	2.38375515	1.98103863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017112-14	NCGC00017112-14	384567974		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	41621-49-2		8.9125093813	-5.05	53.7134607138	2.4	4		80.7243868787	64.29210134	0.0666449773	0.9972511586			CC/1=C/C(=O)N(O)/C(=C1)C2CCCCC2	Prestwick	Prestw-541	-2.62203626	2.39485107	15.28198908	64.29210134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386141-07	NCGC00386141-07	384569112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	592542-60-4				-20.1994034833	4	4		0	-1.84798808				TUBB	COC1=CC(=C(\C=C\[S+]([O-])(=O)CC2=CC=C(OC)C(=C2)NCC([O-])=O)C(=C1)OC)OC	MedChem Express	HY-12037	-5.80195258	-2.72414309	-3.00181928	-1.84798808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163489-03	NCGC00163489-03	384568243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	517-89-5	SHIKONIN;Shikonin			-3.0779698765	4	4		0	-3.45752608			1234	CCR5	CC(C)=CC[C@@H](O)C/1=C/C(=O)C2=C(O)C=CC(=C2C1=O)O	Enzo	CT-115	0.22315202	2.78401437	-4.30563978	-3.45752608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242596-05	NCGC00242596-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	146464-95-1		28.1838293126	-4.55	191.8032541804	5	4		-41.5	33.44262295	0.1943480813	0.9763586857			NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1	Selleck	S1497	42.28730823	41.28124532	42.87446938	33.44262295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166294-08	NCGC00166294-08	384568305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	110871-86-8				0.2770565075	4	4		0	2.9007177				TOP2B	C[C@H]1CN(C[C@@H](C)N1)C2=C(F)C3=C(C(=C2F)N)C(=O)\C(=C/N3C4CC4)C(O)=O	MedChem Express	HY-B0308	-0.36258158	-0.70261188	-0.678166	2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351480-16	NCGC00351480-16	384569008		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1346704-33-3		12.5892541179	-4.9	53.9132287177	3	4		97.7137210766	86.11028316	0.037984981	0.9991090662		EZH2	CCCC\1=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC(=NC=C4)N5CCN(C)CC5)C(=O)NC(=C1)\C	SIGMA	SML0766	-2.9567643	-0.68851968	-3.45664039	86.11028316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378622-10	NCGC00378622-10	363678127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1421373-65-0		1.2589254118	-5.9	33.0549595434	4	4		33.4379985439	-6.36961722	1	0.9998472187		EGFR	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Glixx	GLXC-05459	-3.69833212	0.70261188	29.04319623	-6.36961722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142615-10	NCGC00142615-10	384568167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	51-42-3				12.2326044984	4	4		0	2.09330144				ADRA1A	CNC[C@H](O)C1=CC=C(O)C(=C1)O	Selleck	S2521	3.2342277	-0.09164503	3.53825741	2.09330144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346448-03	NCGC00346448-03	384568779		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	206873-63-4				3.2607517437	4	4		0	-3.39791356				ABCBA	COC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(=C(OC)C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)C=C3)CC2)C=C1OC	Axon Medchem	1960	1.25523013	-1.04774734	4.76046089	-3.39791356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161923-31	NCGC00161923-31	384568216		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	477-47-4				-12.2024079163	4	4		0	-2.60523992				IGFR1	COC1=C(OC)C(=CC(=C1)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)C4=C2C=C5OCOC5=C4)OC	Bio Vision	2765	-2.58939581	-4.04518394	-1.16661681	-2.60523992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351479-01	NCGC00351479-01	363677753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					3.7088348556	4	4		0	1.75154548			80854	SETD7	[O-][S+](=O)(N[C@H](CC1=CC=CC(=C1)C(F)(F)F)C(=O)N2CCCC2)C3=CC4=C(CNCC4)C(=C3)F	SGC	(R)-PFI-2	-0.42471571	4.65577774	0.32904577	1.75154548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346594-02	NCGC00346594-02	363677469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	508-02-1				5.3360195957	4	4		0	3.09985097				PLA2G5	CC1(C)C[C@H](C2CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Selleck	S2334	0.16736402	1.67639575	2.03153426	3.09985097												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167524-02	Amorolfine hydrochloride	170466078	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	78613-35-1	 ;Amorolfine Hydrochloride;Amorolfine; Amorolfine; Amorolfine [USAN:BAN:INN];Amorolfine hcL; Loceryl; Pekiron			-8.0583459388	4	4		0	1.34128167					C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2	Sequoia	SRP0563571a	-2.87308229	-1.52671756	-0.93996361	1.34128167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015452-23	NCGC00015452-23	384567851		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	13311-84-7				-10.5107578348	4	4		0	-4.41132638				AR	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F	Selleck	S1908	-2.28730823	-0.53884149	-1.42510612	-4.41132638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386433-04	NCGC00386433-04	384569140		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			11.220184543	-4.95	48.2498443435	3	4		85.1716603591	70.78986587	0.0474032993	0.9986116952		FGFR1	CC1=NC2=C([NH]1)C=C(C=C2)[N]3N=CC(=C3N)C(=O)C4=CC5=C([NH]4)C=CC=C5	Selleck	S7665	-2.67782427	0.56877713	2.54699818	70.78986587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510692-02	NCGC00510692-02	384569482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1802220-02-5				-13.3975522193	4	4		0	-6.22009569				ALK	C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=C(O1)C=CC(=C4)F)C=C[N]3N=C2	ChemGood	C-1409	-1.08774474	-3.1464793	-5.39584255	-6.22009569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522052-01	NCGC00522052-01	384569512		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1202402-40-1		0.7943282347	-6.1	9.93736697	4	4		17.589920232	0.71770335	1	0.9994451643		ADORA2A	CC1=CC=C(O1)C2=NC(=NC3=C2N=N[N]3CC4=NC(=CC=C4)CO[C@H]5CCOC5)N	ChemGood	C-1392	-3.40826686	3.97128456	10.96859797	0.71770335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023722-16	NCGC00023722-16	384568020		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	50-91-9		5.0118723363	-5.3	-7.2333716319	4	4		10.728883452	6.33971292	0.0784828171	0.9962354727		TYMS	OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(F)/C(=O)NC2=O	Enzo	DL403	-3.69833212	-3.94073621	0.32434026	6.33971292												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250408-02	NCGC00250408-02	384568556		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1086062-66-9		0.2238721139	-6.65	28.8457049699	4	4		11	3.16985646	1	0.7616748936		PIK3CA	COC1=C(N[S+]([O-])(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C3=CC=C4N=CC=C(C5=CN=NC=C5)C4=C3	Selleck	S2658	2.36403191	14.69375286	8.66873065	3.16985646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480817-01	NCGC00480817-01	384569247		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	223387-75-5				6.367049738	4	4		0	0.59380744				HIF2A	OC(=O)CNC(=O)C1=C(O)C2=C(C=CC=C2)C(=N1)Cl	Glixx	GLXC-90112	2.83305694	-1.73020977	-0.14581511	0.59380744												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262376-01	NCGC00262376-01	174006421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	n				1.4072909421	4	4		0	0.66123328			2322	FLT3	C1C[C@H](CN1)NC2=CC=CC(=N2)C3=CN=C4C=CC(=C[N]34)C5=C[NH]N=C5	NCGCChem	JKJ21-005	-0.49477735	2.54974208	0.56417489	0.66123328												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507860-01	NCGC00507860-01	384569336		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1393465-84-3		6.3095734448	-5.2	37.5415687225	4	4		29.5	28.15719753	0.0211216468	0.9997253512		BRAF	CCN(C)[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CN=C(N=C4)C5CC5	Selleck	S7964	2.26058364	3.52617921	11.81573437	28.15719753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022001-19	NCGC00022001-19	384568009		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	518-28-5				-7.7750906382	4	4		0	-0.5074581				TUBB	COC1=C(OC)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)C4=CC5=C(OCO5)C=C24)OC	MedChem Express	HY-15552	-2.03408466	-0.10316875	-3.04654443	-0.5074581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480828-04	NCGC00480828-04	363681111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1431326-61-2		14.1253754462	-4.85	16.3993198458	4	4		20.049365308	18.03782869	0.2092253103	0.9721077167		KDM1A	NC1CCC(CC1)N[C@@H]2C[C@H]2C3=CC=CC=C3	Selleck	S7795	0.65970313	2.63817244	-0.87447109	18.03782869												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263166-10	NCGC00263166-10	384568636		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	803712-79-0		2.2387211386	-5.65	175.2677335606	2.4	4		38.7998673124	13.12799043	1	0.9892437756		BCL2L1	COC\1=C\C(=N/C1=C/C2=C(C)C=C(C)[NH]2)C3=CC4=CC=CC=C4[NH]3	Adooq	A10665	25.56925308	30.30395601	61.38876603	13.12799043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-13	Bortezomib	384568504	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	179324-69-7				-15.7575072313	4	4		0	-3.40909091				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	ActiveBioChem	A-1014	-4.24945613	-2.04673896	-1.32684653	-3.40909091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370777-04	NCGC00370777-04	363677849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1197160-78-3				-8.4655198344	4	4		0	-2.54636444				PIK3CA	CN(C)C1CCN(CC1)C(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6)C=C2	APExBIO	B2179	-2.12357857	1.48068997	-3.11097816	-2.54636444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346959-11	NCGC00346959-11	384568977		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	837422-57-8		14.1253754462	-4.85	11.2960603098	4	4		10.14866886	9.93523697	0.5242289007	0.7827741248		LCK	COC1=CC=C(N(C(=O)OC2=C(C)C=CC=C2C)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(C)CC5)C(=C1)OC	MedChem Express	HY-12299	0.56172078	4.44206991	-0.95722405	9.93523697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165875-04	PB-28	384568294	sigma1/2 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	172907-03-8		11.220184543	-4.95	75.0628868692	3	4		100.289269056	86.10207833	0.0118998894	0.9999126563		SIGMAR1	COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1	Axon Medchem	1272	1.56163626	2.55703568	7.05745115	86.10207833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167532-05	NCGC00167532-05	384568327		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	127294-70-6				-0.8783129788	4	4		0	2.17729393					CNC1CCCN(C1)C2=C(F)C=C3C(=O)\C(=C/N(C4CC4)C3=C2OC)C(O)=O	MedChem Express	HY-B0159	-0.04145937	-1.97519522	-1.45815106	2.17729393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-18	NCGC00024379-18	384568026		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	316-42-7		7.0794578438	-5.15	43.5427955618	4	4		-18.709529192	-5.17460766	0.8050177352	0.9996352137			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	Prestwick	Prestw-NAT-0129	57.64234384	12.57081611	9.33216681	-5.17460766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346490-06	NCGC00346490-06	384568798		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[742112-33-0]				1.9172724156	4	4		0	-5.90979782				PDPK1	NCC(=O)NC1=CC=C(C=C1)[N]2N=C(C=C2C3=CC4=C(C=C3)C5=C(C=CC=C5)C=C4)C(F)(F)F	Tocris	5682	3.88336097	-3.81258613	-1.31233596	-5.90979782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346468-03	NCGC00346468-03	384568787		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	19608-29-8				4.0644643381	4	4		0	1.55520995				AR	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO	MedChem Express	HY-13331	1.58927584	-0.75026795	-0.90405366	1.55520995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015451-11	NCGC00015451-11	384567850		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-6.9056260883	4	4		0	-2.35311101				KCNQ1	CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)N=C1N	NCGCChem	NCGC00015451-10pur	-0.96167444	-1.95509394	-1.89502181	-2.35311101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095597-05	NCGC00095597-05	384568158		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[5508-58-7]		11.220184543	-4.95	37.3659867902	3	4		62.1380824706	47.01891151	0.0297721589	0.9994531882		TNF	C[C@@]1(CO)C(O)CC[C@]2(C)C(C/C=C/3C(O)COC3=O)C(=C)CCC12	Tocris	4626	-1.1313817	0.27493508	7.03865243	47.01891151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346532-01	NCGC00346532-01	174007365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE		VX-222			-4.1136322838	4	4		0	-0.59188682					C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]2CC[C@H](O)CC2)C3=C(SC(=C3)C#CC(C)(C)C)C(O)=O	Selleck	S1480	-1.18795078	1.31357874	-2.22589863	-0.59188682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095055-12	NCGC00095055-12	384568142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	53003-10-4		0.2238721139	-6.65	176.9764385576	4	4		-15	42.77464992	1	0.577467405		WNT1	CCC(C1CCC(C)C(O1)C(C)C(O)C(C)C(=O)C(CC)C2OC\3(O[C@]4(CC[C@@](C)(O4)C5CC[C@@](O)(CC)C(C)O5)C(O)\C=C3)C(C)CC2C)C([O-])=O	MedChem Express	HY-15597	42.45509829	23.52222392	36.03549406	42.77464992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346660-03	NCGC00346660-03	384568891		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	32981-86-5				-2.124749213	4	4		0	-1.83340551					CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](O)/C(=C(/[C@@H](O)C3=O)C5(C)C)C	MedChem Express	HY-16565	-1.10309716	-1.77180388	4.72251466	-1.83340551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263201-04	NCGC00263201-04	384568660		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	890019-63-3				-6.2694444645	4	4		0	-6.68399018				MET	COC1=C(OCCCN2CCOCC2)C=C3N=CC=C(OC4=CC=C(C=C4F)\C5=C\N=C(\NC6=CC=C(F)C=C6)N(C)C5=O)C3=C1	SynKinase	SYN-1111	0.65054448	-1.16083702	-3.03805083	-6.68399018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016418-23	NCGC00016418-23	384567939		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	298-81-7				11.9261887552	4	4		0	-0.84576349				CYP1A2	COC1=C2OC(=O)\C=C/C2=CC3=C1OC=C3	MedChem Express	HY-30151	4.9477735	-0.899042	0.78984485	-0.84576349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183001-01	Tolvaptan	124894207	Vasopressin (AVP) V2 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	150683-30-0	 ; Tolvaptan;Tolvaptan			-9.3899501686	4	4	OPC 41061;OPC-41061;7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;tolvaptan;TOLVAPTAN;Tolvaptan;7-CHLORO-5-HYDROXY-1-(2-METHYL-4-(2-METHYLBENZOYLAMINO)BENZOYL)-2,3,4,5-TETRAHYDRO-1H-BENZAPINE, DL-;CIPLUS_789421;tolvaptanum;	0	-1.76435407			554	AVPR2	Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34	Pharmaron	PH-NIH-116369	-2.30601885	-0.76370857	-2.35883827	-1.76435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379024-02	NCGC00379024-02	384569087		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	189453-10-9		14.1253754462	-4.85	-8.4919903489	4	4		13.947425668	8.01435407	0.312715331	0.9350461263		TUBB	C[C@H]1CCC\C(=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C2=CSC(=N2)C)C	MedChem Express	HY-15278	-4.53952139	-1.03864365	-3.09597523	8.01435407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347956-02	NCGC00347956-02	384569000		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1379686-29-9				0.2065896541	4	4		0	3.1408776				NR1D1	CCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC3=CC=C(Cl)C=C3)C1	XcessBio	M66049-2s	-0.05634596	-2.24787363	-0.60932408	3.1408776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242477-02	NCGC00242477-02	384568490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[870773-76-5]				0.3673365174	4	4		0	1.13933795				RARB	CCCCOCCOC1=C(C)SC(=N1)C2=CC=C(C(O)=O)C(=C2)F	Tocris	4046	-0.42259473	2.33900365	-1.48788437	1.13933795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168110-05	NCGC00168110-05	363676678		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	639089-54-6				-5.8853331016	4	4		0	1.07447748				AURKA	CN1CCN(CC1)C2=CC(=NC(=N2)SC3=CC=C(NC(=O)C4CC4)C=C3)NC5=CC(=N[NH]5)C	Selleck	S1048	-0.53431977	-3.15982293	-4.45707448	1.07447748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186035-08	NCGC00186035-08	384568438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[509093-47-4]				7.5167003785	4	4		0	-1.21589142				IRAK1	[O-][N+](=O)C1=CC=CC(=C1)C(=O)NC2=NC3=CC=CC=C3[N]2CCN4CCOCC4	Tocris	5665	3.49640685	0.5052825	-1.22484689	-1.21589142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-02	NCGC00247029-02	174006875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	154-17-6	2-Deoxyglucose			-4.9659793068	4	4		0	0.82001979					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	SIGMA	D3179	-0.73244887	-2.71015158	-2.59550889	0.82001979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346942-01	NCGC00346942-01	174006541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	211555-05-4	WHI-P97			-5.8540008689	4	4		0	-4.32631132			1956	EGFR	COC1=C(OC)C=C2C(=NC=NC2=C1)NC3=CC(=C(O)C(=C3)Br)Br	Chemscene	CS-0054	0.45605307	-3.78196295	-1.63312919	-4.32631132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160396-04	NCGC00160396-04	170466117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	92623-83-1	Pravadoline;Win-48098; Pravadoline			-8.87490854	4	4		0	-3.64447178				MT-CO1	COc1ccc(cc1)C(=O)c3c4ccccc4n(CCN2CCOCC2)c3C	Enzo	CR110	-2.06157229	-0.95799558	-0.31029619	-3.64447178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510750-02	NCGC00510750-02	384569490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1037592-40-7				-1.2335627586	4	4		0	-2.12074085				SLC7A5	N[C@@H](CC1=CC(=C(OCC2=C3OC(=NC3=CC(=C2)N)C4=CC=CC=C4)C(=C1)Cl)Cl)C(O)=O	MedChem Express	HY-100868	-0.12437811	0.81151432	0.14581511	-2.12074085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370731-05	NCGC00370731-05	384569035		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	936889-68-8				-10.7133064113	4	4		0	-1.87836798					NC1=NC=C[N]2C(=NC(=C12)C3=CC4=C([NH]3)C(=CC=C4)Cl)[C@@H]5CC[C@H](CC5)C(O)=O	SynKinase	SYN-5214	-2.02845471	-2.52126367	-3.38670823	-1.87836798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187911-06	NCGC00187911-06	363677115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	918505-84-7				2.908322527	4	4		0	-3.01770593				BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(Cl)C=C23	ChemieTek	CT-P4720	1.60585998	1.7618469	-0.24089556	-3.01770593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346469-03	NCGC00346469-03	384568788		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	847499-27-8				-8.4895476703	4	4		0	-3.07492421				PSMD1	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)[C@@H](C)O)B(O)O	Glixx	GLXC-90266	-0.48083722	-3.7879945	-2.19581892	-3.07492421												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346612-06	NCGC00346612-06	384568858		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	635318-11-5				-6.2081815661	4	4		0	-0.67744419				GRM2	N[C@]1(C[S+]([O-])(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	MedChem Express	HY-50906	-1.69037893	-0.18226002	-1.79963157	-0.67744419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271415-05	NCGC00271415-05	384568704		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	80621-81-4				3.1510922767	4	4		0	7.23633564				NR1I2	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(=C4C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=C(N=C6C=C(C)C=C[N]56)C4=C3C2=O)O)O	Adooq	A10793	-1.91576278	-0.21263669	3.98186198	7.23633564												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163468-12	NCGC00163468-12	384568241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	50-07-7				-0.6400162714	4	4		0	0.10303209					CO[C@@]12[C@H](COC(N)=O)C/3=C(N1C[C@@H]4N[C@H]24)/C(=O)/C(=C(N)\C3=O)C	MedChem Express	HY-13316	-0.97273599	2.97664479	-0.44869877	0.10303209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016467-10	NCGC00016467-10	384567943		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[491-70-3]				-1.5237877751	4	4		0	0.36759508				PDE4A	OC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC(=C(O)C=C3)O	Tocris	2874	-0.40077391	-0.32154341	-0.78740157	0.36759508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346542-12	NCGC00346542-12	384568828		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	422513-13-1		12.5892541179	-4.9	19.1897628837	3	4		59.6375530979	48.92449834	0.0398119192	0.9990214726		AURKA	CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1	MedChem Express	HY-12054	-3.81841324	-5.40705667	-5.50458716	48.92449834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378873-04	NCGC00378873-04	384569073		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	266359-93-7				-5.5075789546	4	4		0	-0.98537336				CXCR2	CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)N[S+](C)([O-])=O	MedChem Express	HY-15252	-2.47922243	2.21749696	0.01417033	-0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347936-06	NCGC00347936-06	363677722		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	420831-40-9		14.1253754462	-4.85	6.3852781134	4	4		13.8329283159	10.34642032	0.1966469528	0.9756142122		SIRT2	[O-][S+](=O)(N1CCCCCC1)C2=CC(=CC=C2)C(=O)NC3=CC=CC(=C3)Br	Bio Vision	1857	0.22538386	-1.94410693	-0.80770866	10.34642032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356417-05	NCGC00356417-05	384569030		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			11.220184543	-4.95	97.9793914761	3	4		136.4506697474	116.12009238	0.0125509072	0.9999028281		SMYD2	CC1=C[N](CCN2CCN(CC2)C3=C(C=CC=C3)C4=CC(=CC(=C4)C#N)C(=O)NCCCN5CCCC5)C6=C1C=CC=C6	Tocris	5365	1.49316805	2.46051033	8.09125691	116.12009238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485875-01	NCGC00485875-01	363681386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	865838-26-2				-1.9496749966	4	4		0	0				CDK1	NC\1=N\C(=O)N(\C=C1)[C@H]\2[C@H](O)[C@H](O)C(=C2F)\CO	MedChem Express	HY-15228	-0.39442175	-0.45565006	-0.89273062	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386306-06	NCGC00386306-06	363680199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1202757-89-8				-4.468720758	4	4		0	-2.63467766				BTK	COCCOC1=CC=C(NC2=NC=C(F)C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)C=C1	MedChem Express	HY-18012	0.56172078	-0.96168524	-4.66646724	-2.63467766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016535-19	NCGC00016535-19			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	745-65-3				-3.9903688348	4	4		0	-1.48660583					CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	MedChem Express	HY-B0131	-0.67132484	-0.32056175	-1.34609632	-1.48660583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386260-02	NCGC00386260-02	363680172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	194423-15-9				-15.7313379348	4	4		0	1.60242529				EGFR	BrC1=CC(=CC=C1)NC2=NC=NC3=CC=C(NC(=O)C=C)C=C23	APExBIO	A2024	-4.15782775	-4.30731633	-4.72251466	1.60242529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345825-02	NCGC00345825-02	363677372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(1338247-30-5)				-2.2972741953	4	4		0	6.93258758				LIMK1	FC(F)C1=N[N](C(=C1)C2=CN=C(NC(=O)C3CC3)S2)C4=C(Cl)C=CC=C4Cl	SynKinase	SYN-1023	-2.67159885	-2.82399634	1.88453485	6.93258758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015558-16	NCGC00015558-16	384567864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	51-30-9				-1.4289028377	4	4		0	2.78619893				ADRB1	CC(C)NCC(O)C1=CC(=C(O)C=C1)O	Selleck	S2566	-1.49908075	0.12219337	0.33087682	2.78619893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018268-14	NCGC00018268-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	84625-61-6		0.8912509381	-6.05	58.2836262457	3	4		40.2664113126	7.91377983	1	0.9998775843			CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	MedChem Express	HY-17514	-1.60585998	1.94410693	34.64645033	7.91377983												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378801-04	NCGC00378801-04	384569070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	334949-59-6				1.2685224934	4	4		0	3.69515012					CN(C)CC1=CC(=CC=C1)NC(\C2=CC=CC=C2)=C3/C(=O)NC4=C3C=CC(=C4)C(N)=O	MedChem Express	HY-12055	0	-2.06561361	-0.07085164	3.69515012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249685-09	NCGC00249685-09	384568533		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	405169-16-6				-2.6440346146	4	4		0	-5.63732705				FGFR1	CN1CCN(CC1)C2=CC3=C([NH]C(=N3)C/4=C(\N)C5=C(F)C=CC=C5NC4=O)C=C2	MedChem Express	HY-50905	-0.01370051	3.31247138	-1.01705055	-5.63732705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159518-02	NCGC00159518-02	144205289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole			0.9118701293	4	4	LS-172365;CIPLUS_660920;LS-172366;E3810;Sodium Rabeprazole;E-3810;rabeprazolum;Sodium rabeprazole;HS_13;E 3810;CIPLUS_196951;rabeprazole sodium;RABEPRAZOLE SODIUM;2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole;Aciphex;1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt;2-[[[4-??3-Methoxypropoxy??-3-methylpyridin-2-yl]methyl]sulfiny]-1H-benzimidazole sodium salt;LY-307640;LY307640;2-[[[4-??3-Methoxypropoxy??-3-methylpyridin-2-yl]methyl]sulfiny]-1H-benzimidazole sodium sal;Pariet;RABEPRAZOLE;Rabeprazole sodium;SODIUM 2-((4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2-YL)-METHYLSULFINYL)-1H-BENZIMIDAZOLE;Rabeprazole Sodium;rabeprazole;2-(cholromethyl)-4-(3-methoxypropoxy)-3-methylpyridine;Rabeprazole;	0	1.13933795					[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Bionet	KS-1101	0.70432455	-2.64277035	0.1558736	1.13933795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351602-09	NCGC00351602-09	363677771		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1197958-12-5				-3.6257550208	4	4		0	-4.87194583				ALK	COC1=CC(=CC=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[P](C)(C)=O)N4CCC(CC4)N(C)C	Selleck	S7000	1.3837512	-1.11433369	-3.91863596	-4.87194583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165873-03	NCGC00165873-03	384568293		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1049743-58-9]				9.0551633071	4	4		0	-0.96221876				IKBKB	ClC1=CC2=C([NH]C3=C2C=CN=C3)C(=C1)NC(=O)C4=CC=CN=C4	Tocris	4569	4.50762829	0.31301237	-0.44143614	-0.96221876												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167578-04	NCGC00167578-04	384568330		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	145525-41-3				4.885976449	4	4		0	0.19810386					O=C(C[C@H](CC1=CC=CC=C1)C(=O)O[Ca]OC(=O)[C@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)CC4=CC=CC=C4)N5C[C@H]6CCCC[C@H]6C5	MedChem Express	HY-17398	0.20804438	4.60575347	1.41259564	0.19810386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510267-01	NCGC00510267-01	384569424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1844849-10-0				-6.142189695	4	4		0	-3.53456808				EZH2	CO[C@H](C1COC1)C2=C(Cl)C3=C(CCN(C\C4=C(OC)\C=C(\C)NC4=O)C3=O)C(=C2)Cl	ChemieTek	CT-PF0682	-0.59425097	-0.47465932	-2.36220472	-3.53456808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247878-08	NCGC00247878-08	384568519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	747412-49-3		0.316227766	-6.5	121.3681929692	1.4	4		41.645736205	-0.10105385	1	0.9999745565		HSP90AB1	CCNC(=O)C1=NOC(=C1C2=CC=C(CN3CCOCC3)C=C2)C4=C(O)C=C(O)C(=C4)C(C)C	MedChem Express	HY-10215_CM1	12.84118229	36.71910799	43.49526245	-0.10105385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015840-09	NCGC00015840-09	174006856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	60-82-2	Phloretin;PHLORETIN			-9.0100032262	4	4		0	-2.60365077			3383	ICAM1	OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1	Microsource	MS-00300554	-2.31622746	-0.84960501	-0.79458505	-2.60365077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347951-03	NCGC00347951-03	384568996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1235864-15-9				-3.5110270299	4	4		0	-3.62247064				KDM1A	CC(N[C@H]1C[C@@H]1C2=CC=CC=C2)C3=CC=C4OCCOC4=C3	XcessBio	M66045-2s	-0.73509015	1.59487256	-0.05885815	-3.62247064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390770-02	NCGC00390770-02	384569212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	84692-91-1		11.220184543	-4.95	9.626991479	4	4		18.443784472	14.33521005	0.3606030687	0.9107081616		COX10	CC/1=C/C[C@]23O[C@@]2(C)CC[C@@H]4[C@H](OC(=O)C4=C)[C@@H]13	MedChem Express	HY-16059	-2.03648706	3.17702765	2.70717401	14.33521005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484069-01	NCGC00484069-01	363681161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1193383-09-3				-3.7337732746	4	4		0	2.93056157				HIF1A	OC(=O)C1=C[N](N=C1)C2=NC3=CC(=C(OC(F)(F)F)C=C3[NH]2)Cl	MedChem Express	HY-12832	-1.1313817	-2.65770582	-1.68446383	2.93056157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346525-03	NCGC00346525-03	384568819		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1158838-45-9				3.5534894736	4	4		0	2.7573264				AURKA	CCN1CCN(CC1)C(=O)CC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=C(C=C4)C(=O)NC5=CC=CC=C5Cl)C=C2	Selleck	S1451	2.17790977	-1.03864365	-4.78267409	2.7573264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168114-09	NCGC00168114-09	363676679		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	371242-69-2				-0.633517437	4	4		0	-2.64819092				PIK3CA	CC1=CC=CC=C1N2\C(=N/C3=C(C(=CC=C3)C)C2=O)C[N]4C=NC5=C4N=CN=C5N	ChemieTek	CT-IC871	1.07057332	0.18226002	-2.16806008	-2.64819092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024717-10	NCGC00024717-10	384568032		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	51298-62-5		0.3548133892	-6.45	26.2273711852	4	4		-12.584864392	-0.56553089	0.0496034051	0.9984964035		NOS3	COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O	Selleck	S2877	10.46158098	0.81151432	-0.90405366	-0.56553089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179532-03	NCGC00179532-03	170466730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	96-82-2				-7.0608228796	4	4		0	-2.48833593				MMP1	O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	SIGMA	153516	-1.09176341	-1.76083295	-1.69145523	-2.48833593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346505-02	NCGC00346505-02	363677432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	152044-53-6				-21.7273228371	4	4		0	-4.74210931				TUBB	C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Selleck	S1297	-4.76123398	-4.49574727	-4.12356525	-4.74210931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166207-01	NCGC00166207-01	144205901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	38609-97-1				-4.1678532144	4	4	9-oxo-10-acridineacetic acid;Kamedon;9-Oxo-10(9H)-acridineacetic acid;LS-14178;cridanimodum;NCGC_FLUKA_17927;acridone N-methyl-N-(alpha,D-glucopyranosyl)ammonium 10-methylenecarboxylate;(9,10-Dihydro-9-oxo-10-acridinyl)acetic acid;CIPLUS_179328;CIPLUS_737508;10-(Carboxymethyl)-9(10H)acridone;CIPLUS_729115;10(9H)-acridineacetic acid, 9-oxo-;10-carboxymethyl-9-acridanone, sodium salt;Neovir;Cridanimod;10-carboxymethyl-9-acridanone;10(9H)-Acridineacetic acid, 9-oxo-;9-oxo-10(9h)-acridineacetic acid;cycloferon;LS-175964;Camedon;NCGC00166207-01;	0	-3.59112116					O=C(O)CN3c1ccccc1C(=O)c2ccccc23	FLUKA	FLUKA-17927	0.92592593	-4.45567294	-1.04986877	-3.59112116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510231-01	GDC-0077	384569416	PARP inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					19.4118728854	4	4	Pamiparib	0	0.47639671				PARP1	C[C@]12CCCN1C/C3=N/NC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F	ChemGood	C-1286	3.73355961	5.65144341	7.97112348	0.47639671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346602-01	NCGC00346602-01	174006325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	32854-75-4	Lappaconite Hydrobromide			-0.3463788754	4	4		0	-2.58409124					CCN1C[C@@]2(CC[C@H](OC)[C@@]34[C@@H]2C[C@@H]([C@@H]13)[C@@]5(O)C[C@H](OC)[C@H]6C[C@@H]4[C@]5(O)[C@H]6OC)OC(=O)C7=C(NC(C)=O)C=CC=C7	Selleck	S2387	1.47079621	-0.48877348	-2.61693488	-2.58409124												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485941-02	NCGC00485941-02	384569278		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	404844-02-6				4.2492940461	4	4		0	4.63404071				LRRK2	CC1=C(NC2=NC(=CC=N2)C3=CN=CC=C3)C=C(NC(=O)C4=CC=C(CN5CCNCC5)C=C4)C=C1	MedChem Express	HY-G0017	-1.41422712	2.23002902	4.06076102	4.63404071												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160529-08	NCGC00160529-08	384568199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[64461-82-1]				-8.1000322267	4	4		0	-3.30590443				ADRA2A	ClC1=C(N\C2=N\CCN2)C3=NSN=C3C=C1	Tocris	3609	-0.7353981	-2.77989919	-2.58685517	-3.30590443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263158-07	NCGC00263158-07	363677235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	850879-09-3		11.220184543	-4.95	31.4565636651	3	4		61.0831718751	51.39337952	0.0456895669	0.998710714		PDGFRA	S=C(NCC1=CC2=C(OCO2)C=C1)N3CCN(CC3)C4=NC=NC5=C4OC6=C5C=CC=C6	MedChem Express	HY-10206	-2.70460628	-0.42527339	0.35425818	51.39337952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346509-08	NCGC00346509-08	384568811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	958852-01-2		2.8183829313	-5.55	17.6973582162	4	4		20.0684428159	18.29492436	0.0497388725	0.9984751707		PIK3CA	O=C1NC(=O)/C(S1)=C/C2=CC=C3N=CC=C(C4=CC=NC=C4)C3=C2	MedChem Express	HY-12036	-1.69983416	-2.55703568	14.5231846	18.29492436												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378600-02	NCGC00378600-02	363678116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1095173-27-5				8.1631206605	4	4		0	-2.52501925				SHH	CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3[NH]2)NC(=O)NC4=CC=C(C=C4)C#N	Selleck	S7160	4.19777433	0.7290401	-1.68626895	-2.52501925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510708-01	NCGC00510708-01	384569489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1218816-71-7				-1.3849493977	4	4		0	0.48070126				SPHK1	C[C@H](NC(=O)[C@H]1NCC[C@@H]1O)C2=CC=C(C=C2)C3=NOC(=N3)CCC4CCCC4	MedChem Express	HY-101805	-0.48369265	0.32154341	-1.04986877	0.48070126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482879-02	NCGC00482879-02	377020215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	937263-43-9				5.7106127973	4	4		0	7.42109315				ERBB2	CC1=C(OC2=CC3=NC=N[N]3C=C2)C=CC(=C1)NC4=NC=NC5=C4C=C(N\C6=N\C(C)(C)CO6)C=C5	MedChem Express	HY-16069	0.50711368	-1.94410693	0.32591753	7.42109315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016285-09	NCGC00016285-09	384567929		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	63-74-1				-3.6631332729	4	4		0	-0.12992638				CA1	NC1=CC=C(C=C1)[S+](N)([O-])=O	Selleck	S1685	-1.01824353	0.12219337	-1.50398556	-0.12992638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346304-02	NCGC00346304-02	174006393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	303727-31-3	L-779,450	0.1995262315	-6.7	36.4998608861	4	4		8	8.80147163	0.7274371989	0.4106921184	673	BRAF	OC1=CC(=CC=C1Cl)C2=C([NH]C(=N2)C3=CC=CC=C3)C4=CC=NC=C4	Tocris	3185	5.17337032	15.81457743	8.09299588	8.80147163												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025109-13	NCGC00025109-13	384568051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	208260-29-1				12.3345664083	4	4		0	3.45026707				BRAF	CN(C)C1=CC=CC(=C1)C(=O)NC2=CC(=C(C)C=C2)NC(=O)C3=CC=C(O)C=C3	MedChem Express	HY-13343	2.63046245	4.94883153	-0.60159422	3.45026707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263124-09	NCGC00263124-09	384568607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	675576-97-3				-5.2131528374	4	4		0	-1.97074673				MDM2	COC1=CC=C(C(=C1)OC(C)C)C/2=N/[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5	MedChem Express	HY-15335	-1.26778419	-1.64034022	0.92107128	-1.97074673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165952-05	NCGC00165952-05	384568300		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	725247-18-7				-4.3203377895	4	4		0	-0.9538003				ESR1	COC1=C(OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F)C=CC(=C1)\C=C(C#N)\C(=O)NC3=NN=C(S3)C(F)(F)F	MedChem Express	HY-10426	-1.61785216	0.65858404	0.09096422	-0.9538003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159544-04	NCGC00159544-04	384568186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[109826-27-9]		12.5892541179	-4.9	77.9106906369	3	4		118.2117133868	106.31980772	0.0375941728	0.9991272792		CALM1	CC1(CN2CCC(CC2)N3C(=O)NC4=C3C=CC=C4)OCC5=CC=CC=C5[N]6C=CC=C16	Tocris	2255	-0.23493643	0.99525341	-2.36220472	106.31980772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346953-01	NCGC00346953-01	174006712		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	345987-15-7	JNK Inhibitor V	3.9810717055	-5.4	18.3695394712	4	4		30.0795502759	19.56113758	0.0494993718	0.9984911397	5599	MAPK8	N#CC(C1=NC2=CC=CC=C2S1)C3=CC=NC(=N3)NCCC4=CC=CN=C4	EMD Chemicals	420129	-2.14962523	2.74935085	10.46773951	19.56113758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253740-06	NCGC00253740-06	384568567		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	175481-36-4				-1.9437162852	4	4		0	-0.64665127				GRIN2A	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1	MedChem Express	HY-13015	-1.07057332	-0.09113001	1.91299419	-0.64665127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253760-02	NCGC00253760-02	174006227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	54029-12-8	Albendazole oxide;Albendazole Oxide (Ricobendazole)			0.6484049742	4	4		0	-2.95612009					CCC[S+]([O-])C1=CC=C2[NH]C(=NC2=C1)NC(=O)OC	Selleck	S1836	2.14114664	-2.21749696	-1.51622502	-2.95612009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388364-06	NCGC00388364-06	384569169		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1154028-82-6				-2.575072136	4	4		0	4.23248882				HIF1A	O=C\1N(N\C=C1[N]2C=CN=N2)C3=NC=NC(=C3)N4CCOCC4	MedChem Express	HY-12654	-1.72942817	-1.43691064	-0.4548211	4.23248882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189130-07	NCGC00189130-07	384568458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1320288-19-4		14.1253754462	-4.85	8.9350062309	2.4	4		31.9868476879	23.66103652	0.0349539265	0.999247115	10919	EHMT2	COC1=C(OCCCN2CCCCC2)C=C3N=C(N=C(NC4CCN(CC4)CC5CCCCC5)C3=C1)N6CCCN(CC6)C(C)C	MedChem Express	HY-13808	-2.48903974	-1.68015885	-1.74462325	23.66103652												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485478-02	Oritavancin (diphosphate)			DPI_SARS-CoV-2_General		192564-14-0				29.4936929338	4	10		0	8.05420609					[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	-0.07670672	4.9859371	2.32677065	-1.04832524	4.0654564	0.63922271	0.74149834	7.44055229	1.40628995	8.05420609						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159462-20	Ritonavir			DPI_SARS-CoV-2_General		155213-67-5				-5.3561938031	4	10		0	-1.66197903					[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	1.20173869	-0.48580926	-0.58808489	2.63359755	0.53694707	-1.35515213	-1.15060087	-1.09946305	-0.89491179	-1.66197903						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00094047-16	Ivermectin			DPI_SARS-CoV-2_General		70288-86-7		0.0157226828	-7.8034733462	-16.9139942962	4	10		-6.657556704	-5.43864444	0.659795886	0.6121657716			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	-0.62858705	-0.9565455	0.24596884	-1.72178191	6.80513802	3.47089369	48.18256354	-5.05602624	-5.54796392	-5.43864444						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686694-01	Remdesivir			DPI_SARS-CoV-2_General		1809249-37-3		0.024918773	-7.6034733462	353.6733395203	1.1	10		108.2788528524	103.80595015	0.0000010124	0.9930227595			CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	1.95658001	1.74216028	4.10077727	-0.29482712	2.33181453	1.15250603	14.28571429	47.46716698	104.44920933	103.80595015						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016622-11	Hycanthone			DPI_SARS-CoV-2_General		3105-97-3		0.0157226828	-7.8034733462	236.5651036824	1.2	10		84.3139908839	-3.08228357	0.0036171002	0.937117912			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	0.13401233	0.99169124	0.56285178	-2.54623425	-1.52774055	-0.83087644	13.10640579	76.6282498	65.85365854	-3.08228357						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	DPI_SARS-CoV-2_General				0.0625931278	-7.2034733462	107.6876672621	3	10		41.3870275995	34.92361297	0.0022205232	0.9300967904			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097	2.97507371	-1.84937014	0.0804074	0.02680247	-2.22460466	5.65532029	3.45751809	6.5129992	8.60359153	34.92361297						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General		923604-59-5		0.011130807	-7.9534733462	30.5286614489	4	20		13.3532385839	-1.81539248	0.2243296898	0.3930382188			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General		908112-43-6		0.0014012856	-8.8534733462	237.1817261045	1.2	20		52.5882127319	55.25441064	0.0020044235	0.7911580168		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263521-07	NCGC00263521-07	384568684		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	14484-47-0				-0.7700584915	4	4		0	1.34128167					CC(=O)OCC(=O)[C@@]12\N=C(C)/O[C@@H]1C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]23C	MedChem Express	HY-13609	-0.33472803	0.71845532	-2.03153426	1.34128167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507854-01	NCGC00507854-01	384569332		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1857417-13-0		1.2589254118	-5.9	34.2981405799	4	4		31.360203652	-6.53962754	1	0.9997860283			CC1=C2C=C(C#N)[N](CC3=C[NH]N=C3)C2=CC=C1CN4CCC(CC4)NC5=C6C=C(CC(F)(F)F)SC6=NC=N5	Selleck	S7817	-2.80016971	1.03864365	28.15460972	-6.53962754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015580-22	NCGC00015580-22	384567867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	34580-14-8				4.4110655583	4	4		0	1.67464115				HRH1	CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3	MedChem Express	HY-B0157A	1.58085569	-0.48877348	-0.76662244	1.67464115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094087-07	NCGC00094087-07	384568124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	50924-49-7				15.8941084546	4	4		0	-2.9007177				IMPDH1	NC(=O)C1=C(O)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Selleck	S1384	7.03408267	2.41331908	-2.27038184	-2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346640-05	NCGC00346640-05	384568874		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	908115-27-5		8.9125093813	-5.05	75.9206894383	2.4	4		94.6774154536	73.74903772	0.1487793741	0.9860965286		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC=C(C(N)=O)C(=C3)NC4CCC(CC4)OC(=O)CN	MedChem Express	HY-10213	-1.69037893	10.72296476	25.20901233	73.74903772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378614-02	NCGC00378614-02	384569056		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	895519-91-2		7.9432823472	-5.1	84.3686331696	2.3	4		110.4938629406	88.52963818	0.0902627473	0.9949413872		ABL1	CN1CCN(CC1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC(=C(C)N=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	MedChem Express	HY-13905	-2.50739541	7.38153098	27.81635256	88.52963818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263099-07	NCGC00263099-07	384568590		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1080622-86-1				-1.3864184699	4	4		0	-1.87836798				ATM	COC1=C(OC)C=C2C(=C1)N=CN=C2[N]3N=C(N=C3N)C4=NC=CC=C4	SIGMA	SML1115	0.61980561	-1.06318347	-1.17613717	-1.87836798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507881-01	NCGC00507881-01	384569347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1313883-00-9		2.8183829313	-5.55	18.1434822473	4	4		14.59353108	-6.42422527	1	0.9484781456		AKT1	NC1=NC=CC=C1C2=NC3=CC=C(N=C3[N]2C4=CC=C(C=C4)C5(N)CCC5)C6=CC=CC=C6	Selleck	S8339	1.09570042	-2.1612759	11.65391407	-6.42422527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016407-16	NCGC00016407-16	384567937		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	144-82-1				4.5628582	4	4		0	0.50940993					CC1=NN=C(N[S+]([O-])(=O)C2=CC=C(N)C=C2)S1	Microsource	01500549	1.15117892	2.07184379	-0.29429076	0.50940993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346878-04	NCGC00346878-04	384568956		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	(215543-92-3)				-6.4926566538	4	4		0	-3.91222752				FGFR1	CC1=C[NH]C(=C1CCC(O)=O)\C=C\2C(=O)NC3=CC=CC=C23	SynKinase	SYN-1084	-1.27280441	-0.27493508	-0.18047827	-3.91222752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389251-02	NCGC00389251-02	384569172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1594092-37-1]		8.9125093813	-5.05	55.869268432	3	4		82.5520898399	77.91788405	0.0052599129	0.9999829371	9149	DYRK1B	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CN=C4)C=CC(=C1)N5CCN(C)CC5	Tocris	5232	-1.09950522	-1.45910096	2.08744711	77.91788405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016978-13	NCGC00016978-13	384567971		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	135062-02-1				0.4843869113	4	4		0	0.41519299					CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	MedChem Express	HY-15209	0.13743815	-0.30950626	0.05641749	0.41519299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-01	NCGC00510509-01	384569470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	81840-15-5				10.8379610951	4	4		0	0.73903002				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	3.80335258	1.0328068	-0.21255491	0.73903002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090766-15	NCGC00090766-15	384568085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	53-03-2				4.1361118451	4	4		0	-0.31130607				NRC31	C[C@]12CC(=O)[C@H]3[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	MedChem Express	HY-B0214	-0.09708738	4.45669996	2.14832254	-0.31130607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183285-06	NCGC00183285-06	384568418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	641571-10-0		0.2238721139	-6.65	26.5814406542	4	4		14.5	10.07499646	0.6316239883	0.6301867519		ABL1	CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC(=CC=N4)C5=CC=CN=C5)C(F)(F)F	Selleck	S1033	0.12482663	18.76583694	8.03413773	10.07499646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347063-02	NCGC00347063-02	384568980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE			12.5892541179	-4.9	17.4012498695	4	4		25.3495145681	23.12155087	0.0669450185	0.9972323478			OC1=C(O)C=C(C=C1)C2CCN(CC2)C3=CC=NC4=CC=CC=C34	Evotec	MLS004820019	-0.29126214	1.08809062	0.14714538	23.12155087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095124-31	NCGC00095124-31	384568147		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	122320-73-4		3.1622776602	-5.5	27.0348718245	4	4		19.589432112	6.65062969	1	0.9901364414		PPARG	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3	Selleck	S2556	1.62274619	-0.07452676	15.86227192	6.65062969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167768-11	NCGC00167768-11	377020487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	228559-41-9				-3.9515664069	4	4		0	4.88822653				FLT1	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)NC4=CC=C(F)C=C4F)C(=C3)F	MedChem Express	HY-12038	-2.25941423	-0.92800479	-1.69799879	4.88822653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480876-01	NCGC00480876-01	363681112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	900874-91-1		0.7079457844	-6.15	27.3917892333	4	4		12	11.92250373	0.2246232146	0.9678558172		PI4KB	COC1=CC=C(C=C1OC)C2=C3N=C(C)C=C(NCCN4CCOCC4)[N]3N=C2C	Glixx	GLXC-03509	1.25523013	7.66352342	14.19041844	11.92250373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263114-01	NCGC00263114-01	137275958		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	949588-40-3	Org-25935;SCH-900435			4.8682181586	4	4		0	-0.38443795			6536	SLC6A9	COC1=CC=C2[C@@H]([C@@H](CCC2=C1)CN(C)CC(O)=O)C3=CC=CC=C3	ChemAxon	Axon 1563	2.11654755	-0.86956522	-0.56417489	-0.38443795												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345739-02	NCGC00345739-02	174007137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1354037-26-5	KH-CB19			-4.4112735795	4	4		0	-2.66148325			78989	CLK1	CCOC(=O)C1=C(\C(=C/N)C#N)C2=CC=C(Cl)C(=C2[N]1C)Cl	Tocris	4262	-0.39158811	0	-2.03449801	-2.66148325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346578-08	NCGC00346578-08	384568849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	183320-51-6				-15.480380954	4	4		0	-4.66588166				EGFR	COCCOC1=CC2=C(C=C1OCCO)C(=NC=N2)NC3=CC=CC(=C3)C#C	MedChem Express	HY-13256	-2.72640088	-3.12929324	-4.06820221	-4.66588166												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345811-02	NCGC00345811-02	384568755		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			8.9125093813	-5.05	15.4950613769	4	4		-12.2647924599	-5.63732705	0.3474486223	0.9180050787		STAT3	N[S+]([O-])(=O)C1=C2C(=O)C3=C(C(=CC=C3)O)C(=O)C2=CC=C1	Bio Vision	1792	3.9594465	8.1972218	5.53395154	-5.63732705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015479-22	NCGC00015479-22	384567855		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein			-1.991462214	4	4		0	-1.18862318			7153	TOP2A	OC1=CC=C(C=C1)\C2=C\OC3=C(C(=CC(=C3)O)O)C2=O	SIGMA	G6649	-0.62413315	2.51900432	-2.06003531	-1.18862318												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00351607-02	NCGC00351607-02	384569021		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1421783-64-3				-16.5284908278	4	4		0	-6.45252582				ABL1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC4=CN=C5[NH]N=CC5=C4)C=C2C(F)(F)F	Selleck	S7194	-4.53536754	-3.53256819	3.35491466	-6.45252582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263175-02	NCGC00263175-02	384568645		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[238750-77-1]				-20.7532774371	4	4		0	-4.61997019				ANPEP	CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C2=CC=CC=C2	Tocris	3595	-4.9651325	-2.24517288	-4.3662826	-4.61997019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181765-03	Pranlukast hydrate	384568399	Leukotriene CysLT1/2 (LTD4) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	103177-37-3				-1.2179483493	4	4		0	-0.32786885				CYSLTR1	O=C(NC1=CC=C2C(=O)\C=C(/OC2=C1)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	Selleck	S1829	-0.08368201	-0.41909894	-0.66707095	-0.32786885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485484-02	NCGC00485484-02	384569276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1604810-84-5		1.1220184543	-5.95	15.5917592165	4	4		19.682008372	13.47242921	0.2886459861	0.944955655	1022	CDK7	CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-12280	-3.06834031	-0.59871277	19.70891449	13.47242921												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013724-04	NCGC00013724-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	155-41-9				-3.1052801745	4	4		0	-1.69895678					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@@H](C[C@@]2([H])[N+]3(C)C)OC(=O)[C@H](CO)C4=CC=CC=C4	MedChem Express	HY-B0344	-0.36262204	-0.20954947	-1.09157065	-1.69895678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346681-07	NCGC00346681-07	384568905		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1245537-68-1		2.5118864315	-5.6	9.4969767442	4	4		-19.894736844	-6.57894737	0.6831381842	0.52209786		PIK3CA	COC1=CC=C(C=N1)C2=CC=C3N=CC4=C(N(C(=O)N4C)C5=CC=C(N6CCNCC6)C(=C5)C(F)(F)F)C3=C2	APExBIO	A8488	0.10152284	26.11883305	-5.8676102	-6.57894737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370979-01	NCGC00370979-01	363677973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	3920		12.5892541179	-4.9	67.4057730216	3	4		115.3413792452	100.30909626	0.0040329389	0.9999899683		MAPK14	CN\1C(=O)/C(=C(\N=C1NC[C@@H](N)CC2=CC=CC=C2)C3=CC=NC=C3)C4=CC5=C(C=CC=C5)C=C4	Tocris	3920	-1.93177148	-2.24393222	-1.52557583	100.30909626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686671-01	Brincidofovir			DPI_SARS-CoV-2_General		444805-28-1				-11.5577405524	4	10		0	-2.5963378					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	-2.81497677	1.33916371	1.01120525	-0.08198961	-1.99508062	-1.12052473	-1.33916371	-1.66712216	-2.2137196	-2.5963378						3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9	1.7964071856E-8					
NCGC00015735-22	Niclosamide		STAT-3 Inhibitor	DPI_SARS-CoV-2_General		50-65-7		0.0003137088	-9.5034733462	166.1032485771	1.4	10		39.5631320047	11.72451489	0.232358917	0.5972898287		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	MedChem Express	HY-B0497	2.26837934	12.27111233	56.38152501	41.29543591	34.29898879	29.98086909	30.36348729	29.92620935	29.76223012	11.72451489						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263137-03	NCGC00263137-03	384568615		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					2.0136790136	4	4		0	-1.39829261				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(C=C4)C#N)C(F)(F)F	Axon Medchem	1532	1.60295931	-1.45016028	-0.02991325	-1.39829261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384249-01	NCGC00384249-01	384569108		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			11.220184543	-4.95	37.8587173185	3	4		64.3731253159	54.62172505	0.0243452603	0.9996343784		NOX1	CC1=C(C)N=C(CN2CCN(CC2)C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)C(=N1)C	ChemoGenics	CXC195	-0.75352788	-2.03022439	0.53843853	54.62172505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510233-01	NCGC00510233-01	384569418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1923833-60-6		12.5892541179	-4.9	47.6780987669	3	4		69.1826484713	59.65756332	0.0320210208	0.9993672215		IDO1	C[C@H]([C@H]1CC[C@H](CC1)C2=CC=NC3=CC=C(F)C=C23)C(=O)NC4=CC=C(Cl)C=C4	ChemGood	C-1360	1.20665742	-0.34282307	0.35314891	59.65756332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016526-16	NCGC00016526-16	384567947		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	633-65-8, 2086-83-1				-1.3893238005	4	4		0	-2.00933918				PTP4A1	COC1=C(OC)C2=C(C=C1)C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=C2	Microsource	01500811	1.15117892	-2.1612759	-1.88346086	-2.00933918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378793-02	NCGC00378793-02	384569069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	855527-92-3				-2.4067722352	4	4		0	-0.92399404				CXCR3	CCOC1=CC=C(C=C1)N2C(=O)C3=CC=CN=C3/N=C2/[C@@H](C)N(CC4=CC=CN=C4)C(=O)CC5=CC=C(F)C(=C5)C(F)(F)F	MedChem Express	HY-15320	-0.16736402	-0.44903458	-1.39478472	-0.92399404												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346636-03	NCGC00346636-03	363677489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1062161-90-3				0.6009079891	4	4		0	5.00745156				MTOR	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C(=N2)N6CCOCC6	Selleck	S2668	-2.09205021	-1.94581649	5.09399636	5.00745156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521943-01	NCGC00521943-01	384569508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1330782-76-7		10	-5	3.8663483248	4	4		30.8221757279	21.57973174	0.1075745257	0.9928098515		CDK7	CC1=N[NH]C=C1C2=CC\3=C(S2)C(=O)NC(=N3)\[C@@H]4CC5CCN4CC5	ChemieTek	CT-TAK931	-4.43514644	-1.82607394	0.48514251	21.57973174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242054-15	NCGC00242054-15	384568483		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	446859-33-2				-17.4863328624	4	4		0	-0.01537752				TGBR1	CC1=NC(=CC=C1)C2=N[NH]C=C2C3=NC4=C(C=C3)N=CC=C4	MedChem Express	HY-13012	-4.72787246	-3.58142962	-4.14668547	-0.01537752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164590-08	NCGC00164590-08	384568260		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	67392-87-4				-0.5107268781	4	4		0	6.65846532				PGR	C[C@]\12CCC(=O)\C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7	MedChem Express	HY-B0111	-1.20945574	-2.07811349	-1.35401975	6.65846532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016107-09	NCGC00016107-09	363676477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1021868-92-7				3.3249100049	4	4		0	0.83732057				JAK1	CC(C)N(CCC(=O)C1=CC=C2C=CC=CC2=C1)CC3=CC=CC=C3	Selleck	S8004	1.23277737	0.18329006	-0.8255934	0.83732057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346890-02	NCGC00346890-02	384568963		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[252979-56-9]				-13.2182466011	4	4		0	-4.60526316				TOP2A	C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	Tocris	4219	-2.53807107	-1.58851382	-3.12546071	-4.60526316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-20	NCGC00346716-20	384568929		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1195765-45-7		12.5892541179	-4.9	31.4613807067	3	4		35.51619062	32.62559809	0.1614890658	0.9835809971		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	Selleck	S2807	3.26323423	-1.68015885	-0.11794191	32.62559809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420698-02	BPTES	384569223	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[314045-39-1]				3.1778906289	4	4		0	1.10278524				GLS	O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2	Tocris	5301	2.36318408	-3.10825295	-2.15806358	1.10278524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381477-05	NCGC00381477-05	384569098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1523406-39-4		10	-5	11.840715175	4	4		30.876894804	24.03506292	0.069430467	0.9970205807		PIK3C3	C[C@@H]1COCCN1C\2=C\C(=O)N\3CC[C@H](N(CC4=CN=CC(=C4)Cl)C3=N2)C(F)(F)F	Glixx	GLXC-05770	-1.56163626	-3.23074567	0.17497813	24.03506292												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General		53-86-1		0.0015722683	-8.8034733462	14.2067929068	4	10		4.283570084	3.08228357	0.4331822338	0.3338597181		PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	0.67006165	-0.99169124	-1.90297507	1.42053069	2.43902439	5.70892522	10.21173948	1.04529617	-0.72366658	3.08228357						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00651732-01	ROC-325			DPI_SARS-CoV-2_General		1859141-26-6		0.0119228982	-7.9236181626	401.4831491401	2.1	10		106.0979630039	2.22460466	0.0001099818	0.9817851325			CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	1.95658001	-0.0804074	-0.0804074	-1.25971589	0.77727151	0.56285178	7.5314929	41.08818011	110.5065666	2.22460466						8.682634731E-11	1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8					
NCGC00483210-07	NCGC00483210-07			DPI_SARS-CoV-2_General				0.0702306445	-7.1534733462	114.587074778	3	10		48.6973262017	39.01069519	0.0002428132	0.9649611762			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	2.37967914	0.0802139	-1.52406417	-2.00534759	0.0802139	-1.57754011	0.13368984	5.64171123	3.34224599	39.01069519						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	DPI_SARS-CoV-2_General		52-86-8		0.0702306445	-7.1534733462	260.9201826104	3	10		112.6299465239	89.3315508	0.0000140451	0.9849995565			OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	3.12834225	-0.98930481	-0.18716578	1.09625668	-1.31016043	-0.98930481	2.7540107	2.80748663	2.59358289	89.3315508						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389778-03	NCGC00389778-03			DPI_SARS-CoV-2_General		82956-11-4				10.5268744182	4	10		0	1.68449198					NC(N)=NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N	Bio Vision	1760	4.94652406	-0.82887701	4.73262032	-0.50802139	0.13368984	2.64705882	3.71657754	3.60962567	2.80748663	1.68449198						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	DPI_SARS-CoV-2_General		59721-29-8				-0.1474443082	4	10		0	-0.40106952					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-1.73796791	-0.93582888	-1.57754011	0.34759358	-0.56149733	4.14438503	-0.0802139	1.89839572	0.98930481	-0.40106952						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244248-01	NCGC00244248-01			DPI_SARS-CoV-2_General						9.0896124163	4	20		0	6.72741892					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090782-17	Nelfinavir Mesylate			DPI_SARS-CoV-2_General		159989-65-8		0.0049719489	-8.3034733462	187.8542805139	1.1	20		96.0772937248	-2.70053476	5.64E-8	0.9745815741			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159462-20	Ritonavir			DPI_SARS-CoV-2_General		155213-67-5				-7.2919944216	4	20		0	-1.66197903					[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686670-01	GS-441524			DPI_SARS-CoV-2_General		1191237-69-0		0.0055786184	-8.2534733462	418.8291426728	1.1	20		103.6762530153	107.66550523	4.4E-9	0.9663284891			NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00095157-04	NCGC00095157-04	144206994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	53716-50-0	; OXFENDAZOLE;OXFENDAZOLE;Oxfendazole; ; Synanthic; Oxfendazol			-7.7644637691	4	4	OXFENDAZOLE;CLOSANTEL / OXFENDAZOLE;COBALT EDTA / IVERMECTIN / LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SODIUM SELENATE / ZINC EDTA;LS-50557;OXFENDAZOLE / PIPERAZINE AS PIPERAZINE DIHYDROCHLORIDE;LS-177151;oxfendazole monohydrochloride;Methyl 5-(phenylsulfinyl)-benzimidazol-2-carbamate;NCGC00095157-02;NCGC00095157-01;Methyl (5-phenylsulfinyl)-1H-benzimidazol-2-yl carbamate;ABAMECTIN / COBALT AS COBALT DISODIUM EDTA / LEVAMISOLE AS LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SELENIUM AS SODIUM SELENATE;OXFENDAZOLE / PRAZIQUANTEL;oxfendazole;Oxfendazol;RS 8858;oxfendazolum;Oxfendazolum;CIPLUS_181660;methyl 5(6)-phenylsulfinyl-2-benzimidazolecarbamate;OXFENDAZOLE / PYRANTEL EMBONATE;Synanthic;Oxfendazole;COBALT EDTA / LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SODIUM SELENATE / ZINC EDTA;	0	-3.52870813					O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3	SigmaAldrich	34176	-1.87092096	0.88590194	-1.38581748	-3.52870813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390570-02	NCGC00390570-02	384569194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1315329-43-1				0.3637393764	4	4		0	-5.69620253				BRAF	CCN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)\C=C\C4=CN=C5[NH]C=CC5=C4OC)C=C2C(F)(F)F	MedChem Express	HY-12291	3.49362926	-1.72492749	-4.42716123	-5.69620253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263183-02	NCGC00263183-02	384568651		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	955365-80-7		10	-5	-2.3853051251	4	4		29.0251045999	22.414307	0.0246758877	0.9996248927		WEE1	CN1CCN(CC1)C2=CC=C(NC3=NC=C4C(=O)N(CC=C)N(C5=CC=CC(=N5)C(C)(C)O)C4=N3)C=C2	Selleck	S1525	-5.0209205	-4.58015267	-4.45724682	22.414307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522011-01	NCGC00522011-01	384569511		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1155773-15-1		11.220184543	-4.95	12.4702860816	4	4		29.2154811719	21.96721311	0.2725529617	0.9513163674			CCN1C(=O)N\2CC3=CC(=CC(=C3[C@@H](C)\C=C2C14CCN(CC4)CC5=CC(=CC(=C5)C)C)OC)OC	Tocris	5924	-3.09623431	2.93369256	2.72892662	21.96721311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346478-06	NCGC00346478-06	384568792		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1050500-29-2				-19.5201750176	4	4		0	-6.40834575				ERBB2	FC1=CC(=CC=C1)COC2=CC=C(NC3=C4C=C(NC(=O)C=C)C=CC4=NC=N3)C=C2Cl	Selleck	S2185	-4.26778243	-2.78401437	-2.69860522	-6.40834575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346522-06	NCGC00346522-06	384568817		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	959122-11-3				16.4509529982	4	4		0	0.08971292				DGAT1	OC(=O)[C@@H]1CCC[C@H]1C(=O)C2=CC=C(C=C2)C3=CC=C(NC(=O)NC4=CC=CC=C4)C=C3	MedChem Express	HY-10038	6.54097172	1.2830304	-1.73964323	0.08971292												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486944-01	NCGC00486944-01	363681470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-1.7112034974	4	4		0	0.53827751				PAK1	CC(C)NC(=O)N1CC[C@@H](C1)NC/2=N/C3=C(C=CC(=C3)F)N(CC(F)F)C4=C2C=C(Cl)C=C4	SGC	NVS-PAK1-1	-0.44960116	1.09974034	-3.33185906	0.53827751												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00390575-03	NCGC00390575-03	384569195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1446182-94-0				24.9369862922	4	4		0	3.3411834				XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=C(S3)C4=NC=CO4)C5=CC=CC=C5	MedChem Express	HY-15835	8.28880669	0.59532896	1.22644331	3.3411834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346639-03	NCGC00346639-03	384568873		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	624-49-7				9.6569979813	4	4		0	-1.45716809				NFKB1	COC(=O)\C=C\C(=O)OC	Selleck	S2586	3.98684751	-0.68691803	1.49566258	-1.45716809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263091-15	NCGC00263091-15	377020489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1431697-85-6				-5.1977792831	4	4		0	-1.21589142				CDK1	ClC1=C(C(=O)NC2=C[NH]N=C2C(=O)NC3CCNCC3)C(=CC=C1)Cl	MedChem Express	HY-50940A	-1.2299613	-0.5052825	-1.13735783	-1.21589142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346499-02	NCGC00346499-02	384568804		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	841205-47-8				-0.3577055379	4	4		0	-5.11805457				AR	C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	Selleck	S1174	3.35820896	-3.10825295	-4.19947507	-5.11805457												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370783-06	NCGC00370783-06	363677854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1285515-21-0				2.5470717874	4	4		0	0.11310618				LRRK2	FC1=NC=CC(=C1)C2=CC=C(OCC3=CC=CC=C3)C(=C2)C(=O)NC4=CC=CN=C4	Glixx	GLXC-05797	0.78772803	-0.22967386	0.87489064	0.11310618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015884-15	NCGC00015884-15	384567900		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	85409-38-7				-8.4440859109	4	4		0	-2.71454828				NISCH	C1C\N=C(\NC(C2CC2)C3CC3)O1	Selleck	S7548	-1.56163626	-2.80202113	-0.67074949	-2.71454828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159458-11	NCGC00159458-11	384568180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(134523-03-8)		7.0794578438	-5.15	6.9339306433	4	4		14.439632548	10.88646967	0.1422897569	0.9874068314			CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C([N]1CC[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4	SynKinase	SYN-3020	-0.81536761	-1.33210841	-2.44969379	10.88646967												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346487-03	NCGC00346487-03	384568796		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	875320-29-9				-22.7346193973	4	4		0	-6.72981762				HDAC1	C[N]1C=C(CNCC2CCN(CC2)C3=NC=C(C=N3)C(=O)NO)C4=CC=CC=C14	Selleck	S1096	-3.60696517	-6.23181749	-5.92009332	-6.72981762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016759-08	NCGC00016759-08	384567957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	22204-53-1				0.3292374581	4	4		0	5.90163934				PTGS2	COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O	MedChem Express	HY-15030	-1.61785216	1.5566532	-1.48574894	5.90163934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095186-11	NCGC00095186-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	148553-50-8				-0.7229042736	4	4		0	-1.49161925					CC(C)C[C@H](CN)CC(O)=O	MedChem Express	HY-17414	-1.67674546	-0.95799558	7.64456982	-1.49161925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00270540-05	NCGC00270540-05	384568703		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	72432-03-2				-7.6170317788	4	4		0	-0.17942584				GAA	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Selleck	S2589	-2.97316896	1.95509394	-1.79861418	-0.17942584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390660-02	NCGC00390660-02	363680961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1627503-67-6		11.220184543	-4.95	27.2972570198	3	4		56.6812014439	41.8361244	0.0766695498	0.9963592008		ACVR1	COC1=C(OC)C(=CC(=C1)C2=CC(=CN=C2C)C3=CC=C(C=C3)N4CCNCC4)OC	Glixx	GLXC-05339	-2.91515591	0.39712846	4.57024915	41.8361244												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351594-01	NCGC00351594-01	384569013		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	301356-95-6	BCL6 Inhibitor			8.2043943626	4	4		0	3.19976077				BCL6	OC(=O)CC(N1C(=S)SC(/C1=O)=C2\C(=O)NC3=C2C=C(Br)C=C3)C(O)=O	EMD Chemicals	197345	2.53807107	-0.36658011	-0.58970957	3.19976077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346939-07	NCGC00346939-07	384568973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1144035-53-9				-5.072078213	4	4		0	-0.66234913				PDE2A	ClC1=CC(=CC(=C1)COC(=O)N2CCN(CC2)CCC(=O)C3=CC=C4NC(=O)OC4=C3)Cl	MedChem Express	HY-13344	-1.13714207	-0.7785071	-1.61531558	-0.66234913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346722-06	NCGC00346722-06	384568933		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	851881-60-2				-0.6594615346	4	4		0	-3.22352609				GRM5	FC1=CC=C(C=C1)C(=O)N2CCC[C@@H](C2)C3=NC(=NO3)C4=CC=C(F)C=C4	MedChem Express	HY-13058	0.53897181	0.5052825	0.02916302	-3.22352609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522492-01	NCGC00522492-01	384569521		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1462249-75-7				8.9322300447	4	4		0	4.80701258				PFKFB3	FC(F)(F)C1=CC=C2C=CC(=NC2=C1)\C=C\C(=O)C3=CC=NC=C3	MedChem Express	HY-12203	1.61691542	1.76083295	-0.02916302	4.80701258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242056-04	NCGC00242056-04	384568484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	862812-98-4				3.9399633401	4	4		0	-3.33663226				IKBKE	COC1=CC2=C(C=C1OC)[N](C=N2)C3=CC(=C(S3)C#N)OCC4=C(C=CC=C4)[S+](C)([O-])=O	Bio Vision	1811	3.27529022	-1.94457204	-0.8165646	-3.33663226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181098-02	NCGC00181098-02	384568389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	121032-29-9		1.5848931925	-5.8	10.9689294305	4	4		12.373963512	1.69659268	1	0.9995854394		HPRT1	[CH3][O]C1=NC(=NC2=C1N=C[N]2[CH]3[O][CH]([CH2][OH])[CH]([OH])[CH]3[OH])[NH2]	APExBIO	A1379	-1.56163626	-0.68902159	10.67366579	1.69659268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475728-01	NCGC00475728-01	384569231		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1296270-45-5				-11.1880049388	4	4		0	-5.74013855				PIK3CA	C[C@@H](NC1=CC(F)=CC(F)=C1)C2=CC(=CC3=C2OC(=CC3=O)N4CCOCC4)C(=O)N(C)C	ActiveBioChem	A-1610	-1.83803206	-0.99525341	-2.15806358	-5.74013855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378579-06	NCGC00378579-06	384569051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1005342-46-0		12.5892541179	-4.9	29.7894243247	3	4		46.8823071749	42.04722183	0.047909232	0.9985825162		XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(F)C=C4	MedChem Express	HY-15518	-0.42841349	0.5052825	-1.28317294	42.04722183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346551-05	NCGC00346551-05	384568836		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	19171-19-8				0.9742098236	4	4		0	2.51661247				TNF	NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1	MedChem Express	HY-10984	0.04145937	-1.33210841	-0.11665209	2.51661247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390775-03	NCGC00390775-03	384569213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	73069-13-3				-0.1650385979	4	4		0	-4.63404071				TNF	CC/1=C/2C[C@H]3C(=C)CCC[C@]3(C)/C=C2OC1=O	MedChem Express	HY-N0201	2.74360062	-2.62715748	-2.6770943	-4.63404071												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346835-01	NCGC00346835-01	174007481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	13395-35-2	2-Iminobiotin			-7.8793050862	4	4		0	-2.81408581			339345	NOS2	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12	SIGMA	I4632	-0.93457944	-2.43183493	-1.60789845	-2.81408581												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378941-04	NCGC00378941-04	384569076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	329773-35-5				2.5200572889	4	4		0	4.56712287				GUCY1A2	OC(=O)CCCCN(CCC1=C(OCC2=CC=C(CCC3=CC=CC=C3)C=C2)C=CC=C1)CC4=CC=C(C=C4)C(O)=O	MedChem Express	HY-14181	0.46728972	-0.2210759	-2.76445698	4.56712287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00273985-04	NCGC00273985-04	363677309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	915363-56-3				-5.79790357	4	4		0	-5.98185453				MAP3K8	CCN1CCC(CC1)[N]2C=C(CNC3=CC(=C4N=CC(=C(NC5=CC=C(F)C(=C5)Cl)C4=C3)C#N)Cl)N=N2	MedChem Express	HY-32018	-1.7042331	0.60427413	3.7235543	-5.98185453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378976-03	NCGC00378976-03	384569081		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1229705-06-9		10	-5	-5.5780561729	4	4		15.7076782159	10.02355019	0.0482891579	0.9985695583		MDM2	COC1=C(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]2C3=C(F)C(=CC=C3)Cl)C4=CC=C(Cl)C=C4F)C=CC(=C1)C(O)=O	Aobious	AOB87132	-3.3566242	-3.92306518	-2.51271313	10.02355019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250397-04	NCGC00250397-04	384568546		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	284028-89-3				-3.6504086617	4	4		0	-0.16190757				TNKS	OC1=NC(=NC2=C1CSCC2)C3=CC=C(C=C3)C(F)(F)F	XcessBio	M60010-2s	-2.58939581	2.88505572	1.52557583	-0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090903-01	NCGC00090903-01	144204588		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine			10.3738586183	4	4	Salazosulfapyridine;LS-46;SULFASALAZINE;Sulfasalazina;HS_159;SALAZOSULFAPYRIDINE;HS_1313;Sulfasalazine;Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-;HS_1312;sulfasalazine;Salazopyrine;Azulfidine;Salazosulfapiridina;AB07936213-01;Salazosulfapyridinum;Sulfasalazinum;4-(pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene;Salicylazosulfapyridine;sulfasalazinum;NCGC00090903-02;CIPLUS_684989;NCGC00016518-01;CIPLUS_155048;NCGC_Prestw-520;NCGC00090903-03;Sulfasalazine DR;Sulphasalazine, N-;	0	0.39740948			4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	NIEHS	AB07936213	4.5622688	-1.11433369	-1.13670356	0.39740948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016899-11	NCGC00016899-11	384567966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	85416-75-7				-8.9733805194	4	4		0	-2.93056157				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)[C@@H]3CNC(=O)C3	MedChem Express	HY-16900A	-2.14962523	0.91645028	-2.76733343	-2.93056157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386321-01	NCGC00386321-01	384569126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	236392-56-6				-4.7179133885	4	4		0	2.0452099				RRM1	NC(=S)N/N=C/C1=NC=CC=C1N	Selleck	S7470	-2.47388675	-1.25276345	1.35401975	2.0452099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-18	NCGC00244253-18	384568508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	941678-49-5				-13.4772656505	4	4		0	-3.4906966				JAK1	N#CC[C@H](C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	Selleck	S1378	-2.88620121	-1.25276345	-3.75176305	-3.4906966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015823-23	NCGC00015823-23	384567895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	36322-90-4				-5.0528754633	4	4		0	0.23066277				PTGS1	CN1\C(=C(\O)C2=C(C=CC=C2)[S+]1([O-])=O)C(=O)NC3=CC=CC=N3	Microsource	01500491	-2.44639912	0.86956522	0.59238364	0.23066277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351606-08	NCGC00351606-08	384569020		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1370261-97-4		8.9125093813	-5.05	47.0110421189	3	4		69.4335441662	63.24865281	0.011812682	0.9999139445		SYK	N[C@H]1CCCC[C@H]1NC2=NC=C(C(N)=O)C(=N2)NC3=CC=CC(=C3)[N]4N=CC=N4	MedChem Express	HY-15323	-1.18326525	-0.5164034	4.46365311	63.24865281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389231-01	NCGC00389231-01	377020350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	920113-03-7		1.77827941	-5.75	27.0144432562	4	4		14.606548616	11.40712393	0.4564349909	0.8450838133		CDK4	CN1CCC(C1CO)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	APExBIO	B1430	2.64419784	-1.75545718	18.54621597	11.40712393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095188-04	NCGC00095188-04	174007264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE			1.300234004	4	4		0	7.31527819					COC1=C(OC)C(=NC=C1)C[S+]([O-])C2=NC3=CC(=CC=C3[NH]2)OC(F)F	Microsource	MS-01505818	-2.09617756	0.29003206	1.40592282	7.31527819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015874-05	NCGC00015874-05	170466085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	6151-30-0		1	-6	153.9788758303	2.4	4		71.912354176	-5.60788931	1	0.9999593831		PLA2G5	Cl.Cl.O.O.CCN(CC)CCCC(C)Nc1c3cc(OC)ccc3nc2cc(Cl)ccc12	Specs	AT-084/J177276	7.38457323	30.27018776	78.79150464	-5.60788931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179435-05	NCGC00179435-05	384568373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	3778-73-2	 Isofamide (Ifosfamide?);Ifosfamide; Asta Z 4942; Ifosfamida;; Holoxan; Iso Endoxa;IFOSFAMIDE; Iphosphamide; Iso-Endoxan; Ifosfamide Sterile			4.9612133588	4	4		0	4.43037975					ClCCN[P]1(=O)OCCCN1CCCl	Microsource	MS-01505480	1.13714207	0.7785071	-2.57253964	4.43037975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092276-11	NCGC00092276-11	384568101		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					6.3598741973	4	4		0	1.72210774				ROCK1	C[C@@H](N)C1CC[C@@H](CC1)C(=O)NC2=CC=NC=C2	Tocris	1254_CM	0.72612687	2.12181346	2.48279988	1.72210774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094112-11	NCGC00094112-11	384568126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	667463-62-9				-3.2163177131	4	4		0	-6.48188249				GSK3B	O\N=C1\C(NC2=CC=CC=C12)=C3\C(=O)NC4=CC(=CC=C34)Br	MedChem Express	HY-10580	1.01824353	1.52741714	-2.91773199	-6.48188249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345802-09	NCGC00345802-09	384568750		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1316214-52-4				-11.9255135785	4	4		0	-5.70232424				HDAC6	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-16026	-1.66878801	-1.58851382	-3.27868852	-5.70232424												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024928-14	NCGC00024928-14	124886964		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	10540-29-1	Soltamox; "Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife	6.3095734448	-5.2	83.21444721	2.3	4		109.9917741206	101.35700881	0.0620097574	0.9976208606	2099	ESR1	CCC(/C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(C)C)C=C3	SIGMA	T5648	-2.31933248	-0.33603177	64.12994435	101.35700881												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263089-07	NCGC00263089-07	363677197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	722544-51-6				-7.4404176849	4	4		0	-5.09600115				AURKB	CCN(CCO)CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=N[NH]C(=C3)CC(=O)NC4=CC(=CC=C4)F	ChemieTek	CT-A1152H	-0.53740631	1.069192	-4.30139871	-5.09600115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178520-13	NCGC00178520-13	384568357		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	611-75-6		8.9125093813	-5.05	84.8813399995	3	4		103.6111824031	100.25985275	0.0312548948	0.9993970177			CN(CC1=C(N)C(=CC(=C1)Br)Br)C2CCCCC2	MedChem Express	HY-B0372A	2.54560882	-0.36658011	5.29402918	100.25985275												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263125-03	NCGC00263125-03	384568608		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	914913-88-5				2.7842339699	4	4		0	0.30316154				MTOR	COC1=CC=C(COC2=C(OC)C=C3C(=C2)OC(=O)C4=C3C=CC(=C4)C(C)O)C=C1	Axon Medchem	1718	1.75364163	-0.67206354	-2.07550008	0.30316154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247866-05	NCGC00247866-05	384568517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE		NCGC00247866-02; NCGC00247866-02			-0.1405547537	4	4		0	-1.98369983			641	BLM	O=C(NC1=NN=C(S1)C2=CC=NC=C2)NC3=CC(=C(C=C3)C4=C[NH]N=C4)C#N	NCGCChem	DJM11-083	0.57724024	-0.78113486	0.59238364	-1.98369983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017223-05	NCGC00017223-05	384567976		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	77-52-1				-1.5148650109	4	4		0	2.07596494				STAT3	C[C@@H]1CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	Cayman	10072	-0.82462892	-1.45910096	0.08462623	2.07596494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346883-02	6-Bromoindirubin-3'-acetoxime	384568960	GSK-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[667463-85-6]				1.3093483595	4	4		0	-2.2786759				GSK3B	CC(=O)O\N=C1\C(NC2=CC=CC=C12)=C3/C(=O)NC4=C3C=CC(=C4)Br	Tocris	3874	1.18326525	2.97691373	-2.98993907	-2.2786759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346705-02	PMSF	384568924	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	329-98-6				6.7301489403	4	4		0	1.015602					[O-][S+](F)(=O)CC1=CC=CC=C1	Selleck	S3025	2.1783806	3.00717448	-2.42297338	1.015602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188346-18	NCGC00188346-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1092351-67-1				-4.3533505739	4	4		0	-0.78010009					CC(C)N1N=C(C2=CC3=C(N2)C=CC(O)=C3)C4=C(N)N=CN=C14	Bio Vision	1658	-1.46595424	-2.6408182	2.60245289	-0.78010009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			-11.5327391553	4	4		0	1.41647421				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	-3.38075785	-2.67314702	-2.98993907	1.41647421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378599-01	NCGC00378599-01	384569054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1269440-17-6				1.6167232611	4	4		0	-1.41647421				BRAF	COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C2=C[N](N=C2C3=CC(=CC(=C3F)N[S+](C)([O-])=O)Cl)C(C)C	MedChem Express	HY-15605	-0.53528666	-0.60753341	6.39081763	-1.41647421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159360-03	NCGC00159360-03	384568172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	5593-20-4				1.8121300281	4	4		0	-0.89299461				NRC31	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CC\C4=C\C(=O)\C=C/C4(C)C3(F)C(O)CC12C	APExBIO	A8378	-0.19721087	1.73147023	2.53648859	-0.89299461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263160-06	NCGC00263160-06	384568632		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	649735-46-6		14.1253754462	-4.85	3.096098169	4	4		12.7442255959	9.23787529	0.3463490598	0.9186427446		KDR	C[C@@H](O)COC1=C[N]2N=CN=C(OC3=C(F)C4=C([NH]C(=C4)C)C=C3)C2=C1C	MedChem Express	HY-10337	0.05634596	-1.70109356	-3.95352133	9.23787529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390655-01	NCGC00390655-01	363680957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	420126-30-3				-13.2576580917	4	4		0	1.17013087					FC(F)(F)C1=CC=C(NC2=NC(=CS2)C3=C(N=C4C=CC=C[N]34)C(F)(F)F)C=C1	MedChem Express	HY-15961	-3.97239048	-3.7363305	-1.9696755	1.17013087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484080-02	NCGC00484080-02	384569271		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1192189-69-7				-7.261459378	4	4		0	-1.87836798				LIMK1	CN(C)C(=O)OC1=CC=CC(=C1)NC(=O)C2(CN)CCN(CC2)C3=C4C(=C[NH]C4=NC=N3)C	MedChem Express	HY-12659_cm2	-2.11297366	-2.03523694	1.37452175	-1.87836798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507889-01	NCGC00507889-01	384569353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1445993-26-9				-11.3405954596	4	4		0	-4.06466513				BRD4	CC[S+]([O-])(=O)NC1=CC(=C(OC2=C(F)C=C(F)C=C2)C=C1)\C3=C\N(C)C(=O)C4=C3C=C[NH]4	Selleck	S8400	-1.26778419	-3.88821385	-3.35836758	-4.06466513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250404-06	NCGC00250404-06	384568552		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	912445-05-7		0.5011872336	-6.3	59.2436231851	4	4		23	5.97141644	1	0.9999447145		PARP1	C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3[NH]2)C(N)=O	MedChem Express	HY-10130	4.11927878	18.67640483	24.66156563	5.97141644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142598-07	NCGC00142598-07	384568165		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	83-46-5				42.9135173591	4	4		0	2.85835574					CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C	Selleck	S2273	12.33009709	4.99329259	8.29899941	2.85835574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015790-18	NCGC00015790-18	384567891		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	167869-21-8				-5.8824051864	4	4		0	-3.30835572				MAP2K1	COC1=CC=CC(=C1N)\C2=C\C(=O)C3=C(O2)C=CC=C3	MedChem Express	HY-12028	-0.37313433	-0.62777523	-2.88713911	-3.30835572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242495-18	NCGC00242495-18	377020400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	717907-75-0				1.4166611467	4	4		0	4.24148169				PTK2	CN(C1=NC=CC=C1CNC2=NC(NC3=CC=C4NC(=O)CC4=C3)=NC=C2C(F)(F)F)[S+](C)([O-])=O	MedChem Express	HY-10459	0.95356551	-3.04700658	-2.94546515	4.24148169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384179-01	NCGC00384179-01	363679177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	n/a				-0.736834251	4	4		0	-0.45242471				VCP	[O-][S+]1(=O)/N=C(/NC2=CC(=CC=C2)NC(=O)CCl)C3=CC=CC=C13	XcessBio	M60148-2s	0.31785517	-1.14836932	-0.58326043	-0.45242471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510688-01	NCGC00510688-01	384569478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1210608-43-7(free base)		8.9125093813	-5.05	58.4915740893	3	4		90.3988575516	81.37989538	0.0328038259	0.9993357576		PIM1	C[C@@H]1C[C@H](N)C[C@@H](C1)C2=C(NC(=O)C3=CC=C(F)C(=N3)C4=C(F)C=CC=C4F)C=NC=C2	Selleck	S7985	-1.28524046	-3.65947022	5.01603966	81.37989538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015769-14	NCGC00015769-14	384567888		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	11018-89-6				12.1389656265	4	4		0	2.00664068			478	ATP1A3	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C/6=C/C(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Prestwick	Prestw-NAT-0107	2.23447886	3.20757599	3.85020304	2.00664068												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263143-07	NCGC00263143-07	384568618		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1134156-31-2				-6.8688755948	4	4		0	3.75673595				HSPA2	NC1=NC=NC2=C1N=C(NCC3=CC(=C(Cl)C=C3)Cl)[N]2[C@@H]4O[C@H](COCC5=CC=C(C=C5)C#N)[C@@H](O)[C@H]4O	DC Chemicals	DC8299	-2.59191435	-1.21506683	-3.159983	3.75673595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346482-01	NCGC00346482-01	174006230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	16208-51-8	Dimesna			-5.1449884558	4	4		0	-2.0939184					[O-][S+](=O)(CCSSCC[S+]([O-])(=O)O[Na])O[Na]	Selleck	S1201 	-1.60585998	0.33414338	0.41093949	-2.0939184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168085-26	NCGC00168085-26	384568346		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	149647-78-9				-15.1622564948	4	4		0	-6.36762417				HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	MedChem Express	HY-10221	-2.45492372	-1.08809062	-4.82636845	-6.36762417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164549-12	NCGC00164549-12	384568251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	115256-11-6				2.5328444519	4	4		0	-1.66973256					CN(CCOC1=CC=C(N[S+](C)([O-])=O)C=C1)CCC2=CC=C(N[S+](C)([O-])=O)C=C2	MedChem Express	HY-B0232	-0.62413315	1.80354747	5.88581519	-1.66973256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346692-03	NCGC00346692-03	384568914		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1339928-25-4				-23.2929694994	4	4		0	-6.56015835				PIK3CA	COC1=CC=C(C=N1)C2=NC3=C(SC(=C3)CN(C)C4=NC=C(C=N4)C(=O)NO)C(=N2)N5CCOCC5	XcessBio	M60077-5s	-3.96627971	-5.98683203	-5.83260426	-6.56015835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345818-01	NCGC00345818-01	174006826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	192939-46-1	Ximelagatran			4.436890302	4	4		0	5.61570666					CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)N(C)C3=CC=C(C=C3)\C(N)=N\O	SantaCruz Bio	sc-208491 	0.36769905	-0.51932183	-0.48127538	5.61570666												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238452-05	NCGC00238452-05	384568465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	170364-57-5				-2.3309214805	4	4		0	4.89389346				PRKCA	C[N]1C=C(C2=CC=CC=C12)\C3=C(\C(=O)NC3=O)C4=C[N](C5CCN(CC5)CC6=NC=CC=C6)C7=C4C=CC=C7	Axon Medchem	1682	-1.44251167	-1.25248205	-2.04542036	4.89389346												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386237-01	NCGC00386237-01	384569118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	960203-27-4				-10.0387077235	4	4		0	-6.53962754				HTR1D	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C	Selleck	S8021	-1.55564984	-2.04673896	0.36095653	-6.53962754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167487-12	NCGC00167487-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	90357-06-5				-3.9721740386	4	4		0	-4.40306049					C[C@](O)(C[S+]([O-])(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	ChemieTek	CT-BIC	0.16970725	-1.98564228	0.39103625	-4.40306049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522278-02	NCGC00522278-02	384569514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	38101-59-6				-5.140705577	4	4		0	0.83140878				FLT1	N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=CC=CC=C12)C(O)=O	MedChem Express	HY-13718	-2.47922243	0.09113001	0.72268669	0.83140878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505919-02	NCGC00505919-02	384569318		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1799633-27-4				4.8111977335	4	4		0	-1.0469592				MCL1	CN1CCN(CCOC2=C(Cl)C(=C(C=C2)C3=C(SC4=C3C(=NC=N4)O[C@@H](CC5=CC=CC=C5OCC6=CC=N[N]6CC(F)(F)F)C(O)=O)C7=CC=C(F)O7)C)CC1	ChemieTek	CT-S63845	0.61980561	3.79708384	1.94133484	-1.0469592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507844-01	NCGC00507844-01	384569325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	136553-81-6				-7.9615478882	4	4		0	-0.15396459				EDNRA	CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CC3=C[NH]C4=C3C=CC=C4)NC1=O)C(C)C	Selleck	S7883	-2.31018453	-0.75941677	-2.02635681	-0.15396459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162249-09	NCGC00162249-09	384568221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	118427-55-7		10	-5	30.100196869	3	4		42.0938230834	36.45881447	0.0869612837	0.9953107863		ALOX5AP	CC(C)C1=CC=C2[N](CC3=CC=C(Cl)C=C3)C(=C(SC(C)(C)C)C2=C1)CC(C)(C)C([O-])=O	Cayman	10133	0.98605437	-2.00486027	2.47980728	36.45881447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387801-02	NCGC00387801-02	384569162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1352066-68-2				-13.3051722267	4	4		0	0.67921324				MDM2	CC(C)[C@@H](C[S+]([O-])(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)C2=CC=CC(=C2)Cl)C3=CC=C(Cl)C=C3	MedChem Express	HY-12296	-3.75866852	-3.20465047	-2.82519129	0.67921324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164626-07	NCGC00164626-07	384568269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	145821-59-6				8.4460096345	4	4		0	0				SLC6A1	CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3	MedChem Express	HY-B0696A	3.63460475	-2.12831113	0.93321668	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091112-15	NCGC00091112-15	384568094		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	548-62-9		0.4466835922	-6.35	3.6668872564	4	4		-13.451494156	-6.62624513	0.046305893	0.9986869253		TNFR1	CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C/3\C=C/C(/C=C3)=[N+](C)C	MedChem Express	HY-B0324A	6.25088389	-4.39896136	-6.10618138	-6.62624513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168785-05	NCGC00168785-05	384568349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	101831-37-2		11.220184543	-4.95	13.6495482133	2.4	4		38.3131427	29.74595843	0.0264625094	0.9995683736			ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	Selleck	S2028	-2.76095225	-2.06561361	-0.12753295	29.74595843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015389-07	NCGC00015389-07	124879993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL			14.7318066792	4	4	HS_1197;AB08007493-01;Propofol (2,6-diisopropylphenol);LS-996;2,6-Diisopropylphenol;Propofol;propofol HP-beta-CD;Diprivan;NCGC00015389-01;2,6-DIISOPROPYLPHENOL;ici 35868;NCGC00015389-02;propofol;Propofol(2,6-Diisopropylphenol);propofolum;NCGC00091538-06;NCGC00091538-03;NCGC00091538-02;PROPOFOL;NCGC00091538-05;NCGC00091538-04;DIPRIVAN;propofol hydroxypropyl-beta-cyclodextrin;2,6-Bis(Isopropyl)-phenol;NCGC_Prestw-931;CIPLUS_159631;Phenol, 2,6-bis(1-methylethyl)-;Dipravan;	0	-0.09237875			7442	TRPV1	CC(C)C1=CC=CC(=C1O)C(C)C	Tocris	Tocris_0939	5.15565573	-1.2454435	3.58509282	-0.09237875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263208-09	NCGC00263208-09	384568667		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	877877-35-5		0.5623413252	-6.25	76.763614634	1.2	4		32.2884533719	34.2719683	0.0067352268	0.9999720645		BCL2L1	CC(C)C1=CC=CC=C1CC2=CC(=C(O)C(=C2O)O)C(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)C4=C(C=CC=C4)C(C)(C)C	MedChem Express	HY-12020	4.39667129	23.47592786	33.63743378	34.2719683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379220-07	NCGC00379220-07	384569095		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1359164-11-6				-8.9126939919	4	4		0	2.74217586				RORC	OC(C1=CC(=C(C=C1)C2=CC=C(CN3CCN(CC3)CC4=CC=NC=C4)C=C2)F)(C(F)(F)F)C(F)(F)F	SIGMA	SML1170	-3.51464435	-2.90375692	0.06064281	2.74217586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346714-02	NCGC00346714-02	384568928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1001264-89-6				-5.4378565375	4	4		0	-5.09687034				AKT1	CC(C)NC[C@@H](C(=O)N1CCN(CC1)C2=C3[C@H](C)C[C@@H](O)C3=NC=N2)C4=CC=C(Cl)C=C4	XcessBio	M60066-5s	-0.61366806	2.09549469	-2.1831413	-5.09687034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015529-22	Ibuprofen lysine	384567862	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	15687-27-1				-0.7617496976	4	4		0	2.26527571				PTGS1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	APExBIO	A8446	-0.30683403	-0.32929202	-2.06185567	2.26527571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142400-07	NCGC00142400-07	384568162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	474-25-9				-3.8416581341	4	4		0	-0.1587989				NR14H	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Selleck	S1843	-1.10309716	1.77180388	-3.06813055	-0.1587989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346941-01	NCGC00346941-01	174006381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	439574-61-5	ITK inhibitor			-2.4973543466	4	4		0	2.03349282			3702	ITK	COC1=C(C=C(SC2=CN=C(NC(=O)C3=CC=C(CNC(C)C(C)C)C=C3)S2)C(=C1)C)C(=O)N4CCN(CC4)C(C)=O	Chemscene	CS-0048	-1.05873822	-2.32167405	0.44228218	2.03349282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390584-01	Exatecan	384569198	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	169869-90-3				-20.9935816443	4	4		0	-3.94736842				TOP1	CC[C@@]1(O)C(=O)OC/C2=C1/C=C3\N(CC4=C5[C@@H](N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O	MedChem Express	HY-13631A	-4.7715736	-4.46005804	-3.92156863	-3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263570-06	NCGC00263570-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	127373-66-4 (free acid)				-5.9044648151	4	4		0	-2.9007177					CC(C)(C)C(=O)OC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC=C2C(=O)NCC(O)=O	SIGMA	S7198	-1.75489485	0.12219337	0.94353531	-2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242480-02	NCGC00242480-02	384568492		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	873054-44-5		3.1622776602	-5.5	36.7780794424	4	4		24.673056364	-6.54904306	1	0.9633372336		CFTR	CC(C)(C)C1=CC(=C(NC(=O)C/2=C/NC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C	Selleck	S1144	3.26323423	-0.97754697	20.13858175	-6.54904306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522572-01	NCGC00522572-01	384569526		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1428569-85-0				-4.283688122	4	4		0	1.47806005				PIM1	C[N]1N=CC(=C1N2CC[C@@H](N)[C@H](F)CC2)NC(=O)C3=C(N)SC(=N3)C4=C(F)C=CC=C4F	MedChem Express	HY-16976	-1.29595718	-1.88335358	-1.0911152	1.47806005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384181-05	NCGC00384181-05	384569103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1423715-09-6 		1.1220184543	-5.95	69.8479687428	4	4		26.4970284453	34.61157493	0.1613464422	0.9836175362			CC(=N/NC(=O)C1=CC=CC(=C1)[S+]([O-])(=O)N2CCOCC2)\C3=CC(=CC=C3O)Cl	Glixx	GLXC-90051	5.95006935	11.10448651	30.0765156	34.61157493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263236-02	NCGC00263236-02	384568680		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	957135-43-2				6.3133619899	4	4		0	-1.04712042				XIAP	CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](C3=CC=CC=C3)C4=C[N](CCCCC5=CC=C(CCCC[N]6C=C(N=N6)[C@@H](NC(=O)[C@@H]7CC[C@@H]8CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N78)C9=CC=CC=C9)C=C5)N=N4	APExBIO	A8815	0.73509015	2.78730064	4.67922307	-1.04712042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346500-08	NCGC00346500-08	384568805		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	372196-77-5				31.9410636239	4	4		0	7.0342772				PIK3CA	CN(/N=C/C1=CN=C2C=CC(=C[N]12)Br)[S+]([O-])(=O)C3=C(C)C=CC(=C3)[N+]([O-])=O	MedChem Express	HY-13281	9.26080893	-0.47897021	4.8211037	7.0342772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187912-13	NCGC00187912-13	384568446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	936563-96-1				-15.7683559218	4	4		0	-4.99401914				BTK	NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCN(C5)C(=O)C=C	Selleck	S2680	-2.74111675	-2.84099588	-4.3638508	-4.99401914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180796-04	NCGC00180796-04	384568384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	5119-48-2		1.2589254118	-5.9	85.5099915834	3	4		45.5402476763	-6.30980861	1	0.9999630706		NFKB1	C[C@H]([C@H]1C\C(=C(CO)/C(=O)O1)C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)\C=C/C(=O)[C@]6(C)[C@H]4CC[C@]23C	SIGMA	W4394	3.37926033	8.88956774	48.85743771	-6.30980861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378621-01	NCGC00378621-01	384569058		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	775351-61-6				3.7521094936	4	4		0	2.63467766				PRKAA1	C[C@@H]\1/N=C(/N)NC(=N1)\N(C)C	MedChem Express	HY-14771A	1.1919441	0.29003206	-2.09392761	2.63467766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346879-04	NCGC00346879-04	384568957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	113906-27-7				7.2922314884	4	4		0	-3.79227395				TCF4	CC1=CC=C(O1)/C=N/NC(=O)C2=C(OC3=CC=CC=C3)C=CC=C2	Enzo	WN101	2.78779473	1.65449396	2.64861683	-3.79227395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016973-08	NCGC00016973-08	384567970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[112809-51-5]				-0.8504792279	4	4		0	1.31147541				CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Tocris	4382	-1.50627615	2.09549469	0.78835658	1.31147541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263109-15	NCGC00263109-15	384568596		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1032754-93-0				-11.5218081443	4	4		0	2.3835153				MTOR	C[C@H](O)C(=O)N1CCN(CC1)CC2=C(C)C3=C(S2)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	Bio Vision	2668	-2.9686641	-3.75829035	-4.42877292	2.3835153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015096-27	NCGC00015096-27	384567808		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	19774-82-4		8.9125093813	-5.05	84.6254576593	3	4		105.6264744792	98.58526834	0.0284338879	0.9995010263			CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3	MedChem Express	HY-14188	1.92413414	-0.54532056	9.16784203	98.58526834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347067-04	NCGC00347067-04	384568982		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	19992-50-8				24.6277507021	4	4		0	8.28848224				MITF	N[S+]([O-])(=O)C1=CC=C(NC/2=C/C(=O)C3=CC=CC=C3C2=O)C=C1	Glixx	GLXC-03936	6.2946674	2.0486367	1.325811	8.28848224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263207-02	NCGC00263207-02	384568666		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[944328-88-5]				-1.0444306536	4	4		0	4.65938797				ARF1	OC[C@H](CC1=CC=CC=C1)NC2=NC(=NC3=C2N=C[N]3CC4=CC=C(C=C4)C5=CC=CC=C5)OC6=CC7=C(CCC7)C=C6	Tocris	3324	-2.11654755	0.01473839	1.24118477	4.65938797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025330-09	NCGC00025330-09	384568068		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1431697-90-3				4.1837792305	4	4		0	-1.76435407				HCRTR1	CN(C)C1=CC=C(NC(=O)NC2=CC(=NC3=C2C=C(F)C=C3F)C)C=C1	MedChem Express	HY-76612	0.88469906	2.59660913	3.18443167	-1.76435407												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00386314-03	NCGC00386314-03	363680205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1337532-29-2		0.1995262315	-6.7	4.5157340717	4	4		10.732414796	-4.00717703	1	0.597801814		EIF2AK3	C[N]1C=C(C2=C(F)C3=C(C=C2)N(CC3)C(=O)CC4=CC=CC(=N4)C)C5=C(N)N=CN=C15	MedChem Express	HY-13820	-2.27701233	10.26424316	2.1819254	-4.00717703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023193-11	NCGC00023193-11	384568016		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	76-25-5				-0.2697492755	4	4		0	1.16626794				NRC31	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	MedChem Express	HY-B0636	-0.85569253	-0.30548343	1.79861418	1.16626794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508871-01	NCGC00508871-01	384569368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	849675-66-7				0.539157958	4	4		0	-0.35885167				ABCBA	COC1=C(OC)C=C2CN(CCC3=CC=C(C=C3)[N]4N=NC(=N4)C5=CC(=C(OC)C=C5NC(=O)\C6=C\C(=O)C7=CC=CC=C7O6)OC)CCC2=C1	Bio Vision	B1285	4.27846265	0.06109669	-1.26787557	-0.35885167												1.6E-9	8E-9	4E-8	2E-7											
NCGC00025001-03	NCGC00025001-03	384568042		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1104				-6.8383056697	4	4		0	-3.05023923				ADORA3	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=C(Cl)N=C3NCC4=CC=CC(=C4)I	Tocris	1104	-0.10152284	-3.05483428	-3.09597523	-3.05023923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381605-01	NCGC00381605-01	384569101		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-15.5332004635	4	4		0	-1.85406699				PRKCA	C[N]1C=C(C2=CC=CC=C12)/C3=C(/C(=O)NC3=O)C4=C[N](C)C5=CC(=CC=C45)[N+]([O-])=O	Angene	AGN-PC-0LQ2UY	-3.46627991	-3.3603177	-4.21642341	-1.85406699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351598-04	NCGC00351598-04	384569016		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	211555-04-3				-18.812736417	4	4		0	-5.25463644				EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=C(O)C(=C3)Br	Selleck	S2867	-3.71283737	-2.91558541	-4.8160335	-5.25463644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386131-05	NCGC00386131-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	649735-63-7		14.1253754462	-4.85	18.8844956663	4	4		17.878894028	15.25399745	0.4074453502	0.881793779			C[C@H](COC1=CN2N=CN=C(OC3=C(F)C4=C(NC(C)=C4)C=C3)C2=C1C)OC(=O)[C@H](C)N	APExBIO	A2633	3.98058252	-1.98241169	-1.85403178	15.25399745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347958-03	NCGC00347958-03	384569001		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1421227-52-2		15.8489319246	-4.8	18.8688110961	4	4		-22.976154996	-6.64679583	0.6652380238	0.5629414303			CN1CCN(CC1)CC2=CC=C(NC(=O)NC3=CC=C(OC4=CC(=NC=N4)NC(=O)C5CC5)C=C3)C=C2C(F)(F)F	Selleck	S7441	0.44630404	18.97919473	13.49302608	-6.64679583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509937-01	NCGC00509937-01	384569386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1197996-80-7		2.8183829313	-5.55	13.1711094648	4	4		20.235967668	-5.03725782	1	0.997314003		NFKB1	CC(C)NCC[N]1C2=C(C=C(C=C2)C(C)=O)C3=C1C=CC(=C3)C(C)=O	ChemGood	C-1118	-2.14783821	-3.11330639	14.40266828	-5.03725782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484061-01	NCGC00484061-01	363681154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	916151-99-0		0.4466835922	-6.35	11.0516128551	4	4		11.819406264	4.69014301	0.8244336972	0.6960545428	9314		CC1=C(C2=NC3=C([NH]2)C4=CC=CN=C4C5=NC=CC=C35)C6=C([NH]1)C=CC(=C6)F	MedChem Express	HY-16291	-1.09950522	41.48857775	11.90409027	4.69014301												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00510073-01	NCGC00510073-01	384569407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1000009-73-3				-3.2982192938	4	4		0	0.26141781				INPP5D	CC1=CC(=CC2=C1[C@]3(C)CC[C@H]4C(C)(C)CCC[C@]4(C)[C@H]3C2)O	Glixx	GLXC-01973	-2.19901045	-1.75386883	1.26939351	0.26141781												1.6E-8	8E-8	4E-7	0.000002											
NCGC00351482-12	NCGC00351482-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1201438-56-3				-3.1149572533	4	4		0	-5.17344498					C[C@H](NC1=C2N=CNC2=NC=N1)C3=CC4=C(C(Cl)=CC=C4)C(=O)N3C5=CC=CC=C5	Bio Vision	2445	1.11675127	0.09164503	-3.09597523	-5.17344498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160670-08	Mecarbinate	384568202	antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	15574-49-9				1.1010032719	4	4		0	2.25198705					CCOC(=O)C1=C(C)[N](C)C2=CC=C(O)C=C12	MedChem Express	HY-B0376	-1.08234005	2.73240727	0.38887227	2.25198705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160428-03	NCGC00160428-03	384568195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[204205-90-3]				-15.4983163511	4	4		0	-3.63556079				TUBB	ClC1=CC=C(C[N]2C=C(C(=O)C(=O)NC3=CC=NC=C3)C4=CC=CC=C24)C=C1	Tocris	3728	-3.74023839	-1.45016028	-3.17080467	-3.63556079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263192-04	Silmitasertib	384568656	Casein Kinase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1009820-21-6 (parent)				13.7324275199	4	4		0	4.31262879				CSNK2A1	OC(=O)C1=CC2=C(C=C1)C3=CN=CC=C3C(=N2)NC4=CC=CC(=C4)Cl	Axon Medchem	1965	1.60295931	4.96107465	4.21776847	4.31262879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025228-15	NCGC00025228-15	384568060		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	82-08-6		7.0794578438	-5.15	11.1084174095	4	4		12.949375868	9.8768926	0.263336613	0.9554259037			CC(=O)C1=C(O)C(=C(O)C(=C1O)C)CC2=C(O)C(=C3OC(C)(C)\C=C/C3=C2O)C(=O)/C=C/C4=CC=CC=C4	Cayman	12006	-0.37447989	2.60843643	4.09064155	9.8768926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476170-03	NCGC00476170-03	384569240		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1448347-49-6				2.6148526427	4	4		0	6.81464725				IDH1	FC1=CN=CC(=C1)N([C@H](C(=O)NC2CC(F)(F)C2)C3=C(Cl)C=CC=C3)C(=O)[C@@H]4CCC(=O)N4C5=NC=CC(=C5)C#N	NCGCChem	JMR014-047_1st_pos	-0.20729685	-0.07655795	-2.71216098	6.81464725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522470-01	NCGC00522470-01	384569519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1333146-24-9				-5.8804444549	4	4		0	-6.84292379					CNC(=O)CCC1=N[N](C2=CC=C(C=C2)N3CCNCC3)C(=C1)C4=CC=C(C=C4)C5=CC=C(C=C5)C(F)(F)F	MedChem Express	HY-18676	1.06412383	-2.06706477	-2.91630213	-6.84292379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345492-06	PCI-34051	384568736	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	950762-95-5				-3.4573642603	4	4		0	3.45752608				HDAC8	COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1	Selleck	S2012	-2.78940028	-0.05987128	1.60703457	3.45752608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024683-28	NCGC00024683-28			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	20554-84-1		14.1253754462	-4.85	13.6559939596	4	4		24.472803344	20.17883756	0.2584373793	0.9565371187			C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	MedChem Express	HY-N0141	-1.22733612	3.32285586	-0.8793208	20.17883756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163548-03	NCGC00163548-03	384568246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	512-64-1		3.5481338923	-5.45	-0.0959542698	4	4		-9.6870342759	-4.73919523	0.7156496368	0.440081391			CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)C3=NC4=CC=CC=C4N=C3)NC(=O)C5=NC6=CC=CC=C6N=C5	SIGMA	SML4077	-1.58995816	11.34560695	-0.60642814	-4.73919523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094082-08	NCGC00094082-08	384568123		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	362-07-2				6.6928721125	4	4		0	-2.93062201					COC1=C(O)C=C2CC[C@@H]3[C@H](CC[C@]4(C)[C@@H](O)CC[C@@H]34)C2=C1	Selleck	S1233	3.87237128	1.03864365	-2.47678019	-2.93062201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263086-08	NCGC00263086-08	363677195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	501437-28-1				-7.682176522	4	4		0	-3.97727273				RPS6KA1	CC(C)CCN1C(C)C(=N)N(C)C2=C1N=C(NC3=CC(=C(O)C(=C3)F)F)N=C2	MedChem Express	HY-10510	-1.40681653	-1.86344891	0.26536931	-3.97727273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510489-01	NCGC00510489-01	384569451		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1257213-50-5				2.5311872388	4	4		0	0.98616426					C[C@@H](OC(=O)NC1=C(ON=C1C)C2=CC=C(C=C2)C3=CC=C(C=C3)C4(CC4)C(O)=O)C5=CC=CC=C5	MedChem Express	HY-100619	-0.23290862	-1.84704625	5.26473228	0.98616426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015848-05	NCGC00015848-05	384567898		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1986-47-6				8.7694936741	4	4		0	3.53456808				MAOA	N[C@@H]1C[C@H]1C2=CC=CC=C2	Adooq	A13358	1.67219458	0.99525341	1.66229221	3.53456808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345826-04	NCGC00345826-04	363677373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1438391-30-0				-7.0915845407	4	4		0	-3.56284462				MAPK8	C1CCN(CC1)CCOC2=CC(=CC=C2)C3=N[NH]C4=CC=C(C=C34)C5=N[NH]C=N5	MedChem Express	HY-13022	-1.34051962	-0.5052825	-0.93321668	-3.56284462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346808-03	NCGC00346808-03	384568942		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE		GNF 2	11.220184543	-4.95	38.5764123063	3	4		72.1287347128	63.00014138	0.032710855	0.9993395943	25	ABL1	NC(=O)C1=CC(=CC=C1)C2=NC=NC(=C2)NC3=CC=C(OC(F)(F)F)C=C3	NCGCChem	AED003-034	-1.86567164	-3.87383249	-1.48731409	63.00014138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346931-02	NCGC00346931-02	384568967		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	761437-28-9				-7.8742289597	4	4		0	-0.82001979				PTK2	CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=CC=C(C=C3OC)N4CCOCC4	Selleck	S2820	-1.03648425	-2.37329659	-4.22863809	-0.82001979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00489906-01	NCGC00489906-01	384569286		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			14.1253754462	-4.85	0.7570090464	4	4		-11.36885246	-6.55737705	0.6228017173	0.6471634454		MCL1	C[C@@H]1CN(C(=O)C2=C(CCCOC3=CC(=C(Cl)C(=C3)C)C)C4=CC=C(Cl)C(=C4[N]12)C5=C(C)[N](C)N=C5C)C6=C[N](C)C7=C6C=C(C=C7)C(O)=O	Vanderbilt	VU0661013	-0.05578801	0.71845532	7.58035173	-6.55737705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016410-25	NCGC00016410-25	384567938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	148-79-8				9.4805386764	4	4		0	8.01788376				METAP1	[NH]1C2=C(C=CC=C2)N=C1C3=CSC=N3	MedChem Express	HY-B0263	2.14783821	-1.82607394	-1.03092783	8.01788376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488781-01	NCGC00488781-01	363681475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1443763-60-7				6.0244428414	4	4		0	-3.75558867				TTK	COC1=CC(=CC=C1NC2=N[N]3C=C(C=CC3=N2)C4=CC=C(NC(=O)[C@H](C)C5=CC=C(F)C=C5)C=C4)[S+](C)([O-])=O	MedChem Express	HY-12858	4.51882845	-2.90375692	-0.97028502	-3.75558867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015697-01	NCGC00015697-01	11111487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	529-44-2	Myricetin;MYRICETIN			1.6646477534	4	4	myricetin 3-O-(2''-O-galloyl)-beta-D-glucopyranoside;myricetin 3-O-neohesperidoside;NCGC00094083-01;myricetin 7-O-glucopyranosyl-(1-6)-glucopyranoside;NCGC00094083-03;Cannabiscetin;myricetin 7-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside;3,3',4',5,5',7-Hexahydroxyflavone;myricetin 3-O-(2'',3''-di-O-galloyl)rhamnopyranoside;myricetin 3-O-(4''-acetyl)rhamnopyranoside;myricetin 3-O-(2'',3'' -di-O-galloyl)-alpha-rhamnopyranoside;myricetin 3-O-(2''-O-galloyl)-alpha-rhamnopyranoside 7-methyl ether;myricetin 7-O-rhamnopyranosyl-(1-6)-glucopyranoside;myricetin;CIPLUS_154027;m(G)-Glu;MYRICETIN;NCGC00094083-04;NCGC_Prestw-465;myricetin 7-O-alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranoside;myricetin 3-O-(3''-galloyl)rhamnopyranoside 7-methyl ether;3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one;myricetin-DGR;myricetin-2 cpd;NCGC00015697-02;myricetin 3-O-(2''-O-galloyl)rhamnopyranoside 7-methyl ether;Myricetin;NCGC00015697-01;myricetin-3 cpd;myricetin 3-O-(4''-acetyl)-alpha-L-rhamnopyranoside;myricetin 3-O-(3''-galloyl)-alpha-rhamnopyranoside 7-methyl ether;	0	3.99403875			1544	CYP1A2	OC1=CC2=C(C(=C1)O)C(=O)\C(=C(/O2)C3=CC(=C(O)C(=C3)O)O)O	SigmaAldrich	Lopac-M-6760	-0.66945607	1.52671756	-0.97028502	3.99403875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386231-04	NCGC00386231-04	384569117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1186486-62-3				-2.1800254372	4	4		0	1.07655502				CETP	C[N]1N=NC(=N1)N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)[C@H]3CCCN(C[C@H]4CC[C@@H](CC4)C(O)=O)C5=C3C=C(C)C=C5C	MedChem Express	HY-13327	-1.1457578	0.12219337	-0.20639835	1.07655502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386425-01	NCGC00386425-01	384569137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1073154-85-4				-0.5145815331	4	4		0	4.96411483				PTK2	CNC(=O)C1=CC=C(NC2=NC(=C(C=N2)C(F)(F)F)NCC3=C(N=CC=N3)N(C)[S+](C)([O-])=O)C=C1	Selleck	S7654	-0.42059463	-2.44386742	-2.06398349	4.96411483												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263217-05	NCGC00263217-05	384568671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	362003-83-6		14.1253754462	-4.85	13.8732447778	4	4		26.212692832	20.48444976	0.1280481066	0.9897767492		CERK	O=C(NC1=CC2=C(C=C1)N=C(NC(=O)C3=CC=CC=C3)S2)C4C5CC6CC(C5)CC4C6	MedChem Express	HY-13945	0.36258158	-2.26057736	-1.12044818	20.48444976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532324-01	NCGC00532324-01	384569538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1476074-39-1				-1.9605218772	4	4		0	2.23384702				PRKDC	CNC(=O)C1=CC=NC2=C(C=CC=C12)[C@H](C)CNC3=NC=NC(=C3)C4=C(N=C(C)N=C4[2H])[2H]	Astatech	41568	-0.40077391	-2.6795284	-1.04986877	2.23384702												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345844-02	NCGC00345844-02	363677387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(1251752-12-1)				-9.0838011674	4	4		0	-4.35458787				TYK2	CC(C)(C)NC(=O)NC1=CC=CC(=C1)NC2=NC(=C(F)C=N2)NC(C)(C)CO	SynKinase	SYN-1130	-1.11940299	-1.97519522	-2.27471566	-4.35458787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263909-08	NCGC00263909-08	384568699		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	171596-29-5				-5.6692558698	4	4		0	-3.64767425					CN1CC(=O)N2[C@H](CC3=C([NH]C4=C3C=CC=C4)[C@H]2C5=CC6=C(OCO6)C=C5)C1=O	DC Chemicals	DC5901	0.51133223	-1.79145613	-4.28696413	-3.64767425												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095158-04	NCGC00095158-04	170466630		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	3366-95-8	Secnidazole;SECNIDAZOLE			-6.405310834	4	4		0	0.11922504					Cc1ncc([N+]([O-])=O)n1CC(O)C	Vitas	STK590474	-2.84518828	-0.89806915	2.00121286	0.11922504												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015420-15	NCGC00015420-15	384567841		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	518-82-1		2.2387211386	-5.65	-0.4236316937	4	4		17.645684444	9.85698908	0.0255841966	0.999599374		CSNK2A1	CC1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(O)C=C3O)C2=O	Microsource	01500898	-4.28807037	-0.84008843	5.3596615	9.85698908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346566-10	Roflumilast	384568843	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	162401-32-3				-9.4193421062	4	4		0	-1.52237429				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	MedChem Express	HY-15455	-2.74876306	-0.33898305	-1.46685472	-1.52237429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386747-06	NCGC00386747-06	363680432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1616632-77-9				-12.1445412784	4	4		0	-3.95202214				TNFSF10	CC1=CC=CC=C1CN2C(=O)C/3=C(/CCN(CC4=CC=CC=C4)C3)N\5CC\N=C25	Glixx	GLXC-04984	-2.22649808	-1.48857774	-3.52609309	-3.95202214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092314-06	NCGC00092314-06	363676559		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	35943-35-2				3.8544733088	4	4		0	-0.26141781				AKT1	CN1\N=C(N)/C2=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C4=C2C1=NC=N4	Selleck	S1117	1.37438153	1.90125276	-1.12834979	-0.26141781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181033-02	NCGC00181033-02	174006814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	103300-74-9	 ;Taltirelin; Taltirelin; Taltirelin Anhydride; Ceredist;TA-0910			-1.0892824072	4	4		0	0.79174325			7201	TRHR	CN1C(=O)C[C@@H](NC1=O)C(=O)N[C@@H](CC2=CN=C[NH]2)C(=O)N3CCC[C@H]3C(N)=O	SantaCruz Bio	sc-204319 	-0.15201769	0.04593477	-1.89559638	0.79174325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024728-02	NCGC00024728-02	384568033		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[142523-38-4]				-8.8482094233	4	4		0	-2.6014421				INPPL1	CC(OC1=CC=C(O)C=C1)([P](O)(O)=O)[P](O)(O)=O	Tocris	0681	-1.72747374	-1.69958659	-1.86643336	-2.6014421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016000-21	NCGC00016000-21	384567915		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	97-77-8				-5.4003233101	4	4		0	-0.41865165				ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Selleck	S1680	-2.23447886	0.82480525	0.06015942	-0.41865165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510490-01	NCGC00510490-01	384569452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1207253-08-4				-5.0111084384	4	4		0	-2.12213079				HCRTR1	COC1=C(OC)N=C(CNC(=O)C2=CC(=CN=C2C3=NC=CC=C3)C4=CC(=CN=C4)Cl)C=C1	MedChem Express	HY-19914	-1.07481261	-0.70261188	-0.2707174	-2.12213079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390643-01	NCGC00390643-01	384569204		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1234015-54-3				-18.4828335426	4	4		0	-5.76656928				CHEK1	COC1=CC=CC(=C1C2=CC(=N[NH]2)NC3=NC=C(N=C3)C#N)OCCCN	MedChem Express	HY-18174A	-3.38097856	-2.90346352	-5.02115656	-5.76656928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186009-04	NCGC00186009-04	363677107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	648449-76-7		12.5892541179	-4.9	45.2900920734	3	4		67.0483750846	57.61354888	0.048554317	0.9985435196		PIK3CG	FC1(F)OC2=C(O1)C=C(C=C2)\C=C\3SC(=O)NC3=O	Selleck	S2681	1.26778419	-1.0328068	-0.41093949	57.61354888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022304-23	ACETYLCYSTEINE			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	616-91-1				1.495321182	4	4		0	-0.55427252					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	1.18326525	0.57715674	-2.16806008	-0.55427252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345798-03	NCGC00345798-03	384568747		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1271022-90-2				-2.0175998957	4	4		0	-1.04503974				JAK2	CC[N]1C(=CC2=C3[N](C)C=NC3=C(NC4=N[N](C)C(=C4)C)N=C12)C(=O)N(C5CC5)C6CC6	ChemieTek	CT-BMS911_cm1	0.3973147	-1.72492749	-1.49566258	-1.04503974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346821-04	NCGC00346821-04	384568943		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	179528-45-1				4.7639905114	4	4		0	1.41382723				CAPN1	OC(=O)/C(S)=C/C1=CC=C(I)C=C1	Cayman	13859	0.92592593	0.22967386	1.69145523	1.41382723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507864-01	NCGC00507864-01	384569339		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1382979-44-3		12.5892541179	-4.9	4.3790262746	4	4		17.0895728039	12.80927471	0.3001617229	0.9402637928		PIK3CA	CC1(C)OCC[N]2C3=C(N=C12)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	Selleck	S8163	0.12437811	-4.24131067	-3.64537766	12.80927471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522520-01	NCGC00522520-01	384569524		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1449277-10-4		1.5848931925	-5.8	35.6931226917	4	4		26.8925126319	23.27159621	0.1832641086	0.9787228351		MAP4K4	NC1=C2N=C(C=CC2=C(C=N1)C(=O)NC3CN(C3)C(=O)C4CC4)C5=CC=CC(=C5)F	MedChem Express	HY-100343	-0.04145937	-1.57709386	27.90901137	23.27159621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186030-12	NCGC00186030-12	384568437		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	648450-29-7				2.3268568606	4	4		0	-0.56301429				PIK3CG	O=C1NC(=O)C(/S1)=C/C2=CC=C3N=CC=NC3=C2	SIGMA	A0233	0.39598359	1.16083702	1.32350729	-0.56301429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346581-05	NCGC00346581-05	384568850		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	905586-69-8				-17.6832848791	4	4		0	-4.74953082				JAK2	C[C@H](NC1=NC(=C(F)C=C1C#N)NC2=N[NH]C(=C2)C)C3=CC=C(F)C=C3	Axon Medchem	1778	-2.51732428	-4.8571865	-6.1663408	-4.74953082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510484-01	NCGC00510484-01	384569447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	848259-27-8				-2.3730071661	4	4		0	1.66017035				PPARA	CC[C@@H](OC1=CC=CC(=C1)CN(CCCOC2=CC=C(OC)C=C2)C3=NC4=CC=CC=C4O3)C(O)=O	MedChem Express	HY-17618	-0.65054448	-1.71070719	-1.0828696	1.66017035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511348-01	NCGC00511348-01	384569496		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	2055172-43-3				-0.2631795094	4	4		0	-0.99610221				ABHD11	CCC1CCCCN1C(=O)[N]2N=CC(=N2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	Glixx	GLXC-02169	1.01824353	-1.52741714	-1.50398556	-0.99610221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386665-06	NCGC00386665-06	384569144		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1037624-75-1		1	-6	133.4106920527	2.4	4		73.1288163616	-5.93330446	1	0.9999545594		AXL	NC1=NC(=N[N]1C2=NN=C3C(=C2)CCCC4=CC=CC=C34)NC5=CC=C6CC[C@@H](CCC6=C5)N7CCCC7	MedChem Express	HY-15150	3.84669778	31.03711624	70.44668371	-5.93330446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250377-09	NCGC00250377-09	384568537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	503468-95-9		1.4125375446	-5.85	84.0930393132	2.4	4		33.3981801816	0.33203407	1	0.9997502856		PRKDC	O=C1\C=C(OC2=C(C=CC=C12)C3=CC=CC4=C3SC5=C4C=CC=C5)\N6CCOCC6	MedChem Express	HY-11006	7.41055013	10.26424316	40.09625508	0.33203407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249392-05	NCGC00249392-05	377020517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	332012-40-5		3.1622776602	-5.5	28.6474233792	4	4		19.5	-2.9594341	1	0.9846000258		KDR	CNC(=O)C1=NC=CC(=C1)COC2=NN=C(NC3=CC=C(Cl)C=C3)C4=C2OC=C4	MedChem Express	HY-10527	2.20619431	0.12219337	15.85200782	-2.9594341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507856-01	NCGC00507856-01	384569334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1675201-83-8				-1.0259183556	4	4		0	2.99861602					COC1=CC(=CC(=C1CN2CCCC[C@H]2C(O)=O)OC)OCC3=C(C)C(=CC=C3)C4=CC=CC=C4	Selleck	S7911	-1.53930731	0.10316875	0.84626234	2.99861602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263131-05	NCGC00263131-05	384568611		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1196109-52-0				-2.6952382367	4	4		0	-2.15550423				FAAH	FC(F)(F)C1=CN=C(OC2=CC(=CC=C2)CC3CCN(CC3)C(=O)NC4=CC=CN=C4)C=C1	APExBIO	A4374	0.19721087	-0.69866343	-1.57290633	-2.15550423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161408-07	NCGC00161408-07	384568206		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	58579-51-4				9.0596403522	4	4		0	1.97074673				PDE3A	ClC1=CC=C2N/C3=N/C(=O)CN3CC2=C1Cl	MedChem Express	HY-B0523A	2.56374137	-0.42527339	1.91299419	1.97074673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373041-02	NCGC00373041-02	384569046		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	259793-96-9				3.2971065277	4	4		0	8.16012317					NC(=O)C1=NC(=CN=C1O)F	Adooq	A11590	-1.40864911	-0.15188335	1.28949979	8.16012317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263136-07	NCGC00263136-07	384568614		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	929016-96-6				-19.7583958478	4	4		0	-5.54901384				HDAC1	CCCCC1=NC2=CC(=CC=C2[N]1CCN(CC)CC)/C=C/C(=O)NO	Axon Medchem	1777	-3.46622825	-4.13677301	-5.53395154	-5.54901384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346888-03	UK-383367	363677552	Procollagen C-Endopeptidase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	348622-88-8		14.1253754462	-4.85	24.6814985442	4	4		28.620400832	24.56579335	0.2150729647	0.9704006538			NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO	Selleck	S2224	2.91820797	0.56479927	-2.18366736	24.56579335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188863-06	NCGC00188863-06	384568452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	141625-93-6				-2.285752256	4	4		0	-5.54901384				ADRA1A	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C2=C(CCCC)OC3=C2C=C(N[S+](C)([O-])=O)C=C3	MedChem Express	HY-75839	1.5755583	-2.79346665	-0.29913252	-5.54901384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167519-07	NCGC00167519-07	363676664		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	116649-85-5				-6.2292731524	4	4		0	-0.67863707				PTGDR2	OC(=O)CC[N]1C2=C(C[C@@H](CC2)N[S+]([O-])(=O)C3=CC=C(F)C=C3)C4=CC=CC=C14	ChemieTek	CT-RAM	-1.00884467	-1.73020977	-2.77048702	-0.67863707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016569-10	NCGC00016569-10	384567950		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1197-18-8				1.5443419443	4	4		0	-0.16965927				SERPINE1	NC[C@H]1CC[C@@H](CC1)C(O)=O	APExBIO	B1858	-0.40077391	0.78089113	2.97462817	-0.16965927												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346488-03	NCGC00346488-03	384568797		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	869363-13-3				-11.1559345264	4	4		0	-5.41359896				AURKA	OC(=O)C1=CC=C(NC2=NC3=C(C\N=C(/C4=CC(=CC=C34)Cl)C5=C(F)C=CC=C5F)C=N2)C=C1	Selleck	S1100	-0.98995899	-1.80235222	-4.75259438	-5.41359896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022398-13	NCGC00022398-13	384568010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	356-12-7				-4.3737989192	4	4		0	1.58388436				NRC31	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4C[C@H](F)C/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C	MedChem Express	HY-B0485	-1.89664651	1.48857774	-2.51057828	1.58388436												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356145-10	CB-839	384569029	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1439399-58-2				-14.9731352418	4	4		0	-4.10579732				GLS	FC(F)(F)OC1=CC=CC(=C1)CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4)S3)C=C2	MedChem Express	HY-12248	-3.73831776	1.90125276	-5.27503526	-4.10579732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095986-04	NCGC00095986-04	363676578		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	19685-09-7				-15.6260231871	4	4		0	-3.48837209				TOP1	CC[C@@]1(O)C(=O)OCC/2=C1/C=C3\N(CC4=CC5=CC(=CC=C5N=C34)O)C2=O	Selleck	S2423	-2.31538567	-4.99160434	-5.17499252	-3.48837209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181773-01	NCGC00181773-01	144206591		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	198470-85-8	PARECOXIB; Dynastat; 			0.2832667683	4	4	Parecoxib;N-[4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, sodium salt;PROPANAMIDE, N-((4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)PHENYL)SULFONYL)-;N-((P-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)PHENYL)SULFONYL]PROPIONAMIDE;PARECOXIB;CIPLUS_696533;CIPLUS_696534;parecoxib sodium;PARECOXIB Na;PARECOXIB NA;N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide;N-((4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYL)SULFONYL)PROPANAMIDE SODIUM;parecoxibum;Pharmacia brand of parecoxib sodium;SC-69124A;N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt;Dynastat;parecoxib;Parecoxib sodium;PARECOXIB SODIUM;	0	1.86625194					[Na+].CCC(=O)[N-]S(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	Apin	40118p	-0.62189055	-0.68902159	1.370662	1.86625194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347279-01	NCGC00347279-01	174006684		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	873305-35-2	AIM-100			-4.4356765201	4	4		0	-4.38286441			10188	TNK2	C1CO[C@@H](C1)CNC2=NC=NC3=C2C(=C(O3)C4=CC=CC=C4)C5=CC=CC=C5	Axon Medchem	2031	1.34051962	-2.64890522	-3.90784485	-4.38286441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263944-01	NCGC00263944-01	174006252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	25389-94-0	KANAMYCIN A SULFATE			-3.2408931271	4	4		0	-0.31104199					NC[C@H]1O[C@H](O[C@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	Microsource	MS-01500360	-0.62189055	-1.94457204	-0.08748906	-0.31104199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346537-04	NCGC00346537-04	384568826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	862507-23-1		1.4125375446	-5.85	130.6054462476	3	4		93.8288282908	33.22493991	1	0.9998151841		MAPK14	CC(C)(C)C[N]1C(=NC2=C1N=C(C=C2)C3=C(N=C([NH]3)C(C)(C)C)C4=CC=C(F)C=C4)N	APExBIO	A5566	-1.58927584	5.16000612	90.60950714	33.22493991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016497-13	NCGC00016497-13	384567946		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	536-33-4				-5.4427456789	4	4		0	-2.67070882					CCC1=NC=CC(=C1)C(N)=S	Microsource	01500292	-1.61221892	3.69634947	-2.73725372	-2.67070882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263142-04	NCGC00263142-04	363677226		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	393105-53-8		12.5892541179	-4.9	32.8682453783	3	4		58.0842604039	48.9822434	0.0346404489	0.9992594734		SERPINE1	OC(=O)C(=O)C1=C[N](CC2=CC=CC=C2)C3=CC=C(C=C13)C4=CC=C(OC(F)(F)F)C=C4	Glixx	GLXC-04469	-1.30108895	0.06109669	-0.66175365	48.9822434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507869-01	LY-3314814	384569343	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1383982-64-6				17.8975004473	4	4		0	8.83756736				BACE1	CO[C@H]1CC[C@]2(CC1)CC3=C(C=C(C=C3)C4=CN=CC(=C4)C#CC)[C@@]2/5\N=C(C)/C(=N5)N	Selleck	S8193	3.69066066	-0.5164034	3.18832365	8.83756736												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161602-23	NCGC00161602-23			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	10592-13-9				-1.6984862838	4	4		0	1.47806005					[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]4(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]4([H])[C@H]2O	APExBIO	A8420	-0.05634596	-2.43013366	-1.37452175	1.47806005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521067-01	NCGC00521067-01	384569504		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	509080-74-4				-6.1668421755	4	4		0	0.67921324				ICAM1	CN1C(=O)N(C(=O)[C@]12CN(C[C@H]2C3=CC=C(C=C3)C#N)CC4=CC(=CS4)C(O)=O)C5=CC(=CC(=C5)Cl)Cl	Key Organics	HE-0001	-2.51040222	-0.7601729	0.38257799	0.67921324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378921-05	NCGC00378921-05	384569075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1206799-15-6				8.8318006667	4	4		0	6.33394599				MET	C[N]1N=CC2=C1C=C(C(=C2)OC3=CC=C(NC(=O)\C4=C\C=C(\C)N(C4=O)C5=CC=C(F)C=C5)C=C3F)C6=C[NH]N=C6	MedChem Express	HY-15514	-1.42343836	7.85484612	3.20793234	6.33394599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263197-03	NCGC00263197-03	363677258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(1338247-35-0)				-0.6452062639	4	4		0	-4.04354588				LIMK1	CC(C)C(=O)NC1=NC=C(S1)C2=CC(=N[N]2C3=C(Cl)C=CC=C3Cl)C(F)F	SynKinase	SYN-1024	0.56661139	2.52641249	-1.19568387	-4.04354588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378623-01	NCGC00378623-01	384569059		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	110417-88-4				-1.9362526434	4	4		0	0.24541649				TUBB	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	MedChem Express	HY-15580	-0.05656908	-3.81854284	0.99263047	0.24541649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095118-08	NCGC00095118-08	363676573		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	162011-90-7				-13.0234638418	4	4		0	-2.21709007				PTGS2	C[S+]([O-])(=O)C1=CC=C(C=C1)C/2=C(/C(=O)OC2)C3=CC=CC=C3	ChemieTek	CT-RX001	-3.155374	-2.33900365	-2.39478532	-2.21709007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015442-19	NCGC00015442-19	384567846		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	51-21-8				-7.1320148799	4	4		0	-3.1130607				TYMS	F\C1=C\NC(=O)NC1=O	Selleck	S1209	-1.73370319	2.57862573	-3.11948205	-3.1130607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346438-02	NCGC00346438-02	384568777		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	857402-63-2		2.8183829313	-5.55	20.4034117079	4	4		21.8190169999	-2.85593101	1	0.9996476287			CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=CC(=C2O)NC(=O)C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C\[C@H](C)[C@H]1O)/C)/C)O	MedChem Express	HY-10210	-1.42343836	-1.5158475	17.35199767	-2.85593101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022858-10	NCGC00022858-10	384568015		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	15826-37-6		0.316227766	-6.5	22.331564009	4	4		-14.739502328	-1.86625194	0.0997732421	0.993887419			OC(COC1=C2C(=O)\C=C(/OC2=CC=C1)C([O-])=O)COC3=C4C(=O)\C=C(/OC4=CC=C3)C([O-])=O	Prestwick	Prestw-812	9.30071863	0.81151432	-0.84572762	-1.86625194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164634-07	NCGC00164634-07	384568272		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	80573-04-2		15.8489319246	-4.8	9.5111899348	4	4		10.4503904479	7.40845469	0.5848972	0.7075999925		ADORA1	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C2=CC=C(O)C(=C2)C(O)=O	MedChem Express	HY-B0667	2.8883361	-3.29199204	-1.57480315	7.40845469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498437-01	NCGC00498437-01	384569300		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1821428-35-6		3.5481338923	-5.45	46.1381979478	3	4		43.792942662	39.64371554	0.0074700352	0.9999656089		ATM	CN(C)CCCOC1=NC=C(C=C1)C2=CC3=C(C=C2)N=CC4=C3N(C5CCOCC5)C(=O)N4C	ChemieTek	CT-A0156	-0.51133223	-0.38278977	8.57392826	39.64371554												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510505-01	WT-161	384569466	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1206731-57-8				-13.8281692957	4	4		0	-6.51075502				HDAC1	ONC(=O)CCCCCCC(=O)N\N=C\C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-100871	-1.58393438	-1.71070719	-5.32410889	-6.51075502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092357-04	NCGC00092357-04	174007250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	84485-00-7	;Sibutramine hydrochloride;SIBUTRAMINE HYDROCHLORIDE; Meridia			-12.9384321303	4	4		0	-2.20874838			3350	HTR1A	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2	Microsource	MS-01505210	-2.71531608	-2.10783565	-4.12092044	-2.20874838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522303-03	NCGC00522303-03	384569516		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	834153-87-6				0.8888288903	4	4		0	0.76982294				GNRHR	COC1=C(F)C(=CC=C1)C/2=C(C)/N(CC3=C(F)C=CC=C3C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C4=CC=CC=C4)C2=O	Glixx	GLXC-10786	1.26778419	-2.58201701	-1.60124699	0.76982294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263165-02	NCGC00263165-02	363677239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	586379-66-0				2.3671627571	4	4		0	-0.86220169				MAPK14	CNC(=O)C1=CC=C(C)C(=C1)N2C(=C/C(=C(/Br)C2=O)OCC3=C(F)C=C(F)C=C3)\C	Selleck	S2726	-0.22538386	6.16646416	-1.0344339	-0.86220169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163553-03	NCGC00163553-03	363676623		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	518-17-2				-4.83662132	4	4		0	-3.78752887					CN1C2N(CCC3=C2[NH]C4=C3C=CC=C4)C(=O)C5=C1C=CC=C5	Selleck	S2382	0.90153543	-2.94653706	-3.2166643	-3.78752887												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250373-04	NCGC00250373-04	384568535		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	844499-71-4				1.8681445025	4	4		0	5.12239989				PRKAA1	OC1=C(C=CC=C1)C2=CC=C(C=C2)C3=CSC4=C3C(=C(/C#N)C(=O)N4)/O	XcessBio	M60020-5s	-1.92787795	3.50275749	0.7357269	5.12239989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346698-10	NCGC00346698-10	384568918		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1009298-59-2				0.3398262719	4	4		0	0.7641149				MTOR	CNC(=O)C1=CC=CC(=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOC[C@@H]4C)N5CCOC[C@@H]5C	MedChem Express	HY-15247	-1.62274619	1.62468326	3.97292525	0.7641149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263239-03	NCGC00263239-03	384568682		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	821794-92-7				-3.9111163543	4	4		0	-4.24148169				RPS6KA1	COCCNCCC[N]1C2=NC=NC(=C2C(=C1C(=O)CF)C3=CC=C(C)C=C3)N	Chemscene	CS-0648	1.00884467	-2.58765886	-2.15806358	-4.24148169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015646-03	NCGC00015646-03	90341211		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	7554-65-6	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			0.0041895104	4	4		0	-1.81678214			124	ADH1	CC1=C[NH]N=C1	SigmaAldrich	Lopac-M-1387	0.25355684	0.24301337	0.779368	-1.81678214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025325-03	Vapiprost hydrochloride	174006925	Prostanoid TP Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	87248-13-3	GR 32191 hydrochloride; Vapiprost hydrochloride;GR-32191B; 			-6.6132831421	4	4		0	0.09237875			6915	TBXA2R	O[C@H]1C[C@H](OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4	SIGMA	G5044	-2.14114664	-2.46051033	0.72268669	0.09237875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390577-02	NCGC00390577-02	384569196		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1474034-05-3		2.8183829313	-5.55	0.3082657038	4	4		-15.175109664	-6.39592472	0.6958484222	0.4913417388		NRF2	CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)\C=C\4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)NC(=O)C(C)(F)F	MedChem Express	HY-12212	-1.73370319	18.64659413	-5.03237198	-6.39592472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186460-03	NCGC00186460-03	384568440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	218600-53-4				-11.4977815143	4	4		0	-6.45252582				NFKB1	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)\C=C\4[C@@](C)(CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)[C@]3(C)CC2	APExBIO	A3221	-0.73509015	-1.71411537	-5.15008829	-6.45252582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351604-03	NCGC00351604-03	384569019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1396772-26-1				-7.0067581051	4	4		0	-4.89599547				EZH2	C/C1=C/C(=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C4CCCC4)C5=CC=C(CN6CCOCC6)C=C5)C(=O)N1)C	Selleck	S7004	-1.34535368	1.80354747	-1.67745733	-4.89599547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476094-01	NCGC00476094-01	384569239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	112924-45-5		10	-5	54.7005325412	2.4	4		74.3890755706	62.88382623	0.1264429943	0.9900102209			CCCCCCC(C)(C)C1=CC2=C([C@H]3CC(=C/CC3C(C)(C)O2)\CO)C(=C1)O	Cayman	10006350	-1.45631068	5.97704576	10.35903473	62.88382623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024994-12	NCGC00024994-12	384568038		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	14611-52-0		11.220184543	-4.95	6.8953499879	4	4		14.814840504	11.32022074	0.1875114349	0.9778965703		MAOB	C[C@H](CC1=CC=CC=C1)N(C)CC#C	MedChem Express	HY-14199	-1.09570042	0.93903711	0.82401413	11.32022074												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015199-24	NCGC00015199-24	384567821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	305-03-3				-8.1871635696	4	4		0	-3.8205745					OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl	MedChem Express	HY-13593	-1.98335645	-1.08809062	0.70629782	-3.8205745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346600-02	NCGC00346600-02	384568854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	19057-60-4		3.1622776602	-5.5	21.6906947736	4	4		14.90098788	-4.44113264	1	0.9432689015		PRDX1	C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5C/C=C6/C[C@H](CC[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O	Selleck	S2379	2.06415621	-1.1674899	11.91631292	-4.44113264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390633-02	NCGC00390633-02	384569202		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	918633-87-1				-2.4062344695	4	4		0	2.87281651					C[N]1C(=CN=C1[N+]([O-])=O)CO[P](=O)(NCCBr)NCCBr	MedChem Express	HY-10535	-2.37590157	3.91018787	-1.74462325	2.87281651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386398-03	NCGC00386398-03	363680254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1431697-89-0		0.2511886432	-6.6	49.4568929337	4	4		21	20.06578947	0.135831766	0.9884764985		MELK	CN(C)C[C@@H]1CC[C@H](CC1)NC2=C(C=NC3=CC=C(N=C23)C4=CC(=C(O)C(=C4)Cl)Cl)C(C)=O	Glixx	GLXC-05730	0.79767948	4.82663815	22.29102167	20.06578947												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00346579-03	NCGC00346579-03	363677461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	900185-01-5 				0.3178936026	4	4		0	-2.06339713				PIK3CA	CC1=C(C=CC=C1)N2\C(=N/C3=C(C(=CC=C3)C)C2=O)C[N]4N=CC5=C4N=CN=C5N	APExBIO	B2187	0.53662074	1.49686879	-0.79610792	-2.06339713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092290-11	NCGC00092290-11	384568103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	305350-87-2				-16.8773334986	4	4		0	-2.63157895				MAP2K1	NC(\SC1=CC=C(N)C=C1)=C(C#N)/C2=CC=CC=C2C(F)(F)F	MedChem Express	HY-15437	-4.19144307	-2.65770582	-3.36134454	-2.63157895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485933-01	NCGC00485933-01	363681426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1005780-62-0				-9.0733183216	4	4		0	-3.26404927				PDGFRB	C[N]1N=C(C)C=C1C(=O)NC2=CC(=CC=C2C)OC3=N[N]4C=C(NC(=O)C5CC5)N=C4C=C3	MedChem Express	HY-15506	-1.46499507	-1.91373026	-2.22474139	-3.26404927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015870-26	NCGC00015870-26	384567899		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	117-39-5	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal			-3.2124927739	4	4		0	6.12779061				CYP75A12	OC1=CC2=C(C(=C1)O)C(=O)\C(=C(/O2)C3=CC(=C(O)C=C3)O)O	Specs	AE-562/J257905	-2.33835752	-1.0328068	-1.57290633	6.12779061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00354729-02	NCGC00354729-02	384569023		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	630124-46-8				1.8838136882	4	4		0	6.09699769				FLT3	CCN1CCN(CC1)CC2=CC=C(NC(=O)NC3=CC=C(OC4=NC=NC(=C4)NC)C=C3)C=C2C(F)(F)F	MedChem Express	HY-15002	-0.56345964	-2.03523694	0.26923622	6.09699769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-25	MELOXICAM SODIUM		Neuropharmacol 39: 1653 (2000)	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	71125-38-7				2.1037406271	4	4		0	-1.66281755					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	MS-01504150	0.95788139	-2.97691373	4.26526853	-1.66281755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345539-10	NCGC00345539-10	384568737		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	404951-53-7				-18.2670655717	4	4		0	-6.14121975				HDAC1	OCCN(CCC1=C[NH]C2=C1C=CC=C2)CC3=CC=C(\C=C\C(=O)NO)C=C3	Glixx	GLXC-90143	-2.95423024	-3.80086451	-4.97351383	-6.14121975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165915-05	NCGC00165915-05	384568299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	546141-08-6				5.941493451	4	4		0	0.16980331				FAAH	NC(=O)C1=CC(=CC=C1)C2=CC=CC(=C2)OC(=O)NC3CCCCC3	Selleck	S2631	0.79056865	4.66537487	0.76515597	0.16980331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025225-03	NCGC00025225-03	384568059		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1216720-69-2]		3.1622776602	-5.5	35.9481857146	4	4		23.8805336081	-6.0563181	1	0.9009577811		PAR1	CC(C)C1=CC=C(C[N]2C=CC3=C4C(=NC(=NC4=CC=C23)NC5CC5)N)C=C1	Tocris	1592	4.14701803	-2.81711134	18.89346675	-6.0563181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390264-01	NCGC00390264-01	384569183		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	188968-51-6				-19.9221077883	4	4		0	-5.69299553					CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O	Adooq	A12372	-4.26778243	-2.90375692	-3.30503335	-5.69299553												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00183109-08	NCGC00183109-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	376348-65-1				-6.9260598372	4	4		0	0.29806259					CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	APExBIO	A8311	-2.67782427	1.5566532	-2.00121286	0.29806259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263228-01	NCGC00263228-01	137276072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1291779-76-4	FASN BI	1	-6	40.9284917473	4	4		23	21.16244411	0.2375025226	0.9635872443	2194	FAS	CCC(=O)N[C@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=C(O3)C=CC=C4	NCGCChem	FASN BI	0.66945607	6.64571172	26.83444512	21.16244411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165898-11	NCGC00165898-11	384568296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	627536-09-8		11.220184543	-4.95	18.6048606668	2.4	4		34.2218922359	25.1912805	0.0416669197	0.9989298778		TGBR1	FC1=C(C=C(Cl)C=C1)C2=NC3=NC=CN=C3C(=N2)NC4=CC=NC=C4	MedChem Express	HY-13227	-1.01824353	0.06109669	3.33884795	25.1912805												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-13	Valaciclovir	384568359	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	124832-27-5				-4.0449907186	4	4		0	1.4003176					CC(C)[C@H](N)C(=O)OCCOC[N]1C=NC2=C1\N=C(N)/NC2=O	MedChem Express	HY-17425A	-1.8667798	1.09974034	-1.56414498	1.4003176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507841-02	NCGC00507841-02	384569323		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1421438-81-4				-4.3721194545	4	4		0	-0.21654396					C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)C2=C(C=CC=N2)C3=C1C=CC=C3	MedChem Express	HY-12449	-1.44251167	1.86344891	-2.61693488	-0.21654396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164563-12	NCGC00164563-12	384568253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	142217-69-4				1.4759240499	4	4		0	-2.32423849					NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	SIGMA	SML1103	1.47079621	0.36658011	-1.14302903	-2.32423849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263227-02	NCGC00263227-02	384568679		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	256498-66-5				2.9677745197	4	4		0	3.8277512				GUCY1A2	NC1=C(N2CCOCC2)C(=NC(=N1)C3=N[N](CC4=C(F)C=CC=C4)C5=NC=CC=C35)N	Cayman	10011131	-1.02973169	3.23812433	-1.41530296	3.8277512												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00481317-01	CB-5083	363681118	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1542705-92-9				-2.6633010751	4	4		0	-5.89114833				VCP	CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC(=C4COCCC4=N3)NCC5=CC=CC=C5	ActiveBioChem	A-1513	1.75489485	1.68015885	-5.6022409	-5.89114833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507855-03	NCGC00507855-03	384569333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1239875-86-5				-5.4508136862	4	4		0	-6.51913876				AXL	CN1CCN(CC1)C2=CC=C(NC3=NC4=C(C(=C[NH]4)C)C(=N3)C5=CC(=CC=C5)CC#N)C=C2F	Glixx	GLXC-09295	1.31979695	-1.34412708	-4.30487985	-6.51913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386373-08	NCGC00386373-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	901119-35-5				-6.9822879141	4	4		0	-0.40030793					COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)N(COP([O-])([O-])=O)C4=N3)=N2)=CC(OC)=C1OC	Adooq	A11926	-1.49316805	-2.2782503	-1.82797223	-0.40030793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384193-03	NCGC00384193-03	384569104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	171927-40-5				0.2345906861	4	4		0	-2.30946882			4521	MTH1	COC1=CC=C2N=C3[NH]N=C(C)C3=C(NCCOCCO)C2=C1	Chemdea	CD0168	1.07057332	-1.91373026	0.80770866	-2.30946882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185000-18	NCGC00185000-18	384568423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	850140-73-7				-19.0887920326	4	4		0	-5.48113934				EGFR	CN(C)C\C=C\C(=O)NC1=CC2=C(NC3=CC(=C(F)C=C3)Cl)N=CN=C2C=C1O[C@H]4CCOC4	MedChem Express	HY-10261A	-3.83152557	-3.12879708	-4.32194984	-5.48113934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182059-11	NCGC00182059-11	384568409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	144060-53-7				9.3552162042	4	4		0	6.67893024				XDH	CC(C)COC1=CC=C(C=C1C#N)C2=NC(=C(S2)C(O)=O)C	MedChem Express	HY-14268	1.31761442	2.39976151	-0.97115951	6.67893024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	53-86-1				-4.1705526988	4	4		0	0.50940993				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	-2.0110957	-0.22358027	1.05944673	0.50940993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179511-08	NCGC00179511-08	384568376		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	81110-73-8				-0.498853359	4	4		0	-3.0564596					CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2	Microsource	01502331	1.51178918	-0.84960501	-2.11889347	-3.0564596												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356119-03	NCGC00356119-03	384569028		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1619994-68-1]				-2.7144143885	4	4		0	0.23845007				BAZ2B	CCCOC1=CC2=C(C=C([N]2C=C1)C(C)=O)C3=CC=CC=C3[S+](C)([O-])=O	Tocris	5635	-0.72524407	0.23948511	-1.72832019	0.23845007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183873-05	NCGC00183873-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	107007-99-8				-3.1266215355	4	4		0	-2.23546945					CN1N=C(C(=O)NC2C[C@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4	SIGMA	G3796	-0.55788006	1.10761862	-1.15221346	-2.23546945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-16	Ivermectin			DPI_SARS-CoV-2_General		70288-86-7		0.0157226828	-7.8034733462	-11.5415805637	4	10		-6.4308361	-4.52569675	0.6743272315	0.6528039037			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	0.58808489	-0.38353362	0.48580926	0.74149834	3.09383789	7.23600102	70.23779085	-3.70749169	-4.32114549	-4.52569675						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00379064-01	R-7128	377020456		DPI_SARS-CoV-2_General		940908-79-2				16.0135967947	4	10		0	5.27466521					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	-2.2137196	1.94042088	-1.66712216	2.70565728	-1.61246242	-0.73790653	-2.10440011	6.36786007	-1.33916371	5.27466521						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General		17321-77-6		0.0394935937	-7.4034733462	275.8704082626	1.1	20		93.0290806761	90.19029751	0.000278921	0.9919291032		SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00601698-01	Glecaprevir			DPI_SARS-CoV-2_General		1365970-03-1				1.0501097929	4	20		0	-0.1913091					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00345809-03	NCGC00345809-03	384568754		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	784211-09-2				90.150238862	4	4		0	25.83732057				CDK1	CC(C)C1=N[N](C\2=C1C(=O)N\C(=N2)CC3=CC=C(OCCO)C=C3)C4=C(Cl)C=CC=C4Cl	Cayman	21195	17.56345178	16.95433023	20.22703818	25.83732057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522578-01	NCGC00522578-01	384569527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1206123-37-6		11.220184543	-4.95	8.2644738032	4	4		12.2366530441	10.50038491	0.0690431188	0.9970855087		S1PR1	OC(=O)C[C@H]1CCC2=C1[NH]C3=CC=C(OCC4=CC=C(C5CCCC5)C(=C4)C(F)(F)F)C=C23	MedChem Express	HY-12789	-0.19721087	0.39489672	0.92107128	10.50038491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025060-22	NCGC00025060-22	384568045		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	59-05-2				-2.330521607	4	4		0	1.69361047				DHFR	CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O	MedChem Express	HY-14519	-1.29595718	0.85054678	-1.26115913	1.69361047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015981-12	NCGC00015981-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	330161-87-0				-5.5535272765	4	4		0	-0.80953783					CN(C)[S+]([O-])(=O)C1=CC2=C(NC(=O)\C2=C/C3=CC4=C(CCCC4)N3)C=C1	SIGMA	S9692	-0.83573092	-1.63333842	-2.39306013	-0.80953783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-08	Apixaban	363677453	Coagulation Factor Xa Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	503612-47-3				-2.8249259127	4	4		0	-0.53771049				F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	Glixx	GLXC-90058	-0.29126214	-0.31301237	-2.08946439	-0.53771049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346605-03	NCGC00346605-03	384568855		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	67920-52-9				1.86536007	4	4		0	3.70737229				NR1I2	OC(CC1=CC(=C(O)C=C1)O)C([O-])=O	APExBIO	N1804	-0.29126214	0.34282307	1.14773396	3.70737229												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00014873-05	NCGC00014873-05	384567794		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[502137-98-6]				-9.7263308736	4	4		0	-4.35171386				MDM2	CN(C)CCCN\C1=C\2C(=O)N(C)C(=O)\N=C2N(C)C3=C1C=CC=C3	Tocris	3503	-1.70153417	-1.31716809	-1.72832019	-4.35171386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346949-01	NCGC00346949-01	174007427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	n	ICRF-193			-2.4919448392	4	4		0	-0.78425342			7153	TOP2A	CC(C(C)N1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	SantaCruz Bio	sc-200889A	-1.37438153	2.52026529	-0.22566996	-0.78425342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345056-07	NCGC00345056-07	384568731		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	717824-30-1				-4.2810941	4	4		0	-3.45994157				DHODH	COC1=CC(=CC=C1)C2=CC=C(NC(=O)/C3=C(/CCC3)C(O)=O)C(=C2)F	Selleck	S7262	0.96206707	-2.66764923	-3.27221439	-3.45994157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378942-03	NCGC00378942-03	384569077		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	603288-22-8		12.5892541179	-4.9	38.1240484773	3	4		42.4996558181	39.1080365	0.1814992663	0.9791312865		GSK3B	FC1=CC2=C3[N](CCN(CC3=C1)C(=O)N4CCCCC4)C=C2C/5=C(C(=O)NC5=O)\C6=CN=C7C=CC=C[N]67	ActiveBioChem	A-1239	3.82244143	1.51121966	-2.75201914	39.1080365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483168-02	NCGC00483168-02	384569264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					6.1362762488	4	4		0	-0.16190757				PRMT5	O[C@@H](CNC(=O)C1=CC(=NC=C1)NC2CCC2)CN3CCC4=CC=CC=C4C3	SGC	GSK591	2.47979175	-0.13738361	0.02991325	-0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015202-21	NCGC00015202-21			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					4.6123795781	4	4		0	6.96202532					CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O	SigmaAldrich	C0330	-1.02753802	5.51060907	-2.60245289	6.96202532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263094-05	NCGC00263094-05	384568586		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	945595-80-2		12.5892541179	-4.9	23.4953027258	3	4		54.603763106	46.26042698	0.0515406216	0.998358673		AURKA	CC1=CSC(=C1)C2=NN=C(NC3=CC=C(OC4=C(C=CC=N4)C5=CC=NC(=N5)N)C=C3)C6=C2C=CC=C6	APExBIO	A4119	-2.08678828	-4.08819476	-4.14114902	46.26042698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167533-04	NCGC00167533-04	384568328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	224785-90-4				-2.6477474218	4	4		0	1.0745087				PDE5A	CCCC1=NC(=C2[N]1NC(=N\C2=O)/C3=CC(=CC=C3OCC)[S+]([O-])(=O)N4CCN(CC)CC4)C	Prestwick	Prestw-1356	-0.98120509	1.30148522	-2.65383494	1.0745087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160664-04	NCGC00160664-04	384568201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	4008-48-4		12.5892541179	-4.9	43.1226440491	3	4		39.2797366609	37.15537961	0.2207912252	0.9687016381		METAP2	OC1=CC=C(C2=C1N=CC=C2)[N+]([O-])=O	Microsource	01506173	6.23272526	-0.10718114	-0.69991251	37.15537961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021301-09	NCGC00021301-09	384568006		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	67-73-2				-5.6338960369	4	4		0	-1.0745087				NRC31	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	APExBIO	B2095	-0.51133223	-2.71015158	-2.3330417	-1.0745087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510486-01	NCGC00510486-01	384569448		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1236199-60-2				-13.0681181117	4	4		0	-5.48564965					C[N]1C(=NC2=CC(=CC=C12)N(CCCl)CCCl)CCCCCCC(=O)NO	MedChem Express	HY-101780	-1.97622996	-2.37329659	-3.23709536	-5.48564965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510268-01	NCGC00510268-01	384569425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1876467-74-1				-8.6838984717	4	4		0	-0.33203407				ATR	C[C@@H]1COCCN1C2=NC3=C(N=CC=C3C(=C2)C4=CC=N[N]4C)C5=CC=N[NH]5	ChemieTek	CT-BAY189	-1.47079621	-3.11593096	-3.57948564	-0.33203407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346838-01	NCGC00346838-01	174007232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	29388-59-8	Secoisolariciresinol			-6.4807029308	4	4		0	-0.73624946					COC1=CC(=CC=C1O)C[C@@H](CO)[C@H](CO)CC2=CC(=C(O)C=C2)OC	SIGMA	60372	-1.95163343	-2.01619062	0.66175365	-0.73624946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346456-07	NCGC00346456-07	384568781		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	441798-33-0				-7.7997645778	4	4		0	-2.87281651				EDNRA	CCCN[S+]([O-])(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3	MedChem Express	HY-14184	-1.75364163	0.27493508	-1.95518123	-2.87281651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274065-06	NCGC00274065-06	384568711		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	638-94-8				-1.920457883	4	4		0	-1.31370001					CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	MedChem Express	HY-B0248	1.07481261	-2.32167405	-2.9478117	-1.31370001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242490-05	NCGC00242490-05	384568496		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[212391-63-4]		1.4125375446	-5.85	43.1793441458	3	4		44.593500435	-5.7582756	1	0.9943882063		SRC	CCN(CC)CCOC1=CC=C(NC2=NC=C3\C=C(/C(=O)N(C)C3=N2)C4=C(Cl)C=CC=C4Cl)C=C1	Tocris	3785	-4.33863924	0.24301337	37.39549384	-5.7582756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-05	Ixazomib	384568528	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1072833-77-2				-14.5664908734	4	4		0	-3.6759508				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Adooq	A10600	-2.99889442	-2.22018068	-3.73286672	-3.6759508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263223-02	NCGC00263223-02	384568677		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE			14.1253754462	-4.85	-0.610509996	4	4		14.879265096	9.75540789	0.3212800016	0.9308980097		PIK3CA	CN(C)CCN(C)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C3=NC4=C(C=C[N]4CC(F)(F)F)C(=N3)N5CCOCC5)C=C1	Cayman	13838	-0.76008845	-3.62884704	-4.89938758	9.75540789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521942-01	NCGC00521942-01	384569507		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1398568-47-2				-13.6287850136	4	4		0	1.35727414				MDM2	CC1(C)CCC2(CC1)N[C@H]([C@H](C3=C(F)C(=NC=C3)Cl)[C@]24C(=O)NC5=C4C=CC(=C5)Cl)C(=O)N[C@@H]6CC[C@H](OC6)C(N)=O	ChemieTek	CT-DS3032	-3.13709232	-5.0375134	-5.0743657	1.35727414												1.28E-7	6.4E-7	0.0000032	0.000016											
NCGC00507838-01	NCGC00507838-01	384569321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1448232-80-1				-7.8544920863	4	4		0	-6.022904				EGFR	CCC1=NC(=C(NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(C)CC4)N=C1O[C@@H]5CCN(C5)C(=O)C=C)C(N)=O	Selleck	S8412	-1.17468214	-0.75026795	2.3330417	-6.022904												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263181-10	NCGC00263181-10	384568649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	937174-76-0				5.2696980301	4	4		0	-3.33477696				AKT1	CC[N]1C(=NC2=C(N=CC(=C12)OC[C@H]3CCCNC3)C#CC(C)(C)O)C4=NON=C4N	MedChem Express	HY-10249	4.49724226	-2.01619062	-3.30876824	-3.33477696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510482-01	NCGC00510482-01	384569445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	910634-41-2				-9.5634257152	4	4		0	-4.06466513				KIF11	CCNCC[S+]([O-])(=O)NC[C@]1(S\C(=N/N1C(=O)C(C)(C)C)NC(=O)C(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-14846	-0.19721087	-4.43499392	-4.18024656	-4.06466513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183044-01	NCGC00183044-01	124894250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	10118-90-8	Minocycline			12.1063945668	4	4		0	3.50926843					CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O	Vitas	STK177317	3.03744799	3.35370398	-0.88287228	3.50926843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344515-02	NCGC00344515-02	174006179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	4085-31-8	Piperaquine; Piperaquine			13.4463788664	4	4		0	1.38672704					ClC1=CC2=C(C=C1)C(=CC=N2)N3CCN(CCCN4CCN(CC4)C5=C6C=CC(=CC6=NC=C5)Cl)CC3	SIGMA	C7874	2.26074896	4.93367119	4.56150677	1.38672704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386234-03	NCGC00386234-03	363680161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1188910-76-0				3.4528305699	4	4		0	-3.28007917				EGFR	COC1=CC2=NC=NC(=C2C=C1OC)OC3=CC(=CC=C3)NC(=O)NC4=NOC(=C4)C(C)(C)C(F)(F)F	MedChem Express	HY-15200	2.66721946	0.01531159	-1.31233596	-3.28007917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345800-03	NCGC00345800-03	384568749		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	752222-83-6				5.4450612549	4	4		0	-0.16965927				ADORA2B	CCCN1C(=O)N(CC)C2=C([NH]C(=N2)C3=C[N](CC4=CC=CC(=C4)C(F)(F)F)N=C3)C1=O	ChemieTek	CT-CV001	2.08678828	-0.96463022	1.31233596	-0.16965927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025288-07	NCGC00025288-07	384568065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	522-17-8		14.1253754462	-4.85	12.6473879598	4	4		11.333486448	9.38781281	0.4590025737	0.8443829301		PIK3CA	COC1=CC2=C(C=C1OC)[C@H]3[C@@H](CO2)OC4=C(C=CC5=C4\C=C/C(C)(C)O5)C3=O	MedChem Express	HY-13425	2.83305694	-1.94457204	-0.34995626	9.38781281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347903-02	NCGC00347903-02	384568987		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[1050670-85-3]				5.7560814271	4	4		0	0.98967906				P2RX3	COC1=CC(=C(OC2=CN=C(NC(CO)CO)N=C2N)C=C1I)C(C)C	Tocris	4391	1.5063571	4.21068749	-2.53718285	0.98967906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387725-02	NCGC00387725-02	363680650		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1668553-26-1				-8.4612393858	4	4		0	-3.36364949				MCL1	CN(C)[S+]([O-])(=O)N1CCN(CC1)C2=CC=C(OCC3=C(C(=N[N]3C)C)C4=C5[N](CCN6CCOCC6)C(=C(CCCOC7=C8C=CC=CC8=CC=C7)C5=CC=C4)C(O)=O)C=C2	ChemieTek	CT-A121	-1.75364163	-1.71070719	-0.39103625	-3.36364949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378978-02	NCGC00378978-02	384569082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	898280-07-4		12.5892541179	-4.9	2.5649998079	4	4		35.430365472	27.12573986	0.0611927523	0.9976860374		IGFR1	CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)NC3=N[NH]C(=C3)C4CC4)N5CCN(C)CC5	ChemieTek	CT-XL228	-4.01640503	-4.88773484	-5.77530456	27.12573986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025202-12	NCGC00025202-12	384568056		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	73573-88-3		12.5892541179	-4.9	15.2108130269	4	4		19.8355391839	17.5111881	0.1481460024	0.9862709885	3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1CC\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	MedChem Express	HY-17408	1.24451987	-0.39712846	-1.11294932	17.5111881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263162-08	NCGC00263162-08	384568633		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	847925-91-1				-4.5145393262	4	4		0	-2.67898383				NOTCH1	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)NC2=CC=CC=C2C3=C1C=CC=C3	MedChem Express	HY-11102	-2.31018453	-1.06318347	5.9090265	-2.67898383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242489-02	NCGC00242489-02	363677145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	153559-76-3				17.4266537216	4	4		0	4.09545804				RXRA	CC1=CC2=C(C=C1C3(CC3)C4=CC=C(C=N4)C(O)=O)C(C)(C)CCC2(C)C	SIGMA	SML0279	5.21200169	2.46051033	-0.94941193	4.09545804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378780-02	NCGC00378780-02	363678194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					-8.4128635031	4	4		0	-5.68841092				ULK1	O=C(NCCCNC1=NC(=NC=C1C2CC2)NC3=CC=CC(=C3)CN4CCOCC4)C5CCC5	Tocris	5134	-0.04160888	-1.44581905	-4.35550324	-5.68841092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262398-01	NCGC00262398-01	161003999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	n	 NCGC00262398;NCGC00262398	11.220184543	-4.95	51.1523515301	2.2	4		32.5	31.35701146	0.0391610932	0.9990550318	9099	USP2	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=C(C=CC(=C2)Cl)C(=O)NC3=NC(=CS3)C4=CC=CC=C4	NCGCChem	RAP04-025	6.14424411	7.13966314	10.06474397	31.35701146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390695-02	NCGC00390695-02	377020505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1184940-46-2				11.9394415812	4	4		0	1.89613697				SGK1	CCC1=C(C)C(=CC=C1C(=O)NNC(=O)[C@@H](O)C2=CC(=CC(=C2)F)F)O	MedChem Express	HY-15193B	3.95284327	0.7303622	-0.1177163	1.89613697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025329-02	NCGC00025329-02	174007082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	193551-21-2	SB 239063			4.7281815415	4	4		0	5.57520872			1432	MAPK14	COC1=NC(=CC=N1)C2=C(N=C[N]2C3CCC(O)CC3)C4=CC=C(F)C=C4	Tocris	1962	-0.84604716	4.15859293	-0.26486168	5.57520872												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347947-04	NCGC00347947-04	384568994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1099644-42-4]				13.2501866288	4	4		0	9.8768926				TGBR1	CCOC(=O)\C1=C(/C)N\C2=C(C1C3=CC=C(C=C3)C4=CC=CC=C4)\C(=O)CC(C)(C)C2	Tocris	5068	1.26213592	2.48919362	1.29487934	9.8768926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264052-02	NCGC00264052-02	384568702		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	83-49-8		14.1253754462	-4.85	9.5937454929	4	4		11.7822691719	9.58574862	0.3184153711	0.9325945971		NRC31	C[C@H](CCC(O)=O)[C@H]1CCC2C3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C	Microsource	00270049	1.58927584	-1.48522431	-0.84572762	9.58574862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351601-07	NCGC00351601-07	363677769		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	686344-29-6		12.5892541179	-4.9	7.7925262446	4	4		20.059492564	16.17418351	0.2114126263	0.9714849941		CNR1	CCNC1(CCN(CC1)C2=C3N=C([N](C4=CC=C(Cl)C=C4)C3=NC=N2)C5=CC=CC=C5Cl)C(N)=O	MedChem Express	HY-10871	0.06909895	-3.0163834	-3.38291047	16.17418351												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510477-01	NCGC00510477-01	384569440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	497871-47-3				0.7943012422	4	4		0	2.47391952				POLR2A	COC1=CC=C2[NH]C3=C(CCN[C@]34CS[C@H]5[C@H]6[C@@H]7N(C)[C@@H](CC8=CC(=C(OC)C(=C78)O)C)[C@H](O)N6[C@@H](COC4=O)C9=C%10OCOC%10=C(C)C(=C59)OC(C)=O)C2=C1	MedChem Express	HY-16293	-2.76150628	-3.05343511	6.39781686	2.47391952												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00522008-01	NCGC00522008-01	384569510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1607803-67-7]		2.8183829313	-5.55	10.124748404	4	4		14.2426778279	12.36959762	0.0208653377	0.9997329571		ERN1	OC1=CC=C2\C3=C(CNCC3)/C(=O)OC2=C1C4OCCCO4	Tocris	6009	-1.86889819	-1.58658883	9.67252881	12.36959762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345842-03	NCGC00345842-03	384568764		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	874119-56-9		8.9125093813	-5.05	1.6836226743	4	4		12.0364870599	10.00433088	0.0884435802	0.9951938818		ROCK1	CC\1=C(C(\N=C(/N1)C2=CC(=NC=C2)Cl)C3=C(F)C=C(Cl)C=C3)/C(=O)NC4=C(F)C=C5[NH]N=CC5=C4	SynKinase	SYN-1124	-1.69707255	-0.88590194	-1.20318845	10.00433088												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242499-02	NCGC00242499-02	384568502		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[477845-12-8]				-6.0851130024	4	4		0	-0.56301429				PIM1	NC1=NC=CC(=N1)C2=CC3=C(ON=C3C=C2)C4=CC=C(Cl)C=C4	Tocris	3589	-0.9333899	-2.04673896	-2.64701459	-0.56301429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262061-03	NCGC00262061-03	384568570		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-1.8437735622	4	4		0	-0.3609066				PRKCA	C[N]1C=C(C2=C1C=CC=C2)\C3=C(\C(=O)NC3=O)C4=C5CC(CN)CC[N]5C6=C4C=CC=C6	SIGMA	B3931	-0.50912176	2.04673896	-2.58685517	-0.3609066												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00241411-01	NCGC00241411-01	137275845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	509093-60-1	NCGC00241411-01			9.395351495	4	4		0	0.76512199			3654	IRAK1	CC(C)(C)C(=O)OC1=CC2=C(C=C1)[N](CCCO)C(=N2)NC(=O)C3=CC=CC(=C3)[N+]([O-])=O	NCGCChem	JKJ14-093	2.4607552	1.55796548	2.07550008	0.76512199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025177-18	NCGC00025177-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	129-46-4				-2.3477470843	4	4		0	0.59188682					CC1=CC=C(C=C1NC(=O)C2=CC=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC4=C(C)C=CC(=C4)C(=O)NC5=CC=C(C6=C5C(=CC(=C6)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O)=C2)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O	BIOMOL	G430	-1.21623533	0.24438674	-0.57151451	0.59188682												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00161290-05	NCGC00161290-05	174006821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	39746-25-3	16,16-DIMETHYL-PROSTAGLANDIN E2;16,16-dimethyl Prostaglandin E2;16,16-Dimethyl Prostaglandin E2			-1.9148826566	4	4		0	-1.16626794					CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	Tocris	4027	-0.01450326	0.15274171	-1.59221583	-1.16626794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-11	NCGC00241103-11	384568473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	790299-79-5		11.220184543	-4.95	48.1178321485	3	4		63.8274128086	55.42725173	0.0397877809	0.9990226599		FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	MedChem Express	HY-10209	1.77489787	-0.24301337	3.33002692	55.42725173												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346533-13	NCGC00346533-13	384568823		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1009119-64-5				-6.7891678685	4	4		0	-4.12625096					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	MedChem Express	HY-10466	-0.67615157	-1.42770352	-1.40286241	-4.12625096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387821-04	NCGC00387821-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1022958-60-6		3.1622776602	-5.5	16.7015400456	4	4		12.7964763119	-5.29638183	1	0.895731053			COC1=C(NC2=NC(N[C@@H]3[C@@H]4C[C@@H](C=C4)[C@@H]3C(N)=O)=C(Cl)C=N2)C=CC5=C1CC[C@H](CC5)N6CCOCC6	DC Chemicals	DC8138	1.77489787	-1.91373026	9.33824571	-5.29638183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345816-01	NCGC00345816-01	174007112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	170905-75-6	GM-1489			6.0624297055	4	4		0	5.03725782			4312	MMP1	CC(C)C[C@H](CC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@@H](C)C3=CC=CC=C3	SantaCruz Bio	sc-203978	0.30683403	-1.0178117	3.18374773	5.03725782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346693-02	NCGC00346693-02	384568915		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	582315-72-8		1	-6	5.4806162905	4	4		12.68410042	8.7928465	0.1309942706	0.9893466919		CDK1	CCCCOC1=C2C=N[NH]C2=NC=C1C(=O)C3=C(F)C=C(C)C=C3F	Selleck	S2014	-3.48675035	0.89806915	10.27895694	8.7928465												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229512-05	NCGC00229512-05	384568462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[439575-02-7]		12.5892541179	-4.9	31.1405734389	3	4		47.0743317318	42.414307	0.0674293204	0.9971868587		ITK	COC1=C(C=C(SC2=CN=C(NC(=O)C3=CC=C(CNC(C)C(C)(C)C)C=C3)S2)C(=C1)C)C(=O)N4CCN(CC4)C(C)=O	Tocris	5009	0.27894003	0.17961383	-2.00121286	42.414307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164574-14	NCGC00164574-14	363676637		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	183319-69-9				-11.2257646193	4	4		0	-6.02086438				EGFR	COCCOC1=CC2=NC=NC(=C2C=C1OCCOC)NC3=CC=CC(=C3)C#C	ChemieTek	CT-EL002	-0.08368201	-4.10118246	-5.21528199	-6.02086438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167518-12	NCGC00167518-12	384568322		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	162635-04-3				-19.1550907399	4	4		0	-4.73919523				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(C)(CO)CO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	SIGMA	PZ0020	-3.9609484	-3.83176171	-3.69921164	-4.73919523												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263191-02	NCGC00263191-02	363677255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	(492445-28-0)		1.1220184543	-5.95	34.2260923807	4	4		17.5	19.56113758	0.0874888734	0.9952674531		CDK2	CC(C)C1=CN=C(NC(=O)[C@@H](C)C2=CC=C(NC(C)=O)C=C2)S1	SynKinase	SYN-1097	1.35765804	5.10157324	17.98766732	19.56113758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346966-01	NCGC00346966-01	174006754		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	n	HMSL10088			4.9042819022	4	4		0	-3.68124729			8737	RIPK1	O=C(NC1=N[NH]C2=CC(=CC=C12)C3=CC(=CC=C3)C(=O)NC4CC4)C5CC5	LINCS	HMSL10088	3.64870598	-0.06109669	-2.31613777	-3.68124729												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016686-07	NCGC00016686-07	363676490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	7681-93-8				-1.602914889	4	4		0	-0.56818182					C[C@H]1C\C=C/C=C\C=C/C=C\[C@H](C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3\C=C/C(=O)O1)C[C@@H](O)[C@H]2C(O)=O)O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](N)[C@H]4O	Selleck	S1517	-0.76867295	0.06109669	1.06147722	-0.56818182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346654-11	INK-128	384568885	mTORC1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	?1224844-38-5				-13.8711165908	4	4		0	-3.57197844				MTOR	CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14	ActiveBioChem	A-1023	-3.74700662	-0.39489672	-1.94133484	-3.57197844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379214-02	NCGC00379214-02	363678422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	838818-26-1				25.6808988359	4	4		0	4.89599547				TACR1	COC1=CC=C(C=C1)[N]2C(=NN=C2C3=CC=NC=C3)SCCCN4C(=O)C5=C6C(=CC=C5)C=CC=C6C4=O	Selleck	S7490	6.86546463	4.06916083	2.35432607	4.89599547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420882-01	NCGC00420882-01	384569225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-3.5465360993	4	4		0	-0.41728763				GRM3	NC(CC1C2=CC=CC=C2OC3=CC=CC=C13)(C4CC4C(O)=O)C(O)=O	Bio Vision	2875-5	-1.25523013	0.89806915	-0.93996361	-0.41728763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015223-21	NCGC00015223-21			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	41575-94-4				-9.2583514206	4	4		0	0.90948463					[NH3+][Pt-6]1([NH3+])OC(=O)[C]2(C[CH2]C2)C(=O)O1	Selleck	S1215	-2.4607552	-1.58851382	-3.63964506	0.90948463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162399-13	NCGC00162399-13	384568224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	139298-40-1				-5.434532625	4	4		0	-1.68904288					COC1=CC=C(C=C1)[S+]([O-])(=O)N(CCO)C2=C(CN(C)C/C=C/C3=CC=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-15465	-1.8667798	0.58041851	0.2707174	-1.68904288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347952-11	NCGC00347952-11	384568997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	71555-25-4		3.1622776602	-5.5	109.0458210932	2.2	4		65.662679427	71.29186603	0.0358929351	0.9992047301			CC(=N/NC(=S)N1CCC1)\C2=NC=CC=C2	MedChem Express	HY-18634	6.91805656	7.11776386	47.38316379	71.29186603												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263149-06	NCGC00263149-06	384568624		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	497839-62-0				-16.668740909	4	4		0	-5.63510393				EGFR	CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N[C@H](C)C5=CC=CC=C5)N=CN=C4[NH]3	MedChem Express	HY-10045	-3.04268207	-3.0072904	-3.69845543	-5.63510393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484062-02	NCGC00484062-02	384569268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1206163-45-2				-4.1564518591	4	4		0	-3.07929176				JAK1	CC1(C)CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=N[N]34)NC(=O)C5CC5	MedChem Express	HY-16755_cm2	0.42259473	-3.2199271	-0.97775259	-3.07929176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480913-01	NCGC00480913-01	384569250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1345847-93-9				18.9241858246	4	4		0	2.03233256				MET	FC1=CC=C(NC(=O)C2(CC2)C(=O)NC3=CC(=C(OC4=CC(=NC=C4)NC(=O)C5CC5)C=C3F)F)C=C1	Glixx	GLXC-90229	2.39470348	11.17861482	4.97378489	2.03233256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511370-01	NCGC00511370-01	384569499		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1375465-91-0				-16.457401531	4	4		0	-5.60431101				HDAC1	ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1	Glixx	GLXC-09665	-2.73277926	-4.04009721	-3.52841151	-5.60431101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014891-14	NCGC00014891-14	384567795		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	48208-26-0				-3.8335752095	4	4		0	-0.36790717				DNMT1	OC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)N3C(=O)C4=C(C=CC=C4)C3=O	MedChem Express	HY-13642	-0.26352288	-1.80354747	-2.324897	-0.36790717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263135-02	NCGC00263135-02	384568613		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	206884-98-2				11.3841899125	4	4		0	-1.33012594				XDH	CC(C)(C)COC1=C(C=C(C=C1)[N]2C=C(C=N2)C(O)=O)C#N	Axon Medchem	1174	3.12066574	4.27783574	2.03060624	-1.33012594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015207-24	NCGC00015207-24	384567823		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	73963-72-1				-3.4727287261	4	4		0	-3.8771756				PDE3A	O=C1CCC2=C(N1)C=CC(=C2)OCCCCC3=NN=N[N]3C4CCCCC4	MedChem Express	HY-17464	-0.73509015	1.86316888	0	-3.8771756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178318-05	NCGC00178318-05	384568354		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	19767-45-4				-2.8112546112	4	4		0	-3.18926975					[O-][S](=O)(=O)CCS	Selleck	S1735	0.08368201	0.59871277	-1.51607035	-3.18926975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168459-04	NCGC00168459-04	174006302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1172617-47-8	 NCGC00168459-01;NCGC00168459-01	14.1253754462	-4.85	-5.730423626	4	4		15.1861924679	10.22354694	0.2100783037	0.9719588485	5141	PDE4A	COC1=CC(=C(OC)C=C1)C2=NN=C3C=CC(=N[N]23)C4=CC(=C(OC)C=C4)O[C@@H]5CCOC5	NCGCChem	DYD09-025	-3.90516039	-1.406975	-3.45664039	10.22354694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261977-03	NCGC00261977-03	384568569		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	6506-37-2				-0.9343506489	4	4		0	2.98062593					[O-][N+](=O)C1=CN=C[N]1CCN2CCOCC2	MedChem Express	HY-16349	-2.17573222	0.11974255	3.30503335	2.98062593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509997-02	NCGC00509997-02	384569404		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1320346-97-1				-22.3590245793	4	4		0	-5.33532042					COC1=CC=C(C=C1)[S+]([O-])(=O)N[C@@H](CNC2=NC(=NC(=C2C)N3CCC(CC3)C4=NC5=C(CCCN5)C=C4)C)C(O)=O	MedChem Express	HY-100506	-5.10460251	-2.87382128	-4.76046089	-5.33532042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242458-15	NCGC00242458-15	384568488		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	49843-98-3				-0.139521239	4	4		0	2.07596494				SIRT1	NC(=O)C1CCCC2=C1[NH]C3=C2C=C(Cl)C=C3	MedChem Express	HY-15452	-2.03408466	-0.54532056	5.55712271	2.07596494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	59721-29-8				-9.3848445545	4	4		0	-1.276334					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-2.6937878	-2.10759027	-0.11283498	-1.276334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-03	NCGC00183128-03	384568417		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1407-03-0		14.1253754462	-4.85	22.346894912	4	4		19	16.98564593	0.287524568	0.9456239829			[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	APExBIO	B2155	1.63886875	5.2848633	2.53575114	16.98564593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408801-01	NCGC00408801-01	363681051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1149705-71-4		0.6309573445	-6.2	108.8614260315	1.4	4		59.9378593564	46.23205742	0.4063312457	0.8819930868		HSP90AB1	CC[C@@H](C)NC1=CC(=C(C)C=C1C(N)=O)C(=O)NC2C[C@@H]3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5	Glixx	GLXC-90165	0.36258158	35.19169085	69.79212738	46.23205742												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015598-16	NCGC00015598-16	384567869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	4707-32-8				-5.836034249	4	4		0	-1.16626794				TDO2	CC1(C)CC\C2=C(/O1)C3=C(C=CC=C3)C(=O)C2=O	MedChem Express	HY-13555	-1.98694706	-0.58041851	0.73713696	-1.16626794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263119-07	NCGC00263119-07	384568603		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	169939-93-9				-6.8853137952	4	4		0	-6.30980861				PRKCB	CN(C)C[C@@H]1CC[N]2C=C(C3=C2C=CC=C3)C/4=C(/C(=O)NC4=O)C5=C[N](CCO1)C6=C5C=CC=C6	Bio Vision	2156	-0.24655547	-2.29112571	0.08845644	-6.30980861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347278-03	NCGC00347278-03	384568984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	552325-16-3				-11.5981787887	4	4		0	-5.66589684				AKT1	CC1=N[NH]C2=C1C=C(C=C2)C3=CN=CC(=C3)OC[C@@H](N)CC4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-10425	-3.155374	-1.88335358	2.87657645	-5.66589684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347068-02	NCGC00347068-02	384568983		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	314042-01-8				-5.6254143868	4	4		0	-0.73903002					CC1(C)CC2=C(CO1)SC(=C2C(O)=O)NC(=S)NC(=O)C3=CC=CC=C3	Axon Medchem	2184	-1.97210875	-1.00243013	0.94941193	-0.73903002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165966-05	NCGC00165966-05	384568301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	125317-39-7				-8.1020253244	4	4		0	-4.31262879				TUBB	[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@@]7([H])CN(CC(CC)=C7)CC8=C6NC9=C8C=CC=C9)C(=O)OC	MedChem Express	HY-12053A	0.06850253	-1.66386811	-3.67932994	-4.31262879												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346504-07	Avagacestat	384568808	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1146699-66-2				-6.1100816837	4	4		0	-3.79227395				NOTCH1	NC(=O)[C@@H](CCC(F)(F)F)N(CC1=C(F)C=C(C=C1)C2=NOC=N2)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-50845	-0.92926491	-0.87941571	-0.41200706	-3.79227395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483925-02	NCGC00483925-02	384569266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	936694-12-1		1.4125375446	-5.85	56.3535914104	2.4	4		43.7776267959	27.64963917	0.4909680804	0.8138424684	4233	FLT1	COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=S)NC(=O)CC5=CC=C(F)C=C5)C=C4	ChemieTek	CT-MG265_cm1	-1.23439667	-0.7601729	56.32725132	27.64963917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263107-03	NCGC00263107-03	384568594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					12.407939563	4	4		0	4.83939437				PAR2	CC[C@@H](C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C2=CC=NO2)C(=O)N3CCC4(CC3)CCC5=C4C=CC=C5	Axon Medchem	1622	1.65048544	-0.07452676	6.62154208	4.83939437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024901-04	NCGC00024901-04	384568035		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[138356-21-5]		11.220184543	-4.95	14.921673698	4	4		22.793219576	19.43368107	0.0737433813	0.9966421811		SIGMAR1	CN(C)CCN(C)CCC1=CC=C(Cl)C(=C1)Cl	Tocris	0956	0.25104603	-1.07768298	0.72771377	19.43368107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510689-01	NCGC00510689-01	384569479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1943733-16-1				1.5336924186	4	4		0	-1.25186289					COC1=CC=C(C=C1)[S+]([O-])(=O)NCC2=CC=C(C=C2)C(=O)NCCC3=CC=C(Cl)C=N3	Selleck	S8379	0.86471409	1.58658883	-1.21285628	-1.25186289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483135-03	CPI-0610	384569263	Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1380087-89-7				-5.4820876548	4	4		0	-3.6661699					CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(N)=O)C4=CC=C(Cl)C=C4	ChemieTek	CT-C0610_cm2	0.44630404	-2.00568777	-3.54760461	-3.6661699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015385-22	Dipyridamole	384567839	Phosphodiesterase PDE3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	58-32-2				-5.1443940396	4	4		0	-0.1691527				PDE5A	OCCN(CCO)C1=NC(=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO)N4CCCCC4	Prestwick	Prestw-142	-0.71467839	-2.25497421	-2.31311707	-0.1691527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187482-21	NCGC00187482-21	384568445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	957054-33-0				9.8581667515	4	4		0	5.7715311				PIK3CA	C[S+]([O-])(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=CC=CC5=C4C=N[NH]5)N6CCOCC6	MedChem Express	HY-20180	2.36403191	-3.29922102	2.5947221	5.7715311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350511-01	NCGC00350511-01	384569004		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					4.590823662	4	4		0	0.26913876				SUCNR1	ClC1=CC=CC(=C1)C2=CC=C(C=C2)C3=NN=C(CCCC4=NC5=NC=CC=C5C=C4)O3	NCGCChem	PRP003-073	2.94416244	-1.52741714	-2.94854784	0.26913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262306-10	NCGC00262306-10	384568572		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-7.5280194626	4	4		0	-3.3791866				USP1	CC(C)C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NCC3=CC=C(C=C3)[N]4C=CN=N4	NCGCChem	NCGC00262306-03_06_07mix	-2.10297317	2.41331908	-1.88707062	-3.3791866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167453-04	NCGC00167453-04	384568314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	30299-08-2				5.9425481256	4	4		0	-0.16190757					CCC(C)(OC1=CC=C(C=C1)C2(CCCCC2)C3=CC=C(OC(C)(CC)C(O)=O)C=C3)C(O)=O	APExBIO	B2217	1.02753802	2.97664479	1.94436135	-0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250412-15	JQ1		Brd4 Inhibitor	DPI_SARS-CoV-2_General		1268524-70-4				6.9497562369	4	10		0	4.1543822				BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	-2.70704905	-1.20611096	-3.1358885	-1.79576521	-1.0989011	-1.95658001	-3.1358885	-2.92146878	-0.29482712	4.1543822						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015904-05	NCGC00015904-05			DPI_SARS-CoV-2_General		36791-04-5				14.8782396279	4	10		0	4.30481283					NC(=O)C1=N[N](C=N1)C2OC(CO)C(O)C2O	Bio Vision	2199	-0.34759358	0.50802139	0.34759358	0.6684492	-0.93582888	-0.77540107	4.2513369	0.34759358	3.77005348	4.30481283						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00241114-02	NCGC00241114-02	384568479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					14.9617341187	4	4		0	-0.96221876				MAPK14	CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C	Astatech	44169	5.11789182	1.08809062	2.64861683	-0.96221876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-03	NCGC00347284-03			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	781613-23-8		1.4125375446	-5.85	7.9767049828	4	4		12.879334252	-6.36762417	1	0.9998073271			COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	MedChem Express	HY-13314	-2.39944521	-1.68430467	10.56503826	-6.36762417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164624-11	Adefovir dipivoxil	377020406	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	142340-99-6				-1.1895900431	4	4		0	-4.81109382					CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	MedChem Express	HY-B0255	0.06934813	4.30764644	-1.11830489	-4.81109382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346707-05	NCGC00346707-05	384568925		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	193275-84-2				5.0364627629	4	4		0	-2.57535022				COX10	NC(=O)N1CCC(CC1)CC(=O)N2CCC(CC2)[C@H]3C4=C(CCC5=C3C(=CC(=C5)Cl)Br)C=C(Br)C=N4	MedChem Express	HY-15136	1.20665742	-2.01222239	7.56327251	-2.57535022												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481575-01	NCGC00481575-01	363681124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-14.4889442574	4	4		0	-6.31892697				AURKA	CCNC(=O)C#CC1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(CN(C)C)C=C3)C4=CC=CC=C4	APExBIO	B5956	-1.19944212	-3.38272714	-4.00242571	-6.31892697												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00509936-02	NCGC00509936-02	384569385		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1661839-45-7		10	-5	59.9713730987	2.2	4		96.1759691728	76.60208644	0.0125849346	0.9999023135		CDK8	C[N]1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl	Glixx	GLXC-07110	-1.70153417	-0.50890585	10.61249242	76.60208644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015833-18	NCGC00015833-18	384567896		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	98-96-4				-3.4852772428	4	4		0	-1.31147541				FAS	NC(=O)C1=CN=CC=N1	Selleck	S1762	-0.75313808	-1.28723245	0.4548211	-1.31147541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015335-11	NCGC00015335-11	124879863		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	147-24-0	 Difenhidramina; Neo-fluvaleas; Diphenhydramine; Resmin; Benadryl; ;Diphenhydramine; Restamin;Pellit; Advil PM;Diphenhydramine hydrochloride; 2   Diphenhydramine Hcl; Dolestan; Dramamine; Somnium; 9   Dimenhydrinate; Dimenhidrinato; Bietanautine; Mandrax; Visano Cor; Diphenhydramine Tannate; Propain			-7.6760944292	4	4	DIPHENHYDRAMINE HCl	0	-1.15331386			9704	HRH1	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2	BIOMOL	AC763	-0.9895547	-2.57921887	-3.55430183	-1.15331386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346641-07	NCGC00346641-07	363677491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	850173-95-4				1.7064048932	4	4		0	-0.56896817				OPRD1	CCN(CC)C(=O)C1=CC=C(C=C1)C/2=C/C3(CCNCC3)OC4=CC=CC(=C24)O	Glixx	GLXC-90067	-0.57724024	6.1459101	-0.98730606	-0.56896817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345857-05	NCGC00345857-05	384568771		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	910232-84-7				0.2680941632	4	4		0	2.10671998				BTK	CN1\C=C(/N=C(NC2=CC=C(C=C2)C(=O)N3CCOCC3)\C1=O)C4=C(C)C(=CC=C4)NC(=O)C5=CC=C(C=C5)C(C)(C)C	APExBIO	A3302	-1.01704233	3.90567428	-2.05923836	2.10671998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241104-09	NCGC00241104-09	384568474		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	285983-48-4				14.7227319904	4	4		0	10.4720898				MAPK14	CC1=CC=C(C=C1)[N]2N=C(C=C2NC(=O)NC3=CC=C(OCCN4CCOCC4)C5=C3C=CC=C5)C(C)(C)C	MedChem Express	HY-10320	0.79714129	1.96020634	4.99294781	10.4720898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242504-01	NCGC00242504-01	137275858		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1110-40-3	Cortivazol	12.5892541179	-4.9	23.7939083699	2.4	4		31	23.41996002	0.0317502999	0.9993794482		NRC31	C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=N[N]5C6=CC=CC=C6	NCGCChem	Cortivazol	0.9895547	1.51805453	3.86459803	23.41996002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185778-06	NCGC00185778-06	384568427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	104206-65-7				8.1898158878	4	4		0	3.67822966				HPD	[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	MedChem Express	HY-B0607	-0.36258158	5.00992821	4.0984815	3.67822966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378713-03	NCGC00378713-03	384569064		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE			12.5892541179	-4.9	25.993576695	3	4		49.5302172929	43.75919929	0.0462440408	0.9986794022		NOTCH1	CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C	Tocris	5751	-2.20578161	-0.25950237	-1.28626982	43.75919929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345852-03	NCGC00345852-03	384568767		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1092443-55-4		0.5623413252	-6.25	33.3809779793	4	4		19.174064936	17.11804533	0.0936912215	0.9945696338		CDK1	CC(C)C1=C2N=C(N[C@@H](CO)[C@H](O)CO)C=C(NCC3=CC=CC=C3)[N]2N=C1	SynKinase	SYN-1151	-0.56172078	12.89879408	18.60604248	17.11804533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250412-15	JQ1		Brd4 Inhibitor	DPI_SARS-CoV-2_General		1268524-70-4				7.0064694804	4	10		0	3.93048128				BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	-1.63101604	-2.37967914	-1.79144385	-2.27272727	-2.32620321	-1.79144385	-0.72192513	-1.79144385	-0.6684492	3.93048128						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	DPI_SARS-CoV-2_General						8.1818123505	4	20		0	2.65099754					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	DPI_SARS-CoV-2_General		52-86-8		0.0702306445	-7.1534733462	248.7842965104	1.1	20		107.5749716519	89.3315508	0	0.9865840152			OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346712-02	Verteporfin		photosensitizer	DPI_SARS-CoV-2_General		129497-78-5				2.1409310459	4	20		0	0.68324679					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015208-25	NCGC00015208-25	384567824		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	58-08-2				9.0126571667	4	4		0	-0.96221876					C[N]1C=NC2=C1C(=O)N(C)C(=O)N2C	Microsource	01500155	4.17475728	-1.50544045	0.17657446	-0.96221876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167503-02	Aclarubicin	174007366	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	57576-44-0	; Aclacin;Aclarubicin; Aclaplastin; Aclacinon; Aclarubicino;Aclacinomycin A			6.8512111853	4	4		0	-1.30182539			7153	TOP2A	CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(O)C6=C(C=C5[C@H]1C(=O)OC)C(=O)C7=CC=CC(=C7C6=O)O	Carbosynth	OA08264	3.34257975	-0.19376956	-0.82401413	-1.30182539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510704-01	NCGC00510704-01	384569487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1951483-29-6				-11.9338657208	4	4		0	-2.59314456				ERK	C[N]1N=CC=C1NC2=NC=CC(=N2)C3=CC4=C(S3)C(C)(C)N(CCN5CCOCC5)C4=O	MedChem Express	HY-101494	-3.59832636	0.17961383	-1.3341419	-2.59314456												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378983-02	NCGC00378983-02	384569083		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1020315-31-4				6.6576622694	4	4		0	4.13655236				FAAH	FC(F)(F)C1=CN=C(OC2=CC(=CC=C2)C=C3CCN(CC3)C(=O)NC4=NN=CC=C4)C=C1	MedChem Express	HY-14376	1.12699285	2.22549742	-1.24118477	4.13655236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346804-01	NCGC00346804-01	174007089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	321351-00-2	EO 1428			-4.7521196137	4	4		0	-1.76841458			1432	MAPK14	CC1=CC=CC=C1C(=O)C2=CC=C(NC3=C(N)C=C(Br)C=C3)C=C2Cl	Tocris	2908	-1.75920836	1.54753132	-0.02820874	-1.76841458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182045-03	NCGC00182045-03	384568404		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	2033				-6.5552412876	4	4		0	0.75349839				ADA	OC[C@H]1O[C@H](C[C@@H]1O)[N]2C=NC3=C2\N=C/NC[C@H]3O	Tocris	2033	-2.39142386	-1.84229919	0.39492243	0.75349839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	10	-5	54.3983710878	3	4		82.9083709432	77.75119617	0.0481169093	0.9985694373	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-2.30601885	1.25248205	1.85758514	77.75119617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344508-02	NCGC00344508-02	384568718		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[177172-49-5]		12.5892541179	-4.9	61.6971435771	3	4		99.4333425644	89.02511962	0.0051959654	0.9999833485		CASR	COC1=CC(=CC=C1)[C@@H](C)NCCCC2=CC=CC=C2Cl	Tocris	3815	-1.2617839	-1.37467542	-0.94353531	89.02511962												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386429-04	NCGC00386429-04	384569139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	955977-50-1		12.5892541179	-4.9	50.9810384528	3	4		69.4768358499	62.12834854	0.134440174	0.9886862689	5293	PIK3CD	FC1=C(C2=NC3=C(SC(=C3)CN4CCN(CC4)CC5CC5)C(=N2)N6CCOCC6)C7=C([NH]C=C7)C=C1	Selleck	S7623	3.54843129	-2.24393222	-4.21776847	62.12834854												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249661-03	NCGC00249661-03	384568531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					3.1181883382	4	4		0	2.04592287				HPGD	CC1=CC=C(C=C1)[N]2C(=CC(=C2C)C3=NN=C4CCCCC[N]34)C	NCGCChem	DYD019-035	0.50691876	0.87009617	-0.44869877	2.04592287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345822-02	NCGC00345822-02	363677369		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(473382-39-7)				0.3183479946	4	4		0	1.89873418				AKT1	CN(C)CC(C)(C)CNC1=N[N]2C(=NN=C2C3=CC=CC=C3)C=C1C4CCC4	SynKinase	SYN-1005	-0.86313194	1.87757594	-0.29913252	1.89873418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498442-01	NCGC00498442-01	384569303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1801747-11-4				3.4473000406	4	4		0	-0.90484943				PTP2C	CC1(N)CCN(CC1)C2=NC(=C(N=C2)C3=CC=CC(=C3Cl)Cl)N	ChemieTek	CT-SHP099	1.94859038	0.5052825	-0.49577136	-0.90484943												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015513-20	NCGC00015513-20	384567859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	51-45-6 [histamine]				8.2310738049	4	4		0	6.25				HRH1	NCCC1=C[NH]C=N1	Microsource	01500331	-0.1595359	2.10783565	3.56774289	6.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263232-01	NCGC00263232-01	137276076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	311795-38-7	GLS968	11.220184543	-4.95	83.3867113784	3	4		113.1150721216	103.92993818	0.0062919327	0.9999755821	27165	GLS	CN(C)C1=C(Br)C=C(C=C1)C\2NC3=C(\C4=C2C(=O)CC(C)(C)C4)C5=CC=CC=C5C=C3	NCGCChem	GLS968	1.30154816	0.71744772	2.69219264	103.92993818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346743-03	Givinostat hydrochloride	384568939	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-18.0420717582	4	4		0	-5.60788931				HDAC1	CCN(CC)CC1=CC2=C(C=C1)C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=C2	Bio Vision	9431-5	-2.72640088	-4.38101053	-5.47412504	-5.60788931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094994-10	NCGC00094994-10	384568139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	53230-10-7		11.220184543	-4.95	66.4412206647	3	4		72.4867642812	64.69673406	0.1050347318	0.9931347928			OC(C1CCCCN1)C2=C3C=CC=C(C3=NC(=C2)C(F)(F)F)C(F)(F)F	Microsource	01503070	5.79049198	-0.41341295	5.13269175	64.69673406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183105-01	NCGC00183105-01	124894305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	136790-76-6	 Amitiza;Lubiprostone; Lubiprostone; 			-3.9489244973	4	4	PROSTAN-1-OIC ACID, 16,16-DIFLUORO-11-HYDROXY-9,15-DIOXO-, (11.ALPHA.)-;CIPLUS_735350;LUBIPROSTONE;SPI-0211;Lubiprostone;RU-0211;Amitiza;7-((2R,4AR,5R,7AR)-2-(1,1-DIFLUOROPENTYL)-2-HYDROXY-6-OXOOCTAHYDROCYCLOPENTA(B)PYRAN-5-YL)HEPTANOIC ACID;lubiprostone;RU 0211;CYCLOPENTA(B)PYRAN-5-HEPTANOIC ACID, 2-(1,1-DIFLUOROPENTYL)OCTAHYDRO-2-HYDROXY-6-OXO-, (2R,4AR,5R,7AR)-;SPI 0211;(11.ALPHA.,15R)-16,16-DIFLUORO-15-HYDROXY-9-OXO-11,15-EPOXYPROSTAN-1-OIC ACID;RU0211;SPI0211;7-((1R,3R,6R,7R)-3-(1,1-DIFLUOROPENTYL)-3-HYDROXY-2-OXABICYCLO(4.3.0)NONANE-8-ONE-7-YL)HEPTANOIC ACID, L-;	0	-2.46005938			1181	CLCN2	O=C(O)CCCCCC[C@H]1C(=O)C[C@H]2O[C@](O)(CC[C@H]12)C(F)(F)CCCC	APAC	600114	0.40077391	-1.97519522	-2.50801983	-2.46005938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015818-25	Praziquantel	384567893	antiparasitic agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	55268-74-1				-5.8891476375	4	4		0	4.50074516					O=C1CN(CC2N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4	MedChem Express	HY-B0244	-3.0125523	-0.89806915	-1.3341419	4.50074516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387824-01	NCGC00387824-01	384569163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1061318-81-7		1.1220184543	-5.95	118.8470535394	1.3	4		85.2727367517	84.11326379	0.0518541373	0.9983379755		HSP90AB1	CN(C)C1=CC2=C(OCO2)C=C1SC3=NC4=C(C=CN=C4N)[N]3CCNCC(C)(C)C	ChemieTek	CT-CU305	-2.92887029	11.34560695	79.44208611	84.11326379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389621-01	NCGC00389621-01	384569177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	905854-02-6		12.5892541179	-4.9	17.1844205247	3	4		50.6154789149	42.20566319	0.0270743702	0.9995478478			O=C1NC(=O)[C@@H]([C@@H]1C2=C[NH]C3=CC=CC=C23)C4=C[N]5CCCC6=C5C4=CC=C6	APExBIO	A8325	-3.48675035	-3.53240533	-4.27531837	42.20566319												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384474-01	NCGC00384474-01	384569111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	192755-21-8				2.0648604386	4	4		0	-0.26913876				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=C4C=CC=C5	DiverChem	DIV02676	0.01450326	0.97754697	2.21141088	-0.26913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250386-10	NCGC00250386-10	384568539		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	702675-74-9				-10.7157560725	4	4		0	-3.48837209				IKBKE	IC1=C(NCCCNC(=O)C2=CC=CS2)N=C(NC3=CC(=CC=C3)NC(=O)N4CCCC4)N=C1	Glixx	GLXC-04290	-1.90437046	0.41215082	-5.05533952	-3.48837209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498438-01	NCGC00498438-01	384569301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	888478-45-3				-8.4991376337	4	4		0	3.75331175				DDX5	COC1=CC(=CC(=C1)N2CCN(CC2)C(=O)NC3=NC4=C(C=CC(=C4)F)N=C3OC)OC	ChemieTek	CT-RX5902	-4.39786272	1.41963059	-1.52557583	3.75331175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263153-07	NCGC00263153-07	384568627		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	935881-37-1				-16.8702584963	4	4		0	-6.70154107				HDAC1	CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Selleck	S2244	-1.83803206	-4.3638034	-5.8909303	-6.70154107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185756-04	NCGC00185756-04	384568425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	52205-73-9		10	-5	16.3304549462	2.4	4		31.972833404	26.52757079	0.0203391365	0.9997451938			C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P]([O-])([O-])=O	MedChem Express	HY-13627	-1.19944212	-1.22736117	0.60642814	26.52757079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499577-01	NCGC00499577-01	384569309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1918238-72-8				-1.9912969491	4	4		0	-2.87559588				JAK3	CCOC(=O)C1=C[NH]C2=NC=NC(=C12)C3=CC(=CC=C3F)NC(=O)C=C	Organix	O-10105	0.05497526	-0.39793662	0.42313117	-2.87559588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178500-19	NCGC00178500-19	384568356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[18883-66-4]				1.3978914247	4	4		0	2.56804552					CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	Tocris	1621	-0.41231446	-1.01694915	1.77715092	2.56804552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161398-06	NCGC00161398-06	384568205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	504433-23-2				1.0566143101	4	4		0	-1.465311				NTRK1	C[N]1C=C(/C=C/2C(=O)NC3=CC=CN=C23)C4=C1C=CC=C4	MedChem Express	HY-18314	0.53662074	2.47441576	-1.35633201	-1.465311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015887-06	NCGC00015887-06	384567901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	23239-51-2				-6.2560501507	4	4		0	-1.40550239				ADRB2	CC(NCCC1=CC=C(O)C=C1)C(O)C2=CC=C(O)C=C2	APExBIO	B1347	-1.95794054	-1.68015885	1.38581748	-1.40550239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00068236-11	NCGC00068236-11	384568072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	112811-59-3				0.6101144907	4	4		0	-2.12320574				TOP2B	COC1=C(N2CCNC(C)C2)C(=CC3=C1N(\C=C(C(O)=O)/C3=O)C4CC4)F	Prestwick	Prestw-1265	1.60986222	-0.73316023	-2.00501253	-2.12320574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488967-01	NCGC00488967-01	363681477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1449228-40-3				1.4409489337	4	4		0	-0.63291139				CDK8	CN1CCN(CC1)C(=O)C2=CC3=CC=C(CCNC4=C5C=C(C=CC5=NC=N4)C#N)C=C3C=C2	APExBIO	A8732	1.60295931	-1.083804	-2.03410111	-0.63291139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480919-01	NCGC00480919-01	384569251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1346572-63-1		12.5892541179	-4.9	70.2405703915	3	4		114.8964516004	102.13487912	0.0271881889	0.9995438046			CC(C)[N]1C=C(C)C2=C1C=C(C=C2C(=O)NC\C3=C(C)\C=C(C)/NC3=O)C4=CC=C(N=C4)N5CCN(C)CC5	Glixx	GLXC-06400	-1.28524046	-0.99525341	-3.03295421	102.13487912												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507850-01	NCGC00507850-01	384569330		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1446790-62-0		14.1253754462	-4.85	21.9149301313	4	4		21.27952756	18.09698855	0.3834026769	0.8971049776		SYK	CC1=CC=C(NC2=C(N=NC(=C2)N[C@@H]3CCCC[C@@H]3N)C(N)=O)N=C1C	Selleck	S7286	4.15975677	-0.04593477	-3.1496063	18.09698855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346563-03	NCGC00346563-03	384568841		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	29767-20-2				-14.2355965759	4	4		0	-5.62703238				TOP2A	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=CC8=C(OCO8)C=C27	MedChem Express	HY-13761	-1.61691542	-3.65947022	-4.78273549	-5.62703238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016094-10	NCGC00016094-10	384567920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	58053-83-1	17_-hydroxy Wortmannin;Wortmannin			-1.8520580511	4	4		0	2.87281651			5290	PIK3CA	COC[C@H]1OC(=O)C2=COC3=C2[C@@]1(C)\C4=C(C5CCC(=O)[C@@]5(C)C[C@H]4OC(C)=O)/C3=O	BIOMOL	ST-415	-0.16970725	-3.1464793	-1.95518123	2.87281651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347937-02	NCGC00347937-02	384568989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	80306-38-3				-0.8324264376	4	4		0	-4.69178577				RARA	CC1=CC=C(C=C1)\C2=N\C3=CC=C(Cl)C=C3OC2	XcessBio	M60116-2s	0.59397539	4.03238124	-2.37629719	-4.69178577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378902-02	NCGC00378902-02	384569074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	874819-74-6				-3.8243355922	4	4		0	-4.37418796				FLT1	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4	MedChem Express	HY-10330A	1.58393438	-0.91645028	-3.09821026	-4.37418796												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00229511-21	NCGC00229511-21	384568461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	540737-29-9				-8.1001637436	4	4		0	-2.87559588				JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354A	-0.71467839	-2.46131172	-3.44146685	-2.87559588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163469-09	NCGC00163469-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE			0.1258925412	-6.9	89.1529159432	1.4	4		40.708548268	28.43303091	0.4844867273	0.8200074402			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	Selleck	S2324	0.57724024	48.68091378	34.35825106	28.43303091												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00185736-03	NCGC00185736-03	384568424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	171228-49-2		1.4125375446	-5.85	74.0157230811	3	4		51.2296727747	9.57659738	1	0.9997609504		CYP51A1	CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5CO[C@@](C5)(C[N]6C=NC=N6)C7=C(F)C=C(F)C=C7)C=C4	Enzo	AC3226	-0.28172982	3.67557716	49.89372254	9.57659738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378878-02	NCGC00378878-02	363678252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	N.A.				7.2732777409	4	4		0	-0.30909626				CSF1R	CNC(=O)C1=CC=CC2=C1C=CC(=C2)OC3=CC=NC4=CC(=C(OC)C=C34)OCC5(N)CC5	Axon Medchem	1942	3.60323332	0.50373989	-2.93149865	-0.30909626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345836-13	NCGC00345836-13	384568760		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	327033-36-3		12.5892541179	-4.9	67.1488951832	3	4		70.219546066	65.98816226	0.1442112937	0.9869520971		PIM1	FC(F)(F)C1=CC=CC(=C1)/C=C/2SC(=O)NC2=O	Bio Vision	2211	7.21255834	-0.15274171	-0.69183336	65.98816226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095191-14	NCGC00095191-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	204255-11-8				-2.3698235934	4	4		0	1.64539443					CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	MedChem Express	HY-17016	-1.23694338	1.40014738	-2.03102962	1.64539443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242597-02	NCGC00242597-02	363677150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	361442-04-8				-9.9339482534	4	4		0	-1.43010918				DPP4	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	Selleck	S1540	-2.39142386	-2.22549742	-1.72073343	-1.43010918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402368-01	NCGC00402368-01	384569217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1253573-53-3				-20.5809678174	4	4		0	-4.29032754				PIK3CA	COC1=C(F)C=C(NC2=NC=C(C=C2C3=NC(=NC(=N3)N)C)[C@H](C)N4CCN(CC4)[S+](C)([O-])=O)C=N1	Aobious	AOB33711	-4.89279824	-3.93515107	-3.04654443	-4.29032754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161825-08	NCGC00161825-08	384568215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	405911-17-3		1.2589254118	-5.9	21.2732763614	4	4		20.069375968	19.30715935	0.1123664488	0.9921516658		ABCA1	OC(=O)CC1=CC=CC(=C1)OCCCN(CC(C2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC(=C4Cl)C(F)(F)F	MedChem Express	HY-10627A	-2.14114664	0.82017011	16.79183789	19.30715935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262598-03	NCGC00262598-03	384568573		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	64228-81-5	Atracurium besylate			-0.0738076759	4	4		0	0.40030793					COC1=CC2=C(C=C1OC)C(CC3=CC(OC)=C(OC)C=C3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=C(C=C(OC)C(OC)=C5)C4CC6=CC(OC)=C(OC)C=C6)CC2	Selleck	S2113	-0.22538386	0.7290401	-0.43928015	0.40030793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346896-03	NCGC00346896-03	384568966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1108147-88-1		1.2589254118	-5.9	115.858926977	1.4	4		80.609605298	75.84295612	0.082429471	0.9957858974		OPRL1	CC1(CCCCCCC1)N2CCC(CC2)[N]3C4=C(C=CC=C4)N=C3[C@@H]5CCCNC5	Cayman	12037	-1.577687	8.01944107	82.40045345	75.84295612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511392-01	NCGC00511392-01	384569503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1354825-58-3				-6.2755822912	4	4		0	-3.84162496				RIPK2	CC1=CC=C(C=C1)C2=N[N](C3=NC=NC(=C23)N)C(C)(C)CNC(=O)C4=CC=NC=C4	Glixx	GLXC-10673	-0.12330456	-0.38162113	-4.03828896	-3.84162496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345858-03	NCGC00345858-03	384568772		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1125632-93-0				-5.347024562	4	4		0	-2.99731373				FLT1	FC1=C(NC(=O)C2=C(Cl)C(=CC=C2)C3(CC3)C#N)C=C(OC4=NC5=C(C=C4)N=C(NC(=O)C6CC6)S5)C=C1	SynKinase	SYN-1168	0.31785517	-2.28142704	-3.32458443	-2.99731373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253646-08	NCGC00253646-08	384568565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	138112-76-2				3.7621402499	4	4		0	4.94839531				HTR2C	COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1	MedChem Express	HY-17038	0.04145937	0.26029704	-0.32079323	4.94839531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346645-06	NCGC00346645-06	384568877		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	934541-31-8				-9.8073857455	4	4		0	-4.55252368				AURKA	CC[S+]([O-])(=O)C1=CC=CC(=C1)C2=CC(=C(C)C3=C2C4=C([NH]3)N=CC(=C4)C)C(=O)NC5CCN(C)CC5	MedChem Express	HY-12201	-1.53399668	-2.77139795	-0.78740157	-4.55252368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183912-09	NCGC00183912-09	363677100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	865362-74-9				-10.3758493841	4	4		0	-4.01526933				MAPK7	NC1=N[NH]C2=NN=C(C=C12)C3=C4C=CC=C[N]4N=C3C5=CC=CC=C5	MedChem Express	HY-12275	-0.95356551	-2.95513704	-4.111986	-4.01526933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095107-18	NCGC00095107-18	384568145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	21187-98-4				-2.68744972	4	4		0	-2.94076064					CC1=CC=C(C=C1)[S+]([O-])(=O)NC(=O)NN2CC3CCCC3C2	MedChem Express	HY-B0753	1.31288004	-3.04700658	-2.44969379	-2.94076064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166111-06	NCGC00166111-06	384568304		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	50-27-1				-6.3962119227	4	4		0	-2.67070882				ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)O)[C@@H]1C[C@@H](O)[C@@H]2O	Selleck	S2466	-1.04652807	-0.33603177	-2.1356595	-2.67070882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346710-03	NCGC00346710-03	363677530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	130641-38-2				-11.2696586118	4	4		0	-2.10671998					CC(C)(OCC1=N[N](CC2=CC=CC=C2)C3=C1C=CC=C3)C(O)=O	APExBIO	B2156	-3.49092908	1.25276345	-2.36953456	-2.10671998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345881-05	NCGC00345881-05	363677399		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	168626-94-6		7.9432823472	-5.1	5.7001247557	4	4		12.609432572	10.84115024	0.0715631199	0.9968591613		AVPR1A	CC1=NC2=C([NH]1)C3=CC=CC=C3N(CC2)C(=O)C4=CC=C(NC(=O)C5=CC=CC=C5C6=CC=CC=C6)C=C4	MedChem Express	HY-18347A	-0.60472787	-1.34119381	0.11283498	10.84115024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229704-02	NCGC00229704-02	384568463		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	112887-68-0				-9.2395315475	4	4		0	-2.52501925				TYMS	CN(CC1=CC2=C(N\C(=N/C2=O)C)C=C1)C3=CC=C(S3)C(=O)N[C@@H](CCC(O)=O)C(O)=O	DC Chemicals	DC8940	-1.52134103	-2.76427704	-2.19640074	-2.52501925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165782-07	NCGC00165782-07	384568282		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	6823-69-4				4.6899215127	4	4		0	4.37150427				NSMAF	O=C(NC1=CC=C(C=C1)/C2=N/CCN2)\C=C\C3=CC=C(\C=C\C(=O)NC4=CC=C(C=C4)C/5=N/CCN5)C=C3	SIGMA	D1692	-1.21934512	-1.3891009	-0.11965301	4.37150427												1.6E-8	8E-8	4E-7	0.000002											
NCGC00381559-06	NCGC00381559-06	384569099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1187075-34-8				-16.7487460605	4	4		0	-6.25				HDAC1	CN(C)CC1=CC=C(C=C1)[S+]([O-])(=O)[N]2C=CC(=C2)\C=C\C(=O)NO	MedChem Express	HY-14718A	-2.62509065	-3.17702765	-4.5112782	-6.25												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346627-08	NCGC00346627-08	363677484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1138549-36-6				-5.1932013069	4	4		0	-0.89712919				POLR2A	CN1CCCN(CC1)C2=CC=C3C(=O)\C(=C/4SC5=C(C=CC=C5)N4C3=N2)C(=O)NCC6=CN=C(C)C=N6	Glixx	GLXC-90042	-2.10297317	1.03864365	-1.03199174	-0.89712919												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00510504-01	NCGC00510504-01	384569465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1450824-22-2				3.1949417182	4	4		0	2.0939184					OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)[N]3C=C(N=N3)C4=CC=CC(=C4)F)[C@H](O)[C@H]([C@H]1O)[N]5C=C(N=N5)C6=CC=CC(=C6)F	MedChem Express	HY-19940	0.73249753	-0.27339004	-0.07085164	2.0939184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508985-02	NCGC00508985-02	384569373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1642300-52-4				-15.295614142	4	4		0	0.39740948				XPO1	NC(=O)C(=C/[N]1C=NC(=N1)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)/C3=CN=CN=C3	MedChem Express	HY-100423	-4.09645157	-2.88505572	-4.45707448	0.39740948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390715-04	NCGC00390715-04	384569208		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	956590-23-1				-5.0051486155	4	4		0	-1.78837556					CN(C)CCN1C(=O)C2=C3C(=CC=C2)C=C(NC(N)=O)C=C3C1=O	MedChem Express	HY-16509	-0.30683403	-2.06555905	-2.06185567	-1.78837556												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263202-06	NCGC00263202-06	384568661		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1092499-93-8				-11.421716803	4	4		0	-6.10487467				JAK2	FC1=CC(=CC(=C1CN2CCOCC2)F)C3=C4N=C(C=NC4=CC=C3)C5=C[N](N=C5)C6CCNCC6	APExBIO	A3675	-1.7042331	-1.07590273	-2.51057828	-6.10487467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095709-08	NCGC00095709-08	363676577		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	568-72-9				-2.8250398116	4	4		0	3.27541135				TNF	CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C	Selleck	S2365	-2.25398571	-0.01473839	0.70521862	3.27541135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024246-16	NCGC00024246-16	384568022		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	23541-50-6		15.8489319246	-4.8	-5.8311848665	4	4		11.3377997159	5.33599877	0.4386067066	0.8608075807		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(=C3C2=O)O	Selleck	S3035	-1.53930731	-2.7266028	-5.69816643	5.33599877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163127-08	NCGC00163127-08	384568231		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	55079-83-9		11.220184543	-4.95	18.3938357954	4	4		29.6660623681	22.15909091	0.1313372117	0.9892393178			COC1=C(C)C(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1)C)C	APExBIO	A2415	-0.97171864	1.92454559	4.24590889	22.15909091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496910-01	NCGC00496910-01	384569297		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					14.5096931491	4	4		0	1.86929644				HIF2A	OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C3CCCCC3)C1=O	MedChem Express	HY-17608	5.7405124	-0.68691803	-1.52557583	1.86929644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263117-22	NCGC00263117-22	384568601		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	404950-80-7				-21.1560759381	4	4		0	-5.5195761				HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	MedChem Express	HY-10224	-4.23345664	-2.9461151	-5.95273706	-5.5195761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488771-02	NCGC00488771-02	384569284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1803274-65-8				3.1340249976	4	4		0	0.73581435				IDH1	C[C@H]1C[C@H](CC(C)(C)C1)[N]2C(=NC3=CC(=CC=C23)CCC(O)=O)NC4=CC=C(OC(F)(F)F)C=C4	ChemieTek	CT-BAY143_cm1	0.09708738	2.45938292	0.88287228	0.73581435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015647-31	NCGC00015647-31	384567878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	31430-18-9				-14.1505844778	4	4		0	-2.49044856				TUBB	COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CS3	MedChem Express	HY-13520	-4.00832178	-3.05559696	0.1177163	-2.49044856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025207-15	NCGC00025207-15	363676538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	65673-63-4				-2.0272738109	4	4		0	-1.19225037				BCL2	CCOC(=O)C(C#N)C\1C2=CC(=CC=C2O\C(=C1C(=O)OCC)N)Br	Selleck	S1071	-1.0320781	0.59871277	1.54639175	-1.19225037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242598-10	NCGC00242598-10	377020452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	700874-71-1				-7.6332180155	4	4		0	-2.92101341				TGBR1	C1C[N]2N=C(C3=CC=CC=N3)C(=C2C1)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6	MedChem Express	HY-12075	-1.70153417	-2.03562341	0.4548211	-2.92101341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263950-13	NCGC00263950-13	384568701		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	21462-39-5				-1.408814007	4	4		0	-0.11922504					CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	APExBIO	B1913	-1.28312413	3.92156863	-1.12189206	-0.11922504												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-12	NCGC00159337-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	154598-52-4		12.5892541179	-4.9	71.9092342308	3	4		122.4462997115	109.25726588	0.0309278584	0.9994095618			FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#CC3CC3	Glixx	GLXC-04867	-3.18856515	-0.10316875	-2.20028209	109.25726588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018294-13	NCGC00018294-13	384568002		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	22916-47-8		14.1253754462	-4.85	3.5352497461	4	4		15.4083215759	11.11794556	0.2887377887	0.9451671661		CYP19A1	ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(=C1)Cl	APExBIO	B1977	-0.30236394	-1.63596168	-4.09026798	11.11794556												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346527-03	NCGC00346527-03	384568821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	808118-40-3				1.7194754378	4	4		0	1.9138756				HIF2A	CC1=NC(=C(O)C2=C1C=C(OC3=CC=CC=C3)C=C2)C(=O)NCC(O)=O	Selleck	S1007	-0.42059463	2.65770582	-0.70765148	1.9138756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181131-08	NCGC00181131-08	384568392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	152044-54-7				-12.9813318534	4	4		0	0.23923445				TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	MedChem Express	HY-17029	-3.17621465	-3.39086605	-3.83311219	0.23923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015478-17	NCGC00015478-17	384567854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	220904-83-6		7.0794578438	-5.15	60.0335650518	2.2	4		72.5995676168	62.36385046	0.0134441576	0.9998885339		BRAF	OC1=C(Br)C=C(C=C1Br)\C=C2/C(=O)NC3=C2C=C(I)C=C3	MedChem Express	HY-10542	-0.2055076	0.74797741	19.20430751	62.36385046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505117-01	NCGC00505117-01	384569316		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					2.9375429846	4	4		0	8.85807273				EP300	CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)[C@@H](C)C(F)(F)F)C4=O	NCGCChem	CAL008-010_1st_neg	-1.04022191	-0.96884782	-0.50029429	8.85807273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346453-03	NCGC00346453-03	363677410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1001350-96-4				9.0161643916	4	4		0	-3.08476015				IGFR1	C[C@]1(CCCN1C2=N[N]3C=CC=C3C(=N2)NC4=N[NH]C(=C4)C5CC5)C(=O)NC6=CN=C(F)C=C6	ChemieTek	CT-BMS75	4.31345354	0.96884782	-0.52972337	-3.08476015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093560-13	NCGC00093560-13	384568115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	98319-26-7				-8.8271144283	4	4		0	-1.9076006				AR	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)\C=C/[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-13635	-2.0083682	-1.7961383	-1.45542753	-1.9076006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378974-02	NCGC00378974-02	377020266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1225278-16-9		12.5892541179	-4.9	53.643432989	3	4		62.9001490329	58.77794337	0.0539778478	0.9981991597		PDGFRA	C[N]1C=C(C=N1)C2=CC(=CC=N2)OC3=C(F)C=C(NC(=O)C4(CC4)C(=O)NC5=CC=CC=C5)C(=C3)F	MedChem Express	HY-15240	3.23570432	1.52671756	0.54578532	58.77794337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263224-03	NCGC00263224-03	384568678		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	35922-06-6				-3.3911703194	4	4		0	1.37108793				CERS1	CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Cayman	10006305	-0.86471409	-1.94581649	-1.21285628	1.37108793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345781-01	NCGC00345781-01	174006953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	69123-94-0	1-(2 -Deoxy-2 -fluoro-b-D-arabinofuranosyl)uracil			1.6475706657	4	4		0	-1.21482393					OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N2\C=C/C(=O)NC2=O	Carbosynth	ND06062	2.06157229	0.07369197	-3.94922426	-1.21482393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346930-01	NCGC00346930-01	174007462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	181630-15-9	Picoplatin			4.9321593338	4	4		0	1.49161925					CC\1=C/C=C\C=[N]1[Pt](N)(Cl)Cl	Sequoia	SRP02323p	-0.71467839	-0.2210759	8.29337094	1.49161925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00501213-01	NCGC00501213-01	384569312		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1792180-81-4				1.0561879118	4	4		0	1.28588517				JAK3	C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=C3C=C[NH]C3=NC=N2	Toronto Research	P293775	-0.73966642	1.069192	1.7691287	1.28588517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475733-01	NCGC00475733-01	384569233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	289483-69-8		14.1253754462	-4.85	41.6399470457	3	4		31	30.05382775	0.0558701967	0.9980735135			CC1=CC=C(N[S+]([O-])(=O)C2=CC=CC(=C2)C#N)C3=C1C(=C[NH]3)C#N	ActiveBioChem	A-1283	5.14865845	4.70444478	3.92156863	30.05382775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508867-01	NCGC00508867-01	384569367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1260612-13-2		7.9432823472	-5.1	5.0301603647	4	4		11.4235511719	8.52222549	0.3638210591	0.9099588755		PIK3CB	CC1CC2=CC=CC=C2N1C(=O)C\C3=N\C(=O)\C=C(/N3)N4CCOCC4	Bio Vision	B1263	-1.60295931	1.78598687	2.15375411	8.52222549												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263606-06	Tubastatin A	384568693	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1310693-92-5				8.5987312959	4	4		0	-1.89873418				HDAC6	CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO	Selleck	S2627	2.64419784	6.9455045	-2.27340712	-1.89873418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094226-13	NCGC00094226-13	384568127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	10083-24-6				6.0034575716	4	4		0	-0.72122461				SYK	OC1=CC(=CC(=C1)/C=C/C2=CC(=C(O)C=C2)O)O	Selleck	S3026	3.82244143	-2.12181346	-2.48279988	-0.72122461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164385-06	NCGC00164385-06	363676631		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	50-41-9		15.8489319246	-4.8	-0.6720572001	4	4		-9.394014436	-5.74501203	0.6652297391	0.5680532844		ESR1	CCN(CC)CCOC1=CC=C(C=C1)\C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3	Selleck	S2561	0.23578363	-1.59487256	5.91524426	-5.74501203												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244252-03	NCGC00244252-03	384568507		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	936091-26-8				-11.008736767	4	4		0	-6.64498798				JAK2	CC1=C(NC2=CC(=CC=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=C1	XcessBio	M60172-5s	-0.78772803	-2.58765886	-3.17876932	-6.64498798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346721-04	NCGC00346721-04	363677536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1019779-04-4				4.8717908782	4	4		0	-1.15933833				P2RX7	CC1=C(NC(=O)CNC2=CC(=C(F)C=C2)F)C=C(CN3CCNCC3)C=C1	MedChem Express	HY-15469	2.22498618	0.1684275	-0.08748906	-1.15933833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344505-01	NCGC00344505-01	174006301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	729610-18-8	Calindol; Calindol			-4.0432197389	4	4		0	-1.28166915			846	CASR	C[C@@H](NCC1=CC2=C([NH]1)C=CC=C2)C3=C4C=CC=CC4=CC=C3	SantaCruz Bio	sc-211006	-3.12412831	0.35922766	6.64038811	-1.28166915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386370-01	NCGC00386370-01	384569129		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1246560-33-7				-11.0908858868	4	4		0	3.6661699				PIK3CA	CC(C)[N]1C(=NC2=C1N=C(N=C2C3=CN=C(N)N=C3)N4CCOCC4)C	Selleck	S7016	-3.87726639	-3.68208352	-1.94057004	3.6661699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017159-23	Curcumin	384567975	NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	458-37-7		12.5892541179	-4.9	16.8652908256	4	4		32.3622190039	26.49521531	0.120531502	0.9909470349		NFKB1	COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC	MedChem Express	HY-N0005	-1.55184917	1.46632045	0	26.49521531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091019-19	NCGC00091019-19	384568091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	50-02-2				-3.8063822561	4	4		0	0.59808612				NR3C1	C[C@@H]1C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	MedChem Express	HY-14648	-1.52284264	-1.43577211	0.91404983	0.59808612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378431-08	NCGC00378431-08	363678080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1637739-82-2				-3.1194718261	4	4		0	-1.88397129				RALA	C[N]1N=C(C)C2=C1OC(=C(/C#N)C2C3=CC=C(C=C3)C(F)(F)F)/N	Glixx	GLXC-05808	-1.55184917	2.74935085	0.47176765	-1.88397129												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346440-02	NCGC00346440-02	384568778		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[179386-44-8]				5.4300589073	4	4		0	-1.10391522				DRD2	CN[C@H]1CN2C(=O)NC3=C2C(=CC=C3)C1	Tocris	2773	1.10974106	3.15982293	1.73496859	-1.10391522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263531-10	NCGC00263531-10	363677279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	165800-03-3				1.1104059657	4	4		0	-0.33931854					CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Adooq	A10533	0.81536761	-1.66896341	0.64158647	-0.33931854												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346972-08	NCGC00346972-08	384568978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1706522-79-3]		7.9432823472	-5.1	5.8822541501	4	4		19.7803347239	13.94932936	0.1544575191	0.9850821157		SPHK1	CC1=CC(=CC(=C1)OCC2=CC=C(CN3CCC[C@@H]3CO)C=C2)C[S+]([O-])(=O)C4=CC=CC=C4	Tocris	5754	-2.73361227	0.05987128	3.42631898	13.94932936												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182851-05	NCGC00182851-05	384568411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1247-42-3		12.5892541179	-4.9	46.2399007516	3	4		34.8395974949	34.36661699	0.2879890741	0.9451423241		NRC31	C[C@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO	MedChem Express	HY-B0243	7.9776848	1.0178117	-0.75803517	34.36661699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091835-15	NCGC00091835-15	384568099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	55-86-7				-3.5161425329	4	4		0	-1.61483254					CN(CCCl)CCCl	Enzo	AC3170	-1.20377085	0.09164503	1.00250627	-1.61483254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165722-19	Plerixafor hydrochloride	384568275	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					8.6645731559	4	4		0	1.9138756			7852	CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	NCGCChem	AED021-093	0.30456853	1.92454559	7.31239864	1.9138756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163700-14	NCGC00163700-14	384568248		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	2068-78-2				-11.8280484065	4	4		0	-2.30263158			203068	TUBB	CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Selleck	S1241	-2.16098622	-3.94073621	-2.62420758	-2.30263158												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182051-05	NCGC00182051-05	384568406		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	841290-80-0				-15.8133228742	4	4		0	-4.21650718				SYK	COC1=CC(=CC(=C1OC)OC)NC2=NC=C(F)C(=N2)NC3=NC4=C(OC(C)(C)C(=O)N4)C=C3	Selleck	S1533	-3.17621465	-3.23812433	-3.2728881	-4.21650718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167751-05	NCGC00167751-05	384568334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	344930-95-6		8.9125093813	-5.05	29.9099240606	3	4		44.7065913437	37.37120989	0.1122376966	0.992156194		ELA2	COC1=CC(=C2C(=O)N(COC/3=C/C(=O)N4\C=C/C=C(OCCN5CCCCC5)\C4=N3)[S+]([O-])(=O)C2=C1)C(C)C	Axon Medchem	1269	-1.73996438	2.36605098	6.82022136	37.37120989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507859-01	NCGC00507859-01	384569335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1223405-08-0				-4.9949153487	4	4		0	0.4857227				NTRK2	O[C@H]1CCN(C1)C(=O)NC2=C3N=C(C=C[N]3N=C2)N4CCC[C@@H]4C5=CC(=CC=C5F)F	Selleck	S7960	-2.06877654	-0.13738361	0.02991325	0.4857227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015623-11	NCGC00015623-11	384567877		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	6620-60-6				-4.1726751861	4	4		0	-1.86929644					CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1	Prestwick	Prestw-240	-1.76736539	3.8620058	-1.37600957	-1.86929644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510481-01	NCGC00510481-01	384569444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1334294-76-6		11.220184543	-4.95	62.3648827735	3	4		79.2729558915	68.16308507	0.1406646515	0.9875966554		GPR183	ClC1=CC=C(C=C1)/C=C/C(=O)N2CCC3(CC2)CN(CC4=CC=C(Cl)C(=C4)Cl)C(=O)O3	MedChem Express	HY-101192	-0.2055076	8.44145932	8.6449297	68.16308507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00501212-01	NCGC00501212-01	384569311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	944118-01-8				-1.2844850303	4	4		0	-2.48833593				JAK3	NC(=O)C1=CN=C2[NH]C=CC2=C1NC3C4CC5C[C@H]3CC(O)(C5)C4	MedChem Express	HY-19568	0.51133223	-2.64890522	1.60396617	-2.48833593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025230-21	NCGC00025230-21	377020509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	301836-41-9				-10.3453212589	4	4		0	-3.4214619				TGBR1	NC(=O)C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=NC=CC=C3)C4=CC5=C(OCO5)C=C4	MedChem Express	HY-10431	-1.00884467	-3.16949931	-4.28696413	-3.4214619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248196-04	NCGC00248196-04	384568523		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	2226-96-2				1.2340318988	4	4		0	-0.41728763					CC1(C)CC(O)CC(C)(C)N1[O]	Selleck	S2910	1.47838215	-1.91588086	-1.27349909	-0.41728763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346550-03	NCGC00346550-03	384568835		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	936727-05-8				-2.3992343821	4	4		0	4.91803279				CFTR	CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O	APExBIO	A8351	-2.78940028	-1.04774734	2.54699818	4.91803279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167430-04	Tioconazole	170465343	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	65899-73-2	 ; Vagistat-1;Tioconazole; Tioconazol;TIOCONAZOLE; Tioconazole	14.1253754462	-4.85	18.1563146942	4	4		16.8556701	14.5752608	0.37211879	0.9040594685			Clc3sccc3COC(Cn1ccnc1)c2ccc(Cl)cc2Cl	Microsource	01505581	3.57043236	-1.10761862	-1.54639175	14.5752608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016794-14	NCGC00016794-14	174007259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil			-6.5655796507	4	4		0	-4.23248882			5465	PPARA	CC1=CC(=C(C)C=C1)OCCCC(C)(C)C(O)=O	Microsource	MS-01500313	-1.53417015	1.58658883	-0.84899939	-4.23248882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263115-03	NCGC00263115-03	384568599		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	159752-10-0				9.9386477403	4	4		0	0.98684211				GH1	CC(C)(N)C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=C3C=CC=C4)[S+](C)([O-])=O	Axon Medchem	1376	3.2342277	3.1464793	-1.79861418	0.98684211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095264-04	Chloroxine	170465084	Antibacterial	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	773-76-2	; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine	12.5892541179	-4.9	56.7208276224	3	4		77.372224135	71.16573447	0.0437538435	0.9988175596			Oc1c(Cl)cc(Cl)c2cccnc12	Vitas	STK075368	0.80832991	2.36605098	-0.26921926	71.16573447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263138-10	NCGC00263138-10	384568616		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1019206-88-2		14.1253754462	-4.85	33.7287196995	3	4		33.5	30.24727701	0.0373969455	0.9991378385		KDR	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F	MedChem Express	HY-10331A	2.91820797	2.9461151	2.30332037	30.24727701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246966-11	NCGC00246966-11	384568513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	31430-15-6				-14.0203727615	4	4		0	-4.16544009					COC(=O)NC1=NC2=CC(=CC=C2[NH]1)C(=O)C3=CC=C(F)C=C3	MedChem Express	HY-B0294	-2.94560899	-3.5567089	-1.28626982	-4.16544009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346659-04	NCGC00346659-04	384568890		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1013101-36-4 				-13.5845781894	4	4		0	-1.95760966				PIK3CA	COC1=CC=C(C=N1)C2=CC3=C(C)N=C(N)N=C3N([C@H]4CC[C@@H](CC4)OCCO)C2=O	Adooq	A11024	-4.09645157	-2.85452603	0.47861203	-1.95760966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510491-01	NCGC00510491-01	384569453		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	923978-27-2		31.6227766017	-4.5	31.0549926691	3	4		111.5737185279	83.3592535	0.0062525726	0.9999758881		PPARA	CSC1=CC=C(C=C1)C(=O)/C=C/C2=CC(=C(OC(C)(C)C(O)=O)C(=C2)C)C	MedChem Express	HY-16737	-1.34051962	-1.69958659	-1.63312919	83.3592535												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00347955-03	NCGC00347955-03	384568999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1338259-05-4				2.9244785113	4	4		0	-1.86227804				PPARG	C[C@H](NC(=O)C1=CC2=C(C=C1)[N](CC3=CC=C(C=C3)C4=CC=CC=C4C(O)=O)C(=C2C)C)C5=CC=C(C=C5)[N+]([O-])=O	XcessBio	M66048-2s	2.20619431	0.67206354	-2.55677545	-1.86227804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1446502-11-9		14.1253754462	-4.85	5.6006089451	4	4		14.5909732	11.61002614	0.2002271145	0.9746485434		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	-1.07201759	0.84008843	-1.325811	11.61002614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485481-02	NCGC00485481-02	384569275		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	913064-47-8				-0.6251847165	4	4		0	5.51193226				BDKRB1	ClC1=C2C(=CC=C1)CN(C3=CC=CC(=C3)C(=O)N4CCC5(CCN(CC5)C6=CC=NC=C6)CC4)C2=O	MedChem Express	HY-15043	-1.577687	-0.69866343	-0.32591753	5.51193226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095112-07	NCGC00095112-07	384568146		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	70356-09-1				13.2469312677	4	4		0	6.7265234					COC1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)C(C)(C)C	Selleck	S1904	1.71256336	5.1137231	0.38887227	6.7265234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023673-18	NCGC00023673-18	384568019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	58-61-7				4.5759894427	4	4		0	2.39917574				ADORA1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-B0228	0.69872585	3.34300107	-1.9144481	2.39917574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378557-07	NCGC00378557-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1391712-60-9				-0.9113711416	4	4		0	-5.5195761					CNC(=O)C1=CC=CC=C1NC2=NC(NC3=CC=C4C[C@H](CCCC4=C3OC)N5CCN(CCO)CC5)=NC=C2Cl	Glixx	GLXC-90189	1.35635018	-2.12181346	1.76488184	-5.5195761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386509-01	Fluticasone furoate	384569143	Glucocorticoid Receptor (GR) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	397864-44-7		5.0118723363	-5.3	10.1722196032	4	4		19.84422524	15.76390933	0.0775073606	0.9962946847		NRC31	C[C@@H]1CC2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)SCF	Axon Medchem	1172	-2.3701877	-0.04579454	6.40143584	15.76390933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094763-03	NCGC00094763-03	174006989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1405-20-5	; ; polymyxin B(1);POLYMYXIN B SULFATE;Polymyxin B sulphate; Polymycin B sulfate			-5.331156141	4	4		0	-2.00763467					CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)NC([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)C(NC(=O)[C@@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O	TCI	P1923	-1.58927584	-0.19905068	0.52493438	-2.00763467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015026-16	NCGC00015026-16	384567797		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	5908-99-6				-3.2784799566	4	4		0	0.30316154				CHRM1	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	MedChem Express	HY-B0394	-0.08485363	-0.79425691	-3.91036246	0.30316154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015610-29	NCGC00015610-29	384567875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	75706-12-6				2.1079495772	4	4		0	0.99953867				DHODH	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	MedChem Express	HY-B0083	0.30236394	1.54753132	-0.70521862	0.99953867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250411-03	NCGC00250411-03	384568559		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[128253-31-6]				-3.7608799199	4	4		0	-2.3835153				ALOX5AP	OC(=O)[C@H](C1CCCC1)C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C2	Tocris	3541	-0.82462892	1.25276345	-1.0719323	-2.3835153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090762-05	NCGC00090762-05	384568084		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	72559-06-9				-7.4256454819	4	4		0	1.21482393				PRKDC	[H][C@]1(C)\C=C\C=C(C)\C(=O)NC2=C3NC4(CCN(CC(C)C)CC4)N=C3C5=C(C2=O)C(O)=C(C)C6=C5C(=O)[C@](C)(O6)O\C=C\[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@]([H])(C)[C@@]1([H])O	APExBIO	B2126	-2.3364486	-0.36845984	-3.01833568	1.21482393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345799-06	Oprozomib	384568748	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	935888-69-0				-12.3814191623	4	4		0	-2.37105466				PSMD1	COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@@]3(C)CO3	MedChem Express	HY-12113	-2.33835752	-4.49574727	-2.13971943	-2.37105466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	915087-33-1				4.7116154989	4	4		0	1.13933795				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	1.46499507	0.63791009	-0.4676208	1.13933795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015060-28	NCGC00015060-28	384567803		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	446-86-6				0.982897205	4	4		0	0.90484943				HPRT1	C[N]1C=NC(=C1SC2=C3[NH]C=NC3=NC=N2)[N+]([O-])=O	MedChem Express	HY-B0256	1.09176341	-1.97519522	-1.57480315	0.90484943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163505-09	NCGC00163505-09	384568244		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	133053-19-7		12.5892541179	-4.9	30.7207270121	3	4		41.1595208399	36.22225364	0.1932982803	0.9762417332		PRKCA	COC1=CC=C2[N](CCCN(C)C)C=C(C2=C1)C/3=C(/C(=O)NC3=O)C4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-13689	3.05417358	-2.55703568	-3.38291047	36.22225364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507893-01	NCGC00507893-01	384569356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	256476-36-5				11.0267570876	4	4		0	3.13869645				PLAU	CC(C)(N[S+]([O-])(=O)C1=CC2=C(C=C1)C(=CN=C2NC(N)=N)Cl)C(O)=O	Selleck	S8457	3.55168601	0.87276068	-1.42898804	3.13869645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263151-07	NCGC00263151-07	384568625		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	443797-96-4		12.5892541179	-4.9	34.625387808	3	4		37.7163964209	34.51710697	0.2392629852	0.9629762265		AURKA	NC1=NC(=N[N]1C(=O)C2=C(F)C=CC=C2F)NC3=CC=C(C=C3)[S+](N)([O-])=O	MedChem Express	HY-10329	4.55381134	-0.54987017	-3.45916679	34.51710697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092310-14	NCGC00092310-14	384568104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	71675-85-9				1.1741880861	4	4		0	2.41085607				DRD2	CCN1CCCC1CNC(=O)C2=C(OC)C=C(N)C(=C2)[S+]([O-])(=O)CC	MedChem Express	HY-14545	-0.42426814	-0.6415152	1.29342758	2.41085607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165909-10	NCGC00165909-10	384568298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	289905-88-0				8.5107084977	4	4		0	5.00938357					[Cl]C1=CC=CC=C1[C]([N]2C=CC=N2)(C3=CC=CC=C3)C4=CC=CC=C4	SIGMA	T6700	3.84669778	-2.9326409	-4.30139871	5.00938357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025035-05	NCGC00025035-05	124886984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	152121-47-6	 SB-203580;SB-203580	14.1253754462	-4.85	25.0800612449	4	4		31.060747664	26.64923881	0.320120868	0.9310781414	1432	MAPK14	C[S+]([O-])C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=NC=C3)C4=CC=C(F)C=C4	BIOMOL	EI-286	-0.46728972	7.08916728	2.00282087	26.64923881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014670-26	NCGC00014670-26	384567793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	57808-66-9				-11.0930551943	4	4		0	-4.40338722				DRD1	ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2	MedChem Express	HY-B0411	-2.08480068	-1.94410693	-1.60124699	-4.40338722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024309-20	NCGC00024309-20	384568024		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[33286-22-5]				11.952169815	4	4		0	-0.89299461					COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O	Tocris	0685	6.11353712	-2.76427704	-1.51622502	-0.89299461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402345-02	NCGC00402345-02	363681031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	944842-54-0				-7.7819062061	4	4		0	-0.66234913				JAK2	CC[C@@](C)(NC1=CC=NC(=N1)C2=C[NH]C3=C2C=CC=N3)C(=O)NCC(F)(F)F	Glixx	GLXC-90220	-2.45239074	0.74797741	-2.21358062	-0.66234913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507871-01	NCGC00507871-01	384569344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1554458-53-5				-14.6659178594	4	4		0	-3.40005888				TTK	COC1=CC=C(OC2=N[N]3C(=CN=C3C(=C2)NCCC(F)(F)F)C4=CC(=C(C=C4)C(=O)NC5CC5)C)C(=C1F)F	Selleck	S8215	-2.31538567	-3.8620058	-5.02542626	-3.40005888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250383-02	NCGC00250383-02	363677177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	626221-47-4				-5.9190469269	4	4		0	-3.47801499				ERN1	CC1=CSC(=N1)NC(=O)C2=C(N)C3=C(S2)N=C4CCCC4=C3C(F)(F)F	Axon Medchem	1656	-0.20729685	-1.45460113	-2.53718285	-3.47801499												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345451-04	NCGC00345451-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE			3.1622776602	-5.5	53.6428774239	4	4		15.5	19.36943306	0.5686818421	0.7274094785			NC(=O)C1=C2N=C(NC2=CC=C1)C3=C(F)C=C(C=C3)[C@@H]4CCCN4	Selleck	S2197	10.54449972	1.79145613	15.71886847	19.36943306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092372-12	NCGC00092372-12	384568108		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	4311-88-0				-1.9166912656	4	4		0	-0.84829634				RIPK1	CN1C(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC1=S	Glixx	GLXC-12010	0.51133223	-2.74077477	-0.9623797	-0.84829634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178241-13	NCGC00178241-13			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	15663-27-1				2.4398718798	4	4		0	-4.20095279					[NH3+][Pt--]([NH3+])(Cl)Cl	Selleck	S1166	3.11129967	-0.97754697	-2.4063769	-4.20095279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475744-02	NCGC00475744-02	377020261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[1101810-02-9]				-14.7133631584	4	4		0	1.50885296				MTOR	C[C@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S+]([O-])(=O)C4CC4)C5=CC=C(NC(=S)NCCO)C=C5	Tocris	5615	-4.22594732	-4.40461725	-2.81989514	1.50885296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024999-04	NCGC00024999-04	384568040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[62929-91-3]				-1.6495060423	4	4		0	3.75673595				ADRB2	CC[C@H](NC(C)C)[C@H](O)C1=CC=C(O)C2=C1\C=C/C(=O)N2	Tocris	1102	-1.12691928	-2.21749696	-0.04251098	3.75673595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522303-02	NCGC00522303-02	384569515		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	834153-87-6				-2.6100732523	4	4		0	-1.78598922				GNRHR	COC1=C(F)C(=CC=C1)C/2=C(C)/N(CC3=C(F)C=CC=C3C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C4=CC=CC=C4)C2=O	MedChem Express	HY-14789	0.33807579	-1.88335358	-1.17613717	-1.78598922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522465-01	NCGC00522465-01	384569518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1243245-18-2				0.6246693034	4	4		0	-2.85593101				PORCN	CC(=O)N1CCN(CC1)C2=CN=C(NC(=O)CC3=CN=C(C(=C3)C)C4=CC(=NC=C4)F)C=C2	MedChem Express	HY-100408	0.12437811	3.23074567	0.26246719	-2.85593101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387488-03	NCGC00387488-03	363680640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1137868-52-0				-9.7709085625	4	4		0	5.47134402				PLK1	COC1=CC(=C(F)C=C1NC2=NC3=C(C=N2)N(C)C(=O)C(F)(F)CN3C4CCCC4)C(=O)NC5CCN(C)CC5	Glixx	GLXC-05988	-3.5921369	-3.81854284	-2.88765228	5.47134402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345084-02	NCGC00345084-02	384568732		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1132653-79-2				-0.9797873896	4	4		0	-1.90916089				SHH	ClC1=CC=C(CNC(=O)C[C@@H]2C\C=C/CCC(=O)O[C@@H](CNC2=O)C3=CC=CC=C3)C=C1	Cayman	13204	-0.3099028	1.70109356	0.07085164	-1.90916089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386284-05	NCGC00386284-05	363680185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1240299-33-5				-4.9588196937	4	4		0	-3.07929176			367	AR	CC(=O)N1CCN(CCOC2=CC=C(C=C2)C3CCN(CC3)/C4=N/[N]5C(=NN=C5C(F)(F)F)CC4)CC1	Glixx	GLXC-90100	-1.97210875	0.66828676	2.73487318	-3.07929176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159339-04	NCGC00159339-04	384568169		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3810-74-0				-0.5434271409	4	4		0	3.1130607					CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)C=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	MedChem Express	HY-B0472	-1.48404993	2.75748994	-1.44202472	3.1130607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381562-02	NCGC00381562-02	384569100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1403254-99-8				7.9041875587	4	4		0	-2.80175463				EZH2	CCN(C1CCOCC1)C2=C(C)C(=CC(=C2)C3=CC=C(CN4CCOCC4)C=C3)C(=O)NC\C5=C(C)\C=C(C)/NC5=O	XcessBio	M60122-2s	2.87101248	2.63824713	1.17716304	-2.80175463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181000-08	NCGC00181000-08	384568385		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	94055-76-2				-5.9161537478	4	4		0	-3.19796236					CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1	Bio Vision	2624	-1.9556172	-0.31301237	2.41318423	-3.19796236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189393-09	NCGC00189393-09	363677130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1430213-30-1		1.1220184543	-5.95	61.2374499616	1.4	4		43.5167796268	32.57457939	0.378192017	0.8999383434		BLM	FC1=C(C=C(NC(=O)NC2=NN=C(S2)C3=CC=NC=C3)C=C1)C(F)(F)F	MedChem Express	HY-12342	-0.87064677	4.48629613	51.47273258	32.57457939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387224-01	NCGC00387224-01	363680579		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[161832-65-1]				3.7679521261	4	4		0	-0.12992638					C[C@@H]1CC2=C(C=C3OCOC3=C2)C(=N\N1C(C)=O)/C4=CC=C(N)C=C4	Tocris	5032	2.17790977	0.61096686	-3.03805083	-0.12992638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263156-12	NCGC00263156-12	384568630		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	656247-18-6				-1.633042398	4	4		0	-5.78906851			2324	FLT1	COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5	MedChem Express	HY-11106	2.64826032	-2.91616039	-2.9049171	-5.78906851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386428-07	NCGC00386428-07	384569138		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1082949-68-5				-10.5431416575	4	4		0	-3.41801386				RPS6KB1	C[N]1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=N[NH]4)C5=CC=C(F)C(=C5)C(F)(F)F	MedChem Express	HY-12493A	-1.74672489	-1.94410693	-3.10330169	-3.41801386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508823-01	NCGC00508823-01	384569360		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			8.9125093813	-5.05	39.8776123462	3	4		41.0739029991	37.10546574	0.0215081723	0.9997148711			CC1(C)N(CC2=CC=C(C=C2)C3=C[NH]N=N3)C(=S)N(C1=O)C4=CC=C(C#N)C(=C4)C(F)(F)F	NCI	BG-15a	2.11297366	1.7618469	7.89287233	37.10546574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390563-02	NCGC00390563-02	384569193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1133432-46-8				3.9450667849	4	4		0	6.9899923				BTK	CN1CCN(C)C(=O)C1C2=CC=C(N/C3=N/C(=C\N(C)C3=O)C4=C(C)C(=CC=C4)NC(=O)C5=CC6=C(CCCC6)S5)C=C2	MedChem Express	HY-15427A	-0.3099028	0.36452005	-1.06277455	6.9899923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015608-22	Loperamide hydrochloride	384567873	mu-Opioid Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	34552-83-5		12.5892541179	-4.9	94.0542602504	3	4		109.5223432906	98.03311165	0.0560475505	0.9980575444		OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-B0418A	6.42163662	1.38619764	4.8852266	98.03311165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159510-16	NCGC00159510-16	384568183		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	129722-12-9		12.5892541179	-4.9	63.8454622683	3	4		80.6974331209	73.94934201	0.0948171731	0.9944143886		HTR2A	ClC1=CC=CC(=C1Cl)N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2	MedChem Express	HY-14546	3.56449376	1.86316888	-2.61918776	73.94934201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023230-28	NCGC00023230-28			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	912-60-7, 128-62-1 [noscapine]				1.8586609461	4	4		0	-4.10358002					COC1=CC=C2[C@H](OC(=O)C2=C1OC)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34	Microsource	01500443	1.12343967	3.44313609	-0.50029429	-4.10358002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378903-01	NCGC00378903-01	363678268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	911417-87-3				-4.6246847269	4	4		0	-3.98699279			59067	ROCK2	CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC(=C3C=CC=CC3=N2)NC4=CC5=C([NH]N=C5)C=C4	MedChem Express	HY-15307	1.3681592	-2.80202113	-4.54943132	-3.98699279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185916-05	NCGC00185916-05	384568429		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1203494-49-8	 NCGC00185916;NCGC00185916			5.9673274185	4	4		0	-1.3289976			5315	PKM2	NC1=CC(=CC=C1)[S+]([O-])(=O)N2CCCN(CC2)[S+]([O-])(=O)C3=CC4=C(OCCO4)C=C3	NCGCChem	MBB17-039	3.026534	1.11774613	-2.21638962	-1.3289976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356073-13	NCGC00356073-13	384569027		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1044870-39-4				-1.9931051454	4	4		0	-3.63636364				BRD4	COC1=CC(=C2C(=O)N\C(=N/C2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC	Cayman	16424	0.13947001	-0.92800479	1.45542753	-3.63636364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390588-01	NCGC00390588-01	384569199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1450655-76-1				2.4300324746	4	4		0	5.96217699					CC[S+]([O-])(=O)N1CCC(CC1)C(C)[N]2C(=C(C(=O)NC\C3=C(OC)\C=C(\C)NC3=O)C4=C2C=CC=C4)C	MedChem Express	HY-15956	0.22627634	-1.68015885	-2.04542036	5.96217699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167831-05	NCGC00167831-05	363676672		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	86639-52-3				-17.968718442	4	4		0	-4.99401914				TOP1	CCC1=C2CN3C(=O)\C4=C(/C=C3/C2=NC5=CC=C(O)C=C15)[C@@](O)(CC)C(=O)OC4	ChemieTek	CT-SN38	-3.29224075	-4.09347793	-4.24590889	-4.99401914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346932-04	SB-3CT	384568968	MMP2/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	292605-14-2				-0.4734219284	4	4		0	1.13636364				MMP2	[O-][S+](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2	MedChem Express	HY-12354	-0.56562727	0.76370857	-0.58970957	1.13636364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271596-15	NCGC00271596-15	384568705		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	107868-30-4				-0.6533907833	4	4		0	7.39030023				CYP19A1	C[C@]12CC[C@H]3[C@@H](CC(=C)\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CCC2=O	MedChem Express	HY-13632	-2.11297366	-1.2454435	0.12753295	7.39030023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092364-11	NCGC00092364-11	384568107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	123464-89-1				0.403154242	4	4		0	1.84757506				CHRNA7	ClC1=CC=C(C=C1)C(=O)N[C@H]2CN3CCC2CC3	MedChem Express	HY-12560A	-1.35230314	2.73390036	0.80770866	1.84757506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346666-01	NCGC00346666-01	174006218		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	15291-75-5	Ginkgolide A			9.9825252196	4	4		0	-1.75463422			2554	GABRA1	C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)C36[C@@H](O)C(=O)O[C@H]6O[C@@]4(C(=O)O5)[C@@]12O	Selleck	S2026	3.95284327	1.92279028	-0.20600353	-1.75463422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142423-05	NCGC00142423-05	384568163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	60-81-1				8.4579295068	4	4		0	-0.19810386				SCL5A2	OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(=CC(=C2)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2343	2.39944521	4.60575347	-1.05944673	-0.19810386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346886-09	NCGC00346886-09	363677551		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1037184-44-3 				-8.8506126005	4	4		0	-4.64129051				EWSR1	COC1=CC=C(C=C1)C(=O)CC2(O)C(=O)NC3=C(Cl)C=CC(=C23)Cl	Glixx	GLXC-90037	-0.62413315	-1.47562975	-3.94349617	-4.64129051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263090-09	NCGC00263090-09	384568583		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1124329-14-1				-9.151893119	4	4		0	-3.15946349				TTK	COC1=C(NC2=NC=C3N(C)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)OC5CCN(C)CC5	MedChem Express	HY-14710	-1.14365411	-3.29292022	-2.24378411	-3.15946349												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507938-02	NCGC00507938-02	384569357		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					-6.1705769527	4	4		0	-2.47391952					C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CN=C(NCC3=CC=CO3)[N]4C=NN=C24	NCGCChem	PJM011-078	-0.58577406	-1.58658883	-2.45603396	-2.47391952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346547-03	NCGC00346547-03	384568833		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1191951-57-1		12.5892541179	-4.9	81.4572218445	3	4		126.5393372726	114.12816691	0.0246453752	0.9996251793		PDPK1	CCCCCCCCCCCCC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NN=CS2	Selleck	S1556	-1.70153417	0.95794043	-0.24257126	114.12816691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107508-04	NCGC00107508-04	384568161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[901245-65-6]				-2.2599522886	4	4		0	-2.61296376				BRPF1	COC1=CC=CC=C1C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCCC4	Tocris	5385	0.28284542	0.09164503	-1.56414498	-2.61296376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508824-01	NCGC00508824-01	384569361		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	227947-06-0				1.0641259538	4	4		0	6.79948029				AR	CC(C)(C1=CC=C(OCC(O)CO)C=C1)C2=CC=C(OCC(O)CCl)C=C2	SIGMA	92427	-1.44251167	-1.77180388	1.29342758	6.79948029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182549-04	Vicriviroc (SCH-417690)	384568410	Chemokine CCR5 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	541503-81-5				-0.9525244432	4	4		0	3.91222752				CCR5	COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F	Adooq	A10971	-0.67882902	-1.83290057	-1.23326816	3.91222752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093356-10	NCGC00093356-10	384568114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	147-94-4				-6.9576053274	4	4		0	-4.8361484					NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	Selleck	S1648	1.10309716	-3.87963953	-4.93307264	-4.8361484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167525-11	NCGC00167525-11	384568325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	118292-40-3		11.220184543	-4.95	34.6790567767	4	4		13.5	15.90909091	0.0876209971	0.9952986603		RARB	CCOC(=O)C1=CC=C(N=C1)C#CC2=CC=C3SCCC(C)(C)C3=C2	MedChem Express	HY-15388	5.32269761	6.10966855	7.04702934	15.90909091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167496-01	NCGC00167496-01	144206050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	61-73-4	; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue	11.220184543	-4.95	35.7337151516	3	4	Methylene Blue Hydrate;Chromosmon;3,7-bis(Dimethylamino)phenazathionium chloride;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride;Urolene Blue;CIPLUS_682274;L+ ffler's alkaline methylene blue stain solution;chlorure de methylthioninium;Methylthioninium Chloride;Methylene Blue - potassium hydroxide solution;Methylene Blue N;Blue N, Methylen;Methylene Blue zinc chloride double salt monohydrate;Blue, Swis;Methylene blue hydrate;CIPLUS_148989;AB02540576-01;Ehrlich's reagent III;Cloruro de metiltioninio;Methylene blue;METHYLTHIONINIUM CHLORIDE;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride, trihydrate;Methylene Blue solution alkaline according to L+ ffler;Yamamoto Methylene Blue B;Azure II;Methylene Blue zinc chloride double salt;Blue, Methylen;methylthioninii chloridum;Chlorure de methylthioninium;LS-268;Methylene Blue solution;Basic Blue 9;Methylene Blue;Taylor's Blue;1,9-Dimethyl-Methylene Blue;Tetramethylthionine chloride;Methylene blue trihydrate;Methylthioninii chloridum;LS-1619;METHYLENE BLUE;Methylene Blue hydrate;3,7-bis(dimethylamino)phenothiazin-5-ium chloride trihydrate;N, Methylene Blu;CIPLUS_657740;	51.4647021655	45.17321016	0.0884640574	0.9951444358			[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	Labotest	LT00032971	1.29595718	-2.58201701	0.66600538	45.17321016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378575-03	NCGC00378575-03	384569050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	153653-30-6				-0.920069981	4	4		0	0.12317167					OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(CC3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5	MedChem Express	HY-17013A	-0.84518946	0.15188335	1.48788437	0.12317167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015110-20	NCGC00015110-20	384567810		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	125-84-8		12.5892541179	-4.9	2.6178411919	4	4		11.905857744	8.94187779	0.0472492645	0.9986390482		CYP19A1	CCC1(CCC(=O)NC1=O)C2=CC=C(N)C=C2	MedChem Express	HY-B0237	-1.17154812	-0.7783266	-0.75803517	8.94187779												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015089-14	NCGC00015089-14	124879266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	17440-83-4	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren			-15.5636614312	4	4		0	-2.7123696			6339	SCNN1D	NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N	Tocris	Tocris-0890	-4.0167364	-1.88594522	-2.24378411	-2.7123696												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00160217-03	Sophocarpine	363676600	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	6483-15-4				0.5251273304	4	4		0	1.58492823				KCNH2	O=C1\C=C/C[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34	Selleck	S2405	-0.7106599	1.74125554	-0.08845644	1.58492823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344081-06	NCGC00344081-06	384568717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	315702-99-9		1	-6	227.6647531903	2.3	4		126.8737707259	40.55427252	1	0.9999693011			CC1=CC=CC(=C1)NC2=NC(=CS2)C3=CC=NC=C3	SIGMA	S7448	4.39498521	49.24058323	125.84667706	40.55427252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522579-01	NCGC00522579-01	384569528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1234479-76-5				-2.1658670223	4	4		0	3.23325635				ERK5	COC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)N5CCN(C)CC5	MedChem Express	HY-14403	-0.98605437	-0.30376671	-2.64985121	3.23325635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244256-04	NCGC00244256-04	377020319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	111358-88-4				-16.365043511	4	4		0	-4.61298995				JAK1	C[C@@]12O[C@@H](C[C@]1(O)CO)[N]3C4=C(C=CC=C4)C5=C6C(=O)NCC6=C7C8=C(C=CC=C8)[N]2C7=C35	Cayman	12094_CM1	-4.14701803	-1.47562975	-1.85403178	-4.61298995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522007-01	NCGC00522007-01	384569509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1293395-67-1]				-4.7145198765	4	4		0	-0.62593145				CSNK1A1	NC1=NC(=CC=N1)C2=C(N=C[N]2C3CCN(CC3)CC4=NOC=C4)C5=CC=C(F)C=C5	Tocris	6346	-3.23570432	1.19742554	4.54821104	-0.62593145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-02	Verteporfin		photosensitizer	DPI_SARS-CoV-2_General		129497-78-5				2.7706670795	4	10		0	-0.02556891					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-0.84377397	1.40628995	0.43467144	3.19611353	0.43467144	-0.69036052	-0.43467144	5.49731526	0.02556891	-0.02556891						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General		1190307-88-0				11.0313296469	4	10		0	4.72806778					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-0.84722602	0.46460782	-0.9565455	-1.99508062	-2.37769882	-1.55780268	0.02732987	-1.55780268	-0.46460782	4.72806778						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00274060-07	Posaconazole			DPI_SARS-CoV-2_General		171228-49-2		0.0008841514	-9.0534733462	131.7294552337	4	10		23	31.760922	0.1649796444	0.6358346154			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	0.50924685	0.0804074	6.13776467	21.52238006	26.23961404	25.97158939	23.66657733	3.08228357	25.06030555	31.760922						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485478-02	Oritavancin (diphosphate)			DPI_SARS-CoV-2_General		192564-14-0				26.7976075888	4	20		0	8.05420609					[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686671-01	Brincidofovir			DPI_SARS-CoV-2_General		444805-28-1				-5.2294866636	4	20		0	1.09946305					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532																3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9	1.7964071856E-8					
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General		126544-47-6		0.0497194887	-7.3034733462	168.8826143899	1.2	20		66.9693905419	59.98906805	0.0002070325	0.8556496751			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00018268-05	Itraconazole		cytochrome inhibitor	DPI_SARS-CoV-2_General		84625-61-6		0.0702306445	-7.1534733462	189.5160017122	2.4	10		71.4480732463	56.60016398	0.1699439639	0.6300174396			CCC(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Prestwick	Prestw-1139	0.46460782	-0.68324679	1.72178191	19.37687893	26.59196502	15.93331511	6.69581853	3.25225471	11.88849412	56.60016398						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00182390-05	NCGC00182390-05			DPI_SARS-CoV-2_General				0.024918773	-7.6034733462	218.5587309668	1.2	10		72.3727794544	61.51954086	0.0148226769	0.8669490019			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	-1.01120525	0.35528833	0.73790653	0.51926756	3.96283137	8.44493031	25.44411041	16.807871	78.40940148	61.51954086						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00490649-01	NCGC00490649-01			DPI_SARS-CoV-2_General						10.8970952367	4	10		0	3.40391316					CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	-1.58134548	-0.56285178	-0.88448137	-2.17099973	0.67006165	2.2782096	0.45564192	0.56285178	3.88635754	3.40391316						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00246387-06	Arbidol		antiinfluenza drug	DPI_SARS-CoV-2_General		131707-23-8		0.0279593232	-7.5534733462	240.6594570586	1.2	10		79.6294117591	72.43315508	0.0001635988	0.9688913061			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	0.40106952	0.72192513	0.02673797	-1.09625668	0.45454545	0.77540107	2.21925134	16.22994652	83.07486631	72.43315508						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General		53-86-1				3.2674015778	4	10		0	0.45454545				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	-0.93582888	1.25668449	-1.20320856	1.25668449	2.70053476	-0.02673797	2.32620321	-0.50802139	1.14973262	0.45454545						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General		259793-96-9				5.4626272425	4	10		0	0.0802139					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	0.34759358	3.55614973	3.55614973	0.45454545	0.72192513	0.61497326	0.82887701	2.05882353	5.42780749	0.0802139						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016622-11	Hycanthone			DPI_SARS-CoV-2_General		3105-97-3		0.0140128558	-7.8534733462	230.3645339415	1.2	10		78.6524064169	-1.84491979	0.0047439737	0.9304135037			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	-0.0802139	-0.93582888	-0.88235294	0.29411765	1.20320856	1.14973262	5	85.58823529	63.44919786	-1.84491979						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00024379-25	Emetine		antiprotozoal agent	DPI_SARS-CoV-2_General		316-42-7		0.0004431254	-9.3534733462	15.3946315079	5	20		-86.3149767687	-4.3722833	0.0000033134	0.9200420015			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	USP	1235004_cm1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General		747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.0056922733	-8.2447142596	44.3208526477	4	20		12.678470976	15.22273845	0.1040663804	0.5176149685	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978																1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00344623-17	NCGC00344623-17	384568726		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1415800-43-9		3.5481338923	-5.45	12.0086376538	4	4		13.324628912	12.22512686	0.0360454249	0.9992043393		L3MBTL3	O=C(N1CCC(CC1)N2CCCC2)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6	Selleck	S7088	-0.68719076	-0.57479735	7.1932299	12.22512686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499248-01	NCGC00499248-01	384569304		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			1.2589254118	-5.9	15.6427504681	4	4		16.814720812	9.83851675	0.4598277081	0.8421472492		CDK8	COC1CC(C1)C(=O)C2=NC3=C(C=NC(=C3C=C2)N)C4=CC=C(C=C4)C5=C[N](C)N=C5	APExBIO	A8739	-1.92893401	-0.67206354	19.57835766	9.83851675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482383-01	NCGC00482383-01	363681128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1700663-41-7				-3.71186336	4	4		0	-1.34569378				PRMT6	CNCCN(C)CC1=C[NH]N=C1C2=CC=C(O[C@@H]3C[C@H](C3)OCCC4CCOCC4)C=C2	ActiveBioChem	A-1962	-0.91370558	1.61906217	-2.15243992	-1.34569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346876-03	NCGC00346876-03	384568954		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	141400-58-0				-0.9162108952	4	4		0	1.64473684				TXNRD1	CCC(C)SSC1=NC=C[NH]1	Cayman	14192	-1.37781001	0.51932183	1.44478844	1.64473684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480730-01	NCGC00480730-01	377020519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-1.6483508259	4	4		0	1.13636364				EIF2AK3	CN1N(C2=CC=CC=C2)C(=O)C(=C1/C3=CC=CC=C3)/C(=O)C4=CC=C(C)C(=C4N)C5=CC=C6N=C(C)C=CC6=C5	Tocris	5517	-0.59463379	-1.2830304	-0.11794191	1.13636364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-09	NCGC00160398-09	384568193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	82956-11-4				-0.1063673633	4	4		0	-2.13423609				TPSAB1	NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC=C3C=C(C=CC3=C2)C(N)=N	MedChem Express	HY-B0190A	1.5755583	-2.54922913	-1.07687706	-2.13423609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185994-09	NCGC00185994-09	384568432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	403811-55-2		12.5892541179	-4.9	61.0955594006	3	4		70.6897509689	62.82722513	0.1054378312	0.9930815455		MYC	CCC1=CC=C(C=C1)\C=C/2SC(=S)NC2=O	SIGMA	F3680	5.33980583	-0.31301237	1.03001766	62.82722513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386518-01	Cannabidiol	377020361	Cannabinoid Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	13956-29-1		14.1253754462	-4.85	36.84279194	3	4		37.5	32.94184237	0.1156167474	0.9916744519		CNR1	CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O	Axon Medchem	1234	3.95284327	2.10165449	0.94173043	32.94184237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095161-10	NCGC00095161-10	384568152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	90098-04-7				-9.5265898048	4	4		0	-1.609538					OC(=O)C(CC/1=C/C(=O)NC2=CC=CC=C12)NC(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-B0360	-2.42677824	-1.5566532	-1.48574894	-1.609538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018157-21	NCGC00018157-21	384567993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	5104-49-4				8.1176129861	4	4		0	-1.465311					CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	Enzo	DL400	3.00217549	0.03054834	2.1819254	-1.465311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379060-01	NCGC00379060-01	363678333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	902156-99-4		10	-5	14.3241529866	3	4		44.2338096015	35.61602871	0.0202311246	0.9997476694		CDK1	C[S+]([O-])(=O)N1CCC(CC1)NC(=O)C2=C(NC(=O)C3=C(Cl)C=CC=C3Cl)C=N[NH]2	MedChem Express	HY-15241	-3.7853517	-3.05483428	-0.70765148	35.61602871												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346684-02	NCGC00346684-02	384568908		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	65678-07-1		1.4125375446	-5.85	40.3191519013	1.4	4		32.8104719885	23.95334928	0.3599718409	0.9105238506		EGFR	CC(C)(C)C1=C(O)C(=CC(=C1)C=C(C#N)C#N)Br	Selleck	S1234	-1.55184917	-0.06109669	37.80038331	23.95334928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-10	NCGC00249613-10	384568530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	868540-17-4				-12.7460978333	4	4		0	-4.48925523				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	ActiveBioChem	A-1098	-3.13741608	0.80903679	-2.7819324	-4.48925523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509938-02	NCGC00509938-02	384569387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1365888-06-7		14.1253754462	-4.85	11.3108667804	4	4		14.621508168	11.73093906	0.4166893919	0.8757312156		ESR1	CC\C(C1=C(Cl)C=C(F)C=C1)=C(\C2=CC=C(\C=C\C(O)=O)C=C2)C3=CC4=C([NH]N=C4)C=C3	MedChem Express	HY-12864	2.28798466	-3.43459014	-1.28626982	11.73093906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346691-07	NCGC00346691-07	384568913		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	842133-18-0				2.3202151036	4	4		0	-0.28300552				SCL5A2	CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	MedChem Express	HY-10451	-0.06934813	0.43225518	3.44320188	-0.28300552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370925-02	NCGC00370925-02	363677938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1188296-52-7				1.140951837	4	4		0	-4.49978775				CSNK1E	NC1=C2C(=N[N](C3CCOCC3)C2=NC=N1)COC4=CC(=CC=C4)Cl	Axon Medchem	1792	0.7628294	4.06916083	-0.41200706	-4.49978775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162225-11	NCGC00162225-11	384568220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	16595-80-5				4.1367461156	4	4		0	2.14901739				CHRNA3	C1CN\2C[C@@H](\N=C2S1)C3=CC=CC=C3	MedChem Express	HY-13666	1.86567164	-1.88332568	-1.31233596	2.14901739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015245-12	NCGC00015245-12	384567831		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	590-63-6				-0.1316215628	4	4		0	-1.19225037					CC(C[N+](C)(C)C)OC(N)=O	Selleck	S2455	-0.08368201	2.54452926	-1.15221346	-1.19225037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356069-03	NCGC00356069-03	384569025		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1300031-52-0				-11.4279745758	4	4		0	-2.68256334			23476	BRD4	C[C@H]1C[C@@H](NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O	Selleck	S7620	-2.42677824	-1.85600958	-2.75924803	-2.68256334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163470-28	FK-506	384568242	mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	104987-11-3				6.2455591852	4	4		0	0.71535022				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Bio Vision	1563	2.37099024	0.50890585	-1.00060643	0.71535022												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390223-01	NCGC00390223-01	363680864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	102676-47-1				-6.9849025884	4	4		0	-2.7123696				CYP19A1	N#CC1=CC=C(C=C1)C2CCCC3=CN=C[N]23	Adooq	A11088	-1.56206416	0.86813351	-1.7586416	-2.7123696												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164617-14	NCGC00164617-14	384568266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	106685-40-9				6.9285702656	4	4		0	2.8708134					COC1=CC=C(C=C1C23CC4CC(CC(C4)C2)C3)C5=CC=C6C=C(C=CC6=C5)C(O)=O	Enzo	GR111	1.31979695	3.84909119	-1.82809966	2.8708134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181796-03	NCGC00181796-03	384568403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	79517-01-4				-3.3864748479	4	4		0	-0.41866029				SSTR1	C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=C[NH]C5=CC=CC=C45)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1	Enzo	DL309	-1.58085569	1.49686879	-0.61919505	-0.41866029												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346717-02	NCGC00346717-02	384568930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1217486-61-7				-4.9221465229	4	4		0	-4.34206653				PIK3CA	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(N)=O)C3=CC(=NC=C3)C(C)(C)C(F)(F)F	Selleck	S2814	-1.13714207	-1.20592276	2.96141191	-4.34206653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093802-09	NCGC00093802-09	363676565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	53-43-0				9.7514972158	4	4		0	2.13423609					C[C@]12CC[C@H]3[C@@H](C\C=C/4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	Selleck	S2604	3.32922318	-0.01526485	-0.47861203	2.13423609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018172-18	NCGC00018172-18	384567994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	26807-65-8				-3.2641664344	4	4		0	-2.62971865				CA7	CC1CC2=C(C=CC=C2)N1NC(=O)C3=CC=C(Cl)C(=C3)[S+](N)([O-])=O	MedChem Express	HY-B0259	0.64953013	-1.57709386	-2.65383494	-2.62971865												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165889-13	NCGC00165889-13	384568295		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	694433-59-5				-0.3201750732	4	4		0	6.95602997				TGBR1	CC1=NC(=CC=C1)C2=C(N=C([NH]2)C(C)(C)C)C3=CC4=C(OCO4)C=C3	MedChem Express	HY-13521	-2.00386954	-2.58765886	2.01224847	6.95602997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378789-02	NCGC00378789-02	384569068		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	124083-20-13		14.1253754462	-4.85	13.3272724275	4	4		17.609137052	14.62320574	0.3732997074	0.9034842258		CPT1	CCOC(=O)[C@@]1(CCCCCCOC2=CC=C(Cl)C=C2)CO1	MedChem Express	HY-50202	-0.50761421	4.4295097	0.85507887	14.62320574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250412-08	NCGC00250412-08	384568560		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[1268524-70-4]				-7.5858062019	4	4		0	-2.13423609				BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	Tocris	4499	-0.69872585	-2.48816974	-3.52976369	-2.13423609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390548-02	NCGC00390548-02	384569190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1135237-88-5				-0.475537419	4	4		0	3.01736827					CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2=CN=C[NH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O	MedChem Express	HY-13541A	-1.08234005	1.60280873	-1.55548908	3.01736827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250389-02	NCGC00250389-02	384568542		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	479422-22-5		12.5892541179	-4.9	42.9572840964	3	4		75.2789782949	66.73264527	0.0284067819	0.9995020461		PLCG1	CC1=C(CCOC2=CC=C(C=C2)C(O)=O)C3=CC(=CC=C3[N]1C(C4=CC=CC=C4)C5=CC=CC=C5)Cl	Axon Medchem	1609	-1.644555	-1.20961568	-2.68299796	66.73264527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387832-02	NCGC00387832-02	384569164		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	75747-14-7				5.203816293	4	4		0	1.92280503					COC1CC(C)C/C2=C(NCC=C)/C(=O)/C=C(/NC(=O)/C(=C/C=C/C(OC)C(OC(N)=O)/C(=C/C(C)C1O)C)C)C2=O	APExBIO	A4054	0.84300719	1.02587659	1.28317294	1.92280503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390618-04	NCGC00390618-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1429881-91-3				-8.4624470889	4	4		0	-5.40082002					CCCCNC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C4=CC=C(CN5CCN(C)CC5)C=C4	DC Chemicals	DC7931	-0.56661139	-4.67003522	0.4082823	-5.40082002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345496-08	NCGC00345496-08	363677349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	192441-08-0				3.0745114486	4	4		0	-2.14901739			4255	MGMT	NC1=NC2=C([NH]C=N2)C(=N1)OCC3=CC(=CS3)Br	MedChem Express	HY-13668	1.47871752	2.98576022	-1.69145523	-2.14901739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274038-02	NCGC00274038-02	384568708		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	494772-86-0				-11.404210383	4	4		0	-5.11805457				MAP3K7	NC(=O)NC1=C(SC(=C1)C2=CC=C(CN3CCOCC3)C=C2)C(N)=O	Cayman	11140	-0.98120509	-3.29199204	-3.9661709	-5.11805457												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346827-02	NCGC00346827-02	377020326		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	112953-11-4				-13.9370484254	4	4		0	-4.88822653				CDK1	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)[N]3C4=C(C=CC=C4)C5=C6[C@H](O)NC(=O)C6=C7C8=C(C=CC=C8)[N]2C7=C35	SIGMA	U6508	-3.48675035	2.06555905	-2.6379624	-4.88822653												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00505019-01	NCGC00505019-01	384569313		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	308246-57-3				-19.1076960163	4	4		0	-6.0433646				TOP1	COC1=C(OC)C=C\2C(=C1)C(=O)N(CCCNCCO)\C3=C2C(=O)C4=C3C=C5OCOC5=C4	NCI	NSC706744	-3.43595382	-3.61090641	-4.71086037	-6.0433646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346554-01	NCGC00346554-01	174006708		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	948557-43-5	Tie2 kinase inhibitor			-3.4121783995	4	4		0	1.276334			7010	TEK	COC1=CC2=C(C=C1)C=C(C=C2)C3=C(N=C([NH]3)C4=CC=C(C=C4)[S+](C)[O-])C5=CC=NC=C5	Selleck	S1577	-2.11654755	-1.19380987	2.67983075	1.276334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386313-08	NCGC00386313-08	384569124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1232416-25-9		2.2387211386	-5.65	112.644045096	1.4	4		77.7935735568	81.08565278	0.0885930662	0.9951279197		ATR	CNCC1=CC=C(C=C1)C2=NOC(=C2)C3=C(N)N=CC(=N3)C4=CC=C(C=C4)[S+]([O-])(=O)C(C)C	ActiveBioChem	A-1613	-1.20945574	6.8238762	72.04513399	81.08565278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159422-10	NCGC00159422-10	384568176		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1953-02-2				-5.0909862128	4	4		0	2.06339713					CC(S)C(=O)NCC(O)=O	MedChem Express	HY-B0373	-3.14720812	2.62715748	-0.61919505	2.06339713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386692-01	NCGC00386692-01	363680398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1350547-65-7		5.0118723363	-5.3	63.0744990338	3	4		71.5749915048	67.25478469	0.0190775661	0.9997754909	558	MERTK	CCCCNC1=NC=C2C(=N1)[N](C[C@H]3CC[C@H](N)CC3)N=C2C4=CC=C(F)C=C4	Axon Medchem	2086	-2.53807107	-1.31357874	-1.14993366	67.25478469												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00091231-18	NCGC00091231-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			14.1253754462	-4.85	22.2505409283	4	4		25	22.90669856	0.1193384882	0.9911359272			[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	BIOMOL	AC-129	1.29079043	2.50496411	0.11794191	22.90669856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346652-08	NCGC00346652-08	384568883		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	942487-16-3		14.1253754462	-4.85	3.2317590092	4	4		31.709991024	23.3294083	0.0955720685	0.9943332124		AURKA	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C3=C2C=CC(=C3)NC4=NC(=C(C=N4)C(F)(F)F)NC5CCC5	MedChem Express	HY-14574	-3.3566242	-2.88505572	-5.17499252	23.3294083												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346830-03	NCGC00346830-03	384568946		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	10356-76-0				-15.048083714	4	4		0	-2.45805122				DNMT1	NC\1=N\C(=O)N(\C=C1F)[C@H]2C[C@H](O)[C@@H](CO)O2	SIGMA	F5307	-3.57583231	-2.39658067	-3.44002393	-2.45805122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167328-03	Aloxistatin	363676654	Calpain Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	88321-09-9		3.5481338923	-5.45	49.4813242663	2.2	4		48.5863801616	46.49690904	0.0123920707	0.9999053214		CAPN1	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	Selleck	S7393	-1.27414714	-0.68691803	26.41340114	46.49690904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263108-02	NCGC00263108-02	384568595		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	618385-01-6		10	-5	31.6688615387	3	4		54.193638736	45.20164851	0.0324482289	0.9993503926		PAR1	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\C4=CC=C(C=N4)C5=CC=CC(=C5)F	Axon Medchem	1755	-1.73996438	-0.29003206	3.61950344	45.20164851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386312-01	NCGC00386312-01	384569123		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1202759-32-7		15.8489319246	-4.8	4.183148095	4	4		10.194735268	7.43302914	0.5905423598	0.7001442181		BTK	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=CC(=C4)NC(=O)C=C)C=C2	Selleck	S7257	-0.69872585	3.251412	-2.66227939	7.43302914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356067-11	NCGC00356067-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	202590 -98 - 5				-10.0203006321	4	4		0	-3.70422734					CC1=NN=C2[C@H](CC(=O)NC3=CC=C(O)C=C3)N=C(C4=C(SC(C)=C4C)N12)C5=CC=C(Cl)C=C5	ChemieTek	CT -OTX015	-1.20232172	-2.83264431	-3.1496063	-3.70422734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346467-01	NCGC00346467-01	174007403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1200133-34-1	VCH-916			-2.1330107591	4	4		0	3.28007917					COC1CCC(CC1)N(C(=O)C2CCC(C)CC2)C3=C(SC(=C3)\C4=C\CCCC4)C(O)=O	Ontario Chemicals	V1152 	-1.11940299	-1.94457204	-0.52493438	3.28007917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263161-11	NCGC00263161-11	363677237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	956905-27-4				0.6253951005	4	4		0	0.48070126				MET	OCC[N]1C=C(C=N1)C2=CN=C3N=N[N](CC4=CC=C5N=CC=CC5=C4)C3=N2	Glixx	GLXC-90210	-0.87064677	-0.22967386	3.79119277	0.48070126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164578-06	NCGC00164578-06	384568258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	202409-33-4				-4.9998284875	4	4		0	-1.61176304			5743	PTGS2	CC1=CC=C(C=N1)C2=NC=C(Cl)C=C2C3=CC=C(C=C3)[S+](C)([O-])=O	MedChem Express	HY-15321	-0.84300719	-0.04593477	-2.30387868	-1.61176304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095135-12	NCGC00095135-12	384568150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	181183-52-8				10.1906611145	4	4		0	-0.6557377				HTR1B	CN(C)CCC1=C[NH]C2=CC=C(C[S+]([O-])(=O)N3CCCC3)C=C12	MedChem Express	HY-B0383	4.49093445	-2.00568777	0.8793208	-0.6557377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386327-03	NCGC00386327-03	363680213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1246529-32-7				-2.1068356392	4	4		0	-4.72065829				TTK	CC1=CC(=CC=C1NC2=NC3=C(N=C[NH]3)C(=N2)NC4CCCCC4)N5CCOCC5	APExBIO	B3706	1.44251167	-1.16083702	-2.07550008	-4.72065829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016092-09	NCGC00016092-09	384567919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	634908-75-1				-11.9657066695	4	4		0	-3.02937106				HTR1A	COC1=C(C=CC=C1)N2CCN(CC2)CCN(C(=O)C3CCCCC3)C4=CC=CC=N4	MedChem Express	HY-13105	-2.63881253	-1.16433309	-3.07475317	-3.02937106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246968-07	Olmesartan	384568514	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	144689-24-7				-4.1899482064	4	4		0	2.22974012				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	MedChem Express	HY-17004	-2.22649808	0.54532056	-0.78984485	2.22974012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483926-01	NCGC00483926-01	363681145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1123837-84-2		2.2387211386	-5.65	98.8160295562	3	4		72.9468265135	-6.25864985	1	0.9998970738	3815	FLT1	COCCNCC1=CC=C(N=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4	ChemieTek	CT-MG516	0.16492578	1.96020634	67.08039492	-6.25864985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346670-03	NCGC00346670-03	384568896		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	(913376-83-7)				-9.8468762875	4	4		0	-3.79824696				MET	COC1=CC2=NC=CC(=C2C=C1)OC3=CN=C(NC(=O)C/4=C(C)/N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3	SynKinase	SYN-1144	-1.45684442	-0.16212233	-4.5416079	-3.79824696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263532-10	NCGC00263532-10	384568685		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	140462-76-6				-8.2177214509	4	4		0	-2.49422633					CN(C)CC\C=C/1C2=C(COC3=CC=C(CC(O)=O)C=C13)C=CC=C2	MedChem Express	HY-B0426A	-2.16931962	-1.09356015	-0.07085164	-2.49422633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510355-01	NCGC00510355-01	384569430		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-0.4653800544	4	4		0	-0.46189376					CC(C)N1C(=O)NC(=C/C1=O)\N[C@@H](C)C2=CC=CC=C2	Axon Medchem	2683	-0.64797859	-2.55164034	4.74705966	-0.46189376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522639-01	NCGC00522639-01	384569535		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	376641-49-5				-6.5247228062	4	4		0	-2.49422633					CC1=C(C=CC=C1Cl)[S+]([O-])(=O)NC2=NC(=CS2)CCN3CCOCC3=O	Glixx	GLXC-04401	-1.74672489	-1.94410693	1.6579283	-2.49422633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263271-04	NCGC00263271-04	384568683		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1028486-01-2				-15.8206293747	4	4		0	-3.60277136				AURKA	COC1=CC=CC(=C1/C2=N/CC3=C(N=C(NC4=CC(=C(C=C4)C(O)=O)OC)N=C3)C5=CC=C(Cl)C=C25)F	Selleck	S1133	-3.21171996	-3.46294046	-3.58509282	-3.60277136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	83-79-4	;ROTENONE;Rotenone			8.9523944403	4	4		0	4.60700618			51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	4.45266475	-4.19783239	-4.18785522	4.60700618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024359-10	NCGC00024359-10	384568025		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	52-67-5				-1.8853149433	4	4		0	-0.5089778					CC(C)(S)[C@@H](N)C(O)=O	Enzo	AC3217	-0.34549475	-0.01531159	-0.64158647	-0.5089778												1.6E-8	8E-8	4E-7	0.000002											
NCGC00167520-05	NCGC00167520-05	384568323		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	153259-65-5				5.2770886055	4	4		0	-0.65036053				PDE4A	COC1=CC=C(C=C1OC2CCCC2)C3(CCC(CC3)C(O)=O)C#N	Axon Medchem	1592	3.27529022	-2.49578931	-1.22484689	-0.65036053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345823-02	NCGC00345823-02	363677370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(473382-50-2)		12.5892541179	-4.9	61.7099304857	3	4		96.8236584507	86.32829068	0.0266083591	0.9995630884		AKT1	CC(C)(N)C1=CC=C(C=C1)C2=NC3=C(C=CC=C3)N=C2C4=CC=CC=C4	SynKinase	SYN-1006	-0.09673853	-2.09768795	-1.57480315	86.32829068												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021305-08	NCGC00021305-08	124886756		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE		; ;Rapamycin;Sirolimus; Sirolimus; Wyeth Brand of Sirolimus; Rapamune; Rapamycin (Sirolimus)			-15.5006976667	4	4		0	-2.0924643			2475	MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Selleck	S1039	-2.97125484	-4.27193385	-4.81189851	-2.0924643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480785-05	NCGC00480785-05	377020469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1538604-68-0		12.5892541179	-4.9	51.3637683702	3	4		46.2958424751	43.65898487	0.2652122076	0.9539687563		FGFR4	COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=CN=C(NC4=C(C)C=CC=C4NC(=O)C=C)N=C3C=C2)OC	MedChem Express	HY-12823	8.16749585	-1.66896341	-1.370662	43.65898487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346458-02	NCGC00346458-02	363677413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1096708-71-2				-4.9394597288	4	4		0	-3.39843149				BRAF	C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C2=NC=C(S2)C(=O)NC3=NC=C(Cl)C(=C3)C(F)(F)F	MedChem Express	HY-15246	-1.01704233	2.31392778	-2.03102962	-3.39843149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093347-12	NCGC00093347-12	384568112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	72-33-3				-8.8634409435	4	4		0	5.02844841				ESR1	COC1=CC=C2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCC2=C1	MedChem Express	HY-B0390	-3.49092908	-2.31392778	-2.99012694	5.02844841												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346565-07	NCGC00346565-07	384568842		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	697761-98-1				6.054285878	4	4		0	-4.12625096					COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	MedChem Express	HY-14740	4.42315819	-1.00243013	-2.08303812	-4.12625096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167801-02	NCGC00167801-02	384568338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[1188890-36-9]				-2.1354591502	4	4		0	0.76982294				MMP13	O=C(NCCCCN1CCOCC1)C2=CC3=CC=CC=C3O2	Tocris	2632	-1.77489787	1.88335358	0.72268669	0.76982294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346580-02	NCGC00346580-02	363677462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1201898-17-0				-11.1341761459	4	4		0	-1.60123172				TUBB	CC[C@]12\C=C/CN3CC[C@]4([C@@H](N(C)C5=CC(=C(C=C45)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6[NH]C9=C8C=CC=C9)C(C)(F)F)C(=O)OC)OC)[C@](O)([C@@H]1OC(C)=O)C(=O)OC)[C@H]23	Selleck	S2209	-2.14114664	-3.49331713	-3.27334561	-1.60123172												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00507848-01	NCGC00507848-01	384569329		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1346547-00-9		7.9432823472	-5.1	19.0054840646	4	4		16.484204132	15.21170131	0.2290738006	0.9663932484		RIPK2	CC(C)(C)[S+]([O-])(=O)C1=CC=C2N=CC=C(NC3=N[NH]C4=C3C=C(F)C=C4)C2=C1	Selleck	S8261	2.22566559	-0.82017011	3.61343347	15.21170131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390402-02	NCGC00390402-02	363680887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	858474-14-3		12.5892541179	-4.9	53.5009207491	3	4		78.0255021856	65.16043568	0.1475825357	0.986323943		ABCBA	COC1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(O)C4CCCCN4	SynKinase	SYN-5211	-1.30154816	7.34239047	4.27759497	65.16043568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016786-18	NCGC00016786-18	384567959		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	24280-93-1		7.9432823472	-5.1	31.331888799	2.4	4		45.6744843659	33.80924345	0.0620495799	0.9976206528		IMPDH1	COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2	Selleck	S2487	-1.3837512	2.12181346	11.60634161	33.80924345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262945-03	NCGC00262945-03	363677193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	366789-02-8				-6.6724773933	4	4		0	-0.13246983				F10	ClC1=CC=C(S1)C(=O)NC[C@H]2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O	Selleck	S3002	-2.91820797	-0.71744772	1.9742746	-0.13246983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250374-02	NCGC00250374-02	363677173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	156897-06-2				9.3794904235	4	4		0	-0.63291139				ALOX5	CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O	Selleck	S2121	1.73996438	0.32056175	7.41848639	-0.63291139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241342-03	NCGC00241342-03	377020353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-4.4750648366	4	4		0	-4.15665206				CLK1	ClC1=CC(=CC(=C1)CNC2=C(C=NC=N2)C3=CC4=C(OCO4)C=C3)Cl	Evotec	MLS004256649	0.84300719	-3.20012249	-1.83727034	-4.15665206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482810-01	NCGC00482810-01	384569261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1675203-84-5		3.1622776602	-5.5	63.1547745344	3	4		43.0829284351	-6.71286271	1	0.9797752193			COC1=NC(=CC=C1CNCCNC(C)=O)OCC2=C(C)C(=CC=C2)C3=CC=CC=C3	DC Chemicals	DC8381	5.03464856	-0.30548343	34.92254474	-6.71286271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263617-13	M-344	384568694	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	251456-60-7				-19.8016680939	4	4		0	-6.10487467				HDAC1	CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-13506	-3.27102804	-3.75829035	-6.09308886	-6.10487467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014925-06	Topotecan hydrochloride	170465137	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	119413-54-6	; Hycamtamine; Topotecane; Nogitecan hydrochloride;Nogitecan hydrochloride/NSC-609699;Topotecan hydrochloride; Topotecan hydrochloride;TOPOTECAN HYDROCHLORIDE; Nogitecan Hydrochloride; Hycamtin			-13.9371901374	4	4		0	-4.32108258			7150	TOP1	Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O	Prestwick	Prestw-1196	-1.95162177	-2.4907885	-5.69816643	-4.32108258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522107-03	NCGC00522107-03	384569513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	737789-87-6				12.9853576756	4	4		0	-0.67744419				GNRHR	CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)C)C3=C(S2)N(CC4=C(F)C=CC=C4F)C(=O)N(C3=O)C5=CC=C(OC)N=N5	MedChem Express	HY-16474_cm2	4.50767714	-0.21263669	3.04662038	-0.67744419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381563-08	NCGC00381563-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	945755-56-6		4.4668359215	-5.35	77.213785709	2.2	4		68.4739030051	64.84988453	0.0200318796	0.999752484			O=C(NC1=CC=C(C=C1)C2=CC=NC(NC3=CC=C(C=C3)N4CCOCC4)=N2)[C@@H]5CCCN5	APExBIO	A3937	1.38047612	3.61482382	32.46421992	64.84988453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241455-04	NCGC00241455-04	384568480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	317318-70-0	GW-501516;GSK-516;501516	5.6234132519	-5.25	4.890416588	4	4		15.499392468	12.44033872	0.1194510317	0.9911550762	5467	PPARD	CC1=CC(=CC=C1OCC(O)=O)SCC2=C(C)N=C(S2)C3=CC=C(C=C3)C(F)(F)F	NCGCChem	GRB30-029-C4	-1.52134103	-2.91616039	2.16806008	12.44033872												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015225-08	NCGC00015225-08	384567826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[3895-92-9]		14.1253754462	-4.85	13.3730866698	4	4		14.7703523641	10.93148576	0.4082486828	0.8818693039		PRKCA	COC1=C(OC)C2=C[N+](=C3C(=C2C=C1)C=CC4=CC5=C(OCO5)C=C34)C	Tocris	1330	2.47922243	-2.30862697	0.69434604	10.93148576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509909-01	NCGC00509909-01	384569376		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1015474-32-4				1.8884760462	4	4		0	2.6641154				TNF	CC/1=N/C2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N	Selleck	S7892	0.83573092	-0.71744772	-2.48279988	2.6641154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384172-01	NCGC00384172-01	363679175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1422389-91-0				-5.4795753569	4	4		0	-2.32423849					CN1CCN(CC1)C2=CC=C(C=C2NC(=O)C3=CC=C(F)C(=C3Cl)C)[N+]([O-])=O	XcessBio	M60118-2s	-0.62225993	-0.82480525	-2.25597834	-2.32423849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507892-01	NCGC00507892-01	384569355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1383716-46-8		1.1220184543	-5.95	145.3114801557	1.3	4		88.3627613143	76.78648766	0.2818848287	0.9475471617		PIK3C3	CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC=C4	Selleck	S8456	1.44251167	16.6488468	103.86524289	76.78648766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263178-03	NCGC00263178-03	384568647		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1291074-87-7				-10.7189941784	4	4		0	4.08546268				AURKA	CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)\C=C\C4=CC=CC=C4	Selleck	S1181	-2.57389337	-4.79608981	-5.50458716	4.08546268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167510-09	NCGC00167510-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					16.2091792126	4	4		0	0.98537336					[H][C@](C)(O)[C@@]1([H])C(=O)N2C(C(O)=O)=C(S[C@]3([H])CN[C@]([H])(CN[S+](N)([O-])=O)C3)[C@]([H])(C)[C@]12[H]	Selleck	S1374	6.81786167	-1.39732685	-1.37452175	0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018100-16	Fasudil hydrochloride	384567990	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	105628-07-7				-7.4438024303	4	4		0	-3.07929176				ROCK1	[O-][S+](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2	MedChem Express	HY-10341	-2.16931962	-1.0328068	1.60124699	-3.07929176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093985-19	NCGC00093985-19	384568122		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	17560-51-9				2.5597735551	4	4		0	-2.15084194				CA7	CC1NC2=CC(=C(C=C2C(=O)N1C3=C(C)C=CC=C3)[S+](N)([O-])=O)Cl	MedChem Express	HY-B0209	1.45631068	0.7005515	-0.05885815	-2.15084194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263203-06	NCGC00263203-06	384568662		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	827318-97-8				-9.7471354774	4	4		0	-5.37710485				AURKA	CO[C@@H](C(=O)N1CC2=C(C1)C(=N[NH]2)NC(=O)C3=CC=C(C=C3)N4CCN(C)CC4)C5=CC=CC=C5	MedChem Express	HY-10179	-1.37309293	-1.17752273	-2.00117716	-5.37710485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179492-08	NCGC00179492-08	384568374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3385-03-3				-6.0782700325	4	4		0	-2.37724636					CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	Carbosynth	FF23333	-1.26213592	0.16395886	-1.7068864	-2.37724636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346449-02	NCGC00346449-02	363677409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	139145-27-0		12.5892541179	-4.9	7.2169660312	4	4		12.814147016	10.44290364	0.4739370146	0.8315698143		PDE5A	ClC1=CC=C(CCCOC/2=N/NC(=O)C(=C2NCC3=CN=CC=C3)/Br)C=C1	Axon Medchem	1482	-1.51178918	3.6220003	1.05944673	10.44290364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496795-01	NCGC00496795-01	384569291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					6.0093872922	4	4		0	5.00919768					CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)C(C)C(F)(F)F)C4=O	ChemoGenics	CG-JDN-274-2	-1.42857143	6.84155612	1.61859918	5.00919768												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163540-01	NCGC00163540-01	26756923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	520-33-2	DIOSMETINE;DIOSMETIN			1.964661768	4	4	CIPLUS_210346;diosmetin;NCGC00163540-01;DIOSMETINE;	0	-3.84887505					COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	BIOMOL_NP-082	1.65048544	-0.07452676	0.97115951	-3.84887505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090757-12	NCGC00090757-12	384568082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	148-82-3				-8.1275477679	4	4		0	-4.17208027					N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O	MedChem Express	HY-17575	-1.41422712	1.00809531	-3.00797112	-4.17208027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016797-15	NCGC00016797-15	384567960		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	34642-77-8				-2.4585062339	4	4		0	-2.34026174					CC1(C)S[C@H]2[C@H](NC(=O)[C@@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O	Selleck	S2565	-0.14086491	-0.48602673	-0.01417033	-2.34026174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378853-02	NCGC00378853-02	384569071		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	195733-43-8				-2.5124683763	4	4		0	3.94149346				EDNRA	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(OC)C=C2)C(O)=O)C3=CC=C4OCOC4=C3	MedChem Express	HY-15403A	-1.69037893	-0.06075334	-1.57290633	3.94149346												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242486-04	NCGC00242486-04	384568494		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	935666-88-9, 1260222-79-4 (TFA)				-15.3016310127	4	4		0	-6.14121975				JAK1	C[C@H](NC1=NC(=C(Cl)C=N1)NC2=N[NH]C(=C2)C)C3=NC=C(F)C=N3	Selleck	S2162	-2.14979196	-3.11521836	-4.35550324	-6.14121975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509945-01	NCGC00509945-01	384569393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1437321-24-8				3.3184747653	4	4		0	3.53756898				TYRO3	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)\C4=C\N(C(C)C)C(=O)N(C4=O)C5=CC=C(F)C=C5)C=C3F	ChemGood	C-1344	0.01386963	1.29676554	-0.38257799	3.53756898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345839-10	NCGC00345839-10	384568762		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1187595-84-1				0.5913172788	4	4		0	-4.61298995				JAK2	CC[S+]([O-])(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	Bio Vision	2841	2.0110957	0.46206588	-2.03060624	-4.61298995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238624-07	NCGC00238624-07	163827054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	n	NCGC00238624; NCGC00238624			-4.0359446329	4	4		0	-3.48096788			2584	GALK1	ClC1=C[NH]N=C1C\2NC(=N\C3=C2C(=O)CCC3)/NC4=NC5=CC=CC=C5O4	NCGCChem	LLI10-095	-0.90152566	-0.7005515	1.94231901	-3.48096788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015955-22	NCGC00015955-22	384567909		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	18559-94-9				-2.9278362706	4	4		0	-2.2923447				ADRB2	CC(C)(C)NCC(O)C1=CC(=C(O)C=C1)CO	Microsource	01500677	-1.17891817	-0.43225518	3.00176574	-2.2923447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164604-06	NCGC00164604-06	384568263		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	93957-55-2		2.2387211386	-5.65	17.9961179155	4	4		11.5473128159	11.05612894	0.1669263783	0.9825496983		HMGCR	CC(C)[N]1C2=C(C=CC=C2)C(=C1\C=C\[C@H](O)C[C@H](O)CC(O)=O)C3=CC=C(F)C=C3	DC Chemicals	DCAPI1585	1.00884467	-0.87276068	11.11111111	11.05612894												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346517-10	NCGC00346517-10	384568815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	103060-53-3				-5.5120037446	4	4		0	-4.01526933					CCCCCCCCCC(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@@H](C)CC(O)=O	MedChem Express	HY-B0108	-0.20729685	0.32154341	-1.51647711	-4.01526933												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00390536-02	NCGC00390536-02	384569187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1361644-26-9				-6.9027829345	4	4		0	-5.32698138					COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)\C(CO)=N\NC(=O)CCCCCN6C(=O)\C=C/C6=O)O)C(=O)C2=CC=C1	MedChem Express	HY-16261	0.53740631	-2.38277073	-3.7599639	-5.32698138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091641-16	6-Mercaptopurine			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	50-44-2				-9.1331843486	4	4		0	-3.39252202					S=C1NC=NC2=C1NC=N2	MedChem Express	HY-13677	-1.58393438	-2.77989919	-0.87231163	-3.39252202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263226-01	NCGC00263226-01	137276070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	439083-90-6	BAY-60-7550			5.1299371985	4	4		0	3.17167052			5138	PDE2A	COC1=C(OC)C=C(CC/2=N/N\3C(C(C)\N=C3[C@@H](CCCC4=CC=CC=C4)[C@@H](C)O)C(=O)N2)C=C1	Cayman	10011135	0.7888435	2.58201701	-1.51622502	3.17167052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263084-02	NCGC00263084-02	174006719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	612542-14-0	 Hh-Ag1.5;Hh-Ag1.5	14.1253754462	-4.85	6.3665768918	4	4		-13.175109664	-6.39592472	0.6985877119	0.4857020155	54498	SMO	CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(Cl)C5=C(F)C=CC(=C5S4)F	Cellagen	C4412-2s	0.5963939	0.84960501	12.91936433	-6.39592472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095165-08	NCGC00095165-08	384568154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	61422-45-5		1.2589254118	-5.9	25.1092945242	4	4		-18.81668318	-5.26390265	0.025984455	0.9995860202		TYMS	CCCCCCNC(=O)N1\C=C(F)/C(=O)NC1=O	Selleck	S1289	10.41608877	5.44045312	-1.94231901	-5.26390265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263176-03	NCGC00263176-03	363677245		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1174046-72-0		14.1253754462	-4.85	16.0770698208	4	4		15	13.55596434	0.5356759544	0.7688070697		KDR	NC1=C(Cl)C(=CC=N1)OC2=C(F)C=C(NC(=O)\C3=C\N\C=C(C3=O)\C4=CC=C(F)C=C4)C=C2	APExBIO	B1438	0.31900139	6.69250261	0.64743967	13.55596434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510699-01	NCGC00510699-01	384569485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1923851-49-3				-1.1408999027	4	4		0	7.50598086				BRPF1	CCN(C(=O)C1=CC=CC=C1OC)C2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCNC[C@H]4C	MedChem Express	HY-100729	-1.98694706	-2.01619062	-0.38331122	7.50598086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344550-03	NCGC00344550-03	384568722		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	10418-03-8				8.3442987918	4	4		0	4.27338333					C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC5=C(C[C@]4(C)[C@H]3CC[C@]12C)C=N[NH]5	Prestwick	Prestw-1161	-0.23578363	2.63824713	5.59152443	4.27338333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345853-03	NCGC00345853-03	384568768		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	885692-52-4		10	-5	71.4015082431	3	4		99.2720701128	93.61822556	0.0078887024	0.9999616163		CSF1R	CN(C)CC(=O)N1CCC(CC1)C2=CC=C(NC(=O)C3=NC(=C[NH]3)C#N)C(=C2)\C4=C\CCCC4	Activate Scientific	AS10255	-0.29126214	0.28320167	2.82519129	93.61822556												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242484-09	NCGC00242484-09	377020241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1062169-56-5		1.1220184543	-5.95	0.5149762499	4	4		12.35355648	3.90461997	0.5485811423	0.7528255991		MTOR	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5	MedChem Express	HY-12034	-4.0446304	-2.1853016	13.52334748	3.90461997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346650-02	NCGC00346650-02	384568881		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1007207-67-1				-10.5236142563	4	4		0	-4.94783905				PIK3CA	C[S+]([O-])(=O)N1CCC2=C(N=C(N=C12)N3CCOCC3)C4=CN=C(N)N=C4	Selleck	S2699	-1.17154812	-2.60440054	-2.88053366	-4.94783905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346894-04	NCGC00346894-04	384568965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	121584-18-7				0.0813865005	4	4		0	1.84798808				ABCBA	C/C=C/C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C	MedChem Express	HY-17384	-0.61366806	0.83819787	-1.51607035	1.84798808												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00390699-04	NCGC00390699-04	377020209		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	882531-87-5				-9.9935380924	4	4		0	0.98360656				FLT4	COC1=C(F)C=C\2C(=C1)\N=C/3NNC(=C3\N=C2C4=CC=CC=C4Cl)/C	MedChem Express	HY-13737	-2.11994421	-2.84388565	-4.76046089	0.98360656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483927-02	NCGC00483927-02	384569267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1818885-28-7		0.4466835922	-6.35	8.1141266373	4	4		-12.5089418719	-5.00745156	0.1881048981	0.977872884	23476	BRD4	CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)NC4=CC=C(OCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C7CCC(=O)NC7=O)C6=O)C=C4)\N=C2C8=CC=C(Cl)C=C8)C	MedChem Express	HY-16954	5.57880056	-0.62864841	-2.78956944	-5.00745156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263122-02	NCGC00263122-02	363677213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	851776-28-8				-5.7342892094	4	4		0	0.02990431				NIACR1	C1CC2=C(C1)C(=N[NH]2)C3=N[NH]N=N3	Axon Medchem	1576	-0.94271211	-1.2830304	-3.50877193	0.02990431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386347-02	NCGC00386347-02	384569127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	128607-22-7		12.5892541179	-4.9	67.6786647184	3	4		90.2100325769	82.43264049	0.0475731382	0.9986016163	2100	ESR2	OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3	APExBIO	B4871	2.62008734	-0.85054678	-0.04251098	82.43264049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345854-05	NCGC00345854-05	384568769		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1257704-57-6		12.5892541179	-4.9	20.1358542928	3	4		37.760024296	32.147806	0.0405485587	0.9989856192		JAK2	CN1CCN(CC1)C2=CC=CC(=C2)NC3=N[N]4C=CC=C(C5=CC=C(C=C5)[S+](C)([O-])=O)C4=N3	APExBIO	A4146	-0.64797859	-1.88335358	-1.31784044	32.147806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183784-18	NCGC00183784-18	384568420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	5852-78-8				11.7640848874	4	4		0	2.63195132				KDM4A	OC(=O)C1=C2C=CC=NC2=C(O)C=C1	SIGMA	SML0067	3.39805825	-0.16395886	1.76574456	2.63195132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247668-03	LDN-57444	384568515	Reversible, competitive Inhibitor of UCH-L1 deubiquitinase	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	668467-91-2		8.9125093813	-5.05	93.0727001147	2.3	4		103.2256150493	92.51862891	0.0778923461	0.9962393225			CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13	XcessBio	M60204-2s	5.52301255	-0.62864841	14.67556095	92.51862891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378943-01	NCGC00378943-01	363678291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	929007-72-7		12.5892541179	-4.9	38.2788073483	3	4		70.4782086743	60.28708134	0.0800177175	0.9960309148		MAPK8	NC(=O)C1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC(=C3)O	MedChem Express	HY-15737	-3.00217549	1.64961051	-0.38331122	60.28708134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370768-04	NCGC00370768-04	363677843		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	41964-07-2				8.9737317145	4	4		0	0.14952153				LYN	CC1=CC(=CC=C1)OC/2=C/NC(=O)/N=C2	SynKinase	SYN-5050	3.75634518	-0.36658011	-0.678166	0.14952153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	8.9125093813	-5.05	41.1985434381	3	4		60.8800897361	52.59430331	0.0454539271	0.9987240108			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	-0.16903789	-2.2782503	5.5972793	52.59430331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242481-05	NCGC00242481-05	384568493		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	860352-01-8				14.3872221792	4	4		0	-1.83953587				CHEK1	NC(=O)NC1=C(SC(=C1)C2=CC(=CC=C2)F)C(=O)N[C@H]3CCCNC3	Selleck	S1532	6.69902913	0.31301237	-2.23660977	-1.83953587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345846-01	NCGC00345846-01	174006734		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	936091-15-5	TG-46			1.902445304	4	4		0	-4.04697892			3717	JAK2	CC1=C(NC2=CC=CC(=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC=C(CN4CCOCC4)C=C3)N=C1	SynKinase	SYN-1106	2.95423024	0.6707408	-4.41436139	-4.04697892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499351-01	NCGC00499351-01	384569305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	501010-06-6				-11.5398620924	4	4		0	-2.59314456				GGTI	CC(C)C[C@H](NC(=O)N1CCN(CC2=C(C)N=C[NH]2)C(=O)[C@@H]1CC3=CC=CC=C3)C(O)=O	WuXi	GGTI-2418	-2.92887029	-2.00568777	-1.03092783	-2.59314456												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165759-02	NCGC00165759-02	384568278		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	4430				-11.9849593798	4	4		0	-3.96423249				GUCY1A2	NC1=C(C=NC(=N1)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24)C5CC5	Tocris	4430	-2.11994421	-1.73626703	-3.42631898	-3.96423249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347398-04	Ginsenoside Rb1			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	41753-43-9				-0.8874749054	4	4		0	1.66915052					CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0039	-1.22733612	0	0.18192844	1.66915052												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00241102-08	NCGC00241102-08	384568472		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	120685-11-2				-15.8618581624	4	4		0	-6.14008942				PRKCA	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N3C4=CC=CC=C4C5=C6CNC(=O)C6=C7C8=CC=CC=C8N2C7=C35)N(C)C(=O)C9=CC=CC=C9	Bio Vision	2052	-2.0362622	-3.44259841	-5.2456034	-6.14008942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511352-01	NCGC00511352-01	384569497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	376638-65-2				-9.3400419787	4	4		0	0.32786885					CCN(CC)C(=O)CC1=CSC(=N1)N[S+]([O-])(=O)C2=C(C)C(=CC=C2)Cl	Glixx	GLXC-04311	-4.37935844	1.406975	0.8793208	0.32786885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164566-07	NCGC00164566-07	384568254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	147526-32-7		0.2238721139	-6.65	39.8028400251	4	4		16.5	-2.01445487	1	0.7090553766		HMGCR	O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	Enzo	AC3223	2.94117647	21.97494473	11.70662906	-2.01445487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346952-01	NCGC00346952-01	174006970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	359886-84-3	Cdk4/6 Inhibitor IV			-1.0204528813	4	4		0	0.04613255			1019	CDK4	CCNC1=NC(=NC(=C1)NC2CCC(O)CC2)NC3=CC=C4[N](CC5=CC=CC=C5)C=CC4=C3	EMD Chemicals	219492	-1.64925783	1.04642594	3.4696756	0.04613255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General		1502654-87-6				-4.0381844742	4	10		0	-0.99718742					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	2.07108156	-1.50856558	2.78701099	-0.43467144	-0.79263615	-2.94042444	-0.58808489	0.79263615	-2.1733572	-0.99718742						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159462-20	Ritonavir			DPI_SARS-CoV-2_General		155213-67-5				-9.22779504	4	10		0	-2.43235857					[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	0.90188576	-1.77644165	0.08198961	-1.88576114	-0.13664936	-0.73790653	0.30062859	-0.90188576	-2.65099754	-2.43235857						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244253-21	INCB018424			DPI_SARS-CoV-2_General		941678-49-5				-11.432250544	4	10		0	-1.04529617					N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	-1.95658001	-3.02867864	-3.83275261	-3.83275261	-2.54623425	-2.92146878	-3.02867864	-3.77914768	-3.99356741	-1.04529617						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General		55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	0.019793685	-7.7034733462	298.7419414531	2.1	10		102.6337443023	34.81640311	0.0000032407	0.9944964124			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-0.61645671	5.1728759	1.0989011	1.90297507	4.10077727	11.28383811	34.119539	56.3119807	82.73921201	34.81640311						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General		51773-92-3		0.0055786184	-8.2534733462	13.680956839	4	10		24.2449197895	-3.60962567	0.4425850879	0.3500864538		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-1.57754011	1.20320856	-1.09625668	-1.73796791	-1.47058824	7.0855615	51.36363636	75.48128342	-3.12834225	-3.60962567						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00095196-07	TILORONE			DPI_SARS-CoV-2_General		27591-69-1, 27591-97-5 [tilorone]		0.0702306445	-7.1534733462	262.4019188727	2.1	10		109.1750802168	86.81818182	0.0000309611	0.9810697128			CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	2.00534759	1.89839572	-1.4171123	2.32620321	2.32620321	6.55080214	1.68449198	11.63101604	10.45454545	86.81818182						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00229511-27	Tofacitinib			DPI_SARS-CoV-2_General		477600-75-2				-3.1896198411	4	20		0	-0.89491179					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General		192725-17-0		0.0497194887	-7.3034733462	55.1898239924	4	20		20.4619405041	18.52941176	0.5207886199	0.9607342787			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00274060-07	Posaconazole			DPI_SARS-CoV-2_General		171228-49-2		0.0009920342	-9.0034733462	131.9605579505	4	20		21.6839572192	33.71657754	0.0513931727	0.5985415347			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00345855-06	NCGC00345855-06	384568770		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1206161-97-8				0.605529633	4	4		0	-2.70977675				JAK1	[O-][S+]1(=O)CCN(CC1)CC2=CC=C(C=C2)C3=CC=CC4=NC(=N[N]34)NC(=O)C5CC5	ChemieTek	CT-GLPG	1.71855191	-0.94167679	-1.57290633	-2.70977675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018176-05	NCGC00018176-05	384567995		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	53-16-7				5.0089957943	4	4		0	0.31130607					C[C@]12CCC3C(CCC4=C3C=CC(=C4)O)C1CCC2=O	Microsource	01500286	0.84604716	1.53525116	2.20718069	0.31130607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346680-05	NCGC00346680-05	363677514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1030612-90-8				12.3950983165	4	4		0	-0.65091269				SCD	OC(=O)C[N]1N=NC(=N1)C2=CC(=NO2)N3CCC(CC3)OC4=CC(=CC=C4Br)F	MedChem Express	HY-13070	2.56588072	5.052914	4.00235433	-0.65091269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509996-01	NCGC00509996-01	384569403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	476617-51-3				-5.3599261209	4	4		0	-1.10372152				HIF1A	COC(=O)\C1=C(C)\N=C(N[C@@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029B	-2.14979196	2.10165449	-0.7357269	-1.10372152												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167472-10	NCGC00167472-10	384568317		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	68302-57-8				-1.9971085498	4	4		0	4.53055142					CC(C)C1=CC=C2OC3=NC(=C(C=C3C(=O)C2=C1)C(O)=O)N	MedChem Express	HY-B0713	-1.08786611	-2.51459362	-1.21285628	4.53055142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346520-02	NCGC00346520-02	363677439		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	155206-00-1				-8.3467970186	4	4		0	-1.99701937					CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@H](O)[C@@H]1/C=C/C(O)CCC2=CC=CC=C2	Selleck	S1407	-2.51046025	-0.17961383	-0.4548211	-1.99701937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188399-16	NCGC00188399-16	377020258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	162359-56-0				-9.8708071223	4	4		0	-6.19713978				SPHK1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1	MedChem Express	HY-12005	-2.6937878	1.75386883	0.59238364	-6.19713978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017312-04	NCGC00017312-04	363676497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	58-96-8				11.74001397	4	4		0	3.11004785					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2\C=C/C(=O)NC2=O	Selleck	S2029	2.82813633	3.75744616	-0.61919505	3.11004785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509935-01	NCGC00509935-01	384569384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1644545-52-7				-5.0357391796	4	4		0	-2.22254931				IDH1	C[C@@H](NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)N[C@@H](C)C(F)(F)F)C(F)(F)F	ChemGood	C-1090	-0.75352788	0.19844299	-2.27340712	-2.22254931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390606-01	TNKS-656	363680925	Tachykinin NK2 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1419949-20-4				-3.6850626356	4	4		0	0.65091269				TACR2	COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)C\C4=N\C5=C(\COCC5)C(=O)N4	MedChem Express	HY-13990	-2.09431345	1.59487256	0.08828723	0.65091269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345813-03	NCGC00345813-03	384568757		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	118525-40-9		12.5892541179	-4.9	39.0793230102	3	4		35.224015528	33.79085892	0.1975276009	0.9751641056			COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C(=C3O2)CC=C(C)C	SIGMA	SML0551	5.28432732	1.14771203	-0.67686875	33.79085892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025100-17	NCGC00025100-17	384568049		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	244240-24-2				8.0444914333	4	4		0	-1.64143201				BTK	CC(/O)=C(C#N)/C(=O)NC1=C(Br)C=CC(=C1)Br	SIGMA	L6920	3.70319001	1.14771203	-1.41259564	-1.64143201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346598-02	NCGC00346598-02	384568853		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	138-59-0				0.5588639958	4	4		0	-0.22640441					O[C@@H]1C\C(=C/C(O)C1O)C(O)=O	Selleck	S2356	-0.18030513	0.64093009	1.05944673	-0.22640441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet			-13.6183782884	4	4		0	-4.29210134			7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-3.37517434	-1.10761862	-1.45542753	-4.29210134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161418-13	NCGC00161418-13	384568208		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	244218-51-7		1.1220184543	-5.95	11.5303136556	4	4		18.9142259359	-6.67660209	1	0.9996395521		OPRL1	CCC1=CC=C(OCC2=C(C=CC=C2)C(=O)NC3=CC4=C(C=C3)N=C(C)C=C4N)C=C1	MedChem Express	HY-13274	-2.84518828	3.17317767	11.46149181	-6.67660209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163492-01	NCGC00163492-01	26756878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	17397-89-6	CERULENIN;Cerulenin	14.1253754462	-4.85	17.4666595667	4	4	CERULENIN;Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-;(2R,3S,E,E)-2,3-Epoxy-4-oxo-7,10-dodecadienamide;NCGC00163492-01;0   Cerulenin;helicocerin;2,3-Epoxy-4-oxo-7,10-dodecadienoylamide;Cerulenin;LS-63388;CIPLUS_170974;	17	15.23099851	0.1550956552	0.9849616304	2194	FAS	[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O	BIOMOL	BIOMOL_G-237	1.9804742	1.46684628	0	15.23099851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162398-11	NCGC00162398-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			1	-6	35.6700673187	4	4		22	21.609538	0.0569773275	0.9979971466			CN([C@@H](CC1=CC=C(O[S+]([O-])(=O)C2=CC=CC3=C2C=CN=C3)C=C1)C(=O)N4CCN(CC4)C5=CC=CC=C5)[S+]([O-])(=O)C6=CC=CC7=C6C=CN=C7	BIOMOL	EI-230	0.08368201	4.99925161	22.61976956	21.609538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016023-19	NCGC00016023-19	384567916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	83-67-0				3.9780397511	4	4		0	1.37108793				PDE4A	C[N]1C=NC2=C1C(=O)NC(=O)N2C	Selleck	S2368	0.89260809	0.47897021	0.48514251	1.37108793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346671-06	NCGC00346671-06	384568897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	875446-37-0				7.430219744	4	4		0	-0.8806121				CETP	COC1=CC(=C(C=C1C2=CC=C(C=C2CN3[C@@H](C)[C@H](OC3=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C)F	MedChem Express	HY-12090	3.87498232	-1.83290057	-0.75199278	-0.8806121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015554-13	NCGC00015554-13	384567863		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	110448-33-4		11.220184543	-4.95	37.6002546588	3	4		80.2651477632	64.74282297	0.0291156674	0.9994768748		MYLK	[O-][S+](=O)(N1CCCNCC1)C2=CC=CC3=C(I)C=CC=C23	MedChem Express	HY-15417	-3.84336476	-1.98564228	0.58970957	64.74282297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510488-01	NCGC00510488-01	384569450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1808011-22-4				-3.3494884441	4	4		0	4.74210931				SMYD3	[O-][S+](=O)(CC1CCN(CCCC(F)(F)F)CC1)N2[C@@H]3CC[C@H]2CC(C3)NC(=O)C4=CC5=C(NC(=O)C5)C=C4Cl	MedChem Express	HY-19324	-2.70460628	-0.36452005	0.38259884	4.74210931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241111-12	NCGC00241111-12	377020233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	209410-46-8				12.0710962593	4	4		0	1.84757506				MAPK14	FC1=CC=C(SC/2=N/N3\C=N/C(=O)/C(=C3/C=C2)C4=C(Cl)C=CC=C4Cl)C(=C1)F	MedChem Express	HY-10328	4.67671503	-0.30376671	-1.48788437	1.84757506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241107-12	NCGC00241107-12	384568475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	380843-75-4				-8.9770217668	4	4		0	-6.45252582				ABL1	COC1=C(Cl)C=C(Cl)C(=C1)NC2=C(C=NC3=C2C=C(OC)C(=C3)OCCCN4CCN(C)CC4)C#N	Enzo	AC1546	-0.40221914	-3.50275749	-0.97115951	-6.45252582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095164-06	NCGC00095164-06	384568153		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	14222-60-7				-0.345817731	4	4		0	-2.59314456					CCCC1=CC(=CC=N1)C(N)=S	Selleck	S1881	0.08368201	-0.11974255	2.09217708	-2.59314456												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241113-04	NCGC00241113-04	384568478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	252916-29-3				-5.4892775739	4	4		0	-3.85448246				FLT1	CC1=C(CCC(O)=O)C(=C([NH]1)\C=C\2C(=O)NC3=CC=CC=C23)C	Axon Medchem	1891	-0.1979918	-1.98564228	-1.02271018	-3.85448246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-10	Ibandronate sodium hydrate	384568439	Treatment of Osteoporosis	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	138926-19-9				-3.8114644848	4	4		0	-3.73899235					CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	APExBIO	B1772	1.55564984	-2.90209256	3.33884795	-3.73899235												1.6E-8	8E-8	4E-7	0.000002											
NCGC00263016-01	NCGC00263016-01	137275920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	379262-36-9	DE-096			-9.389172289	4	4		0	-5.56220096			59341	TRPV4	CCCCCN(CCC12CC3CC(CC(C3)C1)C2)C(=O)NCCCC4=CC=NC=C4	NCGCChem	BTM10-095	-1.1457578	0.09164503	-3.39083002	-5.56220096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351482-09	NCGC00351482-09	384569009		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1201438-56-3				-10.7007861415	4	4		0	-3.41801386				PIK3CD	C[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=C/C4=C(C(=CC=C4)Cl)C(=O)N3C5=CC=CC=C5	MedChem Express	HY-17044	-1.85941682	-2.12636695	-2.73487318	-3.41801386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187906-15	NCGC00187906-15	377020302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	371935-74-9		2.5118864315	-5.6	4.4588878575	4	4		-11.5017657399	-2.12254139	0.7490166284	0.3307993521		PIK3CA	OC1=CC(=CC=C1)C2=NC3=C(OC4=C3C=CC=N4)C(=N2)N5CCOCC5	Enzo	270460	-2.28848821	19.51110449	-2.50147145	-2.12254139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483929-01	NCGC00483929-01	363681148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					13.8791515204	4	4		0	5.63180982				KEAP1	COC1=CC(=CC2=C1[N](C)N=N2)[C@@H](CC(O)=O)C3=CC(=C(C)C=C3)CN4C[C@@H](C)OC5=C(C=CC=C5)[S+]4([O-])=O	NCGCChem	PJM008-063	2.23300971	3.17483977	2.50147145	5.63180982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250410-11	GSK-650394	384568558	SGK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	890842-28-1		11.220184543	-4.95	32.7994743828	3	4		44.0333239052	34.75307769	0.0794238369	0.9960935906		SGK1	OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5	MedChem Express	HY-15192	0.09708738	2.75748994	6.65097116	34.75307769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018296-15	NCGC00018296-15	384568003		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1104-22-9		14.1253754462	-4.85	29.5938100997	4	4		24.90700412	22.89514646	0.2964249067	0.9417138017		NR1I3	CC1=CC=CC(=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4	MedChem Express	HY-B0349	4.81276006	1.86316888	-1.5891701	22.89514646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093354-13	NCGC00093354-13	384568113		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	98-92-0		2.5118864315	-5.6	-1.0751061782	4	4		15.15062762	7.39195231	0.4124329791	0.8798145792			NC(=O)C1=CC=CN=C1	Selleck	S1899	-3.45885635	1.5566532	1.63735597	7.39195231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386776-01	NCGC00386776-01	384569146		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	220619-73-8		8.9125093813	-5.05	51.8646769694	3	4		64.1812472851	58.03278689	0.0477327458	0.9985925231		RXRA	CC(/C=C/[C@@H]1C[C@]1(C)C2=CC3=C(C=C2)C(C)(C)CCC3(C)C)=C\C(O)=O	Axon Medchem	2408	1.56206416	-0.83819787	7.27713766	58.03278689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346502-06	NCGC00346502-06	384568807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	65928-58-7				6.0527510635	4	4		0	-1.04665072				PGR	C[C@]12CCC\3=C\4CCC(=O)\C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	MedChem Express	HY-B0084	0.94271211	4.94883153	1.38581748	-1.04665072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344588-08	NCGC00344588-08	363677337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1300031-49-5				-9.4511339834	4	4		0	-2.9007177				BRD4	COC1=CC2=C(C=C1C3=C(C)ON=C3C)N=CC4=C2N([C@H](C)C5=CC=CC=N5)C(=O)N4	Selleck	S2780_cm1	-2.2480058	0.97754697	-3.18443167	-2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167746-09	NCGC00167746-09	384568333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	501925-31-1		3.5481338923	-5.45	28.5082024434	4	4		9.5	12.70933014	0.3192804605	0.932319611		CHRNA7	COC1=C(Cl)C=C(NC(=O)NC2=NOC(=C2)C)C(=C1)OC	MedChem Express	HY-12152	4.62654097	1.77180388	8.52130326	12.70933014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186528-19	NCGC00186528-19	384568443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					-3.2716137199	4	4		0	-2.37724636				PKM2	C[N]1C2=C(SC(=C2)[S+](C)[O-])C\3=C1C(=O)N(CC4=CC(=CC=C4)N)\N=C3	Axon Medchem	2240	-0.67961165	2.75748994	-2.41318423	-2.37724636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179642-05	NCGC00179642-05	363676952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	24168-96-5				19.5295656148	4	4		0	2.51874912					ClC1=CC(=C(C=C1)C(C[N]2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl)Cl	Selleck	S2534	6.11650485	2.48919362	0.41200706	2.51874912												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016268-21	NCGC00016268-21	384567927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	59-67-6				15.5669213467	4	4		0	4.41488609					OC(=O)C1=CC=CN=C1	MedChem Express	HY-B0143	4.84049931	-0.64093009	0.32371984	4.41488609												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263639-13	NCGC00263639-13	384568696		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	112522-64-2				-15.7349751721	4	4		0	-5.78241431				HDAC1	CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(N)C=CC=C2	MedChem Express	HY-50934	-2.81729428	-2.21523724	-3.82049727	-5.78241431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017254-05	NCGC00017254-05	384567981		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[20350-15-6]				121.6452947367	4	4		0	-3.57675112				GBF1	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	Tocris	1231	50.57182706	-3.50246969	-3.39599757	-3.57675112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015163-09	Benserazide	170465804	DOPA decarboxylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	14919-77-8	; ; Benserazida; Benserazide Hcl; Ro 8-0576-12; Ro 8-0576-7;Benserazide hydrochloride; Benserazide hydrochloride; Ro 8-0576;BENSERAZIDE HYDROCHLORIDE; Benseraszide; Ro 4460; Ro 4 460			-6.0043984079	4	4		0	-2.20566319			1644	DDC	Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O	Microsource	01500137	-1.53417015	1.58658883	-2.2134627	-2.20566319												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091281-10	NCGC00091281-10	384568095		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1596-84-5				2.9912248068	4	4		0	-0.21654396				KDM2A	CN(C)NC(=O)CCC(O)=O	MedChem Express	HY-13643	1.21623533	0.48877348	-0.42111596	-0.21654396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018099-17	NCGC00018099-17	384567989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	479-18-5				-7.714201193	4	4		0	-0.72274335				XDH	CN1C(=O)N(C)C2=C([N](CC(O)CO)C=N2)C1=O	Enzo	AC3105	-2.91368884	0.66322771	-0.28208745	-0.72274335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345833-01	NCGC00345833-01	174006422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1072959-67-1	SR3677			-7.3847398952	4	4		0	2.93710595			9475	ROCK2	CN(C)CCOC1=CC(=CC=C1NC(=O)C2COC3=CC=CC=C3O2)C4=C[NH]N=C4	SynKinase	SYN-1083	-2.6937878	-1.63596168	-2.22849083	2.93710595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387868-07	NCGC00387868-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	891494-64-7				-7.6624854387	4	4		0	2.9007177					CN1C=C(C=N1)C2=C3N=C([C@H]4CCCNC4)C(Br)=C(N)N3N=C2	Aobious	AOB5556	-2.56707759	-2.47441576	-2.21141088	2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095099-11	NCGC00095099-11	384568144		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	171599-83-0				-6.1797518105	4	4		0	-2.9007177				PDE5A	CCCC1=N[N](C)C2=C1\N=C(/NC2=O)C3=CC(=CC=C3OCC)[S+]([O-])(=O)N4CCN(C)CC4	Enzo	DL261	-1.46482959	-0.97754697	0.58970957	-2.9007177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186464-04	NCGC00186464-04	384568441		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	173334-58-2				9.6949231518	4	4		0	-0.86722488				REN	COCCCOC1=CC(=CC=C1OC)C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C	Selleck	S2199	3.2342277	1.80235222	1.17941914	-0.86722488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022567-15	NCGC00022567-15	384568011		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	4291-63-8				1.7037221658	4	4		0	-4.96411483				ADA	NC1=NC(=NC2=C1N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)O3)Cl	MedChem Express	HY-13599	2.94416244	0.76370857	-3.77414124	-4.96411483												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162400-09	NCGC00162400-09	363676610		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	62996-74-1				-17.983797177	4	4		0	-6.48923445				CDK1	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)[N]3C4=CC=CC=C4C5=C3C6=C(C7=C(C=CC=C7)[N]26)C8=C5CNC8=O	Selleck	S1421	-4.62654097	-4.24621964	2.35883827	-6.48923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092289-01	NCGC00092289-01	26753179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	383907-43-5	NSC-663284; DA-3003-1;DA-3003-1	3.1622776602	-5.5	65.6760970241	3	4	NCGC00092289-02;NSC-663284;NSC663284;NSC 663284;6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione;	38	-5.66676479	1	0.9568956322	5923	CDC25	ClC/1=C(NCCN2CCOCC2)/C(=O)C3=C(C=CC=N3)C1=O	Tocris	Tocris-1867	7.24756816	0.25950237	32.48579121	-5.66676479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181111-05	NCGC00181111-05	384568390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	94497-51-5				28.7977518185	4	4		0	7.86755342				RARB	[CH3][C]1([CH3])[CH2][CH2][C]([CH3])([CH3])C2=C1C=CC(=C2)[NH][C](=[O])C3=CC=C(C=C3)[C]([OH])=[O]	APExBIO	A3856	4.64632455	4.15859293	11.65391407	7.86755342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510269-04	NCGC00510269-04	384569426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1869912-40-2				-17.4170595246	4	4		0	-4.3219076				BRD4	COC1=NN=C2C=CC(=N[N]12)N3CCC(CC3)C4=CC=C(OCCN5CCN(C)C(=O)[C@H]5C)C=C4	Selleck	S8344	-4.12831241	-2.42478671	-2.78956944	-4.3219076												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090782-17	Nelfinavir Mesylate			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	159989-65-8		2.2387211386	-5.65	131.9273184665	3	4		103.9014972875	0.11922504	1	0.9999951717			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	-1.92468619	-0.92800479	95.05761067	0.11922504												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092386-26	NCGC00092386-26	384568111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	79559-97-0		1.4125375446	-5.85	12.1087733003	4	4		14.4409015919	-5.79732431	1	0.9998424987			CN[C@H]1CC[C@@H](C2=CC=C(Cl)C(=C2)Cl)C3=CC=CC=C13	MedChem Express	HY-B0176A	-2.03408466	-0.98747237	12.44005642	-5.79732431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262195-03	NCGC00262195-03	377020177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(449808-64-4)				-8.5033515658	4	4		0	-2.5169267				MAPK14	CN1C(=O)\C(=C/C2=C1N=C(NC3CCOCC3)N=C2)OC4=C(F)C=C(F)C=C4	SynKinase	SYN-1101	-1.5755583	-1.17539307	-2.54262638	-2.5169267												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263174-02	NCGC00263174-02	384568644		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	336113-53-2				-19.7751062524	4	4		0	-5.66676479				KIF11	CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C/2=N/C3=CC(=CC=C3C(=O)N2CC4=CC=CC=C4)Cl	Selleck	S1452	-4.45266475	-2.82399634	-3.14089141	-5.66676479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485951-02	NCGC00485951-02	384569279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1310340-58-9		0.1	-7	393.8481293163	1.3	4		105.4931425094	106.93258758	0.0759735119	0.9964262832		CTSS	CC[C@H](NC(=O)[C@H](C[S+]([O-])(=O)CC1CC1)N[C@@H](C2=CC=C(F)C=C2)C(F)(F)F)C(=O)C(=O)NC3CC3	MedChem Express	HY-15958	67.74900671	98.29033735	103.32037092	106.93258758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095348-11	NCGC00095348-11	384568156		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1968-05-4				0.1089169738	4	4		0	-3.16455696				AR	C(C1=C[NH]C2=C1C=CC=C2)C3=C[NH]C4=C3C=CC=C4	MedChem Express	HY-15758	1.46595424	1.17539307	-2.99132516	-3.16455696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167773-13	NCGC00167773-13	384568335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	507475-17-4		14.1253754462	-4.85	3.0831872572	4	4		10.425544432	8.06565728	0.3480416419	0.9181578061		IKBKB	NC(=O)NC1=C(C=C(S1)C2=CC=C(F)C=C2)C(N)=O	MedChem Express	HY-10074	-0.45769764	0.31301237	-2.85462036	8.06565728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345837-03	NCGC00345837-03	384568761		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1033739-92-2				-9.9969756072	4	4		0	3.90461997				PIK3CA	CC1=C(C=NC(=N1)N)C2=NC3=C(SC(=C3)C(C)(C)O)C(=N2)N4CCOCC4	SynKinase	SYN-1114	-3.15202232	-3.26298458	-3.69921164	3.90461997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250402-05	NCGC00250402-05	384568551		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	461432-26-8				2.0269309712	4	4		0	-3.27868852				SCL5A2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C1	MedChem Express	HY-10450	2.0083682	-0.65858404	-0.27289266	-3.27868852												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263548-23	NCGC00263548-23	384568687		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	143-67-9				-9.4599310396	4	4		0	2.23546945				TUBB	CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]7([C@H]89)C6=C5)C(=O)OC)C1	MedChem Express	HY-13780	-5.43933054	1.91588086	2.03153426	2.23546945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165815-06	NCGC00165815-06	384568286		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	205432-12-8				-7.7243072615	4	4		0	-2.06339713					CCOC(=O)N1CCN(CC1)[N+](/[O-])=N/OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O	Enzo	AC1550	-1.2617839	-1.37467542	-2.8600914	-2.06339713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507845-01	Netarsudil	384569326	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1253952-02-1				-3.3958027958	4	4		0	-5.72564027				ROCK1	CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C	Selleck	S8226	1.52075627	0.53426958	-1.70505534	-5.72564027												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00347939-08	NCGC00347939-08	384568991		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	331244-89-4		1.2589254118	-5.9	14.7451227713	4	4		10.9438964279	0.98616426	1	0.9996575475		BCL2	CCOC1=CC=CC=C1N/N=C2\C(=N/N(C2=O)C3=NC(=CS3)C4=CC=CC=C4)C	MedChem Express	HY-15341	-0.36991369	0.53426958	10.58929106	0.98616426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346951-01	NCGC00346951-01	174007091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	132911-47-8	Fascaplysin	3.1622776602	-5.5	-7.2706747784	4	4		-7.335443036	-5.69620253	0.6612353762	0.5754312174	1019	CDK4	O=C1C2=CC=CC=C2[N+]3=C1C4=C(C=C3)C5=CC=CC=C5[NH]4	SantaCruz Bio	 sc-221607A	-2.01397452	6.45702946	-3.41011068	-5.69620253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390587-01	NCGC00390587-01	363680917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1380672-07-0				1.6716802644	4	4		0	2.98793053			80351	TACR1	C[S+]([O-])(=O)C1=CC=C(N=C1)C2=NN=C(\C=C\C3=NN=C(O3)C4=CC=C(C=C4)C#N)[N]2C5=C(Cl)C=CC=C5	MedChem Express	HY-12438	-2.12357857	1.48068997	5.47412504	2.98793053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509934-01	NCGC00509934-01	384569383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1402608-02-9		12.5892541179	-4.9	23.3561216518	3	4		53.0972471311	43.14100677	0.0407865373	0.998973091		AKT1	NC(=O)C1=N[N]2C(=NC(=C2C3=CC=CC=C3)C4=CC=C(C=C4)C5(N)CCC5)C=C1	ChemGood	C-1071	-1.82216742	-3.06823386	-2.99132516	43.14100677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346724-02	NCGC00346724-02	363677537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	845272-21-1		12.5892541179	-4.9	0.0575308875	4	4		20.3849372439	16.12518629	0.1702635907	0.9817490918		EGFR	C[C@@H]\1COC(=N1)\NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(OCC5=NC=CS5)C=C4)Cl	Selleck	S2755	-3.65411437	-0.74839096	-3.0624621	16.12518629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346450-01	NCGC00346450-01	174006450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	61966-08-3	Tricyclic Nucleoside Monophosphate (TCN-P)			-5.6221204935	4	4		0	-0.90727357			207	AKT1	CN1\N=C(N)/C2=C[N]([C@@H]3O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]3O)C4=C2C1=NC=N4	Berry & Associates	PRA 10162	-2.88620121	3.6403832	-0.16925247	-0.90727357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242057-03	NCGC00242057-03	384568485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	501693-25-0		11.220184543	-4.95	37.7696080626	3	4		46.490850379	41.65769645	0.0135462993	0.9998868853		TEK	COC1=CC=C(C=C1)C2=C(C3=CC=C(NC(=O)NC4=C(F)C=CC(=C4)C(F)(F)F)C=C3)C5=C(O2)N=CN=C5N	Aobious	AOB4188	1.26443101	1.42962417	3.44146685	41.65769645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346976-02	NCGC00346976-02	384568979		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					2.146410578	4	4		0	-2.72129187				USP1	C(C(C([2H])([2H])[2H])(C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NC(C3=CC=C(C=C3)[N]4C=CN=N4)([2H])[2H])[2H])([2H])([2H])[2H]	NCGCChem	DKL016-046	1.20377085	0.58041851	1.00250627	-2.72129187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163135-04	NCGC00163135-04	124892401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	113165-32-5	 Niguldipine;Niguldipine	3.1622776602	-5.5	38.09533597	4	4	NIGULDIPINE	27.6129524961	-6.36961722	1	0.9691794227			COC(=O)C/1=C(C)/N/C(=C(\C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5)C	BIOMOL	CA216	2.94416244	-1.34412708	21.78976854	-6.36961722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509914-01	NCGC00509914-01	384569380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1262417-51-5				28.7195402634	4	4		0	8.34559906				PARP1	NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F	Selleck	S8363	5.82271544	3.8620058	7.02961412	8.34559906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183844-04	NCGC00183844-04	384568421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	163253-35-8				-0.1949189537	4	4		0	-0.25470497				TOP2B	N[C@@H]1CN(CC12CC2)C3=C(F)C=C4C(=O)\C(=C/N([C@@H]5C[C@@H]5F)C4=C3Cl)C(O)=O	MedChem Express	HY-B0395C	-0.42995839	1.50544045	0.05885815	-0.25470497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507890-02	NCGC00507890-02	384569354		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1005264-47-0		7.9432823472	-5.1	10.1085651719	4	4		13.216582448	11.42372402	0.0808966906	0.9959848759		MDM2	CC1=C(C)C=C(N[S+]([O-])(=O)C2=CC3=C(NC(C4C\C=C/C34)C5=CC=C(C=C5)C(O)=O)C=C2)C=C1	MedChem Express	HY-100892	0.17965727	-0.59715204	2.1872266	11.42372402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167403-06	NCGC00167403-06	384568310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	839707-37-8		12.5892541179	-4.9	27.7947998162	3	4		43.3636491068	37.12710307	0.2245094383	0.9675856417		RASAL1	C[N]1N=C(C)C=C1NC2=NC=C3CN(C(=O)N(C)C3=N2)C4=C(C)C=CC(=C4)NC(=O)C5=CC=CC(=C5)C(F)(F)F	Cayman	10009557	2.69485904	-4.82315113	-4.95771362	37.12710307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016611-11	NCGC00016611-11	384567953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	2438-72-4		0.3981071706	-6.4	18.5919748829	4	4		-13.7555886759	-3.12965723	0.0613598591	0.9976960889			CCCCOC1=CC=C(CC(=O)NO)C=C1	Selleck	S3023	8.78661088	0.17961383	-2.33474833	-3.12965723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015155-14	NCGC00015155-14	384567817		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[68099-86-5]		10	-5	74.9825751472	3	4		111.9496352868	93.80029806	0.0105596809	0.9999312215		KCNT1	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3	Tocris	4117	-0.41841004	-0.89806915	9.39963614	93.80029806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167565-02	NCGC00167565-02	384568329		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	51460-26-5				-3.7558105877	4	4		0	-2.20566319					CN1C(CC\2=C\C(=N\NC(N)=O)C(=O)\C=C12)[S]([O-])(=O)=O	Selleck	S3000	-0.16736402	-1.73626703	-0.66707095	-2.20566319												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347286-15	NCGC00347286-15	384568986		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1346574-57-9		0.2238721139	-6.65	22.5890270621	4	4		-14.6553659599	10.73025335	1	0.9995928235		EZH2	CC[C@H](C)[N]1C=C(C)C2=C1C=C(C=C2C(=O)NC\C3=C(C)\C=C(\C)NC3=O)C4=CC=C(N=C4)N5CCNCC5	MedChem Express	HY-13470	10.26499303	-1.7961383	-1.63735597	10.73025335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346459-07	NCGC00346459-07	384568783		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1254473-64-7		12.5892541179	-4.9	5.1045237569	2.4	4		37.4121735159	25.59808612	0.0162968609	0.9998363952		FGFR1	C[C@@H](OC1=CC2=C([NH]N=C2\C=C\C3=C[N](CCO)N=C3)C=C1)C4=C(Cl)C=NC=C4Cl	MedChem Express	HY-13304	-3.72733865	-4.09347793	-2.35883827	25.59808612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263565-06	NCGC00263565-06	384568689		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	60282-87-3				5.6262214789	4	4		0	-1.79425837				PGR	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1\C=C/[C@@]2(O)C#C	MedChem Express	HY-B0110	2.16098622	1.95509394	0.11794191	-1.79425837												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387038-01	NCGC00387038-01	363680531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	(1258292-64-6)		11.220184543	-4.95	7.3655378689	4	4		21.005956932	17.52392344	0.0811456202	0.9959306351	3717	TYK2	ClC1=C(C(=O)NC2=CC(=NC=C2)NC(=O)C3CC3)C(=CC=C1)Cl	SynKinase	SYN-1198	-1.05873822	-2.50496411	-1.82809966	17.52392344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509944-01	NCGC00509944-01	384569392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1492952-76-7		12.5892541179	-4.9	10.5742650215	4	4		17.594739004	14.55696203	0.3246691821	0.9292383564	25	ABL1	O[C@@H]1CCN(C1)C2=NC=C(C=C2C3=CC=N[NH]3)C(=O)NC4=CC=C(OC(F)(F)Cl)C=C4	ChemGood	C-1325	-1.32894917	3.22088231	1.19653006	14.55696203												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263087-10	NCGC00263087-10	384568581		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	755038-65-4				-8.2561435836	4	4		0	-5.66676479				PLK1	CC[C@H]1N(C(C)C)C2=NC(=NC=C2N(C)C1=O)NC3=CC=C(C=C3OC)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6	Selleck	S2235	-1.35635018	-1.6943978	0.89739755	-5.66676479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142599-02	NCGC00142599-02	174007475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	83-48-7	Stigmasterol (Stigmasterin)			-0.3357134227	4	4		0	-1.72486922					CC[C@H](\C=C\[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C	Selleck	S2361	2.25262576	-2.55703568	-2.59550889	-1.72486922												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346739-06	NCGC00346739-06	363677539		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	150812-12-7				-3.6708321052	4	4		0	-3.11041991				KCNQ1	CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N	MedChem Express	HY-15471	0.15201769	-0.96463022	-1.51647711	-3.11041991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386317-04	NCGC00386317-04	384569125		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1211441-98-3				-7.7952158316	4	4		0	0.5089778				CDK4	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5	ChemieTek	CT-LEE011	-1.14704256	-4.21068749	-3.29542141	0.5089778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379021-02	NCGC00379021-02	384569086		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	849643-15-8				2.7555051443	4	4		0	-5.65530892				KDR	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NC[C@H](O)CN4CCOCC4	MedChem Express	HY-10501A	4.29795467	-2.6795284	-3.03295421	-5.65530892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015144-05	NCGC00015144-05	384567813		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	19916-73-5		14.1253754462	-4.85	4.3517212097	4	4		-8.750459488	-3.95871624	0.6239481371	0.6469375735		MGMT	NC1=NC(=C2N=C[NH]C2=N1)OCC3=CC=CC=C3	Adooq	A13706	-0.15201769	4.39442658	6.62000583	-3.95871624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181767-12	NCGC00181767-12	384568400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[134308-13-7]		14.1253754462	-4.85	23.5144225569	3	4		37.464859896	30.39728545	0.1905110637	0.9769510138		COMT	CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(=C2)[N+]([O-])=O)O	Tocris	5864	1.97622996	-3.72071658	-2.36220472	30.39728545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181296-08	NCGC00181296-08	384568395		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	112665-43-7				2.2133735388	4	4		0	4.50074516				TBXA2R	C\C1=C(/C)C(=O)\C(=C(\C)C1=O)C(CCCCCC(O)=O)C2=CC=CC=C2	Enzo	RA119	-1.75732218	3.65214788	1.12189206	4.50074516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371131-09	NCGC00371131-09	363678047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1418013-75-8				-9.5712199902	4	4		0	-6.04066986				VCP	CC1=C(C=CC(=C1)OCC2=NN=C(SC3CCCC3)[N]2C4=CN=CC=C4)C5=CC=C(C=C5)[S+](C)([O-])=O	Glixx	GLXC-03842	-2.36403191	0.48877348	0.91404983	-6.04066986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390270-02	NCGC00390270-02	384569184		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	110267-81-7				-0.0961749048	4	4		0	6.22009569				TOP2A	CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C3=C(O)C4=C(C(=C3C1)O)C(=O)C5=CC=CC=C5C4=O	MedChem Express	HY-B0067	-2.42204496	3.26867267	-1.20890461	6.22009569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247735-03	NCGC00247735-03	363677162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	375815-87-5				-1.555952632	4	4		0	4.36602871				CHRNA3	C1NCC2CC1C3=CC4=NC=CN=C4C=C23	Selleck	S1440	-1.75489485	-0.33603177	-0.14742739	4.36602871												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509941-01	NCGC00509941-01	384569389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1776112-90-3				-11.1933138387	4	4		0	-2.369738			1956	EGFR	COC1=N[N](C)C=C1NC2=C3N=C[N](C)C3=NC(=N2)N4C[C@H](F)[C@H](C4)NC(=O)C=C	ChemGood	C-1263	-2.01397452	-1.72492749	-4.39724798	-2.369738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510705-01	NCGC00510705-01	384569488		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1126084-37-4				3.0557937612	4	4		0	3.87388661				AKR1C3	COC1=CC2=C([NH]C(=C2)C(=O)N3CCC(CC3)CC(C)(C)O)C=C1	MedChem Express	HY-19903	0.59425097	-1.27086204	-0.67074949	3.87388661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263098-05	NCGC00263098-05	384568589		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	117048-59-6				-1.9305688873	4	4		0	-2.20557048				TUBB	COC1=CC=C(\C=C/C2=CC(=C(OC)C(=C2)OC)OC)C=C1O	Axon Medchem	1233	-0.95356551	-2.37329659	5.45348498	-2.20557048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188344-07	NCGC00188344-07	384568447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	923564-51-6		1	-6	28.1132196207	4	4		28.85355648	-1.28166915	1	0.9998959508		BCL2L1	CC1(C)CCC(=C(CN2CCN(CC2)C3=CC=C(C=C3)C(=O)N[S+]([O-])(=O)C4=CC(=C(N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)C=C4)[S+]([O-])(=O)C(F)(F)F)\C1)/C7=CC=C(Cl)C=C7	Selleck	S1001	-4.0446304	3.23304894	25.0151607	-1.28166915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345828-07	NCGC00345828-07	377020265		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	457081-03-7				-10.7937752105	4	4		0	-4.53055142				JAK1	CC(C)(C)C1=NC2=C([NH]1)C3=CC=C(F)C=C3C4=C2\C=C/NC4=O	MedChem Express	HY-14435	-2.0083682	-1.10761862	-2.15281989	-4.53055142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015444-10	NCGC00015444-10	384567848		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	67227-56-9				-6.9375605196	4	4		0	0.13839766				DRD1	OC1=CC=C(C=C1)C2CNCCC3=C2C=C(O)C(=C3Cl)O	Prestwick	Prestw-1713	-1.95162177	0.10316875	-3.04654443	0.13839766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016017-20	NCGC00016017-20	363676471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	175178-82-2				-12.3012870727	4	4		0	0.62799043				EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=CC(=C3)Cl	Bio Vision	1800	-3.93038434	-1.40522377	-2.50626566	0.62799043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378460-08	NCGC00378460-08	363678082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1218942-37-0				8.5740165806	4	4		0	-2.09330144				NOX1	CN(C)C1=CC(=CC=C1)C\2=C\3C(=O)N(NC3=C/C(=O)N2C)C4=CC=CC=C4Cl	MedChem Express	HY-12298	3.84336476	-1.92454559	2.38832375	-2.09330144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162383-05	NCGC00162383-05	384568223		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1404-93-9				0.0485942523	4	4		0	-2.369738					CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=CC4=CC(=C3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)C(=C2)Cl	MedChem Express	HY-17362	1.68516235	-1.32804152	-0.47861203	-2.369738												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00347066-11	KUC105555N	384568981	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	177355-84-9				-9.0429024169	4	4		0	-6.74173524				VCP	C(NC1=NC2=CC=CC=C2C(=N1)NCC3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-15945	-1.55564984	-2.9326409	2.88765228	-6.74173524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164622-16	NCGC00164622-16	384568268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	137234-62-9				-6.8476754429	4	4		0	-0.29217284				CYP51A1	C[C@@H](C1=NC=NC=C1F)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-76200	-2.52886201	-0.13264554	-0.11283498	-0.29217284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015917-09	NCGC00015917-09	384567906		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[1197334-04-5]				3.2798915672	4	4		0	-2.32200523				HTR1A	C[N]1C=CC2=CC3=C(CCN3C(=O)NC4=CC=CN=C4)C=C12	Tocris	1661	1.12699285	-1.3706706	4.42877292	-2.32200523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015578-18	NCGC00015578-18	384567866		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	22071-15-4				-9.1892971965	4	4		0	-2.22974012					CC(C(O)=O)C1=CC=CC(=C1)C(=O)C2=CC=CC=C2	MedChem Express	HY-B0227	-2.39142386	-1.51805453	-0.5077574	-2.22974012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188429-03	NCGC00188429-03	384568449		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	114607-46-4				-7.5002724602	4	4		0	-1.50885296					OC(=O)C(=O)NC1=CC(=CC=C1)C2=NN=N[NH]2	Adooq	A10034	-2.64826032	-1.60996355	2.16806008	-1.50885296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346839-01	NCGC00346839-01	174006584		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	15018-66-3	4-Quinazolinamine			-3.7564082059	4	4		0	1.23171671			1956	EGFR	NC1=C2C=CC=CC2=NC=N1	SIGMA	CBR00181	-1.60585998	-1.51883354	0.69434604	1.23171671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347909-06	NCGC00347909-06	363677719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	870061-27-1				4.8008759808	4	4		0	-1.44726713				P2RX7	ClC1=C(Cl)C(=CC=C1)[N]2N=NN=C2NCC3=C(OC4=NC=CC=C4)C=CC=C3	Aobious	AOB1733	1.04240034	6.37910085	-1.77129092	-1.44726713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159559-10	NCGC00159559-10	384568188		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	107724-20-9				3.0597440894	4	4		0	-0.62208398				NR3C2	COC(=O)[C@@H]1CC/2=C/C(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14	MedChem Express	HY-B0251	-0.06909895	-1.79145613	7.08661417	-0.62208398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015462-22	NCGC00015462-22	384567852		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	29094-61-9				-8.4025359978	4	4		0	-3.13869645					CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)[S+]([O-])(=O)NC(=O)NC3CCCCC3	MedChem Express	HY-B0254	-1.47871752	-1.45460113	-1.80810732	-3.13869645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160421-04	NCGC00160421-04	384568194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	58-46-8				-2.4700864115	4	4		0	-0.56553089				SLC18A2	COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1	Enzo	AC3264	-1.42343836	2.06706477	0.20414115	-0.56553089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346965-01	NCGC00346965-01	174006428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1001343-54-9	HMSL10087	10	-5	27.9077675141	3	4		42.0560122666	36.02431783	0.084554808	0.9955682312	2324	FLT4	COC1=CC(=CC=C1NC2=NC=C3N(C(C)C)C(=O)CCN(C4CCCC4)C3=N2)C(=O)NC5CCN(C)CC5	LINCS	HMSL10087	0.53897181	-2.3426734	1.7789443	36.02431783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159541-03	NCGC00159541-03	384568185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[2799-07-7]				0.7052402762	4	4		0	-2.23384702				KIF11	N[C@H](CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(O)=O	Tocris	2191	2.11442786	-1.14836932	-3.17876932	-2.23384702												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386712-01	NCGC00386712-01	363680410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1314891-22-9		11.220184543	-4.95	15.8170339809	2.4	4		30.7558336839	21.8709398	0.0322526272	0.9993596267	9734	HDAC9	CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4	Axon Medchem	2180	-1.04652807	-0.18329006	3.24860881	21.8709398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480830-01	NCGC00480830-01	384569248		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	288628-05-7				-2.3149466422	4	4		0	-1.42919013				CA2	N[S+]([O-])(=O)OC1=CC=C2\C3=C(CCCCC3)/C(=O)OC2=C1	Glixx	GLXC-06889	0.1979918	1.2830304	-3.79004362	-1.42919013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346572-02	NCGC00346572-02	363677457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	166518-60-1				2.144534167	4	4		0	2.64183629				CYP2C9	CC(C)C1=CC(=C(CC(=O)N[S+]([O-])(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C)C(C)C	Selleck	S2187	0.56569085	-1.22193371	-0.60159422	2.64183629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015316-08	NCGC00015316-08	384567837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	68278-23-9				-1.2714826301	4	4		0	2.75257573				ODC1	NCCCC(N)(C(F)F)C(O)=O	Glixx	GLXC-06672	-1.48433205	-1.3706706	2.03102962	2.75257573												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346621-05	NCGC00346621-05	363677482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	885499-61-6				-11.5221198204	4	4		0	-1.6146394				AKT1	NC1(CCN(CC1)C2=C3C=C[NH]C3=NC=N2)CC4=CC=C(Cl)C=C4	MedChem Express	HY-13260	-2.85871358	-0.28002948	-4.03385049	-1.6146394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346508-12	NCGC00346508-12	384568810		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	677297-51-7				-4.7370618533	4	4		0	-0.53821313				PIK3CA	NC1=NC2=NC(=C(N=C2C(=N1)N)C3=CC(=CC=C3)O)C4=CC=CC(=C4)O	MedChem Express	HY-10111	-1.51181968	1.60648489	-2.28490832	-0.53821313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507842-01	NCGC00507842-01	384569324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	623152-17-0				-3.775439058	4	4		0	0.46189376				MAPK14	CCCNC(=O)C1=C[N]2N=CN=C(NC3=CC(=CC=C3C)C(=O)NC4CC4)C2=C1C	Selleck	S8124	-0.59163262	-2.64277035	-1.0911152	0.46189376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015149-25	NCGC00015149-25	384567815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	28395-03-1				-2.285071376	4	4		0	1.44726713				SLC12A2	CCCCNC1=CC(=CC(=C1OC2=CC=CC=C2)[S+](N)([O-])=O)C(O)=O	MedChem Express	HY-17468	-0.73249753	-2.55164034	0.41093949	1.44726713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015997-12	NCGC00015997-12	384567914		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	107-35-7				-0.0651034983	4	4		0	0.04415661					NCC[S+](O)([O-])=O	Selleck	S2008	-1.05493903	-1.9996947	5.71343105	0.04415661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179501-09	NCGC00179501-09	384568375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	520-26-3				-1.0931355038	4	4		0	-2.06418776					COC1=C(O)C=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-400	0.23493643	1.91394886	-2.12890055	-2.06418776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345082-02	NCGC00345082-02	363677344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-5.4192073987	4	4		0	-6.67326453					CC(C)CNC1=CC=NC(=N1)NCC2=CSC(=N2)C3=CC=CC=C3	Tocris	4888	-0.15201769	1.45460113	-1.51647711	-6.67326453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378390-01	NCGC00378390-01	384569048		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-4.916572336	4	4		0	0.12992638				LIMK1	CN(CC1=CC=CC=C1)C(=O)C2=CC=C(C=C2)[S+]([O-])(=O)NC3=CC=CC=C3	NCGCChem	DYD022-031	-0.42426814	-1.83290057	-3.79004362	0.12992638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346673-02	NCGC00346673-02	384568899		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	802539-81-7				-12.8424469313	4	4		0	4.95163852				CDK1	CNC(=O)C1=N[N](C)C2=C1C(C)(C)CC3=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N=C23	Selleck	S2751	-4.5255268	-4.30731633	-2.82749286	4.95163852												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168784-10	NCGC00168784-10	384568348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	122111-03-9				-16.0230975714	4	4		0	-1.22708243				RRM2	NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	APExBIO	A1402	-4.07297412	-3.51305942	-3.2185291	-1.22708243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263694-01	NCGC00263694-01	174007246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	4727-31-5				2.4682754195	4	4		0	-2.12213079					OC(=O)C1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C3=CC=CC=C3	NCGCChem	DYD08-093	1.07481261	0.58041851	1.29342758	-2.12213079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346569-03	NCGC00346569-03	384568844		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1000669-72-6				-0.7472979272	4	4		0	-1.63129782				ABL1	O=C(N1CCNCC1)C2=CC=C(C=C2)/C=C/C3=N[NH]C4=C3C=CC=C4	Selleck	S2158	1.55564984	-2.9326409	-2.07550008	-1.63129782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346530-09	NCGC00346530-09	384568822		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1236699-92-5				-16.8565345739	4	4		0	-3.63356428				MAP2K1	OC[C@@H](O)CNC(=O)C1=CC=NC=C1NC2=C(F)C=C(I)C=C2	MedChem Express	HY-12042	-3.60614171	-3.58444714	-3.4717302	-3.63356428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094792-07	NCGC00094792-07	384568135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	154-42-7, 5580-03-0 [hemihydrate]		10	-5	29.9664381531	3	4		44.9540036804	37.59815242	0.0445741923	0.9987735894		HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	Microsource	01500573	0.16903789	-1.33657351	3.38670823	37.59815242												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378734-08	NCGC00378734-08	384569066		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	722543-31-9				2.1387961067	4	4		0	-0.70823711				AURKB	CCN(CCCOC1=CC2=NC=NC(NC3=NNC(CC(=O)NC4=CC=CC(F)=C4)=C3)=C2C=C1)CCOP(O)(O)=O	MedChem Express	HY-10127_cm3	2.16931962	-1.88335358	-2.22474139	-0.70823711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016423-15	NCGC00016423-15	170466800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	303-45-7	 (-)-Gossypol;(-)-Gossypol			-4.6516917956	4	4		0	-4.40094201			598	BCL2L1	CC(C)c4c3cc(C)c(c1c(C)cc2c(c1O)c(C=O)c(O)c(O)c2C(C)C)c(O)c3c(C=O)c(O)c4O	Microsource	01504019	0.72612687	-0.50373989	-4.09811547	-4.40094201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481603-01	NCGC00481603-01	377020212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-4.7182532828	4	4		0	-1.52693341				FLT1	CNC(=O)C1=C(C)OC2=CC(=CC=C12)OC3=C4C=C(OC)C(=CC4=NC=N3)OC	APExBIO	B5864	-1.06412383	1.42397795	-2.65383494	-1.52693341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346484-04	NCGC00346484-04	384568794		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(475110-96-4)				-8.7447582141	4	4		0	-1.8379754				PIK3CA	FC(F)C1=NC2=C(C=CC=C2)[N]1C3=NC(=NC(=N3)N4CCOCC4)N5CCOCC5	SynKinase	SYN-1099	-1.86567164	-4.51691931	0.78740157	-1.8379754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181350-14	NCGC00181350-14	384568397		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	212141-51-0		14.1253754462	-4.85	16.9262527488	4	4		18	16.18305183	0.1186908377	0.9912569029		FLT1	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C4=C2C=CC=C4)C=C1	Aobious	AOB5504	1.72535709	0.39712846	0.21055798	16.18305183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346543-05	NCGC00346543-05	384568829		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	334951-92-7		12.5892541179	-4.9	67.6838007644	3	4		79.0549653568	71.93225558	0.0164002116	0.9998340987		MAP2K1	CNC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC(=CC=C3)CN(C)C)C4=CC=CC=C4	MedChem Express	HY-12202	3.09902803	4.10085055	4.49199377	71.93225558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163683-02	NCGC00163683-02	174006806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	58569-55-4	Metenkephalin			-6.5871221257	4	4		0	-2.06312548					CSCC[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(O)=O	Alfa Aesar	J61154	-1.21143823	-1.27582017	-1.51622502	-2.06312548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164587-01	NCGC00164587-01	144205766		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	67814-76-0	Isepamicin; Isepacin; Is??palline; Sch 21420; 			-0.4814472068	4	4	N-(S-3-amino-2-hydroxypropionyl)gentamicin;Sch-21420;ISEPAMICIN SULFATE;NCGC00164587-01;Isepacin;SCH-21420;O-6-AMINO-6-DEOXY-A-D-GLUCOPYRANOSYL-(1-4)-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-B-L-ARABINOPYRANOSYL-(1-6))-2-DEOXY-N1-((S)-ISOSERYL)-D-STREPTAMINE SULFATE;isepamicinum;ISEPAMICIN;CIPLUS_207475;HAPA-B;Is??palline;CIPLUS_749397;Schering-Plough brand of isepamicin sulfate;Isepamicin;D-Streptamine, O-6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-N1-(3-amino-2-hydroxy-1-oxopropyl)-2-deoxy-, (S)-;Isepamicin sulfate;isepamicin sulfate;isepamicin;Sch 21420;isepamicine;LS-146923;CIPLUS_775638;Isepamicin Sulfate;	0	-1.4716287					O=S(=O)(O)O.NCC(O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2OC[C@](C)(O)[C@H](NC)[C@H]2O	Sequoia	SRP01515i	-0.04160888	1.68430467	-0.64743967	-1.4716287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386198-07	NCGC00386198-07	384569114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	211513-37-0				4.6850936943	4	4		0	2.80175463					CCC(CC)CC1(CCCCC1)C(=O)NC2=C(SC(=O)C(C)C)C=CC=C2	MedChem Express	HY-14950	1.12343967	-0.01490535	-0.38257799	2.80175463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015436-14	NCGC00015436-14	384567843		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	146-56-5		1.5848931925	-5.8	13.328630895	4	4		13.4479889039	-6.48082638	1	0.9994035978		DRD2	OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	Microsource	01500994	-1.20665742	-0.7601729	11.71277222	-6.48082638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242476-03	NCGC00242476-03	384568489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1216744-19-2]				3.7662919166	4	4		0	-1.89613697				NR1D1	CC(C)(C)OC(=O)CN(CC1=CC=C(S1)[N+]([O-])=O)CC2=CC=C(Cl)C=C2	Tocris	3663	1.42857143	2.63824713	-0.44143614	-1.89613697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346524-02	NCGC00346524-02	384568818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	65101-87-3		3.1622776602	-5.5	120.8352032943	4	4		-44.1981813379	-6.75809416	0.020699881	0.999735788			CO[C@H]1CCC(O[C@@H]1C)O[C@H]2C[C@@H](O[C@]3(O[C@H](C[C@@H]3C)[C@H]4O[C@@](O)(CO)[C@H](C)C[C@@H]4C)[C@@H]2C)[C@]5(C)CC[C@]6(C[C@H](O)[C@@H](C)[C@H](O6)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C([O-])=O)O5	Selleck	S1450	36.91265893	36.08941969	9.15718868	-6.75809416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522516-01	NCGC00522516-01	384569523		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1311982-88-3				-7.9887366702	4	4		0	-6.75809416					CN1CCN(CC1)C2=CC=C3N=C([NH]C3=C2)C4=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C4)C(C)(C)C)C(C)(C)C	MedChem Express	HY-15843	-0.67716971	-1.69958659	-0.02916302	-6.75809416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346686-10	NCGC00346686-10	384568910		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	905854-02-6				-10.7659026716	4	4		0	-5.68358547				MET	O=C1NC(=O)[C@H]([C@@H]1C2=C[NH]C3=C2C=CC=C3)C4=C[N]5CCCC6=CC=CC4=C56	MedChem Express	HY-50686	-0.42841349	-3.41448476	-4.34529017	-5.68358547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346840-06	NCGC00346840-06	384568949		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	537049-40-4				-4.0929595565	4	4		0	-0.44752418				HDAC6	OCC1=CC=C(C=C1)[C@@H]2C[C@H](CSC3=NC(=C(O3)C4=CC=CC=C4)C5=CC=CC=C5)O[C@@H](O2)C6=CC=C(NC(=O)CCCCCCC(=O)NO)C=C6	SIGMA	SML0065	-0.82025173	-1.03864365	-1.71454354	-0.44752418												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00485430-01	NCGC00485430-01	363681335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					0.7870412995	4	4		0	0.73903002				BTK	NC(=O)C1=C(N)[N](N=C1C2=CC=C(OC3=CC=C(F)C=C3F)C=C2)[C@@H]4CCCN(C4)C#N	SIGMA	PZ0220	1.04240034	-2.12636695	-1.3461811	0.73903002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346802-02	NCGC00346802-02	363677541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[913844-45-8]				-0.3391953214	4	4		0	-3.50926843				ROCK2	C[C@H]1CN(CCCN1[S+]([O-])(=O)C2=CC=CC3=C2C(=CN=C3)C)C(=O)CN	Tocris	2485	0.90152566	-0.90922641	0.88287228	-3.50926843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174736-02	Uridine triacetate	174006168	Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	4105-38-8	Uridine triacetate			-3.7619350744	4	4		0	-0.45280883				TYMS	CC(=O)OC[C@@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2\C=C/C(=O)NC2=O	SIGMA	T6001	-1.87239945	1.17752273	0.76515597	-0.45280883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164619-06	NCGC00164619-06	384568267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	120511-73-1				-6.7310120167	4	4		0	-2.20557048				CYP19A1	CC(C)(C#N)C1=CC(=CC(=C1)C[N]2C=NC=N2)C(C)(C)C#N	Selleck	S1188	-1.06412383	-2.15893431	-1.22484689	-2.20557048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093684-06	NCGC00093684-06	384568117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	378-44-9				-0.6832720698	4	4		0	0.02830055					C[C@H]1CC2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	Microsource	01500144	-0.06934813	-0.31301237	-0.44143614	0.02830055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242493-09	NCGC00242493-09	384568499		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	950769-58-1		2.5118864315	-5.6	66.5890204265	1.2	4		43.8881420671	45.19598132	0.0070767087	0.9999691254		KIT	CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=C[N]4C(=N3)SC5=C4C=CC(=C5)OCCN6CCOCC6	APExBIO	A5793	1.51178918	1.80354747	39.6115362	45.19598132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346557-02	NCGC00346557-02	363677454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	533884-09-2				4.8258976399	4	4		0	-2.09424084				ESR1	OC1=CC=C(C=C1)[C@@H]2OC3=C(C=C(O)C=C3)[C@@H]4CCC[C@H]24	Selleck	S1598	3.45353675	-1.20733343	-2.26603885	-2.09424084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249888-03	NCGC00249888-03	384568534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	68-19-9		0.5011872336	-6.3	15.1346209437	4	4		-13.677161456	-3.48096788	0.1600028036	0.9841321538			CC(CNC(=O)CCC1(C)C(CC(N)=O)\C2=N\C1=C(C)/C3=N\C(=C/C4=N/C(=C(\C)C5=NC2(C)C(C)(CC(N)=O)C5CCC(N)=O)C(C)(CC(N)=O)C4CCC(N)=O)C(C)(C)C3CCC(N)=O)O[P]([O-])(=O)OC6C(O)C(OC6CO)[N]7C=[N+]([Co]C#N)C8=C7C=C(C)C(=C8)C	Prestwick	Prestw-433	6.92094313	1.29676554	-1.20659211	-3.48096788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263210-04	NCGC00263210-04	363677267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	329196-48-7		4.4668359215	-5.35	9.9204490987	4	4		9.480477724	8.87883501	0.3267009172	0.9288800753		SMO	CCOC1=C(OCC)C(=CC(=C1)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC4=C([NH]3)C=CC=C4)OCC	Bio Vision	1976	0.92592593	-2.06706477	3.38291047	8.87883501												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024257-10	NCGC00024257-10	384568023		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	61-76-7				-2.0030037983	4	4		0	-0.70737693				ADRA1A	CNC[C@H](O)C1=CC=CC(=C1)O	Selleck	S2569	-0.22627634	-1.25248205	-0.03007971	-0.70737693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016360-07	Monobenzone	384567934	topical medical depigmentation treatment	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	103-16-2				-9.0312049152	4	4		0	-5.35585391					OC1=CC=C(OCC2=CC=CC=C2)C=C1	Selleck	S1652	-0.84853627	-2.13838399	-1.95518123	-5.35585391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510356-01	NCGC00510356-01	384569431		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-4.0130457838	4	4		0	4.5185506					COC1=CC2=C(OC\C(=C2\C3=CC=C(F)C=C3)CN4CCCC4)C=C1	Axon Medchem	2692	-1.78192618	-0.15274171	-3.91036246	4.5185506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General		747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.0011357578	-8.9447142596	29.7814779348	4	10		7.1784709759	6.16210688	0.0134422252	0.8726624462	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	-0.53694707	1.66197903	-1.81539248	-0.43467144	1.81539248	-0.23012017	3.65635387	8.4121708	6.41779596	6.16210688						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00163413-03	Lycorine HCl			DPI_SARS-CoV-2_General		2188-68-3		0.002220888	-8.6534733462	149.414663668	1.4	10		51.8154650239	8.22835701	0.3156492641	0.6652356238			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	4.79764138	0.99169124	6.94183865	5.70892522	102.62664165	86.97400161	70.30286786	41.89225409	22.11203431	8.22835701						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General		51773-92-3		0.0049719489	-8.3034733462	15.0488294318	4	10		30.1259715903	-4.85124631	0.3916206769	0.3959008576		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-2.01018494	-0.99169124	-3.67193782	-2.33181453	-2.81425891	16.32270169	59.26025194	76.19941035	-3.99356741	-4.85124631						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015256-29	Chloroquine		antimalarial agents	DPI_SARS-CoV-2_General		50-63-5		0.0014298344	-8.8447142596	38.5726088141	4	20		8.426829268	12.96791444	0.0222752008	0.6695215418			CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1																1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00244253-21	INCB018424			DPI_SARS-CoV-2_General		941678-49-5				-8.8170906385	4	20		0	-0.93582888					N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016463-08	NCGC00016463-08	384567942		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	485-35-8				2.963343703	4	4		0	-1.04665072				CHRNA3	O=C1\C=C/C=C2/[C@H]3CNC[C@H](C3)CN12	Selleck	S2287	1.84191443	-1.25248205	-0.11794191	-1.04665072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387042-02	NCGC00387042-02	384569151		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1204144-28-4		7.9432823472	-5.1	-0.3542787003	4	4		13.3716461159	8.1937799	0.0631134521	0.9975698334		PIM1	NC1CCCN(C1)C2=C(C=CC=C2\C=C\3SC(=O)NC3=O)C4=CC=CC=C4	APExBIO	A3962	-2.39303843	-1.55796548	1.03199174	8.1937799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092375-02	NCGC00092375-02	174006314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	409345-29-5	 JNJ-16259685;JNJ 16259685;JNJ-16259685			-4.480599411	4	4		0	0.92378753			2911	GRM1	COC1CCC(CC1)C(=O)C2=CC3=C(C=C2)N=C4OCCCC4=C3	Tocris	2333	-1.60585998	-2.33900365	0.80770866	0.92378753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346634-02	NCGC00346634-02	384568870		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1062159-35-6		1	-6	93.3685072184	2.4	4		58.6045960719	-3.16966181	1	0.9998990903		MTOR	C1CN(CCO1)C2=NC(=NC3=C2C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C6=CC7=C([NH]C=C7)C=C6	Selleck	S2689	-0.48543689	14.59233865	58.35785756	-3.16966181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351609-09	NCGC00351609-09	363677780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	894187-61-2				-23.862681945	4	4		0	-5.87183308				SLC2A1	CC1=CC=C(C=C1)[S+]([O-])(=O)CC2=C(C)OC(=N2)C3=CC=C(C=C3)C(=O)NCC4=CC=CN=C4	MedChem Express	HY-12808	-5.66248257	-3.32285586	-3.85081868	-5.87183308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262929-03	NCGC00262929-03	384568578		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	211915-06-9		0.2238721139	-6.65	25.832391745	4	4		-11.0014903121	-0.83457526	0.4342367158	0.8638405179			CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=NC=CC=C4)[N]2C)C=C1	Selleck	S2154	9.73500697	-0.80826224	3.09278351	-0.83457526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346829-02	NCGC00346829-02	384568945		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	92118-27-9				0.8782217627	4	4		0	0.75349839					CCO[P](=O)(OCC)C(C)NC(=O)N(CCCl)N=O	MedChem Express	HY-B0733	-0.60472787	-0.13264554	2.79266573	0.75349839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263167-10	NCGC00263167-10	384568637		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE			14.1253754462	-4.85	12.8863426105	4	4		28.080394924	22.95863448	0.1101889103	0.9924519573		CDK2	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Bio Vision	9490-5	-0.93457944	-0.13264554	-2.56699577	22.95863448												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025000-22	NCGC00025000-22	384568041		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	65277-42-1		14.1253754462	-4.85	-1.5910310498	4	4		13.155853316	8.90358296	0.2444682074	0.9616398574		CYP19A1	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@@](C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	MedChem Express	HY-B0105	-2.25398571	-0.51584377	-3.04654443	8.90358296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263237-09	JZL-184	384568681	Monoacylglycerol lipase (MAGL) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-6.7454594181	4	4		0	-2.16823005				MGLL	OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC4=C(OCO4)C=C3)C5=CC=C6OCOC6=C5	SIGMA	J3455	-1.12699285	-0.95799558	-2.25669958	-2.16823005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015603-14	NCGC00015603-14	384567871		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	98079-52-8				11.2343798512	4	4		0	2.27272727					CCN1\C=C(C(O)=O)/C(=O)C2=C1C(=C(N3CCNC(C)C3)C(=C2)F)F	MedChem Express	HY-B0455	3.14720812	0.4276768	2.09346897	2.27272727												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00484808-01	NCGC00484808-01	384569273		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					2.055935046	4	4		0	-1.34569378				EP300	C[C@@H]1CC(=O)NC2=CC=CC(=C2N1)C3=C[N](N=C3)C(C)(C)C	NCGCChem	GRB056-041	-0.21754895	4.67389644	0.50125313	-1.34569378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346656-03	NCGC00346656-03	384568887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	779353-01-4		6.3095734448	-5.2	72.6987944786	4	4		-12.5	8.13397129	0.586121022	0.7040891979		CDK1	CCC1=C2N=C(C=C(NCC3=CC=C[N+](=C3)[O-])[N]2N=C1)N4CCCC[C@H]4CCO	Axon Medchem	1776	15.24292966	23.55277226	16.06958573	8.13397129												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509939-01	NCGC00509939-01	384569388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1693758-51-8				-13.513607679	4	4		0	-4.75419488				PIK3CG	C[C@H](NC(=O)C1=C2N=CC=C[N]2N=C1N)\C3=C\C4=CC=CC(=C4C(=O)N3C5=CC=CC=C5)C#CC6=C[N](C)N=C6	ChemGood	C-1186	-1.73996438	-2.91558541	-3.67932994	-4.75419488												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00386427-01	NCGC00386427-01	363680279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1092364-38-9		1.4125375446	-5.85	5.312961984	4	4		12.2387998319	0.16190757	1	0.9995964344		EGFR	COC1=CC2=C(C=C1OC3CCN(CC3)C(=O)C=C)C(=NC=N2)NC4=CC=C(Cl)C(=C4F)Cl	Selleck	S7358	-2.69899986	-1.54174935	9.18336823	0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-07	Niraparib	384568775	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1038915-60-4		12.5892541179	-4.9	53.2944109882	3	4		79.1640611913	66.57344716	0.1366936401	0.9882977665		PARP1	NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	MedChem Express	HY-10619	-1.46595424	6.88444512	3.52976369	66.57344716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346954-01	NCGC00346954-01	174007019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	838823-31-7	TCS 2312			-0.9555319905	4	4		0	-0.33960662			1111	CHEK1	OC1=CC=C(C(=C1)O)C2=CC=C(C=C2)C3=N[NH]C(=C3)NC4=CC=CC(=C4)CNC5CC5	Tocris	3038	0.15256588	1.02846922	-2.58975868	-0.33960662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015254-30	NCGC00015254-30	384567833		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	5786-21-0				8.0544919836	4	4		0	9.28258101				DRD4	CN1CCN(CC1)\C2=N\C3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl	MedChem Express	HY-14539	-0.20804438	1.38619764	0.97115951	9.28258101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510002-01	GLPG0187	384569406	Integrin Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	298708-81-3				2.0651932786	4	4		0	4.27338333					COC(=O)\C1=C(C)\N=C(N[C@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029	0.15256588	-0.7303622	-1.44202472	4.27338333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346531-02	NCGC00346531-02	363677443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	579-13-5		15.8489319246	-4.8	-0.1127528097	4	4		-10.073227672	-6.31102306	0.6928440238	0.5029500772			CC[C@@H]\1CC[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)/C=C/[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@](C)(O)[C@@H](O)[C@H](C)C/C=C\C=C1)[C@@H]2C	Selleck	S1478	0.62413315	-2.63824713	6.94526192	-6.31102306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163107-07	NCGC00163107-07	384568229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[338404-52-7]				8.6378703875	4	4		0	-0.67921324				NR1I3	ClC1=CC=C(C=C1)C2=C(\C=N\OCC3=CC(=C(Cl)C=C3)Cl)[N]4C=CSC4=N2	Tocris	3683	3.00970874	1.08809062	1.00058858	-0.67921324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262829-02	NCGC00262829-02	174006692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	n	C-188-9			-0.2192985343	4	4		0	-6.19713978			6774	STAT3	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=C(O)C3=C2C=CC=C3)C4=C(O)C=CC5=C4C=CC=C5	EMD Chemicals	573128	1.15448048	3.78776713	-1.69252468	-6.19713978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018302-12	NCGC00018302-12	384568004		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	133-67-5				0.2576168136	4	4		0	0.56896817					N[S+]([O-])(=O)C1=C(Cl)C=C2NC(N[S+]([O-])(=O)C2=C1)C(Cl)Cl	MedChem Express	HY-B0235	0.54975261	-0.13264554	-2.11565585	0.56896817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274030-16	NCGC00274030-16	384568707		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1310746-10-1				-8.0863035124	4	4		0	0.62799043				FGFR3	CCN1CCN(CC1)C2=CC=C(NC3=CC(=NC=N3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C=C2	MedChem Express	HY-13311A	-2.21899927	-1.00809531	-3.12546071	0.62799043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263020-01	NCGC00263020-01	137275924		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1221153-14-5	NCGC00263020-01	14.1253754462	-4.85	13.3311100601	4	4		26.5536942919	22.56402708	0.3087760004	0.9363031185	4790	NFKB1	CC(C)[N]1C=C(C2=CC=NC(=N2)NC3=C(C)C=CC(=C3)C(N)=O)C4=C1C=NC=C4	NCGCChem	JKJ22-049	-1.63036032	3.8620058	-2.96141191	22.56402708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510508-01	NCGC00510508-01	384569469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	2018300-62-2		7.9432823472	-5.1	-2.9450036313	4	4		10.3442252399	7.81571975	0.0701893692	0.9969894952		EP300	CCC(=O)N1CCOC2=C(C=C(C=C2C1)C3=CC(=CC(=C3)OC)OC)C(=O)N[C@H]4CCCN(C)C4	MedChem Express	HY-100697	-2.3701877	-1.87757594	-2.03410111	7.81571975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263112-02	NCGC00263112-02	384568598		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	929095-18-1				-12.8824778037	4	4		0	-6.50912693				PLK1	C[C@@H](OC1=C(SC(=C1)[N]2C=NC3=C2C=C(CN4CCN(C)CC4)C=C3)C(N)=O)C5=CC=CC=C5C(F)(F)F	Selleck	S2193	-2.31622746	-1.65449396	-1.35373749	-6.50912693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346491-08	NCGC00346491-08	363677425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	172732-68-2				-4.4042716983	4	4		0	-0.820716				PLA2G5	CCC1=C(C(=O)C(N)=O)C2=C(C=CC=C2OCC(O)=O)[N]1CC3=CC=CC=C3	Glixx	GLXC-05612	-0.67961165	-0.96884782	-1.97174809	-0.820716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346676-04	NCGC00346676-04	384568902		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1095382-05-0				0.0490983323	4	4		0	-6.45252582				AURKA	CN1CCN(CC1)C2=CC=C(C=C2)C3=NC4=C(N5CCN(CC5)CC6=NOC(=C6)C)C(=CN=C4[NH]3)Br	Selleck	S2744	1.65048544	-1.26695484	2.20718069	-6.45252582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263169-06	NCGC00263169-06	384568639		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	714272-27-2				2.2744691432	4	4		0	0				TUBB	CC(C)(C)C1=C(/C=C/2NC(=O)\C(NC2=O)=C\C3=CC=CC=C3)N=C[NH]1	APExBIO	B2298	-0.50209205	-1.91588086	7.004245	0												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015191-21	NCGC00015191-21	384567820		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	80-77-3				-6.6295273028	4	4		0	-1.54992548				GABRA1	CN1C(C2=CC=C(Cl)C=C2)[S+]([O-])(=O)CCC1=O	MedChem Express	HY-B0353	-1.67364017	-1.19742554	-0.51546392	-1.54992548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025072-08	NCGC00025072-08	384568046		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[300576-59-4]				-4.0969372923	4	4		0	-0.47690015				DRD2	CCCN1CCO[C@H]2[C@H]1COC3=CC=C(O)C=C23	Tocris	1243	-2.45467225	4.07124682	-0.4548211	-0.47690015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015718-24	NCGC00015718-24	384567884		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	57149-07-2		14.1253754462	-4.85	15.5791970663	4	4		27.320169248	22.40504383	0.0602396684	0.9977605397		ADRA1A	COC1=C(C=CC=C1)N2CCN(CC2)CC(O)COC3=C4C=CC=CC4=CC=C3	MedChem Express	HY-B0391	-0.05497526	-0.36845984	-1.10014104	22.40504383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390255-01	Maslinic acid	384569181	Glycogen Phosphorylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	4373-41-5				-7.0561501897	4	4		0	-5.64354913				PYGL	CC1(C)CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Adooq	A12089	-1.20945574	0.13264554	0.22566996	-5.64354913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263017-01	NCGC00263017-01	137275921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1093135-60-4	CPG-52364	12.5892541179	-4.9	54.7634355436	3	4		63.7639551	60.848839	0.1310345066	0.9892610166	51284	TLR7	COC1=C(OC)C=C2C(=NC(=NC2=C1)C3=CC=C(C=C3)N4CCN(C)CC4)NCCN5CCOCC5	NCGCChem	BTM10-096	1.59428257	7.11864407	0.33850494	60.848839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390592-01	NCGC00390592-01	363680919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1584713-87-0				-16.343510744	4	4		0	-4.27631579					NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]2\N=C(C3=CC=CC=C3)/C4=CC=CC(=C4NC2=O)F	MedChem Express	HY-12419	-4.19144307	-1.34412708	-2.15243992	-4.27631579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346950-03	NCGC00346950-03	363677566		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	444722-95-6				0.2339244907	4	4		0	-5.62200957				CDK1	N[S+]([O-])(=O)C1=CC=C(NC2=NC3=C([NH]C=N3)C(=N2)OCC4CCCCC4)C=C1	Bio Vision	2313	3.2342277	-2.96318925	-2.50626566	-5.62200957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509886-03	NCGC00509886-03	384569374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	195987-41-8		1	-6	35.9688363588	4	4		30.633374436	-0.16190757	1	0.999780986		COX10	[O-][S+](=O)(N1CC2=CC(=CC=C2N(C[C@H]1CC3=CC=CC=C3)CC4=CN=C[NH]4)C#N)C5=CC=CS5	MedChem Express	HY-16111	-3.02781203	5.44954969	27.58001795	-0.16190757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093828-12	NCGC00093828-12	384568119		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	152121-53-4				46.297898097	4	4		0	10.14130115				MAPK14	[O-][N+](=[O])C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=NC=C3)C4=CC=C([F])C=C4	MedChem Express	HY-10578	7.35717222	14.42527858	14.08914149	10.14130115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167466-04	NCGC00167466-04	384568316		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	13010-47-4				-0.8715951234	4	4		0	0.1913453					ClCCN(N=O)C(=O)NC1CCCCC1	Selleck	S1840	0.50691876	-1.3891009	-1.9144481	0.1913453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347908-01	NCGC00347908-01	174006396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	861393-28-4	A 740003			-5.5382237092	4	4		0	-2.77110137			5027	P2RX7	COC1=C(OC)C=C(CC(=O)NC(N\C(NC2=CC=CC3=C2C=CC=C3)=N\C#N)C(C)(C)C)C=C1	Tocris	3701	-0.51133223	-1.54647068	-1.54564013	-2.77110137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499576-01	NCGC00499576-01	384569308		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1024007-21-3				-14.7125160875	4	4		0	-5.5195761				HDAC1	ONC(=O)C1=CC=C(C=C1)C/2=N/C3=CC=CC=C3OC4=C2C=CC=C4	Organix	O-10099	-1.54815728	-4.10624332	-5.38438528	-5.5195761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163510-01	Aloe-emodin	26756894	Caspase 3 Activator	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	481-72-1	ALOE-EMODINE;Aloe-emodin			1.8900491376	4	4	ALOE-EMODINE;Aloe Emodin;aloe-emodin;ALOE-EMODIN;LS-2202;aloe-emodin 1-O-glucopyranoside;Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,;Aloe-emodin;ALOE EMODIN;Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-;NCGC00163510-02;NCGC00163510-01;aloe-emodin 1-O-Glc;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;CIPLUS_153452;	0	1.04623215			836	CASP3	OCC1=CC(O)=C2C(=O)C3=C(C=CC=C3O)C(=O)C2=C1	BIOMOL	BIOMOL_NP-005	0.56661139	1.14836932	-1.63312919	1.04623215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507861-01	NCGC00507861-01	384569337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1432908-05-8		1.2589254118	-5.9	10.8113884805	4	4		17.7512690319	10.97488038	0.2043697956	0.9735094042		PAK1	CCN1C(=O)\C(=C/C2=CN=C(NCCC3CCN(C)CC3)N=C12)C4=CC=C(C=C4Cl)C5=CN=CC(=N5)C	Selleck	S7989	-3.95939086	-1.25248205	-1.9165561	10.97488038												1.6E-8	8E-8	4E-7	0.000002											
NCGC00496840-01	NCGC00496840-01	384569294		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1883429-21-7				7.253801892	4	4		0	3.78274948				BRD7	COC1=CC(=CC(=C1CN(C)C)OC)\C2=C\N(C)C(=O)C3=C2C=CN=C3	Selleck	S8179	2.31538567	-2.33552129	0.20939276	3.78274948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160527-12	NCGC00160527-12	384568198		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	112885-42-4		1.5848931925	-5.8	19.6339627413	4	4		12.141123496	10.46511628	0.2879606415	0.9454488068		HTR4	CCOC1=CC(=C(Cl)C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(F)C=C3)N	MedChem Express	HY-B0189A	0.97273599	-0.53426958	13.87974873	10.46511628												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346700-13	NCGC00346700-13	384568920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	944261-79-4		12.5892541179	-4.9	30.6509461968	3	4		36.639976441	33.70564117	0.1163081986	0.9915715774		SCN10A	COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(Cl)C=C3)OC	MedChem Express	HY-11079	2.50138198	-0.65839841	-0.67074949	33.70564117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387037-01	NCGC00387037-01	363680530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(1220699-06-8)		1.1220184543	-5.95	29.1360774045	4	4		28.9991708159	1.8379754	1	0.9997882551		MTOR	C[C@H](O)C(=O)N1CCC(CC1)N2C(=O)N(C)C3=C2C4=NC(=CC=C4N=C3)C5=CN=C(C)C=C5	SynKinase	SYN-1194	-2.91597568	6.23181749	22.28054826	1.8379754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186628-01	NCGC00186628-01	124897815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	149-64-4	Butylscopolammonium Br			14.2697254923	4	4	BUTYLSCOPOLAMMONIUM Br	0	2.98062593			1128	CHRM1	CCCC[N+]1(C)[C@H]2CC(C[C@@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	BIOMOL	AC216	3.26359833	2.45472235	2.85021225	2.98062593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510347-01	NCGC00510347-01	384569427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					39.5951652399	4	4		0	6.43815201					CC1=CC=C(NC(=O)NCC2=CC3=C(C=C2)C(=O)N(C3)C4CCC(=O)NC4=O)C=C1Cl	Axon Medchem	2645	7.61506276	12.54303248	9.39963614	6.43815201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346553-10	NCGC00346553-10	384568838		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1092443-52-1		8.9125093813	-5.05	58.2565154482	3	4		84.9640657939	77.4366617	0.0201632042	0.9997491892		CDK7	CC(C)C1=C2N=C(NCCCCCCN)C=C(NCC3=CC=CC=C3)[N]2N=C1	MedChem Express	HY-13266	-0.69735007	-2.06555905	5.15463918	77.4366617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346534-03	NCGC00346534-03	384568824		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[852475-26-4]				-13.8424544404	4	4		0	-4.10579732				HDAC2	C[N]1C=C(/C=C/C(=O)C2=CC=CC(=C2)F)C=C1\C=C\C(=O)NO	Tocris	4077	-3.02363936	-1.51805453	-2.84908322	-4.10579732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346881-02	NCGC00346881-02	384568958		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[5291-32-7]				-9.6408197111	4	4		0	3.30616638				TP53	COCC1(CO)N2CCC(CC2)C1=O	Tocris	3710	-2.91368884	-2.90346352	-3.77997179	3.30616638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167431-03	NCGC00167431-03	124893311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	61379-65-5	Rifapentine; ; Rifapentine; Priftin; Rifapentine Hydrochloride	14.1253754462	-4.85	9.2750725735	4	4		14.6844316721	12.9784689	0.4890294193	0.8168578849	5591	PRKDC	CO[C@H]1/C=C/O[C@@]2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4O)\C=N/N5CCN(CC5)C6CCCC6)O	Toronto Research	R508500	-0.65264685	4.4295097	-2.65369306	12.9784689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00355875-04	NCGC00355875-04	384569024		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-8.8782621138	4	4		0	-3.31937799				LDHA	COC1=NC(=C(C=N1)C2=CC=C3C(=C(C=NC3=C2)[S+]([O-])(=O)NC4CC4)NC5=CC(=CC(=C5)C(O)=O)OC6=CC(=CC(=C6)F)F)OC	APExBIO	B4929	-1.6968818	-0.97754697	-1.97552705	-3.31937799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344764-12	NCGC00344764-12	384568729		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	95809-78-2		0.1995262315	-6.7	6.0831302544	4	4		8.94452502	1.25598086	1	0.4903492205			OC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC2=CC=CC=C2	Selleck	S2776	-1.20377085	9.80601802	1.59221583	1.25598086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015989-22	Thalidomide	384567913	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	50-35-1				-7.9750016611	4	4		0	-2.07536061				TNF	O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1	Microsource	01503607	-2.15097959	-0.04579454	-1.28626982	-2.07536061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346096-02	NCGC00346096-02	174006479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	864082-47-3	GSK429286A			-10.4132587097	4	4		0	-4.63735332			6093	ROCK1	CC/1=C(/C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(F)C=C4[NH]N=CC4=C3	Selleck	S1474	-1.00884467	-3.0163834	-3.23709536	-4.63735332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510443-01	NCGC00510443-01	384569435		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					3.8243236781	4	4		0	4.83528913				MMP	NC(=O)C/1=C(O)/[C@]2(O)[C@@H](C[C@@H]\3CC4=C(C(=CC=C4)O)\C(=C3C2=O)O)CC1=O	SIGMA	PH000869	1.03648425	-1.24023886	-2.24555264	4.83528913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480898-01	NCGC00480898-01	384569249		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	849550-05-6				-13.8637595142	4	4		0	-5.58683413					CNCCCOC1=CC(=C(C(=C1)F)C2=C(N[C@@H](C)C(F)(F)F)[N]3N=CN=C3N=C2Cl)F	Glixx	GLXC-06026	-2.51732428	-2.04673896	-2.61693488	-5.58683413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263173-05	Rucaparib	384568643	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	459868-92-9				31.5953149985	4	4		0	6.85722535				PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	Selleck	S1098	6.27916843	10.47808156	4.45179726	6.85722535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181159-03	Trabectedin	384568393	DNA-Damaging Drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	114899-77-3		0.0446683592	-7.35	11.5696402509	4	4		10.73254536	4.53636783	0.5896933679	0.6998739723		H2AFX	COC1=CC2=C(CCN[C@]23CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=C6C(=C(OC)C(=C7)C)O)[C@H](O)N5[C@@H](COC3=O)C8=C4C(=C(C)C9=C8OCO9)OC(C)=O)C=C1O	MedChem Express	HY-50936	-2.6937878	10.42004422	3.89280677	4.53636783												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00485261-01	NCGC00485261-01	363681270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1310877-95-2		10	-5	6.6059462977	4	4		18.1388125399	13.3630632	0.2401584808	0.9629139793	390245	KDM4E	COC(=O)/C=C/C(=O)N(O)CCCCNCC1=CC=C(COC(=O)NC2=C3C=CC=CC3=CC=C2)C=C1	SIGMA	SML0343	-2.19901045	1.16433309	2.03102962	13.3630632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386195-06	NCGC00386195-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-6.4372000844	4	4		0	-0.56896817					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@H](O)C[C@@]2([H])N3C	Selleck	S2545	-1.6217702	-0.899042	-1.77715092	-0.56896817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510501-01	NCGC00510501-01	384569462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1633350-06-7				-14.7516686472	4	4		0	-3.35642802				BTK	NC(=O)C1=C2NCCC(C3CCN(CC3)C(=O)C=C)[N]2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4	MedChem Express	HY-101474	-2.90181716	-3.15917375	-3.75513674	-3.35642802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601952-15	NCGC00601952-15			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	145224-90-4				-0.1829022181	4	4		0	2.00153965					N[C@@H](CC1=CNC2=CC=C(O)C=C12)C(O)=O	Enzo	AC1292	-1.12691928	1.27582017	0.43928015	2.00153965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346556-03	NCGC00346556-03	384568839		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	425386-60-3				-13.8767781407	4	4		0	-1.07775212				NOTCH1	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCC2=C1C=CC=C2	MedChem Express	HY-10009	-3.04268207	-3.85783718	-3.72679609	-1.07775212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509913-01	NCGC00509913-01	384569379		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	664969-54-4				4.8227978092	4	4		0	-0.42684722					N[S+]([O-])(=O)C1=CC=C(NC(=S)N2CCN(CC2)C\C=C\C3=CC=CC=C3)C=C1	Selleck	S8474	1.68516235	0.90062586	0.29913252	-0.42684722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015615-15	NCGC00015615-15	170464649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	103577-45-3	; ; Prevacid;Lansoprazole; Lansoprazole; Lansoprazol;LANSOPRAZOLE			3.5190950302	4	4		0	5.54220274					FC(F)(F)COc3ccnc(CS(=O)c1nc2ccccc2n1)c3C	Microsource	01503926	-1.17468214	2.49578931	0.90405366	5.54220274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507888-01	NCGC00507888-01	384569352		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1792999-26-8		4.4668359215	-5.35	88.8255940126	2.1	4		88.7824053832	81.37721958	0.0225917085	0.9996851084		TNIK	O[C@H]1CC[C@H](CC1)OC2=CC=CC3=C2N=C(NC4=CC=C5N=C[NH]C5=C4)N=C3	Selleck	S8392	-1.18795078	4.2156713	40.18649421	81.37721958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510442-01	Abametapir	384569434	MMP-9 (Gelatinase B) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					2.5190783941	4	4		0	2.61296376				MMP	CC1=CN=C(C=C1)C2=NC=C(C)C=C2	SIGMA	513040	0.14142271	1.46632045	-1.17310874	2.61296376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344507-02	NCGC00344507-02	174006263		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	652973-93-8	 Calhex 231;Calhex 231			-2.644548714	4	4		0	-2.49747365			846	CASR	CC(N[C@H]1CCCC[C@@H]1NC(=O)C2=CC=C(Cl)C=C2)C3=CC=CC4=C3C=CC=C4	SantaCruz Bio	sc-207394	0.59397539	-0.27493508	-3.00797112	-2.49747365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179302-06	NCGC00179302-06	384568370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	479-41-4				-4.6920164637	4	4		0	-1.57355276				CDK1	O=C\1NC2=C(C=CC=C2)C1=C3\NC4=C(C=CC=C4)C3=O	MedChem Express	HY-N0117	-1.81021072	3.20757599	-1.62430441	-1.57355276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246387-08	NCGC00246387-08	384568511		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	131707-23-8		11.220184543	-4.95	79.2210188175	3	4		117.9254943572	96.93951205	0.031012129	0.9994063632			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	-0.22627634	2.53551245	7.97112348	96.93951205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015443-22	NCGC00015443-22	384567847		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	54143-56-5				-6.1699002647	4	4		0	-0.5074581				SCN5A	FC(F)(F)COC1=CC(=C(OCC(F)(F)F)C=C1)C(=O)NCC2CCCCN2	MedChem Express	HY-17429	-1.45684442	-0.98747237	-1.97461213	-0.5074581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025245-05	NCGC00025245-05	384568062		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[15291-77-7]				-3.4660813895	4	4		0	-0.96878364				GABRA1	C[C@@H]1C(=O)OC2[C@H](O)[C@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]36[C@@H](O)C(=O)O[C@H]6O[C@@]4(C(=O)O5)[C@@]12O	Tocris	1657	-1.29191864	-0.16212233	0.95909732	-0.96878364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164380-01	NCGC00164380-01	26757799		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	566-48-3	4-OH Androstenedione;4-Hydroxyandrostenedione			-7.9573937322	4	4	NCGC00095102-02;4-Hydroxy-4-androstene-3,17-dione;NCGC00095102-01;NCGC00015070-01;4-OH Androstenedione;4-hydroxyandrost-4-ene-3,17-dione;formestane;NCGC00095102-03;NCGC00164380-01;Fromestane;CIPLUS_154577;CGP 32349;4-OHA;formestanum;CGP-32349;Formestane (4-Androsten-4-ol-3,17-dione);4-Hydroxyandrost-4-ene-3,17-dione;4-hydroxyandrostene-3,17-dione;4-Androsten-4-ol-3,17-dione;4-HYDROXYANDROSTENEDIONE;Lentaron;4-OH-A;LS-19455;4-hydroxy-4-androstene-3,17-dione;NCGC00093579-01;NCGC00093579-02;4-hydroxyandrostenedione;FORMESTANE;CGP 32 349;Novartis brand of formestane;Formestane;	0	-0.66123328			1588	CYP19A1	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=C(O)C(=O)CC[C@]34C	SigmaAldrich	MFCD00057814	-2.99615173	-0.86956522	2.1438646	-0.66123328												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00505020-01	NCGC00505020-01	384569314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	915303-04-7				-17.8321678987	4	4		0	-4.96693834				TOP1	COC1=C(OC)C=C2C(=C1)C(=O)N(CCC[N]3C=CN=C3)\C4=C2\C(=O)C5=CC6=C(OCO6)C=C45	NCI	NSC725776	-3.6008796	-4.76050111	-2.28490832	-4.96693834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-24	NCGC00018248-24			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-3.7522048406	4	4		0	-2.07596494					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Bionet	KS-1084	-1.26443101	0.42741341	1.04372355	-2.07596494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346625-03	NCGC00346625-03	384568865		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1218777-13-9		6.3095734448	-5.2	47.0070582662	2.2	4		62.1355386047	55.64280216	0.0196786377	0.9997611585		PIK3CG	FC1=CC=C(C=C1)C2=CC=C(O2)\C=C/3SC(=O)NC3=O	Adooq	A11196	-1.38047612	-1.70109356	14.49624486	55.64280216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181170-09	NCGC00181170-09	384568394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	3543-75-7				6.6151128025	4	4		0	0.69178687				XRCC1	C[N]1C(=NC2=C1C=CC(=C2)N(CCCl)CCCl)CCCC(O)=O	MedChem Express	HY-B0077	1.02753802	2.45764005	2.51271313	0.69178687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165902-08	NCGC00165902-08	384568297		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	658084-23-2		12.5892541179	-4.9	68.2312164732	3	4		87.935679022	80.3503091	0.0819971976	0.9958303798		MET	CN1CCN(CC1)C(=O)C2=C(C)[NH]C(=C2C)\C=C3/C(=O)NC4=CC=C(C=C34)[S+]([O-])(=O)N(C)C5=CC(=CC=C5)Cl	Bio Vision	1938	3.79504042	0.01526485	-2.18366736	80.3503091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475726-01	NCGC00475726-01	377020349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1414943-88-6		3.1622776602	-5.5	23.8905568891	4	4		26.719482116	24.47748013	0.0179869294	0.9998008008		CDK9	COC1=CC(=CC=C1C2=NC(=NC=N2)NC3=CC(=CC=C3)C[S+](C)([O-])=N)F	ActiveBioChem	A-1514	-1.84956843	0.01526485	14.74723302	24.47748013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510463-03	NCGC00510463-03	384569437		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1223001-53-3				-3.5051469449	4	4		0	-3.01736827				STK16	CC1=C(F)C=CC(=C1)N2C(=O)\C=C/C3=C2C4=C([NH]C=C4)N=C3	SIGMA	SML1728	0.3973147	0.29003206	-3.52976369	-3.01736827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018199-09	NCGC00018199-09	384567996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	478-43-3				-4.6705473568	4	4		0	-0.5089778					OC(=O)C1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	Selleck	S2400	-0.34549475	-3.47573113	-1.39982502	-0.5089778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408930-02	NCGC00408930-02	384569221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1030123-90-0		8.9125093813	-5.05	18.4996458376	4	4		27.563082328	23.60329147	0.0414154576	0.9989430594			FC1=CC=C(C=C1)C2=CSC3=C2C(=NC=N3)NCC4=CC5=C(OCO5)C=C4	Glixx	GLXC-06715	-0.11313817	-0.88590194	2.52669574	23.60329147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091861-13	NCGC00091861-13	384568100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	891986				-1.716671611	4	4		0	-1.34257254					CN(C)/N=N/C1=C([NH]C=N1)C(N)=O	Enzo	DL371	0.65054448	-1.83290057	-1.56414498	-1.34257254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479074-01	NCGC00479074-01	363681103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1420477-60-6				1.5497222235	4	4		0	-0.53821313				BTK	CC#CC(=O)N1CCC[C@H]1C2=NC(=C3[N]2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=NC=CC=C5	MedKoo	206112	1.45684442	-1.78334562	0.11283498	-0.53821313												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510495-01	NCGC00510495-01	384569457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	942398-84-7		15.8489319246	-4.8	-5.7460097235	4	4		-8.836027712	-5.69668976	0.6427108721	0.6149911828			CCCCCCCOC1=CC=C(CCC(N)(CO)CO)C=C1C(F)(F)F	MedChem Express	HY-16734A	-1.69037893	-0.30376671	4.35029049	-5.69668976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346607-02	NCGC00346607-02	363677476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	4871-97-0				-6.0450703824	4	4		0	0.49268668					CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C	Selleck	S2407	-2.31018453	-1.45808019	0.72268669	0.49268668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238451-09	NCGC00238451-09	363677132		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	763113-22-0				26.2998114495	4	4		0	2.69355314				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	ChemieTek	CT-A2281	6.97355802	7.95298428	1.31618307	2.69355314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015599-10	NCGC00015599-10	384567870		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	79558-09-1		8.9125093813	-5.05	26.1837569544	3	4		41.8835247956	36.56157218	0.0497046433	0.9984744343		PPARG	CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(=C1O)C(C)=O	SIGMA	L2167	-0.51133223	-2.15893431	2.39136775	36.56157218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166413-09	NCGC00166413-09	384568307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	141396-28-3				9.9541062955	4	4		0	2.35311101					C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)N[S+]([O-])(=O)C2=CC=CC3=C2NCC(C)C3	MedChem Express	HY-B0375A	2.40418611	5.46815335	-2.52669574	2.35311101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356071-12	NCGC00356071-12	404904718		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-8.1566468668	4	4		0	-4.48967807					CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(N)=O)\N=C2C4=CC=C(Cl)C=C4)C	Bio Vision	9404-5	-0.31112997	-3.05483428	-2.6770943	-4.48967807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346675-02	NCGC00346675-02	384568901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1071992-99-8				-4.9277917771	4	4		0	-1.10854503				XIAP	CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC(C)C	Axon Medchem	1985	-1.26778419	-0.42527339	-0.80770866	-1.10854503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510480-01	NCGC00510480-01	384569443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1936529-65-5				-10.1712736575	4	4		0	-4.21862972				SIK	COC1=CN=C(C=C1)N2C(=O)N(CC3=CN=C(NC4=CC=C(C=C4OC)C5CCN(C)CC5)N=C23)C6=C(C)C=CC=C6Cl	MedChem Express	HY-101147	-2.76095225	-1.21506683	1.26115913	-4.21862972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-05	NCGC00346712-05	384568927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	129497-78-5		0.5623413252	-6.25	131.5208931285	1.4	4		69.6750964632	-0.65091269	1	0.9999337929			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Aobious	AOB5623	-2.39944521	56.86391415	67.68687463	-0.65091269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160530-12	NCGC00160530-12	384568200		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	89778-26-7				-4.3519114485	4	4		0	-6.14121975				ESR1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)C2=CC=CC=C2)C3=CC=CC=C3	Enzo	DL519	-1.53952843	2.75748994	3.20776928	-6.14121975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510354-01	NCGC00510354-01	384569429		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-1.371854807	4	4		0	-2.31867666				HHAT	CCC(C)CNCC(=O)N1CCC2=C(C=CS2)C1C3=NC(=CC=C3)C	Axon Medchem	2673	0.48369265	-0.22967386	-1.02070575	-2.31867666												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095042-08	NCGC00095042-08	174006555		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef			-9.5363904263	4	4		0	-4.15665206					S=[P](N1CC1)(N2CC2)N3CC3	Microsource	MS-01503324	-1.9209508	-0.78089113	-1.39982502	-4.15665206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015889-21	NCGC00015889-21	384567903		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	82640-04-8				3.3358473289	4	4		0	-0.62208398				ESR1	OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5	MedChem Express	HY-13738A	-0.76008845	1.94457204	6.27004958	-0.62208398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017245-15	NCGC00017245-15	384567979		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	476-66-4				4.7592559806	4	4		0	2.85593101				AKR1B1	OC1=CC2=C3C(=C1O)OC(=O)C4=CC(=C(O)C(=C34)OC2=O)O	Selleck	S1327	0.20729685	0.71964477	1.13735783	2.85593101												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378857-02	NCGC00378857-02	363678239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	377727-87-2				18.9240288074	4	4		0	1.31370001				ADORA2A	COCCOC1=CC=C(C=C1)N2CCN(CC2)CC[N]3N=CC4=C3N=C(N)[N]5N=C(N=C45)C6=CC=CO6	APExBIO	A3735	6.73172111	-0.45822514	1.53406527	1.31370001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163474-07	NCGC00163474-07	363676621		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	4449-51-8		14.1253754462	-4.85	27.202719934	4	4		26.5059569321	23.19907608	0.3131754406	0.9343150137		SMO	C[C@@H]1CN[C@H]2[C@@H](C)[C@@]\3(CC[C@H]\4[C@@H]5C/C=C6/C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C)O[C@@H]2C1	Selleck	S1146	4.63866497	-2.50496411	-0.33087682	23.19907608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094201-03	NCGC00094201-03	124891671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	27686-84-6	 ; Dihydronorguaiaretic Acid; Nordihydroguaiaretic acid from Larrea divaricata (creosote bush);Nordihydroguaiaretic acid from Larrea divaricata (creosote bush)			1.3019526769	4	4	NCGC00089785-03;1,2-BENZENEDIOL, 4,4'-(2,3-DIMETHYL-1,4-BUTANEDIYL)BIS-, (R*,S*)-;SP-134101;CIPLUS_153652;NORDIHYDROGUAIARETIC ACID;LS-136429;butane, 1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethyl-;4,4'-(2,3 Dimethyl-1,4-butanediyl)bis(1,2-benzenediol);ACTINEX;CIPLUS_213635;4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol;Nordihydroguaiaretic Acid;1,4-Bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane;MASOPROCOL;Masoprocolum;NDGA;masoprocol;LS-174190;MESO-4,4'-(2,3-DIMETHYLTETRAMETHYLENE)DIPYROCATECHOL;Masoprocol;NCGC00094201-02;NCGC00094201-01;masoprocolum;Dihydronorguaiaretic Acid;meso-Nordihydroguaiaretic Acid;NORDIHYDROGUARETIC ACID;Nordihydroguaiaretic acid;NCGC00015741-01;1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-;Nordihydroguaiaretic acid from Larrea divaricata (creosote bush);Actinex;MESO-NORDIHYDROGUAIARETIC ACID;Nordihydroguaiaretic Acid, (R*,S*)-Isomer;	0	3.82560993			240	ALOX5	C[C@H](CC1=CC=C(O)C(=C1)O)[C@@H](C)CC2=CC(=C(O)C=C2)O	SIGMA	N5023	-1.55564984	3.66580113	-0.21055798	3.82560993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346935-09	NCGC00346935-09	384568970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1202916-90-2		14.1253754462	-4.85	1.6851955176	4	4		11.7498872	7.29031327	0.5320871286	0.7733349797		PIM1	CN1CCCN(CC1)C(=O)C2=CC(=CC=C2)C3=CC=C(O3)/C=C4/C(=O)NC5=CC=C(Cl)C=C45	MedChem Express	HY-18095	0.87682082	-2.96318925	-5.624906	7.29031327												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379089-04	NCGC00379089-04	384569094		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	529488-28-6				-24.1769260353	4	4		0	-6.27977479				TOP1	CNCCN1C(=O)C2=CC(=C(OC)C=C2C3=C1C4=CC5=C(OCO5)C=C4N=C3)OC	MedChem Express	HY-16228	-4.29925046	-5.22376661	-4.96315235	-6.27977479												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00187481-08	NCGC00187481-08	384568444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	915019-65-7		1	-6	16.1028546297	4	4		18.4287927919	15.64280216	0.0888877784	0.9951154132		MTOR	CN1C(=O)N(C2=CC=C(C=C2)C(C)(C)C#N)C3=C4C=C(C=CC4=NC=C13)C5=CC6=C(C=CC=C6)N=C5	Selleck	S1009	-3.69066066	-2.21749696	2.67819187	15.64280216												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00386720-01	NCGC00386720-01	363680415		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	186390-48-7				-7.4106421889	4	4		0	-0.5234796					FC(F)(F)C1=CC=C(C=C1)C2=CC=CC=C2C(=O)NC3=CC4=C(CN(CC4)CC5=NC=N[NH]5)C=C3	Axon Medchem	2216	-1.71855191	-1.82260024	-1.94133484	-0.5234796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371001-05	NCGC00371001-05	384569039		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					15.6978119196	4	4		0	0.95458045				SMARCA2	OC1=C(C=CC=C1)C(=O)\C=C\N2C[C@H]3C[C@@H]2CN3C4=NC=CC=C4	MedChem Express	HY-12409	6.64882378	-1.7618469	-1.0911152	0.95458045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024563-11	NCGC00024563-11	384568029		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	123040-16-4				11.463013703	4	4		0	2.0939184				HTR3A	CN1C(=O)COC2=C(C=C(Cl)C=C12)C(=O)NC3CN4CCC3CC4	MedChem Express	HY-B0068	3.91604451	-0.69866343	0.55264277	2.0939184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159574-16	NCGC00159574-16	384568190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	331771-20-1		11.220184543	-4.95	42.6194830756	3	4		79.3053209575	68.05234796	0.0070163608	0.9999696399		AURKA	COC1=C(OCCCN2CCOCC2)C=C3N=CN=C(NC4=CC=C(NC(=O)C5=CC=CC=C5)C=C4)C3=C1	MedChem Express	HY-10128	-2.47922243	-2.15674362	-0.58098342	68.05234796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386449-03	NCGC00386449-03	384569142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1450833-55-2				-16.7539012805	4	4		0	-6.22612141				UBA1	CO[S+]([O-])(=O)N[C@H]1C[C@@H](NC2=CC=NC3=CC(=N[N]23)C4=CC=CC(=C4)SC(F)(F)F)[C@H](O)[C@@H]1O	Aobious	AOB87172	-2.28848821	-3.80086451	-5.15008829	-6.22612141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509915-01	NCGC00509915-01	384569381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1910124-24-1		6.3095734448	-5.2	13.4860061733	4	4		24.9581993559	21.43362081	0.0573496721	0.9979712057		BRPF1	COC1=CC=CC=C1C(=O)NC2=CC3=C(C=C2N4CCNC[C@H]4C)N(C)C(=O)N3C	Selleck	S8265	-1.45107794	-2.46516613	4.14114902	21.43362081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164631-19	NCGC00164631-19	384568270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	557795-19-4				-10.4682872161	4	4		0	-6.33751985				FLT1	CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)/C=C/2C(=O)NC3=CC=C(F)C=C23	MedChem Express	HY-10255A	-0.87682082	-0.2138384	-4.78267409	-6.33751985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179599-13	NCGC00179599-13	384568379		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	62893-20-3				-3.8521417297	4	4		0	-2.12213079					CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C5=CC=C(O)C=C5)C(=O)C1=O	Cayman	16113	0.62225993	-2.65770582	-2.85757257	-2.12213079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387877-01	NCGC00387877-01	363680717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1000023 -04 - 0		10	-5	47.8281516936	3	4		79.8215097736	72.85604311	0.0107679255	0.9999284877		CDK1	CN1CC[C@H]([C@@H]1CO)C2=C3OC(=C/C(=O)C3=C(O)C=C2O)\C4=C(Cl)C=C(C=C4)C(F)(F)F	ChemieTek	CT -VORU	-1.8875898	-2.39975699	-0.18421426	72.85604311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189220-12	NCGC00189220-12	384568460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1255580-76-7		12.5892541179	-4.9	9.1960061507	4	4		17.515256592	15.33889911	0.1066538455	0.992954987		EHMT2	COC1=C(OCCCN2CCCC2)C=C3N=C(N=C(NC4CCN(CC4)C(C)C)C3=C1)C5CCCCC5	MedChem Express	HY-15273	-0.84604716	0.55149799	-0.70629782	15.33889911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242492-04	NCGC00242492-04	384568498		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	321674-73-1				4.387606852	4	4		0	6.22612141				TERT	C\C(=C/C(=O)NC1=C(C=CC=C1)C(O)=O)C2=CC3=CC=CC=C3C=C2	Selleck	S1186	-0.34674064	1.41600835	-0.52972337	6.22612141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475765-01	NCGC00475765-01	384569238		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE					4.5848088582	4	4		0	3.48733234				XIAP	CN[C@@H](C)C(=O)N[C@H]1[C@H](C)N(C(C)=O)C2=C(C=CC(=C2)C#N)N(CC3=C4C=CC=CC4=CC=C3C)C1=O	NCGCChem	DYD027-014	-0.13947001	2.00568777	1.3341419	3.48733234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346638-03	NCGC00346638-03	384568872		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	601514-19-6				-8.6253721701	4	4		0	-1.54468024				GSK3B	NC1=CC(=CC=C1)C2=CC3=C([NH]2)N=CN=C3OC4=CC=CC(=C4)O	Selleck	S1590	-0.65054448	-4.55170307	-3.7599639	-1.54468024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013917-09	NCGC00013917-09	363676433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	56990-57-9				-1.7915439319	4	4		0	-0.41866029					OC1=C(C=C(C2=CC=CN=C12)[S+](O)([O-])=O)\N=N\C3=CC=C4C=C(C=CC4=C3)[S+](O)([O-])=O	Glixx	GLXC-02436	-1.31979695	-0.18329006	2.88957688	-0.41866029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263140-03	NCGC00263140-03	363677225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	309913-83-5		11.220184543	-4.95	12.5594344663	4	4		20.8113818841	16.72055427	0.0926647592	0.9946924597		MAPK14	C[C@H]1CN([C@H](C)CN1CC2=CC=C(F)C=C2)C(=O)C3=C(Cl)C=C4[N](C)C=C(C(=O)C(=O)N(C)C)C4=C3	Axon Medchem	1671	-0.67615157	0.75941677	1.79963157	16.72055427												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387879-02	NCGC00387879-02	384569168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1047645-82-8				-10.1091415656	4	4		0	-4.95765974				AKT1	C[N]1N=CC(=C1C2=C(Cl)SC(=C2)C(=O)N[C@H](CN)CC3=CC=CC(=C3)F)Cl	MedChem Express	HY-15727A	-1.07057332	-3.28068044	-1.9696755	-4.95765974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384167-11	NCGC00384167-11	384569102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	700874-72-2				-0.9291832491	4	4		0	-2.83294842				TGBR1	CC1=CC=CC(=N1)C2=N[N]3CCCC3=C2C4=CC=NC5=CC=C(C=C45)C(N)=O	MedChem Express	HY-13226	-0.81701648	6.68286756	-1.99801615	-2.83294842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015209-16	NCGC00015209-16	384567825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	6055-19-2				-9.417555837	4	4		0	-0.20864382				BCL2	ClCCN(CCCl)[P]1(=O)NCCCO1	Selleck	S2057	-2.92887029	0.23948511	-2.78956944	-0.20864382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346699-02	NCGC00346699-02	384568919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	871026-44-7				-13.0777176119	4	4		0	-6.61698957				EGFR	CC(C)(O)CC(=O)NCC[N]1C=CC2=C1C(=NC=N2)NC3=CC=C(OC4=CC=CC(=C4)C(F)(F)F)C(=C3)Cl	Selleck	S2784	-2.9846583	2.54452926	-3.27471195	-6.61698957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346895-01	NCGC00346895-01	174007115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	100938-10-1	Amastatin			-8.7076497486	4	4		0	-0.02980626			51056	LAP3	CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O	SIGMA	A1276	-3.15202232	0.05987128	-0.97028502	-0.02980626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241112-04	NCGC00241112-04	384568477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[215303-72-3]		10	-5	47.6508344236	3	4		53.9887397106	47.04778403	0.0208214254	0.9997326717		MAPK14	OCCC#CC1=NC(=C([N]1CCCC2=CC=CC=C2)C3=CC=NC=C3)C4=CC=C(F)C=C4	Tocris	2999	1.97991797	2.74935085	7.88088434	47.04778403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249684-04	NCGC00249684-04	384568532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	745833-23-2				2.8079954381	4	4		0	4.22982532				MAPK14	NC(=O)N(C1=NC(=C(C=C1)C(N)=O)C2=C(F)C=C(F)C=C2)C3=C(F)C=CC=C3F	Selleck	S6005	-1.81021072	-1.86344891	7.97112348	4.22982532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095187-09	NCGC00095187-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	196597-26-9				-4.0852123445	4	4		0	1.81678214					CCC(=O)NCC[C@@H]1CCC2=C1C3=C(OCC3)C=C2	MedChem Express	HY-A0014	-1.52134103	-1.33657351	-0.89273062	1.81678214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346546-04	NCGC00346546-04	384568832		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	957116-20-0				-2.9364374526	4	4		0	0.98537336					FC1=CC(=CC(=C1)F)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC=C5C[C@]6(CC5=C4)C(=O)NC7=C6C=CC=N7	MedChem Express	HY-10302	-1.8875898	-1.09356015	2.73487318	0.98537336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346568-05	NCGC00346568-05	363677455		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1032823-75-8				-1.0723520982	4	4		0	-1.87836798				GPR119	CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)[S+](C)([O-])=O	MedChem Express	HY-12066	-0.22538386	0.54678007	0.75102735	-1.87836798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346623-04	BMS-378806	384568863	HIV Attachment Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	357263-13-9				-4.9227154255	4	4		0	2.59314456					COC1=C2C(=NC=C2C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C4=CC=CC=C4)[NH]C=C1	MedChem Express	HY-14134	-3.59832636	0.3891633	2.94117647	2.59314456												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167805-03	NCGC00167805-03	384568340		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[745046-84-8]				-1.5176016286	4	4		0	-1.9076006				CASP3	CC(=O)OCCN1C(=O)C2=C(C)N=C3C=CC(=CC3=C2C1=O)[S+]([O-])(=O)N4CCOCC4	Tocris	2636	-0.08368201	-1.76620266	1.94057004	-1.9076006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510921-01	Lucanthone	384569494	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	548-57-2		12.5892541179	-4.9	69.7751810722	3	4		70.6972864263	63.67836004	0.2005275729	0.9743539281		TOP2A	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1	SantaCruz Bio	sc-396381	9.16419177	-2.13838399	0.39103625	63.67836004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250405-15	NCGC00250405-15	384568553		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1009298-09-2				-12.5240779717	4	4		0	-2.69958135				MTOR	COC1=C(CO)C=C(C=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOC[C@@H]4C)N5CCOC[C@@H]5C	MedChem Express	HY-10422	-1.8667798	-3.87963953	-4.33147842	-2.69958135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024667-19	NCGC00024667-19	384568031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	555-30-6				-2.4718566735	4	4		0	-3.07492421				DDC	C[C@](N)(CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	DL443	1.1313817	-1.31357874	-3.06813055	-3.07492421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346481-02	NCGC00346481-02	363677418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	572924-54-0				-19.3359713987	4	4		0	-4.24942263				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O[P](C)(C)=O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Selleck	S1022	-4.16960135	-4.13122722	-3.75513674	-4.24942263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018261-09	Perhexiline	384568001	mitochondrial carnitine palmitoyltransferase-1 inhbitior	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	6724-53-4, 6621-47-2 [perhexiline]		2.8183829313	-5.55	121.8549688759	3	4		99.6114550071	-5.72748268	1	0.9980621863			C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3	Microsource	01503227	1.0987463	-3.0072904	83.76080487	-5.72748268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389459-01	NCGC00389459-01	377020277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	175865-59-5				6.1122758139	4	4		0	-2.37724636					CC(C)C(N)C(=O)OCC(CO)OC[N]1C=NC2=C1N\C(=N/C2=O)N	APExBIO	B1864	3.48127601	-0.34282307	-1.08887581	-2.37724636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346471-03	NCGC00346471-03	384568789		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	93908-02-2				-15.596524633	4	4		0	-0.50670641				TOP1	CO[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1CO)[N]2C3=C(C=CC=C3Cl)C4=C2C5=C(C6=C([NH]5)C(=CC=C6)Cl)C7=C4C(=O)NC7=O	Cayman	17914	-3.9888424	-3.71201916	-3.4869618	-0.50670641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370832-01	NCGC00370832-01	377020311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	3352		14.1253754462	-4.85	5.8063099336	4	4		24.0233498	17.67511177	0.1240582611	0.9904156076		EGFR	NC1=C(\C=N\OCCN2CCOCC2)C(=NC=N1)NC3=CC(=C(OCC4=CC=CC=C4)C=C3)Cl	Tocris	3352	-1.14365411	-3.3527915	-3.0624621	17.67511177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016645-03	NCGC00016645-03	124882458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	3963-95-9	 ; Methacycline Hcl; Methyleneoxytetracycline;Methacycline hydrochloride; Methacycline hydrochloride; Rondomycin; Globociclina; Physiomycine; Lysocline; Metaciclina			-3.4394698012	4	4		0	0.50526924					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@@H]\3C(=C)C4=C(C(=CC=C4)O)C(=O)C3=C(\O)[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Vitas	STK177310	-0.28284542	-2.35222239	-2.07550008	0.50526924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091823-09	NCGC00091823-09	384568098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	481-74-3				-5.2191080395	4	4		0	0.44752418				FLT1	CC1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	Microsource	00300545	-2.17790977	-1.22193371	1.23326816	0.44752418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274060-07	Posaconazole			DPI_SARS-CoV-2_General		171228-49-2		0.0015722683	-8.8034733462	132.1916606674	4	10		18.7069518716	33.71657754	0.1812100049	0.6174185644			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	1.73796791	1.68449198	7.29946524	8.42245989	28.04812834	26.01604278	13.23529412	11.63101604	17.56684492	33.71657754						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00094047-16	Ivermectin			DPI_SARS-CoV-2_General		70288-86-7		0.0157226828	-7.8034733462	-14.22778743	4	20		-6.657556704	-4.52569675	0.6316186428	0.6204696737			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00651732-01	ROC-325			DPI_SARS-CoV-2_General		1859141-26-6		0.0106262942	-7.9736181626	262.7271401968	1.1	20		117.5781296584	64.19786096	8.334E-7	0.9473145397			CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527																8.682634731E-11	1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8					
NCGC00490649-01	NCGC00490649-01			DPI_SARS-CoV-2_General						11.7342818843	4	20		0	3.40391316					CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389778-03	NCGC00389778-03			DPI_SARS-CoV-2_General		82956-11-4				7.9800485199	4	20		0	1.68449198					NC(N)=NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N	Bio Vision	1760																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00379064-01	R-7128	377020456		DPI_SARS-CoV-2_General		940908-79-2				10.0945628132	4	10		0	2.83814881					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	2.68473536	1.8665303	3.96318077	-0.84377397	0.53694707	-0.69036052	-0.43467144	0.07670672	0.43467144	2.83814881						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00229511-27	Tofacitinib			DPI_SARS-CoV-2_General		477600-75-2				-3.0332505073	4	10		0	-0.89491179					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	-1.91766812	0.9460496	0.89491179	-1.96880593	-0.99718742	2.78701099	-0.99718742	0.43467144	-1.61084122	-0.89491179						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00229511-27	Tofacitinib			DPI_SARS-CoV-2_General		477600-75-2				-3.3459891749	4	10		0	-0.9565455					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	-1.44848319	-1.55780268	2.15905985	-3.3615742	7.89833288	-1.72178191	-1.12052473	-1.83110139	-1.66712216	-0.9565455						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General		915087-33-1				-2.3425842306	4	10		0	-0.84722602				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-2.04974037	-1.72178191	-2.26837934	5.11068598	-0.30062859	0.73790653	0.84722602	0.1913091	-1.22984422	-0.84722602						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015904-05	NCGC00015904-05			DPI_SARS-CoV-2_General		36791-04-5				2.8606029263	4	10		0	1.63495042					NC(=O)C1=N[N](C=N1)C2OC(CO)C(O)C2O	Bio Vision	2199	0.0804074	-1.0989011	-0.9380863	-0.83087644	-1.52774055	-2.22460466	-1.52774055	0.72366658	1.15250603	1.63495042						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090782-17	Nelfinavir Mesylate			DPI_SARS-CoV-2_General		159989-65-8		0.0039493594	-8.4034733462	189.6158370125	1.4	10		72.2315733017	-4.42240686	0.054822527	0.8114364205			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	3.24309836	3.1358885	-1.58134548	4.04717234	9.19324578	61.99410346	94.7467167	89.86866792	34.54837845	-4.42240686						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	DPI_SARS-CoV-2_General		52-86-8		0.0702306445	-7.1534733462	236.6484104105	3	10		101.9667649372	80.97024926	9.996E-7	0.9930490811			OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	2.76065398	0.72366658	-2.81425891	-1.95658001	-1.58134548	1.47413562	-1.95658001	2.59983919	9.30045564	80.97024926						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General		17321-77-6		0.0625931278	-7.2034733462	263.7592334297	2.1	10		112.9690431532	90.19029751	1.62E-7	0.9958879376		SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	-2.86786384	-1.0989011	-3.77914768	-3.72554275	-3.35030823	-2.76065398	1.31332083	2.92146878	20.39667649	90.19029751						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346697-02	NCGC00346697-02	384568917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	666260-75-9				-9.0457275932	4	4		0	-0.38977913				CNR2	FC(F)(F)C1=NC(=NC=C1C(=O)NCC2CCOCC2)NC3=CC=C(Cl)C=C3Cl	Selleck	S2778	-2.31933248	-1.34412708	-2.70717401	-0.38977913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095089-21	NCGC00095089-21	384568143		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	86386-73-4				7.5297160161	4	4		0	0.86220169					OC(C[N]1C=NC=N1)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-B0101	3.40893084	-0.57715674	-2.02635681	0.86220169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015970-10	NCGC00015970-10	174007228		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac			-4.8764684854	4	4		0	1.0469592				ABCC1	C[S+]([O-])C1=CC=C(C=C1)\C=C2\C(=C(\CC(O)=O)C3=C2C=CC(=C3)F)C	Microsource	MS-01500556	-2.22566559	1.57958688	-1.54456568	1.0469592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092309-06	NCGC00092309-06	363676558		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	312636-16-1				4.6904376239	4	4		0	4.12625096				SPHK1	OC1=CC=C(NC2=NC(=CS2)C3=CC=C(Cl)C=C3)C=C1	Selleck	S7176	0.76067052	-2.73390036	2.25308205	4.12625096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522603-01	NCGC00522603-01	384569531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	243984-11-4		14.1253754462	-4.85	-4.946231063	4	4		11.55690942	7.852194	0.2692961775	0.9530091927		TLR4	CCOC(=O)C1=CCCCC1[S+]([O-])(=O)NC2=CC=C(F)C=C2Cl	MedChem Express	HY-11109	-3.38075785	-0.69866343	-2.42312597	7.852194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346874-02	NCGC00346874-02	384568952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	[130332-27-3]		2.2387211386	-5.65	13.435238655	4	4		9.885176188	9.29946112	0.1481376971	0.9863587661		CCKB	C[C@](CC1=C[NH]C2=CC=CC=C12)(NC(=O)OC3C4CC5CC(C4)CC3C5)C(=O)NC[C@H](NC(=O)CCC(O)=O)C6=CC=CC=C6	Tocris	2607	0.33807579	-1.15431349	9.19654244	9.29946112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345851-06	NCGC00345851-06	384568766		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1032754-81-6				-7.4861451597	4	4		0	-3.33946512				PIK3CA	CC1=C(CN2CCN(CC2)[S+](C)([O-])=O)SC3=C1N=C(N=C3N4CCOCC4)C5=CN=C(N)N=C5	MedChem Express	HY-11042	-0.40221914	-2.66805783	-3.00176574	-3.33946512												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345831-03	NCGC00345831-03	363677375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	193746-75-7				-1.7456666454	4	4		0	-2.71685298				MAPK14	COC1=NC=CC(=N1)C2=C(N=C[N]2C3CCNCC3)C4=CC=C(F)C=C4	MedChem Express	HY-18306	0.56865465	-0.55149799	-1.11830489	-2.71685298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390546-03	NCGC00390546-03	384569189		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	904763-27-5				-2.5032485302	4	4		0	-1.41502759					CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=C[NH]C=N2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O	MedChem Express	HY-13535A	-0.51317614	-0.16395886	-0.02942908	-1.41502759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241097-06	NCGC00241097-06	384568469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	(387867-13-2)				-2.8697765042	4	4		0	0.79241545				KIT	COC1=CC2=C(N=CN=C2C=C1OCCCN3CCCCC3)N4CCN(CC4)C(=O)NC5=CC=C(OC(C)C)C=C5	SynKinase	SYN-1088	-1.73370319	3.26427187	-1.88346086	0.79241545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092318-12	NCGC00092318-12	384568105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1177865-17-6		0.3981071706	-6.4	18.8363691369	4	4		-10.259203124	-3.13266927	0.3684810339	0.9070014783		RAC1	CCN(CC)CCCC(C)NC1=NC(=CC(=N1)C)NC2=CC3=C(N)C=C(C)N=C3C=C2	MedChem Express	HY-15723A	8.06109461	0.39712846	0.45119567	-3.13266927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263150-04	NCGC00263150-04	363677230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	401900-40-1				-8.4065636351	4	4		0	-1.55502392				AR	CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C=C1	MedChem Express	HY-12023	-2.16098622	0.2138384	-2.68317853	-1.55502392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015675-22	NCGC00015675-22	384567880		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	78415-72-2				-1.3291874589	4	4		0	0.29904306				PDE3A	C\C1=C(\C=C(\C#N)C(=O)N1)C2=CC=NC=C2	MedChem Express	HY-14252	-0.42059463	-1.03864365	0.35382574	0.29904306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016060-14	NCGC00016060-14	384567917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	67526-95-8				140.5178993314	4	4		0	4.69497608					CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)\C(C)=C/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(C)=O)[C@@H]12)OC(=O)CCC)C	Cayman	10522	49.23857868	7.60653735	8.52130326	4.69497608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346736-01	NCGC00346736-01	174007287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	58-20-8	Testosterone cypionate			7.0666502819	4	4		0	3.8576555			374	AR	C[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5	Selleck	S1700	2.1319797	-0.15274171	-1.65118679	3.8576555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344481-01	NCGC00344481-01	377020180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	n				-4.7288198055	4	4		0	-5.57351809				YES1	CN[S+]([O-])(=O)C1=CC=C2NC(=O)C(=C\C3=C(CCCN4CCN(C)CC4)C5=C(CCCC5)[NH]3)/C2=C1	NCGCChem	PRP01-012	-0.95788139	-1.0328068	3.72679609	-5.57351809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017369-07	NCGC00017369-07	124883152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	491-80-5	BIOCHANIN A;Biochanin A (4-Methylgenistein);Biochanin A			12.4090012922	4	4	CIPLUS_206980;NCGC00022428-03;NCGC00022428-05;genistein 4-methyl ether;BIOCHANIN A;LS-39601;1   Biochanin A;biochanin A;5,7-dihydroxy-4'-methoxyisoflavone;Genistein 4'-methyl ether;5,7-Dihydroxy-4'-methoxyisoflavone;LS-173688;Biochanin A;biochanin A, 14C-labeled;	0	-1.75463422					COC1=CC=C(C=C1)C/2=C/OC3=C(C(=CC(=C3)O)O)C2=O	BIOMOL	NP-034	4.47988904	0.84960501	2.41318423	-1.75463422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390649-02	NCGC00390649-02	384569206		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	600734-06-3		11.220184543	-4.95	67.8456542391	3	4		91.286118583	76.75109665	0.0694860392	0.9970105397		NFKB	OC1=C(C(=CC=C1)OCC2CC2)C3=CC(=C4COC(=O)NC4=N3)[C@@H]5CCCNC5	MedChem Express	HY-50948	0.26352288	5.20196751	8.82872278	76.75109665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508883-01	NCGC00508883-01	384569370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1825345-33-2				-17.3947944462	4	4		0	-5.03725782				PARP1	O=C1N\N=C(\CC2=CC=CC(=C2)C(=O)N3CCN(CC3)C4=NC=CC=C4C#N)C5=CC=CC=C15	SynKinase	SYN-3046	-3.84937238	-1.64646011	-3.79017586	-5.03725782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016706-10	NCGC00016706-10	384567956		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE					-12.1331964283	4	4		0	3.56575718				TUBB	CCCCC1=CC2=C([NH]C(=N2)NC(=O)OC)C=C1	SIGMA	MFCD18910864	-4.35581954	-3.54360776	-1.71454354	3.56575718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-02	NCGC00347284-02	384568985		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	781613-23-8		2.8183829313	-5.55	0.0872386235	4	4		15.522147552	-6.68399018	1	0.9994135255		EGFR	COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	DC Chemicals	DC3129	-3.93155141	-4.18512296	9.02391337	-6.68399018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263092-02	NCGC00263092-02	384568584		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	287405-51-0				-0.6615830779	4	4		0	-2.46860113				TNF	CC1(C)SCCN([C@H]1C(=O)NO)[S+]([O-])(=O)C2=CC=C(OCC#CCO)C=C2	Axon Medchem	1507	1.95163343	-1.46632045	-3.97052188	-2.46860113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346483-02	NCGC00346483-02	384568793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	5022		12.5892541179	-4.9	55.8482001006	3	4		113.02236985	93.70578894	0.0187637033	0.999782789		EGFR	CC1=C2[N](C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)[N](CC6=CC(=CC=C6)F)N=C5	Tocris	5022	-3.36586056	-4.12402627	-3.88028275	93.70578894												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094818-13	NCGC00094818-13	384568137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	84-16-2				2.5502164492	4	4		0	3.43899522				AKR1C1	CCC(C(CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2	Adooq	A10451	0.53662074	-0.39712846	-1.59221583	3.43899522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389510-02	NCGC00389510-02	363680793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	192185-72-1				-4.0048636023	4	4		0	-4.93421053					C[N]1C=NC=C1C(N)(C2=CC=C(Cl)C=C2)C3=CC\4=C(C=C3)N(C)C(=O)\C=C4C5=CC(=CC=C5)Cl	Bio Vision	2296	-1.20377085	2.35222239	1.59221583	-4.93421053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510693-01	NCGC00510693-01	384569483		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1952251-28-3				-2.018693085	4	4		0	0				SYK	C[N]1C=C(C=N1)C2=C3C(=O)NCC3=C(F)C(=N2)N[C@@H]4CCCC[C@@H]4N	Selleck	S8442	0.53528666	-2.2782503	-1.79963157	0												1.6E-8	8E-8	4E-7	0.000002											
NCGC00346672-02	NCGC00346672-02	384568898		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	937265-83-3				-2.0847324526	4	4		0	-0.65091269				ERBB2	CC1=CC(=CC=C1OC2=CC3=NC=N[N]3C=C2)NC4=C5C=C(C=CC5=NC=N4)C6=CC=C(CNCC[S+](C)([O-])=O)O6	Selleck	S2752	-2.42718447	7.16947384	-0.58858152	-0.65091269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242478-04	NCGC00242478-04	384568491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			1.4125375446	-5.85	114.1702384423	3	4		80.2747703081	1.7585693	1	0.9999111234		HSP90AB1	CO[C@H]1C[C@H](C)C\C2=C(/NCCN(C)C)C(=O)\C=C(\NC(=O)\C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(=C/[C@H](C)[C@H]1O)C)C)C2=O	Selleck	S1142	-0.86471409	5.74764257	77.68344451	1.7585693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387244-01	NCGC00387244-01	384569155		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1599432-08-2]				8.2191329892	4	4		0	-3.99403875					COC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC=C(Br)C=C3	Tocris	5203	2.56624826	3.62221224	3.03214069	-3.99403875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508865-03	NCGC00508865-03	384569366		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE			0.7943282347	-6.1	25.0216065414	4	4		10	9.5976155	0.3909630786	0.8933705618			CC[S+]([O-])(=O)C1=CC2=C(OC(=N2)C3=CC4=CC=CC=C4C=C3)C=C1	Axon Medchem	2481	1.53417015	6.37629097	13.55366889	9.5976155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241099-04	Saracatinib	384568470	cSRC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	379231-04-6				-15.3751073141	4	4		0	-5.23325359				SRC	CN1CCN(CCOC2=CC3=NC=NC(=C3C(=C2)OC4CCOCC4)NC5=C6OCOC6=CC=C5Cl)CC1	Selleck	S1006	-2.30601885	-3.81854284	-4.15745245	-5.23325359												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390618-03	NCGC00390618-03	384569201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			2.8183829313	-5.55	61.1884170711	3	4		61.0029663781	-5.72748268	1	0.9993723019			CCCCNC1=NC=C2C(=N1)[N](C=C2C3=CC=C(CN4CCN(C)CC4)C=C3)[C@@H]5CC[C@@H](O)CC5	MedChem Express	HY-12344A	-2.59191435	-3.94896719	48.78843701	-5.72748268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345819-01	NCGC00345819-01	174007301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	15183-37-6	Estetrol			-3.8585492452	4	4		0	0.03079292			2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O	Toronto Research	E668450	-0.87336245	-0.36452005	-1.99801615	0.03079292												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346690-04	NCGC00346690-04	384568912		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	501951-42-4		10	-5	4.2649401104	4	4		10.9199182999	9.45342571	0.1527919649	0.9855170605		TRPV1	FC(F)(F)C1=CN=C(C=C1)N2CC[C@H](C2)NC(=O)NC3=CC=CC=C3Br	MedChem Express	HY-10633	-1.18326525	0.27339004	0.04251098	9.45342571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178377-07	NCGC00178377-07	384568355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	29883-15-6				-4.7910486663	4	4		0	-1.69803311					OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC(C#N)C3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCK-001	-2.09431345	2.93635415	-0.32371984	-1.69803311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250387-06	NCGC00250387-06	384568540		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[881375-00-4]				9.2412460323	4	4		0	8.19672131				PRKDC	CCN1CCN(CC1)CC(=O)NC2=CC=C(C3=C2C4=C(S3)C=CC=C4)C5=C6O\C(=C/C(=O)C6=CC=C5)N7CCOCC7	Tocris	4840	-0.64156206	0.62864841	2.36506974	8.19672131												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346945-06	NCGC00346945-06	363677563		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	648903-57-5				1.6264753808	4	4		0	-1.77566046				SYK	COC1=CC=C(C=C1OC)C2=CC3=NC=C[N]3C(=N2)NC4=NC=CC=C4C(N)=O	MedChem Express	HY-14985	0.53740631	4.33786467	-2.07550008	-1.77566046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686671-01	Brincidofovir			DPI_SARS-CoV-2_General		444805-28-1				1.0987672251	4	10		0	1.09946305					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	0.33239581	-0.12784454	-1.91766812	-1.50856558	-2.42904628	-0.33239581	-1.81539248	-1.50856558	0.02556891	1.09946305						3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9	1.7964071856E-8					
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General		923604-59-5		0.0124889709	-7.9034733462	25.9809246166	4	10		17.4330094639	-1.81539248	0.3454275244	0.4712412423			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	0.79263615	-0.23012017	0.53694707	-1.20173869	-1.61084122	-0.63922271	0.17898236	24.52058297	6.05983125	-1.81539248						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General		915087-33-1				-5.1955439738	4	10		0	-2.12221938				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-0.48580926	5.13935055	2.27563283	-0.58808489	-0.43467144	-1.09946305	-1.5597034	-0.07670672	-0.23012017	-2.12221938						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General		923604-59-5		0.0140128558	-7.8534733462	35.0763982812	4	10		20.8532385839	-3.25225471	0.2066179268	0.6257596744			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-1.83110139	-2.37769882	-0.35528833	3.7441924	-1.77644165	-2.15905985	1.17518448	31.78464061	8.22629134	-3.25225471						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General		1502654-87-6				-12.9161177196	4	10		0	-2.54167805					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	0.5739273	-2.32303908	-1.28450396	-2.15905985	-2.54167805	-2.978956	-3.03361574	-2.65099754	-1.77644165	-2.54167805						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485882-01	BCX 4430	363681391		DPI_SARS-CoV-2_General		222631-44-9				14.1666882027	4	10		0	5.38729563					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	-1.84937014	-0.83087644	0.77727151	-1.63495042	-1.04529617	-0.0804074	-1.20611096	0.61645671	-0.45564192	5.38729563						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General		917389-32-3		0.0557861839	-7.2534733462	79.1034883973	2.4	10		34.827392116	25.6499598	0.0002819498	0.9633564931	3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-3.18949343	0.13401233	2.1173948	-2.59983919	-1.0989011	-0.50924685	2.01018494	5.60171536	11.92709729	25.6499598						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00095196-07	TILORONE			DPI_SARS-CoV-2_General		27591-69-1, 27591-97-5 [tilorone]		0.0625931278	-7.2034733462	285.7761981974	2.1	10		106.238863575	93.35298847	0.0000156627	0.984511765			CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	3.45751809	3.56472795	-1.31332083	-0.0804074	4.36880193	8.01393728	5.54811043	9.7292951	19.69981238	93.35298847						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General		259793-96-9				7.6547059897	4	10		0	2.43902439					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	-2.01018494	-1.31332083	0.50924685	-0.9380863	0.29482712	-1.36692576	2.06378987	1.0989011	2.59983919	2.43902439						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163699-10	Fumagillin			DPI_SARS-CoV-2_General		23110-15-8				14.0922137568	4	10		0	3.71657754					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	2.70053476	2.11229947	2.54010695	0.34759358	-0.13368984	1.25668449	-0.18716578	2.21925134	1.57754011	3.71657754						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163413-03	Lycorine HCl			DPI_SARS-CoV-2_General		2188-68-3		0.001764114	-8.7534733462	151.697532327	1.4	10		56.2121925155	8.90374332	0.1718739194	0.6639635376			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	-0.40106952	1.57754011	7.62032086	7.99465241	69.11764706	85.90909091	72.7540107	39.11764706	20.72192513	8.90374332						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485882-01	BCX 4430	363681391		DPI_SARS-CoV-2_General		222631-44-9				21.0506987981	4	10		0	6.44385027					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	3.07486631	0.45454545	1.84491979	-0.18716578	1.63101604	0.13368984	1.47058824	1.09625668	-0.02673797	6.44385027						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General		192725-17-0		0.0443125409	-7.3534733462	59.487986373	4	10		19.815508016	18.52941176	0.5825634601	0.9737132286			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	-1.09625668	0.56149733	1.68449198	0.02673797	1.57754011	2.00534759	0.40106952	2.9144385	90.93582888	18.52941176						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00095196-07	TILORONE			DPI_SARS-CoV-2_General		27591-69-1, 27591-97-5 [tilorone]		0.0702306445	-7.1534733462	274.089058535	2.1	20		115.3253002321	93.35298847	1E-10	0.9785739337			CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346889-03	NCGC00346889-03	363677553		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	928774-43-0				-5.1315509833	4	4		0	1.25110392					CN(CCO)C(=O)C1=C[N]2C=C(C)N=C2C(=C1)N[C@@H]3CCOC4=CC=CC(=C34)C	Selleck	S2222	-1.5755583	-1.81651656	-1.10679031	1.25110392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346443-01	Rupintrivir	174007383	HRV 3C Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	223537-30-2	AG-7088 (Rupintrivir)			3.1432771971	4	4		0	7.60965558					CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C2=NOC(=C2)C)C(C)C)CC3=CC=C(F)C=C3	Axon Medchem	1571	-1.35635018	0.68691803	0.62817828	7.60965558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015243-14	NCGC00015243-14	384567830		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1163-36-6				-0.3203467131	4	4		0	5.72564027					ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1	Prestwick	Prestw-227	-0.50691876	-0.87009617	-3.85880945	5.72564027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346875-02	NCGC00346875-02	384568953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	2870				10.0116579575	4	4		0	-2.84074183				NOTCH1	C[C@@H](N(C1=CC(=CC=C1F)F)[S+]([O-])(=O)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3CCCC(O)=O	Tocris	2870	5.49390327	-1.63333842	-1.07687706	-2.84074183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242505-01	NCGC00242505-01	137275859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	4906-84-7	deacetyl cortivazol	1.1220184543	-5.95	70.7639864944	3	4		47.0039146658	-3.90050044	1	0.9998918501		NRC31	C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)C=N[N]5C6=CC=CC=C6	NCGCChem	deacetyl cortivazol	-0.67132484	7.12868264	46.66467245	-3.90050044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164632-07	NCGC00164632-07	384568271		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	5630-53-5		0.1995262315	-6.7	-0.3202335018	4	4		7.640156184	1.54548131	0.7423022298	0.3620471205			C[C@@H]1C\C2=C(CCC(=O)C2)/[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13	Microsource	01502343	-2.61679682	8.1972218	-0.74783129	1.54548131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182713-18	NCGC00182713-18	377020273		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[289499-45-2]				-13.7781231829	4	4		0	-0.98616426				EGFR	FC1=C(Cl)C=C(NC2=NC=NC3=C2C=C(NC(=O)C=C)C(=C3)OCCCN4CCOCC4)C=C1	Tocris	5916	-2.7812029	-3.77041673	-4.72629375	-0.98616426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346842-04	NCGC00346842-04	384568951		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-0.2734525849	4	4		0	-0.92728878				IDO1	C[N]1C=C(C[C@@H](N)C(O)=O)C2=C1C=CC=C2	APExBIO	B4900	1.60295931	-2.39658067	-0.32904577	-0.92728878												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00165770-04	NCGC00165770-04	384568280		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1049741-55-0]				12.9655839271	4	4		0	1.75463422					COC1=CC=C(NC2=NC(=CC=N2)NCCO)C=C1	Tocris	3851	3.81414702	3.5921896	-0.8534432	1.75463422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025155-01	NCGC00025155-01	11114076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	26833-87-4	 Ceflatonin; ; Omacetaxine mepesuccinate;Homoharringtonine	7.9432823472	-5.1	53.0343732025	4	4	HOMOHARRINGTONINE HYDROCHLORIDE;HOMOHARRINGTONINE;Homoharringtonine;LS-52751;Ceflatonin;CIPLUS_214595;homoharringtonine;4'-METHYL-2'R-HYDROXY-2'-(4-HYDROXY-4-METHYLPENTYL)-BUTANEDIOATE CHLORIDE, 3R;homoharringtonine, 3H-labeled, (3(R))-isomer;NCGC00025155-01;	-21.5204471519	-5.43370596	0.7830879908	0.9998765324		RPL3	O=C(OC)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]2C(OC)=CC53CCCN5CCc1cc4OCOc4cc1[C@H]23	Tocris	Tocris-1416	14.93758669	53.79341183	13.09593879	-5.43370596												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167793-02	NCGC00167793-02	377020440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[212631-61-3]		5.6234132519	-5.25	6.5202563717	4	4		16.5238860799	13.06376361	0.1720998025	0.9813899083		ERK	CC1=C(NC2=C(C=C(F)C(=C2F)F)C(=O)NOCC3CC3)C=CC(=C1)I	Tocris	2605	-1.17468214	-3.3532384	3.00379119	13.06376361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263133-09	NCGC00263133-09	363677220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	869288-64-2				-9.3676479925	4	4		0	-3.79784689				PTK2	C[S+]([O-])(=O)C1=CC=CC(=C1)CNC2=C(C=NC(=N2)NC3=CC=C4NC(=O)CCC4=C3)C(F)(F)F	Glixx	GLXC-05135	-1.37781001	-0.91645028	-3.39083002	-3.79784689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274171-10	NCGC00274171-10	384568713		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					8.1576255161	4	4		0	1.19617225					NCC(=O)NC1=CC(=CN=C1)\C2=N\N/3C(=O)\C=C(/N=C3S2)N4CCNCC4	NCGCChem	JKJ031-018	0.04350979	7.66763403	2.56523662	1.19617225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164600-03	NCGC00164600-03	174006961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE		Artesunate (AS);Artesunate;ARTEMISININUM; Artesunate (AS)			1.9306930377	4	4		0	2.42861348				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S2265	-0.69872585	0.53426958	2.18366736	2.42861348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094087-08	NCGC00094087-08	384568125		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	50924-49-7				10.0389390814	4	4		0	-2.28142479				IMPDH1	NC(=O)C1=C(O)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-17470	4.26085765	2.67134789	-1.43583608	-2.28142479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381564-09	NCGC00381564-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	937272-79-2		15.8489319246	-4.8	28.3413235902	4	4		-21.906121868	-6.58843489	0.5106506909	0.7949646586			C(CN1CCCC1)OC2=CC=C3NC4=NC=CC(=N4)C5=CC(COC\C=C\COCC2=C3)=CC=C5	MedChem Express	HY-16379	6.4538419	7.91609248	16.09798775	-6.58843489												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510779-01	NCGC00510779-01	384569491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1799759-24-2				2.4600621059	4	4		0	-1.35727414				GLUT1	CC1=C(NC(=O)C2=CC(=NC3=CC(=CC=C23)F)C(N)=O)C(=N[N]1CC4=CC=C(C=C4)C(C)(C)C)C(F)(F)F	SIGMA	SML1780	3.22001106	-3.32261522	-3.47039953	-1.35727414												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263159-10	NCGC00263159-10	363677236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	728033-96-3				-3.4023524091	4	4		0	-1.92280503				PDGFRB	FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=C3C=CC=C4)C=CS2)C=C1	MedChem Express	HY-10204	0.64953013	-1.39335477	-3.79119277	-1.92280503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165799-03	NCGC00165799-03	384568284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[880635-03-0]				1.0187742341	4	4		0	-1.609538				PPARA	CCC(=O)NC[C@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C3=CC=CC=C3)C=C1)N\C(C)=C/C(=O)C4=CC=C(C=C4)C(F)(F)F	Tocris	4618	1.0320781	1.22736117	-1.81928441	-1.609538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263219-03	Elacridar	384568673	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	143664-11-3				-12.3877426124	4	4		0	-5.09687034				ABCBA	COC1=C2NC3=C(C=CC=C3C(=O)NC4=CC=C(CCN5CCC6=C(C5)C=C(OC)C(=C6)OC)C=C4)C(=O)C2=CC=C1	Selleck	S7772	-2.81729428	-1.64646011	-0.33353548	-5.09687034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510690-01	NCGC00510690-01	384569480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1282514-88-8				-14.8265469641	4	4		0	-4.97764531				PIK3CA	CC(C)[N]1N=CN=C1C2=C[N]3CCOC4=CC(=CC=C4C3=N2)O[C@@H](C)C(N)=O	Selleck	S8157	-2.70571827	-2.30504416	-3.69921164	-4.97764531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345018-01	NCGC00345018-01	174006279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	n		14.1253754462	-4.85	-3.9275023365	4	4		14.68410042	10.04470939	0.1825622336	0.9790380535	5141	PDE4A	COC1=CC=C(CC2=CC=C(NC(N)=O)C=C2)C=C1C3=CC=CC(=C3)Cl	NCGCChem	PRP01-072	-3.48675035	-1.31716809	-2.30442693	10.04470939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262608-11	NCGC00262608-11	377020442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	936091-14-4				-16.3041993597	4	4		0	-5.87183308				JAK2	CN1CCN(CC1)C2=CC=C(NC3=NC=C(C)C(=N3)NC4=CC(=CC=C4)[S+]([O-])(=O)NC(C)(C)C)C=C2	MedChem Express	HY-10410	-3.51464435	-2.9636282	-1.24317768	-5.87183308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263021-04	NCGC00263021-04	363677194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	783348-36-7				33.6880181569	4	4		0	10.67583732				IKBKB	COC1=C(Cl)C=C2C(=C1NC(=O)C3=C(C)N=CC=C3)[NH]C4=C2C=CN=C4	MedChem Express	HY-15473	8.13633067	7.02611883	0.02948548	10.67583732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511354-01	NCGC00511354-01	384569498		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1361951-15-6		1	-6	43.9631896063	1.4	4		32.2926033319	28.91746411	0.099647296	0.9938318531		PIM1	CC(C)(O)[C@@H]1CC[C@H](CC1)NC2=N[N]3C(=NC=C3C4=CC(=CC=C4)C(F)(F)F)C=C2	Glixx	GLXC-05022	-1.49383611	5.52925004	31.90328763	28.91746411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510519-01	NCGC00510519-01	384569472		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1857417-10-7				-2.6469314203	4	4		0	-6.45933014					OC1=C(CN2CCC(CC2)NC3=NC=NC4=C3C=C(CC(F)(F)F)S4)C=C5C=C(C#N)[N](CC6=C[NH]N=C6)C5=C1	MedChem Express	HY-19810	-0.30456853	2.16893234	2.06398349	-6.45933014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346937-01	NCGC00346937-01	174007341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	253426-24-3	Ombrabulin			-2.1971513186	4	4		0	-3.60612305			203068	TUBB	COC1=CC=C(\C=C/C2=CC(=C(OC)C(=C2)OC)OC)C=C1NC(=O)[C@H](N)CO	SynKinase	SYN-3001	0.42471571	-0.80903679	-0.02991325	-3.60612305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016246-10	NCGC00016246-10	384567925		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane			-3.583287167	4	4		0	-5.31351192			4312	MMP1	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	Microsource	MS-01500177	-0.42471571	4.35048084	-2.24349387	-5.31351192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509942-01	NCGC00509942-01	384569390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	198474-05-4				3.3288946224	4	4		0	0.95672652				IDO1	FC1=CC2=C([NH]C=C2C3CC(=O)NC3=O)C=C1	ChemGood	C-1264	1.63036032	-0.90062586	-1.31618307	0.95672652												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481652-04	NCGC00481652-04	384569258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1254053-43-4				7.1900122822	4	4		0	5.90226671				AXL	CCC1=NC(=C(NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(C)CC4)OC)N=C1NC5CCOCC5)C(N)=O	MedChem Express	HY-12432	-0.36991369	-2.12181346	7.44839964	5.90226671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345793-01	NCGC00345793-01	174006592		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1100598-32-0	EMD-1214063	12.5892541179	-4.9	76.0299196382	3	4		108.8480842605	95.29195532	0.0299735464	0.9994454878	8731	MET	CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4/N=C(\C=C/C4=O)C5=CC(=CC=C5)C#N	ChemieTek	CT-EMD063	0.73244887	2.77139795	1.42898804	95.29195532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346647-03	NCGC00346647-03	384568878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1116235-97-2		14.1253754462	-4.85	1.4804273523	4	4		-10.3323397919	-6.11028316	0.6039069701	0.6788647961		IGFR1	CNC(=O)C1=C(F)C=CC=C1NC2=C3C=C[NH]C3=NC(=N2)NC4=C(OC)C=C5CCN(C(=O)CN(C)C)C5=C4	Selleck	S2703	0.64156206	-0.08980692	6.39781686	-6.11028316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346582-03	NCGC00346582-03	384568851		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	366017-09-6				-12.3208690113	4	4		0	-2.17585693				ERBB2	FC(F)(F)C1=CC=C(\C=C\C2=NC(=CO2)COC3=CC=C(CCCC[N]4C=CN=N4)C=C3)C=C1	Selleck	S2216	-4.15620642	-0.3891633	0.27289266	-2.17585693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168853-03	NCGC00168853-03	174006790		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	545-47-1	Lupeol			-5.1597893756	4	4		0	-1.64539443					CC(=C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12	SIGMA	L5632	-1.89664651	1.19380987	0.11283498	-1.64539443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159570-14	NCGC00159570-14	384568189		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	213261-59-7				4.6410300591	4	4		0	3.94736842				MDM2	OCC1=CC=C(S1)C2=CC=C(O2)C3=CC=C(CO)S3	MedChem Express	HY-13424	0.826686	-0.33603177	-0.26536931	3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371263-02	NCGC00371263-02	363678072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-11.3585169166	4	4		0	-4.09688995					CN1CCN(CC1)C2=C(NC(=O)C/3=C/NC(=O)/C=C3C(F)(F)F)C=C(C=C2)C4=CC(=CC=C4)CN5CCOCC5	Tocris	5267	-2.88614938	-2.32167405	1.29736105	-4.09688995												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00022678-08	NCGC00022678-08	384568012		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	13292-46-1				3.2367951978	4	4		0	1.88397129				PRKDC	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(C)CC5	Selleck	S1764	0.7106599	-0.27493508	0.29485478	1.88397129												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165721-16	NCGC00165721-16	377020368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	909910-43-6				-10.0273511072	4	4		0	0.36797174				TGBR1	CC1=CC=CC(=N1)C2=N[N](C=C2C3=CC=NC4=C3C=CC=C4)C(=S)NC5=CC=CC=C5	MedChem Express	HY-10432	-2.80860392	-3.28194169	-1.19653006	0.36797174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096081-05	NCGC00096081-05	384568160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	7235-40-7				-6.2618330883	4	4		0	-1.30997939					CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Selleck	S1767	-1.93177148	1.14486338	-1.64522884	-1.30997939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161630-03	NCGC00161630-03	384568212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1476-53-5				7.9721298939	4	4		0	0.54459817				HSP90AB1	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3\C(=C(NC(=O)C4=CC=C([O-])C(=C4)CC=C(C)C)/C(=O)OC3=C2C)O)OC1(C)C	Selleck	S2492	3.82244143	-0.7785071	-2.36314687	0.54459817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345856-01	NCGC00345856-01	174006466		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1357158-81-6	AZD-26			1.5243595398	4	4		0	2.00763467			207	AKT1	NC(=O)C1=CN=C(C2=CC=C(C=C2)C3(N)CCC3)C(=C1)C4=CC=CC=C4	SynKinase	SYN-1160	0.81536761	-0.90338386	-2.04141149	2.00763467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511388-01	NCGC00511388-01	384569502		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1334298-90-6				-10.6173521352	4	4		0	-0.90948463				JAK1	FC1=C(C=CN=C1C(F)(F)F)C(=O)N2CCC(CC2)N3CC(CC#N)(C3)[N]4C=C(C=N4)C5=C6C=C[NH]C6=NC=N5	Glixx	GLXC-10668	-2.60217791	-1.19138537	-3.51932621	-0.90948463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165761-07	NCGC00165761-07	384568279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	547757-23-3		7.9432823472	-5.1	39.6020373183	4	4		18.5630823281	18.5505991	0.5789405402	0.7132585931		IKBKB	CC1=CC=C2N=C(NCCN)C3=NC=C(C)[N]3C2=C1	MedChem Express	HY-10518	8.93791543	-0.88590194	5.05339149	18.5505991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346825-02	NCGC00346825-02	384568944		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	413611-93-5		14.1253754462	-4.85	28.5380426662	4	4		28	25.41903737	0.1058720871	0.9930395832		MYC	[O-][N+](=O)C1=CC=C(NC2=CC=CC=C2C3=CC=CC=C3)C4=NON=C14	SIGMA	G3798	1.86915888	4.082535	2.73624824	25.41903737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346483-11	NCGC00346483-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	714971-09-2		12.5892541179	-4.9	35.490453066	3	4		73.60489788	63.98585268	0.0469739449	0.9986368155			CC1=C2N(C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)N(CC6=CC(F)=CC=C6)N=C5	APExBIO	A2822	-3.05112699	-1.90125276	-4.59802539	63.98585268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023037-06	NCGC00023037-06	124886818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	15500-66-0	; ;Pancuronium bromide; Pancuronium bromide; Bromide, Pancuroniu; Pancuronium Organon; Pancuronium dibromide; Pancuronium Curamed; Bromuro de pancuronio; Pavulon			4.8207764366	4	4	PANCURONIUM Br	0	1.49521531					CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6	BIOMOL	AC232	1.66787527	2.56606079	-3.36134454	1.49521531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016855-19	NCGC00016855-19	384567963		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	43210-67-9				-15.0983222384	4	4		0	-1.44726713					COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)SC3=CC=CC=C3	MedChem Express	HY-B0413	-4.08508241	-3.15917375	-1.9696755	-1.44726713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507883-01	NCGC00507883-01	384569348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1621862-70-1				-5.9495309643	4	4		0	-2.00153965				EZH2	COC/1=C(\CNC(=O)C2=C(C)[N]([C@H](C)C3CCN(CC3)CC(F)(F)F)C4=C2C=CC=C4)C(=O)N/C(=C1)C	Selleck	S8353	-0.87336245	-1.57958688	-1.60124699	-2.00153965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015649-08	Moxonidine hydrochloride hydrate	170466534	Imidazoline I1 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	75438-57-2	 Zint; ; Moxon; MOXONIDINE HCl; Cynt;Moxonidine; Moxonidine; Lilly brand of moxonidine; Physiotens; Normatens;Moxonidine hydrochloride; Moxonidine hydrochloride	15.8489319246	-4.8	9.4491467762	4	4		12.769069692	10.11186341	0.504133344	0.8029788995	11188	NISCH	COc2nc(C)nc(Cl)c2NC1=NCCN1	Prestwick	Prestw-1016	0.83573092	2.79346665	-3.14089141	10.11186341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488701-03	NCGC00488701-03	384569283		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-21.8515243413	4	4		0	-4.5481307				SLC2A1	CC1=C(NC(=O)C2=CC(=NC3=CC(=CC=C23)F)C(N)=O)C(=N[N]1CC4=CC=C(C=C4)C#N)C(F)(F)F	Axon Medchem	2660	-4.45266475	-4.74736681	-5.38438528	-4.5481307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511386-01	NCGC00511386-01	384569501		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1309684-94-3				-8.3859700239	4	4		0	1.22166618				MDM2	COC1=CC(=CC=C1NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@]3([C@H]2C4=CC=CC(=C4F)Cl)C(=O)NC5=C3C=CC(=C5)Cl)C(N)=O	Glixx	GLXC-10659	-3.49362926	-3.80094642	3.26054442	1.22166618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346441-01	NCGC00346441-01	174006706		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	915385-81-8	ABC-294640			6.5017664467	4	4		0	-1.36885487			56848	SPHK2	ClC1=CC=C(C=C1)C23C[C@@H]4C[C@@H](CC(C4)(C2)C(=O)NCC5=CC=NC=C5)C3	ActiveBioChem	A-1269	3.57583231	-1.96916501	-0.32904577	-1.36885487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015609-15	NCGC00015609-15	384567874		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	50264-69-2				-0.2013453562	4	4		0	-0.78010009				HK1	OC(=O)C1=N[N](CC2=C(Cl)C=C(Cl)C=C2)C3=C1C=CC=C3	MedChem Express	HY-B0486	1.08234005	-2.12181346	-1.28626982	-0.78010009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094594-17	NCGC00094594-17	384568133		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1405-89-6				3.4632153019	4	4		0	4.43037975					CCC(C)C(N)\C1=N\C(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=C[NH]3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC	MedChem Express	HY-B0278	-0.26030963	1.51121966	-2.36314687	4.43037975												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346457-03	NCGC00346457-03	384568782		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1032568-63-0				-11.5559734111	4	4		0	-4.35458787				PIK3CA	COC1=C(OCCCN2CCOCC2)C=CC\3=C1/N=C(/NC(=O)C4=CN=C(N)N=C4)N5CC/N=C35	APExBIO	B2178	0.20729685	-3.84320931	-4.22863809	-4.35458787												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00167803-13	GSI-IX	384568339	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	208255-80-5				-15.8657871333	4	4		0	-4.72218295				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@H](C(=O)OC(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-13027	-2.6119403	-3.96570204	-4.14114902	-4.72218295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-18	NCGC00018248-18	384567999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	71125-38-7				2.1250652438	4	4		0	-1.92280503				PTGS1	CN1\C(=C(\O)C2=CC=CC=C2[S+]1([O-])=O)C(=O)NC3=NC=C(C)S3	MedChem Express	HY-B0261	2.00386954	-1.69958659	-0.52493438	-1.92280503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379063-04	NCGC00379063-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	175414-77-4 				-4.4354549459	4	4		0	-3.44973844					CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(O)=O	Chemscene	CS-0790	1.58927584	-3.23074567	-3.06211724	-3.44973844												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00496843-02	NCGC00496843-02	384569296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	887375-67-9				-3.2324458661	4	4		0	-3.13266927				ROCK1	C[C@H]1CNCCCN1[S+]([O-])(=O)C2=CC=CC3=CN=CC(=C23)F	Glixx	GLXC-07646	1.44251167	-2.10783565	-2.46653632	-3.13266927												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346630-05	NCGC00346630-05	363677485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	898562-94-2 (free base)		12.5892541179	-4.9	56.9047955036	3	4		85.180584223	76.84145779	0.0299957685	0.9994447035		PDE10A	C[N]1C=C(C2=CC=NC=C2)C(=N1)C3=CC=C(OCC4=NC5=CC=CC=C5C=C4)C=C3	Glixx	GLXC-90150	0.46728972	-1.19380987	-1.26939351	76.84145779												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263139-03	NCGC00263139-03	384568617		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	136199-02-5				-1.2118111938	4	4		0	5.76656928				ADORA1	CCCN1C(=O)N(CCC)C2=C([NH]C(=N2)C34C[C@@H]5CC(CC3C5)C4)C1=O	Axon Medchem	1603	-1.6217702	-0.33898305	-1.63610719	5.76656928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386415-05	NCGC00386415-05	384569133		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1198300-79-6				-18.983325599	4	4		0	-3.73673689				TYK2	CC[S+]([O-])(=O)N1CCN(CC1)C2=CC=C(NC3=NC(=C(C=N3)C(N)=O)NC4CC4)C=C2	MedChem Express	HY-15999	-4.17811985	-2.9624171	-4.93653032	-3.73673689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483117-01	NCGC00483117-01	363681136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			0.5623413252	-6.25	10.0993589791	4	4		15.08360332	-3.11008468	1	0.9995508587		EP300	CCCOC1=CC=C(CCC2=NC3=C(C=CC(=C3)C4=C(C)ON=C4C)[N]2CCN5CCOCC5)C=C1	Tocris	5801	-2.9863361	4.92102066	9.87671815	-3.11008468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510500-01	NCGC00510500-01	384569461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1817626-54-2				-12.9849401192	4	4		0	-4.31100847					CC[C@H]1[C@@H](COC2=NC=CC3=CC(=C(OC)C=C23)C(N)=O)NC(=O)[C@H]1F	MedChem Express	HY-19836	-2.33835752	-3.34143378	-2.08303812	-4.31100847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486892-01	NCGC00486892-01	384569280		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-10.2019310492	4	4		0	-0.54459817				KDM4B	CC(C)C/1=C(NC2=C(C=N[N]2C1=O)C#N)\C3=CC=CC=C3	NCGCChem	BTM024-079	-2.69899986	-1.96916501	-2.18366736	-0.54459817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188380-05	NCGC00188380-05	384568448		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	923032-37-5		11.220184543	-4.95	25.8611488938	3	4		52.0770030847	44.64866393	0.0796700217	0.9960664478		MAP2K1	COC1=CC(=C(F)C(=C1N[S+]([O-])(=O)C2(CC2)C[C@H](O)CO)NC3=C(F)C=C(I)C=C3)F	Aobious	AOB87134	-1.17468214	-4.76190476	-1.69145523	44.64866393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022735-16	NCGC00022735-16	384568013		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	83-43-2				-3.5676380201	4	4		0	-1.89452849				NRC31	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]\4(C)/C=C\C(=O)\C=C14	MedChem Express	HY-B0260	-0.45605307	1.27086204	-2.68299796	-1.89452849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483924-02	Brigatinib	384569265	IGF-1R Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1197953-54-0				-19.6742445102	4	4		0	-4.53636783				IGFR1	COC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-12857	-3.84826828	-3.25718497	-5.98025388	-4.53636783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165869-22	NCGC00165869-22	384568292		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1219168-18-9				2.250662312	4	4		0	-2.50653545				TGBR1	C1CCN(CC1)CCOC2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC=C5	MedChem Express	HY-13418	0.82462892	-1.40014738	4.2877292	-2.50653545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386261-01	NCGC00386261-01	363680173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1149705-71-4		0.2511886432	-6.6	83.6689028761	1.4	4		41.8301442439	51.38357374	0.5919162497	0.6933073329		HSP90AB1	CC[C@@H](C)NC1=C(C=C(C)C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C(N)=O	Selleck	S7122	0.34251267	42.23782629	21.26832187	51.38357374												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492474-01	NCGC00492474-01	384569289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE			1.4125375446	-5.85	63.8754062362	3	4		41.0651793536	9.41608935	1	0.9999124164			[O-][S+](=O)(NC1=C2N=CC=CC2=C(C=C1)C3=CN=CC=C3)C4=CC=CC(=C4)C(F)(F)F	NCGCChem	PJM010-024	0.70480929	3.65947022	41.14902304	9.41608935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346541-04	NCGC00346541-04	384568827		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1349796-36-6		11.220184543	-4.95	48.6083909812	3	4		78.5754075258	64.01809699	0.0195665944	0.9997638429		MTOR	COC1=CC(=CC(=C1)NC2=NC3=CC=CC=C3N=C2N[S+]([O-])(=O)C4=CC=C(NC(=O)C5=CC=C(C)C(=C5)OC)C=C4)OC	APExBIO	A5634	-1.06412383	0.04593477	4.9285506	64.01809699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253438-12	NCGC00253438-12	384568561		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	755038-02-9				-8.9193475685	4	4		0	-3.53456808				PLK1	CC[C@H]1N(C2CCCC2)C3=NC(=NC=C3N(C)C1=O)NC4=CC=C(C=C4OC)C(=O)NC5CCN(C)CC5	MedChem Express	HY-50698	-0.67716971	-2.22018068	-4.28696413	-3.53456808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346885-02	NCGC00346885-02	384568962		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[130800-90-7]		14.1253754462	-4.85	21.7521053339	4	4		31.59476162	27.14022923	0.1499985601	0.9858855204		SCN2A	CN1CCN(CC1)C2=NC(=C(C=N2)C3=CC(=CC(=C3Cl)Cl)Cl)N	Tocris	4044	0.06934813	2.75748994	-0.91230135	27.14022923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509993-01	NCGC00509993-01	384569400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1401090-53-6				16.0291767042	4	4		0	6.16952031				UGCG	CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)C3=CSC(=N3)C4=CC=C(F)C=C4	MedChem Express	HY-16743	4.45214979	-0.28320167	0.35314891	6.16952031												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510483-02	NCGC00510483-02	384569446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1129403-56-0				-0.3944451514	4	4		0	-6.65511766				PDGFRA	CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)\C=C2\C(=O)NC3=C2C=C(C=C3)C4=CSC(=N4)C5=CC=CC=C5	Selleck	S8572	2.09305614	-0.76370857	-0.33087682	-6.65511766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387039-04	NCGC00387039-04	384569150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1282512-48-4		14.1253754462	-4.85	-3.2570573416	4	4		14.8361201639	9.57659738	0.1338902452	0.9888729497		PIK3CA	CC(C)[N]1N=C(C)N=C1C2=C[N]3CCOC4=CC(=CC=C4C3=N2)C5=C[N](N=C5)C(C)(C)C(N)=O	ChemieTek	CT-G0032	-2.50739541	-2.12636695	-3.61343347	9.57659738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181785-01	NCGC00181785-01	50126334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	170729-80-3	 ;Merck brand of aprepitant; Aprepitant; Emend;Aprepitant;L-754030 /MK-0869/ONO-7436			-5.4989803536	4	4	aprepitantum;MK-0869;5-((2-(1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-1,2-DIHYDRO-3-OXO-3H-1,2,4-TRIAZOL, 2R-(2AR*,3A);Merck brand of aprepitant;CIPLUS_728707;MK 0869;MK-869;MK 869;L-754030-000Z;HS_534;(2R)-(1R)-3,5-bis(trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine;aprepitant;APREPITANT;Emend;Aprepitant;	0	-2.46343341			6869	TACR1	C[C@@H](O[C@H]2OCCN(CC1=NC(=O)N=N1)[C@H]2C3CCC(F)CC3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F	Toronto Research	A729800	0.11269193	-2.39975699	-3.24500496	-2.46343341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159429-14	NCGC00159429-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	303-98-0				-0.0636498835	4	4		0	1.5704388					COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O	Microsource	01504013	-0.64797859	-0.60753341	1.20447782	1.5704388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481574-01	NCGC00481574-01	384569256		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE			10	-5	61.2450995334	3	4		91.5503375559	85.234796	0.0058225793	0.9999790905		EZH2	CC(C)[N]1C=C(C)C2=C(C=C(C=C12)C3=CN=C(C=C3)N4CCN(C)CC4)\C(O)=N\CC5=C(O)N=C(C)C=C5C	APExBIO	B5833	-1.01422736	-1.27582017	1.45954372	85.234796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181345-01	NCGC00181345-01	50125938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	110221-44-8	 ;Temocapril hydrochloride; Temocapril hydrochloride; Acecol			-5.1827649687	4	4	LS-150463;CIPLUS_213546;LS-150462;CIPLUS_213547;Temocaprilum;1,4-Thiazepine-4(5H)-acetic acid, 6-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2S-(2alpha,6beta(R*)))-;TEMOCAPRIL HYDROCHLORIDE;Acecol;TEMOCAPRIL;CS 622;temocaprilum;Temocapril Hydrochloride;TEMOCAPRIL HYCROCHLORIDE;alpha-((2S,6R)-6-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl)acetic acid.HCl;CS622;Temocapril;Temocapril hydrochloride;temocapril;A-(6((S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL)AMINO-5-OXO-2-(2-THIENYL)PERHYDRO-1,4-THIAZEPIN-4-YL)ACETIC ACID(2S,6R)HYDROCHLORIDE;temocapril hydrochloride;CS-622;	0	-1.24522428			1636	ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	APAC	872509	-1.62274619	0.55149799	-0.70629782	-1.24522428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346626-05	NCGC00346626-05	384568866		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	405168-58-3				-11.3135616142	4	4		0	-6.53962754				CHEK1	ClC1=CC\2=C(NC(=O)\C(=C2N[C@@H]3CN4CCC3CC4)C5=NC6=C([NH]5)C=CC=C6)C=C1	MedChem Express	HY-13263	-1.78192618	-4.30731633	1.62430441	-6.53962754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167798-06	NCGC00167798-06	384568337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	61825-94-3				-8.8152969924	4	4		0	-3.73899235					O=C1O[Pt]2(NC3CCCCC3N2)OC1=O	Adooq	A10346	-0.53740631	-0.48877348	-4.78267409	-3.73899235												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346688-04	NCGC00346688-04	363677517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1256580-46-7				-5.6856876959	4	4		0	3.94149346				ALK	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N	ChemieTek	CT-CH542	-2.76095225	-2.61239368	-2.53648859	3.94149346												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346824-01	NCGC00346824-01	174007400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1113-59-3	3-Bromopyruvate			-2.4539390208	4	4		0	2.64819092			29911	HK2	CCOC(=O)C(=O)CBr	SIGMA	E14578	-1.26778419	-0.78979344	-0.92107128	2.64819092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481567-03	NCGC00481567-03	377020225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	946518-61-2				8.1179895636	4	4		0	4.58814473				IKBKB	CN1CCN(CCCNC2=NC=C(Cl)C(=N2)C3=CC4=C(S3)C=CC=C4C(=O)NC5CC5)CC1	MedChem Express	HY-B0788	1.01422736	1.45808019	1.54456568	4.58814473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485486-02	NCGC00485486-02	384569277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	209219-38-5				-2.9613377757	4	4		0	-3.35642802				CCK2	CC(C)(C)C(=O)CN1C(=O)[C@@H](CN(C2CCCCC2)C3=CC=CC=C13)NC(=O)NC4=CC(=CC=C4)C(O)=O	MedChem Express	HY-17617_cm1	-0.36624877	0.36452005	0.32591753	-3.35642802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507840-01	NCGC00507840-01	384569322		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1345407-05-7				-3.5237940217	4	4		0	-1.24416796					NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@@H](CC3=C[NH]C4=C3C=CC=C4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=C[NH]C6=C5C=CC=C6)C(=O)N[C@@H](C(C7=CC=CC=C7)C8=CC=CC=C8)C(=O)N[C@@H](CCCCN)C(N)=O	Selleck	S8199	0.01381979	-2.74077477	-1.02070575	-1.24416796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263126-04	NCGC00263126-04	363677214		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	165377-44-6				-2.5152233709	4	4		0	-2.6014421				SIGMAR1	COC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1	MedChem Express	HY-13510	0.53897181	0.59715204	-3.38291047	-2.6014421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509947-01	NCGC00509947-01	384569394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1708971-55-4				9.3562802187	4	4		0	7.80432631				FGFR4	COCCNC1=CC(=NC=C1C#N)NC(=O)N2CCCC3=CC(=C(C=O)N=C23)CN4CCN(C)CC4=O	ChemGood	C-1366	-1.86567164	-0.32154341	2.50801983	7.80432631												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00179363-05	NCGC00179363-05	384568372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	128-13-2				-7.1321949043	4	4		0	0.24541649					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Selleck	S1643	-1.83849526	-1.2830304	-2.46653632	0.24541649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250396-13	NCGC00250396-13	384568545		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	938440-64-3				-13.6476584132	4	4		0	-4.54742313				MTOR	COC1=C(CO)C=C(C=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOCC4)N5C[C@@H](C)O[C@@H](C)C5	MedChem Express	HY-50710	-2.09305614	-2.44386742	-4.57211611	-4.54742313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162073-12	H-89	384568218	AKT Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	130964-39-5		14.1253754462	-4.85	21.845141619	3	4		39.507518792	31.84808612	0.0985463258	0.9939685461		AKT1	[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23	MedChem Express	HY-15979A	0.42059463	-1.83290057	-2.50626566	31.84808612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379246-01	NCGC00379246-01	363678445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[328087-38-3]		12.5892541179	-4.9	31.1184461209	3	4		55.487807077	49.10287081	0.046024404	0.9986917629		AHR	CC1=CC(=CC=C1NC(=O)[C@@H](N)CCCCN)C2=NC3=CC(=CC=C3S2)F	Tocris	4995	-1.46482959	-0.30548343	-2.32935279	49.10287081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522629-01	NCGC00522629-01	384569532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	300842-64-2		8.9125093813	-5.05	13.0038025403	4	4		23.9679532279	23.12548114	0.1559984238	0.9847183782		KDR	CC1=C(Br)C=C(NC2=NN=C(CC3=CC=NC=C3)C4=CC=CC=C24)C=C1	Glixx	GLXC-07620	-2.05662769	1.48845687	-0.09919229	23.12548114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346683-02	YM-201636	384568907	PIKfyve Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	371942-69-7		1.5848931925	-5.8	74.0723516448	1.4	4		38.0847557408	36.39450969	0.2430551575	0.9617176316		PIKFYVE	NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6	Selleck	S1219	4.6185853	3.92010732	46.26250736	36.39450969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505118-01	NCGC00505118-01	384569317		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					5.942490035	4	4		0	-0.65091269				EP300	CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)[C@@H](C)C(F)(F)F)C4=O	NCGCChem	CAL008-010_2nd_pos	1.28987517	2.10165449	2.38375515	-0.65091269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159349-15	NCGC00159349-15	384568171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	797-63-7				1.1922022159	4	4		0	1.18862318				PGR	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0257	-1.42857143	3.7114324	1.94231901	1.18862318												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521941-01	NCGC00521941-01	384569506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1800340-40-2				-12.8878290116	4	4		0	-5.1266766				BRD4	C[N]1N=NC(=C1C2=CC3=C(N=C2)C4=CC=C(C=C4[N]3[C@@H](C5CCOCC5)C6=CC=CC=C6)C(C)(C)O)C	ChemieTek	CT-BMS986	-2.28730823	-3.05343511	-1.54639175	-5.1266766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025251-09	NCGC00025251-09	384568064		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	196808-24-9				3.7478280159	4	4		0	0.21654396				PPARG	CN(CCOC1=CC=C(C[C@H](NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C(O)=O)C=C1)C4=CC=CC=N4	Bio Vision	2057	1.49908075	-1.00809531	0.66175365	0.21654396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510701-01	NCGC00510701-01	384569486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1693731-40-6		2.8183829313	-5.55	4.8015681115	4	4		14.860203652	10.84163419	0.0117880136	0.9999149757		HSF1	CC1=CC=C(NC(=O)C2=CC3=C(OCCO3)C=C2)C=C1NC(=O)C4=CC5=C(C=C4)N=C(OCCN6CCCC6)C=C5	MedChem Express	HY-101026	-2.80016971	-2.47441576	2.10557979	10.84163419												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00188943-09	NCGC00188943-09	384568454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	65-86-1				-6.2914191876	4	4		0	-0.96722968					OC(=O)C/1=C/C(=O)NC(=O)N1	MedChem Express	HY-N0157	-1.69707255	-1.43577211	-0.33087682	-0.96722968												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378665-03	NCGC00378665-03	384569061		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	219989-84-1				-19.9286282846	4	4		0	-4.60516818					C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	MedChem Express	HY-10222	-3.90326686	-4.06292959	-5.26394947	-4.60516818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025195-09	NCGC00025195-09	384568055		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	78712-43-3				-0.0343353844	4	4		0	-0.98684211				TBXA2R	OC(=O)/C=C/C1=CC=C(C[N]2C=CN=C2)C=C1	Selleck	S2067	-0.04350979	1.2830304	-0.11794191	-0.98684211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485487-01	NCGC00485487-01	363681356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1386874-06-1		7.0794578438	-5.15	-2.1342259166	4	4		14.672226248	9.06100478	0.0414170352	0.9989515415		PIK3CA	CO[C@@H](C)CN1C(=O)N(C)C2=C1C3=CC(=CC=C3N=C2)C4=CC(=CN=C4)C(C)(C)O	MedChem Express	HY-12513	-3.06018854	-2.53551245	0.97302079	9.06100478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347904-03	NCGC00347904-03	384568988		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	227088-94-0		12.5892541179	-4.9	23.0125239279	3	4		47.6892572128	42.00153965	0.1243090301	0.990352001		P2RX7	[O-][N+](=O)C1=CC(=CC=C1)C2=CC=C(OCC(CCC3=CC=NC=C3)N4C(=O)CSC4=O)C=C2	SIGMA	A7231	-3.23989294	1.73147023	-1.88465354	42.00153965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250409-02	NCGC00250409-02	384568557		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	942206-85-1		11.220184543	-4.95	9.5333117788	4	4		25.1779123839	19.89222479	0.1870177035	0.9778558442		TRPV4	CC(C)C[C@H](NC(=O)C1=CC2=CC=CC=C2S1)C(=O)N3CCN(CC3)C(=O)[C@H](CO)N[S+]([O-])(=O)C4=CC=C(Cl)C=C4Cl	SIGMA	G0798	-2.64826032	1.09356015	0.94941193	19.89222479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346893-01	NCGC00346893-01	174007040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	7307-50-7	SL 0101-1			2.7096966299	4	4		0	-3.16966181			6195	RPS6KA1	CC1OC(OC/2=C(/OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC=C(O)C=C4)C(O)C(OC(C)=O)C1OC(C)=O	Tocris	2250	2.1220527	2.2208973	-2.70747499	-3.16966181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160397-13	NCGC00160397-13	384568192		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	57381-26-7				-7.0030352594	4	4		0	-2.68855243				CHRM1	NC1=NC(=NC(=N1)C2=CC(=CC=C2Cl)Cl)N	MedChem Express	HY-B0327	-0.87378641	-1.80354747	-2.14832254	-2.68855243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347946-02	NCGC00347946-02	363677726		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	?1355324-14-9				0.075618242	4	4		0	-2.91495684				IDH1	CC1=CC=CC=C1C(N(C(=O)CNC2=CC=C(C=C2)C#N)C3=CC=CC(=C3)F)C(=O)NC4CCCCC4	XcessBio	M60043-2s	0.20804438	0.61111939	1.85403178	-2.91495684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344513-02	NCGC00344513-02	363677334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[217461-40-0]				-4.1777409907	4	4		0	0.50670641				OPRL1	CCN1C(=O)N([C@@H]2CCN(CC3CCCCCCC3)C[C@H]2CO)C4=CC=CC=C14	Tocris	2598	-0.94839609	-0.65858404	-2.39539115	0.50670641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 			3.274705217	4	4		0	2.08643815				KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	0.30683403	0.08980692	1.24317768	2.08643815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016777-10	Probucol	384567958	Serine Protease Hepsin Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	23288-49-5				-5.2552331399	4	4		0	0.56631893					CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	Selleck	S2119	-2.42677824	1.25729681	-0.51546392	0.56631893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387248-01	NCGC00387248-01	363680593		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[917369-31-4]				-5.4653115982	4	4		0	-0.04330879				TUBB	COC1=CC=C(C=C1)N(C)C2=NC(=NC3=CC=CC=C23)C	Tocris	5231	-1.41422712	-1.25248205	-1.35358701	-0.04330879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016024-05	NCGC00016024-05	90341784		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE		(?)-Taxifolin;Taxifolin (Dihydroquercetin)			-3.7441550359	4	4		0	-1.63129782				NFKB1	O[C@@H]1[C@H](OC2=C(C1=O)C(O)=CC(O)=C2)C3=CC(O)=C(O)C=C3	SigmaAldrich	Lopac-T-4512	0	-2.13838399	-1.47390585	-1.63129782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263216-02	NCGC00263216-02	174006464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1223001-51-1	Torin-2;Torin 2; Torin-2	1.1220184543	-5.95	23.4965555268	4	4		17.3824777199	-1.22708243	1	0.9998097391	2475	MTOR	NC1=NC=C(C=C1)C2=CC=C3N=CC\4=C(N(C(=O)\C=C4)C5=CC(=CC=C5)C(F)(F)F)C3=C2	Tocris	4248	-0.7353981	2.56606079	16.30320349	-1.22708243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346608-02	NCGC00346608-02	384568856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	83207-58-3				6.1481699342	4	4		0	2.4222488					CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O	Selleck	S2415	2.36403191	-1.22193371	-1.20890461	2.4222488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507966-01	NCGC00507966-01	384569359		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1253573-53-3				-14.3315380538	4	4		0	-3.94736842				PIK3CA	COC1=C(F)C=C(NC2=NC=C(C=C2C3=NC(=NC(=N3)N)C)C(C)N4CCN(CC4)[S+](C)([O-])=O)C=N1	ChemieTek	CT-AMG511	-2.7991298	-1.19138537	-4.86510394	-3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510526-01	NCGC00510526-01	384569473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1895895-38-1				-0.0337332214	4	4		0	3.87990762				JAK2	C[N]1C(=NC2=C(C)C(=CC=C12)OC3=CC=NC(=C3)NC(C)=O)NC4=CC=C(F)C=C4F	MedChem Express	HY-18960	-0.70432455	-1.18469016	-0.43928015	3.87990762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347064-04	NCGC00347064-04	363677569		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1346527-98-7		14.1253754462	-4.85	8.0965813616	4	4		-10.670900688	-5.14241724	0.6043957357	0.6775020033		VCP	COC1=C2N=C(N=C(NCC3=CC=CC=C3)C2=CC=C1)[N]4C(=NC5=C4C=CC=C5)N	Glixx	GLXC-02188	1.94393577	1.54921021	8.43134476	-5.14241724												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346655-06	Linagliptin	384568886	DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	668270-12-0				-3.5598703666	4	4		0	-1.17013087				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	MedChem Express	HY-10284	-0.42259473	-0.66828676	-1.62958764	-1.17013087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346544-09	NCGC00346544-09	384568830		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1265916-41-3				-6.5777226314	4	4		0	2.9998585				MAP2K5	CN(C)CC1=CC=CC(=C1)N/C(C2=CC=CC=C2)=C/3C(=O)NC4=CC(=CC=C34)C(=O)N(C)C	MedChem Express	HY-12056	-2.31622746	-1.68430467	-2.47204238	2.9998585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346713-05	NCGC00346713-05	363677532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1035270-39-3		12.5892541179	-4.9	39.2984120569	3	4		49.435441853	44.48846753	0.1497439121	0.9859172414		FGFR3	COC1=CC(=CC(=C1)OC)CCC2=CC(=N[NH]2)NC(=O)C3=CC=C(C=C3)N4C[C@@H](C)N[C@@H](C)C4	ChemieTek	CT-A4547	3.48127601	-1.65449396	-2.41318423	44.48846753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263199-04	NCGC00263199-04	384568659		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	870223-96-4				3.8213403399	4	4		0	-4.11326379				TEK	CNC1=NC(=CC=N1)C2=CC=CN=C2OC3=CC(=CC=C3C)C(=O)NC4=CC=CC(=C4)C(F)(F)F	SynKinase	SYN-1008	3.37517434	0.71845532	-3.18374773	-4.11326379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185997-11	NCGC00185997-11	384568433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	900515-16-4		7.9432823472	-5.1	-4.2655565161	4	4		12.5167363959	6.67660209	0.1891316517	0.9776600094		PIK3CG	OC1=CC(=CC=C1C2=CC=C(O2)\C=C\3SC(=O)NC3=O)F	MedChem Express	HY-13532	-3.34728033	-1.37703937	0.36385688	6.67660209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345805-01	NCGC00345805-01	174006676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	n	STX-0119	8.9125093813	-5.05	19.6309635801	4	4		29.319688408	26.31730908	0.0442237944	0.9987939729	6774	STAT3	O=C(NC1=NN=C(O1)C2=CC=CO2)C3=CC(=NC4=CC=CC=C34)C5=CC=CC=C5	EMD Chemicals	573126	-0.08485363	-1.09974034	1.35358701	26.31730908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345832-03	NCGC00345832-03	384568759		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	271576-80-8				0.1411118802	4	4		0	-1.48693518				MAPK14	OCC(=O)N1CCC(CC1)C2=N[NH]C(=C2C3=NC=NC=C3)C4=CC=C(Cl)C=C4	SynKinase	SYN-1078	-0.50912176	-1.16083702	4.8127538	-1.48693518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345849-02	NCGC00345849-02	377020186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	(944396-88-7)		1	-6	66.7232024742	2.4	4		38.3611233959	12.67942584	1	0.9999061054		PIK3CA	COC1=CC=C(NC2=CC(=NC(=N2)N3CCOCC3)C4=CN=C(N)N=C4)C=N1	SynKinase	SYN-1145	0.91370558	14.26607607	37.62347044	12.67942584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263209-09	NCGC00263209-09	363677266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	71203-35-5		11.220184543	-4.95	52.610583251	3	4		92.2371916726	71.44138756	0.0614225414	0.9976661818		CDC42	COC1=CC=C(C=C1)C2CC(=N/N2C3=CC=C(C=C3)[S+](N)([O-])=O)\C4=CC=CC=C4	Aobious	AOB1515	-2.56707759	1.61906217	6.63423264	71.44138756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183039-03	NCGC00183039-03	384568414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1400-61-9				-0.1677309323	4	4		0	6.30980861					C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H]1C)O2)C(O)=O	Prestwick	Prestw-517	-1.75489485	0.39712846	-0.97302079	6.30980861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346513-02	NCGC00346513-02	384568813		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	69408-81-7				-3.9482865261	4	4		0	-3.94736842				TOP2A	CN(C)CCN1C(=O)C2=C3C(=CC=C2)C=C(N)C=C3C1=O	Selleck	S1367	-0.39158811	-0.76370857	0.76662244	-3.94736842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164591-10	NCGC00164591-10	384568261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	71963-77-4				-6.6139873716	4	4		0	-1.93995381				PfATP6	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	Selleck	S2264	-1.74672489	-1.27582017	0.26923622	-1.93995381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015937-04	NCGC00015937-04	124881420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	124-20-9	SPERMIDINE;Spermidine trihydrochloride			6.2779722185	4	4	SPERMIDINE;NCGC00015937-01;Spermidine 0.1 M solution;NCGC00024903-03;NCGC00024903-02;NCGC00094332-02;NCGC00024903-01;NCGC00094332-01;N-(3-Aminopropyl)-1,4-diaminobutane;1,4-Butanediamine, N-(3-aminopropyl)-;N-(3-Aminopropyl)-1,4-butanediamine trihydrochloride;Spermidine;Spermidine Trihydrochloride;1,8-Diamino-4-azaoctane;Spermidine trihydrochloride;CIPLUS_152753;CIPLUS_173341;CIPLUS_180523;Spermidine phosphate salt hexahydrate;Spermidine Phosphate;Additive Screening Solution 30/Fluka kit no 78374;Spermidine-8-14C trihydrochloride;Spermidine solution;SPERMIDINE TRIHYDROCHLORIDE;Dispermidine triphosphate;	0	2.17914249			2903	GRIN2A	NCCCCNCCCN	BIOMOL	AC-411	0.20804438	3.89029662	2.00117716	2.17914249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242249-05	NCGC00242249-05	384568487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	405554-55-4		15.8489319246	-4.8	8.2217513147	4	4		-7.945167676	-2.03763973	0.692357009	0.5075490398		BRAF	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC4=C(C=C3)\C(CC4)=N\O)C5=CC=NC=C5	MedChem Express	HY-10966	0.56865465	3.77105381	8.09299588	-2.03763973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346584-02	NCGC00346584-02	363677465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	464-92-6				0.3777867895	4	4		0	-0.11320221					C[C@@H]1CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	Selleck	S2266	0.5963939	-0.13414816	-1.38316657	-0.11320221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167740-02	NCGC00167740-02	384568332		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	553-21-9		2.8183829313	-5.55	6.8899410122	4	4		13.474895392	9.12071535	0.0231129355	0.9996749573		TERT	CC/1=C/CC\C(=C/C2OC(=O)C(=C)C2CC1)C	APExBIO	N2333	-1.64574616	0.62864841	5.48817465	9.12071535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024929-02	NCGC00024929-02	384568036		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[133059-99-1]				-9.9110713971	4	4		0	-3.12965723				HCN	CCN(C1=CC=CC=C1)C2=CC(=[N+](C)C(=N2)C)NC	Tocris	1000	-3.93305439	0.89806915	2.6379624	-3.12965723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186046-02	NCGC00186046-02	174006990		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	55750-05-5	Caroverine hydrochloride;Spasmium; Caroverine hydrochloride			-11.734920271	4	4		0	-1.33784407				GR1A1	CCN(CC)CCN1C(=O)\C(=N/C2=CC=CC=C12)CC3=CC=C(OC)C=C3	SIGMA	C1119	-2.80373832	-3.16875461	-1.94640338	-1.33784407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356837-03	NCGC00356837-03	384569033		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1109276-89-2				6.9127029132	4	4		0	3.4906966				DGAT1	NC1=NC=NC2=C1C(=O)N(CCO2)C3=CC=C(C=C3)[C@@H]4CC[C@H](CC4)CC(O)=O	MedChem Express	HY-13009	1.42935679	0.42741341	0.5077574	3.4906966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532294-01	NCGC00532294-01	384569537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE					-22.4869847687	4	4		0	-4.81316316				HDAC1	CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC23CC4CC(CC(C4)C2)C3	NCGCChem	DYD034-032	-4.28807037	-4.70154753	-6.65726375	-4.81316316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015257-18	NCGC00015257-18	384567834		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	637-07-0				-1.1220826973	4	4		0	-2.48748896				PPARA	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1	Microsource	01503429	1.52075627	-1.45016028	-3.05115166	-2.48748896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249759-02	NCGC00249759-02	174006307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1252807-76-3	NCGC00249759-01; NCGC00249759-01	14.1253754462	-4.85	10.4659710168	4	4		15.330690996	13.49720341	0.3877954083	0.8947417639	5141	PDE4A	CC(C)(O)CCC1=CC=C(OCC2=CC3=CC=CN=C3C(=C2)C4=CC=CC(=C4)OC(F)F)C=C1	NCGCChem	PRP01-058	-0.42471571	3.61776828	-1.52557583	13.49720341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186465-06	NCGC00186465-06	384568442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1032350-13-2				-12.6753785059	4	4		0	-5.34294966				AKT1	NC1(CCC1)C2=CC=C(C=C2)C3=C(C=C/4C(=N3)\C=C/N5C(=O)N\N=C45)C6=CC=CC=C6	Axon Medchem	1684	-3.57583231	-2.97664479	3.61950344	-5.34294966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496839-01	NCGC00496839-01	384569293		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1357470-29-1		1	-6	29.8103150423	4	4		30.218454588	25.3606123	0.0648420446	0.9974009644		RET	CN1CCN(CC1)C2=CC=C(NC3=NC=C4\C=C(\C#N)C(=O)N(C5CCCC5)C4=N3)C=C2	Selleck	S8161	-3.93204549	2.82399634	27.07149267	25.3606123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183881-01	NCGC00183881-01	124894598		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	192927-63-2	Moxifloxacin hydrochloride monohydrate			4.9274888976	4	4	BAY-12-8039;MOXIFLOXACIN HCl;HS_149;Moxifloxacin Hydrochloride;MOXIFLOXACIN HYDROCHLORIDE;Moxifloxacin hydrochloride;LS-173737;CIPLUS_730447;AVELOX;CIPLUS_678948;1-CYCLOPROPYL-7-((S,S)-2,8-DIAZABICYCLO(4.3.0)NON-8-YL)-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE;moxifloxacinum;Avelox;moxifloxacine;Moxifloxacin;MOXIFLOXACIN;NCGC00095130-02;Moxifloxacin Hcl;NCGC00095130-01;	0	-0.90561766			7155	TOP2B	Cl.O.O=C(O)C2=CN(c1c(OC)c(c(F)cc1C2=O)N3C[C@@H]4CCCN[C@@H]4C3)C5CC5	Toronto Research	M745000	-0.5963939	4.57594276	5.6209535	-0.90561766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250380-10	NCGC00250380-10	377020384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	878739-06-1		14.1253754462	-4.85	-0.2048515125	4	4		13.7129760279	9.33415347	0.2877144314	0.9456815978		BRAF	CN1\C=N/C2=CC=C(NC3=CC(=CC=C3C)NC(=O)C4=CC(=CC=C4)C(C)(C)C#N)C=C2C1=O	MedChem Express	HY-11004	-1.12699285	-1.8128224	-4.34414669	9.33415347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346936-13	NCGC00346936-13	384568971		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1033769-28-6		2.8183829313	-5.55	152.0096275554	3	4		100.6226516272	-6.19713978	1	0.9994970207		NTRK1	CC1=CC=C(NC(=O)NC2=CC(=CC=C2F)C(F)(F)F)C=C1NC3=CC4=C(C=C3)C(=C/C5=CC=C[NH]5)/C(=O)N4	MedChem Express	HY-13491	6.62451897	4.61311717	91.17066291	-6.19713978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386882-01	NCGC00386882-01	384569147		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			2.8183829313	-5.55	63.0513993795	4	4		29.6298389539	33.46291866	0.2496360713	0.959525323			CN(C1CC[S+]([O-])(=O)CC1)C(=O)CNC(=O)\C=C\C2=CC(=CC=C2)Cl	Evotec	MLS003874889	7.41116751	-0.4276768	27.77532065	33.46291866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345782-02	NCGC00345782-02	384568738		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	200484-11-3				-23.162687092	4	4		0	-5.71172249				IKBKB	ClC1=CC=C(OCCCCCCN\C(NC2=CC=NC=C2)=N/C#N)C=C1	Cayman	11021	-4.74256708	-4.33786467	-5.36635707	-5.71172249												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015034-15	NCGC00015034-15	384567798		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	3544-24-9				1.7700963113	4	4		0	3.76794258				PARP1	NC(=O)C1=CC(=CC=C1)N	Selleck	S1132	-0.44960116	1.64961051	-1.5037594	3.76794258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164547-18	NCGC00164547-18	384568250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	107753-78-6				11.217156085	4	4		0	4.60526316				CYSLTR1	COC1=CC(=CC=C1CC2=C[N](C)C3=CC=C(NC(=O)OC4CCCC4)C=C23)C(=O)N[S+]([O-])(=O)C5=CC=CC=C5C	MedChem Express	HY-17492	1.92893401	3.60470444	0.47176765	4.60526316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164246-18	NCGC00164246-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	50-70-4				4.4664029636	4	4		0	0.48110938					[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO	MedChem Express	HY-B0400	1.67822469	-0.43225518	0.17657446	0.48110938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346463-01	Nesbuvir	174007343	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	691852-58-1	Nesbuvir			-6.2317462151	4	4		0	-3.16966181					CNC(=O)C1=C(OC2=CC(=C(C=C12)C3CC3)N(CCO)[S+](C)([O-])=O)C4=CC=C(F)C=C4	Chemscene	CS-0689	-1.70596394	-1.14771203	1.85403178	-3.16966181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177995-10	NCGC00177995-10	384568352		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	91296-87-6				6.3634310385	4	4		0	-0.36790717					OC(=O)\C1=C\N(C2=CC=C(F)C=C2)C3=C(C=C(F)C(=C3)N4CCNCC4)C1=O	MedChem Express	HY-B0343A	1.42857143	-0.28320167	4.56150677	-0.36790717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188690-09	NCGC00188690-09	384568451		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	150322-43-3				-10.0655529762	4	4		0	0.41728763				P2RY12	CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C3CC3)C4=CC=CC=C4F)S1	MedChem Express	HY-15284	-3.93305439	-0.56877713	0.09096422	0.41728763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164336-05	NCGC00164336-05	174006930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	51-48-9	; Thyroxine I 131; ; Levotiroxina sodica; L-Thyroxine Sodium; Synthroid; Thyroxine I 125; Thyradin; DL-Levothyroxine sodium; Sodium Dextrothyroxine; Euthroid;THYROXINE;Thyroxine (L); Thyrolar; Levoxyl; Thyroxine (L); Levothroid; Euthyral; Sodium levothyroxine; D-Thyroxine; Dextroid;LEVOTHYROXINE; L-Thyroxine Sodium Salt; L-Thyroxine sodium salt; Thyreotom; D Thyroxin; Levothyroxine; D-T4 Thyroid Hormone; Dextrotiroxina sodica; Choloxin			-0.5834513233	4	4		0	0.29806259					N[C@@H](CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O	Microsource	MS-01500774	0.52998605	-0.23948511	-2.85021225	0.29806259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015054-20	NCGC00015054-20	384567802		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	GRT00036		8.9125093813	-5.05	16.6213797515	4	4		15	12.20095694	0.0415047644	0.9989495512		ACHE	NC1=C2CCCCC2=NC3=CC=CC=C13	SIGMA	A3773	1.08774474	1.89399725	4.86510394	12.20095694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346514-07	NCGC00346514-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	859212-16-1		6.3095734448	-5.2	70.5485990668	3	4		61.068554397	57.85394933	0.055453174	0.9980991673		ABL1	CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5	Adooq	A10119	2.9846583	3.56234097	0.97028502	57.85394933												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00025219-10	NCGC00025219-10	377020478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	212844-53-6		12.5892541179	-4.9	-1.6918245086	4	4		14.5951953239	9.68703428	0.1259695926	0.9901685673		CDK1	CC(C)[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NC3=CC(=CC=C3)Cl	MedChem Express	HY-18299A	-1.92468619	-3.41266277	-2.33474833	9.68703428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345807-02	NCGC00345807-02	384568753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1173928-09-0		0.316227766	-6.5	250.4012567595	1.1	4		102.6036396486	99.68240219	0.0244310483	0.9996317116		CTSL1	OC1=CC=C(CCNC(=O)[C@H]2O[C@@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NCC4=CC=CC=C4)C=C1	EMD Chemicals	219502	16.80101824	89.26225752	101.00767033	99.68240219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386417-15	NCGC00386417-15			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1454846-35-5				-10.3962902793	4	4		0	-2.64183629					C[C@H]1OC2=C(N)N=CC(=C2)C3=C(C#N)N(C)N=C3CN(C)C(=O)C4=C1C=C(F)C=C4	DC Chemicals	DC7924	-2.4607552	-1.34412708	-1.71454354	-2.64183629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167739-08	NCGC00167739-08	384568331		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	278779-30-9		11.220184543	-4.95	43.4066137036	3	4		66.5264584547	56.11256343	0.0289236668	0.9994838289		NR14H	CC(C)C1=C(COC2=CC=C(\C=C\C3=CC=CC(=C3)C(O)=O)C(=C2)Cl)C(=NO1)C4=C(Cl)C=CC=C4Cl	MedChem Express	HY-50108	-0.65970313	0.86956522	3.63892807	56.11256343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159508-05	NCGC00159508-05	174006187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94			4.5816149576	4	4		0	6.78148547					[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	330000	-0.68719076	2.4907885	-0.67700987	6.78148547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378965-05	NCGC00378965-05	384569078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1435488-37-1		7.0794578438	-5.15	-6.230277629	4	4		-8.6782254359	-5.98185453	0.6828238318	0.5280876433		ERK5	CCOC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C5CCCC5)C3=N2)C=CC(=C1)C(=O)N6CCC(CC6)N7CCN(C)CC7	MedChem Express	HY-15665	-2.41891149	6.26381724	0.05641749	-5.98185453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346943-03	NCGC00346943-03	384568975		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1088965-37-0		12.5892541179	-4.9	21.962454545	3	4		42.001657081	36.79753657	0.1025395946	0.9934635877		CENPE	CC(C)OC1=CC=C(C=C1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)CC2=CC=C(C=C2)C3=C[N]4C=CC=C([C@H](C)O)C4=N3	Adooq	A11435	-1.60585998	0.75941677	-2.81989514	36.79753657												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090752-04	NCGC00090752-04	26752780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	65646-68-6	ST-602;NSC-374551;SYT-101;McN-R-1967; Fenretinide;Fenretinide	2.8183829313	-5.55	14.3413267322	4	4	4-HPR;NCGC00090752-03;NCGC00090752-06;NCGC00090752-05;NCGC00090752-08;LS-177208;fenretinidum;NCGC00090752-07;MCN-R-1967;MCNR196;CIPLUS_186933;4-HYDROXYPHENYLRETINAMIDE;Retinamide;NCGC00015516-01;4 Hydroxyphenylretinamid;Fenretinide, 13-cis-Isomer;N-(4-Hydroxyphenyl)retinamide;4-Hydroxyphenylretinamide;Fenretinide;Retinoic acid p-hydroxyanilide;CIPLUS_728212;fenretinide;LS-282;N-(4-Hydroxyphenyl)-trans-Retinamide;Retinamide, N-(4-hydroxyphenyl)-;Fenretinimide;13-cis-Isomer Fenretinid;MCN R 196;4-Hydroxyphenyl retinamide;Fenretinide, 13 cis Isome;N-(4-HYDROXYPHENYL)RETINAMIDE;FENRETINIDE;AB02540517-01;	-11.053855208	6.84873355	1	0.5001692003	5915	RARB	C\C1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)NC2=CC=C(O)C=C2)C(C)(C)CCC1	BIOMOL	GR103	2.64909847	13.51915338	-1.29487934	6.84873355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370984-01	NCGC00370984-01	363677978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3963				-0.4429462199	4	4		0	3.50926843			6714	SRC	COC1=CC=C(Cl)C(=C1)NC2=NC=NC3=CC(=C(OC)C=C23)OCC4CCN(C)CC4	Tocris	3963	0.15256588	-3.41332538	-1.53031195	3.50926843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017352-22	NCGC00017352-22	384567987		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	501-36-0	trans-Resveratrol;Resveratrol;RESVERATROL			-3.1396964537	4	4		0	-1.44332814			5743	PTGS2	OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O	Enzo	FR-104	-0.90152566	0.52168729	-0.17657446	-1.44332814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346493-03	NCGC00346493-03	384568800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	896466-04-9				-8.2716623396	4	4		0	-0.56631893				AURKA	O=C(NC1CC1)NC2=C[NH]N=C2C3=NC4=CC(=CC=C4[NH]3)CN5CCOCC5	Selleck	S1134_CM1	-2.0362622	-2.42478671	-1.36446331	-0.56631893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408796-01	NCGC00408796-01	384569220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1113025-87-8				-12.2224184146	4	4		0	-1.52011922				PPP2CA	CN1CCN(CC1)C(=O)[C@@H]2[C@@H]3CC[C@@H](O3)[C@@H]2C(O)=O	Glixx	GLXC-03710	-4.10041841	-2.03562341	-1.42510612	-1.52011922												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00164572-14	NCGC00164572-14	384568257		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	158681-13-1				-10.8056878496	4	4		0	-1.70690451				CNR1	CC1=C([N](N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4	MedChem Express	HY-14137	-1.86915888	-2.46131172	-4.34414669	-1.70690451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165727-10	NCGC00165727-10	377020224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-10.5974060674	4	4		0	-3.67822966				AKT1	O=C1NC2=CC=CC=C2N1C3CCN(CC3)CC4=CC=C(C=C4)C5=C(N=C6C=C7[NH]C=NC7=CC6=N5)C8=CC=CC=C8	SIGMA	A6730	-2.39303843	-1.09974034	-1.38581748	-3.67822966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506803-01	NCGC00506803-01	384569319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE					-9.506320537	4	4		0	-4.6953194				TOP1	CC[C@@]1(O)C(=O)OCC/2=C1/C=C/3N(CC4=C(CCNC(C)C)C5=CC=CC=C5N=C34)C2=O	Tocris	5125	1.63036032	-1.32804152	-4.15794197	-4.6953194												1.6E-8	8E-8	4E-7	0.000002											
NCGC00263200-02	NCGC00263200-02	377020413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	(1258296-60-4)		7.9432823472	-5.1	-0.5278028559	4	4		19.061135704	14.49808655	0.0523739836	0.9983115939		TYK2	CC1=NC(=NC(=C1)NC2=CC(=CC=N2)NC(=O)C3=C(Cl)C=CC=C3Cl)N	SynKinase	SYN-1128	-3.00041102	-3.80094642	-1.49566258	14.49808655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345834-05	NCGC00345834-05	363677378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	303162-79-0		12.5892541179	-4.9	36.0092628362	3	4		61.29271679	54.26847218	0.0737364054	0.9966325148		MAPK14	CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C	MedChem Express	HY-10456	-0.67132484	-0.35109144	-3.70924319	54.26847218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163450-06	Ilomastat (GM6001, Galardin)	384568240	MMP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	142880-36-2				-6.0599003331	4	4		0	2.28142479				MMP1	CNC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO	Selleck	S7157	-2.04137553	-0.83956648	-2.81184565	2.28142479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387189-01	NCGC00387189-01	363680564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[1057394-06-5]		12.5892541179	-4.9	11.6605676631	4	4		12.982662968	11.4617235	0.4377977093	0.8610314726		MAPK14	CC1=C(F)C=C(C=C1C2=C(F)C3=NN=C([N]3C=C2F)C(C)(C)C)C(=O)NC4CC4	Tocris	4753	-0.40221914	4.21821434	1.67745733	11.4617235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015705-13	NCGC00015705-13	384567883		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	41100-52-1				-0.0806201812	4	4		0	-4.30168388				GRIN2A	CC12CC3CC(C)(C1)CC(N)(C3)C2	APExBIO	B3308	1.26213592	0.46206588	-0.58858152	-4.30168388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167816-03	NCGC00167816-03	384568341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[349087-34-9]				-1.7236847783	4	4		0	0.804769				MAPK14	COC1=C(C=CC(=C1)SC)C(=O)N2CCC(CC2)CC3=CC=CC=C3	Tocris	2657	-2.14783821	4.52028139	0	0.804769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509932-01	NCGC00509932-01	384569382		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1234356-69-4				-9.4986275545	4	4		0	-6.7362146				FGFR1	COCCNCCC1=CC(=CC=C1)NC2=NC=C3C[C@@H](C4=CC=CC=C4F)C5=CC=CC=C5C3=N2	ChemGood	C-1033	-1.47838215	-1.19742554	0.21224985	-6.7362146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015147-04	NCGC00015147-04	124879400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	2898-76-2	Benzamil; Benzamil			-7.0689238347	4	4	NCGC00015147-02;NCGC00015147-01;BENZAMIL HYDROCHLORIDE;NCGC_Prestw-657;benzamil amiloride;NCGC00162093-01;NCGC00162093-02;NCGC00162093-03;N-(Benzylamidino)-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride;Benzamil hydrochloride;NCGC00093683-02;NCGC00093683-01;CIPLUS_685443;benzamil;BENZAMIL;N-(N-benzylamidino)-3,5-diamino-6-chloropyrazine carboxamide;	0	-2.10671998			6339	SCNN1D	N\C(NCC1=CC=CC=C1)=N/C(=O)C2=NC(=C(N)N=C2N)Cl	BIOMOL	NA-103	-2.55634964	0.60427413	0.87447109	-2.10671998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346461-02	NCGC00346461-02	384568784		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	475489-16-8		1.1220184543	-5.95	20.4108564832	4	4		16.088510172	-6.25864985	1	0.9996127453		IGFR1	NC1=NC=NC2=C1C(=CN2[C@@H]3C[C@H](CN4CCC4)C3)C5=CC(OCC6=CC=CC=C6)=CC=C5	APExBIO	A2278	-0.90709181	1.63596168	14.92242595	-6.25864985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015924-24	NCGC00015924-24	384567908		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	5985-28-4				5.1274910572	4	4		0	2.75119617				ADRA1A	CNCC(O)C1=CC=C(O)C=C1	MedChem Express	HY-N0132A	1.17476432	-0.45822514	0.56022409	2.75119617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386177-01	NCGC00386177-01	363680135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	161796-78-7				-3.1391137591	4	4		0	0.95672652					COC1=CC2=C([N-]C(=N2)[S+]([O-])CC3=NC=C(C)C(=C3C)OC)C=C1.COC4=CC5=C([N-]C(=N5)[S+]([O-])CC6=NC=C(C)C(=C6C)OC)C=C4	Selleck	S2233	-1.16454309	-0.90062586	-0.35895902	0.95672652												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015977-06	NCGC00015977-06	384567912		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	[85375-15-1]				-7.1871550853	4	4		0	-1.39829261				SLC6A1	OC(=O)C1CCCN(CCC=C(C2=CC=CC=C2)C3=CC=CC=C3)C1	Tocris	1081	-2.09617756	-1.84704625	0.71791804	-1.39829261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181129-08	NCGC00181129-08	384568391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	302962-49-8				-15.0170226948	4	4		0	-3.25287018				ABL1	CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Selleck	S1021	-2.72640088	-3.64829797	-4.39724798	-3.25287018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484067-03	NCGC00484067-03	363681159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1108743-60-7		2.5118864315	-5.6	77.6141084607	3	4		62.730764515	-3.66499853	1	0.9999914222		NTRK1	CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=N[NH]C4=C3C=C(CC5=CC(=CC(=C5)F)F)C=C4)NC6CCOCC6	Selleck	S7998	-0.36991369	0.22897268	54.20281185	-3.66499853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378324-03	NCGC00378324-03	384569047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	41451-75-6		3.1622776602	-5.5	123.1425600814	4	4		-43.657168354	-5.71671148	0.6130146927	0.9999960061		MYC	COC(=O)[C@@]12OC[C@@]34[C@@H](C[C@H]5\C(=C(\O)C(=O)C[C@]5(C)[C@H]3[C@@H](O)[C@@H]1O)C)OC(=O)[C@H](OC(=O)\C=C(/C)C(C)C)[C@@H]24	MedChem Express	HY-N0840	73.80027739	37.72544343	6.73925839	-5.71671148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185956-04	NCGC00185956-04	384568430		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	3861				3.0146807091	4	4		0	-0.73581435				EHMT2	COC1=CC2=C(NC3CCN(C)CC3)N=C(N=C2C=C1OCCCN(C)C)N4CCCN(C)CC4	Tocris	3861	0.40221914	4.27783574	-0.64743967	-0.73581435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379161-04	NCGC00379161-04	363678392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1357171-62-0		1	-6	120.3900875651	2.4	4		83.9480792287	31.72381978	1	0.9999680934		HIF1A	C(NC1=C(N=NC(=N1)C2=NC=CC=C2)C3=CC=CC=C3)C4=CC=C(C=C4)C5=CC=CC=C5	Cayman	14568	-2.66630016	28.4008843	74.21720733	31.72381978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263204-09	NCGC00263204-09	384568663		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1059105-22-4; 693228-63-6		15.8489319246	-4.8	28.0708733718	4	4		19.82510578	16.83838229	0.5198199894	0.7854654597		AURKA	CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4	Aobious	AOB87301	6.56954371	1.34119381	-3.18758815	16.83838229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386367-02	NCGC00386367-02	363680236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1536200-31-3				-8.1337765663	4	4		0	-0.26913876				LRRK2	CNC1=NC(=NC=C1C(F)(F)F)NC2=C(Cl)[N](N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4	MedChem Express	HY-12282	-1.63886875	-1.55796548	-3.80362671	-0.26913876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015437-22	NCGC00015437-22	384567844		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	49562-28-9				2.3540477711	4	4		0	4.00717703				PPARA	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2	Selleck	S1794	-1.78390138	6.72063541	-1.12044818	4.00717703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025172-03	NCGC00025172-03	384568053		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	[84088-42-6]				-5.2402511722	4	4		0	-2.8708134					CN(C1=CC=CC=C1)C(=O)C/2=C(O)/C3=C(C=CC=C3)N(C)C2=O	Tocris	1461	-0.36258158	-1.03864365	-2.06398349	-2.8708134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094872-13	NCGC00094872-13	384568138		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	94-62-2				-6.9517111718	4	4		0	-3.16966181				MAOA	O=C(\C=C\C=C\C1=CC=C2OCOC2=C1)N3CCCCC3	Microsource	01500873	-1.01248266	-1.35638694	-1.50088287	-3.16966181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345841-02	NCGC00345841-02	363677384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	(1124381-69-6)				-3.0515087669	4	4		0	0.16965927				MAP3K5	CC(C)NC1=CC(=CC2=NC(=N[N]12)NC(=O)C3=CN=CC=C3)C(F)(F)F	SynKinase	SYN-1119	-0.81536761	-0.78089113	-0.78740157	0.16965927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346615-02	NCGC00346615-02	384568859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	[1784-03-8]				-7.9287801637	4	4		0	-1.99701937				ANAPC1	COC(=O)[C@H](CCCNC(N)=N)N[S+]([O-])(=O)C1=CC=C(C)C=C1	Tocris	4506	-2.23152022	-0.44903458	-0.60642814	-1.99701937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379012-01	NCGC00379012-01	363678315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	199986-75-9		14.1253754462	-4.85	7.232648631	4	4		17.782898728	14.30700447	0.1465661545	0.9865888796		CDK1	COC1=CC=C(CNC2=C3N=C[N](C(C)C)C3=NC(=N2)N(CCO)CCO)C=C1	MedChem Express	HY-15339	-1.08786611	0.50890585	-1.48574894	14.30700447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023509-18	NCGC00023509-18	384568018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	75330-75-5				2.5674554088	4	4		0	2.09330144				HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	Selleck	S2061	0.53662074	-0.70261188	0.17691287	2.09330144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420704-02	NCGC00420704-02	384569224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE			11.220184543	-4.95	72.3948732223	3	4		99.2832535923	87.05143541	0.0182138193	0.9997953459		XIAP	C[C@@H]1CN(CC(=O)N2CC(C)(C)C3=C2C=C(CC4=CC=C(F)C=C4)C=N3)[C@H](CN1)CN5CCOC[C@H]5C	WuXi	AT-IAP	1.6968818	0.36658011	3.92156863	87.05143541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402372-02	NCGC00402372-02	384569218		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1449578-65-7				-2.3663695763	4	4		0	-6.57894737				KIF11	CCCC1=C(C)SC(=C1)C(=O)N[C@H](CC2=CC=C(N=C2)C3=CC=CC(=C3)OC(F)(F)F)C(=O)N[C@@H]4CCNC4	Glixx	GLXC-03904	1.2617839	0.36658011	-1.32684653	-6.57894737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179250-03	Halofantrine	170465140	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	36167-63-2	; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine	11.220184543	-4.95	67.3585043961	3	4		116.7285289989	89.8923445	0.0112151074	0.9999224185			Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F	Prestwick Chemical, Inc.	Prestw-1031	-1.89992748	-1.95509394	9.1404983	89.8923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386380-02	NCGC00386380-02	384569130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	865854-05-3 				-1.5828853419	4	4		0	-2.09330144				GSK3B	O=C1SN(C(=O)N1CC2=CC=CC=C2)C3=C4C=CC=CC4=CC=C3	APExBIO	B1539	0.47860769	-1.00809531	-0.76662244	-2.09330144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-15	NCGC00263152-15	384568626		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	943319-70-8		0.7943282347	-6.1	4.1438852276	4	4		-11.26479246	-5.63732705	0.0318734259	0.9993820914		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Selleck	S1490	4.5622688	0.01526485	-4.72629375	-5.63732705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244257-02	NCGC00244257-02	384568509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1056634-68-4	CYT387	12.5892541179	-4.9	30.3425766044	3	4		38.1939148349	34.39799823	0.191969922	0.9765805528	3716	JAK1	O=C(NCC#N)C1=CC=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4	NCGCChem	DYD03-070	2.91820797	-0.50373989	-3.52976369	34.39799823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024976-06	NCGC00024976-06	363676534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	124431-80-7				-3.2698585387	4	4		0	0.98616426				ADORA2A	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=C(NCCC4=CC=C(CCC(O)=O)C=C4)N=C3N	Selleck	S2153	-0.83573092	-0.10685392	-2.57253964	0.98616426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021336-14	NCGC00021336-14	384568007		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	15307-79-6				-1.6512345551	4	4		0	-1.30072105				PTGS1	[O-]C(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	Prestwick	Prestw-594	-0.37313433	3.0163834	-2.62467192	-1.30072105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015919-17	NCGC00015919-17	384567907		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	959-24-0				-6.0714654384	4	4		0	-3.56284462				ADRB1	CC(C)NCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0437	-0.34549475	-3.32261522	-0.29163021	-3.56284462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263157-02	NCGC00263157-02	384568631		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1025720-94-8				2.4986700029	4	4		0	-5.65530892				MET	CCOC\1=C(/C(=O)NC2=CC=C(OC3=C(Cl)C(=NC=C3)N)C(=C2)F)C(=O)N(\C=C1)C4=CC=C(F)C=C4	Selleck	S1561	3.3029298	-2.03644159	-0.4082823	-5.65530892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159341-17	NCGC00159341-17	384568170		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	134678-17-4				7.7711436722	4	4		0	2.03591121					NC\1=N\C(=O)N(\C=C1)[C@@H]2CS[C@H](CO)O2	MedChem Express	HY-B0250	2.83305694	0.10718114	-1.51647711	2.03591121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238454-10	NCGC00238454-10	377020194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	677338-12-4				-16.3944044396	4	4		0	-5.15648286				PIK3CA	COC1=CC=C2/C3=N/CCN3\C(=N/C2=C1OC)NC(=O)C4=CC=CN=C4	MedChem Express	HY-12030	-3.29149233	0.26942075	-3.5172832	-5.15648286												1.6E-8	8E-8	4E-7	0.000002											
NCGC00263231-01	NCGC00263231-01	137276075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	394237-61-7	PDHK RIKEN	3.1622776602	-5.5	-4.570914071	4	4		-5.7679425799	-3.13995215	0.7402409059	0.3689580892	5164	PDK2	COC1=CC=C(C=C1)C2=C(C)[NH]N=C2C3=CC=C(O)C=C3O	NCGCChem	PDHK RIKEN	-2.27701233	6.96502215	-1.82809966	-3.13995215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345792-02	NCGC00345792-02	363677355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	906673-24-3				6.491400336	4	4		0	-1.48660583				PDE4A	OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N	ChemieTek	CT-AN2728	3.41142622	0.68691803	-2.27340712	-1.48660583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250399-02	NCGC00250399-02	384568548		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	918504-65-1		2.8183829313	-5.55	29.8931744893	4	4		23.5	16.76479246	0.4176549045	0.8752698327		BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4	Selleck	S1267	2.01397452	8.8078156	8.67484296	16.76479246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476210-01	NCGC00476210-01	377020190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[839706-07-9]				-14.7303417555	4	4		0	-0.82001979				ABL1	CN1C(=O)N(CC2=CN=C(NC3=CN=C(C)C=C3)N=C12)C4=C(C)C=CC(=C4)NC(=O)C5=CC(=CC=C5)C(F)(F)F	Tocris	5607	-3.10945274	-5.22125249	-3.61621464	-0.82001979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378999-05	NCGC00378999-05	377020528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	937270-47-8		14.1253754462	-4.85	98.9137142625	4	4		-38.7829592789	-4.82861401	0.4142455154	0.8766459182		CDK1	CN1C/C=C/CCOC2=CC=CC(=C2)C3=CC=NC(=N3)NC4=CC=CC(=C4)C1	MedChem Express	HY-15166	22.48256625	27.03188145	37.50758035	-4.82861401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345845-02	NCGC00345845-02	363677388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	(936091-56-4)				-13.1380531496	4	4		0	-1.92218976				JAK2	CC1=C(NC2=CC=CC(=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC(=CC=C3)CN4CCOCC4)N=C1	SynKinase	SYN-1107	-2.6113249	-1.8128224	-5.38787024	-1.92218976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347065-03	NCGC00347065-03	363677570		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	1346528-06-0		12.5892541179	-4.9	18.3507134025	3	4		35.006871904	31.35475934	0.1182054746	0.9912920403		VCP	C1CCC2=C(C1)N=C(N=C2NCC3=CC=CC=C3)N4CCOC5=C4C=CC=C5	Bio Vision	2697	-2.08905992	1.42962417	-1.0719323	31.35475934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510167-01	NCGC00510167-01	384569412		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1702809-17-3		8.9125093813	-5.05	9.7664407772	4	4		19.4445250199	17.88277512	0.0468946848	0.9986462638		CDK12	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)N2CCC[C@H](C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=C4C=CC=C5	Glixx	GLXC-09270	-1.20377085	-0.4276768	-0.32434026	17.88277512												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165768-05	NCGC00165768-05	363676640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	516480-79-8		10	-5	48.8579758491	3	4		66.4982057365	58.82177033	0.0091496413	0.9999483774		CHEK2	NC(=O)C1=CC2=C([NH]C(=N2)C3=CC=C(OC4=CC=C(Cl)C=C4)C=C3)C=C1	MedChem Express	HY-13946	0.39158811	0.76370857	4.80613298	58.82177033												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167433-06	NCGC00167433-06	384568312		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	119302-91-9				-5.7310690855	4	4		0	1.31578947					CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C	Enzo	DL187	-2.33502538	-1.25248205	0.17691287	1.31578947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370784-05	Resiquimod	363677855	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	144875-48-9		14.1253754462	-4.85	7.3666288687	4	4		15.0845049319	11.78981454	0.1983789963	0.9751132192		TLR7	CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2[N]1CC(C)(C)O	MedChem Express	HY-13740	0.17810659	-0.56479927	-2.15375411	11.78981454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262995-02	NCGC00262995-02	384568579		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE			0.2238721139	-6.65	64.1696717419	4	4		14.5	21.17913191	0.6802885129	0.5303362489		USP2	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C(=O)NC3=NC(=CS3)C4=CC=CC=C4)C(F)(F)F	NCGCChem	RAP14-094	8.02929795	26.96371153	12.86089239	21.17913191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386361-02	NCGC00386361-02	384569128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1034616-18-6				-8.7464336142	4	4		0	-1.95108158				PLK1	CN1CCN(CC1)C2=CC=C(OC(F)(F)F)C(=C2)NC3=NC4=C(CCC5=C4[N](CCO)N=C5C(N)=O)C=N3	ChemieTek	CT-NMS128	-1.28524046	-3.6900934	-2.04141149	-1.95108158												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242497-14	NCGC00242497-14	384568500		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	879085-55-9				0.1765184897	4	4		0	-1.3289976				SHH	C[S+]([O-])(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3	Selleck	S1082	-0.12437811	-1.54647068	3.67454068	-1.3289976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387711-02	NCGC00387711-02	363680649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	1352226-88-0				-8.5818224326	4	4		0	-2.11624441				ATR	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@@+](C)([O-])=N)C4=CC=NC5=C4C=C[NH]5	MedChem Express	HY-19323	-1.53417015	-1.31716809	-3.09278351	-2.11624441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178869-11	Vidarabine	384568366	Adenosine Receptor Agonist; Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	5536-17-4				-11.4219497744	4	4		0	-4.34531543					NC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC=N1	MedChem Express	HY-B0277	-1.97991797	-0.61096686	-3.85020304	-4.34531543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096060-07	NCGC00096060-07	384568159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	3681-99-0				6.489445717	4	4		0	-0.14952153					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C=CC3=C2O/C=C(C3=O)/C4=CC=C(O)C=C4	Selleck	S2346	2.04496012	2.47441576	-0.50125313	-0.14952153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522632-01	NCGC00522632-01	384569533		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	104012-37-5				1.931553638	4	4		0	2.37105466					CC\C(C)=C\C(=O)O[C@@H]1C[C@@H](C(C)C)[C@H]2[C@@H](CC(=O)[C@H]2[C@@H](C)OC(C)=O)C1=C	Glixx	GLXC-06911	0.05634596	-0.30376671	0.32591753	2.37105466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346657-02	NCGC00346657-02	384568888		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1010085-13-8				-7.8121423057	4	4		0	1.13335296				AURKA	OC(=O)C1(CCC(CC1)OC2=C(F)C(=CC=C2)Cl)CC3=CC=CC(=N3)NC4=NC=CS4	ChemieTek	CT-MK5108	-2.09617756	-2.42711036	-2.30332037	1.13335296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475723-01	NCGC00475723-01	377020299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1169694-98-7				-1.5516407788	4	4		0	7.28584045				CDK4	CN(CCO)C1CCN(CC1)C2=CC=C(NC3=NC=C4C5=CC=NC(=C5[N](C6CCCC6)C4=N3)F)N=C2	ActiveBioChem	A-1611	-2.42498972	-2.67134789	-2.66227939	7.28584045												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00347957-09	NCGC00347957-09	363677733		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	1314241-44-5				1.3912445105	4	4		0	3.57668531				L3MBTL3	BrC1=CN=CC(=C1)C(=O)N2CCC(CC2)N3CCCC3	MedChem Express	HY-15839	-1.30154816	1.6943978	1.22644331	3.57668531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347948-15	NCGC00347948-15	384568995		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	686770-61-6				-7.3529156849	4	4		0	-2.42861348				PORCN	CC1=CC=C2N=C(NC(=O)CS\C3=N\C4=C(\SCC4)C(=O)N3C5=CC=CC=C5)SC2=C1	MedChem Express	HY-13912	-1.5755583	0.10685392	-2.27340712	-2.42861348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386423-05	NCGC00386423-05	384569136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1056901-62-2				-7.8971975939	4	4		0	-6.84292379				AKT1	NC[C@@](O)(C1=CC=C(Cl)C=C1)C2=CC=C(C=C2)C3=C[NH]N=C3	AdvChemBlocks	M15888	0.31785517	-1.73020977	-3.41207349	-6.84292379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015708-19	NCGC00015708-19	363676460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	10347-81-6		12.5892541179	-4.9	75.6189814132	3	4		106.2489885799	95.58250325	0.064314264	0.9974401639			CNCCCC12CCC(C3=CC=CC=C13)C4=C2C=CC=C4	Selleck	S2517	2.80016971	-2.68825416	-1.56414498	95.58250325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480922-01	NCGC00480922-01	377020364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1370256-78-2				-14.3252830029	4	4		0	-4.86502093				FLT3	CC1=CC=C(NC(=O)NC2=NN=C(S2)SC3=NC=NC4=CC(=CC=C34)OCCCN5CCOCC5)C=C1	Glixx	GLXC-06725	-2.2627634	-3.08538262	-3.94044217	-4.86502093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025179-20	NCGC00025179-20	384568054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	84371-65-3		5.0118723363	-5.3	16.9564067372	4	4		28.724437848	20.88927386	0.127098291	0.989933388		PGR	CC#C[C@]1(O)CC[C@H]2[C@@H]/3CCC/4=C/C(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C	MedChem Express	HY-13683	-2.68703154	2.44386742	9.29463077	20.88927386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253562-10	NCGC00253562-10	384568563		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	852808-04-9		11.220184543	-4.95	9.0443992525	4	4		31.2985156719	22.00522836	0.0656024884	0.9973423753		BCL2L1	CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)[S+]([O-])(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=C(C=CC=C5)C6=CC=C(Cl)C=C6)[N+]([O-])=O	MedChem Express	HY-50907	-2.74876306	-1.28224024	0.73342736	22.00522836												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025103-05	NCGC00025103-05	384568050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	[254753-54-3]				-2.9706122278	4	4		0	0.04613255				KIF11	CCOC(=O)C/1=C(C)/NC(=S)NC1C2=CC=CC(=C2)O	Tocris	1305	-1.3468939	2.31392778	-1.69252468	0.04613255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346620-06	NCGC00346620-06	363677481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	801312-28-7				-7.4550560118	4	4		0	-0.86220169				PDE4A	COC1=CC=CC(=C1)NC2=C(C=NC3=C(C)C=C(C=C23)[S+]([O-])(=O)C4=CC=CC(=C4)C(=O)N(C)C)C(N)=O	MedChem Express	HY-10469	-2.16931962	-1.54921021	-0.26923622	-0.86220169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378991-02	NCGC00378991-02	384569084		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	223132-38-5				8.3918613996	4	4		0	0.73903002				PPARG	C[N]1C(=NC2=CC=C(OC3=CC(=C(N)C(=C3)C)C)C=C12)COC4=CC=C(CC5SC(=O)NC5=O)C=C4	MedChem Express	HY-14792B	2.02845471	-1.79222357	5.5972793	0.73903002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346494-06	NCGC00346494-06	363677427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	141430-65-1				-6.0418120961	4	4		0	0.55427252				TUBB	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=C(NC3=CC=C(O)C=C3)N=CC=C2	MedChem Express	HY-13270	-1.07057332	-3.55407047	-1.77129092	0.55427252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346841-07	LY-411575	384568950	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	209984-57-6				-2.2013129927	4	4		0	-2.03233256				NOTCH1	C[C@H](NC(=O)[C@@H](O)C1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-50752	1.01422736	-3.25030377	-1.43120306	-2.03233256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346552-08	NCGC00346552-08	384568837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	391210-00-7				-16.821488792	4	4		0	-1.72210774				MAP2K1	OCC(O)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(=C(F)C(=C1)Br)F	MedChem Express	HY-12062	-3.98684751	-3.77041673	-3.8887227	-1.72210774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250401-11	Flavopiridol	384568550	CDK1/2/4/6/7/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	146426-40-6		0.2511886432	-6.6	27.9344771392	4	4		17.4303329199	14.20370916	0.2884600716	0.9451629059		CDK1	CN1CC[C@H]([C@@H](O)C1)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	MedChem Express	HY-10005	-1.1919441	16.8371241	12.2943464	14.20370916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015693-19	NCGC00015693-19	384567882		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	70476-82-3		14.1253754462	-4.85	-5.6256147804	4	4		11.008268264	5.68358547	0.4249126368	0.8706336647		TOP2A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	MedChem Express	HY-13502A	-1.14704256	-5.00689022	-4.9285506	5.68358547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346510-06	NCGC00346510-06	384568812		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	875337-44-3		3.5481338923	-5.45	31.0657496927	2.4	4		49.548154428	31.947452	0.2001023729	0.9744953655		MET	C[N]1C=NC(=C1)C2=CC3=NC=CC(=C3S2)OC4=CC=C(NC(=S)NC(=O)CC5=CC=CC=C5)C=C4F	MedChem Express	HY-10991	-3.79012869	8.2175042	15.91216724	31.947452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378973-06	NCGC00378973-06	384569080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	934526-89-3		14.1253754462	-4.85	21.0473659443	4	4		14.042713192	12.74722102	0.5585977943	0.7408231412		PIK3CA	COC1=CC=C(Cl)C(=C1)NC2=NC3=CC=CC=C3N=C2N[S+]([O-])(=O)C4=CC(=CC=C4)NC(=O)C(C)(C)N	MedChem Express	HY-16526	5.23264036	0.73316023	-3.36892766	12.74722102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263186-04	NCGC00263186-04	384568653		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1025065-69-3				-8.6184483719	4	4		0	-6.68399018				PIM1	CN1CCC(CC1)CNC2=N[N]3C(=NC=C3C4=CC=CC(=C4)OC(F)(F)F)C=C2	Selleck	S2198	-2.37590157	0.51932183	2.97789141	-6.68399018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387841-01	NCGC00387841-01	363680692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1404456-53-6				-3.8692256089	4	4		0	-2.81507146			8493	PPM1D	CC1=NC=C(Cl)C=C1NCC2=CC=C(S2)C(=O)NC(CC3CCCC3)C(=O)NC4CC4	ChemieTek	CT-GSK283	-1.21623533	1.49686879	0.42111596	-2.81507146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390261-01	NCGC00390261-01	384569182		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	165668-41-7				4.4975170694	4	4		0	2.69958135				CA1	N[S+]([O-])(=O)C1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC3=C2[NH]C=C3Cl	Adooq	A12325	0.28284542	1.16083702	1.35358701	2.69958135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015418-11	NCGC00015418-11	384567840		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_CPE	77-67-8				2.9232195524	4	4		0	-1.92218976					CCC1(C)CC(=O)NC1=O	Microsource	01502196	1.40186916	-1.10537951	0.78984485	-1.92218976												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345806-02	NCGC00345806-02	384568752		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	302566-08-1	Cathepsin S Inhibitor	10	-5	79.0127766803	2.1	4		121.9980153899	96.073903	0.0049105848	0.9999851273		CTSS	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)C=O	EMD Chemicals	219393_cm1	-1.26778419	-0.57715674	15.51650843	96.073903												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509910-02	NCGC00509910-02	384569377		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1532533-67-7		8.9125093813	-5.05	10.9848971221	4	4		21.8594168239	16.32024634	0.0768880726	0.996354024		CSNK1E	CC(C)OC1=C(F)C=C(C=C1)C2=N[N]([C@@H](C)C/3=C(C4=CC(=CC=C4)F)/C(=O)C5=CC(=CC=C5O3)F)C6=C2C(=NC=N6)N	MedChem Express	HY-12279	-1.54951402	0	3.92518067	16.32024634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015766-16	NCGC00015766-16	363676461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	2315-02-8				1.8492074569	4	4		0	-1.60435679				ADRA1A	CC1=CC(=C(O)C(=C1C\C2=N\CCN2)C)C(C)(C)C	Selleck	S2495	-0.5891218	4.80842619	1.70505534	-1.60435679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263280-01	NCGC00263280-01	137276088		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_CPE	932726-23-3	Ac-SAH-p53-8			0.7611026898	4	4		0	-3.42949661			3306	MDM2	CC(C)C[C@@H]1NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@](C)(CCCCCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CCNC(C)=O)[C@H](C)O	NCGCChem	Ac-SAH-p53-8	-0.06850253	5.7243169	-0.71791804	-3.42949661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350780-09	NCGC00350780-09	384569005		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	942183-80-4				-4.5041339425	4	4		0	-5.18261874				MAPK7	O=C(CN1CC[C@H](C1)C(=O)NC2=CC3=C([NH]N=C3C4=CC=NC=C4)C=C2)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	MedChem Express	HY-50846	0.05656908	0.27493508	-1.38366672	-5.18261874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181016-19	NCGC00181016-19	384568387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[153559-49-0]		12.5892541179	-4.9	46.3540226412	3	4		53.8005024241	48.00057745	0.0836404237	0.9956624096		RXRA	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C3=CC=C(C=C3)C(O)=O	Tocris	5819	3.53556781	-0.18329006	2.25597834	48.00057745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510190-02	NCGC00510190-02	384569413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1000998-59-3				-8.6541835031	4	4		0	0.12992638				PPARA	COC(=O)N(CC(O)=O)CC1=CC(=CC=C1)OCC2=C(C)OC(=N2)C3=CC=C(Cl)C=C3	MedChem Express	HY-10678	-2.14962523	-4.2156713	-0.45119567	0.12992638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509999-02	NCGC00509999-02	384569405		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1362850-20-1				-1.0240419802	4	4		0	-0.90948463				PIK3CG	[O-][N+]1=CC(=CC=C1)C2=NC3=C(Cl)C=CC=C3C=C2[C@@H](NC4=C5N=CC=CC5=NC=N4)C(F)(F)F	MedChem Express	HY-16754	0.67882902	-3.5741561	0.60159422	-0.90948463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386421-05	NCGC00386421-05	384569135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1392136-43-4				-12.1052476454	4	4		0	-3.42436678				XPO1	FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)C2=N[N](\C=C/C(=O)NNC3=CC=CC=N3)C=N2	Selleck	S7707_CM2	-3.78640777	-3.47294679	3.64920541	-3.42436678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378595-03	NCGC00378595-03	377020160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	874101-00-5				-7.2355461875	4	4		0	-1.5282298				MAP2K1	OCCONC(=O)C1=CC(=C(F)C(=C1NC2=CC=C(I)C=C2F)F)CN3OCCCC3=O	MedChem Express	HY-14719	-1.01248266	-2.36995081	-2.64861683	-1.5282298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014911-03	NCGC00014911-03	384567796		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	2222-07-3				-10.1306674231	4	4		0	-1.27244451				JAK2	CC(C)(O)\C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@]2(C)[C@@H]3C\C=C4/[C@@H](/C=C(/O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@@]12C	Cayman	14747	-0.59425097	-5.74184658	-5.22018081	-1.27244451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160163-01	NCGC00160163-01	50109897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	512-04-9				-1.3002040967	4	4	(25R)-5-Spirosten-3beta-ol;CIPLUS_153822;NCGC00160163-01;CIPLUS_3729552;Yamogenin;CIPLUS_737995;CIPLUS_679130;DIOSGENIN;sarsasapogenone;sarsasapogenone, (5alpha-25R)-isomer;NCGC00095204-01;CIPLUS_676820;Diosgenin;3beta-Hydroxy-5-spirostene;Spirost-5-en-3-ol, (3beta,25R)-;NCGC00095204-02;	0	-0.08482963			5743	PTGS2	C[C@H]1C2C(CC3C4CC=C5CC(O)CCC5(C)C4CCC23C)O[C@]16CC[C@@H](C)CO6	Prestwick Chemical, Inc.		-0.84300719	3.32261522	-2.01224847	-0.08482963												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164575-06	NCGC00164575-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	191114-48-4				-1.3880210442	4	4		0	-1.31370001					CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CN=CC=C5)C(=O)O[C@]13C)OC	Enzo	AC3258	0.50912176	-2.26057736	-0.18047827	-1.31370001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262542-10	NCGC00262542-10			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE			3.1622776602	-5.5	9.4304047281	4	4		15.736138692	1.57355276	1	0.999352258			[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C3=CC=NC4=C3C=CC=C4	SIGMA	27370	-1.55564984	-1.86344891	10.1669424	1.57355276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346501-04	NCGC00346501-04	384568806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	9041-93-4				-7.3071364393	4	4		0	-1.63202463					C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(=NC(=N1)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)N)C(O[C@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C	Adooq	A10152	-1.38047612	-1.27582017	-2.2814227	-1.63202463												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00347943-09	NCGC00347943-09	363677724		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1373422-53-7				1.3269871573	4	4		0	3.81832179				KDM6B	OC(=O)CCNC1=NC(=NC(=C1)N2CCC3=CC=CC=C3CC2)C4=NC=CC=C4	Glixx	GLXC-01837	-0.73249753	-0.91130012	1.40286241	3.81832179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482953-01	NCGC00482953-01	384569262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1040526-12-2		12.5892541179	-4.9	41.1756640805	3	4		42.253926697	40.83769633	0.1314068147	0.9892045377		TPH2	N[C@H](CC1=CC=C(C=C1)C2=NC(=NC(=C2)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)N)C(O)=O	DC Chemicals	DC9243	2.73231623	4.99329259	0.26486168	40.83769633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371125-09	NCGC00371125-09	363678041		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	487021-52-3		12.5892541179	-4.9	55.1852036916	3	4		72.811843721	68.40243385	0.1113412535	0.9922764774		GSK3A	COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1	Glixx	GLXC-11026	-0.20804438	6.15590997	0.41200706	68.40243385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378675-01	NCGC00378675-01	384569062		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[223472-31-9]				10.4947053468	4	4		0	-1.49992925				MMP1	CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)C1=CC=C(OC2=CC=CC=C2)C=C1	Tocris	2628	3.70319001	1.08809062	2.00117716	-1.49992925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344549-05	NCGC00344549-05	384568721		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	53-39-4				-7.319296573	4	4		0	-1.69803311					C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0707	-2.48266297	-0.96884782	1.38316657	-1.69803311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242498-14	NCGC00242498-14	384568501		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	301836-43-1				-7.269786178	4	4		0	-2.97155795				CSNK1A1	NC(=O)C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=NC=CC=C3)C4=CC=C5OCCOC5=C4	MedChem Express	HY-10324	-1.84466019	2.42957222	-2.91347852	-2.97155795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346648-05	NCGC00346648-05	384568879		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	942918-07-2		14.1253754462	-4.85	13.4245911397	4	4		33.6093613319	26.24063339	0.1338626346	0.9887992631		AURKB	CC[N]1C=C(C2=C3C=C([NH]C3=NC=C2)C4=CC=CC(=C4)CN(C)C)C(=N1)C5=CC=C(NC(=O)N(C)C)C=C5	MedChem Express	HY-70044	-0.84300719	-1.5158475	-4.25780111	26.24063339												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016543-13	NCGC00016543-13	384567948		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	834-28-6				-2.9278600207	4	4		0	0.05655309					NC(=N)NC(=N)NCCC1=CC=CC=C1	MedChem Express	HY-16397A	-0.89828635	-0.41341295	-0.5540974	0.05655309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263185-09	NCGC00263185-09	363677251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1110813-31-4				-20.040763687	4	4		0	-6.81464725				EGFR	COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C3C(=NC=NC3=C1)NC4=CC(=C(F)C=C4)Cl	Glixx	GLXC-90191	-3.026534	-5.28249885	-5.04520268	-6.81464725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164571-04	Dutasteride	384568256	Steroid 5alpha-Reductase Inhibitors	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE					-10.7663980651	4	4		0	-3.22352609					C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	Selleck	S1202	-1.58927584	-3.90445567	-2.24555264	-3.22352609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250390-10	NCGC00250390-10	384568543		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1045792-66-2				-3.8726866816	4	4		0	-6.72981762				HDAC6	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-18613	2.83305694	-3.44510795	-5.24934383	-6.72981762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263171-03	NCGC00263171-03	384568641		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	881202-45-5		8.9125093813	-5.05	26.8953203197	3	4		37.3650171134	34.86357731	0.0962092964	0.9942526034		MDM2	C(CC1=C[NH]C2=CC=CC=C12)NC3=CC=C(NC4=CC=NC=C4)C=C3	Selleck	S1172	0.84853627	-2.41331908	0.51135509	34.86357731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344509-02	NCGC00344509-02	384568719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE					-12.1075999162	4	4		0	-2.92532717				CASR	CC1=CC=C(C(=C1)C)C(C)(O)C2=NC3=CC=CC=C3S2	SIGMA	SML0129	-2.16931962	-3.25030377	-3.01827972	-2.92532717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522633-01	NCGC00522633-01	384569534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	26791-73-1		7.9432823472	-5.1	22.3466775193	4	4		31.416160392	28.85296382	0.0980326313	0.9940340233		NFKB1	C[C@H]1C[C@@H]2OC(=O)C(=C)[C@H]2C\C=C1\C=C\C(C)=O	Glixx	GLXC-13186	0.25355684	-2.43013366	2.62151056	28.85296382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346618-07	NCGC00346618-07	363677479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	873697-71-3				-5.1289266767	4	4		0	-3.02815905				MYH7	COC(=O)N1CCN(CC1)CC2=CC=CC(=C2F)NC(=O)NC3=CN=C(C)C=C3	Glixx	GLXC-90072	-1.12343967	-0.7899836	0.79458505	-3.02815905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181783-05	NCGC00181783-05	384568402		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	123663-49-0				-4.0691454328	4	4		0	-1.95273808			24835	NFKB1	C[S+]([O-])(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)\C(=C/O2)NC=O	MedChem Express	HY-17009	-1.42857143	-0.04471605	1.53031195	-1.95273808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507887-01	NCGC00507887-01	384569351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE					7.0168671687	4	4		0	-4.18848168				DHODH	FC(F)(F)OC1=CC=C(C=C1)C(=O)NCCC(=O)N[C@@H]2CCCC3=C2C=CC=C3	Selleck	S8382	4.84049931	-0.22358027	-2.94290759	-4.18848168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263233-01	NCGC00263233-01	137276077		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1332307-32-0	IPFK2	31.6227766017	-4.5	30.147201694	3	4		86.713372591	65.28937314	0.0524251916	0.9983013271	5208	PFKFB2	NC1=CC=C(C=C1)C(=O)C2=CC3=C([NH]2)C=CC4=CC=CC=C34	NCGCChem	IPFK2	1.06796117	-2.250708	-0.67686875	65.28937314												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263132-03	NCGC00263132-03	384568612		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	[952021-60-2]				-3.2130817922	4	4		0	-5.79669164				CHEK1	C[N]1C=C(C=N1)C2=C3\C=N/NC(=O)C4=C3C(=CC(=C4)NC(=O)[C@H](N)C5CCCCC5)[NH]2	Tocris	4277	0.59425097	0.59715204	-1.16652085	-5.79669164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263555-05	NCGC00263555-05	363677285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_CPE	1262888-28-7				-12.3071161908	4	4		0	-4.86356567				USP10	FC1=CC=C(CNC2=C3C=C(F)C=CC3=NC=N2)C=C1	Bio Vision	2037	-1.47871752	-3.47573113	-3.52872558	-4.86356567												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498432-01	NCGC00498432-01	384569299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1353550-13-6				-8.7072464977	4	4		0	-5.76006929				JAK3	CN1CCN(CC1)C2=CC=C(NC3=NC4=C(SC=C4)C(=N3)OC5=CC(=CC=C5)NC(=O)C=C)C=C2	ChemieTek	CT-HM712	-2.48903974	-0.12219337	2.91773199	-5.76006929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183878-01	NCGC00183878-01	124894594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	74711-43-6	Zaltoprofen			0.0849374153	4	4	CN 100;Zaltoprofenum;Zaltoprofen;CIPLUS_691922;CIPLUS_3889078;CN-100;Peon;10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic acid;zaltoprofenum;Zaltoprofeno;LS-61331;zaltoprofene;ZALTOPROFEN;Zaltoprofene;	0	2.20874838			5742	PTGS1	O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1	Toronto Research	Z146000	1.01824353	-2.26057736	-3.69980448	2.20874838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346549-08	NCGC00346549-08	384568834		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	857531-00-1				10.6576102289	4	4		0	4.69178577				AKT1	ClC1=CC=C(C=C1)C2(CCNCC2)C3=CC=C(C=C3)C4=C[NH]N=C4	MedChem Express	HY-12059	3.5921369	1.61906217	-4.51195669	4.69178577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510695-01	NCGC00510695-01	384569484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	1357920-84-3				-11.9338151827	4	4		0	-4.90430622				ALK	CC(C)NC(=O)[C@@H]1CC[C@@H](CC1)[N]2C(=NC3=CC=C(CN4CCC(CC4)C(C)(C)O)C=C23)NC(=O)C5=CC=C(F)C=C5	MedChem Express	HY-17603	-2.50906454	0.58041851	-2.21141088	-4.90430622												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00386681-01	NCGC00386681-01	363680394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1312815-93-2				18.3754156409	4	4		0	1.32409546				PTGES	OC[C@H]1CCC[C@@H](C1)NC(=O)C2CCN(CC2)C3=NC4=CC(=C(C=C4O3)C5=CC=C(Cl)C=C5)Cl	Axon Medchem	2020	7.04324553	0.09113001	-0.94941193	1.32409546												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161834-01	NCGC00161834-01	26755470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	51333-22-3	; Horacort; Budesonido; Pulmicort;Budesonide; Budesonide, (S)-Isomer; Rhinocort; 6   Budesonide; Budesonide, (R)-Isomer			-1.3434783206	4	4	budesonidum;budesonide;(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione;NCGC_Prestw-518;6   Budesonide;NCGC00015165-01;NCGC00015165-03;Pulmicort;Budesonidum;dexbudesonidum;budesonide sulphotransferase;NCGC00016862-01;CIPLUS_205192;CIPLUS_180950;CIPLUS_205193;Horacort;Budesonide;testosterone sulfotransferase;LS-175261;BUDESONIDE;LS-175262;NCGC00089747-02;NCGC00089747-03;Budesonido;NCGC00094860-01;NCGC00094860-02;Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-;Budesonide, (S)-Isomer;16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione;testosterone sulphotransferase;LS-7235;Budesonide, (R)-Isomer;Rhinocort;	0	-1.75463422				NRC31	[H][C@@]12CC3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)CC(O)[C@@]4([H])[C@@]2([H])CCC5=CC(=O)C=C[C@]45C	SigmaAldrich	B7777	-0.23578363	0.49187658	0.32371984	-1.75463422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498439-01	NCGC00498439-01	384569302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1627696-51-8				18.4270375632	4	4		0	9.14107825				CDK7	C[C@]1(NC(=O)C2=C1C=CC(=C2)C3=C[NH]N=C3)C4=NC=NC=C4F	ChemieTek	CT-LY3177	3.56449376	-0.7601729	4.32607416	9.14107825												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263205-02	NCGC00263205-02	384568664		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	857876-30-3		5.0118723363	-5.3	23.2216042761	4	4		13.5	14.82948918	0.0896256465	0.995056756		FLT1	CC1(C)CNC2=C1C=CC(=C2)NC(=O)C3=CC=CN=C3NCC4=CC=NC=C4	Selleck	S1032	2.39944521	1.59487256	7.00412007	14.82948918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263190-11	NCGC00263190-11	384568655		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	587871-26-9		10	-5	60.8916773887	2.4	4		90.5469878849	69.62742176	0.1382140715	0.9880317008		ATM	O=C/1\C=C(/OC(=C1)/C2=C3SC4=C(SC3=CC=C2)C=CC=C4)N5CCOCC5	MedChem Express	HY-12016	-3.20781032	6.82532555	17.5560946	69.62742176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161419-06	NCGC00161419-06	384568209		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	[82952-64-5]				-8.7490740876	4	4		0	1.60242529				DHFR	COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC	Tocris	2039	-2.80016971	-1.95509394	-2.04542036	1.60242529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-26	NCGC00015810-26	384567892		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	61-25-6, 58-74-2 [papaverine]				-8.101621942	4	4		0	-2.78619893				PDE10A	COC1=C(OC)C=C(CC2=C3C=C(OC)C(=CC3=CC=N2)OC)C=C1	Microsource	01500459	-1.52736529	-1.52741714	-1.50398556	-2.78619893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263172-10	NCGC00263172-10	384568642		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1020172-07-9		12.5892541179	-4.9	41.0894314975	3	4		44.2967710019	42.71690486	0.3727916916	0.9031722292		ABL1	CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC(=N[N]3C4=CC5=C(C=C4)N=CC=C5)C(C)(C)C)C=C2)F	Adooq	A11200_CM1	0.87682082	12.28043379	-2.37629719	42.71690486												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263097-03	NCGC00263097-03	384568588		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	288383-20-0				-7.5968772234	4	4		0	-6.48923445				FLT1	COC1=CC2=C(C=C1OCCCN3CCCC3)N=CN=C2OC4=C(F)C5=C([NH]C(=C5)C)C=C4	Selleck	S1017	0.73966642	-2.47441576	-4.15745245	-6.48923445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481319-01	NCGC00481319-01	384569254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE					-0.8102658135	4	4		0	-1.25598086				ESR1	C[C@@H]1CC2=C([NH]C3=C2C=CC=C3)[C@H](N1CC(C)(C)F)C4=C(F)C=C(\C=C\C(O)=O)C=C4F	MedChem Express	HY-12870	0.68165337	-1.03864365	-1.26787557	-1.25598086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346723-07	NCGC00346723-07	384568934		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	942425-68-5		14.1253754462	-4.85	14.0659460363	4	4		23.6300765159	19.86698741	0.1101254078	0.9924687432		CDC7	O=C1NCCC2=C1C=C([NH]2)C3=CC=NC=C3	MedChem Express	HY-13461A	-0.34674064	1.08809062	-0.94173043	19.86698741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015205-10	NCGC00015205-10	384567822		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	[85532-75-8]				0.4440674408	4	4		0	-2.91495684				NR1I3	CCC(C)N(C)C(=O)C1=NC(=C2C=CC=CC2=C1)C3=C(Cl)C=CC=C3	Tocris	0670_cm1	0.62413315	3.50275749	-2.03060624	-2.91495684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346725-06	NCGC00346725-06	363677538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	956104-40-8				1.2797344873	4	4		0	-2.06594029				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C#N)C(=C4)C(F)(F)F	MedChem Express	HY-16060	0.73509015	1.20733343	0.14714538	-2.06594029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092344-05	NCGC00092344-05	174007302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_CPE	317318-84-6	 GW-0742;GW-0742;GW-610742???			9.5175386839	4	4		0	4.50074516			5467	PPARG	CC1=CC(=CC=C1OCC(O)=O)SCC2=C(C)N=C(S2)C3=CC=C(C(=C3)F)C(F)(F)F	NCGCChem	GRB27-096	0.19525802	0.41909894	7.67131595	4.50074516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-03	NCGC00346560-03	384568840		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	3424-98-4				-1.6616993876	4	4		0	-1.1982099					CC/1=C/N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	Selleck	S1651	-0.56569085	-1.43577211	2.4063769	-1.1982099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346642-04	NCGC00346642-04	384568875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	477575-56-7		15.8489319246	-4.8	-9.4817358412	4	4		-8.0554352519	-6.71286271	0.6940295332	0.5027624684		MET	CC1=C(C(=C([NH]1)/C=C/2C(=O)NC3=C2C=C(C=C3)[S+]([O-])(=O)CC4=C(Cl)C=CC=C4Cl)C)C(=O)N5CCC[C@@H]5CN6CCCC6	Selleck	S1070	-2.0647716	-3.05483428	4.21115957	-6.71286271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015950-05	NCGC00015950-05	124881443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	264218-23-7	SB 415286;SB-415286			3.351463219	4	4	3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione;3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione;3-[(3-Chloro-4-hydroxyphenyl)- amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione;SB-415286;NCGC00025233-04;NCGC00025233-03;SB 415286;NCGC00015950-01;NCGC00025233-01;NCGC00025233-02;CIPLUS_753362;	0	-0.47639671			2932	GSK3B	OC1=C(Cl)C=C(N\C2=C(\C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1	BIOMOL	EI311	2.51732428	-0.79425691	-3.09821026	-0.47639671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510492-02	NCGC00510492-02	384569454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_CPE	1058156-90-3		14.1253754462	-4.85	1.8274139238	4	4		15.677695896	10.9571243	0.378790594	0.9001897947		FLT4	COC1=C(OCC2(N)CC2)C=C3N=CC=C(OC4=C(F)C5=C([NH]C(=C5)C)C=C4)C3=C1	Adooq	A16253	-0.65054448	-1.16083702	-5.56474658	10.9571243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024415-57	NCGC00024415-57	384568027		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_CPE	25316-40-9				-9.8231120187	4	4		0	-3.52870813				TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(=C3C2=O)O	Selleck	S1208	-1.17476432	-2.62715748	-3.36134454	-3.52870813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481653-02	NCGC00481653-02	363681127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	1608125-21-8				-10.0867692197	4	4		0	-1.50885296				PIK3CD	C[C@H](NC1=C2N=C[NH]C2=NC=N1)C3=CC4=CC=C(F)C=C4N=C3C5=NC=CC=C5	MedChem Express	HY-12948	-3.155374	-0.42527339	-0.86438997	-1.50885296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263211-04	NCGC00263211-04	384568668		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_CPE	315703-52-7				6.6319309558	4	4		0	6.49730562				ADH7	CCOC1=CC=C(NC2=NC(=CS2)C3=C(C)N=C4C=CC=C[N]34)C=C1	Chemdea	CD0243	-0.25355684	2.88578372	0.58098342	6.49730562												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345461-06	NCGC00345461-06	384568735		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1229236-86-5				-9.8895554466	4	4		0	-3.36776567				JAK2	CC1=N[NH]C(=C1)NC2=N[N]3C(=C(C)N=C3C(=C2)CN4CCOCC4)CC5=CC=C(Cl)C=C5F	APExBIO	A4147	-1.70596394	-0.28320167	-4.0317834	-3.36776567												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507873-02	NCGC00507873-02	384569345		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	1942114-09-1				-8.8363074321	4	4		0	-0.79241545				EGFR	OC1=CC=C(F)C=C1C(N2CC3=C(C=CC=C3)C2=O)C(=O)NC4=NC=CS4	Bio Vision	B1274	-2.20527046	-1.17752273	-2.56032961	-0.79241545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015049-24	NCGC00015049-24	384567801		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_CPE	520-36-5				2.8022896657	4	4		0	2.91495684				CYP2C9	OC1=CC=C(C=C1)\C2=C\C(=O)C3=C(O2)C=C(O)C=C3O	APExBIO	N1828	-0.20804438	1.47562975	0.17657446	2.91495684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601698-01	Glecaprevir			DPI_SARS-CoV-2_General		1365970-03-1				1.5301615157	4	10		0	-0.53694707					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-0.38353362	-0.33239581	2.1733572	0.84377397	2.12221938	-0.79263615	0.48580926	3.86090514	2.07108156	-0.53694707						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General		126544-47-6		0.0313708766	-7.5034733462	165.2616797936	1.2	10		52.1729736615	52.44183073	0.000766136	0.9500777613			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	-1.61084122	-0.69036052	0.02556891	-2.42904628	-1.30401432	1.5597034	-2.12221938	-0.07670672	50.29404244	52.44183073						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General		908112-43-6		0.001764114	-8.7534733462	225.3183750994	1.2	10		61.4147307983	48.18256354	0.0080999387	0.8924134492		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	1.39382345	2.32303908	4.78272752	36.86799672	27.46652091	40.09292156	54.8510522	51.2981689	66.54823722	48.18256354						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	DPI_SARS-CoV-2_General						6.9075245404	4	10		0	2.65099754					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	-0.9565455	1.28450396	0.30062859	-1.28450396	-0.5739273	-1.50314294	0.73790653	-0.08198961	-0.9565455	2.65099754						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163699-10	Fumagillin			DPI_SARS-CoV-2_General		23110-15-8				8.4703624211	4	10		0	2.1173948					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	-0.0804074	3.45751809	1.52774055	-0.61645671	-0.61645671	-0.40203699	0.29482712	2.33181453	1.84937014	2.1173948						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General						46.4694875852	4	10		0	9.11764706					CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	8.52941176	6.44385027	7.94117647	7.40641711	7.88770053	7.40641711	8.15508021	8.42245989	8.79679144	9.11764706						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General		17321-77-6		0.0279593232	-7.5534733462	287.9815830955	1.1	10		97.6874331568	87.67379679	0.0003965927	0.9592707485		SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	0.34759358	-1.14973262	0.88235294	-1.57754011	-1.20320856	-1.79144385	3.34224599	13.82352941	100.6684492	87.67379679						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015904-05	NCGC00015904-05			DPI_SARS-CoV-2_General		36791-04-5				8.8694212771	4	20		0	4.30481283					NC(=O)C1=N[N](C=N1)C2OC(CO)C(O)C2O	Bio Vision	2199																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	DPI_SARS-CoV-2_General				0.0702306445	-7.1534733462	91.6108097644	2.2	20		44.3870275995	34.92361297	0.000553797	0.8315598242			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00180626-04	Cephaeline			DPI_SARS-CoV-2_General		483-17-0		0.0006259313	-9.2034733462	12.187895929	-1.2	20		-62.8899972704	-2.27563283	7.195E-7	0.9268029241			CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O	Carbosynth	FC19891																1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					